<SEC-DOCUMENT>0001851112-24-000010.txt : 20240306
<SEC-HEADER>0001851112-24-000010.hdr.sgml : 20240306
<ACCEPTANCE-DATETIME>20240306165227
ACCESSION NUMBER:		0001851112-24-000010
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		108
CONFORMED PERIOD OF REPORT:	20231231
FILED AS OF DATE:		20240306
DATE AS OF CHANGE:		20240306

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RISKIFIED LTD.
		CENTRAL INDEX KEY:			0001851112
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		ORGANIZATION NAME:           	07 Trade & Services
		IRS NUMBER:				981342110
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40692
		FILM NUMBER:		24726687

	BUSINESS ADDRESS:	
		STREET 1:		SDEROT SHA'UL HAMELECH 37
		CITY:			TEL AVIV-YAFO
		STATE:			L3
		ZIP:			6492806
		BUSINESS PHONE:		(203) 300-9264

	MAIL ADDRESS:	
		STREET 1:		SDEROT SHA'UL HAMELECH 37
		CITY:			TEL AVIV-YAFO
		STATE:			L3
		ZIP:			6492806

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Riskified Ltd.
		DATE OF NAME CHANGE:	20210312
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>rskd-20231231.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:rskd="http://riskified.com/20231231" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>rskd-20231231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" format="ixt:fixed-false" id="f-51">FALSE</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-52">0001851112</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-53">2023</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-54">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCountry" id="f-55">US</ix:nonNumeric><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCountry" id="f-56">US</ix:nonNumeric><ix:nonNumeric contextRef="c-104" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-639">P4Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-82" decimals="INF" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" scale="0" id="f-648">.5</ix:nonFraction><ix:nonNumeric contextRef="c-6" name="us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" id="f-733">http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-742">http://riskified.com/20231231#AccruedLiabilitiesAndOtherLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" id="f-751">http://riskified.com/20231231#AccruedLiabilitiesAndOtherLiabilitiesCurrent</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="rskd-20231231.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="ilsPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:ILS</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesE1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-07-28</xbrli:startDate><xbrli:endDate>2021-07-28</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesE1ConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-07-01</xbrli:startDate><xbrli:endDate>2023-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="vote"><xbrli:measure>rskd:vote</xbrli:measure></xbrli:unit><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>rskd:segment</xbrli:measure></xbrli:unit><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelAndNonUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelAndNonUSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">rskd:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">rskd:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2013EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2013EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">rskd:A2021EmployeeSharePurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">rskd:TaxYear2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">rskd:TaxYear2042Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-01</xbrli:startDate><xbrli:endDate>2024-02-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-02-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-317"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-318"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-320"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001851112</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_1"></div><div style="min-height:45pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><span><br/></span></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">20-F</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentRegistrationStatement" format="ixt:fixed-false" id="f-2">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-3">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-5"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December 31</ix:nonNumeric>, 2023</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-6">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from           to          </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"/><td style="width:2.673%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.027%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentShellCompanyReport" format="ixt:fixed-false" id="f-7">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of event requiring this shell company report          </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commission file number <ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-8">001-40692</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-9">Riskified Ltd.</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Translation of Registrant&#8217;s name into English)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">State of <ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:edgarprovcountryen" id="f-10">Israel</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Jurisdiction of incorporation or organization)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Riskified Ltd.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-11"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-12">220 5th Avenue</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-13"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-14">2nd Floor</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-15"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-16">New York</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-17"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-18">New York</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-19"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-20">10001</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelName" id="f-21">Eido Gal</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Riskified Ltd.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine1" id="f-22"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-23">220 5th Avenue</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-24"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressAddressLine2" id="f-25">2nd Floor</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-26"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressCityOrTown" id="f-27">New York</ix:nonNumeric></ix:nonNumeric>, <ix:nonNumeric contextRef="c-2" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-28"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-29">New York</ix:nonNumeric></ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-30"><ix:nonNumeric contextRef="c-2" name="dei:EntityAddressPostalZipCode" id="f-31">10001</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Email: <ix:nonNumeric contextRef="c-2" name="dei:ContactPersonnelEmailAddress" id="f-32">ir@riskified.com</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person) </span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________________</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered or to be registered pursuant to Section 12(b) of the Act.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.856%"><tr><td style="width:1.0%"/><td style="width:38.756%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.375%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:38.758%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-33">Class A ordinary shares, no par value</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-34">RSKD</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-35">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities registered or to be registered pursuant to Section 12(g) of the Act.: None</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act: None</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of outstanding shares of each of the issuer&#8217;s classes of capital or common stock as of the close of the period covered by the annual report: As of December&#160;31, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-36">128,738,857</ix:nonFraction> Class A ordinary shares, no par value, and <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-37">49,814,864</ix:nonFraction> Class B ordinary shares, no par value, outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  Yes       </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-38">No</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this report is an annual or transition report, indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;  Yes       </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-39">No</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Note &#8211; Checking the box above will not relieve any registrant required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-40">Yes</ix:nonNumeric>       &#9744;  No</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  <ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-41">Yes</ix:nonNumeric>       &#9744;  No</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or an emerging growth company. See definition of &#8220;large accelerated filer, "accelerated filer,&#8221; and "emerging growth company" in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.827%"><tr><td style="width:1.0%"/><td style="width:19.657%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.748%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:68.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.750%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-42">Accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act.   <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-43">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8224; The term &#8220;new or revised financial accounting standard&#8221; refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the e&#64256;ectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.   <ix:nonNumeric contextRef="c-1" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="f-44"><ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-false" id="f-45">&#9744;</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.   </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="f-46"><ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-true" id="f-47">&#9746;</ix:nonNumeric></ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).   <ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtRestatementRecoveryAnalysisFlag" format="ixt:fixed-false" id="f-48">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark which basis of accounting the registrant has used to prepare the financial statements included in this filing:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:9.101%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.152%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.250%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.253%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAccountingStandard" id="f-49">U.S. GAAP</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International Financial Reporting Standards as issued by the International Accounting Standards Board</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If &#8220;Other&#8221; has been checked in response to the previous question, indicate by check mark which financial statement item the registrant has elected to follow.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;   Item 17         &#9744;   Item 18</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If this is an annual report, indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). </span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  &#9744;   Yes              </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-50">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">   No</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE PAST FIVE YEARS) </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court.</span></div><div style="margin-bottom:9pt;text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#9744;   Yes              &#9744;   No</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_7"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.076%"><tr><td style="width:1.0%"/><td style="width:91.710%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.090%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_10">ABOUT THIS ANNUAL REPORT</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_10">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_22">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_25">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_25">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_28">Item 1. Identity of Directors, Senior Management and Advisers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_28">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_31">Item 2. Offer Statistics and Expected Timetable</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_34">Item 3. Key Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_34">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_49">Item 4. Information on the Company</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_49">49</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_64">Item 4A. Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_64">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_67">Item 5. Operating and Financial Review and Prospects</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_67">67</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_100">Item 6. Directors, Senior Management and Employees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_100">86</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_121">Item 7. Major Shareholders and Related Party Transactions</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_121">110</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_133">Item 8. Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_133">115</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_136">Item 9. The Offer and Listing</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_136">116</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_139">Item 10. Additional Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_139">118</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_172">Item 11. Quantitative and Qualitative Disclosures about Market Risks</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_172">130</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_175">Item 12. Description of Securities Other than Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_175">131</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_178">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_178">131</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_181">Item 13. Defaults, Dividend Arrearages and Delinquencies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_181">131</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_184">Item 14. Material Modifications to the Rights of Security Holders and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_184">131</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_187">Item 15. Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_187">131</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_190">Item 16. [Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_190">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_193">Item 16A. Audit Committee Financial Expert</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_193">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_196">Item 16B. Code of Ethics</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_196">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_199">Item 16C. Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_199">132</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_202">Item 16D. Exemptions from the Listing Standards for Audit Committees</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_202">133</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_205">Item 16E. Purchases of Equity Securities by the Issuer and Affiliated Purchasers</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_205">133</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_208">Item 16F. Change in Registrant&#8217;s Certifying Accountant</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_208">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_211">Item 16G. Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_211">134</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_214">Item 16H. Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_214">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_217">Item 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_217">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_817">Item 16J. Insider Trading Policies</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_817">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_823">Item 16K. Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_823">135</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_220">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_220">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_223">Item 17. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_223">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_226">Item 18. Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_226">137</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_229">Item 19. Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_229">138</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_232">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_232">140</a></span></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_10"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ABOUT THIS ANNUAL REPORT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except where the context requires or where otherwise indicated in this Annual Report on Form 20-F for the fiscal year ended December&#160;31, 2023 (this &#8220;Annual Report&#8221;), the terms &#8220;Riskified,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; &#8220;our company,&#8221; and &#8220;our business&#8221; refers to Riskified Ltd. and its consolidated subsidiaries as a consolidated entity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All references in this Annual Report to &#8220;Israeli currency&#8221; and &#8220;NIS&#8221; refer to New Israeli Shekels, the terms &#8220;dollar,&#8221; &#8220;USD&#8221; or &#8220;$&#8221; refer to U.S. dollars and the terms &#8220;&#8364;&#8221; or &#8220;euro&#8221; refer to the currency introduced at the start of the third stage of the European economic and monetary union pursuant to the treaty establishing the European Community, as amended.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_13"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">BASIS OF PRESENTATION</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Presentation of Financial Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP (&#8220;GAAP&#8221;). We present our consolidated financial statements in U.S. dollars. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our fiscal year ends on December&#160;31 of each year. Our most recent fiscal year ended on December&#160;31, 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain monetary amounts, percentages and other figures included elsewhere in this Annual Report have been subject to rounding adjustments. Accordingly, figures shown as totals in certain tables or charts may not be the arithmetic aggregation of the figures that precede them, and figures expressed as percentages in the text may not total 100% or, as applicable, when aggregated may not be the arithmetic aggregation of the percentages that precede them. Certain amounts in prior periods have been reclassified to conform to the current period presentation. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certain Definitions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Annual Report, except where the context otherwise requires or where otherwise indicated:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Approval rate&#8221; is defined as GMV that has been approved divided by GMV that has been reviewed.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Billings&#8221; or &#8220;amounts billed&#8221; is defined as (1) gross amounts invoiced to our merchants and estimates for cancellations and service level agreements for transactions approved during the period plus (2) changes in estimates for cancellations and service level agreements for orders approved in prior periods. Billings excludes credits issued for chargebacks.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Chargebacks&#8221; refers to forced transaction reversals typically associated with credit and debit card transactions. Chargebacks occur when a cardholder disputes a transaction with its bank and the cardholder&#8217;s bank rules in favor of the cardholder. In such instances, funds associated with the payment are withdrawn from the merchant&#8217;s bank account resulting in a loss equal to the amount of the item that was received by the consumer. Chargebacks are meant as a consumer protection mechanism from fraudulent transactions, however, they may also incite abuse and friendly fraud. For example, friendly fraud may occur when a consumer, rather than returning an order they are dissatisfied with, instead initiates the chargeback process to avoid the complicated returns process. Friendly fraud may violate the merchant&#8217;s cancellation policies and, depending on the jurisdiction, may also be unlawful. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Consumers&#8221; refers to end-consumers who purchase goods or services from our merchants.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Merchants&#8221; refers to the businesses that purchase our products.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Performance Indicators</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Throughout this Annual Report, we provide a number of key performance indicators used by our management and often by competitors in our industry. These are discussed in more detail in the section entitled &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects&#8212;Key Performance Indicators and Non-GAAP Financial Measures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; which also includes non-GAAP financial measures and a reconciliation of our non-GAAP financial measures to the most directly comparable GAAP measure. We define these key performance indicators as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Chargebacks-to-billings ratio&#8221; or &#8220;CTB Ratio&#8221; is defined as the total amount of chargeback expenses incurred during the period indicated divided by the total amount of Billings to all of our merchants over the same period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Gross Merchandise Volume&#8221; or &#8220;GMV&#8221; is defined as the gross total dollar value of orders reviewed through our ecommerce risk intelligence platform during the period indicated, including the value of orders that we did not approve.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">&#8220;Net Dollar Retention Rate&#8221; is defined as amounts billed in the current period to the same cohort of accounts that were active in the prior comparative period. The amounts billed include any upsell and are net of contraction and attrition. We define an active account as an account that generally has (a) submitted at least one order to us for review in every month of the prior comparative period and (b) has not churned during the prior comparative period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Along with the GAAP metrics and non-GAAP financial measures described in Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects&#8221;,</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the aforementioned key performance indicators are used by management and our board of directors to assess our performance, for financial and operational decision-making, and as a means to evaluate period-to-period comparisons. These measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. These key performance indicators may not necessarily be comparable to similarly titled captions of other companies due to different methods of calculation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Reverse Share Split</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021, we effectuated a two-for-one reverse share split of our Class A ordinary shares (the &#8220;Reverse Share Split&#8221;). No fractional shares were issued in connection with the Reverse Share Split. The historical financial statements included elsewhere in this Annual Report have been adjusted retroactively for the Reverse Share Split. Unless otherwise indicated, all other share and per share data in this Annual Report has been retroactively adjusted, where applicable, to reflect the Reverse Share Split as if it had occurred at the beginning of the earliest period presented.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Additional Class B Issuance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately after the effectiveness of the Reverse Share Split, we issued and distributed Class B ordinary shares to holders of the Class A ordinary shares on a two-for-one ratio, such that each holder of Class A ordinary shares received two Class B ordinary shares for each Class A ordinary share held (the &#8220;Additional Class B Issuance&#8221;). The historical financial statements presented prior to the Reverse Share Split included elsewhere in this Annual Report have not been retroactively adjusted for the Additional Class B Issuance.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_16"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Market and Industry Data</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise indicated, information in this Annual Report concerning economic conditions, our industry, our markets and our competitive position is based on a variety of sources, including information from independent industry analysts and publications, as well as our own estimates and research.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our estimates are derived from publicly available information released by independent third-party sources, as well as data from our internal research, and are based on assumptions made by us upon </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reviewing such data and our knowledge of our industry, which we believe to be reasonable. Certain statistical data, estimates and forecasts contained elsewhere in this Annual Report have been derived from:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an independent industry report published by</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> eMarketer, titl</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ed &#8220;Global Retail eCommerce Forecast 2024&#8221; (January 2024); and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an independent industry data set published by eCommerceDB.com as of December 31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the independent industry publications or data sets relied upon by us or otherwise referred to in this Annual Report were prepared on our behalf. Although we believe the data from these third-party sources is reliable, we have not independently verified any such information, and these sources generally state that the information they contain has been obtained from sources believed to be reliable but that the accuracy and completeness of such information is not guaranteed.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Projections, assumptions and estimates of the future performance of the industry in which we operate and our future performance are necessarily subject to uncertainty and risk due to a variety of factors, including those described in </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; These and other factors could cause results to differ materially from those expressed in the estimates made by independent third parties and by us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain estimates of market opportunity and forecasts of market growth included in this Annual Report may prove to be inaccurate. The market for our products is relatively new and will experience changes over time. The estimates and forecasts in this Annual Report relating to the size of our target market, market demand and adoption, capacity to address this demand and pricing may prove to be inaccurate. The addressable market we estimate may not materialize for many years, if ever, and even if the markets in which we compete meet the size estimates in this Annual Report, our business could fail to grow at similar rates, if at all.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_19"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademarks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have proprietary rights to trademarks, service marks and trade names used in this Annual Report that are important to our business, including, among others, Riskified and the Riskified design logo. Solely for convenience, trademarks, service marks and trade names referred to in this Annual Report may appear without the &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;&#8482;&#8221; symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent possible under applicable law, our rights or the rights of the applicable licensor to these trademarks and trade names. We do not intend our use or display of other companies&#8217; trademarks, trade names or service marks to imply a relationship with, or endorsement or sponsorship of us by, any other companies. Each trademark, trade name or service mark of any other company appearing in this Annual Report is the property of its respective holder.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_22"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report contains forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. We intend such forward-looking statements to be covered by the safe harbor provisions for forward-looking statements contained in Section 27A of the U.S. Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the U.S. Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements contained in this Annual Report other than statements of historical fact, including, without limitation, statements regarding our future results of operations and financial position, growth strategy, plans and objectives of management for future operations, including, among others, expansion in new and existing markets, development and introductions of new products, capital expenditures and debt service obligations and the implementation of our share repurchase program, are forward-looking statements. The words &#8220;believe,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;estimate,&#8221; &#8220;potential,&#8221; &#8220;continue,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;expect,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;project,&#8221; &#8220;predict,&#8221; &#8220;forecasts,&#8221; &#8220;aims,&#8221; &#8220;plan,&#8221; &#8220;target,&#8221; and similar expressions are intended to identify forward-looking statements, though not all forward-looking statements use these words or expressions. These forward-looking statements are principally contained in the sections entitled Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; Item 4. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Information on the Company</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; and Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; These statements are neither promises nor guarantees, but involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to, the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to manage our growth effectively;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued use of credit and debit cards and other payment methods that expose merchants to the risk of payment fraud, and changes or proposed changes in laws and regulations, including card scheme rules, or differing interpretations or enforcement of laws or regulations related to use of these payment methods, and the emergence of new alternative payment products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our history of net losses and ability to achieve and maintain profitability;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract new merchants and retain existing merchants;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of macroeconomic conditions on us and on the performance of our merchants;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to improve our machine learning models;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">fluctuations in our CTB Ratio and gross profit margin;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect the information of our merchants and consumers;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to predict future revenue due to lengthy sales cycles;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seasonal fluctuations in revenue;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">competition;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our merchant concentration;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the financial condition of our merchants, particularly in challenging macroeconomic environments;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to increase the adoption of our products and to develop and introduce new products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to mitigate the risks involved with selling our products to large enterprises;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to retain the services of our executive officers, and other key personnel, including our co-founders;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to attract and retain highly qualified personnel, including software engineers and data scientists, particularly in Israel;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes to our prices and pricing structures;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our exposure to potential future litigation claims;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our exposure to fluctuations in currency exchange rates;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional capital;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our third-party providers of cloud-based infrastructure;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property rights;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">technology and infrastructure interruptions or performance problems;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the efficiency and accuracy of our machine learning models and access to third-party and merchant data;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to comply with evolving data protection, privacy and security laws;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">any actual or perceived failure to comply with evolving regulatory frameworks around the development and use of artificial intelligence;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully implement and use machine learning technology and artificial intelligence;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our use of open-source software;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enhance and maintain our brand;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute potential acquisitions, strategic investments, partnerships, or alliances;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential claims related to the violation of the intellectual property rights of third parties;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to comply with anti-corruption, trade compliance, and economic sanctions laws and regulations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to enforce non-compete agreements entered into with employees in certain locations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to maintain effective systems of disclosure controls and financial reporting;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to accurately estimate or judgements relating to our critical accounting policies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our business in China;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in tax laws or regulations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increasing scrutiny of, and expectations for, environmental, social and governance initiatives;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential future requirements to collect sales or other taxes;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential future changes in the taxation of international business and corporate tax reform;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in and application of insurance laws or regulations;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">conditions in Israel that may affect our operations, including the ongoing war between Israel and Hamas, as well as tension between Israel and Hezbollah on the Israel-Lebanon border;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the dual class structure of our ordinary shares;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of our share repurchases (if any);</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our status as a foreign private issuer; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other matters described in the section entitled Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;]</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in this Annual Report primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition and operating results. The outcome of the events described in these forward-looking statements is subject to risks, uncertainties and other factors described in Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and elsewhere in this Annual Report. Moreover, we operate in an evolving environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any estimates or forward-looking statements. We qualify all of our estimates and forward-looking statements by these cautionary statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we may provide information herein or on our website, or documents accessible thereby, that is not necessarily &#8220;material&#8221; under the federal securities laws for Securities and Exchange Commission (&#8220;SEC&#8221;) reporting purposes, but that is informed by various environmental, social, and governance (&#8220;ESG&#8221;) standards and frameworks (including standards for the measurement of underlying data), and the interests of various stakeholders, among other things. Much of this information is subject to assumptions, estimates or third-party information that is still evolving and subject to change. For example, our disclosures based on any standards may change due to revisions in framework requirements, availability or quality of information, changes in our business or applicable government policies, or other factors, some of which may be beyond our control.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates and forward-looking statements contained in this Annual Report speak only as of the date of this Annual Report. Except as required by applicable law, we undertake no obligation to publicly update or revise any estimates or forward-looking statements contained in this Annual Report, whether as a result of any new information, future events, or otherwise, or to reflect the occurrence of unanticipated events or otherwise. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_25"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_28"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_31"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_34"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. KEY INFORMATION</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_37"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">[Reserved]</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_40"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Capitalization and Indebtedness </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_43"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Reasons for the Offer and Use of Proceeds </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_46"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Risk Factors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should carefully consider the risks and uncertainties described below and the other information in this Annual Report before making an investment decision.  Our business, financial condition, results of operations or strategic objectives could be materially and adversely affected by any of these risks and uncertainties. The trading price and value of our Class A ordinary shares could decline due to any of these risks and uncertainties, and you may lose all or part of your investment. This Annual Report also contains forward-looking statements that involve risks and uncertainties. See &#8220;Cautionary Note Regarding Forward-Looking Statements.&#8221; Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including the risks and uncertainties faced by us described below and elsewhere in this Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Business and Industry</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have experienced substantial growth since our inception. If we fail to manage our growth effectively, then our revenues, results of operations, and financial condition may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced substantial growth in our business since inception in 2012. Our revenue was $297.6 million and $261.2 million for the years ended December&#160;31, 2023 and 2022, respectively, representing an increase of 14%. Our historical revenue growth may not be sustainable and should not be considered indicative of our future performance. Since launching our business, we have frequently expanded and enhanced our products, extended our geographic presence, and changed our pricing methodologies. This evolution and associated growth makes it difficult to evaluate our future prospects and the risks and challenges we may encounter. These risks include our ability to:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accurately forecast our revenue and plan our operating expenses;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase the number of new merchants and retain existing merchants using our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully compete with current and future competitors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully expand our business in existing markets, and enter new markets and geographies;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipate and respond to macroeconomic changes and changes in the markets in which we operate;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">successfully execute on our growth initiatives while also focusing on enhanced expense discipline and path to profitability; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accurately adjust our pricing structures for our products;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and enhance the value of our reputation and brand;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">adapt to rapidly evolving trends in the ways merchants and consumers interact with, and shop using, technology;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">accurately predict projected chargeback expenses, especially in new industry verticals, new geographies and with respect to new payment methods, or if new fraud patterns develop more quickly than our ability to detect and block those new fraud patterns;<br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">avoid interruptions or disruptions to our service;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">develop a scalable, high-performance technology infrastructure that can efficiently and reliably handle increased usage, as well as the deployment of new features and products; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">hire, integrate, and retain talented technology, sales, and other personnel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, any material decline in global ecommerce transaction volumes in the future, for whatever reason, may adversely impact our future revenues and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to address the risks and difficulties we face, including those associated with the challenges listed above as well as those described elsewhere in this &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; section, our business, financial condition, and results of operations could be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are dependent upon the continued use of credit and debit cards and other payment methods that expose our merchants to the risk of payment fraud as a primary means of payment for ecommerce transactions. Changes in laws and regulations, including card scheme rules, related to use of these types of payment methods, the emergence of alternative payment products, or the general public&#8217;s use of such alternative payment methods has, and may in the future reduce or change the use-cases for our products, and has and could continue to adversely affect our revenues, our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future success of our business depends upon the continued use of credit and debit cards and other payment methods as a primary means to pay for online purchases and conduct commercial transactions that expose our merchants to the risk of payment fraud. Federal, state or foreign government bodies or agencies have in the past adopted, and may in the future adopt, laws or regulations affecting the use of such payment methods, including with respect to card-not-present transactions. In addition, card schemes such as Visa, Mastercard and American Express, impose rules and other requirements on participants in the payment chain. Changes in these laws, regulations or card scheme rules and terms and conditions of other payment providers could require us to modify our products in order to comply with these changes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the adoption, implementation and evolution of laws, regulations or card scheme rules that operate to reduce fraudulent transactions, shift liability for certain transactions away from merchants and on to other participants in the payments chain, or route transactions through networks or payments rails with different chargeback rules may adversely affect the use-cases and demand for our products, our business, financial condition, and results of operations or require us to make changes to our business and strategies. In addition, to the extent the performance of strong factor authentication protocols, such as 3D Secure, improves over time, or merchant risk profiles or consumer preferences shift over time, we may begin to see merchants electing to voluntarily adopt similar protocols with respect to online transaction volume. The adoption of 3D Secure or other strong factor authentication protocols that reduce online payment fraud, or shift the liability for online payment fraud away from the merchant, may reduce the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">demand or use-cases for our products, reduce the GMV available for us to review, and could adversely affect our revenues, our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we depend upon the general public&#8217;s continued willingness to use credit cards and other payment methods that expose our merchants to the risk of payment fraud as a primary means to pay for online purchases and conduct commercial transactions. While we are able to review and guarantee transactions completed using alternative ecommerce payment methods, such as Apple Pay, Google Pay and Paypal, the increased availability of, and adoption by our merchants and by the general public of these and other alternative payment methods (such as &#8220;buy now pay later&#8221; services, cryptocurrencies or &#8220;digital wallet&#8221; style products or real time payments, including those offered by large &#8220;traditional&#8221; financial institutions with large customer bases), which may be less susceptible to fraud, include native fraud management features, sit outside of the broader chargebacks regime or allow liability for online transactions to be shifted away from merchants, may reduce the attractiveness or use-cases of our products, reduce demand for our products and the GMV available for us to review, and may adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a history of net losses and there are no assurances that we will achieve profitability in the future. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not been profitable since our inception in 2012 and have incurred significant net losses in prior years, including net losses of $59.0 million and $104.7 million for the years ended December&#160;31, 2023 and 2022, respectively. While we have implemented certain cost reduction measures, we anticipate that our non-GAAP operating expenses may increase modestly over the next several years as we continue to strategically hire, expand our partnerships, operations, and infrastructure, continue to expand and enhance our products, and increase our spending on sales and marketing. In addition, our ability to achieve </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and maintain </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">profitability will depend, in part, on our ability to effectively manage and decrease our chargeback expenses, which is dependent on our ability to improve the accuracy of our products. The accuracy of our products is, in part, driven by the amount of information we are able to obtain from processing transactions. In addition, higher rates of inflation in the U.S. and globally, and demand for high-tech personnel in Israel, have impacted, and may continue to impact our costs of labor and the prices at which we are able to acquire goods and services from third-party vendors on which we rely. In many instances, we are not able to increase the prices at which we sell our products and services to offset these higher costs, either partially or at all. We intend to continue enhancing our existing products and may develop and introduce new products through internal research and development, and we may also selectively pursue acquisitions. These efforts may prove more expensive than we currently anticipate. If our revenue declines, or fails to grow at a rate sufficient to offset increases in our operating expenses, we may continue to generate losses and not be able to achieve and maintain profitability in future periods. In addition, our increased focus on expense discipline</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, dilution management, capital allocation initiatives,</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and path to profitability may require us to reduce the resources we can allocate to growth initiatives, which may in turn result in slower than anticipated revenue growth. We cannot assure you that we will become profitable, or that if we do become profitable, we will be able to sustain profitability.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to attract new merchants, retain existing merchants or increase sales of our products to existing merchants, our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth is dependent on our ability to continue attracting new merchants while retaining existing merchants and expanding and enhancing the products we sell to them. In particular, if we are not able to attract new merchants and increase the amount of transactions we process within our existing merchant network, we may not be able to continue to improve our products. Growth in the demand for our products may also be inhibited, and we may be unable to grow our merchant base for a number of reasons, including, but not limited to:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our failure to develop or offer new or enhanced products in a timely manner that are comparable with, or superior to, new technologies or competitor offerings, and that meet the evolving needs of our merchants and changes in the regulatory environment in which we operate; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties providing high quality support or maintaining a high level of merchant satisfaction, which could reduce demand for our products if existing merchants terminate their relationship with us or stop referring prospective merchants to us; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increases in our merchant churn rates, including churn of significant merchants from whom we derive a significant percent of our revenue, which may occur for various reasons including, but not limited to, corporate reorganizations, mergers and acquisitions or bankruptcies affecting our merchant base;<br/> </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perceived or actual security, availability, integrity, privacy, reliability, quality, or compatibility problems with our products, including related to unscheduled downtime, outages, or network security breaches; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued or increased competition in our industry, including greater marketing efforts or investments by our competitors in advertising and promoting their brands or in product development.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends, in part, on our ability to sell additional products to our existing merchants. If our merchants do not purchase additional products from us, or do not renew their agreements upon expiration, our business, financial condition, and results of operations may be adversely affected. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our merchant expansions and renewals may decline or fluctuate as a result of a number of factors, including merchant usage, merchant satisfaction with our products and ecommerce risk intelligence platform capabilities and merchant support, our prices, the prices of competing products, corporate reorganizations, mergers and acquisitions or bankruptcies affecting our merchant base, consolidation of affiliates&#8217; multiple paid business accounts into a single paid business account, the effects of global economic conditions, including recession and inflation, or reductions in our merchants&#8217; spending levels generally. These factors may be exacerbated if, consistent with our growth strategy, our merchant base continues to grow to encompass large online enterprises.    </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our revenue is impacted, to a significant extent, by macroeconomic conditions and the financial performance of our merchants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, the ecommerce retail sector, and our merchants&#8217; businesses are sensitive to macroeconomic conditions. Economic factors, such as interest rates, inflation, currency exchange rates, changes in monetary and related policies, market volatility, consumer confidence, recession or recessionary indicators, supply chain issues, unemployment rates, shifts in consumer spending patterns (for example, between goods and services), and real wages, are among the most significant factors that impact consumer spending behavior. Weak economic conditions or a significant deterioration in economic conditions, including prolonged recession with sustained high interest rates and unemployment rates, may reduce the amount of disposable income available to consumers, which, in turn, reduces consumer spending and merchant transaction volumes. This has had, and may continue to have an adverse effect on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In particular, there are certain industries, including the luxury goods industry, that are particularly susceptible to recession and other macroeconomic conditions, such as inflation, that may reduce consumer discretionary spending. Similarly, external macroeconomic factors and business conditions including global supply chain disruptions, such as those experienced in many industries in </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recent years, have resulted in</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and may in the future result in shortages of raw products and prolonged shipping and delivery times for consumer goods. This may in turn lead to decreased ecommerce transaction volumes as consumers instead opt to purchase stock-on-hand from bricks-and-mortar retailers, rather than </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transact through digital channels. Any reduction in our merchants&#8217; transaction volume directly impacts the revenue we derive from them and, if such reduction continues for a prolonged period, would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to review transactions for fraud, and the fees due to us associated with providing such products, depends upon sales of products and services by our merchants. Certain of our merchants&#8217; sales have and may in the future decrease or fail to increase at rates consistent with prior performance, current expectations, or at all, as a result of factors outside of their control, such as the macroeconomic conditions referenced above, or business conditions affecting a particular industry vertical or region. For example, we continued to see softness in certain industry verticals, including &#8220;Fashion &amp; Luxury&#8221;, &#8220;Home&#8221; and &#8220;General Retail&#8221; throughout 2023, which we believe is partially attributable to a slowdown in consumer discretionary spending as a result of macroeconomic pressures. In our experience, weak economic conditions can also extend the length of our merchants&#8217; sales cycles, and cause consumers to delay making (or not make) purchases of our merchants&#8217; products and services. Even in the absence of macroeconomic factors, the performance of our merchants directly impacts our business, and, as a result, if the sales volume and financial performance of a merchant is negatively impacted for reasons specific to such merchant, our revenues will be negatively impacted. </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a reduction in online engagement </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">generally</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or for any of our individual merchants, including due to a general decrease in online spending or a decreased demand for any of our merchants&#8217; products or services for any reason could lead to a decrease in our merchants&#8217; ecommerce revenues, which, in turn, would harm our revenues or reduce the attractiveness of our products.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to continue to improve our machine learning models or if our machine learning models contain errors or are otherwise ineffective, our growth prospects, business, financial condition, and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are based on our machine learning models and our ability to attract new merchants, retain existing merchants, or increase sales of our products to existing merchants will depend in large part on our ability to maintain a high degree of accuracy and automation in our automated decisioning process. Maintaining or improving the level of accuracy in our automated decisioning process in turn allows us to maintain or improve approval rates for our merchants over time. If our machine learning models fail to accurately detect fraud, detect fraud quickly enough or correctly categorize new risks relating to fraud, or if any of the other components of our automated decisioning process fail, we will typically experience higher than forecasted chargebacks, which in turn puts downward pressure on our gross margins, and may impact our ability to attract new merchants, retain existing merchants or increase sales of our products to existing merchants and our business, financial condition, and results of operations may be adversely affected. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our machine learning models are designed to analyze data attributes to identify complex transaction and behavior patterns, which enables us to detect fraud and illegitimate consumers quickly and accurately. Our ability to accurately detect fraud even as methods of committing fraud evolve and become more sophisticated is dependent on our ability to continuously improve and train these models. However, it is possible that our machine learning models may prove to be less accurate than we expect, or than they have been in the past, for a variety of reasons, including inaccurate assumptions or other errors made in building or training such models, incorrect interpretations of the results of such models, increased fraud sophistication beyond the capabilities of our machine learning models, and failure to timely update model assumptions and paramet</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ers. For example, in the third quarter of 2023, one of our merchants experienced a significant fraud event. In this instance, our machine learning models were not able to effectively block the relevant fraudulent transactions. In addition, because we had not correctly predicted the scope of the fraud event, the overall risk level in the merchant&#8217;s account was underrepresented at the time the event occurred. The combination of these factors meant that we were unable to mitigate the effects of the fraud event quickly enough, which impacted our quarterly gross profit. In addition, our machine learning models may initially be less accurate following expansion into new industry verticals, geographic regions and use-cases, such as review of automated clearing house (&#8220;ACH&#8221;) payments or covering non-fraud related chargebacks. Further, the successful performance of our machine learning </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">models relies on the ability to constantly review and process large amounts of transactions and other data. If we are unable to attract new merchants, retain existing merchants or increase sales of our products to existing merchants, or if our merchants do not provide us with access to a signific</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ant volume of their transaction data or if the number of transactions processed by our existing merchants declines, the amount of data reviewed and processed by our machine learning models will be reduced or may fail to grow at a pace that will allow us to continue to improve the efficiency of our machine learning models, which may reduce the accuracy of such models. Additionally, such models may not be able to effectively account for matters that are inherently difficult to predict or are otherwise beyond our control, such as social engineering and other methods of perpetrating fraud that do not lend themselves well to risk-based analysis. Material errors or inaccuracies in such machine learning models could lead us to make inaccurate or sub-optimal operational or strategic decisions, which could adversely affect our business, financial condition and results of operations. Our inability to train our models or develop new technology that can detect new fraud schemes may also result in significant chargeback expenses, which would materially and adversely impact our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The data gathering for, and development of, our machine learning models have </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">predominantly</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> occurred during a period of sustained economic growth, and our machine learning models have not been extensively tested during a down-cycle economy or recession. For example, consumer spending patterns, transaction volumes and fraud patterns experienced during a down-cycle economy or recession may differ from those experienced during periods of sustained economic growth. There is no assurance that our machine learning models can continue to accurately detect fraud under adverse economic conditions. If our machine learning models are unable to accurately detect fraud under such economic conditions, the performance of our product may be worse than anticipated and we may be required to issue a significant amount of credits as a result of valid chargebacks, which would adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our CTB Ratio and gross profit margin have historically fluctuated from quarter-to-quarter and we expect that to continue. These metrics are managed, and should be analyzed, on an annual basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CTB Ratio and gross profit margin are managed, and are best analyzed, on an annual basis. Historically, our CTB Ratio and gross profit margin have fluctuated between periods, and we expect that these financial metrics will continue to fluctuate between periods in the future, based on a number of factors, including changes in the mix of our merchant industry base, our entry into new geographies and industries, shifts from credit and debit cards towards alternate payment methods, the risk profile of orders approved in the period, technological improvements in the performance of our models, seasonality, large-scale merchant fraud events or security incidents, expansion into other use-cases and other factors. For example, our CTB Ratio and gross profit margins are sometimes negatively impacted in the first several quarters following the onboarding of merchants in new industry verticals or geographic regions, as our machine learning models adapt to the unique fraud patterns and other characteristics associated with transaction volume in those industries or regions. Model performance will generally normalize over time as our machine learning models gather more data and their accuracy improves. We believe that similar trends will continue to affect our future quarterly performance. In addition, order populations in certain industry verticals or geographic regions may be more or less risky. For example, historically &#8220;tickets and travel&#8221; has been a higher-risk, lower-margin industry, while other industry verticals, such as &#8220;electronics&#8221; and &#8220;fashion, cosmetics and luxury goods&#8221; have been lower-risk, higher-margin industries. Any change in our merchant industry mix between periods is likely to impact our CTB Ratio and gross profit margin between periods. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products enable the collection and storage of personal, confidential or proprietary information of our merchants and their consumers, and security concerns could result in liability to us or inhibit sales of our products. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conducting our business, we rely heavily on computer systems, hardware, software, technology infrastructure and online websites and networks (collectively, &#8220;IT Systems&#8221;), including those of third-party service providers, for both internal and external operations. Our operations involve the storage, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transmission and processing of our merchants&#8217; and their consumers&#8217; confidential proprietary data, which can include personal information. Because we make extensive use of third-party suppliers and service providers, successful cyberattacks against such third parties&#8217; IT Systems can also materially impact our operations and financial results. While we have developed systems and processes to protect our IT Systems and the integrity, confidentiality, availability and security of such data, our security measures or those of our third-party service providers, including, but not limited to, the third-party providers of cloud-based infrastructure, or Public Cloud Providers, have in the past and could in the future result in unauthorized access to or disclosure, modification, misuse, loss or destruction of such data. Any security breaches, computer malware, ransomware or extortion based attack, exploited hardware or software bugs, distributed denial-of-service (&#8220;DDoS&#8221;) attacks, misconfigurations or similar vulnerabilities experienced by us or by our third-party service providers, including from diverse threat actors, such as state-sponsored organizations, opportunistic hackers and hacktivists, could expose us to a risk of loss of personal, confidential or proprietary information, operational disruptions, loss of business, severe reputational damage adversely affecting merchant or investor confidence, regulatory investigations and orders, litigation (including class action lawsuits), indemnity obligations, damages for contract breach, fines and penalties for violation of applicable laws or regulations, and significant costs for remediation and incentives offered to merchants or other business partners in an effort to maintain business relationships after a breach, and other liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly experience and expect to continue to experience actual and attempted cyber-attacks </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our IT </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Systems</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, such as through phishing scams and ransomware. </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in the aftermath of Hamas&#8217; attack on Israel on October 7, 2023, many Israeli websites reported a significant increase in DDoS attacks. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although none of these actual or attempted cyber-attacks to date, individually or in the aggregate, has had a material adverse impact on our operations or financial condition, we cannot guarantee that such incidents will not have such an impact in the future. Cyberattacks and other malicious Internet-based activity continue to increase generally. If our products or security measures are perceived as weak or are actually compromised as a result of third-party action, employee or merchant error, malfeasance, stolen or fraudulently-obtained log-in credentials, or otherwise, our merchants may curtail or stop using our products, our reputation could be damaged, our business may be adversely affected, and we could incur significant liability. Further, because our products and services are integrated with our customers&#8217; systems and processes, any circumvention, disruption or failure of our cybersecurity defenses or measures could compromise the confidentiality, integrity, and availability of our customers&#8217; own IT Systems and/or our customers&#8217; proprietary or other sensitive information which could result in legal claims or proceedings (such as class actions), regulatory investigations and enforcement actions, fines and penalties, negative reputational impacts that cause us to lose existing or future customers, and/or significant incident response, system restoration or remediation and future compliance costs. We may be unable to anticipate or prevent techniques used to obtain unauthorized access to or to sabotage systems because threat actors are becoming increasingly sophisticated in using techniques and tools &#8211; including artificial intelligence &#8211; that change frequently, may remove forensic evidence and generally are not detected until after an incident has occurred. As adoption of our products by merchants continues to increase and our brand becomes more widely known and recognized, we may become more of a target for third parties seeking to compromise our security systems or gain unauthorized access to our merchants&#8217; data. Moreover, if a high-profile security breach occurs with respect to another cloud platform provider, our merchants and potential merchant customers may lose trust in the security of cloud platforms generally, which could adversely impact our ability to retain existing merchants or attract new ones. While we continue to implement controls and plans for preventative actions to further strengthen our IT Systems against future attacks, we cannot ensure that such measures will be fully implemented and complied with, provide adequate security, that we will be able to react in a timely manner, or that our remediation efforts following past or future attacks will be successful.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are not able to detect activity on our ecommerce risk intelligence platform that might be nefarious in nature or if we are not able to design processes or systems to reduce the impact of similar activity on a platform of a third-party service provider, our merchants could suffer harm. In such cases, we could face exposure to legal claims, particularly if a merchant suffers actual harm. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There can be no assurance that our cybersecurity risk management program and processes, including our policies, controls or procedures, will be fully implemented, complied with or effective in protecting our systems and information. Any adverse impact to the availability, integrity or confidentiality of our IT Systems may result in significant incident response, system restoration or remediation and future compliance costs. We cannot assure you that any limitation of liability provisions in our contracts for a security lapse or breach would be enforceable, adequate or would otherwise protect us from any liabilities or damages with respect to any particular claim related to such lapse or breach. We also cannot be sure that our existing insurance coverage will continue to be available on acceptable terms or will be available in sufficient amounts to cover one or more large claims related to a security breach, or that the insurer will not deny coverage as to any future claim. Our existing general liability and cyber liability insurance policies may not cover, or may cover only a portion of, any potential claims related to security lapses or breaches to which we are exposed or may not be adequate to indemnify us for all or any portion of liabilities that may be imposed. We also cannot be certain that our existing insurance coverage will continue to be available on economically reasonable terms or in amounts sufficient to cover the potentially significant losses that may result from a security incident or breach, which could therefore have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Lengthy sales cycles with large enterprises make it difficult to predict our future revenue and may cause variability in our operating results.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sales cycle can vary substantially from merchant to merchant, but with large enterprises it typically requires 25 to 55 weeks on average from the time we designate a merchant as a sales qualified lead to execution of an agreement with that merchant. Our ability to forecast revenue accurately is affected by our ability to forecast new merchant acquisitions. Lengthy sales cycles make it difficult to predict the quarter in which revenue from a new merchant may first be recognized. If we overestimate new merchant growth in a particular period or generally, our revenue will not grow as quickly as our forecasts, our costs and expenses may continue to exceed our revenue, and our results of operations will be adversely affected. In addition, we may not meet or may be required to revise guidance that we have provided to the public, if any. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we plan our operating budget, including sales and marketing expenses, and our hiring needs, in part, based on our forecasts of new merchant growth and future sales. If new merchant growth or sales for a particular period is lower than expected, we may not be able to proportionately reduce our operating expenses for that period, which could harm our operating results for that period. Delays in our sales cycles could cause significant variability in our revenue and operating results for any particular period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have experienced in the past, and expect to continue to experience, seasonal fluctuations in our revenues. If we fail to accommodate increased volumes during peak seasons and events, our business, financial condition, and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is seasonal in nature and our GMV and revenues are typically highest in the calendar fourth quarter. Our revenue is directly correlated with the level of revenue that our merchants generate, and our merchants typically generate the most revenue in the calendar fourth quarter, which includes Black Friday, Cyber Monday, the holiday season, and other peak events included in the ecommerce calendar, such as Chinese Singles&#8217; Day and Thanksgiving. Our gross profit margin typically follows a similar trend. For the years ended December&#160;31, 2023 and 2022, calendar fourth quarter revenue represented approximately 28% and 30% of our total revenues, respectively. As a result, our revenue will typically decline in the calendar first quarter of each year relative to the calendar fourth quarter of the previous year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any service disruption affecting our products, especially during the calendar fourth quarter, could have a negative effect on our operating results. Surges in volumes during peak periods may strain our technological infrastructure and merchant support activities, which may reduce our revenue and the attractiveness of our products. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any disruption to our operations or the operations of our merchants during the calendar fourth quarter could lead to a material decrease in revenues relative to our expectations for the calendar fourth quarter, which could in turn result in a significant shortfall in revenue, results of operations and operating cash flows for the full year.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive industry. Competition presents an ongoing challenge to the success of our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in a highly competitive industry, and we expect competition to continue to increase. With the introduction of new technologies and the entry of new competitors into the market, including risk scoring companies that provide non-guaranteed decisions, typically at a lower price point, we expect competition to persist and intensify in the future. This could harm our ability to attract new merchants, increase sales, maintain or increase renewals, and maintain or increase our prices. We believe that our ability to compete depends upon many factors both within and beyond our control, including the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the size of our merchant base;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and market acceptance of products, including the developments and enhancements to those products, offered by us or our competitors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the quality of our products and our merchant service and support efforts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our selling and marketing efforts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our continued ability to develop technology to support our business model;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our continued ability to develop and implement new products to meet evolving merchant needs, use-cases and regulatory requirements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our continued ability to expand into and localize our products in new geographies and new industry verticals in a timely manner;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the pricing structures and pricing practices employed by our competitors; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our brand strength relative to our competitors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of our existing and potential competitors could have substantial competitive advantages, such as greater name recognition, longer operating histories, larger sales and marketing budgets, greater merchant support resources, lower labor and development costs, larger and more mature intellectual property portfolios and significantly greater financial, technical, marketing and other resources. Further, in addition to fraud detection and prevention, certain of our competitors may offer a more comprehensive portfolio of products and services, which may make them more attractive to potential merchants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors may engage in more extensive research and development efforts, undertake more far-reaching marketing campaigns and adopt more aggressive pricing policies which may allow them to attract merchants. Our competitors may develop products that are similar to our products or that achieve greater market acceptance than our products, which could attract merchants away from our products and reduce our market share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if one or more of our competitors were to merge or partner with another of our competitors, our ability to compete effectively could be adversely affected. Our competitors may also establish or strengthen cooperative relationships with our current or future strategic distribution and technology partners or other parties with whom we have relationships (i.e. channel partners), thereby limiting our ability to promote and implement our ecommerce risk intelligence platform. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These competitive pressures in our market, or our failure to compete effectively, may result in price reductions, lower transaction volumes, reduced revenue and gross profit margins, increased net losses, </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">merchant-churn and loss of market share. Any failure to meet and address these factors may adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a substantial merchant concentration, with a limited number of merchants accounting for a substantial portion of our revenues. The loss of a significant merchant would materially and negatively affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our revenues from a few significant merchants, each of which operates in the ecommerce retail sector. For the three years ended December&#160;31, 2023, 2022 and 2021, our three largest merchants in the aggregate accounted for 28%, 25% and 30% of our revenues, respectively. In addition, our five largest merchants in aggregate accounted for approximately 38%, 34% and 39% of our revenues for the years ended December&#160;31, 2023, 2022 and 2021, respectively. If any of these merchants experience declining or delayed sales or other business interruptions due to market, economic, or competitive conditions, the fees we receive from such merchant will decline proportionally. Further, because the retail sector, where most of our major merchants operate, is generally susceptible to macroeconomic factors, we too are susceptible to macroeconomic factors. See &#8220;Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors-Risks Relating to our Business and Industry-Our revenue is impacted, to a significant extent, by macroeconomic conditions and the financial performance of our merchants.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; In addition, we could be pressured to reduce our prices, make other contractual concessions or we could experience a decline in the demand for our products, any of which could negatively affect our business, financial condition, and results of operations. If any of our five largest merchants terminate their relationships with us, become subject to bankruptcy proceedings, or otherwise cease operating, such termination, bankruptcy or cessation of operations would materially negatively affect our business, financial condition, and results of operations. Furthermore, if any of our largest merchants terminate their relationships with us, or if these merchants experience declining or delayed ecommerce sales or other business interruptions, our estimates and forecasts relating to the size and expected growth of our market and our revenues may prove to be inaccurate.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The risk of losing merchants as a result of bankruptcies may be higher due to challenging macroeconomic conditions (including a recession), and could materially and negatively affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past had, and may in the future have, merchants, including significant merchants, whose financial condition deteriorates significantly, or who become subject to bankruptcy proceedings. In particular, merchants who are highly leveraged, operate on narrow margins, or are otherwise susceptible to changes in economic, competitive and market conditions, may be at an increased risk of bankruptcy in a recessionary environment. In addition to a reduction in these merchants&#8217; ecommerce sales volumes, possibly to zero, we are not always able to recover amounts due to us from these merchants, which can have a material adverse impact on our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to develop enhancements to our products, increase adoption and usage of our products, and introduce new products and capabilities that achieve market acceptance, our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to attract new merchants and increase revenue from existing merchants depends on numerous factors, including our ability to enhance and improve our existing products, increase adoption and usage of our products, and introduce new products and capabilities. In particular, if we are not able to develop technology that is able to keep pace with new and increasingly complex fraud schemes or that is able to solve new or different problems for our merchants, we may not be able to achieve a return on investment that satisfies our merchants. The success of any enhancements or new products depends on several factors, including timely completion, adequate quality testing, introduction to the market, and market acceptance. Any products we develop may not be introduced in a timely or cost-effective manner (or at all), may contain errors or defects, or may not achieve the broad market acceptance necessary to generate sufficient revenue. If we are unable to successfully enhance our existing products to meet </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">merchant requirements, increase adoption and usage of our products, or develop new products, our business, financial condition, and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to continue to increase the sales of our products to large enterprises while mitigating the risks associated with serving such merchants, our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth strategy is dependent, in large part, upon the continued increase of sales to large enterprises. For the year ended December 31, 2023, we estimate that more than 90% of our Billings were derived from merchants generating over $75 million in online sales per year. Sales to large enterprises involve risks that may not be present or that are present to a lesser extent with sales to smaller entities, such as longer sales cycles, more complex merchant requirements, substantial upfront sales costs, and less predictability in completing some of our sales. For example, large enterprises may require considerable time to evaluate and test our applications and those of our competitors prior to making a purchase decision and placing an order. A number of factors influence the length and variability of our sales cycle, including the need to educate potential merchants about the uses and benefits of our products, the discretionary nature of purchasing and budget cycles, and the competitive nature of evaluation and purchasing approval processes. As a result, the length of our sales cycle may vary significantly from merchant to merchant, and sales to large enterprises typically take longer to complete. Moreover, large enterprises often request pilot periods or begin by deploying our products on a limited basis, but nevertheless require configuration, integration services, and pricing negotiations, which increase our upfront investment in the sales effort with no guarantee that these merchants will deploy our products widely enough across their organization to justify the substantial upfront investment. Our ability to improve our sales to such large enterprises is also partially dependent on our ability to continue to attract, train and retain sales personnel with experience selling to large enterprises, and competition for such personnel can be intense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as security breaches with respect to larger, high-profile enterprises are likely to be heavily publicized, there is an increased reputational risk associated with serving such merchants. If we are unable to continue to increase sales of our products to large enterprises while mitigating the risks associated with serving such merchants, our business, financial condition, and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of the services of any of our executive leadership team, including our co-founders, who are also our Chief Executive Officer and Chief Technology Officer, could materially and adversely affect our revenues, our results of operations and financial condition. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and future growth depend largely upon the continued services of our executive officers and other key employees in the areas of research and development, marketing, business development, sales, products, and general administrative functions. In particular, the experiences of Eido Gal, our co-founder and Chief Executive Officer, and Assaf Feldman, our co-founder and Chief Technology Officer, are valuable assets to us. Mr. Gal and Mr. Feldman both have significant experience in developing automated risk and identity products and developing robust systems with machine learning algorithms and intelligent UIs for risk management applications and would be difficult to replace. Competition for senior executives in our industry is intense, and we may not be able to attract and retain qualified personnel to replace or succeed Mr. Gal, Mr. Feldman or other key executives. Failure to retain Mr. Gal, Mr. Feldman or other key executives would have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, executive leadership transition periods are often difficult as the new executives gain more detailed knowledge of our operations, and friction can result from changes in strategy and management style. Management turnover inherently causes some loss of institutional knowledge, which can negatively affect strategy and execution.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to attract and retain executives and employees that we need to support our operations and growth, our revenues, our results of operations and financial condition may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To execute our growth plan, we must attract and retain highly qualified personnel. Competition for these personnel is intense, especially for software engineers experienced in designing and developing software as a service (&#8220;SaaS&#8221;) applications and experienced sales professionals. Competition for talent in Israel has in the past been and remains intense. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors &#8213; Risks Relating to our Incorporation and Location in Israel &#8212; Due to competition for highly skilled personnel in Israel, we may fail to attract, recruit, retain and develop qualified employees, which could materially and adversely impact our business, financial condition and results of operations.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; If we are unable to attract such personnel remotely or in cities or countries where we are located, we may need to hire in other locations which may add to the complexity and costs of our business operations. In particular, we </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recently established</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a research and development hub in </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portugal</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in order to enhance and expand our talent pool and to help rationalize our labor costs. There can be no guarantee that we will be successful in </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">continuing to hire</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in this region, that we will be successful in integrating our research and development teams across locations, or that such initiative will lead to meaningful </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and sustainable </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">cost savings. From time to time, we have experienced, and we expect to continue to experience, difficulty in hiring and retaining employees with appropriate qualifications. Many of the companies with which we compete for experienced personnel have greater resources than we have. If we hire employees from competitors or other companies, their former employers may attempt to assert that these employees or we have breached their legal obligations, resulting in a diversion of our time and resources.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, prospective and existing employees often consider the value of the equity awards they receive in connection with their employment, in addition to their cash compensation. The market price of our stock has experienced significant volatility. Significant declines in the value of our stock, has, and may in the future, impact our ability to compensate employees appropriately and to attract and retain talent. If the total compensation, including the amount or value of equity awards offered to employees is perceived to be less favorable than total compensation or equity awards offered by other companies with whom we compete for talent, or the perceived value of our equity awards declines, experiences significant volatility, or increases such that prospective employees believe that they are not being fairly compensated or that there is limited upside to the value of the Company&#8217;s equity awards, it may adversely affect our ability to recruit and retain key employees. If we fail to attract new personnel or fail to retain and motivate our current personnel, our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of continued stock price volatility in the future, we may determine that it is necessary to grant equity awards to our employees, outside of ordinary ranges, to recalibrate total compensation and help recruit and retain talent. Existing shareholders may experience significant dilution of their ownership interests as a result of such grants.</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need to change our prices and pricing structure from</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> time to time, which may negatively impact our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically charge our merchants a percentage of the value of the transactions that we  approve. The fee we charge our merchants is a risk-adjusted price (based on a variety of factors including historical fraud levels, approval rate commitment, industry vertical and geographic region), which is expressed as a percentage of the GMV dollars that we approve. We expect we may need to change our pricing model from time to time, including as a response to updates or enhancements to our product suite, and in response to changes in global economic conditions or reductions in our merchants&#8217; spending levels generally. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through our Chargeback Guarantee product, we provide a Chargeback Guarantee to our merchants for transactions that our ecommerce risk intelligence platform approves that are subsequently determined to be fraudulent and for which a valid chargeback reimbursement request is received by our merchant. Pursuant to our Chargeback Guarantee, we may be required to issue a significant amount of credits to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">merchants. The credit issued via the invoice we provide to our merchants generally equates to the approved transaction amount, which exceeds the fee we charge for the associated transaction. This business model requires us to accurately predict the amount of credits we expect to issue in order to determine the appropriate pricing structure for our products, and failure to do so may negatively affect our financial condition. While chargebacks are intended as a consumer protection mechanism from fraudulent transactions, they are also susceptible to abuse and &#8220;friendly fraud&#8221;. For example, friendly fraud may occur when a consumer, rather than returning an order they are dissatisfied with, instead initiates the chargeback process to avoid a complicated returns process. Friendly fraud may violate the merchant&#8217;s cancellation policies and, depending on the jurisdiction, may also be unlawful. Nevertheless, to the extent a chargeback reimbursement request is received by our merchants, even in instances of friendly fraud or other chargeback abuse, we may be required to issue significant credits to our merchants in respect of these transactions. While we employ a variety of strategies to minimize our exposure to friendly fraud and other chargeback abuses, it is often difficult to differentiate friendly fraud and other chargeback abuses from &#8220;true&#8221; fraud. Any increase in chargeback abuse, including friendly fraud, may impact the our ability to accurately predict the amount of credits we expect to issue in order to determine the appropriate pricing structure for our products, which could negatively impact our business operations and financial performance.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similarly, as we introduce new products, or as a result of the evolution of our existing products, including reviewing ACH payments and covering non-fraud related chargebacks, and as the methods and techniques used to perpetrate fraud evolve, we may have difficulty determining the appropriate pricing structure for our products.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as new and existing competitors introduce new products that compete with ours, or revise their pricing structures, we may be unable to attract new merchants or retain existing merchants at the same price, or based on the same pricing model as we have used historically. Moreover, as we continue to target selling our products to large enterprises, these large enterprises may demand substantial price concessions. As a result, we may be required, from time to time, to revise our pricing structure or reduce our prices, which could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been subject to securities class-action litigation and may be subject to similar or other litigation in the future, all of which will require significant management attention, could result in significant legal expenses and may result in unfavorable outcomes, all or any of which could adversely affect our operating results, harm our reputation or otherwise negatively impact our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have been, and may in the future become, subject to litigation or claims arising in or outside the ordinary course of business that could negatively affect our business operations and financial condition, including securities class actions and shareholder derivative actions, both of which are typically expensive to defend. For example, in May 2022, a putative securities class action complaint was filed in federal court in the United States by certain of our shareholders against us, certain of our current and former officers and directors, and our underwriters alleging violations of the Securities Act in connection with our IPO-related disclosures, and seeking unspecified damages. On June 2, 2023, the Court granted our motion to dismiss the complaint in its entirety, with prejudice.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The outcome of any litigation, regardless of its merits, is inherently uncertain. Any claims and lawsuits, and the disposition of such claims and lawsuits, could be time-consuming and expensive to resolve, divert management attention and resources, cause reputational harm, and lead to attempts on the part of other parties to pursue similar claims. Any adverse determination related to litigation could adversely affect our operating results, harm our reputation or otherwise negatively impact our business. In addition, depending on the nature and timing of any such dispute, a resolution of a legal matter could materially affect our future operating results, our cash flows or both.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are exposed to fluctuations in currency exchange rates, which could negatively affect our operating results.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A majority of our merchant agreements and partner and services contracts are denominated in U.S. dollars, and therefore substantially all of our revenue transactions are not subject to foreign currency risk as the U.S. dollar is also the functional currency of our consolidated subsidiaries. However, an increasing portion of our revenue is denominated in foreign currencies, in particular the Euro ("EUR"). A weakening of foreign currencies against the U.S. dollar will negatively affect our revenues. In addition, an increasing portion of our operating expenses are denominated in foreign currencies and are subject to fluctuations due to changes in foreign currency exchange rates. In particular, any strengthening of the New Israeli Shekels, or NIS, against the U.S. dollar will result in increasing costs. While we have robust hedging programs in place, if we are not able to successfully hedge against these risks in the future, our operating results could be adversely affected. For discussion of the impact of fluctuations in foreign currency exchange rates on our business, see Item 11. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk-Foreign Currency Exchange Risk</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need additional capital, and we cannot be sure that additional financing will be available on favorable terms, if at all.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have funded our operations and capital expenditures primarily through equity issuances and cash generated from our operations. Although we currently anticipate that our available funds and cash flow from operations will be sufficient to meet our cash needs for the foreseeable future, we may require additional financing and we may not be able to obtain such financing on favorable terms, or at all. Our ability to obtain financing will depend on, among other things, our development efforts, business plans, operating performance and the condition of capital markets at the time we seek financing. In addition, various macroeconomic factors, such as the increasingly high U.S. national debt and sustained high interest rates, can reduce the availability of, or increase the price at which we can access additional capital. If we raise additional funds through the issuance of equity, equity-linked, or convertible debt securities, to fund operations or on an opportunistic basis, those securities may have rights, preferences, or privileges senior to the rights of our Class A ordinary shares, or may require us to agree to restrictive covenants or unfavorable terms, and our existing shareholders may experience significant dilution of their ownership interests. Any debt financing we may secure in the future could involve restrictive covenants that may impose significant operating and financial restrictions on us, and may limit our ability to engage in acts that may be in our long-term best interest, including restrictions on our ability to incur indebtedness, incur liens, enter into mergers or consolidations, dispose of assets, pay dividends, make acquisitions and make investments, loans and advances. These restrictions may affect our ability to grow in accordance with our strategy, limit our ability to raise additional debt or equity financing to operate our business, including during economic or business downturns, and limit our ability to compete effectively or take advantage of new business opportunities. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business growth, scale our infrastructure, develop product enhancements, and respond to business challenges could be significantly impaired, and our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In deploying our SaaS products, we rely upon third-party providers of cloud-based infrastructure, or Public Cloud Providers, such as Amazon Web Services. In addition, many of our merchants utilize those same Public Cloud Providers. Any disruption in the operations of Public Cloud Providers or interference with our use of Public Cloud Providers would adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We outsource substantially all of the infrastructure relating to our cloud offerings to Public Cloud Providers, such as Amazon Web Services. Merchants of our cloud-based SaaS products need to be able to access our ecommerce risk intelligence platform at any time, without interruption or degradation of performance, and we provide them with service level commitments with respect to uptime. Our cloud-based SaaS products depend on protecting the virtual cloud infrastructure hosted by Public Cloud Providers by maintaining its configuration, architecture, features and interconnection specifications, as well as maintaining the information stored in these virtual data centers and transmitted by third-party internet service providers. While our Public Cloud Providers typically have robust backup and disaster </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recovery plans and processes in place, any incident affecting our Public Cloud Providers&#8217; infrastructure that may be caused by fire, flood, severe storm, earthquake or other natural disasters, viruses, cyberattacks, terrorist or other attacks, and other similar events beyond our control could negatively affect our cloud-based SaaS products. Certain of these events may become more frequent or severe as a result of climate change. Climate change may also result in certain chronic changes to the physical environment, such as changes to temperature/precipitation patterns or sea-level rise, which may adversely impact the infrastructure we rely on or otherwise adversely impact our operations. A prolonged service disruption affecting our cloud-based offerings for any of the foregoing reasons would negatively impact our ability to serve our merchants and could damage our reputation with current and potential merchants, expose us to liability, cause us to lose merchants or otherwise have an adverse effect on our business, financial condition, and results of operations. We may also incur significant costs for using alternative equipment or taking other actions in preparation for, or in reaction to, events that damage the Public Cloud Provider services we use.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that our service agreements with our Public Cloud Providers are terminated, or there is a lapse of service, elimination of services or features that we utilize, interruption of internet service provider connectivity or damage to such facilities, we could experience interruptions in access to our ecommerce risk intelligence platform as well as significant delays and additional expenses in arranging or creating new facilities and services and/or re-architecting our cloud offering for deployment on a different cloud infrastructure service provider, which may adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any failure to protect our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on a combination of trademark, trade secret, copyright and other intellectual property laws as well as contractual provisions, such as confidentiality clauses, to establish and protect our proprietary technology, our brand and other intellectual property. While it is our policy to protect and defend our intellectual property, our efforts may be inadequate to prevent unauthorized use of our intellectual property rights. We will not be able to protect our intellectual property if we are unable to secure or enforce our rights or if we do not detect unauthorized use of our intellectual property. In addition, defending our intellectual property rights may entail significant expense. Any patents, trademarks, or other intellectual property rights that we obtain may be challenged by others or invalidated through administrative process or litigation. We do not currently have any patents or pending patent applications; however, in the future, we may seek patent protection for our technology, which protection we may not be able to obtain or maintain. In addition, any patents we obtain in the future may not issue with the scope of the claims we seek or may not provide us with meaningful protections or competitive advantages, or may be successfully challenged, invalidated, or circumvented by third parties. Furthermore, legal standards relating to the validity, enforceability and scope of protection of intellectual property rights are uncertain, particularly in certain foreign countries in which we do business, such as China. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have chosen not to register any copyrights, and instead rely primarily on trade secret protection to protect our proprietary software. While we also own unregistered copyrights in our software, copyrights must be registered before bringing a copyright infringement lawsuit in the United States. Because we have chosen not to register our copyrights, the remedies and damages available to us for unauthorized use of software may be limited. Despite our efforts to maintain our source code and certain other technologies as trade secrets, it may still be possible for unauthorized third parties to copy our products and ecommerce risk intelligence platform capabilities and use information that we regard as proprietary to create products that compete with ours. Further, effective patent, trademark, copyright and trade secret protection may not be available to us in every country in which our products are or may become available, or our attempts to register intellectual property rights may be challenged or rejected. The laws of some foreign countries, such as China, may not be as protective of intellectual property rights as those in the United States, and mechanisms for enforcement of intellectual property rights may be inadequate. As we expand our international activities, our exposure to unauthorized copying and use of our products and platform capabilities and proprietary information will likely increase. Accordingly, despite </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our efforts, we may be unable to prevent third parties from infringing upon or misappropriating our intellectual property. Third parties, including former employees, may also breach duties of confidentiality to us. Further, we may be unable to prevent competitors from acquiring trademarks or domain names that are similar to or diminish the value of our intellectual property. We are and may become party to certain agreements that may limit our trademark rights in certain jurisdictions; our ability to use our existing trademarks in new business lines in the future may be limited.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into confidentiality and invention assignment agreements with our employees and consultants and enter into confidentiality agreements with other parties. We also attempt to protect our proprietary technologies by implementing administrative, technical and physical practices, including source code access controls, to secure our proprietary information. However, no assurance can be given that these agreements or practices will be effective in controlling access to and distribution of our proprietary information. Further, these agreements and practices may not prevent our competitors from independently developing technologies that are substantially equivalent or superior to our products and ecommerce risk intelligence platform capabilities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In relation to the field of artificial intelligence and machine learning, there is uncertainty and ongoing litigation in different jurisdictions as to the degree and extent of protection warranted for artificial intelligence and machine learning systems, including as to materials that were created by artificial intelligence technologies. If we fail to protect our intellectual property rights adequately, including with respect to any artificial intelligence or machine learning technologies, our competitors may gain access to our technology and our business, financial condition, and results of operations may be adversely affected. Additionally, we may use artificial intelligence tools, including tools provided by third parties, to develop or assist in the development of our own software code.  While use of such tools makes our development process more efficient, artificial intelligence tools have sometimes generated content that is &#8220;substantially similar&#8221; to proprietary or open source code on which the artificial intelligence tool was trained. If such artificial intelligence tools generate code that is too similar to other proprietary code, or to software processes that are protected by patent, we could be subject to intellectual property infringement claims. Further, we may be unable to recover any or all defense costs or damages as a result of infringement claims from the third-party providers of such artificial intelligence tools. If the artificial intelligence tools we use generate code that is too similar to open source code, we risk losing protection of our own proprietary code that is commingled with such code. In addition, we may experience difficulties in enforcing the intellectual property rights in code generated by artificial intelligence tools. The United States Copyright Office has previously denied copyright protection for images generated by artificial intelligence tools, and the United States Patent and Trademark Office has similarly stated that an artificial intelligence tool cannot be an &#8220;inventor&#8221; of a patent, rendering it impossible to obtain patent protection for inventions created solely by artificial intelligence tools. Finally, the terms of use of any third-party artificial intelligence tools may state that the third-party provider retains rights in the generated code.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be required to spend significant resources in order to monitor and protect our intellectual property rights. Litigation may be necessary in the future to enforce our intellectual property rights and to protect our trade secrets. Such litigation could be costly, time-consuming, and distracting to management. Further, our efforts to enforce our intellectual property rights may be met with defenses, counterclaims, and countersuits attacking the ownership, scope, validity and enforceability of our intellectual property rights, which could result in the impairment or loss of portions of our intellectual property. Our inability to protect our proprietary technology against unauthorized copying or use, as well as any costly litigation or diversion of our management&#8217;s attention and resources, could delay further sales or the implementation of our products and ecommerce risk intelligence platform capabilities, impair the functionality of our products and platform capabilities, delay development and introductions of new products, result in our substituting inferior or more costly technologies into our products, or injure our reputation. Any of the foregoing could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interruptions or performance problems associated with our technology and infrastructure may adversely affect our revenues, our results of operations and financial condition.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our continued growth depends in part on the ability of our existing and potential merchants to access our products and ecommerce risk intelligence platform capabilities at any time and within an acceptable amount of time. Interruptions in our products or performance problems, for whatever reason, could undermine our merchants&#8217; confidence in our products and cause us to lose merchants or make it more difficult to attract new ones. We have experienced, and may in the future experience, disruptions, outages, and other performance problems due to a variety of factors, including infrastructure changes, introductions of new functionality, human or software errors, capacity constraints due to an overwhelming number of users accessing our products and platform capabilities simultaneously, DDoS attacks, or other security-related incidents or attacks. It may become increasingly difficult to maintain and improve our performance, especially during peak usage times and as our products and platform capabilities become more complex and our user traffic increases. If our products and platform capabilities are unavailable or if our merchants are unable to access our products and platform capabilities within a reasonable amount of time or at all, our revenues, our results of operations and financial condition may be adversely affected. We provide credits to our merchants for consumer transactions that our platform approves that are subsequently determined to be fraudulent and for which our merchants receive a chargeback. Any performance malfunction in our platform could result in us approving fraudulent consumer transactions in excess of anticipated levels and, to the extent chargebacks are received by our merchants, require us to issue a significant amount of credits to merchants. Issuing a significant amount of credits or refunds to merchants would negatively impact our financial position. To the extent that we do not effectively address capacity constraints, upgrade our systems as needed, and continually develop our technology and network architecture to accommodate actual and anticipated changes in technology, this may cause merchants to terminate their agreements with us, impair our ability to grow our merchant base, subject us to financial liabilities and our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our proprietary machine learning models rely in part on the use of our merchants&#8217; data and other third-party data, and if we lose the ability to use such data, if our merchants fail to collect such data, if there are disruptions in our ability to access such data, or if such data contain inaccuracies, our business could be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on our proprietary machine learning models, which are statistical models built using a variety of data-sets. Our machine learning models rely on a wide variety of data sources, including data collected from our merchants as part of our automated decisioning process and in some cases data collected from third parties. Under our agreements with certain merchants, we receive licenses to use data collected directly from those merchants&#8217; consumers&#8217; internet browsers. Such licenses may impose restrictions on how such data may be used, including, for example, restrictions on the collection or use of data from certain jurisdictions. If we are unable to access and use data collected from our merchants or their consumers as part of our automated decisioning process, or other third-party data used in our machine learning models, or our access to such data is limited, for example, due to new or changing laws, regulations or policies of third parties, commercial disputes, or access disruptions to third-party data sources due to DDoS attacks, or other security-related incidents or attacks impacting those third-party data sources, our ability to accurately evaluate potential transactions, detect fraud and verify consumers&#8217; data would be compromised. In addition, technology strategies employed by certain merchants, including &#8220;headless commerce&#8221;, which refers to the decoupling of a merchant&#8217;s front-end customer experience technology from their back-end ecommerce platform, may result in the fragmentation of consumer data points across sources. If our merchants are unable to capture all the data points from their consumers that our machine learning models require, the accuracy of our machine learning models may be affected, or we may not be able to do business with merchants employing this, or similar, technology strategies. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third-party data sources on which we rely include Maxmind, Ekata and Emailage. The data received from these third-parties is used by our machine learning models, including to evaluate transactions for potential fraud. Data collected from our merchants as part of our automated decisioning process and other information that we receive from third parties may not accurately detect fraud for a variety of reasons, including errors or inconsistencies in the information collected, changing methods of perpetrating </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">fraud or lack of available information upon which to make a decision. For example, if the information provided by a merchant is inaccurate, it may cause us to inaccurately link a legitimate order with other fraudulent orders.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if third-party data used to train and improve our machine learning models is inaccurate, or access to such third-party data is limited or becomes unavailable to us, our ability to continue to improve our machine learning models would be adversely affected. Although we believe that there are commercially reasonable alternatives to the third-party data we currently license available, this may not always be the case, or it may be difficult or costly to migrate to other third-party data. Our use of additional or alternative third-party data would require us to enter into license agreements with third parties. In addition, integration of the third-party data used in our machine learning models with new third-party data may require significant work and require substantial investment of our time and resources. Additionally, we may not be able to obtain third party data sets required to support new or alternate payment methods. Any of the foregoing could negatively impact our product offerings and our relationships with our merchants, impair our ability to grow our merchant base, subject us to financial liabilities and our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with continuously evolving privacy laws and regulations, including laws and regulations governing processing of personal information, including payment card data, and our actual or perceived failure to comply with such laws and regulations may result in significant liability, negative publicity, and/or erosion of trust and could have an adverse effect on our revenues, our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our third-party service providers are subject to federal, state, and international laws relating to the collection, use, storage, disclosure, retention, security, transfer and other processing of personal data, and consumer information, including payment card data, as such terms are commonly understood. The regulatory framework worldwide for privacy and security, particularly as they relate to the use of data in artificial intelligence and machine learning is rapidly evolving and as a result implementation standards and enforcement practices are likely to remain uncertain for the foreseeable future. We publicly post documentation regarding our data processing practices. Although we endeavor to ensure that our public statements are complete, accurate and fully implemented, we may at times fail to do so or be alleged to have failed to do so. We may be subject to potential regulatory or other legal action if such policies or statements are found to be deceptive, unfair or misrepresentative of our actual practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Complying with these data, data protection, privacy or security laws, regulations, or industry standards has required and may continue to require us to incur substantial operational costs and Company resources. Because the interpretation and application of many privacy and data protection laws and contractually imposed industry standards are uncertain, it is possible that these laws may be inconsistent or conflicting with each other or interpreted and applied in a manner that is inconsistent with our existing data management practices or the features of our products and ecommerce risk intelligence platform capabilities. If so, in addition to the possibility of fines, lawsuits, and other claims and penalties, we could be required to fundamentally change our business activities and practices or modify our products and platform capabilities, which could have an adverse effect on our revenues, our results of operations and financial condition. Any inability to adequately address privacy and security concerns, even if unfounded, or comply with applicable privacy and data security laws, regulations, policies, industry standards, or social expectations of corporate fairness, could result in additional cost and liability to us, damage our reputation, inhibit sales, and adversely affect our revenues, our results of operations and financial condition. Furthermore, the costs of compliance with, and other burdens imposed by, the laws, regulations, and policies that are applicable to the businesses of our merchants may limit the use and adoption of, and reduce the overall demand for, our products. Privacy and data security concerns, whether valid or not valid, may inhibit market adoption of our products, particularly in certain industries and foreign countries. If we are not able to adjust to changing laws, regulations, and standards related to the Internet, our business, financial condition and results of operations may be adversely affected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">United States</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, risks of actual or perceived non-compliance include enforcement actions under federal and state laws, rules and regulations. In addition, privacy advocates and industry groups have approved, and may propose and approve in the future, self-regulatory standards with which we must comply or that contractually apply to us. If we fail to follow applicable security standards even if no consumer information is compromised, we may incur significant fines or experience a significant increase in costs or reputational damage.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. state laws in this area are complex and developing rapidly. Many state legislatures have adopted legislation that regulates how businesses operate online, including measures relating to privacy, data security and data breaches. Laws in all 50 states require businesses to provide notice to consumers whose personal information has been disclosed as a result of a data breach. The laws are not consistent, and compliance in the event of a widespread data breach is costly. States are also constantly amending existing laws, requiring attention to frequently changing regulatory requirements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The California Consumer Privacy Act, or the CCPA, among other things, gives California residents rights over their personal information, provides for civil penalties for violations (as well as a private right of action certain for data breaches) and establishes a dedicated California privacy regulator, the California Privacy Protection Agency. Following the enactment of the CCPA, comprehensive privacy statutes that share similarities with the CCPA have been enacted or are being considered in a number of states. Any failure or perceived failure by us to comply with these laws could result in proceedings or actions against us.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws demonstrate a trend toward more stringent privacy legislation in the United States, which could increase our potential liability and adversely affect our revenues, our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">European Economic Area, United Kingdom and Israel</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The European Economic Area&#8217;s (&#8220;EEA&#8221;) data protection landscape is evolving, resulting in possible significant and operational costs for internal compliance and risks to our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The General Data Protection Regulation 2016/679 (the &#8220;GDPR&#8221;), and the UK Data Protection Act 2018 and the UK General Data Protection Regulation (together the &#8220;UK GDPR&#8221;), impose robust obligations on controllers and processors for the processing of personal data. Failure to comply with these obligations can result in significant fines and other liability under applicable law. In particular, since we are under the supervision of relevant data protection authorities in both the EEA and the United Kingdom, we may be fined under both the GDPR and UK GDPR in respect of the same breach. Additional enforcement action may be taken, such as enforcement notices, assessment notices (for a compulsory audit), orders to cease/change our data processing activities. Further adverse consequences of an infringement of the GDPR or the UK GDPR may include civil claims for material and immaterial damages from the affected individuals. Implementing legislation of individual Member States also provides for criminal sanctions for specific violations, which may also entail the loss of any profits realized as a result of infringements of the GDPR or the UK GDPR. Finally, in addition to these regulatory risks, any infringement of such legislation could lead to reputational risk and significantly undermine customers&#8217; trust in our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is currently complexity and uncertainty regarding transfers of personal data from the EEA to countries outside the EEA. We expect this complexity and uncertainty, and enhanced scrutiny by regulators, to continue and we cannot guarantee the ongoing efficacy and longevity of our data transfer mechanisms (including the European Commission&#8217;s standard contractual clauses, or SCCs). These recent developments may require us to review and amend the legal mechanisms by which we transfer personal data from the EEA and the United Kingdom. As supervisory authorities issue further guidance on personal data export mechanisms, including circumstances where the SCCs cannot be used, and/or take enforcement action, we could suffer additional costs, complaints and/or regulatory investigations or fines, and/or if we are otherwise unable to transfer personal data between and among countries and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regions in which we operate, it could affect the manner in which we provide our products, the geographical location or segregation of our relevant systems and operations, and could adversely affect our business, financial condition and results of operation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The GDPR also imposes stringent rules and restrictions on automated decision making including profiling, that results in a legal or similarly significant effect on an individual. A recent decision of the CJEU has introduced uncertainty in the interpretation of these rules, and may bring certain of our functionalities into scope of these rules on automated decision making. Following a referral from a German court, the CJEU has expanded the scope for automated decision making under the GDPR by finding that automated decision making activities (such as credit scoring) can fall within the GDPR&#8217;s restrictions even if the legal or similarly significant effect for the individual is carried out by a third party (such as a bank declining an application for a loan), in the certain circumstances. According to the CJEU, the concept of a &#8216;decision&#8217; (in automated decision making) needs to be interpreted broadly. The judgment concluded that a decision may include a number of acts which produce a legal effect concerning an individual and also acts which similarly significantly affect the individual.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depending on how regulators and courts apply this judgment going forward, it may have a significant impact on our business operations including our use of automated data processing to enable merchants to accept or decline an order.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the GDPR, we are subject to evolving EU and UK laws on cookies, tracking technologies and e-marketing. Recent European and regulator court decisions are driving increased attention to cookies and tracking technologies. If the trend of increasing enforcement by regulators of the strict approach to opt-in consent for all but essential use cases, as seen in recent guidance and decisions continues, this could lead to substantial costs, and could require significant systems changes, limit the effectiveness of our fraud detection capabilities, divert the attention of our technology personnel, adversely affect our margins, increase costs and subject us to additional liabilities. Regulation of cookies and similar technologies, and any decline of cookies or similar online tracking technologies as a means to identify and potentially target individuals, may lead to broader restrictions and impairments on our marketing and personalization activities, may negatively impact our efforts to understand users, and, as a result of us being able to process less data, make our automated decisioning process less accurate. In light of the complex and evolving nature of EU, EU Member State and UK privacy laws on cookies and tracking technologies, there can be no assurances that we will be successful in our efforts to comply with such laws; violations of such laws could result in regulatory investigations, fines, orders to cease/ change our use of such technologies, as well as civil claims including class actions, and reputational damage.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Digital Markets Act, or the DMA, entered into force and on November 16, 2022, the Digital Services Act, or the DSA, followed. For the DSA, most provisions become applicable on February 17, 2024. The DSA and the DMA focus on creating a safer digital space, protecting fundamental rights of all users of digital services, and establishing a level playing field for businesses and consumers with regards to online platforms. As further guidance is issued and interpretation of both the DSA and the DMA evolves, it is difficult to assess the impact of the DSA and DMA on our business or operations, but, to the extent applicable, it may require us to modify our practices and policies and we could incur substantial costs as a result.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are also subject to the Israeli Privacy Protection Law, 5741-1981, and its regulations, including the Israeli Privacy Protection Regulations (Data Security), 5767-2017, or the Data Security Regulations, as well as the guidelines of the Israeli Privacy Protection Authority, together the PPL, which impose obligations with respect to the manner personal data is processed. In this respect, the Data Security Regulations may require us to adjust our data protection and data security practices, information security measures, certain organizational procedures, applicable positions (such as an information security manager) and other technical and organizational security measures. Failure to comply with the PPL may expose us to administrative fines, civil claims (including class actions) and in certain cases criminal liability. In addition, we may also need to take certain remedial actions to rectify such irregularities, which may increase our costs.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is generally the laws of the jurisdiction in which a business is located that apply, there is a risk that data protection regulators of other countries may seek jurisdiction over our remote activities in locations in which we process data or serve merchants or shoppers but do not have an operating entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that jurisdiction or make changes to our business so that shopper data is only collected and processed in accordance with applicable local law. In addition, because our services are accessible worldwide, certain foreign jurisdictions may claim that we are required to comply with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees or infrastructure. In such cases, we may require additional legal review and resources to ensure compliance with any applicable privacy or data protection laws and regulations. In addition, in many jurisdictions there may in the future be new legislation that may affect our business and require additional legal review.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">China</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various Chinese laws and regulations which impose strict requirements on cybersecurity, data handling and personal information protection. For example, under China&#8217;s Cybersecurity Law (&#8220;CSL&#8221;), any collection, use, transfer and storage of personal information of a Chinese citizen through a network by the network operator should be based on the three principles of legitimacy, justification and necessity and requires the consent of the data subject. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">China&#8217;s Data Security Law (&#8220;DSL&#8221;) regulates data activities and entities and individuals carrying out data (including those relating to personal data) activities must abide by various data security obligations, including, to classify and protect data based on the importance of data to the state&#8217;s economic development, as well as the degree of harm it will cause to national security, public interests, or legitimate rights and interests of individuals or organizations when such data is tampered with, destroyed, leaked, or illegally acquired or used. The CSL and DSL both have a data localization requirement and require personal information processed by operators of critical information infrastructure (&#8220;CIIOs&#8221;) and for important data collected and generated from within China to be stored locally in China unless a security assessment organized by the relevant authorities is passed. Finally, China&#8217;s Personal Information Protection Law (&#8220;PIPL) clarifies the scope of application, the definitions of personal information and sensitive personal information (which includes medical and health information), the legality of personal information processing and the basic requirements of notice and consent, among other things. The PIPL also sets out data localization requirements for CIIOs and personal information processors who process personal information above a certain threshold prescribed by the relevant authorities. The PIPL includes a list of rules which must be complied with prior to the transfer of personal information outside of China, such as compliance with a security assessment or certification by an agency designated by the relevant authorities or entering into standard form model contracts approved by the relevant authorities with the overseas recipient.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the CSL, DSL and the PIPL, the Chinese government authorities promulgated several regulations or released a number of draft regulations for public comments which are designed to provide further implemental guidance in accordance with the laws mentioned above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what impact Chinese laws and regulations, in particular the CSL, DSL and PIPL, or the increased costs of compliance, if any, will have on our operations in China due to their recent enactment and the limited guidance available, particularly on PIPL, which entities are awaiting further guidance on. It is also generally unclear how the laws will be interpreted and enforced in practice by the relevant government authorities as often the abovementioned laws are drafted broadly and thus leaves great discretion to the relevant government authorities to exercise.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As the regulatory framework for machine learning technology and artificial intelligence evolves, including with respect to unintentional bias and discrimination, our business, financial condition, and results of operations may be adversely affected.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business increasingly relies on artificial intelligence, machine learning and automated decision making. The regulatory framework for this technology is rapidly evolving, and we may not always be able to anticipate how to respond to these laws or regulations. Many federal, state and foreign government bodies and agencies have introduced or are currently considering additional laws and regulations governing the use of such technologies. There is also an increase in litigation in a number of jurisdictions, including the United States, relating to the development, security and use of artificial intelligence. In October 2023, President Biden issued the Executive Order on Safe, Secure and Trustworthy Artificial Intelligence (&#8220;The Order&#8221;) with the goal of promoting the &#8220;safe, secure, and trustworthy development and use of artificial intelligence in the United States.&#8221; The Order has established certain new standards for the training, testing and cybersecurity of sophisticated artificial intelligence models, and the Order has also instructed other federal agencies to promulgate additional regulations within certain timeframes from the date of the Order. Federal artificial intelligence legislation has also been introduced in the U.S. Senate. Such additional regulations may impact our ability to develop, use and commercialize artificial intelligence and machine learning technologies in the future. Additionally, in December 2023, new laws regulating artificial intelligence have been enacted in China, and the European Parliament and Council reached a political agreement on the European Union's Artificial Intelligence Act (the &#8220;EU AI Act&#8221;), which seeks to create a comprehensive legal framework for the regulation of artificial intelligence systems across the EU. The final text of the EU AI Act is expected to be published in early 2024 with the majority of obligations expected to take effect by 2026. Once fully applicable, the EU AI Act will have a material impact on the way artificial intelligence is regulated in the EU, including requirements around transparency, conformity assessments and monitoring, risk assessments, human oversight, security, accuracy, general purpose artificial intelligence and foundation models, and fines for breach of up to 7% of worldwide annual turnover. In 2022 and 2023, China implemented a number of regulations to govern generative artificial intelligence, algorithmic recommendation and deep synthesis technologies, namely the Interim Provisions on Management of Generative Artificial Intelligence Services, Administrative Provisions on Algorithm Recommendation for Internet Information Services and Provisions on Management of Deep Synthesis in Internet Information Service, respectively. Such regulations impose strict obligations on service providers, among other entities, with respect to their provision and use of generative artificial intelligence, algorithmic recommendation and deep synthesis technologies. For example, service providers must file the algorithms used and complete a security assessment with the local CAC before the provision of the service. The regulatory framework in China is expected to have a material impact on the way artificial intelligence is regulated in China, and together with developing guidance and/or decisions in this area, may affect our use of artificial intelligence and our ability to provide and to improve our services, require additional compliance measures and changes to our operations and processes, result in increased compliance costs and potential increases in civil claims against us, and could adversely affect our business, operations and financial condition. It is possible that the EU AI Act and the US artificial intelligence framework, along with the adoption of new laws and regulations in other jurisdictions, or the interpretation of existing laws and regulations, may affect the operation of our ecommerce risk intelligence platform and the way in which we use artificial intelligence and machine learning technology, including with respect to how we train our models, unintentional bias and discrimination. Failure to comply with such laws or regulations could subject us to legal or regulatory liability. Further, the cost to comply with such laws or regulations could be significant and would increase our operating expenses, which could adversely affect our business, financial condition and results of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our implementation and use of artificial intelligence and machine learning technologies may not be successful, which may impair our ability to compete effectively, result in reputational harm and have an adverse effect on our business. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use machine learning, artificial intelligence and automated decision making technologies throughout our business, and are making significant investments to continuously improve our use of such technologies. For example, we use machine learning and artificial intelligence technologies to power our ecommerce risk intelligence platform. As with many technological innovations, there are significant risks and challenges involved in developing, maintaining and deploying these technologies and there can be </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">no assurance that the usage of such technologies will always enhance our products or services or be beneficial to our business, including our efficiency or profitability. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, changes and ongoing development in how we use artificial intelligence and machine learning technologies and how we train our models, in particular if those artificial intelligence or machine learning models are (i) incorrectly designed or implemented; (ii) trained or reliant on incomplete, inadequate, inaccurate, biased or otherwise poor quality data; and/ or (iii) are adversely impacted by unforeseen defects, technical challenges, cybersecurity threats or material performance issues, the performance of our ecommerce risk intelligence platform and business, as well as our reputation and the reputations of our customers and partners, could suffer or we could incur liability through the violation of laws or contracts to which we are a party or through civil claims.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for artificial intelligence and machine learning technologies is rapidly evolving and remains unproven in many industries, including our own. We cannot be sure that the market will continue to grow or that it will grow in ways we anticipate. We are in varying stages of development in relation to our products or services which utilize proprietary artificial intelligence and machine learning technologies, and we may not be successful in our ongoing development of these technologies in the face of novel and evolving technical, reputational and market factors. Our failure to successfully develop and commercialize our products or services which utilize proprietary machine learning and artificial intelligence technologies could depress the market price of our stock and impair our ability to (i) raise capital; (ii) expand our business; (iii) provide, improve and diversify our product offerings; (iv) continue our operations and efficiently manage our operating expenses; and (v) respond effectively to competitive developments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuous development, maintenance and operation of our artificial intelligence and machine learning technologies is expensive and complex, and may involve unforeseen difficulties including material performance problems, undetected defects or errors. We may encounter technical obstacles, and it is possible that we may discover additional problems that may prevent our proprietary technologies from operating properly, which could adversely affect our business, customer relationships and reputation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face significant competition from other companies in our industry in relation to the development and deployment of artificial intelligence and machine learning technologies. Those other companies may develop artificial intelligence technologies that are similar or superior to ours and/or are more cost-effective and/or quicker to develop and deploy. If we cannot develop, offer or deploy new artificial intelligence or machine learning technologies as effectively, as quickly and/ or as cost-efficiently as our competitors, we could experience a material adverse effect on our operating results of operation, customer relationships and growth.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our use of open-source software could negatively affect our ability to sell our products and subject us to possible litigation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products incorporate open-source software, and we expect to continue to incorporate open-source software in our products in the future. Few of the licenses applicable to open-source software have been interpreted by courts, and there is a risk that these licenses could be construed in a manner that could impose unanticipated conditions or restrictions on our ability to commercialize our products. Certain open-source licenses may give rise to requirements to disclose or license our source code or other intellectual property if such open-source software is incorporated in, integrated with, or linked to our proprietary software in certain ways. We have guidelines in place which help us to regulate the use and incorporation of open-source software into our products in a manner that is intended to help mitigate the risk of subjecting our proprietary code to these restrictions. However, we cannot be certain that we have incorporated open-source software in our products in a manner that is consistent with these guidelines. If we fail to comply with our guidelines, or if they are flawed, we may be subject to certain requirements, including requirements that we offer our products that incorporate, integrate or link to the open-source software for free, or that we make available our proprietary source code to our licensees. If a third party were to allege that we had not complied with the conditions of one or more of these licenses, we could be required to incur significant legal expenses defending against such allegations and could be subject to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">significant damages, enjoined from generating revenue from merchants using products that contained the open-source software and required to comply with onerous conditions or restrictions on these products. In any of these events, we and our merchants could be required to seek licenses from third parties in order to continue offering our products and to re-engineer our products or we could be required to discontinue offering our products to merchants in the event re-engineering cannot be accomplished on a timely basis. Any of the foregoing could require us to devote additional research and development resources to re-engineer our products, could result in merchant dissatisfaction and may adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the use of open-source software may entail greater risks than the use of third-party commercial software, as open-source licensors generally do not provide warranties or other contractual protections regarding infringement claims or the quality of the code. To the extent that our ecommerce risk intelligence platform depends upon the successful operation of the open-source software we use, any undetected errors or defects in this open-source software could prevent the deployment or impair the functionality of our platform, delay the introduction of new products, result in a failure of our platform, and injure our reputation. For example, undetected errors or defects in open-source software could render it vulnerable to breaches or security attacks and make our systems more vulnerable to data breaches.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on the strength of our brand, and if we are not able to maintain and enhance our brand, we may be unable to sell our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our brand is integral to the growth of our business and to the implementation of our strategies for expanding our business. We believe that our brand has significantly contributed to the success of our business and is critical to maintaining and expanding our merchant base. Maintaining and enhancing our brand may require us to make substantial investments in areas such as research and development, marketing, ecommerce, and merchant experience, and these investments may not be successful.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate that, as our business expands into new markets and new product categories, and as the industries in which we operate become increasingly competitive, maintaining and enhancing our brand may become difficult and expensive. For example, consumers in any new international markets into which we expand may not know our brand and/or may not accept our brand, resulting in increased costs to market to and attract merchants to our brand. Further, as we grow our retail partnerships, it may be difficult for us to maintain control of our brand with our retail partners, which may result in negative perceptions of our brand. Our brand may also be adversely affected if our public image or reputation is tarnished by negative publicity, including negative social media campaigns, security breaches, poor reviews of our products or merchant experiences or negative publicity associated with claims or litigation brought against the Company, regardless of the merit. In addition, ineffective marketing, product diversion to unauthorized distribution channels, product defects, unfair labor practices, spurious lawsuits, and failure to protect our intellectual property rights are some of the potential threats to the strength of our brand, and those and other factors could rapidly and severely diminish customer confidence in us. Maintaining and enhancing our brand will depend largely on our ability to continue to be a leader in the industries in which we operate and to continue to offer a range of high-quality products as well as a leading end-to-end experience to our merchants, which we may not execute successfully. Failure to maintain the strength of our brand could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Acquisitions, strategic investments, partnerships, or alliances could be difficult to identify, pose integration challenges, divert the attention of management, disrupt our business, dilute shareholder value, and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future seek to acquire or invest in businesses, joint ventures, products and platform capabilities, or technologies that we believe could complement or expand our products and platform capabilities, enhance our technical capabilities, or otherwise offer growth opportunities. Any such acquisition or investment may cause us to incur various expenses in identifying, investigating, and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">pursuing suitable opportunities, whether or not the transactions are completed, and may result in unforeseen operating difficulties and expenditures. In particular, we may encounter difficulties assimilating or integrating the businesses, technologies, products and platform capabilities, personnel, or operations of the acquired companies, particularly if we are unable to retain the key personnel of the acquired company, their software is not easily adapted to work with our ecommerce risk intelligence platform, or we have difficulty retaining the merchants of any acquired business due to changes in ownership, management, or otherwise. These transactions may also disrupt our business, divert our resources, and require significant management attention that would otherwise be available for development of our existing business. We have not historically made any acquisitions and have limited experience in acquiring other businesses. Any such transactions that we are able to complete may not result in any synergies or other benefits we had expected to achieve, which could result in substantial impairment charges. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may not be able to find and identify desirable acquisition targets or business opportunities or be successful in entering into an agreement with any particular strategic partner. We expect that certain of our competitors, many of which have greater resources than we do, will compete with us in acquiring complementary businesses or products. This competition could increase prices for potential acquisitions that we believe are attractive. Also, acquisitions are often subject to various regulatory approvals. If we fail to receive the appropriate regulatory approvals, we may not be able to consummate an acquisition that we believe is in our best interests and may incur significant costs. These transactions could also result in transaction fees, dilutive issuances of our equity securities, incurrence of debt or contingent liabilities, and fluctuations in quarterly results and expenses. We could also face risks related to liability for activities of any acquired company as conducted before any acquisition, including intellectual property infringements claims, violations of laws, commercial disputes, tax liabilities and other known and unknown liabilities and litigation or other claims in connection with the acquired company, including claims from any terminated employees, customers, users, former shareholders or other third parties, and our efforts to limit such liabilities could be unsuccessful. Further, if the resulting business from such a transaction fails to meet our expectations, our business, financial condition and results of operations may be adversely affected, or we may be exposed to unknown risks or liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be sued by third parties for alleged infringement, misappropriation or other violation of their intellectual property rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is considerable technology development activity in our industry, and our competitors are vigilant in protecting and asserting their intellectual property rights. Accordingly, our success depends in part on avoiding infringing or otherwise violating the intellectual property rights of others. From time to time, our competitors or other third parties may claim that we are infringing upon their intellectual property rights, and we may be found to be infringing upon such rights. Any claims or litigation, regardless of merit, could cause us to incur significant expenses and, if successfully asserted against us, could require us to pay substantial damages or ongoing royalty payments, could prevent us from offering our products and ecommerce risk intelligence platform capabilities, or could require us to redesign or rebrand our products so that they are non-infringing. Furthermore, we do not currently have a patent portfolio, which could prevent us from deterring patent infringement claims due to our inability to credibly threaten patent infringement counterclaims. Even if we obtain patents in the future, our competitors and others may have significantly larger patent portfolios. Further, non-practicing entities seeking to extract a settlement from companies like us may not be deterred by a patent portfolio of any size because their sole or primary business is the assertion of patent claims.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Litigation is inherently uncertain and even if we were to prevail in the event of claims or litigation against us, these claims, and the time and resources necessary to resolve them, could divert the resources of our management and adversely affect our revenues, our results of operations and financial condition. Moreover, as part of any settlement or other compromise to avoid complex, protracted litigation, we may agree not to pursue future claims against a third party, including claims related to alleged infringement of our intellectual property rights. Any settlement or other compromise with another party may resolve a potentially costly dispute but may also affect our ability to defend and protect our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">intellectual property rights, which in turn could adversely affect our business, financial conditions, and results of operations. We expect that the occurrence of infringement claims is likely to grow as the market for our products grows. Accordingly, our exposure to damages resulting from infringement claims could increase and this could further exhaust our financial and management resources. Patent infringement, trademark infringement, trade secret misappropriation and other intellectual property claims and proceedings brought against us, whether successful or not, could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with the anti-corruption, trade compliance, anti-money laundering and terror finance and economic sanctions laws and regulations of the United States and applicable international jurisdictions could materially adversely affect our reputation and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must comply with anti-corruption laws and regulations imposed by governments around the world with jurisdiction over our operations, which may include the U.S. Foreign Corrupt Practices Act of 1977, or the FCPA, the U.K. Bribery Act 2010, or the Bribery Act, and Chapter 9 (sub-chapter 5) of the Israeli Penal Law, 5737-1977 and the Israeli Prohibition on Money Laundering Law, 5760-2000, collectively, the Israeli Anti-Corruption Laws, as well as the laws of the countries where we do business. These laws and regulations apply to companies, individual directors, officers, employees and agents acting on our behalf. Where they apply, the FCPA, the Bribery Act, and the Israeli Anti-Corruption Laws prohibit us and our officers, directors, employees and business partners acting on our behalf, including joint venture partners and agents, from corruptly offering, promising, authorizing or providing anything of value to public officials for the purposes of influencing official decisions or obtaining or retaining business or otherwise obtaining favorable treatment. The Bribery Act also prohibits non-governmental &#8220;commercial&#8221; bribery and accepting bribes. As part of our business, we may deal with governments and state-owned business enterprises, the employees and representatives of which may be considered public officials for purposes of anti-corruption laws, including the FCPA, the Bribery Act, and the Israeli Anti-Corruption Laws. We also are subject to the jurisdiction of various governments and regulatory agencies around the world, which may bring our personnel and agents into contact with public officials responsible for issuing or renewing permits, licenses or approvals or for enforcing other governmental regulations. In addition, some of the international locations in which we operate lack a developed legal system and have elevated levels of corruption. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business also must be conducted in compliance with applicable economic and financial sanctions, trade embargoes, and export controls, such as those administered and enforced by the U.S. Department of Treasury&#8217;s Office of Foreign Assets Control, the U.S. Department of State, the U.S. Department of Commerce, the United Nations Security Council, the State of Israel, and other relevant sanctions and export control authorities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our global operations expose us to the risk of violating, or being accused of violating, anti-corruption laws, anti-money laundering laws, economic and financial sanctions, trade embargoes and export controls. Our failure to comply with these laws and regulations may expose us to reputational harm as well as significant penalties, including criminal fines, imprisonment, civil fines, disgorgement of profits, injunctions and debarment from government contracts, as well as other remedial measures. Investigations of alleged violations can be expensive and disruptive. Despite our compliance efforts and activities we cannot assure compliance by our employees or representatives for which we may be held responsible, and any such violation could materially adversely affect our business or customers, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">While we may not be able to enforce non-compete agreements we enter into with employees in certain locations, our current and future competition may attempt to enforce similar agreements with individuals we recruit or attempt to recruit.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally enter into agreements with employees in certain locations which prohibit those employees, if they cease working for us, from competing directly with us or working for our current and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future competition for a limited period. However, we may be unable to enforce these agreements under the laws of the jurisdictions in which our employees work, and it may be difficult for us to restrict our current and future competition from benefiting from the expertise our former employees developed while working for us. For example, Israeli labor courts have required employers seeking to enforce non-compete undertakings of a former employee to demonstrate that the competitive activities of the former employee will harm one of a limited number of material interests of the employer that have been recognized by the courts, such as the protection of a company&#8217;s trade secrets or other intellectual property. In addition, in the United States, the Federal Trade Commission (&#8220;FTC&#8221;) has proposed rules that, if adopted, would ban post-termination non-compete clauses and require employers to rescind existing ones.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we hire employees from our current and future competition or other companies, their former employers may attempt to assert that these employees or we have breached their legal obligations, resulting in a diversion of our time and resources. In a similar manner, should our current and future competition succeed in hiring some of our employees and executives, and should some of these employees or executives breach their legal obligations and divulge commercially sensitive information to our current and future competition, our ability to successfully compete with our current and future competition may be hindered.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to maintain an effective system of disclosure controls and internal control over financial reporting, our ability to produce timely and accurate financial statements or comply with applicable regulations could be impaired.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;) requires, among other things, that we maintain effective disclosure controls and procedures and internal control over financial reporting. We are continuing to develop and refine our disclosure controls and other procedures that are designed to ensure that information required to be disclosed by us in the reports that we will file with the SEC is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms and that information required to be disclosed in reports under the Exchange Act is accumulated and communicated to our principal executive and financial officers as appropriate to allow timely decisions regarding required disclosure. We are also continuing to improve our internal control over financial reporting. In order to maintain the effectiveness of our disclosure controls and procedures and internal control over financial reporting, we have expended, and anticipate that we will continue to expend, significant resources, including accounting-related costs and significant management oversight, as well as outside consultants. If any of these controls and systems do not perform as expected, we may experience material weaknesses in our controls.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to furnish a report by management on, among other things, the effectiveness of our internal control over financial reporting pursuant to Section 404(a) of the Sarbanes-Oxley Act in our annual reports. This assessment must include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. The rules governing the standards that must be met for our management to assess our internal control over financial reporting are complex and require significant documentation, testing and possible remediation. Testing and maintaining internal controls may divert our management&#8217;s attention from other matters that are important to our business. Despite our efforts, there is a risk that we will not be able to conclude that our internal control over financial reporting is effective. Any failure to develop or maintain effective controls could cause us to fail to meet our reporting obligations and may result in a restatement of our consolidated financial statements for prior periods. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements. Additionally, when we are no longer an &#8220;emerging growth company,&#8221; our independent registered public accounting firm will be required to formally attest to the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act. At such time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level at which our internal control over financial reporting is documented, designed or operating.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ineffective disclosure controls and procedures and internal control over financial reporting could cause investors to lose confidence in our reported financial and other information and we could become subject to investigations by the SEC or other regulatory authorities, which could have a material negative effect on the trading price of our Class A ordinary shares. In addition, if we are unable to continue to meet these requirements, we may not be able to remain listed on the New York Stock Exchange (&#8220;NYSE&#8221;). </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our estimates or judgments relating to our critical accounting policies prove to be incorrect, our business, financial condition and results of operations may be adversely affected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in our consolidated financial statements and accompanying notes. Actual results could differ materially from these estimates. We base our estimates on assumptions (both historical and forward-looking), trends, and various other assumptions that are believed to be reasonable, as provided in Note 2 to our consolidated financial statements. The results of these estimates form the basis for making judgments about the carrying values of assets, liabilities, and equity, in addition to the amount of revenue and expenses that are not readily apparent from other sources. Significant assumptions and estimates are used to prepare our consolidated financial statements, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#8220;IBR&#8221;) used for operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business, financial condition and results of operations may be adversely affected if our assumptions change or if actual circumstances differ from those in our assumptions, which could cause our results of operations to fall below the expectations of securities analysts and investors, resulting in a decline in the trading price of our Class A ordinary shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our results determined in accordance with GAAP, we believe certain non-GAAP financial measures and key metrics may be useful in evaluating our operating performance. We present certain non-GAAP financial measures and key performance metrics in this Annual Report and intend to continue to present certain non-GAAP financial measures and key performance metrics in future filings with the SEC and other public statements. Any failure to accurately report and present our non-GAAP financial measures and key performance metrics could cause investors to lose confidence in our reported financial and other information, which would likely have a negative effect on the trading price of our Class A ordinary shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct business in China, which exposes us to political, legal, and economic risks, and we may be subject to negative publicity in China, which could damage our reputation and have an adverse effect on our revenues, our results of operations and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Conducting business in China exposes us to political, legal, and economic risks. In particular, the political, legal, and economic climate in China, both nationally and regionally, is fluid and unpredictable. Our products may be subject to regulations in China now or in the future, including with respect to data privacy, foreign exchange controls, and licensing, that may require us to incur new or additional compliance or other administrative costs. Applicable laws and regulations in China may not be well publicized and may not be known to us in advance of us becoming subject to them, and the implementation of such laws and regulations may be inconsistent. Changes in Chinese laws and regulations, including, among others, with regards to disclosure of information, data privacy, intellectual property, tax matters, or changes in their implementation by local authorities, could affect us as well as </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our merchants and could have a material adverse impact on our business, financial condition, and results of operations. Furthermore, our brand could be subject to adverse publicity if incidents related to our image or the products we offer occur or are perceived to have occurred, whether or not we are at fault. In particular, given the popularity of social media in China, including WeChat and Weibo, any negative publicity, regardless of its truthfulness, could quickly proliferate and harm consumer perceptions of and confidence in the Company.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing scrutiny of, and evolving expectations for, sustainability and environmental, social, and governance (&#8220;ESG&#8221;) initiatives could increase our costs, harm our reputation, or otherwise adversely impact our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, as with other companies, are facing increasing scrutiny related to our ESG practices and disclosures from certain investors, capital providers, shareholder advocacy groups, other market participants, customers, and other stakeholder groups. For example, certain institutional and individual investors have requested various ESG-related information and disclosures as they increasingly incorporate ESG criteria in making investment and voting decisions. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With this increased focus, public reporting regarding ESG practices is becoming more broadly expected. Simultaneously, there are efforts by some stakeholders to reduce companies&#8217; efforts on certain ESG-related matters. Both advocates and opponents to certain ESG matters, including diversity, equity and inclusion (&#8220;DEI&#8221;), are increasingly resorting to a range of activism forms, including media campaigns and litigation, to advance their perspectives. To the extent we are subject to such activism, it may require us to incur costs or otherwise adversely impact our business. Such increased scrutiny may result in increased costs, changes in demands for certain products, enhanced compliance or disclosure obligations, or other adverse impacts on our business, financial condition or results of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we may at times engage in voluntary initiatives (such as voluntary disclosures, certifications, or goals, among others), such initiatives may be costly and may not have the desired effect. For example, expectations around our management of ESG matters continues to evolve rapidly, in many instances due to factors that are outside of our control. In addition, we may commit to certain initiatives or goals and we may not ultimately be able to achieve such commitments or goals due to cost, technological constraints, or other factors that are within or outside of our control. Moreover, actions or statements that we may take based on expectations, assumptions, or third-party information that we currently believe to be reasonable may subsequently be determined to be erroneous or be subject to misinterpretation. Even if this is not the case, our current actions may subsequently be determined to be insufficient by various stakeholders. If our ESG practices and reporting do not meet investor, consumer, employee, or other stakeholder expectations, which continue to evolve, our brand, reputation and customer retention may be negatively impacted, and we may be subject to investor or regulator engagement regarding such matters, even if they are currently voluntary. </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain market participants, including major institutional investors, use third-party benchmarks or scores to measure our ESG practices in making investment and voting decisions. As ESG best practices, reporting standards and disclosure requirements continue to develop, we may incur increasing costs related to ESG monitoring and reporting.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">various policymakers, such as the SEC, the European Union, and the State of California, have adopted (or are considering adopting) </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">new sustainability rules and regulations</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, including requirements for the disclosure of certain</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> climate- or other ESG-related information, which may require us to incur significant additional costs to comply and impose increased oversight obligations on our management and board of directors. Operating in more than one jurisdiction is likely to make our compliance with ESG and sustainability-related rules more complex and expensive, and potentially expose us to greater levels of legal risks associated with our compliance. Our failure to comply with any applicable rules or regulations could lead to penalties and adversely impact our reputation, customer attraction and retention, access to capital and employee retention. Such ESG matters may also impact our suppliers and customers, which may augment or cause additional impacts on our business, financial condition, or results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in tax laws or regulations that we are subject to in various tax jurisdictions or disagreements with tax authorities over the application of the current tax laws or regulations may </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">have an adverse effect on us or our merchants and could increase our costs and harm our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New income, sales, use, or other tax laws, regulations, or ordinances could be enacted or new interpretations of existing tax laws, regulations, or ordinances could be adopted at any time. Those changes could adversely affect our domestic and international business operations, results of operations and financial condition. These events could require us or our merchants to pay additional tax amounts on a prospective or retroactive basis, as well as require us or our merchants to pay fines and/or penalties and interest for past amounts deemed to be due. If we are required to collect such additional tax amounts from our merchants and are unsuccessful in collecting such taxes due from our merchants, we could be held liable for such costs, thereby adversely affecting our results of operations and harming our business. If we raise our prices to offset the costs of these changes, existing and potential future merchants may elect not to purchase our products in the future. Additionally, new, changed, modified, or newly interpreted or applied tax laws could increase our merchants&#8217; and our compliance, operating, and other costs. Further, these events could decrease the capital we have available to operate our business. Any or all of these events could harm our business, results of operations, and financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we are subject to taxation in several jurisdictions around the world with increasingly complex tax laws, the application of which can be uncertain. We are currently the subject of a routine tax audit in Israel, administered by the Israel Tax Authority. As a result of this audit or a review of our tax returns by the tax authorities in any other jurisdiction in which we do business, certain additional tax, interest or penalties may be imposed on us. Tax authorities in these jurisdictions may also assert that various withholding requirements apply to us or our subsidiaries or that benefits of tax treaties are not available to us or our subsidiaries.  Moreover, given the multijurisdictional developments under the Organization for Economic Co-operation and Development&#8217;s, or the OECD, efforts to standardize and modernize global corporate tax policy described further below, it is generally expected that tax authorities in various jurisdictions in which we operate may increase their audit activity and may seek to challenge some of the tax positions we have adopted. It is difficult to assess if and to what extent such challenges, if raised, might impact our effective tax rate. Any of these actions by tax authorities could harm our business and our results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results of operations may be harmed if we are required to collect sales or other similar taxes for the sale of our products in jurisdictions where we have not historically done so.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The application of indirect taxes (such as sales and use tax, VAT, GST, business tax, and gross receipt tax) to businesses that transact online, such as ours, is a complex and evolving area. An increasing number of states have considered or adopted laws that attempt to impose tax collection obligations on out-of-state companies. Following the U.S. Supreme Court decision in South Dakota v. Wayfair, Inc., states are now free to levy taxes on sales of goods and services based on an &#8220;economic nexus,&#8221; regardless of whether the seller has a physical presence in the state. As a result, it may be necessary to reevaluate whether our activities give rise to sales, use, and other indirect taxes as a result of any nexus in those states in which we are not currently registered to collect and remit taxes. Additionally, we may need to assess our potential tax collection and remittance liabilities based on existing economic nexus laws&#8217; dollar and transaction thresholds. It is possible that we could face sales tax, VAT, or GST audits and that our liability for these taxes could exceed our estimates as state tax authorities could still assert that we are obligated to collect additional tax amounts from our merchants and remit those taxes to those tax authorities. Further, one or more U.S. state or non-U.S. authorities could seek to impose additional sales, use, or other tax collection and record-keeping obligations on us or may determine that such taxes should have, but have not been, paid by us. We could also be subject to tax audits in states and international jurisdictions for which we have not accrued tax liabilities. A successful assertion by one or more states requiring us to collect taxes where we presently do not do so could result in substantial tax liabilities (including taxes on past sales, as well as penalties and interest), discourage organizations from purchasing our products, or otherwise harm our business, results of operations, and financial condition. We continue to analyze our exposure for such taxes and liabilities, including the need to provide for loss contingencies resulting from these potential taxes and liabilities. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been, and will continue to be, substantial ongoing costs associated with complying with the various indirect tax requirements in the numerous markets in which we conduct or will conduct business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The enactment of legislation implementing changes in taxation of international business activities, the adoption of other corporate tax reform policies, or changes in tax legislation or policies could impact our future financial position and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate tax reform, tackling base-erosion efforts, and tax transparency continue to be high priorities in many tax jurisdictions where we have business operations. As a result, policies regarding corporate income and other taxes in numerous jurisdictions are under heightened scrutiny, and tax reform legislation is being proposed or enacted in a number of jurisdictions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2022, the United States Inflation Reduction Act, among other changes, introduced a 15% corporate minimum tax on certain United States corporations and a 1% excise tax on certain stock redemptions by United States corporations, which the U.S. Treasury indicated may also apply to certain stock redemptions by a foreign corporation funded by certain United States affiliates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2015, the OECD released various reports under its Base Erosion and Profit Shifting, or BEPS, action plan to reform international tax systems and prevent tax avoidance and aggressive tax planning. These actions aim to standardize and modernize global corporate tax policy, including cross-border taxes, transfer-pricing documentation rules, and nexus-based tax incentive practices which in part are focused on challenges arising from the digitalization of the economy. The reports have a very broad scope, including, but not limited to, neutralizing the effects of hybrid mismatch arrangements, limiting base erosion involving interest deductions and other financial payments, countering harmful tax practices, preventing the granting of treaty benefits in inappropriate circumstances, and imposing mandatory disclosure rules. It is the responsibility of OECD members to consider how the BEPS recommendations should be reflected in their national legislation. Many countries are beginning to implement legislation and other guidance to align their international tax rules with the OECD&#8217;s BEPS recommendations &#8213; for example, by signing the Multilateral Convention to Implement Tax Treaty Related Measures to Prevent BEPS, or the MLI, which currently has been signed by over 100 jurisdictions, including Israel, which signed the MLI on June 7, 2017. On September 13, 2018, Israel submitted the ratification documents for the agreement, and the agreement entered into effect in Israel on January 1, 2019. The MLI implements some of the measures that the BEPS initiative proposes to be transposed into existing treaties of participating states. Such measures include the inclusion in tax treaties of one, or both, of a &#8220;limitation-on-benefit,&#8221; or LOB, rule and a &#8220;principle purposes test,&#8221; or PPT, rule. The application of the LOB rule or the PPT rule could deny the availability of tax treaty benefits (such as a reduced rate of withholding tax) under tax treaties. In January 2019 the OECD announced further work in continuation of the BEPS project, focusing on two &#8220;pillars.&#8221; On October 8, 2021, 136 countries approved a statement known as the OECD BEPS Inclusive Framework, which builds upon the OECD&#8217;s continuation of the BEPS project. The first pillar is focused on the allocation of taxing rights between countries for in-scope large multinational enterprises (with revenue in excess of &#8364;20 billion and profitability of at least 10%) that sell goods and services into countries with little or no local physical presence. The second pillar is focused on developing a global minimum tax rate of at least 15% applicable to in-scope multinational enterprises (with revenue in excess of &#8364;750 million). Israel is one of the 136 countries that has agreed in principle to the adoption of the global minimum tax rate. The rules for a global minimum tax are expected to be implemented in a number of jurisdictions with effect from 2024. In particular, on December 15, 2022, Council of the EU unanimously adopted the EU Directive on Global Minimum Tax.  It is expected that the second Pillar rules will be effective for EU member states for fiscal years beginning on January 1, 2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although many of the BEPS measures have already been implemented or are currently being implemented globally, it is still difficult in some cases to assess to what extent these changes our tax liabilities in the jurisdictions in which we conduct our business or to what extent they may impact the way in which we conduct our business or our effective tax rate due to the unpredictability and interdependency of these potential changes. Such legislative initiatives may materially and adversely affect our plans to </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expand internationally and may negatively impact our financial condition, tax liability, and results of operations, and could increase our administrative expenses.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in, or adverse applications of, insurance laws or regulations in the jurisdictions in which we operate could subject our business to additional regulation, which could impact our future financial position and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New insurance laws, regulations, or ordinances could be enacted or new interpretations or adverse applications of existing insurance laws, regulations, or ordinances could be adopted at any time. If the company is classified as an insurance company in any jurisdiction due to our product, the Chargeback Guarantee, such classification could adversely affect our future financial position and results of operations by, among other things, increasing the costs of regulatory compliance, limiting or restricting the products we provide, including our ability to provide the Chargeback Guarantee, or the methods by which we provide them and subjecting us to the possibility of regulatory actions or proceedings. If we are unable to comply with such regulations, we may be precluded or temporarily suspended from carrying on some or all of the activities of our business or otherwise be fined or penalized in a given jurisdiction.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Class A Ordinary Shares</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The share price of our Class A ordinary shares has been and may continue to be volatile</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our Class A ordinary shares has experienced significant price and volume volatility and may continue to fluctuate in the future, substantially as a result of many factors, including:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated fluctuations in our revenues, our results of operations, and our financial condition;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variance in our financial performance from the expectations of securities analysts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our direct or indirect competitors of significant business developments, changes in service provider relationships, acquisitions, or expansion plans;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">geopolitical conditions or uncertainty, which may include war, political instability or unrest, or terrorism (such as the current war between Israel and Hamas, as well as Ukraine and Russia);</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes or proposed changes in laws or regulations or differing interpretations or enforcement of laws or regulations affecting our business, including the laws, regulations, card scheme rules or any other frameworks that have the effect of shifting liability for fraud away from merchants;<br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our pricing model;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">merchant-churn, including churn of significant merchants;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our involvement in litigation or regulatory actions;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our Class A ordinary shares by us or our shareholders, including any sales of Class B ordinary shares, which will automatically convert into Class A ordinary shares upon transfer thereof;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in our industry;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in key personnel;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the trading volume of our Class A ordinary shares;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the timing and amount of our share repurchases (if any);</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">publication of research reports or news stories about us, our competition, or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the estimation of the future size and growth rate of our markets; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and market conditions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Broad market and industry factors have, and may in the future, materially harm the market price of our Class A ordinary shares, regardless of our actual operating performance. In addition, in the past, securities class action litigation has often been instituted against companies whose stock price have declined, especially following periods of volatility in the overall market. We have been subject to securities class action litigation in the past.  Additional securities class action litigation, if instituted against us, could result in substantial costs and a diversion of our management&#8217;s attention and resources. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot predict the impact our dual class structure may have on the market price of our Class A ordinary shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict whether our dual class structure will result in a lower or more volatile market price of our Class A ordinary shares, in adverse publicity or other adverse consequences. Certain investors, including large institutional investors, may prefer companies that do not have multiple share classes or may have investment guidelines that preclude them from investing in companies that have multiple share classes. In addition, certain index providers have previously implemented, and may in the future determine to implement, restrictions on including companies with multiple share classes in certain of their indices. For example, from July 2017 to April 2023, S&amp;P Dow Jones excluded companies with multiple share classes from the S&amp;P Composite 1500 (composed of the S&amp;P 500, S&amp;P MidCap 400 and S&amp;P SmallCap 600). Indices have discretion to reassess and implement such policies with respect to multi-class differing voting right structures. Under any such policies, our dual class share structure would make us ineligible for inclusion in any of these indices. As a result, the market price of our Class A ordinary shares could be materially adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The dual class structure of our ordinary shares has the effect of concentrating voting power with our management and other pre-IPO shareholders, which will limit your ability to influence the outcome of important transactions, including a change in control.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class B ordinary shares have ten votes per share, and our Class A ordinary shares have one vote per share. As of December 31, 2023, our executive officers collectively held approximately 30.65% of the voting power of our outstanding ordinary shares, and our pre-IPO shareholders collectively held approximately 84.08% of the voting power of our outstanding ordinary shares.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, although there are no voting agreements among our pre-IPO shareholders, our management and pre-IPO shareholders, including our co-founders, hold together all of our issued and outstanding Class B ordinary shares and therefore, individually or together, are able to significantly influence matters submitted to our shareholders for approval, including the election of directors, amendments of our organizational documents, executive compensation items and any merger or other major corporate transactions that require shareholder approval. Our management and pre-IPO shareholders, including our co-founders, individually or together, may vote in a way with which you disagree and which may be adverse to your interests. This concentrated voting power may have the effect of delaying, preventing or deterring a change in control of our Company, could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale of our company and might ultimately materially and adversely affect the market price of our Class A ordinary shares. Future transfers by the holders of Class B ordinary shares will result in those shares converting into Class A ordinary shares, subject to limited exceptions. As long as at least 16,232,156 Class B ordinary shares remain outstanding, and without giving effect to any future issuances, the holders of our Class B ordinary </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shares will hold a majority of the outstanding voting power and will continue to control the outcome of matters submitted to shareholders for approval. While our amended and restated articles of association generally prohibit us from issuing additional Class B ordinary shares (other than with the affirmative vote of the holders of at least seventy-five percent (75%) of our outstanding Class B ordinary shares), any future issuance of Class B ordinary shares may be dilutive to Class A ordinary shareholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information about our dual class structure, see Exhibit 2.2 to this Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">An active trading market for our Class A ordinary shares may not be sustained to provide adequate liquidity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An active trading market may not be sustained for our Class A ordinary shares. The lack of an active market may impair your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. An inactive market may also impair our ability to raise capital by selling Class A ordinary shares and may impair our ability to acquire other companies by using our shares as consideration.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we do not meet the expectations of securities analysts, if they do not publish research or reports about our business, or if they issue unfavorable commentary or downgrade our Class A ordinary shares, the price of our Class A ordinary shares could decline.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our Class A ordinary shares relies in part on the research and reports that securities analysts publish about us and our business. The analysts&#8217; estimates are based upon their own opinions and are often different from our estimates or expectations. If our revenues, our results of operations, or our financial condition are below the estimates or expectations of public market analysts and investors, the price of our Class A ordinary shares could decline. Moreover, the price of our Class A ordinary shares could decline if one or more securities analysts downgrade our Class A ordinary shares or if those analysts issue other unfavorable commentary or cease publishing reports about us or our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We qualify as an &#8220;emerging growth company&#8221; and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our Class A ordinary shares less attractive to investors because we may rely on these reduced disclosure requirements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We qualify as an &#8220;emerging growth company,&#8221; as defined in the JOBS Act. Under the JOBS Act, emerging growth companies can delay adopting new or revised financial accounting standards until such time as those standards apply to private companies. We have elected to use this extended transition period under the JOBS Act for adopting new or revised financial accounting standards. For as long as we continue to be an &#8220;emerging growth company,&#8221; we may also take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including presenting only limited selected financial data and not being required to comply with the auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act. As a result, our shareholders may not have access to certain information that they may deem important. We will remain an &#8220;emerging growth company&#8221; until the earliest of: (1) December 31, 2026; (2) the last day of the first fiscal year in which our annual gross revenue is $1.235 billion or more; (3) the date on which we have, during the previous rolling three-year period, issued more than $1 billion in non-convertible debt securities; and (4) the date we qualify as a &#8220;large accelerated filer.&#8221; We cannot predict if investors will find our Class A ordinary shares less attractive because we may rely on these exemptions. If some investors find our Class A ordinary shares less attractive as a result, there may be a less active trading market for our Class A ordinary shares and our share price may be more volatile.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a &#8220;foreign private issuer,&#8221; and, as a result, we are not subject to U.S. proxy rules and will be subject to Exchange Act reporting obligations that, to some extent, are more lenient and less frequent than those of a U.S. domestic public company.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We report under the Exchange Act as a non-U.S. company with &#8220;foreign private issuer&#8221; status. Because we qualify as a &#8220;foreign private issuer&#8221; under the Exchange Act, we are exempt from certain provisions of the Exchange Act that are applicable to U.S. domestic public companies, including (1) the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; (2) the sections of the Exchange Act requiring insiders to file public reports of their share ownership and trading activities and liability for insiders who profit from trades made in a short period of time; (3) the rules under the Exchange Act requiring the filing with the SEC of current reports on Form 8-K upon the occurrence of specified significant events, although we are subject to Israeli laws and regulations with regards to certain of these matters; and (4) the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q containing unaudited financial and other specified information, although we are subject to Israeli laws and regulations with regard to certain of these matters and have historically announced, and intend to continue announcing quarterly unaudited results in earnings press releases. In addition, &#8220;foreign private issuers&#8221; are not required to file their annual report on Form 20-F until four months after the end of each fiscal year, while U.S. domestic issuers that are accelerated filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year, and U.S. domestic issuers that are large accelerated filers are required to file their annual report on Form 10-K within 60 days after the end of each fiscal year. &#8220;Foreign private issuers&#8221; are also exempt from Regulation FD, which prohibits selective disclosures of material information. As a result of all of the above, investors may not have the same protections afforded to shareholders of a company that is not a &#8220;foreign private issuer.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may lose our &#8220;foreign private issuer&#8221; status in the future, which could result in significant additional costs and expenses.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed above, we are a &#8220;foreign private issuer,&#8221; and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act. The determination of &#8220;foreign private issuer&#8221; status is made annually on the last business day of an issuer&#8217;s most recently completed second fiscal quarter. In the future, we would lose our &#8220;foreign private issuer&#8221; status if (1) more than 50% of our outstanding voting securities are owned by U.S. residents and (2) a majority of our directors or executive officers are U.S. citizens or residents, or we fail to meet additional requirements necessary to avoid loss of &#8220;foreign private issuer&#8221; status. If we lose our &#8220;foreign private issuer&#8221; status, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms available to a &#8220;foreign private issuer.&#8221; We will also have to mandatorily comply with U.S. federal proxy requirements, and our officers, directors, and more than 10% shareholders will become subject to the short-swing profit disclosure and recovery provisions of Section 16 of the Exchange Act. In addition, we will lose our ability to rely upon exemptions from certain corporate governance rules of the NYSE. As a U.S. listed public company that is not a &#8220;foreign private issuer,&#8221; we will incur significant additional legal, accounting, and other expenses that we will not incur as a &#8220;foreign private issuer.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">As we are a &#8220;foreign private issuer&#8221; and intend to follow certain home country corporate governance practices, our shareholders may not have the same protections afforded to shareholders of companies that are subject to all corporate governance rules of the New York Stock Exchange.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;foreign private issuer,&#8221; we have the option to follow certain home country corporate governance practices rather than those of the NYSE, provided that we disclose the requirements we are not following and describe the home country practices we are following. We intend to rely on this &#8220;foreign private issuer exemption&#8221; with respect to NYSE rules for shareholder meeting quorums. See Item 6.C. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Board Practices &#8213; Corporate Governance Practices</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; We may in the future elect to follow Israeli practices with regard to other matters. As a result, our shareholders may not have the same protections afforded to shareholders of companies that are subject to all corporate governance rules of the NYSE.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The market price of our Class A ordinary shares could be negatively affected by future issuances and sales of our Class A ordinary shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, there were 128,738,857 Class A ordinary shares and 49,814,864 Class B ordinary shares outstanding. Sales by us or our shareholders of a substantial number of Class A ordinary shares, including Class B ordinary shares, which will automatically convert into Class A ordinary shares upon transfer, in the public market, or the perception that these sales might occur, could cause the market price of our Class A ordinary shares to decline or could impair our ability to raise capital through a future sale of, or pay for acquisitions using, our equity securities. Of our issued and outstanding shares, all the Class A ordinary shares, including Class B ordinary shares, which will automatically convert into Class A ordinary shares upon transfer, are freely transferable, except for any shares held by our &#8220;affiliates,&#8221; as that term is defined in Rule 144 under the Securities Act.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had 8,766,560 ordinary shares available for future grants under our equity incentive plans and 32,280,797 ordinary shares that were subject to outstanding share options and restricted share units, or RSUs. Of this amount, 8,849,876 options were vested and exercisable as of December&#160;31, 2023. Future grants under our equity incentive plans, whether in the ordinary course of business or otherwise, will result in dilution of the ownership interests of our existing shareholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are unable to predict the effect that such issuances and sales may have on the prevailing market price of our Class A ordinary shares.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions of Israeli law and our amended and restated articles of association may delay, prevent, or make undesirable an acquisition of all or a significant portion of our shares or assets.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions of Israeli law and our amended and restated articles of association could have the effect of delaying or preventing a change in control and may make it more difficult for a third party to acquire us or our shareholders to elect different individuals to our board of directors, even if doing so would be considered to be beneficial by some of our shareholders, and may limit the price that investors may be willing to pay in the future for our Class A ordinary shares. Among other things: </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Israeli Companies Law, 5759-1999 (the &#8220;Companies Law&#8221;) regulates mergers and requires that a tender offer be effected when one or more shareholders propose to purchase shares that would result in it or them owning more than a specified percentage of shares in a company; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Companies Law requires special approvals for certain transactions involving directors, officers, or significant shareholders, and regulates other matters that may be relevant to these types of transactions; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Companies Law does not provide for shareholder action by written consent for public companies, thereby requiring all shareholder actions to be taken at a general meeting of shareholders; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated articles of association divide our directors into three classes, each of which is elected once every three years; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an amendment to our amended and restated articles of association generally requires, in addition to the approval of our board of directors, a vote of the holders of a majority of our outstanding ordinary shares entitled to vote present and voting on the matter at a general meeting of shareholders (referred to as simple majority), and the amendment of a limited number of provisions, such as the provision empowering our board of directors to determine the size of the board, the provision dividing our directors into three classes, the provision that sets forth the procedures and the requirements that must be met in order for a shareholder to require the Company to include a matter on the agenda for a general meeting of the shareholders, the provisions relating to the election and removal of members of our board of directors and empowering our board of directors to fill vacancies on the board, requires, in addition to the approval of our board of directors, a vote of the holders of 65% of our outstanding ordinary shares entitled to vote at a general meeting;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated articles of association do not permit a director to be removed, except by a vote of the holders of at least 65% of our outstanding shares entitled to vote at a general meeting of shareholders; </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our dual class ordinary share structure, which provides our existing shareholders, individually or together, with the ability to significantly influence the outcome of matters requiring shareholder approval, even if they own significantly less than a majority of our outstanding Class A ordinary shares and Class B ordinary shares; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated articles of association provide that director vacancies may be filled by our board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, Israeli tax considerations may make potential transactions undesirable to us or to some of our shareholders whose country of residence does not have a tax treaty with Israel, granting tax relief to such shareholders from Israeli tax. For example, Israeli tax law does not recognize tax-free share exchanges to the same extent as U.S. tax law. With respect to mergers, Israeli tax law allows for tax deferral in certain circumstances, but makes the deferral contingent on the fulfillment of numerous conditions, including a holding period of two years from the date of the transaction during which certain sales and dispositions of shares of the participating companies are restricted. Moreover, with respect to certain share swap transactions, the tax deferral is limited in time, and when such time expires, the tax becomes payable even if no disposition of the shares has occurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to pay any dividends in the foreseeable future.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared nor paid any dividends on our ordinary shares. We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance operations and expand our business. Consequently, investors who purchase Class A ordinary shares may be unable to realize a gain on their investment, except by selling such shares after price appreciation, which may never occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has sole discretion whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions and other factors that our directors may deem relevant. The Companies Law imposes restrictions on our ability to declare and pay dividends.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of dividends may also be subject to Israeli withholding taxes. See Item 10.E. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxation &#8212;Israeli Tax Considerations</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We cannot guarantee that our share repurchase program will be utilized to the full value approved or that it will enhance long-term shareholder value. Repurchases we consummate could increase the volatility of the price of our Class A ordinary shares and could have a negative impact on the liquidity of our Class A ordinary shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, our Board of Directors approved a share repurchase program for the purchase of up to $75 million of our Class A ordinary shares (the &#8220;Repurchase Program&#8221;). In November 2023, we received the required approval from the Tel Aviv District Court Economic Department (&#8220;Israeli Court&#8221;) to implement the Repurchase Program. Under the Repurchase Program, repurchases can be made from time to time using a variety of methods, which may include open market purchases, privately negotiated transactions or otherwise, all in accordance with U.S. federal securities laws. The timing, as well as the number and value of any shares repurchased under the program, will be determined at our discretion and will depend on a variety of factors, including management's assessment of the intrinsic value of our ordinary shares, the market price of our ordinary shares, general market and economic conditions, available liquidity, alternative investment opportunities, and applicable legal requirements. Share repurchases could have an impact on the trading price of our Class A ordinary shares, increase the volatility of the price of our Class A ordinary shares, or reduce the liquidity of our Class A ordinary shares. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, repurchases under the Repurchase Program may diminish our cash reserves, which could impact our ability to pursue possible strategic opportunities and acquisitions and could result in lower overall returns on our cash balances.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Repurchase Program does not obligate us to acquire a particular amount of Class A ordinary shares, and the Repurchase Program may be suspended, modified or discontinued at any time at our discretion and without prior notice, which may result in a decrease in the trading prices of our Class A ordinary shares. We cannot assure you that any share repurchases will enhance shareholder value because the market price of our Class A ordinary shares could decline. The current Israeli Court approval of our Repurchase Program is valid through May 19, 2024. We may file extension requests with the Israeli Court on an ongoing basis as required and we may seek to expand the Repurchase Program and increase the aggregate value of the Class A ordinary shares repurchased thereunder, however there can be no guarantee that the Israeli Court will approve such extension or expansion requests.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will continue to incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company we incur, and particularly after we are no longer an &#8220;emerging growth company,&#8221; we will continue to incur significant legal, accounting, and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform, and Consumer Protection Act, the listing requirements of the NYSE and other applicable securities rules and regulations impose various requirements on public companies, including the establishment and maintenance of effective disclosure and financial controls and corporate governance practices. Our management and other personnel continue to devote a substantial amount of time to these compliance initiatives. Moreover, we will continue to incur substantial legal and financial compliance costs, and certain activities will be more time-consuming and costly, as a result of these rules and regulations. For example, these rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance, and could also make it more difficult for us to attract and retain qualified members of our board.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to evaluate these rules and regulations and cannot predict or estimate the amount of additional costs we may incur or the timing of such costs. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our amended and restated articles of association provide that, unless we consent to an alternative forum, the federal district courts of the United States shall be the exclusive forum for resolution of any complaint asserting a cause of action arising under the Securities Act, and the competent courts of Tel Aviv, Israel, shall be the exclusive forum for resolution of substantially all disputes between the Company and its shareholders under the Companies Law and the Israeli Securities Law, which could limit our shareholders&#8217; ability to choose the judicial forum for disputes with us, our directors, shareholders, or other employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated articles of association provide that, unless we consent to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for any claim asserting a cause of action arising under the Securities Act. Section 22 of the Securities Act creates concurrent jurisdiction for U.S. federal and state courts over all such Securities Act actions. Accordingly, both U.S. state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated articles of association provide that, unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Act. This exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Exchange Act, and our shareholders cannot and will not be deemed to have waived our compliance with the U.S. federal securities laws and the rules and regulations thereunder as a result of our exclusive forum provision.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated articles of association further provide that, unless we consent in writing to the selection of an alternative forum, the competent courts of Tel Aviv, Israel, is the exclusive forum for the resolution of (i) any derivative action or proceeding brought on behalf of the Company, (ii) any action asserting a claim of breach of fiduciary duty owed by any director, officer or other employee of the Company to the Company or the Company&#8217;s shareholders, or (iii) any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law, 1968, or the Israeli Securities Law. Such exclusive forum provision is intended to apply to claims arising under Israeli law and does not apply to claims for which the federal courts would have exclusive jurisdiction, whether by law or pursuant to our amended and restated articles of association, as described above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring any interest in any of our securities shall be deemed to have notice of and consented to the foregoing provisions of our amended and restated articles of association. However, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits, or proceedings asserting a cause of action arising under the Securities Act) in other companies&#8217; organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provisions in our amended and restated articles of association. If a court were to find the exclusive forum provisions contained in our amended and restated articles of association to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we believe these exclusive forum provisions benefit us by providing increased consistency in the application of U.S. federal securities laws or the Companies Law, as applicable, in the types of lawsuits to which they apply, such exclusive forum provisions may limit a shareholder&#8217;s ability to bring a claim in the judicial forum of their choosing for disputes with us or any of our directors, shareholders, officers, or other employees, which may discourage lawsuits with respect to such claims against us and our current and former directors, shareholders, officers, or other employees.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that we will not be classified as a passive foreign investment company, which could result in adverse U.S. federal income tax consequences to United States Holders of our Class A ordinary shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We would be classified as a passive foreign investment company, or PFIC, for any taxable year if, after the application of certain look-through rules, either: (i) 75% or more of our gross income for such year is &#8220;passive income&#8221; (as defined in the relevant provisions of the Internal Revenue Code of 1986, as amended, or the Code) (the &#8220;income test&#8221;); or (ii) 50% or more of the value of our assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income (the &#8220;asset test&#8221;). For these purposes, cash and other assets readily convertible into cash or that do or could generate passive income are categorized as passive assets, and the value of goodwill and other unbooked intangible assets is generally taken into account. Passive income generally includes, among other things, rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities and securities transactions. For purposes of the income and asset tests, we will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation of which we own, directly or indirectly, at least 25% (by value) of the stock. The legislative history of the relevant Code provisions indicates that the total value of a publicly-traded foreign corporation&#8217;s assets generally will be treated as equal to the sum of the aggregate value of its outstanding stock plus its liabilities for purposes of the asset test, and publicly-traded foreign corporations often employ such market capitalization method to value their assets. However, the Internal Revenue Service, or the IRS, has not issued guidance conclusively addressing how to value a publicly-traded foreign corporation&#8217;s assets for PFIC purposes. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading value of our Class A ordinary shares has in the past, and is likely to continue to fluctuate. In particular, the market price of the shares of U.S. listed technology companies (including us) has been especially volatile in recent years. In addition, we have a dual class share structure that has the effect of concentrating voting power in our Class B ordinary shares, which are not publicly traded. Our Class A ordinary shares, which are publicly traded, represent approximatel</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">y 20</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% of the voting power of all our outstanding shares. In certain circumstances, including under volatile market conditions and considering the percentage of voting power represented by our publicly-traded Class A ordinary shares, we believe it may be appropriate to employ alternative methods to determine the value of our assets other than the market capitalization method. After considering the total value of our assets determined under an alternative valuation method that takes into account a control premium, we believe that we were not a PFIC for the taxable year ended December 31, 2023. However, if the market capitalization method were determined to be the only appropriate method of valuing our assets, we may well be treated as a PFIC for the taxable year ended December 31, 2023. Therefore, there can be no certainty that the IRS will not challenge such a position and determine that based on the IRS&#8217;s interpretation of the asset test, we were a PFIC for the taxable year ended December 31, 2023. In addition, PFIC status is a factual determination that must be made annually after the close of each taxable year. The trading value of our Class A ordinary shares is likely to continue to fluctuate while the market price of the shares of U.S. listed technology companies continues to be volatile, which may affect the determination of whether we will be considered a PFIC. As our market capitalization and the composition of our income, assets, and operations are subject to change, we cannot assure you that we will not be considered a PFIC for any taxable year. It is possible that the IRS may take a contrary position with respect to our determination in any particular year. Certain adverse U.S. federal income tax consequences could apply to a United States Holder (as defined in Item 10.E. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxation&#8213;U.S. Federal Income Tax Considerations</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) if we are treated as a PFIC for any taxable year during which such United States Holder holds our Class A ordinary shares. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">We are not providing any U.S. tax opinion to any United States Holder concerning our potential PFIC status, and United States Holders should consult their tax advisors about the potential application of the PFIC rules to their investment in our Class A ordinary shares.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For further discussion, see Item 10.E. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxation &#8213; U.S. Federal Income Tax Considerations &#8213; Passive Foreign Investment Company.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a United States person is treated as owning 10% or more of our shares, such holder may be subject to adverse U.S. federal income tax consequences.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our shares, such person may be treated as a &#8220;United States shareholder&#8221; with respect to each controlled foreign corporation, or CFC, in our group (if any). Because our group includes a U.S. subsidiary, certain of our non-U.S. subsidiaries will be treated as CFCs (regardless of whether we are treated as a CFC). A United States shareholder of a CFC may be required to report annually and include in its U.S. taxable income its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and investments in U.S. property by CFCs, regardless of whether we make any distributions. An individual that is a United States shareholder with respect to a CFC generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a United States shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a United States shareholder to significant monetary penalties, and may prevent the statute of limitations with respect to such shareholder&#8217;s U.S. federal income tax return for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in determining whether we are or any of our non-U.S. subsidiaries is treated as CFC or whether any investor is treated as a United States shareholder with respect to any such CFC or furnish to any United States shareholder information that may be necessary to comply with the aforementioned reporting and tax paying obligations. The United States Internal Revenue Service has provided limited guidance on situations in which investors may rely on publicly available information to comply with their reporting and tax paying obligations with respect to foreign-controlled CFCs. A United States investor should consult its advisors regarding the potential application of these rules to an investment in our Class A ordinary shares.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Relating to Our Incorporation and Location in Israel</span></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conditions in Israel, including the recent attack by Hamas and other terrorist organizations from the Gaza Strip and elsewhere in the region, and Israel&#8217;s war against them, may adversely affect our revenues, our results of operations and our financial condition.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under the laws of the State of Israel and many of our employees, including certain members of management, operate from our offices located in Tel Aviv, Israel. In addition, a number of our officers and directors are residents of Israel. Accordingly, political, economic, and military conditions in Israel and the surrounding region may directly affect our revenues, our results of operations, and our financial condition. Since the establishment of the State of Israel, a number of armed conflicts have occurred between Israel and its neighboring countries and terrorist organizations active in the region. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, Hamas and other terrorist organizations infiltrated Israel&#8217;s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Hamas and other terrorist organizations also launched extensive rocket attacks on Israeli population and industrial centers located along Israel&#8217;s border with the Gaza Strip and in other areas within the State of Israel. These attacks resulted in extensive deaths, injuries and kidnapping of civilians and soldiers. Following the attack, Israel&#8217;s security cabinet declared war against Hamas and a military campaign against these terrorist organizations commenced in parallel to their continued rocket and terror attacks. In addition, since the commencement of these events, there have been continued hostilities along Israel&#8217;s northern border (with the Hezbollah terror organization in Lebanon) and southern border (with the Houthi movement in Yemen). It is possible that hostilities with Hezbollah in Lebanon will escalate, and that other terrorist organizations, including Palestinian military organizations in the West Bank as well as other hostile countries, such as Iran, will join the hostilities. Such clashes may escalate in the future into a greater regional conflict. Furthermore, following Hamas&#8217; attack on Israel and Israel&#8217;s security cabinet declaration of war against Hamas, the Houthi movement, which controls parts of Yemen, launched a number of attacks on marine vessels traversing the Red Sea. The intensity and duration of Israel&#8217;s war against Hamas is difficult to predict, as are such war&#8217;s economic implications on the Company&#8217;s business and operations and on Israel&#8217;s economy in general. These events may be intertwined with wider macroeconomic indications of a deterioration of Israel&#8217;s economic standing, potentially including a downgrade in Israel's credit rating by rating agencies (such as the recent downgrade by Moody&#8217;s of its credit rating of Israel from A1 to A2, as well as the downgrade of its outlook rating from &#8220;stable&#8221; to &#8220;negative&#8221;), which may have a material adverse effect on the Company and its ability to effectively conduct its operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Israeli security cabinet&#8217;s declaration of war against Hamas and possible hostilities with other organizations, several hundred thousand Israeli military reservists were drafted to perform immediate military service. Although many of these military reservists have since been released, they may be called up for additional reserve duty, depending on developments in the war in Gaza and along Israel's other borders. Certain of our employees and consultants in Israel have been called up, and additional employees may be called up, for service in the current or future wars or other armed conflicts, and such persons may be absent for an extended period of time. As a result, our operations have and may in the future be disrupted by such absences, which disruption may materially and adversely affect our business and results of operations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that our facilities are damaged as a result of hostile actions, or hostilities otherwise disrupt our ongoing operations, our business could be materially and adversely affected. Our commercial insurance does not cover losses that may occur as a result of events associated with war and terrorism. Although the Israeli government currently covers the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, there can be no assurance that this government coverage will be maintained or that it will sufficiently cover our potential damages. Any losses or damages incurred by us could have a material adverse effect on our revenues, our results of operations, and our financial condition. Any armed conflicts or political instability in the region would likely negatively affect business conditions and could adversely affect our revenues, our results of operations, and our financial condition.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, some countries around the world restrict doing business with Israel and Israeli companies, and additional countries may impose similar restrictions if hostilities in Israel or political instability in the region continue or increase. These restrictions may limit materially our ability to sell our products and provide our services to companies and customers in these countries. Separately, there have been increased efforts by countries, activists and organizations to cause companies and consumers to boycott Israeli goods and services. In addition, in January 2024 the International Court of Justice (the &#8220;ICJ&#8221;) issued an interim ruling in a case filed by South Africa against Israel in December 2023, making allegations of genocide amid and in connection with the war in Gaza, and ordered Israel, among other things, to take measures to prevent genocidal acts, prevent and punish incitement to genocide, and take steps to provide basic services and humanitarian aid to civilians in Gaza. There are concerns that companies and businesses will terminate, and certain companies and businesses may have already terminated, certain commercial relationships with Israeli companies following the ICJ decision. The foregoing efforts by countries, activists and organizations, particularly if they become more widespread, as well as the ICJ rulings and future rulings and orders of other tribunals against Israel (if handed), may materially and adversely impact our ability to sell and provide our products and services outside of Israel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, political conditions within Israel may affect our operations. Israel has held five general elections between 2019 and 2022, and prior to October 2023, the Israeli government pursued extensive changes to Israel&#8217;s judicial system, which sparked extensive political debate and unrest. In response to such initiatives, many individuals, organizations and institutions, both within and outside of Israel, have voiced concerns that the proposed changes may negatively impact the business environment in Israel including due to reluctance of foreign investors to invest or conduct business in Israel, as well as due to increased currency fluctuations, downgrades in credit rating, increased interest rates, increased volatility in securities markets, and other changes in macroeconomic conditions. To date, these initiatives have been substantially put on hold. If such changes to Israel&#8217;s judicial system are again pursued by the government and approved by the parliament, this may have an adverse effect on our business, our results of operations and our ability to raise additional funds, if deemed necessary by our management and board of directors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due to competition for highly skilled personnel in Israel, we may fail to attract, recruit, retain and develop qualified employees, which could materially and adversely impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal research and development activities are conducted from our office in Israel and we face significant competition for suitably skilled software engineers, data scientists and developers in this region. The accelerated economic growth of Israeli tech companies in recent years led to a surplus of job opportunities and intense competition between Israeli-based employers to attract locally qualified employees. As a result, the high-tech industry in Israel has experienced significant levels of employee attrition and continues to face a shortage of skilled personnel. Many of the companies with whom we compete for experienced personnel have greater resources than we do and we may not succeed in recruiting additional experienced or professional personnel, retaining current personnel or effectively replacing current personnel who may depart with qualified or effective successors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effort to retain and develop personnel may also result in significant additional expenses, which could adversely affect our profitability. There can be no assurance that qualified employees will continue to be employed or that we will be able to attract and retain qualified personnel in the future. Failure to retain or attract qualified personnel could have a material adverse effect on our business, financial condition and results of operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It may be difficult to enforce a U.S. judgment against us, our officers, and our directors named in this Annual Report in Israel or the United States, or to assert U.S. securities laws claims in Israel or serve process on our officers and directors. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not all of our directors or officers are residents of the United States, and certain assets are therefore located outside the United States. Service of process upon us or our non-U.S. resident directors and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">officers, and enforcement of judgments obtained in the United States against us or our non-U.S. resident directors and officers may be difficult to obtain within the United States. We have been informed by our legal counsel in Israel that it may be difficult to assert claims under U.S. securities laws in original actions instituted in Israel or obtain a judgment based on the civil liability provisions of U.S. federal securities laws. Israeli courts may refuse to hear a claim based on an alleged violation of U.S. securities laws against us or our non-U.S. officers and directors reasoning that Israel may not be the most appropriate forum in which to bring such a claim. In addition, even if an Israeli court agrees to hear a claim, it may determine that Israeli law and not U.S. law is applicable to the claim. If U.S. law is found to be applicable, the content of applicable U.S. law must be proved as a fact by an expert witnesses, which can be a time-consuming and costly process. Certain matters of procedure will also be governed by Israeli law. There is little binding case law in Israel addressing the matters described above. Israeli courts might not enforce judgments rendered outside Israel, which may make it difficult to collect on judgments rendered against us or our non-U.S. officers and directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, an Israeli court will not enforce a non-Israeli judgment if it was given in a state whose laws do not provide for the enforcement of judgments of Israeli courts (subject to exceptional cases), if its enforcement is likely to prejudice the sovereignty or security of the State of Israel, if it was obtained by fraud or in the absence of due process, if it is at variance with another valid judgment that was given in the same matter between the same parties, or if a suit in the same matter between the same parties was pending before a court or tribunal in Israel at the time the foreign action was brought. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Your rights and responsibilities as our shareholder will be governed by Israeli law, which may differ in some respects from the rights and responsibilities of shareholders of U.S. corporations. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are incorporated under Israeli law. The rights and responsibilities of holders of our Class A ordinary shares and Class B ordinary shares are governed by our amended and restated articles of association and the Companies Law. These rights and responsibilities differ in some respects from the rights and responsibilities of shareholders in typical U.S. corporations. In particular, pursuant to the Companies Law, each shareholder of an Israeli company has to act in good faith and in a customary manner in exercising his, her, or its rights and fulfilling his, her, or its obligations toward the Company and other shareholders, and to refrain from abusing his, her, or its power in the Company, including, among other things, in voting at the general meeting of shareholders, on amendments to a company&#8217;s articles of association, and with regard to increases in a company&#8217;s authorized share capital, mergers, and certain transactions requiring shareholders&#8217; approval under the Companies Law. In addition, a controlling shareholder of an Israeli company or a shareholder who knows that it possesses the power to determine the outcome of a shareholder vote or who has the power to appoint or prevent the appointment of a director or officer in the Company, or has other powers toward the Company has a duty of fairness toward the Company. However, Israeli law does not define the substance of this duty of fairness. There is little case law available to assist in understanding the implications of these provisions that govern shareholder behavior.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_49"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. INFORMATION ON THE COMPANY</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_52"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. History and Development of the Company</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Riskified Ltd. was incorporated on November 26, 2012 and commenced operations in January 2013. In July 2021, we listed our Class A ordinary shares on the NYSE. We are a company limited by shares organized under the laws of the State of Israel. We are registered with the Israeli Registrar of Companies. Our registration number is 51-484411-7.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal executive offices are located at 220 5th Avenue, 2nd Floor, New York, New York 10001.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our website address is </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.riskified.com</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We use our website as a means of disclosing material non-public information. Such disclosures will be made available on the &#8220;Investor Relations&#8221; section of our website. Accordingly, investors should monitor such sections of our website, in addition to following our press releases, SEC filings and public conference calls and webcasts. Information contained </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on, or that can be accessed through, our website does not constitute a part of this Annual Report and is not incorporated by reference herein. We have included our website address, and references to various other documents, in this Annual Report solely for informational purposes. The SEC maintains an internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC at </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">https://www.sec.gov.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our agent for service of process in the United States is Riskified, Inc., located at 220</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5th Avenue, 2nd Floor, New York, New York 10001. For a description of our principal capital expenditures and divestitures for the three years ended December&#160;31, 2023 and for those currently in progress, see Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_55"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Business Overview</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to empower businesses to unleash ecommerce growth by taking risk off the table. We have built a next-generation ecommerce risk intelligence platform that allows online merchants to create trusted relationships with their consumers. Leveraging machine learning that benefits from a global merchant network, our platform identifies the individual behind each online interaction, helping merchants&#8212;our customers&#8212;eliminate risk and uncertainty from their business. We drive higher sales and reduce operating costs for our merchants and assist them to provide superior online shopping experiences for their consumers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe legacy ecommerce fraud platforms and rules-based, in-house solutions are frequently slow, inaccurate, expensive, and inflexible. They can often produce the wrong decision&#8212;by rejecting good transactions or accepting fraudulent ones&#8212;which causes merchants to either lose revenue or incur unnecessary expenses in the form of chargebacks and other fees. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Larger, global merchants can also employ hundreds of support personnel to manually review consumer interactions (e.g., orders, returns, refund claims and account recoveries). We believe these slow manual processes produce poor online shopping experiences that lead to abandoned shopping carts. Additionally, this outdated infrastructure may prevent merchants from adapting to fast-changing consumer preferences and fraud techniques.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecommerce risk intelligence platform is built to solve these problems with proprietary machine learning models that drive an automated decisioning engine. We have designed our platform to be fast, accurate, scalable, and cost-effective. It supports our core Chargeback Guarantee product&#8212;which optimizes merchant approval rates&#8212;as well as our other products that mitigate similar ecommerce risks for those same merchants, including Policy Protect, Dispute Resolve, Account Secure and PSD2 Optimize.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our products are designed to enable merchants to generate additional revenue or cost savings, while improving the online shopping experience for their consumers. Our core product, the Chargeback Guarantee, automatically approves or denies online orders with guaranteed performance levels that vary in accordance with our merchants&#8217; priorities. Our machine learning models analyze hundreds of attributes per transaction, generating decisions in real time. We guarantee the outcome of these decisions by assuming the cost of fraud associated with each order that we approve. Simultaneously, we provide contractual minimum approval rates for our Chargeback Guarantee merchants that are often higher than these merchants can achieve on their own. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We access our merchants&#8217; transaction data through deep integrations into their mission-critical infrastructure, including their ecommerce, order management and customer relationship management systems. Collecting relevant data across our merchant network allows us to identify complex transaction and behavior patterns that are not easily identifiable by merchants on their own. Our ability to help our merchants stems from the fact that we continuously feed this real-time training data into our sophisticated machine learning models. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We service merchants of all sizes, from multi-billion dollar global omnichannel retailers to small pure play merchants, including via partnership integrations with Shopify and other ecommerce platforms, such as Salesforce Commerce Cloud, Commercetools and Adobe Commerce. However, we focus on supporting enterprise merchants, which we define as merchants generating over $75 million in online sales per year. Our merchants include some of the largest ecommerce brands in the world, including Wayfair, Lastminute.com, SHEIN, and Macy&#8217;s. Our merchants operate in a variety of verticals, including Payments, Money Transfer &amp; Crypto, Tickets &amp; Travel, Electronics, Home, Fashion &amp; Luxury Goods, General Retail and Food.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We charge merchants using our Chargeback Guarantee product a percentage of every dollar of GMV that we approve on their behalf, so we are incentivized to approve as many orders as we safely can. We believe that this merchant-centric approach, coupled with our rigorous decisioning process, maximizes our financial results and those of our merchants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fee we charge our merchants is a risk-adjusted price, which is expressed as a percentage of the GMV that we approve. This fee, which is established at contract inception, varies by merchant based on a variety of inputs, including the type of merchant, the order population, the risk level of the end market (including industry and geographic region), the percentage of GMV we review from the merchant, and the guaranteed approval rates we agree to provide. When our merchants ask us to review transactions from end markets that carry higher risk, we may charge higher fees to help offset the increased likelihood of receiving a chargeback. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an approved transaction that we have guaranteed results in an eligible chargeback, we will reimburse the merchant for the amount of the lost sale. In this situation, we record a chargeback expense in cost of revenue and typically reimburse the merchant in the form of credits on future invoices.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Ecommerce Risk Intelligence Platform &amp; Product</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecommerce risk intelligence platform automates the complexities of ecommerce for merchants, and enables them to offer simple, frictionless consumer experiences.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The Riskified Ecommerce Risk Intelligence Platform</span></div><div style="margin-bottom:9pt;text-align:center"><img src="rskd-20231231_g1.jpg" alt="Investor Presentation - Feb 2024 (2).jpg" style="height:351px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Sources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We deeply integrate into merchants&#8217; systems that house and track transaction data and online interactions. Extrapolating this level of access across our global merchant base provides tremendous data resources that we use to train our machine learning models. We can draw insights from billions of historical transactions executed on our merchant network, each of which contains hundreds of data attributes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Analytics</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Extensive and automated analysis of these attributes, both individually and as part of the aggregated global network, positions us to determine which consumers and transactions are legitimate or fraudulent. Our machine learning algorithms produce real-time insights that are trained for anomaly detection and pattern recognition based on the other transactions and interactions that have occurred, and are occurring, on our network.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Merchant Tools</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our dashboards give merchants visibility into every decision that we review. This empowers merchants to review, understand, and override decisions where we are unwilling to guarantee a transaction. Our dashboards also include up-to-date key performance metrics, including order approval rates, account challenges, order declines and chargebacks.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk management is at the very heart of our business. We have established processes that are designed to help us manage our overall chargeback exposure and control realized chargeback expenses within predetermined budget levels. In addition, we adjust our merchants&#8217; approval and chargeback rates in real time to rebalance our exposure and our expected expenses during any given period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Strong track record driven by real-time training data</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our engagement model has built-in feedback loops that provide us with up-to-date, high quality training data in the form of chargeback transactions from across our merchant network. This data constantly updates our models to improve their accuracy. Additionally, we have observed a large and diverse population of chargeback transactions since our founding. Combined with our real-time feedback loops, we believe </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the volume of our high-quality, historical chargeback data is critical to the accuracy of our models. Since our founding, we have incurred relatively few chargebacks, measured as a percentage of our total approved transactions. Historically, chargeback expenses have been in line with our annual budgets.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Active risk monitoring</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We supplement our models with a variety of tools that detect anomalies and prevent fraud in real time. We use a layered approach to ensure that there are multiple levels of analyses performed on each transaction we approve. This layered approach optimizes the overall performance of our ecommerce risk intelligence platform while also creating fail safe mechanisms. For example, our anomaly detection models are designed to detect blind spots that our supervised models cannot. We also employ real-time alerting systems for early detection any time our exposure exceeds certain thresholds. Lastly, we use a combination of automated and manual reviews from highly skilled risk analysts to review our exposure on a regular basis, no less than daily.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Real-time adjustments optimize long term outcomes</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We adjust our merchants&#8217; approval rates in real time as we detect riskier order populations. This allows us to outperform for our merchants when we see safer transactions, while also reducing approval rates when we see riskier transactions. This ability to react opportunistically to changing market conditions and fraud trends allows us to optimize our long term approval rate while also managing our overall chargeback exposure.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Risk diversification</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Significant fraud events, while rare, are typically isolated to a particular merchant or industry. As a result, our chargeback expenses have become less volatile over time as we scale. Furthermore, the average transaction value we approve is less than $200. This means that unexpected chargebacks need to occur in large volumes to meaningfully impact our overall chargeback expenses. As of December 31, 2023, our portfolio of potential chargeback liabilities was diversified across a number of industries, hundreds of merchants and millions of individual transactions. We believe this diversity significantly reduces the likelihood of material unexpected chargeback expenses.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Short-term durations provide rapid visibility</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our merchant agreements generally allow chargebacks to be submitted up to six months from the order approval date. Merchants are also typically required to notify us of an eligible chargeback within five days of becoming aware of a chargeback that occurred within this six month period. As a result, chargeback liabilities typically have very short durations. Approximately 90% of chargebacks are incurred within 90 days of the transaction date. This allows us to forecast the expenses associated with a new cohort of approved transactions at the same time. Furthermore, as we receive chargeback notifications from our merchants, we are able to decline similar future orders in real time.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Products</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our platform includes multiple products that are all built on the same automated decisioning engine. Chargeback Guarantee is our core product that is used by substantially all of our customers. Some merchants also use other products in combination with Chargeback Guarantee to increase the overall value they receive from the platform.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chargeback Guarantee</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product automatically approves or declines online orders with guaranteed performance levels that vary by merchant. Our machine learning models analyze hundreds of attributes per transaction, generating accurate decisions instantaneously. Through our proprietary smart linking technology, we strive to accurately match transactions that occur on our network with other similar transactions that occurred on our network across hundreds of variables per transaction. We guarantee the outcome of these decisions by assuming the cost of fraud associated with each transaction we approve. Simultaneously, we provide contractual minimum approval rates for our Chargeback Guarantee merchants that are often higher than the approval rates that these merchants were able to achieve prior to commencing work with us. In addition, we have built a first-class Chargeback Management System, which is a key component of our </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dispute Resolve</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product. This fully automated workflow product was designed to aid our merchants when they dispute chargebacks for which Riskified is not liable, through a process known as &#8220;representment&#8221;. With Dispute Resolve, we are able to utilize our machine learning technology to automate key elements of the dispute process, such as compiling &#8220;compelling evidence&#8221; submissions for fraud and non-fraud related chargeback abuse, which can occur when consumers knowingly take advantage of the chargeback process (commonly referred to as &#8220;liar buyer&#8221; or &#8220;friendly fraud&#8221;). The visibility, automation and speed that we are able to provide in the chargeback &#8220;representment&#8221; process augments our Chargeback Guarantee offering, and is an important component of our comprehensive chargeback management solution.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth of our merchant network has enabled us to identify many other pain points that our decisioning engine can help solve for our merchants. We are able to help solve these problems using the extensive information we collect from our merchants&#8217; online store fronts and back-end systems including but not limited to, their order management, fulfillment, payments, refunds, returns and other customer support systems. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Policy Protect</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product uses machine learning to detect and prevent refund and returns policy abuse in real-time whenever consumers may be taking advantage of a merchant&#8217;s Terms and Conditions. It is powered by a proprietary engine that forms identity clusters from billions of historical transactions, hundreds of billions of data attributes, and repeat interaction histories for hundreds of millions of consumers, across a global merchant network, broadening the view of customer identity beyond their singular profile with a merchant. Policy Protect helps merchants balance generous policies while protecting their bottom line. With Policy Protect, we enable merchants to offer lenient refund and returns policies, attractive promotions and loyalty programs, and launch limited edition items to their loyal customers while reducing losses associated with return abuse, reseller abuse and other forms of online policy abuse with high levels of accuracy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Account Secure</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product cross-checks every login attempt against the account owner&#8217;s behavior across our entire merchant network, and provides precise real-time actions on compromised accounts such as notification to the true account owner or multi-factor authentication (MFA). Account Secure provides good customers with a better experience by reducing friction while preventing fraudsters and other bad actors from compromising the accounts. Our </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PSD2 Optimize</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> product helps merchants avoid bank authorization failures and abandoned shopping carts resulting from the Strong Customer Authentication (SCA) process mandated by the European Payment Directives for certain European orders. Merchants use PSD2 Optimize to provide superior consumer experiences, increase profitable revenues, and decrease costs, just like they do with Chargeback Guarantee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continuously evaluate our product suite to ensure that we are investing in and allocating resources to those products that deliver the highest return on investment for our merchants and our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shareholders. From time-to-time, we may elect to deprioritize investment in an existing product or to discontinue a product entirely.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Benefits of Our ecommerce Risk Intelligence Platform</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we provide superior outcomes for online merchants by eliminating the friction and uncertainty commonly associated with ecommerce. Our ecommerce risk intelligence platform is designed to provide the following benefits:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Increase sales</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We allow merchants to generate higher revenues by increasing their approval rates for online transactions.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Reduce fraud</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our platform automatically identifies and rejects fraudulent online transactions that would result in unnecessary expenses for our merchants. We also assume the cost of fraudulent transactions if they are approved.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Reduce operating costs</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We replace antiquated systems and labor-intensive, costly fraud fighting methodologies with automated algorithms that save our merchants significant time and money. By reducing the operating costs our merchants incur, we free business resources that can be redirected towards growing their businesses. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Optimize consumer experiences</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Higher approval rates mean lower consumer drop-off and fewer false declines of legitimate consumers. Our product gives merchants the ability to take full advantage of omnichannel flows such as buy-online-pickup-in-store and buy-online-pickup-at-curb without increasing the risk of fraudulent sales. In addition, we enable merchants to maintain consumer-friendly policies by preventing policy abuse and malicious account logins. This builds a stronger, long-term relationship between merchants and consumers, driving more sales to merchants over time.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-right:-18pt;text-align:center;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">The Riskified Value Proposition</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;text-decoration:underline;top:-3.5pt;vertical-align:baseline">(1)</span></div><div style="margin-bottom:9pt;text-align:center"><img src="rskd-20231231_g2.jpg" alt="Business3b.jpg" style="height:452px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"/></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">__________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1) This chart is an illustrative representation that does not represent actual or proportional results of any merchant.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">What Sets Us Apart</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We generate substantial return on investment for our merchants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate substantial return on investment throughout the lifecycle of our relationships with our merchants by increasing merchants&#8217; online sales and reducing their operating costs. As a result, we experience strong retention rates, which supports our organic growth. We believe that the active performance management we perform is an important driver of our merchants' return on investment. We provide performance management through a combination of real time monitoring, proprietary tools, and surgical optimization of specific subsets of our merchants' order volumes. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Powerful flywheel effect </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a market leader in ecommerce risk intelligence. We believe that we receive access to significantly more customer data per transaction than banks and other payment companies and that this privileged level of access means that we are able to provide superior ecommerce fraud and risk analytics. We have built our products around this capability and now review more than $120 billion in GMV annually. Our ecommerce risk intelligence platform gets stronger with each transaction we process and each merchant we add to our network. Each transaction that we review enhances our data sets and our ability to identify similar characteristics between transactions on our network. Our platform evaluates millions of transactions daily using feedback from past transactions, including whether or not those transactions </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">resulted in eligible chargebacks. This drives our sophisticated transaction matching ability. As we grow our network, by increasing GMV from existing merchants and by onboarding new merchants, this sophisticated transaction matching enables us to deliver a strong return on investment for our merchants and drives robust product innovation that enhances the consumer shopping experience. We then leverage this improved ROI for our merchants and our enhanced product suite to attract more merchants, which drives more transactions to our platform. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compounding data advantages over a growing merchant network</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our founding, we have accumulated billions of historical transactions from our merchant network with hundreds of data variables per transaction. As a result we have repeat interaction histories for more than 800 million consumers. This data was collected across our global merchant base comprising hundreds of leading ecommerce merchants, with whom we have built trusted relationships. As a result, our machine learning models are able to create powerful, real-time predictive insights that we believe are difficult to replicate. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The scale of our merchant network and processed volume continue to grow. For the year ended December&#160;31, 2023, our total GMV grew 17% to $123.1 billion compared to the year ended December&#160;31, 2022. We serve some of the largest and most recognizable ecommerce brands globally. B</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ased on data reasonably available to us, o</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ur merchant base includes</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> approximately 50 global ticketing, online travel and ecommerce merchants with annual GMV above $1 billion. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the scale of our ecommerce risk intelligence platform is a competitive advantage because it is the foundation of the scope, depth and power of the data we use to train our models.  </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Strong expertise serving the enterprise market</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We service merchants of all sizes, from multi-billion dollar global omnichannel retailers to small pure play merchants, including via partnership integrations with Shopify and other ecommerce platforms, such as Salesforce Commerce Cloud, Commercetools and Adobe Commerce. However, we focus on supporting enterprise merchants, which we define as merchants generating over $75 million in online sales per year. According to management calculations based on data provided by ecommerceDB, in 2022 enterprise merchants comprised more than 85% of ecommerce sales made directly from the retailer&#8217;s website or mobile app. For the year ended December 31, 2023, we estimate that more than</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 90</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">% of our Billings were derived from enterprise merchants. We are positioned to support enterprise merchants for several reasons. First, our ecommerce risk intelligence platform is highly customizable to meet each merchant&#8217;s unique requirements. Second, we are able to simplify the vast amounts of complexity that are unique to enterprise operating environments. Third, unlike many ecommerce enablement platforms, we do not compete with our merchants to own the consumer relationship through mobile apps or other touch points. We believe this gives us privileged access to significantly more data than banks or other payment companies receive. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Entrepreneurial Culture Fostering Continuous Innovation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our culture is an essential component of our success that allows us to hire and retain top talent. We strive to nurture a highly collaborative working environment where everyone, no matter what location or role, is empowered to solve challenging problems while also contributing to the communities we live in. Our Operating Principles (Clients Success First, Drive Results, Team Up, and Stay Ahead) lay out how our employees should operate to drive success for our clients. We empower our team members to learn and grow and make a conscious effort to promote people from within, offer varied development opportunities, and create space for people to try new things and utilize their unique skill sets. We also host a Fraud Academy for our analytics employees, which includes approximately 60 hours of training, to help our team members further develop their skills.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Our Merchants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecommerce risk intelligence platform is explicitly designed and engineered to integrate with a wide range of merchants. We can accommodate and grow with the world&#8217;s largest merchants:  </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Scale</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: We serve merchants with multiple regional store fronts and large global presences. Our largest merchants generate tens of billions of dollars in online sales each year.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Industry</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our merchants represent diversified online sellers in various industries such as Payments, Money Transfer &amp; Crypto, Tickets &amp; Travel, Electronics, Home and Fashion &amp; Luxury Goods. We categorize general retail merchants and food merchants within our &#8220;General&#8221; category.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Merchant Profile</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our merchants range from direct-to-consumer brands, online-only retailers, omnichannel retailers, online marketplaces, and ecommerce service providers that bear the liability for disputed transactions.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Geography</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Our merchants are located in 40 countries based on the location of the merchant&#8217;s headquarters. Approximately 61% of our Billings for the year ended December&#160;31, 2023 were derived from US-based accounts. Our Billings in Asia-Pacific increased by more than 35% year-over-year in 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Billings by Industry</span></div><div style="margin-bottom:9pt;text-align:center"><img src="rskd-20231231_g3.jpg" alt="industry updated black.jpg" style="height:365px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Billings by Geography</span></div><div style="margin-bottom:9pt;text-align:center"><img src="rskd-20231231_g4.jpg" alt="geo updated black.jpg" style="height:365px;margin-bottom:5pt;vertical-align:text-bottom;width:600px"/></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the year ended December&#160;31, 2023, merchants integrated on our ecommerce risk intelligence platform generated total GMV of $123.1 billion, up from $105.6 billion GMV for the year ended December&#160;31, 2022. Our network is made up of hundreds of retailers including some of the largest ecommerce brands in the world, such as Wayfair, Lastminute.com, SHEIN, and Macy&#8217;s.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding segmental revenue and revenue by geographic region, see Note 3 - Revenue Recognition in our audited consolidated financial statements included elsewhere in this Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Go-to-Market Strategy</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We market our ecommerce risk intelligence platform directly to online merchants primarily through our enterprise sales team, with a strong focus on long-term customer value. Our seasoned direct sales team is highly skilled in identifying online merchant pain points, demonstrating our value-add and providing dedicated support to address the online merchants&#8217; needs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some merchants prefer the flexibility to start their relationship with us by submitting only a portion of their order volumes to us. We welcome this approach and have successfully implemented a &#8220;Land and Expand&#8221; strategy, where we create long-term partnerships that result in strong retention and revenue that is likely to recur. As we gain our merchant&#8217;s trust, we are generally able to increase the GMV they submit to us and the value we provide.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We experience seasonal fluctuations in our revenue as a result of consumer spending patterns. Historically, our revenue has been strongest during the fourth quarter of our fiscal year due to increases in retail commerce during the holiday season. See Item 5.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Trend Information&#8221;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for a description of the seasonality of our business.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property rights are important to the success of our business. We rely on a combination of copyright, trademark and trade secret laws in the United States and in other jurisdictions, as well as confidentiality procedures and contractual obligations in contracts with employees, contractors and third parties, to establish and protect our intellectual property, including our proprietary technology, know-how and brand. We have chosen not to register any copyrights and we do not currently have any patents or pending patent applications, and instead rely primarily on trade secret protection to protect our proprietary software. Further, while we believe intellectual property is important, we believe that factors such as the technological and creative skills of our personnel, creation of new features and functionality, and frequent enhancements to our models, features and proprietary technology are more essential to establishing and maintaining our technology leadership position.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Riskified brand is central to our business strategy, and we believe that maintaining, protecting and enhancing the Riskified brand is important to expanding our business. As of December 31, 2023, we held six registered trademarks in the United States and fifty-eight registered trademarks in foreign jurisdictions, including registrations of RISKIFIED, eConfidence and the Riskified logos. As of December 31, 2023, we had applied for four additional trademark registrations in foreign jurisdictions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to protect our proprietary rights, competitors or other unauthorized parties may attempt to misappropriate our technology or may independently develop similar technologies, and we may not be able to prevent competitors from selling products incorporating those technologies. For more information regarding the risks relating to intellectual property, see Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors &#8212; Risks Relating to Our Business and Industry &#8212; Any failure to protect our intellectual property rights could impair our ability to protect our proprietary technology and our brand.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As with any company operating in our field, we grapple with a growing number of local, national and international laws and regulations. These laws are often complex, sometimes contradict other laws, and are frequently evolving. Laws may be interpreted and enforced in different ways in various locations around the world, posing a significant challenge to our global business. This ambiguity includes laws and regulations possibly affecting our business, such as those related to data privacy and security, pricing, taxation, intellectual property ownership and infringement, anti-money laundering, anti-corruption, product liability, consumer protection, financing, payment authentication, machine learning, economic and financial sanctions, trade embargoes, and export control. Changes to such laws and regulations could cause us or third-party partners on which we rely to incur additional costs and change our or their respective business practices in order to comply. See &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; Data Protection and Privacy</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Anti-Corruption and Sanctions</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Artificial Intelligence&#8221;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further discussion related to the impact of government regulation on our business.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data Protection and Privacy</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws across several jurisdictions regarding privacy and protection of data. Laws and regulations related to data protection, privacy, cybersecurity, consumer protection, financing, payment authentication, point-of-sale lending, and other laws and regulations can be very stringent and vary from jurisdiction to jurisdiction. These laws govern how companies collect, process, and share data, grant rights to data subjects, and require that companies implement specific information security controls to protect certain types of information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For example, we are subject to the PPL, and the more recent Data Security Regulations, which imposes obligations on how personal data is processed, maintained, transferred, disclosed, accessed and secured. The regulations may require us to adjust our data protection and data security practices, information security measures, certain organizational procedures, applicable positions (such as an information security manager) and other technical and organizational security measures. In addition, to the extent that any administrative supervision procedure is initiated by the Israeli Privacy Protection </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Authority that reveals certain irregularities with respect to our compliance with the Privacy Protection Act, in addition to our exposure to administrative fines, civil claims (including class actions) and in certain cases criminal liability, we may also need to take certain remedial actions to rectify such irregularities, which may increase our costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the EU and UK, we are also subject to the GDPR and the UK GDPR, as well as national legislation supplementing the GDPR and the UK GDPR. The GDPR implements stringent operational requirements regarding, among others, data use, sharing and processing, data breach notifications, data subject rights and cross- border data transfers. In relation to data transfers from the EU/UK to the US, the EU-US Data Privacy Framework, the successor of the EU-US Privacy Shield entered into effect in July 2023, and the UK has enacted the UK-US data bridge (the UK extension to the EU-US Data Privacy Framework) to facilitate EU-US and UK-US data transfers, respectively. In addition, the GDPR and the UK GDPR require us to implement appropriate technical and organizational measures to ensure a level of security appropriate to the organization&#8217;s processing requirements and risk. Accordingly, certain cyber security requirements must be fulfilled to ensure that data is processed and stored safely. Organizations must notify the relevant supervisory authority about data breaches within certain time limits and, in some instances, provide notification to data subjects. The GDPR requirements apply not only to third-party transactions, but also to transfers of information between us and our subsidiaries, including employee information. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The GDPR and UK GDPR impose significant penalties for non-compliance (up to EUR 20 million for the most serious breaches of the GDPR, or GBP 17.5 million in the case of the UK GDPR or up to 4% of the total worldwide annual turnover of the preceding financial year, whichever is higher). Further, following Brexit, the UK government has indicated its intention to diverge from the EU&#8217;s privacy framework. In March 2023, the UK Parliament put forward a revised Data Protection and Digital Information Bill, which proposes various amendments to some of the UK&#8217;s key data privacy regulations. Whilst these changes aim to strike a balance between promoting innovation without rebuilding the existing data protection framework (in order to retain the EU&#8217;s adequacy decision for the UK), these prospective changes may require us to make changes to our data privacy compliance operations and/ or to our business practices and may result in substantial costs, which in turn may compromise our growth strategy and otherwise adversely affect our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to evolving EU and UK privacy laws on cookies, tracking technologies and e-marketing. In the EU and UK, informed consent is required for the placement of certain cookies or similar tracking technologies on an individual&#8217;s device and for direct electronic marketing. Consent is tightly defined and includes a prohibition on pre-checked consents and a requirement to obtain separate consents for each type of cookie or similar technology.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 16, 2020, the European Union published a new cybersecurity strategy which aims at adapting online and offline security requirements in response to growing interconnectedness and digitization. In December 2022, the Directive (EU) 2022/2555 of the European Parliament and of the Council of December 14, 2022 on measures for a high common level of cybersecurity across the Union, amending Regulation (EU) No 910/2014 and Directive (EU) 2018/1972, and repealing Directive (EU) 2016/1148, or the NIS 2 Directive, was published in the official journal of the European Union. As EU Member States still need to adopt the NIS 2 Directive into national law by October 17, 2024, it is difficult to assess the impact on our business or operations, but it may require us to modify our cybersecurity practices and policies and we could incur substantial costs as a result.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 1, 2022, the Digital Markets Act, or the DMA, entered into force and on November 16, 2022, the Digital Services Act, or the DSA, followed. As further guidance is issued and interpretation of both the DSA and the DMA evolves, it is difficult to assess the impact of the DSA and DMA on our business or operations, but, to the extent applicable, it may require us to modify our practices and policies and we could incur substantial costs as a result.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to Lei Geral de Prote&#231;&#227;o de Dados, which imposes similar requirements to the GDPR on the collection and processing of data of Brazilian residents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to the CCPA, which, among other things, gives California residents (which may include any of our current or future employees who may be California residents) rights over their personal information, including rights to opt out of certain personal information sharing and requires in-scope business to provide California residents detailed information about how their personal information is used and provide such residents ways to opt-out of certain sales of personal information. The CCPA provides for civil penalties for violations, as well as a private right of action certain for data breaches. Similar laws coming into effect in other U.S. states, the potential for adoption of a comprehensive U.S. federal data privacy law, and new legislation in international jurisdictions may continue to change the data protection landscape globally and could result in us expending considerable resources to meet these requirements. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in China, we are subject to the CSL, DSL, PIPL and other data-related regulations, such as the Cybersecurity Review Measures. The CSL requires certain network operators and service providers to, among other things, take necessary measures to safeguard the operation of networks and imposes certain additional requirements on CIIOs. The DSL provides for data security and privacy obligations on entities and individuals carrying out data processing activities, including but not limited to the collection, storage, use, processing, transmission, provision, and public disclosure of data. The DSL also requires data processors to establish and improve a whole-process data security management system, organize data security education and training, and take corresponding technical measures and other necessary measures to safeguard data security. The DSL requires a national security review procedure for those data activities which may affect national security and imposes export restrictions on certain data and information. Under the Cybersecurity Review Measures, a network platform operator who possesses personal data of more than one million users is required to apply for a cybersecurity review before listing in a foreign country, and the competent governmental authorities may initiate a cybersecurity review if they deem certain network products or services or data processing activities to affect national security. Network platform operators are not defined but are understood to be broadly interpreted to include all network platform operators or service providers, thus providing for a broad application. A mandatory cybersecurity review is likely to prolong the timeline of any contemplated listing abroad and increase the regulatory burden on entities that are subject to this requirement. The PIPL became effective on November 1, 2021. Notably, the PIPL, similar to the GDPR, applies extra-territorially and reiterates the circumstances under which a personal information processor may process personal information, such as when (i) the individual&#8217;s consent has been obtained; (ii) the processing is necessary for the performance of a contract to which the individual is a party; (iii) the processing is necessary to fulfil statutory duties and statutory obligations; (iv) the processing is necessary to respond to public health emergencies or protect the life, health and property safety of natural persons under emergency circumstances; (v) the personal information that has been made public is processed within a reasonable scope in accordance with the PIPL; (vi) personal information is processed within a reasonable scope to conduct news reporting, public opinion-based supervision, and other activities in the public interest; or (vii) under any other circumstance as provided by any law or regulation. Failure to comply with PIPL can result in fines of up to RMB 50 million or 5% of the prior year&#8217;s total annual revenue for the personal information processor and/or a suspension of services or data processing activities. Other potential penalties include a fine of up to RMB 1 million on the person in charge or directly-responsible personnel and, in serious cases, individuals and entities may be exposed to criminal liabilities under other local Chinese law, such as the Criminal Law of the People&#8217;s Republic of China. The PIPL also prohibits personnel responsible for violations of the PIPL from holding high level management or data protection officer positions in relevant enterprises. The CSL, DSL and PIPL also impose certain data localization requirements on CIIOs, important data processors and organizations that process personal information above a certain threshold. Furthermore, the national regulators, namely the Cybersecurity Administration of China and the State Administration of Market Regulation, have continued to issue new guidance and requirements for the processing of personal data. As the introduction of new compliance requirements that occur on an ongoing basis typically apply with immediate effect, they may lead to additional costs and may require further changes to our compliance operations. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors &#8212;Risks Related to our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business and Industry&#8212;Compliance with continuously evolving privacy laws and regulations, including laws and regulations governing processing of personal information, including payment card data, and our actual or perceived failure to comply with such laws and regulations may result in significant liability, negative publicity, and/or erosion of trust and could have an adverse effect on our revenues, our results of operations and financial condition.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Data protection regulators may seek jurisdiction over our activities in locations in which we process data or have users but do not have an operating entity. Where the local data protection and privacy laws of a jurisdiction apply, we may be required to register our operations in that jurisdiction or make changes to our business so that user data is only collected and processed in accordance with applicable local law. In addition, because our products are accessible from various jurisdictions, certain foreign jurisdictions may claim that we are required to comply with their privacy and data protection laws, including in jurisdictions where we have no local entity, employees or infrastructure. In such cases, we may require additional legal review and resources to ensure compliance with any applicable privacy or data protection laws and regulations. In addition, in many jurisdictions there may in the future be new legislation that may affect our business and require additional legal review.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-Corruption and Sanctions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws and regulations of the jurisdictions in which we operate, including the United States, United Kingdom, European Union and Israel, that govern or restrict our business and activities in certain countries and with certain persons, including the economic and financial sanctions and trade embargo regulations administered by the U.S. Treasury Department&#8217;s Office of Foreign Assets Control, and the export control laws administered by the U.S. Commerce Department&#8217;s Bureau of Industry and Security. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors&#8212; Risks Related to our Business and Industry&#8212;Our failure to comply with the anti-corruption, trade compliance, anti-money laundering and terror finance and economic sanctions laws and regulations of the United States and applicable international jurisdictions could materially adversely affect our reputation and results of operations.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we are subject to anti-corruption, anti-bribery, anti-money laundering and similar laws imposed by governments around the world with jurisdiction over our operations, which may include, among others, the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. 201, the U.S. Travel Act, the USA PATRIOT Act, the U.K. Bribery Act 2010, Chapter 9 (sub-chapter 5) of the Israeli Penal Law, 5737-1977, the Israeli Prohibition on Money Laundering Law, 5760-2000 and other applicable laws in the jurisdictions in which we operate. Historically, technology companies have been the target of FCPA and other anti-corruption investigations and penalties. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors&#8212;Risks Related to our Business and Industry&#8212;Our failure to comply with the anti-corruption, trade compliance, anti-money laundering and terror finance and economic sanctions laws and regulations of the United States and applicable international jurisdictions could materially adversely affect our reputation and results of operations</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Artificial Intelligence</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business increasingly relies on artificial intelligence, machine learning and automated decision making, and the regulatory framework for this technology is rapidly evolving. Many federal, state and foreign government bodies and agencies have introduced or are currently considering additional laws and regulations governing the use of such technologies. These additional laws may limit our ability to use these technologies for our business, require us to expend additional resources to be in compliance, or require us to adapt our business practices to comply.  For example, in October 2023, President Biden issued the Executive Order on Safe, Secure and Trustworthy Artificial Intelligence, which established new standards for the training, testing and cybersecurity of sophisticated artificial intelligence models and instructed other federal agencies to promulgate certain additional regulations within certain timeframes from the date of the order. Additionally, new laws regulating artificial intelligence &#8211; in particular generative artificial intelligence, algorithmic recommendation and deep synthesis technologies - have been enacted in China, and in December 2023, the European Parliament and Council reached a political agreement on the EU AI Act, which seeks to create a comprehensive legal framework for the regulation of artificial intelligence systems across the EU and includes requirements around transparency, conformity assessments and monitoring, risk assessments, human oversight, security, accuracy, general purpose artificial intelligence and foundation models, and fines for breach of up to 7% of worldwide annual turnover. The EU AI Act is expected to be published in early 2024 with the majority of obligations expected to take effect by 2026. There is also an increase in litigation in a number of jurisdictions, including the United States, relating to the development, security and use of artificial intelligence. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors&#8212;Risks Related to our Business and Industry&#8212;As the regulatory framework for machine learning technology and artificial intelligence evolves, including with respect to unintentional bias and discrimination, our business, financial condition, and results of operations may be adversely affected</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental, Social and Governance (ESG)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to establish ourselves as a global company, with employees, customers, suppliers and shareholders all over the world, the way that we think about ourselves, our communities and our governance practices has also evolved, including through the lens of ESG best practices.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize the impact that companies like ours may have on the environment. As a result, we are working to integrate sustainability initiatives into our business practices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a business that is conducted predominantly online, our direct carbon footprint is likely to be smaller than those of manufacturing or other resource-intensive businesses. We do, however, also have indirect emissions and other environmental impacts; while we believe these are also smaller than companies in other sectors, we still strive to make sustainable choices and to limit our impact on the environment and climate in various ways.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified two primary sources of environmental impact related to our business operations: (1) our reliance on data centers; and (2) energy consumption and waste derived from our primary office locations in Tel Aviv and New York.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Data Centers:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We do not own or operate our data centers. Instead, we outsource substantially all of the infrastructure relating to our cloud offerings to major vendors such as Amazon Web Services, many of whom have publicly committed to ambitious sustainability targets.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Office Initiatives:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In order to help us set informed energy consumption targets in the future, we have begun to track our monthly energy usage in our Tel Aviv and New York offices. In addition, to aid in the promotion of environmental conservation, we have established a number of waste and energy management initiatives, including installation of energy efficient lighting, recycling and composting areas, return bins to help reduce takeaway plastic use, mass transportation options </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(such as bicycle storage and proximity to public transportation), employee computer repurchase programs (for refurbished ex-company computers), food donation programs, and sustainability based educational and volunteering activities. In addition, our Tel Aviv office, which is our largest site, recently received Leadership in Energy and Environmental Design (&#8220;LEED&#8221;) Operations &amp; Maintenance V4.1 certification with a &#8220;Gold&#8221; rating.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Social</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Riskified Cares&#8221; is our in-house program encompassing social responsibility programs including diversity, equity, and inclusion (&#8220;DEI&#8221;), community outreach and sustainability:</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Diversity, Equity &amp; Inclusion:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our mission is to empower businesses to unleash ecommerce growth by taking risk off the table. We focus on maximizing our merchants&#8217; success, because when they succeed, we succeed. In order to deliver on this mission, we believe it is important to employ a workforce that embodies diversity of background, thought, skill and perspective to expertly assist our diverse merchant base, who also possess these characteristics.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to building an inclusive talent base, while attracting and retaining the brightest and most talented individuals from a diverse range of backgrounds. As of December 31, 2023:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">44% of our global employee base were women;</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">36% of all management positions were held by women; and</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">37% of all technical positions were held by women, which, while reflective of industry standards, is an area we are focused on improving through various initiatives to increase the pipeline of women candidates.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We support identity-based communities through our RiskiPride (LGBTQ+) and Women at Riskified networks. These groups organize social, professional and educational events for members and allies.</span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we believe personal and professional growth are imperative to the well-being of our employees. We have a dedicated Learning &amp; Development team that develops and facilitates learning and growth initiatives which provide our employees with opportunities to acquire new skills and to develop through exploration, experience and learning. For example, we offer DEI-focused learning and development programs, such as Inclusivity Training for our Recruiting team, DEI Workshops for our Human Resources team and Working Globally workshops for all employees. To promote professional development we also offer Resilience and Stress Management workshops, Time Management workshops and programs based on the &#8220;DiSC&#8221; model, which explore unique behavioral preferences and how they can impact interactions between colleagues. Finally, to promote career pathing, we offer programs designed to develop management and leadership skills and to help promote employee engagement. These include a Manager Orientation Program, Manager Accelerator Program, Managerial Skills workshops and peer learning initiatives. </span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:115%">In addition, we have an Employee Experience team that is dedicated to supporting our employees&#8217; physical and mental health. We offer well-being benefits that vary by location, including extended health insurance and free group fitness classes.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Compensation Framework: </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we have implemented a comprehensive framework which guides our pay decisions. We use an objective job evaluation methodology to reduce subjectivity and bias in pay decisions, leading to greater equity in employee compensation.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Community Outreach: </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are focused on social matters that impact our people and the communities in which they live. We recognize and respect our employees&#8217; passion for engaging with their local communities, and actively encourage and facilitate this engagement. For example, we have established &#8220;Riskified Cares Community Outreach&#8221;, which is a robust program that </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">enables employees to give back to the communities in which they live and work by volunteering on company time. Additionally, we have participated in a number of relief initiatives following the events of October 7, 2023, including company and employee donations to Israeli not-for-profit organizations, hosting a blood donation drive at our Tel Aviv office and providing opportunities for our employees to take part in numerous volunteer projects. For the year ended December 31, 2023, our employees volunteered approximately 1,500 hours across 46 different not-for-profit organizations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We seek to uphold corporate governance practices that align with our core values and protect the interests of our stakeholders, including our shareholders, merchants, employees and communities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors has appointed audit, compensation and nominating and governance committees, all guided by committee charters delegating key responsibilities. The roles of each committee are set forth elsewhere in this Annual Report. We have adopted Corporate Governance Guidelines and other key policies, including a Code of Business Conduct and Ethics, an Anti-Corruption Compliance Policy, and a Whistleblower Policy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_58"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Organizational Structure</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The legal name of our company is Riskified Ltd. and we are organized under the laws of the State of Israel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our subsidiaries as of December 31, 2023, are set forth in the table below. Each subsidiary is 100% owned directly by Riskified Ltd.</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.874%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.926%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Place of Incorporation</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified, Inc.</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Delaware, USA</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (Shanghai) Information Technology Co., Ltd</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shanghai, People&#8217;s Republic of China</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (UK) Ltd.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (Japan) K.K.</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:2.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">In December 2023 we filed an application for voluntary striking-off our United Kingdom subsidiary Riskified (UK) Ltd. We expect the voluntary striking-off process to be completed in March 2024.</span></div><div><span><br/></span></div></td></tr></table></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_61"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Property, Plants, and Equipment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal facilities are located in Tel Aviv in Israel and in New York City in the United States and consist of an aggregate of approximately 11,410 square meters (approximately 122,860 square feet) of leased office space, which includes approximately 2,740 square meters (approximately 29,520 square feet) of space that we sublease to other tenants. In 2022, we completed a build-out of our Tel Aviv office. See Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects&#8212;Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for a discussion of costs incurred during the periods presented relating to the expansion and improvement of our facilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These facilities accommodate our principal executive offices, research and development, sales and marketing, design, business development, finance, information technology, and other administrative activities. The leases for these facilities in Tel Aviv and New York City expire in 2031 and 2029, respectively and we have options to renew the leases through 2036 and 2034, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also lease space in Shanghai, China. We believe that our facilities are adequate to meet our needs for the immediate future, and that, should it be needed, suitable additional space will be available to accommodate any such expansion of our operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_64"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4A. UNRESOLVED STAFF COMMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_67"></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion together with our audited consolidated financial statements and related notes included elsewhere in this Annual Report. The statements in this discussion regarding industry outlook, our expectations regarding our future performance, liquidity and capital resources and other non-historical statements are forward-looking statements. These forward-looking statements are subject to numerous risks, uncertainties and assumptions, including, but not limited to, the risks and uncertainties described in &#8220;Special Note Regarding Forward-Looking Statements&#8221; and Item 3.D. &#8220;Key Information &#8212; Risk Factors.&#8221; Our actual results may differ materially from those contained in or implied by any forward-looking statements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Certain information called for by this Item 5, including a discussion of the year ended December 31, 2021 compared to the year ended December 31, 2022 has been reported previously under Item 5 &#8220;Operating and Financial Review and Prospects&#8221; in our </span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">Annual Report for the fiscal year ended December 31, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">, filed with the SEC on February 2</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">4</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">, 202</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">3</a></span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_70"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Overview</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to empower businesses to unleash ecommerce growth by taking risk off the table. We have built a next-generation ecommerce risk intelligence platform that allows online merchants to create trusted relationships with their consumers. Leveraging machine learning that benefits from a global merchant network, our platform identifies the individual behind each online interaction, helping merchants&#8212;our customers&#8212;eliminate risk and uncertainty from their business. We drive higher sales and reduce operating costs for our merchants and assist them to provide superior online shopping experiences for their consumers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe legacy ecommerce fraud platforms and rules-based, in-house solutions are frequently slow, inaccurate, expensive, and inflexible. They can often produce the wrong decision&#8212;by rejecting good transactions or accepting fraudulent ones&#8212;which causes merchants to either lose revenue or incur unnecessary expenses in the form of chargebacks and other fees. We believe these slow manual processes produce poor online shopping experiences that lead to abandoned shopping carts. Additionally, this outdated infrastructure may prevent merchants from adapting to fast-changing consumer preferences and fraud techniques.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ecommerce risk intelligence platform is built to solve these problems with proprietary machine learning models that drive an automated decisioning engine. We have designed our platform to be fast, accurate, scalable, and cost-effective. It supports our core Chargeback Guarantee product&#8212;which optimizes merchant approval rates&#8212;as well as our other products that mitigate similar ecommerce risks for those same merchants, including Policy Protect, Dispute Resolve, Account Secure and PSD2 Optimize.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of our products are designed to enable merchants to generate additional revenue or cost savings, while improving the online shopping experience for their consumers. See Item 4.B. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Business Overview&#8221;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for further information on our products. </span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_73"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Model</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fundamentally, our business model aligns our interests with those of our merchants&#8212;we win when our merchants win. We charge merchants using our Chargeback Guarantee product a percentage of every dollar of GMV that we approve on their behalf, so we are incentivized to approve as many orders as we safely can. We believe that this merchant-centric approach, coupled with our rigorous decisioning process, maximizes our financial results and those of our merchants.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fee we charge our merchants is a risk-adjusted price, which is expressed as a percentage of the GMV that we approve. This fee, which is established at contract inception, varies by merchant based on a variety of inputs, including the type of merchant, the order population, the risk level of the end market (including industry and geographic region), the percentage of GMV we review from the merchant, and the guaranteed approval rates we agree to provide. When our merchants ask us to review transactions from end markets that carry higher risk, we may charge higher fees to help offset the increased likelihood of receiving a chargeback. We may charge merchants for products, other than our Chargeback Guarantee product, based on alternative pricing models, such as a flat subscription fee. None of these products generated material revenues in 2023.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an approved transaction that we have guaranteed results in an eligible chargeback, we will reimburse the merchant for the amount of the lost sale. In this situation, we record a chargeback expense in cost of revenue and typically reimburse the merchant in the form of credits on future invoices.  We have established processes that are designed to help us manage our overall chargeback exposure and control realized chargeback expenses within predetermined budget levels. We do this primarily by controlling the transactions we approve and assessing the cost-benefit of our approvals. Our models are trained on a large and diverse population of historical transactions accumulated since our founding. Combined with the short-term duration of our chargeback portfolio, the dynamic feedback loops in our business model ensure our training sets are constantly updated, thereby increasing the accuracy of our ecommerce risk intelligence platform. We supplement our models with offline tools that are designed to quickly detect different types of anomalies and gaps in our models. We also adjust our approval rates in real time as we detect riskier order populations. Finally, our chargeback expenses typically become less volatile over time as we scale. As of December 31, 2023, our portfolio of potential chargeback liabilities was diversified across a number of industries, hundreds of merchants and millions of individual transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Using our proprietary ecommerce risk intelligence platform, data assets, and scaled merchant network, we are able to control the chargeback expenses we incur, as evidenced by our ability to maintain our annual CTB Ratio between 37% and 41% for the past three years. We use the annual CTB Ratio to evaluate the performance of our business operations and the effectiveness of our models. We believe that CTB Ratio is best analyzed on an annualized basis, rather than quarterly, as individual quarters may fluctuate due to a number of factors, including changes in the mix of our merchant industry and geographic base, the risk profile of orders approved in the period, and technological improvements in the performance of our models.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_76"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Factors Affecting Our Performance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future performance is broadly correlated with global ecommerce trends and will depend on many factors, including the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Chargeback liability shift rules and regulations and adoption of alternative payment methods: </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues are primarily derived from ecommerce merchants that bear the liability for fraud-related chargebacks. The adoption, implementation or evolution of laws and regulations, including card scheme rules has or may result in the shift of liability for certain categories of transactions away from merchants and on to other participants in the payments chain. Further, alternative ecommerce payment methods (&#8220;APM&#8221;) such as &#8220;buy now pay later&#8221;, cryptocurrencies or &#8220;digital wallet&#8221; style products such as Apple Pay, Google Pay, and PayPal may be less susceptible to fraud than traditional payment methods. These APMs may include native fraud management features, sit outside of the broader chargebacks regime or allow liability for online transactions to be shifted away from merchants. The evolution of chargeback liability shift laws and regulations, including card scheme rules, and the emergence of APMs may alter our customer base or the demand for our products, or the GMV available for us to review.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Technology leadership and performance:</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We intend to continue to invest in enhancing our ecommerce risk intelligence platform by developing new products, features, and functionality to maintain our technology leadership. Our ability to innovate is a byproduct of our exceptionally deep technology integrations across a variety of merchant systems. The depth of our integrations allows us to collect and </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">analyze complex transaction data and behavior patterns across our merchant network. We use this data to continuously train our machine learning models as well as to develop new solutions that solve new and different merchant challenges. If revenue contribution from new products with margin profiles that differ from Chargeback Guarantee increases, our overall gross margin profile may change.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">GMV Growth:</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our effectiveness in retaining and expanding our existing merchant base, as measured by Net Dollar Retention, is a critical component of our ability to drive growth. Our Net Dollar Retention rate for 2023 was </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105%</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Acquisition of new merchants in new and diverse industries and geographies is also an important component of our growth as we strive to reduce our dependence on the performance of select merchants, industries and geographies. Our GMV, as compared to global ecommerce GMV calculated by eMarketer, accounted for approximately</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 2%</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of global ecommerce GMV for the year ended December 31, 2023, leaving significant room for our merchant network to continue to grow.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">Macroeconomic Environment:</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We regularly monitor macroeconomic trends and events that may have a material impact on our business, financial condition, and results of operations. These include uncertainty around the war in Israel and other global conflicts, recessionary indicators, inflation rates and interest rates. Challenging macroeconomic conditions may result in reduced consumer spending, risk of merchant bankruptcies or business failures, and foreign currency exchange fluctuations, which may adversely impact our business. We believe that our diversified merchant portfolio and other risk management initiatives assist in mitigating the effects that these macroeconomic events can have on our business.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_79"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Performance Indicators and Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to financial measures determined in accordance with GAAP, we use the following key performance indicators and non-GAAP financial measures to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections, develop annual budgets, and make strategic decisions. By providing these non-GAAP financial measures together with a reconciliation to the most comparable GAAP measure, we believe we are enhancing investors&#8217; understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives. Changes in our key performance indicators may not correspond with equivalent changes in our revenue. Net Profit (Loss) and Adjusted EBITDA for the years 2022 and 2021 have been revised down by $0.7 million and $0.5 million, respectively, to correct an immaterial error as further described in Note 2 to our audited consolidated financial statements included in Item 18 of this Annual Report.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated, unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross merchandise volume (in millions)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Profit</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,097&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Gross Profit</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,026&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,602&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,776&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross Profit Margin</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Gross Profit Margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Profit (Loss)</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,035)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,490)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,076)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,996)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Cash Provided By (Used In) Operating Activities</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free Cash Flow</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,264)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,782)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Merchandise Volume</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the growth in transaction volume using GMV, which represents the gross total dollar value of orders reviewed through our ecommerce risk intelligence platform during the period indicated, including the value of orders that we did not approve. GMV is an indicator of the success of our merchants and the scale of our platform. GMV does not represent transactions successfully completed on our merchants&#8217; websites or revenue earned by us, however, our revenue is directionally correlated with the level of GMV reviewed through our platform and is an indicator of future revenue opportunities. We generate revenue based on the portion of GMV we approve in combination with the associated risk-adjusted fee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the portion of GMV we do not approve and on which do not generate revenue, for example, GMV associated with declined orders, the underlying data for those transactions is valuable for us to enrich our database and enhance our models. GMV may fluctuate in future periods due to a number of factors, including global macroeconomic conditions, changes in the number and mix of merchants on our ecommerce risk intelligence platform, the level of penetration within our merchant base, and our ability to retain our existing merchant base.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define non-GAAP gross profit and adjusted EBITDA, which are non-GAAP measures of financial performance, as gross profit and net profit (loss), respectively, adjusted for, as applicable, depreciation and amortization (including amortization of capitalized internal-use software as presented in our statement of cash flows), share-based compensation expense, payroll taxes related to share-based compensation, litigation-related expenses, provision for (benefit from) income taxes, other income (expense) including foreign currency transaction gains and losses and gains and losses on non-designated hedges, and interest income (expense). Non-GAAP gross profit margin represents non-GAAP gross profit expressed as a percentage of revenue. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that by excluding certain items from the associated GAAP measure that are not core to the performance of our business, these non-GAAP financial measures are useful in assessing our performance and provide meaningful supplemental information and permit investors to view performance using the same tools that we use to budget, forecast, make operating and strategic decisions, and evaluate historical performance. By providing these non-GAAP financial measures together with a reconciliation to the most comparable GAAP measure, we believe we are enhancing investors&#8217; understanding of our business and our results of operations, as well as assisting investors in evaluating how well we are executing our strategic initiatives.. Specifically, we exclude the below items due to the following factors:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Depreciation and amortization: We exclude depreciation and amortization because we believe that these costs are not core to the performance of our business and the utilization of the underlying assets being depreciated and amortized can change without a corresponding impact on the operating performance of our business. Management believes that excluding depreciation and amortization facilitates comparability to other companies in our industry.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Share-based compensation expense: We exclude share-based compensation expense primarily because it is a non-cash expense that does not directly correlate to the current performance of our business. This is because the expense is calculated based on the grant date fair value of an award which may vary significantly from the current fair market value of the award based on factors outside of our control. Share-based compensation expense is principally aimed at aligning our employees&#8217; interests with those of our shareholders and at long-term retention, rather than to address operational performance for any particular period.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Payroll taxes related to share-based compensation: We exclude employer payroll tax expense related to share-based compensation in order to see the full effect that excluding that share-based compensation expense had on our operating results. These expenses are tied to the exercise or vesting of underlying equity awards and the price of our common stock at the time of vesting or exercise, which may vary from period to period independent of the operating performance of our business. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Litigation-related expenses: We exclude costs associated with the legal matter discussed in Item 8.A. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal and Arbitration Proceedings</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; as such costs are not reflective of costs associated with our ongoing business and operating results and are viewed as unusual and infrequent.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We define free cash flow, which is a non-GAAP measure of liquidity, as net cash provided by (used in) operating activities, less cash purchases of property and equipment, and cash spent on capitalized software development costs. We provide free cash flow because it is a liquidity measure that provides useful information to management and investors about the amount of cash generated by the business that can be used for strategic opportunities, including investing in our business and strengthening our balance sheet. Free cash flow is limited, however, because it does not represent the residual cash flow available for discretionary expenditures. Free cash flow is not necessarily a measure of our ability to fund our cash needs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-GAAP financial measures have limitations as analytical tools and should not be considered as an alternative to any measure derived in accordance with, GAAP. Other companies, including companies in our industry, may calculate similarly titled non-GAAP financial measures differently or not at all, which reduces their usefulness as a comparative measure. Some of the limitations are:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">these measures do not reflect our cash expenditures, or future requirements for capital expenditures, or contractual commitments;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">these measures do not reflect changes in, or cash requirements for, our working capital needs;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">these measures do not reflect our tax expense or the cash requirements to pay our taxes; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Assets being depreciated and amortized will often have to be replaced in the future and these measures do not reflect any cash requirements for such replacements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Gross Profit and Non-GAAP Gross Profit Margin</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of our gross profit and gross profit margin, the most directly comparable U.S GAAP measure, to non-GAAP gross profit and non-GAAP gross profit margin for each of the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated, unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">297,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">261,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">229,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">145,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross Profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense included within cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization included within cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll taxes related to share-based compensation included within cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Gross Profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">155,026&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,602&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123,776&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-GAAP Gross Profit Margin</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Adjusted EBITDA</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net profit (loss), the most directly comparable GAAP measure, to adjusted EBITDA for each of the periods presented:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,035)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,705)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,430)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,775)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,180)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(837)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(505)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,520&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,410&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,358&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll taxes related to share-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">459&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">153&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Litigation-related expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">390&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">312&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,490)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37,076)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,996)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Free Cash Flow</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents a reconciliation of net cash provided by (used in) operating activities, the most directly comparable GAAP measure, to free cash flow for each of the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, unaudited)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,355)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,126)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,254)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,886)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,250)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Free Cash Flow</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,924&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34,264)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(33,782)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_82"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#8217; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts with our merchants for our Chargeback Guarantee product obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a six-month period from the date of the transaction.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present revenue net of cancellations and adjustments for minimum service level agreements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead. For products that offer guarantees of past performance, such as our Chargeback Guarantee, we provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. If an approved transaction that we have guaranteed results in an eligible chargeback, we will reimburse the merchant for the amount of the lost sale. In this situation, we record a chargeback expense in cost of revenue and typically reimburse the merchant in the form of credits on future invoices. Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Gross Profit and Gross Profit Margin</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our business continues to grow, we expect our gross profit will increase while our gross profit margin may fluctuate from period to period. Our gross profit margin is highly dependent on our risk-based pricing model which determines the fee we charge our merchants, our approval rate thresholds, the merchant mix of our revenue, new geographies and industries into which we may enter, the risk profile of orders approved in the period, technological improvements in the performance of our models, and seasonality. During periods where we approve a higher percentage of legitimate orders, our CTB ratio is lower and our gross margins are higher. Further, as the merchant mix of our revenues shifts towards industries with historically higher chargeback rates, such as tickets and travel, our CTB ratio may be higher and our gross margins may be lower. We control the decision to approve a particular transaction and continuously monitor our approval rate thresholds to ensure we are not exposed to higher amounts of chargeback risk, and we structure our pricing in a way to mitigate this risk.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operating expenses consist of research and development, sales and marketing, and general and administrative expenses. Compensation and benefits related costs are the most significant component of operating expenses and consists of salaries and benefits, share-based compensation expense, sales commissions, and other employee benefit costs. Operating expenses also primarily include third-party hosting fees and software costs, professional service fees, overhead costs including rent and utilities, marketing and advertising related costs, and depreciation expense. For 2024, we expect that our cost reduction efforts will drive decreases in operating expenses and operating expenses as a percent of revenue, however there may be fluctuations on a quarterly basis.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expenses primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure, including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development expenses also include investments we are making in new products, as well as third-party hosting fees and software costs used by our research and development teams, allocated overhead costs, and depreciation expense. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative expenses primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Income (Expense), Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income (expense), net primarily consists of interest earned on our bank deposits, money market funds, and investments.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense), Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net primarily consists of foreign exchange transaction gains and losses, and gains and losses on foreign currency contracts not designated as hedging instruments. In periods prior to IPO, other income (expense), net primarily consisted of remeasurement gains and losses on our convertible preferred share warrant liabilities and convertible preferred share tranche rights.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for (Benefit From) Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes consists of income taxes related to Israel, United States (federal and state), China, UK, Australia, and Japan taxes. We maintain a full valuation allowance on our Israeli and U.S. deferred tax assets resulting from carryforward tax losses and other reserves and allowances, as we have concluded that it is not more likely than not that the deferred tax assets will be realized due to our history of operating losses and current uncertainty concerning our ability to realize these deferred tax assets in the foreseeable future. Our effective tax rate is primarily affected by the tax rate in Israel and the United States and the relative amounts of income we earn in those jurisdictions, as well as non-deductible expenses, such as share-based compensation, and changes in our valuation allowance.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_85"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8pt">Operating Results</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following section discusses our financial condition and results of operations for the year ended December&#160;31, 2023 compared to the year ended December&#160;31, 2022. For a discussion of our financial condition and results of operations for the year ended December&#160;31, 2022 compared to the year ended December&#160;31, 2021, refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">" in our </span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/rskd-20221231.htm">Annual Report on Form 20-F for the fiscal year ended December 31, 2022, filed with the SEC on February 24, 2023</a></span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. During the second quarter of 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. Certain prior period amounts have been updated to reflect the correction of the immaterial error. See Note 2 to our audited consolidated financial statements included in Item 18 of this annual report for additional details.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables set forth selected consolidated statements of operations data and such data as a percentage of total revenue for each of the periods presented: </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,091&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,150&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">106,170&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">152,519&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">135,097&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122,971&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,301&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2) </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,438&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,710&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52,903&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,368&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">244,445&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">178,914&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(76,849)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,348)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,943)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,775&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,180&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">591&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(122,520)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,237)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,663)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,872)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59,035)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,705)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,430)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_______________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Includes share-based compensation as follows: </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:54.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Includes depreciation and amortization (including amortization of capitalized internal-use software) as follows: </span></div><div style="margin-bottom:9pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:54.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,726&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">880&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,566&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">752&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,013&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">661&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative&#160;</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">783&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">434&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total depreciation and amortization</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,274&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,436&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:54.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">54&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">94&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(42)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(18)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(78)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Years Ended December&#160;31, 2023 and 2022</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,363&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in revenue of $36.4 million, or 14% was driven by a $17.5 billion, or 17% increase in GMV from $105.6 billion to $123.1 billion. Approximately $30.3&#160;million of the increase in revenue was  </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">driven by GMV and Billings from new merchants onboarded to our platform for which a majority is attributable to our tickets and travel, fashion, and food verticals. The remaining $6.1&#160;million increase in revenue was primarily due to upsells net of organic declines and attrition which helped to contribute to our Net Dollar Retention Rate of 105%.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue attributable to issued indemnification guarantees that are accounted for under ASC 460 and included within the $36.4 million increase in revenue, increased by $25.1 million for to the same reasons noted above. Revenue attributable to issued indemnification guarantees as a percentage of total revenue increased from 40% during 2022 to 44% during 2023 due to increases in our CTB Ratio and increases in the risk premium which collectively contributed to increases in the fair value of issued guarantees.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cost of Revenue and Gross Profit Margin </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145,091&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126,150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,941&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit margin</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in cost of revenue of $18.9 million, or 15% was primarily attributable to an increase of $18.6 million in net chargeback expenses that was driven primarily by continuing increases in GMV associated with tickets &amp; travel and food merchants' Billings due to the onboarding of new merchants and an isolated fraud event in the third quarter of 2023. There was also an increase of $1.4 million in cost of revenue due to increases in amortization of deferred contract fulfillment costs and amortization of internal use software. These increases were offset by a decrease of $1.1 million in hosting, software, and data enrichment costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit margin decreased to 51% from 52% due to increases in our CTB Ratio. Our CTB ratio, which is a key driver of our gross profit margin, increased to 41% from 39% and was primarily driven by changes in the merchant mix of our revenues and the aforementioned fraud event in the third quarter of 2023, slightly offset by improvements in our model performance and strategic risk management. The decrease in gross profit margin is partially offset by a reduction in hosting and software costs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Operating Expenses </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,577&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">72,014&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in research and development expenses of $0.4 million was primarily attributable to a decrease of $1.8 million in hosting fees and software costs, a decrease of $1.0&#160;million in payroll and related costs, a decrease of $0.6 million in overhead costs, and a decrease of $0.1 million in professional services fees. These decreases were partially offset by an increase of $3.1 million in share-based compensation expense primarily due to a higher weighted average grant date fair value of awards being expensed during 2023 as compared to 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,441&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing expenses remained relatively flat at $88.4 million. Payroll and related costs increased by $1.9&#160;million primarily due to an increase in sales commissions. Share-based compensation expense increased by $1.2 million due to a higher weighted average grant date fair value of awards being expensed during 2023 as compared to 2022, slightly offset by a decrease in share-based compensation expense associated with equity awards containing performance and service-based vesting conditions. These increases were offset by a decrease of $3.1 million in expenses associated with professional services, marketing, overhead, and travel.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69,350&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">83,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,643)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in general and administrative expenses of $14.6 million, or 17% was primarily attributable to a decrease of $10.1 million in compensation and benefits related costs including a decrease of $9.5 million in share-based compensation expense primarily attributable to awards granted to our Chief Executive Officer, including the Multi-Year Award, slightly offset by an increase in share-based compensation expense due to a higher weighted average grant date fair value of awards being expensed during 2023 as compared to 2022. For further information, see Item 6.B. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">"Compensation."</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remaining decrease consists of a $2.6 million decrease in professional services expenses, $1.5 million in insurance and overhead costs, and a $0.5 million net decrease in other general and administrative expenses such as travel, software, and taxes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Income (Expense), Net</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.609%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.602%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income (expense), net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,775&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,180&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,595&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">124&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income (expense), net increased by $12.6 million, or 124% primarily due to increases in global interest rates.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:45.769%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.281%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.741%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.743%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">837&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">332&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net increased by $0.3 million, or 66% primarily due to a decrease of $1.1 million in net losses on non-designated hedging transactions, partially offset by a decrease of $1.1&#160;million in gains from foreign currency transactions. The decrease in losses on non-designated hedging </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">transactions and the decrease in gains from foreign currency transactions are primarily due to movements in exchange rates between the U.S. Dollar, the Israeli Shekel, and the Euro. The remaining net increase was driven by individually immaterial items. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Provision for (Benefit from) Income Taxes</span></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(dollars in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes decreased by $0.2 million, or (4)%. We maintain a full valuation allowance on our Israeli and U.S. deferred tax assets resulting from carryforward tax losses, capitalized research and development expenses, and other reserves and allowances. The provision for income taxes decreased primarily as a result of uncertain tax positions and change in valuation allowance. Our effective tax rate was (10.89)% and (6.12)% of our net profit (loss) before income taxes for the years ended December&#160;31, 2023 and 2022, respectively. Our effective tax rate is affected by tax rates in foreign jurisdictions and the relative amounts of income we earn in those jurisdictions, as well as non-deductible share-based compensation, prior period adjustments, uncertain tax positions, and changes in our valuation allowance.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impact of Foreign Currency Fluctuation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Item 3D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors&#8212;We are exposed to fluctuations in currency exchange rates, which could negatively affect our operating results.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Item 11. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Quantitative and Qualitative Disclosures About Market Risk-Foreign Currency Exchange Risk</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_88"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.   Liquidity and Capital Resources</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have financed our operations primarily through the issuance of ordinary and preferred shares, warrants, and cash flows from operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal uses of cash has been related to investments in bank deposits, money market funds, and marketable debt securities, funding our operations, capital expenditures, and share repurchases. As of December&#160;31, 2023, our principal sources of liquidity were cash, cash equivalents, bank deposits, and short-term investments of $474.8 million which were held for working capital purposes. Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term investments consists of available-for-sale marketable debt securities. In 2023, we earned $22.8&#160;million of interest income from our bank deposits, money market funds, and marketable debt securities. We expect to continue to utilize bank deposits, money market funds, and other similar investment vehicles to generate returns on our capital in the future, however the amount of interest income we are able to earn may fluctuate from year-to-year as a result of, among other things, changes in global interest rates, changes in the terms of new bank deposits, and changes in our investment strategy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our cash, cash equivalents, short-term deposits, and short-term investments, together with cash we expect to generate from future operations, will be sufficient to meet our working capital and capital expenditure requirements for a period of at least twelve months from the date of this Annual Report. We may require additional capital to respond to technological advancements, competitive dynamics or technologies, customer demands, business opportunities, challenges, acquisitions or unforeseen circumstances and in either the short-term or long-term may determine to engage in equity or debt financings or enter into credit facilities for other reasons.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors including our revenue growth rate, chargeback expenses, merchant churn, regulatory developments, the market acceptance and demand for our offerings, international expansion efforts, and the investments we make that support our business. We may in the future enter into arrangements to acquire or invest in complementary businesses, services, and technologies, including intellectual property rights. If we are unable to obtain adequate financing or financing on terms satisfactory to us or at all, when we require it, our ability to continue to grow or support our business and to respond to business challenges could be significantly limited. In particular, inflation and rising interest rates across the global economy have resulted in, and may continue to result in, significant disruption of global financial markets, which may reduce our ability to access capital. If we are unable to raise additional funds when or on the terms desired or generate cash flows necessary to expand our operations and invest in continued innovation, we may not be able to compete successfully, our business, financial condition and results of operation could be adversely affected. See Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors &#8212; We may need additional capital, and we cannot be sure that additional financing will be available on favorable terms, if at all.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Share Repurchase Program</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As previously announced, on August 8, 2023 our board approved the Repurchase Program, authorizing the Company to repurchase up to $75 million of its Class A ordinary shares, subject to approval from the Israeli Court.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2023, we received approval from the Israeli Court to implement the Repurchase Program, under which we may make purchases of Class A ordinary shares from time-to-time in the open market, including through trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, in privately negotiated transactions or by other means in accordance with U.S. federal securities laws. The timing, as well as the number and value of any shares repurchased under the program, will be determined at our discretion and will depend on a variety of factors, including management's assessment of the intrinsic value of our ordinary shares, the market price of our Class A ordinary shares, general market and economic conditions, available liquidity, alternative investment opportunities, and applicable legal requirements. The share repurchases will be funded from existing cash and cash equivalents. The Repurchase Program does not obligate us to acquire a particular amount of our Class A ordinary shares, and the Repurchase Program may be suspended, modified or discontinued at any time at our discretion and without prior notice.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although our Repurchase Program does not have a set expiration date, the current Israeli Court approval is valid through May 19, 2024. We may file extension requests with the Israeli Court on an ongoing basis as required. For information on share repurchases made pursuant to the Repurchase Program during the year ended December 31, 2023, see Item 16E. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Purchase of Equity Securities by the Issuer and Affiliated Purchasers.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows for the periods presented: </span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.714%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.202%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Statements of Cash Flows Data:</span></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,279&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(26,252)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,278)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">251,559&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(210,012)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(84,441)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,314)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,855&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">423,189&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rates on cash, cash equivalents, and restricted cash</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,701)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,821&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234,110)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">318,470&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our largest source of operating cash flows are from revenues we earn from our merchants offset by the reimbursement for chargebacks. Our largest uses of cash from operating activities are for compensation and benefits related costs, overhead costs including rent and utilities, hosting and software fees, professional service fees, and marketing and advertising related costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported net cash provided by operating activities of $7.3 million for the year ended December&#160;31, 2023, compared to net cash used in operating activities of $26.3 million for the year ended December&#160;31, 2022, representing an increase of $33.5 million in net cash provided by operating activities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The increase in operating cash inflows was primarily driven by improvements in net loss and the timing of working capital cash receipts and payments of approximately $16.0&#160;million and increases in interest received of approximately $19.5&#160;million. These changes were partially offset by an increase in cash outflows associated with foreign currency contracts of approximately $1.8&#160;million. The remaining change is due to individually insignificant items.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investing activities consists of investments in and maturities of short-term deposits, purchases of investments, purchases of property and equipment, and payments of capitalized software development costs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported net cash provided by investing activities of $251.6 million for the year ended December&#160;31, 2023, compared to net cash used in investing activities of $210.0 million for the year ended December&#160;31, 2022, representing an increase of $461.6 million in cash provided by investing activities. This increase in cash provided by investing activities was primarily attributable to a decrease in purchases of short-term deposits of $408.8 million, an increase in maturities of short-term deposits of $75.3 million, and a decrease of $4.8 million in purchases of property and equipment. These cash inflows were partially offset by an increase in cash outflows of $29.1 million related to purchases of marketable debt securities. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing activities consists of proceeds we receive from the exercise of stock options and payments made for the purchase of Class A ordinary shares pursuant to our Repurchase Program. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We reported net cash used in financing activities of $9.3 million for the year ended December&#160;31, 2023, compared to net cash provided by financing activities of $3.9 million for the year ended December&#160;31, 2022, representing an increase of $13.2 million in cash used in financing activities. This increase was primarily driven by payments totaling $13.2 million related to purchases of 3.0 million of our Class A ordinary shares pursuant to our Repurchase Program.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Cash Requirements for Known Contractual and Other Obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have various non-cancelable operating leases for our corporate offices in Tel Aviv in Israel and in New York City in the United States. The leases for these facilities in Tel Aviv and New York City expire in 2031 and 2029, respectively and we have options to renew these leases through 2036 and 2034, respectively. As of December 31, 2023, we had fixed future minimum lease payments of $36.1 million, of which $5.7 million is due in the next twelve months. We incurred an aggregate of approximately $16.0 million in capital expenditures associated with the build-out of our Tel Aviv office from the fourth quarter of 2020 through the year ended December 31, 2022. The build-out of our Tel Aviv office was substantially complete as of December 31, 2022 and we have no material plans to construct, expand, or improve facilities as of December 31, 2023.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluded from the future minimum lease payments discussed above is an unsecured and undated promissory note issued in December 2020 in connection with the execution of a lease agreement for an amount of $2.9 million as of December 31, 2023. The promissory note may only be withdrawn in the event of a material and fundamental breach of the lease agreement. The promissory note expires three months after the lease termination date in 2031. As of December 31, 2023, we were in full compliance of the terms and conditions of the promissory note, and the promissory note has not been withdrawn.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into non-cancelable purchase commitments with various parties primarily for hosting and software services. As of December 31, 2023, we had non-cancelable purchase obligations with a remaining term in excess of twelve months of $1.7 million, of which $1.1 million is due in the next twelve months. These purchase obligations are primarily related to third-party data center costs that are used to host our risk intelligence platform. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on our operating leases, indemnification guarantees, and other commitments, refer to &#8220;Leases&#8221; in Note 7 and &#8220;Guarantees, Commitments, and Contingencies&#8221; in Note 8 of our consolidated financial statements included elsewhere in this Annual Report.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_91"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.   Research and Development, Patents and Licenses, etc.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development activities are primarily located in Israel. Research and development expenses primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure, including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development expenses also include investments we are making in new products, as well as third-party hosting fees and software costs used by our research and development teams, allocated overhead costs, and depreciation expense.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December&#160;31, 2023, 2022 and 2021, research and development costs accounted for approximately 24%, 28% and 24% of our total revenue, respectively. Research and development costs are expensed as incurred, except to the extent that such costs are associated with internal-use software that qualifies for capitalization.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_94"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.   Trend Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Seasonality</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue is correlated with the level of GMV that our merchants process through our ecommerce risk intelligence platform. Our merchants typically generate the most GMV in the calendar fourth quarter, which includes Black Friday, Cyber Monday, the holiday season, and other peak events included in the ecommerce calendar, such as Chinese Singles&#8217; Day and Thanksgiving. Our gross profit typically follows a similar trend. Approximately 28% and 30% of our annual revenue and 32% and 31% of our annual gross profit was earned in the fourth quarter for the years ended December&#160;31, 2023 and 2022, respectively. We believe that similar seasonality trends will continue to affect our future performance.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than as described above and in Item 3.D. "</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", in Item 5.A. "</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating Results&#8212;Factors Affecting Our Performance</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">", and in Item 5.B. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liquidity and Capital Resources</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; of this Annual Report, which are incorporated by reference herein, we are not aware of any trends, uncertainties, demands, commitments or events that are reasonably likely to have a material effect on our net revenues, income from operations, profitability, liquidity or capital resources, or that would cause the disclosed financial information to be not necessarily indicative of future operating results or financial condition.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_97"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.  Critical Accounting Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have provided a summary of our significant accounting policies, estimates and judgments in Note 2 to our audited consolidated financial statements, which are included elsewhere in this Annual Report. The following discussion pertains to critical accounting estimates that management believes are most important to the portrayal of our historical financial condition and results of operations and that require significant, difficult, subjective or complex judgments. Other companies in similar businesses may use different estimation policies and methodologies, which may impact the comparability of our financial condition, results of operations, and cash flows to those of other companies.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Application of Critical Accounting Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consolidated financial statements are prepared in accordance with GAAP. The preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, as well as related disclosures. We evaluate our estimates and assumptions on an ongoing basis. Our estimates are based on historical experience and various other assumptions that we believe to be reasonable under the circumstances. As events continue to evolve and additional information becomes available, our estimates and assumptions may change materially in future periods. Actual results could differ materially from these estimates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates, assumptions, and judgments that we believe have the most significant impact on our consolidated financial statements are described below.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#8220;guarantee obligation&#8221;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being released from risk under the guarantee obligation. Indemnification guarantees are recorded at fair value upon approving a transaction and are not remeasured to fair value each period. The determination of the fair value of our indemnification guarantees requires the use of various inputs and assumptions which include the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Historical chargebacks as a percentage of Billings:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Calculated as historical chargebacks paid divided by the associated Billings. Chargebacks paid are not transactions that are readily observable in a marketplace, however they represent actual transactions between us and the merchant. We utilize historical chargebacks as a proxy to project future chargeback claims. This input has the greatest impact on the overall fair value of the guarantee.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk premium fee:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Represents the fee that we would have incurred from a third-party in order to relieve ourselves from our legal obligation under the guarantee. We primarily use observable inputs and methodologies with a limited amount of judgment and assumptions. For example, we consider the adjusted EBITDA margin of unrelated public companies in the property casualty and multi-line insurance industry as a benchmark for the implied risk premium that an insurer would charge over the expected costs of insuring the guarantee.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Discount rate:</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Utilized to determine the present value of chargeback payments and encompasses the time period in which guarantees are resolved as well as our incremental borrowing cost. We mainly use observable inputs and methodologies with a limited amount of judgment and assumptions, such as U.S. corporate bond yields. Since chargebacks are generally paid within six months from the date of transaction, this input has the least impact on the overall fair value of the guarantee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumptions and estimates involved in calculating the fair value of our indemnification guarantees, as well as the determination of a systematic and rational amortization method for recognition of our guarantee obligations as revenue, involve inherent uncertainties and the application of significant judgment. We will continue to use judgment in evaluating the assumptions related to our indemnification guarantees, and we may refine our estimation process as we continue to accumulate additional data, which could materially impact the timing of our revenue recognition for transactions approved in future periods. The effect of a hypothetical 10% change in the inputs and assumptions of the fair value of the guarantee, as well as a 10% change in the inputs and assumptions of the systematic and rational amortization method, would have impacted our revenue by approximately 1%. Refer to Note 8 of our consolidated financial statements included elsewhere in this Annual Report for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Chargebacks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for chargebacks includes amounts associated with chargebacks that have been submitted and accepted but not yet paid by us as of the balance sheet date and estimates of chargebacks that have not yet been submitted and accepted relating to approved transactions that are accounted for under ASC 450, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450. Inputs and assumptions used by management to calculate the provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our merchant agreements typically allow chargebacks to be submitted up to six months from the order approval date and therefore, since the Company is generally only liable for chargebacks associated with transactions approved in the prior six months, the provision for chargebacks is based on the activity during that period. While the provision amount is correlated to the absolute dollar amount of chargeback expenses we incurred during the prior six months, a driver to the provision amount is the pace at which our merchant portfolio submits chargebacks to us. For example, our provision for chargebacks may be higher as a percent of total chargeback expenses when our merchant portfolio is characterized by slower chargeback submission rates based on historical experience, since a larger portion of the total chargeback expenses would not have been reimbursed to the merchant by the balance sheet date. Conversely, our provision for chargebacks may be lower as a percent of total chargeback expenses when our merchant portfolio is characterized by faster chargeback submission rates based on historical experience, since a larger portion of the total chargeback expenses would have been reimbursed to the merchant by the balance sheet date.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to accumulate data related to chargebacks, we may refine our estimates, which could materially impact our cost of revenue. It is possible that the estimate may change in the near term, and the effect of the change could be material. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of a hypothetical 10% change in the inputs and assumptions would positively impact our cost of revenue by approximately 2% or negatively impact our cost of revenue by approximately 3%. Refer to Note 8 of our consolidated financial statements included elsewhere in this Annual Report for additional information.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost to Obtain a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of four years. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term. The effect of a hypothetical one year decrease in the amortization period would have increased our sales and marketing expenses by approximately $1.1 million.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In establishing deferred income tax assets and liabilities, management makes judgments based on the enacted tax laws and published tax guidance applicable to us as well as the amount and jurisdiction of future taxable income. Deferred tax assets and liabilities are recorded and the need for valuation allowances is evaluated to reduce the deferred tax assets to amounts expected to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our evaluation of the realizability of the deferred tax assets focuses on identifying significant, objective evidence that we will more likely than not be able to realize our deferred tax assets in the future. We record valuation allowances based on an assessment of positive and negative evidence on a jurisdiction-by-jurisdiction basis, which is highly judgmental and requires subjective weighting of such evidence. To make this assessment, we evaluate historical operating results, the existence of cumulative losses in the most recent fiscal years, expectations for future taxable income from each tax-paying component in each tax jurisdiction, the time period over which our temporary differences will reverse and the implementation of feasible and prudent tax planning strategies. If our assumptions and estimates that resulted in our forecast of future taxable income for each tax-paying component prove to be incorrect, we may need to adjust the carrying value of our deferred tax balances. An increase or decrease in the valuation allowance would result in a respective increase or decrease in our effective tax rate in the period the increase or decrease occurs.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of our income tax liabilities involves dealing with uncertainties in the application of complex domestic and foreign income tax regulations. Unrecognized tax benefits are generated when there are differences between tax positions taken in a tax return and amounts recognized in the consolidated financial statements. We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent we prevail in matters for which liabilities have been established, or are required to pay amounts in excess of our liabilities, our effective income tax rate in a given period could be materially impacted. An unfavorable income tax settlement may require the use of cash and result in an increase in our effective income tax rate in the year it is resolved. A favorable income tax settlement would be recognized as a reduction in the effective income tax rate in the year of resolution. Refer to Note 11 of our consolidated financial statements included elsewhere in this Annual Report for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to &#8220;Summary of Significant Accounting Policies&#8221; in Note 2 of our consolidated financial statements included elsewhere in this Annual Report for more information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company&#8221; pursuant to the provisions of the JOBS Act. We rely on certain reduced reporting and other requirements that are otherwise generally applicable to public companies. As an &#8220;emerging growth company,&#8221; we are not required to, among other things, (i) provide an auditor&#8217;s attestation report on our system of internal controls over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act, which would otherwise be required beginning with our second annual report on Form 20-F, and (ii) comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#8217;s report providing additional information about the audit and the financial statements (auditor discussion and analysis). Section 107 of the JOBS Act provides that an &#8220;emerging growth company&#8221; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards. We have elected to use this extended transition period, which allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies, until the earlier of the date we (i) are no longer an &#8220;emerging growth company&#8221; or (ii) affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a result, our consolidated financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_100"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_103"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8pt">Directors and Senior Management</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers and Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the name and position of each of our executive officers and directors as of the date of this Annual Report:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:38.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.978%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Age</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Executive Officers</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><div style="padding-left:18pt;text-align:justify;text-indent:-18pt"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eido Gal</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Founder, Chief Executive Officer, Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assaf Feldman</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Co-Founder, Chief Technology Officer, Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aglika Dotcheva</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Naama Ofek Arad</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Operating Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ravi Kumaraswami</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President of Worldwide Field Operations</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Erez Shachar</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eyal Kishon</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(2)(3)*&#8224;</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aaron Mankovski</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(3)*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tanzeen Syed</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)*</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jennifer Ceran</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)(3)*</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.794%"><tr><td style="width:1.0%"/><td style="width:2.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serves as a member of our Audit Committee.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serves as a member of our Compensation Committee.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serves as a member of our Nominating &amp; Governance Committee.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;*</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Qualifies as independent under the NYSE listing standards.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">&#160;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Serves as lead independent director.</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eido Gal </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">is our Co-Founder and has served as our Chief Executive Officer and as the Chairperson of our board of directors since our inception. Prior to co-founding Riskified, Mr. Gal served as an Analyst at BillGuard from January 2011 to January 2013 and as an Analyst at PayPal Holdings, Inc. from January 2009 to January 2011. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assaf Feldman</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is our Co-Founder and has served as our Chief Technology Officer and as a member of our board of directors since our inception. Prior to co-founding Riskified, Mr. Feldman served as a Developer at BillGuard from September 2011 to November 2012, Vice President of Research &amp; Development at Kinetic Trading from August 2009 to August 2011, Lead Developer at monitor110.com from February 2006 to July 2008, Researcher at MIT Media-Lab from September 2003 to June 2005, Vice President of Engineering at Oddcast Inc. from April 2001 to June 2003, and as a Senior Developer at Earthnoise from August 1999 to March 2001. Mr. Feldman holds a B.A. in Film and Computer Science from Tel Aviv University in Israel and an M.A (Computer Science) from Massachusetts Institute of Technology. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aglika Dotcheva </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has served as our Chief Financial Officer since 2015 and previously as our Vice President of Finance since October 2014. Ms. Dotcheva also serves as a founding member and is on the steering committee of The F Suite, an independent community platform for Chief Financial Officers of leading venture capital funds and high growth technology companies. Ms. Dotcheva also serves on the advisory board of ARK, an AI powered software solution that helps optimize architectural and engineering plans. Prior to joining us, Ms. Dotcheva served as Associate Director at the Central Office of Budget and Financial Planning, Office of the Chief Financial Officer, at New York University. Ms. Dotcheva holds an M.B.A. in Strategy, Finance and Accounting from New York University, and a B.A. in Economics from Columbia University.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Naama Ofek Arad</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our Chief Operating Officer since April 2017 and previously as our Head of Sales Operations since January 2017. Prior to joining us, Ms. Ofek Arad served as a Consultant with The Boston Consulting Group from July 2014 to December 2016 and as an Operations Manager with the Israeli Air Force from 2006 to 2014. Ms. Ofek Arad holds a B.A. in Information Systems and Management from Ben Gurion University in Israel and an Executive M.B.A. from Northwestern University, Kellogg School of Management. Ms. Ofek Arad has notified the company of her intention to resign her role as Chief Operating Officer, for personal reasons. Pursuant to the terms of a separation agreement entered into between the Company and Ms. Ofek Arad, Ms. Ofek Arad will continue to provide services to the Company through June 30, 2024. Her last day of employment is November 1, 2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Ravi Kumaraswami</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as our President of Worldwide Field Operations since May 2022. Prior to joining us, Mr. Kumaraswami served as Chief Executive Officer of Crownpeak Technology, Inc., a digital experience software platform company, from 2017 to February 2022, and as Chief Revenue Officer of Lithium Technologies from 2014 to 2017. Mr. Kumaraswami held various sales and operations positions at SAP Ariba from 2001 to 2013 after beginning his career as a consultant with Accenture in 1990. Mr. Kumaraswami currently serves as an advisor to the board of directors of Crownpeak Technology, Inc. Mr. Kumaraswami holds Bachelor&#8217;s Degree (Honors) in Commerce from Delhi University, is a Fellow Member of the Institute of Chartered Accountants of India and a Graduate Member of the Institute of Costs and Works Accountants of India.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Erez Shachar</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our board of directors since July 2015. Mr. Shachar is the Co-Founder, Director and Managing Partner of Qumra Capital Management Ltd., a venture capital firm founded in 2013. Since 2004, Mr. Shachar has also served as Managing Partner of Evergreen Venture Partners Ltd., a venture capital firm, focusing on investment opportunities in technology companies. Mr. Shachar currently serves as a member of the board of directors of Taboola.com Ltd. (Nasdaq: TBLA), Talkspace, Inc. (Nasdaq: TALK) and several privately held companies and previously served as a member of the board of directors of Fiverr Ltd. (NYSE: FVRR) from August 2014 until August 2020. Mr. Shachar holds a B.Sc. in Mathematics and Computer Science from Tel Aviv University in Israel and an M.B.A. from the INSEAD Business School in France.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Eyal Kishon</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our board of directors since February 2013. Since September 1996, Dr. Kishon has served as Managing Partner of Genesis Partners, an Israel-based venture capital fund and since December 2020, Dr. Kishon has served as Chairman of Deep Insight, an Israel-based venture capital fund. From 1993 to 1996, Dr. Kishon served as Associate Director of Pitango Venture Capital. Prior to that, Dr. Kishon served as Chief Technology Officer at Yozma Venture Capital in 1993. From 1991 to 1993, Dr. Kishon was a Research Fellow in the Multimedia Department of IBM Science &amp; Technology. From 1989 to 1991, Dr. Kishon worked in the Robotics Research Department of AT&amp;T Bell Laboratories. Dr. Kishon currently serves as a member of the board of directors of Valens Semiconductor Ltd. (NYSE: VLNS) and several privately held companies and previously served as a member of the board of directors of Audiocodes Ltd. (Nasdaq, TASE: AUDC) from 1998 to 2023. Dr. Kishon holds a B.Sc. in Computer Science from the Technion &#8211; Israel Institute of Technology and a Ph.D. in Computer Science from New York University. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aaron</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mankovski</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served as a member of our board of directors since September 2017. Since 2000, Mr. Mankovski has served as a Managing Partner of Pitango Venture Capital, a venture capital firm founded in 1993. In addition, Mr. Mankovski founded and served as the Managing General Partner of Eucalyptus Ventures from 1997 until 2016. Mr. Mankovski previously served as a member of the board of directors of Optimal Plus, a privately held company, from November 2007 until July 2020, and currently serves as a member of the board of directors of a number of privately held companies including Tailor Brands Ltd, Silk Inc., DriveNets Ltd., Tabit Technologies Ltd. Tulip and Meta Flow (Lumen). Mr. Mankovski also serves as a member of the general Assembly of O.R.T. Technologies Ltd. and as a board observer for Formlabs and Tomorrow.io. Mr. Mankovski is the Founder and former Chairman of IATI &#8211; </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel Advanced Technology Industries. Mr. Mankovski holds a B.Sc. from Tel Aviv University in Computer Science and Statistics and served as a pilot in the Israeli Air Force. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tanzeen Syed</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served on our board of directors since October 2019. Since July 2018, Mr. Syed has served as a Managing Director at General Atlantic, focusing on investments in General Atlantic&#8217;s Technology sector. Mr. Syed rejoined General Atlantic in July 2018 after also working there from 2006 to September 2013. Prior to rejoining General Atlantic, Mr. Syed served as a Director at Temasek, an investment company, from July 2015 until June 2018, where he led U.S. technology growth investments. Prior to that, Mr. Syed was a Vice President at Great Hill Partners L.P. from October 2013 to June 2015, where he focused on Internet and software growth investing. Mr. Syed currently serves as the chairman of the board of directors of ContextLogic Inc. (dba Wish) (Nasdaq: WISH), a public portfolio company of General Atlantic. Mr. Syed also serves as a director on the board of Kiwi.com, s.r.o., Chess.com, o9 Solutions and Panorama Education, each of which are private portfolio companies of General Atlantic. Mr. Syed holds a B.A. in Economics and Political Science from Macalester College. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Jennifer Ceran</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> has served on our board of directors since February 2021. Ms. Ceran served as the interim Chief Financial Officer for Klaviyo, Inc. from November 2021 to May 2022, the Chief Financial Officer and Treasurer for Smartsheet Inc. from September 2016 to January 2021 and the Chief Financial Officer of Quotient Technology Inc. from September 2015 to September 2016. From October 2012 to September 2015, Ms. Ceran served as the Treasurer and Vice President of Investor Relations at Box, Inc. Ms. Ceran held several roles at eBay Inc. from April 2003 to August 2012, including Vice President of Investor Relations and Corporate Financial Planning and Analysis and Treasurer. Ms. Ceran currently serves on the board of directors of several private and public companies, including Klaviyo, Inc. (NYSE: KVYO), NerdWallet Inc. (NASDAQ: NRDS), Flock Group Inc. and Wyze Labs, Inc. Ms. Ceran holds a B.A. in Communications and French from Vanderbilt University and an M.B.A. from the University of Chicago Booth School of Business. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no family relationships among any of our executive officers or directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no arrangements or understandings with major shareholders, customers, suppliers or others, pursuant to which any person referred to above was selected as a director or member of senior management</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_106"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.     Compensation</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, the compensation of our directors requires the approval of our compensation committee, the subsequent approval of the board of directors and, unless exempted under regulations promulgated under the Companies Law, the approval of the shareholders at a general meeting. Nonetheless, according to the Companies Law, the compensation committee and the board of directors may in special circumstances approve compensation of directors that is inconsistent with our stated compensation policy, provided that those provisions that must be included in the compensation policy according to the Companies Law have been considered by the compensation committee and the board of directors, and provided that shareholder approval will be obtained, subject to the following requirements:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at least a majority of the shares held by all shareholders who are not controlling shareholders and do not have a personal interest in such matter, present and voting at such meeting, are voted in favor of the compensation package, excluding abstentions; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in such matter voting against the compensation package does not exceed two percent (2%) of the aggregate voting rights in the Company.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Officers other than the Chief Executive Officer</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Law requires the approval of the compensation of a public company&#8217;s executive officers (other than the chief executive officer) in the following order: (i) the compensation committee, (ii) the company&#8217;s board of directors, and (iii) if such compensation arrangement is inconsistent with the company&#8217;s stated compensation policy, the company&#8217;s shareholders (by a special majority vote as discussed above with respect to the approval of director compensation). However, if the shareholders of the company decline to approve a compensation arrangement with an executive officer (other than the chief executive officer) that is inconsistent with the company&#8217;s stated compensation policy as set forth in (iii) above, the compensation committee and the board of directors may, nevertheless, elect to override the shareholders&#8217; decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An amendment to an existing arrangement with an office holder (who is not a director) requires only the approval of the compensation committee, if the compensation committee determines that the amendment is not material in comparison to the existing arrangement. However, according to regulations promulgated under the Companies Law, an amendment to an existing arrangement with an office holder (who is not a director) who is subordinate to the chief executive officer will not require the approval of the compensation committee, if (i) the amendment is approved by the chief executive officer, (ii) the company&#8217;s compensation policy provides that a non-material amendment to the terms of service of an office holder (other than the chief executive officer) may be approved by the chief executive officer and (iii) the engagement terms are consistent with the company&#8217;s compensation policy.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chief Executive Officer</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, the compensation of a public company&#8217;s chief executive officer is required to be approved by: (i) the company&#8217;s compensation committee; (ii) the company&#8217;s board of directors, and (iii) the company&#8217;s shareholders (by a special majority vote as discussed above with respect to the approval of director compensation). However, if the shareholders of the company decline to approve the compensation arrangement with the chief executive officer, the compensation committee and the board of directors may override the shareholders&#8217; decision if each of the compensation committee and the board of directors provide detailed reasons for their decision.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The approval of each of the compensation committee and the board of directors should be in accordance with the company&#8217;s stated compensation policy; however, in special circumstances, they may approve compensation terms of a chief executive officer that are inconsistent with such policy, provided that they have considered those provisions that must be included in the compensation policy according to the Companies Law and that shareholder approval is obtained (by a special majority vote as discussed above with respect to the approval of director compensation).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the compensation committee may waive the shareholder approval requirement with regards to the approval of the engagement terms of a candidate for the chief executive officer position, if they determine that (i) the compensation arrangement is consistent with the company&#8217;s compensation policy; (ii) the chief executive officer candidate does not have a prior business relationship with the company or a controlling shareholder of the company; and (iii) subjecting the approval of the engagement to a shareholder vote would impede the company&#8217;s ability to employ the chief executive officer candidate. In the event that the chief executive officer candidate also serves as a member of the board of directors, his or her compensation terms as chief executive officer will be approved in accordance with the rules applicable to approval of compensation of directors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Aggregate Compensation of Office Holders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate compensation, including share-based compensation, paid by us and our subsidiaries to our directors and executive officers for the year ended December 31, 2023 was approximately $29.8&#160;million. This amount includes deferred or contingent compensation accrued for such year (and excludes deferred or contingent amounts accrued for during the year ended December 31, 2022 and paid during the year ended December 31, 2023). This amount includes approximately $0.6&#160;million set aside or </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accrued to provide pension, severance, retirement or similar benefits or expenses, but does not include business travel, relocation, professional and business association dues and expenses reimbursed to office holders, and other benefits commonly reimbursed or paid by companies in Israel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a summary of the (a) salary expenses, (b) cash bonus expenses, (c) social benefit costs and (d) share-based compensation expenses of our five most highly compensated executive officers in 2023, or collectively the "Covered Executives." All amounts reported reflect the cost to the Company as recognized in our financial statements for the year ended December 31, 2023. U.S. dollar amounts indicated for compensation of our Covered Executives are in thousands of dollars.</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:38.352%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.036%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.040%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary Expense</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash Bonus Expense</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Social Benefit Cost</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Share-based Compensation Expense</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Mr. Eido Gal</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Co-Founder and Chief Executive Officer</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$240</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$52</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$144</span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$16,184</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Mr. Assaf Feldman</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Co-Founder and Chief Technology Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$240</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$130</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$111</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$3,807</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ms. Aglika Dotcheva</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$350</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$190</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$145</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,426</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Ms. Naama Ofek Arad</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">Chief Operating Officer</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$217</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$120</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$73</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$1,455</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Mr. Ravi Kumaraswami</span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:100%">President of Worldwide Field Operations</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$400</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$349</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$153</span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$2,469</span></div></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.794%"><tr><td style="width:1.0%"/><td style="width:2.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Salary Expense includes the gross salary paid to the Covered Executives.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Cash Bonus Expense includes cash bonuses and/or commissions paid to our Covered Executives upon compliance with predetermined performance parameters for services rendered in 2023. See &#8220;Bonus Plans&#8221; below.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Social Benefit Cost includes the social benefits paid by us on behalf of the Covered Executives, convalescence pay, contributions made by the company to an insurance policy, 401(k) or a pension fund, work disability insurance, accrued vacation, severance, educational fund and payments for social security.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based Compensation Expense reflects expenses we recognize in connection with share options and RSUs granted to our Covered Executives. See &#8220;Equity Awards&#8221; below.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Share-based Compensation Expense for Mr. Gal reflects, in part, the Multi-Year Award (defined below). In accordance with the terms of his shareholder approved compensation package, no equity awards were granted to Mr. Gal in 2023.</span></div></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bonus Plans</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a performance-based bonus plan that applies to our non-commission based employees, which includes each of the Company&#8217;s office holders, other than Mr. Kumaraswami. This plan is based on our overall financial performance as well as individual performance. The measurements can change from year to year, typically based on one or more financial parameters, and may contain discretionary components. The plan is designed to satisfy the requirements of our Compensation Policy for Executive Officers and Directors and, with respect to Mr. Gal and Mr. Feldman, is applied in a way that is consistent with their shareholder approved compensation packages. The plan is reviewed and approved by our compensation committee and board of directors annually, as is any bonus payment made to an office holder under the plan. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Kumaraswami&#8217;s entitlement to commissions is determined based on his satisfaction of predetermined performance metrics, which typically differ to those applicable to the company&#8217;s performance-based bonus plan, set forth above. Mr. Kumaraswami&#8217;s commission plan is reviewed and approved by our compensation committee and board of directors annually, as is any commission payment made to Mr. Kumaraswami pursuant to the plan.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Awards</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Share Options</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No share options were granted to our directors or executive officers in 2023. As of December 31, 2023, share options to purchase 937,805 Class A ordinary shares granted to our directors and executive officers were outstanding under our equity incentive plans at a weighted average exercise price of $2.51 per ordinary share.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts underlying the share options granted to our office holders are expensed on a straight-line basis over the requisite service period which is generally four to five years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Share Units</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2023, our directors and executive officers were granted 1,526,147 RSUs under our equity incentive plans. In accordance with the terms of Mr. Gal&#8217;s shareholder approved compensation package, no equity awards, including RSUs, were granted to our CEO in 2023. As of December 31, 2023, 9,012,942 RSUs granted to directors and executive officers were outstanding under our equity incentive plans, inclusive of the CEO Multi-Year Equity Award described below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amounts underlying the RSU awards granted to our Covered Executives that contain a performance-based vesting condition and a service-based vesting condition, will be expensed utilizing the accelerated attribution method over the requisite service period which is generally four to five years. As of December 31, 2023, the performance-based vesting condition underlying these awards (being the occurrence of our IPO in 2021) had been achieved and the service-based vesting condition underlying these awards had been partially achieved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assumptions and key variables used in the calculation of such amounts are described in Note 2 to our audited consolidated financial statements included in Item 18 of this Annual Report. All equity-based compensation grants to our Covered Executives were made in accordance with the parameters of our Company&#8217;s compensation policy and were approved by the company&#8217;s compensation committee and board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Certain Arrangements Upon Termination</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equity awards granted to our Covered Executives are subject to a &#8220;double trigger&#8221; full acceleration vesting mechanism upon Merger/Sale (as defined in the 2021 Share Incentive Plan). That is, shares do not automatically vest upon a Merger/Sale, as vesting requires two triggers: (i) Merger/Sale, as well as (ii) termination of employment without &#8220;cause&#8221; or voluntary termination for &#8220;good reason&#8221;, in each case in connection with the Merger/Sale, and provided that such termination occurs in the three months prior to or the twelve months following such Merger/Sale. In addition, in the circumstances described above, our Covered Executives are entitled to receive severance payments in amounts equal to (i) one times their annual salary during the fiscal year in which the termination is effected, (ii) continuation for twelve months of health and social benefits, and (iii) a pro rata portion of their target bonus, if such bonus is earned with respect to the fiscal year in which the termination is effected.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon termination of employment without &#8220;cause&#8221; or voluntary termination for &#8220;good reason&#8221;, not in connection with a Merger/Sale, our Chief Executive Officer, Chief Technology Officer, Chief Financial Officer and President of Worldwide Field Operations are each entitled to receive severance payments in amounts equal to (i) one times their annual salary during the fiscal year in which the termination is effected, and (ii) continuation for twelve months of health and social benefits.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CEO Multi-Year Equity Award</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, our board of directors and shareholders granted to our chief executive officer, Mr. Gal, a multi-year equity award, comprising 3,993,440 RSUs (the &#8220;Multi-Year Award&#8221;). The grant date fair value of the Multi-Year Award, which is the amount of share-based compensation expense that we recognize, is primarily determined based on the share price on the date the award was granted and is not based on our current share price. This amount is expensed utilizing the accelerated attribution method over the requisite service period of ten years. This method attributes higher expenses to the earlier periods of the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">requisite service period. Mr. Gal&#8217;s 2023 compensation, set forth above, in part reflects this Multi-Year Award.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Multi-Year Award is structured so that meaningful value may only be realized upon the achievement of sustained and significant high performance levels. The award is divided into ten tranches that are eligible to vest based on the achievement of stock price goals, which range from $26.67 to $106.67, measured based on the average of our stock price over a trailing 60 trading day period during predefined performance periods, subject to Mr. Gal&#8217;s continued employment as our chief executive officer through each such period. In order to earn all of the tranches, the stock price will have to be more than 5 times higher than the price at IPO. No tranches of the Multi-Year Award were earned or vested in 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the service-based vesting condition, and market-based vesting condition, each described above, the Multi-Year Award is also subject to a performance-based vesting condition. The performance-based vesting condition underlying the Multi-Year Award was satisfied upon the occurrence of our IPO in 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Director Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 15, 2021, our shareholders approved a non-employee director compensation package, pursuant to which we pay each of our non-employee directors who (i) was appointed to our board of directors in connection with our initial public offering or otherwise joins our board of directors in the future, or (i) serves or will serve in the future on a committee of our board of directors, the following compensation:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cash Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We pay to each of our non-employee directors an annual cash retainer with respect to each twelve months of service on our board of directors in an amount of:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:31.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Chairperson</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Lead Independent Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Member</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Board of Directors</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$55,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$45,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$30,000</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.794%"><tr><td style="width:1.0%"/><td style="width:2.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Payments to the Board Chairperson and Lead Independent Director are in lieu of (and not in addition to) the payment referenced for Board membership. In the case of service of less than a full twelve months, the annual fee shall be prorated with respect to the actual period of service.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Ms. Ceran is entitled to receive an annual cash retainer with respect to each twelve months of service in an amount of $50,000.</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional fees with respect to each twelve months of service on committees of the board of directors in the amounts of:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:31.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Chairperson</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Member</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Audit Committee</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$20,000</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$10,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Compensation Committee</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$12,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$6,000</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nominating &amp; Governance Committee</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,000</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other Committees as Authorized by the Board of Directors</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$8,000</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4,000</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:13.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.794%"><tr><td style="width:1.0%"/><td style="width:2.707%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.093%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:120%">Payments to the committee chairpersons are in lieu of (and not in addition to) the payments referenced for committee membership. In case of service of less than a full twelve months period, the annual fee shall be prorated with respect to the actual period of service.</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, individual directors may elect to opt out of, waive, or otherwise forego such cash compensation at their discretion. For the year ended December 31, 2023, Ms. Ceran received total cash compensation of $74,000 in connection with her service on our board and board committees. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The remainder of our non-employee directors elected to waive 100% of the cash compensation payable to them in connection with their service on our board and board committees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Equity-based Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, each of our non-employee directors is entitled to receive equity-based compensation as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Welcome Grant: </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each newly appointed or elected non-employee director shall be entitled to receive a one-time equity award under our 2021 Plan with a grant date fair market value of $350,000. The Welcome Grant shall be granted within 90 days of the date of initial appointment or election to our board (unless a board meeting is not held during such time, in which case the grant will be made at the next board meeting following such period), and shall vest annually over a period of three years from such date, subject to the director&#8217;s continued service through each vesting date.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Grant: </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each non-employee director shall be entitled to receive an equity award, on an annual basis, under our 2021 Plan (subject to their continued service through each applicable grant date) with a grant date fair market value of $175,000. The Annual Grant shall be granted in conjunction with grants to our management, and shall vest on the first anniversary of the date of such grant, subject to each directors continued service through such date. No non-employee director shall receive an Annual Grant in the year in which they receive a Welcome Grant or prior to serving on our board for less than six months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Welcome Grant and the Annual Grants shall accelerate and fully vest upon the occurrence of Merger/Sale (as defined in the 2021 Plan) and a preceding or subsequent termination of service.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, individual directors may elect to opt out of, waive, or otherwise forego their entitlement to such equity compensation at their discretion. For the year ended December 31, 2023, Ms. Ceran received 100% of the equity compensation payable in connection with her service on our board and board committees (being an Annual Grant with a grant date fair market value of $175,000). The remainder of our non-employee directors elected to waive 50% of the equity compensation payable in connection with their service on our board and board committees, and therefore received Annual Grants with grant date fair market values of $87,500.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employment and Consulting Agreements with Executive Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into written employment agreements with each of our executive officers. These agreements generally provide for notice periods of varying duration in connection with the termination of the relevant executive officer&#8217;s employment by us or by the relevant executive officer, during which time the executive officer will continue to receive salary and benefits. These agreements also contain customary provisions regarding non-competition, non-solicitation, confidentiality of information and assignment of inventions. However, the enforceability of the non-competition provisions may be limited under applicable laws. We describe the compensation and severance arrangements with our executive officers above under &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Aggregate Compensation of Office Holders</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors&#8217; Service Contracts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than with respect to our directors that are also executive officers, there are no arrangements or understandings between us, on the one hand, and any of our directors, on the other hand, providing for benefits upon termination of their service as directors of the Company, except with respect to the acceleration of unvested equity grants upon the occurrence of a Merger/Sale (as defined in the 2021 Plan) and a preceding or subsequent termination of service, as described above under </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Aggregate Compensation of Office Holders.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amended and Restated 2013 Equity Incentive Plan</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Equity Incentive Plan, or the 2013 Plan, was adopted by our board of directors on July 3, 2013 and amended and restated on February 23, 2021. The 2013 Plan provided for the grant of equity-based incentive awards to our employees, directors, office holders, and consultants. The U.S. Sub-Plan to the 2013 Plan, which is to be read as a continuation of the 2013 Plan, was adopted by our board of directors on May 10, 2015 and amended and restated on February 23, 2021. The U.S. Sub-Plan governed equity-based incentive awards granted to our United States employees, directors, office holders and consultants, including those who are deemed to be residents of the United States for tax purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We no longer grant any awards under the 2013 Plan as it was superseded by the 2021 Share Incentive Plan, or the 2021 Plan. Awards granted prior to the adoption of the 2021 Plan remain outstanding and are governed by the 2013 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class A ordinary shares underlying outstanding awards under the 2013 Plan that expire, are cancelled, terminated, forfeited or which are settled in cash in lieu of issuance of shares or become unexercisable without having been exercised in full will become available again for future grant under the 2021 Plan. As of December 31, 2023, a total of 10,219,534 share options to purchase ordinary shares, with a weighted average exercise price of $2.43 per share and 5,761,735 RSUs were outstanding under the 2013 Plan, including the U.S. Sub-Plan. Our board of directors, or a duly authorized committee of our board of directors, or the administrator, administers the 2013 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Share Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted the 2021 Plan, in connection with our IPO on July 15, 2021. The 2021 Plan provides for the grant of equity-based incentive awards to our employees, directors, office holders, service providers and consultants in order to incentivize them to increase their efforts on behalf of the Company and to promote the success of the Company&#8217;s business. The 2021 Plan is administered by the compensation committee of our board of directors, which has the authority to amend and rescind rules and regulations relating to the 2021 Plan or terminate the 2021 Plan at any time before the expiration of its ten year term, as well as to approve the conversion, substitution, cancellation or suspension under and in accordance with the 2021 Plan of any or all option awards or Class A ordinary shares, and the authority to modify the option awards to eligible individuals who are foreign nationals or are individuals who are employed outside of Israel to recognize differences in local law, tax policy or custom, in order to effectuate the purposes of the 2021 Plan but without amending the 2021 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum number of Class A ordinary shares available for issuance under the 2021 Plan is equal to the sum of (i) 13,951,037</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Class A ordinary shares, plus (ii) an annual increase on the first day of each fiscal year beginning on January 1, 2022 and ending on and including January 1, 2031, equal to the lesser of (A) 5% of the total number of Class A ordinary shares outstanding as of the end of the last day of the immediately preceding calendar year (calculated on a fully diluted and as converted basis); and (B) such smaller number of Class A ordinary shares as is determined by our board of directors, if so determined prior to January 1 of the calendar year in which the increase will occur, plus (iii) any Class A ordinary shares underlying awards under the 2013 Plan as of July 15, 2021 which, following such date have expired, or were cancelled, terminated, forfeited or settled in cash in lieu of issuance of shares or became unexercisable without having been fully exercised. Notwithstanding the foregoing, no more than 13,951,037 Class A ordinary shares may be issued upon the exercise of &#8220;incentive stock options&#8221;. If permitted by our board of directors, shares tendered to pay the exercise price or withholding tax obligations with respect to an award granted under the 2021 Plan or the 2013 Plan may again be available for issuance under the 2021 Plan. Our board of directors may also reduce the number of Class A ordinary shares reserved and available for issuance under the 2021 Plan in its discretion (provided that such reduction does not derogate from any issuance of Class A ordinary shares in respect of awards then outstanding). As of December 31, 2023, a total of 150,000 share options to purchase ordinary shares, with a weighted average exercise price of $0.0003 per share and 16,149,528 RSUs were outstanding under the 2021 Plan. As of December 31, 2023, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-57">8,766,560</ix:nonFraction> ordinary shares were available for future issuance under the 2021 Plan. In accordance with (ii) above, the number of ordinary shares available for </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">future issuance under the 2021 Plan was increased by an additional 8,927,686 ordinary shares, effective as of January 1, 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan provides for the grant of awards under various tax regimes, including, without limitation, in compliance with Section 102 or Section 3(i) of the Israeli Income Tax Ordinance (New Version), 5721-1961, or the Ordinance, and for awards granted to our United States employees or service providers, including those who are deemed to be residents of the United States for tax purposes, Section 422 of the Internal Revenue Code of 1986, as amended, or the Code, and Section 409A of the Code.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan provides for the grant of stock options (including &#8220;incentive stock options&#8221; and &#8220;non-qualified stock options&#8221;), Class A ordinary shares, restricted shares, RSUs, stock appreciation rights and other share-based awards.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Options granted under the 2021 Plan to Company employees who are U.S. residents may qualify as &#8220;incentive stock options&#8221; within the meaning of Section 422 of the Code, or may be &#8220;non-qualified stock options&#8221;. The exercise price of an option may not be less than the par value of the shares (if the shares bear a par value) for which such option is exercisable. The exercise price of an &#8220;incentive stock option&#8221; may not be less than 100% of the fair market value of the underlying share on the date of grant or such other amount as may be required pursuant to the Code, and in the case of &#8220;incentive stock options&#8221; granted to ten percent shareholders, not less than 110%.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Share Purchase Plan </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted the 2021 Employee Share Purchase Plan, or ESPP, in connection with our IPO on July 15, 2021, to enable eligible employees of the company and certain of its designated subsidiaries to use payroll deductions to purchase the company&#8217;s Class A ordinary shares and thereby acquire ownership interests in the company. Through the date hereof we have not effected any offering under the ESPP.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The ESPP is comprised of two distinct components: (1) the component intended to qualify for favorable U.S. federal tax treatment under Section 423 of the Code (the &#8220;Section 423 Component&#8221;) and (2) the component not intended to be tax qualified under Section 423 of the Code to facilitate participation for employees who are not eligible to benefit from favorable U.S. federal tax treatment and, to the extent applicable, to provide flexibility to comply with non-U.S. law and other considerations (the &#8220;Non-Section 423 Component&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum aggregate number of Class A ordinary shares that are available for sale under the ESPP is 3,742,961, or the ESPP Share Pool, subject to adjustments as provided for in the ESPP. In addition, on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031, the ESPP Share Pool shall be increased by that number of our Class A ordinary shares equal to the lesser of: (i) 1% of the total number of Class A ordinary shares outstanding as of the last day of the immediately preceding calendar year (calculated on a fully diluted as-converted basis); and (ii) such smaller number of Class A ordinary shares as may be determined by our board of directors. In no event will more than 3,742,961 Class A ordinary shares be available for issuance under the Section 423 Component.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, the ESPP Share Pool consisted of 3,742,961 Class A ordinary shares. In accordance with (ii) above, our board of directors has determined not to increase the ESPP Share Pool as of January 1, 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise determined by our board of directors, the compensation committee of our board of directors will administer the ESPP and has the authority to interpret the terms of the ESPP and determine eligibility under the ESPP and applicable law.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_109"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.     Board Practices</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Governance Practices</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to NYSE listing rules and applicable provisions of U.S. securities laws, as an Israeli company, we are subject to various corporate governance requirements under the Companies Law related to matters including, the appointment of external directors (or, to the extent applicable, the provisions permitting us to opt-out of the requirement to appoint external directors), the composition of the audit committee and compensation committee of the board of directors, appointment of an internal auditor and certain approvals of interested party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we are a &#8220;foreign private issuer&#8221; (as such term is defined in Rule&#160;3b-4 under the Exchange Act), we are permitted to comply with certain Israeli corporate governance practices instead of the corporate governance rules of the NYSE, provided that we disclose which requirements we are not following and the equivalent Israeli requirement. As a result, we are exempt from, among other things, the rules prescribing the furnishing and contents of proxy statements. In addition, our officers, directors and principal shareholders are exempt from the reporting and short-swing profit and recovery provisions under Section 16 of the Exchange Act. They are, however, subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as a &#8220;foreign private issuer&#8221;, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. domestic issuers whose securities are registered under the Exchange Act. However, historically we have voluntarily filed financial statements and earnings announcements on Form 6-K on a quarterly basis broadly in line with reporting deadlines mandated for U.S. domestic issuers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information regarding our corporate governance practices and &#8220;foreign private issuer&#8221; status, see Item 16G. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Corporate Governance.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law and our amended and restated articles of association, our business and affairs are managed under the direction of our board of directors. Our board of directors may exercise all powers and may take all actions that are not specifically granted to our shareholders or to executive management. Our chief executive officer (referred to as a &#8220;general manager&#8221; under the Companies Law) is responsible for our day-to-day management. Our chief executive officer is appointed by, and serves at the discretion of, our board of directors, subject to the employment agreement that we have entered into with him. All other executive officers are appointed by the chief executive officer, subject to applicable corporate approvals, and are subject to the terms of any applicable employment or consulting agreements that we may enter into with them.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our amended and restated articles of association, the number of directors on our board of directors shall be no less than three and no more than eleven, divided into three classes with staggered three-year terms. Each class of directors consists, as nearly as possible, of one-third of the total number of directors constituting the entire board of directors. At each annual general meeting of our shareholders, the election or re-election of directors following the expiration of their current term of office will be for a further term of office that expires on the third annual general meeting following such election or re-election. Therefore, each year the term of office of only one class of directors will expire.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our directors are divided among the three classes as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Class I directors are Aaron Mankovski and Erez Shachar, and their terms expire at the annual meeting of shareholders to be held in 2025;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Class II directors are Assaf Feldman and Tanzeen Syed, and their terms expire at our annual meeting of shareholders to be held in 2026; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the Class III directors are Eido Gal, Eyal Kishon, and Jennifer Ceran, and their terms expire at our annual meeting of shareholders to be held in 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our amended and restated articles of association, our directors are appointed by a simple majority vote of holders of our ordinary shares, participating and voting at an annual general meeting of our shareholders. Holders of our Class A ordinary shares and Class B ordinary shares vote together as a single class on the election of directors, with each Class A ordinary share entitled to one vote per share, and each Class B ordinary share entitled to ten votes per share. However, in the event of a contested election, (i) the method of calculation of the votes and the manner in which the resolutions will be presented to our shareholders at the general meeting shall be determined by our board of directors in its discretion, and (ii) in the event that our board of directors does not or is unable to make a determination on such matter, then the directors will be elected by a plurality of the voting power represented at the general meeting in person or by proxy and voting on the election of directors. Each director will hold office until the annual general meeting of our shareholders for the year in which such director&#8217;s term expires, unless the tenure of such director expires earlier pursuant to the Companies Law or unless such director is removed from office as described below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our amended and restated articles of association, the approval of the holders of at least 65% of the total voting power of our shareholders is generally required to remove any of our directors from office or amend the provision requiring the approval of at least 65% of the total voting power of our shareholders to remove any of our directors from office. In addition, vacancies on our board of directors may only be filled by a vote of a simple majority of the directors then in office. A director so appointed will hold office until the next annual general meeting of our shareholders for the election of the class of directors in respect of which the vacancy was created. In the case of a vacancy due to the number of directors being less than the maximum number of directors stated in our amended and restated articles of association, the new director filling the vacancy will serve until the next annual general meeting of our shareholders for the election of the class of directors to which such director was assigned by our board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Chairperson of the Board of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated articles of association provide that the chairperson of the board of directors is appointed by the members of the board of directors from among them. Under the Companies Law, the chief executive officer of a public company, a relative of the chief executive officer or a person who is subordinated, directly or indirectly, to the chief executive officer, may not serve as the chairperson of the board of directors, and the chairperson of the board of directors, or a relative of the chairperson, may not be vested with authorities of the chief executive officer, or of persons who are subordinated to the chief executive officer, unless approved by a special majority of the company&#8217;s shareholders. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The shareholders&#8217; approval can be effective for a period of five years following an initial public offering, and subsequently, for additional periods of up to three years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During a special and annual general meeting of our shareholders prior to our IPO, our shareholders approved, by a special majority, the appointment of Mr. Gal as chairperson of our board of directors in addition to his role as our chief executive officer. Such appointment is valid for an initial term of five years from the closing of our IPO. Following such initial term, each renewal of the appointment of our chief executive officer as chairperson of the board of directors will be subject to shareholder approval by a special majority, as described above, and will be limited to a term of up to three years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Lead Independent Director</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For as long as the chairperson of our board of directors is a member of our management or is otherwise not independent pursuant to the NYSE rules, our board of directors may appoint a lead independent director. The lead independent director responsibilities include:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">98</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">presiding over all meetings of the board of directors at which the chairperson of the Board is not present, including any executive sessions of the independent directors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approving board of director meeting schedules and agendas; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acting as the liaison between the independent directors and the chief executive officer and chairperson of the board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Mr. Gal is currently our chief executive officer and the chairperson of our board of directors, the members of our board of directors have elected Eyal Kishon to serve as the lead independent director.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">External Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, companies incorporated under the laws of the State of Israel that are &#8220;public companies,&#8221; including companies with shares listed on the NYSE, are required to appoint at least two external directors. Pursuant to regulations promulgated under the Companies Law, companies with shares traded on certain U.S. stock exchanges, including the NYSE, which do not have a &#8220;controlling shareholder,&#8221; may, subject to certain conditions, &#8220;opt out&#8221; from the Companies Law requirements to appoint external directors and related Companies Law rules concerning the composition of the audit committee and compensation committee of the board of directors (other than the gender diversification rules under the Companies Law, which requires the appointment of a director from the other gender if, at the time a director is appointed, all members of the board of directors are of the same gender). In accordance with these regulations, we have elected to &#8220;opt out&#8221; from the Companies Law requirement to appoint external directors and related Companies Law rules concerning the composition of the audit committee and compensation committee of our board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exemptions from such Companies Law requirements will continue to be available to us so long as: (i) we do not have a &#8220;controlling shareholder&#8221; (as such term is defined under the Companies Law), (ii) our shares are traded on certain U.S. stock exchanges, including the NYSE, and (iii) we comply with the director independence requirements and the audit committee and compensation committee composition requirements under U.S. laws (including applicable rules of the NYSE) applicable to U.S. domestic issuers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committees of our Board of Directors</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board has three standing committees: an audit committee, a compensation committee and a nominating and governance committee. Each of these committees is governed by a charter that is consistent with applicable SEC and NYSE corporate governance rules and are available on our investor relations website at </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://ir.riskified.com</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The information contained on our website is not incorporated by reference in this Annual Report.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit committee consists of Jennifer Ceran, Eyal Kishon and Erez Shachar. Jennifer Ceran serves as the chairperson of the audit committee. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Companies Law Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, the board of directors of a public company must appoint an audit committee, which must be comprised of at least three directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Listing Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the corporate governance rules of the NYSE, we are required to maintain an audit committee consisting of at least three independent directors, each of whom is financially literate and one of whom has accounting or related financial management expertise.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All members of our audit committee meet the requirements for financial literacy under the applicable rules and regulations of the SEC and the corporate governance rules of the NYSE. Our board of directors has determined that Jennifer Ceran is an &#8220;audit committee financial expert&#8221; as defined by the SEC rules and has the requisite financial experience as defined by the corporate governance rules of the NYSE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has determined that each member of our audit committee is &#8220;independent&#8221; as such term is defined in Rule 10A-3(b)(1) under the Exchange Act which is different from the general test for independence of board and committee members.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee Role</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has adopted an audit committee charter setting forth the responsibilities of the audit committee, which are consistent with the Companies Law, the SEC rules and the corporate governance rules of the NYSE and include:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appointing, compensating, retaining and terminating our independent auditors, subject to ratification by our board of directors, and in the case of retention, to ratification by the shareholders;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing the work of our independent auditors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pre-approving audit and non-audit services to be provided by the independent auditors and related fees and terms;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing the accounting and financial reporting processes of the Company and audits of our consolidated financial statements and making such reports as may be required of an audit committee under the rules and regulations promulgated under the Exchange Act;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing with management and our independent auditor our annual and quarterly consolidated financial statements prior to publication or filing (or submission, as the case may be) to the SEC;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recommending to the board of directors the retention and termination of the internal auditor, and the internal auditor&#8217;s engagement fees and terms, in accordance with the Companies Law as well as approving the yearly or periodic work plan proposed by the internal auditor;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">evaluating the Company&#8217;s compliance with applicable regulatory and legal requirements and overseeing management&#8217;s measures and actions to mitigate any potential noncompliance with such requirements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying irregularities in our business administration, inter alia, by consulting with the internal auditor, and suggesting corrective measures to the board of directors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing information technology, cybersecurity and data privacy related risks;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing policies and procedures with respect to transactions (other than transactions related to the compensation or terms of services) between the Company and officers and directors, or affiliates of officers or directors, or transactions that are not in the ordinary course of the Company&#8217;s business and deciding whether to approve such acts and transactions if so required under the Companies Law; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing procedures for the handling of employees&#8217; complaints as to the management of our business and the protection to be provided to such employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation committee consists of Eyal Kishon, Tanzeen Syed, and Erez Shachar. Eyal Kishon serves as chairperson of the compensation committee. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Companies Law Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, the board of directors of a public company must appoint a compensation committee, which must be comprised of at least three directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Listing Requirements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the corporate governance rules of the NYSE, we are required to maintain a compensation committee consisting of at least two independent directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has determined that each member of our compensation committee qualifies as independent under the corporate governance rules of the NYSE, including the additional independence requirements applicable to the members of a compensation committee.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee Role</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the Companies Law, the roles of the compensation committee are, among others, as follows:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">making recommendations to our board of directors with respect to the approval of the compensation policy for office holders and, once every three years, regarding any extensions to a compensation policy that was adopted for a period of more than three years;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing the implementation of the compensation policy and periodically making recommendations to our board of directors with respect to any amendments or updates of the compensation policy;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">resolving whether or not to approve arrangements with respect to the terms of office and employment of office holders; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">exempting, under certain circumstances, a transaction with our chief executive officer from the approval of our shareholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors has adopted a compensation committee charter setting forth the responsibilities of the committee, which are consistent with the corporate governance rules of the NYSE and include among others:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">recommending to our board of directors for its approval a compensation policy in accordance with the requirements of the Companies Law as well as other compensation policies, incentive-based compensation plans and equity-based compensation plans, and overseeing the development and implementation of such policies and recommending to our board of directors any amendments or modifications the committee deems appropriate, including as required under the Companies Law;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reviewing and approving the granting of share options and other incentive awards to our chief executive officer and other executive officers, including reviewing and approving corporate goals and objectives relevant to the compensation of our chief executive officer and other executive officers, including evaluating their performance in light of such goals and objectives;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">approving and exempting certain transactions regarding office holders&#8217; compensation pursuant to the Companies Law;</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administering and overseeing compliance with our compensation recovery policy adopted in accordance with applicable SEC and NYSE rules; and<br/></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">administering our equity-based compensation plans, including, without limitation, approving the adoption of such plans, amending and interpreting such plans and the awards and agreements </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">issued pursuant thereto, and making awards to eligible persons under the plans and determining the terms of such awards. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Policy under the Companies Law</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under the Companies Law, a public company must have a compensation policy approved by the board of directors (after receiving and considering the recommendations of the compensation committee). In addition, our compensation policy must be approved at least once every three years, first, by our board of directors (upon the recommendation of our compensation committee), and second, by a simple majority of the shares present, in person or by proxy, and voting (excluding abstentions) at a general meeting of shareholders, provided that either:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">such majority includes at least a majority of the shares held by shareholders who are not controlling shareholders and shareholders who do not have personal interest in such compensation policy; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the total number of shares of non-controlling shareholders and shareholders who do not have a personal interest in the compensation policy and who vote against the policy does not exceed two percent (2%) of the aggregate voting rights in the Company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under special circumstances, the board of directors may approve the compensation policy despite the objection of the shareholders on the condition that the compensation committee and then the board of directors determine, on the basis of detailed grounds and after again discussing the compensation policy, that approval of the compensation policy, despite the objection of shareholders, is for the benefit of the company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a company that initially offers its securities to the public, like us, adopts a compensation policy in advance of its initial public offering, and describes it in its prospectus for such offering, then such compensation policy shall be deemed a validly adopted policy in accordance with the Companies Law requirements described above. Furthermore, if the compensation policy is established in accordance with the aforementioned relief, then it will remain in effect for a term of five years from the date such company becomes a public company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation policy must be based on certain considerations, include certain provisions and reference certain matters as set forth in the Companies Law. The compensation policy must serve as the basis for decisions concerning the financial terms of employment or engagement of office holders, including exculpation, insurance, indemnification or any monetary payment or obligation of payment in respect of employment or engagement. The compensation policy must be determined and later reevaluated according to certain factors, including: the advancement of the company&#8217;s objectives, business plan and long-term strategy; the creation of appropriate incentives for office holders, while considering, among other things, the company&#8217;s risk management policy; the size and the nature of the company&#8217;s operations; and with respect to variable compensation, the contribution of the office holder towards the achievement of the company&#8217;s long-term goals and the maximization of its profits, all with a long-term objective and according to the position of the office holder. The compensation policy must consider the following additional factors:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the education, skills, experience, expertise and accomplishments of the relevant office holder;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the office holder&#8217;s position and responsibilities;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior compensation agreements with the office holder;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ratio between the cost of the terms of employment of an office holder and the cost of the employment of the other employees of the company, including employees employed through contractors who provide services to the company, in particular the ratio between such cost to the </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">average and median salary of such employees of the company, as well as the impact of disparities between them on the work relationships in the company;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the terms of employment include variable components - the possibility of reducing variable components at the discretion of the board of directors and the possibility of setting a limit on the value of non-cash variable equity-based components; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">if the terms of employment include severance compensation - the term of employment or office of the office holder, the terms of the office holder&#8217;s compensation during such period, the company&#8217;s performance during such period, the office holder&#8217;s individual contribution to the achievement of the company&#8217;s goals and the maximization of its profits and the circumstances under which he or she is leaving the company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation policy must also include, among other things:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">with regards to variable components:</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">with the exception of office holders who report to the chief executive officer, a means of determining the variable components on the basis of long-term performance and measurable criteria; provided that the Company may determine that an immaterial part of the variable components of the compensation package of an office holder shall be awarded based on non-measurable criteria, or if such amount is not higher than three months&#8217; salary per annum, taking into account such office holder&#8217;s contribution to the company; and</span></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.08pt">the ratio between variable and fixed components, as well as the limit of the values of variable components at the time of their payment, or in the case of equity-based compensation, at the time of grant.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a clawback provision under which the office holder will return to the company, according to conditions to be set forth in the compensation policy, any amounts paid as part of the office holder&#8217;s terms of employment, if such amounts were paid based on information later to be discovered to be wrong, and such information was restated in the company&#8217;s financial statements;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the minimum holding or vesting period of variable equity-based components to be set in the terms of office or employment, as applicable, while taking into consideration long-term incentives; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limit to retirement grants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation policy, which became effective upon the closing of our IPO, is designed to promote retention and motivation of directors and executive officers, incentivize superior individual excellence, align the interests of our directors and executive officers with our long-term performance and provide a risk management tool. To that end, a portion of our executive officer compensation package is targeted to reflect our short and long-term goals, as well as the executive officer&#8217;s individual performance. On the other hand, our compensation policy includes measures designed to reduce the executive officer&#8217;s incentives to take excessive risks that may harm us in the long-term, such as limits on the value of cash bonuses and equity-based compensation, limitations on the ratio between the variable and the total compensation of an executive officer and minimum vesting periods for equity-based compensation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation policy also addresses our executive officers&#8217; individual characteristics (such as their respective position, education, scope of responsibilities and contribution to the attainment of our goals) as the basis for compensation variation among our executive officers and considers the internal ratios between compensation of our executive officers and directors and other employees. Pursuant to our compensation policy, the compensation that may be granted to an executive officer may include: base salary, annual bonuses and other cash bonuses (such as a signing bonus and special bonuses with </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">respect to any special achievements, such as outstanding personal achievement, outstanding personal effort or outstanding company performance), equity-based compensation, benefits and retirement and termination of service arrangements. All cash bonuses are limited to a maximum amount linked to the executive officer&#8217;s base salary.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An annual cash bonus may be awarded to executive officers upon the attainment of pre-set periodic objectives and individual targets. The annual cash bonus that may be granted to our executive officers other than our chief executive officer will be based on performance objectives and a discretionary evaluation of the executive officer&#8217;s overall performance by our chief executive officer and subject to minimum thresholds. The annual cash bonus that may be granted to executive officers other than our chief executive officer may alternatively be based entirely on a discretionary evaluation. Furthermore, our chief executive officer will be entitled to approve performance objectives for executive officers who report to him.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measurable performance objectives of our chief executive officer will be determined annually by our compensation committee and board of directors. A non-material portion of the chief executive officer&#8217;s annual cash bonus, as provided in our compensation policy, may be based on a discretionary evaluation of the chief executive officer&#8217;s overall performance by the compensation committee and the board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The equity-based compensation under our compensation policy for our executive officers (including members of our board of directors) is designed in a manner consistent with the underlying objectives in determining the base salary and the annual cash bonus, with its main objectives being to enhance the alignment between the executive officers&#8217; interests with our long-term interests and those of our shareholders and to strengthen the retention and the motivation of executive officers in the long term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation policy provides for executive officer compensation in the form of share options or other equity-based awards, such as restricted shares and RSUs, in accordance with our equity incentive plan then in place. All equity-based incentives granted to executive officers shall be subject to vesting periods in order to promote long-term retention of the awarded executive officers. The equity-based compensation shall be granted from time to time and be individually determined and awarded according to the performance, educational background, prior business experience, qualifications, role and the personal responsibilities of the executive officer.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our compensation policy contains compensation recovery provisions which allow us under certain conditions to recover bonuses paid in excess, enables our chief executive officer to approve an immaterial change in the terms of employment of an executive officer who reports directly to him (provided that the changes of the terms of employment are in accordance with our compensation policy) and allow us to exculpate, indemnify and insure our executive officers and directors to the maximum extent permitted by Israeli law subject to certain limitations set forth therein.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation policy also provides for compensation to the members of our board of directors as follows: (i) to the external directors, if elected, in accordance with the amounts provided in the Companies Regulations (Rules Regarding the Compensation and Expenses of an External Director), 5760-2000, as amended by the Companies Regulations (Relief for Public Companies Traded in Stock Exchange Outside of Israel), 5760-2000, as such regulations may be amended from time to time, and (ii) to the non-employee directors, in accordance with the amounts determined in our compensation policy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our compensation policy was approved by our board of directors and shareholders and became effective upon the closing of our IPO. Our compensation policy was subsequently amended by our board of directors (after receiving and considering the recommendations of the compensation committee) and shareholders in July 2022. Our compensation policy will remain in effect until August 2, 2026.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nominating and Governance Committee</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our nominating and governance committee consists of Aaron Mankovski, Eyal Kishon, and Jennifer Ceran. Aaron Mankovski serves as chairperson of the nominating and governance committee. Our board of directors has adopted a nominating and governance committee charter setting forth the responsibilities of the committee, which includes:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing and assisting our board in reviewing and recommending nominees for election as directors;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">assessing the performance of the members of our board;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">overseeing our ESG programs, strategies, disclosures and stakeholder engagement, in coordination with other Board committees, as appropriate; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing and maintaining effective corporate governance policies and practices, including, but not limited to, developing and recommending to our board a set of corporate governance guidelines applicable to our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Internal Auditor</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, the board of directors of a public company must appoint an internal auditor based on the recommendation of the audit committee. The role of the internal auditor is, among other things, to examine whether a company&#8217;s actions comply with applicable law and orderly business procedure. Under the Companies Law, the internal auditor cannot be an interested party or an office holder or a relative of an interested party or an office holder, nor may the internal auditor be the company&#8217;s independent auditor or its representative. An &#8220;interested party&#8221; is defined in the Companies Law as (i) a holder of 5% or more of the issued share capital or voting power in a company, (ii) any person or entity who has the right to designate one or more directors or to designate the chief executive officer of the Company or (iii) any person who serves as a director or as chief executive officer of the company. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, Ms. Sharon Cohen, CPA from Brightman Almagor Zohar &amp; Co., a firm in the Deloitte Global Network, is acting as our internal auditor.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Approval of Related Party Transactions under Israeli Law</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiduciary Duties of Directors and Executive Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Law codifies the fiduciary duties that office holders owe to a company. An office holder is defined in the Companies Law as a general manager, chief business manager, deputy general manager, vice general manager, any other person assuming the responsibilities of any of these positions regardless of such person&#8217;s title, a director and any other manager directly subordinate to the general manager. Each person listed in the table under &#8220;Item 6.A. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212;Directors and Senior Management</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is an office holder under the Companies Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An office holder&#8217;s fiduciary duties consist of a duty of care and a duty of loyalty. The duty of care requires an office holder to act with the level of care with which a reasonable office holder in the same position would have acted under the same circumstances. The duty of loyalty requires that an office holder act in good faith and in the best interests of the company.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, a company may approve an act which would otherwise constitute a breach of the office holder&#8217;s fiduciary duty, provided that the office holder acted in good faith, neither the act nor its approval harms the company and the office holder discloses his or her personal interest (if applicable) a sufficient time before the approval of such act. Any such approval is subject to the terms of the Companies Law setting forth, among other things, the appropriate bodies of the company required to provide such approval and the methods of obtaining such approval.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disclosure of Personal Interests of an Office Holder and Approval of Certain Transactions</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Law requires that an office holder promptly disclose to the board of directors any personal interest that such office holder may have and all related material information known to such office holder concerning any existing or proposed transaction with the company. A personal interest includes an interest of any person in an act or transaction of a company, including a personal interest of one&#8217;s relative or of a corporate body in which such person or a relative of such person is a 5% or greater shareholder, director or general manager or in which such person has the right to appoint at least one director or the general manager, but excluding a personal interest stemming solely from one&#8217;s ownership of shares in the company. A personal interest includes the personal interest of a person for whom the office holder holds a voting proxy or the personal interest of the office holder with respect to the officer holder&#8217;s vote on behalf of a person for whom he or she holds a proxy even if such shareholder has no personal interest in the matter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If it is determined that an office holder has a personal interest in a non-extraordinary transaction, meaning any transaction that is in the ordinary course of business, on market terms or that is not likely to have a material impact on the company&#8217;s profitability, assets or liabilities, approval by the board of directors is required for the transaction unless the company&#8217;s articles of association provide for a different method of approval. Any such transaction that is adverse to the company&#8217;s interests may not be approved by the board of directors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated articles of association provide that for non-extraordinary interested party transactions, the board of directors may delegate its approval, or may provide a general approval to certain types of non-extraordinary interested party transactions.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval first by the company&#8217;s audit committee and subsequently by the board of directors is required for an extraordinary transaction (meaning any transaction that is not in the ordinary course of business, not on market terms or that is likely to have a material impact on the company&#8217;s profitability, assets or liabilities) in which an office holder has a personal interest.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A director and any other office holder who has a personal interest in a transaction which is considered at a meeting of the board of directors or the audit committee may generally (unless it is with respect to a transaction which is not an extraordinary transaction) not be present at such a meeting or vote on that matter unless a majority of the directors or members of the audit committee, as applicable, have a personal interest in the matter. If a majority of the members of the audit committee or the board of directors have a personal interest in the matter, then all of the directors may participate in deliberations of the audit committee or board of directors, as applicable, with respect to such transaction and vote on the approval thereof and, in such case, shareholder approval is also required.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain disclosure and approval requirements apply under Israeli law to certain transactions with controlling shareholders, certain transactions in which a controlling shareholder has a personal interest and certain arrangements regarding the terms of service or employment of a controlling shareholder. For these purposes, a controlling shareholder is any shareholder that has the ability to direct the company&#8217;s actions, including any shareholder holding 25% or more of the voting rights if no other shareholder owns more than 50% of the voting rights in the company. Two or more shareholders with a personal interest in the approval of the same transaction are deemed to be one shareholder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of the approvals required under Israeli law for compensation arrangements of officers and directors, see &#8220;Item 6.B. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212; Compensation.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shareholder Duties</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Companies Law, a shareholder has a duty to act in good faith and in a customary manner toward the company and other shareholders and to refrain from abusing his or her power with respect to the company, including, among other things, in voting at a general meeting and at shareholder class meetings with respect to the following matters:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an amendment to the company&#8217;s articles of association (in addition to the approval of our board of directors, as required pursuant to our amended and restated articles of association);</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an increase of the company&#8217;s authorized share capital;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a merger; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">interested party transactions that require shareholder approval.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a shareholder has a general duty to refrain from discriminating against other shareholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain shareholders also have a duty of fairness toward the company. These shareholders include any controlling shareholder, any shareholder who knows that it has the power to determine the outcome of a shareholder vote and any shareholder who has the power to appoint or to prevent the appointment of an office holder of the company or exercise any other rights available to it under the company&#8217;s articles of association with respect to the company. The Companies Law does not define the substance of this duty of fairness, except to state that the remedies generally available upon a breach of contract will also apply in the event of a breach of the duty of fairness.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exculpation, Insurance and Indemnification of Office Holders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, a company may not exculpate an office holder from liability for a breach of the duty of loyalty. An Israeli company may exculpate an office holder in advance from liability to the company, in whole or in part, for damages caused to the company as a result of a breach of duty of care but only if a provision authorizing such exculpation is included in its articles of association. Our amended and restated articles of association include such a provision. An Israeli company may not exculpate a director from liability arising out of a prohibited dividend or distribution to shareholders.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Israeli company may indemnify an office holder in respect of the following liabilities and expenses incurred for acts performed as an office holder, either in advance of an event or following an event, provided a provision authorizing such indemnification is contained in its articles of association:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a financial liability imposed on him or her in favor of another person pursuant to a judgment, including a settlement or arbitrator&#8217;s award approved by a court. However, if an undertaking to indemnify an office holder with respect to such liability is provided in advance, then such an undertaking must be limited to events which, in the opinion of the board of directors, can be foreseen based on the company&#8217;s activities when the undertaking to indemnify is given, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances, and such undertaking shall detail the abovementioned events and amount or criteria;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reasonable litigation expenses, including legal fees, incurred by the office holder (1) as a result of an investigation or proceeding instituted against him or her by an authority authorized to conduct such investigation or proceeding, provided that (i) no indictment was filed against such office holder as a result of such investigation or proceeding; and (ii) no financial liability, such as a criminal penalty, was imposed upon him or her as a substitute for the criminal proceeding as a result of such investigation or proceeding or, if such financial liability was imposed, it was imposed with respect to an offense that does not require proof of criminal intent; and (2) in connection with a monetary sanction;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reasonable litigation expenses, including legal fees, incurred by the office holder or imposed by a court in proceedings instituted against him or her by the company, on its behalf or by a third party or in connection with criminal proceedings in which the office holder was acquitted or as a result of a conviction for an offense that does not require proof of criminal intent; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">107</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses, including reasonable litigation expenses and legal fees, incurred by an office holder in relation to an administrative proceeding instituted against such office holder, or certain compensation payments made to an injured party imposed on an office holder by an administrative proceeding, pursuant to certain provisions of the Israeli Securities Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Israeli company may insure an office holder against the following liabilities incurred for acts performed as an office holder if and to the extent provided in the company&#8217;s articles of association:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a breach of the duty of loyalty to the company, to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a breach of the duty of care to the company or to a third-party, including a breach arising out of the negligent conduct of the office holder;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a financial liability imposed on the office holder in favor of a third-party;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a financial liability imposed on the office holder in favor of a third-party harmed by a breach in an administrative proceeding; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses, including reasonable litigation expenses and legal fees, incurred by the office holder as a result of an administrative proceeding instituted against him or her, pursuant to certain provisions of the Israeli Securities Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An Israeli company may not indemnify or insure an office holder against any of the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a breach of the duty of loyalty, except to the extent that the office holder acted in good faith and had a reasonable basis to believe that the act would not prejudice the company;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a breach of the duty of care committed intentionally or recklessly, excluding a breach arising out of the negligent conduct of the office holder;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an act or omission committed with intent to derive illegal personal benefit; or</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a fine, monetary sanction or forfeit levied against the office holder.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Companies Law, exculpation, indemnification and insurance of office holders must be approved by the compensation committee and the board of directors (and, with respect to directors and the chief executive officer, by the shareholders). However, under regulations promulgated under the Companies Law, the insurance of office holders shall not require shareholder approval and may be approved by only the compensation committee if the engagement terms are determined in accordance with the company&#8217;s compensation policy, which was approved by the shareholders by the same special majority required to approve a compensation policy, provided that the insurance policy is on market terms and the insurance policy is not likely to materially impact the company&#8217;s profitability, assets or obligations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated articles of association allow us to exculpate, indemnify and insure our office holders for any liability imposed on them as a consequence of an act (including any omission) which was performed by virtue of being an office holder. Our office holders are currently covered by a directors and officers&#8217; liability insurance policy.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into agreements with each of our directors and executive officers exculpating them in advance, to the fullest extent permitted by law, from liability to us for damages caused to us as a result of a breach of duty of care, and undertaking to indemnify them to the fullest extent permitted by law. This indemnification is limited to events determined as foreseeable by the board of directors based on our activities, and to an amount or according to criteria determined by the board of directors as reasonable under the circumstances.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">108</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The maximum indemnification amount set forth in such agreements is limited to an amount equal to the higher of $300,000,000, 25% of our total shareholders&#8217; equity (deficit) as reflected in our most recent consolidated financial statements prior to the date on which the indemnity payment is made (other than indemnification for an offering of securities to the public, including by a shareholder in a secondary offering, in which case the maximum indemnification amount is limited to the gross proceeds raised by us and/or any selling shareholder in such public offering) and 10% of our total market cap calculated based on the average closing price our Class A ordinary shares over the 30 trading days prior to the actual payment, multiplied by the total number of our issued and outstanding shares as of the date of the payment (other than indemnification for an offering of securities to the public, including by a shareholder in a secondary offering, in which case the maximum indemnification amount is limited to the gross proceeds raised by us and/or any selling shareholder in such public offering). The maximum amount set forth in such agreements is in addition to any amount paid (if paid) under insurance and/or by a third party pursuant to an indemnification arrangement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the opinion of the SEC, indemnification of directors and office holders for liabilities arising under the Securities Act, however, is against public policy and therefore unenforceable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_112"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.    Employees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, we had 742 employees worldwide, including 266 in research and development (as compared to 781 employees, including 288 in research and development, as of December 31, 2022). Of these employees, 693 are full-time employees and 49 are part-time employees. 509 of our employees are in Israel, 192 are in the United States, 12 are in Shanghai, People&#8217;s Republic of China, and five are in Japan. As of December&#160;31, 2023, we also engaged the services of 24 contractors through third-party professional employer organizations in the United Kingdom, Mexico, Brazil, Spain, Portugal, Australia, and Singapore.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to our Israeli employees, Israeli labor laws govern the length of the workday and work week, minimum wages for employees, procedures for hiring and dismissing employees, determination of severance pay, annual leave, sick days, convalescence, advance notice of termination of employment, equal opportunity and anti-discrimination laws and other conditions of employment. Subject to certain exceptions, Israeli law generally requires severance pay upon the retirement, death or dismissal of an employee, without due cause, and requires us and our employees to make payments to the National Insurance Institute, which is similar to the U.S. Social Security Administration. Pursuant to Section 14 of the Israeli Severance Pay Law, 5723-1963, or Section 14, our employees in Israel, including executive officers and other key employees based in Israel, are entitled to monthly deposits, at a rate of <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="rskd:SeverancePayRate" scale="1" id="f-58">8.33</ix:nonFraction>% of their monthly salary, made in their name with insurance companies. Payments under Section 14 relieve us from any of the aforementioned future severance payment obligations with respect to those employees and, as such, we may only utilize the insurance policies for the purpose of disbursement of severance pay. As a result, we do not recognize an asset nor liability for these employees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of our employees work under any collective bargaining agreements. Extension orders issued by the Israeli Ministry of Economy and Industry apply to us and affect matters such as cost of living adjustments to salaries, length of working hours and week, recuperation pay, travel expenses and pension rights.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never experienced labor-related work stoppages or strikes and believe that our relations with our employees are satisfactory.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_115"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.     Share Ownership</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For information regarding the share ownership of directors and officers, see Item 7.A. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Major Shareholders and Related Party Transactions &#8212; Major Shareholders.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; For information regarding our equity incentive plans, see Item 6.B. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212; Compensation &#8212; Equity Incentive Plans.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_118"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.     Disclosure of Registrant&#8217;s Action to Recover Erroneously Awarded Compensation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_121"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_124"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:8pt"> Major Shareholders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information with respect to the beneficial ownership of our ordinary shares as of January 31, 2024 by:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each person or entity known by us to own beneficially more than 5% of our outstanding shares;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">each of our directors and executive officers individually; and</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">all of our executive officers and directors as a group.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For further information regarding material transactions between us and our major shareholders, see Item 7.B. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Major Shareholders and Related Party Transactions &#8212; Related Party Transactions</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The number of ordinary shares beneficially owned by each entity, person or director is determined in accordance with the SEC rules, and the information is not necessarily indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any ordinary shares over which a person has sole or shared voting power or investment power, or the right to receive economic benefit of ownership, as well as any ordinary shares subject to options, RSUs, warrants or other rights that are currently exercisable or exercisable within 60 days of January 31, 2024.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The percentage of outstanding ordinary shares is c</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">omputed on the basis of 177,630,415 ordinary shares outstanding as of January 31, 2024, comprised of 128,095,751 Class A ordinary shares outstanding and 49,534,664 C</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">lass B</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ordinary shares outstanding.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise noted below, each shareholder&#8217;s address is c/o Riskified Ltd., 220 5th Avenue, 2nd Floor, New York, New York 10001.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">110</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:27.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.483%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of Beneficial Owner</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Combined Voting Power </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:100%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Principal Shareholders</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">General Atlantic RK B.V. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,324,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,649,996&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Qumra Capital </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,429,987&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,859,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Pitango Venture Capital </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(5)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,081,912&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,163,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Phoenix Holdings Ltd. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(6)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,808,288&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,390,524&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Genesis Partners </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(7)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,190,930&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,428,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Capital World Investors </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,774,367&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">Directors and Executive Officers</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eido Gal </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(9)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,770,613&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,113,300&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Assaf Feldman </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(10)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,257,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,113,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Erez Shachar </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(11)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,450,422&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,859,974&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Eyal Kishon </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(12)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,216,392&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,428,474&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Jennifer Ceran </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(13)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">70,423&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aaron Mankovski </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(14)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,462&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Tanzeen Syed</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (15)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Aglika Dotcheva</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline"> (16)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">998,375&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Naama Ofek Arad </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(17)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">830,251&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ravi Kumaraswami </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(18)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">535,086&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">All executive officers and directors as a group (10 persons) </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">(19)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,180,440&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,515,048&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">53.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Indicates beneficial ownership of less than 1%.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The Class B ordinary shares are convertible into Class A ordinary shares on a one-for-one basis, subject to customary conversion rate adjustments for share splits, share dividends and reclassifications. Beneficial ownership of Class B ordinary shares reflected in this table has not also been reflected as beneficial ownership of Class A ordinary shares into which such Class B ordinary shares may be converted.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The percentage under &#8220;Combined Voting Power&#8221; represents the voting power with respect to all of our Class A and Class B ordinary shares outstanding as of January 31, 2024, voting together as a single class. Holders of our Class A ordinary shares are entitled to one vote per share, and holders of our Class B ordinary shares are entitled to ten votes per share.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based solely on information reported on a Schedule 13G on February 11, 2022, General Atlantic RK B.V. ("GA RK") has shared voting and dispositive power over 15,974,994 Class A ordinary shares, which consists of 5,324,998 Class A ordinary shares and 10,649,996 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares held of record by GA RK.GA RK is a wholly owned subsidiary of General Atlantic Co&#246;peratief U.A. ("GA Coop UA"). The members that share beneficial ownership of the shares held by GA RK through GA Coop UA are the following General Atlantic investment funds (the &#8220;GA Funds&#8221;): General Atlantic Partners (Bermuda IV, L.P. (&#8220;GAP Bermuda IV&#8221;), General Atlantic Partners (Bermuda) EU, L.P. (&#8220;GAP Bermuda EU&#8221;) and General Atlantic Co&#246;peratief, L.P. (&#8220;GA Coop LP&#8221;). The general partner of GAP Bermuda IV and GAP Bermuda EU is General Atlantic GenPar (Bermuda), L.P. (&#8220;GenPar Bermuda&#8221;). GAP (Bermuda) Limited (&#8220;GAP Bermuda&#8221;) is the general partner of GenPar Bermuda and GA Coop LP. There are nine members of the Management Committee of GAP Bermuda (the &#8220;GA Management Committee&#8221;). GAP Bermuda, GenPar Bermuda, and the GA Funds (collectively, the &#8220;GA Group&#8221; are a &#8220;group&#8221; within the meaning of Rule 13d-5 of the Securities Exchange Act of 1934, as amended. The business address of the foregoing General Atlantic Entities (other than GA Coop UA) is Clarendon House, 2 Church Street, Hamilton HM 11, Bermuda. The mailing address of GA Coop UA is Raamplein 1, 106 XK, Amsterdam, The Netherlands. Each of the members of the GA Management Committee disclaims ownership of all such shares except to the extent that he has a pecuniary interest therein. Tanzeen Syed, one of our directors, is a Managing Director at GA RK, which manages funds that collectively own the Class A ordinary shares and Class B ordinary shares.</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based solely on information reported on a Schedule 13G on February 14, 2022, Qumra Capital I, L.P ("Qumra Capital LP") has sole voting and dispositive power over 6,431,211 Class A ordinary shares, which consists of (i) 2,143,737 Class A ordinary shares; and (ii) an additional 4,287,474 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held by Qumra Capital LP. Qumra Capital I Continuation Fund, L.P. ("Qumra Continuation LP") has sole voting and dispositive power over 3,858,750 Class A ordinary shares, which consists of (i) 1,286,250 Class A ordinary shares; and (ii) an additional 2,572,500 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held by Qumra Continuation LP. Qumra Capital GP I, L.P. ("Qumra Capital GP"), Qumra Capital Israel I Ltd. ("Qumra Capital GP"), Erez Shachar ("Erez Shachar") and Boaz Dinte ("Boaz Dinte") each share voting and dispositive power over 10,289,961 Class A ordinary shares, which consists of (i) 3,429,987 Class A ordinary shares; and (ii) an additional 6,859,974 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held by Qumra Capital LP and Qumra Continuation LP. Qumra Capital Serves as the general partner for each of Qumra Capital LP and Qumra Continuation LP. Qumra Capital GP GP serves as the general partner for Qumra Capital GP. Erez Shachar, one of our directors, and Boaz Dinte each hold indirectly 50% of the outstanding equity interests of Qumra Capital GP GP and, therefore, possess ultimate shared voting and investment authority with respect to all ordinary shares beneficially owned by the Qumra entities. The business address of each Qumra entity and reporting individual is c/o Qumra Capital, 4 Haneviim St., Tel-Aviv, Israel.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based solely on information reported on a Schedule 13G on February 14, 2022, Pitango Growth Fund I, L.P. has sole voting and dispositive power over 9,063,825 Class A ordinary shares, which consists of (i) 3,021,275 Class A ordinary shares; and (ii) an additional 6,042,550 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held by Pitango Growth Fund I, L.P. Pitango Growth Principals Fund I, L.P. has sole voting and dispositive power over 181,911 Class A ordinary shares, which consists of (i) 60,637 Class A ordinary shares and (ii) an additional 121,274 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held, in the aggregate, by, Pitango Growth Fund I, L.P. and Pitango Growth Principals Fund I, L.P., Pitango G.E. Fund I, L.P. has shared voting and dispositive power over 9,245,736 Class A ordinary shares, which consists of (i) 3,081,912 Class A ordinary shares; and (ii) an additional 6,163,824 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares, held in the aggregate, by Pitango Growth Fund I, L.P. and Pitango Growth Principals Fund I, L.P., for each of which Pitango G.E. Fund I, L.P. serves as the sole general partner. The partners of Pitango G.E. Fund I, L.P. are one individual and eight private companies that are each owned by one of the following individuals - Rami Beracha, Ayal Itzkovitz, Eyal Niv, Ittai Harel, Rami Kalish, Aaron Mankovski, one of our directors, Chemi Peres and Zeev Binman (the "Pitango Principals"). The Pitango Principals may therefore be deemed to possess shared voting and dispositive power with respect to all Class A ordinary shares and Class B ordinary shares held by the Pitango entities. The business address of each Pitango entity is 11 HaMenofim St., Building B, Herzliya, 4672562, Israel.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based on information reported on a Schedule 13G/A filed on January 25, 2024 and information known to the Company as of January 31, 2024, The Phoenix Holdings Ltd. ("Phoenix Holdings") has shared voting and dispositive power over 8,198,812 Class A ordinary shares, which consists of (i) 3,808,288 Class A ordinary shares; and (ii) 4,390,524 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares. The Class A ordinary shares reported by Phoenix Holdings are beneficially owned by various direct and indirect, majority or wholly-owned subsidiaries of Phoenix Holdings (the "Subsidiaries"). The Subsidiaries manage their own funds and/or the funds of others, including for holders of exchange-traded notes or various insurance policies, members of pension or provident funds, unit holders of mutual funds, and portfolio management clients. Each of the Subsidiaries operates under independent management and makes its own independent voting and investment decisions. The business address of Phoenix Holdings is Derech Hashalon 53, Givataim, 53454, Israel.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based solely on information reported on a Schedule 13G/A on February 14, 2024, Genesis Partners IV L.P. ("Genesis IV") has sole voting power and sole dispositive power over 6,195,994 Class A ordinary shares. G.P.R. S.P.V 2 ("GPR") has sole voting power and sole dispositive power over 2,142,711 Class A ordinary shares, which consists of (i) 714,237 Class A ordinary shares; and (ii) an additional 1,428,474 Class A ordinary shares issuable upon conversion, on a one-for-one basis, of an equivalent number of Class B ordinary shares that are held by GPR. Genesis Partners IV Management ("Genesis Management") has (a) sole voting power and sole dispositive power over 280,699 Class A ordinary shares; and (b) shared voting power and shared dispositive power over all 8,338,705 Class A ordinary shares held by Genesis IV and GPR by virtue of its principals affiliation with GPR and by being the general partner of Genesis IV. Eyal Kishon, one of our directors, has shared voting power and shared dispositive power over all 8,619,404 ordinary shares held by Genesis IV, GPR and Genesis Management by virtue of serving as the managing partner of Genesis Management. The business address of Genesis IV, GPR, Genesis Management and Eyal Kishon is 13 Basel Street, Herzliya, 4666013, Israel.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Based solely on information reported on a Schedule 13G filed on February 9, 2024, Capital World Investors (&#8220;CWI&#8221;) has sole voting power and sole dispositive power over 9,774,367 Class A ordinary shares. CWI is a division of Capital Research and Management Company ("CRMC"), as well as its investment management subsidiaries and affiliates Capital Bank and Trust Company, Capital International, Inc., Capital International Limited, Capital International Sarl, Capital International K.K., Capital Group Private Client Services, Inc., and Capital Group Investment Management Private Limited (together with CRMC, the "investment management entities"). CWI's divisions of each of the investment management entities collectively provide investment management services under the name &#8220;Capital World Investors." The business address of CWI is 333 South Hope Street, 55th Floor, Los Angeles, California 90071.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Gal, (a) 4,666,436 Class A ordinary shares, and 9,113,300 Class B ordinary shares held directly by Mr. Gal that are convertible, on a one-for-one basis, into Class A ordinary shares at his election within 60 days of January 31, 2024, and (b) 104,177 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024, but excluding 798,688 Class A ordinary shares underlying tranches 1 and 2 of the Multi-Year Award, for which the vesting eligibility dates occurred on July 29, 2022 and July 29, 2023, respectively, and are therefore eligible to vest upon the satisfaction of the applicable share price targets. For further information related to the Multi-Year Award, see Item 6.B. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">&#8220;Directors, Senior Management and Employees - Compensation."</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Feldman, (a) 4,205,866 Class A ordinary shares, and 9,113,300 Class B ordinary shares, which consists of (i) 1,016,316 Class A ordinary shares and 2,734,200 Class B ordinary shares, that are convertible, on a one-for-one basis, into Class A ordinary shares at his election within 60 days of January 31, 2024, held directly by Mr. Feldman, and (ii) 3,189,550 Class A ordinary shares, and 6,379,100 Class B ordinary shares, that are convertible, on a one-for-one basis, into Class A ordinary shares at his election within 60 days of January 31, 2024 held by Sundance NYC Holdings LLC, and (b) 52,088 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024. Mr. Feldman is the manager of Sundance NYC Holdings LLC, and as such, may be deemed to share beneficial ownership over the securities held of record by Sundance NYC Holdings LLC.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Shachar, (a) 5,736 Class A ordinary shares held directly by Mr. Shachar; (b) 10,289,961 ordinary shares held by Qumra Capital identified in footnote (4) above by virtue of serving as a Managing Partner at Qumra Capital, which manages funds that collectively own such Class A ordinary shares and Class B ordinary shares; and (c) 14,699 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024. Mr. Shachar disclaims beneficial ownership of the ordinary shares held by Qumra Capital, except to the extent of his pecuniary interest, if any, in such ordinary shares.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Dr. Kishon, (a) 10,763 Class A ordinary shares held directly by Dr. Kishon; (b) 8,619,404 ordinary shares held by Genesis IV, GPR and Genesis Management identified in footnote (7) above by virtue of serving as the Managing Partner of Genesis Management, which directly owns or manages funds that collectively own such Class A ordinary shares and Class B ordinary shares; and (c) 14,699 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024. Dr. Kishon disclaims beneficial ownership of the ordinary shares held by Genesis Partners, except to the extent of his pecuniary interest, if any, in such ordinary shares.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Ms. Ceran, (a) 34,525 Class A ordinary shares held directly by Ms. Ceran, and (b) 35,898 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Mankovski, (a) 10,763 Class A ordinary shares held directly by Mr. Mankovski; and (b) 14,699 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024; and does not include the Class A ordinary shares and Class B ordinary shares held by the Pitango entities identified in footnote (5) above. Mr. Mankovski is a Managing Partner at Pitango Venture Capital, which manages funds that collectively own Class A ordinary shares and Class B ordinary shares.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Syed, (a) 10,763 Class A ordinary shares held directly by Mr. Syed; and (b) 14,699 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024; and does not include the Class A ordinary shares and Class B ordinary shares held of record by GA RK identified in footnote (3) above. Mr. Syed is a Managing Director at GA RK., which manages funds that collectively own such Class A ordinary shares and Class B ordinary shares.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Ms. Dotcheva, (a) 586,191 Class A ordinary shares held directly by Ms. Dotcheva, and (b) 412,184 Class A ordinary shares underlying options that are currently vested and exercisable or options and RSUs that will vest and become exercisable (as applicable) within 60 days of January 31, 2024.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Ms. Ofek Arad, (a) 310,440 Class A ordinary shares held directly by Ms. Ofek Arad, and (b) 519,811 Class A ordinary shares underlying options that are currently vested and exercisable or options and RSUs that will vest and become exercisable (as applicable) within 60 days of January 31, 2024.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:4.839%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:79.148%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.713%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(18)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Represents for Mr. Kumaraswami, (a) 394,008 Class A ordinary shares held directly by Mr. Kumaraswami, and (b) 141,078 Class A ordinary shares underlying RSUs that will vest within 60 days of January 31, 2024.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(19)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes 1,324,032 Class A ordinary shares underlying options that are currently vested and exercisable or options and RSUs that will vest and become exercisable (as applicable) within 60 days of January 31, 2024.</span></div></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Registered Holders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January 31, 2024, our Class A ordinary shares were held by 23 record holders, including Cede &amp; Co., the nominee of The Depository Trust Company, and our Class B ordinary share</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s were held by 16 record holders. Based on a review of the information provided to us by our transfer agent, (a) seven record holders, including Cede &amp; Co., holding approximately 80.6% of our outstanding Class A ordinary shares held of record, were residents of the United States, and (b) five record holders, holding approximately 38.1% of our outstanding Class B ordinary shares held of record, were residents of th</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e United States. The number of record holders in the United States is not representative of the number of beneficial holders nor is it representative of where such beneficial holders are resident since many of these ordinary shares were held by brokers or other nominees.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Changes in Ownership</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June and September, 2023, Genesis Partners IV L.P. (&#8220;Genesis IV&#8221;) made a distribution-in-kind of a total of 22,062,992 Class A ordinary shares to its limited partners and 280,699 Class A ordinary shares to its general partner, Genesis Partners IV Management. In June and August, 2023 Genesis IV disposed of a total of 155,540 Class A ordinary shares by way of open-market sales. As a result, Genesis Partner&#8217;s combined voting power in the company decreased from 18.0% to 4.8% during the fiscal year ended December 31, 2023.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To our knowledge, other than as disclosed under this heading, in the table above, our other filings with the SEC and in this Annual Report, there has been no significant change in the percentage ownership held by any major shareholder during the past three years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither our major shareholders nor our directors and executive officers have different or special voting rights with respect to their ordinary shares, except that each Class A ordinary share is entitled to one vote per share and each Class B ordinary share is be entitled to ten votes per share. For additional information about our dual class share structure, see Exhibit 2.2 to this Annual Report.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control Arrangements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not aware of any arrangement that may at a subsequent date, result in a change of control of the Company.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_127"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.    Related Party Transactions</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our policy is to enter into transactions with related parties on terms that, on the whole, are no more or less favorable than those available from unaffiliated third parties. Based on our experience in the business sectors in which we operate and the terms of our transactions with unaffiliated third parties, we believe that all of the transactions described below met this policy standard at the time they occurred. The following includes, among other information, a description of related party transactions, including any presently proposed transactions, as defined under Item 7.B of Form 20-F, since January 1, 2023.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rights of Appointment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current board of directors consists of seven directors. We are not a party to, and are not aware of, any voting agreements among our shareholders.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">113</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registration Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our amended and restated investors&#8217; rights agreement entitles certain of our shareholders to certain registration rights with respect to the registrable securities held by them. In accordance with this agreement, and subject to conditions listed below, the following entities which are affiliates of the company under U.S. securities laws are among those entitled to registration rights under the agreement: entities affiliated with each of Genesis Partners, General Atlantic, Pitango and Qumra, as well as our Chief Executive Officer (and individuals and entities affiliated with our Chief Executive Officer), and our Chief Technology Officer.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Form F-1 Demand Rights</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of at least 30% of the registrable securities then outstanding may request that we register all or a portion of their shares. Following the receipt of such request, we are required to give notice of the request to the other holders of registrable securities and offer them an opportunity to include their shares in the registration statement. Such request for registration must cover securities the aggregate offering price of which, after payment of the underwriting discount and commissions, would exceed $5,000,000. We will not be required to effect more than two registrations on Form F-1 that have been declared effective. The Company has the right to defer such registration under certain circumstances.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Form F-3 Demand Rights </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The holders of at least 15% of the registrable securities then outstanding can make a request that we register their shares on Form F-3 if we are qualified to file a registration statement on Form F-3 and if the offering price, after payment of the underwriting discount and commissions, would equal or exceed $3,000,000. We will not be required to effect more than two registrations on Form F-3 within any 12-month period. We have the right to defer such registration under certain circumstances.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Piggyback Registration Rights </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other security holders, in connection with such offering, certain holders of our registrable securities will be entitled to certain piggyback registration rights allowing the holder to include its registrable securities in such registration, subject to certain marketing and other limitations. As a result, whenever we propose to file a registration statement under the Securities Act, other than with respect to (i)&#160;a registration relating solely to the sale of securities to participants in a company stock plan, (ii)&#160;a registration relating to a corporate reorganization or other transaction listed in Rule 145 under the Securities Act, and (iii)&#160;a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the registrable securities, the holders of these shares are entitled to notice of the registration and have the right, subject to certain limitations, to include their shares in the registration.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Agreements with Directors and Officers</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employment Agreements.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have entered into at-will employment agreements with each of our executive officers who works for us as an employee. These agreements each contain provisions regarding non-competition, confidentiality of information and assignment of inventions. The enforceability of covenants not to compete is subject to limitations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of certain of our executive officers&#8217; employment agreements contain termination or change of control provisions. With respect to certain executive officers, either we or the executive officer may terminate his or her employment by giving advance written notice to the other party ranging from zero to three months. We may also terminate an executive officer&#8217;s employment agreement for cause (as defined in the applicable employment agreement). We describe the arrangements with our executive officers under Item 6.B. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212; Compensation.&#8221;</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">114</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Awards.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Since our inception, we have granted share options to purchase our ordinary shares and/or RSUs to our employees and the board of directors. We describe our equity incentive plans under Item 6.B. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212; Compensation</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exculpation, Indemnification and Insurance.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our amended and restated articles of association permit us to exculpate, indemnify and insure certain of our directors and office holders to the fullest extent permitted by the Companies Law. We have entered into agreements with certain directors and office holders, exculpating them from a breach of their duty of care to us to the fullest extent permitted by law and undertaking to indemnify them to the fullest extent permitted by law, subject to certain exceptions, including with respect to liabilities resulting from the IPO to the extent that these liabilities are not covered by insurance. See Item 6.C. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors, Senior Management and Employees &#8212; Board Practices&#8212;Exculpation, Insurance and Indemnification of Office Holders</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Warrant Agreement</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 27, 2021, we entered into an amended SaaS Agreement (the &#8220;SaaS Agreement&#8221;) with Wayfair. The SaaS Agreement has a five-year term, with an option for the customer to terminate the SaaS Agreement following the three-year anniversary date.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the SaaS Agreement, we issued a warrant to Wayfair to purchase up to 499,500 Class A ordinary shares at an exercise price of $0.007 per share, after giving effect to the Recapitalization (as defined in Note 2 to our audited consolidated financial statements included in Item 18 of this Annual Report). The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. Vesting during the first three years is contingent on the SaaS Agreement being in full force and effect in accordance with its terms and Wayfair not being in default or material breach under the terms of the SaaS Agreement, which includes Wayfair complying with certain volume commitments. Vesting during the last two years is contingent upon the vesting conditions being met during the first three years. As of December 31, 2023, 199,800 Class A ordinary shares issuable to Wayfair upon exercise of the warrant had vested and were therefore, exercisable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years in an aggregate amount of approximately $8.0 million, which represents the grant date fair value of the warrant, and is calculated by using a straight-line interpolation between the most recent third-party valuation immediately preceding the grant date and $19.00 (being the midpoint of the price range set forth on the cover page of our preliminary IPO prospectus, as filed with the SEC on July 28, 2021).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class A ordinary shares issuable to Wayfair upon exercise of the warrant are entitled to certain registration rights under the Investors&#8217; Rights Agreement as described in greater detail above in the section titled &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Related Party Transactions</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Registration Rights</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_130"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.    Interests of Experts and Counsel</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_133"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Consolidated Statements and Other Financial Information </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Consolidated Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Item 18. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Statements.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Legal and Arbitration Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we are involved in claims and legal proceedings related to claims incidental to or arising from our operations.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, a putative securities class action complaint was filed in federal court in the United States by certain of our shareholders against us, certain of our current and former officers and directors, and our underwriters alleging violations of the Securities Act in connection with our IPO-related disclosures, and seeking unspecified damages. The lawsuit was captioned</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> In re Riskified Ltd. Securities Litigation</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 22 Civ. 3545 (DLC) (S.D.N.Y.). Plaintiffs filed an amended complaint on September 15, 2022. We moved to dismiss the amended complaint on October 28, 2022. On June 2, 2023, the Court granted our motion to dismiss the complaint in its entirety, with prejudice. The deadline to appeal has passed and the judgment is now final.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently a party to any legal proceedings that, if determined adversely to us, would, in our opinion, be likely to have a significant effect on our financial position or profitability.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not anticipate paying any dividends in the foreseeable future. We currently intend to retain future earnings, if any, to finance operations and expand our business. Our board of directors has sole discretion in whether to pay dividends. If our board of directors decides to pay dividends, the form, frequency, and amount will depend upon our future operations and earnings, capital requirements and surplus, general financial condition, contractual restrictions, and other factors that our directors may deem relevant.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the years ended December 31, 2023, December 31, 2022 and December 31, 2021, we did not pay any dividends.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Companies Law imposes restrictions on our ability to declare and pay dividends.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment of dividends may be subject to Israeli withholding taxes. See Item 10.E &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Taxation &#8212; Israeli Tax Considerations</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; for additional information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Significant Changes </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_136"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. THE OFFER AND LISTING</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Offer and Listing Details </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Class A ordinary shares commenced trading on the NYSE on July 29, 2021 under the symbol &#8220;RSKD.&#8221; Prior to this, no public market existed for our Class A ordinary shares. Our Class B ordinary shares are neither listed nor publicly traded.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Plan of Distribution </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Markets </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212; Offer and Listing Details</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Selling Shareholders </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not Applicable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E. Dilution </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F. Expenses of the Issue </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">116</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">117</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_139"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. ADDITIONAL INFORMATION</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_142"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A. Share Capital</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_145"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B. Memorandum and Articles of Association</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of our amended and restated articles of association is attached as Exhibit 1.1 to this Annual Report. The information called for by this Item is set forth in Exhibit 2.2 to this Annual Report and is incorporated by reference herein.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_148"></div><div style="-sec-extract:summary;margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C. Material Contracts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except as otherwise disclosed in this Annual Report (including the Exhibits), we are not currently, nor have we been for the two years immediately preceding the date of this Annual Report, party to any material contract, other than contracts entered into in the ordinary course of business:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit101-fx1a1.htm">Form of Indemnification Agreement entered into by and between the Registrant and each director and executive officer (incorporated by reference to Exhibit 10.1 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 19, 2021). See Item 6, &#8220;Directors, Senior Management and Employees&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit102-fx1.htm">Amended and Restated 2013 Equity Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 1, 2021). See Item 6, &#8220;Directors, Senior Management and Employees&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit103-fx1.htm">Amended and Restated U.S. Sub-Plan to the 2013 Equity Incentive Plan (incorporated by reference to Exhibit 10.3 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 1, 2021). See Item 6, &#8220;Directors, Senior Management and Employees&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit104-fx1a1.htm">2021 Share Incentive Plan (incorporated by reference to Exhibit 10.4 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 19, 2021). See Item 6 &#8220;Directors, Senior Management and Employees&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/ex45amendedandrestatedcomp.htm">Amended and Restated Compensation Policy for Executive Officers and Directors (incorporated by reference to Exhibit 4.5 to the Company&#8217;s Annual Report on Form 20-F (File No. 001-40692) filed with the SEC on February 24, 2023). See Item 6, &#8220;Directors, Senior Management and Employees&#8221; for more information about this documen</a></span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">t.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit106-fx1a1.htm">2021 Employee Share Purchase Plan (incorporated by reference to Exhibit 10.6 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 19, 2021). See Item 6, &#8220;Directors, Senior Management and Employees&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit42-fx1a1.htm">2021 Amended and Restated Investors&#8217; Rights Agreement dated as of July 18, 2021, by and among the Registrant and the parties named in Schedule A thereto (incorporated by reference to Exhibit 4.2 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 19, 2021). See Item 7.B. &#8220;Related Party Transactions &#8212; Registration Rights&#8221; for more information about this document.</a></span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit45-fx1.htm">Share Purchase Warrant issued to Wayfair LLC, dated as of June 21, 2021, by and between the Registrant and Wayfair LLC (incorporated by reference to Exhibit 4.5 to the Company&#8217;s Registration Statement on Form F-1 (File No. 333-257603) filed with the SEC on July 1, 2021). </a></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">118</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit45-fx1.htm">See Item 7.B. &#8220;Related Party Transactions &#8212; Warrant Agreement&#8221; for more information about this document.</a></span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_151"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D. Exchange Controls</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are currently no Israeli currency control restrictions on remittances of dividends on our ordinary shares, proceeds from the sale of the ordinary shares or interest or other payments to non-residents of Israel, except for shareholders who are subjects of countries that are, have been, or will be, in a state of war with Israel.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_154"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E. Taxation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following description is not intended to constitute a complete analysis of all tax consequences relating to the acquisition, ownership and disposition of our Class A ordinary shares. You should consult your own tax advisor concerning the tax consequences of your particular situation, as well as any tax consequences that may arise under the laws of any state, local, foreign or other taxing jurisdiction.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Israeli Tax Considerations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a brief summary of the material Israeli tax laws applicable to us. This section also contains a discussion of material Israeli tax consequences concerning the ownership and disposition of our Class A ordinary shares purchased or held by investors. This summary does not discuss all the aspects of Israeli tax law that may be relevant to a particular investor in light of his or her personal investment circumstances or to some types of investors subject to special treatment under Israeli law. Examples of such investors include residents of Israel, traders in securities, not for profit organizations, pension funds and other exempt institutional investors, partnerships and other transparent entities, individuals under the tax regime for &#8220;new immigrants&#8221; or &#8220;returning residents&#8221; and other taxpayers who are subject to special tax regimes not covered in this discussion. To the extent that the discussion is based on new tax legislation that has not yet been subject to judicial or administrative interpretation, we cannot assure you that the appropriate tax authorities or the courts will accept the views expressed in this discussion. The discussion below is subject to change, including due to amendments under Israeli law or changes to the applicable judicial or administrative interpretations of Israeli law, which change could affect the tax consequences described below. The discussion should not be construed as legal or professional tax advice and does not cover all possible tax considerations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">General Corporate Tax Structure in Israel</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli resident companies are generally subject to corporate tax on their taxable income. The current corporate tax rate is 23%. Capital gains derived by an Israeli company are generally subject to the prevailing corporate tax rate.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the aforementioned, the effective tax rate payable by a company that derives income from a &#8220;Preferred Enterprise&#8221;, a &#8220;Special Preferred Enterprise&#8221;, a &#8220;Preferred Technology Enterprise&#8221; or a &#8220;Special Preferred Technology Enterprise&#8221; as further discussed below, may be considerably lower. See &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Law for the Encouragement of Capital Investments</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in this Item below.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Tax Benefits and Grants for Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli tax law allows, under certain conditions, a tax deduction for expenditures, including capital expenditures, related to scientific research and development in the fields of industry, agriculture, transportation, or energy for the year in which they are incurred. Expenditures are deemed related to scientific research and development projects, if:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expenditures are approved by the relevant Israeli government ministry, determined by the field of research;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the research and development must be for the promotion of the company; and</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the research and development are carried out by or on behalf of the company seeking such tax deduction, or that the expenditure is made by a person that carries out the research and does not own an enterprise which is engaged in the field of research, or that such expenditure constitutes a participation in a research carried out by another person, in both cases, subject to the fulfillment of certain criteria set forth in the Israeli tax law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amount of such deductible expenses is reduced by the sum of any funds received through government grants for the finance of such scientific research and development projects. Under these research and development deduction rules, no deduction is allowed for any expense invested in an asset depreciable under the general depreciation rules of the Ordinance. Expenditures that do not qualify for this special deduction are deductible in equal amounts over three years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time we may apply to the Israel Innovation Authority for approval to allow a tax deduction for all research and development expenses during the year incurred. There can be no assurance that such approval will be granted.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Law for the Encouragement of Industry (Taxes), 5729-1969</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Law for the Encouragement of Industry (Taxes), 5729-1969, generally referred to as the Industry Encouragement Law, provides several tax benefits for &#8220;Industrial Companies.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Industry Encouragement Law defines an &#8220;Industrial Company&#8221; as an Israeli resident company which was incorporated in Israel, of which 90% or more of its income in any tax year, other than income from certain government loans, is derived from an &#8220;Industrial Enterprise&#8221; owned by it and located in Israel or in the &#8220;Area&#8221;, in accordance with the definition in the section 3A of the Ordinance. An &#8220;Industrial Enterprise&#8221; is defined as an enterprise, which is held by an Industrial Company, whose principal activity in a given tax year is industrial production.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tax benefits, among others, are available to Industrial Companies:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amortization of the cost of purchased know-how, patents and rights to use a patent and know-how which are used for the development or promotion of the Industrial Enterprise, over an eight-year period commencing on the year in which such rights were first exercised;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">under limited conditions, an election to file consolidated tax returns together with Israeli Industrial Companies controlled by it; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expenses related to a public offering of shares in a stock exchange are deductible in equal amounts over three years commencing on the year of offering.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Eligibility for benefits under the Industry Encouragement Law is not contingent upon the approval of any governmental authority. We believe that we generally qualify as an Industrial Company within the meaning of the Industry Encouragement Law. The Israel Tax Authority may determine that we do not qualify as an Industrial Company, which could entail our loss of the benefits that relate to this status.  There can be no assurance that we will continue to qualify as an Industrial Company or that the benefits described above will be available in the future.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Law for the Encouragement of Capital Investments, 5719-1959</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Law for the Encouragement of Capital Investments, 5719-1959, or the Investment Law, provides certain incentives for capital investment in a production facility (or other eligible assets). Generally, an investment program that is implemented in accordance with the provisions of the Investment Law, is entitled to benefits. These benefits may include cash grants from the Israeli government and tax benefits, based upon, among other things, the geographic location in Israel of the facility in which the investment is made. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">120</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Law has been amended several times over the recent years, with the most significant changes which may be relevant to us effective as of January 1, 2011, or the 2011 Amendment, and as of January 1, 2017, or the 2017 Amendment. The 2011 Amendment introduced new benefits instead of the benefits granted in accordance with the provisions of the Investment Law prior to the 2011 Amendment. However, generally speaking, companies entitled to benefits under the Investment Law as in effect up to January 1, 2011 were entitled to choose to continue to enjoy such benefits, provided that certain conditions are met, or elect instead, irrevocably, to forego such benefits and elect the benefits of the 2011 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Preferred Enterprise Regime - The 2011 Amendment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2011 Amendment canceled the availability of the benefits granted in accordance with the provisions of the Investment Law prior to 2011 and, instead, introduced new benefits for income generated by a &#8220;Preferred Company&#8221; through its &#8220;Preferred Enterprise&#8221; (as such terms are defined in the Investment Law) as of January 1, 2011.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From 2017, and thereafter, the corporate tax rate for a Preferred Enterprise which is located in development zone A is 7.5%, while the reduced corporate tax rate for Preferred Enterprises located in other areas in Israel is 16%. Income derived by a &#8216;Special Preferred Enterprise&#8217; (as such term is defined in the Investment Law) may be entitled to further reduced rates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends paid to shareholders out of preferred income attributed to a Preferred Enterprise are generally subject to withholding tax at source at a rate of 20% or such lower rate as may be provided in an applicable tax treaty (subject to the receipt in advance of a valid certificate from the Israel Tax Authority, or the ITA, allowing for the reduced tax rate). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, the aforesaid will apply).</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The New Technological Enterprise Incentives Regime&#8212;the 2017 Amendment</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Amendment provides new tax benefits for two types of &#8220;Technology Enterprises&#8221;, as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The incentives regime will apply to &#8220;Preferred Technology Enterprises,&#8221; or PTE, that meet certain conditions, including: (1) the R&amp;D expenses in the three years preceding the tax year were on average at least 7% out of the company&#8217;s turnover, or exceeded NIS 75 million for a year; and (2) one of the following: (a) at least 20% of the workforce (or at least 200 employees) are employees whose full salary has been paid and reported in the company&#8217;s financial statements as R&amp;D expenses; (b) a venture capital fund invested at least NIS 8 million in the company and the company did not change its line of business subsequent to such investment; (c) growth in turnover by an average of 25% or more over the three years preceding the tax year, provided that the turnover was at least NIS 10 million, in the tax year and in each of the preceding three years; or (d) growth in workforce by an average of 25% or more over the three years preceding the tax year, provided that the company employed at least 50 employees, in the tax year and in each of the preceding three years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A &#8220;Special Preferred Technology Enterprise&#8221; is an enterprise that meets conditions 1 and 2 in the preceding paragraph, and in addition is part of a group that has total annual consolidated revenues above NIS 10 billion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PTE will be subject to a reduced corporate tax rate of 12% on its income that qualifies as &#8220;Preferred Technology Income&#8221;, as defined in the Investment Law. The tax rate is further reduced to 7.5% for a Preferred Technology Enterprise located in development zone A. These corporate tax rates shall apply only with respect to the portion of income attributed to the intellectual property developed in Israel. In addition, a Preferred Technology Company will enjoy a reduced corporate tax rate of 12% on capital gain </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">derived from the sale of certain &#8220;Benefited Intangible Assets&#8221; (as defined in the Investment Law) to a related foreign company if the Benefited Intangible Assets were acquired from a foreign company on or after January 1, 2017 for at least NIS 200 million, and the sale receives prior approval from the National Authority for Technological Innovation (previously known as the Israeli Office of the Chief Scientist), or IIA. Special Preferred Technology Enterprises will be subject to 6% on &#8220;Preferred Technology Income&#8221; regardless of the company&#8217;s geographic location within Israel. In addition, a Special Preferred Technology Enterprise will enjoy a reduced corporate tax rate of 6% on capital gain derived from the sale of certain &#8220;Benefited Intangible Assets&#8221; to a related foreign company if the Benefited Intangible Assets were either developed by the Special Preferred Enterprise or acquired from a foreign company on or after January 1, 2017, and the sale received prior approval from IIA. A Special Preferred Technology Enterprise that acquires Benefited Intangible Assets from a foreign company for more than NIS 500 million, will be eligible for these benefits for at least ten years, subject to certain approvals as specified in the Investment Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends distributed by a PTE or a Special Preferred Technology Enterprise, paid out of Preferred Technology Income, are generally subject to withholding tax at source at the rate of 20% (in the case of non-Israeli shareholders - subject to the receipt in advance of a valid certificate from the ITA allowing for the reduced tax rate of20% or such lower rate as may be provided in an applicable tax treaty). However, if such dividends are paid to an Israeli company, no tax is required to be withheld (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, the aforesaid will apply). If such dividends are distributed to a parent non-Israeli company holding, solely or together with other non-Israeli companies, at least 90% of the shares of the distributing company and other conditions are met, the withholding tax rate will be 4% (or a lower rate under a tax treaty, if applicable, subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate). </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, the Company has not exhausted the tax benefits that it might be eligible for as a Preferred Technology Enterprise or a Special Preferred Technology Enterprise under the 2017 Amendment.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Taxation of our Shareholders </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capital Gains Taxes </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli capital gains tax is imposed on the disposition of capital assets by an Israeli resident and on the disposition of such assets by a non-Israeli resident if those assets are either (i) located in Israel, (ii) shares or a right to shares in an Israeli resident corporation, or (iii) represent, directly or indirectly, rights to assets located in Israel, unless a specific exemption applies or a tax treaty between Israel and the seller&#8217;s country of residence provides otherwise. The Israeli tax law distinguishes between &#8220;Real Capital Gain&#8221; and &#8220;Inflationary Surplus.&#8221; Inflationary Surplus is a portion of the total capital gain which is equivalent to the increase in the relevant asset&#8217;s price that is attributable to the increase in the Israeli Consumer Price Index or, in certain circumstances, a foreign currency exchange rate, between the date of purchase and the date of disposition. Inflationary Surplus with respect to our shares purchased after being listed is currently not subject to tax in Israel. Real Capital Gain is the excess of the total capital gain over the Inflationary Surplus. Generally, Real Capital Gain accrued by individuals on the sale of our ordinary shares will be taxed at the rate of 25% (for any asset other than shares that are listed on a stock exchange purchased on or after January 1, 2003, the portion of the gain generated up to December 31, 2011 will be subject to the previous capital gains tax rates - 20% or 25% in case of a substantial shareholder as described below). However, if the shareholder is a &#8220;substantial shareholder&#8221; at the time of sale or at any time during the preceding 12- month period, the tax on such gain will be taxed  at the rate of 30%. A &#8220;substantial shareholder&#8221; is generally a person who alone or together with such person&#8217;s relative or another person who collaborates with such person on a permanent basis based on a contract, holds, directly or indirectly, at least 10% of any of the &#8220;means of control&#8221; of the corporation. &#8220;Means of control&#8221; generally include the right to vote, receive profits, nominate a director or an executive officer, receive assets upon liquidation, or order someone who holds any of the aforesaid rights how to act, regardless of the source of such right. Real Capital Gain derived by corporations will be generally subject to the ordinary corporate tax rate of 23% (in 2022 and 2023).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">122</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual and corporate shareholders dealing in securities in Israel are taxed at the tax rates applicable to business income - 23% for corporations in 2022 and 2023 and a marginal tax rate of up to 47% for an individual in 2022 and 2023 unless the benefiting provisions of an applicable treaty applies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a non-Israeli resident who derives capital gains from the sale of shares of an Israeli resident company that were purchased after the company was listed for trading on a stock exchange outside of Israel may  be exempt under Israeli tax law from Israeli capital gains tax so long as the capital gain is not attributed to a permanent establishment that the non-Israeli resident maintains in Israel and so long as neither the shareholder nor the particular capital gain is otherwise subject to the Israeli Income Tax Law (Inflationary Adjustments) 5745-1985. However, non-Israeli corporations will not be entitled to the foregoing exemption if Israeli residents (i) have a controlling interest, directly or indirectly, alone or together with another (i.e., together with a relative, or together with someone who is not a relative but with whom, according to an agreement, there is regular cooperation in material matters of the company, directly or indirectly), or together with another Israeli resident,  of more than 25% in any of the means of control of such non-Israeli corporation or (ii) are the beneficiaries of, or are entitled to, 25% or more of the revenues or profits of such non-Israeli corporation, whether directly or indirectly.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, such exemption is not applicable to a person whose gains from selling or disposing the shares are deemed to be business income.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, a sale of securities by a non-Israeli resident may be exempt from Israeli capital gains tax under the provisions of an applicable tax treaty. For example, under the tax treaty between the Government of the United States of America and the Government of the State of Israel with respect to Taxes on Income, as amended, or the United States-Israel Tax Treaty, the sale, exchange or other disposition of shares by a shareholder who is a United States resident (for purposes of the treaty) holding the shares as a capital asset and is entitled to claim the benefits afforded to such a resident by the United States-Israel Tax Treaty, or a Treaty U.S. Resident, is generally exempt from Israeli capital gains tax unless: (i) the capital gain arising from such sale, exchange or disposition is attributed to real estate located in Israel; (ii) the capital gain arising from such sale, exchange or disposition is attributed to royalties; (iii) the capital gain arising from the such sale, exchange or disposition is attributed to a permanent establishment  of the Treaty U.S. Resident which is maintained in Israel, under certain terms; (iv) such Treaty U.S. Resident holds, directly or indirectly, shares representing 10% or more of the voting capital during any part of the 12-month period preceding the disposition, subject to certain conditions; or (v) such Treaty U.S. Resident is an individual and was present in Israel for 183 days or more in the aggregate during the relevant taxable year. In any such case, the sale, exchange or disposition of such shares would be subject to Israeli tax, to the extent applicable. Under the United States-Israel Tax Treaty, a Treaty U.S. Resident may be permitted to claim a credit for the Israeli tax against the U.S. federal income tax imposed with respect to the sale, exchange or disposition of the shares, subject to the limitations under U.S. laws applicable to foreign tax credits. The United States-Israel Tax Treaty does not provide such credit against any U.S. state or local taxes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regardless of whether non-Israeli shareholders may be liable for Israeli capital gains tax on the sale of our ordinary shares, the payment of the consideration for such sale may be subject to withholding of Israeli tax at source and holders of our ordinary shares may be required to demonstrate that they are exempt from tax on their capital gains in order to avoid withholding at source at the time of sale. Specifically, in transactions involving a sale of all of the shares of an Israeli resident company, in the form of a merger or otherwise, the ITA may require shareholders who are not liable for Israeli capital gains tax on such a sale to sign declarations on forms specified by the ITA, provide documents (including, for example, a certificate of residency) or obtain a specific exemption from the ITA to confirm their status as non-Israeli residents (and, in the absence of such declarations or exemptions, the ITA may require the purchaser of the shares to withhold tax at source).</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">123</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Taxation on Receipt of Dividends </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli residents who are individuals are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, or 30% if the recipient of such dividend is a &#8220;substantial shareholder&#8221; at the time of distribution or at any time during the preceding 12-month period. However, dividends distributed from taxable income accrued from a Preferred Enterprise or a PTE to Israeli individuals are subject to withholding tax at the rate of 20%. However, if such dividends are distributed to an Israeli company, no withholding tax is imposed (although, if such dividends are subsequently distributed to individuals or a non-Israeli company, withholding tax at a rate of 20% will apply (in case of a non-Israeli shareholder &#8211; subject to the receipt in advance of a valid certificate from the ITA allowing the reduced 20%), or such lower rate as may be provided in an applicable tax treaty, subject to the receipt in advance of a valid certificate from the ITA allowing for a reduced tax rate). An average rate will be set in case the dividend is distributed from mixed types of income (regular and preferred income).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli resident corporations are generally exempt from Israeli corporate tax for dividends paid on shares of Israeli resident corporations to the extent such dividend is derived from income which was subject to the regular income tax rates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-Israeli residents (whether individuals or corporations) are generally subject to Israeli income tax on the receipt of dividends paid on our ordinary shares at the rate of 25%, which tax will be withheld at source, unless relief is provided in an applicable tax treaty between Israel and the shareholder&#8217;s country of residence. However, if the shareholder is considered a &#8220;substantial shareholder&#8221; at the time of receiving the dividend or at any time during the preceding 12-month period, the applicable tax rate will be 30%. Such dividends are generally subject to Israeli withholding tax at a rate of 25% so long as the shares are registered with a nominee company (whether the recipient is a substantial shareholder or not). Dividends distributed from income attributed to a Preferred Enterprise or PTE are subject to a reduced tax rate of 20% and the withholding from the payment to non-Israeli residents may be reduced to 20% subject to a withholding tax certificate from the ITA providing so. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reduced tax rate may be provided under an applicable tax treaty. For example, under the United States-Israel Tax Treaty, the maximum rate of tax withheld at source in Israel on dividends paid to a holder of our ordinary shares who is a Treaty U.S. Resident is 25%. However, generally, the maximum rate of withholding tax on dividends that are paid to a United States corporation holding 10% or more of the outstanding voting capital of the Israeli resident paying corporation throughout the tax year in which the dividend is distributed as well as during the previous tax year, is 12.5%, provided that not more than 25% of the gross income of the Israeli resident paying corporation for such preceding year consists of certain types of dividends and interest and further provided that such income was not subject to certain corporate tax benefits under the Investment Law. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Surtax </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the provisions of an applicable tax treaty, individuals who are subject to income tax in Israel (whether any such individual is an Israeli resident or non-Israeli resident) are also subject to an additional tax at a rate of 3% on its annual income from all sources (including, but not limited to, income derived from dividends, interest and capital gains) exceeding NIS 698,280 for 2023 (NIS 721,560 for 2024), which amount is linked to the annual change in the Israeli consumer price index.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estate and Gift Tax</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israeli law presently does not impose estate or gift taxes.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Federal Income Tax Considerations </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary describes certain United States federal income tax considerations generally applicable to United States Holders (as defined below) of our Class A ordinary shares. This summary </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">deals only with our Class A ordinary shares held as capital assets within the meaning of Section 1221 of the Code. This summary also does not address the tax consequences that may be relevant to holders in special tax situations including, without limitation, dealers in securities, traders that elect to use a mark-to-market method of accounting, holders that own our Class A ordinary shares as part of a &#8220;straddle,&#8221; &#8220;hedge,&#8221; &#8220;conversion transaction,&#8221; or other integrated investment, banks or other financial institutions, individual retirement accounts and other tax-deferred accounts, insurance companies, tax-exempt organizations, United States expatriates, holders whose functional currency is not the U.S. dollar, holders subject to any alternative minimum tax, holders that acquired our Class A ordinary shares in a compensatory transaction, holders which are entities or arrangements treated as partnerships for United States federal income tax purposes or holders that actually or constructively through attribution own 10% or more of the total voting power or value of our outstanding shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This summary is based upon the Code, applicable United States Treasury regulations, administrative pronouncements and judicial decisions, in each case as in effect on the date hereof, all of which are subject to change (possibly with retroactive effect). No ruling has been or will be requested from the Internal Revenue Service, or the IRS, regarding the tax consequences described herein, and there can be no assurance that the IRS will agree with the discussion set out below. This summary does not address any United States federal tax consequences other than United States federal income tax consequences (such as the estate and gift tax or the Medicare tax on net investment income).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used herein, the term &#8220;United States Holder&#8221; means a beneficial owner of our Class A ordinary shares that is, for United States federal income tax purposes, (i) an individual who is a citizen or resident of the United States, (ii) a corporation or other entity taxable as a corporation created or organized under the laws of the United States or any state thereof or therein or the District of Columbia, (iii) an estate the income of which is subject to United States federal income taxation regardless of its source, or (iv) a trust (a) that is subject to the supervision of a court within the United States and the control of one or more United States persons as described in the Code Section 7701(a)(30), or (b) that has a valid election in effect under applicable United States Treasury regulations to be treated as a &#8220;United States person.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an entity or arrangement treated as a partnership for United States federal income tax purposes acquires our Class A ordinary shares, the tax treatment of a partner in the partnership generally will depend upon the status of the partner and the activities of the partnership. Such a partner or partnership should consult its tax advisors as to the particular United States federal income tax consequences of acquiring, owning, and disposing of our Class A ordinary shares in its particular circumstances.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE SUMMARY OF UNITED STATES FEDERAL INCOME TAX CONSEQUENCES SET OUT BELOW IS FOR GENERAL INFORMATION ONLY. UNITED STATES HOLDERS SHOULD CONSULT THEIR TAX ADVISORS AS TO THE PARTICULAR TAX CONSEQUENCES TO THEM OF OWNING AND DISPOSING OF OUR CLASS A ORDINARY SHARES, INCLUDING THE APPLICABILITY AND EFFECT OF FEDERAL, STATE, LOCAL AND NON-U.S. TAX LAWS AND POSSIBLE CHANGES IN TAX LAW.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividends</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we do not anticipate paying any dividends in the foreseeable future, as described in &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dividend Policy</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; above, if we do make any distributions, subject to the discussion below under &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Passive Foreign Investment Company</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; the amount of dividends paid to a United States Holder with respect to our Class A ordinary shares before reduction for any Israeli taxes withheld therefrom generally will be included in the United States Holder&#8217;s gross income as ordinary income from foreign sources to the extent paid out of our current or accumulated earnings and profits (as determined for United States federal income tax purposes). Distributions in excess of earnings and profits will be treated as a non-taxable return of capital to the extent of the United States Holder&#8217;s tax basis in those Class A ordinary shares and thereafter as capital gains. However, we do not intend to calculate our earnings and profits under United States federal income tax principles. Therefore, United States Holders should expect to treat </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a distribution as a dividend even if that distribution would otherwise be treated as a non-taxable return of capital or as capital gain under the rules described above. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign withholding tax (if any) paid on dividends on our Class A ordinary shares at the rate applicable to a United States Holder (taking into account any applicable income tax treaty) may, subject to limitations and conditions, be treated as foreign income tax eligible for credit against such holder&#8217;s United States federal income tax liability or, at such holder&#8217;s election, eligible for deduction in computing such holder&#8217;s United States federal taxable income. Pursuant to applicable United States Treasury regulations (subject to temporary relief potentially available under applicable IRS Notices until further IRS guidance), however, if a United States Holder is not eligible for the benefits of an applicable income tax treaty or does not elect to apply such tax treaty, then such holder may not be able to claim a foreign tax credit arising from any foreign tax imposed on a distribution on our Class A ordinary shares, depending on the nature of such foreign tax. Dividends paid on our Class A ordinary shares generally will constitute &#8220;foreign source income&#8221; and &#8220;passive category income&#8221; for purposes of the foreign tax credit. However, if we are a &#8220;United States-owned foreign corporation,&#8221; solely for foreign tax credit purposes, a portion of the dividends allocable to our United States source earnings and profits may be re-characterized as United States source. A &#8220;United States-owned foreign corporation&#8221; is any foreign corporation in which United States persons own, directly or indirectly, 50% or more (by vote or by value) of the stock. In general, United States-owned foreign corporations with less than 10% of earnings and profits attributable to sources within the United States are excepted from these rules. If we are treated as a &#8220;United States-owned foreign corporation,&#8221; and if 10% or more of our earnings and profits are attributable to sources within the United States, a portion of the dividends paid on the Class A ordinary shares allocable to our United States source earnings and profits will be treated as United States source, and, as such, the ability of a United States Holder to claim a foreign tax credit for any Israeli withholding taxes payable in respect of our dividends may be limited. The rules governing the treatment of foreign taxes imposed on a United States Holder and foreign tax credits are complex, and United States Holders should consult their tax advisors about the impact of these rules in their particular situations, including their eligibility for benefits under an applicable income tax treaty and the potential impact of the applicable United States Treasury regulations and IRS Notices.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividends received by certain non-corporate United States Holders (including individuals) may be &#8220;qualified dividend income,&#8221; which is taxed at the lower capital gains rate, provided that (i) either our Class A ordinary shares are readily tradable on an established securities market in the United States or we are eligible for benefits under a comprehensive United States income tax treaty that includes an exchange of information program and which the United States Treasury Department has determined is satisfactory for these purposes, (ii) we are neither a PFIC (as discussed below) nor treated as such with respect to the United States Holder for either the taxable year in which the dividend is paid or the preceding taxable year, and (iii) the United States Holder satisfies certain holding periods and other requirements. In this regard, shares generally are considered to be readily tradable on an established securities market in the United States if they are listed on the&#160;NYSE, as our Class A ordinary shares are. United States Holders should consult their tax advisors regarding the availability of the reduced tax rate on dividends paid with respect to our Class A ordinary shares. The dividends will not be eligible for the dividends received deduction available to United States Holders that are corporations in respect of dividends received from other United States corporations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disposition of Class A Ordinary Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the discussion below under &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8212;Passive Foreign Investment Company</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; a United States Holder generally will recognize capital gains or loss for United States federal income tax purposes on the sale or other taxable disposition of our Class A ordinary shares equal to the difference, if any, between the amount realized and the United States Holder&#8217;s tax basis in those Class A ordinary shares. If any Israeli tax is imposed on the sale, exchange or other disposition of our Class A ordinary shares, a United States Holder&#8217;s amount realized will include the gross amount of the proceeds before deduction of the Israeli tax. In general, capital gains recognized by a non-corporate United States Holder, including an individual, are subject to a lower rate under current law if such United States Holder held shares for more </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">than one year. The deductibility of capital losses is subject to limitations. Any such gain or loss generally will be treated as United States source income or loss for purposes of the foreign tax credit. A United States Holder&#8217;s tax basis in shares generally will equal the cost of such shares. Because gain for the sale or other taxable disposition of our Class A ordinary shares will be treated as United States source income, and United States Holders may use foreign tax credits against only the portion of United States federal income tax liability that is attributed to foreign source income in the same category, United States Holders&#8217; ability to utilize a foreign tax credit with respect to the Israeli tax imposed on any such sale or other taxable disposition, if any, may be significantly limited. In addition, if a United States Holder is eligible for the benefit of the income tax convention between the United States and the State of Israel and pays Israeli tax in excess of the amount applicable to the United States Holder under such convention or if the Israeli tax paid is refundable, the United States Holder will not be able to claim any foreign tax credit or deduction with respect to such excess portion of the Israeli tax paid or the amount of the Israeli tax refunded. In addition, pursuant to applicable United States Treasury regulations (subject to temporary relief potentially available under applicable IRS Notices until further IRS guidance), if a United States Holder is not eligible for the benefits of an applicable income tax treaty or does not elect to apply such tax treaty, then such holder may not be able to claim a foreign tax credit arising from any foreign tax imposed on the disposition of our Class A ordinary shares, depending on the nature of such foreign tax. The rules governing the treatment of foreign taxes imposed on a United States Holder and foreign tax credits are complex, and United States Holders should consult their tax advisors as to whether the Israeli tax on gains may be creditable or deductible in light of their particular circumstances, including their eligibility for benefits under an applicable treaty and the potential impact of applicable United States Treasury regulations and IRS Notices.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Passive Foreign Investment Company </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We would be classified as a PFIC for any taxable year if, after the application of certain look-through rules, either: (i) 75% or more of our gross income for such year is &#8220;passive income&#8221; (as defined in the relevant provisions of the Code) (the &#8220;income test&#8221;); or (ii) 50% or more of the value of our assets (generally determined on the basis of a quarterly average) during such year is attributable to assets that produce or are held for the production of passive income (the &#8220;asset test&#8221;). For these purposes, cash and other assets readily convertible into cash or that do or could generate passive income are categorized as passive assets, and the value of goodwill and other unbooked intangible assets is generally taken into account. Passive income generally includes, among other things, rents, dividends, interest, royalties, gains from the disposition of passive assets and gains from commodities and securities transactions. For purposes of the income and asset tests, we will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation of which we own, directly or indirectly, at least 25% (by value) of the stock. The legislative history of the relevant Code provisions indicates that the total value of a publicly-traded foreign corporation&#8217;s assets generally will be treated as equal to the sum of the aggregate value of its outstanding stock plus its liabilities for purposes of the asset test, and publicly-traded foreign corporations often employ such market capitalization method to value their assets. However, the IRS has not issued guidance conclusively addressing how to value a publicly-traded foreign corporation&#8217;s assets for PFIC purposes. The trading value of our Class A ordinary shares has in the past, and is likely to continue to fluctuate. In particular, the market price of the shares of U.S. listed technology companies (including us) has been especially volatile in recent years. In addition, we have a dual class share structure that has the effect of concentrating voting power in our Class B ordinary shares, which are not publicly traded. Our Class A ordinary shares, which are publicly traded, represent approximately 20% of the voting power of all our outstanding shares. In certain circumstances, including under volatile market conditions and considering the percentage of voting power represented by our publicly-traded Class A ordinary shares, we believe it may be appropriate to employ alternative methods to determine the value of our assets other than the market capitalization method. After considering the total value of our assets determined under an alternative valuation method that takes into account a control premium, we believe that we were not a PFIC for the taxable year ended December 31, 2023. However, if the market capitalization method were determined to be the only appropriate method of valuing our assets, we may well be treated as a PFIC for the taxable year ended December 31, 2023. </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">127</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, there can be no certainty that the IRS will not challenge such a position and determine that based on the IRS&#8217;s interpretation of the asset test, we were a PFIC for the taxable year ended December 31, 2023. In addition, PFIC status is a factual determination that must be made annually after the close of each taxable year. The trading value of our Class A ordinary shares is likely to continue to fluctuate while the market price of the shares of U.S. listed technology companies continues to be volatile, which may affect the determination of whether we will be considered a PFIC. As our market capitalization and the composition of our income, assets, and operations are subject to change, we cannot assure you that we will not be considered a PFIC for any taxable year. It is possible that the IRS may take a contrary position with respect to our determination in any particular year. Certain adverse U.S. federal income tax consequences could apply to a United States Holder if we are treated as a PFIC for any taxable year during which such United States Holder holds our Class A ordinary shares. Under the PFIC rules, if we were considered a PFIC at any time that a United States Holder holds our Class A ordinary shares, we would continue to be treated as a PFIC with respect to such holder&#8217;s investment unless (i) we cease to be a PFIC, and (ii) the United States Holder has made a &#8220;deemed sale&#8221; election under the PFIC rules.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any taxable year that a United States Holder holds our Class A ordinary shares, unless the United States Holder makes certain elections, any gain recognized by the United States Holder on a sale or other disposition of our Class A ordinary shares would be allocated pro-rata over the United States Holder&#8217;s holding period for the Class A ordinary shares. The amounts allocated to the taxable year of the sale or other disposition and to any year before we became a PFIC would be taxed as ordinary income. The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for individuals or the highest rate in effect for corporations, as appropriate, for that taxable year, and an interest charge would be imposed. Further, to the extent that any distribution received by a United States Holder on our Class A ordinary shares exceeds 125% of the average of the annual distributions on the Class A ordinary shares received during the preceding three years or the United States Holder&#8217;s holding period, whichever is shorter, that distribution would be subject to taxation in the same manner as gain on the sale or other disposition of our Class A ordinary shares if we were a PFIC, described above. If we are treated as a PFIC with respect to a United States Holder for any taxable year, the United States Holder will be deemed to own equity in any of the entities in which we hold equity that also are PFICs. Certain elections may be available that would result in alternative treatments of the Class A ordinary shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are a PFIC for any taxable year during which a United States Holder holds our Class A ordinary shares, then in lieu of being subject to the tax and interest charge rules discussed above, the United States Holder may make an election to include gain on the Class A ordinary shares as ordinary income under a mark-to-market method, provided that such Class A ordinary shares are &#8220;marketable.&#8221; The Class A ordinary shares will be marketable if they are &#8220;regularly traded&#8221; on a qualified exchange or other market, as defined in applicable United States Treasury regulations, such as the NYSE. For these purposes, our Class A ordinary shares will be considered regularly traded during any calendar year during which they are traded, other than in de minimis quantities, on at least 15 days during each calendar quarter.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a United States Holder makes an effective mark-to-market election, in each year that we are a PFIC, the United States Holder will include in ordinary income the excess of the fair market value of its Class A ordinary shares at the end of the year over its adjusted tax basis in the Class A ordinary shares. A United States Holder will be entitled to deduct as an ordinary loss in each such year the excess of its adjusted tax basis in the Class A ordinary shares over their fair market value at the end of the year, but only to the extent of the net amount previously included in income as a result of the mark-to-market election. If a United States Holder makes an effective mark-to-market election, in each year that we are a PFIC, any gain that it recognizes upon the sale or other disposition of its Class A ordinary shares will be treated as ordinary income and any loss will be treated as ordinary loss, but only to the extent of the net amount of previously included income as a result of the mark-to-market election.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A United States Holder&#8217;s adjusted tax basis in our Class A ordinary shares will be increased by the amount of any income inclusion and decreased by the amount of any deductions under the mark-to-</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">128</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market rules discussed above. If a United States Holder makes an effective mark-to-market election, it will be effective for the taxable year for which the election is made and all subsequent taxable years unless the Class A ordinary shares are no longer regularly traded on a qualified exchange or the IRS consents to the revocation of the election. United States Holders should consult their tax advisors about the availability of the mark-to-market election, and whether making the election would be advisable in their particular circumstances.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, a timely election to treat us as a qualified electing fund under the Code would result in an alternative treatment. However, we do not intend to prepare or provide the information that would enable United States Holders to make a qualified electing fund election.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are considered a PFIC, a United States Holder also will be subject to annual information reporting requirements. We are not providing any U.S. tax opinion to any United States Holder concerning our potential PFIC status, and United States Holders should consult their tax advisors about the potential application of the PFIC rules to an investment in the Class A ordinary shares. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Information Reporting and Backup Withholding </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend payments and proceeds paid from the sale or other taxable disposition of our Class A ordinary shares may be subject to information reporting to the IRS. In addition, a United States Holder (other than an exempt holder who establishes its exempt status if required) may be subject to backup withholding on dividend payments and proceeds from the sale or other taxable disposition of our Class A ordinary shares paid within the United States or through certain U.S.-related financial intermediaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Backup withholding will not apply, however, to a United States Holder who furnishes a correct taxpayer identification number, makes other required certification and otherwise complies with the applicable requirements of the backup withholding rules. Backup withholding is not an additional tax. Rather, any amount withheld under the backup withholding rules will be creditable or refundable against the United States Holder&#8217;s United States federal income tax liability, provided the required information is timely furnished to the IRS.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Financial Asset Reporting </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain United States Holders are required to report their holdings of certain foreign financial assets, including equity of foreign entities, if the aggregate value of all of these assets exceeds certain threshold amounts. Our Class A ordinary shares are expected to constitute foreign financial assets subject to these requirements unless the Class A ordinary shares are held in an account at certain financial institutions. United States Holders should consult their tax advisors regarding the application of these reporting requirements.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_157"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F. Dividends and Paying Agents</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_160"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">G. Statement by Experts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable. </span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_163"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H. Documents on Display</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the informational requirements of the Exchange Act. Accordingly, we are required to file or furnish reports and other information with the SEC, including annual reports on Form 20-F and reports on Form 6-K.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a &#8220;foreign private issuer,&#8221; we are exempt under the Exchange Act from, among other things, the rules prescribing the furnishing and content of proxy statements, and our officers, directors and principal shareholders are exempt from the reporting and short swing profit recovery provisions contained in </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">129</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 16 of the Exchange Act. In addition, we are not required under the Exchange Act to file periodic reports and financial statements with the SEC as frequently or as promptly as U.S. companies whose securities are registered under the Exchange Act. We are required to make certain filings with the SEC. The SEC maintains an internet website that contains reports, proxy statements and other information about issuers, like us, that file electronically with the SEC. The address of that website is www.sec.gov.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a corporate website at </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://www.riskified.com</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. We make available on our website&#8217;s &#8220;Investor Relations&#8221; page at </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">http://ir.riskified.com</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, free of charge, our Annual Report and the text of our reports on Form 6-K, including any amendments to these reports, as well as certain other SEC filings, as soon as reasonably practicable after they are electronically filed with or furnished to the SEC. The information contained on our website is not incorporated by reference in this Annual Report.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_166"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:12.44pt">Subsidiary Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_169"></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">J.    Annual Report to Security Holders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_172"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to a number of risks arising from our normal business activities. These risks principally involve the possibility of foreign currency exchange risk that may result in unfavorable foreign currency translation adjustments, foreign currency transaction gains and losses, and changes in interest rates that may adversely affect the value of our financial assets and liabilities or future cash flows and earnings. The following provides qualitative and quantitative information regarding these risks.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries. Our revenue is largely denominated in U.S. dollars, however an increasing portion of our revenue is denominated in foreign currencies, in particular the Euro ("EUR"). Additionally, a significant portion of our operating costs in Israel, consisting principally of compensation and benefits related costs, and overhead costs, are denominated in New Israeli Shekel (&#8220;NIS&#8221;). This foreign currency exposure, which we expect to persist, gives rise to market risk associated with exchange rate movements of the U.S. dollar against the EUR and NIS, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To reduce the impact of foreign exchange risks associated with forecasted future cash flows and the volatility in our consolidated statements of operations, we have established a hedging program. We utilize foreign currency contracts, primarily forward and option contracts, with financial institutions to protect against foreign currency exchange risks, mainly the exposure to changes in the exchange rate of the EUR and NIS against the U.S. dollar that are associated with future cash flows denominated in EUR and NIS. We do not enter into derivative instruments for trading or speculative purposes. We account for our derivative instruments as either assets or liabilities and carry them at fair value in the consolidated balance sheets. The accounting for changes in the fair value of the derivative depends on the intended use of the derivative and the resulting designation. Our hedging program reduces but does not eliminate the impact of currency exchange rate movements. We may in the future enter into other derivative financial instruments if it is determined that such hedging activities are appropriate to further reduce our foreign currency exchange risk. The effect of a hypothetical 10% change in foreign currency exchange rates would impact our future results by approximately $0.1&#160;million and $0.3&#160;million as of December&#160;31, 2023 and 2022, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash, cash equivalents, short-term deposits, and short-term investments of $474.8 million as of December&#160;31, 2023. Cash and cash equivalents consist of cash in banks, bank deposits, and money </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">market funds. Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. Our cash, cash equivalents, short-term deposits and short-term investments are held for working capital purposes. Such interest-earning instruments carry a degree of interest rate risk. The primary objectives of our investment activities are the preservation of capital, the fulfillment of liquidity needs and the fiduciary control of cash. We do not enter into investments for trading or speculative purposes. We did not have any debt outstanding as of December&#160;31, 2023. The effect of a hypothetical 10% change in interest rates would have impacted our interest income by approximately $2.3&#160;million and $1.0&#160;million for the years ended December&#160;31, 2023 and 2022, respectively.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_175"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_178"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_181"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_184"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of proceeds</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There has been no material change in the expected use of the net proceeds from our IPO as described in our final prospectus filed with the SEC on July 29, 2021 pursuant to Rule 424(b). As of the date of filing of this Annual Report, we have not used all of the net proceeds from the IPO.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_187"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act that are designed to ensure that information required to be disclosed in the Company&#8217;s reports under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosures. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of December&#160;31, 2023. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December&#160;31, 2023, our disclosure controls and procedures were effective to accomplish their objectives at the reasonable assurance level.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Annual Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over our financial reporting (as such term is defined in Rule 13a-15(f) and 15d-15(f) under the Exchange Act). Our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in &#8220;Internal Control - Integrated Framework (2013)&#8221; issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this assessment, our </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">management concluded that, as of December&#160;31, 2023, our internal control over financial reporting was effective.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Attestation Report of the Registered Public Accounting Firm</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report does not include an attestation report of our independent registered public accounting firm due to a transition period established by rules of the SEC for emerging growth companies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal controls over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the period covered by this Annual Report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_190"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. [RESERVED]</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_193"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board has determined that Ms. Ceran, Dr. Kishon, and Mr. Shachar each satisfy the &#8220;independence&#8221; requirements set forth in Rule 10A-3 under the Exchange Act. Our board of directors has also determined that Ms. Ceran is considered an &#8220;audit committee financial expert&#8221; as defined in Item 16A of Form 20-F under the Exchange Act.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_196"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16B. CODE OF ETHICS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a Code of Business Conduct and Ethics that applies to all our employees, officers and directors, including our principal executive officer, principal financial officer, principal accounting officer, controllers and others performing similar functions. Our Code of Business Conduct and Ethics is intended to meet the definition of &#8220;code of ethics&#8221; under Item 16B of Form 20-F. A copy of our Code of Business Conduct and Ethics is made available to every employee of the Company and is also available to investors and members of the public on our website at https://ir.riskified.com. The information contained on our website is not incorporated by reference in this Annual Report.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will disclose on our website any amendment to, or waiver from, a provision of our Code of Business Conduct and Ethics that applies to our directors or executive officers to the extent required under the rules of the SEC or the NYSE. We granted no waivers under our Code of Business Conduct and Ethics in 2023.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_199"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The audited consolidated financial statements of Riskified Ltd. at December&#160;31, 2023 and 2022 and for each of the two years in the period ended December&#160;31, 2023, appearing in this Annual Report have been audited by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, independent registered public accounting firm, as set forth in their report thereon appearing elsewhere herein, and are included in reliance upon such report given on the authority of such firm as experts in accounting and auditing. The current address of Kost Forer Gabbay &amp; Kasierer is 144 Menachem Begin Road, Building A, Tel Aviv 6492101, Israel.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below sets out the total amount billed to us by Kost Forer Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, for services performed in each of the years ended December&#160;31, 2023 and 2022, and breaks down these amounts by category of service:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">858&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">600&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit-Related Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,054&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">871&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Fees </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit fees for the years ended December&#160;31, 2023 and 2022 relate to fees for the audit of our annual financial statements. This category also includes services that the independent accountant generally provides, such as consents and assistance with and review of documents filed with the SEC.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit-Related Fees </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Audit-related fees for the year ended December&#160;31, 2023 relate to fees for assurance and other services that are reasonably related to the performance of the audit and are not reported under audit fees. We did not have any audit-related fees for the year ended December&#160;31, 2022.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax Fees </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax fees for the years ended December&#160;31, 2023 and 2022 were related to ongoing tax advisory, tax compliance and tax planning services.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pre-Approval Policies and Procedures </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advance approval of the Audit Committee or members thereof, to whom approval authority has been delegated, is required for all audit and non-audit services provided by our auditors.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All services provided by our auditors are approved in advance by either the Audit Committee or members thereof, to whom authority has been delegated, in accordance with the Audit Committee&#8217;s pre-approval policy.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_202"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_205"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fiscal year ended December 31, 2023, we repurchased 3,038,865 Class A ordinary shares for an aggregate purchase price of approximately $13.09 million under our $75 million repurchase program authorized by our board of directors and publicly announced in August 2023. The table below provides detailed information:</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">133</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.192%"><tr><td style="width:1.0%"/><td style="width:20.448%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.810%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.923%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.473%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.142%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">(a)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total Number of Shares Purchased</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">(b)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Average Price Paid per Share</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">(c)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">(d)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Maximum Number of Shares (or Approximate Dollar Value) that May Yet be Purchased Under the Plans or Programs</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.85pt;font-weight:700;line-height:112%;position:relative;top:-3.15pt;vertical-align:baseline">(3)</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">January 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">February 1-28, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">March 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">April 1-30, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">May 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">June 1-30, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">July 1-31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">August 1-31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$75,000,000</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">September 1-30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$75,000,000</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">October 1-31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$75,000,000</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">November 1-30, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571,647</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4.06</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">571,647</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$72,681,803</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:112%">December 1-31, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467,218</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$4.35</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,467,218</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$61,905,365</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:112%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,038,865</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$4.29</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">3,038,865</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">$61,905,365</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:2.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.069%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">As of the settlement date of the transaction. No shares were repurchased by the company during 2023 other than through the publicly disclosed share repurchase program.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(2)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Excludes broker and transaction fees.</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(3)</span></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Approval of the company&#8217;s $75 million share repurchase program in August 2023 was subject to receipt of approval from the Tel Aviv District Court Economic Department. This approval was received in November 2023. </span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No shares were repurchased during 2023 other than through the Repurchase Program.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_208"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_211"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16G. CORPORATE GOVERNANCE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an Israeli company, we are subject to various corporate governance requirements under the Companies Law. However, pursuant to regulations promulgated under the Companies Law, companies with shares traded on certain U.S. stock exchanges, including the NYSE, may, subject to certain conditions, &#8220;opt out&#8221; from the Companies Law requirements to appoint external directors and related Companies Law rules described below concerning the composition of the audit committee and compensation committee of the board of directors (other than the gender diversification rule under the Companies Law, which requires the appointment of a director from the other gender if at the time a director is appointed all members of the board of directors are of the same gender). In accordance with these regulations, we elected to &#8220;opt out&#8221; from those requirements of the Companies Law. Under these regulations, the exemptions from such Companies Law requirements will continue to be available to us so long as: (i) we do not have a &#8220;controlling shareholder&#8221; (as such term is defined under the Companies Law), (ii) our shares are traded on certain U.S. stock exchanges, including the NYSE, and (iii) we comply with the director independence requirements and the audit committee and compensation committee composition requirements under U.S. laws (including applicable rules of the NYSE) applicable to U.S. domestic issuers.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a &#8220;foreign private issuer&#8221; (as such term is defined in Rule 3b-4 under the Exchange Act) and our Class A ordinary shares are listed on the NYSE. As a &#8220;foreign private issuer&#8221; we are permitted to comply with Israeli corporate governance practices instead of the corporate governance rules of the NYSE, provided that we disclose which requirements we are not following and the equivalent Israeli requirement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because we are a &#8220;foreign private issuer,&#8221; our directors and senior management are not subject to short-swing profit and insider trading reporting obligations under Section 16 of the Exchange Act. They are, however, subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on this &#8220;foreign private issuer exemption&#8221; with respect to the quorum requirement for shareholder meetings. Whereas under the corporate governance rules of the NYSE, a quorum requires the presence, in person or by proxy, of holders of at least 33&#8531;% of the total issued outstanding voting power of our shares at each general meeting of shareholders, pursuant to our amended and restated articles of association, and as permitted under the Companies Law, the quorum required for a general meeting of shareholders will consist of at least two shareholders present in person or by proxy in accordance with the Companies Law, who hold or represent at least 33&#8531;% of the total outstanding voting power of our shares, except if (i) any such general meeting of shareholders was initiated by and convened pursuant to a resolution adopted by the board of directors and (ii) at the time of such general meeting, we qualify to use the forms and rules of a &#8220;foreign private issuer,&#8221; in which case the requisite quorum will consist of two or more shareholders present in person or by proxy who hold or represent at least 25% of the total outstanding voting power of our shares (and if the meeting is adjourned for a lack of quorum, the quorum for such adjourned meeting will be, subject to certain exceptions, any number of shareholders). We otherwise comply with and intend to continue to comply with the rules generally applicable to U.S. domestic companies listed on the NYSE.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may in the future, however, decide to use other &#8220;foreign private issuer exemptions&#8221; with respect to some or all of the other NYSE listing rules. Following our home country governance practices may provide less protection than is accorded to investors under the NYSE listing rules applicable to domestic issuers.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to take all actions necessary for us to maintain compliance as a &#8220;foreign private issuer&#8221; under the applicable corporate governance requirements of the Sarbanes-Oxley Act of 2002, the rules adopted by the SEC and NYSE listing standards.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_214"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16H. MINE SAFETY DISCLOSURE</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_217"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16I. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_817"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16J. INSIDER TRADING POLICIES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_823"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16K. CYBERSECURITY</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity Risk Management and Strategy</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have developed and implemented a cybersecurity risk management program intended to protect the confidentiality, integrity, and availability of our critical systems and information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity risk management program is based on various cybersecurity standards in which we are certified, including ISO 27001:2013, ISO 27017, ISO 27018, SOC 1, SOC 2 Type 2 and SOC 3. This </span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">does not imply that we meet technical specifications or requirements at all times, but that these frameworks help us identify, assess, and manage cybersecurity risks relevant to our business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity risk management aligns with and shares common methodologies and reporting channels with our broader risk management.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Key features of our cybersecurity risk management program include, but are not limited to, the following:</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">risk assessments designed to help identify material cybersecurity risks to our critical systems, information, products, services, and our broader enterprise IT Systems environment;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a security team principally responsible for managing (1) our cybersecurity risk assessment processes, (2) our security controls, and (3) our response to cybersecurity incidents;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">processes for monitoring for vulnerabilities of our technology which includes code review (as necessary), testing and analysis of software across the software lifecycle;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the use of external service providers, where appropriate, to assess, test or otherwise assist with aspects of our security controls;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">physical and technical security measures, including encryption, authentication, and access controls;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a bug bounty program to incentivize third-party assistance in detecting bugs, vulnerabilities or other issues in our syst</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ems or software;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cybersecurity awareness training and internal cybersecurity resources for our employees;</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a cybersecurity incident response plan that includes procedures for responding to cybersecurity incidents; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a third-party risk management process for service providers, suppliers, and vendors</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">who access our system and information.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not identified risks from known cybersecurity threats, including as a result of any prior cybersecurity incidents, that have materially affected us, including our operations, business strategy, results of operations, or financial condition. We face risks from cybersecurity threats that, if realized, are reasonably likely to materially affect us, including our operations, business strategy, results of operations, or financial condition. See Part I, Item 3.D. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors&#8212;Our products enable the collection and storage of personal, confidential or proprietary information of our merchants and their consumers, and security concerns could result in liability to us or inhibit sales of our products.</span><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity Governance</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors considers cybersecurity risk as part of its risk oversight function and has delegated to our audit committee overall risk management, including oversight of cybersecurity and other information technology risks.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit committee receives quarterly reports from management on our cybersecurity risks. In addition, management updates our audit committee, as necessary, regarding any significant cybersecurity incidents.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit committee also receives briefings from management on our cyber risk management program. Our audit committee reports to our board of directors regarding its activities, including those related to cybersecurity, as it deems necessary.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management has primary responsibility for our overall cybersecurity risk management program and supervises both our internal cybersecurity personnel and our retained external cybersecurity consultants. Our management, including our Chief Information Officer who reports to our Chief Technology Officer, is responsible for assessing and managing our material risks from cybersecurity threats. Our management&#8217;s experience includes an aggregate of almost two decades of information security and information technology strategy and management experience, including consulting on cloud security and adoption for several technology companies.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management oversees efforts to prevent, detect, mitigate, and remediate cybersecurity risks and incidents through various means, which may include briefings from internal security personnel; information obtained from governmental, public or private sources, including external consultants engaged by us; and alerts and reports produced by security tools deployed in our IT Systems environment.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_220"></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_223"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 17. FINANCIAL STATEMENTS</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have provided financial statements pursuant to Item 18.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_226"></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 18. FINANCIAL STATEMENTS</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statements and Schedule</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following Financial Statements and Financial Statement Schedules as required under Item 18 are attached hereto starting on page F-1 of this Annual Report:</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Audited Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reports of Independent Registered Public Accounting Firm </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated Balance Sheets as of December&#160;31, 2023 and 2022</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated Statements of Operations for the years ended December&#160;31, 2023, 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated Statements of Comprehensive Profit/Loss for the fiscal years ended December&#160;31, 2023, 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated Statements of Changes in Convertible Preferred Shares and Shareholders&#8217; Equity/Deficit for the years ended December&#160;31, 2023, 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Consolidated Statements of Cash Flows for the years ended December&#160;31, 2023, 2022 and 2021 </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Notes to the Consolidated Financial Statements </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Financial Statement Schedules</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Valuation and Qualifying Accounts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other schedules have been omitted since they are either not required or not applicable, or the information has otherwise been included. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">137</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_229"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 19. EXHIBITS</span></div><div><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"/><td style="width:36.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:176.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:31.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:51.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:34.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:51.25pt"/><td style="width:1.0pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporation by Reference</span></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed / Furnished</span></td></tr><tr style="height:24pt"><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111222000006/articlesofassociationjuly1.htm">Amended and Restated Articles of Association of Riskified Ltd.</a></span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40692</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 25, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021014326/exhibit41-fx1a2.htm">Specimen Class A ordinary share certificate of the Riskified Ltd.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 23, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex22descriptionofsecuritie.htm">Description of Securities</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:38pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">2.3</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit42-fx1a1.htm">2021 Amended and Restated Investors&#8217; Rights Agreement, dated as of July 18, 2021, by and among the Registrant and the parties named in Schedule A thereto.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 19, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">2.4</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit45-fx1.htm">Share Purchase Warrant issued to Wayfair LLC, dated as of June 21, 2021, by and between the Registrant and Wayfair LLC</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.1</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit101-fx1a1.htm">Form of Director and Officer Indemnification Agreement</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 19, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.2</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit102-fx1.htm">Amended and Restated 2013 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.2</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.3</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013329/exhibit103-fx1.htm">Amended and Restated U.S. Sub-Plan to the 2013 Equity Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.3</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.4</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit104-fx1a1.htm">2021 Share Incentive Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.4</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 19, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.5</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1851112/000185111223000006/ex45amendedandrestatedcomp.htm">Amended and Restated Compensation Policy for Executive Officers and Directors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20-F</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">001-40692</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.5</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">February 24, 2023</span></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%">4.6</span><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:115%;text-decoration:underline">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001851112/000162828021013981/exhibit106-fx1a1.htm">2021 Employee Share Purchase Plan</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">F-1/A</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">333-257603</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.6</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">July 19, 2021</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit81-20xf2023xlistofs.htm">List of Subsidiaries</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="eg302ex121-20xf2023x302cer.htm">Principal Executive Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ag302ex122-20xf2023x302cer.htm">Principal Financial Officer Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="eg906ex131-20xf2023x906cer.htm">Principal Executive Officer Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:34pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ag906ex132-20xf2023x906cer.htm">Principal Financial Officer Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">**</span></td></tr><tr style="height:44pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="a151riskified-20xf2023xaud.htm">Consent of Kost, Forer, Gabbay &amp; Kasierer, a member of Ernst &amp; Young Global, an independent registered public accounting firm</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">97.1</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit971-policyforrecove.htm">Policy for Recovery of Erroneously Awarded Compensation</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></div></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">138</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="padding-left:18pt;text-indent:-18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"/><td style="width:36.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:1.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:176.50pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:31.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:51.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:34.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:70.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:51.25pt"/><td style="width:1.0pt"/></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:21pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr><tr style="height:30pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL for the cover page of this Annual Report on Form 20-F (embedded within the Inline XBRL document)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.429%"><tr><td style="width:1.0%"/><td style="width:2.330%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.470%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Filed herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">**</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Furnished herewith</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Schedules and exhibits to this Exhibit omitted pursuant to Instructions as to Exhibits to Form 20-F. The Registrant agrees to furnish supplementally a copy of any omitted schedule or exhibit to the SEC upon request.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;&#8224;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Indicates a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain agreements filed as exhibits to this Annual Report contain representations and warranties that the parties thereto made to each other. These representations and warranties have been made solely for the benefit of the other parties to such agreements and may have been qualified by certain information that has been disclosed to the other parties to such agreements and that may not be reflected in such agreements. In addition, these representations and warranties may be intended as a way of allocating risks among parties if the statements contained therein prove to be incorrect, rather than as actual statements of fact. Accordingly, there can be no reliance on any such representations and warranties as characterizations of the actual state of facts. Moreover, information concerning the subject matter of any such representations and warranties may have changed since the date of such agreements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_232"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The registrant hereby certifies that it meets all of the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on its behalf.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"/><td style="width:48.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 6, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Eido Gal</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eido Gal</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.955%"><tr><td style="width:1.0%"/><td style="width:48.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.321%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 6, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Aglika Dotcheva</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aglika Dotcheva</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr></table></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">140</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_235"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">RISKIFIED LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.406%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.394%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Audited Consolidated Financial Statements</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_238">Report of Independent Registered Public Accounting Firm</a></span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (PCAOB ID: <ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-59">1281</ix:nonNumeric>)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_238">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_241">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_241">3</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_244">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_244">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_247">Consolidated Statements of Comprehensive Profit (Loss)</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_247">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_250">Consolidated Statements of Convertible Preferred Shares and Shareholders&#8217; Equity (Deficit)</a></span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_250">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_253">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_253">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_256">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_256">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Statement Schedule</span></div></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_856">V</a><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_856">aluation and </a><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_856">Qualifying</a><a style="color:#0000ff;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_856"> Accounts</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">F-<a style="color:#0e32e1;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i7e2a1111f1af4cbbb4ef5c932730e0bb_856">43</a></span></div></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_238"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div></div><div style="margin-bottom:9pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Shareholders and the Board of Directors of Riskified Ltd.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">      We have audited the accompanying consolidated balance sheets of Riskified Ltd. (the &#8220;Company&#8221;) as of December&#160;31, 2023 and 2022, the related consolidated statements of operations, comprehensive profit (loss), convertible preferred shares and shareholders&#8217; equity (deficit) and cash flows for each of the three years in the period ended December&#160;31, 2023, and the related notes and the financial statement schedule listed in the Index at Item 18 of Part III (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2023 and 2022, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2023, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:54.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.670%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:115%;text-decoration:underline">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-60">KOST FORER GABBAY &amp; KASIERER</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:11pt;font-weight:400;line-height:115%">A Member of EY Global</span></div></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2014.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-61">Tel-Aviv, Israel</ix:nonNumeric></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;6, 2024</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_241"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share data)</span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:63.323%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.367%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.369%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-62">440,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-63">188,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:fixed-zero" scale="3" id="f-64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RestrictedCashCurrent" format="ixt:num-dot-decimal" scale="3" id="f-65">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DepositsAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-66">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DepositsAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-67">287,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-68">46,886</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="3" id="f-69">37,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-70">10,607</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-71">14,371</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-72">28,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-74">532,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="f-75">529,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-76">15,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-77">18,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-78">29,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-79">35,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-80">15,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-81">14,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-82">8,690</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-83">8,922</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-84">601,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="f-85">606,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and Shareholders&#8217; Equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-86">2,573</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="f-87">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-88">24,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-89">24,134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-90">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-91">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="rskd:ProvisionForChargebacksCurrent" format="ixt:num-dot-decimal" scale="3" id="f-92">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:ProvisionForChargebacksCurrent" format="ixt:num-dot-decimal" scale="3" id="f-93">11,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, current</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-94">5,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-95">6,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-96">12,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-97">15,813</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-98">69,811</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-99">72,612</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities, noncurrent</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-100">25,694</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-101">31,202</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, noncurrent</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-102">14,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-103">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-104">110,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="f-105">112,548</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 8)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-106"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-7" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-107"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class A ordinary shares, <ix:nonFraction unitRef="ilsPerShare" contextRef="c-3" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" format="ixt:fixed-zero" scale="0" id="f-108">no</ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-109">900,000,000</ix:nonFraction> shares authorized as of December&#160;31, 2023 and 2022; <ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-110"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-111">128,738,857</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-112"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-113">102,084,746</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-114">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Class B ordinary shares, no par value; <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-116">232,500,000</ix:nonFraction> shares authorized as of December&#160;31, 2023 and 2022; <ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-117"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-118">49,814,864</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="f-119"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-120">68,945,014</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-121">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-3" name="us-gaap:CommonStockValue" format="ixt:fixed-zero" scale="3" id="f-122">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury shares at cost, <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:TreasuryStockCommonShares" format="ixt:num-dot-decimal" scale="0" id="f-123">3,038,865</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:TreasuryStockCommonShares" format="ixt:fixed-zero" scale="0" id="f-124">zero</ix:nonFraction> ordinary shares as of December&#160;31, 2023 and 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="3" id="f-125">13,155</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TreasuryStockValue" format="ixt:fixed-zero" scale="3" id="f-126">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-127">916,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-128">848,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-129">74</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-130">1,639</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-131">411,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-132">352,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-133">491,721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-134">494,436</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-135">601,932</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-136">606,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_244"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share and per share data)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-137">297,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-138">261,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-139">229,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-140">145,091</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-141">126,150</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="f-142">106,170</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-143">152,519</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-144">135,097</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="f-145">122,971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-146">71,577</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-147">72,014</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" format="ixt:num-dot-decimal" scale="3" id="f-148">55,301</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-149">88,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-150">88,438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-151">70,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-152">69,350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-153">83,993</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:GeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="f-154">52,903</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-155">229,368</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-156">244,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="f-157">178,914</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-158">76,849</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-159">109,348</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-160">55,943</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest income (expense), net</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-161">22,775</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" format="ixt:num-dot-decimal" scale="3" id="f-162">10,180</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InterestIncomeExpenseNonoperatingNet" scale="3" id="f-163">591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-164">837</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="f-165">505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" format="ixt:num-dot-decimal" scale="3" id="f-166">122,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-167">53,237</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-168">98,663</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-169">177,872</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for (benefit from) income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-170">5,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-171">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-172">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net profit (loss)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-173">59,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-174">104,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-175">179,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-176"><ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-177"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-178"><ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-179">0.33</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-180"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-181"><ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-182"><ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-183">0.62</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-184"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-185"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-186"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-187">2.35</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted-average shares used in computing net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-188"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-189">176,773,398</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-190"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-191">167,667,374</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-192"><ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-193">76,459,625</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_247"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net profit (loss)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-194">59,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-195">104,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-196">179,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive profit (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt;padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains (losses) on derivative instruments, net</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="f-197">1,634</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="f-198">1,883</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="f-199">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gains (losses) on available-for-sale debt securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" scale="3" id="f-200">86</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="f-201">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" format="ixt:fixed-zero" scale="3" id="f-202">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign currency translation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-203">7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="f-204">68</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-205">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-206">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-207">1,815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-208">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive profit (loss)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-209">57,322</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-210">106,520</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:ComprehensiveIncomeNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-211">179,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_250"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; EQUITY (DEFICIT)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands, except share data)</span></div></div><div style="text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.750%"><tr><td style="width:1.0%"/><td style="width:19.323%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.624%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.259%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.085%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.836%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.085%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.931%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.329%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.223%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.469%"/><td style="width:0.1%"/></tr><tr style="height:40pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Convertible<br/>Preferred Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Treasury Shares</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Profit (Loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholders&#8217; Equity (Deficit)</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-18" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-212">29,878,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:num-dot-decimal" scale="3" id="f-213">159,564</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-19" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-214">14,310,552</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-215">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-216">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-217">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-218">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-219">24,366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-220">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-221">68,399</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-222">44,029</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Series E convertible preferred shares, net of issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-3" name="rskd:PaymentsOfTemporaryEquityIssuanceCosts" scale="3" id="f-223">819</ix:nonFraction> and settlement of tranche rights</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="0" name="rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-224">1,450,414</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-26" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-225">50,519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Series E-1 convertible preferred shares upon exercise of Series E-1 convertible preferred share warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-27" decimals="0" name="rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-226">962,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-3" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-227">6,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Reclassification of convertible preferred share warrants upon IPO</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-228">74,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-229">35,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-230">35,778</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-11" decimals="0" name="rskd:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-231">32,291,470</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-232">291,296</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-233">32,291,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-234">291,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="3" id="f-235">291,296</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of Class A ordinary shares upon IPO, net of underwriting discounts and commissions and other issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-236">19,925,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-237">386,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="f-238">386,591</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-3" sign="-" name="rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" scale="3" id="f-239">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" name="rskd:StockIssuedDuringPeriodSharesRecapitalization" format="ixt:num-dot-decimal" scale="0" id="f-240">94,431,636</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" scale="3" id="f-241">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon exercise of share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-242">2,381,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-243">625,124</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-244">2,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-245">2,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of Class B ordinary shares to Class A ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-29" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-246">7,001,240</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-30" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-247">7,001,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-248">33,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-249">33,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary share warrants issued to a customer</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-250">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" scale="3" id="f-251">777</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-252">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="3" id="f-253">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-254">179,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-255">179,430</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-33" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-256">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="3" id="f-257">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-34" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-258">75,909,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-259">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-35" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-260">88,055,520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-261">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-36" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-262">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-263">775,249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-264">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-265">247,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-266">527,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-267">3,919,606</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-268">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-269">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon vesting of restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-270">3,145,103</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of Class B ordinary share to Class A ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-40" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-271">19,110,506</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-42" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-272">19,110,506</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-10" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:fixed-zero" scale="3" id="f-273">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-274">67,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-275">67,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary share warrants issued to a customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="f-276">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="f-277">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-278">1,815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-279">1,815</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-280">104,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-281">104,705</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-282">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="0" id="f-283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-45" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-284">102,084,746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="f-285">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-46" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-286">68,945,014</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-46" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="f-287">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-47" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-288">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-48" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-289">848,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-49" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-290">1,639</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-50" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-291">352,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-292">494,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-293">3,010,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-294">3,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-295">3,816</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon vesting of restricted share units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross" format="ixt:num-dot-decimal" scale="0" id="f-296">6,365,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Issuance of ordinary shares upon exercise of warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="rskd:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-297">1,187,087</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of Treasury shares</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-298"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-299">3,038,865</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-300">13,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="3" id="f-301">13,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Exchange of Class B ordinary share to Class A ordinary shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-302">19,130,150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-54" decimals="0" sign="-" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:num-dot-decimal" scale="0" id="f-303">19,130,150</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits" format="ixt:fixed-zero" scale="3" id="f-304">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-305">62,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" format="ixt:num-dot-decimal" scale="3" id="f-306">62,410</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Ordinary share warrants issued to a customer</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-52" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="f-307">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued" format="ixt:num-dot-decimal" scale="3" id="f-308">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-55" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-309">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-310">1,713</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-56" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-311">59,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-312">59,035</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:TemporaryEquitySharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-313">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" format="ixt:fixed-zero" scale="0" id="f-314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-57" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-315">128,738,857</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-57" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="f-316">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-58" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-317">49,814,864</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-58" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="0" id="f-318">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-59" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-319">13,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-60" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-320">916,371</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-61" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-321">74</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-62" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-322">411,569</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-323">491,721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_253"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(in thousands) </span></div></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-324">59,035</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-325">104,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-326">179,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unrealized loss (gain) on foreign currency</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-327">850</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" format="ixt:num-dot-decimal" scale="3" id="f-328">2,875</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="f-329">382</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for (benefit from) account receivable allowances</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-330">198</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-331">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-332">268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-333">3,568</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-334">3,607</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="3" id="f-335">1,990</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of capitalized internal-use software costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareAmortization1" format="ixt:num-dot-decimal" scale="3" id="f-336">1,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="f-337">667</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CapitalizedComputerSoftwareAmortization1" scale="3" id="f-338">446</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-339">9,567</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-340">7,135</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CapitalizedContractCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-341">4,667</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of convertible preferred share warrant liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:fixed-zero" scale="3" id="f-342">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:fixed-zero" scale="3" id="f-343">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:FairValueAdjustmentOfWarrants" format="ixt:num-dot-decimal" scale="3" id="f-344">101,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remeasurement of convertible preferred share tranche rights</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:FairValueAdjustmentOfRights" format="ixt:fixed-zero" scale="3" id="f-345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:FairValueAdjustmentOfRights" format="ixt:fixed-zero" scale="3" id="f-346">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:FairValueAdjustmentOfRights" format="ixt:num-dot-decimal" scale="3" id="f-347">21,260</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-348">62,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-349">67,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ShareBasedCompensation" format="ixt:num-dot-decimal" scale="3" id="f-350">33,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash right-of-use asset changes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-351">4,605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-352">4,211</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" format="ixt:fixed-zero" scale="3" id="f-353">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in accrued interest on investments</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-354">2,593</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" format="ixt:num-dot-decimal" scale="3" id="f-355">4,613</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" format="ixt:fixed-zero" scale="3" id="f-356">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ordinary share warrants issued to a customer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-357">1,536</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-358">1,535</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities" scale="3" id="f-359">777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-360">161</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-361">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:OtherNoncashIncomeExpense" scale="3" id="f-362">121</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-363">9,685</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-364">1,715</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" format="ixt:num-dot-decimal" scale="3" id="f-365">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="f-366">8,893</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="f-367">9,707</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:IncreaseDecreaseInCapitalizedContractCost" format="ixt:num-dot-decimal" scale="3" id="f-368">7,744</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-369">1,618</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-370">4,026</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" format="ixt:num-dot-decimal" scale="3" id="f-371">15,079</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-372">373</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" format="ixt:num-dot-decimal" scale="3" id="f-373">1,931</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="f-374">832</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="f-375">199</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="3" id="f-376">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-377">8,398</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:IncreaseDecreaseInGuarantorObligations" scale="3" id="f-378">358</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:IncreaseDecreaseInGuarantorObligations" scale="3" id="f-379">249</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="rskd:IncreaseDecreaseInGuarantorObligations" scale="3" id="f-380">333</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:IncreaseDecreaseInProvisionForChargebacks" scale="3" id="f-381">112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="rskd:IncreaseDecreaseInProvisionForChargebacks" scale="3" id="f-382">40</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:IncreaseDecreaseInProvisionForChargebacks" format="ixt:num-dot-decimal" scale="3" id="f-383">1,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-384">4,580</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-385">2,609</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-386">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-387">5,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-388">8,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-389">7,424</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-390">7,279</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-391">26,252</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="f-392">20,278</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of short-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-393">55,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-394">463,750</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquireShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-395">110,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maturities of short-term deposits</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-396">337,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-397">261,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-398">39,063</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of investments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:num-dot-decimal" scale="3" id="f-399">29,086</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="f-400">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquireInvestments" format="ixt:fixed-zero" scale="3" id="f-401">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-402">1,355</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-403">6,126</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-404">12,254</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:fixed-zero" scale="3" id="f-405">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="f-406">1,886</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsToDevelopSoftware" format="ixt:num-dot-decimal" scale="3" id="f-407">1,250</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-408">251,559</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-409">210,012</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="f-410">84,441</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from issuance of convertible preferred shares and warrants, net of issuance costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:fixed-zero" scale="3" id="f-411">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:fixed-zero" scale="3" id="f-412">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock" format="ixt:num-dot-decimal" scale="3" id="f-413">26,781</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from cash exercise of series E-1 convertible preferred share warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-414">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:fixed-zero" scale="3" id="f-415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromWarrantExercises" format="ixt:num-dot-decimal" scale="3" id="f-416">6,489</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of share options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-417">3,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-418">4,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" format="ixt:num-dot-decimal" scale="3" id="f-419">2,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from initial public offering, net of underwriting discounts and commissions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-420">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:fixed-zero" scale="3" id="f-421">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" format="ixt:num-dot-decimal" scale="3" id="f-422">392,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments of deferred offering costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="f-423">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="f-424">204</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="3" id="f-425">5,302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of treasury shares</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="f-426">13,155</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-427">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:fixed-zero" scale="3" id="f-428">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in) financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-429">9,314</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-430">3,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="f-431">423,189</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effects of exchange rates on cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="f-432">297</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-433">1,701</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:fixed-zero" scale="3" id="f-434">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net increase (decrease) in cash, cash equivalents, and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-435">249,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-436">234,110</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="f-437">318,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash&#8212;beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-438">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-439">425,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-440">106,657</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents, and restricted cash&#8212;end of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-441">440,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-442">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-443">425,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of cash flow information:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for interest</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="f-444">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="f-445">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:InterestPaidNet" format="ixt:fixed-zero" scale="3" id="f-446">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="f-447">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="f-448">18</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="f-449">647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash paid for operating leases, net of incentives received</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="3" id="f-450">6,080</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:PaymentsForRent" format="ixt:num-dot-decimal" scale="3" id="f-451">4,357</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:PaymentsForRent" format="ixt:fixed-zero" scale="3" id="f-452">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities arising from obtaining right-of-use assets</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-453">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="f-454">792</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:fixed-zero" scale="3" id="f-455">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustment to ROU assets upon modification of existing lease</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" scale="3" id="f-456">811</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" format="ixt:fixed-zero" scale="3" id="f-457">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" format="ixt:fixed-zero" scale="3" id="f-458">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Supplemental disclosures of noncash investing and financing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchases of property and equipment during the period included in accounts payable and accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-459">97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="f-460">926</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" format="ixt:num-dot-decimal" scale="3" id="f-461">2,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation capitalized for software development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" format="ixt:fixed-zero" scale="3" id="f-462">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="f-463">299</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" scale="3" id="f-464">131</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:21pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Software development costs, accrued but not paid</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-465">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-466">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid" scale="3" id="f-467">485</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred offering costs accrued but not paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:DeferredOfferingCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-468">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:DeferredOfferingCostsIncurredButNotYetPaid" format="ixt:fixed-zero" scale="3" id="f-469">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:DeferredOfferingCostsIncurredButNotYetPaid" scale="3" id="f-470">204</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Settlement of convertible preferred share tranche rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="rskd:WarrantsAndRightsSettled" format="ixt:fixed-zero" scale="3" id="f-471">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="rskd:WarrantsAndRightsSettled" format="ixt:fixed-zero" scale="3" id="f-472">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="rskd:WarrantsAndRightsSettled" format="ixt:num-dot-decimal" scale="3" id="f-473">23,738</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="f-474">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:fixed-zero" scale="3" id="f-475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:ConversionOfStockAmountConverted1" format="ixt:num-dot-decimal" scale="3" id="f-476">291,296</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reclassification of convertible preferred share warrants upon IPO</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" format="ixt:fixed-zero" scale="3" id="f-477">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" format="ixt:fixed-zero" scale="3" id="f-478">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" format="ixt:num-dot-decimal" scale="3" id="f-479">110,502</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Elimination of par value upon Recapitalization</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" format="ixt:fixed-zero" scale="3" id="f-480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" format="ixt:fixed-zero" scale="3" id="f-481">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" scale="3" id="f-482">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-483">440,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-484">188,670</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="f-485">418,143</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="f-486">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="3" id="f-487">2,347</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="3" id="f-488">6,984</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 34pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents, and restricted cash</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-489">440,838</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-490">191,017</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="f-491">425,127</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these consolidated financial statements.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_256"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:1pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_259"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="f-492" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.       Organization and Description of Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Riskified Ltd., together with its subsidiaries, &#8220;Riskified&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company,&#8221; was incorporated under the laws of the State of Israel in 2012 and commenced operations in January 2013. We have built a next-generation eCommerce risk intelligence platform that allows our customers&#8212;online merchants&#8212;to create trusted relationships with their consumers. Our core product, the Chargeback Guarantee, is designed to ensure the legitimacy of our merchants&#8217; online orders by approving or denying these orders with guaranteed performance levels that vary by merchant. We guarantee the outcome of our decisions by assuming the cost of fraud associated with each approval. We drive higher sales by raising approval rates and reducing fraud and other operating costs for our merchants and strive to provide superior consumer experiences, as compared to our merchants&#8217; performance prior to onboarding us.</span></div></ix:nonNumeric><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_262"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="f-493" continuedAt="f-493-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.       Summary of Significant Accounting Policies</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-494" continuedAt="f-494-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-494-1">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and include the accounts of Riskified Ltd. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="f-495" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Immaterial Prior Period Error Correction</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. We assessed the materiality of the error on the financial statements for prior years individually and in the aggregate, and concluded that it was not material to any previously issued consolidated financial statements. We corrected the error by revising the consolidated financial statements appearing herein. The impact of the errors on the Company&#8217;s consolidated balance sheet as of January 1, 2021 was an overstatement of deferred contract acquisition costs of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-496"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" sign="-" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-497">0.7</ix:nonFraction></ix:nonFraction> million and an understatement of accumulated deficit of $<ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-498"><ix:nonFraction unitRef="usd" contextRef="c-66" decimals="-5" sign="-" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-499">0.7</ix:nonFraction></ix:nonFraction> million. There was no impact of the error on the consolidated statements of cash flows for the periods presented.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" id="f-500" continuedAt="f-500-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of the corrections on the Company&#8217;s consolidated financial statements for the years ended December 31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-501">16,364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-502">1,981</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-503">14,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-504">350,553</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-68" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-505">1,981</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-506">352,534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-507">87,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" name="us-gaap:SellingAndMarketingExpense" scale="3" id="f-508">716</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-509">88,438</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-510">108,632</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-511">716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-512">109,348</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-513">97,947</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-514">716</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-515">98,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-69" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-516">103,989</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-70" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="f-517">716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-518">104,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-69" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-519"><ix:nonFraction unitRef="usdPerShare" contextRef="c-69" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-520">0.62</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:EarningsPerShareDiluted" format="ixt:fixed-zero" scale="0" id="f-521"><ix:nonFraction unitRef="usdPerShare" contextRef="c-70" decimals="2" name="us-gaap:EarningsPerShareBasic" format="ixt:fixed-zero" scale="0" id="f-522">&#8212;</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-523"><ix:nonFraction unitRef="usdPerShare" contextRef="c-10" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-524">0.62</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-1" continuedAt="f-493-2"><ix:continuation id="f-500-1"><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:44.066%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.736%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-525">11,630</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-526">1,265</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-527">10,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-71" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-528">246,564</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-72" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-529">1,265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="f-530">247,829</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-531">70,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" name="us-gaap:SellingAndMarketingExpense" scale="3" id="f-532">545</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:SellingAndMarketingExpense" format="ixt:num-dot-decimal" scale="3" id="f-533">70,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-534">55,398</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" scale="3" id="f-535">545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-536">55,943</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-537">177,327</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="f-538">545</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-539">177,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-73" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-540">178,885</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-74" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" scale="3" id="f-541">545</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="f-542">179,430</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-75" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-543"><ix:nonFraction unitRef="usdPerShare" contextRef="c-75" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-544"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-545"><ix:nonFraction unitRef="usdPerShare" contextRef="c-76" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-546">2.34</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-547"><ix:nonFraction unitRef="usdPerShare" contextRef="c-78" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-548"><ix:nonFraction unitRef="usdPerShare" contextRef="c-77" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-549"><ix:nonFraction unitRef="usdPerShare" contextRef="c-78" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-550">0.01</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-551"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-552"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-553"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-554">2.35</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;2, 2021, we completed our initial public offering (&#8220;IPO&#8221;), in which we issued and sold <ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-555">19,925,000</ix:nonFraction> shares of our Class A ordinary shares at an offering price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-80" decimals="2" name="us-gaap:SaleOfStockPricePerShare" scale="0" id="f-556">21.00</ix:nonFraction> per share, including <ix:nonFraction unitRef="shares" contextRef="c-81" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="f-557">2,625,000</ix:nonFraction> shares of our Class A ordinary shares pursuant to the exercise in full of the underwriters&#8217; option to purchase additional shares. We received net proceeds of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="f-558">386.6</ix:nonFraction> million after deducting underwriting discounts and commissions of $<ix:nonFraction unitRef="usd" contextRef="c-79" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-559">26.2</ix:nonFraction> million, and other issuance costs of $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="rskd:PaymentsOfOtherStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-560">5.7</ix:nonFraction> million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the closing of the IPO, <ix:nonFraction unitRef="shares" contextRef="c-83" decimals="0" name="rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="f-561">962,940</ix:nonFraction> shares of Series E-1 convertible preferred shares were issued upon the exercise of the Series E-1 convertible preferred share warrants. In addition, all convertible preferred shares then outstanding automatically converted into <ix:nonFraction unitRef="shares" contextRef="c-79" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="0" id="f-562">32,291,470</ix:nonFraction> shares of our Class A ordinary shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, deferred offering costs, which consist primarily of accounting, legal and other fees related to our IPO, were capitalized within other assets, noncurrent in the consolidated balance sheets. Upon the consummation of the IPO, $<ix:nonFraction unitRef="usd" contextRef="c-82" decimals="-5" name="rskd:PaymentsOfOtherStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="f-563">5.7</ix:nonFraction> million of deferred offering costs were reclassified into shareholders&#8217; equity as an offset against IPO proceeds. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recapitalization</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021, we adopted new Articles of Association (&#8220;AoA&#8221;), in which, among other things, we implemented, upon the closing of the IPO:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) a dual class ordinary share structure pursuant to which we have two classes of ordinary shares: Class A ordinary shares and Class B ordinary shares. The rights of the holders of our Class A ordinary shares and Class B ordinary shares are identical, except with respect to voting, conversion and transfer rights. Class A ordinary shareholders are entitled to <ix:nonFraction unitRef="vote" contextRef="c-3" decimals="INF" name="rskd:CommonStockVotesForEachShare" format="ixt-sec:numwordsen" scale="0" id="f-564">one</ix:nonFraction> vote per share and Class B ordinary shareholders are entitled to <ix:nonFraction unitRef="vote" contextRef="c-4" decimals="INF" name="rskd:CommonStockVotesForEachShare" format="ixt-sec:numwordsen" scale="0" id="f-565">ten</ix:nonFraction> votes per share. The dual class ordinary share structure concentrates voting power with our pre-IPO shareholders. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters (including the election of directors) submitted to a vote of our shareholders, unless otherwise required by law or our amended and restated articles of association; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the elimination of the par value per ordinary share; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) a two-for-one reverse share split of our Class A ordinary shares (the &#8220;Reverse Share Split&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately after the effectiveness of the Reverse Share Split, we issued and distributed Class B ordinary shares to holders of the Class A ordinary shares on a two-for-one ratio, such that each holder of Class A ordinary shares received two Class B ordinary shares for each Class A ordinary share (the &#8220;Additional Class B Issuance&#8221;).</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-2" continuedAt="f-493-3"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The historical financial statements have not been retroactively adjusted for the (i) dual class structure, (ii) elimination of par value, and (iii) Additional Class B Issuance. As a result, all information associated with these items related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, restricted share units (&#8220;RSUs&#8221;), and warrants to purchase convertible preferred shares are being presented prospectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All information related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, RSUs, and warrants to purchase convertible preferred shares have been retroactively adjusted to give effect to the Reverse Share Split for all periods presented.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StockholdersEquityPolicyTextBlock" id="f-566" continuedAt="f-566-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-566-1">In August 2023, the board of directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-567">75.0</ix:nonFraction>&#160;million of its Class A ordinary shares (the &#8220;Repurchase Program&#8221;). Costs associated with the acquisition of Class A ordinary shares are presented as Treasury Shares on the consolidated balance sheet as a reduction of shareholders' equity.</ix:continuation> Refer to Note 10 for more information on the Repurchase Program.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-568" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives and investments, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#8220;IBR&#8221;) used for operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. We base our estimates on assumptions, both historical and forward-looking, trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="f-569" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the subsidiaries where the U.S. dollar is the functional currency, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars at exchange rates in effect at the end of each period. Foreign currency transaction gains and losses from these remeasurements are recognized in other income (expense), net, within the consolidated statements of operations. Foreign currency transactions resulted in net gains of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="f-570">1.4</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="f-571">2.5</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ForeignCurrencyTransactionGainLossRealized" format="ixt:num-dot-decimal" scale="6" id="f-572">0.2</ix:nonFraction>&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries where the functional currency is not the U.S. dollar, we use the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders&#8217; equity, into U.S. dollars. We record translation gains and losses in accumulated other comprehensive profit (loss) as a component of shareholders&#8217; equity in the consolidated balance sheets.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-573" continuedAt="f-573-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-3" continuedAt="f-493-4"><ix:continuation id="f-573-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk primarily consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivable and derivative financial instruments. We maintain our cash, cash equivalents, restricted cash, short-term deposits, and short-term investments with high-quality financial institutions mainly in the United States and Israel, the composition of which are regularly monitored by us. We have not experienced any material losses in such accounts. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are online merchants. For accounts receivable, we are exposed to credit risk in the event of nonpayment by online merchants to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit to online merchants and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our merchants by performing periodic evaluations of credit worthiness and consumer indebtedness and applying other credit risk monitoring procedures. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="f-574" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:26.624%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-85" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-575">17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-86" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-576">22</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-87" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-577">11</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-88" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-578">13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-89" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-579">16</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-90" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-580">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Represents less than 10%</span></div></ix:nonNumeric></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="f-581" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. We consider all highly liquid investments, with an original maturity of three months or less at the date of purchase, to be cash equivalents. Our restricted cash primarily consisted of cash deposits to back letters of credit related to certain operating leases.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="rskd:ShortTermDepositsPolicyPolicyTextBlock" id="f-582" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Deposits</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term deposits are reported at cost.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-583" continuedAt="f-583-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. We determine the appropriate classification of our investments in marketable debt securities at the time of purchase and reevaluate such designation at each balance sheet date. After consideration of our risk versus reward objectives, as well as our liquidity requirements, we may sell these debt securities prior to their effective maturities. As a result, we classify our investments, including those with maturities beyond 12 months, as current assets in the Consolidated Balance Sheets. We carry these securities at fair value, and report the unrealized gains and losses, net of taxes, as a component of shareholders&#8217; equity, except for changes in allowance for expected credit losses, which is recorded in other income (expense), net, within the consolidated statements of operations. We periodically evaluate our available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, we consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these criteria are </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-4" continuedAt="f-493-5"><ix:continuation id="f-583-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">met, we write down the security to its fair value and record the impairment charge in other income (expense), net within the consolidated statements of operations. If neither of these criteria are met, we determine whether credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-584" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We measure financial assets and liabilities at fair value for each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument&#8217;s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2 &#8211; Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3 &#8211; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivables, derivative financial instruments, accounts payables, accrued liabilities, indemnification guarantees. Cash and cash equivalents, short-term deposits, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Short-term investments and derivative financial instruments are stated at fair value on a recurring basis as disclosed in Note 4 below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record indemnification guarantees that we issue upon approving a transaction at fair value when issued using the income approach. To measure this guarantee, we consider the premium that would have been received for the same guarantee if it were issued in a stand-alone transaction. The fair value of these indemnification guarantees is determined based on historical chargeback claims, a risk premium fee that would be required for a third party to assume this liability, and an appropriate discount rate due to the time period between issuance of the guarantee and settlement or expiration. Historical chargeback guarantee claims are not readily observable in the marketplace and are generally classified as Level 3 inputs. Indemnification guarantees are recorded at fair value when issued and not remeasured to fair value each period. Refer to Note 8 below for more information regarding indemnification guarantees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments, in particular our indemnification guarantees, may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements. Refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:TradeAndOtherAccountsReceivablePolicy" id="f-585" continuedAt="f-585-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The allowance for credit losses is based on our assessment of the collectability of accounts. We regularly review the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current merchant&#8217;s credit worthiness, the age of the balance, the nature and size of the merchant, the financial condition of the merchant, and the amount of any receivables in dispute. Accounts </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-5" continuedAt="f-493-6"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-585-1">receivable deemed uncollectible are charged against the allowance for credit losses when identified.</ix:continuation> The allowance for doubtful accounts was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-586">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" format="ixt:num-dot-decimal" scale="6" id="f-587">0.5</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock" id="f-588" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of the allowance for credit losses:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:84.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-589">487</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="f-590">198</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncollectible accounts charged against the allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="3" id="f-591">170</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries of amounts previously deemed uncollectible</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries" format="ixt:fixed-zero" scale="3" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="3" id="f-593">515</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativesPolicyTextBlock" id="f-594" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to manage risks relating to our ongoing business operations. We enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks attributable to our exposure to changes in the exchange rates of (a) the New Israeli Shekel (&#8220;NIS&#8221;) against the U.S. dollar and (b) the Euro against the U.S. dollar. Our primary objective in entering into these contracts is to reduce the volatility of forecasted earnings and cash flows associated with changes in foreign currency exchange rates. We do not use derivative instruments for trading or speculative purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our derivative instruments as either assets or liabilities and carry them at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. Derivative instruments are recorded as either prepaid expenses and other current assets or accrued expenses and other current liabilities in the consolidated balance sheets. We record changes in the fair value of derivative instruments that are designated as hedging instruments in accumulated other comprehensive profit (loss) in the consolidated balance sheets, until the forecasted transaction occurs upon which we reclassify the related gain or loss on the derivative to the same financial statement line item in the consolidated statements of operations to which the derivative relates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge monetary assets or liabilities denominated in currencies other than the functional currency of a subsidiary. Changes in the fair value on these contracts, as well as the related costs, are recognized in Other income (expense), net, along with the foreign currency gains and losses on the related monetary assets and liabilities. Refer to Note 5 for additional information.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-595" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs are expensed as incurred. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-596" continuedAt="f-596-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of our property and equipment are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.675%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-91" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-597">3</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-92" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:duryear" id="f-598">7</ix:nonNumeric> years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of remaining lease term or estimated useful life</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-6" continuedAt="f-493-7"><ix:nonNumeric contextRef="c-1" name="us-gaap:InternalUseSoftwarePolicy" id="f-599" continuedAt="f-599-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software Costs</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-599-1" continuedAt="f-599-2">Costs related to software acquired, developed, or modified solely to meet our internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs incurred during the preliminary project stage and during the post implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized. Capitalized software development costs are recorded as part of other assets, noncurrent in the consolidated balance sheets. Maintenance costs are expensed as incurred. Capitalized software development costs are amortized on a straight-line basis over the software&#8217;s estimated useful life, which is <ix:nonNumeric contextRef="c-93" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-600">four years</ix:nonNumeric> and are recorded in cost of revenue&#160;in the consolidated statements of operations.</ix:continuation> As of December&#160;31, 2023 and 2022, we have capitalized $<ix:nonFraction unitRef="usd" contextRef="c-94" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="f-601">3.5</ix:nonFraction> million, net and $<ix:nonFraction unitRef="usd" contextRef="c-95" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="f-602">5.0</ix:nonFraction> million, net, respectively, of qualifying software development costs. Amortization expenses related to capitalized software costs were $<ix:nonFraction unitRef="usd" contextRef="c-96" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-603">1.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-604">0.7</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-605">0.4</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><ix:continuation id="f-599-2" continuedAt="f-599-3"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cloud Computing Arrangement Implementation Costs</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><ix:continuation id="f-599-3" continuedAt="f-599-4"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain implementation costs incurred in a cloud computing arrangement during the application development stage pursuant to Accounting Standards Codification, or ASC, 350-40,</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software. </span></ix:continuation><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-599-4">These costs are amortized over the term of the hosting arrangement on a straight-line basis, and are included within operating expenses in the consolidated statements of operations. Costs incurred in the preliminary stages of development are analogous to research and development activities and are expensed as incurred. These capitalized costs are included in other assets, noncurrent in the consolidated balance sheets.</ix:continuation> We have capitalized $<ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="f-606">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:CapitalizedComputerSoftwareGross" format="ixt:num-dot-decimal" scale="6" id="f-607">0.2</ix:nonFraction> million of qualifying cloud computing arrangement implementation costs as of December&#160;31, 2023 and 2022, respectively. Amortization expenses related to capitalized cloud computing arrangement implementation costs were $<ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-608">0.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-609">0.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" format="ixt:num-dot-decimal" scale="6" id="f-610">0.2</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-611" continuedAt="f-611-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease accounting policy under ASC Topic 840, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; until January 1, 2022, prior to the adoption of the new lease guidance was as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are reviewed and classified as either capital or operating leases at their inception. In certain lease agreements, we may receive renewal or expansion options, rent holidays, and other incentives. For operating leases, we recognize lease costs on a straight-line basis once we take control of the space, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted the new lease guidance for our operating lease agreements. Refer to Note 7 below for additional information. Our lease accounting policy under ASC Topic 842, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 842</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; from January 1, 2022, following the adoption of the new lease guidance is as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement meets the definition of a lease at the inception of the lease, and leases are classified at commencement as either operating or finance leases. We do not have any finance leases. Operating lease ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease agreement. Operating lease ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives received prior to lease commencement. Operating lease liabilities are measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using our IBR based on the information available at the commencement date of the lease as our leases generally do not provide an implicit rate. Our IBR was estimated to </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-7" continuedAt="f-493-8"><ix:continuation id="f-611-1" continuedAt="f-611-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include options to extend or terminate the lease when it is reasonably certain that we would exercise that option. We made an accounting policy election for lease agreements with a term of 12 months or less and do not recognize operating lease ROU assets and operating lease liabilities in respect of those agreements. Payments under our lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and operating lease liabilities. Variable lease payments are mainly comprised of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the practical expedient to not separate lease and non-lease components for our leases.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-611-2">We sublease certain office spaces to third parties. Operating sublease income is recognized on a straight-line basis over the term of the agreement.</ix:continuation> </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="f-612" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the recoverability of long-lived assets, including property and equipment, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Recoverability of these assets is measured by comparing the carrying amounts with the future undiscounted cash flows that the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. We determined that there were no material events or changes in circumstances that indicated that our long-lived assets were impaired during the periods presented.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies" id="f-613" continuedAt="f-613-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#8220;guarantee obligation&#8221;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and will be released to revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally <ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteeObligationsTerm" id="f-614">six</ix:nonNumeric> months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a <ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteeObligationsTerm" id="f-615">six</ix:nonNumeric>-month period that is representative of our historical pattern of being released from risk under the guarantee obligation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs and assumptions used by management to calculate this provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. These liabilities are recorded within Provision for chargebacks, net on the consolidated balance sheets and will be reduced by credits issued or cash paid to merchants. Refer to Note 8 below or </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-8" continuedAt="f-493-9"><ix:continuation id="f-613-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates&#8221; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="rskd:WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" id="f-616" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Share Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to IPO, warrants to purchase our Series B/C and E-1 convertible preferred shares were recorded as a liability at fair value on our consolidated balance sheets as the underlying convertible preferred shares were contingently redeemable, upon a deemed liquidation event that is outside of our control, and therefore could have obligated us to transfer assets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B/C convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or upon the completion of a qualified IPO. Upon IPO, the Series B/C convertible preferred share warrants were converted to warrants to purchase ordinary shares, and the then outstanding liability was reclassified to additional paid-in capital in the consolidated balance sheets. The warrants to purchase ordinary shares may be exercised any time prior to, and shall expire upon, the earlier of (a) April 29, 2025 or (b) immediately prior to the consummation of certain deemed liquidation events. In November 2023, the outstanding warrants to purchase ordinary shares were exercised. Refer to Note 9.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series E-1 convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or the completion of a deemed liquidation event, including a qualified IPO. Upon IPO, the Series E-1 convertible preferred share warrants were automatically exercised.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with a SaaS Agreement entered into in 2021, we issued a warrant to a customer to purchase ordinary shares. The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years. As of December 31, 2023, the warrant is outstanding.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-617" continuedAt="f-617-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees as noted above within &#8220;Indemnification Guarantees&#8221;. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#8217; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above within &#8220;Indemnification Guarantees&#8221;, our contracts with our merchants obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a <ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteeObligationsTerm" id="f-618">six</ix:nonNumeric>-month period from the date of the transaction.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present revenue net of cancellations and adjustments for minimum service level agreements.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-617-1" continuedAt="f-617-2"><ix:continuation id="f-493-9" continuedAt="f-493-10"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 606, revenue is recognized when a customer obtains control of promised products. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these products. To achieve the core principle of this standard, we applied the following five steps:</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the contract, or contracts, with the merchant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine that we have a contract with a merchant when the contract is approved, each party&#8217;s rights and obligations regarding the products to be transferred can be identified, the payment terms for the products can be identified, we have determined the merchant has the ability and intent to pay, and the contract has commercial substance. At contract inception, we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Contracts with our merchants are typically for a period of <ix:nonNumeric contextRef="c-1" name="rskd:RevenueTermOfMerchantContract" format="ixt-sec:durwordsen" id="f-619">one year</ix:nonNumeric>.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the products that will be transferred to the merchant that are both capable of being distinct, whereby the merchant can benefit from the products either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the products is separately identifiable from other promises in the contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For SaaS arrangements, we provide access to our cloud-hosted software platform and reviewing and approving eCommerce transaction for legitimacy, without providing the merchant the right to take possession of our software, which we consider to be a single performance obligation. Revenue generated from the issuance of indemnification guarantees is accounted for under ASC 460. Refer to &#8220;Indemnification Guarantees&#8221; above and Note 8 below for additional information.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Determination of the transaction price</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our contracts include an unknown quantity of approved transactions at a fixed contractual rate per approved transaction value executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of products during that month. Certain of our contracts include additional forms of variable consideration such as service level commitments relating to uptime availability and minimum approval rates as well as provisions that provide for reimbursements should our merchant&#8217;s consumer cancel an approved order. If we fail to meet these commitments, merchants are generally permitted to receive a refund in the form of a credit on their invoice. Under certain arrangements, when the merchant&#8217;s consumer cancels an order that we have approved, we provide a refund of some or all of the fees owed by our merchant to us generally in the form of a credit on our merchant&#8217;s invoice. The transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms and conditions vary by contract type, although terms generally include a requirement to pay within 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined that our contracts do not include a significant financing component. The primary purpose of our invoicing terms is to provide our merchants with simplified and predictable ways of purchasing our products; not to receive financing from our merchants or to provide merchants with financing. We applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from merchants (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. We generally do not offer a right of refund in our contracts.</span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-617-2" continuedAt="f-617-3"><ix:continuation id="f-493-10" continuedAt="f-493-11"><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation&#8217;s relative standalone selling price. Access to our cloud-hosted software is considered one performance obligation in the context of the contract and accordingly the transaction price is allocated to this single performance obligation. </span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Recognition of the revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time the related performance obligation is satisfied by transferring control of the promised service to the customer. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products. For SaaS arrangements, we have determined that these arrangements meet the variable consideration allocation exception and revenue is recognized over the contract period in the month that the transactions are approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets consist of unbilled accounts receivable. The terms of our agreements are monthly, annual, or multi-year, and we typically invoice our merchants based on monthly usage. In some arrangements, a right to consideration for our performance under the merchant contract may occur before invoicing to the merchant, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Obtain a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. These costs are recorded as Deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of <ix:nonNumeric contextRef="c-6" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="f-620">four years</ix:nonNumeric>. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions expenses are included in sales and marketing expense in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-621"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-622"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-623">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses recorded during the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Fulfill a Contract </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize payroll related costs of certain integration services required in order to be able to fulfill the obligation to provide our products to our merchants. Integration services are promises that are not capable of being distinct. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and generate or enhance resources that will be used in delivering our SaaS products. These costs are recorded as deferred contract fulfillment costs in other assets, noncurrent on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs to fulfill a contract are amortized on a straight-line basis over the expected period of benefit of <ix:nonNumeric contextRef="c-6" name="us-gaap:CapitalizedContractCostAmortizationPeriod" format="ixt-sec:durwordsen" id="f-624">four years</ix:nonNumeric> and are included in cost of revenue in the consolidated statements of operations. We </span></div></ix:continuation></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-11" continuedAt="f-493-12"><ix:continuation id="f-617-3"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the period of benefit by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of period of benefit involve inherent uncertainties and the application of significant judgment. We periodically review these deferred contract fulfillment costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-625"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-626"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="INF" name="us-gaap:CapitalizedContractCostImpairmentLoss" format="ixt:fixed-zero" scale="0" id="f-627">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> impairment losses recorded during the periods presented.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:CostOfSalesPolicyTextBlock" id="f-628" continuedAt="f-628-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead.</span></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-628-1">Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us.</ix:continuation> Amounts for chargebacks won were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rskd:ChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-629">25.0</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="rskd:ChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-630">20.3</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="rskd:ChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-631">14.3</ix:nonFraction>&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-632" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development costs also consist of third-party software hosting fees used by our research and development teams, depreciation expense, and allocated overhead. Research and development costs are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="rskd:SalesAndMarketingExpensePolicyPolicyTextBlock" id="f-633" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing costs primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead. Sales and marketing costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital marketing programs include advertising, promotional events, and brand-building activities. Advertising costs are expensed as incurred and were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-634">4.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-635">6.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:AdvertisingExpense" format="ixt:num-dot-decimal" scale="6" id="f-636">5.2</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="f-637" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead. General and administrative costs are expensed as incurred.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-638" continuedAt="f-638-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to share-based awards is recognized based on the fair value of the awards granted. The fair value of each share option award is estimated on the grant date </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-12" continuedAt="f-493-13"><ix:continuation id="f-638-1" continuedAt="f-638-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected term of the share option, the expected volatility of the price of our ordinary shares, risk-free interest rates, and the expected dividend yield of ordinary shares. The assumptions used to determine the fair value of the option awards represent management&#8217;s best estimates. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. The related share-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted to employees, RSUs, that vest either upon the (a) satisfaction of service-based vesting conditions only and (b) satisfaction of both service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying ordinary shares as of the grant date. We have also granted to our Chief Executive Officer (&#8220;CEO&#8221;), RSUs, that vest upon the satisfaction of service-based, performance-based, and market-based vesting conditions. A Monte-Carlo simulation model was used to determine the grant date fair value by simulating a range of scenarios with each outcome resulting in a determined value. The grant date fair value of this award is the average of the values determined by each simulation. The simulation was also used to derive the requisite service period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For RSU awards with both service-based and performance-based vesting conditions, the service-based vesting condition has varying terms, but is generally satisfied over <span style="-sec-ix-hidden:f-639">four</span> to <ix:nonNumeric contextRef="c-105" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-640">five years</ix:nonNumeric>. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) the <ix:nonNumeric contextRef="c-106" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-641">six month</ix:nonNumeric> anniversary of or, if earlier, March 15 of the year following, the occurrence of an IPO or (ii) consummation of a merger and acquisition, or M&amp;A, transaction of the Company. The performance-based vesting condition underlying these awards was satisfied upon our IPO. The market-based condition underlying the CEO RSU is satisfied upon the trading price of our ordinary shares meeting certain thresholds.</span></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-638-2">RSU awards with service-based vesting conditions only are recognized using the straight-line method. RSU awards with more than just a service-based vesting condition are recognized using the accelerated attribution method once the performance-based vesting condition is probable of</ix:continuation> occurring which results in higher expenses attributed to the earlier periods of the requisite service period.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-642" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-643" continuedAt="f-643-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute net profit (loss) per share using the two-class method required for participating securities. The two-class method requires income available to ordinary shareholders for the period to be </span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-493-13" continuedAt="f-493-14"><ix:continuation id="f-643-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Under the two-class method, we allocate earnings proportionately to Class A and B ordinary shares outstanding for the period. Prior to IPO, we considered our convertible preferred shares to be participating securities as the holders of the convertible preferred shares would be entitled to dividends in preference to ordinary shareholders. These participating securities do not contractually require the holders of such shares to participate in our losses. As such, net loss for the periods presented was not allocated to our participating securities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic net profit (loss) per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net profit (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net profit (loss) per share is the same as basic net profit (loss) per share in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive.</span></div></ix:continuation><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="f-644" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfOperatingSegments" format="ixt-sec:numwordsen" scale="0" id="f-645">one</ix:nonFraction> operating segment and therefore have <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-646">one</ix:nonFraction> reportable segment. Operating segments are defined as components of an entity that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker, who is our CEO, in deciding how to allocate resources and assess performance. Our chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical region can be found in the revenue recognition disclosures in Note 3 below. Property and equipment, net of depreciation and amortization, by geographic region can be found in Note 6 below. Operating lease ROU assets by geographic region can be found in Note 7 below.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-647" continuedAt="f-647-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company, or EGC, the Jumpstart Our Business Startups Act, or the JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards. We have elected to use extended transition periods permissible under the JOBS Act while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including subsequent amendments thereafter, which established ASC 326. ASC 326 replaces the existing incurred loss impairment model with a current expected credit loss model that requires more timely recognition of estimated expected credit losses over the life of certain financial instruments. Our accounts receivable and available-for-sale debt securities are in the scope of ASC 326. We adopted ASC 326 as of January 1, 2023. The adoption of ASC 326 did not have a material impact on our financial condition and results of operations within our consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reportable Segments (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses, including public entities with a single operating or reportable segment. The updated standard will be effective for annual periods beginning in fiscal 2024 and interim periods beginning in the first quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-647-1"><ix:continuation id="f-493-14"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands disclosures in an entity&#8217;s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The updated standard will be effective for annual periods beginning in fiscal 2026. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div></ix:continuation></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_268"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="f-649" continuedAt="f-649-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.       Revenue Recognition</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-650" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by region in which our merchants&#8217; headquarters are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.611%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.724%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-651">182,806</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-108" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-652">61</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-653">163,920</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-110" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-654">63</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-655">163,681</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-112" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-656">71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa (&#8220;EMEA&#8221;)*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-657">80,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-114" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-658">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-659">71,443</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-116" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-660">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-661">44,850</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-118" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-662">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific (&#8220;APAC&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-663">16,699</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-120" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-664">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-665">12,005</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-122" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-666">5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-667">7,416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-124" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-668">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-669">17,558</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-126" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-670">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-671">13,879</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-128" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-672">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-673">13,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-130" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-674">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-675">297,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-131" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-676">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-677">261,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-132" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-678">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-679">229,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-133" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-680">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Revenue recognized from merchants whose headquarters are in Israel, which is our country of domicile, was $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-681">1.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-682">3.3</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="f-683">2.4</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-684" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue based on the nature and type of service provided to our merchants:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:21.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.239%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fraud review service revenue (ASC 606)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-685">167,278</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-138" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-686">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-687">156,040</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-140" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-688">60</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="3" id="f-689">132,261</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-142" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-690">58</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification guarantee service revenue (ASC 460)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-691">130,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-144" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-692">44</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-693">105,207</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-146" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-694">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-3" name="us-gaap:RevenueNotFromContractWithCustomer" format="ixt:num-dot-decimal" scale="3" id="f-695">96,880</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-148" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-696">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-697">297,610</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-698">261,247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="f-699">229,141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue from our Chargeback Guarantee offering. Revenue generated from other offerings are not material. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allocation of consideration between fraud review service revenue and indemnification guarantee service revenue is a function of the fair value of our chargeback guarantee which represents what we would need to pay a third party to relieve ourselves from our obligations under issued guarantees. The fair value of the chargeback guarantee is primarily determined by utilizing the historical percentage of guarantees issued that resulted in a chargeback plus a risk premium fee that we would have incurred from a third-party in order to relieve ourselves from our legal obligation under the guarantee. Refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-649-1"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the percentage of revenue that are recorded as fraud review service revenue and indemnification guarantee service revenue are a function of changes in the aforementioned fair value of the chargeback guarantee and changes in the speed in which we resolve chargeback claims which impacts the systematic and rational approach that we utilize to record revenue associated with our guarantee obligation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost to Obtain a Contract</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock" id="f-700" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract acquisition costs:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-701">14,383</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-702">10,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-703">6,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-704">8,894</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-705">9,707</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts" format="ixt:num-dot-decimal" scale="3" id="f-706">7,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:CapitalizedDeferredContractAcquisitionCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-707">7,715</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:CapitalizedDeferredContractAcquisitionCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-708">5,689</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:CapitalizedDeferredContractAcquisitionCostAmortization" format="ixt:num-dot-decimal" scale="3" id="f-709">3,642</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-710">15,562</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-711">14,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:CapitalizedContractCostNetNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-712">10,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost to Fulfill a Contract</span></div><ix:nonNumeric contextRef="c-1" name="rskd:DeferredContractFulfillmentCostsTableTextBlock" id="f-713" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract fulfillment costs that are included within in other assets, noncurrent on the consolidated balance sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.912%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.722%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-714">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-715">2,930</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-716">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-717">2,635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-718">2,189</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts" format="ixt:num-dot-decimal" scale="3" id="f-719">1,789</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:DeferredContractFulfillmentCostsAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-720">1,852</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:DeferredContractFulfillmentCostsAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-721">1,446</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:DeferredContractFulfillmentCostsAmortizationExpense" format="ixt:num-dot-decimal" scale="3" id="f-722">1,025</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-723">4,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-724">3,673</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="rskd:DeferredContractFulfillmentCostsNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-725">2,930</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_271"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosuresTextBlock" id="f-726" continuedAt="f-726-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.       Fair Value Measurements</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="f-727" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about our financial instruments that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds included within short-term investments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-728"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-729">28,968</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-730">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-731">28,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:fixed-zero" scale="3" id="f-732">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-733">Derivative financial instruments included in prepaid expenses and other current assets</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-734">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-735">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DerivativeAssets" scale="3" id="f-736">308</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DerivativeAssets" format="ixt:fixed-zero" scale="3" id="f-737">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-738">29,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-739">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-740">29,276</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-741">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-742">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-743">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-744">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:DerivativeLiabilities" scale="3" id="f-745">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-746">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-747">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-748">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" scale="3" id="f-749">462</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-750">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.694%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.723%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-751">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-752">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-753">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-754">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:DerivativeLiabilities" format="ixt:fixed-zero" scale="3" id="f-755">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-756">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-757">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:num-dot-decimal" scale="3" id="f-758">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-3" name="us-gaap:LiabilitiesFairValueDisclosure" format="ixt:fixed-zero" scale="3" id="f-759">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, we did not have any Level 3 financial instruments that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify our derivative financial instruments and government bonds within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Refer to Note 5 for more information regarding our derivative financial instruments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 8 below for more information regarding the fair value of our indemnification guarantees.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-726-1" continuedAt="f-726-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-760" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:43.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.233%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.466%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.237%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-761">28,882</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-762">229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-763">143</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-764">28,968</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:num-dot-decimal" scale="3" id="f-765">28,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="3" id="f-766">229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="3" id="f-767">143</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-768">28,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="0" id="f-769"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" format="ixt:fixed-zero" scale="0" id="f-770">no</ix:nonFraction></ix:nonFraction> short-term investments as of December 31, 2022. <ix:nonNumeric contextRef="c-1" name="us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock" id="f-771" continuedAt="f-771-1" escape="true">The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates:</ix:nonNumeric></span></div><ix:continuation id="f-771-1"><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"/><td style="width:77.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.400%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-3" name="us-gaap:ShortTermInvestments" format="ixt:num-dot-decimal" scale="3" id="f-772"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" format="ixt:num-dot-decimal" scale="3" id="f-773">28,968</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="3" id="f-774">28,968</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-726-2">As of December 31, 2023, the unrealized losses related to short-term investments were not due to credit related losses. Therefore, we did not recognize an allowance for credit losses for our short-term investments. As of December 31, 2023, we did not have any available-for-sale debt securities that have been in a continuous loss position</ix:continuation> for more than twelve months.</span></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_274"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" id="f-775" continuedAt="f-775-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.       Derivative Financial Instruments and Hedging</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notional Amount of Foreign Currency Contracts</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsTextBlock" id="f-776" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency contracts are denominated in NIS and Euro. The gross notional amounts of outstanding foreign currency contracts in U.S. dollar were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.214%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-777">63,716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-778">63,998</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-779">10,314</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-780">13,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total derivative instruments  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-781">74,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DerivativeFairValueOfDerivativeAsset" format="ixt:num-dot-decimal" scale="3" id="f-782">77,812</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Foreign Currency Contracts on the Consolidated Statements of Operations</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="f-783" continuedAt="f-783-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of foreign currency contracts on the Consolidated Statements of Operations during the periods presented were as follows:</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-775-1" continuedAt="f-775-2"><ix:continuation id="f-783-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:30.310%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.797%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.800%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Statement of Operations Location:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-784">168</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-785">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-786">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-787">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-788">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-789">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-168" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-790">146</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-169" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-791">175</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-170" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-792">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-171" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-793">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-172" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-794">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-173" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-795">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-174" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-796">2,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-797">1,718</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-798">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-799">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-800">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-801">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-802">1,051</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-181" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-803">732</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-182" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-804">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-183" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-805">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-184" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-806">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-185" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-807">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-186" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-808">1,263</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-187" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-809">706</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-188" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-810">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-811">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-190" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-812">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-191" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-813">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-192" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-814">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-193" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-815">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-194" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-816">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-195" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-817">534</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-196" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-818">1,659</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-197" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-819">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gain (loss) recognized in earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-820">4,951</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-821">3,331</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-822">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-201" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-823">534</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-202" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-824">1,659</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-203" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="3" id="f-825">59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Profit (Loss)</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="f-826" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, that were recorded in accumulated other comprehensive profit (loss) during the periods presented, and their effect on other comprehensive profit (loss) for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.073%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.727%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-204" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:fixed-zero" scale="3" id="f-827">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" scale="3" id="f-828">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-3" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="3" id="f-829">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-205" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" scale="3" id="f-830">176</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="f-831">176</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-832">1,448</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-833">3,331</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-3" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="f-834">1,883</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="f-835">1,707</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" format="ixt:num-dot-decimal" scale="3" id="f-836">6,585</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-3" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:num-dot-decimal" scale="3" id="f-837">4,951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" format="ixt:num-dot-decimal" scale="3" id="f-838">1,634</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="f-839">73</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-775-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, net deferred gains totaled $<ix:nonFraction unitRef="usd" contextRef="c-206" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-840">0.2</ix:nonFraction> million and were recognized during the year ended December 31, 2022 in the same financial statement line item as the hedged items. As of December 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-841">1.7</ix:nonFraction>&#160;million of net deferred losses were recorded in accumulated other comprehensive profit (loss) and were recognized during the year ended December 31, 2023 in the same financial statement line item as the hedged items. As of December 31, 2023, $<ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-842">0.1</ix:nonFraction> million of net deferred losses were recorded in accumulated other comprehensive profit (loss) of which all are expected to be recognized in the same financial statement line item in the Consolidated Statements of Operations to which the derivative relates over the next twelve months.</span></div></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_277"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="f-843" continuedAt="f-843-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.       Consolidated Balance Sheet Components</span></div><ix:continuation id="f-596-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-844">6,592</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-845">6,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-846">2,593</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-847">2,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-848">16,702</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-849">16,576</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-850">25,887</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="f-851">26,019</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-852">10,248</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="f-853">7,433</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-854">15,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-855">18,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-856">3.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-857">3.4</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:Depreciation" format="ixt:num-dot-decimal" scale="6" id="f-858">1.8</ix:nonFraction> million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our property and equipment, net of depreciation and amortization, by geographic region:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-859">14,209</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-860">16,671</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-861">1,403</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-862">1,796</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-863">27</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="f-864">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-865">15,639</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="f-866">18,586</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-843-1"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="f-867" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-868">4,548</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-869">6,175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-870">6,724</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ContractWithCustomerRefundLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="f-871">5,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" scale="3" id="f-872">462</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DerivativeInstrumentsAndHedgesLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-873">2,397</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-874">1,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-875">1,853</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-876">12,796</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="f-877">15,813</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Noncurrent</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="f-878" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, noncurrent consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.053%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.002%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.004%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-879">14,706</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-880">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, noncurrent</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-881">14,706</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" format="ixt:num-dot-decimal" scale="3" id="f-882">8,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_280"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-883" continuedAt="f-883-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.       Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating leases for our corporate offices in Tel Aviv, Israel and in New York, New York in the United States. The leases for these facilities in Tel Aviv and New York expire in 2031 and 2029, respectively and we have options to renew these leases through 2036 and 2034, respectively. These renewal options are excluded from the calculation of operating lease ROU assets and operating lease liabilities. We sublease a portion of our office space in Tel Aviv and New York.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-884" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost for the years ended December&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.592%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.733%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.734%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-885">6,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-886">6,140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-887">1,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:VariableLeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-888">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-889">170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:ShortTermLeaseCost" scale="3" id="f-890">304</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:SubleaseIncome" format="ixt:num-dot-decimal" scale="3" id="f-891">1,347</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:SubleaseIncome" scale="3" id="f-892">786</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-893">6,075</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:LeaseCost" format="ixt:num-dot-decimal" scale="3" id="f-894">6,915</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease costs prior to the adoption of ASC 842 were $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:OperatingLeasesRentExpenseNet" format="ixt:num-dot-decimal" scale="6" id="f-895">5.9</ix:nonFraction> million for the year ended December 31, 2021. Sublease income was $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue" format="ixt:num-dot-decimal" scale="6" id="f-896">0.1</ix:nonFraction> million for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the weighted average remaining lease term and the weighted average discount rate for our operating leases were <ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-897">6.5</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-898">4.6</ix:nonFraction>%, respectively. As of December&#160;31, 2022, the weighted average remaining lease term and the weighted average discount rate for our operating leases were <ix:nonNumeric contextRef="c-7" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-899">7.4</ix:nonNumeric> years and <ix:nonFraction unitRef="number" contextRef="c-7" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-900">4.6</ix:nonFraction>%, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-901" continuedAt="f-901-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future minimum lease payments included in the measurement of our operating lease liabilities as of December&#160;31, 2023, were as follows:</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-883-1"><ix:continuation id="f-901-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-902">5,744</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="f-903">5,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="f-904">5,759</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="f-905">5,804</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="f-906">5,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="f-907">7,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="f-908">36,055</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="f-909">4,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="f-910">31,309</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our operating lease ROU assets by geographic region:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-911">18,782</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-912">22,560</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-913">10,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-914">12,598</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-915">29,742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="f-916">35,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluded from the tables above is an unsecured and undated promissory note issued in December 2020 in connection with the execution of a lease agreement for an amount of $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="6" id="f-917">2.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ContractualObligation" format="ixt:num-dot-decimal" scale="6" id="f-918">3.0</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively. The promissory note may only be withdrawn in the event of a material and fundamental breach of the lease agreement. The promissory note expires <ix:nonNumeric contextRef="c-1" name="rskd:ContractualObligationTerm" format="ixt-sec:durwordsen" id="f-919">three months</ix:nonNumeric> after the lease termination date. As of December&#160;31, 2023 and 2022, we were in full compliance of the terms and conditions of the promissory note, and the promissory note has not been withdrawn.</span></div></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_283"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock" id="f-920" continuedAt="f-920-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.       Guarantees, Commitments, and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud. Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460 and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-921">12.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GuaranteeObligationsCurrentCarryingValue" format="ixt:num-dot-decimal" scale="6" id="f-922">12.4</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively, and will be released to revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally <ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteeObligationsTerm" id="f-923">six</ix:nonNumeric> months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a <ix:nonNumeric contextRef="c-1" name="us-gaap:GuaranteeObligationsTerm" id="f-924">six</ix:nonNumeric>-month period that is representative of our historical pattern of being relieved from our guarantee obligation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for chargebacks includes amounts associated with chargebacks that have been submitted and accepted but not yet paid by us as of the balance sheet date as well as estimates of chargebacks that have not yet been submitted and accepted relating to approved transactions that are </span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-920-1" continuedAt="f-920-2"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounted for under </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 450, Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs and assumptions used by management to calculate the provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. Provision for chargebacks, net on the consolidated balance sheets were $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="rskd:ProvisionForChargebacksCurrent" format="ixt:num-dot-decimal" scale="6" id="f-925">12.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="rskd:ProvisionForChargebacksCurrent" format="ixt:num-dot-decimal" scale="6" id="f-926">12.0</ix:nonFraction> million as of December&#160;31, 2023 and 2022, respectively, and will be reduced by credits issued or cash paid to merchants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our portfolio of potential chargeback liabilities was diversified across numerous industries, hundreds of merchants, and millions of individual transactions. The maximum potential payment to our merchants for these guarantees at a point in time, if every order we approved was fraudulent, is generally the aggregate approved transaction amount excluding cancelled orders, orders that have expired guarantees, and orders for which guarantees have already been paid. As of December&#160;31, 2023, there was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-8" name="us-gaap:GuaranteeObligationsMaximumExposure" format="ixt:num-dot-decimal" scale="9" id="f-927">57.2</ix:nonFraction> billion in outstanding indemnification guarantees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have had to pay approximately <ix:nonFraction unitRef="number" contextRef="c-1" decimals="3" name="rskd:GuarantorObligationsPercentageOfGuaranteesPaid" scale="-2" id="f-928">0.1</ix:nonFraction>% of guarantees that we have issued and net chargeback expenses for the years ended December&#160;31, 2023, 2022, and 2021, were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rskd:GuarantorObligationsChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-929">121.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="rskd:GuarantorObligationsChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-930">103.2</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="rskd:GuarantorObligationsChargebackExpense" format="ixt:num-dot-decimal" scale="6" id="f-931">85.5</ix:nonFraction> million, respectively, which was in line with our budgets for the associated periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Cancelable Purchase Obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into non-cancelable purchase commitments with various parties primarily for hosting and software services. <ix:nonNumeric contextRef="c-1" name="us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock" id="f-932" continuedAt="f-932-1" escape="true">As of December&#160;31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:</ix:nonNumeric></span></div><ix:continuation id="f-932-1"><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.117%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PurchaseObligationDueInNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="f-933">1,106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PurchaseObligationDueInSecondYear" scale="3" id="f-934">512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PurchaseObligationDueInThirdYear" scale="3" id="f-935">96</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:PurchaseObligation" format="ixt:num-dot-decimal" scale="3" id="f-936">1,714</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Indemnifications and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain parties. In our merchant agreements, we have agreed to indemnify, defend, and hold harmless the indemnified party for third-party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic merchants, we have agreed to indemnify, defend and hold harmless the indemnified party for non-compliance with certain additional representations and warranties made by us. In addition, we have entered into indemnification agreements with our directors and certain officers. As we have a limited history of prior indemnification claims and the payments we have made under such agreements have not had a material adverse effect on our results of operations, cash flows, or financial position, we are unable to reasonably estimate the maximum potential amount of future payments related to these indemnification agreements. However, to the extent that valid indemnification claims arise in the future, future payments by us could be significant and could have a material adverse effect on our results of operations or cash flows in a particular period. As of December&#160;31, 2023 and 2022, we did not have any material indemnification claims that were probable or reasonably possible.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-920-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Occasionally we may be subject to various proceedings, lawsuits, disputes, or claims. We investigate these claims as they arise and accrue liabilities when losses are probable and reasonably estimated. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, a putative securities class action complaint was filed in federal court in the United States by certain of our shareholders against us, certain of our current and former officers and directors, and our underwriters alleging violations of the Securities Act in connection with our IPO-related disclosures, and seeking unspecified damages. The lawsuit was captioned</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> In re Riskified Ltd. Securities Litigation</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 22 Civ. 3545 (DLC) (S.D.N.Y.). Plaintiffs filed an amended complaint on September 15, 2022. We moved to dismiss the amended complaint on October 28, 2022. On June 2, 2023, the Court granted our motion to dismiss the complaint in its entirety, with prejudice. The deadline to appeal has passed and the judgment is now final.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although claims are inherently unpredictable, we are currently not aware of any matters that, if determined adversely to us, would individually or taken together, have a material adverse effect on our business, financial position, results of operations, or cash flows.</span></div></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_286"></div><ix:nonNumeric contextRef="c-1" name="rskd:TemporaryEquityDisclosureTextBlock" id="f-937" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.       Ordinary Share Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, <ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="rskd:StockIssuedDuringPeriodSharesWarrantsExercised" format="ixt:num-dot-decimal" scale="0" id="f-938">1,187,087</ix:nonFraction> Class A shares were issued upon the cashless exercise of the outstanding warrants to purchase ordinary shares.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="f-939" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the following warrants were issued and outstanding:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued and Outstanding Share Warrants</span></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued to customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-222" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-940">499,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-223" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-941">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-222" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-942">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-223" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:fixed-zero" scale="0" id="f-943">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-944">499,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-4" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-945">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:23.419%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.643%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued and Outstanding Share Warrants</span></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants to purchase ordinary shares</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-224" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-946">425,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-225" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-947">850,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-226" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-948">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-227" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-949">0.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 2025</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants issued to customers</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-228" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-950">499,500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-229" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:fixed-zero" scale="0" id="f-951">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-228" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-952">0.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-229" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" format="ixt:fixed-zero" scale="0" id="f-953">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2028</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-954">924,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-955">850,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_289"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock" id="f-956" continuedAt="f-956-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.       Ordinary Shares and Equity Incentive Plan</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of the IPO, our amended and restated AoA became effective, which authorized the issuance of up to <ix:nonFraction unitRef="shares" contextRef="c-230" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-957">900,000,000</ix:nonFraction> Class A ordinary shares with no par value and <ix:nonFraction unitRef="shares" contextRef="c-231" decimals="0" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="f-958">232,500,000</ix:nonFraction> Class B ordinary shares with no par value, respectively.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfStockByClassTextBlock" id="f-959" continuedAt="f-959-1" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the following ordinary shares reserved for future issuance:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.374%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-232" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-960">499,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-233" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-961">1,775,475</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2013 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-234" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-962">15,981,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-235" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-963">20,062,824</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2021 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-236" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-964">16,299,528</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-237" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-965">13,134,652</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available for future issuance under the 2021 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-966">8,766,560</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-238" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-967">8,674,132</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ordinary shares reserved</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-968">41,546,857</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-969">43,647,083</ix:nonFraction></span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-959-1" continuedAt="f-959-2"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span></ix:continuation><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"><ix:continuation id="f-959-2">Includes the warrants to purchase ordinary shares and warrants issued to customers.</ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the board of directors authorized the Company to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-84" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-970">75.0</ix:nonFraction>&#160;million of its Class A ordinary shares. We received approval for the implementation of our Repurchase Program from the Tel Aviv District Court Economic Department (&#8220;Israeli Court&#8221;) on November 20, 2023. The Israeli Court approval is valid through May 19, 2024. We may file extension requests with the Israeli Court on an ongoing basis as required. During the year ended December 31, 2023, we repurchased <ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-971"><ix:nonFraction unitRef="shares" contextRef="c-51" decimals="0" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="0" id="f-972">3,038,865</ix:nonFraction></ix:nonFraction> outstanding Class A ordinary shares for $<ix:nonFraction unitRef="usd" contextRef="c-53" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" format="ixt:num-dot-decimal" scale="6" id="f-973">13.2</ix:nonFraction>&#160;million, including transaction costs of approximately $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="rskd:StockRepurchaseProgramTransactionCosts" format="ixt:num-dot-decimal" scale="6" id="f-974">0.1</ix:nonFraction>&#160;million, through our Repurchase Program. These shares are classified as Treasury Shares on our consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Repurchase Program authorizes us to repurchase Class A ordinary shares, from time to time in the open market, in privately negotiated transactions or by other means in accordance with U.S. federal securities laws. The timing, as well as the number and value of any shares repurchased under the program, will be determined at our discretion under the Board authorized program and will depend on a variety of factors, including management's assessment of the intrinsic value of our ordinary shares, the market price of our ordinary shares, general market and economic conditions, available liquidity, alternative investment opportunities, and applicable legal requirements. The Repurchase Program does not obligate us to repurchase any specific number of shares and may be suspended, modified or discontinued at any time without prior notice. The share repurchases will be funded from existing cash and cash equivalents.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Equity Incentive Plan, or the 2013 Plan, was adopted by our board of directors on July 3, 2013 and amended and restated on February 23, 2021. The 2013 Plan provided for the grant of equity-based incentive awards to our employees, directors, office holders and consultants. The U.S. Sub-Plan to the 2013 Plan, which is to be read as a continuation of the 2013 Plan, was adopted by our board of directors on May 10, 2015 and amended and restated on February 23, 2021. The U.S. Sub-Plan governed equity-based incentive awards granted to our United States employees, directors, office holders and consultants, including those who are deemed to be residents of the United States for tax purposes.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-956-1" continuedAt="f-956-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We no longer grant any awards under our 2013 Plan as it was superseded by the 2021 Share Incentive Plan, or the 2021 Plan. Awards granted prior to the adoption of the 2021 Plan remain outstanding and are governed by the 2013 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan was adopted in connection with our IPO on July 15, 2021. The 2021 Plan provides for the grant of equity-based incentive awards to our employees, directors, office holders, service providers and consultants. The maximum number of Class A ordinary shares available for issuance under the 2021 Plan is equal to the sum of (i) <ix:nonFraction unitRef="shares" contextRef="c-239" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-975">13,951,037</ix:nonFraction> Class A ordinary shares, (ii) any shares subject to awards under the 2013 Plan which have expired, or were cancelled, terminated, forfeited or settled in cash in lieu of issuance of shares or became unexercisable without having been fully exercised and (iii) an annual increase on the first day of each year beginning in 2022 and on January 1st of each calendar year thereafter during the term of the 2021 Plan, equal to the lesser of (A) <ix:nonFraction unitRef="number" contextRef="c-239" decimals="2" name="rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" scale="-2" id="f-976">5</ix:nonFraction>% of the outstanding Class A ordinary shares of the Company on the last day of the immediately preceding calendar year (calculated on a fully diluted, as converted basis); and (B) such amount as determined by our board of directors if so determined prior to January 1 of a calendar year, provided that no more than <ix:nonFraction unitRef="shares" contextRef="c-239" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-977">13,951,037</ix:nonFraction> Class A ordinary shares may be issued upon the exercise of incentive share options.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-956-2" continuedAt="f-956-3"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Options and Shares Available for Grant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share options generally vest over <ix:nonNumeric contextRef="c-240" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-978">four years</ix:nonNumeric> and expire <ix:nonNumeric contextRef="c-240" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen" id="f-979">ten years</ix:nonNumeric> after the date of grant. We issue Class A ordinary shares upon exercise of share options. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="f-980" continuedAt="f-980-1" escape="true">A summary of share options under our equity incentive plan and related information is as follows:</ix:nonNumeric></span></div><ix:continuation id="f-980-1" continuedAt="f-980-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.082%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Share Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise <br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic <br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share, life and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-981">13,785,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-982">2.17</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-10" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-983">6.1</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-984">34,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="f-985">3,010,478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="f-986">1.22</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-987">405,202</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="f-988">3.72</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="0" id="f-989">10,369,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="f-990">2.39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear" id="f-991">5.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" format="ixt:num-dot-decimal" scale="3" id="f-992">24,303</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" format="ixt:num-dot-decimal" scale="0" id="f-993">8,849,876</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="f-994">2.13</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear" id="f-995">5.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" format="ixt:num-dot-decimal" scale="3" id="f-996">22,904</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-980-2">There were no share options granted during the years ended December&#160;31, 2023 or December&#160;31, 2022.</ix:continuation> The weighted-average grant date fair value of share options granted during the year ended December 31, 2021 was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-241" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-997">16.63</ix:nonFraction>. The aggregate grant date fair value of share options vested during the years ended December&#160;31, 2023, 2022, and 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-240" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="f-998">6.9</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-241" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="f-999">12.0</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-242" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" format="ixt:num-dot-decimal" scale="6" id="f-1000">3.2</ix:nonFraction> million, respectively. The total intrinsic value of share options exercised during the years ended December&#160;31, 2023, 2022, and 2021 were $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1001">11.3</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1002">17.4</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" format="ixt:num-dot-decimal" scale="6" id="f-1003">68.6</ix:nonFraction> million, respectively. As of December&#160;31, 2023, unrecognized share-based compensation cost related to unvested share options was $<ix:nonFraction unitRef="usd" contextRef="c-243" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1004">6.4</ix:nonFraction> million, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-240" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1005">1.3</ix:nonNumeric> years.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="f-1006" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes assumptions used to value the employee share options at the grant dates are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.689%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-244" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1007">5.44</ix:nonNumeric> - <ix:nonNumeric contextRef="c-245" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1008">6.60</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1009">67.26</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-245" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1010">68.52</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-244" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1011">0.99</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-245" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1012">1.12</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="c-242" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="f-1013">0.00</ix:nonFraction>%</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assumptions and estimates were determined as follows: </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Fair Value of Ordinary Shares - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to IPO, the fair value was determined by our board of directors, with input from management and valuation reports prepared by third-party valuation specialists. Post IPO, the fair value of each ordinary share was based on the closing price of our publicly traded ordinary shares as reported on the date of the grant. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Term - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected term represents the period that the share options are expected to be outstanding. For share option grants that are considered to be &#8220;plain vanilla,&#8221; we determine the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the share options.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Volatility - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we have a short trading history for our ordinary shares, the expected volatility is derived from the average historical share volatilities of several unrelated public </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-956-3" continuedAt="f-956-4"><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies within our industry that we consider to be comparable to our own business over a period equivalent to the option&#8217;s expected term.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-Free&#160;Interest Rate - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free rate for the expected term of the share options are based on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Dividend Yield.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. As a result, an expected dividend yield of <ix:nonFraction unitRef="number" contextRef="c-240" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1014">zero</ix:nonFraction> percent was used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs vest either upon the satisfaction of service-based vesting conditions, the satisfaction of both service-based and performance-based vesting conditions, or the satisfaction of service-based, performance-based, and market-based vesting conditions. Refer to Note 2 for more information regarding the vesting conditions of our RSUs. RSUs granted under the 2013 Plan can only vest prior to the expiration date of the award which is <ix:nonNumeric contextRef="c-246" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1015">seven years</ix:nonNumeric> from the date of grant. Any RSUs that have not vested will automatically terminate on their expiration date. RSUs granted under the 2021 Plan do not have an expiration date. </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" id="f-1016" escape="true"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:66.207%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.925%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.927%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date Fair Value<br/>Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1017">19,412,262</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1018">9.06</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1019">10,904,664</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1020">5.43</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1021">6,365,261</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1022">7.28</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" format="ixt:num-dot-decimal" scale="0" id="f-1023">2,040,402</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1024">6.31</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="0" id="f-1025">21,911,263</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1026">8.02</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, total unrecognized share-based compensation expense related to unvested RSUs was approximately $<ix:nonFraction unitRef="usd" contextRef="c-247" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="f-1027">115.0</ix:nonFraction> million, which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="c-248" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1028">3.3</ix:nonNumeric> years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Share Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted the 2021 Employee Share Purchase Plan, or ESPP, in connection with our IPO on July 15, 2021, to enable eligible employees of the company and certain of its designated subsidiaries to use payroll deductions to purchase the company&#8217;s Class A ordinary shares and thereby acquire ownership interests in the Company. A total of <ix:nonFraction unitRef="shares" contextRef="c-249" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="f-1029">3,742,961</ix:nonFraction> Class A ordinary shares are available for sale under the ESPP, subject to adjustment as provided for in the ESPP. In addition, on the first day of each fiscal year beginning on January 1, 2022 and ending on and including January 1, 2031, such pool of Class A ordinary shares shall be increased by that number of our Class A ordinary shares equal to the lesser of: (i) <ix:nonFraction unitRef="number" contextRef="c-249" decimals="2" name="rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" scale="-2" id="f-1030">1</ix:nonFraction>% of the outstanding Class A ordinary shares as of the last day of the immediately preceding fiscal year (calculated on a fully diluted as-converted basis); or (ii) such smaller amount as our board of directors may determine. In accordance with the above, our board of directors determined not to increase the number of Class A ordinary shares available for sale under the ESPP as of January 1, 2022, January 1, 2023, or January 1, 2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, all of our employees are eligible to participate if they are employed by us. However, an employee may not be granted rights to purchase our ordinary shares under the ESPP if such employee (i) </span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-956-4"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immediately after the grant would own capital shares or hold outstanding share options to purchase such shares possessing <ix:nonFraction unitRef="number" contextRef="c-249" decimals="2" name="rskd:CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" scale="-2" id="f-1031">5</ix:nonFraction>% or more of the total combined voting power or value of all classes of our shares or any of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have not effected any offering under the ESPP. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CEO Multi-Year Equity Award</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, our board of directors and shareholders granted to our chief executive officer, Mr. Gal, a multi-year equity award, comprising 3,993,440 RSUs (the &#8220;Multi-Year Award&#8221;). The grant date fair value of the Multi-Year Award, which is the amount of share-based compensation expense that we recognize, is primarily determined based on the share price on the date the award was granted and is not based on our current share price. This amount is expensed utilizing the accelerated attribution method over the requisite service period of ten years. This method attributes higher expenses to the earlier periods of the requisite service period.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Multi-Year Award is structured so that meaningful value may only be realized upon the achievement of sustained and significant high performance levels. The award is divided into ten tranches that are eligible to vest based on the achievement of stock price goals, which range from $26.67 to $106.67, measured based on the average of our stock price over a trailing 60 trading day period during predefined performance periods, subject to Mr. Gal&#8217;s continued employment as our chief executive officer through each such period. In order to earn all of the tranches, the stock price will have to be more than 5 times higher than the price at IPO. No tranches of the Multi-Year Award were earned or vested in 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the service-based vesting condition, and market-based vesting condition, each described above, the Multi-Year Award is also subject to a performance-based vesting condition. The performance-based vesting condition underlying the Multi-Year Award was satisfied upon the occurrence of our IPO in 2021. We recognized $<ix:nonFraction unitRef="usd" contextRef="c-250" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1032">8.6</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-251" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1033">13.0</ix:nonFraction>&#160;million, and $<ix:nonFraction unitRef="usd" contextRef="c-252" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="6" id="f-1034">6.0</ix:nonFraction>&#160;million in share-based compensation expense related to the Multi-Year Award during the years ended December 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" id="f-1035" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.432%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.521%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1036">770</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1037">621</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-255" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="f-1038">216</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1039">13,152</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1040">10,005</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1041">4,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1042">19,420</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1043">18,253</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-261" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1044">10,710</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-262" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1045">29,068</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-263" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1046">38,588</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-264" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1047">18,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1048">62,410</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1049">67,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" format="ixt:num-dot-decimal" scale="3" id="f-1050">33,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_292"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1051" continuedAt="f-1051-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.       Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary taxable income in Israel is subject to a corporate tax rate of 23%. However, the effective tax rate payable by a company that derives income from a Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains (which are not &#8216;Inflationary Surplus&#8217;, as described below) derived by an Israeli company are generally subject to the prevailing corporate tax rate.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Law for the Encouragement of Capital Investments, 1959</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1051-1" continuedAt="f-1051-2"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Law for the Encouragement of Capital Investments, 1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Law was significantly amended effective on April 1, 2005, January 1, 2011, and on January 1, 2017, or the 2017 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment included new tax benefits for &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Amendment provides that a technology company satisfying certain conditions should qualify as a &#8220;Preferred Technology Enterprises,&#8221; or PTE, granting a 12% tax rate in central Israel on income deriving from Benefited Intangible Assets, subject to a number of conditions being fulfilled, including a minimal amount or ratio of annual R&amp;D expenditure and R&amp;D employees, as well as having at least 25% of annual income derived from exports to large markets. PTE is defined as an enterprise which meets the aforementioned conditions and for which total consolidated revenues of its parent company and all subsidiaries are less than NIS 10 billion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not adopted the PTE status currently, but believe we are eligible for the PTE status in future tax years and have tax-effected our Israel deferred tax assets and liabilities at the appropriate PTE rates. Our subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1052" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profit (loss) before the provision for income taxes consisted of the following for the years ended December&#160;31, 2023, 2022, and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.951%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1053">23,269</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1054">55,414</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1055">154,549</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1056">29,968</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1057">43,249</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1058">23,323</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1059">53,237</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1060">98,663</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" format="ixt:num-dot-decimal" scale="3" id="f-1061">177,872</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1051-2" continuedAt="f-1051-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1062" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1063">225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1064">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1065">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1066">6,039</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1067">8,715</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1068">121</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1069">5,814</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1070">8,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="f-1071">125</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1072">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1073">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="f-1074">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-265" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1075">16</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1076">2,677</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-267" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1077">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="f-1078">16</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1079">2,677</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:DeferredIncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1080">1,433</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1081">5,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1082">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1083">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1084" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of our statutory income tax expense to our effective income tax provision is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.111%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.682%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.683%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1085">12,245</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1086">22,528</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" format="ixt:num-dot-decimal" scale="3" id="f-1087">40,784</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred enterprise</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" format="ixt:num-dot-decimal" scale="3" id="f-1088">1,652</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" format="ixt:num-dot-decimal" scale="3" id="f-1089">10,573</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" format="ixt:num-dot-decimal" scale="3" id="f-1090">3,052</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-1091">785</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" format="ixt:num-dot-decimal" scale="3" id="f-1092">1,050</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="3" id="f-1093">912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1094">8,158</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1095">9,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" format="ixt:num-dot-decimal" scale="3" id="f-1096">1,753</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-268" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:fixed-zero" scale="3" id="f-1097">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-269" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:fixed-zero" scale="3" id="f-1098">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:num-dot-decimal" scale="3" id="f-1099">23,325</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tranche right revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-63" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:fixed-zero" scale="3" id="f-1100">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-64" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:fixed-zero" scale="3" id="f-1101">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-65" decimals="-3" name="rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" format="ixt:num-dot-decimal" scale="3" id="f-1102">4,890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax income/(expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="f-1103">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" format="ixt:num-dot-decimal" scale="3" id="f-1104">6,675</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes" scale="3" id="f-1105">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1106">587</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" format="ixt:num-dot-decimal" scale="3" id="f-1107">3,351</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="f-1108">98</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="f-1109">5,772</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="f-1110">7,233</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxContingencies" format="ixt:num-dot-decimal" scale="3" id="f-1111">3,784</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1112">2,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1113">12,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1114">4,444</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1115">5,798</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1116">6,042</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="3" id="f-1117">1,558</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate was (<ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1118">10.89</ix:nonFraction>)% for the year ended December&#160;31, 2023, compared to an effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-10" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1119">6.12</ix:nonFraction>)% for the year ended December 31, 2022 and (<ix:nonFraction unitRef="number" contextRef="c-11" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1120">0.88</ix:nonFraction>)% for the year ended December 31, 2021. The effective tax rates for the periods presented are primarily comprised of Israel statutory taxes, warrant revaluation, share-based compensation expense, uncertain tax positions, and changes in valuation allowance position. The difference in the effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1121">10.89</ix:nonFraction>)% for the year ended December&#160;31, 2023 as compared to the effective tax rate of (<ix:nonFraction unitRef="number" contextRef="c-10" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1122">6.12</ix:nonFraction>)% for the year ended December 31, 2022 and (<ix:nonFraction unitRef="number" contextRef="c-11" decimals="INF" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="f-1123">0.88</ix:nonFraction>)% for the year ended December 31, 2021 was related to non-deductible share-based compensation, prior period adjustments, uncertain tax positions, and change in valuation allowance position in Israel and in our U.S. subsidiary.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-1124">5.8</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-1125">6.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:num-dot-decimal" scale="6" id="f-1126">1.6</ix:nonFraction>&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. The provision for income taxes for the year ended December&#160;31, 2023 consisted primarily of income taxes related to the United States and other foreign jurisdictions in which we conduct business.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1051-3" continuedAt="f-1051-4"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1127" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant components of our deferred tax assets and liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.791%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1128">7,550</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1129">7,374</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" format="ixt:num-dot-decimal" scale="3" id="f-1130">1,436</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1131">10,333</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1132">9,059</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="3" id="f-1133">5,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1134">6,762</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1135">5,214</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" format="ixt:num-dot-decimal" scale="3" id="f-1136">1,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="rskd:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1137">5,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="rskd:DeferredTaxAssetsLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1138">6,456</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="rskd:DeferredTaxAssetsLeasingArrangements" format="ixt:fixed-zero" scale="3" id="f-1139">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vacation and convalescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="3" id="f-1140">746</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="3" id="f-1141">730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" scale="3" id="f-1142">799</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-1143">84</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-1144">78</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" scale="3" id="f-1145">93</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-1146">1,946</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" format="ixt:num-dot-decimal" scale="3" id="f-1147">2,166</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsOther" scale="3" id="f-1148">466</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1149">32,986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1150">31,077</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsGross" format="ixt:num-dot-decimal" scale="3" id="f-1151">9,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1152">23,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1153">20,822</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsValuationAllowance" format="ixt:num-dot-decimal" scale="3" id="f-1154">8,699</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1155">9,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" format="ixt:num-dot-decimal" scale="3" id="f-1156">10,255</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxAssetsNet" scale="3" id="f-1157">316</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1158">5,577</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:num-dot-decimal" scale="3" id="f-1159">6,387</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesLeasingArrangements" format="ixt:fixed-zero" scale="3" id="f-1160">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" format="ixt:num-dot-decimal" scale="3" id="f-1161">2,971</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" format="ixt:num-dot-decimal" scale="3" id="f-1162">3,009</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" format="ixt:num-dot-decimal" scale="3" id="f-1163">2,324</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-1164">109</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-1165">279</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="f-1166">283</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="3" id="f-1167">541</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="3" id="f-1168">591</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" scale="3" id="f-1169">397</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1170">9,198</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1171">10,266</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1172">3,004</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="3" id="f-1173">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:DeferredTaxLiabilities" scale="3" id="f-1174">11</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:DeferredTaxLiabilities" format="ixt:num-dot-decimal" scale="3" id="f-1175">2,688</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, we had Israel net operating loss, or NOL, carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-271" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1176">75.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-272" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1177">68.9</ix:nonFraction>&#160;million, respectively, which do not expire. As of December&#160;31, 2023 and 2022, we had U.S. Federal NOL carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-273" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1178">11.7</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1179">11.2</ix:nonFraction>&#160;million respectively, which do not expire.  As of December&#160;31, 2023, we had U.S. State NOL carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1180">24.8</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1181">23.3</ix:nonFraction>&#160;million expire between 2028 and 2043, and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-277" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1182">1.5</ix:nonFraction>&#160;million do not expire. As of December&#160;31, 2022, we had U.S. State NOL carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="c-278" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1183">16.6</ix:nonFraction>&#160;million, of which $<ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1184">15.4</ix:nonFraction>&#160;million expire between 2027 and 2042, and the remaining $<ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-3" name="us-gaap:OperatingLossCarryforwards" format="ixt:num-dot-decimal" scale="6" id="f-1185">1.2</ix:nonFraction>&#160;million do not expire.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021 the net change in the valuation allowance against deferred tax assets amounted to an increase of $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1186">3.0</ix:nonFraction>&#160;million, an increase of $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1187">12.1</ix:nonFraction>&#160;million, and an increase of $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" format="ixt:num-dot-decimal" scale="6" id="f-1188">4.4</ix:nonFraction>&#160;million, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2023, December 31, 2022 and December 31, 2021 was largely attributable to the generation of Israel NOLs, and certain US state NOLs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In establishing deferred income tax assets and liabilities, management makes judgments based on the enacted tax laws and published tax guidance applicable to us as well as the amount and jurisdiction of future taxable income. Deferred tax assets and liabilities are recorded and the need for valuation allowances is evaluated to reduce the deferred tax assets to amounts expected to be realized. As of December&#160;31, 2023 and 2022, we maintained a full valuation allowance on Israel and U.S. net deferred tax assets as we believe, after weighing both the positive and negative evidence, that it is more likely than not that these deferred tax assets will not be realized.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:continuation id="f-1051-4"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of NOLs in the event of an &#8220;ownership change&#8221; of a corporation. Accordingly, a company&#8217;s ability to use NOLs may be limited as prescribed under Internal Revenue Code Section 382, or IRC Section 382. Events which may cause limitations in the amount of the NOLs that we may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the U.S. federal and state NOLs may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. We have completed our evaluation of NOL utilization limitations under Internal Revenue Code, as amended, or the Code, Section 382, change of ownership rules, and have found that the NOLs would not be limited as to the amount that could be used in the current tax year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified unrecognized tax benefits or uncertain tax positions. There has been a liability on uncertain tax positions recorded on our audited consolidated financial statements as of December&#160;31, 2023 and 2022. We do not expect that our assessment regarding unrecognized tax benefits and uncertain tax positions will materially change over the following 12 months.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1189" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of total unrecognized tax position is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.957%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.843%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Tax Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="f-1190">234</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1191">3,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" format="ixt:fixed-zero" scale="3" id="f-1192">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1193">4,119</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1194">7,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1195">54</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1196">11,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" format="ixt:num-dot-decimal" scale="3" id="f-1197">5,273</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="f-1198">13</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="3" id="f-1199">16,512</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the total amount of gross unrecognized tax benefits was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1200">16.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" format="ixt:num-dot-decimal" scale="6" id="f-1201">11.3</ix:nonFraction>&#160;million, respectively, which, if recognized, would affect our effective tax rate. We have elected to include interest and penalties as a component of tax expense. As of December&#160;31, 2023 and 2022, we have accumulated $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="6" id="f-1202">1.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" format="ixt:num-dot-decimal" scale="3" id="f-1203">320</ix:nonFraction>&#160;thousand, respectively, in both interest and penalties associated with uncertain tax positions. We do not expect unrecognized tax benefits to change significantly within the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently under audit for income taxes. As of December&#160;31, 2023, tax years beginning with the year ended December 31, 2019 remain subject to examination by the Israel tax authorities and tax years beginning with the year ended December 31, 2020 remain subject to examination by the Internal Revenue Service and certain U.S. state jurisdictions.</span></div></ix:continuation><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_295"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerShareTextBlock" id="f-1204" continuedAt="f-1204-1" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.       Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-1205" escape="true"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"/><td style="width:21.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.460%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.980%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1206">38,407</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1207">20,628</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-15" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1208">57,734</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1209">46,971</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1210"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1211">90,953</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="f-1212"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="f-1213">88,477</ix:nonFraction></ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net profit (loss) per share</span></div><div style="padding-left:21pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attributable to ordinary shareholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1214">115,005,250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1215">61,768,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1216">92,450,867</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1217">75,216,507</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="f-1218"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1219">38,757,558</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-1220">37,702,067</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-12" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1221">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-13" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1222">0.33</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-15" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1223">0.62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-14" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1224">0.62</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1225"><ix:nonFraction unitRef="usdPerShare" contextRef="c-17" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1226">2.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-1227"><ix:nonFraction unitRef="usdPerShare" contextRef="c-16" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-1228">2.35</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net profit (loss) per share attributable to ordinary shareholders are the same for each class of ordinary shares as they are entitled to the same liquidation and dividend rights. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" id="f-1229" continuedAt="f-1229-1" escape="true">The weighted-average potential ordinary shares that were excluded from the computation of diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive, or whose issuance is contingent upon the satisfaction of certain market conditions, are as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1229-1" continuedAt="f-1229-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"/><td style="width:22.495%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.099%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.442%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.100%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-281" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-282" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1231">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-283" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1232">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-284" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1233">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-285" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1234">17,817,201</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-286" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1235">35,634,404</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-287" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1236">725,334</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-288" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1237">753,565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-289" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1238">873,370</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-290" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1239">850,650</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-291" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1240">1,488,819</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-292" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1241">354,243</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-293" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1242">11,654,082</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-294" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1243">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-295" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1244">16,067,720</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-296" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1245">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-297" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1246">12,239,441</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-298" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1247">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-299" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1248">23,375,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-300" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="f-1249">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-301" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1250">16,176,275</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-302" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1251">2,131,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-303" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1252">1,562,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-304" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1253">1,965,604</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-12" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1254">35,754,530</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-13" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1255">753,565</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1256">33,117,365</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-14" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1257">2,981,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-17" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1258">33,107,849</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="c-16" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="f-1259">37,954,251</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div></ix:continuation></ix:nonNumeric><div style="padding-left:18pt;text-indent:-18pt"><ix:continuation id="f-1229-2" continuedAt="f-1229-3"><ix:continuation id="f-1204-1" continuedAt="f-1204-2"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span></ix:continuation></ix:continuation><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"><ix:continuation id="f-1229-3"><ix:continuation id="f-1204-2">Includes the warrants to purchase ordinary shares and warrants issued to customers.</ix:continuation></ix:continuation> </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_298"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DefinedContributionPlanTextBlock" id="f-1260" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.       Employee Benefit Plans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined-contribution plan in the United States intended to qualify under Section&#160;401 of the Internal Revenue Code, or the 401(k) Plan. The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a&#160;pre-tax&#160;basis. We offer a safe harbor matching contribution in an amount equal to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-1261">100</ix:nonFraction>% of participating employee contributions to the plan up to <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-1262">4</ix:nonFraction>% of the employee&#8217;s eligible compensation. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1263">1.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1264">1.1</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1265">0.8</ix:nonFraction> million, respectively, of expenses related to the 401(k) plan. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Israeli Severance Pay </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. We have elected to include our employees in Israel under Section 14 of the Severance Pay Law, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of <ix:nonFraction unitRef="number" contextRef="c-6" decimals="4" name="rskd:SeverancePayRate" scale="1" id="f-1266">8.33</ix:nonFraction>% of their monthly salary. These payments release us from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, any liability for severance pay due to these employees, and the deposits under Section 14 are not recorded as an asset in the consolidated balance sheets. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1267">4.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1268">4.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:SeveranceCosts1" format="ixt:num-dot-decimal" scale="6" id="f-1269">3.8</ix:nonFraction> million, respectively, in severance expenses related to these employees.</span></div></ix:nonNumeric><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_842"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SubsequentEventsTextBlock" id="f-1270" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.       Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, the Company announced that it has undertaken certain actions to reduce operating expenses by initiating a reduction in force that impacted approximately <ix:nonFraction unitRef="number" contextRef="c-305" decimals="2" name="us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" scale="-2" id="f-1271">6</ix:nonFraction>% of the Company&#8217;s workforce. The majority of the associated costs, which are primarily related to severance and employee benefits, will be incurred in the first quarter of 2024 and are expected to be approximately $<ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-3" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="f-1272">2.0</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><div id="i7e2a1111f1af4cbbb4ef5c932730e0bb_856"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RISKIFIED LTD.</span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Schedule II</span></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-1273" escape="true"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation and Qualifying Accounts</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.441%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.844%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Increase </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Decrease </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1274">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1275">135,942</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1276">135,584</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1277">12,719</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1278">11,980</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1279">121,762</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1280">121,650</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1281">12,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1282">12,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1283">106,587</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1284">106,338</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1285">12,361</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1286">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1287">103,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-316" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1288">103,236</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1289">11,980</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-317" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1290">12,445</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1291">96,383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-318" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1292">96,716</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1293">12,112</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-319" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1294">10,582</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" format="ixt:num-dot-decimal" scale="3" id="f-1295">85,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-320" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesDeductions" format="ixt:num-dot-decimal" scale="3" id="f-1296">84,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-3" name="us-gaap:ValuationAllowancesAndReservesBalance" format="ixt:num-dot-decimal" scale="3" id="f-1297">12,020</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Increases in Guarantee Obligations represent the portion of amounts billed in the period that is allocated to the indemnification guarantee. Increases in Provision for chargebacks, net represent the net chargeback expense recognized in the consolidated statements of operations during the period. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Decreases in Guarantee Obligations represent the amount released to revenue in the consolidated statements of operations during the period. Decreases in the Provision for chargebacks, net represent the amount of chargeback expenses paid during the period.</span></div></ix:nonNumeric><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>2
<FILENAME>ag302ex122-20xf2023x302cer.htm
<DESCRIPTION>EX-12.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iebffb35b8d754e9296ae20318433bdef_1"></div><div style="min-height:16.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 12.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Aglika Dotcheva, Chief Financial Officer, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this annual report on Form 20-F of Riskified Ltd.&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:16.56pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 6, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Aglika Dotcheva</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aglika Dotcheva</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>3
<FILENAME>ag906ex132-20xf2023x906cer.htm
<DESCRIPTION>EX-13.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="iec8fa6887fb34c53b43b3d64db18f8cf_1"></div><div style="min-height:70.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 13.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION PURSUANT TO<br>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO<br>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with the Annual Report on Form 20-F of Riskified Ltd. (the &#8220;Company&#8221;) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 6, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Aglika Dotcheva</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Aglika Dotcheva</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial Officer)</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>4
<FILENAME>eg302ex121-20xf2023x302cer.htm
<DESCRIPTION>EX-12.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i408f162e83e7463a89a95d1ebe7850fe_1"></div><div style="min-height:25.92pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 12.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I, Eido Gal, Chief Executive Officer, certify that&#58;</font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">I have reviewed this annual report on Form 20-F of Riskified Ltd.&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for, the periods presented in this report&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The company&#8217;s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and have&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(c)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Evaluated the effectiveness of the company&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disclosed in this report any change in the company&#8217;s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the company&#8217;s internal control over financial reporting&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The company&#8217;s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company&#8217;s auditors and the audit committee of the company&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(a)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company&#8217;s ability to record, process, summarize and report financial information&#59; and</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:14.246%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:75.799%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(b)</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Any fraud, whether or not material, that involves management or other employees who have a significant role in the company&#8217;s internal control over financial reporting.</font></td></tr></table></div><div><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:25.92pt;width:100%"><div style="text-align:center"><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.864%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 6, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eido Gal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eido Gal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div style="height:20.88pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>5
<FILENAME>eg906ex131-20xf2023x906cer.htm
<DESCRIPTION>EX-13.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if4eb98d87526450daebd0a0e1c4eff96_1"></div><div style="min-height:70.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 13.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">CERTIFICATION PURSUANT TO<br>18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO<br>SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In connection with the Annual Report on Form 20-F of Riskified Ltd. (the &#8220;Company&#8221;) for the year ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the &#8220;Report&#8221;), I certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.655%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:83.390%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.768%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.834%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.098%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58; March 6, 2024</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Eido Gal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1.5pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Eido Gal</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:2.65pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Executive Officer</font></div><div style="margin-bottom:1.5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>6
<FILENAME>ex22descriptionofsecuritie.htm
<DESCRIPTION>EX-2.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i3c0ed73930c240229e98fd5eadbaa8e8_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:right"><font><br></font></div><div style="margin-bottom:0.06pt;margin-top:6pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:127%;text-decoration:underline">Exhibit 2.2</font></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:right"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">REGISTERED PURSUANT TO SECTION 12 OF THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">SECURITIES EXCHANGE ACT OF 1934, AS AMENDED</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As of December 31, 2023, Riskified Ltd. had one class of securities registered under Section 12 of the Securities Exchange Act of 1934, as amended (the &#34;Exchange Act&#34;)&#58; our Class A ordinary shares, no par value (&#8220;Class A ordinary shares&#8221;).</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">References herein to &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and the &#8220;Company&#8221; refer to Riskified Ltd. and not to any of its subsidiaries. The following description may not contain all of the information that is important to you, and we therefore refer you to our amended and restated articles of association (the &#8220;Articles&#8221;), a copy of which is filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) as an exhibit to this annual report on Form 20-F.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Share capital<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">As of December 31, 2023, our authorized share capital consisted of (i) 900,000,000 Class A ordinary shares, of which 128,738,857 shares were issued and outstanding and&#160;232,500,000&#160;Class B ordinary shares, no par value (&#8220;Class B ordinary shares&#8221;, and together with the Class A ordinary shares, the &#8220;ordinary shares&#8221;), of which&#160;49,814,864 shares were issued and outstanding.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Registration number and purposes of the company<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">We are registered with the Israeli Registrar of Companies. Our registration number is 51-484411-7. Our affairs are governed by our Articles, the Companies Law and other applicable law. Our purpose as set forth in the Articles is to engage in any lawful act or activity.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Transfer of shares<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Our fully paid ordinary shares are issued in registered form and may be freely transferred under our Articles , unless the transfer is restricted or prohibited by another instrument, applicable law or, with respect to our Class A ordinary shares, the rules of the New York Stock Exchange (&#34;NYSE&#34;). </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Each Class B ordinary share will convert automatically on a one-for-one basis into a Class A ordinary share upon sale or transfer (other than transfers to certain permitted transferees).</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The ownership or voting of our ordinary shares by non-residents of Israel is not restricted in any way by the Articles or the laws of the State of Israel, except for ownership by nationals of some countries that are, have been, or will be, in a state of war with Israel.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Election of directors<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under our Articles, our board of directors must consist of not less than three but no more than&#160;eleven directors. Pursuant to our Articles, each of our directors will be appointed by a simple majority vote of holders of our ordinary shares, participating and voting at an annual general meeting of our shareholders. Holders of our Class A ordinary shares and Class B ordinary shares will vote together as a single class on the election of directors, with each Class A ordinary share </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#47;Document2</font></div><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 2 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">entitled to one vote per share, and each Class B ordinary share entitled to ten votes per share. However, in the event of a contested election&#58; (i) the method of calculation of the votes and the manner in which the resolutions will be presented to our shareholders at the general meeting shall be determined by our board of directors in its discretion, and (ii) in the event that our board of directors does not or is unable to make a determination on such matter, then the directors will be elected by a plurality of the voting power represented at the general meeting in person or by proxy and voting on the election of directors. </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In addition, our directors are divided into three classes, one class being elected each year at the annual general meeting of our shareholders, and serve on our board of directors until the third annual general meeting following such election or re-election or until they are removed by a vote of 65% of the total voting power of our shareholders at a general meeting of our shareholders or upon the occurrence of certain events in accordance with the Companies Law and our Articles. In addition, the Articles provide that vacancies on our board of directors may be filled by a vote of a simple majority of the directors then in office. A director so appointed will hold office until the next annual general meeting of our shareholders for the election of the class of directors in respect of which the vacancy was created, or in the case of a vacancy due to the number of directors being less than the maximum number of directors stated in our Articles, until the next annual general meeting of our shareholders for the election of the class of directors to which such director was assigned by our board of directors.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Dividend and liquidation rights<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">We may declare a dividend to be paid to the holders of our ordinary shares in proportion to their respective shareholdings. Under the Companies Law, dividend distributions are determined by the board of directors and do not require the approval of the shareholders of a company unless the company&#8217;s articles of association provide otherwise. The Articles do not require shareholder approval of a dividend distribution and provide that dividend distributions may be determined by our board of directors.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Pursuant to the Companies Law, the distribution amount is limited to the greater of retained earnings or earnings generated over the previous two years, according to our then last reviewed or audited consolidated financial statements (less the amount of previously distributed dividends, if not reduced from the earnings), provided that the end of the period to which the consolidated financial statements relate is not more than six months prior to the date of the distribution. If we do not meet such criteria, then we may distribute dividends only with court approval. In each case, we are only permitted to distribute a dividend if our board of directors and, if applicable, the court determines that there is no reasonable concern that payment of the dividend will prevent us from satisfying our existing and foreseeable obligations as they become due.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In the event of our liquidation, after satisfaction of liabilities to creditors, our assets will be distributed to the holders of our ordinary shares in proportion to their shareholdings. This right, as well as the right to receive dividends, may be affected by the grant of preferential dividend or distribution rights to the holders of a class of shares with preferential rights that may be authorized in the future.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Voting rights<br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 3 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Each Class A ordinary share is entitled to one vote per share. Each Class B ordinary share is entitled to ten votes per share. Holders of our Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters (including the election of directors) submitted to a vote of shareholders except as otherwise provided in the Articles or as required by applicable law. Under the Articles and the Companies Law, the holders of our Class B ordinary shares will only vote as a separate class under certain circumstances, including&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">on a proposal to convert the entire class of those shares into Class A ordinary shares on a one-for-one basis, which requires the affirmative vote of the holders of at least 75% of the outstanding Class B ordinary shares for approval&#59;</font></div><div style="margin-bottom:9pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">amendment of the rights of the Class B ordinary shares&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">disproportionate distributions or recapitalizations that adversely impact the Class B ordinary shares&#59; or</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">differing treatment to the Class B ordinary shares in a merger or similar transaction.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Registration Rights<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Certain of our shareholders are entitled to certain registration rights under the terms of our Investors&#8217; Rights Agreement. </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Shareholder meetings<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under Israeli law, we are required to hold an annual general meeting of our shareholders once every calendar year and no later than 15 months after the date of the previous annual general meeting. All meetings other than the annual general meeting of shareholders are referred to in the Articles as special general meetings. Our board of directors may call special general meetings of our shareholders whenever it sees fit, at such time and place, within or outside of Israel, as it may determine. In addition, the Companies Law provides that our board of directors is required to convene a special general meeting of our shareholders upon the written request of (i) any two or more of our directors, (ii) one-quarter or more of the serving members of our board of directors or (iii) one or more shareholders holding, in the aggregate, either (a) 5% or more of our outstanding issued shares and 1% or more of our outstanding voting power or (b) 5% or more of our outstanding voting power.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under Israeli law, one or more shareholders holding at least 1% of the voting rights at the general meeting of shareholders may request that the board of directors include a matter in the agenda of a general meeting of shareholders to be convened in the future, provided that it is appropriate to discuss such a matter at the general meeting. The Articles contain procedural guidelines and disclosure items with respect to the submission of shareholder proposals for general meetings.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Subject to the provisions of the Companies Law and the regulations promulgated thereunder, shareholders entitled to participate and vote at general meetings of shareholders are the shareholders of record on a date to be decided by the board of directors, which, as a company listed on an exchange outside Israel, may be between four and 40 days prior to the date of the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 4 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">meeting. Furthermore, the Companies Law requires that resolutions regarding the following matters must be passed at a general meeting of shareholders&#58;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">amendments to our articles of association (in addition to the approval by our board of directors, as required pursuant to our Articles )&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">appointment, terms of service, or termination of service of our auditors&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">appointment of directors, including external directors (if applicable)&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">approval of certain related party transactions&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">increases or reductions of our authorized share capital&#59;</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">a merger&#59; and</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%;padding-left:14.5pt">the exercise of our board of directors&#8217; powers by a general meeting, if our board of directors is unable to exercise its powers and the exercise of any of its powers is required for our proper management.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Companies Law requires that a notice of any annual general meeting or special general meeting be provided to shareholders at least 21 days prior to the meeting and, if the agenda of the meeting includes (among other things) the appointment or removal of directors, the approval of transactions with office holders or interested or related parties, or an approval of a merger, notice must be provided at least 35 days prior to the meeting. Under the Companies Law and our Articles, shareholders are not permitted to take action by way of written consent in lieu of a meeting.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Quorum<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Pursuant to our Articles , holders of our Class A ordinary shares have one vote for each Class A ordinary share held and holders of our Class B ordinary shares have ten votes for each Class B ordinary share held on all matters submitted to a vote of the shareholders at a general meeting of shareholders. The quorum required for our general meetings of shareholders consists of at least two shareholders present in person or by proxy who hold or represent at least 33&#8531;% of the total outstanding voting power of our shares, except that if (i) any such general meeting was initiated by and convened pursuant to a resolution adopted by the board of directors and (ii) at the time of such general meeting we qualify to use the forms and rules of a &#8220;foreign private issuer,&#8221; the requisite quorum will consist of two or more shareholders present in person or by proxy who hold or represent at least 25% of the total outstanding voting power of our shares. The requisite quorum shall be present within half an hour of the time fixed for the commencement of the general meeting. A general meeting adjourned for lack of a quorum shall be adjourned either to the same day in the next week, at the same time and place, to such day and at such time and place as indicated in the notice to such meeting, or to such day and at such time and place as the chairperson of the meeting shall determine. For so long as we are qualified to use the forms and rules of a &#8220;foreign private issuer&#8221; under the rules of the SEC, at the reconvened meeting, any number of shareholders present in person or by proxy shall constitute a quorum, unless a meeting was called pursuant to a request by our shareholders, in which case the quorum required is one or </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 5 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">more shareholders, present in person or by proxy and holding the number of shares required to call the meeting as described above.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Vote requirements<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Articles provide that all resolutions of our shareholders require a simple majority vote (based on the number of votes cast, with each Class B ordinary share entitled to ten votes and each Class A ordinary share entitled to one vote), unless otherwise required by the Companies Law or by our Articles. Under the Companies Law, certain actions require the approval of a special majority, including&#58; (i) an extraordinary transaction with a controlling shareholder or in which the controlling shareholder has a personal interest, (ii) the terms of employment or other engagement of a controlling shareholder of the Company or a controlling shareholder&#8217;s relative (even if such terms are not extraordinary) and (iii) certain compensation-related matters require specified approval. . </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under our Articles , the alteration of the rights, privileges, preferences or obligations of any class of our shares requires the approval by a resolution of the general meeting of the holders of all shares as one class, without any required separate resolution of any class of shares, except that any amendment to the rights, privileges, preferences or obligations of the Class B ordinary shares requires, in addition, a resolution adopted at a separate class meeting of the Class B ordinary shares by 75% of the total voting power of the then issued and outstanding Class B ordinary shares. </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under our Articles, the approval of the holders of at least 65% of the total voting power of our shareholders is generally required to&#58; (i) remove any of our directors from office, (ii) to amend the provision requiring the approval of at least 65% of the total voting power of our shareholders to remove any of our directors from office, or (iii) certain other provisions regarding our staggered board, shareholder proposals, the size of our board and plurality voting in contested elections. Another exception to the simple majority vote requirement is a resolution for the voluntary winding up, or an approval of a scheme of arrangement or reorganization of the Company pursuant to Section 350 of the Companies Law, which requires the approval of holders holding at least 75% of the voting rights represented at the meeting and voting on the resolution.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Access to corporate records<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under the Companies Law, all shareholders generally have the right to review minutes of our general meetings, our shareholder register (including with respect to material shareholders), our Articles, our consolidated financial statements, other documents as provided in the Companies Law, and any document we are required by law to file publicly with the Israeli Registrar of Companies or the Israeli Securities Authority. Any shareholder who specifies the purpose of its request may request to review any document in our possession that relates to any action or transaction with a related party which requires shareholder approval under the Companies Law. We may deny a request to review a document if we determine that the request was not made in good faith, that the document contains a trade secret or a patent or that the document&#8217;s disclosure may otherwise impair our interests.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Acquisitions under Israeli law</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 6 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:139%">Full Tender Offer</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">A person wishing to acquire shares of a public Israeli company who would, as a result, hold over 90% of the target company&#8217;s voting rights or the target company&#8217;s issued and outstanding share capital (or of a class thereof), is required by the Companies Law to make a tender offer to all of the company&#8217;s shareholders for the purchase of all of the issued and outstanding shares of the Company (or the applicable class). If (a) the shareholders who do not accept the offer hold less than 5% of the issued and outstanding share capital of the Company (or the applicable class) and the shareholders who accept the offer constitute a majority of the offerees that do not have a personal interest in the acceptance of the tender offer or (b) the shareholders who did not accept the tender offer hold less than 2% of the issued and outstanding share capital of the Company (or of the applicable class), all of the shares that the acquirer offered to purchase will be transferred to the acquirer by operation of law. A shareholder who had its shares so transferred may petition an Israeli court within six months from the date of acceptance of the full tender offer, regardless of whether such shareholder agreed to the offer, to determine whether the tender offer was for less than fair value and whether the fair value should be paid as determined by the court. However, an offeror may provide in the offer that a shareholder who accepted the offer will not be entitled to petition the court for appraisal rights as described in the preceding sentence, as long as the offeror and the Company disclosed the information required by law in connection with the full tender offer. If the full tender offer was not accepted in accordance with any of the above alternatives, the acquirer may not acquire shares of the company that will increase its holdings to more than 90% of the company&#8217;s voting rights or the Company&#8217;s issued and outstanding share capital (or of the applicable class) from shareholders who accepted the tender offer. Shares purchased in contradiction to the full tender offer rules under the Companies Law will have no rights and will become dormant shares.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:139%">Special Tender Offer</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if, as a result of the acquisition, the purchaser would become a holder of 25% or more of the voting rights in the company. This requirement does not apply if there is already another holder of 25% or more of the voting rights in the company. Similarly, the Companies Law provides that an acquisition of shares of an Israeli public company must be made by means of a special tender offer if, as a result of the acquisition, the purchaser would become a holder of more than 45% of the voting rights in the company, if there is no other shareholder of the Company who holds more than 45% of the voting rights in the Company. These requirements do not apply if (i) the acquisition occurs in the context of a private placement by the Company that received shareholders&#8217; approval as a private placement whose purpose is to give the purchaser 25% or more of the voting rights in the company, if there is no person who holds 25% or more of the voting rights in the company or as a private placement whose purpose is to give the purchaser 45% of the voting rights in the company, if there is no person who holds 45% of the voting rights in the company, (ii) the acquisition was from a shareholder holding 25% or more of the voting rights in the Company and resulted in the purchaser becoming a holder of 25% or more of the voting rights in the Company, or (iii) the acquisition was from a shareholder holding more than 45% of the voting rights in the company and resulted in the purchaser becoming a holder of more than 45% of the voting rights in the company. A special tender offer must be extended to all shareholders of a company. A special tender offer may be consummated </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 7 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">only if (i) at least 5% of the voting power attached to the company&#8217;s outstanding shares will be acquired by the offeror and (ii) the number of shares tendered in the offer exceeds the number of shares whose holders objected to the offer (excluding the purchaser, its controlling shareholders, holders of 25% or more of the voting rights in the Company and any person having a personal interest in the acceptance of the tender offer, or anyone on their behalf, including any such person&#8217;s relatives and entities under their control).</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In the event that a special tender offer is made, a company&#8217;s board of directors is required to express its opinion on the advisability of the offer, or may abstain from expressing any opinion if it is unable to do so, provided that it gives the reasons for its abstention. The board of directors shall also disclose any personal interest that any of the directors has with respect to the special tender offer or in connection therewith. An office holder in a target company who, in his or her capacity as an office holder, performs an action the purpose of which is to cause the failure of an existing or foreseeable special tender offer or to impair the chances of its acceptance, is liable to the potential purchaser and shareholders for damages, unless such office holder acted in good faith and had reasonable grounds to believe he or she was acting for the benefit of the company. However, office holders of the target company may negotiate with the potential purchaser in order to improve the terms of the special tender offer, and may further negotiate with third parties in order to obtain a competing offer.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">If a special tender offer is accepted, then shareholders who did not respond to or that had objected to the offer may accept the offer within four days of the last day set for the acceptance of the offer and they will be considered to have accepted the offer from the first day it was made.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In the event that a special tender offer is accepted, then the purchaser or any person or entity controlling it or under common control with the purchaser or such controlling person or entity at the time of the offer may not make a subsequent tender offer for the purchase of shares of the target company and may not enter into a merger with the target company for a period of one year from the date of the offer, unless the purchaser or such person or entity undertook to effect such an offer or merger in the initial special tender offer. Shares purchased in contradiction to the special tender offer rules under the Companies Law will have no rights and will become dormant shares.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:700;line-height:139%">Merger</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Companies Law permits merger transactions if approved by each party&#8217;s board of directors and, unless certain conditions described under the Companies Law are met, a simple majority of the outstanding voting rights of each party to the merger that are represented and voting on the merger. The board of directors of a merging company is required pursuant to the Companies Law to discuss and determine whether in its opinion there exists a reasonable concern that as a result of a proposed merger, the surviving company will not be able to satisfy its obligations towards its creditors, such determination taking into account the financial status of the merging companies. If the board of directors determines that such a concern exists, it may not approve a proposed merger. Following the approval of the board of directors of each of the merging companies, the boards of directors must jointly prepare a merger proposal for submission to the Israeli Registrar of Companies.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 8 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">For purposes of the shareholder vote of a merging company whose shares are held by the other merging company, or by a person or entity holding 25% or more of the voting rights at the general meeting of shareholders of the other merging company, or by a person or entity holding the right to appoint 25% or more of the directors of the other merging company, unless a court rules otherwise, the merger will not be deemed approved if a majority of the votes of shares voted on the matter at the general meeting of shareholders (excluding abstentions) that are held by shareholders other than the other party to the merger, or by any person or entity who holds 25% or more of the voting rights of the other party or the right to appoint 25% or more of the directors of the other party, or any one on their behalf including their relatives or corporations controlled by any of them, vote against the merger. In addition, if the non-surviving entity of the merger has more than one class of shares, the merger must be approved by each class of shareholders. If the transaction would have been approved but for the separate approval of each class or the exclusion of the votes of certain shareholders as provided above, a court may still approve the merger upon the request of holders of at least 25% of the voting rights of a company, if the court holds that the merger is fair and reasonable, taking into account the valuation of the merging companies and the consideration offered to the shareholders. If a merger is with a company&#8217;s controlling shareholder or if the controlling shareholder has a personal interest in the merger, then the merger is instead subject to the same special majority approval that governs all extraordinary transactions with controlling shareholders.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Under the Companies Law, each merging company must deliver to its secured creditors the merger proposal and inform its unsecured creditors of the merger proposal and its content. Upon the request of a creditor of either party to the proposed merger, the court may delay or prevent the merger if it concludes that there exists a reasonable concern that, as a result of the merger, the surviving company will be unable to satisfy the obligations of the merging company, and may further give instructions to secure the rights of creditors.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">In addition, a merger may not be completed unless at least 50 days have passed from the date that a proposal for approval of the merger is filed with the Israeli Registrar of Companies and 30 days from the date that shareholder approval of both merging companies is obtained.</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:139%">Anti-Takeover Measures</font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Companies Law allows us to create and issue shares having rights different from those attached to our ordinary shares, including shares providing certain preferred rights with respect to voting, distributions or other matters and shares having preemptive rights. No preferred shares are authorized under our Articles. In the future, if we do authorize, create and issue a specific class of preferred shares, such class of shares, depending on the specific rights that may be attached to it, may have the ability to frustrate or prevent a takeover or otherwise prevent our shareholders from realizing a potential premium over the market value of their ordinary shares. The authorization and designation of a class of preferred shares will require an amendment to our Articles, which requires the prior approval of the holders of a majority of the voting power attached to our issued and outstanding shares at a general meeting of shareholders. The convening of the meeting, the shareholders entitled to participate and the vote required to be obtained at such a meeting will be subject to the requirements set forth in the Companies Law and our amended articles of association.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.15pt;font-weight:400;line-height:139%;position:relative;top:-3.85pt;vertical-align:baseline"> </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 9 -</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Borrowing powers<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Pursuant to the Companies Law and the our Articles, our board of directors may exercise all powers and take all actions that are not required under law or under the Articles to be exercised or taken by our shareholders, including the power to borrow money for company purposes.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Changes in capital<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Articles enable us to increase or reduce our share capital. Any such changes are subject to Israeli law and must be approved by a resolution duly passed by our shareholders at a general meeting of shareholders. In addition, transactions that have the effect of reducing capital, such as the declaration and payment of dividends in the absence of sufficient retained earnings or profits, require the approval of both our board of directors and an Israeli court.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Exclusive forum<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Articles provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States of America shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended (the &#34;Securities Act&#34;). Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions, and accordingly, both state and federal courts have jurisdiction to entertain such claims. While the federal forum provision in the Articles does not restrict the ability of our shareholders to bring claims under the Securities Act, we recognize that it may limit shareholders&#8217; ability to bring a claim in the judicial forum that they find favorable and may increase certain litigation costs, which may discourage the filing of claims under the Securities Act against the Company, its directors and officers. However, the enforceability of similar forum provisions (including exclusive federal forum provisions for actions, suits or proceedings asserting a cause of action arising under the Securities Act) in other companies&#8217; organizational documents has been challenged in legal proceedings, and there is uncertainty as to whether courts would enforce the exclusive forum provisions in our Articles. If a court were to find the choice of forum provision contained in the Articles to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could materially adversely affect our business, financial condition and results of operations. Alternatively, if a court were to find these provisions of the Articles inapplicable to, or unenforceable in respect of, one or more of the specified types of actions or proceedings, we may incur additional costs associated with resolving such matters in other jurisdictions, which could adversely affect our business and financial condition. Any person or entity purchasing or otherwise acquiring any interest in our share capital shall be deemed to have notice of and to have consented to the choice of forum provisions of our Articles. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. </font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">The Articles also provide that unless we consent in writing to the selection of an alternative forum, the competent courts in Tel Aviv, Israel shall be the exclusive forum for any derivative action or proceeding brought on behalf of the Company, any action asserting a breach of a fiduciary duty owed by any of our directors, officers or other employees to the Company or our </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 10 -</font></div></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">shareholders or any action asserting a claim arising pursuant to any provision of the Companies Law or the Israeli Securities Law.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Transfer agent and registrar<br></font></div><div style="text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">The transfer agent and registrar for our ordinary shares is </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10.5pt;font-weight:400;line-height:115%">Equiniti Trust Company, LLC, 48 Wall Street, Floor 23, New York, NY 10005</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:115%">, and its telephone number is (800) 937-5449.</font></div><div style="margin-bottom:0.06pt;margin-top:0.06pt"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Listing<br></font></div><div style="margin-bottom:9pt;margin-top:6pt;text-align:justify;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:139%">Our Class A ordinary shares are listed on the NYSE under the symbol &#8220;RSKD.&#8221; Our Class B ordinary shares are neither listed nor publicly traded.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:0.06pt;margin-top:0.06pt;text-align:justify"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-15.1
<SEQUENCE>7
<FILENAME>a151riskified-20xf2023xaud.htm
<DESCRIPTION>EX-15.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i5ba5461ed993496fbb35436d09b48e96_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 15.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:139%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">We&#160;consent&#160;to the incorporation by reference in the following Registration Statements&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:4.02pt">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Form S-8 No. 333-258461) pertaining to the Amended and Restated Riskified Ltd. 2013 Equity Incentive Plan (including the U.S. Sub-Plan to the Amended and Restated Riskified Ltd. 2013 Equity Incentive Plan), the Riskified Ltd. 2021 Share Incentive Plan and the Riskified Ltd. 2021 Employee Share Purchase Plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:4.02pt">Registration Statement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%"> (</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">Form S-8 No. 333-265150) pertaining to the Riskified Ltd. 2021 Share Incentive Plan&#59;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%;padding-left:4.02pt">Registration Statement (Form S-8 No. 333-270006) pertaining to the Riskified Ltd. 2021 Share Incentive Plan&#59;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:139%">of our report dated March 6, 2024, with respect to the consolidated financial statements of Riskified Ltd included in this Annual Report (Form 20-F) of Riskified Ltd for the year ended December 31, 2023.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.488%"><tr><td style="width:1.0%"></td><td style="width:32.285%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:26.172%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.243%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Kost Forer Gabbay &#38; Kasierer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">March 6, 2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Kost Forer Gabbay &#38; Kasierer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Tel-Aviv, Israel</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">A Member of EY Global</font></td></tr></table></div><div style="margin-bottom:12pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.1
<SEQUENCE>8
<FILENAME>exhibit81-20xf2023xlistofs.htm
<DESCRIPTION>EX-8.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="i8c0d1c22c04443b49fca04a1703251d2_1"></div><div style="min-height:70.56pt;width:100%"><div style="text-align:justify"><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 8.1</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Subsidiaries of the Registrant</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.817%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.953%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.830%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Legal Name of Subsidiary</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Jurisdiction of Organization</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified, Inc.</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (Shanghai) Information Technology Co., Ltd.</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">China</font></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (UK) Ltd.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Kingdom</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Riskified (Japan) K.K.</font></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Japan</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.049%"><tr><td style="width:1.0%"></td><td style="width:2.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.069%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(1)</font></div></td><td colspan="12" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">In December 2023 we filed an application for voluntary striking-off our United Kingdom subsidiary Riskified (UK) Ltd. We expect the voluntary striking-off process to be completed in March 2024.</font></td></tr></table></div><div style="height:70.56pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-97.1
<SEQUENCE>9
<FILENAME>exhibit971-policyforrecove.htm
<DESCRIPTION>EX-97.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2024 Workiva -->
<title>Document</title></head><body><div id="if157415fb43743df9abaa7d51e641dde_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit 97.1</font></div></div><div style="margin-bottom:12pt;text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:64px;margin-bottom:5pt;vertical-align:text-bottom;width:311px"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"><br><br>POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Riskified Ltd. (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) has adopted this Policy for Recovery of Erroneously Awarded Compensation (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) on November 14, 2023.  Capitalized terms used in this Policy but not otherwise defined herein are defined in Section 12.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Persons Subject to Policy</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall apply to and be binding and enforceable on current and former Officers. In addition, the Committee and the Board may apply this Policy, either generally or in specific circumstances, to persons who are not Officers, and such application shall apply in the manner determined by the Committee and the Board in their sole discretion.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Compensation Subject to Policy</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall apply to Incentive-Based Compensation received on or after October 2, 2023. For purposes of this Policy, the date on which Incentive-Based Compensation is &#8220;received&#8221; shall be determined under the Applicable Rules, which generally provide that Incentive-Based Compensation is &#8220;received&#8221; in the Company&#8217;s fiscal period during which the relevant Financial Reporting Measure is attained or satisfied, without regard to whether the grant, vesting or payment of the Incentive-Based Compensation occurs after the end of that period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Recovery of Compensation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In the event that the Company is required to prepare a Restatement, the Company shall recover, reasonably promptly and in accordance with Section 4 below, the portion of any Incentive-Based Compensation that is Erroneously Awarded Compensation, unless the Committee and the Board have determined that recovery from the relevant current or former Officer would be Impracticable. Recovery shall be required in accordance with the preceding sentence regardless of whether the applicable Officer engaged in misconduct or otherwise caused or contributed to the requirement for the Restatement and regardless of whether or when restated financial statements are filed by the Company.  For clarity, the recovery of Erroneously Awarded Compensation under this Policy will not give rise to any Officer&#8217;s right to voluntarily terminate employment for &#8220;good reason&#8221; or due to a &#8220;constructive termination&#8221; (or any similar term of like effect) under any plan, program or policy of or agreement with the Company or any of its affiliates.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Manner of Recovery&#59; Limitation on Duplicative Recovery</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Committee and the Board shall, in its sole discretion, determine the manner of recovery of any Erroneously Awarded Compensation, which may include, without limitation, reduction or cancellation by the Company or an affiliate of the Company, to the extent permitted by law, of Incentive-Based Compensation or Erroneously Awarded Compensation, reimbursement or repayment by any person subject to this Policy, and, to the extent permitted by law, an offset of the Erroneously Awarded Compensation against other compensation payable by the Company or an affiliate of the Company to such person. Notwithstanding the foregoing, unless otherwise prohibited by the Applicable Rules, to the extent this Policy provides for recovery of Erroneously Awarded Compensation already recovered by the Company pursuant to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Section 304 of the Sarbanes-Oxley Act of 2002 or Other Recovery Arrangements, the amount of Erroneously Awarded Compensation already recovered by the Company from the recipient of such Erroneously Awarded Compensation may be credited to the amount of Erroneously Awarded Compensation required to be recovered pursuant to this Policy from such person.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">For Incentive-Based Compensation based on the Company&#8217;s stock price or total shareholder return, where the amount of Erroneously Awarded Compensation is not subject to mathematical recalculation directly from the information in the applicable Restatement&#58; (i) the amount to be repaid or returned shall be determined by the Committee and the Board based on a reasonable estimate of the effect of the Restatement on the Company&#8217;s stock price or total shareholder return upon which the Incentive-Based Compensation was received&#59; and (ii) the Company shall maintain documentation of the determination of such reasonable estimate and provide the relevant documentation as required to the applicable national securities exchange or association. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Administration</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be administered, interpreted and construed by the Committee, which is authorized to make all determinations necessary, appropriate or advisable for such purpose. The Board may re-vest in itself the authority to administer, interpret and construe this Policy in accordance with applicable law, and in such event references herein to the &#8220;Committee&#8221; shall be deemed to be references to the Board.  Subject to any permitted review by the applicable national securities exchange or association pursuant to the Applicable Rules, all determinations and decisions made by the Committee pursuant to the provisions of this Policy shall be final, conclusive and binding on all persons, including the Company and its affiliates, shareholders and employees. The Committee may delegate administrative duties with respect to this Policy to one or more directors or employees of the Company, as permitted under applicable law, including any Applicable Rules. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Interpretation</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">This Policy shall be interpreted and applied in a manner that is consistent with the requirements of the Applicable Rules, and to the extent this Policy is inconsistent with such Applicable Rules, it shall be deemed amended to the minimum extent necessary to ensure compliance therewith.    </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">No Indemnification&#59; No Liability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Notwithstanding anything to the contrary herein or in any arrangement or agreement any person may have with the Company or any affiliate thereof, the Company shall not indemnify or insure any person against the loss of any Erroneously Awarded Compensation pursuant to this Policy, nor shall the Company directly or indirectly pay or reimburse any person for any premiums for third-party insurance policies that such person may elect to purchase to fund such person&#8217;s potential obligations under this Policy.  None of the Company, an affiliate of the Company or any member of the Committee or the Board shall have any liability to any person as a result of actions taken under this Policy. For the avoidance of a doubt, in the event of a conflict between this Policy and any indemnification agreement or undertaking taken by the Company or any affiliate thereof for the benefit of such person, this Policy shall prevail. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Application&#59; Enforceability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Except as otherwise determined by the Committee or the Board, the adoption of this Policy does not limit, and is intended to apply in addition to, any Other Recovery Arrangements. Without limiting the foregoing, in the event of a conflict between this Policy and the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Compensation Policy, the latter shall prevail, except with respect to the recovery of any portion of Incentive-Based Compensation that is Erroneously Awarded Compensation that would not be recoverable under the Compensation Policy, in which case this Policy shall prevail.  Subject to Section 4, the remedy specified in this Policy shall not be exclusive and shall be in addition to every other right or remedy at law or in equity that may be available to the Company or an affiliate of the Company or is otherwise required by applicable law and regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:27pt;text-decoration:underline">Severability</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The provisions in this Policy are intended to be applied to the fullest extent of the law&#59; provided, however, to the extent that any provision of this Policy is found to be unenforceable or invalid under any applicable law, such provision will be applied to the maximum extent permitted, and shall automatically be deemed amended in a manner consistent with its objectives to the extent necessary to conform to any limitations required under applicable law. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Amendment and Termination</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Without limitation of any additional requirements under the Companies Law 5759-1999, the Board or the Committee may amend, modify or terminate this Policy in whole or in part at any time and from time to time in its sole discretion. This Policy will terminate automatically in the event that the Company ceases to have a class of securities listed on a national securities exchange or association in the U.S.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">11.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Disclosure</font></div><div style="margin-bottom:9pt;padding-left:3.6pt;text-align:justify;text-indent:32.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">The Company shall file all disclosures with respect to this Policy required by Applicable Rules.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">12.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%;padding-left:21pt;text-decoration:underline">Definitions</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Applicable Rules</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means Section 10D of the Exchange Act, Rule 10D-1 promulgated thereunder, the listing rules of the national securities exchange or association on which the Company&#8217;s securities are listed, and any applicable rules, standards or other guidance adopted by the Securities and Exchange Commission or any national securities exchange or association on which the Company&#8217;s securities are listed.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Board</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Compensation Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Company&#8217;s compensation policy for officers and directors, as adopted in accordance with the Israeli Companies Law 5759-1999 and as in effect from time to time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Compensation Committee of the Board or, in the absence of such a committee, a majority of the independent directors serving on the Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Erroneously Awarded Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the amount of Incentive-Based Compensation received by a current or former Officer that exceeds the amount of Incentive-Based Compensation that would have been received by such current or former Officer based on a restated Financial Reporting Measure, as determined on a pre-tax basis in accordance with the Applicable Rules.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Exchange Act</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means the Securities Exchange Act of 1934, as amended.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Financial Reporting Measure</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means any measure determined and presented in accordance with the accounting principles used in preparing the Company&#8217;s financial statements, and any measures derived wholly or in part from such measures, including GAAP, IFRS and non-GAAP&#47;IFRS financial measures, as well as stock price and total shareholder return (and any measures that are derived wholly or in part from stock price or total shareholder return). </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">GAAP</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means United States generally accepted accounting principles.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">IFRS</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means international financial reporting standards as adopted by the International Accounting Standards Board.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Impracticable</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means (a) the direct expense paid to third parties to assist in enforcing recovery would exceed the Erroneously Awarded Compensation&#59; provided that the Company has (i) made reasonable attempt(s) to recover the Erroneously Awarded Compensation, (ii) documented such reasonable attempt(s) and (iii) provided such documentation to the relevant listing exchange or association, (b) the recovery would violate the Company&#8217;s home country (Israeli) laws adopted prior to November 28, 2022 pursuant to an opinion of home country counsel&#59; provided that the Company has (i) obtained an opinion of home country counsel, acceptable to the relevant listing exchange or association, that recovery would result in such a violation and (ii) provided such opinion to the relevant listing exchange or association, or (c) recovery would likely cause an otherwise tax-qualified retirement plan, under which benefits are broadly available to employees of the Company, to fail to meet the requirements of 26 U.S.C. 401(a)(13) or 26 U.S.C. 411(a) and the regulations thereunder. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Incentive-Based Compensation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Restatement, any compensation that is granted, earned, or vested based wholly or in part upon the attainment of one or more Financial Reporting Measures and received by a person&#58; (a) on or after October 2, 2023&#59; (b) after such person began service as an Officer&#59; (c) who served as an Officer at any time during the performance period for that compensation (whether or not such Officer is serving at the time the Erroneously Awarded Compensation is required to be repaid to the Company)&#59; (d) while the Company has a class of securities listed on a national securities exchange or association&#59; and (e) during the applicable Three-Year Period. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Officer</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means each person who the Company determines serves as a Company officer, as defined in Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended. </font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Other Recovery Arrangements</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#8221;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">means any clawback, recoupment, forfeiture or similar policies or provisions of the Company or its affiliates, including any such policies or provisions of such effect contained in any employment agreement, bonus plan, incentive plan, equity-based plan or award agreement thereunder or similar plan, program or agreement of the Company or an affiliate or required under applicable law (including, without limitation, the Compensation Policy).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Restatement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means an accounting restatement to correct the Company&#8217;s material noncompliance with any financial reporting requirement under securities laws, including restatements that correct an error in previously issued financial statements (a) that is material to the previously issued financial statements (a &#8220;big R&#8221; restatement) or (b) that would result in a material misstatement if the error were corrected in the current period or left uncorrected in the current period (a &#8220;little r&#8221; restatement)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:100%">Three-Year Period</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221; means, with respect to a Restatement, the three completed fiscal years immediately preceding the date that the Board, a committee of the Board, or the officer or officers of the Company authorized to take such action if Board action is not required, concludes, or reasonably should have concluded, that the Company is required to prepare such Restatement, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">or, if earlier, the date on which a court, regulator or other legally authorized body directs the Company to prepare such Restatement. The &#8220;Three-Year Period&#8221; also includes any transition period (that results from a change in the Company&#8217;s fiscal year) within or immediately following the three completed fiscal years identified in the preceding sentence. However, a transition period between the last day of the Company&#8217;s previous fiscal year end and the first day of its new fiscal year that comprises a period of nine to 12 months shall be deemed a completed fiscal year.</font></div><div style="margin-bottom:12pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%"> FORM OF</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">ACKNOWLEDGMENT AGREEMENT</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">PERTAINING TO THE RISKIFIED LTD. POLICY FOR RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">In consideration of, and as a condition to, the receipt of future cash and equity incentive compensation from Riskified Ltd. or its subsidiaries (collectively, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), _________________ (&#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Executive</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;) and the Company are entering into this Acknowledgment Agreement.  </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Executive agrees that compensation received by Executive may be subject to reduction, cancellation, forfeiture and&#47;or recoupment to the extent necessary to comply with (a) the Policy for Recovery of Erroneously Awarded Compensation adopted by the Board of Directors of the Company (as amended from time to time, the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Policy</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#8221;), and (b) any Other Recovery Arrangements (as defined in the Policy).  Executive acknowledges that Executive has received and has had an opportunity to review the Policy and any Other Recovery Arrangements applicable to Executive. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Executive acknowledges and agrees to the terms of the Policy and any Other Recovery Arrangements, including that any compensation received by Executive shall be subject to and conditioned upon the provisions of the Policy and any Other Recovery Arrangements applicable to Executive. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Executive further acknowledges and agrees that Executive is not entitled to indemnification in connection with any enforcement of the Policy or any Other Recovery Arrangements applicable to Executive and expressly waives any rights to such indemnification under the Company&#8217;s organizational documents or otherwise. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">Executive agrees to take all actions requested by the Company in order to enable or facilitate the enforcement of the Policy and any Other Recovery Arrangements applicable to Executive (including, without limitation, any reduction, cancellation, forfeiture or recoupment of any compensation that Executive has received or to which Executive may become entitled).</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%;padding-left:9pt">To the extent any recovery right under the Policy and any Other Recovery Arrangements applicable to Executive conflicts with any other contractual rights Executive may have with the Company or any affiliate, Executive understands that the terms of the Policy and the Other Recovery Arrangements shall supersede any such contractual rights. Executive agrees that no recovery of compensation under the Policy and the Other Recovery Arrangements will be an event that triggers or contributes to any right of Executive to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar term) under any agreement with the Company or any affiliate.</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:100%">&#91;Signature Page Follows&#93;</font></div><div style="margin-bottom:12pt;text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:justify"><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.064%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">EXECUTIVE</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Signature)</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Print Name)</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Title)</font></td></tr></table></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.064%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Date)</font></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">RISKIFIED LTD.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:40.064%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;</font></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Signature)</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Print Name)</font></td></tr><tr style="height:8pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#160;</font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Title)<br></font><font style="font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%"><br></font></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-top:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">(Date)</font></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>10
<FILENAME>rskd-20231231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:74ab1c91-acf2-4dbd-a834-633eda582453,g:91ce9b07-e870-4283-be19-76a0a0cc8871-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rskd="http://riskified.com/20231231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://riskified.com/20231231">
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rskd-20231231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rskd-20231231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rskd-20231231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rskd-20231231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://riskified.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://riskified.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS" roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS">
        <link:definition>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT" roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT">
        <link:definition>0000007 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical" roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical">
        <link:definition>0000008 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandDescriptionofBusiness" roleURI="http://riskified.com/role/OrganizationandDescriptionofBusiness">
        <link:definition>0000010 - Disclosure - Organization and Description of Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000011 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognition" roleURI="http://riskified.com/role/RevenueRecognition">
        <link:definition>0000012 - Disclosure - Revenue Recognition</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://riskified.com/role/FairValueMeasurements">
        <link:definition>0000013 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedging" roleURI="http://riskified.com/role/DerivativeInstrumentsandHedging">
        <link:definition>0000014 - Disclosure - Derivative Instruments and Hedging</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponents" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponents">
        <link:definition>0000015 - Disclosure - Consolidated Balance Sheet Components</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://riskified.com/role/Leases">
        <link:definition>0000016 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesCommitmentsandContingencies" roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingencies">
        <link:definition>0000017 - Disclosure - Guarantees, Commitments, and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TemporaryEquity" roleURI="http://riskified.com/role/TemporaryEquity">
        <link:definition>0000018 - Disclosure - Temporary Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlan" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlan">
        <link:definition>0000019 - Disclosure - Ordinary Shares and Equity Incentive Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://riskified.com/role/IncomeTaxes">
        <link:definition>0000020 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetProfitLossPerShareAttributabletoOrdinaryShareholders" roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders">
        <link:definition>0000021 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlans" roleURI="http://riskified.com/role/EmployeeBenefitPlans">
        <link:definition>0000022 - Disclosure - Employee Benefit Plans</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://riskified.com/role/SubsequentEvents">
        <link:definition>0000023 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccounts" roleURI="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts">
        <link:definition>0000024 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionTables" roleURI="http://riskified.com/role/RevenueRecognitionTables">
        <link:definition>9954473 - Disclosure - Revenue Recognition (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://riskified.com/role/FairValueMeasurementsTables">
        <link:definition>9954474 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingTables" roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingTables">
        <link:definition>9954475 - Disclosure - Derivative Instruments and Hedging (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsTables" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables">
        <link:definition>9954476 - Disclosure - Consolidated Balance Sheet Components (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://riskified.com/role/LeasesTables">
        <link:definition>9954477 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesCommitmentsandContingenciesTables" roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables">
        <link:definition>9954478 - Disclosure - Guarantees, Commitments, and Contingencies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TemporaryEquityTables" roleURI="http://riskified.com/role/TemporaryEquityTables">
        <link:definition>9954479 - Disclosure - Temporary Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanTables" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables">
        <link:definition>9954480 - Disclosure - Ordinary Shares and Equity Incentive Plan (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://riskified.com/role/IncomeTaxesTables">
        <link:definition>9954481 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables" roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables">
        <link:definition>9954482 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails">
        <link:definition>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails">
        <link:definition>9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails">
        <link:definition>9954486 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails">
        <link:definition>9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionRevenuebyGeographicAreasDetails" roleURI="http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails">
        <link:definition>9954488 - Disclosure - Revenue Recognition - Revenue by Geographic Areas (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDisaggregationofRevenueDetails" roleURI="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails">
        <link:definition>9954489 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDeferredContractAcquisitionCostsDetails" roleURI="http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails">
        <link:definition>9954490 - Disclosure - Revenue Recognition - Deferred Contract Acquisition Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRecognitionDeferredContractFulfillmentCostsDetails" roleURI="http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails">
        <link:definition>9954491 - Disclosure - Revenue Recognition - Deferred Contract Fulfillment Costs (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFinancialInstrumentsDetails" roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails">
        <link:definition>9954492 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofShorttermInvestmentsDetails" roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails">
        <link:definition>9954493 - Disclosure - Fair Value Measurements - Schedule of Short-term Investments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsEffectiveContractualMaturityDatesDetails" roleURI="http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails">
        <link:definition>9954494 - Disclosure - Fair Value Measurements - Effective Contractual Maturity Dates (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails" roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails">
        <link:definition>9954495 - Disclosure - Derivative Instruments and Hedging - Derivative Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails" roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails">
        <link:definition>9954496 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails" roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails">
        <link:definition>9954497 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails">
        <link:definition>9954498 - Disclosure - Consolidated Balance Sheet Components - Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsNarrativeDetails" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails">
        <link:definition>9954499 - Disclosure - Consolidated Balance Sheet Components - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails">
        <link:definition>9954500 - Disclosure - Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails">
        <link:definition>9954501 - Disclosure - Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails" roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails">
        <link:definition>9954502 - Disclosure - Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://riskified.com/role/LeasesLeaseCostDetails">
        <link:definition>9954503 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://riskified.com/role/LeasesNarrativeDetails">
        <link:definition>9954504 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityLeaseScheduleDetails" roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails">
        <link:definition>9954505 - Disclosure - Leases - Maturity Lease Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesMaturityLeaseScheduleDetails_1" roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1">
        <link:definition>9954505 - Disclosure - Leases - Maturity Lease Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesByGeographicRegionDetails" roleURI="http://riskified.com/role/LeasesByGeographicRegionDetails">
        <link:definition>9954506 - Disclosure - Leases (By Geographic Region) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesCommitmentsandContingenciesNarrativeDetails" roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails">
        <link:definition>9954507 - Disclosure - Guarantees, Commitments, and Contingencies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails" roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails">
        <link:definition>9954508 - Disclosure - Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinaryShareWarrantsDetails" roleURI="http://riskified.com/role/OrdinaryShareWarrantsDetails">
        <link:definition>9954509 - Disclosure - Ordinary Share Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanNarrativeDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails">
        <link:definition>9954510 - Disclosure - Ordinary Shares and Equity Incentive Plan - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails">
        <link:definition>9954511 - Disclosure - Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails">
        <link:definition>9954512 - Disclosure - Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails">
        <link:definition>9954513 - Disclosure - Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanRSUActivityDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails">
        <link:definition>9954514 - Disclosure - Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails" roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails">
        <link:definition>9954515 - Disclosure - Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://riskified.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9954516 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails" roleURI="http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails">
        <link:definition>9954517 - Disclosure - Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" roleURI="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails">
        <link:definition>9954518 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" roleURI="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails">
        <link:definition>9954519 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9954520 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails" roleURI="http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails">
        <link:definition>9954521 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Position (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails" roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails">
        <link:definition>9954522 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails" roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails">
        <link:definition>9954523 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansNarrativeDetails" roleURI="http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails">
        <link:definition>9954524 - Disclosure - Employee Benefit Plans - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsDetails" roleURI="http://riskified.com/role/SubsequentEventsDetails">
        <link:definition>9954525 - Disclosure - Subsequent Events (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SECScheduleArticle1209ValuationandQualifyingAccountsDetails" roleURI="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails">
        <link:definition>9954526 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="rskd_A2013EquityIncentivePlanMember" abstract="true" name="A2013EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_StockRepurchaseProgramTransactionCosts" abstract="false" name="StockRepurchaseProgramTransactionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_IndemnificationServiceRevenueMember" abstract="true" name="IndemnificationServiceRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" abstract="false" name="SalesAndMarketingExpensePolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rskd_RevenueTermOfMerchantContract" abstract="false" name="RevenueTermOfMerchantContract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rskd_StockIssuedDuringPeriodSharesRecapitalization" abstract="false" name="StockIssuedDuringPeriodSharesRecapitalization" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rskd_DeferredContractFulfillmentCostsAmortizationExpense" abstract="false" name="DeferredContractFulfillmentCostsAmortizationExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" abstract="false" name="WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rskd_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_TaxYear2042Member" abstract="true" name="TaxYear2042Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rskd_SeriesE1ConvertiblePreferredStockMember" abstract="true" name="SeriesE1ConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_DeferredContractFulfillmentCostsNoncurrent" abstract="false" name="DeferredContractFulfillmentCostsNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_DeferredOfferingCostsIncurredButNotYetPaid" abstract="false" name="DeferredOfferingCostsIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_GuarantorObligationsChargebackExpense" abstract="false" name="GuarantorObligationsChargebackExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_NonIsraelAndNonUSMember" abstract="true" name="NonIsraelAndNonUSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_ConvertiblePreferredShareTrancheRightsMember" abstract="true" name="ConvertiblePreferredShareTrancheRightsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rskd_SeverancePayRate" abstract="false" name="SeverancePayRate" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rskd_FraudServiceRevenueMember" abstract="true" name="FraudServiceRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_CommonStockVotesForEachShare" abstract="false" name="CommonStockVotesForEachShare" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" abstract="true" name="ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" abstract="false" name="OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_WarrantIssuedToCustomersMember" abstract="true" name="WarrantIssuedToCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_StockIssuedDuringPeriodSharesWarrantsExercised" abstract="false" name="StockIssuedDuringPeriodSharesWarrantsExercised" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rskd_SeriesEConvertiblePreferredStockMember" abstract="true" name="SeriesEConvertiblePreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" abstract="false" name="TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rskd_PaymentsOfOtherStockIssuanceCosts" abstract="false" name="PaymentsOfOtherStockIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_IncreaseDecreaseInCapitalizedContractCost" abstract="false" name="IncreaseDecreaseInCapitalizedContractCost" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_MovementInDeferredContractFulfillmentCostsRollForward" abstract="true" name="MovementInDeferredContractFulfillmentCostsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rskd_FairValueAdjustmentOfRights" abstract="false" name="FairValueAdjustmentOfRights" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_WarrantsToPurchaseOrdinarySharesMember" abstract="true" name="WarrantsToPurchaseOrdinarySharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_IncreaseDecreaseInProvisionForChargebacks" abstract="false" name="IncreaseDecreaseInProvisionForChargebacks" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_ExpirationPeriodAxis" abstract="true" name="ExpirationPeriodAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="rskd_DeferredContractFulfillmentCostsTableTextBlock" abstract="false" name="DeferredContractFulfillmentCostsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rskd_A2021EquityIncentivePlanMember" abstract="true" name="A2021EquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_MovementInDeferredContractAcquisitionCostsRollForward" abstract="true" name="MovementInDeferredContractAcquisitionCostsRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="rskd_A2021EmployeeSharePurchasePlanMember" abstract="true" name="A2021EmployeeSharePurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_CapitalizedDeferredContractAcquisitionCostAmortization" abstract="false" name="CapitalizedDeferredContractAcquisitionCostAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_IncreaseDecreaseInGuarantorObligations" abstract="false" name="IncreaseDecreaseInGuarantorObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_PaymentsOfTemporaryEquityIssuanceCosts" abstract="false" name="PaymentsOfTemporaryEquityIssuanceCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_DeferredTaxAssetsLeasingArrangements" abstract="false" name="DeferredTaxAssetsLeasingArrangements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_ProvisionForChargebacksCurrent" abstract="false" name="ProvisionForChargebacksCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_FurnitureAndOfficeEquipmentMember" abstract="true" name="FurnitureAndOfficeEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" abstract="false" name="IncreaseDecreaseToDeferredContractAcquisitionCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_ShortTermDepositsPolicyPolicyTextBlock" abstract="false" name="ShortTermDepositsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rskd_ExpirationPeriodDomain" abstract="true" name="ExpirationPeriodDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" abstract="false" name="ProceedsFromIssuanceOfWarrantsOperatingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" abstract="false" name="SoftwareDevelopmentExpendituresIncurredButNotYetPaid" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_ContractualObligationTerm" abstract="false" name="ContractualObligationTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" abstract="false" name="CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rskd_ProvisionForChargebacksMember" abstract="true" name="ProvisionForChargebacksMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="rskd_CloudComputingArrangementImplementationCostsMember" abstract="true" name="CloudComputingArrangementImplementationCostsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_WarrantsAndRightsSettled" abstract="false" name="WarrantsAndRightsSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" abstract="false" name="IncreaseDecreaseToDeferredContractFulfillmentCosts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" abstract="false" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" abstract="false" name="EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_CustomerBMember" abstract="true" name="CustomerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="rskd_GuarantorObligationsPercentageOfGuaranteesPaid" abstract="false" name="GuarantorObligationsPercentageOfGuaranteesPaid" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="rskd_ChargebackExpense" abstract="false" name="ChargebackExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" abstract="false" name="AccruedLiabilitiesAndOtherLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="rskd_TemporaryEquityDisclosureTextBlock" abstract="false" name="TemporaryEquityDisclosureTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="rskd_NonIsraelMember" abstract="true" name="NonIsraelMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>11
<FILENAME>rskd-20231231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:74ab1c91-acf2-4dbd-a834-633eda582453,g:91ce9b07-e870-4283-be19-76a0a0cc8871-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_617e1fd7-c5c1-4b80-a22d-523de8e4aec5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_617e1fd7-c5c1-4b80-a22d-523de8e4aec5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_033cadbc-1631-469e-ac39-8a244faf0f4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_033cadbc-1631-469e-ac39-8a244faf0f4e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_197a42c4-a4b7-4442-a982-73010c0d3496" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_197a42c4-a4b7-4442-a982-73010c0d3496" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_eeb8baed-518f-49ba-9db9-ec358d08fe3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_eeb8baed-518f-49ba-9db9-ec358d08fe3c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_2ca9c9fa-f701-4518-9542-9cdc9c65a1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_50007c7c-be5b-4d5e-9f37-8d4128a3f712" xlink:to="loc_us-gaap_AssetsCurrent_2ca9c9fa-f701-4518-9542-9cdc9c65a1b3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_817f2d4f-8480-4c4e-9a28-15acad9262e6" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_817f2d4f-8480-4c4e-9a28-15acad9262e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ca5d86eb-3dbd-4d15-832c-3864af612387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_ca5d86eb-3dbd-4d15-832c-3864af612387" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_73c84e57-92db-46ba-a2df-7eca8db44a52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_us-gaap_AccountsPayableCurrent_73c84e57-92db-46ba-a2df-7eca8db44a52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a46acb72-c2a6-4261-998e-2bbfbb08ec3b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a46acb72-c2a6-4261-998e-2bbfbb08ec3b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_970b2fe0-6731-4aa5-899f-9bf47dceecbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_970b2fe0-6731-4aa5-899f-9bf47dceecbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksCurrent_143eae1f-838e-4e74-bcb8-adac423c5f52" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7db6f2c3-3b08-4b88-95d3-9c215afb6a23" xlink:to="loc_rskd_ProvisionForChargebacksCurrent_143eae1f-838e-4e74-bcb8-adac423c5f52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d025219-1c65-4bce-ba34-c408bcf1756a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_547f0d2a-1611-4404-87a5-cf58e66cf48b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d025219-1c65-4bce-ba34-c408bcf1756a" xlink:to="loc_us-gaap_CommitmentsAndContingencies_547f0d2a-1611-4404-87a5-cf58e66cf48b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_56a5af77-bde9-487d-9ea0-70267fffa5a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d025219-1c65-4bce-ba34-c408bcf1756a" xlink:to="loc_us-gaap_Liabilities_56a5af77-bde9-487d-9ea0-70267fffa5a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_dfd61901-77b2-4e22-9601-ef4745e10bc5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_9d025219-1c65-4bce-ba34-c408bcf1756a" xlink:to="loc_us-gaap_StockholdersEquity_dfd61901-77b2-4e22-9601-ef4745e10bc5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_959fdde0-9a76-4972-87e7-3ec9a6a61a80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_959fdde0-9a76-4972-87e7-3ec9a6a61a80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_2b16c755-abe5-4738-b459-e47849b9a588" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:to="loc_us-gaap_CommonStockValue_2b16c755-abe5-4738-b459-e47849b9a588" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3c2c6259-5fad-400e-a121-eee37f414e7c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_3c2c6259-5fad-400e-a121-eee37f414e7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9428fe31-0872-4802-9a2d-fa51417a7054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_9428fe31-0872-4802-9a2d-fa51417a7054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ccfc33da-b1f6-4ec7-bcdf-2fea5dae089e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_8caba22d-6094-426b-8b79-73f8fa3c77d0" xlink:to="loc_us-gaap_TreasuryStockValue_ccfc33da-b1f6-4ec7-bcdf-2fea5dae089e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_ecf64223-9e76-48d0-adfa-c0bd1ca0fdb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1b983f3c-845d-42d7-a899-ffac87403874" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecf64223-9e76-48d0-adfa-c0bd1ca0fdb9" xlink:to="loc_us-gaap_LiabilitiesCurrent_1b983f3c-845d-42d7-a899-ffac87403874" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_c9cd5450-3ae4-4483-b63a-1a395036c1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecf64223-9e76-48d0-adfa-c0bd1ca0fdb9" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_c9cd5450-3ae4-4483-b63a-1a395036c1b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fab03d7b-98fd-416b-893d-c429437a6ab1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_ecf64223-9e76-48d0-adfa-c0bd1ca0fdb9" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_fab03d7b-98fd-416b-893d-c429437a6ab1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_d658324e-174c-4eb8-9cd2-73edb1ee8391" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_DepositsAssetsCurrent_d658324e-174c-4eb8-9cd2-73edb1ee8391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_9f0ff777-4733-4579-af11-44ec8eed6908" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_ShortTermInvestments_9f0ff777-4733-4579-af11-44ec8eed6908" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9ea521f5-1d28-4d01-a9e8-16c0b80810c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_9ea521f5-1d28-4d01-a9e8-16c0b80810c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_62eaed2f-0443-4362-bd76-f42ce63dd6de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_62eaed2f-0443-4362-bd76-f42ce63dd6de" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_e3d9ebbe-0c1f-4d6b-9ac9-3d02c6769ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_RestrictedCashCurrent_e3d9ebbe-0c1f-4d6b-9ac9-3d02c6769ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_da26ce53-bb61-487e-8421-4928b4f4dfff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ee99f30d-961e-4fb8-a9ed-864b9d73ef36" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_da26ce53-bb61-487e-8421-4928b4f4dfff" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14a14a7e-615e-47fc-9f5e-07f1f83657e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a22c3471-345e-4a35-adf2-9374318a462e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14a14a7e-615e-47fc-9f5e-07f1f83657e6" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a22c3471-345e-4a35-adf2-9374318a462e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_acc4290a-dc65-4c5d-ba92-a46bccf1704c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14a14a7e-615e-47fc-9f5e-07f1f83657e6" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_acc4290a-dc65-4c5d-ba92-a46bccf1704c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_d500fe7f-9c50-41ea-a365-db9709d09788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_14a14a7e-615e-47fc-9f5e-07f1f83657e6" xlink:to="loc_us-gaap_OperatingIncomeLoss_d500fe7f-9c50-41ea-a365-db9709d09788" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_8bbfd441-ba93-434d-bf09-3e390cc1fd36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d6477c8a-d312-4fd8-8711-0b7798157875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8bbfd441-ba93-434d-bf09-3e390cc1fd36" xlink:to="loc_us-gaap_OperatingExpenses_d6477c8a-d312-4fd8-8711-0b7798157875" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_3441db89-1d6f-4ab8-ae84-610bd98f5de0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_8bbfd441-ba93-434d-bf09-3e390cc1fd36" xlink:to="loc_us-gaap_GrossProfit_3441db89-1d6f-4ab8-ae84-610bd98f5de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_faaf5037-0904-4473-8be0-3207bf153220" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4108f17e-3f84-4b37-86f6-dc48f2f49042" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_faaf5037-0904-4473-8be0-3207bf153220" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4108f17e-3f84-4b37-86f6-dc48f2f49042" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_6006504f-6264-419c-92f0-ecbce1304270" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_faaf5037-0904-4473-8be0-3207bf153220" xlink:to="loc_us-gaap_SellingAndMarketingExpense_6006504f-6264-419c-92f0-ecbce1304270" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_9dc34cc6-ddf1-4c3c-be67-b64c3bc2974f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_faaf5037-0904-4473-8be0-3207bf153220" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_9dc34cc6-ddf1-4c3c-be67-b64c3bc2974f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c0dcdbe7-6db7-4af8-a590-dd59032b0f79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4e51069b-e3d2-47c1-8ee7-36e8cfa1b8e0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c0dcdbe7-6db7-4af8-a590-dd59032b0f79" xlink:to="loc_us-gaap_Revenues_4e51069b-e3d2-47c1-8ee7-36e8cfa1b8e0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_8ca42dfb-0ae9-4039-8709-e9ad7aa4b384" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_c0dcdbe7-6db7-4af8-a590-dd59032b0f79" xlink:to="loc_us-gaap_CostOfRevenue_8ca42dfb-0ae9-4039-8709-e9ad7aa4b384" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_d1c474d7-dea9-401c-a17e-458529864e1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4e598f9-048a-4a1d-b929-a6633052c912" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d1c474d7-dea9-401c-a17e-458529864e1f" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a4e598f9-048a-4a1d-b929-a6633052c912" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ca2b336d-c78b-4abc-8334-832661775be6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_d1c474d7-dea9-401c-a17e-458529864e1f" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ca2b336d-c78b-4abc-8334-832661775be6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"/>
  <link:calculationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b6ba493c-34fc-4a6c-aa29-3d1670ab0238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8b09fa2d-40ac-411e-8b05-bbd5ad75cad1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b6ba493c-34fc-4a6c-aa29-3d1670ab0238" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_8b09fa2d-40ac-411e-8b05-bbd5ad75cad1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_00d0518e-7841-477f-bbf9-510b2d3efd6c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b6ba493c-34fc-4a6c-aa29-3d1670ab0238" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_00d0518e-7841-477f-bbf9-510b2d3efd6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_7c32808a-f683-4c77-a8dc-14463ed632b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b6ba493c-34fc-4a6c-aa29-3d1670ab0238" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_7c32808a-f683-4c77-a8dc-14463ed632b8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_800af542-a281-4d12-abcf-9be8e34c151b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_665b33fb-1ce9-4e1b-b7c9-722bcc92e4a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_800af542-a281-4d12-abcf-9be8e34c151b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_665b33fb-1ce9-4e1b-b7c9-722bcc92e4a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3961bc0e-2859-4b53-a5b7-90682453df64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_800af542-a281-4d12-abcf-9be8e34c151b" xlink:to="loc_us-gaap_NetIncomeLoss_3961bc0e-2859-4b53-a5b7-90682453df64" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf1ac0b3-46da-411e-8e53-8a033e8b8077" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_14f3e605-2f3c-49a3-9c12-d6480d43ec89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf1ac0b3-46da-411e-8e53-8a033e8b8077" xlink:to="loc_us-gaap_RestrictedCash_14f3e605-2f3c-49a3-9c12-d6480d43ec89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b25ceca7-2742-46b3-be27-8fe83f83dddc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bf1ac0b3-46da-411e-8e53-8a033e8b8077" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_b25ceca7-2742-46b3-be27-8fe83f83dddc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1f4ff65e-c24c-456f-9788-6c08a5036382" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_1f4ff65e-c24c-456f-9788-6c08a5036382" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_bddd23ba-4b84-4d2f-a336-1600d6d87bc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_bddd23ba-4b84-4d2f-a336-1600d6d87bc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_0af6150b-2e30-475e-a746-9164eb2d1a89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_0af6150b-2e30-475e-a746-9164eb2d1a89" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbeca359-2327-42a2-88ad-32c6548e8088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_cbeca359-2327-42a2-88ad-32c6548e8088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f18aa3c7-d743-41ce-b9a0-81bbb1607146" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_NetIncomeLoss_f18aa3c7-d743-41ce-b9a0-81bbb1607146" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c02386e9-1234-4d52-8332-90ca4e90db7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_c02386e9-1234-4d52-8332-90ca4e90db7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4dd018e-25ca-4be1-aff9-f24acad67293" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e4dd018e-25ca-4be1-aff9-f24acad67293" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ebaedb44-4d45-4d83-afe1-deb35205aafc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_ebaedb44-4d45-4d83-afe1-deb35205aafc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_0ccbdc37-3021-4136-8809-a1470dbf9068" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_ShareBasedCompensation_0ccbdc37-3021-4136-8809-a1470dbf9068" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInGuarantorObligations_77fcf89a-e47f-4db6-bab8-59c4de396d78" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInGuarantorObligations"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_rskd_IncreaseDecreaseInGuarantorObligations_77fcf89a-e47f-4db6-bab8-59c4de396d78" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_f00dd703-2070-4570-8b1d-c8673a23af8a" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_f00dd703-2070-4570-8b1d-c8673a23af8a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_93100d9a-9221-41d7-a188-9f341d1ae1bf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_93100d9a-9221-41d7-a188-9f341d1ae1bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_2dc78322-defc-42c9-be3c-19e7dc2c8176" xlink:href="rskd-20231231.xsd#rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_2dc78322-defc-42c9-be3c-19e7dc2c8176" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_44ee0ff5-005a-4190-ad55-893e92ebe4e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_44ee0ff5-005a-4190-ad55-893e92ebe4e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8c2c025d-ebb2-44a4-abe6-62cf04301654" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8c2c025d-ebb2-44a4-abe6-62cf04301654" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_0bfece66-fdb5-49a2-9a2e-0b77bedbd2c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_0bfece66-fdb5-49a2-9a2e-0b77bedbd2c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_e808d658-c082-4aa5-b688-22b10b59249b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_e808d658-c082-4aa5-b688-22b10b59249b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_90aa185d-5023-4a9c-b3af-ea7c6c6248ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_90aa185d-5023-4a9c-b3af-ea7c6c6248ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_c1bb6f4f-7904-4c4d-8e9e-00214aae4c79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_c1bb6f4f-7904-4c4d-8e9e-00214aae4c79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_0c7c42de-1f39-4634-b2c5-668ab8b31011" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInProvisionForChargebacks"/>
    <link:calculationArc order="20" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_0c7c42de-1f39-4634-b2c5-668ab8b31011" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_9ee1ada8-83c4-4b76-9db2-45c64c4a359b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:calculationArc order="21" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_9ee1ada8-83c4-4b76-9db2-45c64c4a359b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FairValueAdjustmentOfRights_7a533b6d-9fb2-42cd-bc7e-9f55cdc44858" xlink:href="rskd-20231231.xsd#rskd_FairValueAdjustmentOfRights"/>
    <link:calculationArc order="22" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_a9940b3e-562f-432f-80d9-3cdf11423a0c" xlink:to="loc_rskd_FairValueAdjustmentOfRights_7a533b6d-9fb2-42cd-bc7e-9f55cdc44858" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_8a89af50-93da-4b62-8ddc-2513b3aa7571" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_8a89af50-93da-4b62-8ddc-2513b3aa7571" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c821e256-bd38-4358-81a8-ac6ca1909e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_c821e256-bd38-4358-81a8-ac6ca1909e2f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_e714b992-f11d-4cc5-a8d2-b0492a23fcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_e714b992-f11d-4cc5-a8d2-b0492a23fcaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_03e27ae8-c9a1-4dbd-b64c-0fd5fc8aad3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_03e27ae8-c9a1-4dbd-b64c-0fd5fc8aad3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0fcaf997-00ef-412e-ae06-2f70b9c4bc17" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_0fcaf997-00ef-412e-ae06-2f70b9c4bc17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_94267292-6017-4fd9-847a-9555eab74a53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_69bb53a7-1d50-4e5b-8c73-8f7db6c16d66" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_94267292-6017-4fd9-847a-9555eab74a53" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1281c332-2c9e-44e5-b24e-5459241a871d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40925cd6-dc95-4193-9df6-fd332cdc0349" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1281c332-2c9e-44e5-b24e-5459241a871d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_40925cd6-dc95-4193-9df6-fd332cdc0349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30d8b66d-3ed3-4a90-bfe0-a6c4fecb4131" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1281c332-2c9e-44e5-b24e-5459241a871d" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_30d8b66d-3ed3-4a90-bfe0-a6c4fecb4131" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_556866a3-5041-4504-b824-887a8f9eb04e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1281c332-2c9e-44e5-b24e-5459241a871d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_556866a3-5041-4504-b824-887a8f9eb04e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35b555db-9efe-4897-9537-341d2bf29c4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1281c332-2c9e-44e5-b24e-5459241a871d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_35b555db-9efe-4897-9537-341d2bf29c4a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_956dea52-35de-4a31-9f16-a989b7608c52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_956dea52-35de-4a31-9f16-a989b7608c52" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_b859fe18-e48e-4636-bd3f-af83a587ae99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_b859fe18-e48e-4636-bd3f-af83a587ae99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_a3e44b01-bcdd-456b-a7dc-b0d062e8e239" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_a3e44b01-bcdd-456b-a7dc-b0d062e8e239" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c212379-07ac-4df3-8915-99c4c7acc217" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_4c212379-07ac-4df3-8915-99c4c7acc217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_dff60878-86f6-4bb6-9e5b-c906562d3839" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_6337a311-9170-41fb-992f-4102c4333797" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_dff60878-86f6-4bb6-9e5b-c906562d3839" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_9288815f-aaf7-4af8-b12e-a38a25faa82e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_b133814b-00f9-4384-b991-b1396e76c993" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9288815f-aaf7-4af8-b12e-a38a25faa82e" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_b133814b-00f9-4384-b991-b1396e76c993" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ccf12cb5-98f7-4478-8d8f-0b771e840367" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_9288815f-aaf7-4af8-b12e-a38a25faa82e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_ccf12cb5-98f7-4478-8d8f-0b771e840367" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_45d5f98d-ddd3-4ab6-9da5-12fe76d53a10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_f6595358-adb8-40b7-a144-c7991e225ab6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_45d5f98d-ddd3-4ab6-9da5-12fe76d53a10" xlink:to="loc_us-gaap_DerivativeLiabilities_f6595358-adb8-40b7-a144-c7991e225ab6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_16e08fbf-8e2e-42ca-9791-a5198b904e0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_322a4780-798a-43d8-aedf-6450b3b3b0e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_16e08fbf-8e2e-42ca-9791-a5198b904e0c" xlink:to="loc_us-gaap_DerivativeAssets_322a4780-798a-43d8-aedf-6450b3b3b0e6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_68eacb52-1b47-4ebd-9f9c-a58eba2a2ba1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_16e08fbf-8e2e-42ca-9791-a5198b904e0c" xlink:to="loc_us-gaap_ShortTermInvestments_68eacb52-1b47-4ebd-9f9c-a58eba2a2ba1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofShorttermInvestmentsDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b0c6607c-72af-402a-bc45-b82d0518a5b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5a9fdfc3-7ed1-499c-bf29-b8176b7e1672" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b0c6607c-72af-402a-bc45-b82d0518a5b1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_5a9fdfc3-7ed1-499c-bf29-b8176b7e1672" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fe84bcae-a8d6-496b-a9aa-545a0a4171ee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b0c6607c-72af-402a-bc45-b82d0518a5b1" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_fe84bcae-a8d6-496b-a9aa-545a0a4171ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69c1c149-f2eb-487e-80c9-63d9325ca8e6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_b0c6607c-72af-402a-bc45-b82d0518a5b1" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_69c1c149-f2eb-487e-80c9-63d9325ca8e6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsEffectiveContractualMaturityDatesDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bd29534f-8fda-4b16-9644-dafc3b663497" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_bda1831b-94f4-4183-a1f2-a6198a8b12b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_bd29534f-8fda-4b16-9644-dafc3b663497" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_bda1831b-94f4-4183-a1f2-a6198a8b12b9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_dab2bbf3-344e-490d-b526-071dbba3ed26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7fc57ecd-023c-43bc-8166-a5bab4f2ac56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dab2bbf3-344e-490d-b526-071dbba3ed26" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_7fc57ecd-023c-43bc-8166-a5bab4f2ac56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_89a6fa46-2ac1-4226-9b07-f4959de377a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_dab2bbf3-344e-490d-b526-071dbba3ed26" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_89a6fa46-2ac1-4226-9b07-f4959de377a1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b307616a-44af-4842-b28b-ac0d723c4944" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_42167bd6-78c9-42a2-a50c-75603e6eeed7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b307616a-44af-4842-b28b-ac0d723c4944" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_42167bd6-78c9-42a2-a50c-75603e6eeed7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_65870cc6-595b-44e5-b0a3-d66de25eea51" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b307616a-44af-4842-b28b-ac0d723c4944" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_65870cc6-595b-44e5-b0a3-d66de25eea51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_2ca87b99-a93d-466f-8584-ff3f3bae7d11" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b307616a-44af-4842-b28b-ac0d723c4944" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_2ca87b99-a93d-466f-8584-ff3f3bae7d11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_f5f53de5-1d44-4c63-9ad0-c7db4f008555" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_b307616a-44af-4842-b28b-ac0d723c4944" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_f5f53de5-1d44-4c63-9ad0-c7db4f008555" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_06f42dff-0907-4ee9-89e4-e8bba8ca1061" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_a12b52db-cb50-4a78-ae2e-b397b6bf8f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_06f42dff-0907-4ee9-89e4-e8bba8ca1061" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_a12b52db-cb50-4a78-ae2e-b397b6bf8f4a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_d92fd0a4-acff-426a-aaf7-493694054f76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_dbebe371-399e-4941-84d0-f757629c415b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d92fd0a4-acff-426a-aaf7-493694054f76" xlink:to="loc_us-gaap_SubleaseIncome_dbebe371-399e-4941-84d0-f757629c415b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_e95ea41f-7f7c-4630-baac-82976765b200" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d92fd0a4-acff-426a-aaf7-493694054f76" xlink:to="loc_us-gaap_VariableLeaseCost_e95ea41f-7f7c-4630-baac-82976765b200" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e03b7096-4a69-46b5-a800-c307eea0355b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d92fd0a4-acff-426a-aaf7-493694054f76" xlink:to="loc_us-gaap_ShortTermLeaseCost_e03b7096-4a69-46b5-a800-c307eea0355b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_f1dfdb48-40c4-41a3-af74-de6f2e415566" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_d92fd0a4-acff-426a-aaf7-493694054f76" xlink:to="loc_us-gaap_OperatingLeaseCost_f1dfdb48-40c4-41a3-af74-de6f2e415566" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesMaturityLeaseScheduleDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ad602f15-3974-45f7-bedc-5a5a8dc8abdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_ad602f15-3974-45f7-bedc-5a5a8dc8abdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d6b8860-16f7-4633-9ee2-69e50e758c70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_9d6b8860-16f7-4633-9ee2-69e50e758c70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_13d1c1b3-3408-40d1-9d53-24be0fbc8f9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_13d1c1b3-3408-40d1-9d53-24be0fbc8f9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2cf040e1-076b-4e83-86cb-a0de8bdc006a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_2cf040e1-076b-4e83-86cb-a0de8bdc006a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_94a34bea-8a63-4ba6-bc34-583471715414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_94a34bea-8a63-4ba6-bc34-583471715414" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e07d4422-4667-4742-8444-0782db8d368f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_733eb1d9-1828-426b-8eb5-d8971aa16d04" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_e07d4422-4667-4742-8444-0782db8d368f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesMaturityLeaseScheduleDetails_1"/>
  <link:calculationLink xlink:role="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa386eae-a8df-48cd-8922-dc7d6ddbeeed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90d0652a-ec61-4af7-980c-a26a67de03c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa386eae-a8df-48cd-8922-dc7d6ddbeeed" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_90d0652a-ec61-4af7-980c-a26a67de03c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_71c07c34-5d22-4734-ab5f-d57af20c7151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_aa386eae-a8df-48cd-8922-dc7d6ddbeeed" xlink:to="loc_us-gaap_OperatingLeaseLiability_71c07c34-5d22-4734-ab5f-d57af20c7151" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_0a0987a3-0860-4bf9-8d2d-505ce3cf50c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_5a141c7b-0ae1-4758-b76c-dafa9e8c974f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_0a0987a3-0860-4bf9-8d2d-505ce3cf50c0" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_5a141c7b-0ae1-4758-b76c-dafa9e8c974f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_3e1aff36-da7b-49db-8424-1233f7983619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_0a0987a3-0860-4bf9-8d2d-505ce3cf50c0" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_3e1aff36-da7b-49db-8424-1233f7983619" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_abb7c8d8-6252-46d7-bc33-862da79ee71a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PurchaseObligation_0a0987a3-0860-4bf9-8d2d-505ce3cf50c0" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_abb7c8d8-6252-46d7-bc33-862da79ee71a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_58dc4239-2ea0-4ebd-a80b-408a341a1d2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_038025b1-2e9c-4512-8c99-c3210f2f668e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_58dc4239-2ea0-4ebd-a80b-408a341a1d2d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_038025b1-2e9c-4512-8c99-c3210f2f668e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d98211c4-a718-46ff-a2cf-679b3eb8d797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_58dc4239-2ea0-4ebd-a80b-408a341a1d2d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_d98211c4-a718-46ff-a2cf-679b3eb8d797" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_9babd03b-395c-40b4-9a2a-48d4c28ef42c" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_9babd03b-395c-40b4-9a2a-48d4c28ef42c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d0520b74-5e43-4f53-9e87-e8eb1897a371" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_d0520b74-5e43-4f53-9e87-e8eb1897a371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_19f50aef-519f-4201-bd19-dd6cc0c6f009" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_19f50aef-519f-4201-bd19-dd6cc0c6f009" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_e8ef74d9-383a-4a87-a10a-259d46edfd86" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_e8ef74d9-383a-4a87-a10a-259d46edfd86" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_f8290057-ce1c-41ac-b072-caef9d070948" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_f8290057-ce1c-41ac-b072-caef9d070948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ebb695e0-63a9-45cb-a81c-36375eeab4dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_ebb695e0-63a9-45cb-a81c-36375eeab4dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0edd4e3d-a788-48c0-a6d6-b07f8913cdbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_0edd4e3d-a788-48c0-a6d6-b07f8913cdbd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_79ac9b09-0f4b-4b0b-9785-3fbdb571aa66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_79ac9b09-0f4b-4b0b-9785-3fbdb571aa66" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_23aa46d8-e2f9-470a-a5a7-e08cf16309b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_79a04f31-7ab8-4db6-b81e-8efb8ac06c78" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_23aa46d8-e2f9-470a-a5a7-e08cf16309b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_981c3fd5-028f-43e9-ad06-a6ffa3542bcd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d517fb07-b420-465e-9223-5682d7d9366b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_981c3fd5-028f-43e9-ad06-a6ffa3542bcd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d517fb07-b420-465e-9223-5682d7d9366b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_072be697-b31b-4d0e-8e32-c50cfb65fc36" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_981c3fd5-028f-43e9-ad06-a6ffa3542bcd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_072be697-b31b-4d0e-8e32-c50cfb65fc36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_14b28205-de56-401c-8dbd-5d76f3865502" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_e8647c91-4d07-4623-b0ef-4b110f96269a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b28205-de56-401c-8dbd-5d76f3865502" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_e8647c91-4d07-4623-b0ef-4b110f96269a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4b71b28b-da3f-441a-9700-d2141bf89cdf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b28205-de56-401c-8dbd-5d76f3865502" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_4b71b28b-da3f-441a-9700-d2141bf89cdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_207b4dbd-a943-47f8-bbb7-787a34a022ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b28205-de56-401c-8dbd-5d76f3865502" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_207b4dbd-a943-47f8-bbb7-787a34a022ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_aeb80bed-7ec0-4d11-895c-25dc22dbd30a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_14b28205-de56-401c-8dbd-5d76f3865502" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_aeb80bed-7ec0-4d11-895c-25dc22dbd30a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_919512bb-c0f1-457e-9920-1ee03fc200d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_919512bb-c0f1-457e-9920-1ee03fc200d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_be3877db-60ea-488c-8b80-6e4f60d7834f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_be3877db-60ea-488c-8b80-6e4f60d7834f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_13acbf20-04e7-463f-b64d-0ce9482408f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_13acbf20-04e7-463f-b64d-0ce9482408f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c8791b9f-4771-4b51-800d-0e04937120c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_c8791b9f-4771-4b51-800d-0e04937120c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_d2f6c35e-8cd4-47bb-ab4c-be01a8550f5a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_d2f6c35e-8cd4-47bb-ab4c-be01a8550f5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredTaxAssetsLeasingArrangements_6f84a7f2-c680-4785-9ad3-6215a9251ef3" xlink:href="rskd-20231231.xsd#rskd_DeferredTaxAssetsLeasingArrangements"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_rskd_DeferredTaxAssetsLeasingArrangements_6f84a7f2-c680-4785-9ad3-6215a9251ef3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_bb635037-91e8-4ec9-aa70-fe6418fed268" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_e712b04c-600f-4fd3-9c96-69772441853d" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_bb635037-91e8-4ec9-aa70-fe6418fed268" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_634a510b-0ff4-4d74-96ed-d137ce19e6f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_1438e899-e293-42cf-b872-653c68c848c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_634a510b-0ff4-4d74-96ed-d137ce19e6f0" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_1438e899-e293-42cf-b872-653c68c848c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_9f15007c-1b23-48d5-9ab4-d370f61c702c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_634a510b-0ff4-4d74-96ed-d137ce19e6f0" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_9f15007c-1b23-48d5-9ab4-d370f61c702c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_e6ef1060-b03e-4d55-a7b2-9c381ed2f934" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_71bd0063-522f-4c0b-97b2-ba2b3107b91a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e6ef1060-b03e-4d55-a7b2-9c381ed2f934" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_71bd0063-522f-4c0b-97b2-ba2b3107b91a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_b004d8ab-4729-4265-b291-9e5efb53da16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxLiabilities_e6ef1060-b03e-4d55-a7b2-9c381ed2f934" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_b004d8ab-4729-4265-b291-9e5efb53da16" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>12
<FILENAME>rskd-20231231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:74ab1c91-acf2-4dbd-a834-633eda582453,g:91ce9b07-e870-4283-be19-76a0a0cc8871-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://riskified.com/role/Cover" xlink:type="simple" xlink:href="rskd-20231231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://riskified.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_7c4f7a8b-e909-4f42-89a2-a3645fa936c7_default" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:to="loc_dei_AddressTypeDomain_7c4f7a8b-e909-4f42-89a2-a3645fa936c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:to="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_6dc645a1-4efc-40a0-a4f4-e2be37e009a2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:to="loc_dei_BusinessContactMember_6dc645a1-4efc-40a0-a4f4-e2be37e009a2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_18ff2194-671c-4943-9736-d8d82098fb76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:to="loc_us-gaap_ClassOfStockDomain_18ff2194-671c-4943-9736-d8d82098fb76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:to="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_153de803-3afd-44f0-b9c0-a578d7c4041f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:to="loc_us-gaap_CommonClassAMember_153de803-3afd-44f0-b9c0-a578d7c4041f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b4e10e42-a1ae-4a10-a69d-bde3dea462d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:to="loc_us-gaap_CommonClassBMember_b4e10e42-a1ae-4a10-a69d-bde3dea462d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_989d5aeb-4786-4ae8-83a5-261af1d69e0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentType_989d5aeb-4786-4ae8-83a5-261af1d69e0d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_78ffc616-d5b8-4c5c-95b9-2fd807043d68" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentRegistrationStatement_78ffc616-d5b8-4c5c-95b9-2fd807043d68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e83303bc-b1ca-440f-8070-fd96fc92d0ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentAnnualReport_e83303bc-b1ca-440f-8070-fd96fc92d0ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9926e2e3-6615-4d41-b167-591c0416c1e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentPeriodEndDate_9926e2e3-6615-4d41-b167-591c0416c1e4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d644022a-4ef3-405e-b244-22eea53f9642" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_CurrentFiscalYearEndDate_d644022a-4ef3-405e-b244-22eea53f9642" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_83a1194e-2dc4-40f6-8232-b72e7dbeec4a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentTransitionReport_83a1194e-2dc4-40f6-8232-b72e7dbeec4a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_46226d7b-a13e-4517-8d1f-c5479343477a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentShellCompanyReport_46226d7b-a13e-4517-8d1f-c5479343477a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b93b9120-0d4c-401f-9089-2cad10dd7d83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityFileNumber_b93b9120-0d4c-401f-9089-2cad10dd7d83" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_95df3d11-70bb-4cb4-850f-eddb50965544" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityRegistrantName_95df3d11-70bb-4cb4-850f-eddb50965544" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6e7dc3a2-ed3d-49de-ace6-ae23d368e5e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6e7dc3a2-ed3d-49de-ace6-ae23d368e5e4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_424a8761-c033-4bae-9765-56c9eec7bf78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_ContactPersonnelName_424a8761-c033-4bae-9765-56c9eec7bf78" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eba8a411-ff14-4f6e-9949-7d5c98330d96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressAddressLine1_eba8a411-ff14-4f6e-9949-7d5c98330d96" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_485f5aff-58b7-4a59-b10e-32fad865b188" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressAddressLine2_485f5aff-58b7-4a59-b10e-32fad865b188" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ebcd26f7-b6c5-47ea-886d-22424262297c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressCityOrTown_ebcd26f7-b6c5-47ea-886d-22424262297c" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_73452e42-bed4-4b0e-80d7-a84bb8a9433f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressStateOrProvince_73452e42-bed4-4b0e-80d7-a84bb8a9433f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_db94dcaf-7150-4b2b-93d2-292251500030" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressPostalZipCode_db94dcaf-7150-4b2b-93d2-292251500030" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_f4599367-9046-43aa-b894-157a7c01b166" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressCountry_f4599367-9046-43aa-b894-157a7c01b166" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_f096bb39-f2f4-48c4-81a3-03c3002c5879" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_ContactPersonnelEmailAddress_f096bb39-f2f4-48c4-81a3-03c3002c5879" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0a4c3ee2-7fe2-4de9-beec-46e5a651461b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_Security12bTitle_0a4c3ee2-7fe2-4de9-beec-46e5a651461b" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_54d1409e-7277-48d5-a741-ec1ea5692193" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_TradingSymbol_54d1409e-7277-48d5-a741-ec1ea5692193" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4d67dcde-07e7-40a7-b12d-0b1e7a6b3452" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_SecurityExchangeName_4d67dcde-07e7-40a7-b12d-0b1e7a6b3452" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_20ea3d56-f4a9-42bd-bf3d-375eaff55599" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_20ea3d56-f4a9-42bd-bf3d-375eaff55599" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_7692d918-b38a-4730-9f97-f842bcea8bd0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_7692d918-b38a-4730-9f97-f842bcea8bd0" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_29a89c9a-ced4-43dd-9eca-9787e0775deb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityVoluntaryFilers_29a89c9a-ced4-43dd-9eca-9787e0775deb" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_911d77d3-9925-48f5-8b46-ed31cb5e49e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCurrentReportingStatus_911d77d3-9925-48f5-8b46-ed31cb5e49e3" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b5455171-247b-4ec6-86fc-733bdefbdb2f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityInteractiveDataCurrent_b5455171-247b-4ec6-86fc-733bdefbdb2f" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_28179d1f-f821-45b5-9eb5-3c169836ca8b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityFilerCategory_28179d1f-f821-45b5-9eb5-3c169836ca8b" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_76d4fd3e-58da-45ff-9ef8-067f41fa3d3e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityEmergingGrowthCompany_76d4fd3e-58da-45ff-9ef8-067f41fa3d3e" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_d63822e2-a209-4a9d-bd2a-eb37f283b424" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityExTransitionPeriod_d63822e2-a209-4a9d-bd2a-eb37f283b424" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_80da4660-1536-480a-aa44-efdcc1885e7a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_80da4660-1536-480a-aa44-efdcc1885e7a" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8fa68c94-3007-4fa3-b112-b91a60fa4142" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8fa68c94-3007-4fa3-b112-b91a60fa4142" xlink:type="arc" order="30"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_a25a7914-b9f6-4b14-9ec9-a96a538d27f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_a25a7914-b9f6-4b14-9ec9-a96a538d27f9" xlink:type="arc" order="31"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_946463e2-c1ad-48ed-8696-148f4dd954ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentAccountingStandard_946463e2-c1ad-48ed-8696-148f4dd954ea" xlink:type="arc" order="32"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3e618b54-cf84-4c5c-9a47-9a8df17770af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityShellCompany_3e618b54-cf84-4c5c-9a47-9a8df17770af" xlink:type="arc" order="33"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6a74600b-fe02-4318-aafc-f02d2c4ae640" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_AmendmentFlag_6a74600b-fe02-4318-aafc-f02d2c4ae640" xlink:type="arc" order="34"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_58838507-6f1f-4d39-95f4-bf8e4de2428f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCentralIndexKey_58838507-6f1f-4d39-95f4-bf8e4de2428f" xlink:type="arc" order="35"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0255c982-87cb-41b6-b81d-6a26656a383e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFiscalYearFocus_0255c982-87cb-41b6-b81d-6a26656a383e" xlink:type="arc" order="36"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_90333040-afef-4af7-82fe-b33c7c19b6b5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_90333040-afef-4af7-82fe-b33c7c19b6b5" xlink:type="arc" order="37"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:to="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_37e5010a-26ac-4e57-8e06-edc27a633a49_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:to="loc_us-gaap_ClassOfStockDomain_37e5010a-26ac-4e57-8e06-edc27a633a49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:to="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_60cc8b6d-cdbc-45fd-8110-8f17955afbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:to="loc_us-gaap_CommonClassAMember_60cc8b6d-cdbc-45fd-8110-8f17955afbb5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_85144032-e5f8-44dd-a804-ab0785874f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:to="loc_us-gaap_CommonClassBMember_85144032-e5f8-44dd-a804-ab0785874f09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:to="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_adb1bee0-3c56-42ce-9b0f-d9c88de7046d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_adb1bee0-3c56-42ce-9b0f-d9c88de7046d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2c52fcf8-dcb8-49dd-9096-37a2db1102d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_RestrictedCashCurrent_2c52fcf8-dcb8-49dd-9096-37a2db1102d6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_a60424f5-e6b6-4cbf-8d22-bbd71a1239f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_DepositsAssetsCurrent_a60424f5-e6b6-4cbf-8d22-bbd71a1239f2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0a8d33e6-2b54-46cc-b5d1-fae33dc7944a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0a8d33e6-2b54-46cc-b5d1-fae33dc7944a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d4babb6-43eb-4cb3-858f-7ba79f1e8858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d4babb6-43eb-4cb3-858f-7ba79f1e8858" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3058daf3-32ec-4969-91cb-883367f0dfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_ShortTermInvestments_3058daf3-32ec-4969-91cb-883367f0dfc4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_16874c71-788f-41f8-b199-22ce471005c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_AssetsCurrent_16874c71-788f-41f8-b199-22ce471005c8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4c446ea8-c0ff-4f94-ad62-f77c1698775d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4c446ea8-c0ff-4f94-ad62-f77c1698775d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1b7090c-0a98-42e9-ac3c-0815a0825f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1b7090c-0a98-42e9-ac3c-0815a0825f4a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_c473725a-a3bc-48bd-b89a-b74fb246f941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_c473725a-a3bc-48bd-b89a-b74fb246f941" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_90d5cd69-0e82-40e6-b8f0-9a5a107c1e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_90d5cd69-0e82-40e6-b8f0-9a5a107c1e0b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_46e88760-cd30-4c39-96f9-e247978ea205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_Assets_46e88760-cd30-4c39-96f9-e247978ea205" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_759909ac-cdbf-4d3a-9303-5e6e89602787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_AccountsPayableCurrent_759909ac-cdbf-4d3a-9303-5e6e89602787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c3a3099e-c4dc-4739-8e9e-aa21217e95b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c3a3099e-c4dc-4739-8e9e-aa21217e95b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_18a948d7-76de-422e-aecd-d25d55c3bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_18a948d7-76de-422e-aecd-d25d55c3bc8f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksCurrent_15713069-f3c2-4f8e-bc98-a4f50b84d8d9" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_rskd_ProvisionForChargebacksCurrent_15713069-f3c2-4f8e-bc98-a4f50b84d8d9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eb52966-5f2d-47f3-9d56-4342c9e3e1af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eb52966-5f2d-47f3-9d56-4342c9e3e1af" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_3bff0d29-aef0-448b-bd12-314f993d66fc" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_3bff0d29-aef0-448b-bd12-314f993d66fc" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_20a9b3e1-0034-497b-8228-a3df2caf1d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_LiabilitiesCurrent_20a9b3e1-0034-497b-8228-a3df2caf1d6e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b31a3af5-1ce9-4e0d-a0cb-90de03194683" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b31a3af5-1ce9-4e0d-a0cb-90de03194683" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_932c258a-784b-4c6d-b185-b1366bb1fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_932c258a-784b-4c6d-b185-b1366bb1fcf3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c18b78e6-1f55-402c-9693-d43da4a06197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_Liabilities_c18b78e6-1f55-402c-9693-d43da4a06197" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_93a8d383-8b12-4fde-8322-d2fe41c0a857" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_93a8d383-8b12-4fde-8322-d2fe41c0a857" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bdb5e13e-7a48-40df-b924-a52de8849c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_CommonStockValue_bdb5e13e-7a48-40df-b924-a52de8849c00" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9fe1c407-9c45-48bb-8473-8e7448d4c4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_TreasuryStockValue_9fe1c407-9c45-48bb-8473-8e7448d4c4a9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e0488ce2-b06d-41ce-9e99-9480c150866b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e0488ce2-b06d-41ce-9e99-9480c150866b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dae92e7d-f3f4-4588-96b5-701d58920ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dae92e7d-f3f4-4588-96b5-701d58920ee5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7f328501-2b74-496f-99e1-7a16732ef975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7f328501-2b74-496f-99e1-7a16732ef975" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b83a7131-3680-4258-b5cb-29d7866a7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_StockholdersEquity_b83a7131-3680-4258-b5cb-29d7866a7d45" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9a4f3d7d-b4bb-4c4e-b561-cb5fdc15b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9a4f3d7d-b4bb-4c4e-b561-cb5fdc15b75d" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_893e5725-7fc0-40f4-b8b7-76efca9ba476_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:to="loc_us-gaap_ClassOfStockDomain_893e5725-7fc0-40f4-b8b7-76efca9ba476_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:to="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7cde62e0-c7d7-4c92-ab00-12547fb70797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:to="loc_us-gaap_CommonClassAMember_7cde62e0-c7d7-4c92-ab00-12547fb70797" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_175b45f2-787e-42e3-837a-a7032d728922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:to="loc_us-gaap_CommonClassBMember_175b45f2-787e-42e3-837a-a7032d728922" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e203835c-26dc-4366-a357-c0018e58e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e203835c-26dc-4366-a357-c0018e58e47f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_46d89d32-f434-4e29-a347-316f66701db6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_46d89d32-f434-4e29-a347-316f66701db6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7b0287cf-46a4-4910-ba50-7d853baa0617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesIssued_7b0287cf-46a4-4910-ba50-7d853baa0617" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c3f1f363-7aea-4645-b0f1-c9f4dd9d3775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c3f1f363-7aea-4645-b0f1-c9f4dd9d3775" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a42716c6-ee35-4038-9575-d7e7a1ace13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a42716c6-ee35-4038-9575-d7e7a1ace13d" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:to="loc_us-gaap_ClassOfStockDomain_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:to="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_73902563-8bb1-4aac-9a68-6100da694c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:to="loc_us-gaap_CommonClassAMember_73902563-8bb1-4aac-9a68-6100da694c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_50faa303-6a15-44f2-901d-2349d1d40cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:to="loc_us-gaap_CommonClassBMember_50faa303-6a15-44f2-901d-2349d1d40cf4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1b32c0f9-ce09-4579-9b65-0683583cdbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_Revenues_1b32c0f9-ce09-4579-9b65-0683583cdbfc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9805a067-cdd5-45d1-87bf-8d48554a963c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_CostOfRevenue_9805a067-cdd5-45d1-87bf-8d48554a963c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c8c90606-08a1-43b1-a334-69a0fe400579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_GrossProfit_c8c90606-08a1-43b1-a334-69a0fe400579" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c5437b98-6f2e-4951-8da5-70248e26af65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c5437b98-6f2e-4951-8da5-70248e26af65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0bbe10a7-7183-4a7f-a416-c7cc5c4996fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0bbe10a7-7183-4a7f-a416-c7cc5c4996fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f090774b-479e-4742-8247-380379b7d193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f090774b-479e-4742-8247-380379b7d193" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d3deacc7-5367-4e52-8748-e348c2a461e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_OperatingExpenses_d3deacc7-5367-4e52-8748-e348c2a461e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_034145fe-997d-4ca5-8fd7-dc51557cd63e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OperatingIncomeLoss_034145fe-997d-4ca5-8fd7-dc51557cd63e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a695a860-9370-40f2-97a8-30b744a912df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a695a860-9370-40f2-97a8-30b744a912df" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad414a86-21d9-4d9d-b182-360d772a979b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad414a86-21d9-4d9d-b182-360d772a979b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce560b49-6c6d-4a46-bbc2-b755bd97ede8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce560b49-6c6d-4a46-bbc2-b755bd97ede8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c945c35a-30c4-4b55-bbaa-d9f510f2d764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c945c35a-30c4-4b55-bbaa-d9f510f2d764" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee0fb767-dd51-47bb-9eea-c6e4173e86a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_NetIncomeLoss_ee0fb767-dd51-47bb-9eea-c6e4173e86a2" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_288e7df3-44e9-49b3-9957-fe50b92c0979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_EarningsPerShareBasic_288e7df3-44e9-49b3-9957-fe50b92c0979" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1e637cdb-7fdb-451e-a0b9-2a3a4e38b6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1e637cdb-7fdb-451e-a0b9-2a3a4e38b6df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_53782c65-591b-48db-96fb-64933d65ac93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_53782c65-591b-48db-96fb-64933d65ac93" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e6082645-fa36-466a-a09c-3c827059818b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e6082645-fa36-466a-a09c-3c827059818b" xlink:type="arc" order="13"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:to="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_6f8edfae-cad7-4263-8e67-f84660eb5370_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:to="loc_us-gaap_EquityComponentDomain_6f8edfae-cad7-4263-8e67-f84660eb5370_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:to="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4def1f2-af52-4f5f-87c1-7d547bf998c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_CommonStockMember_b4def1f2-af52-4f5f-87c1-7d547bf998c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_d844056d-870a-49dd-ae8f-bbec7fb6532b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_d844056d-870a-49dd-ae8f-bbec7fb6532b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8f8c5a1c-a409-485c-a601-45b3f5cbda71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8f8c5a1c-a409-485c-a601-45b3f5cbda71" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ec96fb1b-32dd-4a86-97f4-ee24d45f5837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ec96fb1b-32dd-4a86-97f4-ee24d45f5837" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1e88a89a-6b13-4a07-be04-45c83a08d3de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_RetainedEarningsMember_1e88a89a-6b13-4a07-be04-45c83a08d3de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ca057cb0-2b37-43a7-9cd2-f5a9279788ba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_ca057cb0-2b37-43a7-9cd2-f5a9279788ba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_095eb9fa-6072-45e9-af14-db282cb341f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:to="loc_us-gaap_IPOMember_095eb9fa-6072-45e9-af14-db282cb341f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_fc32b6b9-461b-4f15-98ae-20ce4f294dc1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:to="loc_us-gaap_ClassOfStockDomain_fc32b6b9-461b-4f15-98ae-20ce4f294dc1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:to="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesE1ConvertiblePreferredStockMember_ad07ffc2-e6d7-4bed-a0da-472ee6a1dfbc" xlink:href="rskd-20231231.xsd#rskd_SeriesE1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_rskd_SeriesE1ConvertiblePreferredStockMember_ad07ffc2-e6d7-4bed-a0da-472ee6a1dfbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d7a8b68f-31a2-4e50-a918-6c5e99b4f534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_us-gaap_CommonClassAMember_d7a8b68f-31a2-4e50-a918-6c5e99b4f534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_25d659ab-88bc-40c3-90e5-9d498e0f2e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_us-gaap_CommonClassBMember_25d659ab-88bc-40c3-90e5-9d498e0f2e84" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesEConvertiblePreferredStockMember_b2fce3c2-128b-4dc3-b707-b83ac8a27e39" xlink:href="rskd-20231231.xsd#rskd_SeriesEConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_rskd_SeriesEConvertiblePreferredStockMember_b2fce3c2-128b-4dc3-b707-b83ac8a27e39" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a8f40b16-8ab2-4762-a309-4db1e1fbcc40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a8f40b16-8ab2-4762-a309-4db1e1fbcc40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c87ac7a6-94e5-4938-8344-9aaf3b4204ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c87ac7a6-94e5-4938-8344-9aaf3b4204ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_5a454a3e-b642-49b0-bbf2-456e5643bb43" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_5a454a3e-b642-49b0-bbf2-456e5643bb43" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d11d8921-cd1a-4930-be0f-06c921f16435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d11d8921-cd1a-4930-be0f-06c921f16435" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_a3ce57d0-585b-4d7a-a060-f943c27fbde1" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_a3ce57d0-585b-4d7a-a060-f943c27fbde1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4727aabe-9bf5-423d-959c-a020f0749207" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4727aabe-9bf5-423d-959c-a020f0749207" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_8deeb968-b36b-425b-9399-cf8f6557062e" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_8deeb968-b36b-425b-9399-cf8f6557062e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_72899bc5-eb7e-4d04-be9e-336535a8c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6dedacf4-ec37-4915-b9c9-55344ce68557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_789def0c-d9a8-4f5e-b05e-e440f4c12d38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_789def0c-d9a8-4f5e-b05e-e440f4c12d38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9c7d7a1-8daa-46df-864b-1767d67ede89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockholdersEquity_b9c7d7a1-8daa-46df-864b-1767d67ede89" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1703a6b5-7e92-49e5-b0a8-187d82911b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1703a6b5-7e92-49e5-b0a8-187d82911b4b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_22bdb5a4-a4ba-4c72-9d3f-bcd1a42d6198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_22bdb5a4-a4ba-4c72-9d3f-bcd1a42d6198" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_09d8426f-3354-4487-be43-bec15e73b4ce" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_09d8426f-3354-4487-be43-bec15e73b4ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d33dadb1-fb85-45d3-851d-fe5e20c1cc14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d33dadb1-fb85-45d3-851d-fe5e20c1cc14" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_14ee7e75-4557-4225-a483-3e18a547e1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_14ee7e75-4557-4225-a483-3e18a547e1f7" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_ef50af2e-d8c5-490e-af9b-e8c92bc62fb1" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_ef50af2e-d8c5-490e-af9b-e8c92bc62fb1" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization_ea039feb-8363-49a3-a431-49bae7ec11ff" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization_ea039feb-8363-49a3-a431-49bae7ec11ff" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_915666cd-4e6c-4f48-86c2-ba6a40966443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_915666cd-4e6c-4f48-86c2-ba6a40966443" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_11e6fbd1-da91-46a0-9bee-f216f758af5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_11e6fbd1-da91-46a0-9bee-f216f758af5b" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_54c2b605-52a2-4c4f-98ff-87514ef5752f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_54c2b605-52a2-4c4f-98ff-87514ef5752f" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_2e99101c-0eb1-4a94-ae45-8965d4850600" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_2e99101c-0eb1-4a94-ae45-8965d4850600" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1ca7a67a-9431-4910-b938-3331cdc5f359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1ca7a67a-9431-4910-b938-3331cdc5f359" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3db1fda7-8025-402a-8a74-a93cd9e2ad68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3db1fda7-8025-402a-8a74-a93cd9e2ad68" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_fca386c8-fabb-4d48-ac5b-227a0d2c54f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_fca386c8-fabb-4d48-ac5b-227a0d2c54f1" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_eddae9d0-3531-486e-8ca0-b631b0c89734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_eddae9d0-3531-486e-8ca0-b631b0c89734" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7c708a34-5697-4e18-a68e-6da0e6d6a079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7c708a34-5697-4e18-a68e-6da0e6d6a079" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b22e0597-3c84-4caf-aeb4-db03ae3d7e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b22e0597-3c84-4caf-aeb4-db03ae3d7e5c" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc47f7cd-1544-4caa-9a11-9956f6a83676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_NetIncomeLoss_fc47f7cd-1544-4caa-9a11-9956f6a83676" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ea9254a8-3de8-46d7-87f8-031c3b7a5182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c39025b-e5bf-4a66-887f-3e4112f352e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:to="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e23df111-532d-49f5-bb65-7377dec99bb4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:to="loc_us-gaap_ClassOfStockDomain_e23df111-532d-49f5-bb65-7377dec99bb4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:to="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesEConvertiblePreferredStockMember_f65212a5-17db-4def-ae2b-d5d6f70475d6" xlink:href="rskd-20231231.xsd#rskd_SeriesEConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:to="loc_rskd_SeriesEConvertiblePreferredStockMember_f65212a5-17db-4def-ae2b-d5d6f70475d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts_ca15be10-0784-4e21-a9bc-7f0dc248756e" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfTemporaryEquityIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:to="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts_ca15be10-0784-4e21-a9bc-7f0dc248756e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:definitionLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_46fa9687-0537-4570-ba93-f6bf31a36c40_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_46fa9687-0537-4570-ba93-f6bf31a36c40_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_d604772d-8ce5-44a3-96fe-1db9a7b7a5fe" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_d604772d-8ce5-44a3-96fe-1db9a7b7a5fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17bc4b77-d480-4037-94d2-8f0aa18be463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_NetIncomeLoss_17bc4b77-d480-4037-94d2-8f0aa18be463" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7d466c6c-dfb7-4588-a32c-e661ce511ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7d466c6c-dfb7-4588-a32c-e661ce511ef6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_22669e8d-c904-4cca-8a30-87ae6373f697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_22669e8d-c904-4cca-8a30-87ae6373f697" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2efd3305-9b77-4b87-8bb6-0fc048fbf71f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2efd3305-9b77-4b87-8bb6-0fc048fbf71f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3ea2213e-430f-4b33-a3bf-836375c8c057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3ea2213e-430f-4b33-a3bf-836375c8c057" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b25e46a9-c7b4-4850-8fff-a10de66b144a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b25e46a9-c7b4-4850-8fff-a10de66b144a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_65d4e5f6-a2bf-4987-9c95-2972a99f7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_65d4e5f6-a2bf-4987-9c95-2972a99f7e27" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FairValueAdjustmentOfRights_2257512c-de23-497c-ba8e-fc5d9dd3b1bf" xlink:href="rskd-20231231.xsd#rskd_FairValueAdjustmentOfRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_rskd_FairValueAdjustmentOfRights_2257512c-de23-497c-ba8e-fc5d9dd3b1bf" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1a9e9569-09d2-436f-a11f-ab90d2777b96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ShareBasedCompensation_1a9e9569-09d2-436f-a11f-ab90d2777b96" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17c4bde3-cc0a-42fa-838e-182744d1826a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17c4bde3-cc0a-42fa-838e-182744d1826a" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_c35f72b4-fb22-40a1-8a63-775c2f697a75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_c35f72b4-fb22-40a1-8a63-775c2f697a75" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_166c8911-5d3d-423f-88bb-388324927f96" xlink:href="rskd-20231231.xsd#rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_166c8911-5d3d-423f-88bb-388324927f96" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f0336b74-c5e2-4227-a300-4f95aca6841d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f0336b74-c5e2-4227-a300-4f95aca6841d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e8492fef-6285-4450-b500-2e5630eb1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e8492fef-6285-4450-b500-2e5630eb1b88" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_c40a9997-fe9f-4c20-9fc4-4e6a3eb9ee51" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_c40a9997-fe9f-4c20-9fc4-4e6a3eb9ee51" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_577c01db-175c-408a-8aea-ffb130cb4fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_577c01db-175c-408a-8aea-ffb130cb4fbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d8a6a105-7e06-46bd-85a8-70c81ab1590d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d8a6a105-7e06-46bd-85a8-70c81ab1590d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b4e850bb-8dff-4f1d-b71b-757a396c8a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b4e850bb-8dff-4f1d-b71b-757a396c8a74" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInGuarantorObligations_2689b51d-da68-42e4-ad74-1e124b95f095" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInGuarantorObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInGuarantorObligations_2689b51d-da68-42e4-ad74-1e124b95f095" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_be454a9e-fd7c-449b-868f-68ff08ff2e6e" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInProvisionForChargebacks"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_be454a9e-fd7c-449b-868f-68ff08ff2e6e" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fde38b4b-4568-4630-bce7-336dd1e80f24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fde38b4b-4568-4630-bce7-336dd1e80f24" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2bcdb9b3-4c53-41b9-b024-9d77c394eb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2bcdb9b3-4c53-41b9-b024-9d77c394eb4b" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f1b21f8-1f65-4875-81fa-819eae6d87de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f1b21f8-1f65-4875-81fa-819eae6d87de" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d3346aa1-92b2-4a6c-a19c-61413108365e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d3346aa1-92b2-4a6c-a19c-61413108365e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_81e08ec7-a015-4f79-8b32-f4dc346586fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_81e08ec7-a015-4f79-8b32-f4dc346586fe" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_9e8ad4f8-43e4-4da0-bf41-e9b5e4470a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_9e8ad4f8-43e4-4da0-bf41-e9b5e4470a74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0cf2520-8432-4e0b-937b-c42cbb068e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0cf2520-8432-4e0b-937b-c42cbb068e41" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_0a4cb979-3732-4f51-96cb-19ec484be24a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_0a4cb979-3732-4f51-96cb-19ec484be24a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bd75529-b9c8-4abd-b00f-5146ce059547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bd75529-b9c8-4abd-b00f-5146ce059547" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0a92942e-ef65-4228-a374-8af877fcb833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0a92942e-ef65-4228-a374-8af877fcb833" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_05f17453-71f0-47d2-8485-9f3a19d3e6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_05f17453-71f0-47d2-8485-9f3a19d3e6aa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d68ad27f-14df-47ba-8692-7093d1344a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d68ad27f-14df-47ba-8692-7093d1344a1d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_dcc5f3e4-de05-46be-bed1-d52e6fa2e7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_dcc5f3e4-de05-46be-bed1-d52e6fa2e7ac" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2e481639-fee2-44e1-85b9-f760d0261abb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2e481639-fee2-44e1-85b9-f760d0261abb" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98a1c92f-bca4-43fb-8227-17cbf5c8c0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98a1c92f-bca4-43fb-8227-17cbf5c8c0a4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3d239ef-e34e-4cb1-91a6-12aa1eba882c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3d239ef-e34e-4cb1-91a6-12aa1eba882c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29d1e93-be38-4ff9-a0af-2cda6587861a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29d1e93-be38-4ff9-a0af-2cda6587861a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae5a19-68fe-4ca7-a67c-ba38712cecb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae5a19-68fe-4ca7-a67c-ba38712cecb4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2307d71e-0090-4cb2-9a5d-cd1d03501f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2307d71e-0090-4cb2-9a5d-cd1d03501f93" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecad01e1-9579-4c6b-8dcd-763e37e7fccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_485ff96c-7435-4a25-9e49-71a99d9e8f58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_InterestPaidNet_485ff96c-7435-4a25-9e49-71a99d9e8f58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_0b715ef0-2673-4526-9b2e-78b3bde8fcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_IncomeTaxesPaid_0b715ef0-2673-4526-9b2e-78b3bde8fcb3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_78dada9e-0b2f-4bf0-99fe-4ab9c2623980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_PaymentsForRent_78dada9e-0b2f-4bf0-99fe-4ab9c2623980" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca0600c5-b9a2-45f4-ab4b-8fa2abc5da64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca0600c5-b9a2-45f4-ab4b-8fa2abc5da64" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_6e2ab4d2-179e-4cda-8dc6-2372f406ac16" xlink:href="rskd-20231231.xsd#rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_6e2ab4d2-179e-4cda-8dc6-2372f406ac16" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b65de371-8f8c-4a79-b498-b5aa985b52ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b65de371-8f8c-4a79-b498-b5aa985b52ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3a4fb620-4e98-478f-bdfe-0ff19a9d5737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3a4fb620-4e98-478f-bdfe-0ff19a9d5737" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_e75df18e-ad44-400c-9803-c7edf5aa092c" xlink:href="rskd-20231231.xsd#rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_e75df18e-ad44-400c-9803-c7edf5aa092c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid_55577047-349a-48c4-806b-769a7eb13509" xlink:href="rskd-20231231.xsd#rskd_DeferredOfferingCostsIncurredButNotYetPaid"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid_55577047-349a-48c4-806b-769a7eb13509" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsAndRightsSettled_3b517bf4-c485-4818-9dd6-b5be8344fb3f" xlink:href="rskd-20231231.xsd#rskd_WarrantsAndRightsSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_WarrantsAndRightsSettled_3b517bf4-c485-4818-9dd6-b5be8344fb3f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_891654e9-1285-4aea-9b35-1d740b59f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_891654e9-1285-4aea-9b35-1d740b59f4ae" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_1204c515-91a8-4e57-99df-6a07173a667d" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_1204c515-91a8-4e57-99df-6a07173a667d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_dd955bc9-8186-4a2b-b8b3-a71974883593" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_dd955bc9-8186-4a2b-b8b3-a71974883593" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecca90e2-f48d-44d2-8e4c-73a7b001429a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecca90e2-f48d-44d2-8e4c-73a7b001429a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_73a7ff4e-a85b-417f-b25a-08355efceb27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:to="loc_us-gaap_RestrictedCash_73a7ff4e-a85b-417f-b25a-08355efceb27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee67337d-be36-4812-bc9c-b5e20e62469a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4f6723a3-891a-4edb-96a2-7bda442b11c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4f6723a3-891a-4edb-96a2-7bda442b11c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:to="loc_us-gaap_VestingDomain_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:to="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_fea6fcef-2118-4e1b-a713-f0d06e6141b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_fea6fcef-2118-4e1b-a713-f0d06e6141b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e180de61-d687-4934-8b3a-0434f7ae05d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:to="loc_us-gaap_IPOMember_e180de61-d687-4934-8b3a-0434f7ae05d8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c0b9a246-1cf6-4234-86df-8ca784b15da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c0b9a246-1cf6-4234-86df-8ca784b15da6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70997edd-cfed-418a-882a-04e2d8558b7f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_70997edd-cfed-418a-882a-04e2d8558b7f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17395456-9d37-4cff-a4ac-668f09eadfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17395456-9d37-4cff-a4ac-668f09eadfc7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_83202c1d-b4cb-44b2-bec4-2214f7e8c450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_83202c1d-b4cb-44b2-bec4-2214f7e8c450" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CloudComputingArrangementImplementationCostsMember_c17bdc82-f5e2-4abd-a041-94525b648fab" xlink:href="rskd-20231231.xsd#rskd_CloudComputingArrangementImplementationCostsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:to="loc_rskd_CloudComputingArrangementImplementationCostsMember_c17bdc82-f5e2-4abd-a041-94525b648fab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_557aaade-c848-4de0-a7dc-df9207e1e155_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:to="loc_srt_RangeMember_557aaade-c848-4de0-a7dc-df9207e1e155_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:to="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0e2b4d01-5293-4582-b2ac-300405b34dea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:to="loc_srt_MinimumMember_0e2b4d01-5293-4582-b2ac-300405b34dea" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9b1ff4e-a544-4d7e-aeae-7c2c7c08f38e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:to="loc_srt_MaximumMember_b9b1ff4e-a544-4d7e-aeae-7c2c7c08f38e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_262557e5-867d-48a0-a64e-2aab1bff52f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:to="loc_us-gaap_ClassOfStockDomain_262557e5-867d-48a0-a64e-2aab1bff52f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:to="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesE1ConvertiblePreferredStockMember_2bf600f5-c51d-40d5-948e-166fef4b0067" xlink:href="rskd-20231231.xsd#rskd_SeriesE1ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_rskd_SeriesE1ConvertiblePreferredStockMember_2bf600f5-c51d-40d5-948e-166fef4b0067" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f4ca348b-1b4a-4c69-acad-0ba0c50339ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_us-gaap_CommonClassAMember_f4ca348b-1b4a-4c69-acad-0ba0c50339ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b5c70a6d-61e9-4fbe-ada4-900afed902db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_us-gaap_CommonClassBMember_b5c70a6d-61e9-4fbe-ada4-900afed902db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_86e34f00-f81f-4ab5-a872-147d893d12b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_86e34f00-f81f-4ab5-a872-147d893d12b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0331898d-b80c-401c-8714-28774581407f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0331898d-b80c-401c-8714-28774581407f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2fbcd0e4-0506-4e86-9176-94f740e370c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2fbcd0e4-0506-4e86-9176-94f740e370c6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ba961603-84e8-40cc-bc48-01e5713cabc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ba961603-84e8-40cc-bc48-01e5713cabc1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_82f4ef52-063c-4466-b4dc-0821660ae16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_82f4ef52-063c-4466-b4dc-0821660ae16e" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b60fce64-d200-4542-8f54-1065dcbf5d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b60fce64-d200-4542-8f54-1065dcbf5d3a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfOtherStockIssuanceCosts_a5fe5d52-30cb-4a17-8e38-bee0d78064c6" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfOtherStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_PaymentsOfOtherStockIssuanceCosts_a5fe5d52-30cb-4a17-8e38-bee0d78064c6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockVotesForEachShare_cc971766-53db-4345-9049-2fe1ef4960b6" xlink:href="rskd-20231231.xsd#rskd_CommonStockVotesForEachShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_CommonStockVotesForEachShare_cc971766-53db-4345-9049-2fe1ef4960b6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f2e58fcc-bee4-4c27-ab27-6182d394c981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f2e58fcc-bee4-4c27-ab27-6182d394c981" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1204a37d-3233-4ffb-8663-91b24cdd0d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1204a37d-3233-4ffb-8663-91b24cdd0d94" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ed46eea4-2409-4517-902e-d968596da813" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ed46eea4-2409-4517-902e-d968596da813" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b4c22c1d-8d63-41a4-a3b4-4b2bb849ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b4c22c1d-8d63-41a4-a3b4-4b2bb849ac59" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_52970e89-b7d6-4e81-8b90-dec4f0304ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_52970e89-b7d6-4e81-8b90-dec4f0304ba9" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c737d8c1-7dea-4c34-8c5f-2a26c0ffd580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c737d8c1-7dea-4c34-8c5f-2a26c0ffd580" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a5d80e27-4a07-49d4-9eb3-e0979a2833ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a5d80e27-4a07-49d4-9eb3-e0979a2833ed" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_86a87fbe-e910-4775-ab6a-89dcd35305cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_86a87fbe-e910-4775-ab6a-89dcd35305cc" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fd7469ee-c90c-4d7b-9b24-7af2dda9005c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fd7469ee-c90c-4d7b-9b24-7af2dda9005c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsTerm_a56ae422-2d02-41e0-8f91-993e8638fd84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_GuaranteeObligationsTerm_a56ae422-2d02-41e0-8f91-993e8638fd84" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_RevenueTermOfMerchantContract_c270ca6b-ff24-46c1-bf7b-fba5406f7627" xlink:href="rskd-20231231.xsd#rskd_RevenueTermOfMerchantContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_RevenueTermOfMerchantContract_c270ca6b-ff24-46c1-bf7b-fba5406f7627" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_eb3a7053-7c9d-4813-91fc-e724b5568c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_eb3a7053-7c9d-4813-91fc-e724b5568c85" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss_3d522420-851c-4fcf-bc87-a88960184765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostImpairmentLoss_3d522420-851c-4fcf-bc87-a88960184765" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ChargebackExpense_fcfa60be-f61e-4ffe-a03d-054ce43194e4" xlink:href="rskd-20231231.xsd#rskd_ChargebackExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_ChargebackExpense_fcfa60be-f61e-4ffe-a03d-054ce43194e4" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_cb9cbad3-4086-4149-810e-0a953d6db82a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AdvertisingExpense_cb9cbad3-4086-4149-810e-0a953d6db82a" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_509612d8-ed29-4702-880f-de3fe7916fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_509612d8-ed29-4702-880f-de3fe7916fee" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4021bd9f-819b-41ef-8113-9a76b206e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4021bd9f-819b-41ef-8113-9a76b206e8f2" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4db3a348-46c2-4cdb-969e-417a06657713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4db3a348-46c2-4cdb-969e-417a06657713" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_24ca555c-39bb-41e3-aaf7-1b39ae2e5abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_NumberOfReportableSegments_24ca555c-39bb-41e3-aaf7-1b39ae2e5abf" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e26d7adf-c681-4f86-a986-83cbecfb0bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e26d7adf-c681-4f86-a986-83cbecfb0bd2" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ced861d1-5b6f-4f83-945f-a77e5ee89ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_OperatingLeaseLiability_ced861d1-5b6f-4f83-945f-a77e5ee89ad7" xlink:type="arc" order="28"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:to="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a2d4bcae-b337-4efb-8776-536a3b898811_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a2d4bcae-b337-4efb-8776-536a3b898811_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_170c5e5f-16a9-4d43-bf26-50fb510d623d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:to="loc_us-gaap_AccountsReceivableMember_170c5e5f-16a9-4d43-bf26-50fb510d623d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4ffc2d3c-1ed7-4c7e-816c-4fcb12c00925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:to="loc_us-gaap_SalesRevenueNetMember_4ffc2d3c-1ed7-4c7e-816c-4fcb12c00925" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_0f0eac7f-3cbd-487b-9df2-7dc299af61b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_0f0eac7f-3cbd-487b-9df2-7dc299af61b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1dfaa8f1-f8f9-42e3-89f6-50643485af0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1dfaa8f1-f8f9-42e3-89f6-50643485af0c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:to="loc_srt_NameOfMajorCustomerDomain_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:to="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerAMember_a4c44919-7d9c-4502-b2c9-7f1dde968cd0" xlink:href="rskd-20231231.xsd#rskd_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:to="loc_rskd_CustomerAMember_a4c44919-7d9c-4502-b2c9-7f1dde968cd0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerBMember_9b9fa5e8-c3c5-49d6-9878-22b0b9aea7d9" xlink:href="rskd-20231231.xsd#rskd_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:to="loc_rskd_CustomerBMember_9b9fa5e8-c3c5-49d6-9878-22b0b9aea7d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_16371a9b-5c11-4adb-873c-f791c77f6415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_16371a9b-5c11-4adb-873c-f791c77f6415" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:to="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_cf1e6ba1-f0db-4258-86d6-31fb1ec90275_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:to="loc_srt_RestatementDomain_cf1e6ba1-f0db-4258-86d6-31fb1ec90275_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:to="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_046503fe-bd9f-477d-ad7d-0751d448cc48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_046503fe-bd9f-477d-ad7d-0751d448cc48" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_7d647535-c4b5-4dd3-b3bf-9ee3344cf7cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_7d647535-c4b5-4dd3-b3bf-9ee3344cf7cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_040f1d27-558f-4909-8eb5-d2b02fc30b70_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:to="loc_us-gaap_ClassOfStockDomain_040f1d27-558f-4909-8eb5-d2b02fc30b70_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:to="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_cd65a64c-ff1a-4606-8ac8-c3d7570fc165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:to="loc_us-gaap_CommonClassAMember_cd65a64c-ff1a-4606-8ac8-c3d7570fc165" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_def2fc9a-4558-4143-9c02-143942a4bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:to="loc_us-gaap_CommonClassBMember_def2fc9a-4558-4143-9c02-143942a4bbb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_f0ed382c-5bcf-4062-bdbe-10e934926df3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_f0ed382c-5bcf-4062-bdbe-10e934926df3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b3c5b16-13bd-492b-9d60-0d595abc84fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b3c5b16-13bd-492b-9d60-0d595abc84fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0cb90d28-4890-42a8-8fdf-705c7e897a97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0cb90d28-4890-42a8-8fdf-705c7e897a97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_65441f32-1804-4513-9bb1-b548f523e53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_OperatingIncomeLoss_65441f32-1804-4513-9bb1-b548f523e53e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3af56d62-a7b8-45a5-a5d4-3c47b8b85535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3af56d62-a7b8-45a5-a5d4-3c47b8b85535" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_21f21c02-4eb7-4a64-80e1-2fd91edf9af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_NetIncomeLoss_21f21c02-4eb7-4a64-80e1-2fd91edf9af6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_be2a9879-01d2-476d-88a8-e6512382491c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_EarningsPerShareBasic_be2a9879-01d2-476d-88a8-e6512382491c" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bf93e9e9-8be2-442e-a2f2-3a593661272b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bf93e9e9-8be2-442e-a2f2-3a593661272b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d932cf66-737a-4d9c-b0ca-b2fc7416c279_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_d932cf66-737a-4d9c-b0ca-b2fc7416c279_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_09ce5076-9bda-4d27-a07d-e983bcf58ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:to="loc_us-gaap_ComputerEquipmentMember_09ce5076-9bda-4d27-a07d-e983bcf58ccb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FurnitureAndOfficeEquipmentMember_c1489b90-b713-41bd-850a-4cfd5522192c" xlink:href="rskd-20231231.xsd#rskd_FurnitureAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:to="loc_rskd_FurnitureAndOfficeEquipmentMember_c1489b90-b713-41bd-850a-4cfd5522192c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:to="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_6e0ff443-cccd-49bc-8c8b-f0634558eac3_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:to="loc_srt_RangeMember_6e0ff443-cccd-49bc-8c8b-f0634558eac3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:to="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84f4bb82-a7a9-416c-b37c-733148b40d8d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:to="loc_srt_MinimumMember_84f4bb82-a7a9-416c-b37c-733148b40d8d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31ced675-f5b3-4333-8ae5-dfacf35d758f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:to="loc_srt_MaximumMember_31ced675-f5b3-4333-8ae5-dfacf35d758f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c86dc43c-ba55-4f94-86e1-340eecf7465d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c86dc43c-ba55-4f94-86e1-340eecf7465d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionRevenuebyGeographicAreasDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_15cecf36-abe7-4e8e-992c-1ea2696f3e18_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:to="loc_srt_SegmentGeographicalDomain_15cecf36-abe7-4e8e-992c-1ea2696f3e18_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:to="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cf0d22b0-285f-43c6-b6d9-cbf4bd993349" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_country_US_cf0d22b0-285f-43c6-b6d9-cbf4bd993349" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_1e1a5227-b848-4cfa-a57d-cda6aab1c508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_us-gaap_EMEAMember_1e1a5227-b848-4cfa-a57d-cda6aab1c508" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_0c4531ea-c46c-46f8-8e87-1a913ccf3759" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_srt_AsiaPacificMember_0c4531ea-c46c-46f8-8e87-1a913ccf3759" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_24f4bd5f-22fb-46ac-b004-7f972b461bf3" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_country_IL_24f4bd5f-22fb-46ac-b004-7f972b461bf3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bf722423-9cbd-431c-bbdc-1105c8b7871b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AmericasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_srt_AmericasMember_bf722423-9cbd-431c-bbdc-1105c8b7871b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21971aec-6cc3-4607-acd2-407cc9d2dbf0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_21971aec-6cc3-4607-acd2-407cc9d2dbf0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c4fbea1f-c594-4385-b4df-d346f6b95732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:to="loc_us-gaap_SalesRevenueNetMember_c4fbea1f-c594-4385-b4df-d346f6b95732" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ed73231b-e549-4e0e-b77e-e06e16ab3e14_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ed73231b-e549-4e0e-b77e-e06e16ab3e14_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_e013fd26-519a-4b8d-b47e-f0823eb3c67d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_e013fd26-519a-4b8d-b47e-f0823eb3c67d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_288214bd-b781-488c-a77a-8e560adeb730" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:to="loc_us-gaap_Revenues_288214bd-b781-488c-a77a-8e560adeb730" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c8514a53-5d38-456a-af05-e2e97c5d329d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c8514a53-5d38-456a-af05-e2e97c5d329d" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_dec45895-6cfa-47b0-9f94-0c22df25431b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:to="loc_us-gaap_SalesRevenueNetMember_dec45895-6cfa-47b0-9f94-0c22df25431b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_020a9f72-b945-4e70-a2bf-b98088547a20_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_020a9f72-b945-4e70-a2bf-b98088547a20_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_883612b3-976b-4756-91d0-cef4d814f2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_883612b3-976b-4756-91d0-cef4d814f2c6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_63948ad4-39ce-49c4-9cd0-eec30c525864_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:to="loc_srt_ProductsAndServicesDomain_63948ad4-39ce-49c4-9cd0-eec30c525864_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:to="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FraudServiceRevenueMember_9751e3b1-9e12-4c28-bf8e-70f4ea3bb561" xlink:href="rskd-20231231.xsd#rskd_FraudServiceRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:to="loc_rskd_FraudServiceRevenueMember_9751e3b1-9e12-4c28-bf8e-70f4ea3bb561" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IndemnificationServiceRevenueMember_bb12e1d5-f213-4ca9-b0c4-5d22a9d06c0d" xlink:href="rskd-20231231.xsd#rskd_IndemnificationServiceRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:to="loc_rskd_IndemnificationServiceRevenueMember_bb12e1d5-f213-4ca9-b0c4-5d22a9d06c0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8b6d318-b707-4b42-8760-2b96f7e13d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8b6d318-b707-4b42-8760-2b96f7e13d2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_5cedc0fa-5a11-4703-a742-974021cbedd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_5cedc0fa-5a11-4703-a742-974021cbedd7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90cb9f22-cefb-4200-b5cb-f5b6cb889273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_Revenues_90cb9f22-cefb-4200-b5cb-f5b6cb889273" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_3b02f196-1d4a-4e6c-bb03-81fccfa60f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_3b02f196-1d4a-4e6c-bb03-81fccfa60f27" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_f005d544-9cd6-492a-9cd3-1270ccf6270e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_f005d544-9cd6-492a-9cd3-1270ccf6270e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_86ec3798-8a9d-4fc2-abaf-d2d0081de978" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_86ec3798-8a9d-4fc2-abaf-d2d0081de978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffdb30b2-ecb5-4f9e-be96-58f548112dee_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_ffdb30b2-ecb5-4f9e-be96-58f548112dee_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0e6afae3-cdae-4ada-b1b7-453d24e4203d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0e6afae3-cdae-4ada-b1b7-453d24e4203d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_79b4073e-6602-4abf-8e42-c57a8503cfac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_79b4073e-6602-4abf-8e42-c57a8503cfac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dfbcd372-49e9-4a64-aa65-6a0d95c7f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dfbcd372-49e9-4a64-aa65-6a0d95c7f7a6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74315446-024e-4f1c-825c-9da19f29005a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74315446-024e-4f1c-825c-9da19f29005a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_be7d34d6-4652-4c9f-b0d9-436785c24776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_be7d34d6-4652-4c9f-b0d9-436785c24776" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_85c503b0-5397-4f13-8754-4095d4e8a287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_ShortTermInvestments_85c503b0-5397-4f13-8754-4095d4e8a287" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_29d67b61-08d4-4ad4-ad2f-5bef7e9ceee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_DerivativeAssets_29d67b61-08d4-4ad4-ad2f-5bef7e9ceee6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_62a0c00e-13b1-4117-89bf-528969e55956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_62a0c00e-13b1-4117-89bf-528969e55956" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1abbfaf5-272b-4fa2-b4b7-e92eaee841a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:to="loc_us-gaap_DerivativeLiabilities_1abbfaf5-272b-4fa2-b4b7-e92eaee841a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ae1fa61b-8363-4da9-bbee-0da812e1482c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ae1fa61b-8363-4da9-bbee-0da812e1482c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_4d89a505-8834-45cb-b4dd-a5e4fa647147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_4d89a505-8834-45cb-b4dd-a5e4fa647147" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_fc4d4633-321d-41d4-9b0b-29406b36dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_fc4d4633-321d-41d4-9b0b-29406b36dcd0" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofShorttermInvestmentsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_06b59ae9-71e4-4350-806a-ad243562579c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_06b59ae9-71e4-4350-806a-ad243562579c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_10419c8b-3ef6-45fd-b04e-2c5e1a8f3feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_10419c8b-3ef6-45fd-b04e-2c5e1a8f3feb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_06cc7963-5f9d-4544-9e1e-4e06c7bd16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_06cc7963-5f9d-4544-9e1e-4e06c7bd16a9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1113cc0-5a08-4050-8152-9003775ffbae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1113cc0-5a08-4050-8152-9003775ffbae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ce95f3c-1277-44d7-af09-67f5cb1c885c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ce95f3c-1277-44d7-af09-67f5cb1c885c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b1a1348-ed52-4d0f-8d3e-0548d89d5bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b1a1348-ed52-4d0f-8d3e-0548d89d5bb9" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_4391299d-bf2c-4081-be26-4d8cdc96e757_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_4391299d-bf2c-4081-be26-4d8cdc96e757_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_aaa1815c-1462-4269-8757-abf4dcbae238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_aaa1815c-1462-4269-8757-abf4dcbae238" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:to="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:to="loc_us-gaap_HedgingDesignationDomain_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:to="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2360899f-649d-4f7b-b957-9d5542457e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2360899f-649d-4f7b-b957-9d5542457e5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_37231f33-d7c4-48f8-b76a-abbefa32e414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:to="loc_us-gaap_NondesignatedMember_37231f33-d7c4-48f8-b76a-abbefa32e414" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ad96eb53-d9dc-4145-a0a0-ccd74b002a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ad96eb53-d9dc-4145-a0a0-ccd74b002a7f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:to="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_3badbb0b-0a53-457e-b8a3-a92eba389f5d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_3badbb0b-0a53-457e-b8a3-a92eba389f5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9facdd0e-978d-4fca-9a84-c85007000b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9facdd0e-978d-4fca-9a84-c85007000b18" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_379ff469-7100-4079-ae91-4dbede4ae5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:to="loc_us-gaap_NondesignatedMember_379ff469-7100-4079-ae91-4dbede4ae5d8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_6a8687bd-7e71-466e-afec-54116a54cc5c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_6a8687bd-7e71-466e-afec-54116a54cc5c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_cda76396-5b8f-44bc-909d-7d098b0300b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_SalesMember_cda76396-5b8f-44bc-909d-7d098b0300b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_cfa00225-ccb7-44eb-a336-cfbc598c9fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_CostOfSalesMember_cfa00225-ccb7-44eb-a336-cfbc598c9fd4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10abf71a-770a-4a79-a96a-433bac6458a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10abf71a-770a-4a79-a96a-433bac6458a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_112b43ba-1015-4080-9cb7-dbd8a983178c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_112b43ba-1015-4080-9cb7-dbd8a983178c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2bcfa668-a41b-4142-9d0c-61cb740da3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2bcfa668-a41b-4142-9d0c-61cb740da3ce" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ec8cb172-7df0-490d-9f4b-c2f0aae6c3be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ec8cb172-7df0-490d-9f4b-c2f0aae6c3be" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bf7144f-5e51-4d1b-ad1f-162a4a20f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bf7144f-5e51-4d1b-ad1f-162a4a20f9e1" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_1c7e130f-f709-41c1-9f67-34c05e9d15a0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:to="loc_us-gaap_EquityComponentDomain_1c7e130f-f709-41c1-9f67-34c05e9d15a0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:to="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2588003c-ad33-4046-9220-7bc8bfbd03ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2588003c-ad33-4046-9220-7bc8bfbd03ae" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b3aa077-63b9-4c39-a9d1-7f489617fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_StockholdersEquity_3b3aa077-63b9-4c39-a9d1-7f489617fd7b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e1b28ea0-951d-4e6d-a97c-a4a931da02cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e1b28ea0-951d-4e6d-a97c-a4a931da02cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8fab6743-203e-4605-b5b0-9912b223f816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8fab6743-203e-4605-b5b0-9912b223f816" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7282ab77-b565-493a-9569-be890e43dc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dca88667-4c31-4ff0-9c5b-b7fedd98f249_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_dca88667-4c31-4ff0-9c5b-b7fedd98f249_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_8d58d60a-f327-4d1b-9c4c-071ea99e6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_us-gaap_ComputerEquipmentMember_8d58d60a-f327-4d1b-9c4c-071ea99e6b34" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FurnitureAndOfficeEquipmentMember_11883b24-e56c-4765-bb2a-152878f8a911" xlink:href="rskd-20231231.xsd#rskd_FurnitureAndOfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_rskd_FurnitureAndOfficeEquipmentMember_11883b24-e56c-4765-bb2a-152878f8a911" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_974e94b7-7aef-45f9-a079-762abb516cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_974e94b7-7aef-45f9-a079-762abb516cc7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_20d543ca-9fb0-4153-86b5-12c14435899e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_20d543ca-9fb0-4153-86b5-12c14435899e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1d9ae0f-efc5-4b3e-9786-923c7dc553c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1d9ae0f-efc5-4b3e-9786-923c7dc553c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_771388f7-2738-42a4-9a52-199e0c2b5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_771388f7-2738-42a4-9a52-199e0c2b5a82" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:to="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_92c99b5e-7ae6-4c44-9471-e6580e578cdf_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:to="loc_srt_SegmentGeographicalDomain_92c99b5e-7ae6-4c44-9471-e6580e578cdf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:to="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cbe712fc-122a-42b8-b134-f0519927b5ed" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_country_US_cbe712fc-122a-42b8-b134-f0519927b5ed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_ed0cbf49-9d13-4593-9d6c-2e196f3640bd" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_country_IL_ed0cbf49-9d13-4593-9d6c-2e196f3640bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelAndNonUSMember_195293ab-48e6-48fd-803c-c17fa99f8978" xlink:href="rskd-20231231.xsd#rskd_NonIsraelAndNonUSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_rskd_NonIsraelAndNonUSMember_195293ab-48e6-48fd-803c-c17fa99f8978" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2770d21e-bf69-4004-970c-d073804e84c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2770d21e-bf69-4004-970c-d073804e84c2" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesByGeographicRegionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesByGeographicRegionDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/LeasesByGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:to="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_fd25118a-cea6-4ca4-8e55-a97b880ecaf2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:to="loc_srt_SegmentGeographicalDomain_fd25118a-cea6-4ca4-8e55-a97b880ecaf2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:to="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_2356bd4a-ac22-498a-af5a-a6b270192af1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:to="loc_country_IL_2356bd4a-ac22-498a-af5a-a6b270192af1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_30974cbc-fe31-4f0e-ad93-e18b3b4edc51" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:to="loc_country_US_30974cbc-fe31-4f0e-ad93-e18b3b4edc51" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_28f3f2c8-3537-4d49-a6d3-6765f5b66fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_28f3f2c8-3537-4d49-a6d3-6765f5b66fa5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinaryShareWarrantsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinaryShareWarrantsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinaryShareWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_4ee7439e-d835-45d5-a412-ee5d8b970b19_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_4ee7439e-d835-45d5-a412-ee5d8b970b19_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_21eb0b28-c056-46c7-8b45-85fa9ffa63d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:to="loc_us-gaap_WarrantMember_21eb0b28-c056-46c7-8b45-85fa9ffa63d5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantIssuedToCustomersMember_bfac1119-84e3-4d9a-8c1b-d57a27f5993b" xlink:href="rskd-20231231.xsd#rskd_WarrantIssuedToCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:to="loc_rskd_WarrantIssuedToCustomersMember_bfac1119-84e3-4d9a-8c1b-d57a27f5993b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_ca2d7e34-e057-4bc7-8e43-4fbecf47550c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:to="loc_us-gaap_ClassOfStockDomain_ca2d7e34-e057-4bc7-8e43-4fbecf47550c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:to="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a19779a3-eeaa-41cd-ad7e-e25623c26624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:to="loc_us-gaap_CommonClassAMember_a19779a3-eeaa-41cd-ad7e-e25623c26624" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_fae03ff6-7dc6-4301-b283-9997a979ce4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:to="loc_us-gaap_CommonClassBMember_fae03ff6-7dc6-4301-b283-9997a979ce4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4dc3732-e3d1-4223-8ba9-28efe69df7cb_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c4dc3732-e3d1-4223-8ba9-28efe69df7cb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_c0165720-6892-43ba-9d79-605cccc1c82d" xlink:href="rskd-20231231.xsd#rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:to="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_c0165720-6892-43ba-9d79-605cccc1c82d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_987f6d6e-a1bf-4968-a4a8-3c390802c687_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:to="loc_us-gaap_PlanNameDomain_987f6d6e-a1bf-4968-a4a8-3c390802c687_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:to="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_6766b5fd-9b1c-49bb-9a89-9645532e3eb6" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_6766b5fd-9b1c-49bb-9a89-9645532e3eb6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aa1aca24-9889-46a9-b5a2-04c901682a81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aa1aca24-9889-46a9-b5a2-04c901682a81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_68a7259b-f5d2-4dcd-b95a-1b3dd985c537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_68a7259b-f5d2-4dcd-b95a-1b3dd985c537" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ed91b294-2508-4f27-8730-91b416f688b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ed91b294-2508-4f27-8730-91b416f688b0" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanNarrativeDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_9e1ea4fd-f153-4779-8cf4-c6b3a6221261_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:to="loc_us-gaap_PlanNameDomain_9e1ea4fd-f153-4779-8cf4-c6b3a6221261_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:to="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_02a9f4d8-025f-40fd-8835-e745d00d7879" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_02a9f4d8-025f-40fd-8835-e745d00d7879" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EquityIncentivePlanMember_ef0efd22-50a8-4228-bc4d-13b357cfabc5" xlink:href="rskd-20231231.xsd#rskd_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:to="loc_rskd_A2021EquityIncentivePlanMember_ef0efd22-50a8-4228-bc4d-13b357cfabc5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a3a6116-beb6-496c-9fd2-073bae7aeb38_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6a3a6116-beb6-496c-9fd2-073bae7aeb38_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb90cde-eeab-4768-b04d-c9f022c03722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb90cde-eeab-4768-b04d-c9f022c03722" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a07d69d-491a-4e31-8f20-b5c188c66121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a07d69d-491a-4e31-8f20-b5c188c66121" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ec2f3783-e743-428e-84f4-42a69178733c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:to="loc_us-gaap_VestingDomain_ec2f3783-e743-428e-84f4-42a69178733c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:to="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a9d26b2d-e9f6-4efc-ba7c-bad55b50985f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a9d26b2d-e9f6-4efc-ba7c-bad55b50985f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6d583dbd-066b-4352-92d8-2d60c0de6394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6d583dbd-066b-4352-92d8-2d60c0de6394" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_17aca48c-d6a3-4533-abc3-d36c17bb001d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:to="loc_us-gaap_ClassOfStockDomain_17aca48c-d6a3-4533-abc3-d36c17bb001d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:to="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_08c41b4a-718c-4555-bd0c-08712a63b09a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:to="loc_us-gaap_CommonClassAMember_08c41b4a-718c-4555-bd0c-08712a63b09a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4d7c77c4-9b02-4d78-9898-5b92d575e3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:to="loc_us-gaap_CommonClassBMember_4d7c77c4-9b02-4d78-9898-5b92d575e3c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_a06d0da5-fc2c-482d-9e1a-97d5b55856b0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_a06d0da5-fc2c-482d-9e1a-97d5b55856b0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EmployeeSharePurchasePlanMember_2f186117-70fc-47ed-abed-c971f7af89da" xlink:href="rskd-20231231.xsd#rskd_A2021EmployeeSharePurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:to="loc_rskd_A2021EmployeeSharePurchasePlanMember_2f186117-70fc-47ed-abed-c971f7af89da" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8106ffb8-4b0c-4374-9462-f945acfac46b_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8106ffb8-4b0c-4374-9462-f945acfac46b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_51eca927-1b04-400f-958c-daa8363edf8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:to="loc_srt_ChiefExecutiveOfficerMember_51eca927-1b04-400f-958c-daa8363edf8e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8daee165-416d-4749-a0c1-83e186e67772" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8daee165-416d-4749-a0c1-83e186e67772" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_152417ee-fda3-4793-aaac-eb264f217749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_152417ee-fda3-4793-aaac-eb264f217749" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_00c830f7-43c4-4ba2-a726-cde6345180c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_00c830f7-43c4-4ba2-a726-cde6345180c9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockRepurchaseProgramTransactionCosts_0f408971-6b01-44a6-8dd4-f0296b7dfb12" xlink:href="rskd-20231231.xsd#rskd_StockRepurchaseProgramTransactionCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_StockRepurchaseProgramTransactionCosts_0f408971-6b01-44a6-8dd4-f0296b7dfb12" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_02e67414-8d65-4472-9843-1004aa8fda3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_02e67414-8d65-4472-9843-1004aa8fda3f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_8ac1ebe6-cb80-4ea4-a922-b7d0369c4628" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_8ac1ebe6-cb80-4ea4-a922-b7d0369c4628" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aa492cd2-a467-47af-9689-abc46230b056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aa492cd2-a467-47af-9689-abc46230b056" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e08535ee-6be3-485c-aacd-426992e88947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e08535ee-6be3-485c-aacd-426992e88947" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afe2bd90-adaf-419b-b987-9d894fdda978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afe2bd90-adaf-419b-b987-9d894fdda978" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_590a1bc2-086a-4e1f-97fa-a25dd94f5104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_590a1bc2-086a-4e1f-97fa-a25dd94f5104" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d27da6d5-cda1-49c9-b7bd-525dc7b1613d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d27da6d5-cda1-49c9-b7bd-525dc7b1613d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c089710-c77e-4425-881d-ee7d6e3640f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c089710-c77e-4425-881d-ee7d6e3640f0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_16013766-9df7-433b-bb23-9b2c83ba0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_16013766-9df7-433b-bb23-9b2c83ba0b41" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50d430d7-9db5-421f-bb30-528ec91f40bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50d430d7-9db5-421f-bb30-528ec91f40bd" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_68429a4c-0637-47b3-9416-917139222a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_68429a4c-0637-47b3-9416-917139222a4e" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a9784977-64cb-47fa-98af-6580b9a75341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a9784977-64cb-47fa-98af-6580b9a75341" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_e901c913-8997-4f44-9815-b7195cdec57e" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_e901c913-8997-4f44-9815-b7195cdec57e" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7786dfb3-ea89-4be4-910b-977d312968d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7786dfb3-ea89-4be4-910b-977d312968d8" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_59e37c55-3630-482c-a3ba-0f3a6bd37799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_59e37c55-3630-482c-a3ba-0f3a6bd37799" xlink:type="arc" order="18"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_277616c2-f8ef-4dcd-bd83-dac13d674f3f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_277616c2-f8ef-4dcd-bd83-dac13d674f3f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsToPurchaseOrdinarySharesMember_480c1b33-1bcd-4867-bebb-4164b58712ef" xlink:href="rskd-20231231.xsd#rskd_WarrantsToPurchaseOrdinarySharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:to="loc_rskd_WarrantsToPurchaseOrdinarySharesMember_480c1b33-1bcd-4867-bebb-4164b58712ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_6cefd951-e462-402e-8df0-8794c413e572_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:to="loc_us-gaap_PlanNameDomain_6cefd951-e462-402e-8df0-8794c413e572_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:to="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_38715bf7-b938-43c2-b141-f01b9cbb50d3" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_38715bf7-b938-43c2-b141-f01b9cbb50d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EquityIncentivePlanMember_1a4507ec-279e-44f0-ad52-6a8b71243877" xlink:href="rskd-20231231.xsd#rskd_A2021EquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:to="loc_rskd_A2021EquityIncentivePlanMember_1a4507ec-279e-44f0-ad52-6a8b71243877" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_780f5342-9c34-494e-a3d6-66d4ce721246_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_780f5342-9c34-494e-a3d6-66d4ce721246_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_33bf7018-3574-4d98-b73d-967b9b2e1cee" xlink:href="rskd-20231231.xsd#rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:to="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_33bf7018-3574-4d98-b73d-967b9b2e1cee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c1bd4cca-7949-46ee-89db-5dce3d85507b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c1bd4cca-7949-46ee-89db-5dce3d85507b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:to="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a579320d-cc7e-4b7e-b37d-a96597af7302_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_a579320d-cc7e-4b7e-b37d-a96597af7302_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f91f2c59-cc02-40ed-9c4d-a7f1fa24d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f91f2c59-cc02-40ed-9c4d-a7f1fa24d21d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_142c4150-d0d3-4df8-a1b3-a44b69cbde4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_142c4150-d0d3-4df8-a1b3-a44b69cbde4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0fdafcc0-d12f-4eda-97d3-e67be6326eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0fdafcc0-d12f-4eda-97d3-e67be6326eb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca69376b-bff1-457d-8784-bb3e1b003ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca69376b-bff1-457d-8784-bb3e1b003ff0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2c5fe5e5-78cb-41e3-b98c-1cc863693fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2c5fe5e5-78cb-41e3-b98c-1cc863693fe5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_12304128-ace8-402f-8a04-58382669c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bc2cd26c-e2f1-4fe0-9b0b-8d2fd1eb2f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bc2cd26c-e2f1-4fe0-9b0b-8d2fd1eb2f91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e660b53-3bdb-4667-bc49-34bcdb2e8050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e660b53-3bdb-4667-bc49-34bcdb2e8050" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_843d92e2-bb5a-47ee-9053-e9dc09a694a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_843d92e2-bb5a-47ee-9053-e9dc09a694a3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e81c1638-453c-4134-a288-0e0ca0850ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_26ccde1f-a8eb-44cf-8324-9da397333540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_26ccde1f-a8eb-44cf-8324-9da397333540" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e06e2ab0-fdd1-4cff-878b-3e2db594b9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e06e2ab0-fdd1-4cff-878b-3e2db594b9c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dbc2b807-b89a-42d2-a65e-4294d35c55cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dbc2b807-b89a-42d2-a65e-4294d35c55cd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_32af1693-b147-4bf2-8181-f4d21646467b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_32af1693-b147-4bf2-8181-f4d21646467b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cc5bfa40-c6f4-479e-b198-ea12d259c9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cc5bfa40-c6f4-479e-b198-ea12d259c9f6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aef49527-e54b-4623-a016-a8995907f296" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aef49527-e54b-4623-a016-a8995907f296" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c890e1a3-3a23-4eb4-a244-168a0503235c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c890e1a3-3a23-4eb4-a244-168a0503235c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d11e65bf-5432-47a7-945c-56559e52a9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d11e65bf-5432-47a7-945c-56559e52a9ad" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:to="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06a4a505-6059-40ff-87e3-beb41760c84f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_06a4a505-6059-40ff-87e3-beb41760c84f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d98fa1fb-a9b3-4251-9aba-a2893fe0e570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d98fa1fb-a9b3-4251-9aba-a2893fe0e570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:to="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_77a62ff3-683a-4c5b-8c52-7c9276a347b1_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:to="loc_srt_RangeMember_77a62ff3-683a-4c5b-8c52-7c9276a347b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:to="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b478588b-63cf-4dea-8a0b-ad9640e034ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:to="loc_srt_MinimumMember_b478588b-63cf-4dea-8a0b-ad9640e034ec" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30674d06-9561-4af2-97f6-2bb9623bf149" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:to="loc_srt_MaximumMember_30674d06-9561-4af2-97f6-2bb9623bf149" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd9836a2-9cc2-4e0b-8bcf-49bd2f3b268d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd9836a2-9cc2-4e0b-8bcf-49bd2f3b268d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c1425090-17f9-4077-8ca9-e325423ecdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c1425090-17f9-4077-8ca9-e325423ecdd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1a177306-c0cc-4262-9f96-8e43dee6b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1a177306-c0cc-4262-9f96-8e43dee6b9db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26137b75-fe9d-4893-8060-aa777fd16afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26137b75-fe9d-4893-8060-aa777fd16afc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanRSUActivityDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:to="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_89312bd1-4bf0-4410-8f22-601132607bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_89312bd1-4bf0-4410-8f22-601132607bbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f6ec39a-e307-48c5-8335-cb5f56abc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f6ec39a-e307-48c5-8335-cb5f56abc35b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d7a54dcc-70bb-4610-920c-ae0e4f8d66bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d7a54dcc-70bb-4610-920c-ae0e4f8d66bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_14e96b0e-fdc0-408a-babb-1536af97a3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_14e96b0e-fdc0-408a-babb-1536af97a3dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e77a8a06-eb57-451f-82e7-6f466dd68351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e77a8a06-eb57-451f-82e7-6f466dd68351" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81373cf4-5044-4edc-b480-afa83b9d32c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0ad27f42-9fb3-47ca-9f47-3c6fa1f5dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0ad27f42-9fb3-47ca-9f47-3c6fa1f5dd4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d9fe085-759b-4310-91bb-08de20eee245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d9fe085-759b-4310-91bb-08de20eee245" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9b3efefa-4a05-4371-93af-a1f50ffd8841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9b3efefa-4a05-4371-93af-a1f50ffd8841" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eb53009e-5996-4193-b4dd-ad7482353b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eb53009e-5996-4193-b4dd-ad7482353b7f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a55affa4-f499-4d77-ae8a-ddfed5c9c4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3c09a94f-6d5e-4d61-9bd9-c7c881611869_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3c09a94f-6d5e-4d61-9bd9-c7c881611869_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_249e05c5-6131-482d-8add-8ff640319978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_CostOfSalesMember_249e05c5-6131-482d-8add-8ff640319978" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03db3c12-966e-4e99-9e16-a6ea75806d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03db3c12-966e-4e99-9e16-a6ea75806d53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5f9a53e2-c133-48b2-9a3e-26624af38be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5f9a53e2-c133-48b2-9a3e-26624af38be0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_437965a3-b838-42a9-bf90-93171a2b5449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_437965a3-b838-42a9-bf90-93171a2b5449" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_93a3780f-17bb-451b-a4f5-099e99dcc3a5_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_93a3780f-17bb-451b-a4f5-099e99dcc3a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_f3806fa8-0f6f-4a45-99f8-a9efe4c75e9c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:to="loc_srt_ChiefExecutiveOfficerMember_f3806fa8-0f6f-4a45-99f8-a9efe4c75e9c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_51b02077-8728-491c-b8d5-81dba5308836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_51b02077-8728-491c-b8d5-81dba5308836" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8920b080-73c2-4252-a153-6caaf9bae75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8920b080-73c2-4252-a153-6caaf9bae75a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_32da4d35-09dc-41a8-8472-0e0a7f452d13_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_32da4d35-09dc-41a8-8472-0e0a7f452d13_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_61cbbe11-2591-4073-9051-0bd16642fd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_DomesticCountryMember_61cbbe11-2591-4073-9051-0bd16642fd2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a46d876c-3089-44ed-a685-46132372d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_ForeignCountryMember_a46d876c-3089-44ed-a685-46132372d86f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_50b56a67-3583-486c-ad96-93bd126f911c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_50b56a67-3583-486c-ad96-93bd126f911c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e9efe766-8d7e-4804-8ef8-074be2151440_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:to="loc_srt_SegmentGeographicalDomain_e9efe766-8d7e-4804-8ef8-074be2151440_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:to="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_bd5722be-a597-49c6-9e83-3f23ac6132ab" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:to="loc_country_US_bd5722be-a597-49c6-9e83-3f23ac6132ab" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodDomain_a3f737cd-c066-4c1b-affc-a9e66340b806_default" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:to="loc_rskd_ExpirationPeriodDomain_a3f737cd-c066-4c1b-affc-a9e66340b806_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:to="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TaxYear2042Member_0f44c7d4-b81a-41d2-878c-94e5401bae28" xlink:href="rskd-20231231.xsd#rskd_TaxYear2042Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:to="loc_rskd_TaxYear2042Member_0f44c7d4-b81a-41d2-878c-94e5401bae28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_33ac6118-db34-4079-b0d6-f975a11797a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LatestTaxYearMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:to="loc_us-gaap_LatestTaxYearMember_33ac6118-db34-4079-b0d6-f975a11797a7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4d5045d5-c6dc-4461-97d7-139a5e43c606" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4d5045d5-c6dc-4461-97d7-139a5e43c606" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_16d67a37-e1fa-4f46-acd5-641f203ebee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_16d67a37-e1fa-4f46-acd5-641f203ebee5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_0320dad2-4b08-496f-81d2-66afa7819a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_0320dad2-4b08-496f-81d2-66afa7819a1f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_4dedcdbb-f1a8-4d53-b754-e9819388859e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_4dedcdbb-f1a8-4d53-b754-e9819388859e" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:to="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_94c9a16b-f24b-48a3-b0fc-1aa309697c43_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:to="loc_srt_SegmentGeographicalDomain_94c9a16b-f24b-48a3-b0fc-1aa309697c43_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:to="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_606bc179-7757-48c8-aa0d-028562fb5c84" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:to="loc_country_IL_606bc179-7757-48c8-aa0d-028562fb5c84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelMember_2886c3c1-f8f8-4c57-a33f-a61e11f6d631" xlink:href="rskd-20231231.xsd#rskd_NonIsraelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:to="loc_rskd_NonIsraelMember_2886c3c1-f8f8-4c57-a33f-a61e11f6d631" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae681ba-eb08-4e0c-b794-5e53958b7b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae681ba-eb08-4e0c-b794-5e53958b7b52" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:to="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_acc8907a-0d2b-47f5-8bcd-240b461b6bd2_default" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:to="loc_srt_SegmentGeographicalDomain_acc8907a-0d2b-47f5-8bcd-240b461b6bd2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:to="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_b398626b-056e-45d1-b521-287f5f3c458a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:to="loc_country_IL_b398626b-056e-45d1-b521-287f5f3c458a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelMember_c05c3ebf-2dcf-4e79-bec7-3c41c7b2912c" xlink:href="rskd-20231231.xsd#rskd_NonIsraelMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:to="loc_rskd_NonIsraelMember_c05c3ebf-2dcf-4e79-bec7-3c41c7b2912c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84fb0d54-e19d-4a2b-90d4-d3e44c58f89d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84fb0d54-e19d-4a2b-90d4-d3e44c58f89d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c39df00-3bd8-437d-af64-cf6630fbb593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c39df00-3bd8-437d-af64-cf6630fbb593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4b7b9e4-df5e-4563-b790-d08e93c33562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4b7b9e4-df5e-4563-b790-d08e93c33562" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0d91af59-7c26-477f-aea7-f335396ff820_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0d91af59-7c26-477f-aea7-f335396ff820_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e746328d-1ece-49ce-b437-d99021729bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:to="loc_us-gaap_WarrantMember_e746328d-1ece-49ce-b437-d99021729bd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_981fab86-03f0-42a9-88fb-fbc0cc0b1161" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_981fab86-03f0-42a9-88fb-fbc0cc0b1161" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a43db02d-6905-4db7-bba8-7480d2cdbefb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a43db02d-6905-4db7-bba8-7480d2cdbefb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_ae24d6cc-bf7d-427b-8a68-8f95175d1ba6" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_ae24d6cc-bf7d-427b-8a68-8f95175d1ba6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_b68c7941-d0bf-4b40-8b88-50e0c22ced09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_b68c7941-d0bf-4b40-8b88-50e0c22ced09" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38826166-b6f1-4a6b-b506-6d64bcc0b1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38826166-b6f1-4a6b-b506-6d64bcc0b1a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_af6b9123-2a88-4d85-9b2f-513b2aaa758b" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_af6b9123-2a88-4d85-9b2f-513b2aaa758b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b83d584a-d16c-4f45-945a-175876f43722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b83d584a-d16c-4f45-945a-175876f43722" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_ece3d142-e399-4038-9ac5-53c43d9198c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_ece3d142-e399-4038-9ac5-53c43d9198c3" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_eb43be0b-4927-4633-b059-3d35b7d8b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_eb43be0b-4927-4633-b059-3d35b7d8b3bd" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_870fdef8-559f-45be-a65e-b5a078fe8854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_870fdef8-559f-45be-a65e-b5a078fe8854" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_961bf97f-b210-4fac-840f-cd76314b4c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_961bf97f-b210-4fac-840f-cd76314b4c41" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4980e3-8a9c-494b-80ea-521ea30b9351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4980e3-8a9c-494b-80ea-521ea30b9351" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:to="loc_us-gaap_ClassOfStockDomain_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:to="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_8da075b9-2592-46f4-8441-ca17de9f60cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:to="loc_us-gaap_CommonClassAMember_8da075b9-2592-46f4-8441-ca17de9f60cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_cdf725b1-430b-4eb1-b89c-45d55d17ea46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:to="loc_us-gaap_CommonClassBMember_cdf725b1-430b-4eb1-b89c-45d55d17ea46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e95d3f7e-99b6-4a5b-ba1b-b389621f74a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e95d3f7e-99b6-4a5b-ba1b-b389621f74a4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a29b7dd9-abeb-4438-b71c-3a4a9e08fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a29b7dd9-abeb-4438-b71c-3a4a9e08fc54" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_944faba9-6f6a-4a0c-99bf-ff3304da0233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_944faba9-6f6a-4a0c-99bf-ff3304da0233" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b744f024-0a1e-4b90-8d50-3d8fe0804489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b744f024-0a1e-4b90-8d50-3d8fe0804489" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c0017efc-970e-4b13-a9d6-53bc5e4987fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_EarningsPerShareBasic_c0017efc-970e-4b13-a9d6-53bc5e4987fe" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16a68ce9-15ba-4bb4-873c-102352909735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_16a68ce9-15ba-4bb4-873c-102352909735" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d03cccd-0b79-4ce3-a364-d82f738d25e8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_2d03cccd-0b79-4ce3-a364-d82f738d25e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_74008970-707a-4bfd-817a-9712bff1fbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_74008970-707a-4bfd-817a-9712bff1fbd5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_1e449cc4-5189-4e52-ab6e-c08a3d6caa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_WarrantMember_1e449cc4-5189-4e52-ab6e-c08a3d6caa56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_269001c4-22f5-483b-bf91-0925ca34f118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_StockCompensationPlanMember_269001c4-22f5-483b-bf91-0925ca34f118" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b79bdd35-ee94-4070-be14-9b5dcb0e0735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b79bdd35-ee94-4070-be14-9b5dcb0e0735" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_b8f80e14-eaba-4b1c-8981-be2001a9ac22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:to="loc_us-gaap_ClassOfStockDomain_b8f80e14-eaba-4b1c-8981-be2001a9ac22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:to="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_9f2b4543-a62b-4974-bba6-803b8a7dd9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:to="loc_us-gaap_CommonClassAMember_9f2b4543-a62b-4974-bba6-803b8a7dd9e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_016382a8-08c4-4c49-8a8b-907111d1b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:to="loc_us-gaap_CommonClassBMember_016382a8-08c4-4c49-8a8b-907111d1b3ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6ccdf877-e1fd-4a01-9752-d6ecbaa8272f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6ccdf877-e1fd-4a01-9752-d6ecbaa8272f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:type="arc" order="2" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_73f13912-3b42-43c8-861f-23b7c2970cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_73f13912-3b42-43c8-861f-23b7c2970cb8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_73f13912-3b42-43c8-861f-23b7c2970cb8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_545327c8-5a89-4c9f-b90b-2ed869cccdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4f890eb5-d994-46de-a401-c641cac85f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d526c6a2-d4ce-4ecb-bbb2-38b2307a39cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d526c6a2-d4ce-4ecb-bbb2-38b2307a39cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SubsequentEventsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:to="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_963b8d85-41bd-4cd0-9a0e-0c3228a00916_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_963b8d85-41bd-4cd0-9a0e-0c3228a00916_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f1d619ac-1e07-4d81-ba23-ddd8fe57e9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:to="loc_us-gaap_SubsequentEventMember_f1d619ac-1e07-4d81-ba23-ddd8fe57e9b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_10bd9722-76e1-40db-9fce-53a466322755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_10bd9722-76e1-40db-9fce-53a466322755" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3fa7fef6-8202-48f4-96ea-347e9e63d6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3fa7fef6-8202-48f4-96ea-347e9e63d6a7" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsDetails"/>
  <link:definitionLink xlink:role="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_86d8355a-780a-468e-93b5-88896cec30a4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_86d8355a-780a-468e-93b5-88896cec30a4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember_78d6d2e6-e417-4835-8e72-9b4a01b6dc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantyReservesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:to="loc_us-gaap_WarrantyReservesMember_78d6d2e6-e417-4835-8e72-9b4a01b6dc9e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksMember_707ff42f-7885-444e-bf76-a574411874a4" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:to="loc_rskd_ProvisionForChargebacksMember_707ff42f-7885-444e-bf76-a574411874a4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_eec389d4-56b5-4d5e-8a1e-9fb4a8a3c6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_eec389d4-56b5-4d5e-8a1e-9fb4a8a3c6f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a3c24255-cb14-482c-b5df-1981184213cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a3c24255-cb14-482c-b5df-1981184213cc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7b3b20bc-dad3-4a1a-8c88-112583900501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7b3b20bc-dad3-4a1a-8c88-112583900501" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_208936a2-2599-4cca-8130-9453ec5672dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_9faa537e-68c0-45d2-8503-a98cdcd98026" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesAbstract" xlink:to="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_9faa537e-68c0-45d2-8503-a98cdcd98026" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>13
<FILENAME>rskd-20231231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:74ab1c91-acf2-4dbd-a834-633eda582453,g:91ce9b07-e870-4283-be19-76a0a0cc8871-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_77e2c414-ba75-4ed8-9899-6efc18a2dc0e_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recoveries of amounts previously deemed uncollectible</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_47f5df62-55da-4df8-9a4d-47e2428e6787_terseLabel_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Over-Allotment Option</link:label>
    <link:label id="lab_us-gaap_OverAllotmentOptionMember_label_en-US" xlink:label="lab_us-gaap_OverAllotmentOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Over-Allotment Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OverAllotmentOptionMember" xlink:to="lab_us-gaap_OverAllotmentOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_SeriesEConvertiblePreferredStockMember_5594a51f-7128-47a2-b561-64a4d77b905d_terseLabel_en-US" xlink:label="lab_rskd_SeriesEConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_rskd_SeriesEConvertiblePreferredStockMember_label_en-US" xlink:label="lab_rskd_SeriesEConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series E Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_rskd_SeriesEConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_rskd_SeriesEConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series E Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesEConvertiblePreferredStockMember" xlink:href="rskd-20231231.xsd#rskd_SeriesEConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_SeriesEConvertiblePreferredStockMember" xlink:to="lab_rskd_SeriesEConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_13b68ee2-509e-4973-865d-8a2e9b6536ef_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_951d9e6f-017b-4a3d-95f4-b6c1642c8ba0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_fd1a5ca6-0b1b-447a-98db-161062a95564_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_e4b290a3-411c-48c9-ba53-86fb8e81052a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Software</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Capitalized Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_27745d7c-4a76-47ef-b5a0-9d7662538638_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock_8a25576d-ceec-43bc-940a-ad3d564d8127_terseLabel_en-US" xlink:label="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and Marketing</link:label>
    <link:label id="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock_label_en-US" xlink:label="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense, Policy [Policy Text Block]</link:label>
    <link:label id="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Sales And Marketing Expense, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:href="rskd-20231231.xsd#rskd_SalesAndMarketingExpensePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:to="lab_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TemporaryEquityDisclosureTextBlock_c7876b44-a6bb-4f68-9640-63c55cd4a1e8_terseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Shares</link:label>
    <link:label id="lab_rskd_TemporaryEquityDisclosureTextBlock_label_en-US" xlink:label="lab_rskd_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity Disclosure [Text Block]</link:label>
    <link:label id="lab_rskd_TemporaryEquityDisclosureTextBlock_documentation_en-US" xlink:label="lab_rskd_TemporaryEquityDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityDisclosureTextBlock" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TemporaryEquityDisclosureTextBlock" xlink:to="lab_rskd_TemporaryEquityDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_b719a263-9482-4070-993e-c9132fbe4956_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_3e712b2d-b8ff-4744-bf27-53a74bd23147_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_5a8e6270-4ea3-4148-a989-e7ac58c36101_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_47dec20d-33e3-4353-bfc1-c3fd60974fbf_totalLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_a00310b9-c638-4c2e-b8b2-6adf8d1a0f20_terseLabel_en-US" xlink:label="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software development costs, accrued but not paid</link:label>
    <link:label id="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development Expenditures Incurred But Not Yet Paid</link:label>
    <link:label id="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Software Development Expenditures Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:href="rskd-20231231.xsd#rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:to="lab_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_ba9cdd82-c411-41c8-8bfb-a65708d2a541_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_bb7734d6-6b2e-4b82-a30e-a488cdb2227a_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested as of December 31, 2020 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8dd951a7-1a8b-4c23-9f6c-ba653571443e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested as of December 31, 2021 (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_95ad656a-6bf7-4f9c-ae38-629edef4df4f_terseLabel_en-US" xlink:label="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Options and RSUs</link:label>
    <link:label id="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_label_en-US" xlink:label="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option And Restricted Stock Units [Member]</link:label>
    <link:label id="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_documentation_en-US" xlink:label="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option And Restricted Stock Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:href="rskd-20231231.xsd#rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:to="lab_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_535768bc-6b86-44f6-94c1-efb93145ac1c_verboseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of convertible preferred shares, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_87f19574-9bde-448f-9eb8-3219f5405441_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_bc5ba63c-58ec-4370-a6f9-594b3233eb9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5e1a3f1d-a149-4414-ae87-adbdf276ec38_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effects of exchange rates on cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_c0e855da-d956-49b9-8930-46cd71e0ce8b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_1feb88f9-f6fc-476c-a809-c1e9aa4fce22_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Remaining Contractual Life, Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_671af2f2-2710-45ae-884c-cc83ac5e190a_terseLabel_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer equipment</link:label>
    <link:label id="lab_us-gaap_ComputerEquipmentMember_label_en-US" xlink:label="lab_us-gaap_ComputerEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComputerEquipmentMember" xlink:to="lab_us-gaap_ComputerEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_93b4a8e7-4e1d-4540-9dee-7773cebb520e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest Income, Deposit with Financial Institution, Increase (Decrease)</link:label>
    <link:label id="lab_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_label_en-US" xlink:label="lab_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income, Deposit with Financial Institution, Increase (Decrease)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" xlink:to="lab_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_85bce642-e23c-4092-986d-a2cee8d17bcb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized contract cost, impairment loss</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:to="lab_us-gaap_CapitalizedContractCostImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_9e05a2eb-ad1f-4aed-b5ae-f886931e3bec_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of investments</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_e627c400-6d14-4545-abad-9a45f81b656b_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_6eed2200-b6e2-4c96-a27e-8a1cf9249da3_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">As Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_bde42909-0808-418f-ba83-8cc8ee90c554_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Share Options, Options exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_d668f08d-4579-4ad0-b9ef-6585519446ca_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_af3a3f00-6944-4d1b-9fa5-1045b447cace_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligations</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_66fe297c-7042-4395-ac82-25302754c940_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_cf0cf4eb-6dd5-473d-b2a5-aaccd1e14cd0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedges, Liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedges, Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgesLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_fbed906c-2839-4713-8287-11b2742380b9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax and Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_27cfc376-aac1-47bc-af4e-75c787cbba7e_terseLabel_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:label id="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_label_en-US" xlink:label="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Error Corrections and Prior Period Adjustments Restatement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:to="lab_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_bab6db2a-ddb7-4a68-b2e4-eb95aa541ca3_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_afa79b6c-8288-41bb-8bb4-bae666d49ccf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_a377a242-616f-419f-9b20-925bb029e189_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsTerm_a4c6395a-ffe2-4996-be5b-71fe7bc55cf8_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee obligations, term</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsTerm_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsTerm" xlink:to="lab_us-gaap_GuaranteeObligationsTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_fb9bf916-8c2f-4d74-857e-1a02fc1d8696_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior year tax income/(expense)</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_fc9913fa-f4da-4b42-9cf5-d8f9e4124b0b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_7ddbd38f-ab7a-4c5b-96e4-2bfdac7bb81f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_db8491f0-a326-4628-95e0-77138810768a_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_9ca0b034-9c62-4620-ac14-8c1eb7d8035e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_331d1a20-cc32-4108-946a-aebeb5e5433e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_f4bb2064-0850-4dbe-af2e-8c49f57cdd83_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_1e397727-25a1-4311-998c-74190d49f79d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Grant-Date Fair Value Per Share</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_1cb3f83a-66be-4987-8e3c-a2478003c48d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_5a6ea284-34d1-4f6e-9af7-81b473991635_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_872a4eb1-2a7c-462b-81c2-862c48ba5c47_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_NonIsraelAndNonUSMember_08940151-25cf-4da4-a781-b13e4c1f77fa_terseLabel_en-US" xlink:label="lab_rskd_NonIsraelAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rest of world</link:label>
    <link:label id="lab_rskd_NonIsraelAndNonUSMember_label_en-US" xlink:label="lab_rskd_NonIsraelAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Israel And Non-US [Member]</link:label>
    <link:label id="lab_rskd_NonIsraelAndNonUSMember_documentation_en-US" xlink:label="lab_rskd_NonIsraelAndNonUSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Israel And Non-US</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelAndNonUSMember" xlink:href="rskd-20231231.xsd#rskd_NonIsraelAndNonUSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_NonIsraelAndNonUSMember" xlink:to="lab_rskd_NonIsraelAndNonUSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_c2e25cdb-6e99-44dc-915b-aa87702f345d_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:label id="lab_dei_ContactPersonnelEmailAddress_label_en-US" xlink:label="lab_dei_ContactPersonnelEmailAddress" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Email Address</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelEmailAddress" xlink:to="lab_dei_ContactPersonnelEmailAddress" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_7af30069-88e8-4047-89d9-ba36894ab01c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_c01835b2-933b-4e3a-a016-99d0aaa42836_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury shares at cost, 3,038,865 and zero ordinary shares as of December&#160;31, 2023 and 2022, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_a860d5e4-056c-4d7b-a84b-d02c864247ae_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_f63d63ec-a820-46b1-b2da-5701505062fe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on derivative instruments, net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_9e52db56-713f-4905-b225-adf7b816c93b_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_6419ff03-4c24-4402-92c5-67a42528ba71_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_92da79d9-5168-4c22-94dd-210c42944bc9_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_58f765eb-1e97-4c58-80c1-d5bda7aeb966_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Outstanding Share Options, beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9e22d546-c0ab-40bd-894c-3f986aa7e894_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Outstanding Share Options, ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_5d0482de-ef4f-459b-ad75-771a980351ab_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_6450862c-50c2-48a5-b2c1-796c73336e36_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares upon exercise of share options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_30c08237-a72f-4677-8bbd-8436794efee0_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_f48877ad-dd66-43ba-8d07-e82b4f031786_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average grant date fair value of options granted in period (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_756eeb9b-4ccc-4ba1-8dfc-17ca0095aa4e_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e3ef80cf-38ef-46d8-9e9e-a545223993e5_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss)</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_f7e93aa0-71d3-4466-9bbb-c115a5870830_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_ee3b5c3e-d829-410c-a308-c5af0c9de308_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_76ab8217-af9b-4024-9234-4486053ed257_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_6be47b33-4f19-4eb9-b2aa-f948348b7a23_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_b7b23475-0de7-4a96-ad4b-f421557d8cc1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_f9333b77-897e-4ca0-9b06-fcd1e877f517_negatedTerseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_474ff693-da91-4e62-a1bb-d4324124ec52_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Shareholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_fbfa0728-086c-40b2-8126-8150a010ac72_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_fc8901e1-7914-4ada-9ee7-08130bf5c324_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts_a66f60e7-5eca-423e-a3f7-a2c79edfcbd1_terseLabel_en-US" xlink:label="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of temporary equity issuance costs</link:label>
    <link:label id="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts_label_en-US" xlink:label="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Temporary Equity Issuance Costs</link:label>
    <link:label id="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts_documentation_en-US" xlink:label="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments of Temporary Equity Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfTemporaryEquityIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:to="lab_rskd_PaymentsOfTemporaryEquityIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_1f364bf5-0dcf-4686-a2f0-c8024d0fd92f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_6ad3af75-d707-4a5c-8f86-dc641aae1b3a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_ed5bdb92-5023-49e5-affc-bc98370fd5d4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_c218c999-b894-4845-ab05-e6e0b818c521_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares upon exercise of share options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_baee3fe4-96db-444d-816e-c8c0ad6a6703_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Share Options, Options exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_647b1fa1-fdb4-4666-bfad-03a575b6139f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_220699f9-ce9e-4a0a-8cd6-1524134a9a82_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyTable" xlink:to="lab_us-gaap_IncomeTaxContingencyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_a8094346-834b-4777-be9f-7cb49166fea0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:to="lab_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_6af2a134-d3e5-410a-8c22-d32f01749dc4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_668925ab-cde3-4580-9cbf-10fe6e380412_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</link:label>
    <link:label id="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:to="lab_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_ee85fe57-5856-4b7d-b5f0-39742b54248b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_01310bac-b40c-4454-a82e-fa43e3057921_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_8546fc8d-7e22-41d6-8081-cd4fd2212cf1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares</link:label>
    <link:label id="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Weighted Average Number of Shares [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_9d49054e-f6e0-496e-8d16-496e3d4eb43f_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_525cc1a0-83c5-4424-96fc-b58a4fd049b4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price, Options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_ae4e2de4-3439-45fa-ba9c-dd95e2ded2db_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_8eaf2898-e7b7-4559-8add-6ad402e55b96_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_d4685c18-d5b2-4533-95b4-dd4912acf056_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantor obligations, maximum exposure</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsMaximumExposure_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Maximum Exposure, Undiscounted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsMaximumExposure" xlink:to="lab_us-gaap_GuaranteeObligationsMaximumExposure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_102fa372-aa5d-42ab-85d8-e119e31ab508_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of short-term deposits</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_58ba050f-a1fa-4af3-a66d-907e713db59f_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary share warrants issued to a customer</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Warrant Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_c0542a70-0cf2-483d-bc3e-67bbebf60ae8_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_307d8726-65d1-42f8-b334-4a636da483a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9d94139e-91c4-44b2-bead-f4f38cc8d85d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_4d0fd2e2-6215-4a5b-992b-b63b537b08b8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f7a77d64-9e7c-4098-867e-377951db800b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_035e4d84-0b97-427b-b396-8bfba9db375f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unrealized loss (gain) on foreign currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrealized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_SeriesE1ConvertiblePreferredStockMember_2e0f0a58-1dea-418b-9784-649be912a2df_terseLabel_en-US" xlink:label="lab_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Series E-1 Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_rskd_SeriesE1ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series E-1 Convertible Preferred Stock [Member]</link:label>
    <link:label id="lab_rskd_SeriesE1ConvertiblePreferredStockMember_documentation_en-US" xlink:label="lab_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series E-1 Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:href="rskd-20231231.xsd#rskd_SeriesE1ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:to="lab_rskd_SeriesE1ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_ae9a3cc8-5411-45ab-9483-271a820b0edb_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_fe597f57-774f-4542-8387-8b8658b2d5bb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_08480090-64d7-40a1-9dcc-ec035bba8aef_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants to purchase ordinary shares</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_8ea17879-33e6-4e20-9c10-e26ae578f75b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_f43718e6-5bd3-4b73-9b20-a3a1a72d984b_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Estimate of Fair Value of Investments by Contractual Maturity Dates</link:label>
    <link:label id="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investments Classified by Contractual Maturity Date [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:to="lab_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_fa039f97-8846-46ef-bd0b-b87fd1667f25_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency transaction gain (loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Realized Gain (Loss), Foreign Currency Transaction, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossRealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_8a330958-96f7-4317-8660-a9e38d6cba3d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_c00117f5-e764-4b53-94e6-911fec3f7b2d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments of deferred offering costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_06c30aa4-918d-4a58-aeec-cb39f7509aa1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of stock issuance costs</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_2c4ce086-0370-4d70-9e79-0d86bdb74359_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_e072f267-5efb-4c03-b05a-c660e12e015c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndRetirementDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retirement Benefits [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="lab_us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_fa0b63c3-80fc-44f7-8d0a-7291cd235b6e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_45366c42-ebcf-40eb-958e-4025be6102ed_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract" xlink:to="lab_us-gaap_TemporaryEquityDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_71d0ec3c-5387-4934-b84c-7101fd8cc7ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_4e1fa6fe-f626-4977-ad18-79178e3a598a_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_bec683fe-c355-4b45-b00a-227b59c415d0_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_00bbbbd7-96cb-4e97-bfa6-7c9a17a1c0a7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Service [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesPolicyTextBlock" xlink:to="lab_us-gaap_CostOfSalesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_28461261-b114-4205-bf78-9119191a1b2f_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_62e73d2d-6a56-48f9-89ce-cf2612b2de39_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_d29c26e8-0d39-4784-9270-cdd5556618d7_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Revenues, Total</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_AuditInformationAbstract_label_en-US" xlink:label="lab_rskd_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_rskd_AuditInformationAbstract_documentation_en-US" xlink:label="lab_rskd_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AuditInformationAbstract" xlink:href="rskd-20231231.xsd#rskd_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_AuditInformationAbstract" xlink:to="lab_rskd_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_31b9169a-cac0-4e5b-8026-e5bcd43928fe_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_f8111589-4f49-41e8-bf05-57448754e97e_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_ed86df06-242a-4f8f-9417-beab357496fc_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="lab_us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_1864b35d-19e7-4dc3-b854-7012ea16b063_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_f0f8c1b7-4d3f-4767-a5d6-fdb0bc792a9a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_bf6b6adf-4f2b-4606-8ca0-5d4d0b848f63_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_509428bb-310d-4ff1-b8a5-47e91dc19d39_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate grant date fair value of options vested during the period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_589348bd-776a-4bed-b13a-c0c828e29820_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c9898759-7b71-426a-8c47-17d2ad531a8f_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAccountingStandard_19956dbd-117b-4f24-a790-2577003e7272_terseLabel_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:label id="lab_dei_DocumentAccountingStandard_label_en-US" xlink:label="lab_dei_DocumentAccountingStandard" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Accounting Standard</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAccountingStandard" xlink:to="lab_dei_DocumentAccountingStandard" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_16858f36-f398-44d1-9b8d-862ace652dce_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_77f6cf17-2a3f-4f55-bee9-bb819d2da7d4_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_PaymentsOfOtherStockIssuanceCosts_771d44a5-da71-4e21-b786-3451b7eeac23_terseLabel_en-US" xlink:label="lab_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments of other stock issuance costs</link:label>
    <link:label id="lab_rskd_PaymentsOfOtherStockIssuanceCosts_label_en-US" xlink:label="lab_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Of Other Stock Issuance Costs</link:label>
    <link:label id="lab_rskd_PaymentsOfOtherStockIssuanceCosts_documentation_en-US" xlink:label="lab_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments Of Other Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfOtherStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:to="lab_rskd_PaymentsOfOtherStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_903ea4d6-0877-4ff9-81d1-0770f44b2fab_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_DeferredTaxAssetsLeasingArrangements_40e8b24d-0f1a-49c5-b302-2b0cada55225_terseLabel_en-US" xlink:label="lab_rskd_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_rskd_DeferredTaxAssetsLeasingArrangements_label_en-US" xlink:label="lab_rskd_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:label id="lab_rskd_DeferredTaxAssetsLeasingArrangements_documentation_en-US" xlink:label="lab_rskd_DeferredTaxAssetsLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredTaxAssetsLeasingArrangements" xlink:href="rskd-20231231.xsd#rskd_DeferredTaxAssetsLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_DeferredTaxAssetsLeasingArrangements" xlink:to="lab_rskd_DeferredTaxAssetsLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_afc3a2c5-d251-4d73-9810-de3b5261294c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense not yet recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_a539575d-450f-4165-bf6a-b76ced49bddb_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment during the period included in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2fb0d251-6c19-4aed-a5bb-edc1af5a08e0_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_ed765f0e-6b0e-4229-8e62-0281d4c81269_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_6775639d-e576-4038-a183-b45a27e25b5f_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_8d5eee69-eb9e-47ab-90de-ef3cf83831fd_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_19a0c792-b7b4-41f5-97af-9060bc053603_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_a927f992-a0dd-40a9-b1a7-2311cc035ef1_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Remaining Contractual Life, Options outstanding</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_b036757e-ddaf-4c16-a6da-616efc131544_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities arising from obtaining right-of-use assets</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_26af06e9-d594-4a38-83a1-9360773b3396_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_2bce524b-859f-47de-abd8-cd6ef43ac929_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_a0b551d7-aa91-498b-8001-2920a936889f_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_4b6ca9c2-bc09-452c-b9e2-60f026d3c1e6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_7d77c46b-88b7-4b24-b8d8-30eaf8d07dc6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8c0fdbdc-71c7-432e-a8a2-b5803d2c18db_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_48b714c7-a9fc-4be9-842d-eba1a12d125f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_a843f8d7-1988-4992-b25a-ff4e3d752891_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease liabilities, current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LatestTaxYearMember_14bc6272-b418-482b-9a4b-dbf692207b1a_terseLabel_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Do not expire</link:label>
    <link:label id="lab_us-gaap_LatestTaxYearMember_label_en-US" xlink:label="lab_us-gaap_LatestTaxYearMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Latest Tax Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LatestTaxYearMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LatestTaxYearMember" xlink:to="lab_us-gaap_LatestTaxYearMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_FairValueAdjustmentOfRights_f4da2ceb-e617-43e0-b6ba-a76e8d6a39a1_terseLabel_en-US" xlink:label="lab_rskd_FairValueAdjustmentOfRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of convertible preferred share tranche rights</link:label>
    <link:label id="lab_rskd_FairValueAdjustmentOfRights_label_en-US" xlink:label="lab_rskd_FairValueAdjustmentOfRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment Of Rights</link:label>
    <link:label id="lab_rskd_FairValueAdjustmentOfRights_documentation_en-US" xlink:label="lab_rskd_FairValueAdjustmentOfRights" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment Of Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FairValueAdjustmentOfRights" xlink:href="rskd-20231231.xsd#rskd_FairValueAdjustmentOfRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_FairValueAdjustmentOfRights" xlink:to="lab_rskd_FairValueAdjustmentOfRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_8b56723c-9c72-40c2-bef2-2457661af5d0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Reductions for tax positions of prior years</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_db5ff4fd-461b-483c-ad39-212d0e044e60_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_f23965d8-cc32-46dc-9b4a-080276754f65_terseLabel_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrant revaluation</link:label>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_label_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Warrant Revaluation, Amount</link:label>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_documentation_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Warrant Revaluation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:to="lab_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_707fda24-8c50-4a78-8294-77dd2df21678_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_8ba7bd1e-e4e6-4d47-8d20-a3b7ddb05cf3_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_bc49a760-5087-4f32-82a7-46a2565b08ba_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e081170b-8fcf-4c27-9109-dec7f6d4ba78_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_5ae1ec3e-5af2-4a72-98fe-b757bde88e83_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_a7a8f2a8-4070-48a3-b52d-596b4cc927d9_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityLineItems_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityLineItems" xlink:to="lab_us-gaap_TemporaryEquityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_bd30d0cd-7ea5-456a-8e5f-3275f6819544_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:label id="lab_us-gaap_RevenueNotFromContractWithCustomer_label_en-US" xlink:label="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Not from Contract with Customer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueNotFromContractWithCustomer" xlink:to="lab_us-gaap_RevenueNotFromContractWithCustomer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_2fff6dc3-56c4-40eb-bfd7-01d3462979b3_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additions based on tax positions related to current year</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_a614aea4-0e4a-45ac-ba77-d511d2ecdf01_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_35f561f4-30d0-4e67-bf2c-1111569c9b95_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash&#8212;beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_7c9fceb6-0f3c-483b-a750-eecda83aa270_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents, and restricted cash&#8212;end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_23885f49-1cfb-46f4-9e68-1979043a5b49_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_414f4f26-19e7-418f-ade6-047979b7af40_terseLabel_en-US" xlink:label="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_d1e4459c-179a-4b90-a414-ed4f97cee312_totalLabel_en-US" xlink:label="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other current liabilities</link:label>
    <link:label id="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_label_en-US" xlink:label="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Liabilities And Other Liabilities, Current</link:label>
    <link:label id="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_documentation_en-US" xlink:label="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Liabilities And Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:to="lab_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_24b0f8ac-97f5-4d8f-b78e-a4c34f6ff43d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ExpirationPeriodAxis_3d7d8536-1e10-43f2-ad76-d839517e252f_terseLabel_en-US" xlink:label="lab_rskd_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_rskd_ExpirationPeriodAxis_label_en-US" xlink:label="lab_rskd_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expiration Period [Axis]</link:label>
    <link:label id="lab_rskd_ExpirationPeriodAxis_documentation_en-US" xlink:label="lab_rskd_ExpirationPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodAxis" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ExpirationPeriodAxis" xlink:to="lab_rskd_ExpirationPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_8c08a8dc-676a-452b-bc6e-f5b6e765dd15_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_fe9a016c-f3dc-41fa-9759-8fb70ec43192_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, price per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockPricePerShare_label_en-US" xlink:label="lab_us-gaap_SaleOfStockPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockPricePerShare" xlink:to="lab_us-gaap_SaleOfStockPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_471ff5c7-3521-4324-9943-cc5341094304_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_f257f935-b9f5-4c73-90cc-170f1c9eb247_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_8405c2fd-bfa5-4752-b1b1-d007e80e9dd9_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_efbe9837-9410-413a-af8d-7cdc7e2efc69_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_59f4c031-01da-4b85-b563-21f67ea5bf3d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_50a8c160-af96-4489-a014-af9c64e96bf0_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeveranceCosts1_edc4beaa-b594-422f-b24f-13c2ee6bafe2_terseLabel_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance costs</link:label>
    <link:label id="lab_us-gaap_SeveranceCosts1_label_en-US" xlink:label="lab_us-gaap_SeveranceCosts1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeveranceCosts1" xlink:to="lab_us-gaap_SeveranceCosts1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_b27ef721-64bf-4a80-a285-9a8879cd3e89_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_b7ebdbb1-952d-4ec3-9451-c9b605f34473_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financial assets</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_4fe9f9fe-2273-48ef-818d-cdf59dbaa0cd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_b0bc8396-0bbf-444d-a527-2dd534b42c46_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock, consideration received on transaction</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7b42cce7-eeab-4664-aeb3-da97e2d99473_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_588adb2b-2d54-4517-b935-8a8f39ce5e0e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), before Reclassifications, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_6cb161df-c6e0-475d-8faa-32d182a4601a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_cf247534-88ff-4ec7-bb34-7a5fbd49f58e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_4abff6ef-e629-41f6-8f04-f53452ad965c_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP) Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock_349c314a-140f-48f5-a2bd-d957c2a0f8d6_terseLabel_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock_label_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs [Table Text Block]</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock_documentation_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:to="lab_rskd_DeferredContractFulfillmentCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_236bdf24-3b9c-43ff-8eac-cdeb7894db6b_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer matching contribution, percent of match</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_3f165dc2-51e3-4c66-a1a7-217817b5948c_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_7eac52d7-8cc1-448c-8cd0-710f1862c126_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassAMember_40136ae0-c35f-48ea-9f56-3cc9a376925c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Class A</link:label>
    <link:label id="lab_us-gaap_CommonClassAMember_label_en-US" xlink:label="lab_us-gaap_CommonClassAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Class A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassAMember" xlink:to="lab_us-gaap_CommonClassAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_598b4b08-bb02-4f36-a9a7-5a3d6ccc9862_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_163bae36-35a9-4af6-9247-bd01dc665a9d_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Conversion Description [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:to="lab_us-gaap_ConversionOfStockByUniqueDescriptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_b1cc2944-f921-4b33-9198-d10bf03b4769_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationTable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationTable" xlink:to="lab_us-gaap_IncomeTaxExaminationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_7f5a224e-dee9-4a2c-b6a5-c80c03772e1f_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_c84ae9db-ce68-4232-8bc8-6ce30a971b93_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_ContactPersonnelName_ae1d8f8b-db58-4b69-a810-61cc206ab241_terseLabel_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:label id="lab_dei_ContactPersonnelName_label_en-US" xlink:label="lab_dei_ContactPersonnelName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contact Personnel Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_ContactPersonnelName" xlink:to="lab_dei_ContactPersonnelName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_3c21ba40-5fb4-4d99-87d7-3dc6c5468d58_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_bce432f8-27a9-44c4-9bc6-bc4088de38b1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based payment arrangement, nonvested award, cost not yet recognized amount</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_3e796c52-af62-4a3c-89e1-a96a84ad2aed_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_f2337b20-5559-4b54-bc31-fbe47d00c8e1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Uncertain tax position</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxContingencies_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Contingency, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_9f3aadae-1b73-4eaf-be78-d8f3112e9d1f_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_7063afe6-00e4-419c-9e46-c9b7fa7670bc_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_2c8bd91c-9642-43b0-8085-a543ae641da5_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentRegistrationStatement_c824c261-bdf7-4a4e-8a12-fde14d1389f3_terseLabel_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:label id="lab_dei_DocumentRegistrationStatement_label_en-US" xlink:label="lab_dei_DocumentRegistrationStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Registration Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentRegistrationStatement" xlink:to="lab_dei_DocumentRegistrationStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EMEAMember_cd13a455-18df-4883-a455-115bb00e772f_terseLabel_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EMEA</link:label>
    <link:label id="lab_us-gaap_EMEAMember_label_en-US" xlink:label="lab_us-gaap_EMEAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">EMEA [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EMEAMember" xlink:to="lab_us-gaap_EMEAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_851eb355-f7be-4d57-9e5f-278456682b19_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts_fcc95d2c-b223-4dcb-9992-c23360e4af7e_terseLabel_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Fulfillment Costs</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts_label_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Fulfillment Costs</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts_documentation_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Fulfillment Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:to="lab_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_a77bdcf9-efb6-4a01-871e-dc2fe53a6fe2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Treasury shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_0fbdc1e8-be4d-4dcb-a900-e5d0923e29c5_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_4f58ea64-af67-4a1c-9b37-8140a74733f9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_a8dcb851-5e6b-48bc-8617-fc2ea92b0d18_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:to="lab_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_c5efe772-0f6b-4ac6-b480-8a0856192102_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_d6672de7-3f09-4415-965c-c269ff3857ce_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_8e1d868c-275c-447d-a664-3f01438898b4_terseLabel_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chief Executive Officer</link:label>
    <link:label id="lab_srt_ChiefExecutiveOfficerMember_label_en-US" xlink:label="lab_srt_ChiefExecutiveOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chief Executive Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ChiefExecutiveOfficerMember" xlink:to="lab_srt_ChiefExecutiveOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_a8f667bc-c9c9-4969-862c-bc351b29745a_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_6ce75cb0-4f7e-4ea2-bea7-dbb8c462c647_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward_c0a44d31-8162-4ae0-9f7f-b3fa3c40f4e1_terseLabel_en-US" xlink:label="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Acquisition Costs [Roll Forward]</link:label>
    <link:label id="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward_label_en-US" xlink:label="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Acquisition Costs [Roll Forward]</link:label>
    <link:label id="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward_documentation_en-US" xlink:label="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:href="rskd-20231231.xsd#rskd_MovementInDeferredContractAcquisitionCostsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:to="lab_rskd_MovementInDeferredContractAcquisitionCostsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_6531f8a6-f0c1-48ff-80bf-79e37cc719e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense_d74781c6-1d00-4643-a969-94e1dea698e7_negatedTerseLabel_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Amortization Expense</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense_label_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Amortization Expense</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense_documentation_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:to="lab_rskd_DeferredContractFulfillmentCostsAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_6117851c-4771-44bb-a716-9faf932f0b3d_verboseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of convertible preferred shares, net of issuance costs (in shares)</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_1acf3162-e06d-4cc2-9c04-9f3d31d1d69c_terseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of convertible preferred stock (in shares)</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_documentation_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_068e9487-02c0-4ade-8b6c-d8f32a143e3e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_39033083-56ae-4a7c-97e2-4caddf169a00_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IncreaseDecreaseInGuarantorObligations_be6d9c43-2cff-4f07-8555-fb8c7aef81e7_terseLabel_en-US" xlink:label="lab_rskd_IncreaseDecreaseInGuarantorObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee obligations</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInGuarantorObligations_label_en-US" xlink:label="lab_rskd_IncreaseDecreaseInGuarantorObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Guarantor Obligations</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInGuarantorObligations_documentation_en-US" xlink:label="lab_rskd_IncreaseDecreaseInGuarantorObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Guarantor Obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInGuarantorObligations" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInGuarantorObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IncreaseDecreaseInGuarantorObligations" xlink:to="lab_rskd_IncreaseDecreaseInGuarantorObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_3a26af2a-ad52-4914-afa1-63e0ce3bef54_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_970fd7fe-ea66-4bd6-9b5d-657e90ecca7b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_df63d225-c1ab-4ffc-9b7a-a0747a97441a_terseLabel_en-US" xlink:label="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary share warrants issued to a customer</link:label>
    <link:label id="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_label_en-US" xlink:label="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants, Operating Activities</link:label>
    <link:label id="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_documentation_en-US" xlink:label="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:href="rskd-20231231.xsd#rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:to="lab_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_4d71e1c7-c6fa-4dbb-ad7b-9ea466f8883a_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockAmountConverted1_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Amount Converted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockAmountConverted1" xlink:to="lab_us-gaap_ConversionOfStockAmountConverted1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_e04617ed-eb5a-44b0-a4a3-65fb7bcb7c99_terseLabel_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term deposits</link:label>
    <link:label id="lab_us-gaap_DepositsAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_DepositsAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deposits Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepositsAssetsCurrent" xlink:to="lab_us-gaap_DepositsAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_52443bf2-4bd1-4725-aae2-11ff1f6bf4ea_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Class A Ordinary Shares upon IPO, net of underwriting discounts and commissions and other issuance costs (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_298f2b03-92c9-4d37-bda4-0c7305d99036_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Share Options, Options forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_36f22e3f-185d-485e-a7f4-c27bc4167976_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_806da4ab-ed36-4ae7-a80b-777ad7cc8dc9_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized contract cost, amortization period</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortizationPeriod_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:to="lab_us-gaap_CapitalizedContractCostAmortizationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubleaseIncome_abed0aef-bc7d-469d-a624-11823aa13024_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_SubleaseIncome_label_en-US" xlink:label="lab_us-gaap_SubleaseIncome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sublease Income</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubleaseIncome" xlink:to="lab_us-gaap_SubleaseIncome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_f42504d5-1c4f-4952-85c1-f50c63d8f1a3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments included in accrued expenses and other current liabilities</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_e1234e73-757a-49ed-9850-4ef37423de90_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityPolicyTextBlock" xlink:to="lab_us-gaap_StockholdersEquityPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3e3e422c-54e3-42a1-9a34-ddf12d49cc96_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Unvested beginning balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_8efca0f7-9242-4427-94ea-bc5b859a0547_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Unvested ending balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_65dd617a-f838-4288-beb4-7ed66dad02b8_terseLabel_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred enterprise</link:label>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_label_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Preferred Enterprise, Amount</link:label>
    <link:label id="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_documentation_en-US" xlink:label="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Preferred Enterprise, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:to="lab_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock_1d7da73b-5b52-461b-b36e-6c769e0401b8_terseLabel_en-US" xlink:label="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-Term Deposits</link:label>
    <link:label id="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Deposits, Policy [Policy Text Block]</link:label>
    <link:label id="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Short-Term Deposits, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:href="rskd-20231231.xsd#rskd_ShortTermDepositsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:to="lab_rskd_ShortTermDepositsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_836a1203-fcac-4502-9b00-afafd0ec9bd0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Israel tax benefit at statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_92af2fbe-4e02-43a5-a64a-b2185b6d3b1e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExaminationLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Examination [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems" xlink:to="lab_us-gaap_IncomeTaxExaminationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_17240f6e-b704-4c60-bf3d-ef7457724311_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of deferred contract costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostAmortization_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostAmortization" xlink:to="lab_us-gaap_CapitalizedContractCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_91415566-554a-485b-8aa9-2dc43d4193a8_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_66e6140e-8029-44a4-b8c3-7b1d0c879200_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_bcb672f5-412e-49c1-84e1-0ed97f145c2a_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation capitalized for software development</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Amount Capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_95e9361c-e561-419f-8e0f-31df969f3c87_terseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of convertible preferred share warrants upon IPO</link:label>
    <link:label id="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_label_en-US" xlink:label="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Adjustments To Additional Paid In Capital, Reclassification Of Warrants</link:label>
    <link:label id="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_documentation_en-US" xlink:label="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Adjustments To Additional Paid In Capital, Reclassification Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:to="lab_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_d2350d2c-4faa-4e90-83b3-c973fc110df9_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_de2ef180-877e-4f86-b3a5-1504d051168a_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_8c936bbe-5c2f-4acd-8925-a911bebeca6e_terseLabel_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:label id="lab_dei_EntityAddressesAddressTypeAxis_label_en-US" xlink:label="lab_dei_EntityAddressesAddressTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressesAddressTypeAxis" xlink:to="lab_dei_EntityAddressesAddressTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65a1565c-8ce7-4a78-bddc-f9cca1b290b8_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_197cab05-1960-4d48-86a3-8fe2f6d1c406_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury shares</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_7ad4abe0-682b-49da-8510-e7407e18dbfc_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_439c5f57-33ce-4463-bf11-98d6f19d75f6_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_e318a467-e583-44db-901f-eca2e82f39a4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of noncash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_FurnitureAndOfficeEquipmentMember_e9a923ef-1cd0-4853-95a7-a6ac7256baf4_terseLabel_en-US" xlink:label="lab_rskd_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and office equipment</link:label>
    <link:label id="lab_rskd_FurnitureAndOfficeEquipmentMember_label_en-US" xlink:label="lab_rskd_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture And Office Equipment [Member]</link:label>
    <link:label id="lab_rskd_FurnitureAndOfficeEquipmentMember_documentation_en-US" xlink:label="lab_rskd_FurnitureAndOfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Furniture And Office Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FurnitureAndOfficeEquipmentMember" xlink:href="rskd-20231231.xsd#rskd_FurnitureAndOfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_FurnitureAndOfficeEquipmentMember" xlink:to="lab_rskd_FurnitureAndOfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_91c5346c-d63d-4328-948b-daa6149eb460_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_1d07d68b-3e8b-4a5f-b327-0f376fe4c1e1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_84e304ed-6a4e-4836-8ed8-c47b31f7923a_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_87111746-1767-4906-a1b1-a781453870de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Understatement of accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_ed2d24ca-3270-49d0-b159-41537c4310f2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares upon vesting of restricted share units (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Restricted Stock Award, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_9d8af812-1733-403b-865b-7e19db600bd6_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_91951e22-2d81-4557-b293-2dd4ece53444_negatedTerseLabel_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Preferred Shares into Class A Ordinary Shares upon IPO (in shares)</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:label id="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_documentation_en-US" xlink:label="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_5555a389-01ef-45cd-bc10-16d5cd779707_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_StockRepurchaseProgramTransactionCosts_02de54c3-577c-427c-85e9-5451fc07b7d0_terseLabel_en-US" xlink:label="lab_rskd_StockRepurchaseProgramTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transaction costs</link:label>
    <link:label id="lab_rskd_StockRepurchaseProgramTransactionCosts_label_en-US" xlink:label="lab_rskd_StockRepurchaseProgramTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Transaction Costs</link:label>
    <link:label id="lab_rskd_StockRepurchaseProgramTransactionCosts_documentation_en-US" xlink:label="lab_rskd_StockRepurchaseProgramTransactionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Transaction Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockRepurchaseProgramTransactionCosts" xlink:href="rskd-20231231.xsd#rskd_StockRepurchaseProgramTransactionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_StockRepurchaseProgramTransactionCosts" xlink:to="lab_rskd_StockRepurchaseProgramTransactionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_3310118c-645a-4967-a553-6973253628e2_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_70906e84-ed1e-4c36-ac8e-5cdb5f1ebcc1_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising expense</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_6d6441fd-815e-43d2-b85f-975d75ee1adf_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_9f022392-fb5c-4936-923d-25631a6c46c6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0302b36c-0fb7-4ff4-8ba2-2c58caf21b85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_d7c3c457-8560-4149-9c52-ba817f8af1c5_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Financial Instruments</link:label>
    <link:label id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesPolicyTextBlock" xlink:to="lab_us-gaap_DerivativesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_ed1366ba-2e02-45c5-999c-39406bac290b_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IPOMember_23e125be-cfc8-45a2-a295-07d47492e199_terseLabel_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IPO</link:label>
    <link:label id="lab_us-gaap_IPOMember_label_en-US" xlink:label="lab_us-gaap_IPOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IPO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IPOMember" xlink:to="lab_us-gaap_IPOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_de6c68c5-5680-4353-a908-d9200932c342_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_93c7737a-421f-4e71-ad74-1adf72c6056b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_3e04b4f2-71ab-41bf-8b38-c88cd25d2128_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:to="lab_us-gaap_PurchaseObligationDueInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_9cc04dfb-26e6-46ee-a51d-ec0d01f2bb22_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains (losses) on available-for-sale debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_7a9b52db-745a-4769-bca2-ed98209196ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_504ed876-0342-4990-84f5-19d44edbf2cb_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_f16081dd-6f60-430b-849a-365173957278_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization_73887a16-780f-434c-9df3-aafde994957a_negatedTerseLabel_en-US" xlink:label="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Deferred Contract Acquisition Cost, Amortization</link:label>
    <link:label id="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization_label_en-US" xlink:label="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Deferred Contract Acquisition Cost, Amortization</link:label>
    <link:label id="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization_documentation_en-US" xlink:label="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Capitalized Deferred Contract Acquisition Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:href="rskd-20231231.xsd#rskd_CapitalizedDeferredContractAcquisitionCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:to="lab_rskd_CapitalizedDeferredContractAcquisitionCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock_fd91b234-71e5-480f-8a4d-2fcbc566cf43_terseLabel_en-US" xlink:label="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary Share Warrants</link:label>
    <link:label id="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants and Rights, Rights, Warrants, Policy [Policy Text Block]</link:label>
    <link:label id="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants and Rights, Rights, Warrants, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:href="rskd-20231231.xsd#rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:to="lab_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_620fab47-1104-433f-9068-a25f2ca8c675_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Risks</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_8de4f039-8781-4fc1-91a0-ca8c2685ffce_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_20283b4a-de68-4b1a-a925-c1fad48f5e54_terseLabel_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_ConversionOfStockNameDomain_label_en-US" xlink:label="lab_us-gaap_ConversionOfStockNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Conversion of Stock, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConversionOfStockNameDomain" xlink:to="lab_us-gaap_ConversionOfStockNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_baf3c09d-a108-4882-b30f-a9d65da2b7a5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Temporary Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_a90bffe5-92e7-442b-a6d2-e35a87b0a00e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total derivative instruments</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_111a4b77-9c65-406b-bafe-bffb1a92253a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_843afded-83f9-42ba-8388-9eb5c1725f03_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_78a48c7e-079b-4d91-8b79-c91922f6a6ef_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign currency translation</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_2eacc5d3-1c97-4b5e-ba16-8a3cbb2b0861_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_81749107-c49c-400c-971a-ffe619d3f55e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_b851af11-a142-4b84-a6ed-1f262d4a0aa4_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_161c90ff-1c57-49c0-aa78-43e1507c2e32_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss) attributable to ordinary shareholders, basic</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_291063b0-e03b-457b-a64c-54b8bc0a52fc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_759cc566-6ee6-4047-a52b-4a54932b1fc2_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporates tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_ddd31299-a298-4bea-874c-9791fd469436_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Present value of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_5f233874-1dde-4158-baec-1b1c9556ce73_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_16964368-18a8-4662-a422-399ec79aa564_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total current income tax expense</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_0404e7bb-3114-4ca9-9f71-a01e58458cbc_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_342f3c31-afd9-43fd-9ff3-bc6dc624a494_terseLabel_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary Shares and Equity Incentive Plan</link:label>
    <link:label id="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shareholders' Equity and Share-Based Payments [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingDomain_bd8f4599-073c-498c-910e-d0a2820ffd89_terseLabel_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:label id="lab_us-gaap_VestingDomain_label_en-US" xlink:label="lab_us-gaap_VestingDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingDomain" xlink:to="lab_us-gaap_VestingDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_b3005b3f-dab8-488b-b788-4adb690adccb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_56d7532a-da4c-4be1-8f57-aab03ae32fbe_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Profit (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentShellCompanyReport_ac7c4cc3-b1fa-48af-a512-725c66dc495a_terseLabel_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:label id="lab_dei_DocumentShellCompanyReport_label_en-US" xlink:label="lab_dei_DocumentShellCompanyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Shell Company Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentShellCompanyReport" xlink:to="lab_dei_DocumentShellCompanyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_2a077ff8-2610-4376-ba36-ae83e3c58637_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">increase</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_f3f0b287-5870-4c78-95af-6a881dc0518e_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Defined contribution plan, cost</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_23d866b5-d3a0-4000-8db6-51e109703979_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total ordinary shares reserved (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_87fff979-f1c1-44dd-b41f-d45b4ea1f5eb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_96b0f7f8-0cde-4a88-9fd2-69e4a25e621a_negatedTerseLabel_en-US" xlink:label="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to ROU assets upon modification of existing lease</link:label>
    <link:label id="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_label_en-US" xlink:label="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right Of Use Asset, Lease Modification Adjustment</link:label>
    <link:label id="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_documentation_en-US" xlink:label="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Operating Lease, Right Of Use Asset, Lease Modification Adjustment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:href="rskd-20231231.xsd#rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:to="lab_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_395a90e6-26ab-4293-8d33-7df31bea25fe_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_6c8b2d0d-7184-479e-b5ab-eb0f42278c3c_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ChargebackExpense_0aeb4dff-c850-473d-bf2b-28d1073adc17_negatedTerseLabel_en-US" xlink:label="lab_rskd_ChargebackExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Chargeback expense</link:label>
    <link:label id="lab_rskd_ChargebackExpense_label_en-US" xlink:label="lab_rskd_ChargebackExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Chargeback Expense</link:label>
    <link:label id="lab_rskd_ChargebackExpense_documentation_en-US" xlink:label="lab_rskd_ChargebackExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Chargeback Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ChargebackExpense" xlink:href="rskd-20231231.xsd#rskd_ChargebackExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ChargebackExpense" xlink:to="lab_rskd_ChargebackExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_3e0c9211-7e6b-4d5b-a5ea-ffbc693660a6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_WarrantsAndRightsSettled_60ba6c42-a932-423d-ad17-f21dffce99f3_verboseLabel_en-US" xlink:label="lab_rskd_WarrantsAndRightsSettled" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Settlement of convertible preferred share tranche rights</link:label>
    <link:label id="lab_rskd_WarrantsAndRightsSettled_label_en-US" xlink:label="lab_rskd_WarrantsAndRightsSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants And Rights Settled</link:label>
    <link:label id="lab_rskd_WarrantsAndRightsSettled_documentation_en-US" xlink:label="lab_rskd_WarrantsAndRightsSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants And Rights Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsAndRightsSettled" xlink:href="rskd-20231231.xsd#rskd_WarrantsAndRightsSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_WarrantsAndRightsSettled" xlink:to="lab_rskd_WarrantsAndRightsSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_853febaa-5caf-4d5a-a6dd-64d14180fa3a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_10de8509-103c-43b6-b086-2235d1984e8b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_05661c40-dcea-413f-9825-9d144b4f3c51_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_f7d688dd-ea90-4ccf-b08a-da9f0b8d0a64_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term Investments</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_9ec6dec9-6ded-4585-9aa5-69a5b160975b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4becd94c-0969-4f36-b074-baed02074302_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, value, issued</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_6646b5c2-7b40-491e-8b4e-692751ece710_terseLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:label id="lab_us-gaap_TemporaryEquityByClassOfStockTable_label_en-US" xlink:label="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, by Class of Stock [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable" xlink:to="lab_us-gaap_TemporaryEquityByClassOfStockTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_89f8ad83-c2d4-40a1-b40a-28df24893767_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Government bonds</link:label>
    <link:label id="lab_us-gaap_USGovernmentDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentDebtSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_ae38abab-3542-4d74-9fe7-912a9c274c37_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_4d9d6a15-baaf-4a60-a04b-c0c90497f3f0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Periodic Reduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_f1f7980e-52ee-4efb-8933-16742d76ed10_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_4f9e6549-1038-4241-b6d3-c7d73e28acfc_terseLabel_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of convertible preferred share warrants upon IPO</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_label_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Reclassification Of Warrants</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_documentation_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Reclassification Of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:to="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_5a20a7d0-a617-45a4-b79f-a22f1a3732e7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_d5ceef80-c1bd-41ef-9d95-242e0eef44f4_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer credits</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Refund Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerRefundLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_FraudServiceRevenueMember_fa483aa9-18d9-485b-aa84-92ae4c3fa2ed_terseLabel_en-US" xlink:label="lab_rskd_FraudServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fraud Service Revenue</link:label>
    <link:label id="lab_rskd_FraudServiceRevenueMember_label_en-US" xlink:label="lab_rskd_FraudServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fraud Service Revenue [Member]</link:label>
    <link:label id="lab_rskd_FraudServiceRevenueMember_documentation_en-US" xlink:label="lab_rskd_FraudServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fraud Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FraudServiceRevenueMember" xlink:href="rskd-20231231.xsd#rskd_FraudServiceRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_FraudServiceRevenueMember" xlink:to="lab_rskd_FraudServiceRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_88065ce8-cdc5-4459-bbe6-65688a446123_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Immaterial Prior Period Error Corrections</link:label>
    <link:label id="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:to="lab_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRent_e8b452c2-39dd-4210-9c1a-29fa81586bc2_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:label id="lab_us-gaap_PaymentsForRent_label_en-US" xlink:label="lab_us-gaap_PaymentsForRent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Rent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRent" xlink:to="lab_us-gaap_PaymentsForRent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_7ce4639e-2575-4694-8df6-cf63c5480c1f_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_8a2e3557-ae8f-4bd8-a00b-816985f0ef0d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_3192f789-7f64-4e9e-bf44-6ee1dd013a5a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosures of cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e96d29cf-3973-4395-879a-fa60edad0d50_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_111d9e88-44e1-489b-adc3-095fd40c10c2_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligation_341f2d81-6134-46e1-97d4-d222ba6b0ec6_totalLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_PurchaseObligation_label_en-US" xlink:label="lab_us-gaap_PurchaseObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligation" xlink:to="lab_us-gaap_PurchaseObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_976450ad-39bd-4c2f-bb40-bc81d60fbd20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_f84a2103-045e-44b1-9377-a4b45e7aec84_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ExpirationPeriodDomain_d0bbaf39-e5cd-46df-938c-df2fd6c0c9c4_terseLabel_en-US" xlink:label="lab_rskd_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_rskd_ExpirationPeriodDomain_label_en-US" xlink:label="lab_rskd_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:label id="lab_rskd_ExpirationPeriodDomain_documentation_en-US" xlink:label="lab_rskd_ExpirationPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Expiration Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodDomain" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ExpirationPeriodDomain" xlink:to="lab_rskd_ExpirationPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_9bafe13e-6e61-469c-a0c2-f29d3ea37c88_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IncreaseDecreaseInCapitalizedContractCost_e2fd7505-41b9-4ea6-953b-a92018e844e2_negatedTerseLabel_en-US" xlink:label="lab_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract acquisition costs</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInCapitalizedContractCost_label_en-US" xlink:label="lab_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInCapitalizedContractCost_documentation_en-US" xlink:label="lab_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Capitalized Contract Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:to="lab_rskd_IncreaseDecreaseInCapitalizedContractCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_958cba58-b790-4a0a-a23f-fac5f79f6913_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_f3202961-9978-413e-b9c5-b488aed6ddea_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Authorized amounts under repurchase program</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_9482db81-c0f8-4bff-abf9-d3f2a900bc0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_ee44de0a-6bfc-4954-a345-bf9c41585292_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_960f85c7-17e7-4456-8d25-fa2531772506_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_fc4fc5ea-6ba2-4518-a61a-4e0109325f9a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6171ea45-8fb4-41be-9171-34a3476ccfa4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AddressTypeDomain_2a072719-a139-4fec-a4f7-74a55cbd20a5_terseLabel_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:label id="lab_dei_AddressTypeDomain_label_en-US" xlink:label="lab_dei_AddressTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Address Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AddressTypeDomain" xlink:to="lab_dei_AddressTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_a2ccc923-d9c8-41f6-9502-c23f1866fa88_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk, percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_88dd25d5-ca93-422b-8d31-6c840aa35949_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issued and Outstanding Share Warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_880def7a-7113-453b-9dad-72321fb79cae_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asia Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_bafa0c34-a595-4914-8fa1-5f92b1352aa8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2f7a5645-30d5-448d-a36a-67a94557d7e6_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_60690ba2-c01d-4eb1-99a8-1b0068c019a4_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashCurrent_label_en-US" xlink:label="lab_us-gaap_RestrictedCashCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashCurrent" xlink:to="lab_us-gaap_RestrictedCashCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_5507c568-1ca1-42fc-b6ef-1221fb4834e8_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan [Domain]</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Ownership Plan (ESOP), Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:to="lab_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_377c3002-e750-4d81-b030-dced93b7b9fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_4a075ef4-3ffc-4b49-aff0-99c4ec6810a6_terseLabel_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Net</link:label>
    <link:label id="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy_label_en-US" xlink:label="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:to="lab_us-gaap_TradeAndOtherAccountsReceivablePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_eb29bf28-e0e0-408e-923d-84c5c10b9a11_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_23775660-9a36-4315-ad8f-6952c04fa203_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decrease</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDeductions_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDeductions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_819857d2-eda9-4113-92f6-5cb5113f4341_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Options exercisable</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IL_948b1e25-798f-4513-9e56-92a8fcfc8117_terseLabel_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Israel</link:label>
    <link:label id="lab_country_IL_label_en-US" xlink:label="lab_country_IL" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ISRAEL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IL" xlink:to="lab_country_IL" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ac0397f0-d354-48fe-8dd6-a358e03a0519_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_97ef2d20-4142-431a-87ae-d79322bb86cb_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureTable_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_bc792675-63b4-41fd-95de-9581cc98cc02_terseLabel_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_ProductConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_ProductConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductConcentrationRiskMember" xlink:to="lab_us-gaap_ProductConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_0ec2b6d4-dbb7-432c-bac3-7b4b49188df5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remeasurement of convertible preferred share warrant liabilities</link:label>
    <link:label id="lab_us-gaap_FairValueAdjustmentOfWarrants_label_en-US" xlink:label="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Adjustment of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAdjustmentOfWarrants" xlink:to="lab_us-gaap_FairValueAdjustmentOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_b0b927f6-320c-46a0-95fc-aaa8118be704_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_b7345d19-80f8-475c-bb02-e797b15cbbc3_terseLabel_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of ordinary shares upon exercise of warrants (in shares)</link:label>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_label_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_documentation_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Warrants Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:to="lab_rskd_StockIssuedDuringPeriodSharesWarrantsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_c71e0876-a13a-4d87-86fe-e0f01a21a9e9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software development costs</link:label>
    <link:label id="lab_us-gaap_PaymentsToDevelopSoftware_label_en-US" xlink:label="lab_us-gaap_PaymentsToDevelopSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Develop Software</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToDevelopSoftware" xlink:to="lab_us-gaap_PaymentsToDevelopSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_f9340960-01de-4cb6-b89a-f2414fce1595_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_38f21515-5800-47cf-adf6-915244869950_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from cash exercise of series E-1 convertible preferred share warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromWarrantExercises_label_en-US" xlink:label="lab_us-gaap_ProceedsFromWarrantExercises" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Warrant Exercises</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromWarrantExercises" xlink:to="lab_us-gaap_ProceedsFromWarrantExercises" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_7c1c335b-a52b-41be-9652-b27c659ad13f_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_186a0c9d-7cf2-4181-9146-f4026110458b_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_28ba91e4-54f2-469b-b216-d45ff04fac09_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization_cc6aec0d-c636-4176-bcc4-8ff8604b197e_terseLabel_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization (in shares)</link:label>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization_label_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Recapitalization</link:label>
    <link:label id="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization_documentation_en-US" xlink:label="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:to="lab_rskd_StockIssuedDuringPeriodSharesRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_3fe3cbec-2705-4282-8851-4a9a9e8f7d1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_ae270c5f-fc91-4672-945c-aa23dab7454e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturities of short-term deposits</link:label>
    <link:label id="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_label_en-US" xlink:label="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Maturities, Prepayments and Calls of Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:to="lab_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4075053d-67eb-4f81-829f-cf7057acecd4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_9a8c60ce-b114-45cc-94c2-5b568fba3ad4_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_9b9953a0-f09f-4779-af1d-dabf9cf53373_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:to="lab_srt_ValuationAndQualifyingAccountsDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid_ebb71cdb-ddb8-439f-b528-5c3d0f6d5995_terseLabel_en-US" xlink:label="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of guarantees paid</link:label>
    <link:label id="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid_label_en-US" xlink:label="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Percentage Of Guarantees Paid</link:label>
    <link:label id="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid_documentation_en-US" xlink:label="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Percentage Of Guarantees Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:href="rskd-20231231.xsd#rskd_GuarantorObligationsPercentageOfGuaranteesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:to="lab_rskd_GuarantorObligationsPercentageOfGuaranteesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_3fceb6ae-dcbb-49a2-a5a9-ddc40bd40374_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_5a2ca0ec-1a12-4dbd-b9c1-21dcde2d3c93_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_e25c289e-8930-41a8-bee8-57d9fb1dc016_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_89a7585a-cdaf-475a-93e4-389d6aa60c22_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected term (years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_badc2241-342a-447c-afba-438673c3762c_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_81152032-9353-40ce-bf3a-df539f1963dc_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Profit (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6a691818-7e7f-4e24-a7fd-fcd33808117f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Profit (loss) before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_e01fedf9-b534-4bcb-8019-64981986ff86_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_13590ad2-aa25-48e3-8d18-b8b5cde27678_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d30e45fb-f0db-425a-8341-8d9ed23d4215_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_TaxYear2042Member_50baaa62-427d-4141-9c48-91fbc4c0cd8f_terseLabel_en-US" xlink:label="lab_rskd_TaxYear2042Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Year 2042</link:label>
    <link:label id="lab_rskd_TaxYear2042Member_label_en-US" xlink:label="lab_rskd_TaxYear2042Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Year 2042 [Member]</link:label>
    <link:label id="lab_rskd_TaxYear2042Member_documentation_en-US" xlink:label="lab_rskd_TaxYear2042Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Tax Year 2042</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TaxYear2042Member" xlink:href="rskd-20231231.xsd#rskd_TaxYear2042Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_TaxYear2042Member" xlink:to="lab_rskd_TaxYear2042Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_75ac81ac-b7a8-4c89-b88a-72c1cfb5a7e8_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_34171220-2386-48d4-812c-9642effc0dae_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Preferred Shares into Ordinary Shares upon IPO (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5294734e-737e-487c-aad4-3874ece69bb9_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued, conversion of convertible securities (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_ac840920-b48a-42e5-a5d3-30875575fa0c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_f2a35cf7-8f48-4ba2-ab05-e856cd2df666_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IndemnificationServiceRevenueMember_04dc9e6f-647b-4a6c-962c-f773f630b645_terseLabel_en-US" xlink:label="lab_rskd_IndemnificationServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnification Service Revenue</link:label>
    <link:label id="lab_rskd_IndemnificationServiceRevenueMember_label_en-US" xlink:label="lab_rskd_IndemnificationServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Indemnification Service Revenue [Member]</link:label>
    <link:label id="lab_rskd_IndemnificationServiceRevenueMember_documentation_en-US" xlink:label="lab_rskd_IndemnificationServiceRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Indemnification Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IndemnificationServiceRevenueMember" xlink:href="rskd-20231231.xsd#rskd_IndemnificationServiceRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IndemnificationServiceRevenueMember" xlink:to="lab_rskd_IndemnificationServiceRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_7cc65c0d-035a-497f-a24e-adbcbdf3de46_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_bef5d02a-1230-4dcc-8bfd-13416bb8e46a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_942f19d6-b470-4fc0-9a9e-2b7e2103a869_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_ca2a3e21-a0e2-49d9-b3ce-eeb4d80a00ea_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9f310f60-d8d1-4949-879c-a271442fa452_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_09b0ab0c-5c96-4fcd-91a7-63a138626b31_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_90051e1d-6c2a-4c84-a822-427c18bff110_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_d6ceb80e-4e5b-431f-8e23-95f876eaab89_terseLabel_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_label_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_documentation_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:to="lab_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_763cb6d7-7746-4dea-a363-c3398d5e8f09_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_57b7ab80-b5d0-4a9e-ae9d-7bfe542acf4a_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_20877ef6-f127-43c0-8420-d54ee8de7b13_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price, beginning balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_73645319-3176-4592-875a-130b54462781_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price, ending balance (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_cfa6d81c-4b51-4864-9a3a-76a01cd6c500_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_860073c6-a75a-4d02-91a7-24650f4f7b1f_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_fe2e3e49-4948-488d-9896-1fc5910b7a43_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_d3c78798-fb8e-43d9-ab64-9d006eb504c2_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_13920316-196b-4752-86d0-9b95b7c3dc49_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_22be648f-b12d-452a-8ad8-453703f21ee9_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of convertible preferred shares and warrants, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Convertible Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_90a41446-bfc6-4ffd-ac0a-83ce37f0b129_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_d115d6de-50e7-43d8-89ad-f0fca2bd43a3_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_cd622c5d-4a95-4832-8e8a-949969ea34d1_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_5798865c-83bb-4674-a3ab-c66992b8f855_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_fec6c5b2-389c-4277-a2a9-2f46b654cb80_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesDomain_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_dbf5b322-2d97-4411-9e51-ec9926e02c1b_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ContractualObligationTerm_8f6012ea-e657-4310-b424-616a3e1c774e_terseLabel_en-US" xlink:label="lab_rskd_ContractualObligationTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual obligation, term</link:label>
    <link:label id="lab_rskd_ContractualObligationTerm_label_en-US" xlink:label="lab_rskd_ContractualObligationTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Term</link:label>
    <link:label id="lab_rskd_ContractualObligationTerm_documentation_en-US" xlink:label="lab_rskd_ContractualObligationTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contractual Obligation, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ContractualObligationTerm" xlink:href="rskd-20231231.xsd#rskd_ContractualObligationTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ContractualObligationTerm" xlink:to="lab_rskd_ContractualObligationTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_78fe1cf2-9b93-4228-84ea-edfad06a8a6c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_bacc72b0-012f-4974-aab6-0a23607ed97d_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Restatement Recovery Analysis [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:to="lab_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts_2130de6f-17b0-4bdf-ac71-8b2ee1664813_terseLabel_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Acquisition Costs</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts_label_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Acquisition Costs</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts_documentation_en-US" xlink:label="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) To Deferred Contract Acquisition Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:to="lab_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_58380979-2683-4ede-a38e-1b5210e50dcd_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software and Software Development Costs</link:label>
    <link:label id="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_label_en-US" xlink:label="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software and Software Development Costs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:to="lab_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_6d316e7c-8343-409c-bef8-8a702d1a051e_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits, income tax penalties and interest expense</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_29fa3735-6f52-4e24-9772-ff90a5d9d41e_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a0353cba-b4cd-4a00-a6a1-2dc3e762abce_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c0e61dac-55bc-4d16-9867-69080ad4fd3d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_5a21b68b-f4f7-40bc-9cda-37f4af534472_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Description of Business</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_abfb3222-4d74-42f3-9109-46f97dc04964_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_868cd3c6-c7d3-4cce-b2dd-ed2770b3a30b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_82422a08-2ccb-4227-a561-0f20f7327334_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_3b88e1e6-e9a9-4c45-9a39-d3c91f252162_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive profit (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_BusinessContactMember_e9aa9943-41ce-4b4e-9230-d042184d0423_terseLabel_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Contact</link:label>
    <link:label id="lab_dei_BusinessContactMember_label_en-US" xlink:label="lab_dei_BusinessContactMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Business Contact [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_BusinessContactMember" xlink:to="lab_dei_BusinessContactMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_a610dcac-7dcd-475b-9608-c38a15919565_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_03ca7709-f334-49ea-b221-223bc8379b22_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_a0f5b2c8-ef58-4e79-820f-fbe844da13df_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicLineItems_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems" xlink:to="lab_us-gaap_EarningsPerShareBasicLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_3f5428a5-c982-4ed7-9770-979d85af3328_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total financial liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_0a18828c-8441-450e-a139-e624a95e41a0_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_7d4eb248-fa66-4d37-aa62-ab8ee935b6e5_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule II - Valuation and Qualifying Accounts</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_98e53058-4aac-40b2-85a1-544ccc428bed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOther" xlink:to="lab_us-gaap_DeferredTaxAssetsOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_169b741a-fc19-4cd8-9c55-ea22383f4af9_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by (used in) financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_10484ca2-a7af-4e28-8a0f-afb264624fa1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_0b48a528-82b9-4133-8ea0-714e32585028_terseLabel_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ordinary shares reserved for future issuance, annual increase percentage</link:label>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_label_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Annual Increase, Percent</link:label>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_documentation_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Annual Increase, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:to="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_948bf898-7999-475a-b304-57b891662cf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantees, Commitments, and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments Contingencies and Guarantees [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:to="lab_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_17404093-1a28-45b2-8591-e6d2413481ef_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_3ed29740-0942-424d-9f3f-4af758a22c08_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Indemnifications Guarantees</link:label>
    <link:label id="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_label_en-US" xlink:label="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantees, Indemnifications and Warranties Policies [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:to="lab_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_96602410-c715-4166-aede-26eae5de90f8_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_7618ce37-e961-4150-a001-8398ca6ecc75_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_47f554e6-8a78-482a-b5e3-c39b502a5f03_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_4091effc-4807-4522-979a-46e364b5954e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_5c4ebf9f-faca-4071-8643-02493966e4a6_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_7b024900-6cef-4ccb-a91b-542153917b19_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Percentage of Company's workforce to be impacted (percent)</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Number of Positions Eliminated, Period Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:to="lab_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_f15061db-2e32-4319-98cc-b849b4c01083_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_NonIsraelMember_de923e56-c293-47d2-ab06-3c857d89885f_terseLabel_en-US" xlink:label="lab_rskd_NonIsraelMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_rskd_NonIsraelMember_label_en-US" xlink:label="lab_rskd_NonIsraelMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Israel [Member]</link:label>
    <link:label id="lab_rskd_NonIsraelMember_documentation_en-US" xlink:label="lab_rskd_NonIsraelMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Israel</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelMember" xlink:href="rskd-20231231.xsd#rskd_NonIsraelMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_NonIsraelMember" xlink:to="lab_rskd_NonIsraelMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_d8249062-eb0f-4e2f-95d9-bc5cec8e78b8_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets/(liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_b6344d4a-2601-46a9-b74c-67230f04a10c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Options exercised</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ProvisionForChargebacksMember_85449198-83f6-4d89-b66a-15fa38400b15_terseLabel_en-US" xlink:label="lab_rskd_ProvisionForChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for chargebacks, net</link:label>
    <link:label id="lab_rskd_ProvisionForChargebacksMember_label_en-US" xlink:label="lab_rskd_ProvisionForChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision For Chargebacks [Member]</link:label>
    <link:label id="lab_rskd_ProvisionForChargebacksMember_documentation_en-US" xlink:label="lab_rskd_ProvisionForChargebacksMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision For Chargebacks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksMember" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ProvisionForChargebacksMember" xlink:to="lab_rskd_ProvisionForChargebacksMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_91a298de-43a9-4ffb-814a-60563b27e468_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected costs to be incurred</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_8e46c41c-9964-4cbf-ba0c-e5f118587b36_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net profit (loss) attributable to ordinary shareholders, diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_1ebb8489-64de-4621-8668-b6aa7e51452f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_64e18b4b-614d-4650-a920-cb32cc736b85_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_11922fd8-99d3-44a9-b3c5-a33a95ba1fb2_terseLabel_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_label_en-US" xlink:label="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period, Error Correction, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:to="lab_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_b95f738c-ed12-4b25-8cbe-35073b462732_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInSecondYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInSecondYear" xlink:to="lab_us-gaap_PurchaseObligationDueInSecondYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_3535e1d2-cadf-451b-b79a-f29f9f6c60c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_3243c355-60e1-4de7-a339-46983f1f34e7_terseLabel_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_PurchaseObligationDueInThirdYear_label_en-US" xlink:label="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Purchase Obligation, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PurchaseObligationDueInThirdYear" xlink:to="lab_us-gaap_PurchaseObligationDueInThirdYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_084ee621-0d66-4a2e-b8e6-2ca113521f7e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consolidated Balance Sheet Components</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ProvisionForChargebacksCurrent_97532ecb-5fbb-4952-acc0-325323db6928_terseLabel_en-US" xlink:label="lab_rskd_ProvisionForChargebacksCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for chargebacks, net</link:label>
    <link:label id="lab_rskd_ProvisionForChargebacksCurrent_label_en-US" xlink:label="lab_rskd_ProvisionForChargebacksCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Provision For Chargebacks, Current</link:label>
    <link:label id="lab_rskd_ProvisionForChargebacksCurrent_documentation_en-US" xlink:label="lab_rskd_ProvisionForChargebacksCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Provision For Chargebacks, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksCurrent" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ProvisionForChargebacksCurrent" xlink:to="lab_rskd_ProvisionForChargebacksCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_4b8e6fae-9539-4f0d-8cd4-f65e38f7a7d3_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_293f49da-c833-4ef4-8f64-0cbf3b315e2d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_e8914f34-6325-4919-b349-da079ad8250a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_341c5223-2eba-47e1-974c-b2382e80e1dd_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, shares authorized (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AmericasMember_94a2b89f-c530-4eef-8ad1-65b97cb26a8e_terseLabel_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Americas</link:label>
    <link:label id="lab_srt_AmericasMember_label_en-US" xlink:label="lab_srt_AmericasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Americas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AmericasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AmericasMember" xlink:to="lab_srt_AmericasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_ab7bdc3e-0518-4d7b-9d18-d58934f0df2f_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of capitalized internal-use software costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareAmortization1_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareAmortization1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_4b9103dd-f7e9-44ea-98cb-3b0479964237_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sublease income</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Income Statement, Sublease Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:to="lab_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_f150c56f-2095-4849-a465-45332e76dfc9_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_76c20831-72c9-4236-b9cc-1f38372bbb97_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Fair Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_550f105d-584c-4124-a792-a97dc3c7c104_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_adb638ac-44a9-4861-8dab-67ef3c864ab6_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_ea06b5e8-efe8-4f09-b100-6598bf03bbc1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_da14c3e2-6daa-4b77-a2d3-c96d695defa4_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock</link:label>
    <link:label id="lab_us-gaap_ConvertiblePreferredStockMember_label_en-US" xlink:label="lab_us-gaap_ConvertiblePreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertiblePreferredStockMember" xlink:to="lab_us-gaap_ConvertiblePreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_34707f17-036c-47c5-a65a-a0ecd2970fc1_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_69d53a36-ea3a-41e0-b477-41ccf0cd6d3a_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_77f12f17-625a-451c-bc95-c63bd308cef9_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in valuation allowance for deferred tax asset</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec217688-7d33-4273-9198-0f007edb8a18_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_fec49cb3-3810-4db5-bde5-6daa361f66f3_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_77fd16de-e19f-460d-87cd-2d349a55aed4_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_99db95ef-6f00-4460-bebd-d8829ad01a43_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock split conversion ratio</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="lab_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_1f018e57-b3b1-443d-b6fa-2909413abd8c_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for (benefit from) account receivable allowances</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_a63226e3-e9f1-4967-9749-349e64c6ccc6_verboseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Current period provision</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeAssets_aca98fbf-ec1e-4077-b91b-a595d6fb51a0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative financial instruments included in prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_DerivativeAssets_label_en-US" xlink:label="lab_us-gaap_DerivativeAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeAssets" xlink:to="lab_us-gaap_DerivativeAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_0e9515c0-4b8c-4865-abe0-8a3e4d046fec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_199ace53-5110-479c-820d-474c945f2599_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Leasing Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesLeasingArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9e6f813f-acfb-4acb-83b2-1723718377a4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total deferred income tax expense</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_92ba45c2-030b-4942-8a2b-d97142149767_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_211954c6-5643-4642-8205-a9d41ed6388b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_4ef1f2ed-ba96-4dd1-be58-4b4a9d1d8c52_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from exercise of share options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_4a0d3df7-ebef-42f1-bde2-2203c82decfd_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeasesRentExpenseNet_label_en-US" xlink:label="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Leases, Rent Expense, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasesRentExpenseNet" xlink:to="lab_us-gaap_OperatingLeasesRentExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid_b9e1e174-63b3-4e7f-9378-b5bdacdd0dd3_terseLabel_en-US" xlink:label="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred offering costs accrued but not paid</link:label>
    <link:label id="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid_label_en-US" xlink:label="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs Incurred But Not Yet Paid</link:label>
    <link:label id="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid_documentation_en-US" xlink:label="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Offering Costs Incurred But Not Yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:href="rskd-20231231.xsd#rskd_DeferredOfferingCostsIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:to="lab_rskd_DeferredOfferingCostsIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_SeverancePayRate_dcdf5ea9-9bdc-4c61-b858-768f52c9cb6e_terseLabel_en-US" xlink:label="lab_rskd_SeverancePayRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Severance pay rate</link:label>
    <link:label id="lab_rskd_SeverancePayRate_label_en-US" xlink:label="lab_rskd_SeverancePayRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Severance Pay Rate</link:label>
    <link:label id="lab_rskd_SeverancePayRate_documentation_en-US" xlink:label="lab_rskd_SeverancePayRate" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Severance Pay Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeverancePayRate" xlink:href="rskd-20231231.xsd#rskd_SeverancePayRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_SeverancePayRate" xlink:to="lab_rskd_SeverancePayRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_53c99847-fcb7-4799-b424-83e4149ddfde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Tranche Three</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Three [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_f61feafa-62ee-4b87-9105-025a322507f4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price, Options forfeited (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_23535ad4-d8d0-4d04-8a81-2a2554d9e812_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_868a0dfe-6a04-428b-9134-fb945ff27d92_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_a14dffcf-da6c-446a-a732-d399aa09a692_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_0ed2ce9c-dbfd-4abc-b31d-455793066684_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CommonStockVotesForEachShare_7724d42d-d808-416e-a229-86829dffe8f0_terseLabel_en-US" xlink:label="lab_rskd_CommonStockVotesForEachShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Votes per common share</link:label>
    <link:label id="lab_rskd_CommonStockVotesForEachShare_label_en-US" xlink:label="lab_rskd_CommonStockVotesForEachShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Votes For Each Share</link:label>
    <link:label id="lab_rskd_CommonStockVotesForEachShare_documentation_en-US" xlink:label="lab_rskd_CommonStockVotesForEachShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Votes For Each Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockVotesForEachShare" xlink:href="rskd-20231231.xsd#rskd_CommonStockVotesForEachShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CommonStockVotesForEachShare" xlink:to="lab_rskd_CommonStockVotesForEachShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_941be67e-8c1b-4434-855e-a25576011b71_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer matching contribution, percent of employees' pay</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_74ffb827-3074-4dec-96d7-cd47c16f1903_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, allowance for credit loss</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_3f84ce6a-6a73-4b8f-a6b9-1fa84fa23e89_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f2e9db87-04f3-449d-8ae7-dec0109d148b_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_4ec13b96-6f13-45aa-af07-ffdba8699cde_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic Value, Options outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_76a706af-d2ff-4e9d-a6b7-71edc4802e95_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_ConvertiblePreferredShareTrancheRightsMember_654a289f-e4ae-4b74-b853-f1d455d81137_verboseLabel_en-US" xlink:label="lab_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Share Tranche Rights [Member]</link:label>
    <link:label id="lab_rskd_ConvertiblePreferredShareTrancheRightsMember_fdbb2687-ecc3-46cc-927a-deaad1d68d60_terseLabel_en-US" xlink:label="lab_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible Preferred Share Tranche Rights [Member]</link:label>
    <link:label id="lab_rskd_ConvertiblePreferredShareTrancheRightsMember_label_en-US" xlink:label="lab_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Preferred Share Tranche Rights [Member]</link:label>
    <link:label id="lab_rskd_ConvertiblePreferredShareTrancheRightsMember_documentation_en-US" xlink:label="lab_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Preferred Share Tranche Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:to="lab_rskd_ConvertiblePreferredShareTrancheRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_ad30db81-461b-4710-a574-a8a3f22bc705_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Tranche Two</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="lab_us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_8cb184e4-8f96-437d-a9dc-1646c5c18df6_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_b952bc32-6bba-4196-a2ce-9e94dbd73964_terseLabel_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_b1f0addb-30c2-47a8-94c3-1975b8b0c679_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_cf51b54c-8b19-4cce-906e-d7b908167db1_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_ed8b6504-a4ff-473b-9331-9986b709dbf4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred Policy Acquisition Costs</link:label>
    <link:label id="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Policy Acquisition Costs [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:to="lab_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_70e6939b-6a35-4405-96b1-8c3d0ff2beed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_e941fc72-c68f-418b-b075-944cf07d37f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_2253cf61-24ca-4c3d-b5fb-e5a9abcab1f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-Average Exercise Price, Options exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesMember_4cbda56b-d7fc-493c-af9f-3f6fc6ab91b4_terseLabel_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesMember_label_en-US" xlink:label="lab_us-gaap_SalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesMember" xlink:to="lab_us-gaap_SalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_RevenueTermOfMerchantContract_b8075045-2eec-4159-bd27-ef371ba15d6c_terseLabel_en-US" xlink:label="lab_rskd_RevenueTermOfMerchantContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract term with merchant</link:label>
    <link:label id="lab_rskd_RevenueTermOfMerchantContract_label_en-US" xlink:label="lab_rskd_RevenueTermOfMerchantContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Term Of Merchant Contract</link:label>
    <link:label id="lab_rskd_RevenueTermOfMerchantContract_documentation_en-US" xlink:label="lab_rskd_RevenueTermOfMerchantContract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Term Of Merchant Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_RevenueTermOfMerchantContract" xlink:href="rskd-20231231.xsd#rskd_RevenueTermOfMerchantContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_RevenueTermOfMerchantContract" xlink:to="lab_rskd_RevenueTermOfMerchantContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_e49a44dd-e815-4f8a-9f70-c78a81caf19c_terseLabel_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized Software Costs and Cloud Computing Arrangement Implementation Costs</link:label>
    <link:label id="lab_us-gaap_InternalUseSoftwarePolicy_label_en-US" xlink:label="lab_us-gaap_InternalUseSoftwarePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Internal Use Software, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InternalUseSoftwarePolicy" xlink:to="lab_us-gaap_InternalUseSoftwarePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_16cf1534-ecae-4df3-a0dd-0233aadb4bc7_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vacation and convalescence</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_285aa787-6362-45ff-897d-d2424e67fda0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rollforward of Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:to="lab_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_383b07c1-9c21-4eb6-b200-8d4d68299adf_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_9ffe7133-4862-4ed1-9402-68f8ac3f85f7_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_9310599d-567a-4942-8fa4-f06cc9c495d3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total gain (loss) recognized in earnings</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_8509c6e8-d983-4467-9072-7c4316f1c31a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_86d67a2b-7275-49b2-bf62-c57ee5bb4521_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_64076814-4540-4920-ad82-af8fe7a897dc_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for (benefit from) income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_4e72c99a-6594-4769-8202-ed250e324d5e_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_c65caaae-24e1-4da1-9572-b982017ecfda_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_4054cc73-f00f-4ccc-83f0-7959ddd7818d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Uncollectible accounts charged against the allowance</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_c81434fb-83e7-4f0e-a5f5-be2b14a3c582_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_6860d7e5-bccb-4dbc-b430-d865b5f9f0a6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VestingAxis_c86030e2-3fc1-4c88-92d0-c8ce82305539_terseLabel_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:label id="lab_us-gaap_VestingAxis_label_en-US" xlink:label="lab_us-gaap_VestingAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VestingAxis" xlink:to="lab_us-gaap_VestingAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_877029f9-9791-40f7-9cb4-332cb3783972_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_556ca0aa-d0a2-48e5-b17f-10ec8b48c20d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_c79828c6-d2cb-4bef-8917-329c05b6fc2a_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsNoncurrent_be24202d-0b9e-44ac-86f6-bd2202b9e8f1_periodStartLabel_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Noncurrent</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsNoncurrent_e25cf902-807b-4f83-9184-5d3842ff1baa_periodEndLabel_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Noncurrent</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsNoncurrent_label_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Noncurrent</link:label>
    <link:label id="lab_rskd_DeferredContractFulfillmentCostsNoncurrent_documentation_en-US" xlink:label="lab_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Contract Fulfillment Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:to="lab_rskd_DeferredContractFulfillmentCostsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_f1f54f3d-0eb1-4f4b-8a91-996aa5b6f454_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_90d2899b-972a-48c5-ba00-17de48ebaf56_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_c8dcc794-5316-46e0-ae36-69fac6ffa056_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Overstatement of deferred contract acquisition costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_77d7d2f1-8634-4cf0-a066-bea5cc02337f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Net, Noncurrent</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_04abbba4-9f78-4a1b-ade3-3d5bc0cc065d_periodEndLabel_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Net, Noncurrent</link:label>
    <link:label id="lab_us-gaap_CapitalizedContractCostNetNoncurrent_label_en-US" xlink:label="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Contract Cost, Net, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:to="lab_us-gaap_CapitalizedContractCostNetNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_cade0ce3-6abf-497c-be89-1e83b296b39b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of Class A ordinary shares upon IPO, net of underwriting discounts and commissions and other issuance costs</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_48b1d61d-a53a-40e6-aece-d1e06b451cdc_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_b022e26d-284b-4a00-aeca-85b81083ac69_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_3549bd49-e7f8-42a8-812d-6ad12a9362b8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_6cc17c28-8a97-436f-9ca9-7562a6c0b7b3_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_953567a0-5e81-4e77-b691-341ee39cdb23_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_c0c2ecb2-e349-4473-8d69-4e2fe0be616a_periodStartLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_3262db20-20a7-40e3-a4a4-948288dbbd74_periodEndLabel_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_TemporaryEquitySharesOutstanding_label_en-US" xlink:label="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Temporary Equity, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TemporaryEquitySharesOutstanding" xlink:to="lab_us-gaap_TemporaryEquitySharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_WarrantIssuedToCustomersMember_7979f756-e3d1-42bf-9117-78c00301bf67_terseLabel_en-US" xlink:label="lab_rskd_WarrantIssuedToCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants issued to customers</link:label>
    <link:label id="lab_rskd_WarrantIssuedToCustomersMember_label_en-US" xlink:label="lab_rskd_WarrantIssuedToCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant Issued To Customers [Member]</link:label>
    <link:label id="lab_rskd_WarrantIssuedToCustomersMember_documentation_en-US" xlink:label="lab_rskd_WarrantIssuedToCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrant Issued To Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantIssuedToCustomersMember" xlink:href="rskd-20231231.xsd#rskd_WarrantIssuedToCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_WarrantIssuedToCustomersMember" xlink:to="lab_rskd_WarrantIssuedToCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_d2e883b7-f7d2-44cb-b149-8f1edb874af7_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_16021435-d0e3-468e-ae9b-0756b5608e95_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_479d5f03-551f-4406-827d-900f20ffce78_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_1e9d1cd0-ca03-42d2-8c87-ed3aa23a8d77_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:to="lab_us-gaap_MovementInValuationAllowancesAndReservesRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_78404edc-b8d6-4b00-b37d-d2c01d33fe4e_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_58759df8-f9e0-493f-8e96-b55ff8bfc476_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Due in 1 year or less</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_4c931f09-d930-4149-9584-7248d99c826c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of Treasury shares (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_3ee6a9e2-567c-4a96-a7c1-03c08d4ff6e6_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_IncreaseDecreaseInProvisionForChargebacks_153a9ca8-fa59-48f4-b717-2b6d84190496_terseLabel_en-US" xlink:label="lab_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for chargebacks, net</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInProvisionForChargebacks_label_en-US" xlink:label="lab_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Provision For Chargebacks</link:label>
    <link:label id="lab_rskd_IncreaseDecreaseInProvisionForChargebacks_documentation_en-US" xlink:label="lab_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Provision For Chargebacks</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInProvisionForChargebacks"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:to="lab_rskd_IncreaseDecreaseInProvisionForChargebacks" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_8b386a14-0641-492b-84a7-cb5d246e4fb3_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_bc9c8731-65a7-481b-b84d-560baa64649e_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_93e21b38-c69c-4f93-97e8-52db1466fe0e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">General and Administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_b0b9ef96-b714-4af0-ba6e-35da0ca58ef4_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets/(liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilities" xlink:to="lab_us-gaap_DeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_5e4e9604-5d3e-4426-9e83-77ad86e24961_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sales and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_9e531765-a0ed-4476-8ea7-8c4e7daa69bf_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_0e9ee183-ca9d-4d45-9a25-45e7ea784a0c_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Software Development</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_A2021EmployeeSharePurchasePlanMember_01175906-7108-4590-9e01-fc09cb01978b_terseLabel_en-US" xlink:label="lab_rskd_A2021EmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Employee Share Purchase Plan</link:label>
    <link:label id="lab_rskd_A2021EmployeeSharePurchasePlanMember_label_en-US" xlink:label="lab_rskd_A2021EmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Employee Share Purchase Plan [Member]</link:label>
    <link:label id="lab_rskd_A2021EmployeeSharePurchasePlanMember_documentation_en-US" xlink:label="lab_rskd_A2021EmployeeSharePurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Employee Share Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EmployeeSharePurchasePlanMember" xlink:href="rskd-20231231.xsd#rskd_A2021EmployeeSharePurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_A2021EmployeeSharePurchasePlanMember" xlink:to="lab_rskd_A2021EmployeeSharePurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_fa6a2557-e85a-448a-b248-f5bfe18d530c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_A2021EquityIncentivePlanMember_c07d8e5f-df75-4d03-9913-8ce4489a272e_terseLabel_en-US" xlink:label="lab_rskd_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:label id="lab_rskd_A2021EquityIncentivePlanMember_label_en-US" xlink:label="lab_rskd_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rskd_A2021EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rskd_A2021EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2021 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EquityIncentivePlanMember" xlink:href="rskd-20231231.xsd#rskd_A2021EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_A2021EquityIncentivePlanMember" xlink:to="lab_rskd_A2021EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_07629714-8fab-4f26-82db-655cb445b402_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized software costs</link:label>
    <link:label id="lab_us-gaap_CapitalizedComputerSoftwareGross_label_en-US" xlink:label="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Capitalized Computer Software, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalizedComputerSoftwareGross" xlink:to="lab_us-gaap_CapitalizedComputerSoftwareGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_d3d3b7fd-5f3c-46ef-b3d0-ab7d7b09c802_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest income (expense), net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNonoperatingNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income (Expense), Nonoperating, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNonoperatingNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_3b27b195-e165-4eb6-aa3a-97e63ae74707_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_a24253b6-e685-4346-b0cb-c599b1b21e0b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_08c61737-8056-4ba2-a87d-677913eb5481_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_6829396b-b646-4cd0-90c7-fe6378138d52_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_5216e93e-6d17-4420-9eae-b66d13c4c214_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_d2ea54e2-3358-4bb2-a07a-6a389e85f961_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_992e2ed3-b9d9-4342-b333-5731fbf7f3b0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Bad debts</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_830262ab-8031-440c-8c32-149bafad47de_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exchange of Class B ordinary shares to Class A ordinary shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_52497ea4-68bb-4cb8-868f-e99c440aa14c_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_64708dc0-4b21-4295-b3bb-e3e15e291419_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_201f72b3-5a6e-42d0-81d4-bf38f8042e83_terseLabel_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum ownership of shares</link:label>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_label_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Ownership, Percentage</link:label>
    <link:label id="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_documentation_en-US" xlink:label="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Common Stock, Capital Shares Reserved For Future Issuance, Maximum Ownership, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:to="lab_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_6977bd83-39ed-4dfd-9d73-d219c84e59b0_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4b5c7d7b-dca6-4afe-8a7c-6971d21882d0_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_WarrantsToPurchaseOrdinarySharesMember_942916cf-3b92-400b-bf97-3965aa87333c_terseLabel_en-US" xlink:label="lab_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants To Purchase Ordinary Shares</link:label>
    <link:label id="lab_rskd_WarrantsToPurchaseOrdinarySharesMember_label_en-US" xlink:label="lab_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrants To Purchase Ordinary Shares [Member]</link:label>
    <link:label id="lab_rskd_WarrantsToPurchaseOrdinarySharesMember_documentation_en-US" xlink:label="lab_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Warrants To Purchase Ordinary Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:href="rskd-20231231.xsd#rskd_WarrantsToPurchaseOrdinarySharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:to="lab_rskd_WarrantsToPurchaseOrdinarySharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_661a5c5e-5ce1-4ef5-b8c8-e2f58426cd47_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_af981794-fc70-45d7-8cf0-11de7f70cbdf_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_b5d4fb33-0af9-4cc5-8334-97071ce36be1_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plans</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanTextBlock_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanTextBlock" xlink:to="lab_us-gaap_DefinedContributionPlanTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_dcc3245f-a96d-4e3a-abcf-5da1a2487a34_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_8dd3eae8-b3c6-40e8-afa3-25704c61cd82_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Other liabilities, noncurrent</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_71f0ef29-5c4f-4a68-83ff-edffc3b98073_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_4c7e3a66-322e-4908-b34e-255793114158_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total undiscounted lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_GuarantorObligationsChargebackExpense_c21ea9f3-de4a-475a-a24a-28f4e85f64ba_terseLabel_en-US" xlink:label="lab_rskd_GuarantorObligationsChargebackExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Chargeback expense</link:label>
    <link:label id="lab_rskd_GuarantorObligationsChargebackExpense_label_en-US" xlink:label="lab_rskd_GuarantorObligationsChargebackExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Chargeback Expense</link:label>
    <link:label id="lab_rskd_GuarantorObligationsChargebackExpense_documentation_en-US" xlink:label="lab_rskd_GuarantorObligationsChargebackExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Chargeback Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_GuarantorObligationsChargebackExpense" xlink:href="rskd-20231231.xsd#rskd_GuarantorObligationsChargebackExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_GuarantorObligationsChargebackExpense" xlink:to="lab_rskd_GuarantorObligationsChargebackExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermInvestments_89924586-ed2c-45b1-9871-cf83b54290c9_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_ee455217-e465-443a-9ba8-ea19900d4c84_verboseLabel_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Government bonds included within short-term investments</link:label>
    <link:label id="lab_us-gaap_ShortTermInvestments_label_en-US" xlink:label="lab_us-gaap_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermInvestments" xlink:to="lab_us-gaap_ShortTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_02fa1ed2-1fd9-4b63-b9af-ced7824c958b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpenseMember_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_2de4345d-863b-4b48-bb27-310279b29c6d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxContingencyLineItems_label_en-US" xlink:label="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Contingency [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems" xlink:to="lab_us-gaap_IncomeTaxContingencyLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_f0769307-4bb0-4dbf-842b-e61003c9ead8_terseLabel_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_label_en-US" xlink:label="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward" xlink:to="lab_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_629b49fa-ecaa-497d-bfc2-115b1f13d9f6_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_c29fad10-8bdb-497c-989b-dd779d9efeba_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:to="lab_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_40a68bc4-4f6f-4945-bb79-987cee6881a5_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net increase (decrease) in cash, cash equivalents, and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward_1bd59578-052a-47ad-a16c-39cfb6edc1f9_terseLabel_en-US" xlink:label="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Fulfillment Costs [Roll Forward]</link:label>
    <link:label id="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward_label_en-US" xlink:label="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Fulfillment Costs [Roll Forward]</link:label>
    <link:label id="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward_documentation_en-US" xlink:label="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Movement In Deferred Contract Fulfillment Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:href="rskd-20231231.xsd#rskd_MovementInDeferredContractFulfillmentCostsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:to="lab_rskd_MovementInDeferredContractFulfillmentCostsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_3ac93e77-f456-464e-bafd-5b32963ba7c9_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_612ecd30-f853-43c3-a140-e5c6cb20266d_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CustomerBMember_5a3bca92-54d5-4daf-aec7-cd54a2ff261d_terseLabel_en-US" xlink:label="lab_rskd_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer B</link:label>
    <link:label id="lab_rskd_CustomerBMember_label_en-US" xlink:label="lab_rskd_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer B [Member]</link:label>
    <link:label id="lab_rskd_CustomerBMember_documentation_en-US" xlink:label="lab_rskd_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer B</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerBMember" xlink:href="rskd-20231231.xsd#rskd_CustomerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CustomerBMember" xlink:to="lab_rskd_CustomerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_2869c30f-2590-4fca-af0b-ed6a9bc25cf5_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_d46d42ba-e960-4506-ab77-4a68fd7d2810_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractualObligation_9f4c3990-9911-4eba-892b-ec09f75979eb_terseLabel_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual obligation</link:label>
    <link:label id="lab_us-gaap_ContractualObligation_label_en-US" xlink:label="lab_us-gaap_ContractualObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contractual Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractualObligation" xlink:to="lab_us-gaap_ContractualObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_42c3bcaf-a35e-40f4-bb61-a84c2b484688_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_268d4151-7467-427d-8147-1e40e4d8c8c6_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_ecfac66c-f25f-4474-85d0-58cf6e68d7a0_terseLabel_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reclassification of convertible preferred share warrants upon IPO</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_label_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity</link:label>
    <link:label id="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_documentation_en-US" xlink:label="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:to="lab_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_78fc49ec-36ce-43dc-a16a-042babda4a7f_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_35a94718-86d7-4f05-a1e3-4d0c177de81e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_22343f91-791e-4b5b-9c32-879049b55619_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_812fbb8f-28dd-49c3-afa9-99dd5e686891_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating profit (loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_67201e74-4ee6-4ca5-9e55-edbea55a37ed_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_3797eb7a-c57f-4529-9bc3-553c2a3c1143_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Immaterial Prior Period Error Corrections</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_7089eb62-8780-444c-b336-0ca169bb7694_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_A2013EquityIncentivePlanMember_d84d117b-2486-4fe5-8ee6-0e948042c84b_terseLabel_en-US" xlink:label="lab_rskd_A2013EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2013 Equity Incentive Plan</link:label>
    <link:label id="lab_rskd_A2013EquityIncentivePlanMember_label_en-US" xlink:label="lab_rskd_A2013EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2013 Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_rskd_A2013EquityIncentivePlanMember_documentation_en-US" xlink:label="lab_rskd_A2013EquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2013 Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_A2013EquityIncentivePlanMember" xlink:to="lab_rskd_A2013EquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_b7bbff2d-b3e8-4d80-a8fd-cc0406dea543_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from initial public offering, net of underwriting discounts and commissions</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance Initial Public Offering</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="lab_us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_5a9dfa8d-1dda-45ec-b8e9-d4aac66ccd71_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Gross deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_29e55ecb-899f-453c-a251-dd997a27b615_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantyReservesMember_570d3e92-6fab-4c70-9854-ff297afc5ecf_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantyReservesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee obligations</link:label>
    <link:label id="lab_us-gaap_WarrantyReservesMember_label_en-US" xlink:label="lab_us-gaap_WarrantyReservesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Reserve, Warranty [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantyReservesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantyReservesMember" xlink:to="lab_us-gaap_WarrantyReservesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_2a971d13-cb99-430d-bdec-4471341b9c37_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_ccac2efe-a627-409b-9ab9-f5178e9376e6_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion of Preferred Shares into Ordinary Shares upon IPO</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_c8ea4d9c-56ad-4615-98bb-90b55c54f50a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_454e4e7f-c6a2-4302-8a1a-448e0ab65587_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_6b7c117d-cab5-412d-8836-f6d4553fd6f9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive profit (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CloudComputingArrangementImplementationCostsMember_fc7b7274-d221-401d-8b0e-19fac87e6d85_terseLabel_en-US" xlink:label="lab_rskd_CloudComputingArrangementImplementationCostsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cloud Computing Arrangement Implementation Costs</link:label>
    <link:label id="lab_rskd_CloudComputingArrangementImplementationCostsMember_label_en-US" xlink:label="lab_rskd_CloudComputingArrangementImplementationCostsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cloud Computing Arrangement Implementation Costs [Member]</link:label>
    <link:label id="lab_rskd_CloudComputingArrangementImplementationCostsMember_documentation_en-US" xlink:label="lab_rskd_CloudComputingArrangementImplementationCostsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cloud Computing Arrangement Implementation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CloudComputingArrangementImplementationCostsMember" xlink:href="rskd-20231231.xsd#rskd_CloudComputingArrangementImplementationCostsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CloudComputingArrangementImplementationCostsMember" xlink:to="lab_rskd_CloudComputingArrangementImplementationCostsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_ca824da1-d7b4-4822-b4bd-cecb6034fceb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Options Additional Disclosures</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_5ba5d34c-dd57-4cbb-85b6-be6b3e75e4a3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Derivative Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_1599e9ff-52d0-4778-a2e6-b3395f738baa_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Debt Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_rskd_CustomerAMember_9d6de93b-7dc8-4c51-91c5-82db5998a3c4_terseLabel_en-US" xlink:label="lab_rskd_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_rskd_CustomerAMember_label_en-US" xlink:label="lab_rskd_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_rskd_CustomerAMember_documentation_en-US" xlink:label="lab_rskd_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer A</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerAMember" xlink:href="rskd-20231231.xsd#rskd_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_rskd_CustomerAMember" xlink:to="lab_rskd_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_f1d2eea9-9629-48a4-ac3b-a7aba3eb4e02_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Guarantee obligations</link:label>
    <link:label id="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue_label_en-US" xlink:label="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Guarantor Obligations, Current Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:to="lab_us-gaap_GuaranteeObligationsCurrentCarryingValue" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>14
<FILENAME>rskd-20231231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2024 Workiva-->
<!--r:74ab1c91-acf2-4dbd-a834-633eda582453,g:91ce9b07-e870-4283-be19-76a0a0cc8871-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://riskified.com/role/Cover" xlink:type="simple" xlink:href="rskd-20231231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://riskified.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_5c946c22-6196-40bb-8ca4-0cd364591be7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_5c946c22-6196-40bb-8ca4-0cd364591be7" xlink:to="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressesAddressTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:to="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AddressTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityAddressesAddressTypeAxis_7c4f7a8b-e909-4f42-89a2-a3645fa936c7" xlink:to="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_BusinessContactMember_6dc645a1-4efc-40a0-a4f4-e2be37e009a2" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_BusinessContactMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_AddressTypeDomain_6a53edcd-914b-466e-8e4f-7563aa8dae33" xlink:to="loc_dei_BusinessContactMember_6dc645a1-4efc-40a0-a4f4-e2be37e009a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:to="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_18ff2194-671c-4943-9736-d8d82098fb76" xlink:to="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_153de803-3afd-44f0-b9c0-a578d7c4041f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:to="loc_us-gaap_CommonClassAMember_153de803-3afd-44f0-b9c0-a578d7c4041f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b4e10e42-a1ae-4a10-a69d-bde3dea462d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_cc23914b-2b44-4cb6-87ad-775b63b4e3b8" xlink:to="loc_us-gaap_CommonClassBMember_b4e10e42-a1ae-4a10-a69d-bde3dea462d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_bb16d44d-09ff-4af9-af93-7b36a0ff701d" xlink:to="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_989d5aeb-4786-4ae8-83a5-261af1d69e0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentType_989d5aeb-4786-4ae8-83a5-261af1d69e0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentRegistrationStatement_78ffc616-d5b8-4c5c-95b9-2fd807043d68" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentRegistrationStatement_78ffc616-d5b8-4c5c-95b9-2fd807043d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_e83303bc-b1ca-440f-8070-fd96fc92d0ed" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentAnnualReport_e83303bc-b1ca-440f-8070-fd96fc92d0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_9926e2e3-6615-4d41-b167-591c0416c1e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentPeriodEndDate_9926e2e3-6615-4d41-b167-591c0416c1e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_d644022a-4ef3-405e-b244-22eea53f9642" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_CurrentFiscalYearEndDate_d644022a-4ef3-405e-b244-22eea53f9642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_83a1194e-2dc4-40f6-8232-b72e7dbeec4a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentTransitionReport_83a1194e-2dc4-40f6-8232-b72e7dbeec4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentShellCompanyReport_46226d7b-a13e-4517-8d1f-c5479343477a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentShellCompanyReport_46226d7b-a13e-4517-8d1f-c5479343477a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_b93b9120-0d4c-401f-9089-2cad10dd7d83" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityFileNumber_b93b9120-0d4c-401f-9089-2cad10dd7d83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_95df3d11-70bb-4cb4-850f-eddb50965544" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityRegistrantName_95df3d11-70bb-4cb4-850f-eddb50965544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_6e7dc3a2-ed3d-49de-ace6-ae23d368e5e4" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityIncorporationStateCountryCode_6e7dc3a2-ed3d-49de-ace6-ae23d368e5e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelName_424a8761-c033-4bae-9765-56c9eec7bf78" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelName"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_ContactPersonnelName_424a8761-c033-4bae-9765-56c9eec7bf78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_eba8a411-ff14-4f6e-9949-7d5c98330d96" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressAddressLine1_eba8a411-ff14-4f6e-9949-7d5c98330d96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_485f5aff-58b7-4a59-b10e-32fad865b188" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressAddressLine2_485f5aff-58b7-4a59-b10e-32fad865b188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ebcd26f7-b6c5-47ea-886d-22424262297c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressCityOrTown_ebcd26f7-b6c5-47ea-886d-22424262297c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_73452e42-bed4-4b0e-80d7-a84bb8a9433f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressStateOrProvince_73452e42-bed4-4b0e-80d7-a84bb8a9433f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_db94dcaf-7150-4b2b-93d2-292251500030" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressPostalZipCode_db94dcaf-7150-4b2b-93d2-292251500030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_f4599367-9046-43aa-b894-157a7c01b166" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityAddressCountry_f4599367-9046-43aa-b894-157a7c01b166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_ContactPersonnelEmailAddress_f096bb39-f2f4-48c4-81a3-03c3002c5879" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_ContactPersonnelEmailAddress"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_ContactPersonnelEmailAddress_f096bb39-f2f4-48c4-81a3-03c3002c5879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_0a4c3ee2-7fe2-4de9-beec-46e5a651461b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_Security12bTitle_0a4c3ee2-7fe2-4de9-beec-46e5a651461b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_54d1409e-7277-48d5-a741-ec1ea5692193" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_TradingSymbol_54d1409e-7277-48d5-a741-ec1ea5692193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_4d67dcde-07e7-40a7-b12d-0b1e7a6b3452" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_SecurityExchangeName_4d67dcde-07e7-40a7-b12d-0b1e7a6b3452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_20ea3d56-f4a9-42bd-bf3d-375eaff55599" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_20ea3d56-f4a9-42bd-bf3d-375eaff55599" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_7692d918-b38a-4730-9f97-f842bcea8bd0" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_7692d918-b38a-4730-9f97-f842bcea8bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_29a89c9a-ced4-43dd-9eca-9787e0775deb" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityVoluntaryFilers_29a89c9a-ced4-43dd-9eca-9787e0775deb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_911d77d3-9925-48f5-8b46-ed31cb5e49e3" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCurrentReportingStatus_911d77d3-9925-48f5-8b46-ed31cb5e49e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b5455171-247b-4ec6-86fc-733bdefbdb2f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityInteractiveDataCurrent_b5455171-247b-4ec6-86fc-733bdefbdb2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_28179d1f-f821-45b5-9eb5-3c169836ca8b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityFilerCategory_28179d1f-f821-45b5-9eb5-3c169836ca8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_76d4fd3e-58da-45ff-9ef8-067f41fa3d3e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityEmergingGrowthCompany_76d4fd3e-58da-45ff-9ef8-067f41fa3d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_d63822e2-a209-4a9d-bd2a-eb37f283b424" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityExTransitionPeriod_d63822e2-a209-4a9d-bd2a-eb37f283b424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_80da4660-1536-480a-aa44-efdcc1885e7a" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_IcfrAuditorAttestationFlag_80da4660-1536-480a-aa44-efdcc1885e7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_8fa68c94-3007-4fa3-b112-b91a60fa4142" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_8fa68c94-3007-4fa3-b112-b91a60fa4142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_a25a7914-b9f6-4b14-9ec9-a96a538d27f9" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFinStmtRestatementRecoveryAnalysisFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag_a25a7914-b9f6-4b14-9ec9-a96a538d27f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAccountingStandard_946463e2-c1ad-48ed-8696-148f4dd954ea" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentAccountingStandard_946463e2-c1ad-48ed-8696-148f4dd954ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_3e618b54-cf84-4c5c-9a47-9a8df17770af" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityShellCompany_3e618b54-cf84-4c5c-9a47-9a8df17770af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_6a74600b-fe02-4318-aafc-f02d2c4ae640" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_AmendmentFlag_6a74600b-fe02-4318-aafc-f02d2c4ae640" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_58838507-6f1f-4d39-95f4-bf8e4de2428f" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="36" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_EntityCentralIndexKey_58838507-6f1f-4d39-95f4-bf8e4de2428f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_0255c982-87cb-41b6-b81d-6a26656a383e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="37" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFiscalYearFocus_0255c982-87cb-41b6-b81d-6a26656a383e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_90333040-afef-4af7-82fe-b33c7c19b6b5" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="38" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_cc41645c-1f9d-40b8-8ea3-79beec1b71c0" xlink:to="loc_dei_DocumentFiscalPeriodFocus_90333040-afef-4af7-82fe-b33c7c19b6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/AuditInformation" xlink:type="simple" xlink:href="rskd-20231231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://riskified.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AuditInformationAbstract_4117d011-c286-49fe-8e63-94c44853b419" xlink:href="rskd-20231231.xsd#rskd_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_0ddcf1b6-b792-4e8f-aa41-6e141a7cbb2e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_AuditInformationAbstract_4117d011-c286-49fe-8e63-94c44853b419" xlink:to="loc_dei_AuditorFirmId_0ddcf1b6-b792-4e8f-aa41-6e141a7cbb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_2cfc9661-5804-4d3d-a4ce-f03eebcdc4a7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorName"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_AuditInformationAbstract_4117d011-c286-49fe-8e63-94c44853b419" xlink:to="loc_dei_AuditorName_2cfc9661-5804-4d3d-a4ce-f03eebcdc4a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_9050ba3b-c731-4f8f-84ef-fdb427e5a3b7" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_AuditInformationAbstract_4117d011-c286-49fe-8e63-94c44853b419" xlink:to="loc_dei_AuditorLocation_9050ba3b-c731-4f8f-84ef-fdb427e5a3b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_4817c20a-0fe0-4797-a242-2473edbbd292" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_4817c20a-0fe0-4797-a242-2473edbbd292" xlink:to="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_37e5010a-26ac-4e57-8e06-edc27a633a49" xlink:to="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_60cc8b6d-cdbc-45fd-8110-8f17955afbb5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:to="loc_us-gaap_CommonClassAMember_60cc8b6d-cdbc-45fd-8110-8f17955afbb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_85144032-e5f8-44dd-a804-ab0785874f09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_a2f01b85-1af7-4207-a37f-edbc9bbcc2ed" xlink:to="loc_us-gaap_CommonClassBMember_85144032-e5f8-44dd-a804-ab0785874f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_161682a1-3d12-4f9c-97aa-25ddbfb2304e" xlink:to="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:to="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_adb1bee0-3c56-42ce-9b0f-d9c88de7046d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_adb1bee0-3c56-42ce-9b0f-d9c88de7046d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashCurrent_2c52fcf8-dcb8-49dd-9096-37a2db1102d6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_RestrictedCashCurrent_2c52fcf8-dcb8-49dd-9096-37a2db1102d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepositsAssetsCurrent_a60424f5-e6b6-4cbf-8d22-bbd71a1239f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepositsAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_DepositsAssetsCurrent_a60424f5-e6b6-4cbf-8d22-bbd71a1239f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_0a8d33e6-2b54-46cc-b5d1-fae33dc7944a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_0a8d33e6-2b54-46cc-b5d1-fae33dc7944a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d4babb6-43eb-4cb3-858f-7ba79f1e8858" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_3d4babb6-43eb-4cb3-858f-7ba79f1e8858" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_3058daf3-32ec-4969-91cb-883367f0dfc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_ShortTermInvestments_3058daf3-32ec-4969-91cb-883367f0dfc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_16874c71-788f-41f8-b199-22ce471005c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_98d0d31a-a6c6-41b4-8eec-76bbccb82e10" xlink:to="loc_us-gaap_AssetsCurrent_16874c71-788f-41f8-b199-22ce471005c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_4c446ea8-c0ff-4f94-ad62-f77c1698775d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_4c446ea8-c0ff-4f94-ad62-f77c1698775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1b7090c-0a98-42e9-ac3c-0815a0825f4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_d1b7090c-0a98-42e9-ac3c-0815a0825f4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_c473725a-a3bc-48bd-b89a-b74fb246f941" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_c473725a-a3bc-48bd-b89a-b74fb246f941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_90d5cd69-0e82-40e6-b8f0-9a5a107c1e0b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_90d5cd69-0e82-40e6-b8f0-9a5a107c1e0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_46e88760-cd30-4c39-96f9-e247978ea205" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_8e6d3d01-f960-4aff-a22a-0bec34bf9c2d" xlink:to="loc_us-gaap_Assets_46e88760-cd30-4c39-96f9-e247978ea205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_da4b25e0-6349-4963-8f6b-918e4dca847b" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_759909ac-cdbf-4d3a-9303-5e6e89602787" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_AccountsPayableCurrent_759909ac-cdbf-4d3a-9303-5e6e89602787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c3a3099e-c4dc-4739-8e9e-aa21217e95b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_c3a3099e-c4dc-4739-8e9e-aa21217e95b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_18a948d7-76de-422e-aecd-d25d55c3bc8f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_18a948d7-76de-422e-aecd-d25d55c3bc8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksCurrent_15713069-f3c2-4f8e-bc98-a4f50b84d8d9" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_rskd_ProvisionForChargebacksCurrent_15713069-f3c2-4f8e-bc98-a4f50b84d8d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eb52966-5f2d-47f3-9d56-4342c9e3e1af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_6eb52966-5f2d-47f3-9d56-4342c9e3e1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_3bff0d29-aef0-448b-bd12-314f993d66fc" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_3bff0d29-aef0-448b-bd12-314f993d66fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_20a9b3e1-0034-497b-8228-a3df2caf1d6e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_LiabilitiesCurrent_20a9b3e1-0034-497b-8228-a3df2caf1d6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b31a3af5-1ce9-4e0d-a0cb-90de03194683" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_2e217c10-a8b7-4ed8-9795-7559e6651534" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_b31a3af5-1ce9-4e0d-a0cb-90de03194683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_932c258a-784b-4c6d-b185-b1366bb1fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_932c258a-784b-4c6d-b185-b1366bb1fcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c18b78e6-1f55-402c-9693-d43da4a06197" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_Liabilities_c18b78e6-1f55-402c-9693-d43da4a06197" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_93a8d383-8b12-4fde-8322-d2fe41c0a857" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_CommitmentsAndContingencies_93a8d383-8b12-4fde-8322-d2fe41c0a857" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_bdb5e13e-7a48-40df-b924-a52de8849c00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_CommonStockValue_bdb5e13e-7a48-40df-b924-a52de8849c00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9fe1c407-9c45-48bb-8473-8e7448d4c4a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_TreasuryStockValue_9fe1c407-9c45-48bb-8473-8e7448d4c4a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e0488ce2-b06d-41ce-9e99-9480c150866b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_e0488ce2-b06d-41ce-9e99-9480c150866b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dae92e7d-f3f4-4588-96b5-701d58920ee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_dae92e7d-f3f4-4588-96b5-701d58920ee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7f328501-2b74-496f-99e1-7a16732ef975" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_7f328501-2b74-496f-99e1-7a16732ef975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b83a7131-3680-4258-b5cb-29d7866a7d45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e048f192-a27a-4a9a-8eeb-8d45086e0822" xlink:to="loc_us-gaap_StockholdersEquity_b83a7131-3680-4258-b5cb-29d7866a7d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_9a4f3d7d-b4bb-4c4e-b561-cb5fdc15b75d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_eda6ed0c-b66c-40f2-83e4-4feb6802960d" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_9a4f3d7d-b4bb-4c4e-b561-cb5fdc15b75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e779226b-f165-45a4-907c-e109d521d01d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e779226b-f165-45a4-907c-e109d521d01d" xlink:to="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_893e5725-7fc0-40f4-b8b7-76efca9ba476" xlink:to="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_7cde62e0-c7d7-4c92-ab00-12547fb70797" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:to="loc_us-gaap_CommonClassAMember_7cde62e0-c7d7-4c92-ab00-12547fb70797" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_175b45f2-787e-42e3-837a-a7032d728922" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_abf10872-66b8-4d33-be07-8a5042be61e7" xlink:to="loc_us-gaap_CommonClassBMember_175b45f2-787e-42e3-837a-a7032d728922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_ed72a0c5-22cf-4c64-b787-5e83a87031f2" xlink:to="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_e203835c-26dc-4366-a357-c0018e58e47f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_e203835c-26dc-4366-a357-c0018e58e47f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_46d89d32-f434-4e29-a347-316f66701db6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_46d89d32-f434-4e29-a347-316f66701db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7b0287cf-46a4-4910-ba50-7d853baa0617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesIssued_7b0287cf-46a4-4910-ba50-7d853baa0617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_c3f1f363-7aea-4645-b0f1-c9f4dd9d3775" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_c3f1f363-7aea-4645-b0f1-c9f4dd9d3775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_a42716c6-ee35-4038-9575-d7e7a1ace13d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_f0054670-0b7e-4a2c-a7dc-aee23fd1b1f8" xlink:to="loc_us-gaap_TreasuryStockCommonShares_a42716c6-ee35-4038-9575-d7e7a1ace13d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_ca6a59de-ffcd-4552-a232-648593804460" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_ca6a59de-ffcd-4552-a232-648593804460" xlink:to="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3fdbb813-54fa-4be8-bc7f-6dc759ddca7e" xlink:to="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_73902563-8bb1-4aac-9a68-6100da694c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:to="loc_us-gaap_CommonClassAMember_73902563-8bb1-4aac-9a68-6100da694c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_50faa303-6a15-44f2-901d-2349d1d40cf4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_49979e5f-eeed-48a5-95bb-a5a7ee52f9c4" xlink:to="loc_us-gaap_CommonClassBMember_50faa303-6a15-44f2-901d-2349d1d40cf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_b79c68ca-cd64-474c-9a0c-1f6faebd16d1" xlink:to="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_1b32c0f9-ce09-4579-9b65-0683583cdbfc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_Revenues_1b32c0f9-ce09-4579-9b65-0683583cdbfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_9805a067-cdd5-45d1-87bf-8d48554a963c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_CostOfRevenue_9805a067-cdd5-45d1-87bf-8d48554a963c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c8c90606-08a1-43b1-a334-69a0fe400579" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_GrossProfit_c8c90606-08a1-43b1-a334-69a0fe400579" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_c5437b98-6f2e-4951-8da5-70248e26af65" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_c5437b98-6f2e-4951-8da5-70248e26af65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0bbe10a7-7183-4a7f-a416-c7cc5c4996fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0bbe10a7-7183-4a7f-a416-c7cc5c4996fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_f090774b-479e-4742-8247-380379b7d193" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_f090774b-479e-4742-8247-380379b7d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_d3deacc7-5367-4e52-8748-e348c2a461e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_f4d44871-60eb-4279-a248-4ee4a81b68a5" xlink:to="loc_us-gaap_OperatingExpenses_d3deacc7-5367-4e52-8748-e348c2a461e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_034145fe-997d-4ca5-8fd7-dc51557cd63e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OperatingIncomeLoss_034145fe-997d-4ca5-8fd7-dc51557cd63e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a695a860-9370-40f2-97a8-30b744a912df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeExpenseNonoperatingNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_InterestIncomeExpenseNonoperatingNet_a695a860-9370-40f2-97a8-30b744a912df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_ad414a86-21d9-4d9d-b182-360d772a979b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_ad414a86-21d9-4d9d-b182-360d772a979b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce560b49-6c6d-4a46-bbc2-b755bd97ede8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_ce560b49-6c6d-4a46-bbc2-b755bd97ede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_c945c35a-30c4-4b55-bbaa-d9f510f2d764" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_c945c35a-30c4-4b55-bbaa-d9f510f2d764" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_ee0fb767-dd51-47bb-9eea-c6e4173e86a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_NetIncomeLoss_ee0fb767-dd51-47bb-9eea-c6e4173e86a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_288e7df3-44e9-49b3-9957-fe50b92c0979" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_EarningsPerShareBasic_288e7df3-44e9-49b3-9957-fe50b92c0979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_1e637cdb-7fdb-451e-a0b9-2a3a4e38b6df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_EarningsPerShareDiluted_1e637cdb-7fdb-451e-a0b9-2a3a4e38b6df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_53782c65-591b-48db-96fb-64933d65ac93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_53782c65-591b-48db-96fb-64933d65ac93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e6082645-fa36-466a-a09c-3c827059818b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_6c2ac07a-8eca-4540-9568-ed661c634a7d" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e6082645-fa36-466a-a09c-3c827059818b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9afe4318-cdf1-4952-8fd8-6cd22e22969e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_68dc0501-7e8d-4558-bb64-7841b85ef325" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9afe4318-cdf1-4952-8fd8-6cd22e22969e" xlink:to="loc_us-gaap_NetIncomeLoss_68dc0501-7e8d-4558-bb64-7841b85ef325" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9afe4318-cdf1-4952-8fd8-6cd22e22969e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_878a7ae9-bb29-46df-8a4c-dc04afa9e9fc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_878a7ae9-bb29-46df-8a4c-dc04afa9e9fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dc6a5c62-7f8c-4835-8708-856e71943a95" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_dc6a5c62-7f8c-4835-8708-856e71943a95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a00b2f58-9a06-4f0b-ab16-1d34c7208d06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_a00b2f58-9a06-4f0b-ab16-1d34c7208d06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bd8eaacc-19c2-4bd0-99dd-3031a5e60039" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_b7d056fa-155b-4741-86ef-71ba018e24b7" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_bd8eaacc-19c2-4bd0-99dd-3031a5e60039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_37336bf9-aa50-4153-a80a-385687586319" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_9afe4318-cdf1-4952-8fd8-6cd22e22969e" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_37336bf9-aa50-4153-a80a-385687586319" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_19e1cc2c-3daf-45ee-b7cb-a20b4a113ee8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_19e1cc2c-3daf-45ee-b7cb-a20b4a113ee8" xlink:to="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_6f8edfae-cad7-4263-8e67-f84660eb5370" xlink:to="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_b4def1f2-af52-4f5f-87c1-7d547bf998c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_CommonStockMember_b4def1f2-af52-4f5f-87c1-7d547bf998c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_d844056d-870a-49dd-ae8f-bbec7fb6532b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_TreasuryStockCommonMember_d844056d-870a-49dd-ae8f-bbec7fb6532b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_8f8c5a1c-a409-485c-a601-45b3f5cbda71" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_8f8c5a1c-a409-485c-a601-45b3f5cbda71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ec96fb1b-32dd-4a86-97f4-ee24d45f5837" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_ec96fb1b-32dd-4a86-97f4-ee24d45f5837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_1e88a89a-6b13-4a07-be04-45c83a08d3de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_11eb73f7-e311-4f87-9e3e-d27e77846a9c" xlink:to="loc_us-gaap_RetainedEarningsMember_1e88a89a-6b13-4a07-be04-45c83a08d3de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_ca057cb0-2b37-43a7-9cd2-f5a9279788ba" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_095eb9fa-6072-45e9-af14-db282cb341f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_aca86865-8afd-46a0-a4f5-77e25cbb9e80" xlink:to="loc_us-gaap_IPOMember_095eb9fa-6072-45e9-af14-db282cb341f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_fc32b6b9-461b-4f15-98ae-20ce4f294dc1" xlink:to="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesE1ConvertiblePreferredStockMember_ad07ffc2-e6d7-4bed-a0da-472ee6a1dfbc" xlink:href="rskd-20231231.xsd#rskd_SeriesE1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_rskd_SeriesE1ConvertiblePreferredStockMember_ad07ffc2-e6d7-4bed-a0da-472ee6a1dfbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_d7a8b68f-31a2-4e50-a918-6c5e99b4f534" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_us-gaap_CommonClassAMember_d7a8b68f-31a2-4e50-a918-6c5e99b4f534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_25d659ab-88bc-40c3-90e5-9d498e0f2e84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_us-gaap_CommonClassBMember_25d659ab-88bc-40c3-90e5-9d498e0f2e84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesEConvertiblePreferredStockMember_b2fce3c2-128b-4dc3-b707-b83ac8a27e39" xlink:href="rskd-20231231.xsd#rskd_SeriesEConvertiblePreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_26294ce4-d4c1-4552-a6e5-96b8bc8e3c82" xlink:to="loc_rskd_SeriesEConvertiblePreferredStockMember_b2fce3c2-128b-4dc3-b707-b83ac8a27e39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_0a2ae69e-ec21-4f2a-955f-c805115058ef" xlink:to="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInTemporaryEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:to="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_a8f40b16-8ab2-4762-a309-4db1e1fbcc40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_a8f40b16-8ab2-4762-a309-4db1e1fbcc40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c87ac7a6-94e5-4938-8344-9aaf3b4204ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_c87ac7a6-94e5-4938-8344-9aaf3b4204ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_5a454a3e-b642-49b0-bbf2-456e5643bb43" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_5a454a3e-b642-49b0-bbf2-456e5643bb43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d11d8921-cd1a-4930-be0f-06c921f16435" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_d11d8921-cd1a-4930-be0f-06c921f16435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_a3ce57d0-585b-4d7a-a060-f943c27fbde1" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_a3ce57d0-585b-4d7a-a060-f943c27fbde1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4727aabe-9bf5-423d-959c-a020f0749207" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_4727aabe-9bf5-423d-959c-a020f0749207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_8deeb968-b36b-425b-9399-cf8f6557062e" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities_8deeb968-b36b-425b-9399-cf8f6557062e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquitySharesOutstanding_72899bc5-eb7e-4d04-be9e-336535a8c3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquitySharesOutstanding_72899bc5-eb7e-4d04-be9e-336535a8c3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6dedacf4-ec37-4915-b9c9-55344ce68557" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward_9695409d-802d-4d18-a066-2303f8ac01bb" xlink:to="loc_us-gaap_TemporaryEquityCarryingAmountAttributableToParent_6dedacf4-ec37-4915-b9c9-55344ce68557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_e6f5bee1-39e5-4b5d-8228-e165c9da6c89" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_789def0c-d9a8-4f5e-b05e-e440f4c12d38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_789def0c-d9a8-4f5e-b05e-e440f4c12d38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b9c7d7a1-8daa-46df-864b-1767d67ede89" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockholdersEquity_b9c7d7a1-8daa-46df-864b-1767d67ede89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1703a6b5-7e92-49e5-b0a8-187d82911b4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_1703a6b5-7e92-49e5-b0a8-187d82911b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_22bdb5a4-a4ba-4c72-9d3f-bcd1a42d6198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_22bdb5a4-a4ba-4c72-9d3f-bcd1a42d6198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_09d8426f-3354-4487-be43-bec15e73b4ce" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants_09d8426f-3354-4487-be43-bec15e73b4ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d33dadb1-fb85-45d3-851d-fe5e20c1cc14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_d33dadb1-fb85-45d3-851d-fe5e20c1cc14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_14ee7e75-4557-4225-a483-3e18a547e1f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_14ee7e75-4557-4225-a483-3e18a547e1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_ef50af2e-d8c5-490e-af9b-e8c92bc62fb1" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_ef50af2e-d8c5-490e-af9b-e8c92bc62fb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization_ea039feb-8363-49a3-a431-49bae7ec11ff" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesRecapitalization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_StockIssuedDuringPeriodSharesRecapitalization_ea039feb-8363-49a3-a431-49bae7ec11ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_915666cd-4e6c-4f48-86c2-ba6a40966443" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_915666cd-4e6c-4f48-86c2-ba6a40966443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_11e6fbd1-da91-46a0-9bee-f216f758af5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_11e6fbd1-da91-46a0-9bee-f216f758af5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_54c2b605-52a2-4c4f-98ff-87514ef5752f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross_54c2b605-52a2-4c4f-98ff-87514ef5752f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_2e99101c-0eb1-4a94-ae45-8965d4850600" xlink:href="rskd-20231231.xsd#rskd_StockIssuedDuringPeriodSharesWarrantsExercised"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_rskd_StockIssuedDuringPeriodSharesWarrantsExercised_2e99101c-0eb1-4a94-ae45-8965d4850600" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_1ca7a67a-9431-4910-b938-3331cdc5f359" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_1ca7a67a-9431-4910-b938-3331cdc5f359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3db1fda7-8025-402a-8a74-a93cd9e2ad68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_3db1fda7-8025-402a-8a74-a93cd9e2ad68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_fca386c8-fabb-4d48-ac5b-227a0d2c54f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits_fca386c8-fabb-4d48-ac5b-227a0d2c54f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_eddae9d0-3531-486e-8ca0-b631b0c89734" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_eddae9d0-3531-486e-8ca0-b631b0c89734" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7c708a34-5697-4e18-a68e-6da0e6d6a079" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued_7c708a34-5697-4e18-a68e-6da0e6d6a079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b22e0597-3c84-4caf-aeb4-db03ae3d7e5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_b22e0597-3c84-4caf-aeb4-db03ae3d7e5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fc47f7cd-1544-4caa-9a11-9956f6a83676" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_NetIncomeLoss_fc47f7cd-1544-4caa-9a11-9956f6a83676" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ea9254a8-3de8-46d7-87f8-031c3b7a5182" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ea9254a8-3de8-46d7-87f8-031c3b7a5182" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4c39025b-e5bf-4a66-887f-3e4112f352e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_8f4c260d-d421-4f9f-afb2-dde9adcb8032" xlink:to="loc_us-gaap_StockholdersEquity_4c39025b-e5bf-4a66-887f-3e4112f352e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b9bd921-e2ec-4757-a24e-8f997278c9fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_1b9bd921-e2ec-4757-a24e-8f997278c9fa" xlink:to="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:to="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_e23df111-532d-49f5-bb65-7377dec99bb4" xlink:to="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesEConvertiblePreferredStockMember_f65212a5-17db-4def-ae2b-d5d6f70475d6" xlink:href="rskd-20231231.xsd#rskd_SeriesEConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d7aebbf5-e2ea-495c-8630-4ffa145c8b19" xlink:to="loc_rskd_SeriesEConvertiblePreferredStockMember_f65212a5-17db-4def-ae2b-d5d6f70475d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_5a0585eb-3f1d-4b2c-87cd-6dd73d0d947e" xlink:to="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts_ca15be10-0784-4e21-a9bc-7f0dc248756e" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfTemporaryEquityIssuanceCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_10168ae4-a897-465d-a80b-95a2b5607fe2" xlink:to="loc_rskd_PaymentsOfTemporaryEquityIssuanceCosts_ca15be10-0784-4e21-a9bc-7f0dc248756e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="rskd-20231231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_8a432641-b111-47c7-b5d0-383c44a057e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_8a432641-b111-47c7-b5d0-383c44a057e9" xlink:to="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_46fa9687-0537-4570-ba93-f6bf31a36c40" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_d604772d-8ce5-44a3-96fe-1db9a7b7a5fe" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_2f1d2d59-5d75-40f2-bc49-6dccd5c8b306" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_d604772d-8ce5-44a3-96fe-1db9a7b7a5fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_956d4b31-3f23-40f2-9d41-787f5bb1842e" xlink:to="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17bc4b77-d480-4037-94d2-8f0aa18be463" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_NetIncomeLoss_17bc4b77-d480-4037-94d2-8f0aa18be463" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7d466c6c-dfb7-4588-a32c-e661ce511ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_7d466c6c-dfb7-4588-a32c-e661ce511ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_22669e8d-c904-4cca-8a30-87ae6373f697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_22669e8d-c904-4cca-8a30-87ae6373f697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_2efd3305-9b77-4b87-8bb6-0fc048fbf71f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_2efd3305-9b77-4b87-8bb6-0fc048fbf71f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3ea2213e-430f-4b33-a3bf-836375c8c057" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareAmortization1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareAmortization1_3ea2213e-430f-4b33-a3bf-836375c8c057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortization_b25e46a9-c7b4-4850-8fff-a10de66b144a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortization"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_CapitalizedContractCostAmortization_b25e46a9-c7b4-4850-8fff-a10de66b144a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAdjustmentOfWarrants_65d4e5f6-a2bf-4987-9c95-2972a99f7e27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAdjustmentOfWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_FairValueAdjustmentOfWarrants_65d4e5f6-a2bf-4987-9c95-2972a99f7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FairValueAdjustmentOfRights_2257512c-de23-497c-ba8e-fc5d9dd3b1bf" xlink:href="rskd-20231231.xsd#rskd_FairValueAdjustmentOfRights"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_rskd_FairValueAdjustmentOfRights_2257512c-de23-497c-ba8e-fc5d9dd3b1bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_1a9e9569-09d2-436f-a11f-ab90d2777b96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_ShareBasedCompensation_1a9e9569-09d2-436f-a11f-ab90d2777b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17c4bde3-cc0a-42fa-838e-182744d1826a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17c4bde3-cc0a-42fa-838e-182744d1826a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_c35f72b4-fb22-40a1-8a63-775c2f697a75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease_c35f72b4-fb22-40a1-8a63-775c2f697a75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_166c8911-5d3d-423f-88bb-388324927f96" xlink:href="rskd-20231231.xsd#rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities_166c8911-5d3d-423f-88bb-388324927f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_f0336b74-c5e2-4227-a300-4f95aca6841d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ef1df61e-02ec-49a8-9643-f3213810da62" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_f0336b74-c5e2-4227-a300-4f95aca6841d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e8492fef-6285-4450-b500-2e5630eb1b88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_e8492fef-6285-4450-b500-2e5630eb1b88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_c40a9997-fe9f-4c20-9fc4-4e6a3eb9ee51" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInCapitalizedContractCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInCapitalizedContractCost_c40a9997-fe9f-4c20-9fc4-4e6a3eb9ee51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_577c01db-175c-408a-8aea-ffb130cb4fbe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_577c01db-175c-408a-8aea-ffb130cb4fbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d8a6a105-7e06-46bd-85a8-70c81ab1590d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_d8a6a105-7e06-46bd-85a8-70c81ab1590d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b4e850bb-8dff-4f1d-b71b-757a396c8a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_b4e850bb-8dff-4f1d-b71b-757a396c8a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInGuarantorObligations_2689b51d-da68-42e4-ad74-1e124b95f095" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInGuarantorObligations"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInGuarantorObligations_2689b51d-da68-42e4-ad74-1e124b95f095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_be454a9e-fd7c-449b-868f-68ff08ff2e6e" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseInProvisionForChargebacks"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_rskd_IncreaseDecreaseInProvisionForChargebacks_be454a9e-fd7c-449b-868f-68ff08ff2e6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fde38b4b-4568-4630-bce7-336dd1e80f24" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_fde38b4b-4568-4630-bce7-336dd1e80f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2bcdb9b3-4c53-41b9-b024-9d77c394eb4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_86512945-6955-4b23-b6c7-403ddf1f1b6d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2bcdb9b3-4c53-41b9-b024-9d77c394eb4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f1b21f8-1f65-4875-81fa-819eae6d87de" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2794654a-d8bc-4dd6-8682-a546b1105d8c" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_2f1b21f8-1f65-4875-81fa-819eae6d87de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d3346aa1-92b2-4a6c-a19c-61413108365e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquireShortTermInvestments_d3346aa1-92b2-4a6c-a19c-61413108365e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_81e08ec7-a015-4f79-8b32-f4dc346586fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments_81e08ec7-a015-4f79-8b32-f4dc346586fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireInvestments_9e8ad4f8-43e4-4da0-bf41-e9b5e4470a74" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquireInvestments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquireInvestments_9e8ad4f8-43e4-4da0-bf41-e9b5e4470a74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0cf2520-8432-4e0b-937b-c42cbb068e41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d0cf2520-8432-4e0b-937b-c42cbb068e41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToDevelopSoftware_0a4cb979-3732-4f51-96cb-19ec484be24a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsToDevelopSoftware"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_PaymentsToDevelopSoftware_0a4cb979-3732-4f51-96cb-19ec484be24a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bd75529-b9c8-4abd-b00f-5146ce059547" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_75f0f3ea-e197-44d0-abac-cd13c25b6559" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_1bd75529-b9c8-4abd-b00f-5146ce059547" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0a92942e-ef65-4228-a374-8af877fcb833" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock_0a92942e-ef65-4228-a374-8af877fcb833" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromWarrantExercises_05f17453-71f0-47d2-8485-9f3a19d3e6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromWarrantExercises"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromWarrantExercises_05f17453-71f0-47d2-8485-9f3a19d3e6aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_d68ad27f-14df-47ba-8692-7093d1344a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_d68ad27f-14df-47ba-8692-7093d1344a1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_dcc5f3e4-de05-46be-bed1-d52e6fa2e7ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_ProceedsFromIssuanceInitialPublicOffering_dcc5f3e4-de05-46be-bed1-d52e6fa2e7ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_2e481639-fee2-44e1-85b9-f760d0261abb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_2e481639-fee2-44e1-85b9-f760d0261abb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98a1c92f-bca4-43fb-8227-17cbf5c8c0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_98a1c92f-bca4-43fb-8227-17cbf5c8c0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3d239ef-e34e-4cb1-91a6-12aa1eba882c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_4c6d6d97-a947-4a43-9848-b482f91ca82a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_c3d239ef-e34e-4cb1-91a6-12aa1eba882c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29d1e93-be38-4ff9-a0af-2cda6587861a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e29d1e93-be38-4ff9-a0af-2cda6587861a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae5a19-68fe-4ca7-a67c-ba38712cecb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_65ae5a19-68fe-4ca7-a67c-ba38712cecb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2307d71e-0090-4cb2-9a5d-cd1d03501f93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2307d71e-0090-4cb2-9a5d-cd1d03501f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecad01e1-9579-4c6b-8dcd-763e37e7fccd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ecad01e1-9579-4c6b-8dcd-763e37e7fccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_485ff96c-7435-4a25-9e49-71a99d9e8f58" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_InterestPaidNet_485ff96c-7435-4a25-9e49-71a99d9e8f58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_0b715ef0-2673-4526-9b2e-78b3bde8fcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_IncomeTaxesPaid_0b715ef0-2673-4526-9b2e-78b3bde8fcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRent_78dada9e-0b2f-4bf0-99fe-4ab9c2623980" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsForRent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_PaymentsForRent_78dada9e-0b2f-4bf0-99fe-4ab9c2623980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca0600c5-b9a2-45f4-ab4b-8fa2abc5da64" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_ca0600c5-b9a2-45f4-ab4b-8fa2abc5da64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_6e2ab4d2-179e-4cda-8dc6-2372f406ac16" xlink:href="rskd-20231231.xsd#rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_380d47b1-2e12-4ac0-a258-415cdc82b0d5" xlink:to="loc_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment_6e2ab4d2-179e-4cda-8dc6-2372f406ac16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b65de371-8f8c-4a79-b498-b5aa985b52ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_b65de371-8f8c-4a79-b498-b5aa985b52ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3a4fb620-4e98-478f-bdfe-0ff19a9d5737" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount_3a4fb620-4e98-478f-bdfe-0ff19a9d5737" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_e75df18e-ad44-400c-9803-c7edf5aa092c" xlink:href="rskd-20231231.xsd#rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid_e75df18e-ad44-400c-9803-c7edf5aa092c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid_55577047-349a-48c4-806b-769a7eb13509" xlink:href="rskd-20231231.xsd#rskd_DeferredOfferingCostsIncurredButNotYetPaid"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_DeferredOfferingCostsIncurredButNotYetPaid_55577047-349a-48c4-806b-769a7eb13509" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsAndRightsSettled_3b517bf4-c485-4818-9dd6-b5be8344fb3f" xlink:href="rskd-20231231.xsd#rskd_WarrantsAndRightsSettled"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_WarrantsAndRightsSettled_3b517bf4-c485-4818-9dd6-b5be8344fb3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockAmountConverted1_891654e9-1285-4aea-9b35-1d740b59f4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockAmountConverted1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_us-gaap_ConversionOfStockAmountConverted1_891654e9-1285-4aea-9b35-1d740b59f4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_1204c515-91a8-4e57-99df-6a07173a667d" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity_1204c515-91a8-4e57-99df-6a07173a667d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_dd955bc9-8186-4a2b-b8b3-a71974883593" xlink:href="rskd-20231231.xsd#rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_000b46d4-86ab-48cf-a632-111216d96b23" xlink:to="loc_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization_dd955bc9-8186-4a2b-b8b3-a71974883593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_55953393-6042-4b84-b529-b9b260c1863e" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecca90e2-f48d-44d2-8e4c-73a7b001429a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_ecca90e2-f48d-44d2-8e4c-73a7b001429a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_73a7ff4e-a85b-417f-b25a-08355efceb27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:to="loc_us-gaap_RestrictedCash_73a7ff4e-a85b-417f-b25a-08355efceb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee67337d-be36-4812-bc9c-b5e20e62469a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_65ec530e-5c8a-48ae-bf44-97c3ae1bf8b5" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ee67337d-be36-4812-bc9c-b5e20e62469a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrganizationandDescriptionofBusiness" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrganizationandDescriptionofBusiness"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrganizationandDescriptionofBusiness" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4323ee02-4954-4f7a-8c01-4b0428e56695" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_660ef57b-35c1-49a9-953c-5b55c236cf88" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4323ee02-4954-4f7a-8c01-4b0428e56695" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_660ef57b-35c1-49a9-953c-5b55c236cf88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_742643ec-52cc-420b-9f7c-6a9c535533e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_06b2b8f7-ab54-4230-b640-99628d89d283" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_742643ec-52cc-420b-9f7c-6a9c535533e1" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_06b2b8f7-ab54-4230-b640-99628d89d283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognition" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognition"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognition" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7b17908a-0475-47ba-9dcc-c7c5ef972b6f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3222440a-6e85-4ba3-8e41-64705f0c9ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_7b17908a-0475-47ba-9dcc-c7c5ef972b6f" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_3222440a-6e85-4ba3-8e41-64705f0c9ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://riskified.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_6d78e78e-2dc8-48ee-933f-d11fd8d9709a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_a8ba4be7-9489-4784-a46b-2b969344fc96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_6d78e78e-2dc8-48ee-933f-d11fd8d9709a" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_a8ba4be7-9489-4784-a46b-2b969344fc96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedging" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedging"/>
  <link:presentationLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedging" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2661a6c9-3116-49cf-b3fc-8907e980449e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_91e85704-cccd-4a07-afc6-ba642f090b14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2661a6c9-3116-49cf-b3fc-8907e980449e" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock_91e85704-cccd-4a07-afc6-ba642f090b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponents" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponents"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9aeb92a3-ed7c-4adb-9fac-bc0b39d0fc9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b244b6e9-bb87-4923-8a17-899dd1fc304d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9aeb92a3-ed7c-4adb-9fac-bc0b39d0fc9c" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_b244b6e9-bb87-4923-8a17-899dd1fc304d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/Leases" xlink:type="simple" xlink:href="rskd-20231231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://riskified.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a8f79abb-ad6a-4690-9b08-7a376e528953" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_ef3ebe49-1057-49b4-8457-5d07435617e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a8f79abb-ad6a-4690-9b08-7a376e528953" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_ef3ebe49-1057-49b4-8457-5d07435617e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingencies" xlink:type="simple" xlink:href="rskd-20231231.xsd#GuaranteesCommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://riskified.com/role/GuaranteesCommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f20dc54-1643-4c38-84ec-57635e52ec62" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_f4791bb2-152b-41d1-8222-37a225f91088" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4f20dc54-1643-4c38-84ec-57635e52ec62" xlink:to="loc_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock_f4791bb2-152b-41d1-8222-37a225f91088" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/TemporaryEquity" xlink:type="simple" xlink:href="rskd-20231231.xsd#TemporaryEquity"/>
  <link:presentationLink xlink:role="http://riskified.com/role/TemporaryEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_c06cef92-aba2-46e1-9097-e9ef7de54c9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityDisclosureTextBlock_cddb6dff-bcb4-4f96-806d-81ec2a7b9a1c" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_c06cef92-aba2-46e1-9097-e9ef7de54c9e" xlink:to="loc_rskd_TemporaryEquityDisclosureTextBlock_cddb6dff-bcb4-4f96-806d-81ec2a7b9a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlan" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlan"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlan" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c137c5cc-9e5c-4439-b7bf-cd00e2e2e2c5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_47e63218-38d4-4221-be89-b6812687f34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c137c5cc-9e5c-4439-b7bf-cd00e2e2e2c5" xlink:to="loc_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock_47e63218-38d4-4221-be89-b6812687f34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxes" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_14caf18a-53ce-4651-958c-bb5f28494005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_2a9b90d9-949c-456a-ad47-d7ab713738e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_14caf18a-53ce-4651-958c-bb5f28494005" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_2a9b90d9-949c-456a-ad47-d7ab713738e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholders"/>
  <link:presentationLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_c179e30a-d49c-400b-a37a-2a2678bffd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_e4d0a838-af98-4624-a73b-4f08c63fe24f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_c179e30a-d49c-400b-a37a-2a2678bffd2f" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_e4d0a838-af98-4624-a73b-4f08c63fe24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/EmployeeBenefitPlans" xlink:type="simple" xlink:href="rskd-20231231.xsd#EmployeeBenefitPlans"/>
  <link:presentationLink xlink:role="http://riskified.com/role/EmployeeBenefitPlans" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e02b2ff8-8e3f-4c0d-89be-24eb0cb9565c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanTextBlock_10ce1594-0d89-46d0-9a1e-3e2d83207f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_e02b2ff8-8e3f-4c0d-89be-24eb0cb9565c" xlink:to="loc_us-gaap_DefinedContributionPlanTextBlock_10ce1594-0d89-46d0-9a1e-3e2d83207f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SubsequentEvents" xlink:type="simple" xlink:href="rskd-20231231.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_299ec667-19f5-4d19-b30c-a38378a511ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_ee492f32-3c24-4993-a860-a03f9476ee25" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_299ec667-19f5-4d19-b30c-a38378a511ca" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_ee492f32-3c24-4993-a860-a03f9476ee25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts" xlink:type="simple" xlink:href="rskd-20231231.xsd#SECScheduleArticle1209ValuationandQualifyingAccounts"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_cca3167e-035d-428b-bd14-0ce0118bd9eb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2f50db61-162e-43ad-be46-f29c8790e27e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_cca3167e-035d-428b-bd14-0ce0118bd9eb" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2f50db61-162e-43ad-be46-f29c8790e27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_eee9f9dd-ee2a-4ef1-b1a0-c110c1f24a0a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_eee9f9dd-ee2a-4ef1-b1a0-c110c1f24a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f42e4976-183b-463b-99fc-2b804119de98" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_f42e4976-183b-463b-99fc-2b804119de98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityPolicyTextBlock_7ec37b11-f374-4095-9878-ccc19b00cd76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_StockholdersEquityPolicyTextBlock_7ec37b11-f374-4095-9878-ccc19b00cd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_e7fbcf9f-4f92-4f86-b103-4487f742a691" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_UseOfEstimates_e7fbcf9f-4f92-4f86-b103-4487f742a691" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e97882ce-be95-4cfd-96b5-aabbe51e0d7d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e97882ce-be95-4cfd-96b5-aabbe51e0d7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_57aa5503-7ff3-4bfa-bd8b-885c00339a34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_57aa5503-7ff3-4bfa-bd8b-885c00339a34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_87d40933-86c8-485e-9353-56415b4f4228" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_87d40933-86c8-485e-9353-56415b4f4228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShortTermDepositsPolicyPolicyTextBlock_206cc660-a1e2-46fe-b63b-f010e8ab9d16" xlink:href="rskd-20231231.xsd#rskd_ShortTermDepositsPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_rskd_ShortTermDepositsPolicyPolicyTextBlock_206cc660-a1e2-46fe-b63b-f010e8ab9d16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_5d864848-ddbb-43e1-91f1-a412e557c6f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_5d864848-ddbb-43e1-91f1-a412e557c6f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fd1d1985-5342-419b-a5af-dee62f7185ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_fd1d1985-5342-419b-a5af-dee62f7185ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_899c63cc-ba08-40a2-9c3d-7a6234991091" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TradeAndOtherAccountsReceivablePolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_TradeAndOtherAccountsReceivablePolicy_899c63cc-ba08-40a2-9c3d-7a6234991091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesPolicyTextBlock_81bb43e3-274b-4afa-a8b7-6b9abf9ea161" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativesPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_DerivativesPolicyTextBlock_81bb43e3-274b-4afa-a8b7-6b9abf9ea161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1fbfbcad-162d-416d-9736-9e18985d94b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1fbfbcad-162d-416d-9736-9e18985d94b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InternalUseSoftwarePolicy_d7eee2f2-50be-4de2-8e21-2b74f9166f87" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InternalUseSoftwarePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_InternalUseSoftwarePolicy_d7eee2f2-50be-4de2-8e21-2b74f9166f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_103e6fcf-dbf1-46ea-9c8f-12570f9025d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_103e6fcf-dbf1-46ea-9c8f-12570f9025d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_65a782b1-b951-49c4-b0d4-6900d72a87ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_65a782b1-b951-49c4-b0d4-6900d72a87ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_a9f78a01-296e-44e0-b83f-23c565aef81c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies_a9f78a01-296e-44e0-b83f-23c565aef81c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock_ccb1119e-94bd-4dde-bc66-cd7ffdee8f94" xlink:href="rskd-20231231.xsd#rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock_ccb1119e-94bd-4dde-bc66-cd7ffdee8f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_619836ba-d38a-4ada-87fb-5fd9724469af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_619836ba-d38a-4ada-87fb-5fd9724469af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesPolicyTextBlock_8382a959-2d7c-46d6-b929-68f39e2364dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_CostOfSalesPolicyTextBlock_8382a959-2d7c-46d6-b929-68f39e2364dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_41e13e04-b2f8-45de-b4eb-cf17cd783718" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_41e13e04-b2f8-45de-b4eb-cf17cd783718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock_a795737a-de1f-4d81-a3e0-25cc0ef863ba" xlink:href="rskd-20231231.xsd#rskd_SalesAndMarketingExpensePolicyPolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock_a795737a-de1f-4d81-a3e0-25cc0ef863ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_49120d9f-d92f-4cea-907a-9169a41fc74d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_49120d9f-d92f-4cea-907a-9169a41fc74d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f0a8022f-f9ea-4c7c-90dd-f0dd17075671" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f0a8022f-f9ea-4c7c-90dd-f0dd17075671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_c6edfb1e-8b9a-4ce2-a426-b7fa627a27ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_c6edfb1e-8b9a-4ce2-a426-b7fa627a27ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_8d978af2-74f6-4fb7-ad92-2c0a9085dee3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_8d978af2-74f6-4fb7-ad92-2c0a9085dee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9bca88d6-789f-46ba-bfe3-24bd4cb1f016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_9bca88d6-789f-46ba-bfe3-24bd4cb1f016" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_88eaeac2-02e6-44fd-9556-387efa338be5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_59428706-ceef-48e7-a8a6-5c9d3a95641e" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_88eaeac2-02e6-44fd-9556-387efa338be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_7fdfab3c-4e57-4fc3-a8ef-98fbc1bb538d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1ecb1c6f-736b-4d0f-89b8-8e3337d61d68" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdfab3c-4e57-4fc3-a8ef-98fbc1bb538d" xlink:to="loc_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock_1ecb1c6f-736b-4d0f-89b8-8e3337d61d68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_7f655439-1302-46b0-b3a7-09f14530961c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdfab3c-4e57-4fc3-a8ef-98fbc1bb538d" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_7f655439-1302-46b0-b3a7-09f14530961c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0e4e3873-7981-4090-8f94-9b6bbeb9ae1d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdfab3c-4e57-4fc3-a8ef-98fbc1bb538d" xlink:to="loc_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock_0e4e3873-7981-4090-8f94-9b6bbeb9ae1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a90ea764-1d06-4918-bb8f-f9cca2ba8c63" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_7fdfab3c-4e57-4fc3-a8ef-98fbc1bb538d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_a90ea764-1d06-4918-bb8f-f9cca2ba8c63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognitionTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7fabc1e-15da-4999-b126-d6948194c4a8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1c3fb11f-fa4f-4fac-bad5-a486b75129a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7fabc1e-15da-4999-b126-d6948194c4a8" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_1c3fb11f-fa4f-4fac-bad5-a486b75129a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c430610b-e590-4874-9702-5aa40fe965d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7fabc1e-15da-4999-b126-d6948194c4a8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_c430610b-e590-4874-9702-5aa40fe965d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_bc077f08-951c-4838-b0a9-e45171cfc13b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7fabc1e-15da-4999-b126-d6948194c4a8" xlink:to="loc_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock_bc077f08-951c-4838-b0a9-e45171cfc13b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsTableTextBlock_eb4fe0c6-c6c7-4116-87ef-43a3fbd5be2b" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_e7fabc1e-15da-4999-b126-d6948194c4a8" xlink:to="loc_rskd_DeferredContractFulfillmentCostsTableTextBlock_eb4fe0c6-c6c7-4116-87ef-43a3fbd5be2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_46af18ae-ff77-4621-9b22-474fc9f0d577" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c951f474-4da2-405b-adb7-82634d84b28d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46af18ae-ff77-4621-9b22-474fc9f0d577" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_c951f474-4da2-405b-adb7-82634d84b28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_dc16f6d0-6241-472f-9936-ff1e2ac9ca14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46af18ae-ff77-4621-9b22-474fc9f0d577" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_dc16f6d0-6241-472f-9936-ff1e2ac9ca14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_32ec3a60-cff6-4070-a59f-97f8e3498937" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_46af18ae-ff77-4621-9b22-474fc9f0d577" xlink:to="loc_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock_32ec3a60-cff6-4070-a59f-97f8e3498937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74692243-22bc-42cb-b7f8-59532c2317f7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_d5d1903e-f85b-4895-b073-31a6e42aea00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74692243-22bc-42cb-b7f8-59532c2317f7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock_d5d1903e-f85b-4895-b073-31a6e42aea00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_96c4945d-610a-48aa-8c23-901e50ee855c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74692243-22bc-42cb-b7f8-59532c2317f7" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_96c4945d-610a-48aa-8c23-901e50ee855c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f2db9525-8792-4f7e-9500-3d9d1c3ad6c7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_74692243-22bc-42cb-b7f8-59532c2317f7" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_f2db9525-8792-4f7e-9500-3d9d1c3ad6c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7383fdb-028f-4ad3-a77b-439c30735b05" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ed65d1c4-bd28-4aed-88d9-cb126d5f3617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7383fdb-028f-4ad3-a77b-439c30735b05" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_ed65d1c4-bd28-4aed-88d9-cb126d5f3617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_02084f8e-2ded-4f96-bd89-008fac899d75" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7383fdb-028f-4ad3-a77b-439c30735b05" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_02084f8e-2ded-4f96-bd89-008fac899d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f20f1dd7-ea06-446e-a690-e1d051e52d77" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d7383fdb-028f-4ad3-a77b-439c30735b05" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_f20f1dd7-ea06-446e-a690-e1d051e52d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_114a16df-8850-4c2d-8561-2988202e1336" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_38f1c703-e52c-4679-a83b-2fa6369be791" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_114a16df-8850-4c2d-8561-2988202e1336" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_38f1c703-e52c-4679-a83b-2fa6369be791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_337012da-e354-4488-8e18-c9e64c3e6de3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_114a16df-8850-4c2d-8561-2988202e1336" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_337012da-e354-4488-8e18-c9e64c3e6de3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#GuaranteesCommitmentsandContingenciesTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61196e30-8ee0-4cc6-9447-be8487a35da8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_1b0fd939-4d61-45df-bd46-bddc47d54560" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_61196e30-8ee0-4cc6-9447-be8487a35da8" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock_1b0fd939-4d61-45df-bd46-bddc47d54560" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/TemporaryEquityTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#TemporaryEquityTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/TemporaryEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_ee533c37-716c-4af5-a1a6-a50fea06da5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_9a3b9ac3-3798-4666-982e-5f4325817d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_ee533c37-716c-4af5-a1a6-a50fea06da5f" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_9a3b9ac3-3798-4666-982e-5f4325817d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_9af0d95c-a0fa-4b9a-b369-7e00abeaa01e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_9af0d95c-a0fa-4b9a-b369-7e00abeaa01e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_47cfb739-89dc-470c-b8b3-fd05f9ec1790" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_47cfb739-89dc-470c-b8b3-fd05f9ec1790" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_f3c36739-6666-4011-b5d1-cacb8e5f113d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_f3c36739-6666-4011-b5d1-cacb8e5f113d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_8da194a2-9599-4ecd-be3a-01b6388342df" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:to="loc_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock_8da194a2-9599-4ecd-be3a-01b6388342df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_d4c20018-4dad-4dc9-969c-7d305b81cb94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa913c63-8e9e-4d73-88bd-c867cf24af0e" xlink:to="loc_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock_d4c20018-4dad-4dc9-969c-7d305b81cb94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b423d68b-e9ed-4bc8-bc80-44f3e4852e8a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_b423d68b-e9ed-4bc8-bc80-44f3e4852e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e5df57cf-fcfd-480e-87ab-38bd142496e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_e5df57cf-fcfd-480e-87ab-38bd142496e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_2db106c1-33e0-469d-b5fc-252bd77ff75d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_2db106c1-33e0-469d-b5fc-252bd77ff75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6801a9cb-14c9-462e-99d3-85ba6889d2e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_6801a9cb-14c9-462e-99d3-85ba6889d2e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_94377e1e-af67-45e9-a960-73ca6815345a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5c1c7e68-ef2b-439e-a2eb-b35482c7ae9a" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_94377e1e-af67-45e9-a960-73ca6815345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables"/>
  <link:presentationLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_49faee32-b670-4371-b33c-81c67a97ff12" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_72489ba1-8ee3-421e-938c-7561c0b10229" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49faee32-b670-4371-b33c-81c67a97ff12" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_72489ba1-8ee3-421e-938c-7561c0b10229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_565c8c71-b6a6-4ee2-803f-6fe56f81f9c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_49faee32-b670-4371-b33c-81c67a97ff12" xlink:to="loc_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock_565c8c71-b6a6-4ee2-803f-6fe56f81f9c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_aafd6bd0-4b71-41a3-9229-75ff2d078dd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_aafd6bd0-4b71-41a3-9229-75ff2d078dd5" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ddcd8dad-4423-4c42-b2a7-9baeaf86ebc7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4f6723a3-891a-4edb-96a2-7bda442b11c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d3c51fd1-f612-42b7-8388-1298ce462bab" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4f6723a3-891a-4edb-96a2-7bda442b11c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_4dd3d08d-b1fb-4e25-97b8-fd1cd410ae27" xlink:to="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_fea6fcef-2118-4e1b-a713-f0d06e6141b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_ba6eb291-be83-43f4-b349-fafb36c87f9c" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_fea6fcef-2118-4e1b-a713-f0d06e6141b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_e8b7dd74-8e3b-4aca-b3d1-64ca843b9b93" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IPOMember_e180de61-d687-4934-8b3a-0434f7ae05d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IPOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:to="loc_us-gaap_IPOMember_e180de61-d687-4934-8b3a-0434f7ae05d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OverAllotmentOptionMember_c0b9a246-1cf6-4234-86df-8ca784b15da6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OverAllotmentOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b86df63e-89fc-435e-b4c5-8b73e2c1a101" xlink:to="loc_us-gaap_OverAllotmentOptionMember_c0b9a246-1cf6-4234-86df-8ca784b15da6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_70997edd-cfed-418a-882a-04e2d8558b7f" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17395456-9d37-4cff-a4ac-668f09eadfc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareAndSoftwareDevelopmentCostsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_2234fa75-e92c-4fca-9b7b-38535949bf99" xlink:to="loc_us-gaap_SoftwareAndSoftwareDevelopmentCostsMember_17395456-9d37-4cff-a4ac-668f09eadfc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b5b96719-0e96-45e6-b6c6-8e2fbb0dc8b2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_83202c1d-b4cb-44b2-bec4-2214f7e8c450" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_83202c1d-b4cb-44b2-bec4-2214f7e8c450" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CloudComputingArrangementImplementationCostsMember_c17bdc82-f5e2-4abd-a041-94525b648fab" xlink:href="rskd-20231231.xsd#rskd_CloudComputingArrangementImplementationCostsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_282ba619-3bd9-4d1f-b5f4-d85ac0951102" xlink:to="loc_rskd_CloudComputingArrangementImplementationCostsMember_c17bdc82-f5e2-4abd-a041-94525b648fab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_557aaade-c848-4de0-a7dc-df9207e1e155" xlink:to="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_0e2b4d01-5293-4582-b2ac-300405b34dea" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:to="loc_srt_MinimumMember_0e2b4d01-5293-4582-b2ac-300405b34dea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b9b1ff4e-a544-4d7e-aeae-7c2c7c08f38e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_62862734-685b-4f2a-af83-7926591d90da" xlink:to="loc_srt_MaximumMember_b9b1ff4e-a544-4d7e-aeae-7c2c7c08f38e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_262557e5-867d-48a0-a64e-2aab1bff52f8" xlink:to="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeriesE1ConvertiblePreferredStockMember_2bf600f5-c51d-40d5-948e-166fef4b0067" xlink:href="rskd-20231231.xsd#rskd_SeriesE1ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_rskd_SeriesE1ConvertiblePreferredStockMember_2bf600f5-c51d-40d5-948e-166fef4b0067" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_f4ca348b-1b4a-4c69-acad-0ba0c50339ab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_us-gaap_CommonClassAMember_f4ca348b-1b4a-4c69-acad-0ba0c50339ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_b5c70a6d-61e9-4fbe-ada4-900afed902db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c5c8e16-6343-479f-8496-2e557aebc31f" xlink:to="loc_us-gaap_CommonClassBMember_b5c70a6d-61e9-4fbe-ada4-900afed902db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_445801ea-cec5-4341-aa1b-f96d8e1674f6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_86e34f00-f81f-4ab5-a872-147d893d12b5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_86e34f00-f81f-4ab5-a872-147d893d12b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0331898d-b80c-401c-8714-28774581407f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0331898d-b80c-401c-8714-28774581407f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2fbcd0e4-0506-4e86-9176-94f740e370c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_2fbcd0e4-0506-4e86-9176-94f740e370c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_ba961603-84e8-40cc-bc48-01e5713cabc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_ba961603-84e8-40cc-bc48-01e5713cabc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_82f4ef52-063c-4466-b4dc-0821660ae16e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_82f4ef52-063c-4466-b4dc-0821660ae16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_b60fce64-d200-4542-8f54-1065dcbf5d3a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_b60fce64-d200-4542-8f54-1065dcbf5d3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_PaymentsOfOtherStockIssuanceCosts_a5fe5d52-30cb-4a17-8e38-bee0d78064c6" xlink:href="rskd-20231231.xsd#rskd_PaymentsOfOtherStockIssuanceCosts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_PaymentsOfOtherStockIssuanceCosts_a5fe5d52-30cb-4a17-8e38-bee0d78064c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockVotesForEachShare_cc971766-53db-4345-9049-2fe1ef4960b6" xlink:href="rskd-20231231.xsd#rskd_CommonStockVotesForEachShare"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_CommonStockVotesForEachShare_cc971766-53db-4345-9049-2fe1ef4960b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f2e58fcc-bee4-4c27-ab27-6182d394c981" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_f2e58fcc-bee4-4c27-ab27-6182d394c981" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1204a37d-3233-4ffb-8663-91b24cdd0d94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_1204a37d-3233-4ffb-8663-91b24cdd0d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ed46eea4-2409-4517-902e-d968596da813" xlink:href="rskd-20231231.xsd#rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_ed46eea4-2409-4517-902e-d968596da813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b4c22c1d-8d63-41a4-a3b4-4b2bb849ac59" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b4c22c1d-8d63-41a4-a3b4-4b2bb849ac59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_52970e89-b7d6-4e81-8b90-dec4f0304ba9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCurrencyTransactionGainLossRealized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossRealized_52970e89-b7d6-4e81-8b90-dec4f0304ba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c737d8c1-7dea-4c34-8c5f-2a26c0ffd580" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_c737d8c1-7dea-4c34-8c5f-2a26c0ffd580" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a5d80e27-4a07-49d4-9eb3-e0979a2833ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_a5d80e27-4a07-49d4-9eb3-e0979a2833ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedComputerSoftwareGross_86a87fbe-e910-4775-ab6a-89dcd35305cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedComputerSoftwareGross"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedComputerSoftwareGross_86a87fbe-e910-4775-ab6a-89dcd35305cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_fd7469ee-c90c-4d7b-9b24-7af2dda9005c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_fd7469ee-c90c-4d7b-9b24-7af2dda9005c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsTerm_a56ae422-2d02-41e0-8f91-993e8638fd84" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsTerm"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_GuaranteeObligationsTerm_a56ae422-2d02-41e0-8f91-993e8638fd84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_RevenueTermOfMerchantContract_c270ca6b-ff24-46c1-bf7b-fba5406f7627" xlink:href="rskd-20231231.xsd#rskd_RevenueTermOfMerchantContract"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_RevenueTermOfMerchantContract_c270ca6b-ff24-46c1-bf7b-fba5406f7627" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_eb3a7053-7c9d-4813-91fc-e724b5568c85" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostAmortizationPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostAmortizationPeriod_eb3a7053-7c9d-4813-91fc-e724b5568c85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostImpairmentLoss_3d522420-851c-4fcf-bc87-a88960184765" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostImpairmentLoss"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_CapitalizedContractCostImpairmentLoss_3d522420-851c-4fcf-bc87-a88960184765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ChargebackExpense_fcfa60be-f61e-4ffe-a03d-054ce43194e4" xlink:href="rskd-20231231.xsd#rskd_ChargebackExpense"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_rskd_ChargebackExpense_fcfa60be-f61e-4ffe-a03d-054ce43194e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_cb9cbad3-4086-4149-810e-0a953d6db82a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AdvertisingExpense_cb9cbad3-4086-4149-810e-0a953d6db82a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_509612d8-ed29-4702-880f-de3fe7916fee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_509612d8-ed29-4702-880f-de3fe7916fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_4021bd9f-819b-41ef-8113-9a76b206e8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_4021bd9f-819b-41ef-8113-9a76b206e8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_4db3a348-46c2-4cdb-969e-417a06657713" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_NumberOfOperatingSegments_4db3a348-46c2-4cdb-969e-417a06657713" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_24ca555c-39bb-41e3-aaf7-1b39ae2e5abf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_NumberOfReportableSegments_24ca555c-39bb-41e3-aaf7-1b39ae2e5abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e26d7adf-c681-4f86-a986-83cbecfb0bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e26d7adf-c681-4f86-a986-83cbecfb0bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_ced861d1-5b6f-4f83-945f-a77e5ee89ad7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_fb1e9ce0-0fe1-4038-b4de-32270bc0ca04" xlink:to="loc_us-gaap_OperatingLeaseLiability_ced861d1-5b6f-4f83-945f-a77e5ee89ad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8a43a477-d6f7-4e57-bce6-8095aa3e08af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8a43a477-d6f7-4e57-bce6-8095aa3e08af" xlink:to="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_a2d4bcae-b337-4efb-8776-536a3b898811" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_170c5e5f-16a9-4d43-bf26-50fb510d623d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:to="loc_us-gaap_AccountsReceivableMember_170c5e5f-16a9-4d43-bf26-50fb510d623d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4ffc2d3c-1ed7-4c7e-816c-4fcb12c00925" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_e55973e7-a652-4652-bf82-faf48987bdb3" xlink:to="loc_us-gaap_SalesRevenueNetMember_4ffc2d3c-1ed7-4c7e-816c-4fcb12c00925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_0f0eac7f-3cbd-487b-9df2-7dc299af61b0" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_1dfaa8f1-f8f9-42e3-89f6-50643485af0c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_ab455b2b-6b75-4749-92a8-672af21ddb3e" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_1dfaa8f1-f8f9-42e3-89f6-50643485af0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_3ab97f7e-0bb7-48f2-93e3-22ac7aa5ead4" xlink:to="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerAMember_a4c44919-7d9c-4502-b2c9-7f1dde968cd0" xlink:href="rskd-20231231.xsd#rskd_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:to="loc_rskd_CustomerAMember_a4c44919-7d9c-4502-b2c9-7f1dde968cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CustomerBMember_9b9fa5e8-c3c5-49d6-9878-22b0b9aea7d9" xlink:href="rskd-20231231.xsd#rskd_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_73c06ab7-162a-48bd-a6c7-c7424022ca69" xlink:to="loc_rskd_CustomerBMember_9b9fa5e8-c3c5-49d6-9878-22b0b9aea7d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_ee6122c2-b43e-4678-abea-c50f606ac1b0" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_16371a9b-5c11-4adb-873c-f791c77f6415" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_2a338344-deab-4f70-b17a-6af8d062f832" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_16371a9b-5c11-4adb-873c-f791c77f6415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_51c3fbfe-19d3-4206-9db3-b5d236d6bb09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_51c3fbfe-19d3-4206-9db3-b5d236d6bb09" xlink:to="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:to="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_cf1e6ba1-f0db-4258-86d6-31fb1ec90275" xlink:to="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_046503fe-bd9f-477d-ad7d-0751d448cc48" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_046503fe-bd9f-477d-ad7d-0751d448cc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_7d647535-c4b5-4dd3-b3bf-9ee3344cf7cb" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_ecee2719-779b-49fc-9fbf-3bdc2845d75d" xlink:to="loc_srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember_7d647535-c4b5-4dd3-b3bf-9ee3344cf7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_040f1d27-558f-4909-8eb5-d2b02fc30b70" xlink:to="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_cd65a64c-ff1a-4606-8ac8-c3d7570fc165" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:to="loc_us-gaap_CommonClassAMember_cd65a64c-ff1a-4606-8ac8-c3d7570fc165" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_def2fc9a-4558-4143-9c02-143942a4bbb4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_832f29bd-fc65-4b23-b0c7-310b25a9cd18" xlink:to="loc_us-gaap_CommonClassBMember_def2fc9a-4558-4143-9c02-143942a4bbb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable_3468147b-5997-4edc-8ee1-093a6a32cefa" xlink:to="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_f0ed382c-5bcf-4062-bdbe-10e934926df3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_f0ed382c-5bcf-4062-bdbe-10e934926df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b3c5b16-13bd-492b-9d60-0d595abc84fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_6b3c5b16-13bd-492b-9d60-0d595abc84fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_0cb90d28-4890-42a8-8fdf-705c7e897a97" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_SellingAndMarketingExpense_0cb90d28-4890-42a8-8fdf-705c7e897a97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_65441f32-1804-4513-9bb1-b548f523e53e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_OperatingIncomeLoss_65441f32-1804-4513-9bb1-b548f523e53e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3af56d62-a7b8-45a5-a5d4-3c47b8b85535" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3af56d62-a7b8-45a5-a5d4-3c47b8b85535" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_21f21c02-4eb7-4a64-80e1-2fd91edf9af6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_NetIncomeLoss_21f21c02-4eb7-4a64-80e1-2fd91edf9af6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_be2a9879-01d2-476d-88a8-e6512382491c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_EarningsPerShareBasic_be2a9879-01d2-476d-88a8-e6512382491c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_bf93e9e9-8be2-442e-a2f2-3a593661272b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems_e96d1405-3f69-463d-96ca-a53a3f4c7e82" xlink:to="loc_us-gaap_EarningsPerShareDiluted_bf93e9e9-8be2-442e-a2f2-3a593661272b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_f40b082e-9734-4a72-841e-439c31cde2d1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_f40b082e-9734-4a72-841e-439c31cde2d1" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_434f835e-9a4b-4098-acad-894952c7800f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_434f835e-9a4b-4098-acad-894952c7800f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_effacee1-c81e-4b37-a4ba-0677253b5015" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_effacee1-c81e-4b37-a4ba-0677253b5015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_270eaede-f878-47de-b609-25ef7dc7c97f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_270eaede-f878-47de-b609-25ef7dc7c97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_effa8f7e-b641-4110-bc41-5bed409b5697" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries_effa8f7e-b641-4110-bc41-5bed409b5697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ce3ec179-d9ed-4a28-87d7-ad818e2fe139" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_768a910b-0558-42b5-a255-f74d23b7ff96" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_ce3ec179-d9ed-4a28-87d7-ad818e2fe139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_65123e60-d070-488c-a1ac-21ebce8becc3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_65123e60-d070-488c-a1ac-21ebce8becc3" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_d932cf66-737a-4d9c-b0ca-b2fc7416c279" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_09ce5076-9bda-4d27-a07d-e983bcf58ccb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:to="loc_us-gaap_ComputerEquipmentMember_09ce5076-9bda-4d27-a07d-e983bcf58ccb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FurnitureAndOfficeEquipmentMember_c1489b90-b713-41bd-850a-4cfd5522192c" xlink:href="rskd-20231231.xsd#rskd_FurnitureAndOfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_262b4e4d-a864-4e1b-8c65-dfee56476fba" xlink:to="loc_rskd_FurnitureAndOfficeEquipmentMember_c1489b90-b713-41bd-850a-4cfd5522192c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:to="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_6e0ff443-cccd-49bc-8c8b-f0634558eac3" xlink:to="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_84f4bb82-a7a9-416c-b37c-733148b40d8d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:to="loc_srt_MinimumMember_84f4bb82-a7a9-416c-b37c-733148b40d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_31ced675-f5b3-4333-8ae5-dfacf35d758f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ec81aca2-afde-4d7e-993c-a1fed630cefa" xlink:to="loc_srt_MaximumMember_31ced675-f5b3-4333-8ae5-dfacf35d758f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_0adc45f9-4ad5-4da7-b4ef-74c71d1c3e53" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c86dc43c-ba55-4f94-86e1-340eecf7465d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_bfdc4946-69d8-4e55-984e-f5ef38ee5591" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_c86dc43c-ba55-4f94-86e1-340eecf7465d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionRevenuebyGeographicAreasDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a81267f2-1543-4990-b004-d789380c821c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_a81267f2-1543-4990-b004-d789380c821c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_15cecf36-abe7-4e8e-992c-1ea2696f3e18" xlink:to="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cf0d22b0-285f-43c6-b6d9-cbf4bd993349" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_country_US_cf0d22b0-285f-43c6-b6d9-cbf4bd993349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EMEAMember_1e1a5227-b848-4cfa-a57d-cda6aab1c508" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EMEAMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_us-gaap_EMEAMember_1e1a5227-b848-4cfa-a57d-cda6aab1c508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_0c4531ea-c46c-46f8-8e87-1a913ccf3759" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_srt_AsiaPacificMember_0c4531ea-c46c-46f8-8e87-1a913ccf3759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_24f4bd5f-22fb-46ac-b004-7f972b461bf3" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_country_IL_24f4bd5f-22fb-46ac-b004-7f972b461bf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AmericasMember_bf722423-9cbd-431c-bbdc-1105c8b7871b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_AmericasMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_637b5227-3e12-48f4-8fc8-6bee23598944" xlink:to="loc_srt_AmericasMember_bf722423-9cbd-431c-bbdc-1105c8b7871b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_21971aec-6cc3-4607-acd2-407cc9d2dbf0" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c4fbea1f-c594-4385-b4df-d346f6b95732" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_1a678c37-632c-4782-b3f3-f1102e7fa77f" xlink:to="loc_us-gaap_SalesRevenueNetMember_c4fbea1f-c594-4385-b4df-d346f6b95732" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_ed73231b-e549-4e0e-b77e-e06e16ab3e14" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_e013fd26-519a-4b8d-b47e-f0823eb3c67d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7a23c48c-d826-4d3f-85ca-c5307125de96" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_e013fd26-519a-4b8d-b47e-f0823eb3c67d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db2a0387-7ed4-4cc1-8fe1-b50e92042988" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_288214bd-b781-488c-a77a-8e560adeb730" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:to="loc_us-gaap_Revenues_288214bd-b781-488c-a77a-8e560adeb730" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_c8514a53-5d38-456a-af05-e2e97c5d329d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_2d9d3b45-2b7f-4a95-be15-819754b09376" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_c8514a53-5d38-456a-af05-e2e97c5d329d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_673c770d-9db2-4a91-828d-e5c63fc2b619" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_673c770d-9db2-4a91-828d-e5c63fc2b619" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_51ef7ae4-2c9c-46a9-b715-af2d8fec47ea" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_dec45895-6cfa-47b0-9f94-0c22df25431b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_a90e61f3-64bc-405b-85a0-dabbe38d38dc" xlink:to="loc_us-gaap_SalesRevenueNetMember_dec45895-6cfa-47b0-9f94-0c22df25431b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_020a9f72-b945-4e70-a2bf-b98088547a20" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductConcentrationRiskMember_883612b3-976b-4756-91d0-cef4d814f2c6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ProductConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_7f2811ce-faf6-4820-a5d4-6a2dfcf504f3" xlink:to="loc_us-gaap_ProductConcentrationRiskMember_883612b3-976b-4756-91d0-cef4d814f2c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_63948ad4-39ce-49c4-9cd0-eec30c525864" xlink:to="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FraudServiceRevenueMember_9751e3b1-9e12-4c28-bf8e-70f4ea3bb561" xlink:href="rskd-20231231.xsd#rskd_FraudServiceRevenueMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:to="loc_rskd_FraudServiceRevenueMember_9751e3b1-9e12-4c28-bf8e-70f4ea3bb561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IndemnificationServiceRevenueMember_bb12e1d5-f213-4ca9-b0c4-5d22a9d06c0d" xlink:href="rskd-20231231.xsd#rskd_IndemnificationServiceRevenueMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_84592620-7ad0-41a3-aa32-e2fb00105b58" xlink:to="loc_rskd_IndemnificationServiceRevenueMember_bb12e1d5-f213-4ca9-b0c4-5d22a9d06c0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_34ca4ded-fce0-44c0-9a7b-cbcbd0f8e5e8" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8b6d318-b707-4b42-8760-2b96f7e13d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_b8b6d318-b707-4b42-8760-2b96f7e13d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueNotFromContractWithCustomer_5cedc0fa-5a11-4703-a742-974021cbedd7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueNotFromContractWithCustomer"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_RevenueNotFromContractWithCustomer_5cedc0fa-5a11-4703-a742-974021cbedd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_90cb9f22-cefb-4200-b5cb-f5b6cb889273" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_Revenues_90cb9f22-cefb-4200-b5cb-f5b6cb889273" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_3b02f196-1d4a-4e6c-bb03-81fccfa60f27" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5195afdd-6376-4281-8bd0-3ce4651437d9" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_3b02f196-1d4a-4e6c-bb03-81fccfa60f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionDeferredContractAcquisitionCostsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dbc8bc1f-664b-4168-88f9-8f760a7d1144" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:href="rskd-20231231.xsd#rskd_MovementInDeferredContractAcquisitionCostsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_dbc8bc1f-664b-4168-88f9-8f760a7d1144" xlink:to="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_6926fa3f-cd67-4192-936d-82320e985617" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_6926fa3f-cd67-4192-936d-82320e985617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts_21df105b-c1ac-4d2a-87ca-75ba74af41ed" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:to="loc_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts_21df105b-c1ac-4d2a-87ca-75ba74af41ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CapitalizedDeferredContractAcquisitionCostAmortization_9d0e801d-c05b-4826-8a09-203732b083b1" xlink:href="rskd-20231231.xsd#rskd_CapitalizedDeferredContractAcquisitionCostAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:to="loc_rskd_CapitalizedDeferredContractAcquisitionCostAmortization_9d0e801d-c05b-4826-8a09-203732b083b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalizedContractCostNetNoncurrent_9b45a374-6ce3-4541-ac38-249b15093ead" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CapitalizedContractCostNetNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractAcquisitionCostsRollForward_23c89f7b-5a5c-4565-ae21-16a8febc41fa" xlink:to="loc_us-gaap_CapitalizedContractCostNetNoncurrent_9b45a374-6ce3-4541-ac38-249b15093ead" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#RevenueRecognitionDeferredContractFulfillmentCostsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_483726dc-1348-48d9-98f1-bf0bc0cca77c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:href="rskd-20231231.xsd#rskd_MovementInDeferredContractFulfillmentCostsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_483726dc-1348-48d9-98f1-bf0bc0cca77c" xlink:to="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsNoncurrent_c59d4e04-d36f-43f0-b7c0-fbec7093b783" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:to="loc_rskd_DeferredContractFulfillmentCostsNoncurrent_c59d4e04-d36f-43f0-b7c0-fbec7093b783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts_7ab3fdd6-b9da-40fe-9ed2-10cf90cfbc4f" xlink:href="rskd-20231231.xsd#rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:to="loc_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts_7ab3fdd6-b9da-40fe-9ed2-10cf90cfbc4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsAmortizationExpense_3e89fce1-f18f-4999-81f9-fa8dd2445835" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsAmortizationExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:to="loc_rskd_DeferredContractFulfillmentCostsAmortizationExpense_3e89fce1-f18f-4999-81f9-fa8dd2445835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredContractFulfillmentCostsNoncurrent_1e9de952-0b7a-4711-b467-f9c3716f97f2" xlink:href="rskd-20231231.xsd#rskd_DeferredContractFulfillmentCostsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_MovementInDeferredContractFulfillmentCostsRollForward_03a2616d-2462-4c8b-a968-4d48699f3215" xlink:to="loc_rskd_DeferredContractFulfillmentCostsNoncurrent_1e9de952-0b7a-4711-b467-f9c3716f97f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_3fb04b31-7e2b-4aaf-a9f9-374e985ff5b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_3fb04b31-7e2b-4aaf-a9f9-374e985ff5b6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_f005d544-9cd6-492a-9cd3-1270ccf6270e" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_86ec3798-8a9d-4fc2-abaf-d2d0081de978" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ef88bc7e-97ac-42c8-8687-a792c52b1b79" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_86ec3798-8a9d-4fc2-abaf-d2d0081de978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_ffdb30b2-ecb5-4f9e-be96-58f548112dee" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_0e6afae3-cdae-4ada-b1b7-453d24e4203d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_f93be875-06f7-45cc-a9d0-829e434791ca" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_0e6afae3-cdae-4ada-b1b7-453d24e4203d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79b4073e-6602-4abf-8e42-c57a8503cfac" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_dfbcd372-49e9-4a64-aa65-6a0d95c7f7a6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_dfbcd372-49e9-4a64-aa65-6a0d95c7f7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_74315446-024e-4f1c-825c-9da19f29005a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_74315446-024e-4f1c-825c-9da19f29005a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_be7d34d6-4652-4c9f-b0d9-436785c24776" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_7c8cebe9-1ee7-4b37-bed1-c503b1b3dd66" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_be7d34d6-4652-4c9f-b0d9-436785c24776" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_0192bcf5-7f4a-408c-ac65-597bbf777343" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermInvestments_85c503b0-5397-4f13-8754-4095d4e8a287" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_ShortTermInvestments_85c503b0-5397-4f13-8754-4095d4e8a287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssets_29d67b61-08d4-4ad4-ad2f-5bef7e9ceee6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_DerivativeAssets_29d67b61-08d4-4ad4-ad2f-5bef7e9ceee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_62a0c00e-13b1-4117-89bf-528969e55956" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract_72c055fa-9152-4777-aeef-218650ac5a2b" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_62a0c00e-13b1-4117-89bf-528969e55956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_1abbfaf5-272b-4fa2-b4b7-e92eaee841a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:to="loc_us-gaap_DerivativeLiabilities_1abbfaf5-272b-4fa2-b4b7-e92eaee841a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_ae1fa61b-8363-4da9-bbee-0da812e1482c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract_c824433c-a10a-4139-a3a1-ff25bdd76a19" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosure_ae1fa61b-8363-4da9-bbee-0da812e1482c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_4d89a505-8834-45cb-b4dd-a5e4fa647147" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration_4d89a505-8834-45cb-b4dd-a5e4fa647147" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_fc4d4633-321d-41d4-9b0b-29406b36dcd0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_870760d2-b8e5-476b-8892-ac6c03e38071" xlink:to="loc_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration_fc4d4633-321d-41d4-9b0b-29406b36dcd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsScheduleofShorttermInvestmentsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_a1f4eec6-c984-43a0-b893-3d1e4da861d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_a1f4eec6-c984-43a0-b893-3d1e4da861d4" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_06b59ae9-71e4-4350-806a-ad243562579c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentDebtSecuritiesMember_10419c8b-3ef6-45fd-b04e-2c5e1a8f3feb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_USGovernmentDebtSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_bb2537ed-a6f3-4fec-8be9-a0938d4b5932" xlink:to="loc_us-gaap_USGovernmentDebtSecuritiesMember_10419c8b-3ef6-45fd-b04e-2c5e1a8f3feb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_e87e1d98-9810-4362-a10a-0caa3fc0f788" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_06cc7963-5f9d-4544-9e1e-4e06c7bd16a9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss_06cc7963-5f9d-4544-9e1e-4e06c7bd16a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1113cc0-5a08-4050-8152-9003775ffbae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b1113cc0-5a08-4050-8152-9003775ffbae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ce95f3c-1277-44d7-af09-67f5cb1c885c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_4ce95f3c-1277-44d7-af09-67f5cb1c885c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b1a1348-ed52-4d0f-8d3e-0548d89d5bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_eeaa3e15-a323-4c17-bf6c-a82cdc114cda" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_0b1a1348-ed52-4d0f-8d3e-0548d89d5bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#FairValueMeasurementsEffectiveContractualMaturityDatesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5e67d795-406c-4440-b708-81f826b6eb26" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_453e2740-38ec-47a0-bfc5-3b6a9510be5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5e67d795-406c-4440-b708-81f826b6eb26" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue_453e2740-38ec-47a0-bfc5-3b6a9510be5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7e21ac6b-4188-481e-bea1-fdcb9ae781c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5e67d795-406c-4440-b708-81f826b6eb26" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_7e21ac6b-4188-481e-bea1-fdcb9ae781c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db49980e-e80b-42f8-a887-dc2621b92ebb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_db49980e-e80b-42f8-a887-dc2621b92ebb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_4391299d-bf2c-4081-be26-4d8cdc96e757" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_aaa1815c-1462-4269-8757-abf4dcbae238" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_405a44d4-802c-43e8-9ff2-c8247264e331" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_aaa1815c-1462-4269-8757-abf4dcbae238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:to="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7f5e6dfe-7f38-4ebd-b9d8-fdfd732f8406" xlink:to="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2360899f-649d-4f7b-b957-9d5542457e5b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_2360899f-649d-4f7b-b957-9d5542457e5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_37231f33-d7c4-48f8-b76a-abbefa32e414" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_27b57d1b-01f4-423e-8002-3c3224f1230b" xlink:to="loc_us-gaap_NondesignatedMember_37231f33-d7c4-48f8-b76a-abbefa32e414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_1c06bdb6-21aa-4c3e-809b-0e513631bdbb" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ad96eb53-d9dc-4145-a0a0-ccd74b002a7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_8a91c612-c01e-4dd9-bf9f-dba5b08cbbd1" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_ad96eb53-d9dc-4145-a0a0-ccd74b002a7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a368073c-3913-470a-99d4-1a0e462cad39" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a368073c-3913-470a-99d4-1a0e462cad39" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:to="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_3badbb0b-0a53-457e-b8a3-a92eba389f5d" xlink:to="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9facdd0e-978d-4fca-9a84-c85007000b18" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_9facdd0e-978d-4fca-9a84-c85007000b18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_379ff469-7100-4079-ae91-4dbede4ae5d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_68abf4ae-80c1-40a5-aa06-98a224250dbd" xlink:to="loc_us-gaap_NondesignatedMember_379ff469-7100-4079-ae91-4dbede4ae5d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_6a8687bd-7e71-466e-afec-54116a54cc5c" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesMember_cda76396-5b8f-44bc-909d-7d098b0300b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_SalesMember_cda76396-5b8f-44bc-909d-7d098b0300b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_cfa00225-ccb7-44eb-a336-cfbc598c9fd4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_CostOfSalesMember_cfa00225-ccb7-44eb-a336-cfbc598c9fd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10abf71a-770a-4a79-a96a-433bac6458a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_10abf71a-770a-4a79-a96a-433bac6458a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_112b43ba-1015-4080-9cb7-dbd8a983178c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_112b43ba-1015-4080-9cb7-dbd8a983178c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2bcfa668-a41b-4142-9d0c-61cb740da3ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_2bcfa668-a41b-4142-9d0c-61cb740da3ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ec8cb172-7df0-490d-9f4b-c2f0aae6c3be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherNonoperatingIncomeExpenseMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_4d67ea57-a29e-4b88-8c3a-150e40af5487" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpenseMember_ec8cb172-7df0-490d-9f4b-c2f0aae6c3be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_980e51b9-1941-4d09-94f6-75f4b03a6f76" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bf7144f-5e51-4d1b-ad1f-162a4a20f9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_806fa745-8053-447b-bbca-c3b2c7ebe5b9" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6bf7144f-5e51-4d1b-ad1f-162a4a20f9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aa3edfa2-3ea7-4e68-9542-bc4a3e25dd33" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_aa3edfa2-3ea7-4e68-9542-bc4a3e25dd33" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_1c7e130f-f709-41c1-9f67-34c05e9d15a0" xlink:to="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2588003c-ad33-4046-9220-7bc8bfbd03ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_5edc76c6-4187-4adb-b773-32682fff464a" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_2588003c-ad33-4046-9220-7bc8bfbd03ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable_a32358c2-7d5e-4178-98f4-29f3776e8a16" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_f8ed42c6-d35b-4e3b-92b9-051765f5900b" xlink:to="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_3b3aa077-63b9-4c39-a9d1-7f489617fd7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_StockholdersEquity_3b3aa077-63b9-4c39-a9d1-7f489617fd7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e1b28ea0-951d-4e6d-a97c-a4a931da02cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax_e1b28ea0-951d-4e6d-a97c-a4a931da02cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8fab6743-203e-4605-b5b0-9912b223f816" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_8fab6743-203e-4605-b5b0-9912b223f816" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7282ab77-b565-493a-9569-be890e43dc7b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward_ce5553f7-5a48-46a2-b073-d932e59f1aab" xlink:to="loc_us-gaap_StockholdersEquity_7282ab77-b565-493a-9569-be890e43dc7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ba3ea8d-a831-4213-b397-af40e7ece655" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8ba3ea8d-a831-4213-b397-af40e7ece655" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_dca88667-4c31-4ff0-9c5b-b7fedd98f249" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComputerEquipmentMember_8d58d60a-f327-4d1b-9c4c-071ea99e6b34" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_us-gaap_ComputerEquipmentMember_8d58d60a-f327-4d1b-9c4c-071ea99e6b34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_FurnitureAndOfficeEquipmentMember_11883b24-e56c-4765-bb2a-152878f8a911" xlink:href="rskd-20231231.xsd#rskd_FurnitureAndOfficeEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_rskd_FurnitureAndOfficeEquipmentMember_11883b24-e56c-4765-bb2a-152878f8a911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_974e94b7-7aef-45f9-a079-762abb516cc7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_63670dfa-2d6e-40ca-97ce-21fe04ad238f" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_974e94b7-7aef-45f9-a079-762abb516cc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_8b114d8a-528a-457b-988e-b3f4c1e4eaea" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_20d543ca-9fb0-4153-86b5-12c14435899e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_20d543ca-9fb0-4153-86b5-12c14435899e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1d9ae0f-efc5-4b3e-9786-923c7dc553c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d1d9ae0f-efc5-4b3e-9786-923c7dc553c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_771388f7-2738-42a4-9a52-199e0c2b5a82" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_64bc2b24-dc7e-4615-b944-c18a3c2bee35" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_771388f7-2738-42a4-9a52-199e0c2b5a82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d449fff-c52e-49dc-8a14-289fb26c56c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_b11b1d50-fce6-4d20-a9d8-3b44acb91e06" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_3d449fff-c52e-49dc-8a14-289fb26c56c0" xlink:to="loc_us-gaap_Depreciation_b11b1d50-fce6-4d20-a9d8-3b44acb91e06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_2266690a-b3ef-420a-af9e-5df9dbe20d92" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractWithCustomerRefundLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:to="loc_us-gaap_ContractWithCustomerRefundLiabilityCurrent_2266690a-b3ef-420a-af9e-5df9dbe20d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_1214d106-d74d-4839-b3bf-9696f75b4746" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_1214d106-d74d-4839-b3bf-9696f75b4746" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_9c8c7ba0-d215-4dff-8c1a-537fdcb3ee00" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DerivativeInstrumentsAndHedgesLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgesLiabilities_9c8c7ba0-d215-4dff-8c1a-537fdcb3ee00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7a715a48-6010-4175-bba3-18bfc54c036a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_7a715a48-6010-4175-bba3-18bfc54c036a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_99df5754-fd61-4aab-af6c-053ba8b74cb7" xlink:href="rskd-20231231.xsd#rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e21569c9-4fe2-46e8-9e22-bc09a68a1286" xlink:to="loc_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent_99df5754-fd61-4aab-af6c-053ba8b74cb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9062da8f-2489-4a16-bbce-e643bf6474b1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_a81143ec-3e8a-4f6b-8cd2-5a072bb3dce2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9062da8f-2489-4a16-bbce-e643bf6474b1" xlink:to="loc_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent_a81143ec-3e8a-4f6b-8cd2-5a072bb3dce2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_42fd84a9-b233-4e96-9ebf-010b8ac54549" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9062da8f-2489-4a16-bbce-e643bf6474b1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_42fd84a9-b233-4e96-9ebf-010b8ac54549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8792ea2-9c1f-4570-b1ef-a761ede8a6c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e8792ea2-9c1f-4570-b1ef-a761ede8a6c2" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:to="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_92c99b5e-7ae6-4c44-9471-e6580e578cdf" xlink:to="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cbe712fc-122a-42b8-b134-f0519927b5ed" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_country_US_cbe712fc-122a-42b8-b134-f0519927b5ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_ed0cbf49-9d13-4593-9d6c-2e196f3640bd" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_country_IL_ed0cbf49-9d13-4593-9d6c-2e196f3640bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelAndNonUSMember_195293ab-48e6-48fd-803c-c17fa99f8978" xlink:href="rskd-20231231.xsd#rskd_NonIsraelAndNonUSMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_318e7d6b-c7e0-4f17-8f6f-6547b0460b62" xlink:to="loc_rskd_NonIsraelAndNonUSMember_195293ab-48e6-48fd-803c-c17fa99f8978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_aad94369-72cd-4046-af85-9c7b57be46eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_2770d21e-bf69-4004-970c-d073804e84c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_9dea349f-c381-4385-9d94-eb30235c4aa4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_2770d21e-bf69-4004-970c-d073804e84c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_02a80800-c68e-417d-a237-4f73a9e1379c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:to="loc_us-gaap_OperatingLeaseCost_02a80800-c68e-417d-a237-4f73a9e1379c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_57286bed-37ec-4ee7-a7d8-b1ff03d3714f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:to="loc_us-gaap_VariableLeaseCost_57286bed-37ec-4ee7-a7d8-b1ff03d3714f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_6c488415-891a-45e6-ac7b-5140ce7ec026" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:to="loc_us-gaap_ShortTermLeaseCost_6c488415-891a-45e6-ac7b-5140ce7ec026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubleaseIncome_942e4b5d-0c1a-475b-94de-f83a3ba03d37" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubleaseIncome"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:to="loc_us-gaap_SubleaseIncome_942e4b5d-0c1a-475b-94de-f83a3ba03d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_ab031479-60f8-4358-9f0e-e0b0032b8808" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_ec011116-30fc-46dc-87a7-7d6ee5f29016" xlink:to="loc_us-gaap_LeaseCost_ab031479-60f8-4358-9f0e-e0b0032b8808" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_f12c7b66-babe-4b01-8e33-ed8a55098ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_f12c7b66-babe-4b01-8e33-ed8a55098ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_a088631c-cc91-4450-ad96-d0425b42e4ec" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_a088631c-cc91-4450-ad96-d0425b42e4ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_616a45a5-5b88-496a-8125-9e88338ab5af" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_616a45a5-5b88-496a-8125-9e88338ab5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e3c0045b-a2f8-47cd-82a1-e97dafb5b07b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_e3c0045b-a2f8-47cd-82a1-e97dafb5b07b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_42f6fae8-3c5d-4150-9d07-7c1287884e15" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_us-gaap_ContractualObligation_42f6fae8-3c5d-4150-9d07-7c1287884e15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ContractualObligationTerm_26a3b55f-1876-4237-adec-a52da08ae302" xlink:href="rskd-20231231.xsd#rskd_ContractualObligationTerm"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d900984b-0876-4b8f-ac20-891ec96dc83b" xlink:to="loc_rskd_ContractualObligationTerm_26a3b55f-1876-4237-adec-a52da08ae302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesMaturityLeaseScheduleDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7a05d9f-5c54-478d-b25a-7689a2a8f2ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_a7a05d9f-5c54-478d-b25a-7689a2a8f2ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_051cf62b-76bc-4193-85a7-6ac984ce51ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_051cf62b-76bc-4193-85a7-6ac984ce51ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_11a7ee79-ff8b-4963-9f40-9f28a88032f1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_11a7ee79-ff8b-4963-9f40-9f28a88032f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02c3334f-32de-410d-9936-90eba466be94" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_02c3334f-32de-410d-9936-90eba466be94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_480813bc-da32-4a05-b737-3381a129b82c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_480813bc-da32-4a05-b737-3381a129b82c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b2de1ec1-755e-4559-9572-0b25e9c9c21f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_b2de1ec1-755e-4559-9572-0b25e9c9c21f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b5b91a8c-8b00-49a9-9bf9-8f22956748e4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_b5b91a8c-8b00-49a9-9bf9-8f22956748e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_49f7d72d-b69b-41b5-ad80-e5c5ccd54e9a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_49f7d72d-b69b-41b5-ad80-e5c5ccd54e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_5d1b45ac-8195-4c71-90df-97994f429875" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3f9e1069-b3e7-4552-b8eb-d06ac18fdbca" xlink:to="loc_us-gaap_OperatingLeaseLiability_5d1b45ac-8195-4c71-90df-97994f429875" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesMaturityLeaseScheduleDetails_1"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://riskified.com/role/LeasesByGeographicRegionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#LeasesByGeographicRegionDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/LeasesByGeographicRegionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_b909ca33-dc11-4994-9b8f-39f99197c911" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_22c6c026-1b59-4e00-bef5-dc9435f8419e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b909ca33-dc11-4994-9b8f-39f99197c911" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_22c6c026-1b59-4e00-bef5-dc9435f8419e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_b909ca33-dc11-4994-9b8f-39f99197c911" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:to="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_fd25118a-cea6-4ca4-8e55-a97b880ecaf2" xlink:to="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_2356bd4a-ac22-498a-af5a-a6b270192af1" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:to="loc_country_IL_2356bd4a-ac22-498a-af5a-a6b270192af1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_30974cbc-fe31-4f0e-ad93-e18b3b4edc51" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7d7f206e-5aac-4b76-8a67-129e6c4ebe87" xlink:to="loc_country_US_30974cbc-fe31-4f0e-ad93-e18b3b4edc51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_3a1de2e2-6f80-436f-8953-0898051252ba" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_28f3f2c8-3537-4d49-a6d3-6765f5b66fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_2d4f27f2-bcaf-4658-9939-33aad41beda0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_28f3f2c8-3537-4d49-a6d3-6765f5b66fa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#GuaranteesCommitmentsandContingenciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93d29bf1-ed6b-4111-9d50-407ad80e0c8b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsCurrentCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_GuaranteeObligationsCurrentCarryingValue_93d29bf1-ed6b-4111-9d50-407ad80e0c8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsTerm_d2c7dbd5-1196-418a-8f6e-d70f7e441dbb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_GuaranteeObligationsTerm_d2c7dbd5-1196-418a-8f6e-d70f7e441dbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksCurrent_db55c5ce-33fd-4f6c-babd-a050268e6f2e" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_rskd_ProvisionForChargebacksCurrent_db55c5ce-33fd-4f6c-babd-a050268e6f2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteeObligationsMaximumExposure_efaecb9b-9de0-4f92-9ce0-04bdbf38ef9f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GuaranteeObligationsMaximumExposure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_GuaranteeObligationsMaximumExposure_efaecb9b-9de0-4f92-9ce0-04bdbf38ef9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_GuarantorObligationsPercentageOfGuaranteesPaid_051b27f5-38b5-4a34-9914-fba86431d516" xlink:href="rskd-20231231.xsd#rskd_GuarantorObligationsPercentageOfGuaranteesPaid"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_rskd_GuarantorObligationsPercentageOfGuaranteesPaid_051b27f5-38b5-4a34-9914-fba86431d516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_GuarantorObligationsChargebackExpense_f9a68a34-ce9c-456d-b2c3-89b05beeaff8" xlink:href="rskd-20231231.xsd#rskd_GuarantorObligationsChargebackExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_rskd_GuarantorObligationsChargebackExpense_f9a68a34-ce9c-456d-b2c3-89b05beeaff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesRentExpenseNet_9532667a-bff9-4eb4-b7e3-539b67e57119" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesRentExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_OperatingLeasesRentExpenseNet_9532667a-bff9-4eb4-b7e3-539b67e57119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_db65f045-1331-4d19-802f-51816df2a661" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue_db65f045-1331-4d19-802f-51816df2a661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractualObligation_91635a72-4389-444e-abaa-d1342407c714" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ContractualObligation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_us-gaap_ContractualObligation_91635a72-4389-444e-abaa-d1342407c714" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ContractualObligationTerm_05598490-c5ab-426a-84f4-cd4750f73b60" xlink:href="rskd-20231231.xsd#rskd_ContractualObligationTerm"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_8baa0106-ce22-49d1-8926-c97185a9dbc1" xlink:to="loc_rskd_ContractualObligationTerm_05598490-c5ab-426a-84f4-cd4750f73b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55adcb5d-339f-42c5-947d-e525982b4741" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2d53ae48-9536-47ca-9dfb-acbd359dc3e3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55adcb5d-339f-42c5-947d-e525982b4741" xlink:to="loc_us-gaap_PurchaseObligationDueInNextTwelveMonths_2d53ae48-9536-47ca-9dfb-acbd359dc3e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInSecondYear_88913506-de81-47d7-9329-44b357bf03b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInSecondYear"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55adcb5d-339f-42c5-947d-e525982b4741" xlink:to="loc_us-gaap_PurchaseObligationDueInSecondYear_88913506-de81-47d7-9329-44b357bf03b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligationDueInThirdYear_09265134-6cbc-4db3-9061-fea1a3ea7826" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligationDueInThirdYear"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55adcb5d-339f-42c5-947d-e525982b4741" xlink:to="loc_us-gaap_PurchaseObligationDueInThirdYear_09265134-6cbc-4db3-9061-fea1a3ea7826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PurchaseObligation_bbd41b30-efb7-4915-8d6e-2239d0e6f8fa" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PurchaseObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_55adcb5d-339f-42c5-947d-e525982b4741" xlink:to="loc_us-gaap_PurchaseObligation_bbd41b30-efb7-4915-8d6e-2239d0e6f8fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinaryShareWarrantsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinaryShareWarrantsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinaryShareWarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityDisclosureAbstract_cd728294-38fb-40eb-9f69-a59451aac141" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityByClassOfStockTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityDisclosureAbstract_cd728294-38fb-40eb-9f69-a59451aac141" xlink:to="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_4ee7439e-d835-45d5-a412-ee5d8b970b19" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_21eb0b28-c056-46c7-8b45-85fa9ffa63d5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:to="loc_us-gaap_WarrantMember_21eb0b28-c056-46c7-8b45-85fa9ffa63d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantIssuedToCustomersMember_bfac1119-84e3-4d9a-8c1b-d57a27f5993b" xlink:href="rskd-20231231.xsd#rskd_WarrantIssuedToCustomersMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_80275e0a-bc5d-4ca9-b2a6-9d4f4522e79f" xlink:to="loc_rskd_WarrantIssuedToCustomersMember_bfac1119-84e3-4d9a-8c1b-d57a27f5993b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_ca2d7e34-e057-4bc7-8e43-4fbecf47550c" xlink:to="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_a19779a3-eeaa-41cd-ad7e-e25623c26624" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:to="loc_us-gaap_CommonClassAMember_a19779a3-eeaa-41cd-ad7e-e25623c26624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_fae03ff6-7dc6-4301-b283-9997a979ce4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_4968ae1f-16cc-44aa-8ab3-0f1f618297ff" xlink:to="loc_us-gaap_CommonClassBMember_fae03ff6-7dc6-4301-b283-9997a979ce4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_c4dc3732-e3d1-4223-8ba9-28efe69df7cb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_c0165720-6892-43ba-9d79-605cccc1c82d" xlink:href="rskd-20231231.xsd#rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_17d6e45f-723d-41ad-bba3-ac4258c53198" xlink:to="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_c0165720-6892-43ba-9d79-605cccc1c82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_987f6d6e-a1bf-4968-a4a8-3c390802c687" xlink:to="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_6766b5fd-9b1c-49bb-9a89-9645532e3eb6" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_bbb0ea47-50e2-4a0a-bfee-e660f4e20005" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_6766b5fd-9b1c-49bb-9a89-9645532e3eb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TemporaryEquityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityByClassOfStockTable_794889f3-9a76-49ba-9c98-38cfc68e2dfb" xlink:to="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aa1aca24-9889-46a9-b5a2-04c901682a81" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_aa1aca24-9889-46a9-b5a2-04c901682a81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_68a7259b-f5d2-4dcd-b95a-1b3dd985c537" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_68a7259b-f5d2-4dcd-b95a-1b3dd985c537" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ed91b294-2508-4f27-8730-91b416f688b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TemporaryEquityLineItems_07189709-1166-432e-afc5-885959a1c4ad" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ed91b294-2508-4f27-8730-91b416f688b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95e3e22a-9694-4069-a5ef-ef88450f9400" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_95e3e22a-9694-4069-a5ef-ef88450f9400" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_9e1ea4fd-f153-4779-8cf4-c6b3a6221261" xlink:to="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_02a9f4d8-025f-40fd-8835-e745d00d7879" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_02a9f4d8-025f-40fd-8835-e745d00d7879" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EquityIncentivePlanMember_ef0efd22-50a8-4228-bc4d-13b357cfabc5" xlink:href="rskd-20231231.xsd#rskd_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_5b5e7883-3249-47bc-be07-d8f770871e08" xlink:to="loc_rskd_A2021EquityIncentivePlanMember_ef0efd22-50a8-4228-bc4d-13b357cfabc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6a3a6116-beb6-496c-9fd2-073bae7aeb38" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb90cde-eeab-4768-b04d-c9f022c03722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_4fb90cde-eeab-4768-b04d-c9f022c03722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_1a07d69d-491a-4e31-8f20-b5c188c66121" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ac9ce9e-b119-48d7-853a-7acb415657b9" xlink:to="loc_us-gaap_EmployeeStockOptionMember_1a07d69d-491a-4e31-8f20-b5c188c66121" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_VestingDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingAxis_ec2f3783-e743-428e-84f4-42a69178733c" xlink:to="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a9d26b2d-e9f6-4efc-ba7c-bad55b50985f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheTwoMember_a9d26b2d-e9f6-4efc-ba7c-bad55b50985f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6d583dbd-066b-4352-92d8-2d60c0de6394" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationAwardTrancheThreeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VestingDomain_4c916013-abf3-48b7-8d0e-fe404f81dcb6" xlink:to="loc_us-gaap_ShareBasedCompensationAwardTrancheThreeMember_6d583dbd-066b-4352-92d8-2d60c0de6394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_17aca48c-d6a3-4533-abc3-d36c17bb001d" xlink:to="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_08c41b4a-718c-4555-bd0c-08712a63b09a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:to="loc_us-gaap_CommonClassAMember_08c41b4a-718c-4555-bd0c-08712a63b09a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4d7c77c4-9b02-4d78-9898-5b92d575e3c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_e6b89eca-c8a6-49c2-9e93-a4b5c68a7ed6" xlink:to="loc_us-gaap_CommonClassBMember_4d7c77c4-9b02-4d78-9898-5b92d575e3c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis_a06d0da5-fc2c-482d-9e1a-97d5b55856b0" xlink:to="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EmployeeSharePurchasePlanMember_2f186117-70fc-47ed-abed-c971f7af89da" xlink:href="rskd-20231231.xsd#rskd_A2021EmployeeSharePurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain_feea2830-2f37-49d3-8489-dab1f2507428" xlink:to="loc_rskd_A2021EmployeeSharePurchasePlanMember_2f186117-70fc-47ed-abed-c971f7af89da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_8106ffb8-4b0c-4374-9462-f945acfac46b" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_51eca927-1b04-400f-958c-daa8363edf8e" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ffdbe6c0-aaa3-4b20-9815-b7397c39a68e" xlink:to="loc_srt_ChiefExecutiveOfficerMember_51eca927-1b04-400f-958c-daa8363edf8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d97b9b4-e4ab-430e-a48e-5a9c0f492aa2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_8daee165-416d-4749-a0c1-83e186e67772" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_8daee165-416d-4749-a0c1-83e186e67772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_152417ee-fda3-4793-aaac-eb264f217749" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_152417ee-fda3-4793-aaac-eb264f217749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_00c830f7-43c4-4ba2-a726-cde6345180c9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_00c830f7-43c4-4ba2-a726-cde6345180c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_StockRepurchaseProgramTransactionCosts_0f408971-6b01-44a6-8dd4-f0296b7dfb12" xlink:href="rskd-20231231.xsd#rskd_StockRepurchaseProgramTransactionCosts"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_StockRepurchaseProgramTransactionCosts_0f408971-6b01-44a6-8dd4-f0296b7dfb12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_02e67414-8d65-4472-9843-1004aa8fda3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_02e67414-8d65-4472-9843-1004aa8fda3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_8ac1ebe6-cb80-4ea4-a922-b7d0369c4628" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent_8ac1ebe6-cb80-4ea4-a922-b7d0369c4628" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aa492cd2-a467-47af-9689-abc46230b056" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_aa492cd2-a467-47af-9689-abc46230b056" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e08535ee-6be3-485c-aacd-426992e88947" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_e08535ee-6be3-485c-aacd-426992e88947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afe2bd90-adaf-419b-b987-9d894fdda978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afe2bd90-adaf-419b-b987-9d894fdda978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_590a1bc2-086a-4e1f-97fa-a25dd94f5104" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_590a1bc2-086a-4e1f-97fa-a25dd94f5104" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d27da6d5-cda1-49c9-b7bd-525dc7b1613d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d27da6d5-cda1-49c9-b7bd-525dc7b1613d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c089710-c77e-4425-881d-ee7d6e3640f0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2c089710-c77e-4425-881d-ee7d6e3640f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_16013766-9df7-433b-bb23-9b2c83ba0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_16013766-9df7-433b-bb23-9b2c83ba0b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50d430d7-9db5-421f-bb30-528ec91f40bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_50d430d7-9db5-421f-bb30-528ec91f40bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_68429a4c-0637-47b3-9416-917139222a4e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_68429a4c-0637-47b3-9416-917139222a4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a9784977-64cb-47fa-98af-6580b9a75341" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_a9784977-64cb-47fa-98af-6580b9a75341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_e901c913-8997-4f44-9815-b7195cdec57e" xlink:href="rskd-20231231.xsd#rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage_e901c913-8997-4f44-9815-b7195cdec57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7786dfb3-ea89-4be4-910b-977d312968d8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_7786dfb3-ea89-4be4-910b-977d312968d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockPricePerShare_59e37c55-3630-482c-a3ba-0f3a6bd37799" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SaleOfStockPricePerShare"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_32c01b51-ef08-41e5-b41e-24c375f137bb" xlink:to="loc_us-gaap_SaleOfStockPricePerShare_59e37c55-3630-482c-a3ba-0f3a6bd37799" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6fa4458-e93d-4c01-89fe-57fa64fefd96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_d6fa4458-e93d-4c01-89fe-57fa64fefd96" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockByUniqueDescriptionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConversionOfStockNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockByUniqueDescriptionAxis_277616c2-f8ef-4dcd-bd83-dac13d674f3f" xlink:to="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_WarrantsToPurchaseOrdinarySharesMember_480c1b33-1bcd-4867-bebb-4164b58712ef" xlink:href="rskd-20231231.xsd#rskd_WarrantsToPurchaseOrdinarySharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConversionOfStockNameDomain_2d32c938-dd06-4c21-a05c-7e77bb045449" xlink:to="loc_rskd_WarrantsToPurchaseOrdinarySharesMember_480c1b33-1bcd-4867-bebb-4164b58712ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_6cefd951-e462-402e-8df0-8794c413e572" xlink:to="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2013EquityIncentivePlanMember_38715bf7-b938-43c2-b141-f01b9cbb50d3" xlink:href="rskd-20231231.xsd#rskd_A2013EquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:to="loc_rskd_A2013EquityIncentivePlanMember_38715bf7-b938-43c2-b141-f01b9cbb50d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_A2021EquityIncentivePlanMember_1a4507ec-279e-44f0-ad52-6a8b71243877" xlink:href="rskd-20231231.xsd#rskd_A2021EquityIncentivePlanMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_50fb65ea-019d-44f7-8f6e-0f177e5f198f" xlink:to="loc_rskd_A2021EquityIncentivePlanMember_1a4507ec-279e-44f0-ad52-6a8b71243877" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_780f5342-9c34-494e-a3d6-66d4ce721246" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_33bf7018-3574-4d98-b73d-967b9b2e1cee" xlink:href="rskd-20231231.xsd#rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_57c49897-3e5b-49e0-b6d7-902c19d4934f" xlink:to="loc_rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember_33bf7018-3574-4d98-b73d-967b9b2e1cee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c5e1aa94-50e7-4322-944b-3139422752d4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c1bd4cca-7949-46ee-89db-5dce3d85507b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_3328b8ac-3ea8-42d7-b643-ed08d7a5c6be" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_c1bd4cca-7949-46ee-89db-5dce3d85507b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b4e980d-0cc5-40f7-b8fa-ee874fb920e5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8b4e980d-0cc5-40f7-b8fa-ee874fb920e5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:to="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_a579320d-cc7e-4b7e-b37d-a96597af7302" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_f91f2c59-cc02-40ed-9c4d-a7f1fa24d21d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_f91f2c59-cc02-40ed-9c4d-a7f1fa24d21d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_142c4150-d0d3-4df8-a1b3-a44b69cbde4b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6198fadd-bd34-49e7-9e04-e86b20cd59a1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_142c4150-d0d3-4df8-a1b3-a44b69cbde4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_f86e5159-e55c-4b47-8e4d-86aded227fc4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0fdafcc0-d12f-4eda-97d3-e67be6326eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0fdafcc0-d12f-4eda-97d3-e67be6326eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca69376b-bff1-457d-8784-bb3e1b003ff0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_ca69376b-bff1-457d-8784-bb3e1b003ff0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2c5fe5e5-78cb-41e3-b98c-1cc863693fe5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2c5fe5e5-78cb-41e3-b98c-1cc863693fe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_12304128-ace8-402f-8a04-58382669c5ac" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_1e28cfd9-3dd7-4021-8885-bccd4f797938" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_12304128-ace8-402f-8a04-58382669c5ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bc2cd26c-e2f1-4fe0-9b0b-8d2fd1eb2f91" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bc2cd26c-e2f1-4fe0-9b0b-8d2fd1eb2f91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e660b53-3bdb-4667-bc49-34bcdb2e8050" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5e660b53-3bdb-4667-bc49-34bcdb2e8050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_843d92e2-bb5a-47ee-9053-e9dc09a694a3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_843d92e2-bb5a-47ee-9053-e9dc09a694a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e81c1638-453c-4134-a288-0e0ca0850ea1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_d19c67d9-9298-41af-9c18-278553578b10" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_e81c1638-453c-4134-a288-0e0ca0850ea1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_26ccde1f-a8eb-44cf-8324-9da397333540" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_26ccde1f-a8eb-44cf-8324-9da397333540" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e06e2ab0-fdd1-4cff-878b-3e2db594b9c4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e06e2ab0-fdd1-4cff-878b-3e2db594b9c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dbc2b807-b89a-42d2-a65e-4294d35c55cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_dbc2b807-b89a-42d2-a65e-4294d35c55cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_32af1693-b147-4bf2-8181-f4d21646467b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_32af1693-b147-4bf2-8181-f4d21646467b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cc5bfa40-c6f4-479e-b198-ea12d259c9f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_cc5bfa40-c6f4-479e-b198-ea12d259c9f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aef49527-e54b-4623-a016-a8995907f296" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_aef49527-e54b-4623-a016-a8995907f296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c890e1a3-3a23-4eb4-a244-168a0503235c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_4e0ec140-99ac-4505-ad15-c3ba5d9eaf02" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_c890e1a3-3a23-4eb4-a244-168a0503235c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d11e65bf-5432-47a7-945c-56559e52a9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8f920c6b-2a94-47df-9ff1-55ccbece0484" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_d11e65bf-5432-47a7-945c-56559e52a9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd27462d-ff7a-492a-ba28-bf57c3732041" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_cd27462d-ff7a-492a-ba28-bf57c3732041" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:to="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_06a4a505-6059-40ff-87e3-beb41760c84f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_d98fa1fb-a9b3-4251-9aba-a2893fe0e570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_c36d4ea8-d0c6-46e5-b4ac-5b63c10dcc3c" xlink:to="loc_us-gaap_EmployeeStockOptionMember_d98fa1fb-a9b3-4251-9aba-a2893fe0e570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:to="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_77a62ff3-683a-4c5b-8c52-7c9276a347b1" xlink:to="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_b478588b-63cf-4dea-8a0b-ad9640e034ec" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:to="loc_srt_MinimumMember_b478588b-63cf-4dea-8a0b-ad9640e034ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_30674d06-9561-4af2-97f6-2bb9623bf149" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_2b40e7d2-1b3d-4663-a3e3-df4a3a9fc9e3" xlink:to="loc_srt_MaximumMember_30674d06-9561-4af2-97f6-2bb9623bf149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_bd4dacb7-4fe3-4b3a-ae48-2d407237b27e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd9836a2-9cc2-4e0b-8bcf-49bd2f3b268d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_fd9836a2-9cc2-4e0b-8bcf-49bd2f3b268d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c1425090-17f9-4077-8ca9-e325423ecdd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c1425090-17f9-4077-8ca9-e325423ecdd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1a177306-c0cc-4262-9f96-8e43dee6b9db" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1a177306-c0cc-4262-9f96-8e43dee6b9db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26137b75-fe9d-4893-8060-aa777fd16afc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_306020f6-28e1-42e6-bbdc-34a8dd9fd1c2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_26137b75-fe9d-4893-8060-aa777fd16afc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanRSUActivityDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bc807502-bd19-4be6-9e5b-d5747ba25387" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_bc807502-bd19-4be6-9e5b-d5747ba25387" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:to="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_ab2f9fbe-2b50-4ee2-a5bc-6fb49701e34b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_89312bd1-4bf0-4410-8f22-601132607bbc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3bcc0e92-750a-441f-9270-0775467894f5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_89312bd1-4bf0-4410-8f22-601132607bbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_59ea6c36-c331-4339-961b-7ecffaa92137" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f6ec39a-e307-48c5-8335-cb5f56abc35b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_8f6ec39a-e307-48c5-8335-cb5f56abc35b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d7a54dcc-70bb-4610-920c-ae0e4f8d66bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_d7a54dcc-70bb-4610-920c-ae0e4f8d66bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_14e96b0e-fdc0-408a-babb-1536af97a3dc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_14e96b0e-fdc0-408a-babb-1536af97a3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e77a8a06-eb57-451f-82e7-6f466dd68351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_e77a8a06-eb57-451f-82e7-6f466dd68351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81373cf4-5044-4edc-b480-afa83b9d32c0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_b8a0f00a-4256-43e5-81e4-a96172d8b8b8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_81373cf4-5044-4edc-b480-afa83b9d32c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f50155c-b18d-4ae8-bc6c-470896c23827" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0ad27f42-9fb3-47ca-9f47-3c6fa1f5dd4a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0ad27f42-9fb3-47ca-9f47-3c6fa1f5dd4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d9fe085-759b-4310-91bb-08de20eee245" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_6d9fe085-759b-4310-91bb-08de20eee245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9b3efefa-4a05-4371-93af-a1f50ffd8841" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_9b3efefa-4a05-4371-93af-a1f50ffd8841" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eb53009e-5996-4193-b4dd-ad7482353b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eb53009e-5996-4193-b4dd-ad7482353b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a55affa4-f499-4d77-ae8a-ddfed5c9c4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_eab6396a-d0d4-4c59-92e1-7cfd7a495cba" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_a55affa4-f499-4d77-ae8a-ddfed5c9c4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb953051-87b4-46a7-80e4-8ba44b36f544" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_eb953051-87b4-46a7-80e4-8ba44b36f544" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3c09a94f-6d5e-4d61-9bd9-c7c881611869" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_249e05c5-6131-482d-8add-8ff640319978" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_CostOfSalesMember_249e05c5-6131-482d-8add-8ff640319978" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03db3c12-966e-4e99-9e16-a6ea75806d53" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_03db3c12-966e-4e99-9e16-a6ea75806d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_5f9a53e2-c133-48b2-9a3e-26624af38be0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_5f9a53e2-c133-48b2-9a3e-26624af38be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_437965a3-b838-42a9-bf90-93171a2b5449" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_bdb1bef9-429e-4665-8a22-a96860d10524" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_437965a3-b838-42a9-bf90-93171a2b5449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_93a3780f-17bb-451b-a4f5-099e99dcc3a5" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ChiefExecutiveOfficerMember_f3806fa8-0f6f-4a45-99f8-a9efe4c75e9c" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ChiefExecutiveOfficerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_8ebf5ab5-315d-47a5-a2fb-62c87e6b8095" xlink:to="loc_srt_ChiefExecutiveOfficerMember_f3806fa8-0f6f-4a45-99f8-a9efe4c75e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_cbc423b4-ea77-4bd0-9437-2d3c2cf5cba8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_51b02077-8728-491c-b8d5-81dba5308836" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_050f632f-9ca2-43c6-ba5b-5fa027c6065b" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_51b02077-8728-491c-b8d5-81dba5308836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_af157bcf-a8cf-4cf2-888e-0fa043217587" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_8920b080-73c2-4252-a153-6caaf9bae75a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1698f96a-2ee8-4465-849b-023cca389e47" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_8920b080-73c2-4252-a153-6caaf9bae75a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9cfa156b-0464-4535-bad9-bb1c7bfeed29" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9cfa156b-0464-4535-bad9-bb1c7bfeed29" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_32da4d35-09dc-41a8-8472-0e0a7f452d13" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_61cbbe11-2591-4073-9051-0bd16642fd2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_DomesticCountryMember_61cbbe11-2591-4073-9051-0bd16642fd2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_a46d876c-3089-44ed-a685-46132372d86f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_ForeignCountryMember_a46d876c-3089-44ed-a685-46132372d86f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_50b56a67-3583-486c-ad96-93bd126f911c" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_f7c231f5-f751-44e3-8609-6cbba9065e9e" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_50b56a67-3583-486c-ad96-93bd126f911c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_e9efe766-8d7e-4804-8ef8-074be2151440" xlink:to="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_bd5722be-a597-49c6-9e83-3f23ac6132ab" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_15c8acdf-ced0-47a8-95be-8e95d20b1abe" xlink:to="loc_country_US_bd5722be-a597-49c6-9e83-3f23ac6132ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:href="rskd-20231231.xsd#rskd_ExpirationPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_ExpirationPeriodAxis_a3f737cd-c066-4c1b-affc-a9e66340b806" xlink:to="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_TaxYear2042Member_0f44c7d4-b81a-41d2-878c-94e5401bae28" xlink:href="rskd-20231231.xsd#rskd_TaxYear2042Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:to="loc_rskd_TaxYear2042Member_0f44c7d4-b81a-41d2-878c-94e5401bae28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LatestTaxYearMember_33ac6118-db34-4079-b0d6-f975a11797a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_LatestTaxYearMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_rskd_ExpirationPeriodDomain_508fa95d-0869-4e35-918e-61ddb8ccb2f7" xlink:to="loc_us-gaap_LatestTaxYearMember_33ac6118-db34-4079-b0d6-f975a11797a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_8d501dd4-b058-45a6-8845-c024a6badeb2" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_4d5045d5-c6dc-4461-97d7-139a5e43c606" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_OperatingLossCarryforwards_4d5045d5-c6dc-4461-97d7-139a5e43c606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_16d67a37-e1fa-4f46-acd5-641f203ebee5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_16d67a37-e1fa-4f46-acd5-641f203ebee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_0320dad2-4b08-496f-81d2-66afa7819a1f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_0320dad2-4b08-496f-81d2-66afa7819a1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_4dedcdbb-f1a8-4d53-b754-e9819388859e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_259d7699-ede8-4876-9ec6-ca7119e923cc" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_4dedcdbb-f1a8-4d53-b754-e9819388859e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_5dd77517-70cd-4654-8369-82ac2548ff73" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_5dd77517-70cd-4654-8369-82ac2548ff73" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:to="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_94c9a16b-f24b-48a3-b0fc-1aa309697c43" xlink:to="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_606bc179-7757-48c8-aa0d-028562fb5c84" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:to="loc_country_IL_606bc179-7757-48c8-aa0d-028562fb5c84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelMember_2886c3c1-f8f8-4c57-a33f-a61e11f6d631" xlink:href="rskd-20231231.xsd#rskd_NonIsraelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_32c6a8e2-7a4c-40ca-9aae-dd68ba6db648" xlink:to="loc_rskd_NonIsraelMember_2886c3c1-f8f8-4c57-a33f-a61e11f6d631" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_55d68c23-4f11-4e3f-bccd-b86c0f8642ca" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae681ba-eb08-4e0c-b794-5e53958b7b52" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_b24ef85c-514b-41ac-84b0-5965a9184c2a" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1ae681ba-eb08-4e0c-b794-5e53958b7b52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0e450c66-7873-4899-b3e7-7b3f953598d3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0e450c66-7873-4899-b3e7-7b3f953598d3" xlink:to="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:to="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_acc8907a-0d2b-47f5-8bcd-240b461b6bd2" xlink:to="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IL_b398626b-056e-45d1-b521-287f5f3c458a" xlink:href="https://xbrl.sec.gov/country/2023/country-2023.xsd#country_IL"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:to="loc_country_IL_b398626b-056e-45d1-b521-287f5f3c458a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_NonIsraelMember_c05c3ebf-2dcf-4e79-bec7-3c41c7b2912c" xlink:href="rskd-20231231.xsd#rskd_NonIsraelMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7e3a9d29-a138-4116-a0f9-e629a2fc3dc7" xlink:to="loc_rskd_NonIsraelMember_c05c3ebf-2dcf-4e79-bec7-3c41c7b2912c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExaminationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationTable_73bf0a59-aeff-49bf-b5a3-4a25e1b7395b" xlink:to="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84fb0d54-e19d-4a2b-90d4-d3e44c58f89d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_84fb0d54-e19d-4a2b-90d4-d3e44c58f89d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c39df00-3bd8-437d-af64-cf6630fbb593" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3c39df00-3bd8-437d-af64-cf6630fbb593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_e4b7b9e4-df5e-4563-b790-d08e93c33562" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExaminationLineItems_275b3ed9-be23-4cbc-a46c-34b6b768a39b" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_e4b7b9e4-df5e-4563-b790-d08e93c33562" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0856bcc4-0eb4-4798-935a-4997698b7a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0856bcc4-0eb4-4798-935a-4997698b7a3f" xlink:to="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0d91af59-7c26-477f-aea7-f335396ff820" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_e746328d-1ece-49ce-b437-d99021729bd1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:to="loc_us-gaap_WarrantMember_e746328d-1ece-49ce-b437-d99021729bd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_981fab86-03f0-42a9-88fb-fbc0cc0b1161" xlink:href="rskd-20231231.xsd#rskd_ConvertiblePreferredShareTrancheRightsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5a92156b-2318-4025-ab4a-cdbb12f6d7c8" xlink:to="loc_rskd_ConvertiblePreferredShareTrancheRightsMember_981fab86-03f0-42a9-88fb-fbc0cc0b1161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxContingencyLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyTable_e3d025b2-9dc2-47f4-a185-ec1e078a12f9" xlink:to="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a43db02d-6905-4db7-bba8-7480d2cdbefb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a43db02d-6905-4db7-bba8-7480d2cdbefb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_ae24d6cc-bf7d-427b-8a68-8f95175d1ba6" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount_ae24d6cc-bf7d-427b-8a68-8f95175d1ba6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_b68c7941-d0bf-4b40-8b88-50e0c22ced09" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_b68c7941-d0bf-4b40-8b88-50e0c22ced09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38826166-b6f1-4a6b-b506-6d64bcc0b1a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_38826166-b6f1-4a6b-b506-6d64bcc0b1a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_af6b9123-2a88-4d85-9b2f-513b2aaa758b" xlink:href="rskd-20231231.xsd#rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount_af6b9123-2a88-4d85-9b2f-513b2aaa758b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b83d584a-d16c-4f45-945a-175876f43722" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes_b83d584a-d16c-4f45-945a-175876f43722" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_ece3d142-e399-4038-9ac5-53c43d9198c3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_ece3d142-e399-4038-9ac5-53c43d9198c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_eb43be0b-4927-4633-b059-3d35b7d8b3bd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationTaxContingencies"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxContingencies_eb43be0b-4927-4633-b059-3d35b7d8b3bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_870fdef8-559f-45be-a65e-b5a078fe8854" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_870fdef8-559f-45be-a65e-b5a078fe8854" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_961bf97f-b210-4fac-840f-cd76314b4c41" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_961bf97f-b210-4fac-840f-cd76314b4c41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4980e3-8a9c-494b-80ea-521ea30b9351" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxContingencyLineItems_a781d788-aee7-4eb4-adeb-eee30a527f96" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_1a4980e3-8a9c-494b-80ea-521ea30b9351" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6cf73dc4-e9b5-473f-9f57-2588c2be25e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_6cf73dc4-e9b5-473f-9f57-2588c2be25e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8588483b-206d-4e4d-a34f-0402ad64415e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_8588483b-206d-4e4d-a34f-0402ad64415e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5718deb6-347d-4f93-a93f-ddc8851ccc6d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation_5718deb6-347d-4f93-a93f-ddc8851ccc6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_DeferredTaxAssetsLeasingArrangements_70bd6150-bab6-4ccf-bdeb-3086a6c14d0f" xlink:href="rskd-20231231.xsd#rskd_DeferredTaxAssetsLeasingArrangements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_rskd_DeferredTaxAssetsLeasingArrangements_70bd6150-bab6-4ccf-bdeb-3086a6c14d0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_c0e54832-7137-4831-8d15-08c204a92c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences_c0e54832-7137-4831-8d15-08c204a92c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0eec9dd4-f9a1-48fb-b667-8fabecd6f8d0" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts_0eec9dd4-f9a1-48fb-b667-8fabecd6f8d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOther_0b3d0d33-5079-4344-a810-bd344dc91ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsOther"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsOther_0b3d0d33-5079-4344-a810-bd344dc91ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1fce9202-24c5-457e-a48e-fba9efeba0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1fce9202-24c5-457e-a48e-fba9efeba0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d0885f3d-884c-4d86-af7e-ea07a6426b72" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_d0885f3d-884c-4d86-af7e-ea07a6426b72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_205dbc07-dfd4-4a7d-b225-2d981650ea5f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxAssetsAbstract_10a4d665-54ff-4a3e-bdaf-262c8f81eef6" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_205dbc07-dfd4-4a7d-b225-2d981650ea5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4bfcf143-d383-46cb-91cc-b94e264fa2ef" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesLeasingArrangements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesLeasingArrangements_4bfcf143-d383-46cb-91cc-b94e264fa2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_51124cd1-d329-4720-afca-be59745674f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts_51124cd1-d329-4720-afca-be59745674f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_30a9d2c7-0636-4963-a26d-7696f6c065cf" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_30a9d2c7-0636-4963-a26d-7696f6c065cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_cc9f476f-b5ad-4c42-913a-606c75afd8ed" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware_cc9f476f-b5ad-4c42-913a-606c75afd8ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_b8cffec0-f51e-4f61-9597-e59712602878" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_3ddfcdfc-ee9f-4a24-8ef5-8c2b1292dc0d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_b8cffec0-f51e-4f61-9597-e59712602878" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_144f39fd-4778-4b9f-afda-d9127e614e80" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_144f39fd-4778-4b9f-afda-d9127e614e80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilities_8789215d-d5d2-4712-b634-b484f2703fa6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DeferredTaxLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_DeferredTaxLiabilities_8789215d-d5d2-4712-b634-b484f2703fa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8cb1622-0bf1-461c-8870-d6db74857856" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_b8cb1622-0bf1-461c-8870-d6db74857856" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_dd615d47-abdf-42fd-814a-df83850544dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_2989abfd-c572-433d-97d4-ad092eca30a7" xlink:to="loc_us-gaap_OperatingLossCarryforwards_dd615d47-abdf-42fd-814a-df83850544dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_73979cff-0a12-4bad-99d8-a9af7b8cf1d4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73979cff-0a12-4bad-99d8-a9af7b8cf1d4" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_47310772-9ab2-441c-a1d2-a7758657cb5e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_47310772-9ab2-441c-a1d2-a7758657cb5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0c83804d-0e71-473b-b82f-7280a0e5b6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_0c83804d-0e71-473b-b82f-7280a0e5b6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f03ef012-320a-4228-9615-73aaacf6775d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_f03ef012-320a-4228-9615-73aaacf6775d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_05081988-fe68-4911-bea3-ac244f245264" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_30f81017-9662-4689-b3a7-fb6193cc92b6" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_05081988-fe68-4911-bea3-ac244f245264" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4f66a48-2302-4a28-b9ca-bf2d5512797b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_73979cff-0a12-4bad-99d8-a9af7b8cf1d4" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_d4f66a48-2302-4a28-b9ca-bf2d5512797b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_174ff72e-7753-4489-a8f2-afc72b347386" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_174ff72e-7753-4489-a8f2-afc72b347386" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:to="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_0ebf46bc-fcc4-4563-8b00-6e39f1fc75a2" xlink:to="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_8da075b9-2592-46f4-8441-ca17de9f60cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:to="loc_us-gaap_CommonClassAMember_8da075b9-2592-46f4-8441-ca17de9f60cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_cdf725b1-430b-4eb1-b89c-45d55d17ea46" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8c486873-5e5d-47d0-b51d-607f3081c570" xlink:to="loc_us-gaap_CommonClassBMember_cdf725b1-430b-4eb1-b89c-45d55d17ea46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_a86e198e-b733-41dd-95bc-ac78b8cc89cd" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e95d3f7e-99b6-4a5b-ba1b-b389621f74a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_e95d3f7e-99b6-4a5b-ba1b-b389621f74a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a29b7dd9-abeb-4438-b71c-3a4a9e08fc54" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_a29b7dd9-abeb-4438-b71c-3a4a9e08fc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_944faba9-6f6a-4a0c-99bf-ff3304da0233" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_944faba9-6f6a-4a0c-99bf-ff3304da0233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b744f024-0a1e-4b90-8d50-3d8fe0804489" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_b744f024-0a1e-4b90-8d50-3d8fe0804489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_c0017efc-970e-4b13-a9d6-53bc5e4987fe" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_EarningsPerShareBasic_c0017efc-970e-4b13-a9d6-53bc5e4987fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_16a68ce9-15ba-4bb4-873c-102352909735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_0e9e3e94-a530-4383-bf27-be5b73c2d59f" xlink:to="loc_us-gaap_EarningsPerShareDiluted_16a68ce9-15ba-4bb4-873c-102352909735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_f1e49fb4-fe15-402f-b784-8aa40dfaaa45" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1e49fb4-fe15-402f-b784-8aa40dfaaa45" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_2d03cccd-0b79-4ce3-a364-d82f738d25e8" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertiblePreferredStockMember_74008970-707a-4bfd-817a-9712bff1fbd5" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ConvertiblePreferredStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_ConvertiblePreferredStockMember_74008970-707a-4bfd-817a-9712bff1fbd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_1e449cc4-5189-4e52-ab6e-c08a3d6caa56" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_WarrantMember_1e449cc4-5189-4e52-ab6e-c08a3d6caa56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_269001c4-22f5-483b-bf91-0925ca34f118" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_StockCompensationPlanMember_269001c4-22f5-483b-bf91-0925ca34f118" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_b79bdd35-ee94-4070-be14-9b5dcb0e0735" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_73ed27c4-60c0-4760-b081-2f818a3361e8" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_b79bdd35-ee94-4070-be14-9b5dcb0e0735" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:to="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_b8f80e14-eaba-4b1c-8981-be2001a9ac22" xlink:to="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassAMember_9f2b4543-a62b-4974-bba6-803b8a7dd9e1" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:to="loc_us-gaap_CommonClassAMember_9f2b4543-a62b-4974-bba6-803b8a7dd9e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_016382a8-08c4-4c49-8a8b-907111d1b3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_490ef023-81d7-45a4-9be3-638992cd91e2" xlink:to="loc_us-gaap_CommonClassBMember_016382a8-08c4-4c49-8a8b-907111d1b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_aefe69ca-3f27-4c55-a5ad-14d1481650a5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6ccdf877-e1fd-4a01-9752-d6ecbaa8272f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_fae96ada-b81e-4d03-afba-81999a775637" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_6ccdf877-e1fd-4a01-9752-d6ecbaa8272f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_f1e49fb4-fe15-402f-b784-8aa40dfaaa45" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_73f13912-3b42-43c8-861f-23b7c2970cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:to="loc_us-gaap_StatementClassOfStockAxis_73f13912-3b42-43c8-861f-23b7c2970cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_545327c8-5a89-4c9f-b90b-2ed869cccdb2" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_4f890eb5-d994-46de-a401-c641cac85f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CommonClassBMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_EarningsPerShareBasicLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable_122f52c5-d394-4e05-8476-be936e3cc0a4" xlink:to="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d526c6a2-d4ce-4ecb-bbb2-38b2307a39cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicLineItems_dfb774b9-890d-4716-a7f6-0eb7078a13ce" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_d526c6a2-d4ce-4ecb-bbb2-38b2307a39cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#EmployeeBenefitPlansNarrativeDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_81a0c530-6572-4ee2-9b65-56f6e25e6677" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_81a0c530-6572-4ee2-9b65-56f6e25e6677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2920084b-d700-475c-a09c-6b7a9db0526b" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2920084b-d700-475c-a09c-6b7a9db0526b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_f8f55f08-c7da-4d5b-a23c-3b99f61a5151" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_f8f55f08-c7da-4d5b-a23c-3b99f61a5151" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_SeverancePayRate_f3e4c2b3-a13c-46c7-8ed5-3ac8034b0305" xlink:href="rskd-20231231.xsd#rskd_SeverancePayRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:to="loc_rskd_SeverancePayRate_f3e4c2b3-a13c-46c7-8ed5-3ac8034b0305" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeveranceCosts1_194d6a2c-c0ab-4203-9dbc-5046a2dac46d" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SeveranceCosts1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CompensationAndRetirementDisclosureAbstract_8ed916ff-69ef-4bda-8f4c-00ee8b1d5054" xlink:to="loc_us-gaap_SeveranceCosts1_194d6a2c-c0ab-4203-9dbc-5046a2dac46d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SubsequentEventsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SubsequentEventsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SubsequentEventsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_8bfdef12-a9d0-46aa-b69d-c81757b0d065" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_8bfdef12-a9d0-46aa-b69d-c81757b0d065" xlink:to="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_963b8d85-41bd-4cd0-9a0e-0c3228a00916" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_f1d619ac-1e07-4d81-ba23-ddd8fe57e9b7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_6b7fa53d-abec-4a6e-a92a-a357748fd3cb" xlink:to="loc_us-gaap_SubsequentEventMember_f1d619ac-1e07-4d81-ba23-ddd8fe57e9b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_80780c64-538a-491d-b87e-cf4381c0f9e9" xlink:to="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_10bd9722-76e1-40db-9fce-53a466322755" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:to="loc_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent_10bd9722-76e1-40db-9fce-53a466322755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3fa7fef6-8202-48f4-96ea-347e9e63d6a7" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_e6166395-6b32-4083-801d-3499eb8f9395" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_3fa7fef6-8202-48f4-96ea-347e9e63d6a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="simple" xlink:href="rskd-20231231.xsd#SECScheduleArticle1209ValuationandQualifyingAccountsDetails"/>
  <link:presentationLink xlink:role="http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_40dd8ee8-ba8b-4c9d-a07d-e000eac26a0d" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_40dd8ee8-ba8b-4c9d-a07d-e000eac26a0d" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesTypeAxis_86d8355a-780a-468e-93b5-88896cec30a4" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantyReservesMember_78d6d2e6-e417-4835-8e72-9b4a01b6dc9e" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_WarrantyReservesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:to="loc_us-gaap_WarrantyReservesMember_78d6d2e6-e417-4835-8e72-9b4a01b6dc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_rskd_ProvisionForChargebacksMember_707ff42f-7885-444e-bf76-a574411874a4" xlink:href="rskd-20231231.xsd#rskd_ProvisionForChargebacksMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesDomain_00e962c8-5a34-4b0a-bbf7-b04945ff3ba3" xlink:to="loc_rskd_ProvisionForChargebacksMember_707ff42f-7885-444e-bf76-a574411874a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:href="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd#srt_ValuationAndQualifyingAccountsDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureTable_76c83d78-d2f8-4a71-a039-47a86a12b94f" xlink:to="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_MovementInValuationAllowancesAndReservesRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsDisclosureLineItems_ba2d93b0-bf5b-4a27-b570-5f55a08e48be" xlink:to="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_eec389d4-56b5-4d5e-8a1e-9fb4a8a3c6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_eec389d4-56b5-4d5e-8a1e-9fb4a8a3c6f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a3c24255-cb14-482c-b5df-1981184213cc" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_a3c24255-cb14-482c-b5df-1981184213cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7b3b20bc-dad3-4a1a-8c88-112583900501" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesDeductions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesDeductions_7b3b20bc-dad3-4a1a-8c88-112583900501" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_208936a2-2599-4cca-8130-9453ec5672dd" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInValuationAllowancesAndReservesRollForward_acf4e63f-46ee-452a-84c2-bd69e908cc60" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_208936a2-2599-4cca-8130-9453ec5672dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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M8,6 8[%8 2L&'(O%"E@QX%@L5L"* <=BL0)6##@6BQ6P^A^CM.2%!RS)+
*  !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>rskd-20231231_g1.jpg
<TEXT>
begin 644 rskd-20231231_g1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (< \ # 2(  A$! Q$!_\0
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MT#_H-:?_ .!"_P"-'*^P>TAW1K45D_\ "4Z!_P!!K3__  (7_&C_ (2G0/\
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MWI7_ $$;7_OZO^-']MZ5_P!!&U_[^K_C1R2[![>E_,OO+]%4/[;TK_H(VO\
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M !H_X2G0/^@UI_\ X$+_ (T<K[![2'=&M163_P )3H'_ $&M/_\  A?\:/\
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MO+?BIJ$\WB..Q+G[/!"K*F>-S9)/UZ"O2_"G_(LV?T;_ -"->4_$[_D<Y?\
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MKZ9:2B.YU&TAD(#!9)U4D'H<$U+<7]G9VXN+F[@@A.,22R!5.?<\4_9STTW
ML455;4K!+-;QKVV6U;@3&50A_P"!9Q2PZC97%L]Q#>6\D$8)>5)5*J!R<D'
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MVF'U*CV/*/\ A5.I?]!&U_)O\*/^%4ZE_P!!&U_)O\*]7HH]M,/J5'L>4?\
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MOY-_A7J]%'MIA]2H]CRC_A5.I?\ 01M?R;_"MSPEX"O-!\0PZA->02HBNI5
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M"-E$;2(4/S,3\W+#H:]@HH \@NO'/B27Q!;P6]RMHCPV<EI;7J1PF]$BJ7+
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MU]&R*\.M'E:L:(VK%0MG'C^[4MPDDMM+'#,8960JDH4,4)'#8/!QUP:;:?\
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M%E (H9/.B0(,(^2=P]#DGFKM>.Z/>:K%I[:3'),_]O2,L$N2?)*R%)?_ !P
MUW83#2K1DXRM:WZZ_))L3=CU&;0=)N+=H)M-M9(FD:4JT0/SGJWU/K4D.CZ;
M;I;I#8V\:VS%X0L8&QCU(]Z\Q75XCX%\.:5=7LT*7DDDES,@9G6))&] 3R<
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MM%S;SY\O[OE!!CKSG9^&:R;/1=4CU^SMDCN5TRSOI;D&:.-0H8/T<,2^2W'
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MUJ,MV+L+ODM)-OEYQY#$XSGOG\/>JNJ>,;B"ROYM/TJ29;.Y6W:9W41DEE'
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M[>^-[#IEHEUG/FK$ P/J/0^]1CPUHBW@NQI5H+@2>:)?*&[?G.[/KGFO*O\
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M:/[&QG\GXK_,.9'K%%>3_P#"XY_^@+'_ .!!_P#B:/\ A<<__0%C_P# @_\
MQ-']C8S^3\5_F',CUBBO)_\ A<<__0%C_P# @_\ Q-'_  N.?_H"Q_\ @0?_
M (FC^QL9_)^*_P PYD>L45Y/_P +CG_Z L?_ ($'_P")H_X7'/\ ] 6/_P "
M#_\ $T?V-C/Y/Q7^8<R/1+C0+&ZFNI9%DW7,D,LF&Q\T6-N/RJ&3POI\DYG!
MGCF,\D_F1RE3N=0KCZ$**X-/C!.ZL1HT>5&<?:#R/^^:;_PN.?\ Z L?_@0?
M_B:U66YBME^*_P ^PKH[M/"6FP_9?(>[@-O&L.Z&X9#(BG(5L=><U87P]8+Y
M>%D_=W;WB_/_ ,M'W9_#YCQ7GG_"XY_^@+'_ .!!_P#B:/\ A<<__0%C_P#
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M;3/L5O:;9?*M[>:W3Y^=DHPWX\5P/_"XY_\ H"Q_^!!_^)H_X7'/_P! 6/\
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M/^%QS_\ 0%C_ / @_P#Q-']C8S^3\5_F',CUBBO)_P#A<<__ $!8_P#P(/\
M\31_PN.?_H"Q_P#@0?\ XFC^QL9_)^*_S#F1ZQ17D_\ PN*X_P"@)'_X$'_X
MFGO\7[A%!;1HPQ_A^T'I_P!\T?V/C/Y?Q7^8<R/5:*\G_P"%QS_] 6/_ ,"#
M_P#$T?\ "XY_^@+'_P"!!_\ B:/[&QG\GXK_ ##F1ZQ17D__  N.?_H"Q_\
M@0?_ (FC_A<<_P#T!8__  (/_P 31_8V,_D_%?YAS(]8HKR?_A<<_P#T!8__
M  (/_P 31_PN.?\ Z L?_@0?_B:/[&QG\GXK_,.9'K%%>3_\+CG_ .@+'_X$
M'_XFC_A<<_\ T!8__ @__$T?V-C/Y/Q7^8<R/6**\G_X7'/_ - 6/_P(/_Q-
M'_"XY_\ H"Q_^!!_^)H_L;&?R?BO\PYD>L45Y2GQ@G?<?[&C  R3]H/_ ,33
M?^%QS_\ 0%C_ / @_P#Q-']CXS^3\5_F',CUBBO)_P#A<<__ $!8_P#P(/\
M\31_PN.?_H"Q_P#@0?\ XFC^QL9_)^*_S#F1ZQ17D_\ PN.?_H"Q_P#@0?\
MXFC_ (7'/_T!8_\ P(/_ ,31_8V,_D_%?YAS(]8HKR?_ (7'/_T!8_\ P(/_
M ,31_P +CG_Z L?_ ($'_P")H_L;&?R?BO\ ,.9'K%%>3_\ "XY_^@+'_P"!
M!_\ B:/^%QS_ /0%C_\  @__ !-']C8S^3\5_F',CUBBO)_^%QS_ /0%C_\
M @__ !-'_"XY_P#H"Q_^!!_^)H_L;&?R?BO\PYD>L45Y3)\8)T;;_8T9/?\
MT@__ !--_P"%QS_] 6/_ ,"#_P#$T?V/C/Y/Q7^8<R.^'A;3A>_:@;C(G>X6
M/S3L5W!#$#WR:8GA/38OLY@:Z@,,2PYBG93(B_=#8ZXYYZ\UPG_"XY_^@+'_
M .!!_P#B:/\ A<<__0%C_P# @_\ Q-;_ -G9EV_%?YBNCT.;P]83V-_9NLGE
M7LWGRX<@[_EY![?=6FQ^'+".Y2X_?/,LZW&YY,DN(_+!/K\OZUY]_P +CG_Z
M L?_ ($'_P")H_X7'/\ ] 6/_P "#_\ $U*RW,4K6_%?YA='6ZMX2,BP_P!E
MB*-U:8L\D\J-^\;<1E#RN<_*?S%;VD:>-*T>SL!)YGV>)8]^,;L#KBO-/^%Q
MS_\ 0%C_ / @_P#Q-'_"XY_^@+'_ .!!_P#B:J>79A."A*.B\U_F%T>L45Y/
M_P +CG_Z L?_ ($'_P")H_X7'/\ ] 6/_P "#_\ $UA_8V,_D_%?YCYD>L45
MY/\ \+CG_P"@+'_X$'_XFG'XP3JBL=&C^;M]H/\ \31_8^,_D_%?YAS(]6HK
MR?\ X7'/_P! 6/\ \"#_ /$T?\+CG_Z L?\ X$'_ .)H_L;&?R?BO\PYD>L5
MII_JU^@KQ3_A<<__ $!8_P#P(/\ \33Q\;-1 P-'M<#IF1J/[%QC^S^*_P P
M4D>U45XK_P +MU+_ * ]K_W\:C_A=NI?] >U_P"_C4?V)C/Y?Q0^9'M5%>*_
M\+MU+_H#VO\ W\:C_A=NI?\ 0'M?^_C4?V)C/Y?Q0<R/:J*\5_X7;J7_ $![
M7_OXU'_"[=2_Z ]K_P!_&H_L3&?R_B@YD>U45XK_ ,+MU+_H#VO_ '\:C_A=
MNI?] >U_[^-1_8F,_E_%!S(]JHKQ7_A=NI?] >U_[^-1_P +MU+_ * ]K_W\
M:C^Q,9_+^*#F1Y;1117VYD%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% $T@\R,2CJ.&_QJ&G1R&-LCGU!Z&I#
M&DG,3 '^XQQ^1I; 0T5(8)1UB?\ [YI/)D_YYO\ ]\FG= ,HI_DR?\\W_P"^
M31Y,G_/-_P#ODT70#**?Y,G_ #S?_ODT>3)_SS?_ +Y-%T RBG^3)_SS?_OD
MT>3)_P \W_[Y-%T RI8R'3RF..<J3V--\F3_ )YO_P!\FCR9/^>;_P#?)I.S
M 1T9&*L,&FU.IG5=IC9E'9ES2_-_SZC\C2Y@*]%6/F_Y]1^1H^;_ )]1^1HY
M@*]%6/F_Y]1^1H^;_GU'Y&CF KT58^;_ )]1^1H^;_GU'Y&CF KT58^;_GU'
MY&CYO^?4?D:.8"!6*,&4X(J4^3)SGRV[C&13OF_Y]1^1H^;_ )]1^1I-@,\N
M/_GNGY'_  H\N/\ Y[I^1_PI_P W_/J/R-'S?\^H_(T7_K00SRX_^>Z?D?\
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M=^861S4?@6_GU""VM]0TN>.>%YDN8[@F+:GWLG&01[BLG5](&DM$!J6GWOF
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-6"BBBN@04R;_4O]#3Z9-_J7^AI,"A&BNV&D6,8ZMG'Z U)Y$?\ S]P_D_\
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M&$4Y1BW:_;HG_D/E/,J*[:/0=)ET?^WVMFBM+>WECN+4RMD7(8*BYZ\[E/\
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MDO/)SRQ)]#VJA;W-Q:2^;;3RPR8QNC<J<?45!O3^^OYT;T_OK^=3&G"*:2W
MU;77;ZST^YM(9"IN)4F:8,PD#+GH0>^XYJK'J%["93%>7"&7F0K*PW_7GFJF
M]/[Z_G1O3^^OYT*G!7=MP'44W>G]]?SHWI_?7\ZL!U%-WI_?7\Z-Z?WU_.@!
MEQ_J'K/J_.ZF!@&!/UJA43W&%6)OGMH)#UP4/X8Q^A'Y57J=_P#CPA_ZZO\
MR2LWN@(****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO[I_*C8W]T_E6I11R 9>QO[I_*C8W]T_E6I11R 9>QO[I_*C8W]T_E6I11R
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M(!E[6'\)_*DK1F_U+_2LZI:L,*G?_CPA_P"NK_R2H*G?_CPA_P"NK_R2H>Z
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MN-J;@[#..W %<]7=2J>TAS6M_5B0IDW^I?Z&GTR;_4O]#6C S:***Q&%%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M2"VT8]>35,HRJ&*D!NA(ZU*Y6VD]@,[[/+_<_6C[/+_<_6MW3M*NM3O4M(%
MD=&D7?P"%4L?T!IEU8O:B F2&7SH5E'E/NV@YX;T;CI2O#FY;ZC,7[/+_<_6
MC[/+_<_6M+RW\S9L;?\ W<<TWI5\J$9_V>7^Y^M'V>7^Y^M:%%'(@,_[/+_<
M_6C[/+_<_6M"BCD0&<8)%!)7@>]1UHS?ZE_I6=4R5AA4[_\ 'A#_ -=7_DE0
M5.__ !X0_P#75_Y+4/= 04444P"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH L-^\LD8=8F*GZ'D?KFJ]20RF)\X#*1AE/0BI#;K+S;N#_L.
M0&'^/X5-^7<"O14_V*Z[6TI^B$T?8KO_ )]9O^_9I\T>X%BU_P!0/J:FJ.&-
MXH@LB,C>C#!J2MH[""K-A8S:E?P65N%,T[A$#' R?>JU:WA>YAL_%&FW-Q(L
M<,=PK.[=%&>M35E*-.4H[I,$3:EX3U73+22ZD6">")MLKVTRR>6?]H Y%8>#
M@''!KN'N-)T*/79UU:'4)M2C>&.WMU;:H=LEF8@#('2M+7/$.CS69$;6USIK
MO"8[0S-OA"D$A8]F$. 0?FYSWKSX8RLFDX.5^MK=NC]?G8JR//K*S>^O(K9)
M(HFDSAYG"(,#/+'@=*KA2?IG&>U>DG6XQXMLKR?Q':3Z4+EW@@12#;H48+D;
M1MQD+C/O5!M5LIO PLY]0AB:.V"QQ6TSYD?=G:\17&>N7![52QM6ZO#1V[Z7
MO?HMK(+'&7MF]E>RVK/%*T9P6A<.IXSP1UJN 2< 9->GSZ]9S:AJQTO6[73[
MJ2_28W4BG$T 0#:" >C G;WS55_%5E:@MH]TMK')KIE9%7!\@H@+8QPI(/%3
M#'5FDO9ZV7==/3[M_.P61YU2D$'!&#74V.H:7;?$2XO96C^PFZG,4@3<B9+;
M'V]P"0:ZG3-1CGU;3(;C5;?4-4ABNVEO8E+*L9C.U22!NQR>G'2M*V-G3UY+
MJU_P;[>6OJM 2/-+.QN;^Y%M:PF28J6"@@< $D\^P-$UF\%I;7#20LMP&*JD
M@++@X^8=O;/6O1[3Q+!::AHR76NP7%V(KB.YO8P=@5AF-6;:"<, >G%4[37K
M:UM;0RZE#)>0V6HJ\@.0TKR$J>1SNZC(K+Z[7O\ P]/G_>\O)=.H61Y[M(SP
M>.M3WEF]E*D;R0R%HUD!BD#@!AG!([^HKO6\5QW,*0W.HHZ3:%(EP& ^>XPP
M4,<<MTQ5K2]=M8=5>[AURW@6/3K>-8)798YIA'CYR 3A><@=<BG+'5HIMT]O
M77IV"R/,,$YP.E%>E:3K]G!IY5]0LS>I=S27S/,T<=WN;(;B,[U(R-O'TKG=
M;UQ9_"^D:?9S*D6V5I[=.=A\UF4$XSP#6M/%U9SY?9VUM>_KKMY:>O05CEZ*
M**[Q!6;-_KG^M:54Y+2Y>1F6WE92<@A"0:SFTEJ!6HJ?[%=_\^LW_?LT?8KO
M_GUF_P"_9K/FCW&0CJ*U*I"RNLC_ $:;_OV:NUI3:>PB>RM);^^M[.  S3R+
M&@)P-S' _G6GJWAF\T: RW-Q8N5?RVCAN5=P>>JCGM5?P]/%:^)-+N)W"0Q7
M<3NYZ*H8$FNGA\46LWC>&22VTRWM(M0:3[7#!M=ERV"S=\YR:Y<15KPJ>XKQ
M2N_\AI(X?!/0'IFDKT/P[XBA!FO+O5MET]\@E5I?*7R   0%0[NXV],?G3K:
M\T>::Q==4M+6+3]:FN-C[ANB9U*E  >,#VQ42QU2,FG3>GKV].^@['!V%C/J
M5_!9VX!EF<1IN.!D],FH98VAF>)_O(Q4X]17IFE:]8QG3VM]:M;*"&^F>^AD
M4YN-TA*,,*<_+@=L5RWAW4X+#Q'J-XTZ1AK>Y$3L,@L0=HQWR:(8NK+G?)LM
M%KKJ_+\KA8P9;-X;.WNFDA*SE@$60%UVD?>7J,YX]:@P<@8.37?Z7XCMQ;:1
M/=7Z&[CCU!IB_)#N!LR,8Y-6-)UZ*_\ [+EN+S?JPT^ZB^U>49&MY-_[MF !
M. N>>V:F6,K03O3VOW_O>6VF_FM LCS>K%Y9O97 A>2&1BBOF%PX^89QD=^:
MZKQV9OLNA+<W0N;C[*[/+L*[\R'!P0#SZD<]:OWOB6"VL]7DT[4%2ZDAL%A9
M/O$HI#X^E6L74E&,X1O>_P#Z4EO;Y["L<-%8W,UG<7<<1:"V*B5\CY"Q(7\\
M&J^#@''!KTB^\1V]PGBFWMM5AC2Z2WEB&2JRGRP)E&!]YL8I^M^(=+GM2+:>
MUDLI'@\B%IFWV^TC)6/9A,8(/S<@]ZSCCJS:3I[V^6B?;S?W,=D>:@$D  G-
M !.< \5Z(?$L=WK?B#R]6AM;F0A--O9%PB1AR64$ [=P/7%2:/KMI;VUTC:K
M:MJ/VTRSW!D:%+E,#'(C.X#GY<#UYJGC:JC?V>NG?K\OEZ] LCS8 GH*O6^D
M7=PMF^U(H;N0Q132N%0L,9R>V,BO1-.U-8-*T>[BU.UTJR:^NI)86#$21;U)
M1?EYX.,''4>E5[/Q+:2P:3MU..WM+75'=[:0D$0E@8\#'11FLY8^L[\E/9OO
MTOY=UYA9'F[H49EX.TX)4Y'YTT G.!TKTG2M=T^*UL2FJVUK90/,=1LY(R6N
MMS$@@8._(P.2,5%IWB>U@DT.S%ZD6G?8YTNX6Y )\S:K<<]5_.M'C:NMJ>WK
MTOY;Z:>JU"QYW3)O]2_T-/ILBL\;*H)8C  ')KT7L29E%3_8KO\ Y]9O^_9H
M^Q7?_/K-_P!^S6'-'N,@HJ?[%=_\^LW_ '[-'V*[_P"?6;_OV:.:/<"]VHHH
MKH$%%%% !72^$M7MM(BUB2<PEY;(I#'-'O21MP.TCH?QKFJLVUFUS#<RK+"@
MMX_,*R/M+\@84=SSTK&O3C4IN,]G;\QHZO0_$%O(^H74LMKIEYY4:0I;!K:)
MP&)8DQ@G=R,>OO6E>>(=*_M&]EM+RV ?5K>YC,D3%"JQ_,Q &?O?C7#6VEW5
MU97=W&H$5K&LDA8X)!8*,>O)JH4<!25(#=#CK7(\#1G-R3\K?<_T_$=V>EGQ
M!HJ:Y#<2ZB7N'LYHA)]HEECMI&8%2KLN\9&X' .W(KE?%.I07VK6KY@N/)B5
M)98I'?S<$GYF95)..,X]*P8;6>>:*&.)F>5PB#IN;.,5=.AW@,D;>4+F.Z%H
M;8R#S"YST'<9&,]**6$HT)J7-K;JPNV=SJWB+3YK36"VM1W=G<I#]DL%C93&
MJNI9.F%X!Z'G%&L^)M(E9&,MO>V#W<$J6Y>0O"BD$@1E0J<97 /.:XG5-!GT
ME)3/=6;O%-Y#QQ3;G#8R>/0=,^M9AC<,%*,&/08Y-94LNP[2E&3:7RZ+LEV0
M<S/0FUR)/$D=W=^)8KVS/VDQ1JCCR0\;!005XZ@8'2JX\26EKIQ:TOO+NET.
M"V0J#D2K(20..H'.:XVVTZ[NTN7@@9Q;1^9-T&Q<@9Y]R*+JQDM9(8_,BF:6
M)91Y+[\!AG!QT([BK6!H747+:W;IKLEYA=GH%OXFTN6ZGE>]5+^XTVU3[6S/
M'B11^\4NJEE)XY YQBN-\3WT6HZ]/<1>200H9X2Q61@ "WS ')[\<GFLD(S'
M 4DYQ@"D(*D@@@CJ#6U#!4Z,^>+=[6_+_(3=Q****[1!1110!'-_J7^E9U:<
MBL\;*JEF(X &2:I_8KG^*%D'J_RC]:RFTGJ!!5BY'EI% ?O("S>Q/;\L4H,5
MK\P999ATQ]U??W/Z57)+,6)))Y)-9[NXQ****H HHHH **** "BBB@ HHHH
M**** "BBB@ HJC_;,'_/I)_W^'_Q-']LP?\ /I)_W^'_ ,37']?H=_P O451
M_MF#_GTD_P"_P_\ B:/[9@_Y])/^_P /_B:/K]#O^ %ZBJ/]LP?\^DG_ '^'
M_P 31_;,'_/I)_W^'_Q-'U^AW_ "]15'^V8/^?23_O\ #_XFC^V8/^?23_O\
M/_B:/K]#O^ %ZBJ/]LP?\^DG_?X?_$T?VS!_SZ2?]_A_\31]?H=_P O451_M
MF#_GTD_[_#_XFC^V8/\ GTD_[_#_ .)H^OT._P" %ZBJ/]LP?\^DG_?X?_$T
M?VS!_P ^DG_?X?\ Q-'U^AW_   O451_MF#_ )])/^_P_P#B:/[9@_Y])/\
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M\\X?^_8HYJ?8"?[%'ZR?FO\ C1]BC]9/S7_&H/M;?\\X?^_8H^UM_P \X?\
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M?^^!_C4%%'-Y 3[+4])I!]8Q_C2-;G:7C=9%'7;U'U%0TY':-PZ'##O1==4
MVDJ:X5=RNHPLB[@/3U_7-0TFK.PT%%%% PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ KV_6?AUHEWK.BRZ);)NM9K-=6L 2=T,C*?-'.<<D''UXQSXA79
M)\2-6A\90>)+>**&>.!+=X024EC48PWUP#[$"L*L9MIP?<I-=3N[+PKI*Z=X
MCFM]$TBXGMO$,]I$-0N&AC2$*"%#;AR#V]S69X5MM&OOB)+X;U/POH[+,S2;
M[:=Y%B"P!@J,&P1E<GW8UST/Q(;[-J5M?Z!I]_!?ZE)J31SE\)(P P,'H!_.
MLS3/&!T;QF/$6GZ5:6^U2J6:%O*7,>PXYSZGZFLE3J6E?\_^".Z-_3H-)\9>
M'?$BV>@6ECJEG!%<6JVS.<J'Q)]XGL1^==1+X$\.VWB:QNA:I-H^G:=<_P!I
M)D[7GMQM<DYZDNI_#ZUYAX1\57?@_75U2SBCF;RVB>*3.UU;L<>X!_"KT7Q
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!+;N([A';@
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MT7_?3?XT?:(?^?:+_OIO\:Q:*/K#[!RFU]HA_P"?:+_OIO\ &C[1#_S[1?\
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MS(.4W?MJ_P#/%/\ OMO\:/MJ_P#/%/\ OMO\:PJ*/K,@Y3=^VK_SQ3_OMO\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2OAGH5OXKT5;R\GNK&ZNGM9+681B1G"EE/[N4XC8 \Y!!&,<UFYPZCLSBO\
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MR.>*AUKQ%J7B%K5]2DCEDMH5A21851BH  W$ %C@ 9-95%%D 4444P.W\/\
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MDL !=0B*3! /*@D=^H)!Z]ZMCQCK!UJYU:9[6XNKJ)89Q<6D4B.BA0 492O
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ML*U^('B*T@ACBN;<F 2K%+):1/)&LF=ZJY4D [CP#WJFGB[6H[BVG6[ DMK
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M>#C(^\>.GM5F?QQKD^K66IB2TAN[*4S126]E%%ESC<S;5&XG SG-<Y12Y5V
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MLC  LQ^G JK10DEL 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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? HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>rskd-20231231_g2.jpg
<TEXT>
begin 644 rskd-20231231_g2.jpg
M_]C_X0#H17AI9@  34T *@    @ !@$2  ,    !  $   $:  4    !
M5@$;  4    !    7@$H  ,    !  (   (3  ,    !  $  (=I  0    !
M    9@        "0     0   )     !  B0   '    !# R,C&1 0 '
M! $" P"2A@ '    $@   ,R@   '    !# Q,#"@ 0 #     0 !  "@ @ $
M     0  !$*@ P $     0   Q:D!@ #     0          05-#24D   !3
M8W)E96YS:&]T  #_X@_024-#7U!23T9)3$4  0$   _ 87!P; (0  !M;G1R
M4D="(%A96B 'Z  ! !4 #  [ !5A8W-P05!03     !!4%!,
M            ]M8  0    #3+6%P<&P
M                                 !%D97-C   !4    &)D<V-M   !
MM   !)QC<')T   &4    "-W='!T   &=    !1R6%E:   &B    !1G6%E:
M   &G    !1B6%E:   &L    !1R5%)#   &Q   " QA87)G   .T    "!V
M8V=T   .\    #!N9&EN   /(    #YM;6]D   /8    "AV8V=P   /B
M #AB5%)#   &Q   " QG5%)#   &Q   " QA86)G   .T    "!A86=G   .
MT    "!D97-C          A$:7-P;&%Y
M
M                    ;6QU8P         F    #&AR2%(    4   !V&MO
M2U(    ,   ![&YB3D\    2   !^&ED       2   ""FAU2%4    4   "
M'&-S0UH    6   ",&1A1$L    <   "1FYL3DP    6   "8F9I1DD    0
M   ">&ET250    8   "B&5S15,    6   "H')O4D\    2   "MF9R0T$
M   6   "R&%R       4   "WG5K54$    <   "\FAE24P    6   ##GIH
M5%<    *   #)'9I5DX    .   #+G-K4TL    6   #/'IH0TX    *   #
M)')U4E4    D   #4F5N1T(    4   #=F9R1E(    6   #BFUS       2
M   #H&AI24X    2   #LG1H5$@    ,   #Q&-A15,    8   #T&5N054
M   4   #=F5S6$P    2   "MF1E1$4    0   #Z&5N55,    2   #^'!T
M0E(    8   $"G!L4$P    2   $(F5L1U(    B   $-'-V4T4    0   $
M5G1R5%(    4   $9G!T4%0    6   $>FIA2E     ,   $D !, $, 1  @
M '4 ( !B &\ :@!ISNRW[  @ $P 0P!$ $8 80!R &< 90 M $P 0P!$ $P
M0P!$ "  5P!A '( ;@!A %, >@#M &X 90!S "  3 !# $0 0@!A '( 90!V
M &X _0 @ $P 0P!$ $P 0P!$ "T 9@!A '( =@!E ', :P#F '( ;0!+ &P
M90!U '( 90!N "T 3 !# $0 5@#D '( :0 M $P 0P!$ $P 0P!$ "  80 @
M &, ;P!L &\ <@!I $P 0P!$ "  80 @ &, ;P!L &\ <@!, $, 1  @ &,
M;P!L &\ <@!! $, 3  @ &, ;P!U &P 90!U '(@#P!, $, 1  @!D4&1 9(
M!D8&*00:!#X$.P1,!#X$0 0^!#($. 0Y "  3 !# $0@#P!, $, 1  @!>8%
MT07B!=4%X 797VF"<@!, $, 1 !, $, 1  @ $T X !U $8 80!R &4 8@!N
M /T ( !, $, 1 0F!#($-01"!#T$/@0Y " $%@0: "T$- 0X!$$$/P0[!#4$
M.0!# &\ ; !O '4 <@ @ $P 0P!$ $P 0P!$ "  8P!O '4 ; !E '4 <@!7
M &$ <@!N &$ ( !, $, 1 DP"0()%PE "2@ ( !, $, 1 !, $, 1  @#BH.
M-0!, $, 1  @ &4 ;@ @ &, ;P!L &\ <@!& &$ <@!B "T 3 !# $0 0P!O
M &P ;P!R "  3 !# $0 3 !# $0 ( !# &\ ; !O '( :0!D &\ 2P!O &P
M;P!R "  3 !# $0#B .S \<#P0/) [P#MP @ [\#N /, [T#MP @ $P 0P!$
M $8 Y !R &< +0!, $, 1 !2 &4 ;@!K &P :0 @ $P 0P!$ $P 0P!$ "
M80 @ &, ;P!R &4 <S"K,.DP_ !, $, 1'1E>'0     0V]P>7)I9VAT($%P
M<&QE($EN8RXL(#(P,C0  %A96B        #S40 !     1;,6%E:(
M (/?   ]O____[M865H@        2K\  +$W   *N5A96B         H.
M$0L  ,BY8W5R=@        0     !0 *  \ %  9 !X (P H "T ,@ V #L
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M.VL[JCOH/"<\93RD/.,](CUA/:$]X#X@/F ^H#[@/R$_83^B/^) (T!D0*9
MYT$I06I!K$'N0C!"<D*U0O=#.D-]0\!$ T1'1(I$SD42155%FD7>1B)&9T:K
M1O!'-4=[1\!(!4A+2)%(UTD=26-)J4GP2C=*?4K$2PQ+4TN:2^),*DQR3+I-
M DU*39--W$XE3FY.MT\ 3TE/DT_=4"=0<5"[40914%&;4>92,5)\4L=3$U-?
M4ZI3]E1"5(]4VU4H5755PE8/5EQ6J5;W5T17DE?@6"]8?5C+61I9:5FX6@=:
M5EJF6O5;15N56^5<-5R&7-9=)UUX7<E>&EYL7KU?#U]A7[-@!6!78*I@_&%/
M8:)A]6))8IQB\&-#8Y=CZV1 9)1DZ64]99)EYV8]9I)FZ&<]9Y-GZ6@_:)9H
M[&E#:9II\6I(:I]J]VM/:Z=K_VQ7;*]M"&U@;;EN$FYK;L1O'F]X;]%P*W"&
M<.!Q.G&5<?!R2W*F<P%S77.X=!1T<'3,=2AUA77A=CYVFW;X=U9WLW@1>&YX
MS'DJ>8EYYWI&>J5[!'MC>\)\(7R!?.%]07VA?@%^8G["?R-_A'_E@$> J($*
M@6N!S8(P@I*"](-7@[J$'82 A..%1X6KA@Z&<H;7ASN'GX@$B&F(SHDSB9F)
M_HIDBLJ+,(N6B_R,8XS*C3&-F(W_CF:.SH\VCYZ0!I!ND-:1/Y&HDA&2>I+C
MDTV3MI0@E(J4])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<
MB9SWG62=TIY GJZ?'9^+G_J@::#8H4>AMJ(FHI:C!J-VH^:D5J3'I3BEJ:8:
MIHNF_:=NI^"H4JC$J3>IJ:H<JH^K JMUJ^FL7*S0K42MN*XMKJ&O%J^+L "P
M=;#JL6"QUK)+LL*S.+.NM"6TG+43M8JV ;9YMO"W:+?@N%FXT;E*N<*Z.[JU
MNRZ[I[PAO)N]%;V/O@J^A+[_OWJ_]<!PP.S!9\'CPE_"V\-8P]3$4<3.Q4O%
MR,9&QL/'0<>_R#W(O,DZR;G*.,JWRS;+MLPUS+7--<VUSC;.ML\WS[C0.="Z
MT3S1OM(_TL'31-/&U$G4R]5.U='65=;8UUS7X-ADV.C9;-GQVG;:^]N W 7<
MBMT0W9;>'-ZBWRG?K^ VX+WA1.',XE/BV^-CX^OD<^3\Y83F#>:6YQ_GJ>@R
MZ+SI1NG0ZEOJY>MPZ_OLANT1[9SN*.ZT[T#OS/!8\.7Q<O'_\HSS&?.G]#3T
MPO50]=[V;?;[]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M__]P87)A
M       #     F9F  #RIP  #5D  !/0   *6W9C9W0          0 !
M      $    !          $    !          $  &YD:6X         -@
MKA0  %'L  !#UP  L*0  "9F   /7   4 T  %0Y  (S,P ",S,  C,S
M      !M;6]D        !A   *!1_6)M8@
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M]O?X^?K_V@ , P$  A$#$0 _ /[^**** "BBB@ HHHH **** "BBB@ HHHH
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M^?X7/"#B5+ W3ZM*^.H1Y;6[@/8 @=Q0!_:9?_\ !?C_ ()=V/P/\$_M&?\
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M<IXA\/W&MZ5J6@64=K%;B.%KF)H'C@M7>)DBEBD2>(N)%!5]H^< _KRHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** /_0_OXHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[&,\4 ;E%%% !15>ZN[6QA-Q>R)#&O5G(51^)J6*2.:-9H6#(P!4KR"#TQ0
M^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH __]'^_BBBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** /_TO[^**** "BBB@ HHHH **** "BBB@ HHHH
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ME==Q\PY8%4QC %=U'AS,*F"GF"HM4H\JNTUS<SY5RZ>]JK:;$\\;\I^C]%>
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M9U_;H^'\MW\9_P#A*#]O@O\ 07U?4-0EDN%,$L,HB<M&GWMN[]X,L@DWX/\
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M]U2E2A[*/)^ZNI7EK*[5E9$/#>?X'\XO_!1GP9\%?V</VTO@1\2OC#X-MU^
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M:FSR7CK<31Q2/<3RL'W^3&(M@V@YX_7F/_@L!_P2DED6)/VDOAGEB ,^*=.
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M(>.M?\#^%O!/Q>\)ZOJ'Q*6X/A>"RU2"=M4^RL4E$&QB&*.K(5X.]2F-RD
M^-?^"<OP4_X*^^'_ (L:Y\4O^"E/B_X<3Z)<Z7'::3X6\#:4ZBUO%?)NVO)H
MXI58INC:+,R,"I4Q[2&_9>BB@ HKE/'7CKP5\,/!NJ?$3XCZM::#H&B6TE[J
M&HW\R6]K:VT*[GEED<A$1%&69B !6/\ "GXM_"WX[> -.^*WP5\1:;XL\,:L
M)&L=5TBYCO+*X$3M$_ES1%D;;(C(<'AE([4 >AT444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%(2JKN;@"N8O_&O@_2\B_P!3M8B/X3*N[\@<_I2ND5"$I:15SJ**\AO_
M (Y?#FQXCNWN".T43?S( KB[[]I'0X\C3--GE]/-98_Y;JAU(+J=M/*\5/:F
M_P OS/I*BOCN_P#VBO$\W&G65M /]K<Y'ZJ/TKCKWXQ?$/4.&OS$OI$BI^N,
M_K4/$1.VGP_BI;V7]>1]ZUBWWB/P_IG_ "$;ZW@QV>15_0FOSVN_$7B#5,_V
ME?3S@]I)&8?K654/$]D=D.&_YZGW(^[;[XO?#ZQ^4WXE8=HD9OU Q^M<?>_M
M >&HN-/L[B8_[6U!_,_RKY"%6!VJ'7D=D,@PT=[O^O*Q]$WG[0&L2?\ (.T^
M&+T\QB_\MM<K>?&#QY><)<K #VCC4?S!->4#M5@=JAU)=SJAEN%AM31TUWXK
M\3:CQ>ZA<2 ]C(=OY=*PB23DTP4ZHN=:A&*M%6'I5A*KI5A*0B85,.E0BIAT
MJ$23)3Z8E/IDDR]*D7K4:]*D7K29#)1TKW+X,?ZS4/I%_P"S5X:.E>Y?!C_6
M:A](O_9JUP_QH\[-/]UG\OS1[O1117I'QX5^;7_!7/\ Y1^^.?\ ?TK_ -.%
MM7Z2U^;7_!7/_E'[XY_W]*_].%M65?\ AR]#Z'A'_D>8#_K[3_\ 2T?Q:444
M5X!_<9[/\"_V@_B]^S7XPF\??!35_P"Q=6GM7LGG^SP7&8)&1V7;/'(@RR*<
MA<\5Z%\;/VW/VJ?VBM#'ACXP>,KO5=,W*YLTCAM+=V7[I>.WCB1\$9&X'!Y%
M?*U?9_[&/[+WA_\ :)\0^(O$/Q(UA_#_ ((\#Z:VKZ]?0*'G\E<[8H001YC[
M6P2I V]"< Z0<G[B9X>9T,KPU\UQ=&'/"WO\B<^R2=N:]]$EU,KX:?MW?M4_
M"/P';_#7P-XI:#2+$LUE%<6MM=O9E_O?9Y)XG>+J>$8 9XP:R/@C^VA^TO\
MLZZ7J&A_"/Q/)IUAJ<WVF>UE@@NH3/Q^]5)XY%1^!\R@9VC/05]B^'_V;_V*
MOVL?"_B?2/V0KCQ/H7C7PQITNJP:?XB,$L&J6MO@.$:'_5R\KWP,CY2,E?D!
M_P!BO]H]/@];?'LZ /\ A%;RT%Y!>"YA/F(T@B55C#^89&<X$87=CG&*MJHK
M6?W'DT<1D%?VM+$4(4Y2E%2A4A&+E)ZQNGI*^KCOK?K<YV;]J[]H&YTFXT2[
M\1/-;W7B1?%THE@@=GUE  MP7:,MP% \O/E\?=J#Q7^U)\=O&^C>+/#_ (HU
MW[39^.+^'4];C^RVZ?:KJWQY;Y2)3'MP/EC**>XK[S^"_P#P2T^*EG-X@U?]
MIC1)]*TJS\)ZAJ]K]DO;=IXKV!%>!+B-#(R!AOX*C.W&01BODGX6?L)_M.?&
M3P);_$7P-X?233+\RKI_VF[M[66_:#[XMHII$>7;@CY1C(P.1BDX5/,NCFG#
MDI3E"5)*#C[WN<MWJK2VNN2_ERI]#C;7]K3]HBP\4^$O&NG>)IK75/ VF1:-
MHL\$4,1M[& $+"0D8$JX)!\T.6'#9JW\4_VO_P!H;XR:WHGB+QOK^;KPW<&[
MTQK&V@L/LUPS*S2H+:.+]X6126.3P*V/A[^Q)^TM\4/ MY\2?"'AWS-'TR]N
M=.O9I[B&W-M/:1^9*)4E=60*,#)'+$*/F(%3R?L/?M(V_P -/^%K7VC6]KIQ
MTW^V5@GO[6*];30N_P"TK:M*)O*VC.=F<#@8I6J6ZV.IU<@A63O152/NKX+J
M]_=[J]WIYLZ7Q_\ \%%_VR/B?X9U+P=XU\8M=Z9K-G]AOK<65I&L\)QG=L@4
M[^ -XPV. <<5\2T45$I-[L]C!9=A,'%PPE&-.+Z1BHK\$@KU7X$_\EO\&_\
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MX+X8IUY4JU2;O+ELJM/]T_J_M7&3Y'&;C4_=W7*OFK#]K4MI^7G8_5/]G?\
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M:U\-Z1]CU&>*:XN;N[E>9@SNCN99UW-))(TJA.?V4_X)R?M8?\%:OB[\6Y/
M?[=?P?\ !FG>$+O1I-5TWQWX#UP7NDR31R(@M/):6YD:1P^X-YB*%1L;NWX6
M^&_@[\2/AW_P0"_9E^ ?[3/[%OB?X\Z1:7>MOXMT"..XTSQ-X:_T^\:VGM;1
M%341/*)MV8T5/)!#L%D4UYG_ ,$*?V4OC1X#_P""M_\ PM[]AWX6_%;X+?LP
M'P_=1^*=+^)P>U^W:D\4JPI:1-@2^7.8&1LRO&J2[I%#JE 'SS_P1:_X*E?!
MS_@E-_P3@_:2^,WCQ5UCQ3J_Q1N[#PGX:C?%QJ^I?98L* ,LL$65:>7'R+A1
MEW16_3O_ (*]?M3_ !^3_@AGX8_:+_X*B_ ?P5KNO^(O&6DS0>!;B74K:+2H
M9H+A[>2XEANH[A+T*K;XT=51)#$X)W"OP._96_X-[?VP_B]^SE\;/VPM'TCQ
MG\.OCK\-/&:ZS\/M%U;3)M+74H[!OM<DENMU$KR32G8+9T_=^;"$;(?*?L3_
M ,%:/B%^W%_P53_X-_\ PLVM_ /X@:/\9M+\:Z1!XD\+?\(KJ<=U)+:VUR)+
MZTMVM_,>SEWHVY5*PNQB8Y4%@#XV_P"#G+XB_MG_ !'^)_[-/[/\_P +=(3X
M07]_I-SX(M8+Z.*'Q%J<UK8I-83PBY#6\5NT_P!FB=TA'ERL0Y&2/O;6O&'A
MCX$_\%%/V O@+\=OV5O '@3XA:MIU\X@TJ654\)337]VYCL4L;IK&8%B;A3*
M)O+EE=D*L37JW_!=?]F?]H_XN^,O^"?%U\)_A_XD\3Q>"_%5G<>('TG2;J]7
M285?1\O>&&-A;H!%)EI=H&QO[IQZG_P5*_9W^/\ \0?^#@G]C#XS^ ? WB#6
M_!WA:&4:UKNGZ9<W.F:<3/,0+JZCC:&#@@_O&7@B@#MOVA/^"SW[=?QJ_;B\
M=_L)?\$</@[HGQ*U3X1_NO&?B/Q3>FTTRWO VQK6%!/:G>LJ/#N,A+2(^(_+
MC,A]*_9*_P""_7A;QG^S'\>O'7[:_@F;X9?$_P#9D$B>./"UO,+I97R\5N;&
M3[K"XG3R%&YD5BC>8T;J]?S:_MA_\$I!^QI_P5)^+WQE_:V_9@\:_M*?!'XL
M:Q>>(M$U7P#<Z@M]HUSJ-RUU+%/%82KG8TS0XN2@D"H\;YWI7Z/?L]_\$A/A
M#^U-_P $R/VDM$_9H_9D\5_LQ>,/B+8)H^@VOC;6KRYN=:M]*GMM2M&FM[R;
M?9F2[M_*;?$%5&#+)(I8  \)^/G_  5W_P""Q_[:?_!,+XP_';QG^RSIMC^S
MIX[\):YIUEK>EZD/[7T^VGBE@6]EAFG\RZMHGQYLD=G"NP-(#M6OWM_X-E/^
M4''P(_Z]=<_]/5_7\Z7P]_;$_P""KC?\$??$_P#P1_U#]C#X@7GC?P[X+U3P
MI/XA>SG@TT:2D<JK)$GV;%Q<BW_=6\,$LGVEU#H6W;*_II_X-X?A9\3O@I_P
M1P^"_P ,/C+X<U3PCXETJWUA;W2=:LY;"^MC+J][(@E@G5)$W1LKKN495@1P
M10!^TM%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M5*]U+3M-C\W4;B.W7UD8(/UQ7 ZE\8OAAI.?M6M6S8_YXGSO_18:DVD:TZ%2
MI_#BWZ(]+HKYUU+]IWX<V>19)=79[;(PJ_\ CY4_I7G^I?M8-RNCZ,!Z---_
M[*J_UJ'5@NIWT\EQL]J5O6R/LJBOSWU']ICXCWO%G]ELQV\N+<?_ !\L/TKA
M;_XL_$G53B[UFY /:)O*'Y(%J'B(]#T*?#&)?Q22_KT/T\FG@MHS+<.L:#NQ
MP*XW4/B5X TK(O-7M01_"D@<C\%R:_,.XOKV_E\V^F>9O5V+']::O6LWB>R.
MVGPO#[=3[E8_034/VA_AO99^S2SW>/\ GE$1_P"A[*X34?VHK%,KI.D._H99
M0GZ*&_G7QY14.O([H</8.&Z;]7_E8^B[_P#:2\;W7%C;VMLO;"LS?J<?I7%W
MWQ?^)&I#]_JLJ ]H@L7_ * !7ER]*L+TJ'4D^IV4\NPL/AIK[C5O-8U?5'W:
MG=37!_Z:N7_G505"O6IA4'6HI*R1*M2#K4:U(.M!),*E2HA4J4 6$J2HTJ2@
MS 58':JXJP.U BP.U6!VJN.U6!VH()A3J:*=0)[#TJPE5TJPE!!,*F'2H14P
MZ5"))DI],2GTR29>E2+UIL2,Y"(,D] *Z*R\)^);[!MK&8CU*%1^9XHLV]#*
M<XQ^)V,0=*]R^#'^LU#Z1?\ LU<K9_"KQ;< >;''!_ON/_9<UZ]X$\%W7A,7
M#74RRF<(,(.!MS_C6]"G)23:/(S+%T94)0C)7TV]4>AT445WGRX5^;7_  5S
M_P"4?OCG_?TK_P!.%M7Z2UY5\:_@QX!_:"^&NH?"7XG6TEWHFJ&$W$44C0L?
M(D25,.A!&'1>GTJ*D>:#BCU<AQM/!YEA<75^&G.$G;>T9)NVW1'^?)17]E'_
M  YQ_80_Z%Z^_P#!E<?_ !='_#G']A#_ *%Z^_\ !E<?_%UY?U&IY'])?\1I
MR'_GW5_\!C_\F?QKU]X?L-?M&_#CX-7WC'X8?&^WN9? _P 1]*_LC5)K$9N;
M1AN\J=%_B\O>V1@GD$ XVG^CC_ASC^PA_P!"]??^#*X_^+H_X<X_L(?]"]??
M^#*X_P#BZ<<'5B[JQPYEXL<.8[#2PM:G5Y7;:,4U9IIKW]&FDUZ'XP?#KXA_
ML5_L+:/XG^(OP-\?7GQ.\<:YI4^DZ/&-*FTRVTY+K&Z6<S??9=H^X<]MHSN7
MQ[XD_M-_#F/P/^S9)X5NSJ][\,4-QK&G^7+$J31W<4ZQ[I$5&WJF,H6 [U_0
M!_PYQ_80_P"A>OO_  97'_Q='_#G']A#_H7K[_P97'_Q=:?5JMK*R1XU+C[A
ME55B*[Q%2I>[E*-/5<DJ:C:+BDE&3MRI:ZGYKS?'S]AW0_CO\2_VF-(^*=Y?
M7?Q'\+:E90Z-/H]VK6=S=11@12S@,IPT86,*NQ1U8 *6Q/AI^V-^SSXK^"OP
MP36_$6@>#/%/PVLH=/E&N>&)=;F(M2OE7%A/#CRW.T,58J=_.0%RWZA_\.<?
MV$/^A>OO_!E<?_%T?\.<?V$/^A>OO_!E<?\ Q=5[&MV1YKXKX5<%&4\2VN5)
MN-'11BX*-K<K7*[:IO1:GX!_&C]J/PC\4_V,-3\$:AJZ2^-=8^)MSXFN[2"U
MEMXY+.:T=//Z&)0TI'[OS"P/.,#-?2-M^T;^RQK7[.:^%?COXLTOXA&S\+C3
MM*M9O#<UKXET^^CA"PQ)J"GR/(B?/S%B6&,[N<_K7_PYQ_80_P"A>OO_  97
M'_Q='_#G']A#_H7K[_P97'_Q=2L/6\COJ\=<*RIQI1]O%1FYKEC333=M$]XK
M2WNV=M+G\:]%?V4?\.<?V$/^A>OO_!E<?_%T?\.<?V$/^A>OO_!E<?\ Q=9?
M4:GD?5?\1IR'_GW5_P# 8_\ R9_&O7JOP)_Y+?X-_P"PYIW_ */2OZT_^'./
M["'_ $+U]_X,KC_XNM70O^"1G[$GAG7+/Q'HFA7T%[I\\=S;R?VA.VR6)@R'
M#,5."!P1BA8&IY&.(\9<BG2G!0JZIKX8]O\ $?IG116!K_\ PDQ@2/PP+82G
M[S7.[:H]@O4_D*]<_EXYJ_(N?B=I\,/)M;*:23V#E57^5>B5R?A?PRVAB:^U
M"=KS4+O:;B=@!G:,!5   4=A_D=90 4444 %%8'BKQ#;>$?"^H^*KR">YATR
MUFNGAM(S-/(L*%RL<8Y=R!A5'4X%?F=X0_X*BZ1=?&+PC\*_B_\ "SQC\.K?
MQ_<BS\/:GKMM''%<W#X"1R(KEHF<LJ@?,067( Y'L99D&/S"G4J8.ES*"N[-
M7T5W9-IRLDW:*=DB93C'<_5"BORI^)__  5-\">'?CAXF^ _PV\">+/'1\&K
MY?B35_#UE]JMM*D(((8*=S&,@[\ '*,%#%37R%^Q;_P49M_@+_P3.\)_&?\
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M7>7)'_/39"I_(N?TKS;5/VR/%4^1HNCVMMZ><[38_P"^?+J/:Q/1I</8^?\
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M?LW^-/ OP3U+^Q_%>JZ3<6^F78D,)CG9> )%YC+#*AQRA.1TK^>/P)_P3_\
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MTDIKGY;.G-QER1CW5F3]7CW/P]^%_P +_P!N;XO_ /!1SP9^UW\>/AI:>!M
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MPE91Z5J/B9=:@=;FULX/*MWMK6'<RN=BE@PVGIB+MX_\ OV.?VCO!7_!._\
M:!^!?B?PY]F\4^-]9\37>B6/VNU?[3#J%M#';MYB2F*/>R$8D=2N.0!BOW/H
MK*IQQ7]I4J8?"TJ7/*G.2BIV<J<I33]ZI*UW)W2TLDHJ-@5%=6?S:^./V(?V
MJE3]GT>._ 5_\0?!G@WP3:Z-K/@_3O$$6E/9ZW&'S<M(MQ%'(,&-=T<I'[OD
MA<;N9M?^"?'[7W_#%7[3'PH/@N2#7_B'XKL-3\/V$VM6U_)<6D-_%.Q:\EF7
M<4C4DO<&.23&2-QQ7].%%>S#Q8S:,:<51I^[.$]JEKPK>V7N^TY?BTDU%2E'
M1RNDR?JT?Z]+'Y)_M/?LQ_&_XA_$;]E?7O!VA_;+7X;ZQ#=>(G^TV\?V*%([
M52</(IDYC;B(.>.G2N.\'?!/]K;X*?\ !0SXQ>/O"?@&Q\4^"/BS9VLD>KW6
MIPVT-G-863JD4]OAYG22X81/M3B,[QNP5K]G:*\*AQOBZ>%^IRHTY4_9RIV:
MEM*K[:^DU[T9I<O2RLTR_8J]_P"MK'\SOP._8C_:A\,_M4>!?'GPE^$,_P "
M8M-U>.Z\7W5GXICU#0M2L5(\V&"Q5GE'G*&"(25CR <8!'],5%%<G%'%>)SV
MK2JXF$8NG'E5N=MJ]]95)3F^RO*R6B2'3I*&B"BBBOES0**** "BBB@#_]?^
M_BO%/C]\?OAY^S3\.Y/BE\49)X='@GBMY)+>+SF5ICA?E'.,\<9QGTZ>UU^5
M7_!9C_DQC6/^PGIW_HT5G5ERP;70]GAS 4L=FF&P=;X)SC%VWLW;0;_P^:_8
M9_Z"^I_^"Z6C_A\U^PS_ -!?4_\ P72U_'-17F?7JGD?TA_Q!?(/YJG_ (%'
M_P"0/[&?^'S7[#/_ $%]3_\ !=+1_P /FOV&?^@OJ?\ X+I:_CFHH^O5/(/^
M(+Y!_-4_\"C_ /(']C/_  ^:_89_Z"^I_P#@NEH_X?-?L,_]!?4__!=+7\<U
M%'UZIY!_Q!?(/YJG_@4?_D#^QG_A\U^PS_T%]3_\%TM'_#YK]AG_ *"^I_\
M@NEK^.:BCZ]4\@_X@OD'\U3_ ,"C_P#(']C/_#YK]AG_ *"^I_\ @NEH_P"'
MS7[#/_07U/\ \%TM?QS44?7JGD'_ !!?(/YJG_@4?_D#^QG_ (?-?L,_]!?4
M_P#P72T?\/FOV&?^@OJ?_@NEK^.:BCZ]4\@_X@OD'\U3_P "C_\ (']C/_#Y
MK]AG_H+ZG_X+I:/^'S7[#/\ T%]3_P#!=+7\<U%'UZIY!_Q!?(/YJG_@4?\
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M/1II0GZ*K?SK14H]$>;5S6O+XJK^7_ /JFQT31M+ &FVD-OC_GG&J_R%:E?
M&H_M0>/[SY+""TM%[%4+M_X\<?I7GVH_&3XG:MD7.LSH#VAQ#_Z %K11/.GC
M([O4_3R66*",RS,$4=23@"N+U+XE> -(R+[6+16'\*R!V_)<G]*_+V]U/4M3
M?S=2N)+AO61BQ_6J:]:?*<LL>^D3]#M2_:-^&EAD6TL]YC_GC$1_Z'LK@-2_
M:HM%!&CZ.S^AFE"_HJG^=?&OI3NU-11QU,?5Z:'T1J'[2_C^\)6QBM;1>VU"
MS?\ CQ(_2N#U+XN?$G5>+G6)U![1$1?^@!:\T7K4O>M.5'%4Q-66\B[>:A?Z
M@_FW\\D[>LC%C^M0KTJ'M4R]*9P2$7K3^U,7K3^U!@R4?=IPZ4T?=IPZ5:.9
MBBOK#]E__7:S_NV__L]?)XKZP_9?_P!=K/\ NV__ +/4U/A.S)_]\I_/\F?7
M%%%%<Q]\%?%W_!0C_DTCQ1_O6'_I7#7VC7Q=_P %"/\ DTCQ1_O6'_I7#5TO
MCC\CQN(O^13B_P#KW/\ ])9_-11117LG\J!1110 4444 %%%% !1110 4444
M %=[\*O^2G^&_P#L*6?_ *-6N"KO?A5_R4_PW_V%+/\ ]&K2>QT87^-3]4?U
MUT445XA_7AYYJW_)2='_ .O6Y_\ 9:]#KSS5O^2DZ/\ ]>MS_P"RUZ'0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '
M_]#^_BORJ_X+,?\ )C&L?]A/3O\ T:*_56ORJ_X+,?\ )C&L?]A/3O\ T:*R
MK_PY>A]/P5_R/L!_U\A^:/XY****\ _MT**** "BBB@ HHHH **** "BBB@
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M1JVI:5H^J:]\,Y="V0PVD^GKH:6PB&&B5MLRRH_(^;>7Z=@/$OAKK_A3Q/\
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MF$A>U3+TJ'M4R]*#GD(O6G]J8O6G]J#!DH^[3ATIH^[3ATJT<S%%?6'[+_\
MKM9_W;?_ -GKY/%?6'[+_P#KM9_W;?\ ]GJ:GPG9D_\ OE/Y_DSZXHHHKF/O
M@KXN_P""A'_)I'BC_>L/_2N&OM&ODS]MZTM[_P#9PU:QNUWQ37FE1NOJK7T
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M+7H=>>:M_P E)T?_ *];G_V6O0Z "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH __]+^_BORJ_X+,?\ )C&L?]A/3O\
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MHKZP_9?_ -=K/^[;_P#L]?)XKZP_9?\ ]=K/^[;_ /L]34^$[,G_ -\I_/\
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M,/\ S[:C_P"!9_\ B:/^':7[,/\ S[:C_P"!9_\ B:/K< _XAEF_>'_@3_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
M_];^_BN=\4>+O"W@C26U[QCJ-MI5BC*C7%W*L,09N "S$ 9[5T5?!O\ P4B_
MY-:U'_K]L_\ T8*J$;R2/.S;&RP>"K8J*NX1;MZ(^A/^&EOV=O\ H>M _P#!
MA!_\71_PTM^SM_T/6@?^#"#_ .+K^46BN[ZG'N?D/_$5<9_T#Q^]G]77_#2W
M[.W_ $/6@?\ @P@_^+H_X:6_9V_Z'K0/_!A!_P#%U_*+11]3CW#_ (BKC/\
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M/Z]//-6_Y*3H_P#UZW/_ ++7H=>>:M_R4G1_^O6Y_P#9:]#H **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M'__0_OXKX-_X*1?\FM:C_P!?MG_Z,%?>5?!O_!2+_DUK4?\ K]L__1@K2E\<
M3PN*/^11B_\ KW+\C^<FBBBO8/Y8"BBB@ HHHH **** "BBB@ HHHH ****
M.\^%G_)3O#G_ &%+/_T:M?UV5_(G\+/^2G>'/^PI9_\ HU:_KLK@QFZ/VKPH
M_@8KUC^3"BBBN(_6@K\V_BA_R4+5_P#KY>OTDK\V_BA_R4+5_P#KY>M:6Y\W
MQ-_ AZ_H<'1116Y\6%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_LM>AT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!__T?[^*^#?^"D7_)K6H_\ 7[9_^C!7WE7P;_P4B_Y-:U'_ *_;
M/_T8*TI?'$\+BC_D48O_ *]R_(_G)HHHKV#^6 HHHH **** "BBB@ HHHH *
M*** "BBB@#O/A9_R4[PY_P!A2S_]&K7]=E?R)_"S_DIWAS_L*6?_ *-6OZ[*
MX,9NC]J\*/X&*]8_DPHHHKB/UH*_-OXH?\E"U?\ Z^7K])*_-OXH?\E"U?\
MZ^7K6EN?-\3?P(>OZ'!T445N?%A1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5]5?LP_\?&L_[MO_ .SU\JU]5?LP_P#'QK/^
M[;_^SU%3X3U<D_WVG\_R9];4445S'Z&%?%W_  4(_P"32/%'^]8?^E<-?:-?
M%W_!0C_DTCQ1_O6'_I7#5TOCC\CQN(O^13B_^O<__26?S44445[)_*@4444
M%%%% !1110 4444 %%%% !7=_"W_ )*;X<_["=G_ .C5KA*[OX6_\E-\.?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7U5^S#_Q\:S_NV_\
M[/7RK7U5^S#_ ,?&L_[MO_[/45/A/5R3_?:?S_)GUM1117,?H85\7?\ !0C_
M )-(\4?[UA_Z5PU]HU\7?\%"/^32/%'^]8?^E<-72^./R/&XB_Y%.+_Z]S_]
M)9_-11117LG\J!1110 4444 %%%% !1110 4444 %=W\+?\ DIOAS_L)V?\
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M4?\ K]L__1@K2E\<3PN*/^11B_\ KW+\C^<FBBBO8/Y8"BBB@ HHHH ****
M"BBB@ HHHH **** .\^%G_)3O#G_ &%+/_T:M?UV5_(G\+/^2G>'/^PI9_\
MHU:_KLK@QFZ/VKPH_@8KUC^3"BBBN(_6@K\V_BA_R4+5_P#KY>OTDK\V_BA_
MR4+5_P#KY>M:6Y\WQ-_ AZ_H<'1116Y\6%%%% !1110 4444 %%%% !1110
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M[PM-X2U;X@?"G0DT.^TWQ';27WAW5;<;CM;,0D&QG<H?*!)8'Y"H->S^$O\
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M?\(+;QC??#DVC?;)=52SB\JXA\S]XD@4M(Q^6*.,\X8DC !H6_\ P5\\,/\
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MT9PY:;K6BY?O)1HNT[)*VBUWUZ=A1KIV^1^S5%?ROWW_  6N^./B#1M7^/\
MX4\2>!-)T73KYEL? .HI<G6[[3XW"EVN4S&D[+DH!A>/NG #?1W[2W_!47XM
MZ=\8?"NA>"]?T3X4^!O$WA33_$>DZ_XETJZU*/5)K^-)!;[K;*PK&&VN<94J
M23AE%;3\(N((5H4*D(IM2_FT<$FXV46Y-)K^&IIZV?NRL?6H6/Z$JXOPE\1_
MA]X^NM5L? VN6&L3:%=OI^HI97$<[6EW']Z&8(3Y<B]T;!'I7*? 'QAXB^('
MP6\,^-?%M_HVJ:GJ=A%<7-WX=D:;2Y9'')MG<EC'Z9-?@Y8_M?>./@3^SS^U
MW\:/A1H'A[1=<\%?$I[&V>WL2J78DU&.U:6Z D_>2F-V.05&XYQR:\#).$:^
M8SQ&&I/]["=.FND>:I45-7ZVN^B^1<ZJC9]#^D*BOPIA_:\_X*#_  F_:(^"
MUA^T*GA&?P?\9I#906.B1SFYT^9XXS'YDLNW<P::,L5W(0' 5?E)^9?V$O''
M[4'P>_:L_:>^*WQ@U;0KW1?!3?VGXZBL8IO-NI;6TO98/[-#@!%#(V\28R,8
MKV(>&N*^J5\5+$T_<IQG!1?-[2]7V+@G96:EILTY.*6CYE'UA72M_5C^G"BO
MYQ9?V_?^"F?AW]G:R_X**>)-%\'R_"JZN8WD\,PB<:I#ILUQ]FCE\XC;O9B/
MFR1@JWE@$JO[YGX@?VQ\(O\ A:G@6QDU;[5H_P#:NGV8(CDN=\/G0Q=PK/PO
M?!->#GO!^-RKD=:4)*4I4[PDFHU(6YH2>EI1NO[MMFS2%52V/1Z*_GQ_89_X
M*,?M!_M%?&'0= \?>/\ P+87FIWUQ!J_@B[TV]TW5;!(_,VI:32G9<3?*N4+
M-@$]Q7,?M8_\%,_VA/A;\0_'4GPU^)7PT>/P3?2)!X5,%Y/>7EM V&26[(2W
M%U@-F"*0$%2H^88KWEX6YS_:3ROW?:**E]NVLN5:\FU_M6Y+:\UM2/K$.7FZ
M'] ^H>/_  'I/BZP^'VJZW86VO:K')+9:;+<QI=W,<0)=HH2P=U0*2Q52 ![
M5UU?@+XR^+6G?$__ (*5?LG?'6>'^S[3Q#\/]5UUHB=WD1W6F7$Y7.!G8&QG
M':OEF^_X+7?''Q!HVK_'_P *>)/ FDZ+IU\RV/@'44N3K=]I\;A2[7*9C2=E
MR4 PO'W3@!NFCX5YIBXT/J2NW3C*=]HSE5JTU!<J?_/IN[M%?::5B?K,5O\
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MW-*F/P^9NHE6H\JIN,*<5%1;<4H1BH63;TY?+8:I1Y7'H?G!\>?V&?'OC?\
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M*TI?'$\+BC_D48O_ *]R_(_G)HHHKV#^6 HHHH **** "BBB@ HHHH ****
M"BBB@#O/A9_R4[PY_P!A2S_]&K7]=E?R)_"S_DIWAS_L*6?_ *-6OZ[*X,9N
MC]J\*/X&*]8_DPHHHKB/UH*_-OXH?\E"U?\ Z^7K])*_-OXH?\E"U?\ Z^7K
M6EN?-\3?P(>OZ'!T445N?%A1110 4444 %%%% !1110 4444 %%%% !1110
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MR %"_/W@K_@C'X4\*?L0^)OV2KKQO)>:SXAUFUUJ+Q1_9WERVDMEY2P*EO\
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MJ^(?@_XB66GO;"QO?#=M<6%XHE#[Q?6EQ@PG*CRL+AAN]*_/K_@IY9_M7O\
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M+*/#V7\083 0I?[-3DI5K?%:<^=T[K_GU3Y:=K_$I;-Z52YW!OKT/PX^ /\
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M8^#/ &J>$=#L;GQ+XCU^"XGM;S5KB"*4V]C#&"5B(D#;G7(&1P5 ?Z)\5_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\,O9T*KK8ZG&HJE"$+\RBU6Y[.3</<MR/1I6Y97^QS'UC:T?Z1_5U17XH?\
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M8+^$?Q*_9(?]CCQQJ_B#5=!D9)&U6\OA=:P9DN/M/F_:)HW7>7R#^[V["5
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB_Y-:U'_ *_;/_T8*TI?'$\+BC_D48O_ *]R_(_G)HHHKV#^6 HHHH ****
M"BBB@ HHHH **** "BBB@#O/A9_R4[PY_P!A2S_]&K7]=E?R)_"S_DIWAS_L
M*6?_ *-6OZ[*X,9NC]J\*/X&*]8_DPHHHKB/UH*_-OXH?\E"U?\ Z^7K])*_
M-OXH?\E"U?\ Z^7K6EN?-\3?P(>OZ'!T445N?%A1110 4444 %%%% !1110
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M]>.E7]2U/3=%L)=5UBXBM+6!=TDTSB.-%]2QP *_G[_X)H?LV_"+XB_M;_M
M?'3QK82W_B'P?\4];71G:YF2"S:2:7?(L*.L;.X(4LZM\H &*^F/^"POP\\-
M?%#X1^"O"^L>._#_ (1O8O$D-[9:?XKG>WT;6GM8G8VUTT>"J8Q\Q(7G;D,Z
MD?+XGA#!T\_HY)'$RLU'GE[/X;PY_=C&3<DE;5\MM;KE5S157R<]C]9-$U[0
M_$NG)J_AR]@O[23[DUM(LL;8]&4D53T3Q?X3\2SW%KX<U2TOY;1MLZ6TR2M$
MWHP4G:?8U_(UK7QBUO1?V)?VB/AQ\"/ ^E>!_$V@WVAGQ/J'@;4)+_1[K3[L
MLCO:L'E$&U5VRJC_ '&;=M*L!WHT']C/X6?M-_LS7O\ P2_U@W?BK6-4M[;Q
M%#IUY+=&XT=_+^TG4$9W$+A/-9DVKM4%MHV)7T[\)E%55*O-.\U#]W&44H48
MUKU9QJ-4XSC)*#7-?=I?"L_K.VG];:'[Y_L[?MFZ+\=OB)\6O VI:2GAV#X5
M:\-#EO9[Q7CNR6D428,<8BR4P%W-UZU]AW.MZ+9R6T-W>01->G;;J\BJ93QP
M@)^;MTK^2OXT6-Y?_L[_ +?L-C$TK)X\TJ0J@R0D>JJS'Z*H)/H!7TO^T!^T
M?\"?C;\<OV+-!^$OBK3O$%]IFM6<U[;V,RS26@=+1%68+GRGW(PV/AACI3S#
MPTI5L0IX)N-+WDTHN2AR8.E7NW?[<IN.MDNG9$<1IK_6MC]E/AY^VK\(?BK\
M8/'_ ,"O HN+CQ#\/E@^T+*T$=O>O<1-*BVLGFL7P$(<LJA?I7:_LT?&7QA\
M9O@;IOQ7^*7A@>!=1NOM'VG3);R.\6W2"5T#&9 BX95#<J-N<=LU^!W[+/P,
M_91^$W_!3+X_>"Y["QT76_#EM"_@>RGNY$G'VO39VO?LZ/)F?,+[F#!]JG(P
M*^1+'4[R/_@EG^S1X8\=WEYIWPGUGQS?V_C:XM"R#[)_:$AC21DY$93SF^J
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M[-GTU7A<G[+_ .S7+<Z]>3?#[PW))XI &LLVE6S'4 '$F+C,?[T>8JOA\_,
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M\&_\%(O^36M1_P"OVS_]&"M*7QQ/"XH_Y%&+_P"O<OR/YR:***]@_E@****
M"BBB@ HHHH **** "BBB@ HHHH [SX6?\E.\.?\ 84L__1JU_797\B?PL_Y*
M=X<_["EG_P"C5K^NRN#&;H_:O"C^!BO6/Y,****XC]:"OS;^*'_)0M7_ .OE
MZ_22OS;^*'_)0M7_ .OEZUI;GS?$W\"'K^AP=%%%;GQ84444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %?57[,/_'QK/^[;_P#L
M]?*M?57[,/\ Q\:S_NV__L]14^$]7)/]]I_/\F?6U%%%<Q^AA7Q=_P %"/\
MDTCQ1_O6'_I7#7VC7Q=_P4(_Y-(\4?[UA_Z5PU=+XX_(\;B+_D4XO_KW/_TE
MG\U%%%%>R?RH%%%% !1110 4444 %%%% !1110 5W?PM_P"2F^'/^PG9_P#H
MU:X2N[^%O_)3?#G_ &$[/_T:M)[&^%_C0]4?UVT445XA_7IYYJW_ "4G1_\
MKUN?_9:]#KSS5O\ DI.C_P#7K<_^RUZ'0 4444 ?*7[=_P#R9#\8O^Q)U_\
M](9J_FY\91^&/!'PT_8L^.G[1FBS:]\&]"T*XM]7B^SF[M8+R93Y33Q896#-
MY;;2/G6)E&>E?UYU%-##<1-!<(KQN,,K#((],5][PIQO_8V'^K.ASISE)M3Y
M':5&5)J+Y7RR2E>,M;-?"85*/,[W/Y3_ (877@OXZ?MI_M&3_L*:8=%MO$GP
MCNDT$6]BVD+=74IM4\VWB98B@F?A)-J9;YO>OE/X(^$_A]\6_A9\/OV9]1^*
M&G^!O'FF:W;1VVAP?#^X_P"$AT[5HI?]9)?QRHS 'YY'8C"@;E4H O\ ;
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M?@?\'?%W_!,?]J/XC^*/#&F:AX@L_$?BC[/J5Q:QR7</V*"":$1RD;T"2,S
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M'IX>G%^RK.JK[.\%!Q:[66ZU5]"ITE*]^UC\"_V+?A?9?&+]KGP_\>O$%O\
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MW9IR74;]#^2B+X ?&C]G'QU\6O@S\6],^,5WI7C36=0OK&;X=V=K?Z5K=KJ
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5]5?LP_\?&L_
M[MO_ .SU\JU]5?LP_P#'QK/^[;_^SU%3X3U<D_WVG\_R9];4445S'Z&%?%W_
M  4(_P"32/%'^]8?^E<-?:-?%W_!0C_DTCQ1_O6'_I7#5TOCC\CQN(O^13B_
M^O<__26?S44445[)_*@4444 %%%% !1110 4444 %%%% !7=_"W_ )*;X<_[
M"=G_ .C5KA*[OX6_\E-\.?\ 83L__1JTGL;X7^-#U1_7;1117B']>GGFK?\
M)2='_P"O6Y_]EKT.O/-6_P"2DZ/_ ->MS_[+7H= !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_7IYYJW_ "4G1_\ KUN?_9:]#KSS5O\ DI.C_P#7K<_^RUZ'0 4444 %%%%
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M;_PQE^R[_P!"78?D_P#\51_PQE^R[_T)=A^3_P#Q5?&7_#ZC]B+_ )^M9_\
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M1X,?(R4'[L^O'S+XL_X)VZA<?$CQ;;>!O%NC:;X/TKQ%+X>TC4M>N'C-_=J
MQ@3R(9,F+<$DE*I'NZ'L,7X:_P#!1'QS\)_"?P?\*>#M,>"'X83:L;Y#>'R-
M;M]6G\UX981&%CV(6123+@G> ,8KJ_A=_P %$],^&OA/6?AAI7AC6--\*3ZW
M/K6D6NA^(YM*N[#[1]^U>YA@Q/;\?*&C5E]2:ZKTFDOZV/S%83B;#UJ]:C>2
ME*5DY)^ZZLK64I<L6J?)RJ*2Y6U+WXHS)?\ @GX-&_9EUOXD>,?$EAI'C;1O
M%1\/RZ3<71$:; ZF!E6!B;J1E$L6V3RV@^;.<"O!?%'[''Q-\):G\3])U&^T
MMY/A.MNVKF.64K,+F58E^S9A&[#,,[Q'QT]*[*W_ &S%OOA?XS^'GC?0;C6K
MCQ!XBC\4:7J$^IR//87\*&*/SFD1VNE6/"X9E)QR?3UGXO?\% _AW\1O#7Q'
MM?#GPQ70]=^*-M:)K&I_VQ)< 36LL<@:.!H0BH=GW00<G.[ Q4OV5OZ_KL>G
M1GQ%2K<LX<T92W]RT5>EM[U^51]HEN[I>3.6U3_@FG\6])^)S_!^;Q9X1?7H
M=.N-5G@349,6]I;013[YR8!Y.]9,)Y@7[I)PFUFR4_X)T?&#4?$_A;1/"6N^
M'=>T[Q;IU_J=EK&GW4LMB(=*P+L,?($I:)F"[(XG8D\#KBQK/[=O]K?M-^-?
MVC/^$5\O_A,/#<OA_P#L_P"W9^S^;8167F^;Y WX\K?LV+UV[N,UC^ _VRM%
M\,>"_ACX)UOPO>7"?#===\N\T[69=,NY9-9FCE62*2&+,+0;-N#YJR \@=*/
MW7]?UV!2XF5.G)I.7(N96AI)TYMV]Y?#-0BM;--O;;YA^+OPR'PE\8-X2&NZ
M9XA B2476E/(\(W9&QA-'%(DBX^9'0$<5Y?7U-^UM^TQ<?M2_$'3O&L^E'3!
MI>EP:4C3W'VN\N4MV<B6YG\N+S93OP6"*, #%?+-8RM?W=CZW+)8B6%IO%QY
M:EM5H]?EI]P4445)W'L?[.W_ "<#X%_[&'3/_2F.O] VO\_+]G;_ ).!\"_]
MC#IG_I3'7^@;7J9?M(_G'QR_WK!?X9?F@HHHKT#\)"BBN$/Q0^'4>I3://K=
ME#=6[F*2*698V#KP1AB.GM07"E.?P1O;L=W15.RU'3]1C\[3YXYT]8V##]*N
M4$-6T"BBB@ HHHH *IW>GV%^GEWT$<R^CJ&'ZU<HH$TGHSA+[X8_#_4,_:-(
MMAG_ )YH(_\ T#%<?>_L_P#PXN_]1#-;?]<I2?\ T/=7M=%/F9S3P.'G\5-?
M<CYCO?V9=%?_ )!NJ31>GF(LG\ME<=??LT>)(_\ D':A;3?]= T?\@U?9M%5
M[1G'/(\'+[%O1L^ ;[X#_$FS_P!5:)< =XI5_DQ4_I7'WWP\\=:=DW>D70 [
MK$6'YJ"*_2ZBJ55G%/AK#OX)-?=_D?E+/;7%J_E7,;1MZ,,&H:_5J:WM[E/*
MN$61?1@"*Y6]^'W@?4?^/O2;1B>XB53^8 -/VOD<<^&)?8J?@?F?17W_ 'WP
M(^&MYS'9O;D]XI6_D21^E<=??LT^&),G3K^YA_WPKC] M5[2)QSX>Q<=K/T?
M_#'QC17T[??LRZQ'_P @W5(9?3S(S'_+=7'WW[/WQ&M/^/>*"Y_ZY2@?^A[:
MI3B<<\IQ<-Z3^6OY'B5%=Y??"_X@Z=G[1I%R<?\ /-/,_P#0,UR%WINH:>VR
M_@D@/I(A7^8IW1QSH5(?'%KY%*BBBF9!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?57[,/_'QK/\ NV__ +/7RK7U5^S#
M_P ?&L_[MO\ ^SU%3X3U<D_WVG\_R9];4445S'Z&%?%W_!0C_DTCQ1_O6'_I
M7#7VC7Q=_P %"/\ DTCQ1_O6'_I7#5TOCC\CQN(O^13B_P#KW/\ ])9_-111
M17LG\J!1110 4444 %%%% !1110 4444 %=W\+?^2F^'/^PG9_\ HU:X2N[^
M%O\ R4WPY_V$[/\ ]&K2>QOA?XT/5']=M%%%>(?UZ>>:M_R4G1_^O6Y_]EKT
M.O/-6_Y*3H__ %ZW/_LM>AT %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\H?\0?SW_H/C]\_\C^T[_AG;]G[_ *$7P]_X++;_ .-T?\,[?L_?]"+X>_\
M!9;?_&Z_BQ_X;^_;4_Z*9K__ (%M1_PW]^VI_P!%,U__ ,"VH^NT_P"4/^(/
MY[_T'Q^^?^1_:=_PSM^S]_T(OA[_ ,%EM_\ &Z/^&=OV?O\ H1?#W_@LMO\
MXW7\6/\ PW]^VI_T4S7_ /P+:C_AO[]M3_HIFO\ _@6U'UVG_*'_ !!_/?\
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M1_PJ;X5_]"SI7_@%#_\ $5Z!13NS#ZI0_P"?:^Y'G_\ PJ;X5_\ 0LZ5_P"
M4/\ \11_PJ;X5_\ 0LZ5_P" 4/\ \17H%%%V'U2A_P ^U]R//_\ A4WPK_Z%
MG2O_  "A_P#B*/\ A4WPK_Z%G2O_  "A_P#B*] HHNP^J4/^?:^Y'G__  J;
MX5_]"SI7_@%#_P#$4?\ "IOA7_T+.E?^ 4/_ ,17H%%%V'U2A_S[7W(\_P#^
M%3?"O_H6=*_\ H?_ (BC_A4WPK_Z%G2O_ *'_P"(KT"BB[#ZI0_Y]K[D>?\
M_"IOA7_T+.E?^ 4/_P 11_PJ;X5_]"SI7_@%#_\ $5Z!11=A]4H?\^U]R//_
M /A4WPK_ .A9TK_P"A_^(I\?PJ^%\3K+%X;TM64@@BSA!!'I\M=[11=A]4H?
M\^U]R"LO4]$T?6?+&KVT=R(B2@E4,H)&.AXK4HI'0,1$B01Q@*JC  X  I]%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9Y>8X.C"A*<(V>GYH]QHHHKO/F KQWX^?'_X._LO?"G4_C?\>]=A\->%-&,
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M=LL<\AQ?"=/)*=+'.+K^ZW>$N925>-U=4W>/L.;_ )>6?PJFI)-DU4Y]-O\
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M?#[VGRO#+*'>0W EZ,N4\ORAUSN[5\$M_P $9O'*^$G_ &<;?XYZU'\#7O\
M[:?"7]GPFYV>;YWDB]WYV^9\_P#JMN[GR]WS5VY7GO"U6&&^ORIN4*>'A+VE
M.I)>S@I^VIT^5>[5UCRSTCVFA.%17Y?/_@&YJ'_!4#Q-X"^*OQ)3QXMH/"/_
M  K>R^(G@5GA\FXN(;F&/%O,0Y5W>XD\M<8P$->&:-_P51_:;UG]E31])?3]
M,LOCKJ?C^T\%_P!GS6K>0J7BB>.X, DSM\MUC^]][FOMG]LS_@E1\-/VM?$W
MPTU2UUG_ (1;3? $,>FW%A#:?:5U'289(7CLRYFC\H((V"L1)C?G;Q6UK_\
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M\/4W-3A\*7PVU=U*ZYF^O-UN;1Q#M9_UMT/Z_P#]K/X=?"[_ ()<'X8_L-?
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MX5^+_P 8O^2K>(O^PA<?^AFOV@K\7_C%_P E6\1?]A"X_P#0S6%?9'U_!_\
M'J?X?U//5Z4\4Q>E/%<Q^@DJ]*L+TJNO2K"]*"&2+UJ85"O6IA2>PB<=*E45
M$.E2J*1#)!5A>U5Q5A>U-;")UZ4HI%Z4HI,S)EZ5,E0KTJ9*0GL6$J2HTJ2D
M2QRU,O:H5J9>U BRO:K"]:KKVJPO6@S)Z***!/8F7I5A>E5UZ587I002+UJ8
M5"O6IA0)[$JU*O6HEJ5>M!!-4R]*AJ9>E %A>E.IJ]*=09CTJPE5TJPE!++*
M5.M0)4ZT$D@I12"E%!,BP.U3CI4 [5..E)DDZ]*D6HUZ5(M3T))JE3I452IT
MID,D%3#I4(J8=*D@E2O<_@UUU'_MC_[-7AB5[G\&NNH_]L?_ &:ML/\ &CS\
MT_W6?R_-'N-%%%>D?'A7X6?\')__ "AF^+?_ %U\/?\ IYL:_=.OPL_X.3_^
M4,WQ;_ZZ^'O_ $\V->EDO_(PP_\ CC^:,ZW\.7H?Y85%%%?OQ\^?J?\ \$4/
M@1\)/VF?^"GOPL^!WQTT6+Q#X4UV;5%O]/F=XXYA!IMU-&"T3(XVR1HW##IZ
M5^^?Q?\ V _V5/B]^S%^TAXA^('[).J?LQS?"+1K_5/"WC.;4[]K?6+FS,@@
MMQ;WBQJZW)1!E%EP)/E96V[OYR/^"4_[67PY_89_;\^'O[5/Q:LM2U#P]X3E
MU![NWTB.*6\<75A<6J>6DTL$9P\JD[I%^4'&3@5]W^._^"N_@S]J/]BOXR_L
MC_MH77C'Q//J/B:3Q9\,=<+I?W6F7&Z3;97YN+M"+3RR$41F;RO,<JIV1BOF
M<TP^+GC(SHW4$H;-Z>\[V2:3TM>ZV.JE*"A9_P!:&O\ &;_@E/\ $S]H+X_?
M"KX/?!KP[X,^'0G^!FB_$36KZVU&^GL3IP,B3ZC>>9;M.+N0[ ]O;Q2@?+AF
M^9A;_8%_X)T_L^G]K_Q9\*/B9XG\(_&OP\/A5XD\4:;=>';NZ:&UO++Y(?M$
M;I;307,3JQ\F1?NE6((85I:I_P %5_V6_%G[5'P@^-37_P 3_ UO\.O@SH?P
M_;5_"3V%KJL&MZ7)(TDRP32RP7FGNK[#%,\1?.2@V@'ZBM_^"^G[,OA[]M[0
M?VI+'PYXCUN_\.?#C6/"=QXHOM,TRWUGQ#J]Y)&]K<7UI:RPVJ6\/EX^21GV
ML1MKGJ2S+V?LHQ?PO;2SUZ_<M].UM2E[*]SX9_94_P""5OQ"^%O[5?[.>@?M
M#6/A+7=?^+,TNH0_#37[N\M;J/3!;S/%/JIM[>3[*DNP-$G[R0L-K1X615^J
M_AU_P3O_ &4_A;_P2Q^-?[:GQ$D^'WB'QI/K^K^']&L=0U;44M/#[6L,S?8;
M=(O+,VK,P5[:.;*F+RRSC<ZGS_2/^"PW[)_CO]KG]GS_ (**?'3PWXDM_C-X
M$9[+XAR:+963:=X@M8+6:VM;VWW7<!2\ :-98S$D10X5@(T5OA[XA_M\_![Q
M;_P3;\>?L=Z;INLIXF\4?&FY^(UI<R0P"P32IK(6RQ2.)S(+D.,E%B:/;_RT
MSQ6DH8^M*//>/P\UM%I*5TO*UM=VM^R2=-+3^M$?5_[6O_!)CQ_\1_V_?B9\
M/O!^E^!O@KX*^&GA[0]7\3:FFIWDOAK1X;VTB\H_:+B 7+SW3[BD0AY<,,G!
M<_+9_P""*W[5&O\ [37PZ_9W^$VJ^'?&NG?%;3Y]7\->,-)NW?0+C3K+/VN9
MYFB62,VI&V:,Q;PQ55#%ES^K5K_P<&? 5/VU_C;X_LM+\9Z+\-/C1H7ARP.H
MZ9'81>)]&U#P]:^3'<00RRSV<B,S2!D>3E=I[%3X=H__  7%\%_#G]NGP!\6
M1K?C_P"+7PP\.:#JN@:M;^,8],L]49-=PM[+81V 2*)<16Q$<DI+^4073?E8
MHULVC%14-H*U^_)^?-IJ]OO&XT;[]?Z_ Y#XM_\ !,KX$?LY_P#!)GXO?&;_
M (2KP5\6/%6C>--%T[2/%G@_4Y+V*TMY2J7-JZ?(JN3\WS(P9&5D8CI_.-7[
MU_'#]M;_ ()E^"O^"=WQ)_83_8CT?XC&3QGXHTOQ#%J?C :<R;;,C=$1:2 Q
MA$4!/DD,A)+%!@5^"E>QE/MN2HZ]]9:75M+1Z=/0PJ\MUR]@KZ'_ &1/^3L/
MAA_V-NB?^ED5?/%?0_[(G_)V'PP_[&W1/_2R*N^O_"EZ/\B([H_VB:***_G4
M^B"O//AA_P BN?\ KYN?_1C5Z'7GGPP_Y%<_]?-S_P"C&H ]#HHHH ^8_P!J
M7]E'X=_M<>%_#OA+XD7FHV5MX9U^S\1VK:;)%&[W5DDB(DGFQ2@Q$2G<%"MP
M,,*=#^RG\/(?VM)?VR5O-1_X2>7P]_PC9M?,B^P?9!*)MP3RO,\S<,9\W;C^
M&OIJBO4I9WCJ=!8:%5JFE*-NG+.W,OG97]">2.]C\V?%W_!,;X4^(/B?XW^(
MGAGQEXO\)VOQ'5O^$DT?0]0CMK&_E=61I&#0O(I;>Q;:X!)(^Z2ISO&__!*C
M]G_QG^S7X$_9J76O$.G6WPVNWOM!UNUN88]6@EDD>1LRK $^\P/RQJ040@Y'
M/Z;T5ZD>-,[C[+EQ4OW;BX[:.,7"/36T&XZW]W38GV4.Q^=GP+_X)E_ CX%_
M%C6_C+!K/B7Q9K/B;P]+X;U@^);]=26^MIWB:228M$)&D81*A^<1[. @KYON
M_P#@AG^R]>>$M4^&[>,O'D7A2]G^TV>AIK*_8-.F\P.7@A>!D9\ Q[I5D.QC
M_'AQ^PWBCQ+HG@SPSJ/C#Q-.+73=)M9;RZF*EA'! A=VPH+':H)P 3Z"OSOT
MG_@L+_P3<UK48=*L_BA9I).P13/97UO&"?[TDMNB*/=B *]O*<^XSQ<JF*RV
M=>HUR*3A%R2Y/@ORQ:5E>VVEUL1*%):2L??5QX!\,ZA\/7^%VLP_;M&GTXZ5
M/#,?]=;-%Y+*Q7;]Y.#C'MBORX?_ ((V_!2\^&=I\%=7^(?CZZ\(:3J":CI6
MCOJ=O]EL71V?:B&U(89=OO[L _+@DD_H'XC_ &F?@=X4^)O@WX/ZSK\2Z_X_
MAFN- @B1YH[R*W3S&998U:)5V<J68!OX<U[O7@8+.LZRB*="I.DJEIK2R?*Y
M14XW71\T;Q\X]T6X0D?,GA+]E+X>>#?VI/%7[6^F7FHOXD\7Z9;:5>6TLD1L
M4AM!&$,2"(2!CY2Y+2,.N .WS_;?\$N?V93^SQXQ_9GUMM5U70/&?B&X\43S
M74\7VRSU&X6-=]K)'#&J!!&-H9'X+!MRG%?77@KX^_"/XB_$SQ5\'?!FL+>^
M)/!)MEUJS$,J&U-VI:++NBQON4$_(S8[XJI\0OVB?@]\*_B3X/\ A%X[U@6/
MB#QY+/!H=KY,K_:7M55I!O1"D>-R@;RN2<"MJ.9\04Z\:5*515%&G)))J2A2
MAS4Y)6ORPA[R>W+KL'+"Q\/?"W_@DS\%?AK\4O!7QIO_ !KXV\4>(_ LDK6$
M^N:JEXC0NGEI R-!\D,0R46(QG+'<6&T+I_\%?\ X2?$KXW_ +"OB/X=_"71
MKG7];NKW37ALK1=TKK%<QLY X^ZHR?:OH#QY^WA^R9\,_B_/\!/&7C&"V\6V
MME-J%QI\=O<7#06]O UU(9'AB>.,K ADVLP;;R!R*]M^#?QA^'GQ^^&>D_%_
MX47_ /:?A_6XFEL[GRWAWJCF-LI(JNI5U*D%1TKTIYUQ%A\;@L_S&G.7LG"5
M-U(M0:YG.*3LERR:DU;HG;8GDA9PB? 7P@_X)2_ ?P!\8?#OQXU_7?%7BB^\
M+QJV@Z5X@U,WUAH[8&!;HZ>8!$?]4K2,%P#RP!&?\8?^"0/[.?Q7^(OB#Q_I
M/B+Q9X,A\8R>;XBTCP[J2VFG:HY.YFFA:)\[V.6 .WJ0H)S7ZM5X[\<?C]\(
MOV;?!2_$3XUZPNAZ,]U%9+<-#+,//GSL7;"CMS@\XP*YL+QCQ)7QL)X;$U)5
MFE"*CJVKW45%+7WM5I?FUW&Z5-+5:'A.H?L"? *7Q-\(?$'AV.]T*#X)_:QX
M>T^PDC6U87BQK)]I\R.220_NPVX2(Q8L6+$US=I_P3:_9M/@OXI?#[Q+'J&N
MZ5\6]>G\1ZO%?31YM[V>0R@VC0Q1-$(W.4W%VXP21D'[\HKRX\4YO%**Q4]+
M6UUTFZJUWO[1N=^[*]G'M_6Q^;_P'_8-\&_L:7FI?%WP[XL\>>/[_1]&N;33
MM,UC5C>1QVJ@2BVMX(TB0LQ0! 05!QA0>:^3/^";7[(_B_\ X:V^*?[>?Q2\
M!3_#P^*YWC\/Z'?NLEU"MV1)>7#J /+:5U&T8!&^1?NX)_=.BO37'&9/#XRG
M5ES5,1&,)3=[JFGS<JBK1U:U?+>UTK79/L8Z6Z'C?[0/P(^'O[3/P=USX&_%
M."2?0]?A6*<0OY<J&-UDC>-L'#QR(K+D$9'((XKXQ\(_\$P/AUH?CCX>?$3Q
M;\0O&_BO4OAC.\NB#5]0@FMXXV5$$31BV4; (UY4K(W\3$!0OZ945Y&7\1YE
M@L/+"X6NXTW?16^U'DE;33FC[KM:ZM?9%.G%N[1^/7B7_@BU^SWKA\3C2?'/
MCS18_&FJW6J:Y!I^K1PV]Z+IMYMY(!;^4T2'=Y>Y&<;CN9A@#WCXU?\ !,W]
MG3XP? SP1\!].?4_"-A\.ITN?#][H=PL-[:2*/F(ED23)=L2.V QD ;(-?H;
M17H5..<_G.E.6,G>F[Q\GR\M]M?=]W6_NZ;:"]C#L?FQ\)O^"6_P'^$WQ \2
M_$Z'Q'XNU_6?&'AJ?POJ]SK&K&XGN;>Y:-I)C.L:3K<8B50R2!%4?*@JK\.?
M^"7OPP\&?$OPO\1O&7CSQOX\3P/,;GP]IGB755O+/3YL *Z*L4;$I@;,M@8'
M!P*_3&BLY\:9W/G<L5+WH\KVVMRV6FGNOETMIIL'LH=C\M-:_P""3OP:_P"$
MTUSQ#\,O''CGX?Z/XHNGO-7\/^&=8^PZ7<S28WGRO+9D#]&"L %^5=J@"OU
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MI29).O2I%J->E2+4]"2:I4Z5%4J=*9#)!4PZ5"*F'2I()4KW/X-==1_[8_\
MLU>&)7N?P:ZZC_VQ_P#9JVP_QH\_-/\ =9_+\T>XT445Z1\>%?A9_P ')_\
MRAF^+?\ UU\/?^GFQK]TZ_"S_@Y/_P"4,WQ;_P"NOA[_ -/-C7I9+_R,,/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MXH_\'+?_ !NOZ/:*/[?S'_H(E]X>PI_RH_G"_P"(5W_@D_\ ] WQ1_X.6_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
%HHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>rskd-20231231_g3.jpg
<TEXT>
begin 644 rskd-20231231_g3.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0#*17AI9@  34T *@    @ !@$2  ,
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M;YBJ-(54GD@<U]'T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!_]#^_BBBB@ KG_"?A/PKX"\*Z9X%\"Z9::+H
MFBVD-AI^GV$*6UK:6ML@CBAABC"I'%&BA$1 %50   *Z"B@ HHHH **** /@
M#_@D[_RBR_9I_P"R5>#?_31:U]_U\ ?\$G?^467[-/\ V2KP;_Z:+6OO^@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /_1_OXHHHH **** "BBB@ HHHH ^ /^"3O_ "BR_9I_[)5X-_\ 31:U
M]_U\ ?\ !)W_ )19?LT_]DJ\&_\ IHM:^_Z "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]+^_BBBB@ HHHH
M**** "BBB@#X _X)._\ *++]FG_LE7@W_P!-%K7W_7P!_P $G?\ E%E^S3_V
M2KP;_P"FBUK[_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#__T_[^**** "BBB@ HHHH **** /@#_@D[_P H
MLOV:?^R5>#?_ $T6M??]? '_  2=_P"467[-/_9*O!O_ *:+6OO^@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH Y?Q?XT\,> ]'.O>+;M;.T#B/>RLQ+-T 506)X)X'05Y3_
M ,-1? O_ *#G_DK<?_&JX;]LR+SOA?8+G'_$TB/_ )"FK\SOL/\ M_I7H8?
M3JPYTOR/F,UXLR[+Z[P^)J\LK)VY9/?T31^M7_#47P+_ .@Y_P"2MQ_\:H_X
M:B^!?_0<_P#)6X_^-5^2OV'_ &_TH^P_[?Z5O_953M^*/._XB#DW_/\ _P#)
M)_\ R)^M7_#47P+_ .@Y_P"2MQ_\:KT;P1\2/!7Q&MI[OP9?+>I;,%EPCQLI
M;IE753@X.#C!Q7XG_8?]O]*^]/V(H/(_X2?G.?L7_M:L:^7SIP<VMO-'=EO&
M&68[$QPN'K<TY7LN62V3;U:2V1]Z4445YQ]4?A/1117WA_'84444 =W\+?\
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MX7$)_P R_(****\$_4@HHHH _]+^_BBBB@ HHHH **** "BBB@#X _X)._\
M*++]FG_LE7@W_P!-%K7W_7P!_P $G?\ E%E^S3_V2KP;_P"FBUK[_H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ***\G^./B;6_!_P +=4\1^')_L][;
M>1Y<FU7QOF13PP(.02.15TX.<E!;MV.;&XJ&&P]3$U$W&$7)VWLE=VVUT/6*
M*_)W_AI?XV_]!K_R6@_^-T?\-+_&W_H-?^2T'_QNO4_L:OW7X_Y'Y_\ \12R
MK_GU4^Z/_P F?K%17Y._\-+_ !M_Z#7_ )+0?_&Z/^&E_C;_ -!K_P EH/\
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M_P!3C_Y3O_NBC_AW)_U./_E._P#NBOTXHH_U>R__ )]?C+_,/^(></?] O\
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M[OF:>VFED@HHHKX ],**** /_]/^_BBBB@ HHHH **** "BBB@#X _X)._\
M*++]FG_LE7@W_P!-%K7W_7P!_P $G?\ E%E^S3_V2KP;_P"FBUK[_H ****
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M23_Y4O\ [FH_U"S[_H&_\GA_\D']KX3^?\'_ )']R7P-_P"2*>#_ /L":?\
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MPK_P67_9STK_ ()N:)_P4A_:9TC6?A7HVK:=:7":+JMNTEY>7EW8+J,4&EN
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M"B?W5?L+_P#)DOP=_P"Q'\/?^D$%?4]?.O['\,5O^R7\+H(%"1IX1T1551@
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M4_\ B:Z&BOU?^VLQ_P"@F?\ X'+_ #/\N_[;S'_H)J?^!R_S.>_X1+PI_P!
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M>_[&VT_]([VOY8:_J>_X+@_\FH>'O^QMM/\ TCO:_EAKZO)O]V7JS^*/'_\
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M!_X1G_@G3\.]#\WS_(_M?Y]NW.[4[MNF3ZXZU_'Y7]DG_!*?_DP?P'_W%/\
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M(_SSZ***_1#_ "G"BBB@#Z&_9%_Y.O\ AA_V-NB_^ED5?W55_"K^R+_R=?\
M##_L;=%_]+(J_NJKYG/OXD/0_L+Z-/\ R+,?_P!?(_\ I(4445X)_2P4444
M?__2_OXHHHH **** "BOY[_^#@7]I[]I3]E[X9?##Q7\,O$7B+P#\/+GQ7I0
M\9^,_#.GQZC<:,L6LZ28/M<;+(PL9;8W_F(D;_:;A+>TD#0W$D<GYT_M??\
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M /D*C_A2W[1/_1)_B)_X1FM__(5?K'_$5^(?^AI+_P "B?R3_:/B=_S[Q?\
MX)G_ /('RY_PI'PI_P _%W_WVG_QNC_A2/A3_GXN_P#OM/\ XW7U'_PI;]HG
M_HD_Q$_\(S6__D*C_A2W[1/_ $2?XB?^$9K?_P A4?\ $5^(?^AI+_P*(?VC
MXG?\^\7_ ."9_P#R!_1S_P $%?"VG^$?V0/$FFZ:\CQOXQO)292"<FRL1V X
MX]*_;>OP&_X)7?&_3?V;_P!GS6/ _P 9_!GQ$T;5+OQ#<7T4'_" >)KC=;O;
M6L:MN@TR11EHW&"<\=,$9_2W_AO#X(_] /XB?^&X\6?_ "HK\@SW,*V.Q];%
MXBISSF[N7=]S^Q> YX^?#^"EF:DL0X+GYTU*]WNFDT_D?9E?YY]?VR?\-X?!
M'_H!_$3_ ,-QXL_^5%?QM_\ "EOVB?\ HD_Q$_\ ",UO_P"0JZ,DK4X>TYY)
M;;NW<_%_I$9#F>9?V9_9V%J5N7VW-[.$IVO[*U^5.U[.U][/L>?T5Z!_PI;]
MHG_HD_Q$_P#",UO_ .0J/^%+?M$_]$G^(G_A&:W_ /(5>]]<H?\ /R/WK_,_
MFC_43B7_ *%>(_\ !-3_ .1//Z^AOV1?^3K_ (8?]C;HO_I9%7G/_"EOVB?^
MB3_$3_PC-;_^0J]E_9T\!?&KP'^T'X$\<>*_A=\1+72]&\0Z7?7D_P#PA6NO
MY=O;W,<DC;4L69MJJ3A02>P)K.KBZ#A)*HMGU7^9Z>2\#\1PS##3GEE=14X-
MMT:B22DKM^Z?W%T5\9_\-X?!'_H!_$3_ ,-QXL_^5%'_  WA\$?^@'\1/_#<
M>+/_ )45\.?Z-'X6_P#!<'_DZ_P]_P!BE:?^EE[7XVU^MW_!5'6?%G[2'[0>
MC^./@Q\/?B)K.EVGAZWL99_^$%\16^VX2YNI&7;/IT;'"R(<@8YZY!Q^:/\
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M-XATN^O)_P#A"M=?R[>WN8Y)&VI8LS;54G"@D]@37]7_ /PWA\$?^@'\1/\
MPW'BS_Y45\[G56$YP<))Z=&?U3]'S)<PR[+\;#,,-.C*4XM*<)0;7+NN9*Y]
MF45\9_\ #>'P1_Z ?Q$_\-QXL_\ E17N?PF^-/@_XTZ==ZIX/L]>LXK*18I%
MU[0-3T"1F89!CCU.UM7D7'5HU90>"<\5XI_0AZS1110!_]/^_BBBB@ HHHH
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MDUYOJ_[7'[*7A_X36/Q[U[XG>$[+P+JD@BL_$=QK5G'I-P[$@+%>-*('8E6
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MFERR6MW:VMU;Z:@DO ES<01P>;:QD/<0&030I\SHHYH _0*BOS;E_P""N_\
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MC3]1MMPCF169&X<*ZLKJR.C*&5E*L 016%^S9^TG\%?VO/@KHO[1'[.^M?\
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MSLP^5KJ;S./ZCZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** /_7_OXHHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>rskd-20231231_g4.jpg
<TEXT>
begin 644 rskd-20231231_g4.jpg
M_]C_X  02D9)1@ ! @$ 2 !(  #_X0#*17AI9@  34T *@    @ !@$2  ,
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M\O/T]?;W^/GZ_\0 'P$  P$! 0$! 0$! 0        $" P0%!@<("0H+_\0
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M;YBJ-(54GD@<U]'T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!_]#^_BBBB@ KG_"?A/PKX"\*Z9X%\"Z9::+H
MFBVD-AI^GV$*6UK:6ML@CBAABC"I'%&BA$1 %50   *Z"B@ HHHH **** /@
M#_@D[_RBR_9I_P"R5>#?_31:U]_U\ ?\$G?^467[-/\ V2KP;_Z:+6OO^@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /_1_OXHHHH **** "BBB@ HHHH ^ /^"3O_ "BR_9I_[)5X-_\ 31:U
M]_U\ ?\ !)W_ )19?LT_]DJ\&_\ IHM:^_Z "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]+^_BBBB@ HHHH
M**** "BBB@#X _X)._\ *++]FG_LE7@W_P!-%K7W_7P!_P $G?\ E%E^S3_V
M2KP;_P"FBUK[_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#__T_[^**** "BBB@ HHHH **** /@#_@D[_P H
MLOV:?^R5>#?_ $T6M??]? '_  2=_P"467[-/_9*O!O_ *:+6OO^@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH_X>(?MB?]#A_P"4^Q_^1Z]W_4;'_P \/OE_\B?GG_$P7#O_ #XK_P#@-/\
M^6G]/E%?S!_\/$/VQ/\ H</_ "GV/_R/1_P\0_;$_P"AP_\ *?8__(]'^HV/
M_GA]\O\ Y$/^)@N'?^?%?_P&G_\ +3^GRBOS-_X)Q_M(_%KX_6'BVT^*VH)J
M<NC/8M;SB".!]MT)MRD1*BD#R@1\N>3D]*_3*OF,PP-3!XB6&JM<T;;;:I/R
M[GZSPWQ!AL[RVEFF$4E3J7LI)*7NR<7=)M;I[-A1117&>X%%%% '_]7^_BBB
MB@ HHHH **** "BBB@#X _X)._\ *++]FG_LE7@W_P!-%K7W_7P!_P $G?\
ME%E^S3_V2KP;_P"FBUK[_H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/_9*O!O_ *:+6OO^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:OPO_P"ADTO_ ,#(?_BJ/^%J_"__ *&32_\ P,A_^*H_XAC'_GW6^[_[0/\
MB-7&/_0OI_\ @JM_\L/[9/!7C7PM\1?"UEXU\%7J:AI>H)YEO<1@A74$J>&
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M;OVZ/^3VOC%_V/'B'_TOGK_21K_-N_;H_P"3VOC%_P!CQXA_]+YZ_=OHM_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /Q^_P""U_Q/T/X4?LK:#X@\
M017$L%QXJM+8+;*K-N:TO'&0S*,?(>_7%?R\_P##9GPO_P"?#5/^_4/_ ,>K
M^A+_ (.+_P#DR7PM_P!CQ8_^D&H5_%Y7]G^"' 64YMPO#&8R,G-SFM)65DU8
M_*^+?#G)LYS!XW'1DZC26DFE9;:'Z8_\-F?"_P#Y\-4_[]0__'J/^&S/A?\
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M?U.5_G+X\?\ )=9C_P!PO_3%,]O!_P &/]=0HHHK\A.D**** /_1_OXHHHH
M^#_^"F?PZU?XL_L2>-/A[H'BG0?"%_J3:8MM>^*9F@T2XF34+9TT^_='1_LN
MI,HL)E0[W2X*J&8A3_*]^R7XX_9 U3_@BW\)_#_Q"_9ZNO&OQ.TC4;;P_P""
M?AN-7NM5T[Q1XGU'P[IUVNJFT6?[$EI)8W,5]>">+R]/G:X8;;EF=_[;?&'@
MWPA\0_"U_P"!O'^E6>N:)JL+VU[I^H0)<VMS#(,-'+%(&1T8<%6!!KY&M?\
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M4F1VB52SDL<DYKN_%_[.'[//Q"^(&B_%CQ]X#\.ZYXJ\-A5TG6=0TNVN=0L
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M++]FG_LE7@W_ --%K7W_ $ %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 ?@5_P<7_\F2^%O^QXL?\ T@U"OXO*_M#_ .#B_P#Y,E\+
M?]CQ8_\ I!J%?Q>5_H']'3_DCJ?_ %\J?FCQ\;_%"BBBOW4XPHHHH _U.***
M*_R'/I#Y8_;H_P"3)?C%_P!B/XA_]()Z_P VZO\ 21_;H_Y,E^,7_8C^(?\
MT@GK_-NK^U/HM_\ (KS'_KY'_P!)/+S#XHA1117]2'GA1110!_?5_P $4_\
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M&_\ IHM:^_Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M^>TYN_/;=]N5_F']D_6/WG/;Y7_4_E7HK^JBBOU?_B*__4'_ .5/_M _U?\
M^GGX?\$_E7HK^JBBC_B*_P#U!_\ E3_[0/\ 5_\ Z>?A_P $_J0HHHK_ #G
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M7PM:K*A*S:71/KYIGQ'&V?8[*Z%*I@:G(Y-IZ1>EO[R9],?\/&_^I._\J/\
M]ST?\/&_^I._\J/_ -SU^8]%?>?ZPYA_S]_"/^1^=?\ $0^(?^@K_P DI_\
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M^,T?\-D?M(?]#'_Y)VO_ ,9KYCHKW?[2Q?\ S^E_X$_\SY'_ %ES?_H,J_\
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M*** "BBB@ HHHH **** "BBB@ HHHH **_A3/_!=W_@HF22/$&E#V_LJW_\
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M4G[<'C;X??\ "-?VA_9_]F_Z1]L\K?YMA;2?<\E\8WX^\<XS[5\&_P##QO\
MZD[_ ,J/_P!SU_7_  SXMXC!Y/@L)&M%*G2IQ^!OX8);V\CYROQ)PU2J2IU\
M0U.+:DN6>C6ZTC;?L>'?\.X_C?\ ]!30_P#O_<?_ "/1_P .X_C?_P!!30_^
M_P#<?_(]>X_\/&_^I._\J/\ ]ST?\/&_^I._\J/_ -SU[?\ Q&C$_P#/^/\
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MPK_P67_9STK_ ()N:)_P4A_:9TC6?A7HVK:=:7":+JMNTEY>7EW8+J,4&EN
MB:C'- 2\$\81&1',P@:*9(@#]>Z*_'#XH?\ !;W]E/X8^ ? OCO_ (1SQ?K[
M>-OAK%\79-.TFQM9;S1?![QQ2/?ZB)+N.)5B\T(Z6\D\A96V*P )/BI_P7-_
M8D^%GBZ;1WC\0Z]X?TG3_"^J>(/%.E6,<FC:#:>,RO\ 8\E\\L\5QBZ5T<>1
M!,45@7VT ?L?17X>:+_P7^_8FUC5?VEM$DTCQ99W7[+<U[!XDCN+.T!U22QO
M);"0:5MO6\XFXC1%$_V<_OHLXW';^@G[!7[:OPL_X*)?LG>%/VQ?@II^JZ7X
M9\8?;OL=KK<4,%_'_9]Y/8R>:D$UQ$,RV[E=LK90@G!RH //_P#@D[_RBR_9
MI_[)5X-_]-%K7W_7P!_P2=_Y19?LT_\ 9*O!O_IHM:^_Z "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_+'H
MHHK_ %X/FPHHHH *_M#_ .#=#_DR7Q3_ -CQ??\ I!I]?Q>5_:'_ ,&Z'_)D
MOBG_ +'B^_\ 2#3Z_"OI%_\ )'5/^OE/\V=F"_BG[ZT445_GX>P?P?\ _!9K
M_E)1\2/^X/\ ^FNSK\OZ_4#_ (+-?\I*/B1_W!__ $UV=?E_7Z-@?]VI?X5^
M1_,N??\ (SQ7_7R?_I3"BBBNH\D*_>#_ (-Y_P#D]'Q/_P!B5>_^EUA7X/U^
M\'_!O/\ \GH^)_\ L2KW_P!+K"N#-/\ =*GH?0\*?\C?#?XC^R"BBBOSX_H\
M_!__ (.&/^3+O#'_ &.ME_Z0W]?QOU_9!_P<,?\ )EWAC_L=;+_TAOZ_C?K[
M?(?]T7JS\&\0?^1O+_#$****]D^("BBB@#_4 HHHK\O/ZP/E_P#;>_Y,N^+W
M_8E:_P#^D,U?YS]?Z,'[;W_)EWQ>_P"Q*U__ -(9J_SGZ^MX<_AU/4_'/$W_
M 'K#_P"%_F%%%%?1GYD%%%% ']X'_!&7_E&O\-_^XQ_Z=+ROU K\O_\ @C+_
M ,HU_AO_ -QC_P!.EY7Z@5^<X[_>:O\ B?YG]-9#_P BS"_]>X?^DH*_SG_V
MWO\ D]'XO?\ 8ZZ__P"ETU?Z,%?YS_[;W_)Z/Q>_['77_P#TNFKV>'/XE3T/
MB/$W_=</_B?Y'R_1117UI^.!1110!_4!_P &W?\ S6;_ +EW_P!R%?U 5_+_
M /\ !MW_ ,UF_P"Y=_\ <A7]0%?!YU_OE3Y?DC^A.!_^1)A_^WO_ $N04445
MY9]8%%%% '__UO[^**** /E?]MOX7Z9\:?V5_&7PLUSX>0?%>QUJTCM[GPI<
M:@NE_P!I0>=&TBQ7;86&XC4&6W8O$/.1 98<^:GX1_L._L*?M8O_ ,&]GC/]
MF7XP:)JVJ^.->\ ZO%X"\/\ BZ:W?5]&FU7PLE@EEYDQ1+(&^EO5MHI71[2S
MN$@F,961%_J$HH _CT^*G_!+[]OSPS\.O 6O_#GX?IXHUOQ!^QRG[.>OZ4FK
M:?;2:!K<D4+&[FDGN$AGMHW:5':UDF<E,HK*0:\E^,O_  0__;JT7X;_ !<_
M9 ^'&@6GB?0/CWX/^"GAVY\6QZG:V]KX?F^&D-M:7SW,$\D=W*LZ6WF0?9H9
M22V&VG-?VRT4 ?P_P?\ !$;]O+6OVN]:^(MUX632_"7Q _:1\8ZSXSW:C82?
MVA\.+S5="US3I]B7#./,NM)D3R=IN$\SYXE4DU_0%_P05_9<^.W[%W_!)[X4
M_LT?M+Z%_P (UXV\-?V[_:6F_:K>\\G[9K%]=0_OK66:%MT,T;_)(V-V#A@0
M/U^HH ^ /^"3O_*++]FG_LE7@W_TT6M??]? '_!)W_E%E^S3_P!DJ\&_^FBU
MK[_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** /\L>BOO_\ X=Q_&_\ Z"FA_P#?^X_^1Z/^'<?QO_Z"FA_]
M_P"X_P#D>O\ 53_6_)O^@J/XGD_V;B?^?;/@"BOO_P#X=Q_&_P#Z"FA_]_[C
M_P"1Z/\ AW'\;_\ H*:'_P!_[C_Y'H_UOR;_ *"H_B']FXG_ )]L^ *_M#_X
M-T/^3)?%/_8\7W_I!I]?S=_\.X_C?_T%-#_[_P!Q_P#(]?U2?\$.O@IXJ^!'
M[)_B'PCXNN+2YN;GQ;=WBM9N[H$>SLD )=$.[*'MC&.:_%?'[B#+L9PE4HX:
MNI2]I3=EZLWPV#K4Y\U2#2/V5HHHK^%3O/X/_P#@LU_RDH^)'_<'_P#379U^
M7]?J!_P6:_Y24?$C_N#_ /IKLZ_+^OT; _[M2_PK\C^9<^_Y&>*_Z^3_ /2F
M%%%%=1Y(5^\'_!O/_P GH^)_^Q*O?_2ZPK\'Z_>#_@WG_P"3T?$__8E7O_I=
M85P9I_NE3T/H>%/^1OAO\1_9!1117Y\?T>?@_P#\'#'_ "9=X8_['6R_](;^
MOXWZ_L@_X.&/^3+O#'_8ZV7_ *0W]?QOU]OD/^Z+U9^#>(/_ "-Y?X8A1117
MLGQ 4444 ?Z@%%%%?EY_6!\O_MO?\F7?%[_L2M?_ /2&:O\ .?K_ $8/VWO^
M3+OB]_V)6O\ _I#-7^<_7UO#G\.IZGXYXF_[UA_\+_,****^C/S(**** /[P
M/^",O_*-?X;_ /<8_P#3I>5^H%?E_P#\$9?^4:_PW_[C'_ITO*_4"OSG'?[S
M5_Q/\S^FLA_Y%F%_Z]P_])05_G/_ +;W_)Z/Q>_['77_ /TNFK_1@K_.?_;>
M_P"3T?B]_P!CKK__ *735[/#G\2IZ'Q'B;_NN'_Q/\CY?HHHKZT_' HHHH _
MJ _X-N_^:S?]R[_[D*_J K^7_P#X-N_^:S?]R[_[D*_J KX/.O\ ?*GR_)']
M"<#_ /(DP_\ V]_Z7(****\L^L"BBB@#_]?^_BBBB@ HHHH **** "BBB@#X
M _X)._\ *++]FG_LE7@W_P!-%K7W_7P!_P $G?\ E%E^S3_V2KP;_P"FBUK[
M_H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K\8?\ @N?\<_B_
M^S_^R5X>\8_!7Q#>^&M4NO%UI92W5A)Y4CV[V=[(T9(_A+QH2/517[/5^!7_
M  <7_P#)DOA;_L>+'_T@U"OO_"S"T<3Q9EM#$04X2J).,DFFK/1IZ,YL93C.
MA.$U=-;/5'\T'_#S#]OO_HK7B/\ \#&_PH_X>8?M]_\ 16O$?_@8W^%?#=%?
MZ)_ZD\/?]"VA_P"":?\ \B?*_P!E8+_GQ#_P&/\ D?<G_#S#]OO_ **UXC_\
M#&_PH_X>8?M]_P#16O$?_@8W^%?#=%'^I/#W_0MH?^":?_R(?V5@O^?$/_ 8
M_P"1]RC_ (*8_M^*0P^+7B/C_I[8_P!*_P!%.O\ +'K_ %.*_E;Z3.29=E_]
ME?4,-3I<WM[\D(PO;V-K\J5[7=K[79[6486C1Y_8P4;VO9)=^P4445_*Q[)_
MG-_\-D?M(?\ 0Q_^2=K_ /&:/^&R/VD/^AC_ /).U_\ C-?,=%?KO]I8O_G]
M+_P)_P"9_-7^LN;_ /095_\ !D_\SZ<_X;(_:0_Z&/\ \D[7_P",T?\ #9'[
M2'_0Q_\ DG:__&:^8Z*/[2Q?_/Z7_@3_ ,P_UES?_H,J_P#@R?\ F?3G_#9'
M[2'_ $,?_DG:_P#QFOZO_P#@A1\2_&WQ4_9'\1>(?'E[]OO(?%]W;I)Y<<6(
MULK)@,1JHZLQSC/-?Q25_9!_P;S_ /)EWB?_ +'6]_\ 2&PKPN(L9B*F#<:E
M235UHVV?7<$9SF&)S2-+$8F<X\LM)3DU]S=C]X****_/S]G/X/\ _@LU_P I
M*/B1_P!P?_TUV=?E_7Z@?\%FO^4E'Q(_[@__ *:[.OR_K]&P/^[4O\*_(_F7
M/O\ D9XK_KY/_P!*84445U'DA7[P?\&\_P#R>CXG_P"Q*O?_ $NL*_!^OW@_
MX-Y_^3T?$_\ V)5[_P"EUA7!FG^Z5/0^AX4_Y&^&_P 1_9!1117Y\?T>?@__
M ,'#'_)EWAC_ +'6R_\ 2&_K^-^O[(/^#AC_ ),N\,?]CK9?^D-_7\;]?;Y#
M_NB]6?@WB#_R-Y?X8A1117LGQ 4444 ?Z@%%%%?EY_6!\O\ [;W_ "9=\7O^
MQ*U__P!(9J_SGZ_T8/VWO^3+OB]_V)6O_P#I#-7^<_7UO#G\.IZGXYXF_P"]
M8?\ PO\ ,****^C/S(**** /[P/^",O_ "C7^&__ '&/_3I>5^H%?E__ ,$9
M?^4:_P -_P#N,?\ ITO*_4"OSG'?[S5_Q/\ ,_IK(?\ D687_KW#_P!)05_G
M/_MO?\GH_%[_ +'77_\ TNFK_1@K_.?_ &WO^3T?B]_V.NO_ /I=-7L\.?Q*
MGH?$>)O^ZX?_ !/\CY?HHHKZT_' HHHH _J _P"#;O\ YK-_W+O_ +D*_J K
M^7__ (-N_P#FLW_<N_\ N0K^H"O@\Z_WRI\OR1_0G __ "),/_V]_P"ER"BB
MBO+/K HHHH __]#^_BBBB@ HHHH **** "BBB@#X _X)._\ *++]FG_LE7@W
M_P!-%K7W_7P!_P $G?\ E%E^S3_V2KP;_P"FBUK[_H **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ K\=/\ @MSX^\*_#K]E/P_K?B[PU:>*K:7Q
M9:0+:7FS8CM9WC"0;XY1N 4K]T'#'GL?V+K\'_\ @X8_Y,N\,?\ 8ZV7_I#?
MUZV18FKA\?1KT)<LXNZ:Z'CY_C*N%RZOB*#M.*NG9/\ !IK[T?SA?\-2_!#_
M *(WH?\ Y+__ "'1_P -2_!#_HC>A_\ DO\ _(=?#E%?L'^N6=_]!4OP_P C
M\8_U^SW_ )_K_P  I_\ R!]Q_P##4OP0_P"B-Z'_ .2__P AT?\ #4OP0_Z(
MWH?_ )+_ /R'7PY11_KEG?\ T%2_#_(/]?L]_P"?Z_\  *?_ ,@?<?\ PU+\
M$/\ HC>A_P#DO_\ (=?Z#M?Y?]?Z@%?"<:YSC<?[#ZY5<^7FM?I?EO\ ?9'W
M_ N?X[,_K'UVIS<O+;W8QM?FO\*5]EN%%%%?"'Z ?Y?]%%%?J!_)X4444 %?
MV0?\&\__ "9=XG_['6]_](;"OXWZ_L@_X-Y_^3+O$_\ V.M[_P"D-A7C9]_N
MC]4?;^'W_(WC_AD?O!1117Q!^\G\'_\ P6:_Y24?$C_N#_\ IKLZ_+^OU _X
M+-?\I*/B1_W!_P#TUV=?E_7Z-@?]VI?X5^1_,N??\C/%?]?)_P#I3"BBBNH\
MD*_>#_@WG_Y/1\3_ /8E7O\ Z76%?@_7[P?\&\__ ">CXG_[$J]_]+K"N#-/
M]TJ>A]#PI_R-\-_B/[(****_/C^CS\'_ /@X8_Y,N\,?]CK9?^D-_7\;]?V0
M?\'#'_)EWAC_ +'6R_\ 2&_K^-^OM\A_W1>K/P;Q!_Y&\O\ #$****]D^("B
MBB@#_4 HHHK\O/ZP/E_]M[_DR[XO?]B5K_\ Z0S5_G/U_HP?MO?\F7?%[_L2
MM?\ _2&:O\Y^OK>'/X=3U/QSQ-_WK#_X7^84445]&?F04444 ?W@?\$9?^4:
M_P -_P#N,?\ ITO*_4"OR_\ ^",O_*-?X;_]QC_TZ7E?J!7YSCO]YJ_XG^9_
M360_\BS"_P#7N'_I*"O\Y_\ ;>_Y/1^+W_8ZZ_\ ^ETU?Z,%?YS_ .V]_P G
MH_%[_L==?_\ 2Z:O9X<_B5/0^(\3?]UP_P#B?Y'R_1117UI^.!1110!_4!_P
M;=_\UF_[EW_W(5_4!7\O_P#P;=_\UF_[EW_W(5_4!7P>=?[Y4^7Y(_H3@?\
MY$F'_P"WO_2Y!1117EGU@4444 ?_T?[^**** "BBB@ HHHH **** /@#_@D[
M_P HLOV:?^R5>#?_ $T6M??]? '_  2=_P"467[-/_9*O!O_ *:+6OO^@ HH
MHH **** "BBB@ HHHH ***_F#_X+5_ /X\?%3]J70-?^&'B2+1]/@\*VMN\#
MWEQ;DS+=WC,^V%&4Y5E&2<\8Z 5]7P9PU3SW,EE]3$QH)Q;YY)M:=+)K<PQ#
MQ"A_LT%.79OE_%*7Y']/E%?P!_\ #&_[7_\ T/-O_P"#.]_^,T?\,;_M?_\
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M^H%?E_\ \$9?^4:_PW_[C'_ITO*_4"OSG'?[S5_Q/\S^FLA_Y%F%_P"O</\
MTE!7^<_^V]_R>C\7O^QUU_\ ]+IJ_P!&"O\ .?\ VWO^3T?B]_V.NO\ _I=-
M7L\.?Q*GH?$>)O\ NN'_ ,3_ "/E^BBBOK3\<"BBB@#^H#_@V[_YK-_W+O\
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M-_$3_P )#6/_ )$K^EC_ ((V_%8_LI_LQ:[\//CYX(^(F@ZQ>>*+K48;?_A
M?$MUNMI+2TB5]]OIDJ#+Q.,%@W&<8()\G.L31GAG&$TW=;-,^PX&RK&T,TC4
MKT)QCRRU<6E][2/Z-**^,_\ AO#X(_\ 0#^(G_AN/%G_ ,J*/^&\/@C_ - /
MXB?^&X\6?_*BOCS]J/Y"_P#@LU_RDH^)'_<'_P#379U^7]?K)_P4T^'?QO\
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MK[#)<31AAE&<TG=[M(_%>.<JQM?-)5*%"<H\L=5%M?>DSPNBO=/^&5/VN?\
MHC?Q$_\ "0UC_P"1*/\ AE3]KG_HC?Q$_P#"0UC_ .1*];Z]AO\ G['[U_F?
M'_V#F?\ T"U/_ )?Y'A=%>Z?\,J?M<_]$;^(G_A(:Q_\B4?\,J?M<_\ 1&_B
M)_X2&L?_ ")1]>PW_/V/WK_,/[!S/_H%J?\ @$O\C_2,HKXS_P"&\/@C_P!
M/XB?^&X\6?\ RHH_X;P^"/\ T _B)_X;CQ9_\J*_.3^FCK/VWO\ DR[XO?\
M8E:__P"D,U?YS]?W>?M3_M>_#;XC_LQ?$?X>>#/#7Q$O-8U[POK&G6-O_P *
M[\51^;<W5I+%$F^3251=SL!EF"C.20.:_BW_ .&5/VN?^B-_$3_PD-8_^1*^
MGR'$4J=.:J32UZM(_*/$/+L7B<10EAZ,II1=^6+=M?),\+HKW3_AE3]KG_HC
M?Q$_\)#6/_D2C_AE3]KG_HC?Q$_\)#6/_D2O?^O8;_G['[U_F?GG]@YG_P!
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M_@O\??"Y\<? GQ?HGC715F:W.H:#J$&I6HF3&Y/-MWD3<N1E<Y&:]0K^=?\
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M/'UUKEQ<36FF31-+&TZR3"&")',H2,)]Y2!]0_M->)O@9\7?AO\ "'_@E/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /_5_OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MYP_:S^+_ (C^!/P(UCXF>$H+>XU"Q:V2)+I6:+]],D9+!60G 8X^8<_E7T?7
MQY^WGX0\4^.?V7]?\.>#=/N-4U"62S:.VM8S+*X2XC9MJJ"3@ DX'05W99"G
M+%T8U?A<HWOM:^IX'%=;$4<EQM7"-JK&E4<;:OF47:WG?8_*/_AZS^TC_P!
M[0/_  %G_P#DBOVG_9C^*.N_&CX%>'OB;XFA@@O]4BE:9+8,L0:*5X_E#%B,
MA0>2>:_F>_X9=_:1_P"A"U__ ,%\_P#\17]&O[%7A?Q'X,_9@\*>&O%EC-IN
MH6T,_G6UPACECWW$K ,IP02I!P?6OL.*\'E]+"PEA(Q4N;H];6?_  #\/\',
M[XEQF;UZ><U*LJ2I-KG32YN>%K72ULV?GE_P4M_X++Z!_P $Z?VAOA[\"[KP
M')XOM_%%M%JGB'4TU+[$OA_29]0@TY+MXOLT_G*TLK#:7A&Y0N[YLK%\;O\
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M\6_ /6-#\,6<VH7DCVK)! A>1@LR$X49)P 2<=J_&/\ X4!\<?\ H4-8_P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** /_7_OXHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
F**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545889264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-40692<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Riskified Ltd.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">L3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">220 5th Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A ordinary shares, no par value<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RSKD<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag', window );">Document Financial Statement Restatement Recovery Analysis [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">U.S. GAAP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001851112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">128,738,857<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">49,814,864<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Eido Gal<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">220 5th Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">US<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">ir@riskified.com<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtRestatementRecoveryAnalysisFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtRestatementRecoveryAnalysisFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545744448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">1281<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">KOST FORER GABBAY & KASIERER<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Tel-Aviv, Israel<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545966624">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 440,838<span></span>
</td>
<td class="nump">$ 188,670<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCashCurrent', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,347<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepositsAssetsCurrent', window );">Short-term deposits</a></td>
<td class="nump">5,000<span></span>
</td>
<td class="nump">287,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">46,886<span></span>
</td>
<td class="nump">37,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">10,607<span></span>
</td>
<td class="nump">14,371<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Short-term investments</a></td>
<td class="nump">28,968<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">532,299<span></span>
</td>
<td class="nump">529,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">15,639<span></span>
</td>
<td class="nump">18,586<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">29,742<span></span>
</td>
<td class="nump">35,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Deferred contract acquisition costs</a></td>
<td class="nump">15,562<span></span>
</td>
<td class="nump">14,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets, noncurrent</a></td>
<td class="nump">8,690<span></span>
</td>
<td class="nump">8,922<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">601,932<span></span>
</td>
<td class="nump">606,984<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">2,573<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">24,016<span></span>
</td>
<td class="nump">24,134<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee obligations</a></td>
<td class="nump">12,719<span></span>
</td>
<td class="nump">12,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ProvisionForChargebacksCurrent', window );">Provision for chargebacks, net</a></td>
<td class="nump">12,092<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">5,615<span></span>
</td>
<td class="nump">6,214<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">12,796<span></span>
</td>
<td class="nump">15,813<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">69,811<span></span>
</td>
<td class="nump">72,612<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, noncurrent</a></td>
<td class="nump">25,694<span></span>
</td>
<td class="nump">31,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, noncurrent</a></td>
<td class="nump">14,706<span></span>
</td>
<td class="nump">8,734<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">110,211<span></span>
</td>
<td class="nump">112,548<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and Contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares at cost, 3,038,865 and zero ordinary shares as of December&#160;31, 2023 and 2022, respectively</a></td>
<td class="num">(13,155)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">916,371<span></span>
</td>
<td class="nump">848,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive profit (loss)</a></td>
<td class="nump">74<span></span>
</td>
<td class="num">(1,639)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(411,569)<span></span>
</td>
<td class="num">(352,534)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">491,721<span></span>
</td>
<td class="nump">494,436<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">601,932<span></span>
</td>
<td class="nump">606,984<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value, issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, value, issued</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ProvisionForChargebacksCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision For Chargebacks, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ProvisionForChargebacksCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481990/310-10-45-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 26: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepositsAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepositsAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-5<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481404/852-10-50-7<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481520/505-30-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545846816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - &#8362; / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">3,038,865<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">&#8362; 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued (in shares)</a></td>
<td class="nump">128,738,857<span></span>
</td>
<td class="nump">102,084,746<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding (in shares)</a></td>
<td class="nump">128,738,857<span></span>
</td>
<td class="nump">102,084,746<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares, issued (in shares)</a></td>
<td class="nump">49,814,864<span></span>
</td>
<td class="nump">68,945,014<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares, outstanding (in shares)</a></td>
<td class="nump">49,814,864<span></span>
</td>
<td class="nump">68,945,014<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177547069088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 297,610<span></span>
</td>
<td class="nump">$ 261,247<span></span>
</td>
<td class="nump">$ 229,141<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">145,091<span></span>
</td>
<td class="nump">126,150<span></span>
</td>
<td class="nump">106,170<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">152,519<span></span>
</td>
<td class="nump">135,097<span></span>
</td>
<td class="nump">122,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">71,577<span></span>
</td>
<td class="nump">72,014<span></span>
</td>
<td class="nump">55,301<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">88,441<span></span>
</td>
<td class="nump">88,438<span></span>
</td>
<td class="nump">70,710<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">69,350<span></span>
</td>
<td class="nump">83,993<span></span>
</td>
<td class="nump">52,903<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">229,368<span></span>
</td>
<td class="nump">244,445<span></span>
</td>
<td class="nump">178,914<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit (loss)</a></td>
<td class="num">(76,849)<span></span>
</td>
<td class="num">(109,348)<span></span>
</td>
<td class="num">(55,943)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNonoperatingNet', window );">Interest income (expense), net</a></td>
<td class="nump">22,775<span></span>
</td>
<td class="nump">10,180<span></span>
</td>
<td class="nump">591<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">837<span></span>
</td>
<td class="nump">505<span></span>
</td>
<td class="num">(122,520)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="num">(53,237)<span></span>
</td>
<td class="num">(98,663)<span></span>
</td>
<td class="num">(177,872)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for (benefit from) income taxes</a></td>
<td class="nump">5,798<span></span>
</td>
<td class="nump">6,042<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (59,035)<span></span>
</td>
<td class="num">$ (104,705)<span></span>
</td>
<td class="num">$ (179,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)</a></td>
<td class="nump">176,773,398<span></span>
</td>
<td class="nump">167,667,374<span></span>
</td>
<td class="nump">76,459,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">176,773,398<span></span>
</td>
<td class="nump">167,667,374<span></span>
</td>
<td class="nump">76,459,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,757,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">115,005,250<span></span>
</td>
<td class="nump">92,450,867<span></span>
</td>
<td class="nump">38,757,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">61,768,148<span></span>
</td>
<td class="nump">75,216,507<span></span>
</td>
<td class="nump">37,702,067<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNonoperatingNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net amount of nonoperating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNonoperatingNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482916/730-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482517/912-730-25-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545735632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (59,035)<span></span>
</td>
<td class="num">$ (104,705)<span></span>
</td>
<td class="num">$ (179,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive profit (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Unrealized gains (losses) on derivative instruments, net</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="num">(1,883)<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax', window );">Unrealized gains (losses) on available-for-sale debt securities</a></td>
<td class="nump">86<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation</a></td>
<td class="num">(7)<span></span>
</td>
<td class="nump">68<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive profit (loss)</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="num">(1,815)<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive profit (loss)</a></td>
<td class="num">$ (57,322)<span></span>
</td>
<td class="num">$ (106,520)<span></span>
</td>
<td class="num">$ (179,254)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539905488">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Series E-1 Convertible Preferred Stock [Member]</div></th>
<th class="th"><div>Common Class A</div></th>
<th class="th"><div>Common Class B</div></th>
<th class="th"><div>Series E Convertible Preferred Stock [Member]</div></th>
<th class="th">
<div>Common Stock </div>
<div>Common Class A</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Common Class B</div>
</th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Profit (Loss)</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="nump">29,878,116<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 159,564<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward', window );"><strong>Increase (Decrease) in Temporary Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred shares, net of issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">962,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,450,414<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of convertible preferred shares, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,519<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants', window );">Reclassification of convertible preferred share warrants upon IPO</a></td>
<td class="nump">$ 74,724<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of Preferred Shares into Class A Ordinary Shares upon IPO (in shares)</a></td>
<td class="num">(32,291,470)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</a></td>
<td class="num">$ (291,296)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,310,552<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="num">(44,029)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 24,366<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (68,399)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of Preferred Shares into Ordinary Shares upon IPO (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">32,291,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of Preferred Shares into Ordinary Shares upon IPO</a></td>
<td class="nump">291,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">291,296<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants', window );">Reclassification of convertible preferred share warrants upon IPO</a></td>
<td class="nump">35,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">35,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of Class A Ordinary Shares upon IPO, net of underwriting discounts and commissions and other issuance costs (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of Class A ordinary shares upon IPO, net of underwriting discounts and commissions and other issuance costs</a></td>
<td class="nump">386,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization', window );">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</a></td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_StockIssuedDuringPeriodSharesRecapitalization', window );">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,431,636<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,381,269<span></span>
</td>
<td class="nump">625,124<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options</a></td>
<td class="nump">2,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,948<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Exchange of Class B ordinary shares to Class A ordinary shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,001,240<span></span>
</td>
<td class="num">(7,001,240)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">33,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,489<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Ordinary share warrants issued to a customer</a></td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive profit (loss)</a></td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">(179,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(179,430)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75,909,531<span></span>
</td>
<td class="nump">88,055,520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2021</a></td>
<td class="nump">$ 527,596<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">775,249<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="num">(247,829)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization', window );">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,919,606<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options</a></td>
<td class="nump">$ 4,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of ordinary shares upon vesting of restricted share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,145,103<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Exchange of Class B ordinary shares to Class A ordinary shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,110,506<span></span>
</td>
<td class="num">(19,110,506)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 67,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67,766<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Ordinary share warrants issued to a customer</a></td>
<td class="nump">1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive profit (loss)</a></td>
<td class="num">(1,815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,815)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">(104,705)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(104,705)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,084,746<span></span>
</td>
<td class="nump">68,945,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,084,746<span></span>
</td>
<td class="nump">68,945,014<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">$ 494,436<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">848,609<span></span>
</td>
<td class="num">(1,639)<span></span>
</td>
<td class="num">(352,534)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization', window );">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options (in shares)</a></td>
<td class="nump">3,010,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,010,478<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of ordinary shares upon exercise of share options</a></td>
<td class="nump">$ 3,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross', window );">Issuance of ordinary shares upon vesting of restricted share units (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,365,261<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_StockIssuedDuringPeriodSharesWarrantsExercised', window );">Issuance of ordinary shares upon exercise of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,187,087<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchase of Treasury shares (in shares)</a></td>
<td class="num">(3,038,865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,038,865)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchase of Treasury shares</a></td>
<td class="num">$ (13,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13,155)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits', window );">Exchange of Class B ordinary shares to Class A ordinary shares (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,130,150<span></span>
</td>
<td class="num">(19,130,150)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 62,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">62,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued', window );">Ordinary share warrants issued to a customer</a></td>
<td class="nump">1,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive profit (loss)</a></td>
<td class="nump">1,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,713<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">(59,035)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(59,035)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,738,857<span></span>
</td>
<td class="nump">49,814,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,738,857<span></span>
</td>
<td class="nump">49,814,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2023</a></td>
<td class="nump">$ 491,721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="num">$ (13,155)<span></span>
</td>
<td class="nump">$ 916,371<span></span>
</td>
<td class="nump">$ 74<span></span>
</td>
<td class="num">$ (411,569)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Reclassification Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_StockIssuedDuringPeriodSharesRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_StockIssuedDuringPeriodSharesRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_StockIssuedDuringPeriodSharesWarrantsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Warrants Exercised</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_StockIssuedDuringPeriodSharesWarrantsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Adjustments To Additional Paid In Capital, Reclassification Of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 25<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481284/470-20-25-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInTemporaryEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInTemporaryEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480767/946-205-45-4<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481004/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.E.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542602400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS&#8217; DEFICIT (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rskd_SeriesEConvertiblePreferredStockMember', window );">Series E Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_PaymentsOfTemporaryEquityIssuanceCosts', window );">Payments of temporary equity issuance costs</a></td>
<td class="nump">$ 819<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_PaymentsOfTemporaryEquityIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments of Temporary Equity Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_PaymentsOfTemporaryEquityIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rskd_SeriesEConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rskd_SeriesEConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545581952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (59,035)<span></span>
</td>
<td class="num">$ (104,705)<span></span>
</td>
<td class="num">$ (179,430)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized loss (gain) on foreign currency</a></td>
<td class="num">(850)<span></span>
</td>
<td class="num">(2,875)<span></span>
</td>
<td class="nump">382<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for (benefit from) account receivable allowances</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">3,568<span></span>
</td>
<td class="nump">3,607<span></span>
</td>
<td class="nump">1,990<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareAmortization1', window );">Amortization of capitalized internal-use software costs</a></td>
<td class="nump">1,532<span></span>
</td>
<td class="nump">667<span></span>
</td>
<td class="nump">446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortization', window );">Amortization of deferred contract costs</a></td>
<td class="nump">9,567<span></span>
</td>
<td class="nump">7,135<span></span>
</td>
<td class="nump">4,667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAdjustmentOfWarrants', window );">Remeasurement of convertible preferred share warrant liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">101,413<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_FairValueAdjustmentOfRights', window );">Remeasurement of convertible preferred share tranche rights</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">21,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation expense</a></td>
<td class="nump">62,410<span></span>
</td>
<td class="nump">67,467<span></span>
</td>
<td class="nump">33,358<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Operating Lease, Right-of-Use Asset, Amortization Expense</a></td>
<td class="nump">4,605<span></span>
</td>
<td class="nump">4,211<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease', window );">Interest Income, Deposit with Financial Institution, Increase (Decrease)</a></td>
<td class="nump">2,593<span></span>
</td>
<td class="num">(4,613)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities', window );">Ordinary share warrants issued to a customer</a></td>
<td class="nump">1,536<span></span>
</td>
<td class="nump">1,535<span></span>
</td>
<td class="nump">777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other</a></td>
<td class="nump">161<span></span>
</td>
<td class="nump">180<span></span>
</td>
<td class="num">(121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(9,685)<span></span>
</td>
<td class="num">(1,715)<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_IncreaseDecreaseInCapitalizedContractCost', window );">Deferred contract acquisition costs</a></td>
<td class="num">(8,893)<span></span>
</td>
<td class="num">(9,707)<span></span>
</td>
<td class="num">(7,744)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="num">(1,618)<span></span>
</td>
<td class="nump">4,026<span></span>
</td>
<td class="num">(15,079)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">373<span></span>
</td>
<td class="nump">1,931<span></span>
</td>
<td class="num">(832)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued compensation and benefits</a></td>
<td class="num">(199)<span></span>
</td>
<td class="nump">291<span></span>
</td>
<td class="nump">8,398<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_IncreaseDecreaseInGuarantorObligations', window );">Guarantee obligations</a></td>
<td class="nump">358<span></span>
</td>
<td class="nump">249<span></span>
</td>
<td class="num">(333)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_IncreaseDecreaseInProvisionForChargebacks', window );">Provision for chargebacks, net</a></td>
<td class="nump">112<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="nump">1,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Increase (Decrease) in Operating Lease Liability</a></td>
<td class="num">(4,580)<span></span>
</td>
<td class="num">(2,609)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">5,126<span></span>
</td>
<td class="nump">8,710<span></span>
</td>
<td class="nump">7,424<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by (used in) operating activities</a></td>
<td class="nump">7,279<span></span>
</td>
<td class="num">(26,252)<span></span>
</td>
<td class="num">(20,278)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireShortTermInvestments', window );">Purchases of short-term deposits</a></td>
<td class="num">(55,000)<span></span>
</td>
<td class="num">(463,750)<span></span>
</td>
<td class="num">(110,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments', window );">Maturities of short-term deposits</a></td>
<td class="nump">337,000<span></span>
</td>
<td class="nump">261,750<span></span>
</td>
<td class="nump">39,063<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(29,086)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(1,355)<span></span>
</td>
<td class="num">(6,126)<span></span>
</td>
<td class="num">(12,254)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToDevelopSoftware', window );">Capitalized software development costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,886)<span></span>
</td>
<td class="num">(1,250)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash provided by (used in) investing activities</a></td>
<td class="nump">251,559<span></span>
</td>
<td class="num">(210,012)<span></span>
</td>
<td class="num">(84,441)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock', window );">Proceeds from issuance of convertible preferred shares and warrants, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">26,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromWarrantExercises', window );">Proceeds from cash exercise of series E-1 convertible preferred share warrants</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,489<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of share options</a></td>
<td class="nump">3,841<span></span>
</td>
<td class="nump">4,059<span></span>
</td>
<td class="nump">2,948<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from initial public offering, net of underwriting discounts and commissions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">392,273<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of deferred offering costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(204)<span></span>
</td>
<td class="num">(5,302)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury shares</a></td>
<td class="num">(13,155)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by (used in) financing activities</a></td>
<td class="num">(9,314)<span></span>
</td>
<td class="nump">3,855<span></span>
</td>
<td class="nump">423,189<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effects of exchange rates on cash, cash equivalents, and restricted cash</a></td>
<td class="nump">297<span></span>
</td>
<td class="num">(1,701)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase (decrease) in cash, cash equivalents, and restricted cash</a></td>
<td class="nump">249,821<span></span>
</td>
<td class="num">(234,110)<span></span>
</td>
<td class="nump">318,470<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash&#8212;beginning of period</a></td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">425,127<span></span>
</td>
<td class="nump">106,657<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents, and restricted cash&#8212;end of period</a></td>
<td class="nump">440,838<span></span>
</td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">425,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures of cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid for income taxes</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">18<span></span>
</td>
<td class="nump">647<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Payments for Rent</a></td>
<td class="nump">6,080<span></span>
</td>
<td class="nump">4,357<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating lease liabilities arising from obtaining right-of-use assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">792<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment', window );">Adjustment to ROU assets upon modification of existing lease</a></td>
<td class="num">(811)<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment during the period included in accounts payable and accrued expenses</a></td>
<td class="nump">97<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="nump">2,042<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount', window );">Share-based compensation capitalized for software development</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">299<span></span>
</td>
<td class="nump">131<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid', window );">Software development costs, accrued but not paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">485<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredOfferingCostsIncurredButNotYetPaid', window );">Deferred offering costs accrued but not paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">204<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockAmountConverted1', window );">Conversion of convertible preferred shares into Class A ordinary shares upon IPO</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">291,296<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity', window );">Reclassification of convertible preferred share warrants upon IPO</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">110,502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization', window );">Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">440,838<span></span>
</td>
<td class="nump">188,670<span></span>
</td>
<td class="nump">418,143<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,347<span></span>
</td>
<td class="nump">6,984<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents, and restricted cash</a></td>
<td class="nump">440,838<span></span>
</td>
<td class="nump">191,017<span></span>
</td>
<td class="nump">425,127<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember', window );">Convertible Preferred Share Tranche Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of noncash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_WarrantsAndRightsSettled', window );">Settlement of convertible preferred share tranche rights</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,738<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_DeferredOfferingCostsIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Offering Costs Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_DeferredOfferingCostsIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_FairValueAdjustmentOfRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value Adjustment Of Rights</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_FairValueAdjustmentOfRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_IncreaseDecreaseInCapitalizedContractCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Capitalized Contract Cost</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_IncreaseDecreaseInCapitalizedContractCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_IncreaseDecreaseInGuarantorObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Guarantor Obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_IncreaseDecreaseInGuarantorObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_IncreaseDecreaseInProvisionForChargebacks">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Provision For Chargebacks</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_IncreaseDecreaseInProvisionForChargebacks</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Right Of Use Asset, Lease Modification Adjustment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds from Issuance of Warrants, Operating Activities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Software Development Expenditures Incurred But Not Yet Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_WarrantsAndRightsSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants And Rights Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_WarrantsAndRightsSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareAmortization1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for amortization of capitalized computer software costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -SubTopic 20<br> -Topic 985<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareAmortization1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockAmountConverted1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockAmountConverted1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481877/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost capitalized for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAdjustmentOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (income) related to adjustment to fair value of warrant liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 13<br> -SubTopic 10<br> -Topic 480<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481766/480-10-25-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAdjustmentOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in interest income on deposit with financial institution.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (a)<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (c)<br> -Subparagraph (2)(i)<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (c)<br> -Subparagraph (2)(ii)<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1402<br> -Paragraph (c)<br> -Subparagraph (2)(iii)<br> -Publisher SEC<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToDevelopSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToDevelopSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-13<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromWarrantExercises">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from holders exercising their stock warrants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromWarrantExercises</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545653440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Description of Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">Organization and Description of Business</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.       Organization and Description of Business</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Riskified Ltd., together with its subsidiaries, &#8220;Riskified&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, &#8220;our&#8221; or the &#8220;Company,&#8221; was incorporated under the laws of the State of Israel in 2012 and commenced operations in January 2013. We have built a next-generation eCommerce risk intelligence platform that allows our customers&#8212;online merchants&#8212;to create trusted relationships with their consumers. Our core product, the Chargeback Guarantee, is designed to ensure the legitimacy of our merchants&#8217; online orders by approving or denying these orders with guaranteed performance levels that vary by merchant. We guarantee the outcome of our decisions by assuming the cost of fraud associated with each approval. We drive higher sales by raising approval rates and reducing fraud and other operating costs for our merchants and strive to provide superior consumer experiences, as compared to our merchants&#8217; performance prior to onboarding us.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 275<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//275/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 250<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//250/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542911984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.       Summary of Significant Accounting Policies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and include the accounts of Riskified Ltd. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Immaterial Prior Period Error Correction</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. We assessed the materiality of the error on the financial statements for prior years individually and in the aggregate, and concluded that it was not material to any previously issued consolidated financial statements. We corrected the error by revising the consolidated financial statements appearing herein. The impact of the errors on the Company&#8217;s consolidated balance sheet as of January 1, 2021 was an overstatement of deferred contract acquisition costs of $0.7 million and an understatement of accumulated deficit of $0.7 million. There was no impact of the error on the consolidated statements of cash flows for the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of the corrections on the Company&#8217;s consolidated financial statements for the years ended December 31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Initial Public Offering </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August&#160;2, 2021, we completed our initial public offering (&#8220;IPO&#8221;), in which we issued and sold 19,925,000 shares of our Class A ordinary shares at an offering price of $21.00 per share, including 2,625,000 shares of our Class A ordinary shares pursuant to the exercise in full of the underwriters&#8217; option to purchase additional shares. We received net proceeds of $386.6 million after deducting underwriting discounts and commissions of $26.2 million, and other issuance costs of $5.7 million.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately prior to the closing of the IPO, 962,940 shares of Series E-1 convertible preferred shares were issued upon the exercise of the Series E-1 convertible preferred share warrants. In addition, all convertible preferred shares then outstanding automatically converted into 32,291,470 shares of our Class A ordinary shares. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the IPO, deferred offering costs, which consist primarily of accounting, legal and other fees related to our IPO, were capitalized within other assets, noncurrent in the consolidated balance sheets. Upon the consummation of the IPO, $5.7 million of deferred offering costs were reclassified into shareholders&#8217; equity as an offset against IPO proceeds. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recapitalization</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 28, 2021, we adopted new Articles of Association (&#8220;AoA&#8221;), in which, among other things, we implemented, upon the closing of the IPO:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) a dual class ordinary share structure pursuant to which we have two classes of ordinary shares: Class A ordinary shares and Class B ordinary shares. The rights of the holders of our Class A ordinary shares and Class B ordinary shares are identical, except with respect to voting, conversion and transfer rights. Class A ordinary shareholders are entitled to one vote per share and Class B ordinary shareholders are entitled to ten votes per share. The dual class ordinary share structure concentrates voting power with our pre-IPO shareholders. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters (including the election of directors) submitted to a vote of our shareholders, unless otherwise required by law or our amended and restated articles of association; </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the elimination of the par value per ordinary share; and</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii) a two-for-one reverse share split of our Class A ordinary shares (the &#8220;Reverse Share Split&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Immediately after the effectiveness of the Reverse Share Split, we issued and distributed Class B ordinary shares to holders of the Class A ordinary shares on a two-for-one ratio, such that each holder of Class A ordinary shares received two Class B ordinary shares for each Class A ordinary share (the &#8220;Additional Class B Issuance&#8221;).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The historical financial statements have not been retroactively adjusted for the (i) dual class structure, (ii) elimination of par value, and (iii) Additional Class B Issuance. As a result, all information associated with these items related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, restricted share units (&#8220;RSUs&#8221;), and warrants to purchase convertible preferred shares are being presented prospectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All information related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, RSUs, and warrants to purchase convertible preferred shares have been retroactively adjusted to give effect to the Reverse Share Split for all periods presented.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares (the &#8220;Repurchase Program&#8221;). Costs associated with the acquisition of Class A ordinary shares are presented as Treasury Shares on the consolidated balance sheet as a reduction of shareholders' equity. Refer to Note 10 for more information on the Repurchase Program.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives and investments, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#8220;IBR&#8221;) used for operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. We base our estimates on assumptions, both historical and forward-looking, trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the subsidiaries where the U.S. dollar is the functional currency, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars at exchange rates in effect at the end of each period. Foreign currency transaction gains and losses from these remeasurements are recognized in other income (expense), net, within the consolidated statements of operations. Foreign currency transactions resulted in net gains of $1.4&#160;million, $2.5&#160;million, and $0.2&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries where the functional currency is not the U.S. dollar, we use the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders&#8217; equity, into U.S. dollars. We record translation gains and losses in accumulated other comprehensive profit (loss) as a component of shareholders&#8217; equity in the consolidated balance sheets.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk primarily consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivable and derivative financial instruments. We maintain our cash, cash equivalents, restricted cash, short-term deposits, and short-term investments with high-quality financial institutions mainly in the United States and Israel, the composition of which are regularly monitored by us. We have not experienced any material losses in such accounts. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are online merchants. For accounts receivable, we are exposed to credit risk in the event of nonpayment by online merchants to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit to online merchants and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our merchants by performing periodic evaluations of credit worthiness and consumer indebtedness and applying other credit risk monitoring procedures. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Represents less than 10%</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. We consider all highly liquid investments, with an original maturity of three months or less at the date of purchase, to be cash equivalents. Our restricted cash primarily consisted of cash deposits to back letters of credit related to certain operating leases.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Deposits</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term deposits are reported at cost.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. We determine the appropriate classification of our investments in marketable debt securities at the time of purchase and reevaluate such designation at each balance sheet date. After consideration of our risk versus reward objectives, as well as our liquidity requirements, we may sell these debt securities prior to their effective maturities. As a result, we classify our investments, including those with maturities beyond 12 months, as current assets in the Consolidated Balance Sheets. We carry these securities at fair value, and report the unrealized gains and losses, net of taxes, as a component of shareholders&#8217; equity, except for changes in allowance for expected credit losses, which is recorded in other income (expense), net, within the consolidated statements of operations. We periodically evaluate our available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, we consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these criteria are </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">met, we write down the security to its fair value and record the impairment charge in other income (expense), net within the consolidated statements of operations. If neither of these criteria are met, we determine whether credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We measure financial assets and liabilities at fair value for each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument&#8217;s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2 &#8211; Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3 &#8211; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivables, derivative financial instruments, accounts payables, accrued liabilities, indemnification guarantees. Cash and cash equivalents, short-term deposits, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Short-term investments and derivative financial instruments are stated at fair value on a recurring basis as disclosed in Note 4 below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record indemnification guarantees that we issue upon approving a transaction at fair value when issued using the income approach. To measure this guarantee, we consider the premium that would have been received for the same guarantee if it were issued in a stand-alone transaction. The fair value of these indemnification guarantees is determined based on historical chargeback claims, a risk premium fee that would be required for a third party to assume this liability, and an appropriate discount rate due to the time period between issuance of the guarantee and settlement or expiration. Historical chargeback guarantee claims are not readily observable in the marketplace and are generally classified as Level 3 inputs. Indemnification guarantees are recorded at fair value when issued and not remeasured to fair value each period. Refer to Note 8 below for more information regarding indemnification guarantees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments, in particular our indemnification guarantees, may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements. Refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The allowance for credit losses is based on our assessment of the collectability of accounts. We regularly review the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current merchant&#8217;s credit worthiness, the age of the balance, the nature and size of the merchant, the financial condition of the merchant, and the amount of any receivables in dispute. Accounts </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">receivable deemed uncollectible are charged against the allowance for credit losses when identified. The allowance for doubtful accounts was $0.5 million and $0.5 million as of December&#160;31, 2023 and 2022, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of the allowance for credit losses:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:84.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncollectible accounts charged against the allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries of amounts previously deemed uncollectible</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to manage risks relating to our ongoing business operations. We enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks attributable to our exposure to changes in the exchange rates of (a) the New Israeli Shekel (&#8220;NIS&#8221;) against the U.S. dollar and (b) the Euro against the U.S. dollar. Our primary objective in entering into these contracts is to reduce the volatility of forecasted earnings and cash flows associated with changes in foreign currency exchange rates. We do not use derivative instruments for trading or speculative purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our derivative instruments as either assets or liabilities and carry them at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. Derivative instruments are recorded as either prepaid expenses and other current assets or accrued expenses and other current liabilities in the consolidated balance sheets. We record changes in the fair value of derivative instruments that are designated as hedging instruments in accumulated other comprehensive profit (loss) in the consolidated balance sheets, until the forecasted transaction occurs upon which we reclassify the related gain or loss on the derivative to the same financial statement line item in the consolidated statements of operations to which the derivative relates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge monetary assets or liabilities denominated in currencies other than the functional currency of a subsidiary. Changes in the fair value on these contracts, as well as the related costs, are recognized in Other income (expense), net, along with the foreign currency gains and losses on the related monetary assets and liabilities. Refer to Note 5 for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs are expensed as incurred. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of our property and equipment are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of remaining lease term or estimated useful life</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to software acquired, developed, or modified solely to meet our internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs incurred during the preliminary project stage and during the post implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized. Capitalized software development costs are recorded as part of other assets, noncurrent in the consolidated balance sheets. Maintenance costs are expensed as incurred. Capitalized software development costs are amortized on a straight-line basis over the software&#8217;s estimated useful life, which is four years and are recorded in cost of revenue&#160;in the consolidated statements of operations. As of December&#160;31, 2023 and 2022, we have capitalized $3.5 million, net and $5.0 million, net, respectively, of qualifying software development costs. Amortization expenses related to capitalized software costs were $1.5 million, $0.7 million, and $0.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cloud Computing Arrangement Implementation Costs</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain implementation costs incurred in a cloud computing arrangement during the application development stage pursuant to Accounting Standards Codification, or ASC, 350-40,</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These costs are amortized over the term of the hosting arrangement on a straight-line basis, and are included within operating expenses in the consolidated statements of operations. Costs incurred in the preliminary stages of development are analogous to research and development activities and are expensed as incurred. These capitalized costs are included in other assets, noncurrent in the consolidated balance sheets. We have capitalized $0.7 million and $0.2 million of qualifying cloud computing arrangement implementation costs as of December&#160;31, 2023 and 2022, respectively. Amortization expenses related to capitalized cloud computing arrangement implementation costs were $0.2 million, $0.2 million, and $0.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease accounting policy under ASC Topic 840, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; until January 1, 2022, prior to the adoption of the new lease guidance was as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are reviewed and classified as either capital or operating leases at their inception. In certain lease agreements, we may receive renewal or expansion options, rent holidays, and other incentives. For operating leases, we recognize lease costs on a straight-line basis once we take control of the space, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted the new lease guidance for our operating lease agreements. Refer to Note 7 below for additional information. Our lease accounting policy under ASC Topic 842, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 842</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; from January 1, 2022, following the adoption of the new lease guidance is as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement meets the definition of a lease at the inception of the lease, and leases are classified at commencement as either operating or finance leases. We do not have any finance leases. Operating lease ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease agreement. Operating lease ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives received prior to lease commencement. Operating lease liabilities are measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using our IBR based on the information available at the commencement date of the lease as our leases generally do not provide an implicit rate. Our IBR was estimated to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include options to extend or terminate the lease when it is reasonably certain that we would exercise that option. We made an accounting policy election for lease agreements with a term of 12 months or less and do not recognize operating lease ROU assets and operating lease liabilities in respect of those agreements. Payments under our lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and operating lease liabilities. Variable lease payments are mainly comprised of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the practical expedient to not separate lease and non-lease components for our leases.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sublease certain office spaces to third parties. Operating sublease income is recognized on a straight-line basis over the term of the agreement. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the recoverability of long-lived assets, including property and equipment, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Recoverability of these assets is measured by comparing the carrying amounts with the future undiscounted cash flows that the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. We determined that there were no material events or changes in circumstances that indicated that our long-lived assets were impaired during the periods presented.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#8220;guarantee obligation&#8221;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and will be released to revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being released from risk under the guarantee obligation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs and assumptions used by management to calculate this provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. These liabilities are recorded within Provision for chargebacks, net on the consolidated balance sheets and will be reduced by credits issued or cash paid to merchants. Refer to Note 8 below or </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates&#8221; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Share Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to IPO, warrants to purchase our Series B/C and E-1 convertible preferred shares were recorded as a liability at fair value on our consolidated balance sheets as the underlying convertible preferred shares were contingently redeemable, upon a deemed liquidation event that is outside of our control, and therefore could have obligated us to transfer assets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B/C convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or upon the completion of a qualified IPO. Upon IPO, the Series B/C convertible preferred share warrants were converted to warrants to purchase ordinary shares, and the then outstanding liability was reclassified to additional paid-in capital in the consolidated balance sheets. The warrants to purchase ordinary shares may be exercised any time prior to, and shall expire upon, the earlier of (a) April 29, 2025 or (b) immediately prior to the consummation of certain deemed liquidation events. In November 2023, the outstanding warrants to purchase ordinary shares were exercised. Refer to Note 9.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series E-1 convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or the completion of a deemed liquidation event, including a qualified IPO. Upon IPO, the Series E-1 convertible preferred share warrants were automatically exercised.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with a SaaS Agreement entered into in 2021, we issued a warrant to a customer to purchase ordinary shares. The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years. As of December 31, 2023, the warrant is outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees as noted above within &#8220;Indemnification Guarantees&#8221;. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#8217; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above within &#8220;Indemnification Guarantees&#8221;, our contracts with our merchants obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a six-month period from the date of the transaction.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present revenue net of cancellations and adjustments for minimum service level agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 606, revenue is recognized when a customer obtains control of promised products. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these products. To achieve the core principle of this standard, we applied the following five steps:</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the contract, or contracts, with the merchant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine that we have a contract with a merchant when the contract is approved, each party&#8217;s rights and obligations regarding the products to be transferred can be identified, the payment terms for the products can be identified, we have determined the merchant has the ability and intent to pay, and the contract has commercial substance. At contract inception, we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Contracts with our merchants are typically for a period of one year.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the products that will be transferred to the merchant that are both capable of being distinct, whereby the merchant can benefit from the products either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the products is separately identifiable from other promises in the contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For SaaS arrangements, we provide access to our cloud-hosted software platform and reviewing and approving eCommerce transaction for legitimacy, without providing the merchant the right to take possession of our software, which we consider to be a single performance obligation. Revenue generated from the issuance of indemnification guarantees is accounted for under ASC 460. Refer to &#8220;Indemnification Guarantees&#8221; above and Note 8 below for additional information.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Determination of the transaction price</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our contracts include an unknown quantity of approved transactions at a fixed contractual rate per approved transaction value executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of products during that month. Certain of our contracts include additional forms of variable consideration such as service level commitments relating to uptime availability and minimum approval rates as well as provisions that provide for reimbursements should our merchant&#8217;s consumer cancel an approved order. If we fail to meet these commitments, merchants are generally permitted to receive a refund in the form of a credit on their invoice. Under certain arrangements, when the merchant&#8217;s consumer cancels an order that we have approved, we provide a refund of some or all of the fees owed by our merchant to us generally in the form of a credit on our merchant&#8217;s invoice. The transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms and conditions vary by contract type, although terms generally include a requirement to pay within 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined that our contracts do not include a significant financing component. The primary purpose of our invoicing terms is to provide our merchants with simplified and predictable ways of purchasing our products; not to receive financing from our merchants or to provide merchants with financing. We applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from merchants (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. We generally do not offer a right of refund in our contracts.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation&#8217;s relative standalone selling price. Access to our cloud-hosted software is considered one performance obligation in the context of the contract and accordingly the transaction price is allocated to this single performance obligation. </span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Recognition of the revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time the related performance obligation is satisfied by transferring control of the promised service to the customer. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products. For SaaS arrangements, we have determined that these arrangements meet the variable consideration allocation exception and revenue is recognized over the contract period in the month that the transactions are approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets consist of unbilled accounts receivable. The terms of our agreements are monthly, annual, or multi-year, and we typically invoice our merchants based on monthly usage. In some arrangements, a right to consideration for our performance under the merchant contract may occur before invoicing to the merchant, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Obtain a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. These costs are recorded as Deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of four years. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions expenses are included in sales and marketing expense in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Fulfill a Contract </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize payroll related costs of certain integration services required in order to be able to fulfill the obligation to provide our products to our merchants. Integration services are promises that are not capable of being distinct. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and generate or enhance resources that will be used in delivering our SaaS products. These costs are recorded as deferred contract fulfillment costs in other assets, noncurrent on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs to fulfill a contract are amortized on a straight-line basis over the expected period of benefit of four years and are included in cost of revenue in the consolidated statements of operations. We </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the period of benefit by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of period of benefit involve inherent uncertainties and the application of significant judgment. We periodically review these deferred contract fulfillment costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us. Amounts for chargebacks won were $25.0&#160;million, $20.3&#160;million, and $14.3&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development costs also consist of third-party software hosting fees used by our research and development teams, depreciation expense, and allocated overhead. Research and development costs are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing costs primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead. Sales and marketing costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital marketing programs include advertising, promotional events, and brand-building activities. Advertising costs are expensed as incurred and were $4.9 million, $6.0 million, and $5.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead. General and administrative costs are expensed as incurred.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to share-based awards is recognized based on the fair value of the awards granted. The fair value of each share option award is estimated on the grant date </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected term of the share option, the expected volatility of the price of our ordinary shares, risk-free interest rates, and the expected dividend yield of ordinary shares. The assumptions used to determine the fair value of the option awards represent management&#8217;s best estimates. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. The related share-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted to employees, RSUs, that vest either upon the (a) satisfaction of service-based vesting conditions only and (b) satisfaction of both service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying ordinary shares as of the grant date. We have also granted to our Chief Executive Officer (&#8220;CEO&#8221;), RSUs, that vest upon the satisfaction of service-based, performance-based, and market-based vesting conditions. A Monte-Carlo simulation model was used to determine the grant date fair value by simulating a range of scenarios with each outcome resulting in a determined value. The grant date fair value of this award is the average of the values determined by each simulation. The simulation was also used to derive the requisite service period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For RSU awards with both service-based and performance-based vesting conditions, the service-based vesting condition has varying terms, but is generally satisfied over <span style="-sec-ix-hidden:f-639">four</span> to five years. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) the six month anniversary of or, if earlier, March 15 of the year following, the occurrence of an IPO or (ii) consummation of a merger and acquisition, or M&amp;A, transaction of the Company. The performance-based vesting condition underlying these awards was satisfied upon our IPO. The market-based condition underlying the CEO RSU is satisfied upon the trading price of our ordinary shares meeting certain thresholds.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSU awards with service-based vesting conditions only are recognized using the straight-line method. RSU awards with more than just a service-based vesting condition are recognized using the accelerated attribution method once the performance-based vesting condition is probable of occurring which results in higher expenses attributed to the earlier periods of the requisite service period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute net profit (loss) per share using the two-class method required for participating securities. The two-class method requires income available to ordinary shareholders for the period to be </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Under the two-class method, we allocate earnings proportionately to Class A and B ordinary shares outstanding for the period. Prior to IPO, we considered our convertible preferred shares to be participating securities as the holders of the convertible preferred shares would be entitled to dividends in preference to ordinary shareholders. These participating securities do not contractually require the holders of such shares to participate in our losses. As such, net loss for the periods presented was not allocated to our participating securities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic net profit (loss) per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net profit (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net profit (loss) per share is the same as basic net profit (loss) per share in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in one operating segment and therefore have one reportable segment. Operating segments are defined as components of an entity that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker, who is our CEO, in deciding how to allocate resources and assess performance. Our chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical region can be found in the revenue recognition disclosures in Note 3 below. Property and equipment, net of depreciation and amortization, by geographic region can be found in Note 6 below. Operating lease ROU assets by geographic region can be found in Note 7 below.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company, or EGC, the Jumpstart Our Business Startups Act, or the JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards. We have elected to use extended transition periods permissible under the JOBS Act while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including subsequent amendments thereafter, which established ASC 326. ASC 326 replaces the existing incurred loss impairment model with a current expected credit loss model that requires more timely recognition of estimated expected credit losses over the life of certain financial instruments. Our accounts receivable and available-for-sale debt securities are in the scope of ASC 326. We adopted ASC 326 as of January 1, 2023. The adoption of ASC 326 did not have a material impact on our financial condition and results of operations within our consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reportable Segments (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses, including public entities with a single operating or reportable segment. The updated standard will be effective for annual periods beginning in fiscal 2024 and interim periods beginning in the first quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands disclosures in an entity&#8217;s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The updated standard will be effective for annual periods beginning in fiscal 2026. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 235<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//235/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177543825200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.       Revenue Recognition</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by region in which our merchants&#8217; headquarters are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa (&#8220;EMEA&#8221;)*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific (&#8220;APAC&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Revenue recognized from merchants whose headquarters are in Israel, which is our country of domicile, was $1.3 million, $3.3 million, and $2.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue based on the nature and type of service provided to our merchants:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fraud review service revenue (ASC 606)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification guarantee service revenue (ASC 460)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue from our Chargeback Guarantee offering. Revenue generated from other offerings are not material. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allocation of consideration between fraud review service revenue and indemnification guarantee service revenue is a function of the fair value of our chargeback guarantee which represents what we would need to pay a third party to relieve ourselves from our obligations under issued guarantees. The fair value of the chargeback guarantee is primarily determined by utilizing the historical percentage of guarantees issued that resulted in a chargeback plus a risk premium fee that we would have incurred from a third-party in order to relieve ourselves from our legal obligation under the guarantee. Refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the percentage of revenue that are recorded as fraud review service revenue and indemnification guarantee service revenue are a function of changes in the aforementioned fair value of the chargeback guarantee and changes in the speed in which we resolve chargeback claims which impacts the systematic and rational approach that we utilize to record revenue associated with our guarantee obligation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost to Obtain a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract acquisition costs:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost to Fulfill a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract fulfillment costs that are included within in other assets, noncurrent on the consolidated balance sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-15<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-12<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-13<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542673232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.       Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about our financial instruments that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds included within short-term investments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-733">Derivative financial instruments included in prepaid expenses and other current assets</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-742">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-751">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, we did not have any Level 3 financial instruments that are measured at fair value on a recurring basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify our derivative financial instruments and government bonds within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Refer to Note 5 for more information regarding our derivative financial instruments.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 8 below for more information regarding the fair value of our indemnification guarantees.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Securities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no short-term investments as of December 31, 2022. The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:77.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>As of December 31, 2023, the unrealized losses related to short-term investments were not due to credit related losses. Therefore, we did not recognize an allowance for credit losses for our short-term investments. As of December 31, 2023, we did not have any available-for-sale debt securities that have been in a continuous loss position<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542702800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock', window );">Derivative Instruments and Hedging</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.       Derivative Financial Instruments and Hedging</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notional Amount of Foreign Currency Contracts</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency contracts are denominated in NIS and Euro. The gross notional amounts of outstanding foreign currency contracts in U.S. dollar were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total derivative instruments  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Foreign Currency Contracts on the Consolidated Statements of Operations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of foreign currency contracts on the Consolidated Statements of Operations during the periods presented were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Statement of Operations Location:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(706)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gain (loss) recognized in earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Profit (Loss)</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, that were recorded in accumulated other comprehensive profit (loss) during the periods presented, and their effect on other comprehensive profit (loss) for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,707)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2021, net deferred gains totaled $0.2 million and were recognized during the year ended December 31, 2022 in the same financial statement line item as the hedged items. As of December 31, 2022, $1.7&#160;million of net deferred losses were recorded in accumulated other comprehensive profit (loss) and were recognized during the year ended December 31, 2023 in the same financial statement line item as the hedged items. As of December 31, 2023, $0.1 million of net deferred losses were recorded in accumulated other comprehensive profit (loss) of which all are expected to be recognized in the same financial statement line item in the Consolidated Statements of Operations to which the derivative relates over the next twelve months.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 815<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//815/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545795248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Consolidated Balance Sheet Components</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.       Consolidated Balance Sheet Components</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization expenses were $3.6 million, $3.4 million, and $1.8 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our property and equipment, net of depreciation and amortization, by geographic region:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,209&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,671&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,403&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,796&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of world</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Expenses and Other Current Liabilities</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Noncurrent</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, noncurrent consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, noncurrent</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//210/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542739968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.       Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have non-cancelable operating leases for our corporate offices in Tel Aviv, Israel and in New York, New York in the United States. The leases for these facilities in Tel Aviv and New York expire in 2031 and 2029, respectively and we have options to renew these leases through 2036 and 2034, respectively. These renewal options are excluded from the calculation of operating lease ROU assets and operating lease liabilities. We sublease a portion of our office space in Tel Aviv and New York.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost for the years ended December&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease costs prior to the adoption of ASC 842 were $5.9 million for the year ended December 31, 2021. Sublease income was $0.1 million for the year ended December 31, 2021.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, the weighted average remaining lease term and the weighted average discount rate for our operating leases were 6.5 years and 4.6%, respectively. As of December&#160;31, 2022, the weighted average remaining lease term and the weighted average discount rate for our operating leases were 7.4 years and 4.6%, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future minimum lease payments included in the measurement of our operating lease liabilities as of December&#160;31, 2023, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,746)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our operating lease ROU assets by geographic region:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Excluded from the tables above is an unsecured and undated promissory note issued in December 2020 in connection with the execution of a lease agreement for an amount of $2.9 million and $3.0 million as of December&#160;31, 2023 and 2022, respectively. The promissory note may only be withdrawn in the event of a material and fundamental breach of the lease agreement. The promissory note expires three months after the lease termination date. As of December&#160;31, 2023 and 2022, we were in full compliance of the terms and conditions of the promissory note, and the promissory note has not been withdrawn.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542667056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees, Commitments, and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock', window );">Guarantees, Commitments, and Contingencies</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.       Guarantees, Commitments, and Contingencies</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud. Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460 and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and was $12.7 million and $12.4 million as of December&#160;31, 2023 and 2022, respectively, and will be released to revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being relieved from our guarantee obligation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for chargebacks includes amounts associated with chargebacks that have been submitted and accepted but not yet paid by us as of the balance sheet date as well as estimates of chargebacks that have not yet been submitted and accepted relating to approved transactions that are </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">accounted for under </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 450, Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs and assumptions used by management to calculate the provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. Provision for chargebacks, net on the consolidated balance sheets were $12.1 million and $12.0 million as of December&#160;31, 2023 and 2022, respectively, and will be reduced by credits issued or cash paid to merchants.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, our portfolio of potential chargeback liabilities was diversified across numerous industries, hundreds of merchants, and millions of individual transactions. The maximum potential payment to our merchants for these guarantees at a point in time, if every order we approved was fraudulent, is generally the aggregate approved transaction amount excluding cancelled orders, orders that have expired guarantees, and orders for which guarantees have already been paid. As of December&#160;31, 2023, there was $57.2 billion in outstanding indemnification guarantees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, we have had to pay approximately 0.1% of guarantees that we have issued and net chargeback expenses for the years ended December&#160;31, 2023, 2022, and 2021, were $121.8 million, $103.2 million, and $85.5 million, respectively, which was in line with our budgets for the associated periods.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Cancelable Purchase Obligations</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, we enter into non-cancelable purchase commitments with various parties primarily for hosting and software services. As of December&#160;31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Indemnifications and Contingencies</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of business, we agree to indemnify certain parties. In our merchant agreements, we have agreed to indemnify, defend, and hold harmless the indemnified party for third-party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic merchants, we have agreed to indemnify, defend and hold harmless the indemnified party for non-compliance with certain additional representations and warranties made by us. In addition, we have entered into indemnification agreements with our directors and certain officers. As we have a limited history of prior indemnification claims and the payments we have made under such agreements have not had a material adverse effect on our results of operations, cash flows, or financial position, we are unable to reasonably estimate the maximum potential amount of future payments related to these indemnification agreements. However, to the extent that valid indemnification claims arise in the future, future payments by us could be significant and could have a material adverse effect on our results of operations or cash flows in a particular period. As of December&#160;31, 2023 and 2022, we did not have any material indemnification claims that were probable or reasonably possible.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal Proceedings</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Occasionally we may be subject to various proceedings, lawsuits, disputes, or claims. We investigate these claims as they arise and accrue liabilities when losses are probable and reasonably estimated. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2022, a putative securities class action complaint was filed in federal court in the United States by certain of our shareholders against us, certain of our current and former officers and directors, and our underwriters alleging violations of the Securities Act in connection with our IPO-related disclosures, and seeking unspecified damages. The lawsuit was captioned</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> In re Riskified Ltd. Securities Litigation</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, 22 Civ. 3545 (DLC) (S.D.N.Y.). Plaintiffs filed an amended complaint on September 15, 2022. We moved to dismiss the amended complaint on October 28, 2022. On June 2, 2023, the Court granted our motion to dismiss the complaint in its entirety, with prejudice. The deadline to appeal has passed and the judgment is now final.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although claims are inherently unpredictable, we are currently not aware of any matters that, if determined adversely to us, would individually or taken together, have a material adverse effect on our business, financial position, results of operations, or cash flows.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments, contingencies, and guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//450/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 440<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//440/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 460<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//460/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542596560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityDisclosureTextBlock', window );">Convertible Preferred Shares</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.       Ordinary Share Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, 1,187,087 Class A shares were issued upon the cashless exercise of the outstanding warrants to purchase ordinary shares.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the following warrants were issued and outstanding:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued and Outstanding Share Warrants</span></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued to customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Disclosure</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542663824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock', window );">Ordinary Shares and Equity Incentive Plan</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.       Ordinary Shares and Equity Incentive Plan</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the completion of the IPO, our amended and restated AoA became effective, which authorized the issuance of up to 900,000,000 Class A ordinary shares with no par value and 232,500,000 Class B ordinary shares with no par value, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the following ordinary shares reserved for future issuance:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2013 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,981,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,062,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2021 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,299,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,134,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available for future issuance under the 2021 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ordinary shares reserved</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,546,857</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,647,083</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Includes the warrants to purchase ordinary shares and warrants issued to customers. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares. We received approval for the implementation of our Repurchase Program from the Tel Aviv District Court Economic Department (&#8220;Israeli Court&#8221;) on November 20, 2023. The Israeli Court approval is valid through May 19, 2024. We may file extension requests with the Israeli Court on an ongoing basis as required. During the year ended December 31, 2023, we repurchased 3,038,865 outstanding Class A ordinary shares for $13.2&#160;million, including transaction costs of approximately $0.1&#160;million, through our Repurchase Program. These shares are classified as Treasury Shares on our consolidated balance sheet. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Repurchase Program authorizes us to repurchase Class A ordinary shares, from time to time in the open market, in privately negotiated transactions or by other means in accordance with U.S. federal securities laws. The timing, as well as the number and value of any shares repurchased under the program, will be determined at our discretion under the Board authorized program and will depend on a variety of factors, including management's assessment of the intrinsic value of our ordinary shares, the market price of our ordinary shares, general market and economic conditions, available liquidity, alternative investment opportunities, and applicable legal requirements. The Repurchase Program does not obligate us to repurchase any specific number of shares and may be suspended, modified or discontinued at any time without prior notice. The share repurchases will be funded from existing cash and cash equivalents.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2013 Equity Incentive Plan, or the 2013 Plan, was adopted by our board of directors on July 3, 2013 and amended and restated on February 23, 2021. The 2013 Plan provided for the grant of equity-based incentive awards to our employees, directors, office holders and consultants. The U.S. Sub-Plan to the 2013 Plan, which is to be read as a continuation of the 2013 Plan, was adopted by our board of directors on May 10, 2015 and amended and restated on February 23, 2021. The U.S. Sub-Plan governed equity-based incentive awards granted to our United States employees, directors, office holders and consultants, including those who are deemed to be residents of the United States for tax purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We no longer grant any awards under our 2013 Plan as it was superseded by the 2021 Share Incentive Plan, or the 2021 Plan. Awards granted prior to the adoption of the 2021 Plan remain outstanding and are governed by the 2013 Plan.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Plan was adopted in connection with our IPO on July 15, 2021. The 2021 Plan provides for the grant of equity-based incentive awards to our employees, directors, office holders, service providers and consultants. The maximum number of Class A ordinary shares available for issuance under the 2021 Plan is equal to the sum of (i) 13,951,037 Class A ordinary shares, (ii) any shares subject to awards under the 2013 Plan which have expired, or were cancelled, terminated, forfeited or settled in cash in lieu of issuance of shares or became unexercisable without having been fully exercised and (iii) an annual increase on the first day of each year beginning in 2022 and on January 1st of each calendar year thereafter during the term of the 2021 Plan, equal to the lesser of (A) 5% of the outstanding Class A ordinary shares of the Company on the last day of the immediately preceding calendar year (calculated on a fully diluted, as converted basis); and (B) such amount as determined by our board of directors if so determined prior to January 1 of a calendar year, provided that no more than 13,951,037 Class A ordinary shares may be issued upon the exercise of incentive share options.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Options and Shares Available for Grant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share options generally vest over four years and expire ten years after the date of grant. We issue Class A ordinary shares upon exercise of share options. A summary of share options under our equity incentive plan and related information is as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Share Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise <br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic <br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share, life and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,785,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,010,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no share options granted during the years ended December&#160;31, 2023 or December&#160;31, 2022. The weighted-average grant date fair value of share options granted during the year ended December 31, 2021 was $16.63. The aggregate grant date fair value of share options vested during the years ended December&#160;31, 2023, 2022, and 2021 were $6.9 million, $12.0 million, and $3.2 million, respectively. The total intrinsic value of share options exercised during the years ended December&#160;31, 2023, 2022, and 2021 were $11.3 million, $17.4&#160;million, and $68.6 million, respectively. As of December&#160;31, 2023, unrecognized share-based compensation cost related to unvested share options was $6.4 million, which is expected to be recognized over a weighted-average period of 1.3 years.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes assumptions used to value the employee share options at the grant dates are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.44 - 6.60</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.26% - 68.52%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99% - 1.12%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00%</span></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These assumptions and estimates were determined as follows: </span></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Fair Value of Ordinary Shares - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to IPO, the fair value was determined by our board of directors, with input from management and valuation reports prepared by third-party valuation specialists. Post IPO, the fair value of each ordinary share was based on the closing price of our publicly traded ordinary shares as reported on the date of the grant. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Term - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expected term represents the period that the share options are expected to be outstanding. For share option grants that are considered to be &#8220;plain vanilla,&#8221; we determine the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the share options.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Volatility - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we have a short trading history for our ordinary shares, the expected volatility is derived from the average historical share volatilities of several unrelated public </span></div><div style="margin-bottom:9pt;padding-left:36pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">companies within our industry that we consider to be comparable to our own business over a period equivalent to the option&#8217;s expected term.</span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Risk-Free&#160;Interest Rate - </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free rate for the expected term of the share options are based on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards. </span></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Expected Dividend Yield.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. As a result, an expected dividend yield of zero percent was used.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Share Units</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs vest either upon the satisfaction of service-based vesting conditions, the satisfaction of both service-based and performance-based vesting conditions, or the satisfaction of service-based, performance-based, and market-based vesting conditions. Refer to Note 2 for more information regarding the vesting conditions of our RSUs. RSUs granted under the 2013 Plan can only vest prior to the expiration date of the award which is seven years from the date of grant. Any RSUs that have not vested will automatically terminate on their expiration date. RSUs granted under the 2021 Plan do not have an expiration date. </span></div><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date Fair Value<br/>Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,412,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,904,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,365,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,040,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,911,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><span><br/></span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023, total unrecognized share-based compensation expense related to unvested RSUs was approximately $115.0 million, which is expected to be recognized over a weighted-average period of 3.3 years.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">2021 Employee Share Purchase Plan</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We adopted the 2021 Employee Share Purchase Plan, or ESPP, in connection with our IPO on July 15, 2021, to enable eligible employees of the company and certain of its designated subsidiaries to use payroll deductions to purchase the company&#8217;s Class A ordinary shares and thereby acquire ownership interests in the Company. A total of 3,742,961 Class A ordinary shares are available for sale under the ESPP, subject to adjustment as provided for in the ESPP. In addition, on the first day of each fiscal year beginning on January 1, 2022 and ending on and including January 1, 2031, such pool of Class A ordinary shares shall be increased by that number of our Class A ordinary shares equal to the lesser of: (i) 1% of the outstanding Class A ordinary shares as of the last day of the immediately preceding fiscal year (calculated on a fully diluted as-converted basis); or (ii) such smaller amount as our board of directors may determine. In accordance with the above, our board of directors determined not to increase the number of Class A ordinary shares available for sale under the ESPP as of January 1, 2022, January 1, 2023, or January 1, 2024. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, all of our employees are eligible to participate if they are employed by us. However, an employee may not be granted rights to purchase our ordinary shares under the ESPP if such employee (i) </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">immediately after the grant would own capital shares or hold outstanding share options to purchase such shares possessing 5% or more of the total combined voting power or value of all classes of our shares or any of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2023, we have not effected any offering under the ESPP. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">CEO Multi-Year Equity Award</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, our board of directors and shareholders granted to our chief executive officer, Mr. Gal, a multi-year equity award, comprising 3,993,440 RSUs (the &#8220;Multi-Year Award&#8221;). The grant date fair value of the Multi-Year Award, which is the amount of share-based compensation expense that we recognize, is primarily determined based on the share price on the date the award was granted and is not based on our current share price. This amount is expensed utilizing the accelerated attribution method over the requisite service period of ten years. This method attributes higher expenses to the earlier periods of the requisite service period.  </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Multi-Year Award is structured so that meaningful value may only be realized upon the achievement of sustained and significant high performance levels. The award is divided into ten tranches that are eligible to vest based on the achievement of stock price goals, which range from $26.67 to $106.67, measured based on the average of our stock price over a trailing 60 trading day period during predefined performance periods, subject to Mr. Gal&#8217;s continued employment as our chief executive officer through each such period. In order to earn all of the tranches, the stock price will have to be more than 5 times higher than the price at IPO. No tranches of the Multi-Year Award were earned or vested in 2023. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the service-based vesting condition, and market-based vesting condition, each described above, the Multi-Year Award is also subject to a performance-based vesting condition. The performance-based vesting condition underlying the Multi-Year Award was satisfied upon the occurrence of our IPO in 2021. We recognized $8.6&#160;million, $13.0&#160;million, and $6.0&#160;million in share-based compensation expense related to the Multi-Year Award during the years ended December 31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//505/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542718736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.       Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ordinary taxable income in Israel is subject to a corporate tax rate of 23%. However, the effective tax rate payable by a company that derives income from a Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains (which are not &#8216;Inflationary Surplus&#8217;, as described below) derived by an Israeli company are generally subject to the prevailing corporate tax rate.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Law for the Encouragement of Capital Investments, 1959</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Law for the Encouragement of Capital Investments, 1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets).</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Investment Law was significantly amended effective on April 1, 2005, January 1, 2011, and on January 1, 2017, or the 2017 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment included new tax benefits for &#8220;Technological Enterprises,&#8221; as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2017 Amendment provides that a technology company satisfying certain conditions should qualify as a &#8220;Preferred Technology Enterprises,&#8221; or PTE, granting a 12% tax rate in central Israel on income deriving from Benefited Intangible Assets, subject to a number of conditions being fulfilled, including a minimal amount or ratio of annual R&amp;D expenditure and R&amp;D employees, as well as having at least 25% of annual income derived from exports to large markets. PTE is defined as an enterprise which meets the aforementioned conditions and for which total consolidated revenues of its parent company and all subsidiaries are less than NIS 10 billion.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not adopted the PTE status currently, but believe we are eligible for the PTE status in future tax years and have tax-effected our Israel deferred tax assets and liabilities at the appropriate PTE rates. Our subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profit (loss) before the provision for income taxes consisted of the following for the years ended December&#160;31, 2023, 2022, and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,663)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,872)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of our statutory income tax expense to our effective income tax provision is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,784)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred enterprise</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tranche right revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax income/(expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate was (10.89)% for the year ended December&#160;31, 2023, compared to an effective tax rate of (6.12)% for the year ended December 31, 2022 and (0.88)% for the year ended December 31, 2021. The effective tax rates for the periods presented are primarily comprised of Israel statutory taxes, warrant revaluation, share-based compensation expense, uncertain tax positions, and changes in valuation allowance position. The difference in the effective tax rate of (10.89)% for the year ended December&#160;31, 2023 as compared to the effective tax rate of (6.12)% for the year ended December 31, 2022 and (0.88)% for the year ended December 31, 2021 was related to non-deductible share-based compensation, prior period adjustments, uncertain tax positions, and change in valuation allowance position in Israel and in our U.S. subsidiary.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was $5.8 million, $6.0 million and $1.6&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. The provision for income taxes for the year ended December&#160;31, 2023 consisted primarily of income taxes related to the United States and other foreign jurisdictions in which we conduct business.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant components of our deferred tax assets and liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vacation and convalescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,688)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, we had Israel net operating loss, or NOL, carryforwards of approximately $75.7&#160;million and $68.9&#160;million, respectively, which do not expire. As of December&#160;31, 2023 and 2022, we had U.S. Federal NOL carryforwards of approximately $11.7&#160;million and $11.2&#160;million respectively, which do not expire.  As of December&#160;31, 2023, we had U.S. State NOL carryforwards of approximately $24.8&#160;million, of which $23.3&#160;million expire between 2028 and 2043, and the remaining $1.5&#160;million do not expire. As of December&#160;31, 2022, we had U.S. State NOL carryforwards of approximately $16.6&#160;million, of which $15.4&#160;million expire between 2027 and 2042, and the remaining $1.2&#160;million do not expire.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the years ended December&#160;31, 2023, 2022, and 2021 the net change in the valuation allowance against deferred tax assets amounted to an increase of $3.0&#160;million, an increase of $12.1&#160;million, and an increase of $4.4&#160;million, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2023, December 31, 2022 and December 31, 2021 was largely attributable to the generation of Israel NOLs, and certain US state NOLs. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In establishing deferred income tax assets and liabilities, management makes judgments based on the enacted tax laws and published tax guidance applicable to us as well as the amount and jurisdiction of future taxable income. Deferred tax assets and liabilities are recorded and the need for valuation allowances is evaluated to reduce the deferred tax assets to amounts expected to be realized. As of December&#160;31, 2023 and 2022, we maintained a full valuation allowance on Israel and U.S. net deferred tax assets as we believe, after weighing both the positive and negative evidence, that it is more likely than not that these deferred tax assets will not be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of NOLs in the event of an &#8220;ownership change&#8221; of a corporation. Accordingly, a company&#8217;s ability to use NOLs may be limited as prescribed under Internal Revenue Code Section 382, or IRC Section 382. Events which may cause limitations in the amount of the NOLs that we may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the U.S. federal and state NOLs may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. We have completed our evaluation of NOL utilization limitations under Internal Revenue Code, as amended, or the Code, Section 382, change of ownership rules, and have found that the NOLs would not be limited as to the amount that could be used in the current tax year.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have identified unrecognized tax benefits or uncertain tax positions. There has been a liability on uncertain tax positions recorded on our audited consolidated financial statements as of December&#160;31, 2023 and 2022. We do not expect that our assessment regarding unrecognized tax benefits and uncertain tax positions will materially change over the following 12 months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of total unrecognized tax position is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Tax Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the total amount of gross unrecognized tax benefits was $16.5 million and $11.3&#160;million, respectively, which, if recognized, would affect our effective tax rate. We have elected to include interest and penalties as a component of tax expense. As of December&#160;31, 2023 and 2022, we have accumulated $1.0&#160;million and $320&#160;thousand, respectively, in both interest and penalties associated with uncertain tax positions. We do not expect unrecognized tax benefits to change significantly within the next twelve months.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not currently under audit for income taxes. As of December&#160;31, 2023, tax years beginning with the year ended December 31, 2019 remain subject to examination by the Israel tax authorities and tax years beginning with the year ended December 31, 2020 remain subject to examination by the Internal Revenue Service and certain U.S. state jurisdictions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//740/tableOfContent<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-14<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-21<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482526/740-270-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542783824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.       Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:21.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,628)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,734)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,953)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net profit (loss) per share</span></div><div style="padding-left:21pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attributable to ordinary shareholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,005,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,768,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,450,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,216,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,757,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,702,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic and diluted net profit (loss) per share attributable to ordinary shareholders are the same for each class of ordinary shares as they are entitled to the same liquidation and dividend rights. The weighted-average potential ordinary shares that were excluded from the computation of diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive, or whose issuance is contingent upon the satisfaction of certain market conditions, are as follows:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:22.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,817,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,634,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,654,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,067,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,239,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,375,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,176,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,754,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,565&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,117,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,981,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,954,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span>Includes the warrants to purchase ordinary shares and warrants issued to customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//260/tableOfContent<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542588704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanTextBlock', window );">Employee Benefit Plans</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.       Employee Benefit Plans</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a defined-contribution plan in the United States intended to qualify under Section&#160;401 of the Internal Revenue Code, or the 401(k) Plan. The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a&#160;pre-tax&#160;basis. We offer a safe harbor matching contribution in an amount equal to 100% of participating employee contributions to the plan up to 4% of the employee&#8217;s eligible compensation. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $1.5 million, $1.1 million, and $0.8 million, respectively, of expenses related to the 401(k) plan. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Israeli Severance Pay </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Israel&#8217;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#8217;s salary for each year of employment, or a portion thereof. We have elected to include our employees in Israel under Section 14 of the Severance Pay Law, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments release us from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, any liability for severance pay due to these employees, and the deposits under Section 14 are not recorded as an asset in the consolidated balance sheets. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $4.2 million, $4.5 million, and $3.8 million, respectively, in severance expenses related to these employees.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//715-70/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540151824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Events</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.       Subsequent Events</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2024, the Company announced that it has undertaken certain actions to reduce operating expenses by initiating a reduction in force that impacted approximately 6% of the Company&#8217;s workforce. The majority of the associated costs, which are primarily related to severance and employee benefits, will be incurred in the first quarter of 2024 and are expected to be approximately $2.0&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//855/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540151824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">Schedule II - Valuation and Qualifying Accounts</a></td>
<td class="text"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Valuation and Qualifying Accounts</span></div><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at beginning of period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Increase </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Decrease </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Balance at end of period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">135,942&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(135,584)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,719&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,980&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">121,762&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(121,650)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">106,587&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(106,338)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,361&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">103,196&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(103,236)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,980&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Guarantee obligations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,445&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(96,716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,112&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for chargebacks, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">85,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(84,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,020&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Increases in Guarantee Obligations represent the portion of amounts billed in the period that is allocated to the indemnification guarantee. Increases in Provision for chargebacks, net represent the net chargeback expense recognized in the consolidated statements of operations during the period. </span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt">Decreases in Guarantee Obligations represent the amount released to revenue in the consolidated statements of operations during the period. Decreases in the Provision for chargebacks, net represent the amount of chargeback expenses paid during the period.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540842752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span></div>The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and include the accounts of Riskified Ltd. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Immaterial Prior Period Error Corrections</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Immaterial Prior Period Error Correction</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. We assessed the materiality of the error on the financial statements for prior years individually and in the aggregate, and concluded that it was not material to any previously issued consolidated financial statements. We corrected the error by revising the consolidated financial statements appearing herein. The impact of the errors on the Company&#8217;s consolidated balance sheet as of January 1, 2021 was an overstatement of deferred contract acquisition costs of $0.7 million and an understatement of accumulated deficit of $0.7 million. There was no impact of the error on the consolidated statements of cash flows for the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityPolicyTextBlock', window );">Treasury Shares</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Shares</span></div>In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares (the &#8220;Repurchase Program&#8221;). Costs associated with the acquisition of Class A ordinary shares are presented as Treasury Shares on the consolidated balance sheet as a reduction of shareholders' equity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives and investments, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#8220;IBR&#8221;) used for operating lease right-of-use (&#8220;ROU&#8221;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. We base our estimates on assumptions, both historical and forward-looking, trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the subsidiaries where the U.S. dollar is the functional currency, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars at exchange rates in effect at the end of each period. Foreign currency transaction gains and losses from these remeasurements are recognized in other income (expense), net, within the consolidated statements of operations. Foreign currency transactions resulted in net gains of $1.4&#160;million, $2.5&#160;million, and $0.2&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For subsidiaries where the functional currency is not the U.S. dollar, we use the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders&#8217; equity, into U.S. dollars. We record translation gains and losses in accumulated other comprehensive profit (loss) as a component of shareholders&#8217; equity in the consolidated balance sheets.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Risks</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risks</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our financial instruments that are exposed to concentrations of credit risk primarily consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivable and derivative financial instruments. We maintain our cash, cash equivalents, restricted cash, short-term deposits, and short-term investments with high-quality financial institutions mainly in the United States and Israel, the composition of which are regularly monitored by us. We have not experienced any material losses in such accounts. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers are online merchants. For accounts receivable, we are exposed to credit risk in the event of nonpayment by online merchants to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit to online merchants and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our merchants by performing periodic evaluations of credit worthiness and consumer indebtedness and applying other credit risk monitoring procedures. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Represents less than 10%</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Cash, Cash Equivalents, and Restricted Cash</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash, Cash Equivalents, and Restricted Cash</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. We consider all highly liquid investments, with an original maturity of three months or less at the date of purchase, to be cash equivalents. Our restricted cash primarily consisted of cash deposits to back letters of credit related to certain operating leases.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ShortTermDepositsPolicyPolicyTextBlock', window );">Short-Term Deposits</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Deposits</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term deposits are reported at cost.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Short-term Investments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Investments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. We determine the appropriate classification of our investments in marketable debt securities at the time of purchase and reevaluate such designation at each balance sheet date. After consideration of our risk versus reward objectives, as well as our liquidity requirements, we may sell these debt securities prior to their effective maturities. As a result, we classify our investments, including those with maturities beyond 12 months, as current assets in the Consolidated Balance Sheets. We carry these securities at fair value, and report the unrealized gains and losses, net of taxes, as a component of shareholders&#8217; equity, except for changes in allowance for expected credit losses, which is recorded in other income (expense), net, within the consolidated statements of operations. We periodically evaluate our available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, we consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these criteria are </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">met, we write down the security to its fair value and record the impairment charge in other income (expense), net within the consolidated statements of operations. If neither of these criteria are met, we determine whether credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We measure financial assets and liabilities at fair value for each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument&#8217;s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1 &#8211; Quoted prices (unadjusted) in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2 &#8211; Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3 &#8211; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivables, derivative financial instruments, accounts payables, accrued liabilities, indemnification guarantees. Cash and cash equivalents, short-term deposits, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Short-term investments and derivative financial instruments are stated at fair value on a recurring basis as disclosed in Note 4 below.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record indemnification guarantees that we issue upon approving a transaction at fair value when issued using the income approach. To measure this guarantee, we consider the premium that would have been received for the same guarantee if it were issued in a stand-alone transaction. The fair value of these indemnification guarantees is determined based on historical chargeback claims, a risk premium fee that would be required for a third party to assume this liability, and an appropriate discount rate due to the time period between issuance of the guarantee and settlement or expiration. Historical chargeback guarantee claims are not readily observable in the marketplace and are generally classified as Level 3 inputs. Indemnification guarantees are recorded at fair value when issued and not remeasured to fair value each period. Refer to Note 8 below for more information regarding indemnification guarantees.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments, in particular our indemnification guarantees, may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements. Refer to Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TradeAndOtherAccountsReceivablePolicy', window );">Accounts Receivable, Net</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The allowance for credit losses is based on our assessment of the collectability of accounts. We regularly review the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current merchant&#8217;s credit worthiness, the age of the balance, the nature and size of the merchant, the financial condition of the merchant, and the amount of any receivables in dispute. Accounts </span></div>receivable deemed uncollectible are charged against the allowance for credit losses when identified.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesPolicyTextBlock', window );">Derivative Financial Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Financial Instruments</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into derivative instruments to manage risks relating to our ongoing business operations. We enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks attributable to our exposure to changes in the exchange rates of (a) the New Israeli Shekel (&#8220;NIS&#8221;) against the U.S. dollar and (b) the Euro against the U.S. dollar. Our primary objective in entering into these contracts is to reduce the volatility of forecasted earnings and cash flows associated with changes in foreign currency exchange rates. We do not use derivative instruments for trading or speculative purposes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for our derivative instruments as either assets or liabilities and carry them at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. Derivative instruments are recorded as either prepaid expenses and other current assets or accrued expenses and other current liabilities in the consolidated balance sheets. We record changes in the fair value of derivative instruments that are designated as hedging instruments in accumulated other comprehensive profit (loss) in the consolidated balance sheets, until the forecasted transaction occurs upon which we reclassify the related gain or loss on the derivative to the same financial statement line item in the consolidated statements of operations to which the derivative relates.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge monetary assets or liabilities denominated in currencies other than the functional currency of a subsidiary. Changes in the fair value on these contracts, as well as the related costs, are recognized in Other income (expense), net, along with the foreign currency gains and losses on the related monetary assets and liabilities. Refer to Note 5 for additional information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs are expensed as incurred. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of our property and equipment are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of remaining lease term or estimated useful life</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InternalUseSoftwarePolicy', window );">Capitalized Software Costs and Cloud Computing Arrangement Implementation Costs</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Capitalized Software Costs</span></div>Costs related to software acquired, developed, or modified solely to meet our internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs incurred during the preliminary project stage and during the post implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized. Capitalized software development costs are recorded as part of other assets, noncurrent in the consolidated balance sheets. Maintenance costs are expensed as incurred. Capitalized software development costs are amortized on a straight-line basis over the software&#8217;s estimated useful life, which is four years and are recorded in cost of revenue&#160;in the consolidated statements of operations.<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cloud Computing Arrangement Implementation Costs</span></div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize certain implementation costs incurred in a cloud computing arrangement during the application development stage pursuant to Accounting Standards Codification, or ASC, 350-40,</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Internal Use Software. </span>These costs are amortized over the term of the hosting arrangement on a straight-line basis, and are included within operating expenses in the consolidated statements of operations. Costs incurred in the preliminary stages of development are analogous to research and development activities and are expensed as incurred. These capitalized costs are included in other assets, noncurrent in the consolidated balance sheets.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease accounting policy under ASC Topic 840, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; until January 1, 2022, prior to the adoption of the new lease guidance was as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leases are reviewed and classified as either capital or operating leases at their inception. In certain lease agreements, we may receive renewal or expansion options, rent holidays, and other incentives. For operating leases, we recognize lease costs on a straight-line basis once we take control of the space, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2022, we adopted the new lease guidance for our operating lease agreements. Refer to Note 7 below for additional information. Our lease accounting policy under ASC Topic 842, &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ASC 842</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; from January 1, 2022, following the adoption of the new lease guidance is as follows:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement meets the definition of a lease at the inception of the lease, and leases are classified at commencement as either operating or finance leases. We do not have any finance leases. Operating lease ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease agreement. Operating lease ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives received prior to lease commencement. Operating lease liabilities are measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using our IBR based on the information available at the commencement date of the lease as our leases generally do not provide an implicit rate. Our IBR was estimated to </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include options to extend or terminate the lease when it is reasonably certain that we would exercise that option. We made an accounting policy election for lease agreements with a term of 12 months or less and do not recognize operating lease ROU assets and operating lease liabilities in respect of those agreements. Payments under our lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and operating lease liabilities. Variable lease payments are mainly comprised of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We elected the practical expedient to not separate lease and non-lease components for our leases.</span></div>We sublease certain office spaces to third parties. Operating sublease income is recognized on a straight-line basis over the term of the agreement.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We evaluate the recoverability of long-lived assets, including property and equipment, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Recoverability of these assets is measured by comparing the carrying amounts with the future undiscounted cash flows that the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. We determined that there were no material events or changes in circumstances that indicated that our long-lived assets were impaired during the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies', window );">Indemnifications Guarantees</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Indemnification Guarantees</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#8217;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#8220;guarantee obligation&#8221;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Guarantees</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and will be released to revenue in the consolidated statements of operations.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being released from risk under the guarantee obligation.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or ASC 450</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inputs and assumptions used by management to calculate this provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. These liabilities are recorded within Provision for chargebacks, net on the consolidated balance sheets and will be reduced by credits issued or cash paid to merchants. Refer to Note 8 below or </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Item 5. &#8220;</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Operating and Financial Review and Prospects</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8212; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Accounting Policies and Estimates&#8221; </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for additional information.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock', window );">Ordinary Share Warrants</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ordinary Share Warrants</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to IPO, warrants to purchase our Series B/C and E-1 convertible preferred shares were recorded as a liability at fair value on our consolidated balance sheets as the underlying convertible preferred shares were contingently redeemable, upon a deemed liquidation event that is outside of our control, and therefore could have obligated us to transfer assets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series B/C convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or upon the completion of a qualified IPO. Upon IPO, the Series B/C convertible preferred share warrants were converted to warrants to purchase ordinary shares, and the then outstanding liability was reclassified to additional paid-in capital in the consolidated balance sheets. The warrants to purchase ordinary shares may be exercised any time prior to, and shall expire upon, the earlier of (a) April 29, 2025 or (b) immediately prior to the consummation of certain deemed liquidation events. In November 2023, the outstanding warrants to purchase ordinary shares were exercised. Refer to Note 9.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Series E-1 convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or the completion of a deemed liquidation event, including a qualified IPO. Upon IPO, the Series E-1 convertible preferred share warrants were automatically exercised.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with a SaaS Agreement entered into in 2021, we issued a warrant to a customer to purchase ordinary shares. The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years. As of December 31, 2023, the warrant is outstanding.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees as noted above within &#8220;Indemnification Guarantees&#8221;. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#8217; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As noted above within &#8220;Indemnification Guarantees&#8221;, our contracts with our merchants obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a six-month period from the date of the transaction.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present revenue net of cancellations and adjustments for minimum service level agreements.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 606, revenue is recognized when a customer obtains control of promised products. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these products. To achieve the core principle of this standard, we applied the following five steps:</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the contract, or contracts, with the merchant</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine that we have a contract with a merchant when the contract is approved, each party&#8217;s rights and obligations regarding the products to be transferred can be identified, the payment terms for the products can be identified, we have determined the merchant has the ability and intent to pay, and the contract has commercial substance. At contract inception, we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Contracts with our merchants are typically for a period of one year.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Identification of the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Performance obligations promised in a contract are identified based on the products that will be transferred to the merchant that are both capable of being distinct, whereby the merchant can benefit from the products either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the products is separately identifiable from other promises in the contract. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For SaaS arrangements, we provide access to our cloud-hosted software platform and reviewing and approving eCommerce transaction for legitimacy, without providing the merchant the right to take possession of our software, which we consider to be a single performance obligation. Revenue generated from the issuance of indemnification guarantees is accounted for under ASC 460. Refer to &#8220;Indemnification Guarantees&#8221; above and Note 8 below for additional information.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Determination of the transaction price</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our contracts include an unknown quantity of approved transactions at a fixed contractual rate per approved transaction value executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of products during that month. Certain of our contracts include additional forms of variable consideration such as service level commitments relating to uptime availability and minimum approval rates as well as provisions that provide for reimbursements should our merchant&#8217;s consumer cancel an approved order. If we fail to meet these commitments, merchants are generally permitted to receive a refund in the form of a credit on their invoice. Under certain arrangements, when the merchant&#8217;s consumer cancels an order that we have approved, we provide a refund of some or all of the fees owed by our merchant to us generally in the form of a credit on our merchant&#8217;s invoice. The transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payment terms and conditions vary by contract type, although terms generally include a requirement to pay within 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined that our contracts do not include a significant financing component. The primary purpose of our invoicing terms is to provide our merchants with simplified and predictable ways of purchasing our products; not to receive financing from our merchants or to provide merchants with financing. We applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from merchants (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. We generally do not offer a right of refund in our contracts.</span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Allocation of the transaction price to the performance obligations in the contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation&#8217;s relative standalone selling price. Access to our cloud-hosted software is considered one performance obligation in the context of the contract and accordingly the transaction price is allocated to this single performance obligation. </span></div><div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">5.</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt">Recognition of the revenue when, or as, a performance obligation is satisfied</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue is recognized at the time the related performance obligation is satisfied by transferring control of the promised service to the customer. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products. For SaaS arrangements, we have determined that these arrangements meet the variable consideration allocation exception and revenue is recognized over the contract period in the month that the transactions are approved.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Balances </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets consist of unbilled accounts receivable. The terms of our agreements are monthly, annual, or multi-year, and we typically invoice our merchants based on monthly usage. In some arrangements, a right to consideration for our performance under the merchant contract may occur before invoicing to the merchant, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Obtain a Contract</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. These costs are recorded as Deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of four years. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales commissions expenses are included in sales and marketing expense in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost to Fulfill a Contract </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We capitalize payroll related costs of certain integration services required in order to be able to fulfill the obligation to provide our products to our merchants. Integration services are promises that are not capable of being distinct. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and generate or enhance resources that will be used in delivering our SaaS products. These costs are recorded as deferred contract fulfillment costs in other assets, noncurrent on the consolidated balance sheets. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized costs to fulfill a contract are amortized on a straight-line basis over the expected period of benefit of four years and are included in cost of revenue in the consolidated statements of operations. We </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the period of benefit by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of period of benefit involve inherent uncertainties and the application of significant judgment. We periodically review these deferred contract fulfillment costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfSalesPolicyTextBlock', window );">Cost of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead.</span></div>Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development costs also consist of third-party software hosting fees used by our research and development teams, depreciation expense, and allocated overhead. Research and development costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock', window );">Sales and Marketing</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales and Marketing</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales and marketing costs primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead. Sales and marketing costs are expensed as incurred.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Digital marketing programs include advertising, promotional events, and brand-building activities. Advertising costs are expensed as incurred and were $4.9 million, $6.0 million, and $5.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">General and Administrative</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">General and administrative costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead. General and administrative costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to share-based awards is recognized based on the fair value of the awards granted. The fair value of each share option award is estimated on the grant date </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected term of the share option, the expected volatility of the price of our ordinary shares, risk-free interest rates, and the expected dividend yield of ordinary shares. The assumptions used to determine the fair value of the option awards represent management&#8217;s best estimates. These estimates involve inherent uncertainties and the application of management&#8217;s judgment. The related share-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have granted to employees, RSUs, that vest either upon the (a) satisfaction of service-based vesting conditions only and (b) satisfaction of both service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying ordinary shares as of the grant date. We have also granted to our Chief Executive Officer (&#8220;CEO&#8221;), RSUs, that vest upon the satisfaction of service-based, performance-based, and market-based vesting conditions. A Monte-Carlo simulation model was used to determine the grant date fair value by simulating a range of scenarios with each outcome resulting in a determined value. The grant date fair value of this award is the average of the values determined by each simulation. The simulation was also used to derive the requisite service period.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For RSU awards with both service-based and performance-based vesting conditions, the service-based vesting condition has varying terms, but is generally satisfied over <span style="-sec-ix-hidden:f-639">four</span> to five years. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) the six month anniversary of or, if earlier, March 15 of the year following, the occurrence of an IPO or (ii) consummation of a merger and acquisition, or M&amp;A, transaction of the Company. The performance-based vesting condition underlying these awards was satisfied upon our IPO. The market-based condition underlying the CEO RSU is satisfied upon the trading price of our ordinary shares meeting certain thresholds.</span></div>RSU awards with service-based vesting conditions only are recognized using the straight-line method. RSU awards with more than just a service-based vesting condition are recognized using the accelerated attribution method once the performance-based vesting condition is probable of<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Profit (Loss) Per Share Attributable to Ordinary Shareholders </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We compute net profit (loss) per share using the two-class method required for participating securities. The two-class method requires income available to ordinary shareholders for the period to be </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Under the two-class method, we allocate earnings proportionately to Class A and B ordinary shares outstanding for the period. Prior to IPO, we considered our convertible preferred shares to be participating securities as the holders of the convertible preferred shares would be entitled to dividends in preference to ordinary shareholders. These participating securities do not contractually require the holders of such shares to participate in our losses. As such, net loss for the periods presented was not allocated to our participating securities. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our basic net profit (loss) per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net profit (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net profit (loss) per share is the same as basic net profit (loss) per share in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Information</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segment Information</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate our business in one operating segment and therefore have one reportable segment. Operating segments are defined as components of an entity that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker, who is our CEO, in deciding how to allocate resources and assess performance. Our chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue by geographical region can be found in the revenue recognition disclosures in Note 3 below. Property and equipment, net of depreciation and amortization, by geographic region can be found in Note 6 below. Operating lease ROU assets by geographic region can be found in Note 7 below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As an emerging growth company, or EGC, the Jumpstart Our Business Startups Act, or the JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards. We have elected to use extended transition periods permissible under the JOBS Act while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued Accounting Standards Update (&#8220;ASU&#8221;) No. 2016-13, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments &#8211; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including subsequent amendments thereafter, which established ASC 326. ASC 326 replaces the existing incurred loss impairment model with a current expected credit loss model that requires more timely recognition of estimated expected credit losses over the life of certain financial instruments. Our accounts receivable and available-for-sale debt securities are in the scope of ASC 326. We adopted ASC 326 as of January 1, 2023. The adoption of ASC 326 did not have a material impact on our financial condition and results of operations within our consolidated financial statements.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reportable Segments (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses, including public entities with a single operating or reportable segment. The updated standard will be effective for annual periods beginning in fiscal 2024 and interim periods beginning in the first quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): </span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, which expands disclosures in an entity&#8217;s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The updated standard will be effective for annual periods beginning in fiscal 2026. We are currently evaluating the impact of this standard on our financial statement disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_SalesAndMarketingExpensePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sales And Marketing Expense, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_SalesAndMarketingExpensePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ShortTermDepositsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Short-Term Deposits, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ShortTermDepositsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants and Rights, Rights, Warrants, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480981/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfSalesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cost of product sold and service rendered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Topic 705<br> -Publisher FASB<br> -URI https://asc.fasb.org//705/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfSalesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its derivative instruments and hedging activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(n))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//830/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//460/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480091/360-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 4<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482338/360-10-05-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479886/946-10-S99-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-17<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-25<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-28<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-19<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InternalUseSoftwarePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 30<br> -Paragraph 1<br> -SubTopic 40<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482633/350-40-30-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -SubTopic 50<br> -Topic 350<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482610/350-50-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InternalUseSoftwarePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 205<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483504/205-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480321/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org//606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-29<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org//718/tableOfContent<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481062/946-235-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TradeAndOtherAccountsReceivablePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481569/310-20-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-11B<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-6<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 310<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TradeAndOtherAccountsReceivablePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545891120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock', window );">Schedule of Immaterial Prior Period Error Corrections</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the effects of the corrections on the Company&#8217;s consolidated financial statements for the years ended December 31, 2022 and 2021:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2022</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(350,553)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,981)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(352,534)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,722&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">716&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88,438&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(108,632)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109,348)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(97,947)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,663)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(103,989)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(716)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(104,705)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.62&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:44.066%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.736%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31, 2021</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Previously Reported</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Adjustment</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As Revised</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,630&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(246,564)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,265)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(247,829)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,165&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">545&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,398)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,943)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Profit (loss) before income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,327)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,872)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(178,885)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(545)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(179,430)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.01)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedules of Concentration of Risk, by Risk Factor</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:26.624%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.844%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accounts Receivable</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer A</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer B</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">________________</span></div><div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Represents less than 10%</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock', window );">Rollforward of Allowance for Credit Losses</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of the allowance for credit losses:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:84.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current period provision</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">198&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncollectible accounts charged against the allowance</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(170)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Recoveries of amounts previously deemed uncollectible</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">515&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of our property and equipment are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of remaining lease term or estimated useful life</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-12<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482989/270-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177544607648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Revenue from External Customers by Geographic Areas</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue by region in which our merchants&#8217; headquarters are located:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.611%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.724%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">182,806&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,920&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163,681&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe, the Middle East and Africa (&#8220;EMEA&#8221;)*</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71,443&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44,850&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific (&#8220;APAC&#8221;)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,699&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,005&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,416&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Americas</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,558&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,879&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,194&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt">Revenue recognized from merchants whose headquarters are in Israel, which is our country of domicile, was $1.3 million, $3.3 million, and $2.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes revenue based on the nature and type of service provided to our merchants:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.496%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percentage of Revenue</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except where indicated)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fraud review service revenue (ASC 606)</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,278&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">156,040&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132,261&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">58&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Indemnification guarantee service revenue (ASC 460)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105,207&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96,880&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">297,610&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">261,247&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229,141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock', window );">Deferred Policy Acquisition Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract acquisition costs:</span></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,263&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,894&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,707&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,715)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,689)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,642)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,562&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,383&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredContractFulfillmentCostsTableTextBlock', window );">Deferred Contract Fulfillment Costs</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents a roll-forward of deferred contract fulfillment costs that are included within in other assets, noncurrent on the consolidated balance sheets:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.912%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning balance</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions to deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,635&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,189&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,789&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred contract fulfillment costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,852)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,446)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,025)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,456&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,673&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,930&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_DeferredContractFulfillmentCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Contract Fulfillment Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_DeferredContractFulfillmentCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the movement in deferred policy acquisition costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479432/944-30-50-2B<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479432/944-30-50-2B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 944<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479401/944-30-55-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph a<br> -SubTopic 10<br> -Topic 280<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542970432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables present information about our financial instruments that are measured at fair value on a recurring basis:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds included within short-term investments</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-733">Derivative financial instruments included in prepaid expenses and other current assets</span></span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,276&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-742">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.720%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.723%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 2&#160;</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level 3&#160;</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Financial Liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:f-751">Derivative financial instruments included in accrued expenses and other current liabilities</span></span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total financial liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Debt Securities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term investments consisted of the following:</span></div><div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:43.566%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.466%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.237%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amortized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Cost</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gains</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrealized</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Losses</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Government bonds</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,882&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total short-term investments</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,882&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">229&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(143)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock', window );">Schedule of Estimate of Fair Value of Investments by Contractual Maturity Dates</a></td>
<td class="text">The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates:<div style="margin-bottom:9pt;text-indent:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:77.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Due in 1 year or less</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,968&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540184176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock', window );">Schedule of Derivative Instruments</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our foreign currency contracts are denominated in NIS and Euro. The gross notional amounts of outstanding foreign currency contracts in U.S. dollar were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments:</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,716&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,998&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,314&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,814&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Total derivative instruments  </span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74,030&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,812&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effect of foreign currency contracts on the Consolidated Statements of Operations during the periods presented were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.797%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.800%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Designated as Hedging Instruments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Derivatives Not Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Statement of Operations Location:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">168&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(175)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,659)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,718)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,051)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(732)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,263)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(706)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total gain (loss) recognized in earnings</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(534)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,659)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Accumulated Other Comprehensive Income (Loss)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents the net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, that were recorded in accumulated other comprehensive profit (loss) during the periods presented, and their effect on other comprehensive profit (loss) for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.073%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2020</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">176&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,448&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,331)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,883)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,707)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,585&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive profit (loss)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,634&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance as of December 31, 2023</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(73)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4E<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4E<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 815<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1A<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1B<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-8<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-5<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4C<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542849184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated useful lives of our property and equipment are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.675%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.125%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7 years</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shorter of remaining lease term or estimated useful life</span></td></tr></table></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net </span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Computer equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,592&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and office equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,593&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,531&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,702&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,576&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, gross</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,887&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,019&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,248)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,433)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,639&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,586&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses and other current liabilities consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,548&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,175&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,724&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,388&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative financial instruments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">462&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,397&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,853&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,796&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,813&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, noncurrent consisted of the following:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.053%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.002%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.004%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other tax liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,706&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities, noncurrent</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,706&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,734&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542862368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of operating lease cost for the years ended December&#160;31, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.592%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.733%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.734%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease cost</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,140&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Variable lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,010&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,257&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term lease cost</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">170&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">304&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sublease income</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,347)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(786)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease cost</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,075&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,915&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The future minimum lease payments included in the measurement of our operating lease liabilities as of December&#160;31, 2023, were as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,714&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,804&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,851&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,183&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total undiscounted lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36,055&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: imputed interest</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,746)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,309&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our operating lease ROU assets by geographic region:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,782&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,560&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,598&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease right-of-use assets</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,742&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,158&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177543858448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees, Commitments, and Contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock', window );">Recorded Unconditional Purchase Obligations</a></td>
<td class="text">As of December&#160;31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:<div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.117%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year Ending December&#160;31,</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">512&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">96&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,714&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of unconditional purchase obligation recognized as liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482648/440-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 470<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481544/470-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542665056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Temporary Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityDisclosureAbstract', window );"><strong>Temporary Equity Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2023 and 2022, the following warrants were issued and outstanding:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:23.419%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.643%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issued and Outstanding Share Warrants</span></td><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A Ordinary Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B Ordinary Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants issued to customers</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.01&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">June 2028</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545553408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of Stock by Class</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the following ordinary shares reserved for future issuance:</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.374%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">499,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,775,475&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2013 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,981,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,062,824&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share options and RSUs issued and outstanding under the 2021 Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,299,528&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,134,652&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available for future issuance under the 2021 Plan</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,766,560&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,674,132&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total ordinary shares reserved</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,546,857</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43,647,083</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span>Includes the warrants to purchase ordinary shares and warrants issued to customers.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Share-based Payment Arrangement, Option, Activity</a></td>
<td class="text">A summary of share options under our equity incentive plan and related information is as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.601%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.082%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Share Options Outstanding</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Outstanding Share Options</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise <br/>Price</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Life (Years)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic <br/>Value</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share, life and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,785,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.17&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,326&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options exercised</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,010,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.22&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options forfeited</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(405,202)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.72&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2023</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,369,534&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.39&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,303&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,849,876&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.13&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>There were no share options granted during the years ended December&#160;31, 2023 or December&#160;31, 2022.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Black-Scholes assumptions used to value the employee share options at the grant dates are as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.689%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected term (years)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.44 - 6.60</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.26% - 68.52%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.99% - 1.12%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.00%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock', window );">Schedule of Unvested Restricted Stock Units Roll Forward</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:66.207%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.925%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.927%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average<br/>Grant-Date Fair Value<br/>Per Share</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19,412,262&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.06&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,904,664&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.43&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6,365,261)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.28&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,040,402)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.31&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unvested as of December 31, 2023</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,911,263&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.02&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock', window );">Disclosure of Share-based Compensation Arrangements by Share-based Payment Award</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.521%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">621&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,152&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,005&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,253&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,710&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,068&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,588&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total share-based compensation expense</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62,410&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67,467&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,358&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -SubTopic 10<br> -Topic 820<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-5<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481142/505-10-45-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-10<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-8<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-6<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in restricted stock units (RSUs).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542034080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income before Income Tax, Domestic and Foreign</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profit (loss) before the provision for income taxes consisted of the following for the years ended December&#160;31, 2023, 2022, and 2021:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,269)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55,414)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(154,549)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,968)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43,249)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,323)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(53,237)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(98,663)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(177,872)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provision for income taxes was as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(225)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,039&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,715&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,814&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8,719&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Israel</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,677)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,433&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income tax expense</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2,677)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,433&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total provision for income taxes</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Effective Income Tax Rate Reconciliation</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of our statutory income tax expense to our effective income tax provision is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:56.111%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.682%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.683%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Israel tax benefit at statutory rate</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,245)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,528)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(40,784)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred enterprise</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,652&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,573&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,052&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign rate differential</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(785)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,050)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">912&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,158&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,717&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,753&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrant revaluation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,325&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tranche right revaluation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prior year tax income/(expense)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,675)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Permanent differences</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">587&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,351)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Uncertain tax position</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,772&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,233&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,784&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,961&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,444&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,798&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,042&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the significant components of our deferred tax assets and liabilities:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.791%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,550&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,436&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,333&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,059&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,212&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred Compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,762&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,214&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vacation and convalescence</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">746&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bad debts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,946&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,166&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">466&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32,986&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31,077&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,015&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(23,783)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,822)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,699)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,203&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,255&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">316&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,577)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,387)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred contract acquisition costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,971)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,009)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,324)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(109)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(279)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(283)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized Software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(541)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(591)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(397)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross deferred tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,198)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,266)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,004)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax assets/(liabilities)</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,688)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits Roll Forward</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the beginning and ending balance of total unrecognized tax position is as follows:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.957%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.843%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Unrecognized Tax Benefits</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; January 1, 2021</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">234&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,885&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2021</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,119&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(54)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2022</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,252&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additions based on tax positions related to current year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,273&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Reductions for tax positions of prior years</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance &#8211; December 31, 2023</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,512&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 9<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Paragraph 12<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545887088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Earnings Per Share, Basic and Diluted</a></td>
<td class="text"><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented:</span></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"><tr><td style="width:1.0%"></td><td style="width:21.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.265%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.460%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.444%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.980%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="9" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(38,407)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,628)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57,734)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46,971)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(90,953)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(88,477)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average shares used in computing net profit (loss) per share</span></div><div style="padding-left:21pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">attributable to ordinary shareholders, basic and diluted</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,005,250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,768,148&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">92,450,867&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,216,507&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38,757,558&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,702,067&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net profit (loss) per share attributable to ordinary shareholders, basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.33)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.62)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.35)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock', window );">Schedule of Weighted Average Number of Shares</a></td>
<td class="text">The weighted-average potential ordinary shares that were excluded from the computation of diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive, or whose issuance is contingent upon the satisfaction of certain market conditions, are as follows:<div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:22.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.099%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.442%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.100%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year Ended December 31,</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class A</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Class B</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Convertible preferred shares</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,817,201&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,634,404&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase ordinary shares</span><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">725,334&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">873,370&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">850,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,488,819&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">354,243&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding share options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,654,082&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,067,720&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,239,441&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Unvested RSUs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,375,114&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,176,275&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,131,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,562,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,965,604&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,754,530&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">753,565&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,117,365&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,981,665&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33,107,849&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,954,251&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">_________________</span></div><span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(1)</span>Includes the warrants to purchase ordinary shares and warrants issued to customers.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536226128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jul. 28, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($) </div>
<div>vote </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Aug. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Overstatement of deferred contract acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (15,562,000)<span></span>
</td>
<td class="num">$ (14,383,000)<span></span>
</td>
<td class="num">$ (10,365,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (6,263,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Understatement of accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">411,569,000<span></span>
</td>
<td class="nump">352,534,000<span></span>
</td>
<td class="nump">247,829,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Sale of stock, consideration received on transaction</a></td>
<td class="nump">$ 386,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">204,000<span></span>
</td>
<td class="nump">5,302,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_PaymentsOfOtherStockIssuanceCosts', window );">Payments of other stock issuance costs</a></td>
<td class="nump">$ 5,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stock split conversion ratio</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossRealized', window );">Foreign currency transaction gain (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="nump">2,500,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Accounts receivable, allowance for credit loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 515,000<span></span>
</td>
<td class="nump">487,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsTerm', window );">Guarantee obligations, term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">six<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_RevenueTermOfMerchantContract', window );">Contract term with merchant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostAmortizationPeriod', window );">Capitalized contract cost, amortization period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostImpairmentLoss', window );">Capitalized contract cost, impairment loss</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ChargebackExpense', window );">Chargeback expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(25,000,000)<span></span>
</td>
<td class="num">(20,300,000)<span></span>
</td>
<td class="num">(14,300,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,900,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 62,410,000<span></span>
</td>
<td class="nump">67,467,000<span></span>
</td>
<td class="nump">$ 33,358,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29,742,000<span></span>
</td>
<td class="nump">35,158,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 31,309,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=rskd_SeriesE1ConvertiblePreferredStockMember', window );">Series E-1 Convertible Preferred Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of convertible preferred stock (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">962,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">962,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CommonStockVotesForEachShare', window );">Votes per common share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Authorized amounts under repurchase program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 75,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CommonStockVotesForEachShare', window );">Votes per common share | vote</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Software Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">$ 400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rskd_CloudComputingArrangementImplementationCostsMember', window );">Cloud Computing Arrangement Implementation Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedComputerSoftwareGross', window );">Capitalized software costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember', window );">Software and Software Development Costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">19,925,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Sale of stock, price per share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 21.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payments of stock issuance costs</a></td>
<td class="nump">$ 26,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Stock issued, conversion of convertible securities (in shares) | shares</a></td>
<td class="nump">32,291,470<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember', window );">Over-Allotment Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Sale of stock, number of shares issued in transaction (in shares) | shares</a></td>
<td class="nump">2,625,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ChargebackExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Chargeback Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ChargebackExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_CommonStockVotesForEachShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Votes For Each Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_CommonStockVotesForEachShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_PaymentsOfOtherStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments Of Other Stock Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_PaymentsOfOtherStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_RevenueTermOfMerchantContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Term Of Merchant Contract</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_RevenueTermOfMerchantContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity, Stock Issued During Period, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482686/350-30-45-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedComputerSoftwareGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481283/985-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedComputerSoftwareGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostAmortizationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -SubTopic 40<br> -Topic 340<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostAmortizationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossRealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of realized gain (loss) from foreign currency transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481956/830-20-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 830<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481926/830-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossRealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describe the approximate term of the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 50<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147477123/405-50-65-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482477/820-10-65-13<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 832<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483482/832-10-65-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479845/805-20-65-3<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479832/842-10-65-5<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-2<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 11.M.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480530/250-10-S99-5<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483194/926-20-65-2<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 69: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 70: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 71: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 72: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 73: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 74: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483421/250-10-45-6<br><br>Reference 75: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 76: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 77: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 78: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482833/825-10-65-6<br><br>Reference 79: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 80: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 81: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 82: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 83: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 84: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 85: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 86: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 87: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 88: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 89: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 90: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 91: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481925/310-20-65-2<br><br>Reference 92: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480424/946-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481139/470-20-50-1E<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=rskd_SeriesE1ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=rskd_SeriesE1ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rskd_CloudComputingArrangementImplementationCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=rskd_CloudComputingArrangementImplementationCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_SoftwareAndSoftwareDevelopmentCostsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_OverAllotmentOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177534218112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details) - Customer Concentration Risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">17.00%<span></span>
</td>
<td class="nump">22.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts Receivable | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">11.00%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
<td class="nump">16.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481027/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rskd_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rskd_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=rskd_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=rskd_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536404064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jan. 01, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Deferred contract acquisition costs</a></td>
<td class="nump">$ 15,562<span></span>
</td>
<td class="nump">$ 14,383<span></span>
</td>
<td class="nump">$ 10,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(411,569)<span></span>
</td>
<td class="num">(352,534)<span></span>
</td>
<td class="num">(247,829)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="nump">88,441<span></span>
</td>
<td class="nump">88,438<span></span>
</td>
<td class="nump">70,710<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit (loss)</a></td>
<td class="num">(76,849)<span></span>
</td>
<td class="num">(109,348)<span></span>
</td>
<td class="num">(55,943)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="num">(53,237)<span></span>
</td>
<td class="num">(98,663)<span></span>
</td>
<td class="num">(177,872)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="num">$ (59,035)<span></span>
</td>
<td class="num">$ (104,705)<span></span>
</td>
<td class="num">$ (179,430)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">(0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">(0.33)<span></span>
</td>
<td class="num">(0.62)<span></span>
</td>
<td class="num">(2.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">(0.33)<span></span>
</td>
<td class="num">(0.62)<span></span>
</td>
<td class="num">(2.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Deferred contract acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16,364<span></span>
</td>
<td class="nump">$ 11,630<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(350,553)<span></span>
</td>
<td class="num">(246,564)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,722<span></span>
</td>
<td class="nump">70,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(108,632)<span></span>
</td>
<td class="num">(55,398)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(97,947)<span></span>
</td>
<td class="num">(177,327)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (103,989)<span></span>
</td>
<td class="num">$ (178,885)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember', window );">As Previously Reported | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2.34)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Deferred contract acquisition costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (1,981)<span></span>
</td>
<td class="num">$ (1,265)<span></span>
</td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,981)<span></span>
</td>
<td class="num">(1,265)<span></span>
</td>
<td class="num">$ (700)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">716<span></span>
</td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(716)<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(716)<span></span>
</td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net profit (loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (716)<span></span>
</td>
<td class="num">$ (545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustment | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember', window );">Adjustment | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems', window );"><strong>Error Corrections and Prior Period Adjustments Restatement [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (0.01)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-10<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483581/946-220-45-7<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483499/205-20-50-7<br><br>Reference 35: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1A<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-1B<br><br>Reference 38: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480990/946-20-50-11<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_ScenarioPreviouslyReportedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RestatementAxis=srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540252672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Beginning balance</a></td>
<td class="nump">$ 487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Current period provision</a></td>
<td class="nump">198<span></span>
</td>
<td class="nump">$ 3<span></span>
</td>
<td class="nump">$ 268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Uncollectible accounts charged against the allowance</a></td>
<td class="num">(170)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries', window );">Recoveries of amounts previously deemed uncollectible</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Ending balance</a></td>
<td class="nump">$ 515<span></span>
</td>
<td class="nump">$ 487<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in allowance for credit loss on accounts receivable, from recovery.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479319/326-20-50-13<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177541784464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember', window );">Furniture and office equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, useful life</a></td>
<td class="text">7 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536373536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Revenue by Geographic Areas (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 297,610<span></span>
</td>
<td class="nump">$ 261,247<span></span>
</td>
<td class="nump">$ 229,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 182,806<span></span>
</td>
<td class="nump">$ 163,920<span></span>
</td>
<td class="nump">$ 163,681<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">61.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">71.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 80,547<span></span>
</td>
<td class="nump">$ 71,443<span></span>
</td>
<td class="nump">$ 44,850<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember', window );">EMEA | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 16,699<span></span>
</td>
<td class="nump">$ 12,005<span></span>
</td>
<td class="nump">$ 7,416<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia Pacific | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">$ 3,300<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 17,558<span></span>
</td>
<td class="nump">$ 13,879<span></span>
</td>
<td class="nump">$ 13,194<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AmericasMember', window );">Americas | Revenue Benchmark | Geographic Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_EMEAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_EMEAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AmericasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AmericasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539758448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues, Total</a></td>
<td class="nump">$ 297,610<span></span>
</td>
<td class="nump">$ 261,247<span></span>
</td>
<td class="nump">$ 229,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rskd_FraudServiceRevenueMember', window );">Fraud Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue from Contract with Customer, Excluding Assessed Tax</a></td>
<td class="nump">167,278<span></span>
</td>
<td class="nump">156,040<span></span>
</td>
<td class="nump">132,261<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=rskd_IndemnificationServiceRevenueMember', window );">Indemnification Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueNotFromContractWithCustomer', window );">Revenue Not from Contract with Customer</a></td>
<td class="nump">$ 130,332<span></span>
</td>
<td class="nump">$ 105,207<span></span>
</td>
<td class="nump">$ 96,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | Fraud Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">56.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">58.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue Benchmark | Product Concentration Risk | Indemnification Service Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk, percentage</a></td>
<td class="nump">44.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 91<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-91<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479941/924-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueNotFromContractWithCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue that is not accounted for under Topic 606.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueNotFromContractWithCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480097/470-10-S99-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-42<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rskd_FraudServiceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rskd_FraudServiceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=rskd_IndemnificationServiceRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=rskd_IndemnificationServiceRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_ProductConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539768864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Deferred Contract Acquisition Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_MovementInDeferredContractAcquisitionCostsRollForward', window );"><strong>Movement In Deferred Contract Acquisition Costs [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Capitalized Contract Cost, Net, Noncurrent</a></td>
<td class="nump">$ 14,383<span></span>
</td>
<td class="nump">$ 10,365<span></span>
</td>
<td class="nump">$ 6,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts', window );">Increase (Decrease) To Deferred Contract Acquisition Costs</a></td>
<td class="nump">8,894<span></span>
</td>
<td class="nump">9,707<span></span>
</td>
<td class="nump">7,744<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CapitalizedDeferredContractAcquisitionCostAmortization', window );">Capitalized Deferred Contract Acquisition Cost, Amortization</a></td>
<td class="num">(7,715)<span></span>
</td>
<td class="num">(5,689)<span></span>
</td>
<td class="num">(3,642)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CapitalizedContractCostNetNoncurrent', window );">Capitalized Contract Cost, Net, Noncurrent</a></td>
<td class="nump">$ 15,562<span></span>
</td>
<td class="nump">$ 14,383<span></span>
</td>
<td class="nump">$ 10,365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_CapitalizedDeferredContractAcquisitionCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Capitalized Deferred Contract Acquisition Cost, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_CapitalizedDeferredContractAcquisitionCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) To Deferred Contract Acquisition Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_MovementInDeferredContractAcquisitionCostsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Movement In Deferred Contract Acquisition Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_MovementInDeferredContractAcquisitionCostsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalizedContractCostNetNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479483/340-40-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalizedContractCostNetNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540259168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue Recognition - Deferred Contract Fulfillment Costs (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_MovementInDeferredContractFulfillmentCostsRollForward', window );"><strong>Movement In Deferred Contract Fulfillment Costs [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredContractFulfillmentCostsNoncurrent', window );">Deferred Contract Fulfillment Costs, Noncurrent</a></td>
<td class="nump">$ 3,673<span></span>
</td>
<td class="nump">$ 2,930<span></span>
</td>
<td class="nump">$ 2,166<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts', window );">Increase (Decrease) To Deferred Contract Fulfillment Costs</a></td>
<td class="nump">2,635<span></span>
</td>
<td class="nump">2,189<span></span>
</td>
<td class="nump">1,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredContractFulfillmentCostsAmortizationExpense', window );">Deferred Contract Fulfillment Costs, Amortization Expense</a></td>
<td class="num">(1,852)<span></span>
</td>
<td class="num">(1,446)<span></span>
</td>
<td class="num">(1,025)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredContractFulfillmentCostsNoncurrent', window );">Deferred Contract Fulfillment Costs, Noncurrent</a></td>
<td class="nump">$ 4,456<span></span>
</td>
<td class="nump">$ 3,673<span></span>
</td>
<td class="nump">$ 2,930<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_DeferredContractFulfillmentCostsAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Contract Fulfillment Costs, Amortization Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_DeferredContractFulfillmentCostsAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_DeferredContractFulfillmentCostsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Contract Fulfillment Costs, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_DeferredContractFulfillmentCostsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) To Deferred Contract Fulfillment Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_MovementInDeferredContractFulfillmentCostsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Movement In Deferred Contract Fulfillment Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_MovementInDeferredContractFulfillmentCostsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177547214176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Financial Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Government bonds included within short-term investments</a></td>
<td class="nump">$ 28,968<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Asset, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Prepaid expenses and other current assets<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration', window );">Derivative Liability, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Accrued expenses and other current liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Government bonds included within short-term investments</a></td>
<td class="nump">$ 28,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative financial instruments included in prepaid expenses and other current assets</a></td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">29,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative financial instruments included in accrued expenses and other current liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Fair Value, Inputs, Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Government bonds included within short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative financial instruments included in prepaid expenses and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative financial instruments included in accrued expenses and other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Fair Value, Inputs, Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Government bonds included within short-term investments</a></td>
<td class="nump">28,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative financial instruments included in prepaid expenses and other current assets</a></td>
<td class="nump">308<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">29,276<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative financial instruments included in accrued expenses and other current liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Fair Value, Recurring | Fair Value, Inputs, Level 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Government bonds included within short-term investments</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeAssets', window );">Derivative financial instruments included in prepaid expenses and other current assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total financial assets</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract', window );"><strong>Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Derivative financial instruments included in accrued expenses and other current liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosure', window );">Total financial liabilities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480493/946-210-55-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(3)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column A)(Footnote 3))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480524/946-210-50-6<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(e))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H)(Footnote 7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(9)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G)(Footnote 8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5C<br> -Subparagraph (SX 210.12-13C(Column H))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SX 210.12-13(Column G))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5A<br> -Subparagraph (SX 210.12-13A(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5B<br> -Subparagraph (SX 210.12-13B(Column E)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480032/946-320-S99-5B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 22: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-10<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes derivative liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial and nonfinancial obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540843008">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Short-term Investments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">$ 28,882<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">28,968<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember', window );">Government bonds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss', window );">Amortized Cost</a></td>
<td class="nump">28,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(143)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 28,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_USGovernmentDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542774944">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Effective Contractual Maturity Dates (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue', window );">Due in 1 year or less</a></td>
<td class="nump">$ 28,968<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 28,968<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480832/942-320-50-3A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481800/320-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481830/320-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177544582960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivative Instruments and Hedging - Derivative Instruments (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivative instruments</a></td>
<td class="nump">$ 74,030<span></span>
</td>
<td class="nump">$ 77,812<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivative instruments</a></td>
<td class="nump">63,716<span></span>
</td>
<td class="nump">63,998<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Foreign Exchange Forward | Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Total derivative instruments</a></td>
<td class="nump">$ 10,314<span></span>
</td>
<td class="nump">$ 13,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-22<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483466/210-20-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483444/210-20-55-7<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4B<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -SubTopic 20<br> -Topic 860<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481326/860-20-50-4D<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177546001424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">$ (4,951)<span></span>
</td>
<td class="num">$ (3,331)<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">168<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">(146)<span></span>
</td>
<td class="num">(175)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">(2,659)<span></span>
</td>
<td class="num">(1,718)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">(1,051)<span></span>
</td>
<td class="num">(732)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">(1,263)<span></span>
</td>
<td class="num">(706)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">(534)<span></span>
</td>
<td class="num">(1,659)<span></span>
</td>
<td class="nump">59<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Not Designated as Hedging Instrument | Other income (expense), net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Total gain (loss) recognized in earnings</a></td>
<td class="num">$ (534)<span></span>
</td>
<td class="num">$ (1,659)<span></span>
</td>
<td class="nump">$ 59<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480434/815-10-50-4A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OtherNonoperatingIncomeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540800912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward', window );"><strong>Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 494,436<span></span>
</td>
<td class="nump">$ 527,596<span></span>
</td>
<td class="num">$ (44,029)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Other comprehensive profit (loss)</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="num">(1,883)<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">491,721<span></span>
</td>
<td class="nump">494,436<span></span>
</td>
<td class="nump">527,596<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember', window );">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward', window );"><strong>Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(1,707)<span></span>
</td>
<td class="nump">176<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax', window );">Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)</a></td>
<td class="nump">6,585<span></span>
</td>
<td class="nump">1,448<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent', window );">Other comprehensive profit (loss)</a></td>
<td class="nump">1,634<span></span>
</td>
<td class="num">(1,883)<span></span>
</td>
<td class="nump">176<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">$ (73)<span></span>
</td>
<td class="num">$ (1,707)<span></span>
</td>
<td class="nump">$ 176<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax, before reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482765/220-10-50-4<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 220<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482739/220-10-55-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480167/946-830-55-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545935600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 25,887<span></span>
</td>
<td class="nump">$ 26,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(10,248)<span></span>
</td>
<td class="num">(7,433)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">15,639<span></span>
</td>
<td class="nump">18,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">6,592<span></span>
</td>
<td class="nump">6,912<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember', window );">Furniture and office equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">2,593<span></span>
</td>
<td class="nump">2,531<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 16,702<span></span>
</td>
<td class="nump">$ 16,576<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=rskd_FurnitureAndOfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542608224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 3.6<span></span>
</td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="nump">$ 1.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545538240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent', window );">Customer credits</a></td>
<td class="nump">$ 6,724<span></span>
</td>
<td class="nump">$ 5,388<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">4,548<span></span>
</td>
<td class="nump">6,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities', window );">Derivative Instruments and Hedges, Liabilities</a></td>
<td class="nump">462<span></span>
</td>
<td class="nump">2,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">1,062<span></span>
</td>
<td class="nump">1,853<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent', window );">Accrued expenses and other current liabilities</a></td>
<td class="nump">$ 12,796<span></span>
</td>
<td class="nump">$ 15,813<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Liabilities And Other Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerRefundLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 27<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479777/606-10-55-27<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerRefundLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177542803392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent', window );">Deferred Tax and Other Liabilities, Noncurrent</a></td>
<td class="nump">$ 14,706<span></span>
</td>
<td class="nump">$ 8,734<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, noncurrent</a></td>
<td class="nump">$ 14,706<span></span>
</td>
<td class="nump">$ 8,734<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545939280">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 15,639<span></span>
</td>
<td class="nump">$ 18,586<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">1,403<span></span>
</td>
<td class="nump">1,796<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">14,209<span></span>
</td>
<td class="nump">16,671<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rskd_NonIsraelAndNonUSMember', window );">Rest of world</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">$ 27<span></span>
</td>
<td class="nump">$ 119<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479440/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 360<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480842/942-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rskd_NonIsraelAndNonUSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rskd_NonIsraelAndNonUSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177541965344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 6,242<span></span>
</td>
<td class="nump">$ 6,140<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">1,010<span></span>
</td>
<td class="nump">1,257<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">170<span></span>
</td>
<td class="nump">304<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubleaseIncome', window );">Sublease income</a></td>
<td class="num">(1,347)<span></span>
</td>
<td class="num">(786)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total operating lease cost</a></td>
<td class="nump">$ 6,075<span></span>
</td>
<td class="nump">$ 6,915<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubleaseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of sublease income excluding finance and operating lease expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubleaseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536325184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">6 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">4.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual obligation</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ContractualObligationTerm', window );">Contractual obligation, term</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ContractualObligationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual Obligation, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ContractualObligationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue recognized for the period under subleasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481475/840-20-55-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540806096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Maturity Lease Schedule (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 5,744<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">5,714<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">5,759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">5,804<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">5,851<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">7,183<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total undiscounted lease payments</a></td>
<td class="nump">36,055<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(4,746)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of operating lease liabilities</a></td>
<td class="nump">$ 31,309<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539882928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases (By Geographic Region) (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 29,742<span></span>
</td>
<td class="nump">$ 35,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">29,742<span></span>
</td>
<td class="nump">35,158<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">18,782<span></span>
</td>
<td class="nump">22,560<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">18,782<span></span>
</td>
<td class="nump">22,560<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">10,960<span></span>
</td>
<td class="nump">12,598<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">$ 10,960<span></span>
</td>
<td class="nump">$ 12,598<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539762768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Guarantees, Commitments, and Contingencies - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsCurrentCarryingValue', window );">Guarantee obligations</a></td>
<td class="nump">$ 12,719<span></span>
</td>
<td class="nump">$ 12,361<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsTerm', window );">Guarantee obligations, term</a></td>
<td class="text">six<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ProvisionForChargebacksCurrent', window );">Provision for chargebacks, net</a></td>
<td class="nump">$ 12,092<span></span>
</td>
<td class="nump">11,980<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteeObligationsMaximumExposure', window );">Guarantor obligations, maximum exposure</a></td>
<td class="nump">$ 57,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_GuarantorObligationsPercentageOfGuaranteesPaid', window );">Percentage of guarantees paid</a></td>
<td class="nump">0.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_GuarantorObligationsChargebackExpense', window );">Chargeback expense</a></td>
<td class="nump">$ 121,800<span></span>
</td>
<td class="nump">103,200<span></span>
</td>
<td class="nump">$ 85,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesRentExpenseNet', window );">Lease cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue', window );">Sublease income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractualObligation', window );">Contractual obligation</a></td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_ContractualObligationTerm', window );">Contractual obligation, term</a></td>
<td class="text">3 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ContractualObligationTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual Obligation, Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ContractualObligationTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_GuarantorObligationsChargebackExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Chargeback Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_GuarantorObligationsChargebackExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_GuarantorObligationsPercentageOfGuaranteesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Guarantor Obligations, Percentage Of Guarantees Paid</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_GuarantorObligationsPercentageOfGuaranteesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ProvisionForChargebacksCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Provision For Chargebacks, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ProvisionForChargebacksCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractualObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractualObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsCurrentCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsCurrentCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsMaximumExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsMaximumExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteeObligationsTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Describe the approximate term of the guarantee or each group of similar guarantees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482425/460-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteeObligationsTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue recognized for the period under subleasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481475/840-20-55-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasesRentExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 840<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481501/840-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasesRentExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536198496">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInNextTwelveMonths', window );">2024</a></td>
<td class="nump">$ 1,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInSecondYear', window );">2025</a></td>
<td class="nump">512<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligationDueInThirdYear', window );">2026</a></td>
<td class="nump">96<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PurchaseObligation', window );">Total</a></td>
<td class="nump">$ 1,714<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInSecondYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInSecondYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PurchaseObligationDueInThirdYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PurchaseObligationDueInThirdYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539860720">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Ordinary Share Warrants (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">41,546,857<span></span>
</td>
<td class="nump">43,647,083<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember', window );">Options and RSUs | 2013 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">15,981,269<span></span>
</td>
<td class="nump">20,062,824<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="nump">499,500<span></span>
</td>
<td class="nump">924,825<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">850,650<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants to purchase ordinary shares | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">425,325<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants to purchase ordinary shares | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,650<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 0.28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_WarrantIssuedToCustomersMember', window );">Warrants issued to customers | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="nump">499,500<span></span>
</td>
<td class="nump">499,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 0.01<span></span>
</td>
<td class="nump">$ 0.01<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_WarrantIssuedToCustomersMember', window );">Warrants issued to customers | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TemporaryEquityLineItems', window );"><strong>Temporary Equity [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Issued and Outstanding Share Warrants (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Weighted-Average Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rskd_A2013EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rskd_A2013EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_WarrantIssuedToCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rskd_WarrantIssuedToCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540127376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
<th class="th"><div>Jul. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased (in shares)</a></td>
<td class="nump">3,038,865<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Shares repurchased</a></td>
<td class="nump">$ 13,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_StockRepurchaseProgramTransactionCosts', window );">Transaction costs</a></td>
<td class="nump">$ 100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">41,546,857<span></span>
</td>
<td class="nump">43,647,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">10,904,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 62,410<span></span>
</td>
<td class="nump">$ 67,467<span></span>
</td>
<td class="nump">$ 33,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=rskd_A2021EmployeeSharePurchasePlanMember', window );">2021 Employee Share Purchase Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,742,961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent', window );">Ordinary shares reserved for future issuance, annual increase percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage', window );">Maximum ownership of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">900,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Share-based compensation expense not yet recognized</a></td>
<td class="nump">$ 115,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Chief Executive Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 8,600<span></span>
</td>
<td class="nump">$ 13,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Share-based Payment Arrangement, Tranche Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average grant date fair value of options granted in period (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 16.63<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1', window );">Aggregate grant date fair value of options vested during the period</a></td>
<td class="nump">$ 6,900<span></span>
</td>
<td class="nump">$ 12,000<span></span>
</td>
<td class="nump">$ 3,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based payment arrangement, nonvested award, cost not yet recognized amount</a></td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition</a></td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">8,766,560<span></span>
</td>
<td class="nump">8,674,132<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,951,037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent', window );">Ordinary shares reserved for future issuance, annual increase percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Annual Increase, Percent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved For Future Issuance, Maximum Ownership, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_StockRepurchaseProgramTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Repurchase Program, Transaction Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_StockRepurchaseProgramTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=rskd_A2021EmployeeSharePurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis=rskd_A2021EmployeeSharePurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545741344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details) - shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">41,546,857<span></span>
</td>
<td class="nump">43,647,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rskd_A2013EquityIncentivePlanMember', window );">2013 Equity Incentive Plan | Options and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">15,981,269<span></span>
</td>
<td class="nump">20,062,824<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">8,766,560<span></span>
</td>
<td class="nump">8,674,132<span></span>
</td>
<td class="nump">13,951,037<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember', window );">2021 Equity Incentive Plan | Options and RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">16,299,528<span></span>
</td>
<td class="nump">13,134,652<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=rskd_WarrantsToPurchaseOrdinarySharesMember', window );">Warrants To Purchase Ordinary Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Total ordinary shares reserved (in shares)</a></td>
<td class="nump">499,500<span></span>
</td>
<td class="nump">1,775,475<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rskd_A2013EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rskd_A2013EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=rskd_A2021EquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConversionOfStockByUniqueDescriptionAxis=rskd_WarrantsToPurchaseOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConversionOfStockByUniqueDescriptionAxis=rskd_WarrantsToPurchaseOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177541738480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Share Options, beginning balance (in shares)</a></td>
<td class="nump">13,785,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Outstanding Share Options, Options exercised (in shares)</a></td>
<td class="num">(3,010,478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Outstanding Share Options, Options forfeited (in shares)</a></td>
<td class="num">(405,202)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding Share Options, ending balance (in shares)</a></td>
<td class="nump">10,369,534<span></span>
</td>
<td class="nump">13,785,214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, beginning balance (in dollars per share)</a></td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options exercised (in dollars per share)</a></td>
<td class="nump">1.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options forfeited (in dollars per share)</a></td>
<td class="nump">3.72<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, ending balance (in dollars per share)</a></td>
<td class="nump">$ 2.39<span></span>
</td>
<td class="nump">$ 2.17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Life, Options outstanding</a></td>
<td class="text">5 years 6 months<span></span>
</td>
<td class="text">6 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Options outstanding</a></td>
<td class="nump">$ 24,303<span></span>
</td>
<td class="nump">$ 34,326<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate Intrinsic Value, Options exercised</a></td>
<td class="nump">$ 11,300<span></span>
</td>
<td class="nump">$ 17,400<span></span>
</td>
<td class="nump">$ 68,600<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Outstanding Share Options, Options exercisable (in shares)</a></td>
<td class="nump">8,849,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Options exercisable (in dollars per share)</a></td>
<td class="nump">$ 2.13<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Life, Options exercisable</a></td>
<td class="text">5 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Options exercisable</a></td>
<td class="nump">$ 22,904<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Share-based Payment Arrangement, Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Stock Options Additional Disclosures</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Share-based payment arrangement, nonvested award, cost not yet recognized amount</a></td>
<td class="nump">$ 6,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (e)(1)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536037280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details) - Share-based Payment Arrangement, Option<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">67.26%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years 5 months 8 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.99%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.52%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.12%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540266032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2023 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested as of December 31, 2020 (in shares) | shares</a></td>
<td class="nump">19,412,262<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">10,904,664<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(6,365,261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares) | shares</a></td>
<td class="num">(2,040,402)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested as of December 31, 2021 (in shares) | shares</a></td>
<td class="nump">21,911,263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted-Average Grant-Date Fair Value Per Share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested beginning balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 9.06<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">5.43<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">7.28<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">6.31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Unvested ending balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 8.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177546191824">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 62,410<span></span>
</td>
<td class="nump">$ 67,467<span></span>
</td>
<td class="nump">$ 33,358<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember', window );">Chief Executive Officer | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">8,600<span></span>
</td>
<td class="nump">13,000<span></span>
</td>
<td class="nump">6,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">770<span></span>
</td>
<td class="nump">621<span></span>
</td>
<td class="nump">216<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">13,152<span></span>
</td>
<td class="nump">10,005<span></span>
</td>
<td class="nump">4,246<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Sales and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">19,420<span></span>
</td>
<td class="nump">18,253<span></span>
</td>
<td class="nump">10,710<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total share-based compensation expense</a></td>
<td class="nump">$ 29,068<span></span>
</td>
<td class="nump">$ 38,588<span></span>
</td>
<td class="nump">$ 18,186<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=srt_ChiefExecutiveOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545467136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance for deferred tax asset</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">16,512<span></span>
</td>
<td class="nump">11,252<span></span>
</td>
<td class="nump">$ 4,119<span></span>
</td>
<td class="nump">$ 234<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, income tax penalties and interest expense</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">75,700<span></span>
</td>
<td class="nump">68,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">11,700<span></span>
</td>
<td class="nump">11,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | UNITED STATES</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">24,800<span></span>
</td>
<td class="nump">16,600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | UNITED STATES | Tax Year 2042</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">23,300<span></span>
</td>
<td class="nump">15,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | UNITED STATES | Do not expire</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Operating loss carryforwards</a></td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="nump">$ 1,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ExpirationPeriodAxis=rskd_TaxYear2042Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ExpirationPeriodAxis=rskd_TaxYear2042Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_ExpirationPeriodAxis=us-gaap_LatestTaxYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_ExpirationPeriodAxis=us-gaap_LatestTaxYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536280672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="num">$ (53,237)<span></span>
</td>
<td class="num">$ (98,663)<span></span>
</td>
<td class="num">$ (177,872)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="num">(23,269)<span></span>
</td>
<td class="num">(55,414)<span></span>
</td>
<td class="num">(154,549)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rskd_NonIsraelMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Profit (loss) before income taxes</a></td>
<td class="num">$ (29,968)<span></span>
</td>
<td class="num">$ (43,249)<span></span>
</td>
<td class="num">$ (23,323)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479557/942-235-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -SubTopic 20<br> -Topic 940<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481913/940-20-25-1<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rskd_NonIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rskd_NonIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177546181664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Provision for Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">$ 5,814<span></span>
</td>
<td class="nump">$ 8,719<span></span>
</td>
<td class="nump">$ 125<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense</a></td>
<td class="num">(16)<span></span>
</td>
<td class="num">(2,677)<span></span>
</td>
<td class="nump">1,433<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">5,798<span></span>
</td>
<td class="nump">6,042<span></span>
</td>
<td class="nump">1,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IL', window );">Israel</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="num">(225)<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=rskd_NonIsraelMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationLineItems', window );"><strong>Income Tax Examination [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income tax expense</a></td>
<td class="nump">6,039<span></span>
</td>
<td class="nump">8,715<span></span>
</td>
<td class="nump">121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income tax expense</a></td>
<td class="num">$ (16)<span></span>
</td>
<td class="num">$ (2,677)<span></span>
</td>
<td class="nump">$ 1,433<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IL">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IL</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=rskd_NonIsraelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=rskd_NonIsraelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540802160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Effective Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Israel tax benefit at statutory rate</a></td>
<td class="num">$ (12,245)<span></span>
</td>
<td class="num">$ (22,528)<span></span>
</td>
<td class="num">$ (40,784)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount', window );">Preferred enterprise</a></td>
<td class="nump">1,652<span></span>
</td>
<td class="nump">10,573<span></span>
</td>
<td class="nump">3,052<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="num">(785)<span></span>
</td>
<td class="num">(1,050)<span></span>
</td>
<td class="nump">912<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">8,158<span></span>
</td>
<td class="nump">9,717<span></span>
</td>
<td class="nump">1,753<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes', window );">Prior year tax income/(expense)</a></td>
<td class="num">(302)<span></span>
</td>
<td class="num">(6,675)<span></span>
</td>
<td class="nump">84<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Permanent differences</a></td>
<td class="nump">587<span></span>
</td>
<td class="num">(3,351)<span></span>
</td>
<td class="nump">98<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxContingencies', window );">Uncertain tax position</a></td>
<td class="nump">5,772<span></span>
</td>
<td class="nump">7,233<span></span>
</td>
<td class="nump">3,784<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="nump">2,961<span></span>
</td>
<td class="nump">12,123<span></span>
</td>
<td class="nump">4,444<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Total provision for income taxes</a></td>
<td class="nump">$ 5,798<span></span>
</td>
<td class="nump">$ 6,042<span></span>
</td>
<td class="nump">$ 1,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Corporates tax rate</a></td>
<td class="nump">10.89%<span></span>
</td>
<td class="nump">6.12%<span></span>
</td>
<td class="nump">0.88%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember', window );">Warrants to purchase ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount', window );">Warrant revaluation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,325<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember', window );">Convertible Preferred Share Tranche Rights [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxContingencyLineItems', window );"><strong>Income Tax Contingency [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount', window );">Warrant revaluation</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 4,890<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Preferred Enterprise, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Warrant Revaluation, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxContingencyLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxContingencyLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-10<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479360/740-10-S99-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482659/740-20-45-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=rskd_ConvertiblePreferredShareTrancheRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177539848784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development expenses</a></td>
<td class="nump">$ 7,550<span></span>
</td>
<td class="nump">$ 7,374<span></span>
</td>
<td class="nump">$ 1,436<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">10,333<span></span>
</td>
<td class="nump">9,059<span></span>
</td>
<td class="nump">5,212<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation', window );">Deferred Compensation</a></td>
<td class="nump">6,762<span></span>
</td>
<td class="nump">5,214<span></span>
</td>
<td class="nump">1,009<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_DeferredTaxAssetsLeasingArrangements', window );">Operating lease liabilities</a></td>
<td class="nump">5,565<span></span>
</td>
<td class="nump">6,456<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences', window );">Vacation and convalescence</a></td>
<td class="nump">746<span></span>
</td>
<td class="nump">730<span></span>
</td>
<td class="nump">799<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts', window );">Bad debts</a></td>
<td class="nump">84<span></span>
</td>
<td class="nump">78<span></span>
</td>
<td class="nump">93<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOther', window );">Other</a></td>
<td class="nump">1,946<span></span>
</td>
<td class="nump">2,166<span></span>
</td>
<td class="nump">466<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Gross deferred tax assets</a></td>
<td class="nump">32,986<span></span>
</td>
<td class="nump">31,077<span></span>
</td>
<td class="nump">9,015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(23,783)<span></span>
</td>
<td class="num">(20,822)<span></span>
</td>
<td class="num">(8,699)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total deferred tax assets</a></td>
<td class="nump">9,203<span></span>
</td>
<td class="nump">10,255<span></span>
</td>
<td class="nump">316<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements', window );">Operating lease right-of-use assets</a></td>
<td class="num">(5,577)<span></span>
</td>
<td class="num">(6,387)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts', window );">Deferred contract acquisition costs</a></td>
<td class="num">(2,971)<span></span>
</td>
<td class="num">(3,009)<span></span>
</td>
<td class="num">(2,324)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="num">(109)<span></span>
</td>
<td class="num">(279)<span></span>
</td>
<td class="num">(283)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware', window );">Capitalized Software</a></td>
<td class="num">(541)<span></span>
</td>
<td class="num">(591)<span></span>
</td>
<td class="num">(397)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Gross deferred tax liabilities</a></td>
<td class="num">(9,198)<span></span>
</td>
<td class="num">(10,266)<span></span>
</td>
<td class="num">(3,004)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Net deferred tax assets/(liabilities)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11)<span></span>
</td>
<td class="num">(2,688)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Increase (decrease) in valuation allowance for deferred tax asset</a></td>
<td class="nump">$ 3,000<span></span>
</td>
<td class="nump">$ 12,100<span></span>
</td>
<td class="nump">$ 4,400<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_DeferredTaxAssetsLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Leasing Arrangements</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_DeferredTaxAssetsLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479853/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesLeasingArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesLeasingArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177536051872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Reconciliation of Unrecognized Tax Position (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Beginning balance</a></td>
<td class="nump">$ 11,252<span></span>
</td>
<td class="nump">$ 4,119<span></span>
</td>
<td class="nump">$ 234<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Additions based on tax positions related to current year</a></td>
<td class="nump">5,273<span></span>
</td>
<td class="nump">7,187<span></span>
</td>
<td class="nump">3,885<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Reductions for tax positions of prior years</a></td>
<td class="num">(13)<span></span>
</td>
<td class="num">(54)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Ending balance</a></td>
<td class="nump">16,512<span></span>
</td>
<td class="nump">11,252<span></span>
</td>
<td class="nump">$ 4,119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Unrecognized tax benefits, income tax penalties and interest expense</a></td>
<td class="nump">$ 1,000<span></span>
</td>
<td class="nump">$ 320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545955680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)</a></td>
<td class="nump">176,773,398<span></span>
</td>
<td class="nump">167,667,374<span></span>
</td>
<td class="nump">76,459,625<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">176,773,398<span></span>
</td>
<td class="nump">167,667,374<span></span>
</td>
<td class="nump">76,459,625<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net profit (loss) attributable to ordinary shareholders, basic</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (90,953)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net profit (loss) attributable to ordinary shareholders, diluted</a></td>
<td class="num">$ (38,407)<span></span>
</td>
<td class="num">$ (57,734)<span></span>
</td>
<td class="num">$ (90,953)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38,757,558<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">115,005,250<span></span>
</td>
<td class="nump">92,450,867<span></span>
</td>
<td class="nump">38,757,558<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net profit (loss) attributable to ordinary shareholders, basic</a></td>
<td class="num">$ (20,628)<span></span>
</td>
<td class="num">$ (46,971)<span></span>
</td>
<td class="num">$ (88,477)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net profit (loss) attributable to ordinary shareholders, diluted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (88,477)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">61,768,148<span></span>
</td>
<td class="nump">75,216,507<span></span>
</td>
<td class="nump">37,702,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)</a></td>
<td class="num">$ (0.33)<span></span>
</td>
<td class="num">$ (0.62)<span></span>
</td>
<td class="num">$ (2.35)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-15<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483589/942-220-S99-1<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483586/944-220-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482635/260-10-55-52<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-11<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483443/250-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-31<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482810/280-10-50-32<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-11<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 5<br> -Subparagraph (SAB Topic 6.B)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540201216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">176,773,398<span></span>
</td>
<td class="nump">167,667,374<span></span>
</td>
<td class="nump">76,459,625<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember', window );">Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">35,754,530<span></span>
</td>
<td class="nump">33,117,365<span></span>
</td>
<td class="nump">33,107,849<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">115,005,250<span></span>
</td>
<td class="nump">92,450,867<span></span>
</td>
<td class="nump">38,757,558<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">753,565<span></span>
</td>
<td class="nump">2,981,665<span></span>
</td>
<td class="nump">37,954,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicLineItems', window );"><strong>Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)</a></td>
<td class="nump">61,768,148<span></span>
</td>
<td class="nump">75,216,507<span></span>
</td>
<td class="nump">37,702,067<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">17,817,201<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember', window );">Convertible Preferred Stock | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">35,634,404<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase ordinary shares | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">725,334<span></span>
</td>
<td class="nump">873,370<span></span>
</td>
<td class="nump">1,488,819<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase ordinary shares | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">753,565<span></span>
</td>
<td class="nump">850,650<span></span>
</td>
<td class="nump">354,243<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">11,654,082<span></span>
</td>
<td class="nump">16,067,720<span></span>
</td>
<td class="nump">12,239,441<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Share-based Payment Arrangement | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Common Class A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">23,375,114<span></span>
</td>
<td class="nump">16,176,275<span></span>
</td>
<td class="nump">1,562,388<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">2,131,015<span></span>
</td>
<td class="nump">1,965,604<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-60B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177540927424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution, percent of match</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employer matching contribution, percent of employees' pay</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Defined contribution plan, cost</a></td>
<td class="nump">$ 1.5<span></span>
</td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_rskd_SeverancePayRate', window );">Severance pay rate</a></td>
<td class="nump">8330.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeveranceCosts1', window );">Severance costs</a></td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 3.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_rskd_SeverancePayRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Severance Pay Rate</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">rskd_SeverancePayRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>rskd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeveranceCosts1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeveranceCosts1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545778608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events (Details) - Subsequent Event<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
</tr>
<tr><th class="th">
<div>Feb. 29, 2024 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent', window );">Percentage of Company's workforce to be impacted (percent)</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Expected costs to be incurred</a></td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147479823/420-10-S99-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 420<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147482017/420-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 855<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.0.1</span><table class="report" border="0" cellspacing="2" id="idm140177545991120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember', window );">Guarantee obligations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">$ 12,361<span></span>
</td>
<td class="nump">$ 12,112<span></span>
</td>
<td class="nump">$ 12,445<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">increase</a></td>
<td class="nump">135,942<span></span>
</td>
<td class="nump">106,587<span></span>
</td>
<td class="nump">96,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Decrease</a></td>
<td class="num">(135,584)<span></span>
</td>
<td class="num">(106,338)<span></span>
</td>
<td class="num">(96,716)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">12,719<span></span>
</td>
<td class="nump">12,361<span></span>
</td>
<td class="nump">12,112<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=rskd_ProvisionForChargebacksMember', window );">Provision for chargebacks, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward', window );"><strong>SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at beginning of period</a></td>
<td class="nump">11,980<span></span>
</td>
<td class="nump">12,020<span></span>
</td>
<td class="nump">10,582<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">increase</a></td>
<td class="nump">121,762<span></span>
</td>
<td class="nump">103,196<span></span>
</td>
<td class="nump">85,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesDeductions', window );">Decrease</a></td>
<td class="num">(121,650)<span></span>
</td>
<td class="num">(103,236)<span></span>
</td>
<td class="num">(84,013)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Balance at end of period</a></td>
<td class="nump">$ 12,092<span></span>
</td>
<td class="nump">$ 11,980<span></span>
</td>
<td class="nump">$ 12,020<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInValuationAllowancesAndReservesRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInValuationAllowancesAndReservesRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesDeductions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesDeductions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=us-gaap_WarrantyReservesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesTypeAxis=rskd_ProvisionForChargebacksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesTypeAxis=rskd_ProvisionForChargebacksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>101
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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M(&V V=\*H8^&/:"9W-%?4$L#!!0    ( (J&9EBI9JPBZ@8  +$?   8
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MR&;9O!]NOFBQK5^Q+H76HJ@_;CB#]:H,X/]K(?3SE^JM[?$M_?P_4$L#!!0
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MEDU>QKRK1D0$\.=SC-GK0/1M39_N_P%02P,$%     @ BH9F6"N=[BZ"!@
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MS4+=9E^R<II7VP*['X!B56]'Q<<$#+4)06D3*,V#TBB4YFN"_:!TAVB6V^V
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MB;MP#1JA@"T&I4_Y$$SZ1=D.4TX4EU/ZRE2K/=.VTR:2(LOW\8>*[6!!F"J
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M!(39K)XX+L)"6D>F+F:Q(.(L#%PV= .[WFVUY1B'NI8(;DNC'&( T1*+-E]
M1TO<!/)H J\RXQR09DXKT'KP$!F=>Y%D5LNA>3V(Q:IC\.99,LN(#60<N IU
MNN[#A+790P(N4VOH@UZQPT_7:FM#^Z3Y'D03(SY,P&@D4 ($6F-PW#\O?^O
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ML:5%DG,?[ %?FD)R8ZW.RQ,G\XI 0G18M,Q$:6.'9NH%PYCYE8 $!O*$- &
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MP0O7K8J\0)KJM,Y(Y8&3_Z8*I=6'!0K+U4<7$K?MTG:XZ^K57;LBEV@GX4>
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M[!J UB^V>G7#SF?.OVLH3!&;MX/V\GUB+&) 0X2$%I;[A\;C/.\996I1'70
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M\8$<(1:CX"AEH6++S-YM-_;J<L;B8,[9QXS:^[_GDP+\GX-;XU&M1G:!3:@
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MY/7I2+CX73!>!%OSM[C,AF!+_KF";Y6C!7B^L*B4Z8(.Z#[.7OT;4$L#!!0
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MP0<?J/TA_+%=2P.V&FYUO0#U.,6#!)TM'^0D.*05N,$Z'AF<I(X:67$,_6S
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M,;)_4YN2?A:W-'5MMO1RHR3$%RZ [U?&U/X-/J#]G>3+_P=02P,$%     @
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M1W_O6=.?D0&]60QS^=XT#!WK-B4&>)_<](!1SR%QO)CC+U2=!OCK>U$T%U<
M&D0D]4UMB%-F<CI7)>KT@   1EK35?;>FDZ&[+_A1F?-7@] 2-!)QP6,@BM
M,+)[X68O"N;\<3KQXCG"N2N5/;#VO5D4 "&]* Y%Z$WP!:,W!NO"4DTSZ$?^
MI_(_BN>@/O*Q;'(A%AA%;S; F.<THZ>,RK",M>#<\V'8!4(C!H\X"L6O4E/I
M)4R7>6U7W8\+3J)(?,'"!/FA:;Y_<,/4FR\FT"R#JPDPV$;6$9<CYRE('$Z0
M<:,9@@7RSZ?BD]);65!4-_I1KQG-8RSUPLB'<G/QM6A:$79I:6RCA!"* Q$C
MN<E@L*QXAT*SY@ZB$U22PZ$%FB$@A8_T\'RX>.I-I],6(X:C\>-!5+4-"B'"
MR)^,YXN+9P<@>1HCN4XV\T8Q1!2!/IJ-_>!Q) /&VQ%DF#]N@V\+[C%CT^[>
MH>DH4R-XL"^X!=>$C&B#,&;8#I$BE2N%2X0N\CFO/=CF*+;0BIV*31<7'DKA
MD(>-+2L)>]6<<FNSVFK8A9'@U!T<ULG8?\:!A!Q]%SY ]G_I0XX\K7+NR"!&
M41;/L9#&3>I_3IF99EE*2^M@-%F_U>U@_ C#_\CNO?,4GF8*1N.OXYMQUP/=
MC1]39L^C\1R--S>(GCB?C2?--Z9\[H]G[8,G-2<>K&=VUFWYCV5Z5&AT#527
M*JY3:PGU?$;TOA8\M-Q4G'\\I?.PMW)XW^_Z..QM6[[G8Q]R-]I@@Y:?3GW>
M'U=F9KC*>?@!MT)5MEQRP-K6$K,)FDBD;1]UEZK:*V63)D$>\Q!HYQ_>=:(5
M)BMA $%,4&72BJ85VKFKT:D:IR WRXY430%Z:.QVL?5)UX-6?*CF(,E.,;V#
M$0[SLE!.0(J[1S3O3RW^[X])OQ"?(9G4=-(&)BG&DKS<\:SML(UZG1C59,)_
MPWC*U64:SL3/\$N)G)1L+>K9J?J'*&8+E/4%:A(*:\?T71\X9UX\"WC%%-0F
MDX7XV%'"7*D./!1YT2S"GFDT:^OU+S)Q"5WP)(@,5R9AW(RG,Q&'$Q$O%N*M
M)*V6,"+*:XP^(A0?.59];X%EJ*6SF9CBW_]I4F#(^B'J[GQ&]IW$,>F&IO:7
M 3RAQCV>A]1+3KQY0'T"NO7%XN)^#]JCO?""24AF"Z(('&:'/CKP^7T#<4OS
MO%P]1S@VY$:P%'6Q:%#".?XVQFJIPE!\="YD\GN=.?Q+2D-[H6;L4XM#_N".
M. RXV2,G5W9&5MAEPP/UAQ?%_#^I[0XNLS\(&LI5M:?R.XJF1#-:,.4%9!HP
M=-_7HX7G+V@>(J/,9DX>R$'A-F#"RU%O-W6I$?>OONU=O1F*D[CB[!JHBA96
M ;" I@TBQ96!XBBR^<SQYX]_]RRP(/FA76I1A4;H[T!.GHS/XV@<'Z+^;#Y>
M=%6A#^"> \:TY-,#9%RFU?CQXG*-^JNB8_2<I/NA<+Y_7S@\"=HG3Y?M4"0N
M#(\2*)CV*R9^MTS/@W <MF)9WBV\@]_<V0(S<XO.6M$U)CD,=39J-S]*_N"I
M\ONSKJ3WY?>C\?0!^>-&_N"$_,$I^=^CM%)9^;.=0UM)NYZ(G@SU19(O8 :3
MS97 =@Y  =0,1M#\/.S:'>_H1S\8^_U?TZ,5T\YB0VU.N_8!R=-'&V>XEQUN
M6/G0DJXPJDIGR]I6=-<)V1N99M)W\(' :1I0UYM^O>%)@V/*T"V?4(;H9&9#
M @^=3@R7?D]@VFPNB[;R&P#SMSI=V]L;VSF7;FIPUQ#MB1Q1ZNX8Z/&ZSE+K
M\=TN1S_B]*I-_[RW:WR8POT#O>YTLG=#.1YJ-8Z/(+7BTQ)-/FJRH%"NMQKP
MK^'[#_N##4%-PX,](AR*5@I2U[-1-Y.X74OB:PO5(\&6,I,<28+2@7L^&'[E
MP1S!2%(,%RUKX.8@&+&RJL![3V\A4#PLT4[;D99'E%M[+E^HM>0OBNY P-"S
MUR!917;9TEEIGGWCXUDZKR;4X-]!R S;9X]TXW4'%K'W>7RLEJ,]Y'-S=&\I
MIREJ\XSO ]R%GB>RK>V2D;+(#]?SNR"L*SC[CS8_*/K;J?;6W7?*HKF!*?=(
M)F3$SH%4>^&RZEUM\Z!\E5#8P%14I]KK:G<1#-DXQNYL,-ND:^Z=\VR;-;=S
MNKW,LB?9PTK?N%=0PGG 7<#UYW?]9V/QX9:SSUU6@$TB:^,XR78$ZN61.ZAF
ML>SUG^)]M44WNE# 3&"G-G=U9R\.FLOP1HFJ9.WK;9W;R+AO06*UM8?H,',T
M>2;*6R@J\5TK]9PYV*EZ++X>^HKG/ KAE>LO* 0[$&OLV;NEHF&YDO9\SUT'
M=38 -K>@>21EWU3NBH]O[/E6\-#<5@RL!RH[<=H!&,CZJ[)7(Q01N6KN17K'
M?C8*#P*SS_V!0#B,>C=9VQ\.0J2S?*>GKG/E2@*+MT(<I&UV6H/N^6;296,O
M3)W17.SPGH278AE/HBZXFM/UYJ*H,P:A186)DP.=$!?SYQ\."=J;8"ATXBR%
M$4$KON1:4@,C6QBG0#VUK</VTIZHR#IEG0[NY;K!FYUI"YG\ 2:S:EUC9 \*
M8!?F F@SANNC!F R2CR@-I$\I0##(W5Z.N.7+AK/WKI;KV[*QYR[Y5>IQH,W
M +1XJ=99P>T=SU$%R[64N:T<*W=G>21H=TAU>/S_M;^07I!ZVVAT;^A_ZU@P
M. ),#]X70(<3A%-QE;97RFT+<<^5[?E/$V:,':$WGT?($O?&B#MQ.M@*U7;M
MH;II)]+[8AVW7E//]Q=/%RWV_'G\IT3#J'ILKN-&\5SX/L;UX.FB15X0AW].
M-#_\L6@AB3;S(@3CCYL:"DD;<EU16O-D?CI7^(@3$T]T-$*&#\ZWZ!%6HB/J
M.:B3?)YW[^JK>[^J02]^!]1:T15#>JM'4;MA>UITNKEM*(WK!?A$C9.JNV5[
M]%A-W5;B:JKB0]M[I[AA,&D3[+Z^R#UNWDY*:,HD8[K[#,M.(NX1OIWV"D67
M!:;#-ZZ(@2L-A?H.A$1'#]T:G/I5M>U$^WJ"*W\,U$>GR0_,_MV["1W*L7X/
M'SXCO>W0V^\BU'>YS>R%;ML"=)>6LH;EM9L?BO2IG.'!QW&^WPC<*'V;)>IP
MN..; FY%#@Z^QT-OE%[VWO;=*@R6]$XS7<X@!^V+O^W3]K7I*_NV<+?<OG/]
M#\RE]*9DKE;8.AG'T9D]%&R^5.6.WQU&1%;EEC]NE(2':0%^7Y5EU7PA!NW+
MY&_^ U!+ P04    " "*AF98J\51<> $  !F#   &0   'AL+W=O<FMS:&5E
M=',O<VAE970R,2YX;6R]5PMOVS80_BL'=2A2@+5)ZNDT,9"D&S9@;8.F73$,
MPT!+M$54$E62BM-_OR,E.TZ;9 .Z+D"L$\F[^[Y[T.>3K38?;2VE@YNVZ>QI
M5#O7'\_GMJQE*^Q,][+#G;4VK7#X:C9SVQLIJJ#4-G-.:39OA>JBY4E8NS3+
M$SVX1G7RTH =VE:8S^>RT=O3B$6[A;=J4SN_,%^>]&(CKZ1[WU\:?)OOK52J
ME9U5N@,CUZ?1&3L^3_SY<. W);?V0 ;/9*7U1__R2W4:40](-K)TWH+ Q[6\
MD$WC#2&,3Y/-:._2*Q[*.^L_!>[(926LO-#-!U6Y^C0J(JCD6@R->ZNW/\N)
M3^KME;JQX1.VX]DLBZ <K-/MI(P(6M6-3W$SQ>% H: /*/!)@0?<HZ. \J5P
M8GEB]!:,/XW6O!"H!FT$ISJ?E"MG<%>AGEN^QKQ?&KU6#HY^U=8^@TMIX*H6
M1L*9<T:M!B=6C02GX8VI5(>9&[=KW532V).Y0QC>V+R<7)Z/+OD#+AF'5[IS
MM84?NTI6=PW,$?^>!-^1..>/6GPIRQG$C "G/'[$7KP/2ASLQ0_8^U&83G4;
M>Q"+/\Y6UAFLH3_O(SR:2^XWY_OJV/:BE*<1-HZ5YEI&RZ=/6$9?/ (VV8--
M'K/^?3+XN$O&9_#-;N%=+6&M&[P6,-8P'K;265PTK@:'VZ5N>S03^E>O??NI
M$D170:6:P<D*.D313RB:@*)'%#:@$%^@T#L4]A %.@NN4$_IRD+(4(>VC^%W
M*<Q8HX 5)ML5FMY5F?_@_H/!12.LA;/I>?Z/[T>J0X]ZL$C$$I WI>S=#C-R
MNV5084<_@]=#*XUPVAR'H-^E^Z](DGLB]P,<Q05):/[,BYR2C!=!3'.2QTD0
MDXPL<A;$!26+- YB@6HYJKV4G<8;:43V(5Q_LGHNKA'L1H[^+0P6?2'A,9,^
MT=^<LOO8,)822E/"4PH9(WE6$)84L. D22DILAQRW&0926D.R#M'EFE:0(QD
M*2<4#WP=V_\ %X:+SN(Q;@="QN\*?!:G!\+Y=ZAS?]+7N16M#$4O15E#&6H2
M6^NN$AZW_O3GH(;MH%R#*-#XWD2C/@VJ&EMS1'JM*HF"\85@9Z&]MU]61:^=
MMR::KQRZ6C@\[]W=E,W@FVYM='O?-? _-#^L9"FP=K%T/9AP0>$XA"/&T%10
M(QT\(3USIYX'/#A;$/0"VUI[-6L'T95>0/2=+WRT"T.ONRF$3MFU*'>42FD<
M3E#XS6X^(BM4J93?PZ(*;.QT4]KO=BM=Z YSY)2/%X9A+8U!#U-RGCXI..,O
M'GRRG!3XSRF#."59G.#%DL '80P&R/KX]X,I:YR>OLK[$=XO.4])'"?8HS%)
MLQ2*/"9Q3J' WLVPHQE)\-(IV *M)X0G,;P9G'58=CXQ8\)U'^*%-P&J)(06
M_!9=YAN<Y)S>+G'"XP5)$K9?>H_\K4_]VZOW%KA'D!+&DD,S+,\(SU/@A&'(
M*4L16IIQ$A<%2HL,N2/O=]IA@6,@<@22QG3/*X[18$[BS%M8%(AT6J08OV3A
M;Z.%)Y@R^.O+/Q^H^Z:%^<'LA]\3FS#A^J(;.C>.@?O5_1!]-LZ.M\?'"?R5
M,!N%(6SD&E7I+$^CL9MW+T[W89)<:8=S:1!K_"$@C3^ ^VN-[3V]> ?[GQ;+
MOP%02P,$%     @ BH9F6$G<#\ZQ!   #@L  !D   !X;"]W;W)K<VAE971S
M+W-H965T,C(N>&ULK59=;]LV%/TK%VY3;( K?Z8-$L= DG98@!4PDG5]&/9
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M\PJ$16@LPUO)\!95<&$)#N=,GG5S 0K NE%FA0@9:BQEB)=*L<F\\]:R#"_
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MIDA+&+FHF^0=_%'GR9NF@3^NZJ9AHK1C2_YSADY>=PT>9KLSR=&D36(0\1)
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M[=H0U@[(LP!>#$&S"'30&6!=)C]C=LO95=J4-::>=:4TOR*&B2'E<0X0L.H
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M/KKVQOQTL3GSG0SEJTA^R17A#L>"O;X^;9]LQNZIV]<)J%$Y1'1U?PP4.WT
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M(_<X*O9&[HP*JCY]@'1L-!/$H#1C6%$FE"\.3BS:QLK0B)NK,#X#@72&>3M
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M[S3![5"U]ZZV8^3*W77FTN"1V#7MH8(K.P"_+Z0TNXY=H+O\CO\"4$L#!!0
M   ( (J&9EC0@W:4,@0  #H,   9    >&PO=V]R:W-H965T<R]S:&5E=#(X
M+GAM;+U744_C.!#^*Z/L:@42D#:%4KIM): +NQ)("-B]A],].,FDL7#LGNVT
M<+_^QDX:VF[)LCKI7IK8\7S^OIGQ>#I:*OUD<D0+SX609ASDULZ'86B2' MF
MCM0<)7W)E"Z8I:&>A6:ND:7>J!!AU.GTPX)Q&4Q&?NY.3T:JM()+O--@RJ)@
M^N4"A5J.@VZPFKCGL]RZB7 RFK,9/J#]/K_3- H;E)07* U7$C1FX^"\.[SH
MN_5^P0^.2[/V#DY)K-23&WQ+QT''$4*!B74(C!X+O$0A'!#1^+O&#)HMG>'Z
M^PK]RFLG+3$S>*G$'SRU^3@8!)!BQDIA[]7R*]9Z3AQ>HH3QO["LUW8"2$IC
M55$;$X."R^K)GFL_O,<@J@TBS[O:R+.<,LLF(ZV6H-UJ0G,O7JJW)G)<NJ \
M6$U?.=G9R17C&GXP42+<(C.E1O*X-;#WR&*!9G\46MK%K0V3&O&B0HS>0.Q&
M<*NDS0U\D2FFFP AT6LX1BN.%U$KXA23(^AU#R#J1+T6O%ZCN>?Q>K_6/.4F
M$<K)-O#G>6RLIC3Y:Y?H"O)X-Z0[.D,S9PF. SH;!O4"@\FG#]U^YW,+X>.&
M\'$;^N2!CF):"@25P2OY S@W!BE63*9PPUG,!;><A-2!3(&R_AZ34FLN9W#!
M##>[E+7NO5O98XZ0*4$GVB%;GRK@/TL+7%:UPA^ZF H!J%)#QB63"6>"OI.;
MRRK-;,XL,(U0K#C3.',2%SX^#H+._DI#[#0,2;?S!*4%%C'J)C76? ,WN$ !
MW?H9U<\>['%)FZK2D-/,/EPUK"I?#N%:+5!+QPYB16N(;B)*2F0ZF#8G:Y,K
M;0\MZH(^+=#82LE'B 8'9_T!O7SZ,(BZT>==4U/4?,%<(7K#(<UNM!,Y=,YX
M"OA,)=A@%6AE<Y+L'.(HLBH#>IU!L\7Z^Z.RA/^Z4[V<B)T=1*?]3:[;4Z^^
M64NNX>])8$FB2VR5(-8R]R,<]Z,-5IOC;3V_8[L[::+_E#3_HV.B@][9Z6;
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M?:/;2U$[L6KK+R(K94F$?KBA>R1J9T#?*Z7L8>(<=#?3^3]02P,$%     @
MBH9F6,T\/I;  P  ZP@  !D   !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL
MA59M;]LV$/XK!ZT8$D")WBW9LPTDZ8H5:- @3CH,PS[0]MDB2HD:2<7UO]^1
MLE6W4;POYI&\>_C<FT_3G51?=8EHX%LE:CWS2F.:21#H58D5T]>RP9IN-E)5
MS-!6;0/=*&1K9U2)( [#45 Q7GOSJ3M[4/.I;(W@-3XHT&U5,;6_12%W,R_R
MC@>/?%L:>Q#,IPW;X@+-<_.@:!?T*&M>8:VYK$'A9N;=1)/;S.H[A2\<=_I$
M!NO)4LJO=O-Q/?-"2P@%KHQ%8+2\X!T*88&(QK\'3*]_TAJ>RD?T#\YW\F7)
M--Y)\2=?FW+F%1ZL<<-:81[E[@\\^.,(KJ30[A=VG6Z:>;!JM9'5P9@85+SN
M5O;M$(<3@R)\PR ^&,2.=_>08_F>&3:?*KD#9;4)S0K.56=-Y'AMD[(PBFXY
MV9GY)R27-%P\L:5 ?3D-#(':JV!U +CM .(W *(8[F5M2@V_UVM<_P@0$)N>
M4GRD=!N?17R/JVM((A_B,$[.X"6]BXG#2\Z[^/?-4AM%5?#/D),=1#H,83MC
MHANVPIE'I:]1O: W__67:!3^=H9@VA-,SZ%W!'VXD]H,43MK/$SMJ418R:J1
M-=9&@]P =;%BAM=;$/8UNM4&J*?!D.H>F=* -G] T<=JB:K/ +!Z;848=J@0
MF"8S0;VL)_ 7V75I'S!S)A>\IA=DJPE$7\+G(1;O8.3':>S6* WA"U/<5N.I
M3N2'44B_<9;#HI3*7!E4U0\:>0A)F,*B77:GO*8((%Q$?I+FEW"1%Z-+>)*&
MB>%@V.?#/'/K.,K@3&*S/K'9_R16:Z3,?G?[D.I/Y" 7W.Q]N&>F520-9?XL
M^MN9W[0$B?;?@E?M,4@-VU>N&"@NHK4I<ZDA-;HF=7OI"J55K^(C#G0YM1%S
MY?0JW?[KZKBI9$N8QR*Q<#^;I13MS,_3U&XR*T9.'%DQ&ULQ)[$(W6EAQ2P"
M\I'FSX8J '(_*I)#5EMZ0Z_LF^3<3TXGE-LL YN0"?"J:8T+ $$@I?XB)0Y4
M'0\VC$3YA8D6A[KF-!#OK!-). 87<N>T532N=)L.20^&\_'S,P5*(UTO][!%
MN56L*3GE'+<TJ2ARPS$>;*F/6C$4Q"8J_+RP713'?C8*X;GFULF%88;81J$_
MIL.([L;%&VV@[ 2[DINK5N.1(,&-*3@6-\G\*"L&^R(X&4 5JJT;LQI<,KI9
MU)_VD_RF&V#?U;O/@'NFMKS61&E#IN%U3DV@NM':;8QLW#A;2D/#T8DE?8V@
ML@ITOY'2'#?V@?[[9OX?4$L#!!0    ( (J&9E@\I5.>K0(  ,\%   9
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M?!B!;=='*WA3-2.[-)X60',L:>.B#09TOS+&[X00H-OA^5]02P,$%     @
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M<"\9N9?LYYZOFIN7JD; 1Q]6 0MNO=12=E%RKXK=Q;/8CA"FFGV6P#Z.;6<
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MT7W0+]=T 4?# O1]V;9N^\ *QBO]V9]02P,$%     @ BH9F6*3N&QX$!P
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MV[IAZ[XPK\$Z+W?_LV^](PX*V,$S!9R^@#,LX#U3P.T+N,<6\/H"WK$%_+Z
M?VR!H"\0=+[?.:OS=)PUV=5%Q9Y(U5IS6ONA"U=7FCLX+]O,NFTJ_FO.RS57
MM[N,(NR>W.8/97Z?+[*R(=>+!=N635X^D!M6Y(N<UN2,W/*\7FX+VEI_XN4:
M6N5906ZJG%7DAF^P)4FJBF_,657M<J<F[V+:9'E1O^>$+[<Q>??3>_(3F9)Z
ME54<FY?D2YDW]<_\2_[Y'RNVK;-R65],&WY\;2VGB_Y8/NZ.Q7GF6&R'_,+*
M9E63I%S2I0R8<L?LO>-\]\Y'1TN,Z>*<N/;/Q+$<5U&A^?'%'47Q^/CBMJ)X
MHB_^EZP\)];SQ=/C]VYI?.GN,\WM>.XSO'%B\"C+N7.]_"_/>-YN-37Y3.N&
M)UB[0?[]5\XBG_A6_1]56NQV[*EWW+;-'^I-MJ"7$][XUK1ZI).K/_[!#JP_
MJ4**A,5(6(*$I2"8E K>/A4\'9VGUCWE:; D"WZZ5KQSX1W,K]N\SKO.9L'J
M1GGV[Z!!!VU[S,<KV_<#?F(]'L9/8>6YD2M;Q0HKRPU\V2K1'H:IQ\>[#)Q
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M;'*%V.3JQ:;C!@/*91!ZLG$LD;082DN@M!1%DR,NY"S7/]E@ "I_06DQE)9
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M,YXPK0'__9ZQYOM&NX/]^U>N_@]02P,$%     @ BH9F6#MRY\A< P  2@L
M !D   !X;"]W;W)K<VAE971S+W-H965T-# N>&ULK59M;],P$/XK5I@02-O2
MI*^,-M+:,($$TM0R^(#XX";7QIIC!]MMX=]S3M+0ES2L4K^TL7W/X[OG[/,-
M-U(]ZP3 D-\I%WKD),9D=ZZKHP12JF]E!@)7%E*EU.!0+5V=*:!Q#DJYZ[=:
M/3>E3#C!,)][5,%0K@QG AX5T:LTI>K/&+C<C!S/V4Y,V3(Q=L(-AAE=P@S,
M4_:H<.16+#%+06@F!5&P&#GWWETXL/:YP3<&&[WS36PD<RF?[>!3/'):UB'@
M$!G+0/%O#1/@W!*A&[]*3J?:T@)WO[?L#WGL&,N<:IA(_IW%)ADY X?$L* K
M;J9R\Q'*>+J6+Y)<Y[]D4]JV'!*MM)%I"48/4B:*?_J[U&$'X/5. /P2X!\"
M.B< [1+0?BF@4P(ZN3)%*+D.(34T&"JY(<I:(YO]R,7,T1@^$S;M,Z-PE2'.
M!+,BW40NR(PM!5NPB I#[J-(KH1A8DD>)6<1 TUNR%1R>](V5,46<,_QT% 1
M <%),E$0,T,^2ZW1^$T(AC*NWR+L:1:2-U=OR15A@GQ-Y$I3$>NA:]!_ZX4;
ME;Z."U_]$[YZ/ODBA4DT^2!BB/<)7 R\BM[?1C_V&QE#B&Y)V[LF?LMOUS@T
M>3G<KX&'+X=[#=&TJURV<[[V";XR:9I,(0*VIG,.UZ>31'[8=)*'(I\_Z])1
M;->IW\X6I#N=T0A&#E8<#6H-3O#ZE==KO:^3\I)DX87(]F3N5#)WFMB#,2R9
M$/9JS"FWRM9)5U#T<@I;>M=!9] ?NNM=11JW.5>1"Y'M*=*M%.DV*C)9*058
M-3)03,8D4W+-[+M0)TS!U-T1QGLW.!"F>R1>>]\B/+;P>_]8]H+H54'T&H-X
M$EA+\^<([PV^1^5=BA*JEA 3NL0W5!MB$ES<WJFZ 'M' =YX_=9!A(VNG)OZ
M"Y'MJ=:O5.LWJH:E1JXQ[5CR\46@:2$:;K1F6.?Y'WR#(47Y5KOJULG6/Y+M
M4+-&1\[5[$)D>YH-*LT&C9KAZ_6?ZC$X.MY=KWL@Q['-484)&_TX-TIWI\M(
M 2^%[=;P@MB4%T]N-5LUA/=Y'W0P/\9&L>CK_M$47>87O&MXRPB'!5*V;OMX
M'E31N14#([.\EYE+@YU1_IE@LPO*&N#Z0DJS'=@-JO8Y^ M02P,$%     @
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M5(!$HU!H*F6-(\?]<^D+U(B#HE$H-)74QHMCHS4U=SKOH#,-[7[["]BU)FR
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M2IX8>]:=FW1@6-HAR"&1F@&KWP+&D.>:2+GQN^$TVB4U<+V]8O]2:5=:GK"
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M2?7>5LU,E5# M8&:GS(F5QV]0%N417\!4$L#!!0    ( (J&9ECGA2P8"@,
M *()   9    >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;+5674_;,!3]*U:&
M)I" ?*? VDBT 8T')E1@>YCV8)+;)L*Q.]MIV7[];"?-^I%6E<9>$MLYY]Y[
M[G7LVU\P_BIR (G>2D+%P,JEG%W9MDAS*+$X9S.@ZLN$\1)+->536\PXX,R0
M2F)[CA/9)2ZH%??-V@./^ZR2I*#PP)&HRA+S7T,@;#&P7&NY,"ZFN=0+=MR?
MX2D\@GR>/7 ULULK65$"%06CB,-D8%V[5TE/XPW@:P$+L3)&6LD+8Z]Z<I<-
M+$<'! 12J2U@]9K#" C1AE08/QN;5NM2$U?'2^NW1KO2\H(%C!CY5F0R'U@7
M%LI@@BLBQVSQ&1H]H;:7,B+,$RT:K&.AM!*2E0U915 6M'[CMR8/*P0WVD'P
M&H*W20AV$/R&X!]*"!I"8#)32S%Y2+#$<9^S!>(:K:SI@4FF82OY!=5E?Y1<
M?2T43\9CF .M (TA95-:F%J<H00FP#ED:,2HY*HVZ+8BDX(057"I%H44Z#@!
MB0LB3A3^^3%!QT<GZ @5%#WEK!*89J)O2Q6A]F.G333#.AIO1S2NA^Z5QUR@
M&YI!MF[ 5M):?=Y2W]#;:S&!]!SY[BGR',_O"&AT.-WKH">'T]T]:ORV6KZQ
MY^^P=\_F8$IP1P^JT?<Q(P2I'V2!>?:CJQZUOZ#;GSYSKL0,IS"PU*$B@,_!
MBC]^<"/G4U<NW]-8\D[&UO(<M'D.]EF/#\CM*?K":%HI%)5=B:T=1,:!/GOG
ML1_UU Z<KR9L&^1=^LXZ*.D N5'4@M8$AJW <*_ .YJJ2T* _HOKT0EZ8H?L
MJ2ZMM:]P-<+(#S>T=H#<B\L-K=L@M[<"6M,:M5JC?R_F=<FX+'YC<P#>O*E;
M54"7U&@KP#/W(O0VM':A@B#:$-N%<KRP6VVO5=O[WUNWM[7A@B#<"'ZT#=K>
MW\DV:&U_UP+ME=NK!#XU78! *:NHK _Z=K5M-*[-_;JQ/E0-2-TO_#53=R_W
MF$\+*A"!B3+IG/=4TGG=$=03R6;FCGQA4MVX9IBK)@JX!JCO$\;D<J(=M&U9
M_ =02P,$%     @ BH9F6'ZM,8:0!0  '"@  !D   !X;"]W;W)K<VAE971S
M+W-H965T-#8N>&ULQ5K;;MLX$/T50ELL6B"-1=+QI6L;B).F#= "0=QV'XI]
MH&TZ%BJ)7I*R4V _?DE9$25+87RAG9?$DF:&<XY(SM%(O17CO\2<4@D>HS 6
M?6\NY>)#HR$F<QH1<<X6-%979HQ'1*I#_M 0"T[)-'6*P@;R_58C(D'L#7KI
MN3L^Z+%$AD%,[S@02101_GM(0[;J>]![.G$?/,RE/M$8]!;D@8ZH_+ZXX^JH
MD4>9!A&-1<!BP.FL[UW"#U>XHQU2BQ\!78G";Z"AC!G[I0]NIWW/UQG1D$ZD
M#D'4OR6]HF&H(ZD\_LV">OF8VK'X^RGZ30I>@1D30:]8^'<PE?.^U_' E,Y(
M$LI[MOI,,T 7.MZ$A2+]"U:9K>^!22(DBS)GE4$4Q.O_Y#$CHN#0;#_C@#('
MM.$ F\\XX,P!IT#7F:6PKHDD@QYG*\"UM8JF?Z3<I-X*31#KVSB27%T-E)\<
MW)" @Q\D3"CX2HE(.%7W2 KP'HS4C)DF(05L!FZ"F,23@(3@-A:2)VN;M]=4
MDB 4[Y3U]]$U>/OF'7@#@AA\F[-$D'@J>@VI<M0C-299/L-U/NB9?*[IY!Q@
M> :0CW"-^]7V[JCLWE#,Y/2@G!Z4QL//T5,'_*S QZ405)\9DE"=H6"4KKU/
MG"6+('X0X.?E6/FIR?I/'1?KP9OU@^L5_$$LR(3V/;5$!>5+Z@W^_ .V_+_J
MF'$4K,03SGG"MNB#3VQ)>:S9 6.F;KR:!9,PF=*IFLYRKJ:$F#,NWTO*(W5I
M285,F:SC9#U0*QU(;T++ >IT6YU>8UD$6[7R<XL2@F:.H'G8G?X2D'$0!C*@
M>]_NILO;[2A8B:R+G*P+Z^V^ICQ8$KT!KQ? &1A)(M.MH[Q=W#$1I-OUSX^/
M4F_^8[6A?(P5NYSH\[4TV<>^XW1!@BF@CZJ4"2J VF@ DW/*U7[)N4Z!I(NR
MCC1KZ#U):^6DM;8E[6DN_79+G'W\R\F$)]1*7&CF>!U[UOA[LM?.V6M;LS>%
MZ@S<4YVP6G!U)%C#[+K(' 4K(>[DB#NO67LZ+GER%*S$4S?GJ7NJVM/=JO98
MT]D3+/2-8/.WW49F^50("K(LAZ^@+P[8+(=9(A<%.K"_288]VWW9*,A7:&7C
M&Y,*OB'"@@96T* N:K<V\5C'VQ>/T9OP0,'I0(9 I[+35;0R849X0KORW&DY
MD$-+X##+ICB+FBVT.8>J1@AWV_4"%1J%"JV:KC+77TJUN4VJ52-+JD8?0KM(
MJZW6X#]0/'\;+Q(]M[_0)0T!K(7@2*]E6(^A_J"1?[#UFO4<.E)G&5?'T'K0
MB#UH5WL.:WHV4G&&^YN+X!@R#QJ=!ZWRZ)05O?,R%\>0<M!H.6@7<SO4\^[+
M6(ZAU)!1:LA_]5J.',FOK(5T##&'C)A#=C%WXEJ.JHIP<P993<HH"RU%JR+:
MM8QGT:Q9VDS*61I=A>RZ:O<*CFJSMXZR\_QT%*W,B1%@Z, >X8'=8*?]05?1
MREP9!8CL"M!A!<]&*FG4FL=R>T+[ C;R#FW=WCMR%<\2L3^7V[/=EPTCX)!=
MP&U?QU%5G]4]E]O'VQ>/T6CHP&:<BUKNM"7G*EJ9,"/DD%W(G;J65]5@]6&W
MQNCYAUUL=!ZV=^1V+.BXVE:KIEIC9$G5*"QL5UB[5_6ZE[!#^RB[SE17T<J<
M&#V&7_4=+W;:;7,5K<Q5X37OZ=[S5IMDF[K6GLR^8(W<P_9^V^DJ.JYVX2I<
M'$/.82/GL%W.;5_/<56M5; <0ZEAH]3P@8TX![4<.^W&N8I6)LR(.6P7<R>N
MY?CECIW5I(S22#QL;\/M6L8[ED]0LBQM)NLL&X5/M_1W<U\)?U#,@I#.E(]_
MWE80^?I3M/6!9(OT:ZXQDY)%Z<\Y)5/*M8&Z/F-,/AWH#\3R#P('_P-02P,$
M%     @ BH9F6 C/Z"HM P  U@P  !D   !X;"]W;W)K<VAE971S+W-H965T
M-#<N>&ULS5==3]M $/PK)Q=55 +\D<0X-+$$05 DJ! I]*'JP\7>Q"=L7WIW
M3FA_??=LQR3$.)#FH2^)S][9G9D[;S:].1>/,@)0Y"F)4]DW(J6F)Z8I@P@2
M*H_X%%)\,N8BH0J78F+*J0 :YJ D-AW+<LV$LM3P>_F]6^'W>*9BEL*M(#)+
M$BI^GT',YWW#-A8W[M@D4OJ&Z?>F= )#4/?36X$KL\H2L@12R7A*!(S[QJE]
M,K =#<@C'AC,Y=(UT5)&G#_JQ578-RS-"&((E$Y!\6L& XACG0EY_"J3&E5-
M#5R^7F2_R,6CF!&5,.#Q=Q:JJ&]X!@EA3+-8W?'Y%R@%=72^@,<R_R3S,M8R
M2)!)Q9,2C P2EA;?]*DT8@E@MU\!."7 >2N@50):N=""62[KG"KJ]P2?$Z&C
M,9N^R+W)T:B&I7H;ATK@4X8XY5]0)L@#C3,@-T!E)@#W2$ER2(9X8L(L!L+'
M9!AQH0X5B(1<I3.0J@C:/P=%62P_8?C]\)SL[WTB>X2EY%O$,TG34/9,A21U
M*3,H"9T5A)Q7")U#<$1:]@%Q+*=5 Q^\'>ZLPDVTIO+'J?QQ\GRMC?X<D%,I
M 56C+G+-Z(C%3#&0"]]"@J?R#H),")9.\JBO/!75C3,JF20_KK$ N5*0R)]U
MYA1LVO5L]#M](J<T@+Z!+ZT$,0/#__C!=JW/=5;M*-F*<:W*N%93=O\TP2/#
M_J M RY5G=0"[^9XW6UFON-Y'F[:;%G#>I151:P0:U?$VHW$+@67DMSCSM X
MYW>)S:[VH!9Y.LL$G>X+>HVUMK2X4RGIO$_)-:ZA5DIG3<JAW6Z]T-)8;4LM
M;J7%;=3R_)[5T7?7=\+KNMX+_NY;C\IQ1>JXV6 ^ Y'J7D=&_)5NUICAO2_L
MCI*MB/4JL=Y_U>F\71JWHV0KQG4KX[K_V.FZ-<=WO=,U5ME2@VT]SP'6CMIB
MF:BY+S97VU;-TE1C[ZHUEIDV],;F>MOJ>9Y"[,;?Z@WML02[&_IC<XWW:C"7
MADX]\=]0,<$30V(88WKKZ!@=%<4072P4G^9SZ(@KG&KSRPC_>(#0 ?A\S+E:
M+/1H6_V5\?\"4$L#!!0    ( (J&9E@S'* L4@(  .P%   9    >&PO=V]R
M:W-H965T<R]S:&5E=#0X+GAM;*U474_;,!3]*U<>FD#:2)J4KF-I)&B'V ,2
M@L$>ICVXZ4UCX<29[;3P[W?MI%G12H>FO23^N.?XG&-=)VNE'TR!:.&QE)69
ML,+:^C0(3%9@R<VQJK&BG5SIDEN:ZF5@:HU\X4&E#*(P' 4E%Q5+$[]VK=-$
M-5:*"J\UF*8LN7XZ1ZG6$S9@FX4;L2RL6PC2I.9+O$5[5U]KF@4]RT*46!FA
M*M"83]C9X'0Z=/6^X%[@VFR-P3F9*_7@)E\6$Q8Z02@QLXZ!TV^%4Y32$9&,
MGQTGZX]TP.WQAOW">R<O<VYPJN0WL;#%A(T9+##GC;0W:GV)G9\3QY<I:?P7
MUEUMR"!KC%5E!R8%I:C:/W_L<M@"#(8O *(.$+T6$'> V!MME7E;,VYYFFBU
M!NVJB<T-?#8>36Y$Y6[QUFK:%82SZ047&NZY;!"ND)M&(UV1-? >/N<Y^HQA
MJBJK*>^&2[CBMM'"/@&=A@8.9VBYD.:( '>W,S@\.((#$!5\+51C>+4P26!)
MICLLR#I)YZVDZ 5),\R.(1Z\@RB,XAWPZ>OAT7-X0.'T"45]0I'GB_^>T$R8
M3"H7DH'O9W/C4_FQRV%+.=Q-Z3KSU-0\PPFCUC.H5\C2MV\&H_#3+K__B>R9
M^[AW'^]C3V=DFZYS $_(-2@-$LW..VUI1I[&/1VK-!I_'(V38+5M9>]A_VAE
MV%L9[K7R^R)WZ1^^2O^?56%?T8H*MGK1O8-77"]%92BWG##A\8<3!KI]6]J)
M5;5OS[FRU.Q^6-!SC-H5T'ZNE-U,7,?W#WSZ"U!+ P04    " "*AF98W>M/
M*-D"   I"P  &0   'AL+W=O<FMS:&5E=',O<VAE970T.2YX;6S%5MM.VT 0
M_965BRHJM?B6. EU+$'2"J2V0ES:AZH/BSV)5]A>=W>34*D?WUG;+ XU$2!+
MO"1[F7-VYLR,->&&BQN9 BARFV>%G%JI4N6A;<LXA9S* UY"@3<++G*J<"N6
MMBP%T*0"Y9GM.4Y@YY055A169V<B"OE*9:R ,T'D*L^I^',,&=],+=>Z.SAG
MRU3I SL*2[J$"U!7Y9G G6U8$I9#(1DOB(#%U#IR#V<3;5\9?&>PD:TUT9%<
M<WZC-Z?)U'*T0Y!!K#0#Q;\US"#+-!&Z\;OAM,R3&MA>W[%_KF+'6*ZIA!G/
M?K!$I5-K;)$$%G25J7.^.8$FGJ'FBWDFJU^R:6P=B\0KJ7C>@-&#G!7U/[UM
M=&@!W,$C *\!>$\%^ W KP*M/:O"FE-%HU#P#1':&MGTHM*F0F,TK-!9O% "
M;QGB5#0'P=942TE."ZG$"C.D)*%%0DX@6;)B23Z01XSVYZ HR^0[-+FZF)/]
MO7=DC[""7*9\)9%"AK9"'_5+=MSX<US[XSWJ3WQ ?/<]\1S/[X#/G@[WMN$V
M*F/D\8P\7L7GOUR>(UV(3#&09,YDG'&Y$KC^^06IR*F"7/[JDJ%^=]#]KN[=
M0UG2&*86-J<$L08K>OO&#9R/7:+T1+8ED6\D\G>Q1Y=<T0P[QPC%[H7J"KQF
M"RHV_8U91Z.!XSNAO6Y'U&$U&KN>L=IR=6!<'>QT%1L?V[H@GV[CE!9+('BP
MH2(A?['$)=Y0!0FATN3V/N==D>Q\[+DI[(EL2Y>AT67X2E4^[%.BGLBV) J,
M1$&O55ZS#5OU&_@C-WA0Y5U6D\FXN\I'QM712ZO\&U<OJO2=#SXWC3V1;6DS
M-MJ,7ZG2QWU*U!/9ED03(]&DUTJ?_/>E=AW?'3RH] XK?]RRJEVU6X.,'B*_
M4H$YD22#!>*<@Q&VBJ@'LWJC>%G--M=<X:14+5.<94%H [Q?<*[N-GI<,M-Q
M] ]02P,$%     @ BH9F6/J>O%B-!@  AC@  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3 N>&ULQ5M1;]LV$/XKA%<,*=#&%BG;2988:,QN+;"N1=)N#\,>
M5(FVA4JB2])).^S'CY(5T;1E6JK/T(MMR<>/NH_W27<B>?W(Q1>Y8$RA;VF2
MR9O>0JGE5;\OPP5+ WG.ERS3_\RX2 .E#\6\+Y>"!5'1*$WZ># 8]=,@SGJ3
MZ^+<!S&YYBN5Q!G[()!<I6D@OM^RA#_>]+S>TXF[>+Y0^8G^Y'H9S-D]4Y^6
M'X0^ZE<H49RR3,8\0X+-;GJOO"OJ^WF#PN+/F#W*C=\H=^4SYU_R@[?136^0
M7Q%+6*ARB$!_/; I2Y(<25_'UQ*T5_69-]S\_83^:^&\=N9S(-F4)W_%D5K<
M]"YZ*&*S8)6H._[XAI4.#7.\D">R^$2/I>V@A\*55#PM&^LK2.-L_1U\*XG8
M:."-]C3 90.\W<#?TX"4#4C3!G[9H*"ZOW:EX($&*IA<"_Z(1&ZMT?(?!9E%
M:^U^G.7C?J^$_C?6[=2$,A$_!#GWZ&TFE5CI,542!5F$WK!H'F=S]!*]GLWT
M,"$^0YIKS62&IBLA6!9^1U.>*:$'3R(]B&K!\A.2)W$4*!:A>Z6_<L2\[?LE
M$T$^V!*=4::".)'/-?BG>XK.GCU'SU"<H8\+OI*Z<WG=5]J[_!K[8>G)[=H3
MO,<3#Z-W^F(6$KW.(A;9 'U-2\4-?N+F%CL1*0O/$?%>(#S I.:"ILV;XYKF
MM'ESS^$-J4::%'C^7CRI1ZX8ED!6@VL&O8YQ)V)^2[J2RR!D-SU]SY%,/+#>
MY.>?O-'@ESJV(,$H$)C%I%\QZ1?HY,<U\RJ_G<4J9A+16(8)ERM]'>COWS44
M>JLU(?^IX]N'Y!L2C *!67P/*[Z'SLC]R%60H+E^B*$SS:2^:P@6\GD6_ZMC
M69]D@<@TZ;7WC#7RJ$#.GX$/DY?^Y5#KZ6&3JAHK0LB6%=VU&E06EF.CRK'1
M49)$_Z$[]L"R%:MSS8G=-E@@P2@0F,7IN.)TW)$XQY!\0X)1(#"+[XN*[XN3
MB7.-/-P0E#>ZV)+FKLU@2Y8N"\NER\JERV-E.>6RR&G$?GDZ^V@;+I!@% C,
MXM8;F(1ST)% RXZ!* =%HU!H-ND;6;YW,I66T)L">^GYHRV=UEJ-AUM:K;':
M(U8/&]_P\4]1J3T,%T6415JS"5_NRWG=O;6.(D@T"H5F,VTJ"(]T)5W02@,4
MC4*AV:2;8L-SYM;'2=??%24>#2^WM5MCYHV]BVWQ[IKM$Z])[3UW;M] O/=!
MPM9!E@;B"U/:H-979T>M0P@2C4*AV22;,L,;=:5;T"($%(U"H=FDFSK$<Z;=
MQ^EV7"/(P4[96F<V)GA;MKM6^V1KDG[/G?4WD.UO+&-",Y!'61"E<1;K/XL@
MK/78V5_K0()$HU!H-M>F&O$NNU(O:(T"BD:AT.PWOZ9*P<Z$_"CUEM"V>O&(
M;*FWSFP\V,JK:8W5'O5B4PU@=S700+WOU8()[6C(4X;.V+<ERR1[_@)EK#9I
M=G?8-I) T2@4FDVV*4\P[DB^&+12 46C4&@VZ:92P>[)CJ/D2PZ]<IH>-J%.
M$]LK4PI@=RGP!U?H1Z9QW+"M P5T8@$*S:;4U!]XV)4Z0>L14#0*A6:3;NH1
M[)[W.$J=H]VGYI#XVP*ML?)V"E]:8[9A8WMG$G_L3OR;J-0]L^/NH'7H@,XU
M0*'9Y)K" U]TI5?0"@04C4*AV:2;"@2[)T2.TNOEX:?I01/J-+&70Y@4G[A3
M_(8Z;3#5X^ZH]3H)T(D'*#2;9%-J$*\CO1+0D@,4C4*AV:2;DH.X9T2.T6L)
M[=+K81/J-+&]VEB_Y,[I&S]7F\_UN'ML'4.P*YQ.,>U 3*U!NEKD1$"K$5 T
M"H5FDVZJ$7*ZE4XEM%.X!TVHT\3VRJ3[Q)WN-Q1NPWD>=V>MPP=TR@$*S2;:
M5!ZDJ[5/!+0B 46C4&@VZ:8B(:=; $4.KFZ:'C:A3A/;*Y/R$W?*WU"S[29Y
MW'VVCB+0^08H-'M%L2E&_*Y61?F@Q0DH&H5"LTDWQ8E_NE51OFLE4\G501/J
M-+&],MF_[\[^&TJWY0R/N]/6800ZV0"%9A-N"A._JV51/FA] HI&H=!LTC?V
M8)QN650);:WWWWV'7&=5\PZYQFSG'7)_8X-6RL2\V.@F4<A7F5KO1ZK.5IOI
M7A5;R+;.WWI7=+TESL"L=^B]"X2.-(D2-M.0@_.QOJ>(]::W]8'BRV(;V&>N
M%$^+GPL61$SD!OK_&>?JZ2#OH-IZ./D?4$L#!!0    ( (J&9EA)J91^\ ,
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ME6WEJ%R W2^E-$\3URWZGT/V%U!+ P04    " "*AF98>B=I AL#   M#0
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MR:9-6K6J:;L7TUXX< E6P6:V2;IO/]LD+"64[L7>!#_<_>]W%^-CO&7\4>0
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M<_!-H@V926N.)4[&G&T1U]9*30],;8RWRH90_2\N)%>[1/G)Y"NH&@ATCLP
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M-W!MH/97C,G]1 =HOP>2/U!+ P04    " "*AF98-2V1!S(#   N#   &0
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MR.HK+Q<$QX0I _E^3JG8W*@3H^:$</(34$L#!!0    ( (J&9EADR.#780D
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MU7BKU=BL55;RF&3/@ZWB^4JKVWDU1XX/<J1GCSQ_,AKO*:DIZ/K>V)JX:L'
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M >+ZDA"^&\BMNG8O-_H)4$L#!!0    ( (J&9EA(,^U7NP4  +H?   9
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M _@U<AI8)S70G-4<@:/:@;4P_+U>0N@Z3A>&IMK0ZU8+--7\D=^HUNYEG7W
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M'NJ[D2BKNK*C^-H61B]<Z3++-G-="8,P$_3S)>?JT#$+U+5U\C]02P,$%
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M'MX_>7_GQ5LQ<Z;QC2R_\,*L9L$X@ (7;%.:.[E[CXV@H?.7RU+[?]@U<Z,
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M4:082_"<9U3,K%3*];EMBSC%.1)G;(VINK-D/$=2G?*5+=8<HZ1(RC/;=9S
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MCKH.W0_S7?^017>U.QPNWA<HJ]:Z.>*/6!*ZZN4RB'+T!#&)%IE":RNX6R+
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MZ+P\52\;DFV+8^-[)B7+BLL-P3'AN8&ZOV),/C?R >K?-BS^!U!+ P04
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M@2F O+^F5#R?J <T?U-$_P%02P,$%     @ BH9F6"+']<?]!   ^Q0  !D
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M/$@&*(<Y617JCF_^@EI06/%EO)#F&VUJK#M V4HJ7M;&>@8E9=M?\EP[8L\
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M0>/\<46PE#$#R.\+2L7V)>N@N@2>_ ]02P,$%     @ BH9F6.>)IS'@!@
M#C0  !D   !X;"]W;W)K<VAE971S+W-H965T-S<N>&ULU5M=;]LV%/TKA <,
M*9#4(JDO9XF!).RP NT6).OZ,.Q!L>A8J"1Z))VTP'[\*-DQ38FF[8$+W)=$
MDB^/R'OOT>41Q8MGQK^(&:42?*W*6EP.9E+.SX=#,9G1*A-OV9S6ZI<IXU4F
MU2E_'(HYIUG>-JK*(0J">%AE13T87[37;OGX@BUD6=3TE@.QJ*J,?[NF)7N^
M',#!RX6[XG$FFPO#\<4\>Z3W5'Z:WW)U-ERCY$5%:U&P&G ZO1Q<P7."TZ9!
M:_%'09_%QC%HAO+ V)?FY'U^.0B:'M&23F0#D:E_3_2&EF6#I/KQ]PITL+YG
MTW#S^ 7]YW;P:C /F: WK/Q<Y')V.4@'(*?3;%'*._;\"UT-*&KP)JP4[5_P
MO+(-!F"R$))5J\:J!U51+_]G7U>.V&@ XRT-T*H!ZC8(MS3 JP9XWP;AJD'8
M>F8YE-8/))/9^(*S9\ ;:X76'+3.;%NKX1=U$_=[R=6OA6HGQ[^JU+KE;%I(
M</*!"?$&W%(.[F<9I^!*2EX\+&3V4%(@&?B-YT6MDF/Y\XR5.>4"G(%[E8SY
M0MFP*;BJ97%&BG+1A!/<T\F"%[*@ IP0*K.B5#<X Z)I+RZ&4@V@Z<9PLNKL
M];*S:$MG(0(?62UG KRK<YJ; $,U\O7PT<OPKY$3D=#)6X#A*4 !PI8.W>S?
M'%F:D_V;0\=H\#J8N,7#6_#>9;PNZD>A8W@*KC-13$[!PS=PPZI*,>VFS(0X
M!>_K2;E0\7P$OS^SY47PD<H9R\&?'Q0N>"]I)?ZR!6G9B=#>B>9!=2[FV81>
M#M232%#^1 ?C'W^ <?"3S<$^P8@G,,/YX=KYH0M]_+E]Q-#\+'NB7#TR5UD.
M%H+FH*C!A%5SQ0KE\%IQ;K[B7-ER;J[BU9J#K,,Y]L(YL<&Y4Y W#%.X)PIX
M>9\WMD@M>QRU/6XJP-,8)G&28#Q*+X9/FV&P6,9)'"<X"4U+TK=,XC :Q2A:
M&QK^B];^BYS^VTQ/<&4;C;/]H7GG$XQX C/\%J_]%CM)WSQQ<\L#]]W7AN J
M1Z:<50WY5?9E;:U5C^G^DV(GZV.?WO<)1CR!&=Y/UMY/G%EK>%]H[U/#^Q/3
M^_3%^YKW.XB<]$B'HR0*(QQT>&PQQ! F.(XZ-+8:!DD:CNPT3M<.28^A!J4^
ML]$G&/$$9CA_M';^Z+NK0:-^98%1$$0HZN9NWW*$PBA(XZ23NWU#G":*#U%J
MSUT8Z-EPL'\1NK;.4)T AV:>5S3B"\UTWH:4@$=1B5;=\!4"GVC$%YH9 J1#
M@(ZA'*UZ84P"(QQUB\R-Q0Z-4ACWJI'%$">C*$01W$)IK8G@48@BZ%45>44C
MOM#,"&AA!+\_903[,B96VBB%85<962R3",$X"KIER6*)DR1 P48!,UVHM1'<
M)8YJY3M9-&._Y71*.5=CO)=L\@7\ W9+)S?\P=GI53SY0C-=J^43/ []!+T*
M**]HQ!>:&0*MH>!1B"C8USS=*>AN$V(Q@4D*$Q1L*U5:.D&G.#B$Y?:YJ5=5
MY!6-^$(S7:N%$1P=!\N= NW@$/A$([[0S#?M6ELAM[9Z)9:O>N%B^6X38C%1
M\UL<AD%H9SG2,@DY-<#X<\9Y5DO13&+F"SZ998)V9C-BKZ+NOL^AN>85C?A"
M,WVL=1!"1T%WY)1C!X? )QKQA6:&0.LNY%05KT9WW)^>HPCCL,OYOEV:8)ST
MB-^W4YH@3>&6]Z)(RR"T0P;]!]Y;R[S[/@<GG4\TX@O-]+'622@Z#MY[U5->
MT8@O-#,$6D\AIUAX-=['^[V"LMBE41!W7SX3BQV.0A3B+;37X@:YQ4V;4&?-
MMRDYN,V^5;26X*IY$CS2]GBO2N^\Q<'IYA.-^$(SW:LU$W*O-[T:X[UJ*Z]H
MQ!>:&0*MK9![U>FU&&];28JC,$A1E_,6RSB($Z71NZRW6"*$1V&X1<QC+7>P
M6^X<R'MKI7??XN!/;;PN-OE",]VK510^CL4F[%5D>44COM#,$&B1A8]BL0GW
MUX:Z@GZW"7&:F [8^-S.+7'NJ)"\F,CU2[I/=:'F]R=W]Y_$F[T*N_L&!V>7
MWX_I_H]5(ZSE$@Z/@^!>U917-.(+S0R!5E/8O>KT6@2/^JO$2IE'$'9%O,42
M-LMV*.DN*-LLHQCA=,LG(ECK&^S6-P>1WE[5O:X$>44COM!,YVJQA)/C(+U7
M0>45C?A",T.@!15V+T*]%NG3W56];X(@A@'LD;UO"$=Q%/?>U0\W-DI4E#^V
M&TZ$&LRBELM- ^NKZTTM5^U6CL[U:WA.EEM3-,QRI\S'C#\6M0 EG2K(X&VB
M>L67FT^6)Y+-V^T8#TQ*5K6',YKEE#<&ZO<I8_+EI+G!>@O0^%]02P,$%
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M,(NJU:T&BF_+YF_)E6XER\<-1CD6!J#?KSA7;P/S@>8?#K-_ 5!+ P04
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MOQKF#1A8'LCT=VN-[S9>(?OK -O3?16"S12O1&RF^%H#XE\W8*2I?[>Q/,#
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MHAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"R0_L?@!02P,$%
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MKFK1F3U  @I.6GRC,WN !!0P"ZA;VQ)_UW=14Z]N;R**B004G+0$UQET)*"
M64 8LS/H2$ !LX P)M5Y -O1F 6$,:G. Z2@@%E!&)/J/$ 6"D[92] I'P7(
M0L$;]A(<T3IM0D06"IDM=("Y?Q9=%^?J,C?%1!8*F2V$,9\I)K)0R&RA \RZ
MBI1%.M%M;R)M$PJ1A4)F"X%HUJ4NBHDL%+[E@Z##:';*1R&R4'C21T+4Z2&R
M4,AL(8Q)G1["MFAF"QUO)/H]@U),9*&0_9'004?1T>5:B P4<C\.0KU%W0YS
M9*#+QD#]YN3BT\?8#DJFXIG]B,+NCV02+8RH7YKV/<?SZQ:^=94D8[MOGMWE
M,M[_W\[^?XX^_0-02P,$%     @ BH9F6+3%"JYH @  1R\  !H   !X;"]?
M<F5L<R]W;W)K8F]O:RYX;6PN<F5L<\W:2VZC0!2%X:U8+""X;MV'TXHSZDFF
MK6P .>6'8AL$M#K9?5O.P#ZH!SV)."-4("[_Z ,!3[_*L1D/[7G8'[IA\7$Z
MGH=UM1_'[D==#YM].37#0]N5\^7(MNU/S7A9]KNZ:S;OS:[4LEQZW=_/J)Z?
M[F<N7C^[\C\3V^WVL"D_V\WO4SF/_QA<_VG[]V%?RE@M7IM^5\9U57\<;[N'
M^KI)#Y?)U>+E;5WU+V^IJN<.$@B2^8,R!.7Y@Q2"=/X@@R";/\@AR.</"@B*
M^8-6$+2:/^@1@A[G#TI+E'%)D#3!FD#KA%PG J\3@IT(Q$Y(=B(P.R':B4#M
MA&PG K<3PIT(Y$Y(=R*P.R'>B4!O0;V%0&]!O85 ;YD\;!/H+:BW$.@MJ+<0
MZ"VHMQ#H+:BW$.@MJ+<0Z"VHMQ#H+:BW$.B=4>],H'=&O3.!WAGUS@1ZY\G+
M$@*],^J="?3.J'<FT#NCWIE [XQZ9P*],^J="?3.J'<FT%M1;R706U%O)=!;
M46\ET%M1;R706R<ONPGT5M1;"?16U%L)]%;46PGT5M1;"?16U%L)]#;4VPCT
M-M3;"/0VU-L(]#;4VPCT-M3;"/2VR<=* KT-]38"O0WU-@*]#?4V KT-]38"
MO1WU=@*]'?5V KT=]78"O1WU=@*]'?5V KT=]78"O7WRLPF!WHYZ.X'>CGH[
M@=Z.>CN!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>,?E9
MD$#O0+V#0.] O8- [Q7JO?I.O8?Q\UB&6\_7&J__G52/EW/+[?+7Y==.O%^L
MKCC7]Q7#\U]02P,$%     @ BH9F6"P!9SL; @  #BX  !,   !;0V]N=&5N
M=%]4>7!E<UTN>&ULS=K-3N,P% 7@5ZFR18WK?QA1-C#;&1;S B:YI5&3V+(-
M4]Y^G!20&#$5J$AS-HU:V_?<^$K?JI>_G@*EQ7[HQ[2NMCF';XRE9DN#2[4/
M-):5C8^#R^5KO&?!-3MW3TRL5H8U?LPTYF6>:E17ES>T<0]]7GS?EY]3Y\=U
M%:E/U>+ZL''*6E<NA+YK7"[K['%L_TI9/B?4Y>2\)VV[D,[*AHJ]FS"M_#O@
M^=S/1XJQ:VEQZV+^X8:RB^U[EO)33ZD^7N*='OUFTS74^N9A*$?J%"*Y-FV)
M\M#7AZ)GQY-SN6$Z?/*3\^<RQP++SMOH0RH3B_3YN)>13*>7H12BF+OCK_B:
M6$J?_'XT3;NE]H/9Y7I_^[B;YY'8_#C]CM_.^+7^)_L0('U(D#X42!\:I \#
MTH<%Z>,<I(\+D#[X"J41%%$Y"JD<Q52.@BI'496CL,I17.4HL'(4606*K )%
M5H$BJT"15:#(*E!D%2BR"A19!8JL D56B2*K1)%5HL@J4625*+)*%%DEBJP2
M15:)(JM$D56AR*I09%4HLBH4616*K I%5H4BJT*15:'(JE!DU2BR:A19-8JL
M&D56C2*K1I%5H\BJ4635*+)J%%D-BJP&15:#(JM!D=6@R&I09#4HLAH460V*
MK 9%5HLBJT61U:+(:E%DM2BR6A19+8JL%D56BR*K19'U_'_*>N?][HOCYV<]
MN&Y\R6?SW\"O_@!02P$"% ,4    " "*AF98!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (J&9EAS
MG\-%[P   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( (J&9EB97)PC$ 8  )PG   3              "  <T!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ BH9F6%A\=>GE!@
M,R,  !@              ("!#@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( (J&9EBE6:$$1 (  ,4%   8              " @2D/
M  !X;"]W;W)K<VAE971S+W-H965T,BYX;6Q02P$"% ,4    " "*AF98J6:L
M(NH&  "Q'P  &               @(&C$0  >&PO=V]R:W-H965T<R]S:&5E
M=#,N>&UL4$L! A0#%     @ BH9F6'560TT1 P  LPL  !@
M ("!PQ@  'AL+W=O<FMS:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( (J&
M9E@KG>XN@@8  !HC   8              " @0H<  !X;"]W;W)K<VAE971S
M+W-H965T-2YX;6Q02P$"% ,4    " "*AF982FUQ/[@#  !2#   &
M        @('"(@  >&PO=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%
M  @ BH9F6'VWY<RJ$   V-L  !@              ("!L"8  'AL+W=O<FMS
M:&5E=',O<VAE970W+GAM;%!+ 0(4 Q0    ( (J&9EA 61=QA@(  !<%   8
M              " @9 W  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"
M% ,4    " "*AF98\'#@AE<-  #H1   &               @(%,.@  >&PO
M=V]R:W-H965T<R]S:&5E=#DN>&UL4$L! A0#%     @ BH9F6!52,;L!!
M^@@  !D              ("!V4<  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX
M;6Q02P$"% ,4    " "*AF98:6H T ,H   'A@  &0              @($1
M3   >&PO=V]R:W-H965T<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( (J&9EA<
M$03/+0<  &T2   9              " @4MT  !X;"]W;W)K<VAE971S+W-H
M965T,3(N>&UL4$L! A0#%     @ BH9F6-H!U;O<!   C0T  !D
M     ("!KWL  'AL+W=O<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (J&9EAF'H97\ (  -X&   9              "
M@<:<  !X;"]W;W)K<VAE971S+W-H965T,3@N>&UL4$L! A0#%     @ BH9F
M6$C\X?'_$P  ,SD  !D              ("![9\  'AL+W=O<FMS:&5E=',O
M<VAE970Q.2YX;6Q02P$"% ,4    " "*AF98[W$__# 0  !8+@  &0
M        @($CM   >&PO=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0
M   ( (J&9EBKQ5%QX 0  &8,   9              " @8K$  !X;"]W;W)K
M<VAE971S+W-H965T,C$N>&UL4$L! A0#%     @ BH9F6$G<#\ZQ!   #@L
M !D              ("!H<D  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q0
M2P$"% ,4    " "*AF98OE@\&-T"   Y!@  &0              @(&)S@
M>&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;%!+ 0(4 Q0    ( (J&9EBV4Q&]
MK@,  (\)   9              " @9W1  !X;"]W;W)K<VAE971S+W-H965T
M,C0N>&UL4$L! A0#%     @ BH9F6+&[<&B$-0  1\,  !D
M ("!@M4  'AL+W=O<FMS:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "*
MAF98PM'OIU\&  !T$   &0              @($]"P$ >&PO=V]R:W-H965T
M<R]S:&5E=#(V+GAM;%!+ 0(4 Q0    ( (J&9EBP(T<:FP4   @/   9
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M970S,2YX;6Q02P$"% ,4    " "*AF98/*53GJT"  #/!0  &0
M    @(&H*0$ >&PO=V]R:W-H965T<R]S:&5E=#,R+GAM;%!+ 0(4 Q0    (
M (J&9EB%ADC6QP(  %X&   9              " @8PL 0!X;"]W;W)K<VAE
M971S+W-H965T,S,N>&UL4$L! A0#%     @ BH9F6.Q4&K5J!@  W@\  !D
M             ("!BB\! 'AL+W=O<FMS:&5E=',O<VAE970S-"YX;6Q02P$"
M% ,4    " "*AF98I.X;'@0'   "$P  &0              @($K-@$ >&PO
M=V]R:W-H965T<R]S:&5E=#,U+GAM;%!+ 0(4 Q0    ( (J&9EB^2L>>V@0
M /4+   9              " @68] 0!X;"]W;W)K<VAE971S+W-H965T,S8N
M>&UL4$L! A0#%     @ BH9F6*OZ@H[A#0  &I8  !D              ("!
M=T(! 'AL+W=O<FMS:&5E=',O<VAE970S-RYX;6Q02P$"% ,4    " "*AF98
MS_,&53@#  !F#P  &0              @(&/4 $ >&PO=V]R:W-H965T<R]S
M:&5E=#,X+GAM;%!+ 0(4 Q0    ( (J&9EB=X#D?V@D  (ME   9
M      " @?Y3 0!X;"]W;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%
M  @ BH9F6#MRY\A< P  2@L  !D              ("!#UX! 'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6Q02P$"% ,4    " "*AF98=<AD[VL"   B!P
M&0              @(&B80$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+
M 0(4 Q0    ( (J&9EAB=J<<?@4  /XH   9              " @41D 0!X
M;"]W;W)K<VAE971S+W-H965T-#(N>&UL4$L! A0#%     @ BH9F6!JLCWP8
M!   !!4  !D              ("!^6D! 'AL+W=O<FMS:&5E=',O<VAE970T
M,RYX;6Q02P$"% ,4    " "*AF98 KI7U!<#  "@"0  &0
M@(%(;@$ >&PO=V]R:W-H965T<R]S:&5E=#0T+GAM;%!+ 0(4 Q0    ( (J&
M9ECGA2P8"@,  *()   9              " @99Q 0!X;"]W;W)K<VAE971S
M+W-H965T-#4N>&UL4$L! A0#%     @ BH9F6'ZM,8:0!0  '"@  !D
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M=#4P+GAM;%!+ 0(4 Q0    ( (J&9EA)J91^\ ,  -P.   9
M  " @5^* 0!X;"]W;W)K<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @
MBH9F6##Z&.=S P  M@X  !D              ("!AHX! 'AL+W=O<FMS:&5E
M=',O<VAE970U,BYX;6Q02P$"% ,4    " "*AF98+ HZ79@"  #,!@  &0
M            @($PD@$ >&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4
M Q0    ( (J&9EB3,/0-]P(  !4(   9              " @?^4 0!X;"]W
M;W)K<VAE971S+W-H965T-30N>&UL4$L! A0#%     @ BH9F6$=?>!1\ @
M* 8  !D              ("!+9@! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX
M;6Q02P$"% ,4    " "*AF98>B=I AL#   M#0  &0              @('@
MF@$ >&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( (J&9E@1
M$O_IR (  !L(   9              " @3*> 0!X;"]W;W)K<VAE971S+W-H
M965T-3<N>&UL4$L! A0#%     @ BH9F6#4MD0<R P  +@P  !D
M     ("!,:$! 'AL+W=O<FMS:&5E=',O<VAE970U."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (J&9EC- WUAA00  "T<   9              "
M@<*Q 0!X;"]W;W)K<VAE971S+W-H965T-C,N>&UL4$L! A0#%     @ BH9F
M6&3(X-=A"0  1E@  !D              ("!?K8! 'AL+W=O<FMS:&5E=',O
M<VAE970V-"YX;6Q02P$"% ,4    " "*AF98]")"U=X#  #7%0  &0
M        @($6P $ >&PO=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0
M   ( (J&9EA(,^U7NP4  +H?   9              " @2O$ 0!X;"]W;W)K
M<VAE971S+W-H965T-C8N>&UL4$L! A0#%     @ BH9F6%"D5BF9 P  9P\
M !D              ("!'<H! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q0
M2P$"% ,4    " "*AF98FAN Q6 #  #I"P  &0              @('MS0$
M>&PO=V]R:W-H965T<R]S:&5E=#8X+GAM;%!+ 0(4 Q0    ( (J&9E@U\2.H
M>P0  "H9   9              " @831 0!X;"]W;W)K<VAE971S+W-H965T
M-CDN>&UL4$L! A0#%     @ BH9F6 )&9&4(!0  YR   !D
M ("!-M8! 'AL+W=O<FMS:&5E=',O<VAE970W,"YX;6Q02P$"% ,4    " "*
MAF98IU(RECT#  "0#0  &0              @(%UVP$ >&PO=V]R:W-H965T
M<R]S:&5E=#<Q+GAM;%!+ 0(4 Q0    ( (J&9EA>=%,DHP,  +(0   9
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M970W-BYX;6Q02P$"% ,4    " "*AF98YXFG,> &   .-   &0
M    @(%Y]@$ >&PO=V]R:W-H965T<R]S:&5E=#<W+GAM;%!+ 0(4 Q0    (
M (J&9EA%#PY2'@,  .$*   9              " @9#] 0!X;"]W;W)K<VAE
M971S+W-H965T-S@N>&UL4$L! A0#%     @ BH9F6"#*N>9G @  8P4  !D
M             ("!Y0 " 'AL+W=O<FMS:&5E=',O<VAE970W.2YX;6Q02P$"
M% ,4    " "*AF98#- <Q0<$  !\$   &0              @(&# P( >&PO
M=V]R:W-H965T<R]S:&5E=#@P+GAM;%!+ 0(4 Q0    ( (J&9E@2X"$+4@,
M ,84   -              "  <$' @!X;"]S='EL97,N>&UL4$L! A0#%
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K @!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !8 %@ 'Q@  !\7 @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>320</ContextCount>
  <ElementCount>413</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>78</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS??? DEFICIT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS??? DEFICIT</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS??? DEFICIT (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS??? DEFICIT (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Organization and Description of Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrganizationandDescriptionofBusiness</Role>
      <ShortName>Organization and Description of Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Revenue Recognition</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognition</Role>
      <ShortName>Revenue Recognition</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Derivative Instruments and Hedging</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/DerivativeInstrumentsandHedging</Role>
      <ShortName>Derivative Instruments and Hedging</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Consolidated Balance Sheet Components</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponents</Role>
      <ShortName>Consolidated Balance Sheet Components</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Guarantees, Commitments, and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/GuaranteesCommitmentsandContingencies</Role>
      <ShortName>Guarantees, Commitments, and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Temporary Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/TemporaryEquity</Role>
      <ShortName>Temporary Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Ordinary Shares and Equity Incentive Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlan</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders</Role>
      <ShortName>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Employee Benefit Plans</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/EmployeeBenefitPlans</Role>
      <ShortName>Employee Benefit Plans</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://riskified.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9954473 - Disclosure - Revenue Recognition (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognitionTables</Role>
      <ShortName>Revenue Recognition (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/RevenueRecognition</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9954474 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/FairValueMeasurements</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9954475 - Disclosure - Derivative Instruments and Hedging (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/DerivativeInstrumentsandHedgingTables</Role>
      <ShortName>Derivative Instruments and Hedging (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/DerivativeInstrumentsandHedging</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9954476 - Disclosure - Consolidated Balance Sheet Components (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables</Role>
      <ShortName>Consolidated Balance Sheet Components (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/ConsolidatedBalanceSheetComponents</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9954477 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/Leases</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9954478 - Disclosure - Guarantees, Commitments, and Contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables</Role>
      <ShortName>Guarantees, Commitments, and Contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/GuaranteesCommitmentsandContingencies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9954479 - Disclosure - Temporary Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/TemporaryEquityTables</Role>
      <ShortName>Temporary Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/TemporaryEquity</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9954480 - Disclosure - Ordinary Shares and Equity Incentive Plan (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/OrdinarySharesandEquityIncentivePlan</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9954481 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/IncomeTaxes</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9954482 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables</Role>
      <ShortName>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9954486 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9954488 - Disclosure - Revenue Recognition - Revenue by Geographic Areas (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails</Role>
      <ShortName>Revenue Recognition - Revenue by Geographic Areas (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9954489 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails</Role>
      <ShortName>Revenue Recognition - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9954490 - Disclosure - Revenue Recognition - Deferred Contract Acquisition Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails</Role>
      <ShortName>Revenue Recognition - Deferred Contract Acquisition Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9954491 - Disclosure - Revenue Recognition - Deferred Contract Fulfillment Costs (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails</Role>
      <ShortName>Revenue Recognition - Deferred Contract Fulfillment Costs (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9954492 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9954493 - Disclosure - Fair Value Measurements - Schedule of Short-term Investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Short-term Investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9954494 - Disclosure - Fair Value Measurements - Effective Contractual Maturity Dates (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails</Role>
      <ShortName>Fair Value Measurements - Effective Contractual Maturity Dates (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9954495 - Disclosure - Derivative Instruments and Hedging - Derivative Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails</Role>
      <ShortName>Derivative Instruments and Hedging - Derivative Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9954496 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails</Role>
      <ShortName>Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9954497 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails</Role>
      <ShortName>Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9954498 - Disclosure - Consolidated Balance Sheet Components - Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9954499 - Disclosure - Consolidated Balance Sheet Components - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9954500 - Disclosure - Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9954501 - Disclosure - Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9954502 - Disclosure - Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails</Role>
      <ShortName>Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9954503 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9954504 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9954505 - Disclosure - Leases - Maturity Lease Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/LeasesMaturityLeaseScheduleDetails</Role>
      <ShortName>Leases - Maturity Lease Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9954506 - Disclosure - Leases (By Geographic Region) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/LeasesByGeographicRegionDetails</Role>
      <ShortName>Leases (By Geographic Region) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://riskified.com/role/LeasesTables</ParentRole>
      <Position>60</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9954507 - Disclosure - Guarantees, Commitments, and Contingencies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails</Role>
      <ShortName>Guarantees, Commitments, and Contingencies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9954508 - Disclosure - Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails</Role>
      <ShortName>Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9954509 - Disclosure - Ordinary Share Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinaryShareWarrantsDetails</Role>
      <ShortName>Ordinary Share Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9954510 - Disclosure - Ordinary Shares and Equity Incentive Plan - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9954511 - Disclosure - Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9954512 - Disclosure - Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9954513 - Disclosure - Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9954514 - Disclosure - Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9954515 - Disclosure - Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails</Role>
      <ShortName>Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9954516 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9954517 - Disclosure - Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9954518 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Provision for Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9954519 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Effective Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9954520 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9954521 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Position (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails</Role>
      <ShortName>Income Taxes - Reconciliation of Unrecognized Tax Position (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9954522 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails</Role>
      <ShortName>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9954523 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails</Role>
      <ShortName>Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables</ParentRole>
      <Position>77</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9954524 - Disclosure - Employee Benefit Plans - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9954525 - Disclosure - Subsequent Events (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SubsequentEventsDetails</Role>
      <ShortName>Subsequent Events (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://riskified.com/role/SubsequentEvents</ParentRole>
      <Position>79</Position>
    </Report>
    <Report instance="rskd-20231231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9954526 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails</Role>
      <ShortName>SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts</ParentRole>
      <Position>80</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" isDefinitelyFs="true" isUsgaap="true" original="rskd-20231231.htm">rskd-20231231.htm</File>
    <File>rskd-20231231.xsd</File>
    <File>rskd-20231231_cal.xml</File>
    <File>rskd-20231231_def.xml</File>
    <File>rskd-20231231_lab.xml</File>
    <File>rskd-20231231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>rskd-20231231_g1.jpg</File>
    <File>rskd-20231231_g2.jpg</File>
    <File>rskd-20231231_g3.jpg</File>
    <File>rskd-20231231_g4.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="1">http://fasb.org/srt/2023</BaseTaxonomy>
    <BaseTaxonomy items="1128">http://fasb.org/us-gaap/2023</BaseTaxonomy>
    <BaseTaxonomy items="59">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>108
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "rskd-20231231.htm": {
   "nsprefix": "rskd",
   "nsuri": "http://riskified.com/20231231",
   "dts": {
    "inline": {
     "local": [
      "rskd-20231231.htm"
     ]
    },
    "schema": {
     "local": [
      "rskd-20231231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "rskd-20231231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "rskd-20231231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "rskd-20231231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rskd-20231231_pre.xml"
     ]
    }
   },
   "keyStandard": 368,
   "keyCustom": 45,
   "axisStandard": 30,
   "axisCustom": 1,
   "memberStandard": 57,
   "memberCustom": 19,
   "hidden": {
    "total": 11,
    "http://fasb.org/us-gaap/2023": 5,
    "http://xbrl.sec.gov/dei/2023": 6
   },
   "contextCount": 320,
   "entityCount": 1,
   "segmentCount": 78,
   "elementCount": 640,
   "unitCount": 7,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2023": 1128,
    "http://xbrl.sec.gov/dei/2023": 59,
    "http://fasb.org/srt/2023": 1
   },
   "report": {
    "R1": {
     "role": "http://riskified.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://riskified.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorFirmId",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
     "longName": "0000003 - Statement - CONSOLIDATED BALANCE SHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:RestrictedCashCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "longName": "0000004 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:TreasuryStockCommonShares",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "longName": "0000005 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CostOfRevenue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS",
     "longName": "0000006 - Statement - CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)",
     "shortName": "CONSOLIDATED STATEMENTS OF COMPREHENSIVE PROFIT (LOSS)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
     "longName": "0000007 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS\u2019 DEFICIT",
     "shortName": "CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS\u2019 DEFICIT",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "us-gaap:TemporaryEquitySharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical",
     "longName": "0000008 - Statement - CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS\u2019 DEFICIT (Parenthetical)",
     "shortName": "CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED SHARES AND SHAREHOLDERS\u2019 DEFICIT (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-25",
      "name": "rskd:PaymentsOfTemporaryEquityIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-25",
      "name": "rskd:PaymentsOfTemporaryEquityIssuanceCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R9": {
     "role": "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "longName": "0000009 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ForeignCurrencyTransactionGainLossUnrealized",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R10": {
     "role": "http://riskified.com/role/OrganizationandDescriptionofBusiness",
     "longName": "0000010 - Disclosure - Organization and Description of Business",
     "shortName": "Organization and Description of Business",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPolicies",
     "longName": "0000011 - Disclosure - Summary of Significant Accounting Policies",
     "shortName": "Summary of Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://riskified.com/role/RevenueRecognition",
     "longName": "0000012 - Disclosure - Revenue Recognition",
     "shortName": "Revenue Recognition",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://riskified.com/role/FairValueMeasurements",
     "longName": "0000013 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://riskified.com/role/DerivativeInstrumentsandHedging",
     "longName": "0000014 - Disclosure - Derivative Instruments and Hedging",
     "shortName": "Derivative Instruments and Hedging",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponents",
     "longName": "0000015 - Disclosure - Consolidated Balance Sheet Components",
     "shortName": "Consolidated Balance Sheet Components",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://riskified.com/role/Leases",
     "longName": "0000016 - Disclosure - Leases",
     "shortName": "Leases",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://riskified.com/role/GuaranteesCommitmentsandContingencies",
     "longName": "0000017 - Disclosure - Guarantees, Commitments, and Contingencies",
     "shortName": "Guarantees, Commitments, and Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://riskified.com/role/TemporaryEquity",
     "longName": "0000018 - Disclosure - Temporary Equity",
     "shortName": "Temporary Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "rskd:TemporaryEquityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rskd:TemporaryEquityDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlan",
     "longName": "0000019 - Disclosure - Ordinary Shares and Equity Incentive Plan",
     "shortName": "Ordinary Shares and Equity Incentive Plan",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://riskified.com/role/IncomeTaxes",
     "longName": "0000020 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R21": {
     "role": "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders",
     "longName": "0000021 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders",
     "shortName": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://riskified.com/role/EmployeeBenefitPlans",
     "longName": "0000022 - Disclosure - Employee Benefit Plans",
     "shortName": "Employee Benefit Plans",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://riskified.com/role/SubsequentEvents",
     "longName": "0000023 - Disclosure - Subsequent Events",
     "shortName": "Subsequent Events",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts",
     "longName": "0000024 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "longName": "9954471 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables",
     "longName": "9954472 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://riskified.com/role/RevenueRecognitionTables",
     "longName": "9954473 - Disclosure - Revenue Recognition (Tables)",
     "shortName": "Revenue Recognition (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://riskified.com/role/FairValueMeasurementsTables",
     "longName": "9954474 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://riskified.com/role/DerivativeInstrumentsandHedgingTables",
     "longName": "9954475 - Disclosure - Derivative Instruments and Hedging (Tables)",
     "shortName": "Derivative Instruments and Hedging (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables",
     "longName": "9954476 - Disclosure - Consolidated Balance Sheet Components (Tables)",
     "shortName": "Consolidated Balance Sheet Components (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R31": {
     "role": "http://riskified.com/role/LeasesTables",
     "longName": "9954477 - Disclosure - Leases (Tables)",
     "shortName": "Leases (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables",
     "longName": "9954478 - Disclosure - Guarantees, Commitments, and Contingencies (Tables)",
     "shortName": "Guarantees, Commitments, and Contingencies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://riskified.com/role/TemporaryEquityTables",
     "longName": "9954479 - Disclosure - Temporary Equity (Tables)",
     "shortName": "Temporary Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "rskd:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "rskd:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables",
     "longName": "9954480 - Disclosure - Ordinary Shares and Equity Incentive Plan (Tables)",
     "shortName": "Ordinary Shares and Equity Incentive Plan (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://riskified.com/role/IncomeTaxesTables",
     "longName": "9954481 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R36": {
     "role": "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables",
     "longName": "9954482 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)",
     "shortName": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9954483 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CapitalizedContractCostNetNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-82",
      "name": "us-gaap:SaleOfStockConsiderationReceivedOnTransaction",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R38": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails",
     "longName": "9954484 - Disclosure - Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Concentration Risks (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-85",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails",
     "longName": "9954485 - Disclosure - Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Immaterial Prior Period Error Corrections (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CapitalizedContractCostNetNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-67",
      "name": "us-gaap:CapitalizedContractCostNetNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R40": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails",
     "longName": "9954486 - Disclosure - Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details)",
     "shortName": "Summary of Significant Accounting Policies - Rollforward of Allowance for Credit Losses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivable",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R41": {
     "role": "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails",
     "longName": "9954487 - Disclosure - Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)",
     "shortName": "Summary of Significant Accounting Policies - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-91",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
     "longName": "9954488 - Disclosure - Revenue Recognition - Revenue by Geographic Areas (Details)",
     "shortName": "Revenue Recognition - Revenue by Geographic Areas (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
     "longName": "9954489 - Disclosure - Revenue Recognition - Disaggregation of Revenue (Details)",
     "shortName": "Revenue Recognition - Disaggregation of Revenue (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Revenues",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-137",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "us-gaap:RevenueFromContractWithCustomerTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R44": {
     "role": "http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails",
     "longName": "9954490 - Disclosure - Revenue Recognition - Deferred Contract Acquisition Costs (Details)",
     "shortName": "Revenue Recognition - Deferred Contract Acquisition Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:CapitalizedContractCostNetNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R45": {
     "role": "http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails",
     "longName": "9954491 - Disclosure - Revenue Recognition - Deferred Contract Fulfillment Costs (Details)",
     "shortName": "Revenue Recognition - Deferred Contract Fulfillment Costs (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "rskd:DeferredContractFulfillmentCostsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rskd:DeferredContractFulfillmentCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-18",
      "name": "rskd:DeferredContractFulfillmentCostsNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "rskd:DeferredContractFulfillmentCostsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R46": {
     "role": "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails",
     "longName": "9954492 - Disclosure - Fair Value Measurements - Schedule of Financial Instruments (Details)",
     "shortName": "Fair Value Measurements - Schedule of Financial Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-149",
      "name": "us-gaap:ShortTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R47": {
     "role": "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails",
     "longName": "9954493 - Disclosure - Fair Value Measurements - Schedule of Short-term Investments (Details)",
     "shortName": "Fair Value Measurements - Schedule of Short-term Investments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R48": {
     "role": "http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails",
     "longName": "9954494 - Disclosure - Fair Value Measurements - Effective Contractual Maturity Dates (Details)",
     "shortName": "Fair Value Measurements - Effective Contractual Maturity Dates (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:ShortTermInvestments",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "us-gaap:ShortTermInvestments",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "us-gaap:FairValueDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
     "longName": "9954495 - Disclosure - Derivative Instruments and Hedging - Derivative Instruments (Details)",
     "shortName": "Derivative Instruments and Hedging - Derivative Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeInstrumentsTextBlock",
       "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
     "longName": "9954496 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details)",
     "shortName": "Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on the Consolidated Statement of Operations (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-198",
      "name": "us-gaap:DerivativeGainLossOnDerivativeNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails",
     "longName": "9954497 - Disclosure - Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details)",
     "shortName": "Derivative Instruments and Hedging - Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Income (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-204",
      "name": "us-gaap:StockholdersEquity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R52": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
     "longName": "9954498 - Disclosure - Consolidated Balance Sheet Components - Property and Equipment, Net (Details)",
     "shortName": "Consolidated Balance Sheet Components - Property and Equipment, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails",
     "longName": "9954499 - Disclosure - Consolidated Balance Sheet Components - Narrative (Details)",
     "shortName": "Consolidated Balance Sheet Components - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:Depreciation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R54": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails",
     "longName": "9954500 - Disclosure - Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)",
     "shortName": "Consolidated Balance Sheet Components - Accrued Expenses and Other Current Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ContractWithCustomerRefundLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ContractWithCustomerRefundLiabilityCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R55": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails",
     "longName": "9954501 - Disclosure - Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details)",
     "shortName": "Consolidated Balance Sheet Components - Other Liabilities, Noncurrent (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
     "longName": "9954502 - Disclosure - Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details)",
     "shortName": "Consolidated Balance Sheet Components - Property, Plant and Equipment (by Geographic Region) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-218",
      "name": "us-gaap:PropertyPlantAndEquipmentNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://riskified.com/role/LeasesLeaseCostDetails",
     "longName": "9954503 - Disclosure - Leases - Lease Cost (Details)",
     "shortName": "Leases - Lease Cost (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeaseCost",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://riskified.com/role/LeasesNarrativeDetails",
     "longName": "9954504 - Disclosure - Leases - Narrative (Details)",
     "shortName": "Leases - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-11",
      "name": "us-gaap:OperatingLeasesRentExpenseNet",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R59": {
     "role": "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails",
     "longName": "9954505 - Disclosure - Leases - Maturity Lease Schedule (Details)",
     "shortName": "Leases - Maturity Lease Schedule (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R60": {
     "role": "http://riskified.com/role/LeasesByGeographicRegionDetails",
     "longName": "9954506 - Disclosure - Leases (By Geographic Region) (Details)",
     "shortName": "Leases (By Geographic Region) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R61": {
     "role": "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
     "longName": "9954507 - Disclosure - Guarantees, Commitments, and Contingencies - Narrative (Details)",
     "shortName": "Guarantees, Commitments, and Contingencies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:GuaranteeObligationsCurrentCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:GuaranteeObligationsMaximumExposure",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-8",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails",
     "longName": "9954508 - Disclosure - Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)",
     "shortName": "Guarantees, Commitments, and Contingencies - Non-Cancelable Purchase Obligations Maturity Schedule (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:PurchaseObligationDueInNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R63": {
     "role": "http://riskified.com/role/OrdinaryShareWarrantsDetails",
     "longName": "9954509 - Disclosure - Ordinary Share Warrants (Details)",
     "shortName": "Ordinary Share Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-3",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "rskd:TemporaryEquityDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
     "longName": "9954510 - Disclosure - Ordinary Shares and Equity Incentive Plan - Narrative (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "rskd:StockRepurchaseProgramTransactionCosts",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R65": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails",
     "longName": "9954511 - Disclosure - Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - Schedule of Ordinary Shares Reserved for Issuance (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-236",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R66": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails",
     "longName": "9954512 - Disclosure - Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - Stock Option Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
     "longName": "9954513 - Disclosure - Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - Black-Scholes Assumptions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-242",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-242",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "4",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R68": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
     "longName": "9954514 - Disclosure - Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - RSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
     "longName": "9954515 - Disclosure - Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details)",
     "shortName": "Ordinary Shares and Equity Incentive Plan - Share-based Compensation Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-253",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R70": {
     "role": "http://riskified.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9954516 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-271",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R71": {
     "role": "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
     "longName": "9954517 - Disclosure - Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Profit (Loss) before Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-134",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R72": {
     "role": "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
     "longName": "9954518 - Disclosure - Income Taxes - Schedule of Provision for Income Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Provision for Income Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentIncomeTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
     "longName": "9954519 - Disclosure - Income Taxes - Reconciliation of Effective Income Tax Provision (Details)",
     "shortName": "Income Taxes - Reconciliation of Effective Income Tax Provision (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9954520 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails",
     "longName": "9954521 - Disclosure - Income Taxes - Reconciliation of Unrecognized Tax Position (Details)",
     "shortName": "Income Taxes - Reconciliation of Unrecognized Tax Position (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R76": {
     "role": "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
     "longName": "9954522 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details)",
     "shortName": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Earnings Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-17",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R77": {
     "role": "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
     "longName": "9954523 - Disclosure - Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details)",
     "shortName": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders - Schedule of Anti-Dilutive Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-12",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:EarningsPerShareTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails",
     "longName": "9954524 - Disclosure - Employee Benefit Plans - Narrative (Details)",
     "shortName": "Employee Benefit Plans - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DefinedContributionPlanTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:DefinedContributionPlanTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://riskified.com/role/SubsequentEventsDetails",
     "longName": "9954525 - Disclosure - Subsequent Events (Details)",
     "shortName": "Subsequent Events (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-305",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-305",
      "name": "us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "div",
       "us-gaap:SubsequentEventsTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true,
      "unique": true
     }
    },
    "R80": {
     "role": "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails",
     "longName": "9954526 - Disclosure - SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)",
     "shortName": "SEC Schedule, Article 12-09, Valuation and Qualifying Accounts (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-307",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-317",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-3",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "rskd-20231231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "rskd_A2013EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "A2013EquityIncentivePlanMember",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2013 Equity Incentive Plan",
        "label": "2013 Equity Incentive Plan [Member]",
        "documentation": "2013 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_A2021EmployeeSharePurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "A2021EmployeeSharePurchasePlanMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Employee Share Purchase Plan",
        "label": "2021 Employee Share Purchase Plan [Member]",
        "documentation": "2021 Employee Share Purchase Plan"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_A2021EquityIncentivePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "A2021EquityIncentivePlanMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2021 Equity Incentive Plan",
        "label": "2021 Equity Incentive Plan [Member]",
        "documentation": "2021 Equity Incentive Plan"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountingPoliciesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Accounts Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r35",
      "r805"
     ]
    },
    "us-gaap_AccountsReceivableAllowanceForCreditLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableAllowanceForCreditLossTableTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rollforward of Allowance for Credit Losses",
        "label": "Accounts Receivable, Allowance for Credit Loss [Table Text Block]",
        "documentation": "Tabular disclosure of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r890"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r334"
     ]
    },
    "rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "AccruedLiabilitiesAndOtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other current liabilities",
        "totalLabel": "Accrued expenses and other current liabilities",
        "label": "Accrued Liabilities And Other Liabilities, Current",
        "documentation": "Accrued Liabilities And Other Liabilities, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses",
        "label": "Accrued Liabilities, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation and amortization",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services."
       }
      }
     },
     "auth_ref": [
      "r82",
      "r222",
      "r625"
     ]
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r245",
      "r246",
      "r516",
      "r781",
      "r848"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive profit (loss)",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r45",
      "r46",
      "r135",
      "r228",
      "r621",
      "r648",
      "r652"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Profit (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r21",
      "r46",
      "r527",
      "r530",
      "r595",
      "r643",
      "r644",
      "r848",
      "r849",
      "r850",
      "r864",
      "r865",
      "r866"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-in Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r467",
      "r468",
      "r469",
      "r663",
      "r864",
      "r865",
      "r866",
      "r934",
      "r966"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Address Type [Domain]",
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization",
        "label": "Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization",
        "documentation": "Adjustments To Additional Paid In Capital, Elimination Of Par Value Upon Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of convertible preferred share warrants upon IPO",
        "label": "Adjustments To Additional Paid In Capital, Reclassification Of Warrants",
        "documentation": "Adjustments To Additional Paid In Capital, Reclassification Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of convertible preferred share warrants upon IPO",
        "label": "Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity",
        "documentation": "Adjustments To Additional Paid In Capital, Reclassification Of Warrants, Including Portion Attributable To Temporary Equity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r97",
      "r433"
     ]
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share warrants issued to a customer",
        "label": "Adjustments to Additional Paid in Capital, Warrant Issued",
        "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r83",
      "r159"
     ]
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net profit (loss) to net cash provided by (used in) operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising expense",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r476"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r464",
      "r475"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, allowance for credit loss",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r337",
      "r356",
      "r357",
      "r361",
      "r958"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recoveries of amounts previously deemed uncollectible",
        "label": "Accounts Receivable, Allowance for Credit Loss, Recovery",
        "documentation": "Amount of increase in allowance for credit loss on accounts receivable, from recovery."
       }
      }
     },
     "auth_ref": [
      "r360"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Uncollectible accounts charged against the allowance",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance."
       }
      }
     },
     "auth_ref": [
      "r359"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "srt_AmericasMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AmericasMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Americas",
        "label": "Americas [Member]",
        "documentation": "Continents of North and South America."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of intangible assets",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r77",
      "r80"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r303"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "srt_AsiaPacificMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "AsiaPacificMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asia Pacific",
        "label": "Asia Pacific [Member]",
        "documentation": "Region of Asia Pacific."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r173",
      "r224",
      "r259",
      "r310",
      "r323",
      "r327",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r514",
      "r517",
      "r556",
      "r617",
      "r706",
      "r805",
      "r818",
      "r896",
      "r897",
      "r946"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r218",
      "r230",
      "r259",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r514",
      "r517",
      "r556",
      "r805",
      "r896",
      "r897",
      "r946"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total financial assets",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "rskd_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://riskified.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorLocation",
     "presentation": [
      "http://riskified.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditorName",
     "presentation": [
      "http://riskified.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r342"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r343"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails": {
       "parentTag": "us-gaap_AvailableForSaleSecuritiesDebtSecurities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Due in 1 year or less",
        "label": "Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One",
        "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), with single maturity date and allocated without single maturity date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r615"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails": {
       "parentTag": "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
       "weight": 1.0,
       "order": 2.0
      },
      "http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsEffectiveContractualMaturityDatesDetails",
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value",
        "totalLabel": "Fair Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r341",
      "r362",
      "r610",
      "r873"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ]
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Contact",
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r824",
      "r825"
     ]
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchases of property and equipment during the period included in accounts payable and accrued expenses",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareAmortization1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedComputerSoftwareAmortization1",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 17.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of capitalized internal-use software costs",
        "label": "Capitalized Computer Software, Amortization",
        "documentation": "Amount of expense for amortization of capitalized computer software costs."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r180"
     ]
    },
    "us-gaap_CapitalizedComputerSoftwareGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedComputerSoftwareGross",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized software costs",
        "label": "Capitalized Computer Software, Gross",
        "documentation": "Amount before accumulated amortization of capitalized costs for computer software, including but not limited to, acquired and internally developed computer software."
       }
      }
     },
     "auth_ref": [
      "r972"
     ]
    },
    "us-gaap_CapitalizedContractCostAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostAmortization",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 21.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of deferred contract costs",
        "label": "Capitalized Contract Cost, Amortization",
        "documentation": "Amount of amortization expense for asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_CapitalizedContractCostAmortizationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostAmortizationPeriod",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized contract cost, amortization period",
        "label": "Capitalized Contract Cost, Amortization Period",
        "documentation": "Amortization period of cost capitalized in obtaining or fulfilling contract with customer, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r834"
     ]
    },
    "us-gaap_CapitalizedContractCostImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized contract cost, impairment loss",
        "label": "Capitalized Contract Cost, Impairment Loss",
        "documentation": "Amount of impairment loss for asset recognized from cost incurred to obtain or fulfill contract with customer."
       }
      }
     },
     "auth_ref": [
      "r364"
     ]
    },
    "us-gaap_CapitalizedContractCostNetNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CapitalizedContractCostNetNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred contract acquisition costs",
        "negatedTerseLabel": "Overstatement of deferred contract acquisition costs",
        "periodStartLabel": "Capitalized Contract Cost, Net, Noncurrent",
        "periodEndLabel": "Capitalized Contract Cost, Net, Noncurrent",
        "label": "Capitalized Contract Cost, Net, Noncurrent",
        "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer; classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r363"
     ]
    },
    "rskd_CapitalizedDeferredContractAcquisitionCostAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CapitalizedDeferredContractAcquisitionCostAmortization",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capitalized Deferred Contract Acquisition Cost, Amortization",
        "label": "Capitalized Deferred Contract Acquisition Cost, Amortization",
        "documentation": "Capitalized Deferred Contract Acquisition Cost, Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      },
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r220",
      "r779"
     ]
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsAxis",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Axis]",
        "label": "Cash and Cash Equivalents [Axis]",
        "documentation": "Information by type of cash and cash equivalent balance."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash, Cash Equivalents, and Restricted Cash",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits."
       }
      }
     },
     "auth_ref": [
      "r53",
      "r172"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents, and restricted cash\u2014beginning of period",
        "periodEndLabel": "Cash, cash equivalents, and restricted cash\u2014end of period",
        "totalLabel": "Total cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r145",
      "r257"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash, cash equivalents, and restricted cash within the consolidated balance sheets to the amounts shown in the consolidated statements of cash flows above:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net increase (decrease) in cash, cash equivalents, and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r145"
     ]
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of noncash investing and financing activities:",
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_ChargebackExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ChargebackExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Chargeback expense",
        "label": "Chargeback Expense",
        "documentation": "Chargeback Expense"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ChiefExecutiveOfficerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ChiefExecutiveOfficerMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chief Executive Officer",
        "label": "Chief Executive Officer [Member]",
        "documentation": "Person with designation of chief executive officer."
       }
      }
     },
     "auth_ref": [
      "r872"
     ]
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/Cover",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r225",
      "r226",
      "r227",
      "r259",
      "r292",
      "r293",
      "r300",
      "r302",
      "r308",
      "r309",
      "r345",
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r556",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r694",
      "r717",
      "r735",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r831",
      "r855",
      "r868"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price (in dollars per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r400"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfWarrantOrRightOutstanding",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issued and Outstanding Share Warrants (in shares)",
        "label": "Class of Warrant or Right, Outstanding",
        "documentation": "Number of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_CloudComputingArrangementImplementationCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CloudComputingArrangementImplementationCostsMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cloud Computing Arrangement Implementation Costs",
        "label": "Cloud Computing Arrangement Implementation Costs [Member]",
        "documentation": "Cloud Computing Arrangement Implementation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r40",
      "r120",
      "r618",
      "r693"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsContingenciesAndGuaranteesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommitmentsContingenciesAndGuaranteesTextBlock",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantees, Commitments, and Contingencies",
        "label": "Commitments Contingencies and Guarantees [Text Block]",
        "documentation": "The entire disclosure for commitments, contingencies, and guarantees."
       }
      }
     },
     "auth_ref": [
      "r154",
      "r155",
      "r893"
     ]
    },
    "us-gaap_CommonClassAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassAMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/Cover",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Class A",
        "label": "Common Class A [Member]",
        "documentation": "Classification of common stock representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_CommonClassBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonClassBMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/Cover",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Class B",
        "label": "Common Class B [Member]",
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r966"
     ]
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total ordinary shares reserved (in shares)",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "documentation": "Aggregate number of common shares reserved for future issuance."
       }
      }
     },
     "auth_ref": [
      "r41"
     ]
    },
    "rskd_CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary shares reserved for future issuance, annual increase percentage",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Annual Increase, Percent",
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Annual Increase, Percent"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum ownership of shares",
        "label": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Ownership, Percentage",
        "documentation": "Common Stock, Capital Shares Reserved For Future Issuance, Maximum Ownership, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r809",
      "r810",
      "r812",
      "r813",
      "r814",
      "r815",
      "r864",
      "r865",
      "r934",
      "r962",
      "r966"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in dollars per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares authorized (in dollars per share)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r694"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares, issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, shares, outstanding (in shares)",
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r128",
      "r694",
      "r712",
      "r966",
      "r967"
     ]
    },
    "us-gaap_CommonStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CommonStockValue",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, value, issued",
        "label": "Common Stock, Value, Issued",
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r619",
      "r805"
     ]
    },
    "rskd_CommonStockVotesForEachShare": {
     "xbrltype": "integerItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CommonStockVotesForEachShare",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Votes per common share",
        "label": "Common Stock, Votes For Each Share",
        "documentation": "Common Stock, Votes For Each Share"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Components of Deferred Tax Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Components of Deferred Tax Liabilities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive profit (loss)",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r240",
      "r242",
      "r249",
      "r612",
      "r630"
     ]
    },
    "us-gaap_ComputerEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ComputerEquipmentMember",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer equipment",
        "label": "Computer Equipment [Member]",
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r72",
      "r118",
      "r119",
      "r332",
      "r764"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r72",
      "r118",
      "r119",
      "r332",
      "r653",
      "r764"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r72",
      "r118",
      "r119",
      "r332",
      "r764",
      "r833"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Risks",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r189"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r764"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk, percentage",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r72",
      "r118",
      "r119",
      "r332"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Describes the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r72",
      "r73",
      "r118",
      "r171",
      "r764"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r68",
      "r72",
      "r118",
      "r119",
      "r332",
      "r764"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Email Address",
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contact Personnel Name",
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerRefundLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractWithCustomerRefundLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer credits",
        "label": "Contract with Customer, Refund Liability, Current",
        "documentation": "Amount of liability for consideration received or receivable from customer which is not included in transaction price, when consideration is expected to be refunded to customer, classified as current."
       }
      }
     },
     "auth_ref": [
      "r900"
     ]
    },
    "us-gaap_ContractualObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ContractualObligation",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual obligation",
        "label": "Contractual Obligation",
        "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments."
       }
      }
     },
     "auth_ref": [
      "r858"
     ]
    },
    "rskd_ContractualObligationTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ContractualObligationTerm",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual obligation, term",
        "label": "Contractual Obligation, Term",
        "documentation": "Contractual Obligation, Term"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConversionOfStockAmountConverted1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockAmountConverted1",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of convertible preferred shares into Class A ordinary shares upon IPO",
        "label": "Conversion of Stock, Amount Converted",
        "documentation": "The value of the stock converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_ConversionOfStockByUniqueDescriptionAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockByUniqueDescriptionAxis",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Conversion Description [Axis]",
        "label": "Stock Conversion Description [Axis]",
        "documentation": "Information by description of stock conversions."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "us-gaap_ConversionOfStockNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConversionOfStockNameDomain",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Stock, Name [Domain]",
        "label": "Conversion of Stock, Name [Domain]",
        "documentation": "The unique name of a noncash or part noncash stock conversion."
       }
      }
     },
     "auth_ref": [
      "r55",
      "r56",
      "r57"
     ]
    },
    "rskd_ConvertiblePreferredShareTrancheRightsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ConvertiblePreferredShareTrancheRightsMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Convertible Preferred Share Tranche Rights [Member]",
        "terseLabel": "Convertible Preferred Share Tranche Rights [Member]",
        "label": "Convertible Preferred Share Tranche Rights [Member]",
        "documentation": "Convertible Preferred Share Tranche Rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ConvertiblePreferredStockMember",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Stock",
        "label": "Convertible Preferred Stock [Member]",
        "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option."
       }
      }
     },
     "auth_ref": [
      "r395",
      "r396",
      "r397",
      "r812",
      "r813",
      "r814",
      "r815"
     ]
    },
    "us-gaap_CostOfRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfRevenue",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Revenue",
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r140",
      "r259",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r556",
      "r896"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of revenue",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CostOfSalesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CostOfSalesPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of Revenue",
        "label": "Cost of Goods and Service [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cost of product sold and service rendered."
       }
      }
     },
     "auth_ref": [
      "r842"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total current income tax expense",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r499",
      "r507",
      "r857"
     ]
    },
    "rskd_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CustomerAMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer A",
        "label": "Customer A [Member]",
        "documentation": "Customer A"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_CustomerBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "CustomerBMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer B",
        "label": "Customer B [Member]",
        "documentation": "Customer B"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer Concentration Risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r69",
      "r332"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss",
        "documentation": "Amortized cost, after allowance for credit loss, of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r874"
     ]
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Debt Securities",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r875",
      "r876",
      "r877",
      "r878",
      "r879",
      "r880",
      "r881",
      "r882",
      "r883",
      "r884",
      "r885",
      "r886"
     ]
    },
    "rskd_DeferredContractFulfillmentCostsAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "DeferredContractFulfillmentCostsAmortizationExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred Contract Fulfillment Costs, Amortization Expense",
        "label": "Deferred Contract Fulfillment Costs, Amortization Expense",
        "documentation": "Deferred Contract Fulfillment Costs, Amortization Expense"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_DeferredContractFulfillmentCostsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "DeferredContractFulfillmentCostsNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Deferred Contract Fulfillment Costs, Noncurrent",
        "periodEndLabel": "Deferred Contract Fulfillment Costs, Noncurrent",
        "label": "Deferred Contract Fulfillment Costs, Noncurrent",
        "documentation": "Deferred Contract Fulfillment Costs, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_DeferredContractFulfillmentCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "DeferredContractFulfillmentCostsTableTextBlock",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Contract Fulfillment Costs",
        "label": "Deferred Contract Fulfillment Costs [Table Text Block]",
        "documentation": "Deferred Contract Fulfillment Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total deferred income tax expense",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r167",
      "r194",
      "r506",
      "r507",
      "r857"
     ]
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Gross deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r124",
      "r125",
      "r174",
      "r493"
     ]
    },
    "rskd_DeferredOfferingCostsIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "DeferredOfferingCostsIncurredButNotYetPaid",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred offering costs accrued but not paid",
        "label": "Deferred Offering Costs Incurred But Not Yet Paid",
        "documentation": "Deferred Offering Costs Incurred But Not Yet Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredPolicyAcquisitionCostsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredPolicyAcquisitionCostsTableTextBlock",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Policy Acquisition Costs",
        "label": "Deferred Policy Acquisition Costs [Table Text Block]",
        "documentation": "Tabular disclosure of the movement in deferred policy acquisition costs."
       }
      }
     },
     "auth_ref": [
      "r639",
      "r646",
      "r806",
      "r960"
     ]
    },
    "us-gaap_DeferredTaxAndOtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAndOtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Tax and Other Liabilities, Noncurrent",
        "label": "Deferred Tax and Other Liabilities, Noncurrent",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences, with jurisdictional netting, and liabilities classified as noncurrent and other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r494"
     ]
    },
    "rskd_DeferredTaxAssetsLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "DeferredTaxAssetsLeasingArrangements",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities",
        "label": "Deferred Tax Assets, Leasing Arrangements",
        "documentation": "Deferred Tax Assets, Leasing Arrangements"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets/(liabilities)",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r931"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsOther",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Deferred Tax Assets, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development expenses",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vacation and convalescence",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Compensated Absences",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from compensated absences (includes, but not limited to, sick and personal days)."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred Compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Employee Compensation",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from employee compensation."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Bad debts",
        "label": "Deferred Tax Asset, Tax Deferred Expense, Reserve and Accrual, Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r495"
     ]
    },
    "us-gaap_DeferredTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Net deferred tax assets/(liabilities)",
        "label": "Deferred Tax Liabilities, Net",
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r100",
      "r931"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capitalized Software",
        "label": "Deferred Tax Liabilities, Deferred Expense, Capitalized Software",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized software."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred contract acquisition costs",
        "label": "Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from capitalized costs classified as other."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesLeasingArrangements": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesLeasingArrangements",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Operating lease right-of-use assets",
        "label": "Deferred Tax Liabilities, Leasing Arrangements",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from leasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Property and equipment",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r932"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Defined contribution plan, cost",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r429"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contribution, percent of employees' pay",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contribution, percent of match",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DefinedContributionPlanTextBlock",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlans"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plans",
        "label": "Defined Contribution Plan [Text Block]",
        "documentation": "The entire disclosure for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r428",
      "r429"
     ]
    },
    "us-gaap_DepositsAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepositsAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term deposits",
        "label": "Deposits Assets, Current",
        "documentation": "Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment within one year or during the operating cycle, if shorter."
       }
      }
     },
     "auth_ref": [
      "r846"
     ]
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r81"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 19.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r313"
     ]
    },
    "us-gaap_DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Asset, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative asset."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_DerivativeAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeAssets",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments included in prepaid expenses and other current assets",
        "label": "Derivative Asset",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r555",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r700",
      "r701",
      "r746",
      "r749",
      "r752",
      "r753",
      "r754",
      "r755",
      "r780",
      "r810",
      "r963"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r683",
      "r685",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r723",
      "r724",
      "r725",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r746",
      "r747",
      "r752",
      "r754",
      "r808",
      "r810"
     ]
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total derivative instruments",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r110",
      "r134",
      "r231",
      "r780"
     ]
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeGainLossOnDerivativeNet",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total gain (loss) recognized in earnings",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r111",
      "r112",
      "r113",
      "r683",
      "r685",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r723",
      "r724",
      "r725",
      "r726",
      "r729",
      "r730",
      "r731",
      "r732",
      "r746",
      "r747",
      "r752",
      "r754",
      "r780",
      "r808",
      "r810"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgesLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgesLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedges, Liabilities",
        "label": "Derivative Instruments and Hedges, Liabilities",
        "documentation": "Sum as of the balance sheet date of the (a) fair values of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and (b) the carrying amounts of the liabilities arising from financial instruments or contracts used to mitigate a specified risk (hedge), and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedging"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging",
        "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]",
        "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts."
       }
      }
     },
     "auth_ref": [
      "r170",
      "r521",
      "r533"
     ]
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresTable",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Table]",
        "documentation": "Disclosure of information about derivatives and hedging activities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DerivativeLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_LiabilitiesFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative financial instruments included in accrued expenses and other current liabilities",
        "label": "Derivative Liability",
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset."
       }
      }
     },
     "auth_ref": [
      "r232",
      "r233",
      "r555",
      "r675",
      "r676",
      "r677",
      "r678",
      "r681",
      "r682",
      "r683",
      "r684",
      "r685",
      "r707",
      "r709",
      "r710",
      "r747",
      "r748",
      "r749",
      "r752",
      "r753",
      "r754",
      "r755",
      "r780",
      "r963"
     ]
    },
    "us-gaap_DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "label": "Derivative Liability, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes derivative liability."
       }
      }
     },
     "auth_ref": [
      "r519"
     ]
    },
    "us-gaap_DerivativesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DerivativesPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Financial Instruments",
        "label": "Derivatives, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r104",
      "r105",
      "r107",
      "r115",
      "r261"
     ]
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueLineItems",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Line Items]",
        "label": "Disaggregation of Revenue [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTable",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue [Table]",
        "label": "Disaggregation of Revenue [Table]",
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r419",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796"
     ]
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r899"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Disclosure of Share-based Compensation Arrangements by Share-based Payment Award",
        "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]",
        "documentation": "Tabular disclosure of share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r94"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Accounting Standard",
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825",
      "r827"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825",
      "r827"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Registration Statement",
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r819"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Shell Company Report",
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r824"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r826"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Domestic Tax Authority",
        "label": "Domestic Tax Authority [Member]",
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EMEAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EMEAMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EMEA",
        "label": "EMEA [Member]",
        "documentation": "Regions of Europe, Middle East and Africa."
       }
      }
     },
     "auth_ref": [
      "r968",
      "r969",
      "r970",
      "r971"
     ]
    },
    "us-gaap_EarningsPerShareAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net profit (loss) per share attributable to ordinary shareholders, basic (in dollars per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r277",
      "r278",
      "r280",
      "r281",
      "r283",
      "r289",
      "r292",
      "r300",
      "r301",
      "r302",
      "r306",
      "r543",
      "r544",
      "r613",
      "r631",
      "r782"
     ]
    },
    "us-gaap_EarningsPerShareBasicLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareBasicLineItems",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "label": "Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r300"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net profit (loss) per share attributable to ordinary shareholders, diluted (in dollars per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r277",
      "r278",
      "r280",
      "r281",
      "r283",
      "r292",
      "r300",
      "r301",
      "r302",
      "r306",
      "r543",
      "r544",
      "r613",
      "r631",
      "r782"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63"
     ]
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EarningsPerShareTextBlock",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholders"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Profit (Loss) Per Share Attributable to Ordinary Shareholders",
        "label": "Earnings Per Share [Text Block]",
        "documentation": "The entire disclosure for earnings per share."
       }
      }
     },
     "auth_ref": [
      "r288",
      "r303",
      "r304",
      "r305"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effects of exchange rates on cash, cash equivalents, and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r562"
     ]
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporates tax rate",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "rskd_EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred enterprise",
        "label": "Effective Income Tax Rate Reconciliation, Preferred Enterprise, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Preferred Enterprise, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrant revaluation",
        "label": "Effective Income Tax Rate Reconciliation, Warrant Revaluation, Amount",
        "documentation": "Effective Income Tax Rate Reconciliation, Warrant Revaluation, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r37"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation capitalized for software development",
        "label": "Share-Based Payment Arrangement, Amount Capitalized",
        "documentation": "Amount of cost capitalized for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r465"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized amount",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based payment arrangement, nonvested award, cost not yet recognized, period for recognition",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r466"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense not yet recognized",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r927"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option",
        "label": "Employee Stock Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Ownership Plan (ESOP) Name [Axis]",
        "label": "Employee Stock Ownership Plan (ESOP) Name [Axis]",
        "documentation": "Information by name of employee stock ownership plan."
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "us-gaap_EmployeeStockOwnershipPlanESOPPlanDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EmployeeStockOwnershipPlanESOPPlanDomain",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Ownership Plan (ESOP), Plan [Domain]",
        "label": "Employee Stock Ownership Plan (ESOP), Plan [Domain]",
        "documentation": "Entities identify multiple employee stock ownership plans by unique name."
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Country",
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Addresses, Address Type [Axis]",
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r830"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r828"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r821"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r829"
     ]
    },
    "us-gaap_EquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shareholders\u2019 equity:",
        "label": "Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r214",
      "r244",
      "r245",
      "r246",
      "r269",
      "r270",
      "r271",
      "r274",
      "r284",
      "r286",
      "r307",
      "r349",
      "r355",
      "r401",
      "r467",
      "r468",
      "r469",
      "r502",
      "r503",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r542",
      "r563",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r595",
      "r643",
      "r644",
      "r645",
      "r663",
      "r735"
     ]
    },
    "us-gaap_ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ErrorCorrectionsAndPriorPeriodAdjustmentsRestatementLineItems",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "label": "Error Corrections and Prior Period Adjustments Restatement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r283",
      "r284",
      "r285",
      "r286",
      "r306"
     ]
    },
    "rskd_ExpirationPeriodAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ExpirationPeriodAxis",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Period [Axis]",
        "label": "Expiration Period [Axis]",
        "documentation": "Expiration Period"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_ExpirationPeriodDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ExpirationPeriodDomain",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Period [Domain]",
        "label": "Expiration Period [Domain]",
        "documentation": "Expiration Period [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_FairValueAdjustmentOfRights": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "FairValueAdjustmentOfRights",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 22.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of convertible preferred share tranche rights",
        "label": "Fair Value Adjustment Of Rights",
        "documentation": "Fair Value Adjustment Of Rights"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAdjustmentOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAdjustmentOfWarrants",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 18.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remeasurement of convertible preferred share warrant liabilities",
        "label": "Fair Value Adjustment of Warrants",
        "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability."
       }
      }
     },
     "auth_ref": [
      "r2",
      "r11"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails",
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548",
      "r551"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails",
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548",
      "r551"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r24"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r548",
      "r599",
      "r600",
      "r601",
      "r787",
      "r788",
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueByMeasurementFrequencyAxis",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Axis]",
        "label": "Measurement Frequency [Axis]",
        "documentation": "Information by measurement frequency."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548",
      "r549",
      "r550",
      "r552"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueDisclosuresTextBlock",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Disclosures [Text Block]",
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information."
       }
      }
     },
     "auth_ref": [
      "r546"
     ]
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r422",
      "r427",
      "r548",
      "r599",
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 2",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r422",
      "r427",
      "r548",
      "r600",
      "r787",
      "r788",
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Inputs, Level 3",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r548",
      "r601",
      "r787",
      "r788",
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementFrequencyDomain",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measurement Frequency [Domain]",
        "label": "Measurement Frequency [Domain]",
        "documentation": "Measurement frequency."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r393",
      "r422",
      "r423",
      "r424",
      "r425",
      "r426",
      "r427",
      "r599",
      "r600",
      "r601",
      "r787",
      "r788",
      "r797",
      "r798",
      "r799"
     ]
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FairValueMeasurementsRecurringMember",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring",
        "label": "Fair Value, Recurring [Member]",
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r552"
     ]
    },
    "us-gaap_FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsFinancialAssetsBalanceSheetGroupingsAbstract",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]",
        "label": "Financial Instruments, Financial Assets, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FinancialInstrumentsFinancialLiabilitiesBalanceSheetGroupingsAbstract",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]",
        "label": "Financial Instruments, Financial Liabilities, Balance Sheet Groupings [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r365",
      "r366",
      "r367",
      "r368",
      "r605",
      "r609"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r79"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Tax Authority",
        "label": "Foreign Tax Authority [Member]",
        "documentation": "Designated tax departments of governments entitled to levy and collect income taxes from the entity outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ForeignCurrencyTransactionGainLossRealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossRealized",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency transaction gain (loss)",
        "label": "Realized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of realized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r714",
      "r816",
      "r937",
      "r938",
      "r964"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 15.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unrealized loss (gain) on foreign currency",
        "label": "Unrealized Gain (Loss), Foreign Currency Transaction, before Tax",
        "documentation": "Amount, before tax, of unrealized gain (loss) from foreign currency transaction."
       }
      }
     },
     "auth_ref": [
      "r147",
      "r715",
      "r816",
      "r937",
      "r938",
      "r965"
     ]
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Currency",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy."
       }
      }
     },
     "auth_ref": [
      "r561"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Exchange Forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r700",
      "r704",
      "r709",
      "r725",
      "r731",
      "r750",
      "r751",
      "r752",
      "r810"
     ]
    },
    "rskd_FraudServiceRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "FraudServiceRevenueMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fraud Service Revenue",
        "label": "Fraud Service Revenue [Member]",
        "documentation": "Fraud Service Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_FurnitureAndOfficeEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "FurnitureAndOfficeEquipmentMember",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and office equipment",
        "label": "Furniture And Office Equipment [Member]",
        "documentation": "Furniture And Office Equipment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense",
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line."
       }
      }
     },
     "auth_ref": [
      "r141",
      "r719"
     ]
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeneralAndAdministrativeExpenseMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and administrative",
        "label": "General and Administrative Expense [Member]",
        "documentation": "Primary financial statement caption encompassing general and administrative expense."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GeographicConcentrationRiskMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographic Concentration Risk",
        "label": "Geographic Concentration Risk [Member]",
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa)."
       }
      }
     },
     "auth_ref": [
      "r71",
      "r764"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r139",
      "r259",
      "r310",
      "r322",
      "r326",
      "r328",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r556",
      "r784",
      "r896"
     ]
    },
    "us-gaap_GuaranteeObligationsCurrentCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteeObligationsCurrentCarryingValue",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee obligations",
        "label": "Guarantor Obligations, Current Carrying Value",
        "documentation": "The current carrying amount of the liability for the freestanding or embedded guarantor's obligations under the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r383"
     ]
    },
    "us-gaap_GuaranteeObligationsMaximumExposure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteeObligationsMaximumExposure",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantor obligations, maximum exposure",
        "label": "Guarantor Obligations, Maximum Exposure, Undiscounted",
        "documentation": "Maximum potential amount of future payments (undiscounted) the guarantor could be required to make under the guarantee or each group of similar guarantees before reduction for potential recoveries under recourse or collateralization provisions."
       }
      }
     },
     "auth_ref": [
      "r382"
     ]
    },
    "us-gaap_GuaranteeObligationsTerm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteeObligationsTerm",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee obligations, term",
        "label": "Guarantor Obligations, Term",
        "documentation": "Describe the approximate term of the guarantee or each group of similar guarantees."
       }
      }
     },
     "auth_ref": [
      "r381"
     ]
    },
    "us-gaap_GuaranteesIndemnificationsAndWarrantiesPolicies": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "GuaranteesIndemnificationsAndWarrantiesPolicies",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indemnifications Guarantees",
        "label": "Guarantees, Indemnifications and Warranties Policies [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for guarantees, indemnifications and product warranties, and methodologies used in determining the amount of such liabilities."
       }
      }
     },
     "auth_ref": [
      "r380"
     ]
    },
    "rskd_GuarantorObligationsChargebackExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "GuarantorObligationsChargebackExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Chargeback expense",
        "label": "Guarantor Obligations, Chargeback Expense",
        "documentation": "Guarantor Obligations, Chargeback Expense"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_GuarantorObligationsPercentageOfGuaranteesPaid": {
     "xbrltype": "percentItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "GuarantorObligationsPercentageOfGuaranteesPaid",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of guarantees paid",
        "label": "Guarantor Obligations, Percentage Of Guarantees Paid",
        "documentation": "Guarantor Obligations, Percentage Of Guarantees Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r520"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "country_IL": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "IL",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/LeasesByGeographicRegionDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israel",
        "label": "ISRAEL"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IPOMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IPOMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IPO",
        "label": "IPO [Member]",
        "documentation": "First sale of stock by a private company to the public."
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r823",
      "r824",
      "r825"
     ]
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment of Long-Lived Assets",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r153"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Profit (loss) before income taxes",
        "terseLabel": "Profit (loss) before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r136",
      "r178",
      "r310",
      "r322",
      "r326",
      "r328",
      "r614",
      "r627",
      "r784"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Axis]",
        "label": "Income Statement Location [Axis]",
        "documentation": "Information by location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r369",
      "r372",
      "r720"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement Location [Domain]",
        "label": "Income Statement Location [Domain]",
        "documentation": "Location in the income statement."
       }
      }
     },
     "auth_ref": [
      "r372",
      "r720"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Axis]",
        "label": "Income Tax Authority [Axis]",
        "documentation": "Information by tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Authority [Domain]",
        "label": "Income Tax Authority [Domain]",
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyLineItems",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Line Items]",
        "label": "Income Tax Contingency [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxContingencyTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxContingencyTable",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Contingency [Table]",
        "label": "Income Tax Contingency [Table]",
        "documentation": "Disclosure of information about tax positions taken in the tax returns filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other income tax contingencies. Includes, but is not limited to, interest and penalties, reconciliation of unrecognized tax benefits, unrecognized tax benefits that would affect the effective tax rate, tax years that remain subject to examination by tax jurisdictions, and information about positions for which it is reasonably possible that amounts unrecognized will significantly change within 12 months."
       }
      }
     },
     "auth_ref": [
      "r19",
      "r103",
      "r165",
      "r166"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information."
       }
      }
     },
     "auth_ref": [
      "r260",
      "r479",
      "r485",
      "r490",
      "r497",
      "r504",
      "r508",
      "r509",
      "r510",
      "r662"
     ]
    },
    "us-gaap_IncomeTaxExaminationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationLineItems",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Examination [Line Items]",
        "label": "Income Tax Examination [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxExaminationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExaminationTable",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Examination [Table]",
        "label": "Income Tax Examination [Table]",
        "documentation": "A summary of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the Increase or Decrease in the liability from the prior period, and any penalties and interest that have been incurred or accrued."
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for (benefit from) income taxes",
        "totalLabel": "Total provision for income taxes",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r195",
      "r285",
      "r286",
      "r314",
      "r483",
      "r505",
      "r632"
     ]
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r481",
      "r482",
      "r490",
      "r491",
      "r496",
      "r498",
      "r656"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Israel tax benefit at statutory rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r484"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent differences",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxReconciliationPriorYearIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationPriorYearIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior year tax income/(expense)",
        "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxReconciliationTaxContingencies",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Uncertain tax position",
        "label": "Effective Income Tax Rate Reconciliation, Tax Contingency, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in income tax contingencies. Including, but not limited to, domestic tax contingency, foreign tax contingency, state and local tax contingency, and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r928"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for income taxes",
        "label": "Income Taxes Paid",
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income."
       }
      }
     },
     "auth_ref": [
      "r51",
      "r54"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsPayable",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable",
        "label": "Increase (Decrease) in Accounts Payable",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accounts receivable",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 16.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued expenses and other liabilities",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r852"
     ]
    },
    "rskd_IncreaseDecreaseInCapitalizedContractCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IncreaseDecreaseInCapitalizedContractCost",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Deferred contract acquisition costs",
        "label": "Increase (Decrease) In Capitalized Contract Cost",
        "documentation": "Increase (Decrease) In Capitalized Contract Cost"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued compensation and benefits",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "rskd_IncreaseDecreaseInGuarantorObligations": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IncreaseDecreaseInGuarantorObligations",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee obligations",
        "label": "Increase (Decrease) in Guarantor Obligations",
        "documentation": "Increase (Decrease) in Guarantor Obligations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Operating Lease Liability",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "documentation": "Amount of increase (decrease) in obligation for operating lease."
       }
      }
     },
     "auth_ref": [
      "r836",
      "r852"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Prepaid expenses and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "rskd_IncreaseDecreaseInProvisionForChargebacks": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IncreaseDecreaseInProvisionForChargebacks",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 20.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for chargebacks, net",
        "label": "Increase (Decrease) In Provision For Chargebacks",
        "documentation": "Increase (Decrease) In Provision For Chargebacks"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInTemporaryEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "IncreaseDecreaseInTemporaryEquityRollForward",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "label": "Increase (Decrease) in Temporary Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_IncreaseDecreaseToDeferredContractAcquisitionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IncreaseDecreaseToDeferredContractAcquisitionCosts",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) To Deferred Contract Acquisition Costs",
        "label": "Increase (Decrease) To Deferred Contract Acquisition Costs",
        "documentation": "Increase (Decrease) To Deferred Contract Acquisition Costs"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_IncreaseDecreaseToDeferredContractFulfillmentCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IncreaseDecreaseToDeferredContractFulfillmentCosts",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) To Deferred Contract Fulfillment Costs",
        "label": "Increase (Decrease) To Deferred Contract Fulfillment Costs",
        "documentation": "Increase (Decrease) To Deferred Contract Fulfillment Costs"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_IndemnificationServiceRevenueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "IndemnificationServiceRevenueMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Indemnification Service Revenue",
        "label": "Indemnification Service Revenue [Member]",
        "documentation": "Indemnification Service Revenue"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 14.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest Income, Deposit with Financial Institution, Increase (Decrease)",
        "label": "Interest Income, Deposit with Financial Institution, Increase (Decrease)",
        "documentation": "Amount of increase (decrease) in interest income on deposit with financial institution."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r198",
      "r199",
      "r200"
     ]
    },
    "us-gaap_InterestIncomeExpenseNonoperatingNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestIncomeExpenseNonoperatingNet",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest income (expense), net",
        "label": "Interest Income (Expense), Nonoperating, Net",
        "documentation": "The net amount of nonoperating interest income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r253",
      "r255",
      "r256"
     ]
    },
    "us-gaap_InternalUseSoftwarePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InternalUseSoftwarePolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized Software Costs and Cloud Computing Arrangement Implementation Costs",
        "label": "Internal Use Software, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs incurred when both (1) the software is acquired, internally developed, or modified solely to meet the entity's internal needs, and (2) during the software's development or modification, no substantive plan exists or is being developed to market the software externally."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r4"
     ]
    },
    "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Estimate of Fair Value of Investments by Contractual Maturity Dates",
        "label": "Investments Classified by Contractual Maturity Date [Table Text Block]",
        "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LatestTaxYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LatestTaxYearMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Do not expire",
        "label": "Latest Tax Year [Member]",
        "documentation": "Latest identified tax year."
       }
      }
     },
     "auth_ref": [
      "r929"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/LeasesLeaseCostDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r582",
      "r804"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://riskified.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease, Cost",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r941"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://riskified.com/role/LeasesByGeographicRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://riskified.com/role/LeasesByGeographicRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r581"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r580"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://riskified.com/role/LeasesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r942"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total undiscounted lease payments",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r590"
     ]
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://riskified.com/role/Leases"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r577"
     ]
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r259",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r515",
      "r517",
      "r518",
      "r556",
      "r692",
      "r783",
      "r818",
      "r896",
      "r946",
      "r947"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and shareholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r133",
      "r175",
      "r623",
      "r805",
      "r856",
      "r887",
      "r936"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Shareholders\u2019 Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r38",
      "r219",
      "r259",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r515",
      "r517",
      "r518",
      "r556",
      "r805",
      "r896",
      "r946",
      "r947"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "LiabilitiesFairValueDisclosure",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total financial liabilities",
        "label": "Liabilities, Fair Value Disclosure",
        "documentation": "Fair value of financial and nonfinancial obligations."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r792",
      "r899",
      "r959",
      "r961"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term Investments",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MaximumMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r430",
      "r603",
      "r640",
      "r684",
      "r685",
      "r739",
      "r741",
      "r743",
      "r744",
      "r756",
      "r774",
      "r775",
      "r786",
      "r789",
      "r800",
      "r807",
      "r898",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "MinimumMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r430",
      "r603",
      "r640",
      "r684",
      "r685",
      "r739",
      "r741",
      "r743",
      "r744",
      "r756",
      "r774",
      "r775",
      "r786",
      "r789",
      "r800",
      "r807",
      "r898",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ]
    },
    "rskd_MovementInDeferredContractAcquisitionCostsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "MovementInDeferredContractAcquisitionCostsRollForward",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractAcquisitionCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement In Deferred Contract Acquisition Costs [Roll Forward]",
        "label": "Movement In Deferred Contract Acquisition Costs [Roll Forward]",
        "documentation": "Movement In Deferred Contract Acquisition Costs"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_MovementInDeferredContractFulfillmentCostsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "MovementInDeferredContractFulfillmentCostsRollForward",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDeferredContractFulfillmentCostsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement In Deferred Contract Fulfillment Costs [Roll Forward]",
        "label": "Movement In Deferred Contract Fulfillment Costs [Roll Forward]",
        "documentation": "Movement In Deferred Contract Fulfillment Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MovementInValuationAllowancesAndReservesRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "MovementInValuationAllowancesAndReservesRollForward",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "label": "SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r792",
      "r899",
      "r959",
      "r961"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from financing activities:",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r254"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from investing activities:",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by (used in) operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r145",
      "r146",
      "r147"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash flows from operating activities:",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      },
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net profit (loss)",
        "terseLabel": "Net profit (loss)",
        "label": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r137",
      "r147",
      "r179",
      "r217",
      "r238",
      "r241",
      "r246",
      "r259",
      "r273",
      "r277",
      "r278",
      "r280",
      "r281",
      "r285",
      "r286",
      "r298",
      "r310",
      "r322",
      "r326",
      "r328",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r544",
      "r556",
      "r628",
      "r716",
      "r733",
      "r734",
      "r784",
      "r816",
      "r896"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net profit (loss) attributable to ordinary shareholders, basic",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r277",
      "r278",
      "r280",
      "r281",
      "r289",
      "r290",
      "r299",
      "r302",
      "r310",
      "r322",
      "r326",
      "r328",
      "r784"
     ]
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net profit (loss) attributable to ordinary shareholders, diluted",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders."
       }
      }
     },
     "auth_ref": [
      "r252",
      "r291",
      "r294",
      "r295",
      "r296",
      "r297",
      "r299",
      "r302"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r280",
      "r287",
      "r306",
      "r339",
      "r340",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r370",
      "r467",
      "r468",
      "r469",
      "r500",
      "r501",
      "r502",
      "r503",
      "r511",
      "r512",
      "r513",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r553",
      "r554",
      "r557",
      "r558",
      "r559",
      "r560",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r606",
      "r607",
      "r608",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654"
     ]
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r280",
      "r287",
      "r306",
      "r339",
      "r340",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r370",
      "r467",
      "r468",
      "r469",
      "r500",
      "r501",
      "r502",
      "r503",
      "r511",
      "r512",
      "r513",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r553",
      "r554",
      "r557",
      "r558",
      "r559",
      "r560",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r591",
      "r592",
      "r593",
      "r594",
      "r595",
      "r606",
      "r607",
      "r608",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654"
     ]
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recently Adopted Accounting Pronouncements and Recently Issued Accounting Pronouncements",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_NonIsraelAndNonUSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "NonIsraelAndNonUSMember",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rest of world",
        "label": "Non-Israel And Non-US [Member]",
        "documentation": "Non-Israel And Non-US"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_NonIsraelMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "NonIsraelMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Non-Israel [Member]",
        "documentation": "Non-Israel"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NondesignatedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NondesignatedMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingDerivativeInstrumentsDetails",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Not Designated as Hedging Instrument",
        "label": "Not Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_NumberOfOperatingSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfOperatingSegments",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of operating segments",
        "label": "Number of Operating Segments",
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r871"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating profit (loss)",
        "terseLabel": "Operating profit (loss)",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r310",
      "r322",
      "r326",
      "r328",
      "r784"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r583",
      "r804"
     ]
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesMaturityLeaseScheduleDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Present value of operating lease liabilities",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, current",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities, noncurrent",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/LeasesByGeographicRegionDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "label": "Operating Lease, Right-of-Use Asset, Periodic Reduction",
        "documentation": "Amount of periodic reduction over lease term of carrying amount of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r853"
     ]
    },
    "rskd_OperatingLeaseRightOfUseAssetLeaseModificationAdjustment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "OperatingLeaseRightOfUseAssetLeaseModificationAdjustment",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Adjustment to ROU assets upon modification of existing lease",
        "label": "Operating Lease, Right Of Use Asset, Lease Modification Adjustment",
        "documentation": "Operating Lease, Right Of Use Asset, Lease Modification Adjustment"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r589",
      "r804"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r588",
      "r804"
     ]
    },
    "us-gaap_OperatingLeasesIncomeStatementSubleaseRevenue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesIncomeStatementSubleaseRevenue",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sublease income",
        "label": "Operating Leases, Income Statement, Sublease Revenue",
        "documentation": "The amount of revenue recognized for the period under subleasing arrangements."
       }
      }
     },
     "auth_ref": [
      "r185"
     ]
    },
    "us-gaap_OperatingLeasesRentExpenseNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLeasesRentExpenseNet",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails",
      "http://riskified.com/role/LeasesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lease cost",
        "label": "Operating Leases, Rent Expense, Net",
        "documentation": "Rental expense for the reporting period incurred under operating leases, including minimum and any contingent rent expense, net of related sublease income."
       }
      }
     },
     "auth_ref": [
      "r184"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating loss carryforwards",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "presentation": [
      "http://riskified.com/role/OrganizationandDescriptionofBusiness"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Description of Business",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r149",
      "r150",
      "r168"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets, noncurrent",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r223"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign currency translation",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r8",
      "r20",
      "r169"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains (losses) on available-for-sale debt securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax",
        "documentation": "Amount, after tax and adjustment, of unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale) and unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r234",
      "r235",
      "r236"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)",
        "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax",
        "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r31",
      "r46",
      "r245",
      "r563",
      "r566",
      "r569",
      "r848"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains (losses) on derivative instruments, net",
        "verboseLabel": "Other comprehensive profit (loss)",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent",
        "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent."
       }
      }
     },
     "auth_ref": [
      "r236"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Other comprehensive profit (loss)",
        "terseLabel": "Other comprehensive profit (loss)",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r31",
      "r239",
      "r242",
      "r248",
      "r563",
      "r564",
      "r569",
      "r611",
      "r629",
      "r848",
      "r849"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEPROFITLOSS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive profit (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails": {
       "parentTag": "rskd_AccruedLiabilitiesAndOtherLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsAccruedExpensesandOtherCurrentLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Other Liabilities, Current",
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r37",
      "r805"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      },
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsOtherLiabilitiesNoncurrentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities, noncurrent",
        "totalLabel": "Other liabilities, noncurrent",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r39"
     ]
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Noncurrent Liabilities",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of other noncurrent liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r142"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OtherNonoperatingIncomeExpenseMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "label": "Other Nonoperating Income (Expense) [Member]",
        "documentation": "Primary financial statement caption encompassing other nonoperating income (expense)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OverAllotmentOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "OverAllotmentOptionMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Over-Allotment Option",
        "label": "Over-Allotment Option [Member]",
        "documentation": "Right given to the underwriter to sell additional shares over the initial allotment."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRent",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments for Rent",
        "label": "Payments for Rent",
        "documentation": "Cash payments to lessor's for use of assets under operating leases."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury shares",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r50"
     ]
    },
    "rskd_PaymentsOfOtherStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "PaymentsOfOtherStockIssuanceCosts",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of other stock issuance costs",
        "label": "Payments Of Other Stock Issuance Costs",
        "documentation": "Payments Of Other Stock Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsOfStockIssuanceCosts",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments of deferred offering costs",
        "terseLabel": "Payments of stock issuance costs",
        "label": "Payments of Stock Issuance Costs",
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "rskd_PaymentsOfTemporaryEquityIssuanceCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "PaymentsOfTemporaryEquityIssuanceCosts",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments of temporary equity issuance costs",
        "label": "Payments of Temporary Equity Issuance Costs",
        "documentation": "Payments of Temporary Equity Issuance Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireInvestments",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of investments",
        "label": "Payments to Acquire Investments",
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_PaymentsToAcquireShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToAcquireShortTermInvestments",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of short-term deposits",
        "label": "Payments to Acquire Short-Term Investments",
        "documentation": "The cash outflow for securities or other assets acquired, which qualify for treatment as an investing activity and are to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "us-gaap_PaymentsToDevelopSoftware": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PaymentsToDevelopSoftware",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Capitalized software development costs",
        "label": "Payments to Develop Software",
        "documentation": "The cash outflow associated with the development or modification of software programs or applications for internal use (that is, not to be sold, leased or otherwise marketed to others) that qualify for capitalization."
       }
      }
     },
     "auth_ref": [
      "r144"
     ]
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926"
     ]
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r847"
     ]
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Immaterial Prior Period Error Corrections",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error."
       }
      }
     },
     "auth_ref": [
      "r843"
     ]
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from initial public offering, net of underwriting discounts and commissions",
        "label": "Proceeds from Issuance Initial Public Offering",
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of convertible preferred shares and warrants, net of issuance costs",
        "label": "Proceeds from Issuance of Convertible Preferred Stock",
        "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "rskd_ProceedsFromIssuanceOfWarrantsOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ProceedsFromIssuanceOfWarrantsOperatingActivities",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary share warrants issued to a customer",
        "label": "Proceeds from Issuance of Warrants, Operating Activities",
        "documentation": "Proceeds from Issuance of Warrants, Operating Activities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturities of short-term deposits",
        "label": "Proceeds from Maturities, Prepayments and Calls of Short-Term Investments",
        "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term."
       }
      }
     },
     "auth_ref": [
      "r48",
      "r143"
     ]
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromStockOptionsExercised",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from exercise of share options",
        "label": "Proceeds from Stock Options Exercised",
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r27"
     ]
    },
    "us-gaap_ProceedsFromWarrantExercises": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProceedsFromWarrantExercises",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from cash exercise of series E-1 convertible preferred share warrants",
        "label": "Proceeds from Warrant Exercises",
        "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants."
       }
      }
     },
     "auth_ref": [
      "r851"
     ]
    },
    "us-gaap_ProductConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProductConcentrationRiskMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product Concentration Risk",
        "label": "Product Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues during the period from a specified product are to a specified benchmark, such as total net revenues, segment revenues or product line revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r604",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r777",
      "r790",
      "r806",
      "r837",
      "r894",
      "r895",
      "r899",
      "r959"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r329",
      "r604",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638",
      "r777",
      "r790",
      "r806",
      "r837",
      "r894",
      "r895",
      "r899",
      "r959"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, gross",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r152",
      "r221",
      "r626"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentNet",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      },
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net",
        "label": "Property, Plant and Equipment, Net",
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r616",
      "r626",
      "r805"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment, Net",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r12",
      "r190",
      "r193",
      "r624"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-Lived Tangible Asset [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, useful life",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_ProvisionForChargebacksCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ProvisionForChargebacksCurrent",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for chargebacks, net",
        "label": "Provision For Chargebacks, Current",
        "documentation": "Provision For Chargebacks, Current"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_ProvisionForChargebacksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ProvisionForChargebacksMember",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for chargebacks, net",
        "label": "Provision For Chargebacks [Member]",
        "documentation": "Provision For Chargebacks"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ProvisionForDoubtfulAccounts",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesRollforwardofAllowanceforCreditLossesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for (benefit from) account receivable allowances",
        "verboseLabel": "Current period provision",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r251",
      "r358"
     ]
    },
    "us-gaap_PurchaseObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligation",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total",
        "label": "Purchase Obligation",
        "documentation": "Minimum amount of purchase arrangement in which the entity has agreed to expend funds to procure goods or services from a supplier."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligationDueInNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails": {
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024",
        "label": "Purchase Obligation, to be Paid, Year One",
        "documentation": "Amount of purchase arrangement to be paid in next fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInSecondYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligationDueInSecondYear",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails": {
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Purchase Obligation, to be Paid, Year Two",
        "documentation": "Amount of purchase arrangement to be paid in second fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PurchaseObligationDueInThirdYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "PurchaseObligationDueInThirdYear",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails": {
       "parentTag": "us-gaap_PurchaseObligation",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesNonCancelablePurchaseObligationsMaturityScheduleDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Purchase Obligation, to be Paid, Year Three",
        "documentation": "Amount of purchase arrangement to be paid in third fiscal year following current fiscal year. Includes, but is not limited to, recorded and unrecorded purchase obligations, long-term purchase commitment, and short-term purchase commitment. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeAxis",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r421",
      "r430",
      "r460",
      "r461",
      "r462",
      "r602",
      "r603",
      "r640",
      "r684",
      "r685",
      "r739",
      "r741",
      "r743",
      "r744",
      "r756",
      "r774",
      "r775",
      "r786",
      "r789",
      "r800",
      "r807",
      "r810",
      "r891",
      "r898",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RangeMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r376",
      "r377",
      "r378",
      "r379",
      "r421",
      "r430",
      "r460",
      "r461",
      "r462",
      "r602",
      "r603",
      "r640",
      "r684",
      "r685",
      "r739",
      "r741",
      "r743",
      "r744",
      "r756",
      "r774",
      "r775",
      "r786",
      "r789",
      "r800",
      "r807",
      "r810",
      "r891",
      "r898",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RecordedUnconditionalPurchaseObligationsTextBlock",
     "presentation": [
      "http://riskified.com/role/GuaranteesCommitmentsandContingenciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recorded Unconditional Purchase Obligations",
        "label": "Recorded Unconditional Purchase Obligations [Table Text Block]",
        "documentation": "Tabular disclosure of unconditional purchase obligation recognized as liability."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r892"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use."
       }
      }
     },
     "auth_ref": [
      "r123",
      "r478",
      "r954"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r477"
     ]
    },
    "srt_RestatementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementAxis",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Axis]",
        "label": "Revision of Prior Period [Axis]",
        "documentation": "Information by adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r306",
      "r350",
      "r351",
      "r503",
      "r538",
      "r542",
      "r543",
      "r544",
      "r576",
      "r594",
      "r595",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654"
     ]
    },
    "srt_RestatementDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RestatementDomain",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revision of Prior Period [Domain]",
        "label": "Revision of Prior Period [Domain]",
        "documentation": "Adjustment to previously issued financial statements. Includes, but is not limited to, adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r269",
      "r270",
      "r271",
      "r273",
      "r274",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r306",
      "r350",
      "r351",
      "r503",
      "r538",
      "r542",
      "r543",
      "r544",
      "r576",
      "r594",
      "r595",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654"
     ]
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r845",
      "r854",
      "r955",
      "r957"
     ]
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents [Domain]",
        "label": "Cash and Cash Equivalents [Domain]",
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r220"
     ]
    },
    "us-gaap_RestrictedCashCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedCashCurrent",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash, Current",
        "documentation": "Amount of cash restricted as to withdrawal or usage, classified as current. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r845",
      "r854"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected costs to be incurred",
        "label": "Restructuring and Related Cost, Expected Cost",
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost."
       }
      }
     },
     "auth_ref": [
      "r371",
      "r373",
      "r374",
      "r375"
     ]
    },
    "us-gaap_RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Percentage of Company's workforce to be impacted (percent)",
        "label": "Restructuring and Related Cost, Number of Positions Eliminated, Period Percent",
        "documentation": "The number of positions eliminated during the period as a percentage of total positions eliminated during the period in connection with the restructuring plan(s)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated deficit",
        "negatedTerseLabel": "Understatement of accumulated deficit",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r159",
      "r622",
      "r647",
      "r652",
      "r661",
      "r695",
      "r805"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Deficit",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r214",
      "r269",
      "r270",
      "r271",
      "r274",
      "r284",
      "r286",
      "r349",
      "r355",
      "r467",
      "r468",
      "r469",
      "r502",
      "r503",
      "r525",
      "r528",
      "r529",
      "r532",
      "r542",
      "r643",
      "r645",
      "r663",
      "r966"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r311",
      "r312",
      "r321",
      "r324",
      "r325",
      "r329",
      "r330",
      "r332",
      "r418",
      "r419",
      "r604"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r410",
      "r411",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r776"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "presentation": [
      "http://riskified.com/role/RevenueRecognition"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Text Block]",
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts."
       }
      }
     },
     "auth_ref": [
      "r196",
      "r402",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r420"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue from External Customers by Geographic Areas",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r28"
     ]
    },
    "us-gaap_RevenueNotFromContractWithCustomer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RevenueNotFromContractWithCustomer",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails": {
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Not from Contract with Customer",
        "label": "Revenue Not from Contract with Customer",
        "documentation": "Amount of revenue that is not accounted for under Topic 606."
       }
      }
     },
     "auth_ref": [
      "r841"
     ]
    },
    "rskd_RevenueTermOfMerchantContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "RevenueTermOfMerchantContract",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract term with merchant",
        "label": "Revenue, Term Of Merchant Contract",
        "documentation": "Revenue, Term Of Merchant Contract"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Revenues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "Revenues",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      },
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "verboseLabel": "Revenues",
        "totalLabel": "Revenues, Total",
        "label": "Revenues",
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)."
       }
      }
     },
     "auth_ref": [
      "r247",
      "r259",
      "r311",
      "r312",
      "r321",
      "r324",
      "r325",
      "r329",
      "r330",
      "r332",
      "r345",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r391",
      "r392",
      "r556",
      "r614",
      "r896"
     ]
    },
    "srt_RevisionOfPriorPeriodErrorCorrectionAdjustmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "RevisionOfPriorPeriodErrorCorrectionAdjustmentMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment",
        "label": "Revision of Prior Period, Error Correction, Adjustment [Member]",
        "documentation": "Cumulative increase (decrease) to previously issued financial statements for correction of error."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r283",
      "r284",
      "r285",
      "r286"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease liabilities arising from obtaining right-of-use assets",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r587",
      "r804"
     ]
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, consideration received on transaction",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "documentation": "Cash received on stock transaction after deduction of issuance costs."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNameOfTransactionDomain",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Domain]",
        "label": "Sale of Stock [Domain]",
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, number of shares issued in transaction (in shares)",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SaleOfStockPricePerShare",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock, price per share (in dollars per share)",
        "label": "Sale of Stock, Price Per Share",
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_SalesAndMarketingExpensePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "SalesAndMarketingExpensePolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and Marketing",
        "label": "Sales And Marketing Expense, Policy [Policy Text Block]",
        "documentation": "Sales And Marketing Expense, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Sales [Member]",
        "documentation": "Primary financial statement caption encompassing revenue from sale of goods and services rendered in the normal course of business."
       }
      }
     },
     "auth_ref": [
      "r29"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://riskified.com/role/RevenueRecognitionDisaggregationofRevenueDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofConcentrationRisksDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Benchmark",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r332",
      "r832"
     ]
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScenarioPreviouslyReportedMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "As Previously Reported",
        "label": "Previously Reported [Member]",
        "documentation": "Represents amount as previously reported before adjustment for retrospective application of amendment to accounting standards, other change in accounting principle, correction of error, and other revision."
       }
      }
     },
     "auth_ref": [
      "r215",
      "r269",
      "r271",
      "r273",
      "r274",
      "r277",
      "r278",
      "r286",
      "r306",
      "r503",
      "r538",
      "r542",
      "r543",
      "r576",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r650",
      "r651",
      "r652",
      "r654",
      "r835",
      "r838",
      "r839",
      "r840",
      "r867",
      "r888",
      "r889",
      "r935",
      "r943",
      "r944"
     ]
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Liabilities",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accrued liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)."
       }
      }
     },
     "auth_ref": [
      "r46",
      "r939",
      "r940"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r164"
     ]
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instruments, Gain (Loss)",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments."
       }
      }
     },
     "auth_ref": [
      "r108",
      "r112",
      "r520"
     ]
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfDerivativeInstrumentsTextBlock",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Derivative Instruments",
        "label": "Schedule of Derivative Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information about a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item."
       }
      }
     },
     "auth_ref": [
      "r23",
      "r104",
      "r105",
      "r106",
      "r107",
      "r109",
      "r112",
      "r114",
      "r116"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic and Diluted",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r869"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicByCommonClassTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEarningsPerShareBasicByCommonClassTable",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "label": "Schedule of Earnings Per Share, Basic, by Common Class, Including Two Class Method [Table]",
        "documentation": "The table contains disclosure pertaining to an entity's basic earnings per share."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r64",
      "r292",
      "r293",
      "r300"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Effective Income Tax Rate Reconciliation",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "us-gaap_ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfErrorCorrectionsAndPriorPeriodAdjustmentRestatementTable",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "label": "Schedule of Error Corrections and Prior Period Adjustment Restatement [Table]",
        "documentation": "Schedule of prior period adjustments to correct an error in previously issued financial statements. The disclosure may include, but is not limited to: (1) the effect of the correction on each financial statement line item and any per-share amounts affected for each prior period presented (2) the cumulative effect of the change on retained earnings or other appropriate components of equity or net assets in the statement of financial position, as of the beginning of the earliest period presented, and (3) the effect of the prior period adjustment (both gross and net of applicable income tax) on the net income of each prior period presented in the entity's annual report for the year in which the adjustments are made. This table can be used to disclose the amounts as previously reported and the effect of the correction or other adjustment on per line item or per share amount basis. This table uses as its line items financial statement line items that are affected by prior period adjustments."
       }
      }
     },
     "auth_ref": [
      "r277",
      "r278",
      "r279",
      "r283",
      "r284",
      "r285",
      "r286",
      "r306"
     ]
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r547",
      "r548"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income before Income Tax, Domestic and Foreign",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r857"
     ]
    },
    "us-gaap_ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Immaterial Prior Period Error Corrections",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table Text Block]",
        "documentation": "Tabular disclosure of changes in accounting principles, including adoption of new accounting pronouncements, that describes the new methods, amount and effects on financial statement line items."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r65",
      "r66"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyandEquipmentNetDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Option, Activity",
        "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]",
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r25",
      "r26",
      "r95"
     ]
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockByClassTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stock by Class",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r84",
      "r85",
      "r86",
      "r87",
      "r88",
      "r89",
      "r90",
      "r127",
      "r128",
      "r157",
      "r158",
      "r159"
     ]
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "presentation": [
      "http://riskified.com/role/TemporaryEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Stockholders' Equity Note, Warrants or Rights",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable."
       }
      }
     },
     "auth_ref": [
      "r93"
     ]
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits Roll Forward",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r803",
      "r930"
     ]
    },
    "us-gaap_ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unvested Restricted Stock Units Roll Forward",
        "label": "Schedule of Unvested Restricted Stock Units Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in restricted stock units (RSUs)."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccounts"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule II - Valuation and Qualifying Accounts",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r268"
     ]
    },
    "us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ScheduleOfWeightedAverageNumberOfSharesTableTextBlock",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Weighted Average Number of Shares",
        "label": "Schedule of Weighted Average Number of Shares [Table Text Block]",
        "documentation": "Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit)."
       }
      }
     },
     "auth_ref": [
      "r60"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedules of Concentration of Risk, by Risk Factor",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r67",
      "r68",
      "r72",
      "r73",
      "r118",
      "r171"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r820"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r822"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/LeasesByGeographicRegionDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r330",
      "r331",
      "r677",
      "r680",
      "r682",
      "r740",
      "r742",
      "r745",
      "r757",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r778",
      "r791",
      "r810",
      "r899",
      "r959"
     ]
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Information",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for segment reporting."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r316",
      "r317",
      "r318",
      "r319",
      "r320",
      "r330",
      "r785"
     ]
    },
    "us-gaap_SellingAndMarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense",
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingAndMarketingExpenseMember",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsontheConsolidatedStatementofOperationsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sales and marketing",
        "label": "Selling and Marketing Expense [Member]",
        "documentation": "Primary financial statement caption encompassing selling and marketing expense."
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "General and Administrative",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "rskd_SeriesE1ConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "SeriesE1ConvertiblePreferredStockMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series E-1 Convertible Preferred Stock [Member]",
        "label": "Series E-1 Convertible Preferred Stock [Member]",
        "documentation": "Series E-1 Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_SeriesEConvertiblePreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "SeriesEConvertiblePreferredStockMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Series E Convertible Preferred Stock [Member]",
        "label": "Series E Convertible Preferred Stock [Member]",
        "documentation": "Series E Convertible Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeveranceCosts1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SeveranceCosts1",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance costs",
        "label": "Severance Costs",
        "documentation": "Amount of expenses for special or contractual termination benefits provided to current employees involuntarily terminated under a benefit arrangement associated exit or disposal activities pursuant to an authorized plan. Excludes expenses related to one-time termination benefits, a discontinued operation or an asset retirement obligation."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "rskd_SeverancePayRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "SeverancePayRate",
     "presentation": [
      "http://riskified.com/role/EmployeeBenefitPlansNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Severance pay rate",
        "label": "Severance Pay Rate",
        "documentation": "Severance Pay Rate"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award vesting period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r801"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r452"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r450"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested as of December 31, 2020 (in shares)",
        "periodEndLabel": "Unvested as of December 31, 2021 (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Unvested beginning balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)",
        "periodEndLabel": "Unvested ending balance, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r447",
      "r448"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Grant-Date Fair Value Per Share",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested, Weighted-Average Grant-Date Fair Value Per Share (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r451"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected dividend yield",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r461"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r460"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk-free interest rate",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r462"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r432",
      "r434",
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Options Additional Disclosures",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Share Options, Options exercisable (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number",
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price, Options exercisable (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r441"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value, Options exercised",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Outstanding Share Options, Options forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period",
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average grant date fair value of options granted in period (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology."
       }
      }
     },
     "auth_ref": [
      "r453"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value, Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value",
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Outstanding Share Options, beginning balance (in shares)",
        "periodEndLabel": "Outstanding Share Options, ending balance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "documentation": "Number of options outstanding, including both vested and non-vested options."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Weighted-Average Exercise Price, beginning balance (in dollars per share)",
        "periodEndLabel": "Weighted-Average Exercise Price, ending balance (in dollars per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan."
       }
      }
     },
     "auth_ref": [
      "r439",
      "r440"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanRSUActivityDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r435",
      "r436",
      "r437",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price, Options exercised (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares."
       }
      }
     },
     "auth_ref": [
      "r444"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Exercise Price, Options forfeited (in dollars per share)",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated."
       }
      }
     },
     "auth_ref": [
      "r445"
     ]
    },
    "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheThreeMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche Three",
        "label": "Share-Based Payment Arrangement, Tranche Three [Member]",
        "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Tranche Two",
        "label": "Share-Based Payment Arrangement, Tranche Two [Member]",
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r431",
      "r438",
      "r457",
      "r458",
      "r459",
      "r460",
      "r463",
      "r470",
      "r471",
      "r472",
      "r473"
     ]
    },
    "rskd_ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Options and RSUs",
        "label": "Share-Based Payment Arrangement, Option And Restricted Stock Units [Member]",
        "documentation": "Share-Based Payment Arrangement, Option And Restricted Stock Units"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award expiration period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r802"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanBlackScholesAssumptionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected term (years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r459"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic Value, Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value",
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Contractual Life, Options exercisable",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-Average Remaining Contractual Life, Options outstanding",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate grant date fair value of options vested during the period",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value",
        "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock."
       }
      }
     },
     "auth_ref": [
      "r454"
     ]
    },
    "us-gaap_ShareholdersEquityAndShareBasedPaymentsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShareholdersEquityAndShareBasedPaymentsTextBlock",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlan"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Shares and Equity Incentive Plan",
        "label": "Shareholders' Equity and Share-Based Payments [Text Block]",
        "documentation": "The entire disclosure for shareholders' equity and share-based payment arrangement. Includes, but is not limited to, disclosure of policy and terms of share-based payment arrangement, deferred compensation arrangement, and employee stock purchase plan (ESPP)."
       }
      }
     },
     "auth_ref": [
      "r156",
      "r160"
     ]
    },
    "rskd_ShortTermDepositsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "ShortTermDepositsPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-Term Deposits",
        "label": "Short-Term Deposits, Policy [Policy Text Block]",
        "documentation": "Short-Term Deposits, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      },
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/FairValueMeasurementsScheduleofFinancialInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term investments",
        "verboseLabel": "Government bonds included within short-term investments",
        "label": "Short-Term Investments",
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current."
       }
      }
     },
     "auth_ref": [
      "r176",
      "r177",
      "r846"
     ]
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r584",
      "r804"
     ]
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SignificantAccountingPoliciesTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Summary of Significant Accounting Policies",
        "label": "Significant Accounting Policies [Text Block]",
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity."
       }
      }
     },
     "auth_ref": [
      "r148",
      "r258"
     ]
    },
    "us-gaap_SoftwareAndSoftwareDevelopmentCostsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareAndSoftwareDevelopmentCostsMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software and Software Development Costs",
        "label": "Software and Software Development Costs [Member]",
        "documentation": "Purchased software applications and internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_SoftwareDevelopmentExpendituresIncurredButNotYetPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "SoftwareDevelopmentExpendituresIncurredButNotYetPaid",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software development costs, accrued but not paid",
        "label": "Software Development Expenditures Incurred But Not Yet Paid",
        "documentation": "Software Development Expenditures Incurred But Not Yet Paid"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SoftwareDevelopmentMember",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Software Development",
        "label": "Software Development [Member]",
        "documentation": "Internally developed software for sale, licensing or long-term internal use."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State and Local Jurisdiction",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/Cover",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesScheduleofImmaterialPriorPeriodErrorCorrectionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r197",
      "r225",
      "r226",
      "r227",
      "r259",
      "r292",
      "r293",
      "r300",
      "r302",
      "r308",
      "r309",
      "r345",
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r556",
      "r657",
      "r658",
      "r659",
      "r660",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r694",
      "r717",
      "r735",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r831",
      "r855",
      "r868"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r44",
      "r214",
      "r244",
      "r245",
      "r246",
      "r269",
      "r270",
      "r271",
      "r274",
      "r284",
      "r286",
      "r307",
      "r349",
      "r355",
      "r401",
      "r467",
      "r468",
      "r469",
      "r502",
      "r503",
      "r525",
      "r527",
      "r528",
      "r529",
      "r530",
      "r532",
      "r542",
      "r563",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r595",
      "r643",
      "r644",
      "r645",
      "r663",
      "r735"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProfitLossbeforeProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofProvisionforIncomeTaxesDetails",
      "http://riskified.com/role/LeasesByGeographicRegionDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r202",
      "r211",
      "r330",
      "r331",
      "r677",
      "r680",
      "r682",
      "r740",
      "r742",
      "r745",
      "r757",
      "r763",
      "r765",
      "r766",
      "r767",
      "r768",
      "r769",
      "r770",
      "r771",
      "r772",
      "r773",
      "r778",
      "r791",
      "r810",
      "r899",
      "r959"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r307",
      "r604",
      "r655",
      "r674",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r713",
      "r718",
      "r719",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r735",
      "r811"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICITParenthetical",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed."
       }
      }
     },
     "auth_ref": [
      "r269",
      "r270",
      "r271",
      "r307",
      "r604",
      "r655",
      "r674",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r694",
      "r697",
      "r698",
      "r699",
      "r700",
      "r701",
      "r702",
      "r703",
      "r704",
      "r705",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r713",
      "r718",
      "r719",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r735",
      "r811"
     ]
    },
    "us-gaap_StockCompensationPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockCompensationPlanMember",
     "presentation": [
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement",
        "label": "Share-Based Payment Arrangement [Member]",
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares."
       }
      }
     },
     "auth_ref": [
      "r870"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversion of Preferred Shares into Ordinary Shares upon IPO (in shares)",
        "terseLabel": "Stock issued, conversion of convertible securities (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r43",
      "r87",
      "r159",
      "r394"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfUnits": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesConversionOfUnits",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exchange of Class B ordinary shares to Class A ordinary shares (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Units",
        "documentation": "The number of shares issued during the period upon the conversion of units. An example of a convertible unit is an umbrella partnership real estate investment trust unit (UPREIT unit)."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r87",
      "r127",
      "r128",
      "r159"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Class A Ordinary Shares upon IPO, net of underwriting discounts and commissions and other issuance costs (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r127",
      "r128",
      "r159",
      "r657",
      "r735",
      "r759"
     ]
    },
    "rskd_StockIssuedDuringPeriodSharesRecapitalization": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesRecapitalization",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Elimination of ordinary share par value and issuance of Class B ordinary shares upon Recapitalization (in shares)",
        "label": "Stock Issued During Period, Shares, Recapitalization",
        "documentation": "Stock Issued During Period, Shares, Recapitalization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesRestrictedStockAwardGross",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon vesting of restricted share units (in shares)",
        "label": "Stock Issued During Period, Shares, Restricted Stock Award, Gross",
        "documentation": "Total number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r159"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanStockOptionActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon exercise of share options (in shares)",
        "negatedTerseLabel": "Outstanding Share Options, Options exercised (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "documentation": "Number of share options (or share units) exercised during the current period."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r127",
      "r128",
      "r159",
      "r444"
     ]
    },
    "rskd_StockIssuedDuringPeriodSharesWarrantsExercised": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "StockIssuedDuringPeriodSharesWarrantsExercised",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon exercise of warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Warrants Exercised",
        "documentation": "Stock Issued During Period, Shares, Warrants Exercised"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion of Preferred Shares into Ordinary Shares upon IPO",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r44",
      "r159"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of Class A ordinary shares upon IPO, net of underwriting discounts and commissions and other issuance costs",
        "label": "Stock Issued During Period, Value, New Issues",
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r127",
      "r128",
      "r159",
      "r663",
      "r735",
      "r759",
      "r817"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of ordinary shares upon exercise of share options",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "documentation": "Value of stock issued as a result of the exercise of stock options."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r44",
      "r159"
     ]
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Authorized amounts under repurchase program",
        "label": "Stock Repurchase Program, Authorized Amount",
        "documentation": "Amount of stock repurchase plan authorized."
       }
      }
     },
     "auth_ref": []
    },
    "rskd_StockRepurchaseProgramTransactionCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "StockRepurchaseProgramTransactionCosts",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transaction costs",
        "label": "Stock Repurchase Program, Transaction Costs",
        "documentation": "Stock Repurchase Program, Transaction Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total shareholders\u2019 equity",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r128",
      "r131",
      "r132",
      "r151",
      "r696",
      "r712",
      "r736",
      "r737",
      "r805",
      "r818",
      "r856",
      "r887",
      "r936",
      "r966"
     ]
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock split conversion ratio",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one."
       }
      }
     },
     "auth_ref": [
      "r34"
     ]
    },
    "us-gaap_StockholdersEquityPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StockholdersEquityPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Shares",
        "label": "Stockholders' Equity, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income."
       }
      }
     },
     "auth_ref": [
      "r14",
      "r738"
     ]
    },
    "us-gaap_SubleaseIncome": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubleaseIncome",
     "crdr": "credit",
     "calculation": {
      "http://riskified.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Sublease income",
        "label": "Sublease Income",
        "documentation": "Amount of sublease income excluding finance and operating lease expense."
       }
      }
     },
     "auth_ref": [
      "r586",
      "r804"
     ]
    },
    "us-gaap_SubsequentEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventLineItems",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Line Items]",
        "label": "Subsequent Event [Line Items]",
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventMember",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event",
        "label": "Subsequent Event [Member]",
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTable",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event [Table]",
        "label": "Subsequent Event [Table]",
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeAxis",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Axis]",
        "label": "Subsequent Event Type [Axis]",
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventTypeDomain",
     "presentation": [
      "http://riskified.com/role/SubsequentEventsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Event Type [Domain]",
        "label": "Subsequent Event Type [Domain]",
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r597"
     ]
    },
    "us-gaap_SubsequentEventsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsequentEventsTextBlock",
     "presentation": [
      "http://riskified.com/role/SubsequentEvents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Subsequent Events",
        "label": "Subsequent Events [Text Block]",
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business."
       }
      }
     },
     "auth_ref": [
      "r596",
      "r598"
     ]
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SubsidiarySaleOfStockAxis",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of Stock [Axis]",
        "label": "Sale of Stock [Axis]",
        "documentation": "Information by type of sale of the entity's stock."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponents"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consolidated Balance Sheet Components",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity."
       }
      }
     },
     "auth_ref": [
      "r844"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosures of cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_TaxYear2042Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TaxYear2042Member",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Year 2042",
        "label": "Tax Year 2042 [Member]",
        "documentation": "Tax Year 2042"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reclassification of convertible preferred share warrants upon IPO",
        "label": "Temporary Equity, Adjustments To Additional Paid In Capital, Reclassification Of Warrants",
        "documentation": "Temporary Equity, Adjustments To Additional Paid In Capital, Reclassification Of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityByClassOfStockTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityByClassOfStockTable",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary Equity, by Class of Stock [Table]",
        "label": "Temporary Equity, by Class of Stock [Table]",
        "documentation": "Table of capital stock that is classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. This table may include a description by series, value, shares authorized, shares issued and outstanding, redemption price per share and subscription receivable."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r84"
     ]
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r384",
      "r386",
      "r387",
      "r388",
      "r391",
      "r392",
      "r474",
      "r620"
     ]
    },
    "us-gaap_TemporaryEquityDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Temporary Equity Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_TemporaryEquityDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TemporaryEquityDisclosureTextBlock",
     "presentation": [
      "http://riskified.com/role/TemporaryEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible Preferred Shares",
        "label": "Temporary Equity Disclosure [Text Block]",
        "documentation": "Temporary Equity Disclosure"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityLineItems",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Temporary Equity [Line Items]",
        "label": "Temporary Equity [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquitySharesOutstanding",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning balance (in shares)",
        "periodEndLabel": "Ending balance (in shares)",
        "label": "Temporary Equity, Shares Outstanding",
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "rskd_TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Conversion of Preferred Shares into Class A Ordinary Shares upon IPO (in shares)",
        "label": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities",
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, Conversion Of Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of convertible preferred shares, net of issuance costs (in shares)",
        "terseLabel": "Issuance of convertible preferred stock (in shares)",
        "label": "Temporary Equity, Stock Issued During Period, Shares, New Issues",
        "documentation": "Temporary Equity, Stock Issued During Period, Shares, New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Conversion of convertible preferred shares into Class A ordinary shares upon IPO",
        "label": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities",
        "documentation": "Temporary Equity, Stock Issued During Period, Value, Conversion Of Convertible Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of convertible preferred shares, net of issuance costs",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "documentation": "Value of new stock classified as temporary equity issued during the period."
       }
      }
     },
     "auth_ref": []
    },
    "srt_TitleOfIndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualAxis",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Axis]",
        "label": "Title of Individual [Axis]",
        "documentation": "Information by title of individual or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": [
      "r872",
      "r945"
     ]
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanSharebasedCompensationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of Individual [Domain]",
        "label": "Title of Individual [Domain]",
        "documentation": "Title of individual, or nature of relationship to individual or group of individuals."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TradeAndOtherAccountsReceivablePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TradeAndOtherAccountsReceivablePolicy",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Net",
        "label": "Accounts Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r182",
      "r183",
      "r335",
      "r336",
      "r338"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://riskified.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TranslationAdjustmentForNetInvestmentHedgeRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TranslationAdjustmentForNetInvestmentHedgeRollForward",
     "presentation": [
      "http://riskified.com/role/DerivativeInstrumentsandHedgingEffectofForeignCurrencyContractsonAccumulatedOtherComprehensiveIncomeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]",
        "label": "Derivatives used in Net Investment Hedge, Net of Tax [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Shares",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r91"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of Treasury shares (in shares)",
        "terseLabel": "Shares repurchased (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r128",
      "r159"
     ]
    },
    "us-gaap_TreasuryStockValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValue",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS": {
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury shares at cost, 3,038,865 and zero ordinary shares as of December\u00a031, 2023 and 2022, respectively",
        "label": "Treasury Stock, Value",
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r91",
      "r92"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCONVERTIBLEPREFERREDSHARESANDSHAREHOLDERSDEFICIT",
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of Treasury shares",
        "terseLabel": "Shares repurchased",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r22",
      "r91",
      "r159"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2023",
     "localname": "US",
     "presentation": [
      "http://riskified.com/role/ConsolidatedBalanceSheetComponentsPropertyPlantandEquipmentbyGeographicRegionDetails",
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/LeasesByGeographicRegionDetails",
      "http://riskified.com/role/RevenueRecognitionRevenuebyGeographicAreasDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UNITED STATES",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "USGovernmentDebtSecuritiesMember",
     "presentation": [
      "http://riskified.com/role/FairValueMeasurementsScheduleofShorttermInvestmentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Government bonds",
        "label": "US Government Debt Securities [Member]",
        "documentation": "Debt securities issued by the United States government."
       }
      }
     },
     "auth_ref": [
      "r956"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r480",
      "r487"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Reductions for tax positions of prior years",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r488"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits, income tax penalties and interest expense",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return."
       }
      }
     },
     "auth_ref": [
      "r486"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofUnrecognizedTaxPositionDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additions based on tax positions related to current year",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r489"
     ]
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r75",
      "r76",
      "r187",
      "r188",
      "r191",
      "r192"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesNarrativeDetails",
      "http://riskified.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (decrease) in valuation allowance for deferred tax asset",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r492"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r267"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "increase",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r265"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDeductions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDeductions",
     "crdr": "debit",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decrease",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction",
        "documentation": "Amount of decrease in valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r266"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesDomain",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves [Domain]",
        "documentation": "Valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r266",
      "r267"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ValuationAllowancesAndReservesTypeAxis",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves Type [Axis]",
        "documentation": "Information by valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r263",
      "r264",
      "r266",
      "r267"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "srt_ValuationAndQualifyingAccountsDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureLineItems",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267"
     ]
    },
    "srt_ValuationAndQualifyingAccountsDisclosureTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2023",
     "localname": "ValuationAndQualifyingAccountsDisclosureTable",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts Disclosure [Table]",
        "documentation": "Disclosure of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r201",
      "r262",
      "r263",
      "r264",
      "r266",
      "r267"
     ]
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://riskified.com/role/LeasesLeaseCostDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://riskified.com/role/LeasesLeaseCostDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r804"
     ]
    },
    "us-gaap_VestingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingAxis",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Axis]",
        "label": "Vesting [Axis]",
        "documentation": "Information by vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926"
     ]
    },
    "us-gaap_VestingDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "VestingDomain",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanNarrativeDetails",
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting [Domain]",
        "label": "Vesting [Domain]",
        "documentation": "Vesting schedule of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r901",
      "r902",
      "r903",
      "r904",
      "r905",
      "r906",
      "r907",
      "r908",
      "r909",
      "r910",
      "r911",
      "r912",
      "r913",
      "r914",
      "r915",
      "r916",
      "r917",
      "r918",
      "r919",
      "r920",
      "r921",
      "r922",
      "r923",
      "r924",
      "r925",
      "r926"
     ]
    },
    "rskd_WarrantIssuedToCustomersMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "WarrantIssuedToCustomersMember",
     "presentation": [
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants issued to customers",
        "label": "Warrant Issued To Customers [Member]",
        "documentation": "Warrant Issued To Customers"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantMember",
     "presentation": [
      "http://riskified.com/role/IncomeTaxesReconciliationofEffectiveIncomeTaxProvisionDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/OrdinaryShareWarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants to purchase ordinary shares",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r808",
      "r809",
      "r812",
      "r813",
      "r814",
      "r815"
     ]
    },
    "rskd_WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock",
     "presentation": [
      "http://riskified.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ordinary Share Warrants",
        "label": "Warrants and Rights, Rights, Warrants, Policy [Policy Text Block]",
        "documentation": "Warrants and Rights, Rights, Warrants, Policy"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_WarrantsAndRightsSettled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "WarrantsAndRightsSettled",
     "crdr": "credit",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Settlement of convertible preferred share tranche rights",
        "label": "Warrants And Rights Settled",
        "documentation": "Warrants And Rights Settled"
       }
      }
     },
     "auth_ref": []
    },
    "rskd_WarrantsToPurchaseOrdinarySharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://riskified.com/20231231",
     "localname": "WarrantsToPurchaseOrdinarySharesMember",
     "presentation": [
      "http://riskified.com/role/OrdinarySharesandEquityIncentivePlanScheduleofOrdinarySharesReservedforIssuanceDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants To Purchase Ordinary Shares",
        "label": "Warrants To Purchase Ordinary Shares [Member]",
        "documentation": "Warrants To Purchase Ordinary Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_WarrantyReservesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WarrantyReservesMember",
     "presentation": [
      "http://riskified.com/role/SECScheduleArticle1209ValuationandQualifyingAccountsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Guarantee obligations",
        "label": "SEC Schedule, 12-09, Reserve, Warranty [Member]",
        "documentation": "Reserve for expected cost from warranty provided on specific product or service."
       }
      }
     },
     "auth_ref": [
      "r859",
      "r860",
      "r861",
      "r862",
      "r863"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofAntiDilutiveSecuritiesDetails",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, diluted (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r291",
      "r302"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "presentation": [
      "http://riskified.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://riskified.com/role/NetProfitLossPerShareAttributabletoOrdinaryShareholdersScheduleofEarningsPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted-average shares used in computing net profit (loss) per share attributable to ordinary shareholders, basic (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r302"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "4",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482338/360-10-05-4"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "SubTopic": "20",
   "Topic": "940",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481913/940-20-25-1"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "13",
   "SubTopic": "10",
   "Topic": "480",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "SubTopic": "50",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482610/350-50-25-6"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "30",
   "Paragraph": "1",
   "SubTopic": "40",
   "Topic": "350",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482633/350-40-30-1"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-20"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(g)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "470",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481544/470-10-50-1"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "SubTopic": "20",
   "Topic": "985",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c),(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-2"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)",
   "SubTopic": "10",
   "Topic": "820",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "a",
   "SubTopic": "10",
   "Topic": "280",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(c)(2)",
   "SubTopic": "20",
   "Topic": "860",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4D"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(27)",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-4"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.20)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.21)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.24)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.25)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-15"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-1"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "250",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-12"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "270",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482989/270-10-45-13"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-16"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-21"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "350",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "25",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481284/470-20-25-2"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "480",
   "SubTopic": "10",
   "Section": "S99",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480244/480-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481142/505-10-45-2"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-10"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-4"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-5"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-8"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481549/505-30-45-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481520/505-30-50-4"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "40",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480489/718-40-50-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-6"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-3"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-8"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "740",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1A"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-1B"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a),(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4B"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4C"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4D"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-7"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-8"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "820",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "210",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03.17)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-5"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480981/942-825-50-1"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "985",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-7"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03.9)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "235",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//235/tableOfContent"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "250",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//250/tableOfContent"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//275/tableOfContent"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480091/360-10-S99-2"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "440",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//440/tableOfContent"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "460",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//460/tableOfContent"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//505/tableOfContent"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-6"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-7"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r166": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r167": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r168": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//810/tableOfContent"
  },
  "r169": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-19"
  },
  "r170": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//815/tableOfContent"
  },
  "r171": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21"
  },
  "r172": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r173": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r174": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r175": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r176": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r177": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r178": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r179": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r180": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-2"
  },
  "r181": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11B",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-11B"
  },
  "r182": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-15"
  },
  "r183": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "10",
   "Topic": "310",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-6"
  },
  "r184": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481501/840-20-50-1"
  },
  "r185": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "840",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481475/840-20-55-3"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482659/740-20-45-2"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//606/tableOfContent"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(a)",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "(c)",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483466/210-20-50-3"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-10"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-1"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 6.B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-17"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-2"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-1"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(n))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-6"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480530/250-10-S99-5"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//260/tableOfContent"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-16"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-40"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-3"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-29"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-1"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481962/310-10-50-4"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481569/310-20-50-1"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481925/310-20-65-2"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479344/326-20-45-1"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479130/326-30-45-1"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-3"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147477123/405-50-65-1"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479823/420-10-S99-2"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//460/tableOfContent"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1E"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-17"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-18"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-19"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-20"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//715-70/tableOfContent"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//718/tableOfContent"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-1D"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-3"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "15",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.E.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483406/720-35-50-1"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483044/730-10-05-1"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//740/tableOfContent"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-10B"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-25"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482525/740-10-45-28"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-10"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-14"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-17"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-19"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-20"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-21"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-9"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-1"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479360/740-10-S99-2"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482526/740-270-50-1"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482603/740-30-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479845/805-20-65-3"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4E"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-5C"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-5"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-2"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-6A"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482477/820-10-65-13"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-10"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482833/825-10-65-6"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//830/tableOfContent"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "832",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483482/832-10-65-1"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479832/842-10-65-5"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//842-20/tableOfContent"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-1"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//855/tableOfContent"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "855",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483194/926-20-65-2"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-3A"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480424/946-10-50-3"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-13"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-12"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-6"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5A",
   "Subparagraph": "(SX 210.12-13A(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5A"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5B"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-5C"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483444/210-20-55-22"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482739/220-10-55-15"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482785/280-10-55-47"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482663/740-10-55-217"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479589/842-20-55-53"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3"
  },
  "r832": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18"
  },
  "r833": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B"
  },
  "r834": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "340",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479483/340-40-50-2"
  },
  "r835": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3"
  },
  "r836": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r837": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4H",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H"
  },
  "r838": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r839": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7"
  },
  "r840": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "SubTopic": "10",
   "Topic": "250",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8"
  },
  "r841": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2"
  },
  "r842": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Topic": "705",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//705/tableOfContent"
  },
  "r843": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "205",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483504/205-10-50-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//210/tableOfContent"
  },
  "r845": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4"
  },
  "r849": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5"
  },
  "r850": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6"
  },
  "r851": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14"
  },
  "r852": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r853": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28"
  },
  "r854": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8"
  },
  "r855": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1"
  },
  "r858": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3"
  },
  "r859": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r860": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(1)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r861": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C(2)))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r862": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r863": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-4"
  },
  "r864": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23"
  },
  "r865": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24"
  },
  "r866": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5"
  },
  "r867": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-12"
  },
  "r868": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55"
  },
  "r869": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r870": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1"
  },
  "r871": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-18"
  },
  "r872": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13"
  },
  "r873": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481830/320-10-45-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r879": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r880": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-2"
  },
  "r881": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r882": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r883": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r884": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r885": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-3"
  },
  "r886": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9"
  },
  "r887": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3"
  },
  "r888": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r889": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4"
  },
  "r890": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13"
  },
  "r891": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10"
  },
  "r892": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-6"
  },
  "r893": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//450/tableOfContent"
  },
  "r894": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9"
  },
  "r895": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1"
  },
  "r896": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r897": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A"
  },
  "r898": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B"
  },
  "r899": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5"
  },
  "r900": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-27"
  },
  "r901": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r902": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r903": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r904": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r905": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r906": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r907": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r908": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r909": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r910": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r911": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r912": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r913": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r914": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r915": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r916": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r917": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r918": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r919": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r920": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r921": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r922": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r923": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r924": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r925": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r926": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r927": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2"
  },
  "r928": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-12"
  },
  "r929": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15"
  },
  "r930": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-15A"
  },
  "r931": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-2"
  },
  "r932": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482685/740-10-50-6"
  },
  "r933": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480434/815-10-50-4A"
  },
  "r934": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28"
  },
  "r937": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481956/830-20-45-1"
  },
  "r938": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481926/830-20-50-1"
  },
  "r939": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20"
  },
  "r940": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4"
  },
  "r942": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-6"
  },
  "r943": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r944": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2"
  },
  "r945": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2"
  },
  "r946": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r947": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7"
  },
  "r948": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r949": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r950": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3"
  },
  "r951": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r952": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r953": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4"
  },
  "r954": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1"
  },
  "r955": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1"
  },
  "r956": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480832/942-320-50-2"
  },
  "r957": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r958": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1"
  },
  "r959": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r960": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B"
  },
  "r961": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H"
  },
  "r962": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4"
  },
  "r963": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6"
  },
  "r964": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r965": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1"
  },
  "r966": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r967": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3"
  },
  "r968": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1"
  },
  "r969": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2"
  },
  "r970": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3"
  },
  "r971": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6"
  },
  "r972": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>109
<FILENAME>0001851112-24-000010-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001851112-24-000010-xbrl.zip
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MR-Y^))LC]>Y.X["KS!-^$TH#]AQVT#D)0Y+#[H[?QO^)8GADDI_K^PN K2"
MXMNW#P]7T2A&\7\'BY4AMQ+L>ZJ(]UX%UY1;QPNV.("ADH3R=UL(QW!1+J>X
M]@Y^AW,N0L+7LU\WR]56]UU;K;%/+_\RH5BQ,PLDY:382&V\#JRL./^(D!"W
M(W.]+K+1B95G>9E9-Y>H?P-02P,$%     @ BX9F6%ZTU5 ^"   :$L  !X
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MSEUYM;2M\7I4]VTU\5JY!W"OLCF+#4K$!L(.O*I%7/JW'$JN-L+Z7F93K:9
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MYLC)I=ELLN%"9>,]3?Z972CMN8NLOP!02P,$%     @ BX9F6!KO><:%)P
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M"12%=_!7V2Y0 S%5;8&?BY>Q?UR@PLPQQT*("44;RZ,,] Q8F1(;8BU<S<'
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M044;DE:5\':CN9A!,G-1RV_L16W*]5\=L9_B)*0>FQSMHM>-X]U!XGH=EIO
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MUWNZKB1G84-Y[/2"0::(=1MAOP57F,/3#'+X)%T3'08F--E,;:&PF[>X1U?
M6"_+J,K:D':;>D[O8'A[CT?]#I,Q&D*J:F5*N?R43C>_,0W?)Q-[..E@46@
M$Z=L'!*J,I(]4CN8F4LC.U^D#%IF4XUTN[NFT^98)EXOQ(XN7!E.A!B ]RRA
MK3:R+R[:4$53.<].@,PA\KH4O:I_^2-FM(ZVO!L#.Z?)!HXATL+P=8Q<)U&9
M+/=3CN,#R 4H>P\M+Q@,5?U,K52&X$;=L3=&BENQ130V,MW&07 .0K-.F2E7
M>:-,T=52O^RO68(YPUN6IC:)75,YE$OL=*$X6Y$C[IX#I'Q3F3UC6EC5RL4Z
M7BFBRU/[P8=<+=4UWQ=);DUB!S$ 528ZE@]G<VF!RL/+J*[KJL.KM*B#76&
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MV:JW7&5 N4P979O+(CS,Z.T<.X_!:;"<1H+/(P?0O\E5FH=;<#"H4GNI@$0
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MW^ID_13T%%KL7ZJZYL $7VFQJ]UK_K$U6F8YV;!3S,15UNY:$#3=PRM#*.,
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MO>3A%"(4;MEI%$5T-8F&'$,AE^7$<I0K+M><" ==^)D.8-YPB73_\)JP?6!
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MG@S,[JTP_WSF][WHR8*Z?>_>SB4JADF5<:O=^UM.*<=/-@-O0+W#7[<S8)(
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M1O(+3-SK <-LVK7A8UG$@;:!S4 'Q:1YS%KA#1RHKX39II*>',_::> YB;L
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M^\%D.683R$]7W;#S7*L;UEPZATOGB-GE85I3*6DZ9GERWQS>$]2E9J:EC]=
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MQV^7\"]-6KCH75U[GT[_./'^/.E=7CVEF8]K!OY#D0)@)X$R'03%"AZ9WBZ
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M\^0#*+EQ@G .Z+9QBUY7_\SOD%H$TJ$HG8DB0%)"]8-ICQZ:'+ K*94FDPB
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MD+:8(,>UMR8!'9!\N)* R*,,#'**D>-L9**4"UZ7-ONZ_PL]#"G '^5I/,/
M%QU5G33O7I3 ZQCOHM)< $B^5(_N4X,"&M/=ERA()1M[[;IKOT!MK?4HL=+_
M"AA+I@J0")SK?:HB$)FV<F8M',R43-#E#5@N]=-$.BP8^BF$=$T4R[:(3@H
MTQKRW)(8)1/W0P%_;HW9=SA)F6] WEUT]$K?%4H0]$U*$D#52A&2I(]0D--=
M6E6%_@WO,, P,.P<"%N_#KQ--!68TQ'&-UP8NT-F=*"P@YN1[F%AZGIL;T!F
MD(9\H4UWSYGJ!(>8HP\6=@V;ZG-;LX<GB1# SE+X2=E[/E,-UE%^TA:+/00Y
MW1.$ TK2S)"V1N3+ ][((C^7#MLGL(QG]S!<4L"%>U<C!-?5) JS.C&X<VP.
M!L#J'E*Z4X>\"1S X6<YJ=W,RVZ3+4"'+90>J7I;06\K\&VUIGV,62A>SZ.<
M'TP]HFL$YE6;C.B*PRHRV<X2=.;[BJK4W22#5<@1<X62..96F(D&O<XO*L7Q
M*$3BP"#8HDRX)R<]R00G&9!($RF6,0BADLTKM_(MCHBKS&=OM*2E0D0A3Q3I
M>&(^!2QC"[=DT@GLC>C]M53*B)VOA(E:?!!1SE;U7I%KA0,OQ.4#&0=*BZS@
M/@?DI:"/T@XXD#E0\6QNT9-2&YZ_>@+T3(5B$F,_4#MXV82V/G1["@9.@+$T
M!#KZ?25$B' !%6+"N,$B0!.5*ZJB,#"VTP[[.6*V/I59.@;T&:GYR6KA112/
MRFR9:R 7;\DH+FFKE)JIHLBPV**%3$@5%ENX+Z0]6J]Z%6_$HZ#$A.[!@((9
M/89_&'Q7NJX>/%U!6$]C-3*+<"%Q&W9SSYO\>-[\_J/RYI^=;K^R]#N7"MRI
M4EF\C\ ?ZT2T]TF"L$B67X :Z(;E,NINZB[@7XD"F"QN:7,MY=K',Q-&Z]4N
M?3+&5&@,C><^$S(%FGDW6/Z339$J!=Q"V1:%,\3>)(58\30Q>HZZFWZV45"E
M-,O[%,27>V0HT=$.EEHVY@(7B4QX.9(42_U1K:Q$3"^W7H-B("DQ+CHD>01(
MP#<,=&-4E.V#3#E:YU*WM\^3"F^V4(F?%K"P#I"T Q/H)KT?.8$^P99Q-A3@
M!>:@QQV-6<#QB;GP\@G\UH1@JR#;;4*P/WN$TL&$W(/D/V&M9DC?X^06;$19
M65;F7S)8=8MJ)RB9-V0G]M$ 86 K(PT52?(HDG%F%PIJ7+XUPU/0:> S(>L=
M\8XGJ?PV*3=AIR5[>%E<+4)2"07BG&)$O+%JTQA&&E+UR9;:_X#^>_<,_B@N
M-1)*P NS:#U>L2*>_CE*^H2^%'SGQSH"\DDA/UKWN]IA_OH_&2 [G#-^^0M5
MN#:8_3R83?Q/\#)N%_#Z^*$-6AKI1P-3D>:I8K1NK;2B,PHWJ%39JJ.P54,,
M">JC0<,OPNQ14DRDCH*IP59IS("39R)+%K!O<AN9PLQ$NCK[?,2B0=OK1=F(
M8H6V=!EQ2Z&2F0@5"AAJR[@Y50'&"WO->D/0]&[PR$*RKJ<Z>]EH?"V=%(V.
M-+5N$;\A U.:R?+D"DV1<FR5#"L\0$E?R33:NEY0O5A@Y*;<M-?/LV)QABX>
MYD]I0Y1OB_$UY3N8W3:^.[[I$#@' VWL:24L:T?'BS3Y%_>-'5)HPN4R#EU.
MF&<X2L'VA!>H+-$78&"4%!D/X$:QJ;A=AOT*S[E5/YG'J@8RDY"@J+7RC9=,
ML@&C6$4Y/IT(7HXUN1)<TDDB+"<G!1S969+-C*>XA3^WOB3)=S5Q5?E6M*!:
MCU0E)P,&[';:'YT+V6$K#^^31(3V>A/*5!9@44TL=P6<)(\P\),3K\::"E&$
M>3RDLS0D7J>8+6)P49BK0NT%26I3=<XX-A$NW +)B5IQ)&V_E)B/]-D 0T$Y
M1NTP9FR8XAK0?&^QU$;[%JM%(4;M*#U%28(PEEP_X]++J1:CLC K)UM).J9\
MC[&*!M^&442)6UA_X7-3D2:SJ\*Q6G21 5:]1?D<9&8J*P,.45N$&::+96J7
M+;W;@(_)NX'_'R03*55]-F$^'ABRS2!(J:)D1,DAYNI)&OKXI(=.1=U/(E,]
M\[9X+1,*U;B,&\83'*.\Q[8"R*,'GJS/(0%S Y(ZE!)$N^5L 2)=<QC\Y5EQ
M!L4Q+J@CMKO^*+(;H/X/+X78@:$;%9"E2E:Y*_@2J._'/<1';GJ(<4 *Q[.M
M56[W/Y4."<@X03F/8C+%WV4>K7FGEJGHI(]2A<1?O9B-^7W5YE+=0_4C'.-G
MU9/'1AU+H6AA%A/&^)"CPP]%YRA=R5=\ UH'3I>*DF'2]JZ22(="044%="<&
MT7K"*SRLUE,MUF2";3LP_"L3XOF*)/0^&G*/L/[F?*+82VAKA^Z>[>?(!)>=
M$O_^M\[![EK,U4)\%UF8\,_N8==TCQ+3<3_!+E9H+) 98'71(CV6#)Y,MDXA
M:,DX1HL*)X$%WK)IRZ1)DLR@/$F0[\BU%)L?Y%&$X6,@0<K,2X0(D=]2*T<K
M=.U%[%:R.D48*ORE/TFN:E\/.!8+$Y%#4\X@X2S6R4R[Q'HE>A*J+HDL<8W8
MM")W1546EM#;1N:B&DUA.QX3&%A32JE7E=JC<*)*)!-J1 /*D\Q3PKLGV,HG
MI6O@\3E.+V_1X<[LI.V=8/C3;,3>Q^PV*,EQ9@E-4JKNM8+L0J$R^M#,D99(
M2%:Z'!T'W$O5ZC9!A"IZVUE&)\UN]Z5UTGP6Y^Z"YC.];]AUK7?YIW=V?GWB
M79Y\[EU^/#W[['TZO_PG_+GUY?S\'_CYZKIW??+UY.SZJDY*QW5E=!F-$<JG
M(*,\4D:YE?" K$I99YC::*4""39 /2;M)ZFL11,ZY8^ZFF&_L8LTO$'5^4H.
MQT*S[0O\H]HB77)*RN_YE$_6.3K:(\:L.#+)H'LV)G5X'XV0HD)DP9XHF7/Q
M4D6("-[T2N6:=0]ZI7>QWL'L>&?'[EM8RC@I7ZZ33$@2F2=T3A8]X>1.&EG6
MHW87/LJ^N,AFP4:8B]ZQJI%J4>EOW06/MC-BP-8OJ8U:(8O WLB4G].Z.S5>
M'\L_IIT#*%YU1JTR&4W"C>;]+6WOB@Q-F2$(0Q#-ZO*$?&D@2Y1];!)^"=KR
M8<43[E%WP;2%-542AC9Z^1V&%\EJ),L->P: 59Q,3$ZQ[J%I,EWQ5FU*DV6*
M_AU9\12$F2FO"W@_,P(ZZ4>*'(HFGZ@RT)N4JN]D9E/*334U/&J8,NQUEO)[
ML%O:MK=)&IC&H<I//-N8%#3MN;ZUH,;-?J<-U-GO)PG5:;"Y&Q#UPCB?NP&,
M$C#,)Q5+218P]^ [5#WF5P<+>&[?55].I#=X_FN.C1]FOS8.C+EMA^.Y[Q K
M9[^37HQ2WUYMERO'EX1ZRLMZ-8J(<#"]!Z2H9E,P@Q1LH/-[>%LN=)&E1(&D
M]'2= 7[/ HRB*M2TDOQW,XS$5/N*HMRW%G[4]=AA!AWHC':=.R&K?ZMNC:):
M6J_YO(Q_OMX%-4YX[V>H.^8A"7_@C^-04(%X6D3\E$L 6Z+!5BA]1Q:NY;'\
M&R-7<%$1T-+>>56<8AQ0.E1 /@)TZ\AH 0HWAJ4'D=8-6N48'/X\0H%E*WY6
M1*$H):'8 EJW95WC_O6**$1"NZ4PM-(G[^/!ECZ!!X2\F/0@8N,M=3M6KN/P
MCR;58KFI%H0T_3!2KG^I_1$J*8W1I,5'TW?-X2_W\+5"%TB7V:"ZNYS-!'2+
M-EWK)2L"[B:)X%:YOO(14B@<5M4W4;LO&5(QH2?B5GA[8#=(C-BM3BD>JCJR
M4N"<FMX)?P0D+)O0M:3##_F'=(4!4P%ND!4)*CRFCGO20S>03Z 26O, Z=J3
MRILZ#ZEPS;RT20'Q8+545J8KJX%%E,@KD[357=J2:+!W!:Q#&K53>?X9=?W3
MS4\*IJ*DA!QT@(*-4<_,9 ":@;RJ@<UJV3K6QH-J0#12[L&*-(IA=&.EZU\;
MD"P9),HCP:0C:LS\-*DH14%C(5<</]8--NPTJE)CE@9(JZ4;+:!5 (IR'F1Q
M$+"T&!L$,UE4-$X"'C7@6#8X!E%.M=1$&:KHWO1-(B*1;6ZD,/'D*3=06"U1
MJ':[<QFV<UVC9&*LZCK:0&754"'O:V&QWW!D7"H3-N+Q,!M-/<&P8[0_]>&?
M!B)+AHB0]561-\NV%#": U^Z_:QJ<I.&Z:^"O6A6+LNGL=U6<]0KL@R*F*VQ
M!>8$:DOF;&-G'^P1A"U=1BQ"UB[CJ[9%P>.;,$UB<K$V %NMZ UC'TMKU>@J
ME5*MH6=RPLEIE>CH=RGRS4LA[P9<*_9QR\P9;GRD0@=EU"P,[#:HDRT,^%")
MPD"TQZ5O$P,\#:16"RGEG)+!<36=0)$5O^-^3G[>9#" 'U+E%I9N<M6(36#'
MJ\AV7,M.'EN#A/)D[P'@BTZZW-VXS@T-^?V$U]CR$X]@!5 ]<*Z/+&.HI#*1
M#+);C(B3:L*Y:K(H:Y3]$/-;1)4Z(R=!/X6KKCT;U#D8ZBB>JE+!FBT5D='E
M6R)+T3Q-GR:_FI.NHA8*O:*_!3TP.F]/^V"B(D77CS#;K=$75@R"6<>+F=/.
M=6HO5?(U<%BMX)!=%; .5+?84TF\S<&OX.#M5AMJEHWL,^E'21YLR0YF83Q(
MF>'\#1R>)T2BF\M%$9>)>:8,3-;?-7!8MBN-^Z,8GCR<*@>+C?4R+2G-)R8I
MR8ZM VCZ$6^$]$K<FQR-])!$,24'Z=XYVL59'4_7UZKQEC:CHUPB[9Y&PZ(!
MVZI3(:@ EQQD'+UE"":RZ(KQJRVT,6YT3R0AR["FE.O7@&?I/=*F.MM;,C+5
M[AE;6"AMN!)D*N$2D_: -X[Y;4*%W50K*CMYS91GJ51,--61AEE4F@G4P'6U
M9"=R8G]8[C\M"MH,8.88YXP ;*#V?%!3A (*7KPE.\D91UASWJNE$AZ/9)\X
M.\.8FK2D\%5S^BL^?8K%<,L!QOR_\E#HYNJJZ#CTU= =5?>#BES,J4F'K!]@
MP)YH2'T#L"4#K(",=$3:I18TI(_&OZNHM<SK6VRTRFNL%G(-N%9 7POT.*SU
MWO(3;<7J?C5T22@G;E'5O<X#@:VIJN*JFIX&<JN62U3T1*/N=)<Z-DRYKIBD
M>6.4!Y(H-1W F$RYK,)2=:!>E/@-N)ZG^E&I#J;HT1-3D?&QD./NA!_)4 /-
MGDRBV78;LO,Z/*4!U(HCTZK?)'!%TU82%(A_Y<'0M$PIVF)2T@<VA/%)-:')
MG_C3)(G0*=60U2J@93IK CD=@XW:..A6%>G'#"EV5U51VQSYDH]<97I2%H6?
MYL!%T(6M5"[JJJ-BSR#V6W8.+HO #$K,"-0A=MN*U8Q08$R45=: :W5FCZF*
M ;LT+?I?P+9HIJ,LB]%S$I"<&FBL'AHV P.;$T[=V*!J(I?*'C"R1%:4I:!E
M4?XN<+V4>M\UB4Q+$B3D,Y;-8 M0@,I+K*J1,,_2$D17@IN$R*+1#R.[1([_
MJ^K(1W24Q,,$_[YE.+8EN\4Y)VHA!._O;,S*P_" +*EK7]7%_'_ZP"/92%>C
MR]^VOO ^B_&6) UXVJ115R+7WN:E43?,\_ZV#A1 S:6?%>15D7JB$AUF!O V
M<NMGCQZ,?]TPCHW1L%_4YE-XKT/JW_U+<^@_:]MC]S9L4@+_1_-)<)#!1+4H
MILG8Z5/'XC7G7(7<TAH9LRS#C,[2G"JK86C3+_01.VBKSHW_72>D_#/)@8_1
M9!KLBIBBOQ.G1]_39%;H1A"ZF;*RM; #028'-LCQK)05?']KQ@=[70/-C^5
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MB\K9CS^JFHD)9]\!QC@SR\R2"2A./J@4J$#D?()CQC1XB4QG!XG=J@EC2 ?
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M+6S_<_)W(12_R5*]BS3Q.0]>)B#W:P+(CVVORC?MR-:?Z&6W(CH^ \,S5Y,
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M"+D$$!E!JWC)SD?9AH(3D@$5(O-$.THV9DD*]BS9,D6M5!=?[1)&]R0=/([
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M-(I"C%F2#3K?+<Z<:=L[T5\60_]4BJ(>S5@858:Z5#8B=LE2A7WJ&LN_,DY
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M>DW"DQ@#XJ#!A/429X\[[+F3H @C5EO<>Q#>[Q9\I#A\)& M6.JR%L7(6I5
ME,XI0Q,:@J3:VPRJJ+><6;:<D=<JPJ</%&+.-&H9AW>SGLK"C23K%,D6BC,J
M#%*.IMDIQW8]@RH$(HQ>,!4K2VYEWWW5T+VB_[SIK:_FHM F4QID)*.0,NU?
M\4?*2"W:VV!"GK*#I&NJN'+.O:3L'T'N>=4S@"SV+1PD6_@I;4>@RN-0Q?YP
MMA2\$:U9GYPT-LJ3<.1W"C SLOE1^*:*T!(X*DJOK\K+TK@1IJ+HFJQXBK!\
MB.2BC?L)0(,""P/+UETXZ!I??MZK2,EF]PI$/2*=I@/%X5\YGU4LBO-!*8.O
MDE(48CXQMB+UF=XYH=P+4P5BLC+1.*-X@XT"1&PF7PDT"?@^PCBR"6,_]$Y2
MI99A+1G3D]8B%I^;$+R:_D/M''5:)3$!/81'C8B?HWU+CJJ\V\*[;+W'K'.9
MAG=-DHD9675OFFDU-+720&\&5Y 3&NEQ.H.R)8&F)QN$_G>N6^ZGP!U-OBD6
MCI$^RU20? O7!(+#?IA;BI\654^R":#$B"K?]LS,!^I%FR8Q($Q%!NQ )L^B
M!BR0=GRY0;O@JMBFCNG)C<E-JAV7=TF3I#!=7Y5KSG;/,=M&1CO'PG'NZW?2
MZ4O-D!^6.3,K/25B[HC"9#R17"G)%,&)(EY$O!&SL%>W]-(0>VZ9$E8,D-"\
MLC298)!5%JX6';(KNY297'%=&BDS=!4CA^]]XD.ZLY5V/!2S+62:/OEUJ(EB
MM7>U7@D,I[$>/J,;%11:N^J1[8TXN\'I892G.)[DJ)N**=BA8ZIE2P,0Z, -
M,+-=_K5XU#HQ>9E5><O[(M3%KV8(W6N-!BC33%[[Z;5W)1^H(T]5HU9*';]5
MIF4Q U&&Y>'LK5[7LHNH^C#KWK*R5<)89C-0Q$HB9JN)157'HKJ;'HMZIB*Q
M<5B4\UIM_1=E&5=P./U3B6O:+!.U%N,D9K&GYP1IAFOSU+;WH<@+(->T<4L5
M<Y0M\L-*WE#W2:D@1BOPZT_[2&D9C19B0X;)#U*\RPP+JD$I^J(4S*"H +$<
MOI8H73@&3?D=9L><*(\HEK2J!]C1'*&ZAF=:+[,VHDNZK-9D]JG/-3$KRQX=
M89'PH DB^B<]5D7F'2D^AU<\P.L>:))GTE?4"L6D6'0!14D>J/C&[& 4V,:%
MG-%UC%=Y%\4CYR<"QWIZW:(*XSS&Z9"4OQE8,<5$EA%%B:!GTJ!:E8X$GT*1
MHV6*W?AED$%N3\E]<Y!2,YOKRM8J9-@8F0X^ ,DM&=\RJ>X"7B>I3'V2(1["
M3++OHH1.4,L\L@25U(-CQ@:JL&^5V(=6;PRPWTH&6QI .H7BX\?DRN10*,RG
M-R.D&>;6C%-M)]SD$=HJ)OW*=I[VITHQ4>'&Q^*&M-.#4#HZLQ%V1_-F&Y;0
M7.@M,<&&12G%*$OMD!+JKP0F'=IJ<#*@_2NBQ[]!XH5"-E1"/%##]'(5.=;S
M\R0H?T#1:Y6B8*6& 7K-0ITA4QBQ#Z!O;F%C&@@SX[XL-:TRK>&2V1XJILVM
M_!W3B(JP?BH/.PKU]]YKRQ$3,4KLH>]QSG >9H*4FH"/8^()0&1#?<ARFZ::
M7B8$2(PFYZK2HB:@3LO.K]0W,TRBHKT4LF.?E.V*$=Q*%[9#;#22199XC7D0
M%B.2<<!53',.S'0[#%;:Z0?2:#,EE7KT$K70BU7+O5*:N;G4[@6+!9CD!C5O
M6K@(M%(>UFP:]3]U=^2TG#6NVMGK6>9):?J4N4BVQ22/9@9B9T*I52@\M[3T
M="Q$MZ[*.2V>'3L.I2VLJYJPJ(Z6K0<PS7=$><0^4SI,(0F=*\<LIYWH4EKD
M$&,F*WY_!RY9Z,-$$6BSRIE4^-<YB#9TCA^T5*HN-8Z1OX>%00H2 AC47**N
M2:J"9Z, UX*[^J2>X4 B4)UH@KO*.%8C4R67H#+Z:B:!A0(@TUM6<:0<.J4/
M=3A,T:^,'C[9[*FJRX/6L^-951N+,*LR*F[-0!MK6BVY0G.JAE&.=.D*Q<M(
MH91(&^O'S<R//"Z9#E;C(VR(ADVC3\G4YYE.UT'/@G+W%%E3&K!6H\+3F92Y
MI$HG9W*:DVI<3",)V7>=J23A$,F:#M"S0L&#V:BJK:CI_NJR"QCGI2GQE%.$
M^!H-X.$R,QP4DHA3B5:1UQU-M^0X.'A6E RWT/L+$EHJ4C+%SV10M69\9-3+
M*T^I+9YNOR['!I?[),M:4JU$*<VNSY62$I3;JRXN]#&A,6TB8+]OF]Z,X\U*
M&=:YZ7-M0DUAK<PE0RNL"!A0CI@:GENT J@R\5I4(^:'J9^/,=A#$"GT2MWR
M@NJS)(80:1G4"/A 3K0DX"DTD2]8H(%R=\Z8AY;I2!*^/$NY^AVP^4+9"GVC
MRO+F+K4U:*.B%=T,2_,%2QW^C1\46$*$BFLX%DHE]SE';=8:P&SKM:C/WJ\C
M<WRH+RO9U3V5ZFS+Q+G*VGO1YX82RG)C6D0RO42E<"8FA&).I:7/:H;!$T1H
M%"KL!6F,3A:_R'03P J56*^.Q5LA19=(?::@S]QX'6LV*IVBK"X@ERF&Q;"4
M2ZK4:J[C8AL9>RTPT&[1@M'8K FD9,RI +B/V5)#S>ZP;>QTMAXK5A1O;8=<
M&TD2R4A+I_/.LA__?_;>;<N-Z]H2_!6,ZG8W.48D+5&69)>>:(KR895DJDRZ
M..HQ  0R0P0BT!% IM)?WWO-==T[ F!2-S(EGH=C,0'$95_67I>YYJ3$#*%,
MD2H*Q+SZ39X8+HYL"(,"$Z6\ACN"JE*/9%J$JT5SS8$5ESVL,*?*3(R<(27S
M-'Y;#0TZGS0ZJKPGY,GHPN,E_)G84,WJ9:RQ3F.C_8V#-["-7!"[2;=+S_6F
MH\W'()95GQ818 6&N/&.-W!I'*BH?!!AWI#3(DJ8-]*J&@Q$E@+2J:5:W;D%
M,9<5Y$3(=^DY>NZ-VTCU[4)+ZT6"A(=04-XB"<RK5FJSR/H8\;)F%<JS!-NW
M/T@ [W(2NO\P2MBEAR']38_UF!'+[Q18A$_!6N=;8L_BY".V/CE1,2%8P*I9
M_EB1QO*"VUJ(G607LXD*DN<;/K<(G M>FJ:;) XEW2DFQ')![BREW8$6.O.4
M[%Q1]/CF*'E/TVCFS!M9(SD"*T/PU^NT#:&1:>H*A:B@8;=I06!J"N4AEQED
M5\"-H;+I.\@ B4 WP.JJZ:T\"WROPOCGLZ)Q NXS'U-<XSLQF#/[)MV"Z7$V
M(GI"0(P:0\<]#+.WI4,LI*E[*\\5.I:Z0S:658S/6OO3L,TZDT4L]SOO19)=
M3:N=&$> 2\!RE48S<_0VU,J 1*!TAD;'HLHY3MN,AX@O/VJ$P[?Y6(6;K<)]
M]KNKPKW_7<^P8ZHYT1:=A1[GT0#VNZOBTNY)8<FN##G<GX*;8F3>=MBHM[TF
MLU^=MOM5;O11S-#^FP5+DAR")$&,@+)*'Q5.BC!?H%LGA'@6(34N 8UZ7>&L
M8Z]OKJ'C5_&\3ZCG4H"'4ICEQAWA ?,V*F[*6HL09'!3O\WMMMXS!:+X33<:
M!DM0PUJ[=MJF+_(WO(%)2XE'P4OR@X4&^\'R_E-O[#8R$L)V1M4B&-[B"3$F
M*);*P.#X'<+B-1^I[71AHZ>7XHL)/FT9*<=I-E;$1LUG4C.PNVH.A7T135"F
MS:UMD7!^"7;7L\X(_&;NG)1X,[Q;7;JL[HYP!99>:O L4EI7M_X>]:CCITN'
M;L" #WM_Y0+SA0&'BO9V^)N/DFY9:X!;L;<M[7SZ;A3-+/926Z2.&TRC><G3
M5\T7V^ASR=&*\376@YRHWD*H;7BZ_A#<H+:T0;$0JWG+:4(\Q5#N!GH?XP1?
MPA#0#>:6D0(,?YF5I+T0"/^8.2-?5N21RLK)A=YYH%%_UE&E$#?FE%C"/7"=
MPQSQ_INB>GW$\Z #I.X4N7XP'+@? +#O6X0XMQG')ELNWLI!<T5Z&P\G6CT=
M\ZKLQ:8U@.0&,:OX+HSY9XC7,+;C/L439'W"L,''N 9_ZG&)YG)>R5BF+M'@
M55<&>9P8ZS3,SE0EC4#CXO'G=('//T_VHWF#OO9:-JCR0S,(^D9)C,!4XW='
M)IN?&7)[&_(ZE,"P^3'M)"L]=R[&)0!N5ICE*TU8AY0URR??^Z?:T?+'"G:8
M^V7LE<]$FAXM9E?IV>5(0Z$M.:9AJ\\FEB.[(5JX@;Y'YY5FA[2]GXP494+!
MR93]\-+DO#/"86TI'&(.)# Z^EG'#>.!WXD1[#HNDKSGVKZ6G+M1#JZ\ZDRY
MW7@3;UJ<)_2RLWZ&T2N#J >M<X@,RX%5-*E1/SU59([MVCULQ6E)%+I6KW0/
M1%(E%&_W#H";C0TEE0J+MCRN+YM#C!-X\;)1-"5#ZX36B4KQNPDW!\V^C&O1
ME@9-Y]QB#%XV[HI5//?%7DV8D,9/UB\!W@E1S[V*C'8(.=.".(#J%>R4\,Z7
M-$8^,K9^-^H"&D-].*V- 75R2)2_>[3XFKB?S?O/C(24<7 "19]BYC2*Q];\
M30L/7FY_K\[[U[(;"S$6IT&["ZC%FZ^LVRV&7\I9J[8S,$?VNUT/+C'G+].V
M96LFKM_(Y<7<77.GUJ_$7'B?S,Z+6*-M1Y\%3SBJ&?G'=_];AD/X@RG<<(\"
MG3&>PJ>^N6Y=DV6AY+>>G'S*!]4Z8S 'M]@V='=%+E/]@?=V6\J1S\)#.)B"
M*K@]G7YK8<)A]@QGG]=).@&)'A=_WQ*<Y)LAG4?I] 7N8/%=6B_U+:-IKZ#F
M>"L#&;%J6(;2.BB7LXWBN6%]#H?I/*6NLV1K7D+@T4HZ7]<<CKY*K_IFO&RO
M(<;TPJA"\UXA'PG.R<-KBZUGW-)%SP)QH@61,:Z3&5PUU$?Z__Q?GW[QR5>?
M?<J &=PW_<?CZM2PV>AF_&W4L_DC_)WT'(__^B=<Y[-/_F18YOX 4+8264NF
M ST@7,HS'ON)V^,OJ$*EDXF%*Q9H^I"OH;==:#I8'8E3;R5T<%3F05:>?GRO
MMCM#H3F''^ ,N42I0SPP_AQSB"T]NU5640[&2O5Y"#P-T!8OCX,T(\\9;NV3
M(WL[.KM,T>@[;2\JI5^UQM$Z24Q@.BI/ZSLPHG\L.<R7'/[RL>3PJ^S;L%^E
MS)^#[=#''?XRH7![ZPZ>R ]8.BOJ$-CY'ZTF9_M<OT<\ZK>>J]X70A387A7(
M(9=0H-M0GM+O7YWPRW)?.\4T5\FCI -/GXC*)>]JN3\,-YM?JUD8H[R@"J%X
M?VU-[^FL?*I_[;N%', T,LD(7_9" +$EB1P[\53:75:-NH3WZG![AQ$J^3A6
M8;Q*+CT)*QXM7JM;VE(];NV]1AFOF=)AP*T#8X9\0^_1#Z+9S>I4%+=GHMM4
M+!R3-XQY(M'JSE+P"MX@9E4#SZXCTYN[0> +Y$ ;&N>+?9KY0W7ZI:GKII5V
M+:KH=2/5" J@+30;BW#Z[<3S.0]EE>L*Z&>J-J_D]C-?X?.7E91*(H4)9SB]
M7).+I 'GK6S : &F4*-5;O4ID6"NRVIPEO_^#MMB3VF=[O)BVVP.__VS+XJ-
M<O%>=@IZSK[XZGW@U?/Q^/0OCSZG]X<) NM&04-#2:JO/H[V+S_:AW9G8L\L
M%BZ56^'%\2 @WP.!+5#!NU?T&_X#K%K/16V%B4MSF#4G\@8S6_AQ=G^%V44I
MQL$7&40^VU\:# ([+X&2H/<^3LPO/#&,YMUN\WV'_/7'$?_51MR5-X-WH(RT
MD8VVMPV0-ZX0R]/'F?FM9P9>J.&MR9^,M.6H&$):)FO1EA)73K86>D^DLHBS
MZN.4_E93"D*\-<<\8-OJ5T*Q%H\FH9HK605/T,]-T>@?Y_-7\",HV$*A65.K
MVB?'?]XC/TKM=M*M:&B,Z.#13SY.SB^_V;@I27M*)NFX, 7W*HWS71!1-0!A
MWD@44RFAZ!!04EG6IUZ3[!$A:+VJ=DE]<<VPZ.J=@7.XY N-^UBH$'I#^C50
M5<,L[H+1&22V(U>>%"#2[DGOM,)UD)?9ULM^F'"P Y9CM\)->C#9HK3!;2,-
MMSX0.*(!;P_E1_MMVX\E@P=$B/B!K, MS&QD2:OP!EZJM"<-+;>M U1,4%%:
M79R>JK%FV54N+Q]GC,HNB HIP]P+;'MHKH1%RM[EI)I]K-\ LD7:#'PIK]D@
MI35I/;M?6^'%S,BQZC--!U[8V;<HS5L/JZO)@I+HHF*B\0,-&'ZZJ8<+@%KA
M0]DR6-6[?9T6$(\YNB=E;(D/8.0YT@- $<\^(:Q)@AD)"4$?_\7<2ZG7YSZ>
MZH%8D;J?-.+S=]+C4P[0=MTDF0&845[7S!H'RR=<U#>U8"PGL7.H%LJ-QBLB
MR;A/BRI#FI'03P#;S^Q6R*0QQO226Y69QD<$@*0?=/K#ZE1&-DK!&&G '%QP
M;J$ <=Z,U&#0CE<B>*(]E:M>C#9V0V00"NW_PR" ;D6SN6"*<G:I/0O1H7$7
M6<^\=N[BTC=7:;4H+#&_]8/V4?,(S<\=40_+=1Y6#!Y?2A.*UM[#>%$3<']H
MBDCHKIV$]PO]R!3V\<Q6_5N#@&FE1#*(05)R9F%I:[F6$[D"@MUKO&" ($[%
M+BI388IX@#D.[BB9V37:5/"1$/0$+N#SWQTNX#<?0SVC+E97T.I&,,U5V^PX
M0N=>V"%(E_!IOA[ $Y#K8M:W?V#ECM?6O1/C!^<JZ$%T-PC1()]Z1J+I,@O!
M?V!],Q%9*JX;.JQR8"M)-.EDYN@'>Y194:M _?^;SMS[/S1>4S5J:*]+$9L3
M0ZP]&IOF9G9X">\&YHN-^(<")C#EB'#L-F!'&AO:/XZ<)+*5N^ G\?\?*XKR
MTTK(.NG'B/K&Z(V69%RZO$@P)MWW\5__E"[W^01+>0I%.=&@W=  SM[VU"US
M'.=G] "?_44>X&^3!S#<S4\8E^+1T=;A#&=SJLJ"_A2ZGS6A^(G&EPG:)XR4
M( !7KM#%F@$?ZFAH_V'%7<WNFI3:3)L&FH#0N:+/L<Z$HD-W+D%4%9@:6AK
M,39AM6*QYK#$*&(A-QS 95-Q_*&/\"Y9K16!JITV9SR.% BU*G)<KX;>1*9,
M&>:&/NPYWKK##QXM7C:-<;)3>_9GC[Y^I'_XU9)D)^WZO'GX%_G&W_ 37] _
MQL6_X&LQS0Z-X=]U(="2>RY9YHL"H:Z"*E4N<PHZ-@J^J97FMA@H7R*&!7([
M/*= ,TE/O(?\YJ=?33JT+#Y3=WP=J$0<C5-Q&D:H@7INE3_RD2/:;]P(KE>,
M;*8E8'O=[-!L)(Z^1^VR^6/P_A,.OW.2CL'$G#&-U(#<=M),T YSH>9QK)3\
M*1W^/TCKR[+NWI"U6=U&UK2<C6^Q8J239A\E8ZGWQ N$ZY!I2F_J<A>A$Z_T
M%G[IP1*[18D#[;G3D?O)@V8*O>]DW_UDOI.E%SDKZ;T44GAK@!N"D3!<DO<P
M-6OK=-O$1)"W1<JY1UZUR/"BN=TE7.^7?_Q*5;B8H3LGSRJ(+&UE*@O"LA')
M'#U=%7G*.<<3-C,P9-<N'_FP"E3R'[W@(GR)C/M7]5I1E 6"$]^M"FRF=I/.
M.\4W '3-#2!E_X>V9R<YJSE@(Z<?WMD(PC'U1LCPA+@,>28"Y]TVW)^^K@SM
MVU.OVD ]SY:9F<A$%WY-4,!S/R^K&3DP+OI[VO5W$,Y!2?_H_@@OAPJUK5UJ
MXF^ZZW;H.TKC97ZXD.!K<DHF+!I [?DJ[9REK/8I<$ROAKSA?YJAKS*",*10
M IT;\V,H=X9L3*6?*6X==4%.D5SD%,"_@:#R!V 5G?K-*3VUBE%"(G,WQLDE
ME9B2AN0XBLI5Z?.L#6[>Y# 8V,)Z7["T:#UD4@>Y0[OK'Z+;]6UH=14W4%!Z
MX'>8(8]4>#F9(!+;H:[ &<'-(K4O"T13^W 2LG+WK[]:)@;W%*G@%"A'RZQU
M>_*F:?;I2M!23%X1W34,(=/+@IBK^;&0=]<:7KC8"'TM\' .(A4MC&GI"[O1
MHH)HGV9Y W0?D&%%;Q$,*U$/HXS"-)II<8\;<&QE,1AR<:$CAAS;;$^GA\@&
M-ZP"%=J<600"5^*Q$&.HO$P*V"5=;WC]68])T2PR"]KFI*\]THU!M>/HV.)8
M9PBJGLE +IPECC%5BP<@1Z6:[L/*R$' HTI$Y**[0[\9C>4*JT<&GQYZ.?3U
M',:\P]%(YV)Z.VO/#D1.LO6TY3\WM4X8NK6YF=]"EO_^6):9+<M\\;$L\TN5
M93)\Z3N:;NPDWJ_1M'P )!4?J+,UJ]R >'U.C1,$LQ-*+-:6W8DTDW2X#$@5
MEF+#P!Y1D!3SNG>9GC^$4R49$<%2@)^+ST2D1TDU &//Q$-HQ1/M T$+>X??
M1N9O;KYRCHJBE+#P*@*U."JQ%G.,]8/@@/[F%9*_MVC%$(0+5Y+6.;>:L8O
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M5:%&"#GY!4+5\G+;+].(S/6%4W'?.-R,&*[LDAT)4T*/R1/A;"CW"SGSZFH
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MTXFMGE["_+KR?1%]S5L:%R+*TRCG7LNMDT=ATZF>>SY*=PU90)D93>>*5U#
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M42EHL!J3&5IORUQ:R9,HZ[7@5.0:'P;8*F]/XRTH3C$$\].7WT;LK!FSUGB
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M\EURU@DR9LU=V)S;G]B-$WN%A#8WAT:E<:FL:@O1:!JP,1R+)Z-S).A 320
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M-;1DQ[A\TK7=;"5CLF)>X?FPC Z!9-G! ;2GV%+,/5/,98?\5V*:)6E6673
M*0=4"')]2]>OI]]>/_1%/9,=4Y^!CB+NCSX1\N.H6#RX?F@(@A!3>JC)6.?(
M9GOO[)?'8GE]'T%(TQDQTR2)];.L'8]S>VWU4^*_<4)$B8RR<UAY+'@CFGS3
MW#&;EL8RN18C-RP=.,,L!SE0PL. '2A:S>FQJ:DU:Y#OB7MB92R-<\*X8E<H
M$8:FUY"[U0?P5KS](!)+O')M;V8#@QJX+T;Z7C.@"_7N^2<]V\WHCE?M7G.4
M:I'NEX/\6DQN#*AM_U&-"<,FW<FDL2RVF@;&Q.F*8ZC LX0X6^W_3U[?5/H
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M &)#V8V8+_4K9ADN$QFEA9#BB'O6X3LG@J6E1AE;DE_GA*)*M%+W%:?HHS/
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M(6OUH=$6 06ZBM-W=VHR0D7&?R6A1,S(G"JR""I;'+1Y]ZL^Q7WX7=KR_;5
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MM,%NJ*6"!5K8)PYEFN<!T#<-.3;4[V7[_$<2$.%C)K,D7DNF 5Y?UT)[DOZ
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MZV=/J*6<NEL7'FOET-Y8"A1(ELDL'J9;9]W(G4+7BY&^U"3PIRE59;C/9X;
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M1?&HF8]1!3KS0C=:FN :1]A2>Z1S=]-A2'EAO&T,RV.S5;8\Z]RW8?SLCTK
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MC,A'7I8QD<X^144NQ'I.?373VK$;UZO5<-1HVE=YVD)1F)<G7]IBXO#+O?E
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MO4XL43IZ.;1 42I':+0U!PE8JGKST0G5ERB^@M;M*VXT;J"7=/BB$LW*2W0
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M7DM(L:#CF76=M$I3.$20M.Y+5X1<$? NJ5T\N5EN7V"Y)2LHKA%AJC66",[
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MQKV0XDSSJ_?I?6QQDK0<C7/LB;J6=<HEQB]@[&]J%Z.UB_M_]-K%[Y!>8;$
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M_87J_%^-7,F]FC33$NKJ3*1Z]&U,=8@E7AC8D9TB:F_%>O,1A%,C[ *NA"P
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MU_N"^T<+U"(BMC+QO129 O()H4F&Y[YCZQ9AY#;_KI*#!JVFDU[DZ/SYG^O
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M78>^($*W$-XB;&0R^W5'V,L74)4IN$; >VV8M5!0\L#[DQ$/OB+I%ZX:38,
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M6+3-A)!>FL&LE\OFO0N.S%9QU4G2I2.2Z##P!(C#.<*D/_1.0LQ:9F]?O[P
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MA!>>4\3BEP'P4JW3K*4MHGY9_V]?*:TF2 P.J=6Q(>6V0<87LKUD(M!!35E
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MCY2D6,>F@LTJ<PKT.+,1_!W0,;VQ;';&ZI/<2-U*?AH:"]XA8B$&1!]GW!(
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M'53U$9*07G6$UYL5B]:X7^Y5ZH)B\NI#04-A97&WR,D\O7GS8VY)(<3O1)Q
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MPY?5E*,R7;;O_G$[E\</%[>B@;[*=@ ,/K5IK':X2)C'Q^T8<UA@9/Z*\L0
M;A.+$@Q#VG@(O]-7@UL9&<ZPY/%UT+8VBUK<3]8D,Q1/#'O/Z1M%220DE17#
M/C4O>OTF[9=Q%U4+E]&;M7E!D@Q<\\VOC#0,0P]>0H^RX.+6 ?<>H0*Z[1[S
M.2"]9+1'ZTX726D+"^04"^%9M).>[TT+P8 DHT^!+0TS$\[,GBE4L)++"N06
M3+_2:J]1930OF7ORI_'QUC1T@+%0?%5*W*0\>;3TS^I)K=GR8#\/@IF<_AK?
MD0>F\*<RUO($[]55X2!6P>E*^6)9I6JSJABQ2J^>O+D!)O9JY;U>1@C7T4-
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M(HSAD.'Y 04,!N45#XX@%<,Y%T)H34X49;-:C]V9HSH/":%<XNOINL% /\)
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M%/E0N0%%C0@UC*=GCAI+<'ER+C#ZHB*J#HL:8$4I?/#_Q,-3S#A5+$X/P+[
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M?Z7BW/+3*.^%I9!E-.R,BX=*6.6T1$64W6+K#M<*%RM"C?@.@0T7KJ8HMLI
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M_#"HO[51B!L/YY0"^& 2'5(9WR[]'DO?']'28WS*<'ASW Q:^B5R3($NYRW
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MBCU7A)X ?UM@QR?!.2N0&DSCS69B37^FN60!LQP*)72<#R8(SZ1X_(1/(90
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MHE%/%HV5[WF!>'+3;@?0]J.R:1QIJH^,1'^D68T/QA#^H=R)G&6->0Y:Z7K
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M.)E3T.]=V(-QMUGWP>THW\\:1^BB>W(X0H^QAO2LJO:^ZK+HC[K(]W([>]>
MSC<$0@H0K"A)):JE@3RB^HJY[0T;.*GI6$(>)1H-7$,>*HBCQ" A9D1Q?S7-
MXH3;^;%_+D=(2AC!7 VB !]JHJ(6$J0\&'R. 25.?H^D/$HTXN@L2M GBD!G
M+(4K_VVTFE/[+/Z2,!6Y1WL9R3(M!+R+YND-O4[@GQ#2720)0Y!(^"+YIQS-
M4?V6X%I2AN,IC*=1S<I_4N-N%./HPZID=N4.(8[I.*?"+B#=WPITS_!X;LR@
M"OJ%,F&^^V7.Z!YO(S1]V<#)NY8[V_C0?K\S+#-S[S7_0RAYC[_%7PE4(>=*
M+BD Q)="%8"<!P8S<DY.O"+\%(WIJ_C+-2  @T_@BI9Q'.GY! NR3OG[:W>C
M6VVHD?V[OV*$C)][HTZW",#*($T\<'IUCGJEH$8J'C/I# N/(9 $F+D" 26L
MW4I&];"P3#3X*$NE@DR2:,8]V]0YO\4RC1 'R$5>.;42M&R9&EJ15"2*D+I(
M"!V:F%S,"7W<+O$#[]'WNC2VF??H^XK2W@+\< GUFN\*C8D,7ZA$7"T@V13P
M5@M_T9AX!%CR5^83E*"]=9Q,9A9]KYFL+"=X.5457?-],>QU1@]^/>U^7:_;
MZ3[X_308F9-0*NFN^:-R\9-M57;GNA4O #=-8W^:I0KWSM5,/(1L9$IHA73S
M^+L7.=*Y7=:O=YX0MC*&^<4O\77R@=!+###U\L"JCXZ^$ JWW[UN!=K[2:>G
M1V! X1=&<AL0>*-T^5M=T=A,7?ZVHB*SH,M!9F9">(F!:);CF(GOX 3Y+'E)
M&LV^@3&5 TIJ;4SP-QI)Q$"'V8579D+E5*,&-<ODK%3<2HM6%<7229H\H$=A
M:KN=+^QW)@^NM'O]G+)-*XS;IE[6U[OL<"U=:82'%9Y1?-<NU=,W;J;;,;[V
M$<,:PQ-]@.G'"+I*/?R?RUCQ?P^CF]"ZDF9Z)F'F/Q+TWD>&2<.37+-C=J!Z
M_IU\I9K-X2Y503AHB!D894PM-T/L0PGVJIW5@-U A8\]BV)0,(SI/T>8:3Q?
M7T5@75XC05,H<<T4$OX?XL;Z;W!/K2N$YY)HD/\(?8T (<'TC+>D9"48J/;F
M"_"QQ6<2A!O9"$ZWWU.,?I,BHY^"OZ4IJ[N#@$:1NH+?*(>@4-W@:2/YM/Z@
MS ]8)+8Q -/H'1XHG.\()\C0WN"F^ZMLQ2\H^ X_]T>Y$6.3*T_ FS\/.^-<
MF;%[*M<N!,$I4BT0Y!RHL8Q8D4"&W,4B%@M)NU#A[1?5Y#:=SY;330PQF1]X
MYP@0*)69WA*6@_RRGB.@W1*1.V.$-(>OP])T"^Q.MX#..2P/=[X.U76239%X
M0=J.C(@.LW8K-\<IR$ 8H2',>HM11QEP/$GC#%%$&;Z:N#]E(,:4R.HW]%NV
MA>HL2>_DLB3'U]]OOF.P76&6&D0".[0-HGUF"=I#[A2E&?$E0RL+R2,BO4%@
MM'3H0=Y7/NB F%#8F8R-#2DM\G2D&<(]% 2JFZL*L-9GF4*O=^5 7-!)>:H"
MM92&/_W9,>S!74=+\=46!H9 FU$8$ HJOMZ+W9M0:4K,J*0\!'W4B>D!ITG$
M"8&%\@;Z5D+@ED9:_4Z^;^B>$)KMAB36> 8C]^; HNIZNOWF(&<8S55D%B9U
MYBL.O!R$GP!I-6RN^EMIE#EL;'GX2S>1T/HBS->L;N&I0S.&-;<F[PAS\L6.
MT*ZX[9C3(^HWS6MP4Z '*5EJVE4 @5GYBH4$SZ(R[2B\(DSO!H]@93Y.<8?<
M;>'L&D64;P*/PC4"[I+B"KLSB'%I7B*-(D<N-WU,BZAG1'ONMH@XTE0Y*)QF
MOA*&]Y8N_=@[Q\7:X)EU+;XN97*3F1*0.D-RW>+Z,5L-TC$PG8J_$'A>P:!(
M$:FW6<$#1!A>,9EV 6:XR,;+5C+BBGMBQ=D1^N("S#TPQ421?=R0232AYZ@D
M(\6GP4Z3(MA%9P$5U)A^+K_RSGCJE?DLXDJ-*!0 2^YO/^9"&8XS$W0N9PA)
M<O@YSEO#7T60B)NE5,(5?&7W):2=]!I"2'N%A+2?37KYUWDBP[8^P9*%,J/X
M.Z@)YF 2Z:QNU\>=Y1FQ.4<S65,JA\@511#-7*;RD1YNI[A0YD,4/Y7Q<Y,G
M=-_RBKR>8A?1NWK3EL>V<WZI<%>&,F/*I(38Y%4D#EE^%J![/7/KF4J*;PQY
ML 0>;H'5+;LU(.J2V&6GBA@N\SGI12J/G<O5B%-R+EQ),"O#= JU'&RX&5/6
M,$L YAG"I8SQX1>R1/$@R='F.OGN;7.#)%):H4SNA:NV<K\Q&10-$BPL#Z:7
ME&@@\LM$W;18T5*\;OEJH1L%2QYN$TS:..1#4()8++ZQY0_6L<"U-&2C46?S
MK1$-3NZ(/VN?'K%2[=TKQXN,Y!Y92'< ^A^%J(@S^ 4>=_$+/VWPBY(9BOBJ
MTJQR"&BG&,GWQ4+M@(<"H0(T-AD_:XW.3Q0!J:*+@\?E/R\?#,E'%YR#P.0R
M1+]DFA1% :E3TB0(][^V!@VYME[CM?4U1AZ4][GM4D^YW\$2172=I,WJ.>S;
MKE(F:_0QGQ>K*TP' P(\&7B@WGWX)\MJL:B1\GY)'G;=]V;A"L?\.>EFC=7+
M<)HU-1TQU:"5CJ^6SL(,^[D\-RY%*167GE3ZB?5;@$23;V.P&^%^N=J@#_0!
MO&[\%SYG22;E!APFW#C3Y%T+]QO''@S+4H4D],34.&P^]* @KI;H[0GK"UP5
M =NSO?$KZ[7+P>NO2Z057X!Q$BYX[@OB'L3:23\UIL^<"TCWK+BI4SP9X-$5
M=9Y4=_VN5G<N&[MJ0^FOCOQ6K_RMPMLQ&"L)O16K93$(/-];KRN-[I3UK4&R
MS,I2SB[)CP[/5++ZF#R+3.Q'PY=1,O!G2%&$#2.Y^2B)A5V*E(&DSF)_JH-Z
M,NF2,Q?^5!?*%I.S\#A4@3_9>FF&G<L:+4U>[OZ9>2IE2[!B>+PDX<6_XZG_
ME ONT=;1%+-AY[?:$63^KOC#.$P@4URPNE2,?R3Y4P&*2BIT=?^X%'O0.59R
M"RAL0G<?AB9\9DC%+V(8UR4;4/++L?I##K^9B)&LEROO-=6Y&2%$*G&^I QG
MD#3IE$AQO^$E@6$N)LO2$70A52G'A;#N0[4ND),6K42APX"8W?B6D Z9G=.[
M6;FMBLJ>=X=R;C2F&V)HG;EH[I)CZB>S($H*81PS5H6\O[PJBHG6IS)>CV)4
MU[1,4OWG\2S-#1M7T<>V&;WJC)ZS.Z-W@'\Q_JGA:< G]Q/>@*=SA06,8.M9
ME^S2HA2_25(R[!J5^% E*+IFS/W_V?ORYC:2*\^O4M%K3Y ;19BWI-;:$=31
M;=G=DD94N\/[ST8"2(#5*E1AZB %?_I]5UYU@ !%BH"$CIFP2%9EY?'RW>_W
MI$&8==KX"?C*K78.RO>(6)LVZR9._T<]GMIL</("'YN4*E6/$W:MW>(-;G#B
MU1S#4=CL3&*MR)/FS(@YO< <G+<4MP!B>:Y'IU%VV15 9DPRPX]YG?WPQT(M
M5&KV"V8&*@-]8YU>V*:F1%6V';NW\R! $LRY@-=L<UWBIH6D7'QV&S^0Q"[*
M#<PD><=HZJY)/05ND:WCR)JJQ60C:,_D>#FA7U=7^3@W#>Q=RW/8#37B/K:<
MB=AP^'5L0-R]^M@U^>3T8MK>G*-P>;B>34[$N^ .J";R_LWPB7<K17'87:\Y
M);6CF^_/%Q?O340?G[+[)/EF76/*;2BEC2LU0@Y9CBJ!99E\,E*D6#_B"DU)
MQ>54!ZY0 O)')I,F3*Y$U+[%;9S0@3?9>%5$ T*7.!G$&EOU4J(7>DUZ)];1
M7)1="-XKL'L<7X"'/3:"TRD2TCZYG3&'E/E6M!9_X]GHI(Q9E5)[G8Y'23&J
M9YBY92+-HHGZ)KN^SE.Q:+W^]+ZZ-T1O"D[=] V.;]D&Y!I2\F746=(//9\
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M(B]!6>QC!U_.#K=*P?C]*DD)',8AP0;.[H1*'H8,D31IA"HP HJF+<HJ!%=
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M"TISES4V)TA?<\@)PN&"CC%4P^>;5*$@]!FTR$,53:F9I\C$5H#;1FC1(+[
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M=>LIC@=/#M<K7>@M@C@;'#Y;7IEQ]X*#!Z>,)RL1!K"B-3+O'TE#7FTIE[I
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M_0W>RQWW",)/ZSLZ\V9&I\K$]88:QDJNC WM!-.$??1.L$L%H4"K)Q:7Q#2
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MF*6K1Y -*&%)6 #^K;'1TV^+C=Z6?VF*55P%3G2C77D*0R=E&9;"8$]/PC#
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MCH\.CIZ='UF'IGV4W0&XJ+5"2:SY-=Q5#Q,TBNWR3\'2,:M'!I11J_AKC:F
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M U],B;GKX2W'"W,2/SD]CGV;BOXB3#?/TZ N6HW_J,M*BI#*,#]2>!&QCRA
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MZ6 *5WR<UM!>L'TW]NMXI8D%@^I(NGCBE3+VK2>GK>8!7=V7OU>W;HEIA,I
MD<98PY G!1Y#(=0L>PSMJVVZA5B4Y<_>]).Q.L1($0R50Q"9Y&$SU@G^4GJQ
M>HETM@^MD+\IS)00JFTA@N1*0SH@$Z\I5CV/;,2*OK&A/+M[<U]Q]RQ'1]Q4
M9F5!:#'LI (X[C 0A5[C;H+M3 G^M1B@'XBP^L)+W&] ^DG35V@NY"F#R?0'
MSQ$!FANLVH_#BT!3B0";.!HQ,2J?EDQN(F9P>AL$VX!M$X.@F#^,A+\*V-X;
MI[XW=F#)K#MVI4=$& /6BXE[1^-N4,_!M%OD\-4PPYH68AB=MQNT+?>A6X?Y
M!9-ZW\ $YIIF8167S5Q$?R8<G!TV(.B1G'VW"+UDK'F8IUP:BKA57+465TF[
MK6H:]E2Y0 FMO65OA/LGZ?@*S<!Q,*)YD'$X>O_L4FFP_BK1IN! ]X=-O^_8
MR]-=[.6[C+W,"0F(1!4UK$^M<%]F:& 2E'4.= @>-O(2]KV*^],']")D(BO$
M2M!A3:T2OMUUH<M=3/R>3YY%/0'D-@_8N>Q'5WKL"LRF6/!>+@]A[T[C;J<Q
MJA(GF]-$)24U6N!FC[VWPC-L>Q1#+,U913/<4)VLMU[,V ,(-\.I;>EBN8K<
M[0)85E+N>5QZB_2O73#(BU"37NW[*?H5F<W<]Y[NC*8^<BN==[W>L)']$424
MR23V\]>Q8M9<'4*6Q!],KPF3;BYYWX'G#,:,3>:W$W_N>YS(RN'I5# E,J\Z
MD"N,7,C%:L8F0H+H2NVJU4'D)P3X[4RPRJE.IXWU]>Z'/[^J4&.>GZF,Y,)B
MPH/34O%4-KLJ\3I86QCGI!#0I;%Y\ABZ1L0N"VS'IFCL(>8%6=_FX_ >6_?P
M21DJGV,DV  -.6N\68WL550N+?X-:O$:@Y!4A#G =#*SU@>J$H[V3$VF1$NF
MA/F.R:*(RHK5#5S91'/J/=6@GK3L\C H+TYB]HX_+5],)K&)85-O&^\%WV,=
MBQYYF[]:%0ZC$6'\^2O[G8@I%;5?]T@Y=D4'PG_A+.]*"!M&!UL5^NGWT7+%
M+O$=.@+R>RVYC.1%DMZ9 GKF@0\1P!]&2<6+P:!/6#&]!ENYM8"\KSXGYM03
MZ\MDZOT2GBCI++P&O_#<CQA[.D,3;<&U7EJ9M'S"[$!N,$!O ;:O5R'3*E_?
M]_\*Y[--):-]H"&R5U;KV_Z )7,21C1"'ZR%/+.$ 7<)T_%"0HHIKZR3CKB_
M>I9SZI2D]GD%M/9)24YBDBF]/W!:B==)5*%B7C .DZH819)AMC+I)N^1&M5P
MPR?)G[@$:<%4@#DF(LD=";6>)S^AT8QN]!!N!N6+;DJ][E55S7_\RU^28E D
MY2?"F1S #CY.Q2Y[7/U*:F2QBIBF[*K90G'\!,KT$'.'I \;)_#!4Q<<5OI
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M-H4I+QS\L[%2]X,R"]^R<1#52!DA/, $-4U529Z8>3 O&L\%,PN0R<6I9$'
MP @K2MTPL*RT"<#6QWK$-5LW5XQEQMFK6%/-0@4^*%J/__ED@MF3':TU NUG
M5][S$*H*F"Y@IW"['(_"#6H,$/$XE3"X[05L8 U(;\ H.N?5,%G[5;B3-AX_
M/@+?J02,IN&(P>H4 F8VG]JT(,FM.3?V1F]M"E9OBJ[+Q H@+]NPM&$BEI^F
MY;*P.C*PNC^\)!'KNTYU@%GN<AUVB72/EDC7<UUWZ73;3!SWDDYWBP1I)=7=
MY-TI=9M&%0^8T]*S8]A3'K/K26+Z>U2O?6)AH8^'#[6DCB<HH6G4'?>=\J8=
MVAVX?5N%V[KDENXZQ2[>C]!3Y7(-C)M->DTXN4O-KM_'PYAD$H*TH0K7R+.W
M7WS#&W'51MP-3I;<&@ONY,4@KA8 +0,5'FM&$<.Z6/C86+'7H)!A4BH8T$Q-
M=7Z!NU)Y&55-N#O77,G[TLZA]6 .+?(.(Q(P<O@@FM5U?.3UDG@2I;%_,6F2
M PO?E :A153/Q\99U3.-'3G<.SF N7OMN^G@'-#SYWGK5%%@3H+7HK;!8*RW
MTJ";8Q,!KU'=I,%:=MZ[A_#><1T[9AVR1F@Q*))B5,^PGG:$5=[*][?R<2Y#
MI+'IS;X4:76^V"9]:)5DWUZS9>V4WY63?=?/XPW4L)WJ]<#I(3U2C1+]J])=
MCV[MIR>E(["Q@JA*1YH'QY+:HR<"WH!AY&M],%3H80D?2V%SF"W#]ZI%[S-Q
M,Z> 8!Y _TOSN<V4:BL-Y*</ F0K[EY;!YB!@F$RE<OP!L%$]$QV>EY@7"N
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M@:RJN;L,#WT92,X&%?*CO+3"L%.1(]"N4*8Z1$WW;O@*G28G>9BBY(;$#31
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M3*=$FYFFDU]V@'?."S%,S<0!WOSO5F.[('&?FA@>\_S2_$!T_L=2U0\EF].
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M#=T'DY!\"/8X^()Q\ 7I;$H!3N>'Y:ZX83B(<L[>K)(B<Z<&(N0()"/,]4,
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MSFX-"LJXZ%[4<1C+GM2]N><:W7 $G4@$Z):$!$(RP3FD,R- +)?XW$Q+_29
M-A2'$7BJ KP3;M"42J19?N$YZF6494*Y6RA=OBV7'[_R4)288(@0>M6=)AU,
M#+;7V5%<70(5E>>>5_N-Q,O!!+$@H(Z=51<G>YFFG?0V<2_QA.A6SY^(W>&!
M$[@>^79F'<JIJ^]4J4 NC7P4JJ$LK"OIN['%^96#D)K@T- \GLY:7)"T>$T=
M?X96Q8ET L=8FG*7:=2>6<E&KE7.\HE585-->=]XX'(NE7L^)BU4V0MJ<XG/
MW''DV4U>J1R(HA!NT'.9J+1RY7*-! X/JN4.<+G PWC(_4E);GZK%HH+DRXY
M-)=;+Q6?AG,"2J)4KBU(A@JNDAZ0;"%2W0<8CE972BU24L/GZO[M6;F3(IGJ
MAI+I567=@ZT&9]= ;@B03KY+ W,U2N=Z_-SS:]N_PGW9C>KORV8';G=DOO&4
MO"0P[5B'=66Y[26 5?/><X2QV.N82;\ N^$D^%?<BWMJ[A@;'MM"F*8/JJ.7
M^I.1WAV\C_O*>TQ&;ED7GNDUPA^2,Z.TE_UB>A9=!"TW2HFY3M$/[WM5Y==S
M%*%%K<Z1&,,:&?V \V?*T@^7N,&6!%,<?ZY0NZ+DJU3>5!QM&8^\+_K?1Z6-
M! GJ'[<)^B\Q7"B*AQRY1GO5N?GH9<)^JO)S)D>$1L85X*1SHZ1HSJD=&"89
MF]0N.A98'X&!N?X!'>,U49X*KO7RQ)NC6#U>S%$* (61PQEN8C_DH)23(TV,
MT>ZR(@Q)8 5T\8? _RR0F7<*$LBH(]R,@]))[?NT %FZ"/JBRFQ*8:R+A4*D
MCBTJ#Q(-B@>A?O%*@[I<,"UU7\QC3D&&#"H]\+0+4\-9)QPCE!*I^81>'E;
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MU;.E323<:"(53Z^5,DA6/_%@R44W/]!9S);L]H:$]]LKOY;6Y"Q0B&'8GSJ
MWE(G39JD#<>/Q7BL%##D,554J:C2#GRP@UGW++&7X"2+&(D#*W^;9E3AIMI*
M&=6IAP)6>4QV%"2X+9M9'0K@I5<2IG$<+)8H9:T7S#A*'B*C2,/WZ:*:@A"?
M,CP04-6-Z4# L_1%IXA'P E5\X\X@CT9HGZ?4'JLMKHCD/KD<E?@L<+W*M1-
M>ZL>JF,.HR$-PZ#+5(G<GSK@PXMY]1+J1L&'Q=H%O9=5C' H^RH_DU3U>2VC
M.:=/H);1J-7=3U6)*=>&NK"9C]4Y'NI?[JRR?[E9\XZ.>X<7)^>7)V>GWME[
MC-A]OCBY/#GN>6>7'XXOO,L/W5/O^-^?3R[_M+Y<)QWFR4(%^P\+]\@GTW3R
MPT5\15>8[L6E=W+RZ(7O-U:9AEM(P^^[GS]>]GSOZ.3WDZ/CTR.O>W%QW+WH
M_HJ!$?CSZ/CCR>F_/Q^?'JX=\2;?0++[[54^N7;-^]2]/+XXZ7[T/IT=G;P_
M.>PB'^IYEV? =XZ]BY-?/USV++;TI_?A[./1\04?ZN?>,7YW?G%V>'Q\]!*.
M=14F7'YBG]E%HPHJ5W/J"]"^32>*!)W8P(;12V-4$G$J<D61Y8]*"'3:KB)%
MS>3D_(SQS13XH;AC1Z3$P^])=9CE=GZ,RF0$?>1?,^S\<$ J1\/I!7@Q \6[
MW6QO];<93EJ\8N+*Y+P=_K28!V.\O*C%S0B\0U=>E:R#"O;.S[Z!N3RL5.B9
MF$NGYAV>G5Y>G'UD9D%<X@@CY2M&NTLZE(Y-IPE4QJ,<,=G1#CQDRT"*H?"H
MA[,UZW=O9W,.S<H&]LHF>F7458T;19)YZ. -7E#"?Z,5[#0Z6^$VV]"=H?Q5
ME:.L(@#L:!98WB37G6;<4+;)$>Z':KZA;O F#?=T&J5*Z*MX=\0MQ#-"&*1%
M(OX.(B&.,=BB&K?S**%3@DZ@X9Q7G9-]QW:Y? L\Q\R!=D5:1HXM7T+.AK)3
MY0LV_6S\_[/W+LR)(TO:\%]1L&<WNC=D&MVXN'>)H&W<PYD>VVN[S^S$%U]L
M%%#8.B,D1A*^G%__5E;I!HB+0( $.1$S8QLAJ3*?O%1F5N94I"7%\8CQ>&J;
M4;]BT>K>)L\\7)XL3N3GYU]@(&GWG>TV^5[S3IR;X'<2G\7'<(//%IL.0QT(
M%!N$)XZ';&WB.$1<2!#Q(49,,#AZ"6[DP 3XO.WHFRB3C#@>]]X'ZL-@B+!#
M"^^O%E5)4M%UGX=88+\[8&MZ#0^6P-WXL?1PMQ[%#$04)$FVR#B(S+0Y(<DT
M\U9D!%M'A9X(3G)'[9;L1$]$L>;9:0/A<S<0O]7A@&^\Q5G0*X\AC$9Z2]YV
M8<$4KK _JKSR#>1-E\';&<?MJ()1/= RP'L)#N4F0CY!*\14&%CTE5I%\^HR
MFI??(F1&2F.V;M"!J:*\XY$5FAS1/#)F5W2>OF"D6&E[9L52J&-O H'1<+QQ
ME#P/3VZ%MHK_/H2!>3X-CGV ;YDDSFS]57P ;)T)"RW8:,:"C999L,_SZH6/
M^YH.A KG66'/"X.-J7HABKLM+"'M]6<&W#!7F+O5$O148 3S>58F.CTPAYD+
M#J-G4>5]XY(QA3"N]$FM*=KG\&1!,(8O:)3(+.K89&J;*]Q'X(W#^^G>N<_$
M#L:L1,H-^@H/W\B'^);G\9SQM_A]32]!#J$L,$&4GB!2,$&T>X(H*9$9C=CF
M\O@&AC\4Z9);HHX/D["23;Y"T7Z(S_'=\P&$_$AV4)-R8[KC@BU\371B?B,?
M5ZZ$':Y!=2>HX4;4$.@0936 K<0)1S&:<:9:QX3DFA@'1$31L>AX%8Q321:'
MP;$;OE<(2,X/#8$-'%.75ZL\N\X;4_#1B<N2@^TJKF(Z2>]&Q,""J9+)FJTT
M_>(M5S ;;[DW=5C$YL 9\,JCV;$J I7\)'SH RR(2C#_E3>=%3&]J ">=^IW
M@^.\T=&V>.+<PA<R*MOM V>MS?JT'"EP5J]*_]]#]['[\(_N]?^__1HW:VMR
MK#5VJE+GYW7O2;JZ^^VWWM-3MRO=]&X[MU>0B^C^[WWWX:E,X@U._S<'*G%?
MR&*9X6]BA@UA.^]KMRK]RE1\V"/X-Q>*0@@<30VF"C 3XXV$OQVX[K&!&403
MVF:ZI,SX^V+74NM<:$L/V</;]OG;,NL2=]& 5^<M7)>^/RB<9#O8:'=!ID/3
MYP$JL3^(Q97RUD+A:\_.).GY= Q8@->(FZLL>>OM)6&S4Z;'DH1O$">_YHFT
M[M,OO:NBA<?7ER="N<K0F? ]KNC2S/CY+3P4=B4VP!SM769!!D$A$Z\("/KB
M!H.VQ0!JRJ>W!%U>1,?^$*+S,<ZXYPN-XEA.&(2+/XS1F/)APD&+/@U,CQ6^
M *\S]L B0H"63STR&1U)?%0G[)>WP>I-+RZ\!C,(U6$B&LC>,VJ!&@C6(+@A
MY=\-Q4B(2" ^WV;$!Z:<#)Q)= QHPS<27=WC<5J.1'D#G) ET= L$50/!]R+
M25W)KYE!EP)!N#'?4T5>;. 3SQT[!P_"]R=>2LN 8QQ>+[2T\::D8:IC@9#)
MG@2,&=S_>B,F=Z!$>Z:XHU$6@,P+K(CLAG8#MB7SXA?UY \&H:1TIUG8WP1%
M8F+<%%OK,[,XP$7F,(M%A+F;C7%MBUCX]J9CLP/FQS(=5U7I_J''?*9[YC1U
MKJ[N?MX^=6Z?I)MN4'4#3F3OJG 9U[5G(KD[(=(W\5F8U!Y%# $/H<*0?OC#
M*FB3-:6%8?XM&/@I .B_.4%Y8I"V"S?E*XH599 )]AU1TYJV/>+&D5<]A$MB
M*NE7Q_-!83,D?R?]/OF0_H.,)U^E7XEG,ET%:;A <<++=5TX*R6N^(-9JF?I
MN^7TH7XU4^!!M!I).HHBM1+WI76I8R<61"V/OHG*#?8?,_!783>7G"#E4LOD
MN1>>:.([T^".<&PQFM!'IOY+=#J57\6#(1 M$ZTG>4_7^(WYHX!BL,_C-D"<
MC/&3/936T1%,@J+KTF_49HQFMO(;(Q)SD!W"=J;?IJ9H]MR1I2=J29U7)A5U
MO:4J-<9=<::S5,;AB8]P 2O<IY"Q%>?/@B$%O@-UV4$3[#ZS(<+WF'IYXA%$
M"BJM33@!%OA* B5)0<M4 \R/Z$),F^T;8*AHT,,X&"G<A[&!/GUV7($K\>Q+
M3".DIQ'4DTLCI-U-R$#$.Y<Y#!<#.& Z\>AE^,/7H6B>>FG:G%+\2U]G[V^P
M^[]"6_L!L0+6\<>)C^,E5VMBV;[+_AV&3PX^KK*/OBS^O5&K:@T]]:-:54G]
M^[);*6JUJ:N9;K7\[[J>[1LK7TI;>:LOG%Z"9HPMP/C_KFB5&(>\]]%E35(8
M6[_,7M9:N$R=O,.%BW(VST+!O?RDK[G.8>/@^ -F:G5G=)[$U%V$=W^X&T'B
MRP+$0_&[ B,]P'V28&5?2T(JL  S=-EVG9L1*A#VN7N< A75W-#5V@>ZQN9P
M:-%#T^43=WR=*;O%T/N<A4(P)^3998['\")XR\& TM%HU<JA<=N^\;#>_/.%
M=WB$]H8F"E(#X<JROII4[%7^;:?%)1?EPET+LJJFT10>\BZK WG-M,KEFG/=
MXY)*!-%5='35:[7CH"NSPAWQ?\JD<"\>@K92:8HW6K.:;<VI8E(D1.E9 97.
MV+VIJ[G'I?H\I\837DVL?CT.8T[;M7HB[]O+]Z9FL$A84HQZ:?V1DV6*VE#0
MC._!C%N6=,<[?YV5"3^JN4 [7E#&Y&3'!8VUPLK\$V3+LJK1V7@B6YPT=*:0
MBL@04#RY#7 N1"FJ*"IRS="WL[EYT*6@ 1V4@W.3@^:VGN>QI(";L2\\YUN8
MVHZLA[.B<'ZIVIF*UQ[!:V_1$RYHTL[;\29O(:K/@WK&8&YG6K58T(<]JAGA
MU:M!-9,7EZ[P:D?1'SDNL J*DZ!-S#.U88"[]1'-7Y!%31,1U?'1$#GHT C-
M^P:B2630/^+5I&^\\#X:YKK8I*9HE4?;H',F]ED^E%Z$$P$6T+H:K"D8C3L4
MQ*,%9]$V=T@J?'100QO44H6M+F+(AQ5Y8OYCT)A$U,B22-+2FTN2[=>HEAR=
M8;RN5)B$E]Y:;_)SAPE0.?:SPX_YQ</N/V3^FVB\$6$5_C2QF$KE9QX"R):<
M_?<NO>A DYM79ASNF5<Q"%OSQTV;R@4-/EKT53 M7%B@)X3!331N<*,S&:+D
M=\2;_+R]../XNW&U;M2T;4@M^BQ:\O#.'$$U/]=N,.0P4D>V8U^(W^)24&$E
M>>TSM]#PL>,6#D>K;0);Y=H5Q8,#7D7A:\@6=ETP&"(S4U;S0E1-N\/8R4AY
M0-1)9L*@'W%Y M#?OK,N4RR%/AQQ796Z_]O][5XTM+QYN/N-M[3\T7M\ZMU^
MEQZ?.K?7G8=K]M'=P_Q9U%(=F,BIO:Y:*W2GY'JW*MW_?+CZI?/8Y1U)%UHB
M2]_^X!SN/3[^[#[P\R^=FYO>CU[GJ7L=??>A5+R]CH_CCTP/&GFG.&=2?![E
MC0^@G;J#%]YH1Y-K6E-NU@WI"MK%2QVF:MC.&?J8>R_$#=U3ID2>GUVN4Z3P
MRW!",NBL-MOR6]&JM58T/B(^D/6WAA']-7Z':#),H,?^%2O-E!/(O#,8/[X"
M30%LF^VX!D*1=J;/4\]/=#I/'G6(QN -J4_X7BIQ8A"/ RPY#J#-$@:/ ^1P
M'*!E5)66FO4T@ J%]\V<2OB;2OI#,I?P-ZI&LY[7N8+&ZL, 97^IEIKM5B6C
ME++F@,FZO."*4ON4>.[A:^I;ZQP1!63ZGI\(W>!L0@XG$-:0964N)*$B]VAG
M-J/9)_)YJ?T]^LOQ/*]T&XTY?A0^T7WH/^4\]-VH-HT-WBO%%X$<R(5655)L
M$'2 A#LP4BMSI$:$;H30?H$1VF$49!Z8=,^=\7O":#]A6.5 +1DZ543G-N@<
M%!B=Z_0G),3NB>B4>!]NZSK1MN[>(C;O'G(O]H@> F0+@ P+#)#?R+LYGHX7
M(?*)<;T3QQ6D:S$!^!\PMS9H2?@;^9#^H#ZT]H\!]3/J'K,4/"51A]H.ZG#;
M,KRE%15;.>'L-OO#TT+0@N/I[\2>0O!*N0A#7IN<%-ZJ//S@Y-SWGF9E.2F2
M$<F(9#P_,F8U+64P$C>T[P960FUN;"4VQ,WI(P#7C>L^AW7OX4QJ853@;X1M
MF KB)9\<DI!22"FD5%GT>!G4=6?BFA:HZQJZJ[AN7#>N^]S<U:*$=$\.1T@I
MI!12JBQ:O S*^N]3FZ*OBKX+KAO7?8:^ZM^G%CJKZ%@@I9!2)T:I4W16@V.#
MF?0UFG%<-ZZ[;.O^6\.0V:WA7W199Y7@(YWXXJ!XIFT[6D[T,9!22*E3U.=E
M4-MW ]\)E#8ZK[AN7/?IKAN=UZ5:\-9Y1=\U,Z",AB+7]092:KWHZ=5:'>F$
MB,I1F:MRO:G(S5J^FNH$7-JH8]T9^[2JK-<;LJHTSV[E3-5JQMFM^HSY75?D
M5LV0M?I67,^]RT'!_-T5/54*>0"Z>/8W?<1WU/04J;@#%9FR5EM(0<3AL7&8
MR8AD]*9WFP%TX-:R]:IB:)E;RU95+9^&HJK&-LK9&HJ6\%:M7?J<KA"IM'YB
MPKO@T,M)I!H;^67K&T4JZK9K2O9(._"R.EXX],*COF_QD4_2$+J+!7_V779S
M,H!N757IU@E;H ?#4>*NZ?T/?CF,0H%).4/1@YU/5'&"&0YL6?X+TS//8MY"
MU+.<"?O <N F_.8IC="K*:0_$5BM[?!82EAUWX/Y8'W7^1,&*\%8G!A)8L12
M=J;F-1;Y:-Q>V\"NE-SNS,W/"91 -$$E.>5@F8C/S2N0WH@G>=/^/^G A[$N
M+AU0<^)'HQ7@:2/7&?/G/5%+ZKPR1^3:]'S7', 4EZGK2]V!8SMC<R!=TPEQ
M?=!MP32[Z![P&'[O8/9,E#D10Q.60;1@<Q#7C#I9JK0WT-(/,:?N4Y5QEF$I
MS4(/2[FI2E>_=&Z_=Z7>K?30_=Y[?'KHW#X%,'Z4KKH/3[V;/V 03N?JZN[G
M[1/[M$R#46X=>X=1-XI2:.Y]9]R[>[B_>^@\=:7O=__H/MQV;J^Z9>)/!X:Y
M2#W/)=0R0RW*Y]. SDQHPU?BFLX4!F>Z$\<%;^V9Z2W7Y@.M@CEC8DKF-.K]
M>L5O!U/;?I"WJO2+\T;95V287>--84(GU[+/4XL/@.'CNL93BX_,6G87.7A'
M^)6/T0KT#+/T,&J':?L!LU&$J=6?U<<JHZ,S^%.B[TR;V,\P_U-,$36#63VW
M?SQV96E,/N3D4L,[,%4^Y#UCV?= (M7:5P?LP=3GORE?8W,P\XZSY& W9*K?
M,=ER&;.!8M;<))UPX-_<3:86GY3C#5RS#]XN'Z'#WHF]GATN (@1-+:=G3@Y
MB(:6P1/@,LH\(7Y=_%'PC90!/Y]F5#.%4:K #H9EZGKFB,&.WPK><3FGWE[,
MP4M(#$^\G* $=_G!KD:/C$DIGAP\T&37B!FOOCFFR>N%186;0?]JRXHFLRU?
M%" ZW'F0<;BHSU6IESJ=S:-)<'*9H!:[E1C-N!(0CC<G$\%CYP0BZI(\_RBX
MEK[3\43(!;\KGUR[ F=OS-L!>/BF/>5C3?N,7J_$M'CT@_W.A-=S),MAT"'>
MI?3)_ Q+&CJ)>:/AJN VKL.\)Y@F"0+VXEA#&%LI5OF).TKL=1B<Q\")(1TQ
MS;)4:#_+[&GL<3!-*I!7X,4N,@NH9O<4:^##,#_BL7HQ2*+!P/-*BN\.LDE+
M4M92%!Y_=XN\,>&)7SB>]Q;(<P $6,3GY*>,/_P&0V=,/:;6&56]*5TU>_',
MIV+I9S$5Z[!4_5U8_4@-C!R7?6S#B+E7L/@"DVNU !/D!S ,6O]"3ZB$;B#1
M4F?@?Q83EID^6#;P#E[$8GLKH2!"F:E*X+!L]GZ!#S-A;P<"S+5V4E/$3D^*
M1S-Q(6P ,T1-F[T$&<8;S33_9UZVY7CT*&^2#XHV"#G-FL5 =]-H//2(J5WG
MC>N.0$7!A6S?""8S?.7$ETLUG/4;'9 ID& CH,DA)P$GLRZ31VT3IK$2FTDX
M]R9"^B7\.._%<=G[<6(R=HR"R;>,H2;')#,_\)$8R T_.7VFTP)?5.#VD8K@
MD5(/N9M$,9]P^ &/EJ67T+E-O !W9Q+WY.XN/$P*;!N(BHA..&\VT_8OYF3^
MP5K:@V?<QL?NE0!@J:#P.Q]T_2&$FRF/E4B(G:%(N$&"F9Z8)$C]U]1QI^.D
M</"QF0D'ACF)%#@-L]9A@"])[E8VE6PR]R#AV4[8#^!F\%F_3.=XX)&[$*.&
MZ1EL@\'N(5Z"WX[I!(L]WI<TC2W)T)2O_QZ%O_FT%KYP4)&^YS-N SQ?'8[2
M"4,:G]&1=*?8YH(PK<)<6NH2*UPG7)58OC>[]>(3D<=B1JD %'L4=Z<ARA>L
MFVEG9V!R  NOB]$L5JE+??]%?@1#J->]8N3'>DSYSU#*?W-FKQ0D]],)OFSD
M\L(>Q>%L@:\RV0SNN)8[F[%%!B^6LAT"V\: NPU9"FXQU]* @&I@_AEG1_\C
M<$OM5PKV-<E# EP#_PV4!1FR[4B<&%DRN)6[XLE=%3P]Y:WXCN>O*?/S1A]B
M_T#%@%O''0<;UU X-E7DC"?"^@U(<#,.#N:)1FB99S]P'32] ^&(S;F_AJ^J
ML15#F<\#!D1\,60>[$2'_V07V1'&+<)V,.R;8DTSTL U$E [_DYX([[T/DV-
M10@@B=TAP,B.)O4DB<+VLK\'.^@WTYO=& G3YU,[<(3BC>+\]DFP-4 ##/A=
ML4V)HS$ISEK)[-&8<*W!,3[UIS-6?4@'S&D(Q4#$*#8T6=XRF^4Y8SY3'J(7
M 1C%C8%XG)[</>&F7;J)_$* XPM\=>!,V3;](]UMA<4$/BC#O,>#:W[@5/"P
M#L"6ZT?A&9M,N7A<1\0Z??$]YK"P^6ZUF!R/Y<$G?U+.")$M]"2;,BIZL"$!
MB9URYVW,)#&(##*),3G%R<;[D9BN"2*N#Z<&R'@D;I_8U+NX>[>8SPE.(/M$
MK=54.2&T<Q8 7$.0^QE&<CW'+$,:MS:-R^N%CLO_4I5^Z]UVI<?.3??I#^FZ
M]WCUX^[QYT.I(O.W;#,3 V4'7C4*S:M>-<$?2(%U'JXAW75S]]#M?;^5_O[S
MH?=XW;MZZMW=/DI/OW2>I/N'[C^ZMT]2[_;QOBL^.$/&-@O.V+]7@4&]Z^Z#
M]/30X3R]O_O1N^IUSY);JE9H;OU:E:[^^-9]8!:#"=S3'YNSZ.!O?/4!>1XZ
MF+JF_R$]F-Z?TF^).! S=X\^6-3GC_QPMK0*Z"!N"D_.#)DC:CF38*]N,@>$
M+QA^EP8S)'&!)(G06%SNXHO-/G-E F\P"'S8(Q-6;K*]GO\A\PN?7?XCW_&+
M+)()'X;[H0'[&"J!).^#N?W!?M"T86_(8P4Y>H)'I/T=K'0SVGI2G]>W,/<Z
M2I7/?#-RN^)=<! &A3V>.3+I,)GJZCW>22H3 .52K2F:'/ZN-.(?F[+T>'<E
M*>)_JO3T,:'L?UP"V!^TH/ (,TCI&23CY#)(Q1&<H<,V(Q".-WEH(<R!0*1#
M8GKGQ1:Z@^V$HV("3X1JDCE:G^_(($;ER5)_ZHO[B'SYB$D=?7/</SWIA5H3
MV*$)'38"K>5Y;/,FM)<0UA0QABH\B[XF@J']J<=6XI5K&[M>1W$Y\^(H4!#+
M@LPVTU9CZK\X0_::SQ#%$7'@,"$"&0>;6L%W.8E<A\ V=NX9IZ'N?V4;ZQ$E
M$/KQ(D.WH6GEQ<<"I6$JRC+'IL@[RD'@- CA7&:@5E"2>P'UMY=:?8Y^%\4B
M( ]UU*.^,(5XJUD**GK5 (IQ1@HU(93-D'I,2H1SQ!5*J$TD&'SN,M<H584$
MFF/>'9*3OA!/!@^G Y_]F2WA%>)S<I0 #R6*F\&)"V';WI/T&+A5U'XU7<>&
M=_R*J#DV:H@4L=^G3.P9N^R!.>%1<@CL0MH"HGJC,#<-2O23\GF9)HD!"!"!
M@",@XY,:E$J%UP;E6 %H/FGBX^"!(H0_<V]X*6"TAY Y.F0BO@I0.+;I.[P"
M'GY]G5J09.%;*S.V.=Q# HO\$6P4 O,"-GL(X>%7D[[Q^ILH2OV9F1@JXKM\
MRV83Z\,S^1T]9^2_\7*+@>MX(EL=_<TR1W3P,; H0N7H4 '&\.S2**X4#NQ%
MF,J!%/X;5"Z(XR1,_S#C)/-$<.#R @K DXZ3@.P3R*4*]X\GGR*@+6@81,'1
M43!Y88(+K@2O_XKW2B&KQI1X4W>V+I;: _=C$M1H3!GG;3_85041G &HB;/F
M\K$<AO[T6>I#HO8CVBSP;"N$/<Q7=GLH?W*'%W!:[".059X$-&WFD_*,+6,P
MNPMC^(*Y",1<)!IY8(E+-?,="P7T2AM<62A\",S..0*P8&IFUF,DP!4(?4!5
MI&F';@0$@KD9FO-=J<=P-@A\&H <'4\LYX/2LU0M!>/L?#H@W W$&X:)Q8_U
M$#]V++F;.N2!CY$3[BW$F8OENPO "/+[^/Q.6I"4"!6W_;SN;-&9]*:0V^0_
M@L"_4GOHN-XQ#&BE+16*V)4VU! &GE-H5NGX-!-=89*1A^Q%X,NDPR#&Q8^?
M_6D[;_:<)O!?7$K\&4^4ET,Q[3&U1/&N#6X/E.HOT2&RT$/\X6&@#4H.1R-Q
MTFXZ<W=@@S-A+E!0"1D&[!D%1<97#IXM=CB)*^&$H0G553R0%Q[LY.62(P(E
M5_%*4]?(7U.&TD_VJ\4H.Y0ET56 >(Y-^NR=+?-/*&CG=6)S"]G[,AXIE>Z9
M_$L]6>H!2K7J=34L2]N;-/-[79H^(\A@ Y#Q5/T-X97(00=Q2%Z$P5&VBQ%U
MA3PE;5E!L2+/6+"O0!*'44/4^A)+GDE; V'$?ICZ4+.7$-!PKSNFT%,@<?;/
M='F=\70<:;_D=AA.V<*.:6H-0SPS]]HRPSRX.%#)SQB^F'W3ESQBQ1&<<$W5
M@JFTH!:Q--4=WZ.BR+*EY%**[WE5.Z]=3PT%2V# X1LFPRC_F\-/6[/[2J.I
M'4O#"X%TA47%0?GP(,?<05;X+F1/Y_R!&344W9X]=&X_ ,D)L;5,2%(B+LGU
M9>GRI/-$"MJP>'#,P64ZFX?Q(?D9F(*$'^782X+XGC@_/A2J6$Y^9SJ!ME9>
M&G\@1QU';T'?/Q-76% X)&(^VSPQSFZRQ'"6GO;$\IR8 7VFN4=P,FLEX9?E
M7ZM2.G<%*\/L_J)$QE0'F8/2[U<>69D]<RY.\UNAM,TPA/.1/75((<01,12/
M;2\INJFGU;24NNBF&-*5D DP#\P1&H,?%"4EA=,2AFM"X[!9<0-WC:83V#Q"
M'HLM7=2"+(D."0_-IE:4XG8IG)I@TA.E-6:_P=TPRP?G3$CR$GL%Q\5?F)Y@
M"C<V2G<CIBB9:H#=VIS$BXN?8JL57"M#N=Y\OE8D4,+(5Y2]Y:YC6 &P;I<P
M__91.S+ZSJAB4A'7#4(N#"+D^=GE9ISOE:RQ$QQS'-(!&0IO,FE_9\SS$L,<
M;B$2M4^<F?$;)$D:4)XOE.WN+&<ZG'T*/U#"V^?Q^ ''3?)QT?FOTMFCI(D!
M1X@R>M/1*,3/Q&6+!?R)(#RSZTSO/O-LFZB1&M,A)-]2JT($?P)+'?4V"^M"
MQY3P?C(\M2L.G7%(S!O!2+X61>OK[ ZG'\@7_YHX2 0+@UV2:'DI]D?B5%(0
MNYW)'T5R&4LBVXX],P+QLT13$>MC$*6NGRP2\X*=CK@L%@?'L<!'Y4'A89B7
M2"]KV?YDBUK;J*0^;.(+O94/;0;3]SCWG8<GJ=?K;;_R0A\F:%2EFQYT0NMU
M?DB/3QWVQ^[M4ZE.?83QL*B+1QQUX6?D1<U8\B VC[HHS1W07"\R3YN[\O3@
M[WT3<>PQYABOC1^\T.'4*E5$X2E9/BHM75K*!]%R/8GW'0UZ,8C#J %H13,6
MWR=PJ03E)7 ZV2=NZ!B 0R[=7"CB,"ISGCJV/65/>>!&($,YZ\%1T($](4VE
MC%<F !2NLN$AL/\.>.-AES6?(>(9^@  Q.Z%Y]$9\'/J K?N>/EQ%*3Z>JI?
M,?\,1D/P6,0W8O%*D<<72GTNWHP9X>BN__@WI5[[&D[OXMJ!_: B]?.B?D+U
M,K+?14D:OE."',8')2YXNN ^I'.%_U<->:.@:.R).=#SQZ4OE.WV7WE/Z9'I
M?_GA>#&O1J8'17;(LL*P+&Z0=@5]CY@K H&:>Y>.J O6Y3%H?&4'/P8=<(*(
MB]1E?H[_\>6:[:<'IH\R63P&$^]%NF$.+2K,(S'GUH'<5- [;X93J?N+ COY
M*[<]B)$=,/(/8DU)E'C^']$,#ESYP*LO%74[T&>+)[6]:$_,HSQ]2FW)"5H:
M>E";#3+!&WM*U.3?@,*H://LB-_CMB"\, ?$*!F5A3Q,? J#/R,(] [GIWSD
ME:W"/&.89VPLSS-FB<FU*N7*3C*"#2[8]Z$-W*4W'4,2\.OQ%;2((;:J4O=_
M?^E]ZZ7$#3?"]*R*:BXI(#[LN#^]WJS6:N+!Z?/^HGF0,Q]H]:IJI'^T]#NK
M/MCB*TL^:-2K1FYWTY1J([=E&DJ.--/T'(G6J.5XLTV6&4PMF]/VBB& F,?0
MZETN4XSBS,!NKM-07"7W[+ 3(YCN_H?T !M-FBP\3 R+FR.[6MN [%O,5 MO
ML4>#NAEUNN^BQO7629N@5^X9Z9M1X)K/X>&E$!EFI!=\43?,5SVAU9C,["<1
M6OH5I8E=Z1?%V 0;R&NV43^I1;%]X1?I9NK:IL<VEYM8#7V%U=AJ'OCRN:-[
M(D;Z;$ZEJF3@[+J)Z?D2(MIJI%!C-,J?&N*MAG00N!:7//$.5[&7(:G;-BJD
M_NOQWDQZ<>F(X=3W)][EER]O;V]5]H+59^?U2\<=O$#!]A<Z?";NER'QR1>E
M:;!=M/J%O6CPHZIR<-6_A),DG%%BCL0_I]:'4GWQF91V$N,G'L+Q$YW$^(E.
M_#7X%8X0B:-I/_PA4XID?D.\8N3\-D!*US%'D"FU=G&S@5"5>Y$,/Q=ZK=Y2
M3WZEFZG(<J_QAO;=*12AJX8\6WNPRXHC<['_K=@QQ#Q/TXD&LB &,C:,_,>Z
MVE2;-56I*;JFUK\$R]&5B]&[0E1A&!^A-2HSCDOFXX4]@P?!V0$^-GM[VU@*
M=7*A?.GL8\=PA+5HFG:A&HUZ33N1!>F9]%:15_)WYIQ*0:7!5KIXB5W22FZ7
M-K'>:)>*89?HNZH.XX"E,PH.YIA4&)=$,!.,QV/XJ;>5T3A /F'_4>4CR-1_
M;A CTIIYJXU5<I3[.A6#ZPYM34%+[E+"GKM*?GF9C?[U@*D,U&N%\+>U5E.)
M_&V5^]M!((J7$Z9&HWKA8+RPM/0!WIBYY,\N#8XHBZHY47_/_0<8S0%WE,/9
MG63L!./KQ0$)EP2C:OCH6(B2P;P$,A:')</:->;V^^(TSDFZ\R?B,9Z@,Y_%
MV2OR2H0PMO)VYK7<@TS'L,HZ6F6TRH6PRIK:BJRR 58YB('Q2-?]%/JV>53Z
MG;C<; :3T7V'_>5C1$Q7^O'C:MX(VU12E3DCW*?^&U3AIICAQ)W0TA9V)2=H
M:8T368FPM+E'S5:52)3$T"9"H\4RM&AOS]7>)G;![-?D-A@J ODI\J!%'C>.
M88<M..<_MJ.!??$.^!1-)N::BKH@I79:R:;\]Z>G8395-)MH-HMD-A/;5*6F
MQOO4U+ Q3&T.NA PPRFF_;#-K$7L4[26)Z*/3]%6GE8L%TUEFJDL:((5326:
M2F8JM36F\F?UL2H]3OL7]WPNE6A(@O:SA"LY1?MY*DM!^[G<?A8T%8KV\USM
MYTR$5E\H5!*9T=,WBQB$+>J"F&'43V0I&(1=81D-M(QH&0MQI%SC*(?C<KI!
MQ#:2[2+=8!,)<VA6;#&A S"U/9&WO'<L<R"&(77?Z6#*36B0Y!0=9</TYW8'
M(K*B)_S^ =O\;'#(_.17NWC:_!2\IM,I*8K/C^NB^V]FV[P1WE+[*F[9M:4T
M9KV.9AW->F$WO/6%#6]WS$>)46FN)A@WO@5?RREN?.LGLI32;'P/2I4FMF I
MD>4)7J2I7*BU]Q%XB>^6Z?G.R!/6XP?[A9]QG_8]<V@2%T^Y%_"4>[DUAH)=
MFTJE,IZUFDK?%36A,]A?!M05*N/>A=&]$V(M1H>DJZCM$@\D)>9_/M(!_QN[
M4]B0Z9&X?6)3[^+NW:(?4F? -9%:JZFH@5 #Y:R!L#]/>300"360NDX#Q9.-
M4 .A!BJR!M+0!RJ1!J+/K5J=:2 MX0.QO^3D [$[H08JE@8Z#Q6$3E!Y5! )
M59"Z3@5MXP2A"BJE"M)+KH(,](+*I((40W'#KMFQ%B+3H5!!,!079LDR=?&K
MX_FR=..XU)6E[Z3?)Q_2?Y#QY*OT*_%,RO],I#&?60S7=UW;\X,K_G"F]K/T
MW7+ZQ&)7P1C0(9U0/K50<GDC(@IC12?3OF4.)")&JS+.2R,3!C2ADBK43DU5
M2ET!PM?9:B04%599E$-=!2_2:B@7$U[".')<EUW_&K1U3M0U/O _NQ]"%;F.
M39VI9S'GYXVXP[EZR'-0,.6H2/S/S:O0<M=!!RZB4*J]V\<CNTH'77*/SQF6
M_O?;PP^IQWP# E/&KYW!5#10RIL011&\<EGV<@]I *EZO/KE7*7JB;P[MC/^
MD+KO/K-M$ 6 1MIC@F)V5#'[PF>KAT8M86^#+S94=N>)XYG<ZW&I12#<'(Q7
M%W=-?BL8SEZ+OT+ZGF--_>5?F7'GO.EX3-R/N5GOK31ZYD<\I;:.>JH(83;G
M7(#$?U_<& C/]*+O4O+G!1FQ][PDUAOY\  YB56/V>J2)%Y&G26$,/G^]%(1
M$RC$2Z54RL\S-0#I!2@(_N69NUT$M^.0B#G*A[XQ\EIDXM'+\(>O0].;6.3C
MTN12?L&_-,<W8[*HAN!YXN-@S7J]*<:S@\[GTA4\>=V(^'J.\^:5'"?$*XUZ
MU<CM;II2;>2VS$V&UV_^9GJ.1&O4<KS9)LL\62?CJO,#G8S(R;@BUF!JB53$
M#]/^LP\'$]#E0,\^7Z&[[FXR /BTA>Z:CDS;1$DKLJ25/S+UH_/M["4M-F\_
M2)]:*&Y%%;?R&[;[ARZ*6R1N]RZ%G#.ZDT66NOP'@!U8ZK+T;CHIB8/D*!2%
M\?2H!($T429F>E+'MJ?$DA[HQ'%]B4D?'X8!/5&D3U#7,83$Z9O)KA4CI)*W
M'0;R^1D%M% AYLVBD8=Z?1[C_;_Y?V8#JED#LX>-I+:TJJZV_GUY(/7?TR)B
M:E73TC^I5974OR^[4\NHZHW5MPHT=GG5U7]FT"$;KD+P\.!]+$R+:4P88 M:
M,\VL[JN28T%R#BWD_YE6RE%F5DY=V_1>CL3. FKQ;3L5%9K+X=QIT00O*#?S
M1$=VYB!UQ1\D9VSZ/J]7C>ONH:3%G?+:>P^&<+(_=1/?CURIJO0T-WT3AHCQ
M:T8"8Y(WG4PL/E>,6-:'1!@Y)[R0C=@?T;.]<$0V\^>"%PT[QS]VKZ3IA/EO
M+OUK2CV_BE#=I;=6H1';LX=P"@00*XV)S=QYP U;CLV3_8".05CJZ+@?T@0F
M#,!8.Q@E*RY.@<=2=W+C5/GA2@;@* QA.Q(2#N/SI!&WNTP(%R1X=HL#5(*O
MNG22"#H(X7\3PW9A++W_0OR9.?7!3'I&\"&%6U,R>)$<^"N7;H^NN^,+>:52
M'T;Q\EMXCD6MCVAKUJ<V'9E^>'R'WSA^ML/T WM<8KEP\S'Y2-SU+[9(7M,/
MDW\' 8%,FSU@+.(J?$DOC$+\<N8<#RS'$S.%-WXDOP<\UW9\=A^VYI%%!Z";
MV,/FOE!E^E$">8*GR_",]42"6[/;FFS7)?J9 L;?B-"$EN7 X2?[68+S"^R3
ML<-^#M_8%)3CO4_%"P>LAB4"\]@;3ERV X:U\6<,>"6Q+TLNX6MGB[/Y$P<^
M "9Q)_;T$?MK5>H,V)= 0U@?LKBK-&!?8K>S';8VR^05CHS8H+8Y/=8LF#UN
M\$) ;)DD_"NX)@!!\CW"5V!4_<UQ*6SDY1GNLL4RIMM '4Z&:?^?;&V,H,QR
MN*$AV>2-(E2Q]V+:@ED=$]8$-QT&+S+/Z*6;.2QV6BQV:BTO=H(%F</_KI@-
MJA*%_3-2R$@?]/M]G8Z,04M3&UJ-UOK]_U,UM5*N$JG%NP5_8=[$P7G32.7-
M8^_[;>?IYT/W<;?HQ&$1!:ZE&[N6H)," P#6(+!DS+*,*04E;EFA>@%/T71#
M\\GL$#.AH#YF@H"1TC>%[1A"^[P!F7I!LVDR]5\<IKF$DI7X\0V/\5#8%?A)
M&&$BC+ ;Q1G!0O?I"[%&R]7'3@@L"M?2L?;0>_RU=]/K7DL_GJXS4T"(B0OW
M.WPTK%YM&4;6:)C>K&IJ>MAK63AL^=_U>K9O+'NI[.^T[$Y:JZJU&F4-T:W7
M--PX_$9<9O?KO'7FB>12-ESYMX_+_..3^1^#W' U7[PO4M<<.M)W8BT_?'7T
MW$M1F']+QG03]@>:%_P9MA+8X)E#"5[L:PD6N8 '1,(BD9Y,W]H("B58R]6+
M24>+C8YVB@MMZ-%OYZVASX,^#_H\Z/-L[_-TGBWS3S@8Z0]>Z"M!UP=='UCD
M,E@@(,[! UKHLU8 #^A@8?-"1LCU6CX1<J-D$?*C!L!K&8*2QX_4]QB%WR'
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M>]1HT,M&5>76[BT83JZ,_;" B">-TO<)M3WJ[30O8?>DY+XF*9S$FYV)%_I
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M<[ :8BI [.F%2F0 ?>V(#348DNWXU)-@:@9[,9.]Y;-++&E"7!]*W?P7ZE%
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MXG#7=HWK-_$\S_'[9^*"A0T3$^UMS\8AR[,A_7P L6>'E'V(")MU,UO7H!=
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MN(\4PC-*^.&!ADY!1^@4,XZR9VL3/*U;XY!6K8\<R4ER 3-*PA DFJHHYRW
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MN#7PD)C]3[-H7!6":8*<P-^HW AX*:G_ ,[ JC8UZO "^2V8\CA$ZIEPP0O
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M-..Z@J:NH.%2F<(*FG+4#RFS"R1YIVIU-;&.LWUT[>F/TYOIO8\>+<N8T]3
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MD4)-TH//<-8GA/K2LRHEU/J&Y,S]A7IB_V#6S;^9[Q6(A-9I :L/5$7]18B
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MF;D]=73EG%,9G+>_AYK/?./$3[J"TVDDYL')TAN3+*"9ZX72U'AE\,M"BE-
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M ?M9EEQV6!KNU6_0#,]XZJ"(4X>K9:,SGCHHXM3A:MGHC*<.BCAU:! ;E=L
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MQ^-QETUT<ZBI?:W#.N/Q_ZKH)1VR=8ZM2!E[G#,?WNF^?&5&P(+\AOE XQP
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M$+!-<=<'M#GX! L*IN;@%TS N?1(]V>TKRS9$[QT' <\1H*PG'ER]JUQT!F
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M-Y@ 70.^\ N>2[[:GI/8:I[9_K2<YJT9%H'MX-/NOSW>)(X,MH9R*"\S?EW
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M Q:&3LR=&'# WX[-(MH%SL NQ&/"*)QC-D0NXPB-M,!)] /CH%U/!N'])'*
MI>.K8L<,YDB3A/^YN-S L;B;PJ081&)B^T$H60:%N\R F=$6Z9B!F%/R& P/
M:S=YXB](C>&2;Z<$87H'+HAKP5UT*VX8,#+;DK7<>$5RY)23O,J##L32G,$_
MW&YA0RX'.]A07=G]*LV#MT2M^YA8WX"B(.<I[X&=2IFOUQKEMSE_2J:ZS^YF
M?&ERV!$O#%R<K@O?YP?OU.9;-G,\#K!X[)HE_0?X:$9.XH@;,4=8-GJ*%NW!
M -'PO)UVS ([^/D7SB6__@S<CS@@=-"!%V:V5C:'!3;PJ9>]-#5**9_0QL[J
M..5E%!5.(:0'@SKS?$15 #YMG/;I'Z1]DEV/^+PS2D!=$NDE=9!:ER";DU\0
M;*R>$(MP(PTW-!%NB'"# HNB<$.[ .Q6R5T]'AP\9JIQXD.0VQ5?[S=T3YOD
MM:]6&<6;W&"K<(]:PKA$V@I$I'9SFGX)QH:6E+D!\< MYI7P_?I?%SF\-@JI
MZ(]_,-H,!DMO>];J03],T?P(KLP;J/" N4O-/VB-)F@8T:8%ZYL^?*>>',3#
MIC+>/97Q^E2679KY1/:;Q[ U"L%]W# -\N30-.%!&YHE"H7HL)Z,UT8+1S8M
M:\]6K=AVJFQ#FBI<:#+QL9S<(K(51&G/*!]Y,*I!)Z\-!IT\&-4M1D4SG-'Z
MX#.!/H\',[9Z3D$_[8ER3\QV^2*01J+4! X=%7S,;12N W$5:3,^TH+QQYLG
M#<&3ZO;;_?Z@&N@F^*$_K A/JM>I"$]*#*K$H ;;X<".09M2E:9!;ZW:_ S:
MM$#@RA,K0QYIA7!GA.6*U>7:,QI/VC_I [-N;F$X$"-)28L0B7)GJ5&(H'+E
M5%X6;M[!S;B1@'MD7^T)DS[\$WVTGP71CT8W?'GQ&26LW*<).\34E Q8F9[-
MV)[&D^P#99)Y$3S""F1P[$V&\T"5*TL.<B<ZO7-PB[FK#.&"\7,92C:WL0S1
MY]<X ]'( 6=*.?!# 5JP9R'5P4%][ 1DO(.'^-B@W/;N0*'MW?Y EU7E:&B:
M^F!F',UR-9*\TEVMZ][X;;L<;6G\MKUS=87"E#@ML<^RTCNN2(K4UDAM*_GC
MD<;*3T7VJX8,MV$_KKI-RIW<E#K &?_WF?DSM7 [$[<MEXRFM4:]94%";F/M
M@(IJH3VO37MNU9HWV@G59AIL4)BQGR^B+9F[VQII75E3>S71HY5"*]47E2/9
MB4LS:]X-,-*'2DL@Z8CFGA(>>$DF/Z3B!YK9\YO$G2A=?#C0J?A0Z<C=?A[@
M+K=OT@!4I*/9J49R='4-F@_VTY7C_/1@A\5)Y">XC\^!R[KK/0AZVVI=P)\N
MU+RY-O>_$_"KQ,RFV;+O9LNL8C-[I+_ZA=,_\I?ZH[0=[K=&W8XNJYV\#MG?
M"M<GVA?QGK#"I:UP@1R5M<,#<&?;_;H@Z5ZZY?&E[W^O2,+;3[8V]S_;(QI^
MGQUUML-/7O[,:X@-@&6M-Y1UK:IV#)=O B6B['<69?=J>AHV[.!IF':-G73*
M6\.:,UR9]O!U.PP;*JV1WM8K.0P3RO-*E>=6I5GCP[ AIA1T9:V31S^^ HCZ
M!D4'GS-5Z55&"&5AQ]=_$@'$H3*:6='# HBAAATD!MVA/.A7=59="1^([4.Q
M?=B0\"(CA&7#BRXEVQUM%YN]:]@,A7^F\&(S,VT*+XI+H%?#"QW#"U7DV@GE
M66UX40VCKX87>V+W9^*+'FA151YVZI+T7]#&92OTR\DZ85P>/&)+:;Q*@' ^
MXWA<KK=6MY^ YUFK+0&"M9X ?(63\ 5!N I_48M:DR!DVUM2TV?$-7T</HX0
M%":&[2_!H?<:WH:.!0JAW6V%B-_DNZC=(P\_=W@OA$>RZ=B3?OP$M/@"I(B#
M_[P7@[A*O78O[\9P5#PCK>#;D[:(+%)VY?DJ<X1L3G#DJE*@_ 3OL;7WR)$J
M[Q\TKX34*4E+-RL9#C!U/K\I+:4P_B7GO:$=0>WFC:==:D&3EN7$<?E+3EYM
MQ.3!?G<PQ2"?8;"<O,\0OAVA39Q%#.E/70H+D.Y7!6X)1'ANF=N'\XX/S99I
M'=2V\9#MS.Q"8*&ATLZKNP/E3]E'[=2."&"^E7Y[D\MUN$ JC60)+&8:M/,[
M:)N$\W9E^W5=K"+79Z;WXE('#!+5&,76S$R9&M&DT$6A!W?%AG-5N'=Z'GF5
MN*,GS^<8,_>)H^(6K\B#%P^'@R$3E;._8Q>;!R_\)X/7)G,M3_<N6L(\$R[)
MGH+MLQ](_@QL?$I@PC S\I[@G-@#UZDL*MC)"!0;$<^/O\+K=L?_0"<$WEUJ
MK!0RC'3\&NY@J>V.U)[=!@$+@UO7^FH;8]NA?B6_4S,@9CVZW['?#%H6N #F
M[2<??T5D4[R?9OS,S*EK8PNQ8C@PF$=O'?FKYO$/&N%?'0@T;Y[,J><P:D03
MS1)LLH#S(S?+!"H:<\Z:#!MA!MK:HL8&^/,*0-F^06&K(;!C Z6M*!7A5D%T
M,M@.IE4-1E-# $(0FT;ZG(M43P%:=72265UIB [O.\),^9R:3X0'_[#8&]WH
M\/;790ER(63? TX-U&ZWLC S:X$3PY(LUG[' S#@/IX/=+LY_^!FE^M37;A<
MR3QH8Z37V8[6>9BT[LZ)JZ.TOGH(( [NV***7+)KD,B]NQ2L;@P5"^PA<>@V
M1O]'NES?P<DKZ&( 4QD"C_?;!<@"/RW%=?])ZK6<I-*A>%K/[W;]5(4L-\KR
M?K>#OVXF/J..E0S;MTD^T*V*P]OW)<_=\[$ZKMD76++[>,4V,[J";7F'^;W\
MN@OS_C/$C<*V<B));J95A@ECST)+6MC,V5P\?=S$SQ,L79'Q_12ORF96UE!8
M._GSIY_R@6#^^']#F\EZ;EIA.^#,1A5U2 A"ZG4>\&.>;$/GY3;4ONV\%6IS
MPYGW!D7TH]9;F_K-1>;^'_]OH*J]-&6D\I?3LXJ:BA0-9Y5"2K>M(T60AZ5_
M)"=YCTDOA[C;R(UTLK%O)=RWI)_4_;='WC0[<\3_MF>;*IGW_K/=>13RWL_+
M)MYI!W)^^N$S[(P=8(>M.4P\;HUH^]8-? P7F2NIIS70.\ V?=_PT*1HB$F+
MM-7>&#1R?O82MWTR'2_ (]*57N#S: SKZ2RP+[M%S>/6VOT%\7B7STEZ=*3[
MNNU]96<H1.=0T4DM,.XH7$Q4GJE[6'8_#9@#V(2Z&",_Q"=/U'(MG.8. WRV
M?IJ5:5[7EKYX_LH=G+T"_CC\&OM68A?+]'9:N<XO<P?[C[X:KNTXADQ?*K^
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MP=!]+P+BTRX/WX^)>1CT*IW+TGZBX;M)!$B^0TSX&*@D,U<"ER"KR;?>R>.
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M#^=-S5'Z_Q+>-LP%U8[MSYFWLD'2%.8C^;PYV!^@'@*O?@ -#MBX#YO-FM4
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MN L%1%STE,T"2ZX=(O/1"JDX_S[-9;\*:>TK%U4TLB^EI)QH*#5!K&?B? +
MIZ3BE1UK*73II4V<-E7W:)E5#*'G..%25(/+YRU-148B14_(#R1/D:'PEQJF
MA3Y:N\S%+/=JEQE-@505K.D:IW<TT2KUR;1%L>@'9!7^WEF(UGYR44^S3-YV
M28C[K<P/.=I#$525TCLJL-5BGHN%FF+>[*P./13<7=(0N8.7%?>/,L51^7?I
M6]D=AC/L8?$:@_U:@+58C86\/\W%3TTM)%(%Q+I([Q"-'$H=D-'G:$:%>,KV
MRC33 _$=U7C[M1N]'*VAY *NIH:B;"(CG(\<B?BC76P=ZT4:,\L.^-E-SS%:
MR(CZ(289%H*UEI,+V-I./-[*=&ZVN<6^OB^KE/JQD0:EC@+)OV)+P\8D2DBU
MH.8BL=%QI.B#W%II,!:59H EI%HL<B'1!(MF3^-4,\3Q7ODMWA6PAV4K&RU$
MN:!E E$2CE;])MFV. )6U-*_=_8$V>^=(VC[!.UZIXF)CH<6JI(K/<&;Z^,D
MP>;4;*5QJQIG+:8[W G:^*'/#!+B]\7<VQ.GM!Y#ZCSQ/C.:>5CEQ"7^L\J@
M>5 %M*:SRR'LMEB>ME.]0*P8R&B6C@"-]OUKYPU_$SW.<J=X*P,MS)K[4$',
M\(A-R2'L2NZ^$F,=ED5O1#$]Y]UT9V\"2)J M5YZS"M.GY$[)W08!*'P>ONV
MA0JBM=:2BT;:6$LV-6R3+E9*G@**U3I:51FTC#A?1_(E13V1:26RN?9M/>4B
MM%:2BSQ:68D0#)1D$(L^6D()3-<>=+[RCL7I@A[O-LN5=1K0'L1H+2(7MK2Q
M""F\'4D'&?%'JRB!:SSY<BB_4,!:BWXN4&J#/A=X= -:;RU^F_'%DBMV<I ?
M2)VC/>*]#PTFPK1&D8OR60T2HDA;Z@"R2L3;XHTTE,QU0I46&-OHM7#F(H%K
M%Q,U?:F0:=JUH]31K4(S<18?\>_/.. "Q<P\):@(864Y6JAS <(-J#?.:6<N
M,E+R0:* FNVOW6!U-(X$M$,9PT[@YT)\V\$_XER(LS@MZ3O8P]%AZ^3(3%(F
M:;N*B%>0H,4^%_?;P'Y=IK" ]"A06C1C%@VW@K17QN=E^6.^OD$R9%\QFW$7
M_CH+V/X>IHW>GYP!%I@KJ7).U_3TQ"V=](M/U3'J/R54CR2(3F_OQ05HN&O!
MWW[W9%'WSTI473^2V4C@*UXDF?;B :0^]A<)K8U='$RXUFP.<,'ENJ.)-<NP
M.9I7!81[?(E]@[U0C-<3Y(A]5LNQY\ J:$TM%V;<MZD)_=JQ@B#5L)$&5_2&
MN4J!!R-&6O!S4<;B5]<U/A:Q^6XZN]OBBFFUX!1<0[GQ>KMF8E'A?716>.W
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M4#(F<-P8(%\G1%5$2+JY_]D(^Z"*TIN1[YJ6? A)MZQ!OAE.YP:/G ^F!&6
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M<1!CM&!KF;$*3 A,#Z'4;D0[I)W2AU5KAPNS9_+5HWKCZ8<GM0SFP_I>TE'
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MC[(7[T;#Y<A(%31G$5@II$RS5> -9LA<VH3<HRFM:Z3N@=1\Q'687$F'SGM
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M2^ ,R2@-/""=9IS &)\A9B2H01F1F[_?UU <$]5W$6QC:_W,=*E&Z\@[GW5
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M:&-N77GR$1#=1*C7B=8MB'[_"2<3,O,_A^FW-2HRX87)-I*%+\G"U]R"R[Q
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MAB2L48Z25M)&3W9?$0C*:]IR<J@51@01A0G%M*_?N0'0X?6@$7'71](UDOH
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MB35O>[XKMG^IVC T-NQIN1'GM%MWO:N]]$9$H<G="1Z2C;3I.DW[;2D% HF
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ME:"T,$ ZCF!=E#$3FA1;'\97(!PK[7>7\X IIEU,:;H<69=#KJ63+(K:R)V
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M0 &F.#HM)1V4SFL)S'E'1H;0(K;.57T$SEB1G)8<N/\>VT;:TX[<E"PTYRY
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M%)>HF_=4>%ESTP\Q0/;61(?YG'>G+NZ YK7,31^DF<=G:N\CUA'FIK,2C<8
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M79 V)^<XGF(%W7ZTCH'7NQQS>8B.KGOZ-^^YPORU,KC--N^NB\[47R6'-7!
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MZL@L\&ESQB.0 \-&/S-HO&E( V<ZIJ"*Q@N*Y4 :3:8C&.!M\]@'T=K+G.M
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M47?@,YZ>:BB0D!'*'OC.I)"B!YT4B=(<^0#R7/5SQ5Q7ZAZ5BC]Y#3^\EC&
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MT/B8I8'D=.U:.U.^(6\B2@QZ;'0MU.3'7X0%?SW-P9':Y <=>- /J]BY%1;
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MMT6_,D5X<4J7L%^LFZ3OCK&!1XU_&D=A&(X$,.,7L;Q;)#B6'<S3HNW:Z$J
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M]/G-2 4VYV!T)OI#&]88EAQ&7/VBN0:G\Z*$=(91V])W4&BK5()*FR882U,
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M?O5"$5I[-)@V+_O@-4]_*M0_6!=^0>,W<=;E--FADYROHJ1P,7XSGZ/<" .
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M \P[N,_>1_>IY[S/>7_/\_V^/^Y[[A57K^M:ZUIW#&/2TGZ:/D47U<""@S!
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M1=\N:B4IJO#=,ZN>HN7)K Z=?FD[2(6]")+9 2:.U+/QQE@=6T <+B!?:C/
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M*B&GJ.H[H&"BS+M8]>D;3V?[6H?3*"O->^K<$=JZ* !/:9G-VTCFK/;JOH2
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M!*"$ ?QL=3^-M]1;N7]K*:Q9,34#7,8-<\&2GSD>>=[R'QO#P-%.K_LK_$B
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MG%4"R?MHN19:VDJP2W)FX;J,YL;VHFO#C7%@ E[H4U\IK^US.M@8ZTX,+"5
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M/_/[I((P^P'>OZ!3*$+\N';".(DMHRI0G#J!=H"A3:63=&!1B0]+,OYYIXG
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MN<,I=VE>T9^M0<I9#Y^N,IT!.4;'?:N']G8YT*[^0 *<-BU%2X).AI-8.W]
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MY3M:.! 1+5F&8@@Q2/S]B5;%:C07A,E;U.K9*%Q%<44?HG1?FT^X5HW>7J\
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M(IS:G*Z<MSF?<?9RKG#1<DEP&7!Y<R5S57*]Y\)P<W K<EMS1W#G<;=S+_!
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M?PFK9H I4I1JTP^MKGNO4*I5\7[>0^& T#?689.SZB=P?BV)#"G$54ZB?"D
M7EAO\S8%H![$O"^F )@'1'U\";R[7;\OG&ML3R;KP:GV.PK(]:K@-PP%^:J%
M1V*F"T1(^:B%&?GD0HSQCH#3@9,21J7W@,RK(;QD^4K%I-P0_YU]I:'U)@ZX
M]=F4#O<(10%H\*#=CI^(,(S)UA$*P/!E%H]8@B6Z8YXG1X7XX-LV-ISA!7UG
MKJ3IQ,$5H$--?I=H]85CBC;00C'T$0Y+80\P1CUSIS[L[1S9>)67JJ+5,B&[
M.+%S3( <(6O7,R:\6[AZ0>2K__9C%"^R,72G!X47M2%R5..8\ P+J;#N)K62
MM820M<DE+&N\1T5TGB7:+#H(M[0MI9&X]+HYP]P3-P#PB91$I8.*:F%XB=QQ
M:V36*WB[I_C3?7-,3?CD<MOOO'#&ZM+$X;A'B]WB9<ZWS:G>)E^N\ G@J[!(
MJ8U:PVLA7B/84)U:%, =QA0S<\A+Y.QWP(IT8_U[<BTV[&-23O@]$JM-._-5
M'O<@85:.8\:BH81E=UDPA52([*3;VI??^EB,ZAQ&0O=VIFOA+#Y(07>\CK^+
M7.@CT?CS28<.9ZW59_MW1]T\G2U.O.7O;VXLVR3S$YK(#!N@SDR@<UN(8N!U
MXC,%Z)2B  NEN>!B:PLJ.(8A]365>-O39(75."0L^CS,I4MCLHEX=#Q;BB,B
M.9&+._KI&D!N>_'_PW:B?/COM\6E!9(C(UO#ZUMTLJ4LGSX%K+)2V/3.TV]9
M6*KP\N#N-?2.5YB56KMPZRUKP3O#B1P.9)8-4AT%<"O$RQ[#MV(CNYZ/+""Z
MHY&]_-6W0^D^GO!S:8WL50X[(7N\.7-5RAXJ6.%V]Z3OA,* Z152*WIA#C$+
M7]XG\@8A4^88,/=:2(^C?)=A,'QY3]/\3)C"A4*/5$2]U>;<HI];QOP6Y,@5
M9W+&9[_JG:/SR ]^JPX^1K/7W?Q;7A[/C+G)K[2%.H=IS$ D:)A$^C__9%]U
M4.7WS-8Y]89[?H(5W$(+_AY)%'0@4,5,HIO"X@F(:?)@#"<%N%-F0AVQ?=;#
M'NY75T.032J#2ARZ8>B^Q=CNJS1$8<'E54U*1B^4L(,KRZJ#"M5IAEXH1+-N
MDJ6,,1O:]W5:1DL[8M\]ZW!?&Q;.]61(TZ]^**,[7'/_!-"'JL _2_.<]+0]
M=9+&<)?^K(+ANQ<EGV\";R6><$&('4[D;E23?X\_7A6YX$'D2NY#P"ST,<KW
M,;V*\YQS>F6VAKE7FP.=7U0T^M WJW#2KS7K]]1<P-X+$@ ROD00<-2D2J5J
M_)GD3CC&U/AT5XQ'EQ#\3>:WJ1O[LQ530^T^#I]Z4.ZGD^M^&/%]?I6U5@7I
MW[OM%>F!@A6Z2AO#C4=?.?>/U?U$<42$=^].=U8C9VT[BM1F9BIV*W2O?^(0
M25$0>'PSH/P]G2$P4URG%.VAAR'=_I[[\[.R=<UR2%U+/__:K>QK$*NG6)6X
ME2G4(D^R::.OR>;2SJ:+Y0_R^TNC$CGYLZ?[-ETU3&E7N,RT:+B=OF]/]G$&
M1A[7YO_I<<PR1KPD27\U]>K=VR* 9;7P[7$NX%"R^";C_X:&H(S^]]M\,E@/
M,JLX!<B2(8(AXQ4WFIP]:[.E%',"7'D]\[MW4>#YC*-JH@!CL]X &3SNW*OQ
MHO)$]L@E#R*'D2&I)D:)/&J.ARX19UA+7QH];TJHKY:>([^/O-.8X/4<UECS
MP#6=7;3#-?M [1;2D?QNOB%EOAY&Y&_"RIN#9V>6/;Y\B>Z.!N=R.1RV'FX?
M]N)$:.)FMJ.F4:C#T,,J<S.?0'7)'RX94:]$ +Z)Z@&R,#B(E2B!KZ8 M.MX
M 3*C"4%E7:40TQB29S2,ZL&2GMLM3>PEJP^]D--H#1,3B?1T-2!KJ8@&,?/(
MI$^DSR)QI:0\M \<KVB^U@>OLXD/0=-,?\N).3K:4,CBQ9[@N]?N,FO1H*+/
MYK;U\'6SKHOCF)6<T?83V%1Z8B'&+OT._!5B<X<@1QXNK+/I2N<@FF#W>^&0
M;S8%K)BS#Y;R7BC>K4W0QK6NI0ZIZKA_?M6X(ZWG+ZLU,HJD1B\4([C0OO[3
M\\O]-V-4HJ#8PC<CW'B)KJ9,)WM\*H\14\).I9S&4Z\P'GD-\OJ^;[+W3<UK
MCV%K361& Q\P66B=1+NG?^HV)J'W=A*/0C_*=K#CPWPYE]"QF],5]6L$[HXA
MIG@IX4=-,L:UHJ>U'PB_R)K2!L=IDIZBO L3.<@?*0!=/3QQ[@1^C:" ]W@S
M<S_"H6].OKY@;N%['"39TWC<0'E>MA3&?N\N6Q_A^ _E#S1(_'$8D9L)%P/Z
MW1+5V8Z)"L%_7/7.32M:SO?K[R8+U84Z;#GMD0H5>A]OI2FIEV3%OGC-)S>0
M^C.'R-VZO-8)3SFTV3R#C<>!28_\$@5@BBCLU3Q#,(D/85'I";3_["5_8E(=
MT0"I]YV[ZIQ1E#Q8(-2JT>/R'7$?]:D:=YQ4KLD?\V:.&9S^:Y1,<ST6]P"C
MTA^D3Z:>\,W]/C-E5.=9\KH=DFCVZ-/UCLN12UIU\:3YMR1:5*<?VE<^%@V>
M4DQDAEF")9&FC:";N(1((#QK"M(<=0X7>I]=-W-9DE#;=6"]V<W<K&NNI8F@
M +=O(WS028@&%)$;O3BRF8&]O^#1(Q2\.-*],?MMB\A>&ETUM]$O(/;H4E$I
M?>5^VRD]^@N98O>*15L%W3((+ 0A+_BKPNX1O'S\K1CN* T\<FF'-DIGK(/)
MBVU&;+NAU6@\Y-O>:RI[(U>QU\TJ =T)HAZ%SAD74WESC:QMB%Q-9.M64@IB
MTR*/ IR?E*IQR$/C-9(MZ^WX.>6[OMQ:7LQ1ECS5L=P 1#MB4616-9^1M)C3
M>#WP+5, TN,V?X+>.HK%CW^\]^AQS)SK^%9IZB-'V92P??%E&GV3GS%^DPK;
MY]I(Z8M(O#QL\]A2(5[<J00,-_K)IAVW.UMD2+$40"]BG. BY"&9_/Q '7?D
M\\!=^N@""P8F:NKT13V<$:8I%K7P ,W9(4;N0V(L8&GPHQ3@*LFIVS:38-",
M]T?)5MVJGJ7>O?LI354T4R]G$"D=2G.$7F]WYA3L&Z(?C1=KBM44176VD4_B
M:T"U9Q%<&E;N2_)'I_%D@@%VY5G@1GB EU>X\]G>-N7);Q(&KJ^-V@?'MO7Q
MOM_?:O'#,;8HO!PJ&>T_@A<M3=& 8>EP?MBUKFBF?A4UV9$[&E8ON\4FX\LK
M*XF\-)H3OI5C*A&NX0E2#P2/=8=4;R')#*D40/(3J0"]F1MA0@&,PSX2U5"=
MQF#ZU@ZO\]\Z %52OX^SP2LMI'/I+#.Q(+K6EU)SO?N+(U $M=5IVX:N@>[!
MW!!;7QM/4=7/7*D-I%[PJ%1 KPC ZZ9(]TT8*,!ZU<Q-S:7B)$G@?T.#4L;^
M^T65OUMUN)<7ZAK.9E3TPV")DXKIX& D6X3(3)ZKJ_MS>SWGYUW9F O*SP(E
M+YA] ]Y UZU?/*%*DOS=F+>T]<<:G-D^^KHTLZEF(I2@FZ'?AC(ZA1(J^26?
M,%KGAA66UE<Z4P<<^3PDGUT4WKQ0Y_IR(<A[B\L4HO/O+6)^BQ?+:X-'$#0C
M=I:FXHOBP(.H:^[HQ,](SRK(R;9)Y;&+28N&C5T#T"NWT^[8+,>_29]9)C-)
M$72)XJ,=2E&G\"C,JB^38^I*_?6UEKCS-0.C@D6M P?WR-Q[!PB&I3I!4>R'
M\DOYDF_/_Y3@D[N:9X!\BWC]WHH+*458TXG:P/KC7I'R$1[->ULRR_VI(2AF
M;[44;ZR#T^4R_>ZB*X]?I8<+#,SN.+H28_ 2\ 0-A45_O&%('QK[3%[S-L=E
M$91G+__.U29IPP&J'[L%#ZOA!!F!S64KTQS1:H_!S0FK+_D58T8.UY)6'8ZV
MZUQW2L9V+U" A#:+)02UIY/H^':#/[UT1X.7X'?W5S;F;]XA;CJ;.#VL1GQ$
M7/.?]KB M_# ]MM@MY/]%V5U[83K)N96+O">ZND5.G;6S5WZS1WJ%+CAL0>N
M'F+TIGDQWPUT2"41E1UCDV<GR[56]<:R;.Y^BADOK)M\B8E#I;=XI-3GI=/,
M!&K6< \J/=,+>CX5$%!QY('A8S;]I1;Y. H@T,%&=,XSO;UHDZA( =@:[W]-
M'MD\F R$O';$EF<-,%MZ^)M]9LQ]Y"?']GA-U_!DV/T5+YWUI^-Z9>/#L$='
M2W2B2* [*TAY,50;AZB[':<CYO4PDT_+@,G)J7T#KI0[6ZSG$-)NKI'.00H%
M,JOP3\&XSQ-HS_0X- =9G.@2+: U1F1:VC*YD+9+=]*>%/OV>&BNE_B#J< ?
MK+;<%UT!F]"C@N^DKY0^E)8U3Y=N-0X.UK0:*FTO:\SC'!'8+7RZ9W.3R$<J
M0WC 9XZOXOH7XE,5"SDO>W6'OE-68=SM:Y[A*V5Y50!U]6\/)HN0&A!NA?11
MAA3@[MFE](0Y^"NL9);6)"=2-U.T'] ]4#=[KT7?H](07)%S$C?63;*/&9/>
MULAL<9QI&(-K^$86FI@A[Q=B/J/Y&DP2Y^NGNJ-/S7?G!A$%QS?]%-6_Z \S
MP\2^M X:[Q4X(V4-4ZZQ8R?VX9?P$K@W>).BJ),8W5+".?Q4UZ%\ M%X$=^0
MP[-?K,[PT?F'1/;TBL:;UV(&$FFK[8)(AE7;B-Z6J.'==?CUF9!E*W6Q)M$'
M!(XRO4-">LV+:EZ\.D$GBHGT)(1IA"N*!VN=OV3$HF;!,M%H0<>F>J0[C?%K
M$ / /M8,CT<UFFR68GWZ:XGR>"\LW?G)G_AP"O!DQDE/-'V%M"-/Q^$K%.;W
MAGM5XZE@OFV;QH[)\CZRF2Q[=CX_:34MM]#(#*E,-"15(ZX6WIE325[T2(\*
M+O8Z*MFBXZDXVUJ?YN(&;V5F.%#!UBM_^5+>#Q[;>:@&1!KJ6N&TC2%^ \O3
MUWWIHWRUO.\<BY*;44#CV,,I*IN,6JVUU:KX;CQ^9??=FD%?4H"-]]2:>>#*
M=GM_V:BG7,1\%F$PZ6!JF7<KD' J9J2EMS0^1A&_IH>9*[I1M-C0UFSYL$B5
MU6)'VB.UAV:YFGL\HA07A^==*(1Y:LIB;9)#RF5E>CE[?9XY&005>K1G!SZ<
M/ *9(<2+T/%5664M7_8:-BT\0>8=W))!R>7.#E2Y18IQ_[!N)[B2!\E\> \O
M;(XC%I?HO^A[?LG!Z.S%+\>:FG-IW3*.B6AZ6>O27;UQPV887=>_-1).T"+/
MHMDT(1&7' 6L,(BX/=G3UF.AT6=R[?Q2-P/JMN_ICYXJUW]#HR/"IW';\5,,
M_[NR#]4).-:33WF^?GULTRK961**E1#;WNZXT))AK;=^EON'_%T*<&UG&M&'
MYA18F+_3<>R;6GKBI.X=+XQ3WVY;8O[ 0W7'*3K)9QEI#RK+8R;A=9=N+3M4
MQQU.I2E&.L8,'HY<S+N4N<ZSXB]/ 9;GX/([O/?QEJR/]ZKLW)KO>&S.\7M;
MKS:)5@_5AC5^D7]UL/SYD"/IX"H!-T>Z%X).',%XF.'3%_$:QH)@;1%)UY[J
MZ'>ZZ:UL?NQ%L%@-]TCQ2-I!>,DGJHUT5D_/]Q?RMIUA5N&/O]MV]N5W7,WE
M6.?K%94%;C:,5HT\6GRT=$+T):3T%"O/T9>ZIJ&R;]\]]H_FM'&X7@E]Y/ !
M5R;SHQ!G!6:2*5'T^"',CS=AA1Q1KHO#$DOPY)"-R$<AJG(7W.4D"#72^IM6
M#UW=KA'>ZT*6.L;'R++$4Y,=HM]1=/7Y06/+O6I*;>'A,_;Z+,-M''<EM_//
MOW+OW.>N<KVWRL<_7I18)+H82:B:-,EYI!ZE,I[G&WLZV4:O>!190 'JY[=2
M61,)9[WAW*"Y:.X(-=R&(9:F(SX\=(FI,=TX]LK0VIL1=G-Q*_>NM:(%SIO7
MB"JDBJAP,%[A)?5ZD-,2UC7CBQ@P3:UG8K&?V5:ZY]C69 0)S4A^B(.=7&9_
MN1#L&()W.)G-'U%E)"GUMO19YNU2WJ<_7@I$$3BW1")1R,GX^3V;KWI;8 %%
M8X?7P80OZ"40W0D*$=5=9 4L*KYJ2SCG8N;R%L/*T*E>D;MQ^M-='@(92;=3
MIF;17.!*\9^.7] M+8T(7D:FU?NS?&])8= (RPF7SCSP'QT,,F.@IKTFU=FY
ME'^)8WA1-]4F+F=',,MU\*"]EW9>MMKGDG)8TV?&9Y&%QF9V_'0)BG#N;]D=
M8ICV3?[L_&B.8=]0G^-#S*.O!VO5."J>A0@O=:B0BM#^\.F=A;G[RW"&]0ZE
M#_ ENO@]Q_/DJ0O-+8X[H3[7?N@Q)U64!G.#!T/5N:6V=[16R7TVAXW\][,.
MGQ7DRVW6&Y7?./XXT\9C=L^F"U4WOU6RB."(Z2V D<I17K(.NI@;/K@"WZ%Z
M]-5ZNY2TI P&Q\>9G'<_#T]V9./-L",+._TF#"II9!@^YQ*6)T. [VMS3;Z;
M?KZNX=LTLYN=W4#@EOUR[<4P#BLK;Y/LQU]41 OE%1US5QM:J#+#:KY/V PC
M6$&_%4Z;+$VEN^.1F/$EUKN5&Y@="G"NOBW- #Y$F'-B%9U1V_QR4T:^']X$
MW[R-F3+[&((Z&J7SH;Y\F/6[NL"&U_:#J[%+6H9/]?;K[DK<>B.X=#?CJM/4
MIQ.RER(EAM[*3'_+KXP\>R^X;ZKYIQ7W2FY\/^SV#9NNG_CIEQ&EAK>[8%2?
MJVJGS))Y$O'6=G6OOF).7M=@C:CR6/38TB9H1/EA.DJ6$7<Z%,8:2"JZYOL_
M["_+D!Y8&5VU(@PHQYZ[ H&F/7A?^PY9]\!=]W)&5.5NJP2Q<N;M >S1M<AA
M[D4D,]IK?GIC6;<:%D_FC!@RP'+OX>1?EK3?'326^+2<I37VP,GJ EI"]>VZ
MTX:=2\"#5S]PMDE^')OC)MM7<B-IN,PN+R,HXV2RS$B';)3N*)F5*(U5Z1UA
MZU;J*UST%=^W:4[Z)/5HL>;N\] 4!:O/5O2F^D>V93[XK*3/%I(OYBSSDA+(
MQRC &,,+Z,&S.G![C* 6"@[OYGDKPQDUI4;\CX8;'<U_7BLW>C]329"9\5?.
M'NL*YNV."-<1O(S$3:5J_IBAII;4]IVXDCA9UPN36V-3YK4$+7^Q+R*9GKEG
MPC3[TVR.F+/2]Z+84!BMG5EY,I,CA@G'\E$#W,C4>-)CQ<*D.5I_3F\5<Y_P
M*0$A);JF1H[.%::AH,&$FD:J'ZW 8;07!: EDD?A-&C7G=CY)MZM$JR:^@L*
MX EGD24W+\U#ADM1K@Y>:)?<W0N-=50&!FE&;S4>-1U7>FEIG!>P"Z">R$8%
M$Z['?*8 $/3"X_DZS6:")7DT1T4A J7C><4ADN_.5$Z.#4NM3&3$=(:]'F+.
MW<K4+L%*%)7?> O<[L[X$6SIPM5F@B?1#+0_<0,)BU&#1K[XAF8*&8%Y^RY^
M)8@@IC?=%<Y/4G^^8YRR+MU7H;$:)F<S!8;9AD(X60/TF!%Z(1$)12\\GQ/'
M[AWJ/@A\,8LWZBF$^<H.C,M%Z7G(%5>6GRB(8:L/C+IW<,)*%/KNX#I 7D L
MY"(PYL-,9$:;!2'__KFC>,?E]+C&&<7L6 3^8LA*3;II'.ZTHOFTVL"2VRZN
MC@V C%/'LL0\M,&*$;QC/A1BS)!XL:E-=\(94(DS9&:B^VM\/+80EX65^*2(
M%MS@<9EQY+WXFH?GPW2W8.:7L@S9S][WOQYX"I;)^+K_J)XA], QUO)X%;T^
M)",%\$Y/FJ_OJR'H$.6P,6B>NTM;G#WW!BJ9!N+">0I">V?U'A8_*LI43G=]
M8JVG*Z,%__* FV@<,SD/ONR%E\AZ/:*@P?((7F)J,Q"[NK&8'E?5QNM^8R<H
M-=KK^:S2@V?W1]R]NJ(KO[RQ/I&GW4IKS>CS%KU0B<!8P-,1=>E;9S'I9/J#
MRI@QT+'T&BH+\W1>QEC>92JO)IN9U<H73!KEHLI]D0]GEH?TU,5''IV9/V:+
M>0/_\I.;J(SJ/()8J)R3_  J4F:/(G+>-R ]]4=[%]Z99ZM/+D?#(JH=Q[?W
M2$B#CQ5;J\T^=KD'/-<MNZ]]OQYR-6*:$:X VY?0HOGUS>C_9\U*H-WDXGB?
M__;QV^065>2:UIC_!:?BUPXCB4YTM4O&YU5$ZJ^@R;'T5?8[R_YWBPY\CQ4$
MD[]9D4SV7H0>;\D_^69)##.."MP,L7D?CA*2RTMF.<OY86 %K443K(+BC7(/
M)C_7KZ0 &X_!#7QU^"J636TQ<\EI77YCX'#P2<'JS,?PSP,UU>5L-%'.P<MP
MKGE4__NB,W2US68'S(QO,@W$?'=K7+]??Q%1,BH4,.".*]T7V6Q%"^ -ATBA
M1 GX9W4*L"<X=3H4Z]]U+]!_S83\_4K,Z^H<FQ+]=A^5Q!SMYT?$:+#*(Q'M
M^'>!39=J^HLRP/P6/MEB$A\C-TFT"(P(18J*'D?(NIQ__3[X<9W'D[WJ7#K#
M??G;\ TEV#,D08FK;-#"H%;ADS37J[& M)88S_T;DL6MZ8\8\2)DQL#E'7[B
M25)BF_,R*CZWY'UR^73C8^&V^GN]BC'NF_2SMD&G4BP)_(0YM#)ZH0JUFSX/
MYDWH$M1ZUTQM9<D9AYH=3(GJB-J;+N_UC\\KQSX/:1]X4H X+*D._:TT(ID"
M0)]1 '[$8AOJVLZAU-QQ"O!F'='7853<AO"26\/%XXXZ4 "M>@J H:< &?O5
MW<@9#S+C:6PZ$L5(E,'F)!//O>B%7FYO2'TW-O"JR$J^P>0+39;'9^N='G0:
M$F,!'KUFVL%89,]1-<PF+TNM5/7<*OVS:Q[>K<"SY5=GJB^"!\^YSXYVQ!#L
MQR^WZRUZ%X2<ER/>3UK;R0Y(ZPG?'N?>1+[J3]-4)=KBE;!Y.J3G2D(6E_'N
M='?\)7PJPPSD..8M$EXV\>Q>,H"EON.&S5N>#2Q($%]J7PL_A'/F+IW$7[0*
M%13B-<RI;5DQ])]1CVRQ_SXCX],P>K!& 5B6"1ZHT4M87C*= 5D1U1U!GI[?
MLVC3H0"WQE"I,241")P5*4V3ARB'=_7 QLYWAQLM#W/,VGQL2$7:M=9,%/.6
M\;&H\;EZ\CELPZ-61IB!:J;T1=AF'>$D>3@@*A +OQ/?IXR52 H]R]&W4GVU
MKK;IU:M<_:>!N)C:SQ4Q+AY/G%-\N^4,DZ_SFJ@-?->T/Q,]FR.*"#>60E_W
MG#5PR$!?[YV906JOML-P#T%/I4;D=9OBA[KG%+#1JP\"7_8_U0EE>3?,^9WC
MYEL_>M4??&SG?ZZ^ M,W)'D>#M.PB%XH%,!3@%[^JY7/!YV;&PIP.ID20@DC
M*[-",EO^=W%D3JS*IGGC#9[[RHG%\U$1K])DE;:%5AJ:,F?8CI^.RN31.0@/
M^'QCRAU[>E%^<WI!%0Q.J.1"-B(/63ZO<T[^5?WXD^:)[267' ?M$W4[7D(&
MZ@\;+R\+W-6T<S#@.S$N%W?<TGOAV+-F2U=Z)^+$HI"#V=R-O1\(1=2_+;AT
MO#]\5IV<%)Z QJB98*LGAN$X4=+##@GRZ!PW5O-^<2JL*Q?=S4=$(>+M<?YB
MV\DTNRS]P]+G?KP,NBTL/_A4]6A@1<P[=,U^'P40()X:TSCR,B)<>_(GFH-%
MQGXL2J;LLC?/N-><PT6)U*H,)ZD8$[&;-$'?YR;:\TU6%>-0W;M>T7HZ1[T0
M[DS:!IY;9-ZRMK"IIMX8?E(Y>+ ^F3LU%NH;WE5P!GNUR..)0W*EKJ?<2DC#
MS<=T]V[O5D6\K5(G"_3CWE. XOPE>2+K?:+/3Q_#CQVT%*"KE?2BC09S>[$.
MSX8WT<XQRD8UC@3Y+<>&IUX<'2Z4NUCDW)!.1Z=*BR[D3WH\VM1V8YHKX,B=
M\A]7CM'0"4CP.8W=<:^6/[514M _68B90S2&D[AVV%$+(87+3LF82-P74G7H
M2'(,SZ@2*O&H<,'8#YN:6,_<0^-JP?O':PMNL 4BH39E1 8*D#F_,$]@]9H_
M/"O-;8 ,_M3G]BBH>\*'Q601Y7*V';8G4(7J85I"U3W%.U;VE.</!?&5,P=H
M7F9WI.'>H\-TOL6[]F1N:(;&O?3'R9Z?N'6"^G:?:NA/[9F6P1^5YV)&L-J7
M"C2N+O5%Y*4OZEK#*V_( EQF.D!4$R&0 KS-(EZA #4B/?##<THQ1\& K8%>
MN ^O0VS1$?CQ LOP-"4DE\/WEB\-/3GLG[P+=%H>;KNG7$L?4M>=$#J<VAO6
MB2XP[L,32Z5?YKB/A:RI9>0]=O?ENGQ=UJ_ITOZZSQ'#%'>YJRAQ='TX+KW3
M!"_%"Z9EY+&CTF-MG,_Q77/3]2P>/06<_ERV<U[8'N[*)P?H %-GH?/YO0%A
MQ-86$X$H6!XN&-Q?@5%2I+(.P8BDM;[L><8H?WA22&MBR'1(CC',]+5^E:SU
MW'71T-1M;EME+<GIOC/5WV.6)F>VJ,/-*I*>G62& &GQF"V+J0D*T&-=OHD)
M..S(:L]][$_#F%%J/%;;(!=QYKRQRI;H@R]//=QS/F:W%/;J]5CC9PF*4>SC
M"-_(B"J)292W+&_/C%,KHX(,=<L[<O3M'D3;Y->'V%A V&8,V;#S1IXK9@ .
M%EX>#M6\WCR'L.X1.OR9$)O)G?K32[(RE[#0(\]:LWV4KJA<5B_2VW@P&.LZ
M0*[Q/N.<%)'+,*%VLM/Z"/4-EY;Y%"5WZZPY5BEYGV$OF<'3E[C&V@1=-[W>
M=LGV&?3K"7C*EU61TK_V6^!1BP((O$3UE@[V_F)\CPSJR+>CTCD&!L[C;6=4
MXD,^55?Z/9E7>F:N/V!]3GQJ]Z/NU[U9Y(?]31W,_4545^%T7J=9E!*&7%B$
M\OJFYOAQP\[AF7RP^JS($7%WR+,@6^)[@]6.FC35Q527Q/-E*0 M 'U5.C48
M*"$X.?RJMDOU=>\$KI KU#!?+3#9]*YJAY7)THK#5LE<_;<7K87OT#W5/.01
M>!V:R)V\%)^"6'CB)$0>'VUS++&%T2&17K[E=@=>S(%ON4P35@[>'K6VBC$7
M4.6XVL'S@0A9WH&C.F4UI7HQ1KH=R;IC,:>-7WR_H1&VZ<>I$SLI_^7LJRNV
M6JL\F1K$#B<#" -\QNW>.07=1]PI'D%?/;S6,];-I\86VFP.&Z0%'^I^/^<\
MWF[R91;V[+K7;F2:4?@[TLYUN3A_ELB->2SBX<ZGC0OX:.P/7#<FO0=<9DB^
M>E^;GJ,\'W;:9F6A;^Y'Q'R>'N:]]\K)L):^-F6QV+QR7Y7,OUO]R6,)N:E
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M>'4'%KQ%1G<44&_D%<I*+QRBVS?+Z_CTU5OMZS;VWUYZ[J0'(<G<4@1_NK;
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MO=WK?.YFV+M:\*+M4(&8*$8]KH]'QUSL7 _$L,EDS<=$VQ\IRWU<39\^WC3
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M\Y D!9,",7\>36._R09#M5(9=ZA=N??V0C8XZ ;J-WIJFLJL!=H6Q J>];P
M%<$GH<+(%MX*-4E8Y]#S+P<_H4&ORWMM9L!^[5Z_!AAAJ58#+Z9DY:1+#Z$O
M59PQ>+^)"6CI5'[)Z+A-/[^.OO[:C>R8O=[_<8GQQ/_'ZR;+S"SQDZ%5TC3
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MV9T\6:EFXFM9X SH\R35$=_G05Q$?P;V<KAER/E"ZBB0VW-/INQJ!1,UH*V
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M;9YRS,A-\C20N!W87(@?Q3:7G$-:IUX-OG/Y"GP.P%^<Z]4;K^=^'5:HEOO
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M!S.97/MEDCV/)KO9IT)M=0M2K$DA+&@97.KPZF'ENI_V+;/)TUF%5X$EQ95
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MGI/@ V^:,UBTBJ9% ]-86#D[A>P*)9T%2&G0?_\54@WZ)SQ780/)E.&^T&:
MR%7.P(]"6$,6?EUV+((67 FFG(!2])R7P7A]8*Q.=:C8MT%)2/WRI7GM&7O?
MU\+R?/JLLZ^4[Q/NEQ:SLWD'F,2FAR7:PO; _HP_?"$+_5]>U3'X'Z'FUE4:
M*VZ*#CI+6B7*#:G<F(J[O&$Q*#[XA$_FR8.@J+=B[\3$'I2"3F:<8G: D9YM
M0U)#''@7:_BTQZ1>4_HH#PWM&(Q_LIQ\<+WK!$W:\3]T$&D(C.^"5FQ0.1D2
M;"IS@PZ*,P_K((.Q4*P%=(\*IAP79E</:J?(]Z[?I(/NSK:"21)U=-"L"=!\
MB<8 3GT5PX/5 C$T14W1-?"_SOE_SA%<_.OB-K\\,&'05[ARV771/+@]/N5C
M/AQ"N'06[Z;$H2V6IM>??;XGM)Q3&,14L,0,^"8O/^#4,8=F4MQ;C HC&X,N
M%EA='<L;OL4(QU"W*0K2!+=9"4HR< 8859VE@]04R;JP#!J$FD*[0"IL#\1$
M*FPYINQ6/^OF2S Z-?)(X[9QO+34C\J/VQ2YZ!S58DTK'2E< >$1%?O,AWNG
M ER:U;( 1J,'.&E8+8"8[':'?#9@@&F=OR&!#OHFR)#[V;74C#JPM<K&8<S\
M"D2))I6TC:J:ID8KOO*&8%B!ND.>U+=F];!2>7NJ:$O6*RQ Q"V;%'25_E A
M'Z*#H% 6FF9C3/\GN\K]X^QKYA_R#P?[,6#?CQNVXF;%/MKU?96&,45[[L(K
M&<)$S[S<Z5+Y&H\VXB1EY9:Z)*H_'[#O#9>;^N&?_V,GX0I4J] ,/'9U^A(L
MV&..#@KTQ!L:C%U-LR3RY-)FMP081(KXK$:6I0C$;"QO_J!M;P(:W(7L:[/X
M1^QUV0Q<"W1)WVM0U,X8Z/U*Y22G[F4E-C,"M,*='O!+Z+$/Y#0V#'CR-^[G
M< ;L&.1L\ZX*]&#2X:7U7G2)6J;EQ.4WP$L2U4@<\4,-OSJ]@]F/.V%@L.MN
M#R;+N*I/PTXPV"!_P-V8.GH?T$'\;+)L";Q-L0 'EC0[^7O1LB6 79.L>5AE
MJ87%0<=P1ESN>[O0)^@JGV,U&7RPAP0"UPP1RT#,&M0"NP_MJ=)&. ;L(27
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MEJS[8%LKYV I"=;9&<\6 <:@M?YBG*2:M7]*.BP[2XH!Q'R1*3O@R>XZ)&=
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M%;:_-OX)OOI@Y.7!BL#2A($66.EN*_L1-X1TWXYG#(S'ERP49#5XX:KULJ&
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ML[)E4UCVR27@MH*A.D+,-^P?2?VA?^59_P_,LS)S-U'N$TPRF4GN*%*_0(R
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MY'[X.HL?RKFJ6F1W99;9_]";_F\KM,=H%MHO\!FHPP:VD/B-M$O6'%W>S93
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MHL23A,'G"#20CHKX">MA7 /#G2@EE+1FK(UI#C5QG5)Q''( FPU)3 @; Y.
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MK-F'6OHUS/F*:'3\P8/_VTWEOTJ0__=26>.Q2VZ=LA-R%?D9BZR+VC?0AH6
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MWC%3*)Q^#=(?DXGU1]OR0>SPX(;DGMY^!:1/%,L**T]GENO+NJ'^I/W%\'6
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M1]XWE!*SWHU?_W1!;-YX,6$5G\!:C[9%QA".*?E4.?(%7,Q@)*YH\#55[&U
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M_U^G59+C.1B?5?6Y0T6E6U^:U23^4TS-_YU#_'?-0@Q53>Z_]RT^,>DLIWR
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M8?@(@CUQ< T5&UOS"\;//RFIWGO;[=W"_'QOZ 7XVUIYQY0L"*[_6-SG2=@
M4K6MDQUCEVV&E/+(]:/NDW\45BC"F#*HXY:HC#\VZQ(/L11/F(:LZ0$7R9+Z
MU^<)Q LQP\=TY2>HW;T&N=>6ZU4P 1=.)3J/66J<5.Y)TWW8$WA<F>>9<F+-
MM+3^:K/O%(#,)'00Q]<,%K1Z\R^278!O&IGB5[C@[3,;[+[+R*H>I&#RK3=4
M?/*FZW.P]:*ZXSESK9X=6/UG$V,TYYB,3Y91LHB0B'F9B/XIX"Q)='O#>;Q2
MRP-F"6Q"!@^B(E\U#U#4"2^GCJ+2!K)MLMLZ9G/6OS$$Z0_%BWQX^@CJ8MAP
MS_N5Z=>Y?1>2-G2:>NNOSH)UWU=QPR3J8WQXP%T0R2E9'KV'&&9N*W<A;%:-
ME.'E!4YFE82X$,7[]Y5C9O,;FK$B) /H-U!=20_PHCGY81L>EMAY^[<;89S#
M;+ZXB&"IS2[L.(F]F6AB_ZCTGZ%E8<[$HLP1;#_8_&WF-#]]^4;? &^2Z7%^
M_6:9D*O;):E$?^4%4=F=C!L>T)A#J<>&:5ULPT21P97SQ/1/)7%0WFT3;FJF
M@*Q'</'28. 91_1[;5:9C5?,>>(X#X(7,8?D1MS$V,;"G V(VI 0D2C(@T^J
MLVEK,%:BWN$BEL?H33<XZ="L..EQ]V)'C."%@:M0T[^%_*ZHIIHWB-4TJBBQ
MC"0&#M\TG_7974%IXPZ##'7^O(S;Y@AF;Z_?U!-TN<$%7MP/GV=+PXTL_"C?
M=B@;^%+V\!I")MZX=6=]277$3Y7;9".=.GCG*+$*N 6<F6$C?J:1P&'*EVKH
M#;+Q')4'G(E)CC\:M9C3T2U3$5FK8N%3,&I(<31.Q=S#C!$[[?(,[UE%Q%%J
M:F(P$M%-!HD9]/7MVLI(0SVYHO<%' <ZRSF:TS\+J_^V@F+X^A\RCOY/,6:E
M2!,OT^;Z']C.MA.N%U,'SNS)]B$4SK';W/RAT)<Z0M86N"44YWWNC.WKCDLU
MH_1_F-#!6$/\WNILXBG@TF;OWK41MQ)OB:9)+;:^QY9I7W62Z_.@5F<]E%)^
MFF@UOOMYNQO#IY,TX>L[*6;=T"P;,%68IK:"]Z%A?X49Y.4LY %>DS W^$HO
M,P8K=^O(X)KU^ O&!IG6.&##);9U9\KBZ[B+:P?\?N)3:KP0*2)LU0<YB$Z.
MA_(C+;<(5*&)P"NQ53O>%KO?=:^SB+HZPCX4G+U]]4[2ZW73GU[Y6%7\Y/@
M=V92CFWJVM-9>_9CA%N<*#I;B%3ZHXVSJ0;W^O759?=I1*/I8"O<M("(U M5
MRGO#,$M@#<N8OV3?PAEX></SGZ2+&\I:3TSTWV,]#BE,145]]_24XBI=O_W^
MDCTI6:$'BB.CKF9X;<_.-L_1!$[G93(CKJ0+14<D82Y4QY>.8Q9$0LL:<S4Q
M0^KGI>M'&J^)G_N'MQ9BAY\J!O7F1\/J&DMBX2_0\SZ'B?9_&+4%?A3-[98T
M3CG5!3"8CD6<&WNV>'7O_L.CFE0H+W42Q=UY'1Q&%EW-=1F:LC"XY[49SO-A
M+9.$CTTA (]]1Z4C:"HG.1%Z@3K%#YQ]V=8Q96LMU _GN'5L,/NT;@!MNWS_
MEUC'Q\;I]9)<IQ2SP!V.MLI30# 'P7/G)%,.U;$G'?QYG.R/\YJC)??X5WN1
MTK)1/[+'UJ[8I^6D1RL\_<5NTOWR:?AEP.HAVP;;#W!%/U0 /TA3 >:8Q6'I
M(YXYE,K^Q_J/ !   +@*X.0U!5E*)J?VZW^LT#=*_[+8M!BPJ-?N-D]C),YT
M(?_#AP#41U1VV+ ^C1M$2?P+-SA:L.(<G2"91@&[^E\-[K_0N&[*_.>'Z4]4
M/]/)+0L$!=(!3?U_GGGH^O\DYA"O'5&N7HV[534>_S^MC?O_YF[WY\8[)<@*
M/Z@R$ F\=(\TZX@*MT]<0'O'S=^Z)L:Y_W3$?O;G<@J\RI8T:?Q:]0&OZ3!4
MX5\6]]CP>SOU:*8%'K,9N1:RPFI%CG@%SP?GU[:/"<KD6O$<?RZZD.4F(6R"
MZ4J#:=F;,?R\8H^B1;68S'.3+<'*HFVORR\- J P,NSOLAQ$@HC"A\%<@5?!
M.;0<>Q7N2:AP"*D@ZCYE9[59%#Y;U"5ZLW/FZ1D [X6QAZ5\TDDP.T0DC 7A
M&$-)4O&M($88_W!T3&FT'$$'5G*EKF'5?)#"B7,AD A21_OEIX":IE_5+7A]
MS\\QQ;4LC1P<!G K*(\J%EC79"DH[<(7 +H+E81UBYP"G! )^6?4^*%C*T)I
MIDT3:MR^Q09N*LS+WZL_/1$)>O,N=IXN;>3Q?N\&4K%F<L3#(U09C)5DMH\3
MNO2V@+Z\  !0 B@939M*@90'U]QZDJ3J/]IMWBJ9&#W0J\&KFJU=JDK!R?^U
M/]LBBGR&L!#S<>Q31K.+6L3:"AL/)?BX"M M.G0Y9W8AJD7CP4;BY\F'RFG6
M=&]A=JA(-:$ZHO2+L-+M2_EG1PM<U:Q^G/,EW/H<JS;WX2JY\DK[M_U6$<Y5
MIB;7ZI)^KHI\T*Q0://!>]4<F&)H9SC!=P=J#8Z@7M;"^1C/P%]ETR5"7-#C
M5R&/,WYN6^ (*:7]%W,E9Y I@N55YUK&_.M#U%]7,L"$7LW%(%;S01<A<IB:
MB$[IK]-'Q:U$H>+QHE_N!_<=6J(QP!N)\]?.[G"49-AS89/$=]O$W>$O/LZ$
M1^)EW$<#%GH7VK>J5D^\CYK"C3ZU ?D]0%_WNIE8H3]61"D%<)/,5]4%:TP,
M^9=_*WE-/4)ZN.TX2#:>?_AT1P"0+YO ^EIQ,&X1UBV.<(D@R5I"1[@)-1A5
MVP>3<JSEK@J9P>\2=1]]W%?K5WFJU7A&XN%0'4/SU\$M+[9T?O'1+4WFDKC4
MI^L;]8L+Q9^]9_6JE)15Z78*YHDD@COE'0UR7%0=GN&%4'U +N*QX33V2[T;
MQ+@\9SWNDO:M6DUF9@,1B0?>!@+"G<$X S*+RZI++^H<N 2=&0EW6 L#]:X(
MPJ.I*SUSYB05"[WO+"'#0N^2A.:[\2-[Y\766>*T?NNQ&6*65N3$C*-OE*CI
M>YB+[% 96>HVMAS;CCGJDAW0T@N+A(LXIBY0W'$^WU$R.S@?0Y=0W8 NZ*\
M%Y_X"#=]O0H<CG?T?7V%(?7!O;$[K?7'7M=-L[*</U2&^?@DE(V*"_W*&!9R
M3-U)U= 4$QNBP>SJK?^(6OPOC^[_A3X("RO ;1,<<7SCW?'222!N%6.%F(9$
MFY^ZELQN#D);WY\,V3S+?^G]$#"HN(V$F_8!Z:IW.X6LP>=6^T>(NXKICM&;
M3YK>[26^YWW?O=BLZ/V8+F$.24/^Y#B5$#0L>K8 /=YOP+"%T2[RH&$L\</)
M[9Z[LPHO6B.DO_?(5.P:Z/\\!9A1L@,1R3:*T^0+I6:6K1-5Z*9&O0>'7N+/
M.I<L8*@^?&)\DXK4:G57_JN?FZEI:L<D'CI;NNB7AA&0YO;C_+;%#?=G)E/>
M&K>V^&QB^F"7$<XU+,1!S")9F!C%AXKVGNS!',9BA]*N?7;J:4*EUR8DB7]3
MX<,E8Y+[Q*\D/N_JY)^6"_70%\J87-[04!R3*> :]&[\\QMU78U# ^^ IA:!
MWC9$L:NQS7A6KW-_L2Z42>][V=@799[\-.?DQ92J01Z$BQB_RN=#@.!,8M$C
MR_SC9KBBOKU0CW(/?]=0IQ"%JIZ31Q*K2>WUS;MOAJ^'FOO8(V;@YU(+L$T_
M@[>%W$TL55N+&@+K)P+(PSA83W(LZIIS2T07%3@MYUR/@=4MPO,,^7)<>_(4
MZ;+7Y/@4GD[L_9QL=!5L;&UVX/WZK8B/"RSV[>4#_O0_4S@29BQGK>(4P+$(
M3O6Y? JP^PT5\-B.OSCK-.DMD.[P&+F/?%GV<X"DBQW8^>.,4%138KK,E,!_
MT^?L;W\/I><V0S]LENZE:D?X?;=NA>7\<X?4FSW)ZK50T/5]_Z,:\ K]H?N!
M=>-B1[;)HO[NHFR#"BV;5QGD_T?67?YM:9;-OVWZ]S_2D?_$@^F_C-W_%P*A
M__]J_[B4".T%8%MU.%[Z[>Z7VJG#7X*MK2U9X5H,=T1=@ARZC)]JJ[ZNZ2\%
MK=8 6:D"_:7$38(])8]LN+8'<$L=806_$2%Q?50_1JZ@AM(+ 03&%B9X.1CX
MQ;:9H]> DVQ/>0<5@-PA0KB.JEP>M#?7QSY^+MLN<_,\3F4I!((_,/T)(K,B
M_AK-<9+%*;$J=VD!FQF+A7!@F,Z:=>96N!Y/P$WM,<LYH5KLRY-9!F,/SW;'
M/CO#]L> WO'#JU8-SWX[?IFZ"GKHZ+WJQXK-8S/"A2?9&TGPLJKG$[Q'PM/O
M?1RA'ZG?@4T*W4 D8K42R-O)]QOH.*4RY1%R\=.SRSO>:3R?/WB+\5QXW'OM
MVP.VP\:Q^H(%JT5S&VMUAKDL=GQ[>4.[;^YKRHYC0,V:I3G.-D%%G48>^RF%
M"#=E+^ZUQ[B:/A^^!0\EMH^QS2.UUNIJKH83=V7Z\[*2D\0/+0FQE$*U\Y P
M2AO,81$6P2\V!=<5S@PITWN5#1FYT\CQTN)MAG7KI<UOD(&7V\WO%&M"Y7"=
MR7/N80\+.^(R;H""<Q9">57$;WW3^;;[+*#-@V>[EKG/M6;C9)X:+H#7BG;^
ML*A>BFR(!RWH7'Z:HG@*R "/H]9VC]:*;*<;514TOF8:STK=;&A\$ZPM.R:0
MR#%=VW46D8\@"L?L+.+B,=)8'])]2 "^*K*9>@,'ZU?U"G#QR$J](I_J%CST
MM:#2<_?2L[&J_=<7Q;>2B1+2O>.,D*=$K=6:*]O\RKA30*2//5Y0H<D"%K<9
M&L9C$6J6F]@XI15>E@#IB]KT5E=*V2?F7>N>&O^UGM+W;50KSV8<#;]'F1_0
M&Q;RLI5L;-LPE36V%5%-GM5CM?E!UBT1KD&/S$MC!4EIEH_K!N8/G02-55G[
MJ:QXB6/V3MX92>F-!J_ZHH9A\4<K"==S2^;G]N6J(/:SA[;SF82W1%^<0-<?
MTS=DO4\H5Y>^/S%O&B]+'X96J>W4*2._ACSB,0[Z5GH*\,T)FJRD>R4+G!]'
MNV 52'=M3@'=TD<1P9@J!Z/F)OQUI<#U9LTU+9@T5N2I9O"U%@.Y+/GJF0M-
MB;&V^F1A0V.CBE'E4?5CW_?/HCAG.\P'"HS6%(=OR8V&(6WIQ[>5W2A>GTF;
M)&7H0IOTH,_;?'8X8YF;*'I>C<VC5SV#$-H/WAUVNZX=P6LO\;[+>G2N*BS&
MO^I7DY^E>G#(>;U708L50^5.*B]?Y^<TZU!UJ+)F*[;4L5- \X[\'=G*/)7)
M0K$(0<%7Y?7 +Z6"?\[8ZE)_ !M@7?F)"%Z$_2@=6CJN8>^:K5OVS,>Y)L)=
MB4D+.MU'QA^D("5+"?)JG Y%*KV].L:U]&#A-=T5O5NMM_SLMDS;@TE^.4E-
MNB6.6LS%B-DFD!--?B$1EZ!B9#O\*:"KYFQ\?/(ULIJ9VH^Z!N;%E8X^/3')
MRCP/CJZ'O'6EMD5!B'JM 5M.B#.1IYAL2BQ"OUFUUMS& MVFA.!)>*_)R];G
MN-[=1*>K^Q5X^R[*$?E($F0&RGLH*ZS[22<(+!5ZA8_#$K?1(+T:*KJ[KCV(
M/%Q 'N_\VG>&]) ^W XK][LMOJ[+I[\/(@KE[TR@D_E6;-Q0EX_R>5&+1"3F
M1QU3'<SUL8,VUSWF]P<YOU^_-C=IK^7GV6C<Y%4[ZY?@<F2I\Q(R6Q%386(5
M:[21J7"SP0L*\Y/1MM$V336%PB(>4_L;0-?!M"D3,@.7*T7^9H_3R:HJUG:X
M\"IQZ#&F5"$93I]OSUAEQH3EV*\"33I02!&)M634O7%.J[D#6YSS( %&#*9!
MOE1:URD IQ_VP)O*YZYV9EH$']69%2Q$S;R.[P>]PVB%T&4A=M:B3X+?,7W?
MMN5P0]2!NMKSB3<^HAH;_EA5X<\]@3.ZE>>4'9QE=/-2*5U#;4B$\N6< <VR
M+'M$9T81I3VT3?JG(]U'F"Z):/B7O"64BQ6&?5G?"#BJ3\=,Z1I27BQJ-)X"
MSI$D\73Q$%'TK2_Y_1:YQ1_2FC-9K;^_B_'9K=Z7"8ORT1+T&ZCKZTYY+:;U
M3\04&[D'NJ1&/PD/PV_VPKBE((:XXX%7&YFO&S:FR4SX<T\]F+F71#\L+31G
M,3PTOY-Z)3QKZ0'#!\K;4T"X _DQ#MAO,!_3114CNJ#+5&X47)*2M)O,"Y'*
M..>EDH+(E$6HO/U>]#[OOG*HZ3<7. <O0OAS]L.*G#3#U U#0[]G;AY2P84!
MD(^IEKJ/\KY6A"C.$T#A(&[:S2@, J_![ZS9TC5'2T!NT"B<RU9S52C;CQG)
M+A#BTFO.5^<:ZQ/GQS;L5)H)$91FLCC.8!!%3V9#DRZI/.?H&V>IB:;.N4'B
M,EC8$W7?E?WSKB;KFY-28,UFSEI&*YZG]Q1P$>'-DQ_SS( I%\_]#?4\=?'&
MG$$&)C S9<A$V? /8V3$@(?' /3*WZ46\%U"%.6] R6FT4-W<7&<?2O5@QF)
M&@D4_S)*ERFT)"U0>7=72A[-<S[!ZQSPTPN([ BU'KM]H)/S3.<Z6NK16F24
MY71^P\^H#5E,QX9P7IR2!/\-Y,B?V<&CV IP?4_;!6Q35O5ODPQ3CA(O^//O
M*?"2";:WDH=LKP[,)PZW2R4"KY3:96_?Y%P/-$GSL?ZT[SO@.XE(8KH.#MI>
M<\%*DAZXY3>$$P'$8I1Y>WU3/N8B(J3 V@WISD$2<(OG=19.%)C_O90JOQ'4
M/'HXUY\<R?\/,:(2VG,*H .YZ?DM#L"0ZGTF<]D9*6%WNTNWODMRH[R&S)SL
M")T6C\'.)ZV;<NLFN!HF3:,;ICR5!:(Z/PPT8M)#IXXI&[O[I*6<X@9DAC!)
M^C<!5+2='VMS/J*7.S,>>^2A6\$H9+4TXJ/B)^'%.?Q0W8MQ_JR68LW;F[0A
MC=B"L9P"'*9(IM#O:JQM^(0JOZ\:GU:L+;>:7T GO98+E8N-SGG('"W1>?N>
M9.(R"<^)HFB?Q45""B49(OF9C1A2 19Y,IUSW[S8-7$)Y))]LPHQ>N(4Y,1#
M7&Z M%B0?^-J8JAGYF'=5R"V-6#F'8-DGT;K.RK/WBUE2:7?F!%B5PL0&GH;
MH@&O8PY..!KD3S)$SQJ 7$C#TWY5$1MP2:!3;'QZ^:UI/<\IWXS?HJ"P%E'3
MS%5:>/VY0ZE K'X^A@&HXF#U5;H>U'E83^A:_G7D* 3I0^AHRF3,A=.;PT>R
MU ?A6*_RH(@D)C&F7P8Q<,,75403)M9Q(?BM'Y>]55HG73_9M:9 9DXNJ;\S
M\^V'J9P">&A4W_8UOQQMA/H@8A-P _10-19NBA9M[#!FF+K5BJA/>L%0XI%8
M=/X.N2)*.83/8P,8_V>PSV?AU38&168!H?OA7PSB;,2F''$.I6I&W&J=J"VW
MO E-@<=,WD[>"]6!7?=LG**[7O@M[-OSW9HM7<_[FFZJ[T<5B#-ZAA +]^9(
M2WNE07+3:)9L(C-MOY!;OJHG0H(J#S%&3YX"7%FDTQH"E0^:SVW;YC0C<$8&
M$7\&=SS6@(M,:&A:2(4%6&T5.5)HJ\N6/EU=WWO9SD'AC /EE]C\O8';XMM8
M5H(WT; 8.A9D6S?VN43R.%(RP+7AGJ15 S2LP3=2.5NFJA6?\4]$6C953XV.
MJ+PJ'$&C6NF43](T,1B!>6*:^*+,DO*Y<YD_\V*!TWI,L_3^@. 0TU>G-UQK
MYP96D]B'#Q1G<J$A^_:W?VB+B^@7+MG*%7[TSJB"*%D<3Y9/O_?R_DYMIW*1
MK7#-?3Y7P#!3W1P//0.;22\YP^*PS_R86[OVYK[-&_8<00I> )*I1R6QOJ>3
M-P\YU:>46Q39G%AWOB7KIIOEQ#GF%A(]U0$J!!W)OPAS'F>A#@"Y.Z^Z';C9
MW,(;Q,)5W2I_7_SMMM&91)$D[]T=#>*-"3PY^[JJF9.>[C59Z\<N5 :Z"&RX
M&D725E]53K0??Y8ZH@NZ=K3=P5S9X"03EM[0S1+R*$3-*@$5^FZ^MVE/EPF=
M1,<%JGSAZV<&U=99&5/9&FBNJXLO<V$K^.G?T="X #+ST*1A_VN8/=L^K"=_
M46&U>0"89*- R2>+J Q7@1FK3 CFY/2F%M(SV8B=[W7UVK5/][Y)(==. :L?
M+3CZ$(S0 >BE'U0Q<*8^/HK247#%RT&W-;0]M((]R..94*KB0MQ#D[OIXR/C
M<L31_^_Y>U,FB:W+.&2404-;!^QJDU/"4^)>&Y&F5US@W-#<SKX!-W(J+)<;
MFK/=!Q4])CNMGGC-[DJ:C'YQ77'R56*[TW<_B$X16?AZ\%-%&C&Y=[9)_D_N
M* 4>-*=A<MG"F'G(RNFA_$L_)8<JF"2H%K&#P'6B_A9O)R-UM2<WV_&S-6@@
MZ]8X^)A5>V->7:6PFT$97OBD_Z?\])*EB KF*U2%.@D\J_8/C0FJP)P,(M7H
M\2:Y9<02;;QT%",AW4>F8[FTMBE[Q4'6X0-AZ'<!5,%%/,5F&]>6;A7X1)B)
M^=Y WDTC$6DG;QNSUGOF>J1.;#H6I??V3W\Z<LO_3_4<+7Y]Z MEP/G/&J=,
MT/"6Q.GA2T'4W[L"(O,FN!NOG=;YT\D9T(D,&HE@I;V/8B [7)ST" D6>&JM
M-CL+O&H)>31;?6C)&="<K%S)?6%^#!4R;/=M,6X]>I'D2PN1,EQ^G\]YZ""W
M=#0\#%,E,F R.V>J^^6WA=SV;_;!)XQO,0?K<<(.#.&/\<WTY>6*G/Q 9IR0
M2H7HYP]A+MG^1OG28H:-C_VKM465]Y%C^,2CC3:-J:I1*4M@P7M##6B ][_5
MH[#_ZLSU?^1JP04P,!'D9+ 0@P'%(=!*Q C<=J_%S\9W>D?4="_?E_V:%[?X
M949?7Y315S8UQO?V9Q^_AC+\7^R]9U03T?LN&@LB3:17B0H(TD&:M-AH(D5Z
MCU*D"0@(! B)(KU*EQH%Z272I8:.=.D0:D(3I"2((9K"Q7//N?>>\_E_/YQU
M?K/6?)N]9\_>;WF>F=GO ZD;T.#,-&B:KO<4(/R=M;-#JVO<]<2XF#<[]TB(
M64AIR31O6(03N0A(G&'X6?I#7"8'4DK5+#!5++]S1.VQA/Z?5.$ZVZ]"566^
MUO??YE6T?NJ_-QH2%, F8]K1\,97?WBAZ-*?''?"8Y4&IT>Y 2[3V8?OH()8
M!(/A&IS-+2 [,LZ?=J'X2_-;X884?L=AUP_LMQ,5DV./$/2P86"=]%OPXYPN
M%+.:0M'@)T/AV1SAQG1/_HS4$0ZG%$[+'JT#E@MR[W6,F.^#A:$,E#;$^OC^
M,A:\L-X9R"M5MZ:NU&U.O3[5D' WVZHDV^IZ0MHW(5EVL&SD][=ON47"Q'?
M#-2%U5IX NR64A>*#OKPNS^0K3+A\M1:>\)F$)MJLDQ :_65I[J"U\2;6%*W
M/S!@_K@+#_*F/-VJC2\LS 9?R5;=_Y+V<?P%#M&3%)5_KG5&FLSP<0<M\7=S
M<777V-*Z[^5<IK'OE(&CF9Q.[]%AAD8#L)<Y$GQ%0P(2U":,U[LWU:9;U$JK
M&)Q7&?C*RSZAULSYVYY/LOU]/"UAB)*NP>X1/![9(00Y!3R:4  R!P'1G$V!
M;OS?^=)8']$#/V0^X#&[+QS4!YTBV<&[C#0NP$:!@'KIQ)6KK5-D/^:8 [7V
M6Y/C1I8:<XR&M5C+)6TIS=:K0G;-QJ]>N<N1H]3['4I#K2.TC0L?L]990)O,
M<VJ)_@9_M>W>CM&YCW^%"9"YB0]QF=U'1!$,/.(8R>QZ0A,_:^V?:_[]L:VG
MPP[OF]Y$NNL;/I;_)!Y>'"[\7-NJ\\>"PCLN?5>[4VI?IGOPNEUE9=+BX;OZ
M>IT2KWNJP2X-T)XJV'Q,&?4[^,I+&!^DI*L)P4A^6NC^-WU_>LZ34B8S-6FR
M927V/H']A> 6:PD]\N15\R_#,T>ATF^2I*%.TVUPVCB%!.EN<QC#C$M=8TOS
MM+G3=#UQ\VK1$6Q?[>OG%_<N63IW+I_Y[>XARUB"-2Y"M_^Q7&FJY\^[)H]]
MEH>SI?54@QCR\_9@X39D+J*J&VVT9Y6:2*$F,"[K\YR9Q+.G975AW,MO$"@A
MV<'4 %^/6%S3WB>2%%&0I$IE88[2X)FRT6DA^<?9["C6M#?,71B+"0_2E2E7
M*F-Z<PG",0U974=VC4>N "?:S-91K)9NP8'17M<;IJ1$LLRDMIKM\$*@5:E"
M,:Y2I,Z,OZ?X_2DIA7;?+7%Q<1VTVW9>KX\F+V/='44.LWN#(F_$MZEU'Z;"
M3K8*U952C#=M&W_5GD S(M B>;NH\U1Z#]1502*RBOA0LPW_2):;S3R[FZO=
M,G8/?>LVB@]FZW*0HL*+,"2*X[QUB:]/ 9?ED72NLRNLR79\CV*[+T[%?EM<
MXGL6)G'G6J_GQB][/UP.H8^2 5.%9*QWH6C;0@N(468-YH'U=2W::06A6YJ[
MNZJU3O1D+-'L+"8JXN?V94F!*]!SE'PD^>K*A8F2QH0#?_&XR!G_#_&>DB/9
MSR+:"C?*%1]6 P 9?[ZH+P&978@?YN+B,?SR'+I^OS0?B&,F]ELW= /=!^7X
MUZJV8)5D12(S3F]M*RD0<PH(7[DZT:;@6.KG?RG+D:G<L!\$$31;[1H8S5?>
M>0"]1.0#]F@1)8'OY(5Q?KF-8?(_?8K9MNB:&Q8V3@%5YPV;3_H/&D3ZD EG
M+(IZ >(#M</G]+8$1K[>ADO=;:";/"=X"O"_P-_J2#1E2YQA[CI,/*.<9Q@:
MR 2*UZ"'9!KB%7/8\Y^D6CZI_6-\+B^Q<$NK_PKWA<1@BSCI?5UCR)\0 P/G
M0]+LEDW(HI]4]O)KZ67B$W@TN$YD;QWO]M($&_6F#81EWON6P7"GU*WQY-(*
M.ZFFW^Y*+W")&^S^>Y3YX83:G<)%2$A/P"LW N?32D7"[$2E41]OO%B!*'TY
M+0  J&;#CO>CPA'GR-*G +J2?C"+)<1#;^6F3=R?#(X@YD=/CD;?GIBRO9VL
M4>,BZ9 !Q!@<]A![$@9U+MS5X)KJX6LW$/]*'?7\<NGYG92+FO<O1J'OW2PV
MK1.;M]3M_UPJXDHVH#<LV E<<!?8=3$I(@L233XUMOV5CI3/4<2;U+=,A UQ
MGP+J[;H8YVR,@C8BGSW)J4O]:1^*02Y($RQQC@O#&%#D"M<4V*"=-[W09H>S
MIJ$=N_X2G\Q]^^::IW^7$8"[LQC*2ZD\"PX(-)=QZP2,CKBJ@Y?<CSW,1P]M
MVCO=\T$-8V)=$CH]=\8?K_T>)XH"]_0P%>!&#P2[FNI+Q,N,'J;@G(A>OD?1
MIM">%YM+/O4N50%37=M#E;CO)38( ]<BU7W7Y6!/6(ZK/L;C1W!);])"(<&?
MV%=M0\S!CK\A@[">6A,/-/W+SY; 3^Q*7,<CQWJ7@V-"=8\QT037:C7S^EJ(
M!6XEW3\4X[DZW\1FU7VTL]A=$9H^M,4T%,N<V73CWIYX!+&!9 0;.P6<5U,O
M)E9@3^+K\V@-9R^]%&YN-I+*/-?T@.N6)J!,XN.;R[\Y&($-AGO+_IC0"_V-
M,*6)DDFH"2S;/C60 ZW+L;R7*]GV\O,[*<C"].N^Y[P\O3^F<AW-IF9E)FU;
M-5P'BN=:[*1]2/G:199D)6)0,63E!.N5\W%GEBHT_5'/IMU:W#+E+T2P?WXC
M5S1Y(J":O>;"A0NQOTPI:7#G^>-]1VUP))6+!(QV3@PUOO#9^@-2*/I *TNM
MO9;#.ROP0N2&G]WH:M]XI#F0K:J#P?YGA@^D]JAW]Y6;_G4NPQ>5WU[0S3US
M>HYPQ^F UCZ":LY\^(D,U!BWJ-@LDNI 0PY*?_?R]Q\M3#UGI\A;L_">[3MS
M3/1(';(8G!YU:YE+?/-'LUWC)<SLP 07D+&#;P4RUH-57XVJ7X ^++)I*,HH
M)23S+7H$?)/5E 7+"JHFFEE>,>3XLX\C$:X36Y'4I10J&E1_&'/<[FO(;+.\
MLW)ULG[8\/9+3Y$40\GB]+ L(9TB_Q\P%R$9 #U)I O1P+RWC>?":GW"P3OS
M%2<:X&P[(=2I8NOE >'N(&V/A/(@V7Q^J0 !/HXQ8A-AC))*IL4+:S!#AK$"
M[XJ)6<L.*M"3Y,]E@NON(.6$1"V.:!'!\ZVUN\U;'+,]SW^,Y[]N!G]=2A=!
M2<ZL\XA4F.N#Y)P^[BT<ST!L$;5G\'%.<JP]2*GGD&E0)/8>[[!B^LL!HW.]
M'[Z.P-L%'"HPOWX!EC5!6.U]:1((*H _#S'!EL2_1ES9E;/L^/S%G>NV5_^D
MG.F0TGO%39V_\?2_V_GL)M4>?D)#,C6_ZL4Q_!!L#O,G)3'&\EB&<%Q/<L??
MX ]@S:[B4-8*48"4V9BY% 1X;-@G/4R=U6"%WL8SJC!UH# )M_Z"&/29^F.;
M.(V^R>]4X6Z&&'V#1L:+SD_LB[^-=VB&QR#J O=.\(6F#;-4:0C?/;SF?DIX
M6*B%0=B!SG>_>OG2 :^@Q2DT2@WE"2>*C7=+OT.=5]->EUZ(ZX-QX9/BR.J!
M;A=;G#*!KH925AFW^27DM,;8E)?B3?E?=)R<>8DQ;'RUCI!3O$)^C8],QP3.
M7.5S/72QW,@L?JP]G&X<]$Q&-?L$5'.'+"]#C.[^[/QT3$8ORW#Y:5H51[F^
MOKK2=")$M7#I=;OXD^_'\_*>G&AQ557+6=%G;R_Z#/ RBI67GC.] KAPONVG
M&9$+9V)'? OL"_7NYI7<CKT1W9E=/WNU?;?7XL6$K#YQ\6@=]#KY^UP_N FT
MWP4G@:AC, [B;QR]/E^?8KXPGC.O2--'4&$T-Z,IS&[RT7>=K.>;;ZY@::_'
M_OA(J1;!:>]SX4UZP/QJNA@F8*<]7<.D4&.*:@EO4<5J@<O^;N]G]X,US0A[
M'ME6$;8(S-+J[BG KM!_I+@R9QM:6T*GG>X!<T\V_XE\YI>P%YJ* 4:BKD#/
M86B((6OJ%_0GY"^RBNUD<-;86+V5O77O1H*Y#'^*S>9&:O:1)Q=!A9+2INI,
MR?E$EL$55:$6;TZK?3T.N5=PP+1BVAEDJ\L=P-)DROA@76&1^/]B#8O_@35<
MPN:>?,UW-FW-W@SL?8]8_[^Q!@B_NI]%$B7+$".XNA'1X*OUDL!>8W;PEV5[
M;?YHI_Z)6P:"DLEO-GUE8['=)F,O-G!#%=NMT#;JB=3^(LS\=ZB4R<9/QZ_$
M0I(ZF9:X0D@A.^%>Q&!+OIP"DE[,5-YH=7U[]P9C:=_] UK:]F!05)OJ60JG
M<\U8X<45)71D%2]HW6RJKX]Y'L8]5_#9]7QY8B= ?!AVDSIQ"CBGP>+1F,]#
M+,121'I.YF93P39]<-_W/))5T_4I3+U,Y>P;)(NQ? Y*A8*D'^'C7)N24K2:
ML$B/*O#B(K%\UE4*3')V3!WV\Y-CJ_%4*UEN==W-/>HT8VR2[WM>Y1;"K3EV
M^Y<O>B<D3SIP:N1N0=9) \>1.F)_G\2URTN(PX0PQZQ<RSX%]-Z2+>G,K*E[
MXNQ9J@RZ[==]J?]@9HG\G%(.?W$*6#@QFSJ63H I3*K)AI0SS7X!+WTV5G'Q
MHI2\SUH/ZB;A;9,$1\QT)B!6OX8(24+5DRM#Z,6J1J!:2/XI0#,HJ<<P 4C7
M(==7-HHKZ544N)&DV>K!L/4EZX6EE$GE2XLWFL'^K\P_&<<OBTWXI/R8R?[#
MI-&ER6[^\'\P;]!_5&#^C^3TP-NPY5/ D1.(&[6G.W<*.(YTIWI!G8&1:BRX
M*8($<8>DY5KGL7KI6)(>NVH1M[=U,,LPF/9'7\W2^=GH9N.DAG],FDL1W-Z?
M_7N/#]O]5['XKSWBC&'JLN"0[EQO2D+4W[I/8[F;MZ;_7"O2,LV.VX36/K:(
M;Z@#TT4\5AL[ :6= B*Y[!G.[N-&G4BE=F<_G_!LT\4E[LBS>#N@'RS;/?8T
M&6V*R;@9YH(10F=YYZQTF! %,:"H54XJ)U2#DO4;&,L+?]L65.P1,+'H^@H*
M^GH&[:,,9@HR*4Z9^*'X3F"^MH/,1R\ST?.G@)< @(SR^4^<C<.OO&856&LC
MI-]^+?UQ9P=LIM<W]U@N@E\\]C%"<#N\.$_,*]O7[Y.PT&R5:-=!6B7ZSE]D
M%A&$<US;[D;&@7"6X^@'H%@JWR3YL<1K.+,$79FUMC\_+#2B_-M38<:/7P N
MU<H[V>3\9J*_R]DZ=+&U/:RR^K%3JK>V&GVBYWTW6E\AX=W@^2%!7P:AEWU*
M$=<%&%XC]V^^+Z_=?_X>TO?*F7I[KGNF4.%^@^%NAOW$(B7[RI65@_P9I::>
MIC:3'A$B5>375!#V\ V"&[16!*\]B8&=MUY O?D-9X 4252MU9*NU3W<6-46
MHV05)KEG,J>+7O#_X3$"<D!$@.K@<1I*L.G5&N9>3]XI;;Q%K#\%XL:2("_Q
MWM6W+LC34VZ@5GE]Q%C[JC,MO9D./_Q)= SOY?5S9EH ?@#-JU56J'@U<: S
M>#42*EBIBVFW,:W)F%PT#Q/.\%#RO^&L*71)-K7YOO*HWT"OT(^V:V*^)4 7
M>I_,^K8"C+U_H;&^R4G5N)LP^Z9',=*)$@7^Z0$<<=ECH^T;1P\0,HC/2:KD
MEU\@]8<+&K-__ WO?#A0<)6R1G?!]^-]'CF*(%.(G0I_SPR5)IX8A/? >N\Q
M85>9R->:FCLZ=%\>>.WM=;D=O'R6;N^D:6\#H!6[D_Y )MBBC=J/JLD,/P4X
M'C)Y?+?R"(Z*)6MCE^_M9A^TE[^?"VSB[MZ^QN+;>]YR\\-V+G-M*=;^;J&&
M<,]6D*<RB5^^ ,.GP/FG_?-R?IG!YS,.+V!65!G[&AZP+E5R% &,1SDCT(&$
M5$I./9QX:_O=QD3;P[5]<_1)[UR M=L77E@Z7=)X),$H6D3XT9L:!_Z:>WIZ
ML:14*ETS#H7)_[<]G)Y2MCFIIEILW13Y.X%34JC'C97O\L'-=BOS1?<D82<
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M9!*'TCX33FH5PPX'>JG9%&FOE3FPW:J?$Y588'C)G:H\AJ_S7ED^6E>SZ,Z
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MS+U\IK:L*L_M?#3D0+A%RQ6]++EPL4KTM;]86?\D[,>MK\ASL%74!90K/$I
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MB*J]@/J?^C&%]_# AE''PO,PP[,6%OU@W-^D^3@JK %!YD)0Q9*(H=I[FJ<
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M'#1)_A73T!-4(VFR<>$LGO->8.I0CW%UHMZL09O,IK_4@L_+\P:@(QJ<UA_
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MSF>')-=!"5E8YXW]T_"_1S!U>3'58!WQ=+5=(B" M)4!(M]<D_>/>G;&D+_
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MMW\[\8U[:ZO7:1FF*!F":BFOBV=4L$"CI<$J$@M)SFGOIY=:7Q<>'5W>RYL
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M^9FC\/Z+FL/=/0CN:K85W%?R%02R*GL-7$4JY'WP942D$CJFR/D%EUR",_U
M6>[Y8*S]4XI *RBY^BG-/3-%MF9^?8H6),K>C!K_,%L8AW1!C]((X+?]W;X]
M;U&<,V3(%UO.^]=9H"19O/"1XPFU,9?L&T\\=Y '>AP&A_?E,<IM?[NBR(_^
MI&I>JQM!46E;&$;>(F-QO_J[ZDS36T8)<AH%D:;6DY$$%J@3-=K9B265T$VF
M12%&8D,N5W[L'#V9/5W2_D4SX?MAMS\Y^I7O1IK'Y+O@T@#SSAWR58Q@@43I
MYV:@4=:(LP.0JQT/,.IEE/?9H9DU3\S^=(FL)+$KT4MR3PL5F69D"$QQ93K&
M%*_-3+@6&HQV?_OY<*!@/>>G5^GRI_+!6?=1I4%_9@T+I+P,!'&U3F0UM@/[
M9@@O@'1M(:RZ@WE<;8US/HXN(5PS9 I>-%3:"QZ9W/*,'127= (KFL+>@:L5
M6^/C\8+0Z:]-_-2065X2 EM8&#YNVK^F\N':Q36GWMC?RW)='/+R#EF5'L]4
MN9(RT>!>?(M)!)14V'0B4)< 'H=6(0E\?4^OQ%<'(4Q0%($S8.6N"9K:VI_)
M[IA9J:90,OM:!*.>%NB"K.FA2T"L*8IO8&W0$?RCGO0FU_RMIKZ%V&];%5]_
M00,VGH<1YC2M7S<OC,:I9CH:*^=;\92Q/R*ZR)3-^E9[CM<W&F1)S?(N(20#
MZYD<LF1D>T9\#.0<78X,>T&7)6P<G>KQ^!1H;A>^8&1]O^;K'#:=?YV@?/+<
M78LC>R:'@O:%*6\!%S>NF+>0\EJ1;-6B',T8Z&FX!CC23R&DXZ!!]'6IT=\)
M;\]<#4IUNJ)T5L*#$'@@TB0X@GDLB1Q/@,7 C9&/4+'<= @I($8Q?P#MJU>E
MX6%9YNEY>4'ETY9ZU3V0','GQ4F;L/C'C$+H U&36=T837XREN <MP[G)FLT
M4Z2-,,/,-K8UZ]3/)ZGK'L)=;^?31SQ:BQ.:M#:)^RNUZ(,-5L*),=<SS+[N
M;O"O$7EM(:W]NSL+QMB\Z'DETS)G1BB^'PJ! ]# YD5=+D7\AO%7@T^ZCH'C
MX"&D)O<#)XMS=#66U<80N32VI1<):OM7V;MO5G&^:@U'?\%.9R*K4>TF8UH.
M0PJ:VF1H"^S4=KT'1/[]]^C'?OGN?,.<TTK=[MX8AJCNP1L--6PA%]-H<DP<
MC)17C3H4^&JV(!?N7+QR:465*8[;=M>0^'KJZ?C3U.AW0XO.?PIN8C.GE>6?
MX2OQ=.ZM#BP["^1"-*>440=GBS2=9E:)XK0SBFN3?/A;U7;/S__H-^"MOY3Q
M1 [B%'/R6BN1O*79]L9MGDJ]&ZON)]P(L;QV#6+KUI7Q^MJ#N8+!?)-4HKK/
M_?SO*MR1.&3+;:AK#S^B>XJ+-$Y5^P[A)EGL[VRG]N,#,S0^%-KD&2X,]??=
MFW_081E]XJV <Q'Z%?,(LL60J1F(FO8BLG%%;M#59A2YZ>?[9@=]XT^Y)-3B
MJ@7*'1-O*W*?TCIW0Q!QZYB,A9((\P5S!%4!::3IP/6I(>0>0EITYRNX,VEF
M9L8(LC#3HJ*AYU1W7/11V!3TO<>>C9J@IK,K[$0O<CJ-*?V6[CM =R=?<+?%
M=(J*G5!=7W.I&"M+KKC=5U7*8RW\R+Q^WN3="Y"S?Y?(I@CL&.ZG;'_GU3KF
M:L#KVN24P$E[\X#X+PLL4%HJ\GC!IZ1'@\:AJH!L#KP^3.=1HV"IXC0.-6(^
M[99KDT"=V(7*OH\D_Y2"]&1&"5ET+IOQX8!I'WPP2FK/XJF$R)=61AIRN@AV
MQ@OING&$?ISZ=1;&1M?%P1&2+S5ZCG5X>UR,+SJ_?B?_7FOD^7?TM\V>/=("
M+8R3Y,*U X NGPE84\Y!M*-.J^BM$ZM.R)M4U@PI./%MY0]E1%5,?'K\B2-3
M).?)GDUY2!3VJ]=:+<T2KD#N0+V%7(4_18HM"]E_JDD=>Q3,5O!A(>W[J*>4
M3J*>J&J,#U>IR!>-AL77*X^I0Z3M06>Y$KG^B-I?*?S& R7W.DI_ZEN4,Z4E
MB-RI^;/E&6 59(L?;N87HB6#N!N&?NH!A[)UQ%/HSTL9Y389FR-VT5:P%/WN
MJI_U@H9AW<^91Q@%4'?TZ-<9W34:B49)K>]5 ;/3#2I#13>NE+J*J]:E3HP4
M)]Z"#HFW")HU?'GWZ@4;(I$YC/_J&4VS1_Q!2#&R_1BWC*2X3G4<C_Z1MV5[
MS*,@+A#_9'[BT/=:^S;QF"CZ4R",Q%*UVE$ H7:$'6=VXD_OQ'K-%':$U(]X
M:8H7N]1!1^?"/=1M$M0^<[9>>J??)S]7ORCQB-NR);#AB%/J RJBX9QLW:!%
MFOABC)Q9E&4R\5=C<NZ\_$^(3<>]_-R2S$<+]8K4AYT=>*HLEGB-O14<#ZU*
M:TWX)/U*DV/&CHLST'*QRA4Q+/<[P<&0N'!QKL4J'N1]EDD,+B^E.;! +3>@
M3[!CP@2_-"+,G7!=JQG/MR-3%7B.M/_GXI7HTL3H4T&/Q[&N"0$BEQZ@,9[\
M$'N:.^)71OP: ".']3",[ 8U1TE*16'6>8^;"N+*FIBMR4X5W(D7J:;BE\Q'
M>?QYMU$OD=/IV#.:)N2V9I0@UE4QQK:P792+,-X90L@ZL]XJ;(W)\K]BY*UI
M1*/$Y)Y94 DZSOE.J7 TQ8$W_*!-)"Y?2(0:Y=T@L3(0JW[%2:_5U"HF$Z_A
MXQK28V?/3>L:+X_HRC[.J <L_;CG#;):[;L!]*A+'XP:,/-X/;IP?'EH80 V
MJ:?<*8*)$4@[>W#=VG--!&2GLL]+4YH 9GO5QND6-'-H%W$DJ35M[-$P1KX@
M.CJD6VF:[7*[0;S"NX/P5KWQ*@)5^%N7"542V<: $7J^]P"J]DR#UL6*0K@C
MV:@GRI)(U/XT9K'YZTFDDY-$KCFWTX)<V/>;=T^XPGD8KX$ A^?4"B*8C''-
M#J%G-XX9?)RB^HL*7AFY,J^*2=BS6WA_I5_O@CNSK.=/(962JD58%"P\,?.,
M&O&FV,C"P_Y/EI[^78OB[W+1\U62@L7X#XG[;K,Y=V.UW5'O]X?IO%V45R3I
MM]OQ;]40UZG/9^WY['U.J%F1FL+8U@)4AW"7CQBXE[Z)N1_D="#[^I( ^I<%
M>00>")":$485"[06W<T"%2R5CJ.AT_%(?C_LZ*(V(V6G)_82]B5=MK2@,,^N
M,-R1NV!4XMWG_NAWZ\C@9E[98>EGK?%E]"!@#%!8H-?CL\[?43$P4EIHVM^M
MSR_QK>!'S!X\(ZMN5('9MQ"TNNCDN:'X%/&A?KC78N;BF5;KYUTK.FJOIR<<
M57Q+"8O&JZ,W88DJPGUC$^4^_IZA63K5S"KG5GQE %&7;$X)(A6N?9@V"KR'
M:66!(AW$A.1_.T)=JX>& ]YI3H[[&SI(6,HSMK(OPP(0[=AJ<(?)6/TL>P?^
MS,-NB #5V@YH8$B;%Z?TG_KL >2GW_WK;=(3CUKC)#I)PXN[=!XG OH-$U"V
M+9 F,+-5W5<='\,\.\ZA2TJ9BBR\ZAU2H!^%^Z;[''39<.FCAJJ)J!(4N*,C
M=O0[CG*7D4(7)=TT9:.D/ZIT,WY_WNC6["Y&(6'@F$ ):IU-M+1EYE?Z[<W@
M]$9U@_$9.8M"+O^)@5DK2U'?[.*J61V*G4&Q16UMK3H@M>C+9&3,-C("3+(U
MX:9KD4]NK#'8IW_OQ_:D*DT9E?4FD*X*CA7R$J)I"*"I1IY(9S7 T#&V2TU<
MX./]2]](+5LL4+5Q!@;Z6&EO9+P>2786V*,W8A40I2N ,M!)F &/FY@SRE08
MCSW75)!'H*_*X1 *2K[M0LZ4UC/)I:[D37K.L$:]=8L"X-0GY%]4/1;(61@9
M%SR _+O 2BQLA8V2/F1E>V7-14_NC2_ 6:"5FO7%KLDM:T_K;%*UC6,35L[S
M;F'$Z\9\]42'/\<18UD0R_7!(<VO_=<+7A-,86D]S .U1<B6NYI&TXI1V#/F
MG=$NFN* 5IGJFI$.NT?8]+QXKC9<T^ZW5DI 2*1F]?=+IX;#7? D2_"8USU&
MRI50R6V&4M=L>>$LS80-:%RWV]2M_)G(V6^7CBECNOSB-T+7W8FH<67F,5,2
MCE)-5FLS,AN^!WC?SHAT^/(RAN_46&B^GZB4X+G M:[TO,V71T?D3TNI+7KQ
M5J,!FRK!^<N1+5J^+-!X=_66D*V$N0$!7[$@6WU4(6-('@7M/N O]9UC#I6N
M7)_1P_[AF5(KKM@JBM(0YWF1:S8WV17G?[_,VCI+IW& &.+KJ8)^C-G9 W,R
M>U$D2ZXH#]J=0/QT3RM6.%">,)1.6KGYP!-^CW.KIVSE\IQAPF?0YTMYQ;<0
MN[>._1FH+T6V6 $Q(SX*S %U_IL5L$?]8C3_VR:I5=NXL)+EL>PM%TR-#H]]
M8JG7G?CT!=\G([=B$I(H_.WQ5&E8>R.4\I(L3>2@B=/-D>&8IJN;X^VJ_$+7
MFZJ=GVL^"--TU9!.I:>*9U9HOM%P[]7TH[&OXD_M](0AI,C6\078@:83*UQ%
M$Y,3KGU[=0.)0?<FY_7.W&26"G*<Z[S_3B__ ^F^[/2>BSF\8F@%_LNAU;6X
MPTQ?W[+6UNWSGJ][HIJ>S^#P_BI3=P!Q&@=T(A!Q .D<.,4"::?-W,.56Q/]
M$WY=22BZA#S[^H'DIL7:Q.5O+]SW8ACI1*RK*B.&!7+O0@N[9:CTO"&@.BZY
M76I.9%14D]ZM)YYI<ZG:W&4SWUKO%$"OIF+/5GE1)?$Q#9=0PIK\!%24F1U5
M>/:XV]>LD_;GKR&_[IRP*/<\S S^*9U<6F$^QUF8?4-E^IDN]X,OR17OOE\U
M?YXEB/:N=K%82';JXN]Z3"H[4[.0XHIQ!Q^'7V$4(;V0H[H4/T9FDS@U15-6
ML15U&AI!5ZJS+S&2*J6XOV=/NY+8-'"FP53C182;ZN"#B8Q]=\H\HQZB"I>G
M+J+AEZGWR%J$X3?&$8Z\@^5II5I^?D53A@_/7+%6*F&DXKS//>1<:>>5>!&X
M'S*#H7-_9?(%K.63DBA.P&AM6X.22E44N.\R^YD]6Y!)1JR7A+ FJDHQ:6%C
M$G69XB3@-@<W ";I##7Z,7ECQKK#ZR6*.ZUU3+>CRS>Z/=CO3^3)0M7YV#RI
MJ:#'I@(/UOVKGAX)5N7WZFV#$.Y;*:Y^*\+%#-?@1G_J6)>R&W7M^JE0X/N;
MJDR^Z;4A>,J9RDUZ? 8=F#=L:HP\NC5-#?$'S _A7!:Z(':.VCC#W^OU6;$=
MY:3<]LSCJ"ZG@\S4;0545L))R,-KN_&C 91T1L65GG%,.[@BC1B@&.&G!VLS
MF+&_2&OK->"\D^USVPGB.HE9\&K@./@JD>LD*8)^II1YVN0U\@"$EP5J#5H$
M/MZ1-;,E:-84AQXB5&FGG)Z%<H7HJ#W%USFDCX\UE8 KI:!>7%0/%/4.<L$"
ML)@337@-M8W_LP5@#0O4[!_D0*NW_I"^T"!5]/#9>W7?O?O>(O];>]\9U537
MK1N[2(ET*1*5WD2E*2VB @("TIL0%9 F1)02(! !::'DE2*^*$2I(ET(" *1
M+D61+D%*Z%422MB0=L-W[AGGWO-]/\Z/>^^?>W[L/<8>>^[5UYS/7'NM9Z90
MGBU:4+X3!U)M85]J>PQ7<SYTY ^&PUX5C@V9ZX7K!/PS3U][N [M,!!$-:)I
MI1*#VF4*L0:9B#()]*0EN_*-I[E/-T%:Y.3LM[8XVT5U&C]T!M4&B9KZ=#%W
M%A\CC.N(+Q[W$I ].USL\^23(2[V_5&Q%R@Y=)),#47[<2PGC/LU<>F!>Y>%
M!3JQIJH)8SIIP,X$<7G0H_%+[$6HZ0XX.9<AVD]E1_T4M& II\2I6=CW6IH6
MC#+%!.6DEZ"FO)F@MH,??(('T767\KTANP0FB*RZ&/8P=C/<8 .UHB3$!/UD
M24L7,0RV4_]/)*[RC[1U&3ED+)V%9S=#L',H0RAI ?/+D?&\/H/!\8@)$H82
MOT,J:NF' I1H9[XS5&GCJ-9V)LB'"=J7=>BD4_ T$PB)C!I',= VE4Q0&$OS
M\AJ,R*"DYR#_7>+_UR5N)_8!$NIKYD38Z5^(7(/^';XO@[X7ZI_7O)<_)*$@
M]%0Y\LH)_OT 6+M!,Q,$R BN9Y71'$@U\<6T6\.%U0W#:_<SI0((Y*XK\K)[
M(:?]8(3& .+'&[9S29A>Y/4NY<3Z K%K34KCUZ1[2K)2< S)Y0IS/?Z!<,0_
M'1NAO_NG<[4C_!2#41**O(**W=':";%LO\RZGD'>I1PLV\O5'ZS@1PI=V"F*
MOM'H]<!P[8+?0+ZY.5>Z'/K6%5T;09PM_X-02\>362$6:+UE(UGE*V[+EI(W
M&N5<\Z0K'\@9)<D9W:KLL53RBO9R6[^>($\H47(H:_S8LO.N-QLM\\[LH=M_
M'%C1_?=<KF>W%5N4.\1[6:_J'AV^LOW!RVWYNH!@OD9FH^R0$,:H(MU)KN6N
ML4*^*>ZPU:JN1&2:Q2ESW2L*7,-7E^\>W Q33!OE]#Z,YM_&:;-)%5GFZUD4
M&KE>T;7D2C]9%&N4PF;1V#<]ZF3 ^,7"Y</$^/_UA\$XF)S;]QTZX;Y)Z_^C
M8JX78M 9_:]^!DQHT!28H"C68)SGF&*!\=7R6/SVEHOS*Y;)$.>  K-[N1I3
MK1GO&7;6= M4\T6&%!(,L!K]J!0]AP4&;M$TS-!-?#CR0DR&CDB8A8^0K[/9
M)PD?2K%_,&_W4\BA<)_/6L(,FZ7RWY<!271!4:WK6^=L4\K R(ZC&/^U34WL
MJ.":)?4IRZDX)D+_U"1 .PY(%S@R?H2# %EB.3<,,&AM.ONY9@@7NKKZH:4+
M[AGP\>M][[':5]&3HAVW4ESK.'0VZ15X+XP(XQL+&Z)<^\:#9N8ST"YDI1>,
M\RLA:A5:CQ_[:AEEG\5'1,^G#]6'=(KBZS2)/'I\SU\HGA%_ACKV84,D7ES3
M/OBH7Z)M"?(TD)5/$P<:<Y 69.D8%;S(N*<@U/.-WJAYP>#&9W'7E<22GM2W
MKJX8HTUOTHZZZE6D+%)M>,)H]>^FA@E?']&;..Q.[<U])HA>PCB+/#@O>@\2
M ZT8_9ID2MB$$]AG;;)F5\<>CU^ G+1?N<LI_"U;W0#/(\ZE?HL>5Y[/D F?
M@%:7,$'<J.F<[!,-(XH7_>$OU-1"RJ/6"@<5\J.,ALY__EUKGMMBO<@3_:8W
M33/X8]FUP_@$_+@ZI0-HI/K3GGT!MLA_V8T[=WG#"\<\"5;01X/5X^QZ8\=*
M\R1?=W*X7#T6WR7Q-G//]%-A:\/V-)G'-,R_J:$?E18<ID-LT,/65T,;,+%3
MO#K<2%=Z&>H^EJ!.F6@8+&^PGL%'$\I32U:Z.,SO>9-T%,3">N8V.#9?&U\\
MNI;'.>Z5L2X[4QY'<$]BP6UH+!17^)QQ#IKP9K8SYJ*6Z@P>XB4&J6^*T-O!
MCRN>8WS;G/.6%5RT</%X$7'=EP],Y"G,7EA83O^3YWGJPW6[Q5,-(.WG2W*C
M7'JF5RS[I6K&[56]5=TV[$LSG8ZL"CMTLCQ)LC+E$[!,U06*&:>,J5>03L,/
MAQLX2;MZ(P=KE_H#DS+5JXUJ>PU%N9?U$UTO'DW^8=<0Y;=X#< SV)^1,RA?
MZ7FHZ4SHIZE.SB"GC#8L)PX+7MX$4G:$1WM00AT9)^]\B'"S/^H<DO7QPHFH
MF'%8M\EMM[2V<PJ!LA)*]TV5.Z>A<N/@ORQS+;)NJ_ZI7N^A#PN.ZJ]E,4%7
MW.)\5/I6IAALN>0J5L?$LF:,#/V]SE'&=PU:;0@3%(%C5Z\>>.]ME3G:&I+Q
MYF)1]9WC2_-BP;[&.VQ1$;!:/'A#1ZN+7$Z$QX6#IA!&2H#T+2C81CO@HN,=
M1M=MG4Z9NF2Z&Q-D3'4G($OI$=]2L5<A6PF&;G&7DM"Q(HXGA,2PIK(S"T2?
M[SG?6J3.H]WG)9YP:?C9/_P<8/UV7DBR=QR >^>5UP\[D,,N;@?)G4F0**T<
M0YK!CT+;\*?QK>=6B55%$UD2AEDSG=_AXH%_GLVO_P@N-_TO_%$JGBPIU3?N
MV;XV6P\E'#!;+[HL139L$6-IZ$5&DR]JV\7V_>A+I':JK8GI?H])$NR&<7RB
MI6%;S!U:]SO>]!-7K_(=6JTVUP,%0SOPR3 VO+M9["B,CZ'J_<1#F#/U@N&S
M2X_V?A/->53= [73^;(U[EO0>($I$IZ"!IZYD=VG%PKIE43ZK6\UN\YW:JB)
M%UW\/KDF=8Q8-'Q8AJ&9()*S6>RD!OE$I(Z@=Z9[@M3@MC=6:#E3=^#8)T/P
MN"_/?&ZC0J=DCK7,!7'OXUW+)N3'^-J+E=003R:H8O<Y0_6WIT -'GQN"*?M
MY23'-I\94#>F0-;]JTBKSOH'_<.7.)%*6.'T5<%C"=](P-+#(6\SPH][OW__
M56B<#@U4R9N7[_+*QZ4D#)<%V1?A?%2@[X3E]UKIE2A/+'H?WP&/=Q8#E,A1
M':^F2&6/T]Z@.!'F<!4?M3_L8;V962L;:7N?<B,G[9,E3US[-?QK+/PWMEH0
MTZ!,/0/\7#6XDSKC6QG@-N-1FIMT 2_PJ?V$G-7:Y$TU7H]C%9<N'6=O56@F
M?GAH;>>0$Z)Z]3-CP3H%^=.VX=QZ3T!HV*O7C$H1PM1(Y[:@LRVY<-:]A0D:
MFR*V[[;C$S-SEIK.#G+(/POL-[R4V'>A'=)U2O/M%QDBHB\_W!YI2"]KNHB4
M.SC_C'Q FLM\48]YP9J'D1OM-9DBQTZ_H>I'U/I:3VT=[@Y_# JQG3=;YRT,
M)Z $4=-I(7WK*#)F!ABM1@D9NFOW1>MGG<351E&-KA(WI9,BDF_/Z2F\OUPK
M,_:@OGX3S"D97Q[UZD%\M 9__@VYW[\'*(0/^C]3+,S-[!W8QNY9EKONV8S2
MP*N%QD,EN"RU*;M!R/>:^GBI>)+^W)-3;T6Y7Z[;%G=K298MZP@ (@6(-\[U
MQB)G-6_$K,PLF-5QW!V/"=+ISI7^9;NY,P,=[Z-DD"Z^)&()4<THO@:WF5*-
MW;:[=GWP4H2A"I[#JR;YSZ?2Q*X%N;3QBA.N:9NZ'"]L8UOO<2;TR=G$\'AI
M)>D]DR58($>29D_PYX7@=IT^9KD=+4,YIMD2W9,:;E(?T$)9+9:.-*>_8@C0
M[#\#*&(2N+7>][U0K%GDOMVD1^GF^2VUQY.; H&_38\+"GW;N]C'."5/=408
M,-@*445.WI4PY"W,S+TISFGRV6[]HQ[G!2&>]RU[?N=>+@JX>L8E17Z@!7!+
M:FN)'2;S_5Y<<XQM>BONK/4S[4UD4HK9WWI=96T--QS+ER']2LGA4.0%P)LL
MWH(]V>!3HHB):_#=Y5YZ]4CHWH1J3K'1D9PK4C][=L>>$1K1^,R-./QQO <L
M$D\RAXRYM#)!8CK2AF3UOL:1O.KZN@ICV?4\JM8-_]_)DZZ/ \_L(GNVN%YW
M+@O2^'MF#=K!SR$5&W%-4C2Q$<F?N''-[QI7X>>MW/4RY[F_<I4T%(GG/YN]
M*I?0[G95%,_ST5B@"1I\XT_ULKSTR>]Z,L63ZHWK^3$?EZ4E:_<@^=NV6QNS
M&W&0VA-KME1C)-]HDQ32#L+= "4'.43='%:YIK+T.+<J93GG.@4=C7WL_.1<
M4N'\H2U\,J1UB@\%!X\_&IV57A<B?9E9H2GWZYQ9J4_.R@$"1<Y()L/7/M,&
M1E.,=,TOW!<(".#\<HK_4E AL='3,EEIM3J\9":SF/K#V5W=Y&;&V-;4W]K!
MUX(#/H<&X'!KX1N(W=F-%F@,Y'2#)*FXTZ'EES=#X]4,)]?/5ODWM=4GW0Z]
M%.+U"*"NO5M$%Y-B*?& -GG*BFR:1"JW$\[OB]RQ]W=R.GJEG1+Z"^%/GY%Y
M<E+\J9OI554:$]1.O8W 4*J!4NH)6A Y*2\PI*D4-?,!;L,OS]OW:(32=^%(
MO^OEC7':M7%",1#%.'6(O#AMUHPBP#HRCPT).DQDM'_!LWM8]L%/W2SL5$B)
M$(_6LU<SX!KV?+;E,_'7I3 ,$)V>)8P(06WX/*V>2Q.'EEJU+GMH=OQL6B'@
MPBX8C C0H=/W&%DRY=W@D^%=4Z2[9B<0XFTO5V#5BGUH. X.OE?Z]JFG#4G$
MZ<ESRF:SCN/IPVI7TEMEH3*S\)9Z"(V/=[9O798$G09_!4=KT/:5VK%GO#>7
MQ10;8ZY^'TXOB[P<*M_QS5K,[F]IZCMDR;M3>[\AA\R$YQ7P0D:E5XT&4RCQ
MND]-D9L6+QS05O,?'?/J<PT<QHLA R;\6YAU'[)%YW306O\L.+XV6]R,C0ER
M72Z[/YR/HSZIJ4OEOH[$['G=*4'SOI=P1[-0W@FJ4W@_XR2]E 'V$(Y-;G"?
M*6>G6;U:(%!:.QBB)D(U<3];@QXNUZO%]T0>M3C[/MPO]N8])+3Y:L/X,9C(
M#2\YK&JJY6[=^3Z)O)SI3/18E[^#$U> E<,=1F3X:6088$!>.1N(>E'?LK),
M++4($[20YZC8$QSYM76!OB*U7@>Y,A_&&<J)DL57*;&T+0'?#N5">4S%38&:
M%&M;>Z!LP&Y;9N0OO0=\.?M_)FQLJ'IM2=3/#3BKNWP?)/^..,._C8V%PO&8
M*0$M>:HH8D?5IC\/>#G#>=.8K"70G]/Z@9T];OU9C&7U;6LL6Z* G,:I_<?C
MK6PW>:_.?W[=_18F;_8FD_-NNFO^'YDFCQ:;N7H3B35W#OWL348-]/V^_.81
M!V"+:L!R&8Y=!K)(TD1*/F5<49YH53\2E?/[A0!V/-RM_L:?KR=:E=?A;\Y(
M-:G1XY@@+Z6DOQC].KRD$^M.9,U.,1%R0:EVKT-&-,V<.(Y0R3)U*I_O+/C=
M=BB!LR(*=W/6BS[?EV30VNMV1X)L5*U-N%O<73>O+M3\/;0RRE.B9(X^M![D
MC7.>D/8.A@SH\=-2EF"UA>LXZBT@J U?[=Z*X0:FS(9] F1'6YL$?FJ=VR^/
M_8YK&JC9#?)Z43UP!-=GM?KU/N_^4T"7K.E$[OL* =,<R64)S]ZO9.PK""<Q
MTA7,1"FUQ\]MMLY_.Q)9F@YZ'F(+Y2.):9Z/OO:PD$UM3]0EM,/&E-"A[G0M
M%S&A&E:V/))(T<Y!,\*@+@D;@(ST^NXTA5ZQC4KJFG:4+_6U4V&"V!V6[\+L
MFEU\Y$I>]MJG_]WM[DO\DNM[*&:R"D8>74^@PAF$*;ZFPS0AX-T4FY8ZZ:6B
MXD\'N\Z#A;][Q=P2V2[BP;K]GRVKI?HC'0,"ADG[_G[6))S?4$9%0@!V0]&P
M2%^T;(B^,"_)O[;W"F.53J 0I#+>4_%VC'-DK@BB(L]J6Y-<4^V@ROB9WE%U
M6PN%2S>%=]R#SEM?7S$$V6X%%803\*2[2LG0BH>(V*]LP:$S9B<1"S .1*L=
MJ33--C-MWSK/6WS"_OKUN&]!T3[/G_+'#+O42K<Q0;Q:>E1])JA9LTEM68P7
M(,YH/YIMX59<9_P]8\+%?O81H<VQ5Z*B7B;P6X;25G"WH9F2[[5R?6STZ\\F
M"LX7N-$?BXPSLI&U:0_S]NX/6=6E8J"*H^ZN9B.">C\9&2J*H3?)I@G>_WG'
MZW?>Q.+<]W+=!N>B(N4=\)E.5Z#C5=/E-%YUXO%BTK.V>B8HOCK)KYI^TP%[
M?? <UK$?"95\J^.4E7CG]DL7N;GNP":C1?9ZO %^^C7J[.-P901ONUH\6=D.
MB'B6XW6YC=(D/I [L!-VX9KXWH,Z;F250,!?\8?$DQJM1M.S2!(D.XV]:(X[
M<A:%%G=WK?Z47C0+_5U]D6+AM4IL' @Z->JE""E,,]=#LE7\R]-K_T?([8?"
M3]*T,#-3';!32(7,V;7X&6WG'A//S[W> 7(==NZ)SQ%G^_AW.SNQB:@J<"L4
M@NBC/,8!\OE-T<1EN(JWTYU[W[D:X(K*)^N]<QN-JA/PW9LUTPS^O=B"%8T8
MS(?QE?T[?3X!WA=,."K51I-OG2N6%8T\>91[H(E&!M/X$E@:U;]X-6&# S#4
MLOYHUY05//-Y.]WID8>$F6*5U(:"IG2W_4/1^QSW;2I2C*;>;PG]@*%+T?D6
MW(L%Z776AI;59:5*06$J?^JE@^#Y#;94?J0 T.A-JFUAG"8KUKZ@N94A+U>.
MG!NX,"AF-53VWCB^(#OT^=++ZH_1NJW8B;<1FS$D5"2$9*9X<Q;37(R*<Q"K
M^NCH-4H)&@U\M;FD?L0X\!,/1&)%824BCYM64EE]G_:FEI;;Z0\=A\^419"E
MOS)!?"7;=$D<& 3<1UB:)<V\;I5,:=?27#A\O\.I%MQ]Y>(-6L-IEFL6"R7=
MQ:!1G-L83D=[(*AU_U4A4?OB[*W!'>-?OB8#GJ.'FI_'E;G$14\&UF9\>:Z<
M&%6H*K4#&XF-5P!S_WRW3/PXL32\=S9KQ5FCD\B .+N58F\6_V2"[FM#V@+Q
M[-4FTIU^ZN@F60)A<LP37'B[V,='_+9TBF%;]*FVERGO0 .G]8=!O*&V] @:
MYPR*O38.ZHZ*ZYF511'E*TCH9K5TJ;<ZHZ&?@V,,TCO3U.;X+5^^G3VB R%B
M",4=MEB>)K[5_?FU<-%88HE O5O!^P*'OQ>-;^>[>XK)NHW)$W_Q'^//2+0E
M8*NQZW6DD7'BV?(734>]0L+ZT-)DIW*TQ)"*XA'JX6Z"L:1/HDOZ?(IW[%^Q
MCQ[>/50-MM#Y,<[.?_%\?GR^49;^'G:S,SUT8\8K^_?;FMU<^:FP(Q8L/.MV
M#RE!1L4@G;1W_N#S/+,O]5<[!8[;]$L-3&=J]N0E].*"G496)M[LNB85IE\E
MM#1L45[1$QF"AL%D]QG(5XQ@*TH]0LM800,?,SLHB7/2&-G<F8Y6S%.X-2/0
M]IB?C[-0U&=B6D>#CD,:S*($EJ&G>9N=^0=4US4=:D87\175V=?@<$4L8JOJ
MR5?]]:W;+T_NJFM?[S2?G0)D8MNGA#PT?KS,\1 3(97VQ:LB DH?,D&W*KQ#
MBZD)GHS^DW]G&QZRF]^+%7IXI2UE/F;9/B\Z]BM9P<N\V*)T/@=UV&8AP3,O
MBSY\T5;,M@1>I<T^LT'C=6D+/P[X9ZN3](N+5H*XO4(",_S<BY>>+45/6;J(
M\CA6_^FXM77IQ96.U;_L;<_9ND^;C?%2@@ ?J@U"B2A5.;L*%P;0HVTC(39X
MXL* %'IPH>^M>%V@:_K#!Y415M(5:SKA0"P51;M+WHA!&A/'S<!+&D>S+PX]
MQB694N^@ER_F#2FX;ED$>%YTO?7PUS>K4Y<WGS_UMKS'ZHTXY*W1!K<<Y!UL
M<SA7;+N&::%/<5])<X&*;6;T]X_IL&J-7AV;'ZYV#8UM7*_;!?.RX[S9VG R
M&@$KO@75%,_5,YM;H>6W]D;K>I2B]Y_A<8MKM=Y4]1X?OYGOM^T1&6VV&4$C
MD\+HT03%<]VK<(7!O>?R7;5S$2Z:5LC>POGR.._EOH0I7&P;/KGI2!4)V@8H
M!%SSGS#:,*\:=K5W-(]0LFNH*99-BZF=#)*K5U8"71*U[0U(W(/_60OS-383
MXE!X@ GZ4(XK]5[V$7A5L[\+?S8<?I0)ZH*3X/18E0VZ6#HC*H"!Q!Y&S=4"
MZHS6S" &QH@)TJW?OD+/"^>=Q5([3M"4:3-\YGHATM-$6 (3= 8_5XQ(8+0(
M0O:%R@G_O/_\ <PU#'6"Y=,4 BC+/MM\+4O!?"W;R_ML<O^Q#?Q\BI+#:ROY
MD0*^[!;ILW+6_*>7+3[DW93@?Q!J[6<CB%.MB!_-E\ES3LM)599R3K]B)3]0
M8'0C5( G[\- 7IZQ*.X*Y8--@?/0R4\'B\@?5P_6DSFZEG+01RE2!XO(U@$'
MZ\E'>?X]%[8U(YS<SH=7^<[5ITTLE8QB"IS3#CT(L2PJ'LC2?;U=S&8]4")Y
M]%.WU>I=2=-JGMNR>N?R^7@O?%VW3$X'L6YI?TNL#N0Y)(58)5C^3/%*U["R
MEO,O8)7WTO)=]&O_HG/I\K\9G %#J'4,X[OSF?0_J./U*U!*)Q/TJ+2""1+6
MH@W21U!*W\5F]?AL\Y (E@=+$\4R03*/@%HFR.F 1J3PC3!]L+RE#[@&9=S]
M3H8SZ@_(-<S45)==\9L'I(K)T$SET@/C-A_-2F2CLP];Q 21], 1$#:H)Q:0
MW6CIBY@ZJV+7<)-H$NAC#M_>RYI-?G#\38#*_>H[R6I=PNH<&B&V&UA6;_T"
M4ZR 1NKE\ &Q\T $56(%6R4Z=;+:FV[9,JG\QA+O'?9PH??;N5J!W03A^M]I
MNFGV3R3V[!U]-Q;%&6QF5'OD-7H,"MX7B\>9M1<K&M\E[;Z8'Q+[,W4[618N
MZF1WSZ'P5:KQ47>P7&J]WIYNA^FQL*E9/""/CX)Z07^5SRJM8:@>3HC.MJT5
M':G4=BQ'0,LR*J#@GF^J3_K>YR\W%+4^<=]Z!)?O??HQ4%]^X=D=G8N(;S^2
MAGABOB]O:(Y)I0Z,UO]:R9>1L6>"'(29("'\=!H+5T$]E#!3IYK 2&'21I3.
M63;&<0\\MVKQJH_^?BAOX9$+9A\F@U^M7_WRUQH8#N=[A_S\:.^U(ST"-9T%
MK5JFE]/L2;DS[O$T<7)Y:RO1-E[+O& "$?AG^3VNX=/>>>HMWU>#NL]XBR%2
M>M1\N\@S-J]8S7_,EOZ*9D^U0IX#AD991:!QPDFKTS]B270<BDT[NJSX>&U^
ME[CAE6:53\W!A?5-K7Q]W,BY=X1#^^@I!OLR]0H02IG\B?(RAG A,(YXTF)K
MDDM+D)A,TZ!*3YA[FT;CW,O&TO:=_)(*0GZ#CK..H1"E4L0[.Z]*R7TM5Y#4
M6%TU6OZ[=A"'DPV5_PVX4ZQ8*LN&=@-PI%HS?H2<6.=T(2H&P8 JE?H74$Y5
MZI<>QP_;S7#E=IV//NMS5#GC"A5#:A<[9ZF8@![L(^,LJEF3"7*#1N-)QI D
M5$UAFZ$.!!';D;JZCX_=]CY[TV;(8K!UW9OC.T7$/Z%'V:NWV9EP[5.!DD)5
MTH_"OFT,H*"^AIW%$Q8I2%9!T$A_TE2\(D,9P9W=,R.:J9B>ZCEY#A<YXNWM
M.!XV^H2OX5"NO<ME"3TN_N=)_$UB+!V-I(F1X31>>">V<O)-P:KL#)P/Z5D'
M)'D^D[C$?G2@X)- #U^R]!7VOV8E!:0P<%IU'W_>>TRIS-8D%*Q:[6!D:]P]
M,AI8NY;B/S"XWP^Q98S@2888",V C@^70NJ0PC.FX9%-IP!/XCK8EJQ6D)DU
MUR3<3VRL3NB&>GQ^?J]AU^QSW@VQ>Y>ZFI]MCK'J(!\^S!I@ZZJD59;!,?D(
M!'74![7[Z(3!6ITO#?A.;+,G:?1 O?]>\'AU^WN1R*/$]H;+UG?;,Z#%-GC2
M$_>O5G0<0PU@]!B3LQ-(@[/ZT<2>(Q^67_[2FPD3N4O:*4\]VW:Z1X'R5%SY
MMI"8J:WGFA40B&$-JW82K!4[7O@5(J!?.\L$)< XM*Z]6ZD_7@J?/;/=HVV>
MZM0RV?/@[//;.??T'M]Z:F2\=TO09,\NUU$MT<I*+1)'W0Q'$KPHU(Y9?>H.
M W_DKP,U<[0;X*9>8WD>4N%*R$=,T(OB9IB EG4N8E!OL!HC@(!:IE#DC8.-
M\K\7%W[[.$>;NG+)U<WUH0;JZC!UE-Q*&3E )X \@VV"+$WAI<=MH^(ZS(2
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M*2@R=FV4!7"* LI/+X],<99-4G5'UGT?8&PB[26"1:Z4'-+9.K+9D<=W@\L
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MZD6;-2<WK2]XJM(^?9\$=.(=1R9/+6+/D-F8X7/>/%OW->MMW.^!L&79XI=
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M<HD\L0_)SZ"-V:'#P*1^"T<T/?^VA[ZCLQ2_]99!@)Y6CW^Y1^$^(B[ R64
MY+Y8-L.?E #]3[3S?]P5[T<::"35K7V$8"@IB: J3(-0<<.;T5] (+LB41T/
MWS BF-0F5DV< \QJ#%!XM+)5SL($0OZZ)\RG\9HQVA,_%R(*=^*D'\9\)(I]
ME[E6;?%E2AYVE4H$+M&XQ[1*T^9T8!![XTS[B]KSQVY/BU[*3\;,A//( F8F
MH(7\W'@=XBY]W<G8URF=X;[O-^<X3 ?:]\:3+'^::9PU)^V0:LS=]3O39@KL
M:U^'VIAEI+_9I;8^ZK:"X%K"99A!#65R]HPTCQ7"\W)FL' #C!Z_J@XW%BY-
M&NQA]9FGN/"J3B[Y=GM[R;"+^IM=SJ_#FZPN9D8XJVX(+3-FJ6+ &8G#Q+L,
M6A"H6/BX=/"2&4DAX](,NC2VNJ.9N; TN:FY":-[!-UJMJ-M_2S[<=FWE,WV
M/K?\8Q>;:P4UG:<U:\E-PV&@M\5-B9Q,5M.('7;#L^-X%:[*%>/=YMY,[]S:
M%'Z-V429I[WQB-3AZJ2&F#F=G]]5':>JN[RAZO2$6$72OBK@\VUXA[$AH0*2
MKYXG1Y93,O( !<VJ#\_92&03B4^(9ZUC'X4G4OT]I4=>.,4N;)E3B7Y4=KPX
M;]%\F/;T@?1E^+\'"4>=>1R,Q<EZSU3(&%(N(56K,MS>ZGJ?V.7!6I%U^Y'.
MOH<!'_IW1SP6"SM.V8T](I?H\$!./1PK1#'=UT!L1XVQ<(7S!6T2GFC30&$,
M,C_' PRSMA_;7KZ@7JCG6\Z5:F:KM"V6W% <U/K(W;>>G81KC "U'EI*[I^R
M"\\(QHIVS4G%F,KBHZ\\5??M[GO:LK&+KECDIW"7/;89"]6M#DOT'*FF78UP
M^\[HK?^I!W>00E-Z!3)N-+58-#.Z#3^'WF-A-FWI"H0\ W]X!%A>*Z0@C_@#
M[7V.=$N.B*!0%HU<D;0 ^3J#AHMS$3;ENP@:&T+:RVCX76()P(V_M^>&'D=D
M,-]B-+TM&#?NL!?Z[ROH'*);ES].T=5.^VY]^N6UY,+I\Z3%96CO>_XV/+(6
M;8^P0X)T69AZ::%0>F9_6W/L*:0I;^_(+5ZKNZ=&0EOV.=N+J1H5AYT?LFYW
M&LTO3WLNMWX1KMN77VYBH*&1J>YAKSY)<7E_3YOQZ>P8*S3 XHR;>8'=F,G0
M8OW*@52! 2T:YMA5\$UI1:CP*M)7]P6U3!DM):5L@0\ YA?8) ]B<V-]8,<D
M'F5 ):Y]!<B2"EN]P TNZ6#RP-H0YD9^4^5/3/P2GKD^(!"]R,<A[R2RR!>H
MI^H!X0[6V&0?T'JJX53!)'74.3V 7"!)SD#:,YFCD=009!*XG6KK^XB_-7X4
MR3^4LZ5#" 0SH))ZF[J%8T 2-=K'[XKZHW-OIIA*P"6;X/;ZQ18=S_M?&^6J
M6^R^\_!XE=?Y)(T!DE*$L62P,L9<ISO<B;[-H=9RFK'[AG6B0$>EV?3I%K0I
M)Z_:017,:$+:@.5BGP0*:4\!<UPJ0P2AJX$UJ1]'\=_T0!9LTP$F+8&N(8)D
MY\8@7^6IN*1ZH9S--Q'$"?&V)*]<9$YVPU@LW+& DT1,'X)'RA"N+E)4Z-0V
M+@;CDBO^^;Q)ZU_)Y\UD*:?80ZB*KPV8,7N)M]E.:^M%D-2F5] RB)60@GEM
M+-(TU<N]\#S18,_(:68U-F=WT=%DF]UE9\->]$?"\G![=CRERM!,N!([5VH7
M_"7$D.:\_,AG=%U:WN*R6Y=D:1]+\37H-*0BF#2)!'C*&KA*2@%;I/:P8T2H
M>!H>O\E#HY<(7RJP#[?-N&*USKLLH^,B_^B!LS:^V6JW\;.=C 7?L;6K[L]1
MVO!BTSGCT8+'[)?5V6DN2J"<)%GO:6,=P+8<!S'L!8+ IEV;#T#[0QK"]>RU
MLJE$7GX#;F;'&I#2FY, L]&-R>RSTL0<X./;^YGX[1Z4\VQJP<>(PE]()=>B
MCYB8_DC!.XD@I ,8OZ/Y72"'&K:0)TX-">E&7*.D1+JXS3C@:'%@E6-!(V=@
M(H\E>_W-(X/B[HDS6(ZGW9UNMQ)K]579YALO-.\K5\NIK:@V7,8.ZU$HQI8:
M:2\[F&C@N^?' 0>>UE:?WJ(;.V8#/PP%-*D-OZ6.O?Q['@#O."LF$.Y5<!%!
M=)#>(2^#0@F:T WTX<%=, A B3IX-MG\&>E52R(EM,<,1K"=.>#,;=E4X2@3
MWTOYES3I/?GH7\Y=]T]G;DWBP1PTZ(4(<J,&5N<GV3T.80_)1$7+B<OX+)RU
M_(P)XCV!KR$_H*.>(F@./'BZ$AE/6T/VIW2^B5M,DSD8QSIPP,7E<_/ =\3>
M?VEJ%'>QNT%]\NJ-!_2^GR:8ZT#!?J?VMO]X+.Z_^XD=_!C(C4=<?3)H*XCA
M]&Z0+0.\BRAC:GU^<')J?5X&:=^:-;4\GQMQH(<72_.HP6.*E]3V$98-'UDW
M>:<1=<>)%'(AHZA-L&B"BDL!>+KQZ&^?61]I/[5G 2K^ !$/5.E<MC8N 9"_
MZ]DDF4)4?,#C!OX8^?'@!7"Y@EH1)&7&]B#F7$HB9P Q4%SOPFECPT5[1JY?
MFALUC#XMG],4_LQ<L65W67_5T^4!#<MOSMJ(%?ZB=1ZEL8>4M.#HE"(4?&Y[
MN+)YO6-VG9_QDT,%8\;NRK9KUSJ&[Y%_>TQNX>+ELC<OUWF>J;O&5#?U[,9R
MW(H/['O^ I"^D*4C> (FK(/1?_6'^)VRS;P<K2EX99 Q_?*8/"T/Y9Q%\/CZ
M0'30#-B/*F([.CV%V,"Y0>X:3"=S6>7Q"]6Q-!!^U'2=)"E VT.1T3 TB#D)
M2J?Z13<R/9.80/+E1%#W8F0N/ Q@+LF^C#PGV <02@NHH%=_('W/2B^*88QJ
MG%'3CU<!\9Q_$N9$(OF;Z2M/TCUN]P YX2?T<G1/.MFR8>OZ.G2/VU@%*0DZ
MHR;=62$$PJ6OI X-23OE=$KM:%!Q1_>G _<Z5F6KNYB:)SE?&*PKW_BMBST(
MOC3YXQAGM#MY7[BM2>.6W>LB]WWI:WP1Z_86!ZA;$"R"GK+(;2)H< I@I$60
M!0V_ HB@_NL=&\#*W$5O4/(J.GI?FSR( -U?= P(;@%P[&474+[M6!N^"A$
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MA+V'.&^"H2P_MPP%_8/ADF[DBH5/V&U2)U[PY'PWJ89N;3WW;GKU)G8>FPA
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MAX<+1OP=ABZ1'QU*F^1XJO7X]EO)HPN/+3;=%Z,CNHMX4HLM[OOX;W%^*$D
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M/% ]P43'4.^)8,=Y/(4ZB6(X/N$%%?Q4P$_L;F(.7_U4>[@(62$N'NJ.7-X
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MAPN2YQS[]5O5*@,5Y9S^(L>0V6.2][Z^8S@95M]W5#KC^&VMK0]066&JT_"
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M/C 0?GU4,JJ<BG[\.=SM1!@Q>[C!37,IY6B&=VU#HW;=74N%O7$-0)UP! X
MDV$M01>KV:R6 T9.=L5 Q9TP!]@Z*<7(=4Y<@:N$SYS:=[4!;%](Q-W!L&+M
MI*Y4I787(YE[.['QV-;-A8R$Z U0':'=S9->%$DR*/$);3#/"C%,X^?YS!YY
M<?C@_NEGK0773K7*?_/$D['ZF+N /=>89SC<K(OQ&]/FG:7W'KDZ/3N=7G.E
M5"5IW_63GU23/Z=V)GQ=OO!>-=+UU8_S+V^/UT5^^=D0<LVZ8Y+SL"S;>3U9
M^IIC8C_OVV9W#B$(G#4)Y"H(AJF*6$T_1V=-P*XK2Y<RHTBIS7+-]#];Z@X>
M2,X^]4J'-W;1>^?-WIGA6+U7MZEI6#7AZ7'"TY5A?JC)%$XYVX@)805U.I_-
M*/D V65-/XN[3FZN&3'981CMPC2U?CP[ZQ.0/RPJ]T(UB[KW0,ZX/+^1CR<C
M(8]P-=O'W@"Z99\BPNDN[Y=JRLZL=ZY<'B;^^@X_85!?18Z=78#H06_K[I$4
MF;21A"82#KQE/\.U&F+U>'["9SBW@&!94R<IG7H+[D=)0UGM0+[B5.^MHJQ1
M)NKN\KMP6GKEWB[(*S'&^ZB>I+:8KFW<0&P7F66'FEKD[ 5><#4PUB3 ^XT;
MD&+3[T_$+W%SKM&L<45^#G69H8Z.:2X6W\Q4'98.UR1TWG&\U4![_XD_+L3@
M%RA $[QTGNW-$2;\QR\!< NU6O"BW!E M3?L(T<+=!;L?(UJG8^S?N2\=UIT
M6)3,T]) AI@4F!SR]WHQD/DY_>:L7!8_'49[#:N!=VR DIL-TCL?^M=%8@^@
MC3BU;/$.*\_B2;<)I$*:[^=MB3?,6:72O\:P/EL"#W]X@O=^U;B#KX,=Q!'Q
MK8@),*V\AGL1.Z PQE.9E62M39")!N!J>.@W?CF:F<\?(=[_,O7NA=QWTZ??
MZ.=5IM^+_GL/"*7(U@A^&<P;%DFN?I!#BPAJ.U.7C+OCC^Q\>SE9L/!;6\5E
M$.,><%*;<B2[!QD">NEQ) $ML.-2L[_S-[?5WA=T>W-V\^-Y(ERUGE(<"DZ7
MT/"L)^^T5:MO_)BQX)%@>5A/ZTMEU->6D[T1U8@DJA295DT5@RIASH]!(3-H
M*^>&S O#.L'_U,PC'2QJ4]_>N8HPMKQF'M;EZC!\[^^QVN).#A3WY%2)1O>O
MMG+DD^MO#8=1H0]JPM6PW6,M9.(:!:<$$!@'% BQ?^I7_#N>!F;&AX(^+U]:
M_ZUYDK.93A(QI_B5F,!B -SF+%E8X/8K X;R)NGIH_:GJAR4\3#U&JO5RUI;
MF?3D$('=W(-HY#FV=]>,\Z)5#=NF$4G/.:1%[&$Z_UAS;+94GAU5](=*Q,]:
M7K39LYUU8]O7'U<?%)UY>;GN><A2'[2DYU2UYK76L1_YWPO>SIXQ6-'M_P>F
MX]H@\0V(=C?I:\/!5N^UF2NWTBR5CG_XT))F$[Z3;U6N2*]K/RO*J'M<2HJ@
MAT?8C'9N@+[\SA_5;^Q5^(LI5C!<U?J[W7\YOT=#\\?%QC')>G.'L[U:[CKV
MWPJ/()6F3U."[S^T*S0/N&RS/E73 /D*Z4 !JN),[3D"H$YFHKCJO@KSL9YL
M2!<Y<3VS'0R>[@T*UBHC]O1:69,N$93\%2Y^E)KHEO=(N+WK^H[MJBF59&_P
MN) /=_#3<3Z()XFL='N6_PH%DH#82Q <6I1K:&G.=*^S=MB?L0BOK7UBAL(;
M[OL=4-!P2V'O[L;7GG^D:3BF.LMQLWU -$4@TUS#K]X ;9>+KP&+(\D_AZ;X
MZ<Z#G(@/4VOLKA]A6 _L;VVV(=;QE,$TSQ"(>X-Q8-EGII!T4<63X]1_N=>=
M.S/#WKH37JB8SWKEYNUN&G;R.H+ISGQ('SOZN>O9NLJ_)WQA[GM$5B3?3HDY
M X\L,['.FYKE76"AGII(L1]:&2].T.OK1B812XF]JE9WHYBREQ:J5!.W5/@>
M;\_IDK85.H@(+X*=N10WAXN$JC:Q8K,94^2X!KE'?^!2N  @TS5W05OZ>LTP
M&=L0W3ED79U:VG\DY\73QS/?'B3#M5YFK_<0Q#?K2?H2(H4)./.Q-O80[^&8
M6/P[/X6DVE2OJMGPJ>S>"ZS4;34U-:5!KG#];)MQ1M+X(YOCNT'88X(),NMR
MRF0=YQ&_Y V_!"OJURP'.,Y97QB[X$*0_7FFN=*WU*DI,Z.NPM5E^[?*49I/
M^N>Z$UU%QZU+CJ9>UXZX)>1,UX5CP BI,6<%(@F.>S<8TB3:.I9%G.R+,C$-
M#RGR/4,;OCLYN:.@GOAXX=)\Q;-_H_/=@?4IQ\(( ]3'$$6!#'80MC,8D0P1
MK6G$20%V[5<5DV"VM=,JK_:]4HS;N?!YH?OG9WFGRQ5;I6X@JKW_,[DD0#-?
M, "I;JX1*FYP%,F4@U_BFRX-3891;^=:^>)"@@[8Z4SDA_Q[YBTO?VT'B->S
M"=&"-G*=W))V 5#4!JDAM#?BXANP)<B"\A?W&S+R[JV'<D+($X*>?66#VU5B
MKNJNY&NJ=EB\).D<9.-XTE%SL62V$8?%+LPMR=,F,,_3^!"*8)]%+LW2.ZCH
MIYSS]:3W(@$7 U_-.]CMR'EZ,RVOHHA3FP#B:0"%0I"C\3^0SG,-L9\W0*(F
M>N7H4-M!@:2/0P,\&:-=/$MU_NFNDD6UC/TLKV#ELZM.RMFU<ZB0Q%8-%:E4
MF_8@&V+ &R"Q7]A!!?$6W<=4<6J7@EARO^]:LPS0EN75,1#GSNI!Q__M\5ER
M*_,,NI_0*T$JEOO\751F*^SO/S,0[@QVFW#\.N@N^@:(F8AC2\Y@C,MX)@U
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M6W*C]F@F>[6U(4?PELX]%!&4/WXN,U&GH$=5[KB%4G%(D/87>$!9W1<'.Z*
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M]<>453G7!=!# !2U41BIQ[':<7E1_$7PC 9@6[7W]VV:75@3<!X-@W"/+=H
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MK]H(2GDO K*WPT8* ^4,'C<)(?]?5L91D-!3H/HW(*#'DD*O"J#6U&4"Z $
M[R40CSZIQ0 "?BC(^X/'40((_H&?4:&YP3U1A!S?2L)E7'Y4--&9.=RU^7M'
M?[G]!:^"<WM^K!C3NK=414WY;%2I_S7-"5],!6#V0"!V".:ETAS!=>()^614
MQ[<CQ(4%>@..?7NQ3D#P=WY60U?.C_K-H^,W%>GW^@OW>7][U5GE.'/-/.YM
MW3/'>SYN\XJ>%QB6LZ46MV4I'74<;0G9X#"$^5FS\1D=((4WR0_PP-3U,,@S
MNF.+X"_#;D#-#*=0WS;.CED4OI0.FK[S+L]0Y4K<C/)[=!. 0<E-YIR?S2,D
M7*.9X+Z=@6>51^Y&4B=]W(TN3QO9 VK(9*07L(U<;O=R;(7M07:##-S]0@ Q
MX#N@Q$UZ?-_QLW,4-MA@1+>\41"-5S78?1W-J3DT0)&>J[3Q>#@2I ;4I.:,
M;Z0']OU;QJ93:$PXF6\ JLN[7 D!Y (<ZJ,'U D*OY#6-TG2 ?.C N-Z_C-V
M=38)*TE=CJG;FC&-@8</ #H3@UF^G[0S#_5$>GZN7VV'RPKA"0?:#V> @@AX
M_S(43.XONUC!;;QOMDE]Y(%](*XWUN P$(NF/ED[\V"/UI_M^M]ONU)E^&FF
MQH@AQP.Q?(*>8+?()]T^HN?@4.6969WCW.TR%&CGX-"Y/<?8;Z90_F#50D6U
M78MZWOP>5C%144YC.<#M#7L ^<Z<HK .X#H\=K>2E@UT%-SW/)NR(>M,DXN+
MB_.7#>FR2DZ78I[4Z,\MEJF65I3^4#XO]F2TZ-2/6/0L AICL1+^+4P!$7];
M"L3RBG\5EQ?4R7A&D#_9G'=7V<%7GR!>[+=[FAN=\&-+XHF)G=N<:HTC$@LT
MH06FZ^$R?_B$;43JAKN60:@9-0BV:D9U?@\*K]IV^.JY4QV2F5?K0!&H)8XW
M+*O>D-A8<V-NU;++H7DB/)PY2>44C448^W+WZ&?8TV>IC6K5[4!"SM>V%T$)
M1G%&VP.LM'S57USW=/)U^KB&J6\NP[^'<;5Z_3JY"WABI Z:!+XGC9 3&($_
M30A+(65E(![5N#.\%<\+93<2:OB48).KJ5X[#"K-=#M?.^<4[ \[>^Z!: .
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M7<0#V0H0RE:1%P<,)=%$*IIMR&^3PC1F<#J-P)5G]OY\J&(*.(QY70*HWET
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M@T F@+H215AL1W@!/W>@\\6L@3U499.G>"; )(#00\+%>QQP O_662RYWT!
M/AVB28U+_<]/T<9=W#8#MW$OV9?[/?>/K^%)/3_L_^U[/I=P6P"%WIA&)2B]
MN?AGH1<R#76T2[Y4MWVGE2=RG(1/Y\TG78*3^.#-$URM\'ZSB+ A$=J!-<[
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M]Z+3AQG3M1\VO2*X3FT[K$'RYAEY>CM.9QY\4] 5.,C? 5=, 3'E&M(4,!^
MC<F_?)Y"2\$(UY/:\),6V&J8L>H9/*Z.8]51\AOXTK1H"K+;&X?&@'-W+Q)
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MG2[9RN$I+10!%/'I8;(3C[E J_6=5W^OEGLSY7Q#:]X'DD'QL=^YEUJNA-7
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M56"!KIE>F 8S.R6QX0'\M.'BSQJZ+2,;_R_X?<.+QTLJ>P \*1$+PK-J%'M
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M<A,[,8J6=N<&P!-?6\\/V# $%$= L0043^#C#%C:W,U.C*GC%>T$V%I>W8[
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M3;#E$^PQVEX,'!>!LRV--V:VS/3*]. [%M";&'"'JGH>@/)6:&\,+S/7WO,
MVVDY/A^#.AHYN\XM&_-)UU1Y>_] BDHKZK8P$4XH$RF*H(AB=5X/\@CF..60
M1$P(S,.,,BL7G1'5J0V@O9Y%K&>BC2:] <66#[ <*CXT E%#,\DW3I9&TQY$
M&_I]O:8="Y[K,UF)[,NB,J(YKWUE \.)M67ULIOBZ(]H]9?REBFCKA)OVZRK
M]K-%+H*$1()"PD,)$1%<=VT24&*<YG$H8BJ8@VDU1',>R^FC^ORKTKKM+6RQ
MHVZG(@:Q,],,HZ%P4@@;JJ I04\7O#5 P5H+F(CG:?$/DIIUS9L(?;S4C=YQ
M]G_<%]U(MRO>W3W?"66/B'JA:_$R% 0PY2'29Z<$$DHXS E*) YIFJ1V!L%E
M6M/[03:4VPOX ]K6+I&+@!F[17S 8.T:<4# Q3ER339_#I*+E.9VDEP3^8RC
MY.HK]AT5/S.Q(E51?JS$8U&NZ^73)W7*J-0>N/%I"L$C)2*DJ8@@8GFJ;/M,
M0$Q")O,(Y9S$IFT6KQ&;^B:^!CO*8$/:O./B5:R&E[)O!"PWZ%/)/?HY;60;
MT:SQ*HG9.CB:"KO?UM'XG9EK)9W>HVQJ(G&!HCS(88 ##%&():0$QQ SAH7(
M Y8D=LWG?7,XL<+XL&[J1FU\^K:T96QWR7KF8OT9*N-<G#F+*_3GFH\?Y(+\
MAZEF<PW3YZY:<Y&_/T9UFFOP>JM"<Y608P%_-=;=7:7]$VKX#_*3>!2KM7A7
MK,3;1MS7"YZF6 98WU=E.42$*Y,M%Q*F"4Z2,$<H95:7S]<(3JQ[#\EKITK/
M /A=LP!:'BR3>ZYB:*8V?2)CIP5'@F)?$M]04E_%[J^1F[>,O:'P)P7J3=]S
M33)F^G'^VTK)P0M-@RPWWL</=%ET=.M=QU B8Q)+[9)16@ B'E*82Y+ ,$ )
M12ACA%GE#EIS,+&JV/ ##A@"&X[ 'DNV.<FV4)LID$D!M-,H%MCU67Y392P[
M0N(M?]F6_LS9S([PG.8VNP[DIJW>B;H68MM$[IV^F'[7]U!\VKBH7ZW%?PI2
MO2D>Q2)-I8CRC,$L0!%$<9Y PG $HR0.HBQ!+$=&?3)<&9A85ZDO'K930M8(
MFNF@*7&Q4T$=)S=[32-;9F[ EIT;?:M$1=N/X09HCH!FR9_V<07#D_*Q)C^K
M[G$%YUCU.(_CVO&L*AX5I4>Q5Q'T=L7_0_ [4;_;]7%=,!DPB02%*><)1%G,
M(8V4?40(8SP4(6+<2N484Y[Z"+7EXZ"\K[[)Z5C9+3'K&RUS= W/5%-@9GFX
M\@.70]\Q2]&]M18SI3MS]S!+.$X;A-D.X*I@N@*$7\AW-7I;:WAO\/=EUY%F
MU2PD%3P/4@8C'.=*OX0QQ!'.8!C2*$-1C .:V^D7,\*3JY>^ */BHUTE7=WP
M/5;:LN'L2@KH.&Q-M8M_Q&R5BQ>P')2+G>3>=(LAV9E5BQT8IYK%\GW'(BE5
M558O2S44:\]BNJE*59155YKQEO_7N@_CT>GX?56[G0\SRIAD<99J\R54VH8R
M2)1U [.$93ACE)+,RMLSBIN)55#+&]ACKEU:+7M]\5*PQR#8XW"$%WG<])@I
MK-E M]-B4^-M7YC$!TZ^2I",XF7>8B,^8#LI*^)E4(<0ILU@OXCRKB(/7PM&
MEK??BWI!"4VY.LI!SFD&$4FQ.M@)! 7-$Z(;[3&+V*5+5"96<?ODP.^:H*&Z
M&H9F6 UY$]A.O=C(:A>:=$V6,3%)%\>>+QCIFG@'44A7'W9-N=0Y2LHT>E74
M;%G6ZTKL7T&1+*?J"*0./CJ2B%*(*460$I&F*4<Y8T;M3DR(3;P@.]+:CK?U
MF0PB9&87^)+;;EWN1 8[NN#W22Z"3"3TEETX0&KFY,'K0I_F!AJ\,W,DX1M2
M5&WI^-NZ7M]O F$>A*X8]JIX++A8<5UM;$'B+",1BF :IE+I@US"G$8!S*.$
MTB#*18BM7"*3<SSU0:8G"7A/$SP58FD8FSS?M)DIJ1]J,NPTG8<P0RU$US$#
M[(EQ [93O)&D+0/Y P0>VJ+^W(&(QOS^,0(3;>'W%JAH3=AM,_EE310KC3B,
M+JCN%P2Q-%8',2BESBS)\Q12D5"8A5)DE"4)DU9U>R\1FOJ MB$+RAW=&] ,
M5=2R \I,Z_H0W_*XUE$LJ_THH1O/M<2NB>5)&UTD,ZL2N2;L\=J_^OS(HYR.
M%EJQ8EFT0[?>''T[O_V[J!>2YE3F80HQBY0EQS,$<9()&)(@DBSD.,U3IY/=
M==H3+^S.K?FDHTT:=?(I6L(__R2Z/A#6)6[,(;4\"OH%RM(AW)82[J[,MV?$
MMKSU(5<WO9.XC=W9/T'?@-M[7;ET@@.D.2Z^SY,&E)_G>&D.R<73IL40KLGE
M2B9=FD*/_ZFH_[&[.Y$LS\-8*HL!<0(15>?'G,D$<BQS@<((T< RM_P2J8E5
MRP%AH"F/N(\: ,Q,D_B!P4YQN"+@D%Q^33AON>47"<V<6GY-X-/,\JMOC G^
M;0/]ZJYOTL[?F7%.>8PE)#13:YDIPS]/!8(1E9RPC%(<6GF$!VA-O)@[FBY!
MO>>1,5NTGN2U6[6;4-V.[+0]S P$]!I^>Y[2,T3:#HI\/JAV^!7[*]5?R7^5
MU<MUW:@]O:K;"T-.,<I#&4 21RE$:81AGH@ 9ED88QP&68J-T@O/#S_U?MO3
MLKY /0/$]9O3<>)9[J.&DEE=EUX68,0]Z9E!9[L@O2S0_LWHP%..^]\N.*SO
MR+#M=ILS$M @1LJ 32.]G-3"8J$Z.[-0T(SC($ZLHK0NDYI\:;74P'+'P%\M
M]\++*!ENA5YDM]P)]P,W-QA,T?OWNG"^=L'+A.;=!*\*?+('7G_#JQ_L9=LU
MZ>UJ/QQ4[<)-K;WIG?=]N2R_Z2;TBS@.>4C4ZF8L5NL\#-2VB5("B:"")B)!
M<6RUSL>S-+4^Z%J<%2OPN"$-R(:V%Y^9#?RC7&D3@3J5AVV'_$&P><<RV/(,
MMDS/YGMS '):EYP-0S^"I\X!0$,'GLO(CD$E:UJ+_UXK[?SZ4?WS18WRJM3]
M.18241H%*8(!3@*(.!60R$@H6PCE,LD8Y]@H3/,JI8E5WXXN: D#31G\WM&V
M[4-\$2TSE>8% SM-Y2B^?:##-=%\!2A<I#-O8,$U<4\" JZ^,'-4F&[MT3SM
M)>.UF3-?E.;I:R6]+]O2M((?]>_Y15]NOE)[W394X5.Y7+XI*SWJ(A1QGF51
M!J.$A!#%80CS'#.8H3 /N%(=6<YGB2&;1KZ)E=5)&[F6&:BYV0]AVO8%GRD4
M;:+OBJ'2_+&X_J'#W#J1#S*ENY3&1DF]J[6W%?Q,*[I6>'#\C9OB$/V#3NQS
M1])-)-T?(^YNVJGU%J4W,9MNIL!^Z*!HD^OW?#"_"J*#T?F'E3IJK*NJ6-VI
M!Q2;U>97)611M\6D%B&CL<0Q@6FJS'Z4XPQB$3-((I1A]75@"%MMXMXXFWC[
MW2D\W>Z]I]YF4^ZSTY?<LCP[^)L=LVWS63"WV_ \P6V]\7B'QM.6X8^O696]
M=SB/U;1_ J-KB^PQL/GT=1>"V.X$!QU]ZJ9>)"05),((QHBK8Y%,!<R)5&HU
MI"B+\SQ,X\2APXX[1T:K>G3_G:W/<]NQB^BV)W5;XJ[MWF5=X<AY"LS4YL2(
MCB]3<G#'M?U+S]A-;^X?=@(;0GE,[1)'@/Q7,[%EY+GJFS@"-E#QQ'5$QQHH
MI-*-F^N/HFKMXE?%<JT4PP)G$4&"AC B&=/WYE0I-A9!G$;*5*0D82BSJFYR
MGL[$UM][T8"'JI1% W[2?03_#![44FI[!P#2-%5!UTU;:[4I-6K%BE1/W9^_
MEDL%HEJ/O&.T;3K E6%/JGHWB&5P^B6PS?28!P@MK\1Z@COGE%)/'5&/E46&
MI?)5,^0"E7FK@0R+>E+GX\KC=@N^JO_!%\J&>EM71$G9VE._?>X;Z@0X1T&8
MJ-6>,)U<0A D&0XA#6.!6"BS3!H%G0T1F7BIZV(GNE#[M[(RS><=A&1X3?H2
MU&Y!*B*PHPANNR.5^OAZ=R%SH7G)6N='ZS297/@#:N- &*^/3(3JE)%^LM4P
MH?J_5LL,OCN+BC'A?J-?C)ZU4RY<%#JZO5'' :6MZG*U$LO7]Z18WG*NIK)>
ML$@HU<(I3$6>0X0X@WF84$@(SK(@DC%*C-Q/UPA-'733D09;VJ E#GKJ9BOP
M*EC#JL<G!';JQU5ZXS5H*MH9HZ 6["]WY>//:HC.'E _[,R JP//LDA-Q=LL
M5./G'>^9V5?!UTOQ07ZL2F72-D\?U70W2B%H7_B#ULR==S(C,@Z"-(<8"PQ1
M@#*(<YY#2N)4&0Z$!B&SN@ V)#SQ8MX0OP$M^=9+N67 S2-L#*GA/>D$0-DM
M^7$8V=\?6@KLZV+/E.R\-VZ68)Q<A=F^[Z9&OE2MN_;I<U.R?[0^W04+0APG
M-()Y'%.(1$P@"<(4YCD/""$HPG'JX!H]I32/RW-#MV\Z"$C3^CEO0'P3Q/@&
MITF[+OY'5,=>!/5LVZ?\E6"M>?7/_Q2FP;_$X0W0W\'V+?5#= /4HP]=^.GR
MR4[EG('?3+DXHNFD1K8(ML1NNALB?VKCLBB>%,09 K.J@LL"'B_Z@2?=EO<M
M8SIVN?ZDOL+%8]MF3S1]^/^"X#3@B4 P2%*FBU(HBQXC"GD0,9RB"&7$*NI^
MB-C$UL"&M%J*&]HW8"4LZZD/HF6V+GUA8+="M^)_VA.?2 7D+HX=2%V4N!*\
M:,"[LMXEY/A;R2;">UK3@Z1F7=TF0A^O<Z-WW%9\=\U0WC]4XJM8U6U_!QW3
MKJ?\):F_OE%?A[;'PR^D6.D/;_771#&R)'5=R()U(3<K?9GQD72=&=*8I[%@
M2CM$ 40I#2&-.(%)%H1)D 1I)*WTA'\6)]8NOZV47NXN[^X42W5W'2'J/X-R
M!?BN(4JQBS]RT#X3S%PNDHC3)(59&$N(\B!1,Q<ED'"941RF+(_IXE%4M/QC
MS-T^J\:SU]W LGV>#Z^5GGV:S+:6YX7>;D/J;[T/,.\SLW[2K/U9[3Z*9:!Y
M[OH&W0#-]O:OW>9US'QK<ROVU8&6^-VZI@/7TX8W 8.S;I/3 7R\N4Y(:60<
MZ-O5P[JIWPEU3HS[.YM45_6500P1BQ!$*%#'[H@E,,W403N),"59Z!39>4IK
MQEC-CKBN@*+(@]@Q,/,,7&::TA,(=BIO0/[KEWSN(9.71?0=!'F&TO.$-5X6
M^6*@XL K'OQF2MG<EZOVFK]>Y,HTSK2#/0E3K)>U6M&(<QB% 4-1CA!E5D6[
M+U*:>#WO_&::<!M!TWG%+.VERT@Y>+I<Y1_G\.JHWG11-!Y#]ZZ*-H4#[(#.
M\_G!SHD[Z X[^\+,.9I],LD'I4L:98H6J[OWZW9?2K#,TD10&(H\TW7:,,0!
M"R%/J-(&1- \31</;8N?SPVI&L.K-M]\VBR98V[-;?\=U6[%[/+<J+@K5CHL
M"E"R;)U2SFK%_QSF(HIX@E+( D(A"BB'.$<,QC+'*2&94+_U<_AZQ?\P,[CA
MU<?\B>[3'W#R#*]DGW,Z[/8@#\FGVVG;8_L&=(S_ %FCUS!][KS/B_S],3(W
MK\'K+??R*J&QG<G;+*-M0ZX/\DVQ4NJG(,N/99>X\OI[HP_Z="E>K];WHBO1
MNDAX@'#$!10228B2G$+"LT378B2Y+AT7$JLZR&,9FMA>WVO,W?*GS-5M6\E2
M@BV/8,,D^'W')MCCTS)J9O0\F:GN.=&WT]0S #^B6_HXM+PW47=DYYEZJX\#
M[W++]9'CVI>JW=6I6O'_;TV6A7S2>9G]-:1A)4GS@28TBUZ_!)O0J!L01C#(
M;_:JMNG[@1U;8'LO[K-<ACT,(^K!&A*:K4:LG>#[=6,MWW0\V6M/P=NZ7@O^
M:JUSC;NVNJT/L/W;ATT')U&Q0ADRBQ0E@4Z+@TG (H@PT5>DZN2>Y2G+XCA.
M16S5F<6:@XG- LU*>UA36]%Q>-OZ02T9T3.B'^ARZ\J.0\LCG37RAD>V*?&T
MU#VM([3C!73,]/V\;S:._^Z1GB6PY<GC:<L5#E^G*6OZ\YZ67.$Y.0TY#V2?
M>_.E(OK4]/GIGI;+11RP $=Q!DFF6T6E6::; '.(49QF.1)2B, TV>9@Y,GO
M"TCG,FJ)F2?3'$H_K!1&R61[!V DCE5VS%G6G=)A#D>:+?_EK #["2_G'W@>
M+WU;VJE^N^I6[M6Z3PN),,XRPB'G:0I13 G$/,B@P!%%,HC##-M9 O/R/_'R
MWM:E(WU=NKNV+AW7=>FDOOI^;.O2:2NCW_W:!]0+Q0ITGF@O6?AS?ROF<2Q/
M.-?/YW;NA-+SO[&2S(H;_CB^:<=I^4$\U[;<_Z'\VHY3X]OK[<J&VY;X7C2[
M6+9%EJ1"T)Q"Q!B#B))0;5B2P3!C) CRA! D%DW9D*79AG4PNM5VLJ5AK&=.
M:KO8[0*'0(A82!PP"6,LM,G,,<Q%+B!)4!)%<9['(K'9N=V!\%#D9@P09IN5
MLWAV6XF6["#FUY]>/RN!)ZU[./:L.O&L6,<:Z_Q#OEHO+60F\IB0 &8ACR%"
MRA3.*:60A6%"$IP%. YLE,HIB8DURQ?]"F"G#9?&]EMR[K,TW1([UU]IRJ9*
MGI?:&0+/W$3ITJ(;>'+L[?;+OA+C7O,*(6*:L%A CJ-<MT-BD,0!ABPA,F Y
M%^H7MYOK4V+SW4IO:#OV^AA$S/8.>1P.SO?#YA",N/&]+)OWV]PSI)[IIO:R
MT)=O80?>&9GH\:JHF3+FUNI;8=FE;VB(Z;ZB>XT%]NA.TF3 1$#?F0OG2#U/
MZL* T!=S%X;><?R>EI4ZJ*ZZG8P]?5''U%J-JL^S.NU)_[ILS\&G_:A30G$4
M9I!(?>X,(@3S*-:)2S@-DECP*+$J+.K,R<3;5L\7V#!FF<'DC*^ADI@#-4L-
M<@08V&>J2]O<8POT+;$G;8T]&B5?:LB9CWEUU%BX3A38Z %=G63?^J@2?6U;
ME2OU(Q-=5Y!JT\EO_XEBQ8J'I>AJ>Z54H(S&ZN@K0V5["YI#&A$"98YPC##-
M2&359F\4-Q-KN1U9';*XXJ3B-?CMH;W3T4MVURMS[\DMAVY%UL;-CJF#:R;,
M[73DQ' [>-$\P.3-ZS:&EYF]=!Y@._7J^1C4T0LHZEJ(#P]MF.GJ[IT@M:AW
M-@G-J#+QL@0&7&00D3R%A",*)8K"),DX9LPJ17V8W,0JKZ-FZ0H<QL?0+>A-
M:DL784M7W\KVE$%'6JF3*8PN,S%]^0^'B<WK2S02_,2O:/:60['X+^+^H:Q(
M]=2U1AN*9WNI>Z-5M;+$/LCNYT9'GG_6_7I:E^="YG$<4QV)EF<"(D8"F-,@
MA9+Q4. LDTF8692$],Z@T?(974ERQX8.<V$[1L!#M>G[TD?6%JNF!"]U01%P
M>S[L]NW'#Q8EW[W.YK#">I[)<8O1VW#9]]G<Q-\.ANCNS>('"?8X!CN6GVMF
M+"KX/]<,N97]GW^F[%H'3('F8+\!KP3G:U(P!4X'G0TF(3#Z<OQVQ5M.^KY"
M'6];SS[*D)1I'D-.\A BD4:0A)1"CN((A1$2+(FL#&1#PE.;RCLVVN/IY[W.
M2O_\3]H+_"_]:G:^61_&U?J^W1M:SK?PVQ+KS=,DMR>VPOJ_J!\F^US7]T9@
M#%SJF[UOG]KQ6IW6FZ?7WUMO9YO9V2FPA:22!%F$88!U[>6 1A"'4:K^20(2
MA %AF9'.&"(RL7[HR(+7W\&.<+^%FV=_7 1H>/'[$MMNH;M(;)4@<DTDIUR1
MBX/.EC9R3:S]#)*KS[IMYKK!6%4P=?#3)2#5<M?_T<O\D2RUD^W\IWW50<EP
M'H1")X6&""+""<R%R-3:#>. RH2I?=YF@Q_#S,2+NJW*VCJC]0][U!VC=D;A
M;F8 S(6FG:X8 :2U5> # 4^6PBA69K4>?(!V;%%X&=/!V=<G)M0?Y-'Y:9/]
MW75<)FDJTT IKD0P E$4"TABF4$2L2P77#+*C3SY%C0G5E<;)K1#KMGZ&$1G
M@!>;U'>+OM8V<!KXT?R#9*>%]O$Y]L& ;6F X8[4SOA8>+/\X^3FI_*!EYWG
MR4[R09^2X5#S>8OL9#OP UF^ZM@=YY$42WV!^J:L/BM=_$K09N<^NF7J&[1>
MZLN"7ZJRKG==('3FQ0LARTI\(=\7H8Q3I*Q &'#=?C?%J5*H,H ,!Q'B@>1Y
M)!WZ97EA;IZ+D98#L-<EXUW;'L.R^8Z7R3 S&>?#UC%BG#9[/NX;L.47*MI0
M<WP#]K@$9R= EUO5K.J&"1Y[_/B$SE<S("\\S=LUR">,)^V%O [NIEM?:AQT
M?+W>?S\5]3]>B!7[>D^J?_0I&RGA,9%9 GD6Z+"2A$$LE>[D+$4A(2*DL5'7
M<E."4Q^<]\D#31]L&7 \.U^%T$S9^03&\@P\"A-KU60JJ">M<Y7<K K%5/AC
M76'\WM@VQ5K-L/)NI16-4B^*C)!%4W\JETNEIG1*?1O+MHNK$KIX.LTCF"CD
M(<I% HF4#%*6XSA3=E7"K;QN[JQ,K#HVC.E#QSYK>N,&&^: Y@[T[+GV-;:>
M S,-,P^R=KK''M0^P'::9(3Q$'GOEFS-R#/U3W8%[')'9><1O1:E[%I9G*^-
MR*(0LSS/(<4Y@@@CI?MHD$"1BH!B];<DLHJYM6=A8IWG7I9R1-<!^WF@1(A8
M"@3SE%.($.(0AZE09WL6$)Z2- MBA[/]1-,Q^B _T/IA4]-R,R]\UGDPW(<F
M_99;[C\>"VEMV-VKI35Y15$#T*8M*3K$P(]04]0 (,.BHB8CC;6^7Y-*]]VI
M%<5-/:N"W:[XJV*YUKKBT.Q+449#24(H.57;3YJFD$K"81"3)$MH&L:Y=#.]
MK?B8T>[>\*675[<F;T#+6WN'VW/G:G;;@6]K<T\&J;O!;83F3/:V$SS>C6T[
M+I[)TG:"ZK*9[3:<FZ;K2F(I8UX7]5!$VXSC-F4TBH(TSV4.F2X)ATA (&8\
MA6$2H3!&)"?8*CKW(J6I+>:NE)H^ONY1=DO"O8R6F?+Q@H&=>G$4WUIQ7!7-
MDVJX3&?6Q7]5W./E??V%L06Q-F&Y3_:MA @.<A2C%.(8J>-:EF60BES"C%&4
MAVDJ!3&JG>Z3J8G5PEYUJ2V/\[=^&C%G9AIG[IFPO;"=91)&% 4;CYKWXF$C
M6'JF(F/C0;Q<C,S#V#.7V6__^9NHF^U!-ERD1$9$6560QR+1E0NUL15%ZM=(
M!F&&<L[L[FP\,C>Q(FXI@L>.9%_Q?J;2]N=FPO 4^4SXSNY+ZV:G9]B_#VT"
M&)^[B/PYUOX8%>('0/56_GV(AJ,!O"WS]T%>9:N^Q->>#R_%>900"AD7,40)
M#F#.J(1A($4J8AR@T.K<ZYF_J<WB+;?:^.H4 QU4(/5.@]!3#6)I&'N>2T,;
M^?EFR-)</C,YP]J]'E3ODWH2)T+5ESGMF;MY+>MIH#TQLB<BXQH8>7]?KMK:
M,"_Z/#<A<")%DL$$)RE$-..0)C* <9ZAB"8H0MBJ4_4IB<F#'S7!ON#-"]LH
MQQ,\S-3=."GM--:A@.#WCI[7V,5+PGB+5CPA,'-\XB4!3R,2+SXY;T'0=\5*
MO%5G\7H1A'$84,(@10&#""4($AP)* F*11PD66X7CC.:HXG7L^+OL ;E/H<*
M^ZNE*C6CH.5TIO*@N[DR4QZSSH"=KID%_-F*A9X ]LP%0W?\_"&*AI[ YZMP
MZ.G 8T-,CIJ?O5]KU=U;7/51C -.4"H9YC 34011R%.( QRJLRJ2/(K"B$F[
M^$87+F8,+SEI?-CQM3W^V#;;=@+=-K!D(BC=PTJNHCA32(D#,-X#2FQX>*9P
M$@>8+@>3N SFJ-&*NU4A"T;4P6^G-W6)^F*_[&_.41XD2!F!J0@@RE,!,0_3
M]J>8(T%1;!<C9T1V:IVUOK_7D=AZ1>WX.; S>HXL%989IH8:RCM2EBII&)F)
M*BO;2>U+WY@1G5?!6 %QHE'LWI[H3O6BE^DH /A29]G-WY4YQ\0BB1+&0A)
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M/FTZUGSMIRVE.^@_;?NN8R3-B9FXS9;)2<P8A@D*0XAT&<<<X1A&64AP%-!
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MK%C'R^W\0VX+Z\-#V]5B===>MFR;8KQ7[+8.C3;W-,QPEL,X%BE$(M)US<,
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M.UNNU3[U1L&FV5UW=\ ?Y&M2:5]\K;AHN>U\9(L$YS'"E,,L2PE$5'!(PYA
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MU]<^0;?C 7Q33( -%Y9%?*\#:;:\_<)CM]#'(F-?=-=86%^U=:\3G+>$KC$
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M@F-"HBSH)^KUBO^0T[3A:\))$NHOSS(]48QQ(E$.0R8I1*E:4;E(,0S5025
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MFC6P3[NU,V_ %OL-?P</W8"/.^Q_'<3>X7SM"2]OA^RQ_,Q\TO8$W^EQV]?
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M1A[Q[4GO]NO.JEU'XKS6H>,/V&E*56X67[3+=OVCJ!9I*E*(0@'R,,( (8(
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M(N.6&SB,D*<$/V,Y!Y/V+J\R7R*>L40'R77F3\T\S./SOFD,9$F,4@9X&G.
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MZP8FT671S,']L!4WJS_$C\W]=['\)GY?KS:/U2(6(:)(1B"#A ($J00YC7/
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MHR^.S/8@<])6&\B. 6/;I.T'TQWCGOL=X[9=Q[BB8ZC7>,]+W[U3()MM"M-
M9V?1+_39V_'2Z[,W>7.] 0"F;:IWBO#/T$QO !##)GI#*XSJ05,[XFW8.8<9
MPC#, $.8 12&#. ,$B"E2"'FL4P2NYK'(Q)37WEUK5;:0]Z8-C-]8 ROLD:)
M:WES92FI:R>9$\+X;2#3)_ 6?6-."'BF7<RI3]JI7E5N%CHX?RM_)W]?E^^5
M>Z'\D;+]DM$\@41"" C4Y;(T1T"=)SF ,DHCCDA(B%&JS""5J16P)6:I>L/
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M%?PU24,Z5S1\&DX;\O-;00=P3IHTEW7<[--_-7G%71(BSR5*, 9A%C. <,X
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MS07UM?$;4)S7'S"'X,A-L'C4P7OX&]%UOYLZQ40?KJNO8J.\>[Y(0TI2AB)
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MI!'5J:-X#0_!S4JNRR<RJ"HCH#,-Z'D&Q#:VUV"QHS]/H-Y*:F]A/Q.:,T<
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M15VC/<JM_2*>VRB2.M,]E.3I>KMY7)?:-E\_Z1(^N)"Q>FU8G5PQSG(]<UD
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M]J(C)SI,V1DW1VJ/K2HFZ??+UK1)S!:_=AD0_2JD.XW<5K@#R':K/@YT;I[
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M\FF_E;E?Z^\70CXL9OH+3!M6E85H6V"T5^CXJ::Y%)#H90M2@B! $ E 5*X
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MY#3+\@)FJG+B\'$1'OLMO%RLE_.9J _P6UV26IFZ$'1ILOV.+V0G:.T<1BS
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M#TT)P%O8WO"92 L/S;G,6'CTN7!=0Y]FZ[_?_9RMIR4114[S$DB:Z[=I)E/
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MMS_EBL_64DR15)F"4@!&20F0$!E@LL  ,:17;B8P+Z!C\<&PQ/@5"+7\NN9
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M*B0E@##! >*E#I5P@4%58E5 3C@KK6:=GKU[[$Q@)\[,*3>M4I;'<N>1L'"
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M\U)&KD49-/6T$F7XX[[)C_7LVZ(^/UW_AQ3?ZH$1W0CD-@/.RX)32B6 2&8
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M$."T8H;M)@<DPP@4(L<(*I4Q2EN8WR[$,X/<:?"O!?&P2XT(FIN3?1%8.3"
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MW8!3(&_GH\&H#N\&B(Y]WBVW\BTEU%Y!KC<?Z4R8N;051BF2@@.&10D02U/
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MKO]@LMY3E58ER=/*,$BG  FF $:0 5EF&A1.)!78Q05X:1'9-;R1J]D/:L8
MKY/MNCD/T_KT(M^DUJ@>UFBH/LS"^6KT2UH%'5V'WZ.P<RG1 79S-3&Q=79%
M-V$3R$7YZ3"JZ[H)IF.7=MO- HW8G):0,$04!9)3"A"I!&"*ZUU/5K!,9;D@
MJG0J:#N6,,IQUSY\[P9KWCA7TW>>9L2MRLD<S8C#,T/O/D[N_[S#,B_N*RY^
MT#-ERK]+L9W+>_5VM5JN7B]7*\GKY.S=0M2\@,V9^'[]]UCNOAB"\2F'>G&*
M+ 68"6;6)P<$$P:$J"HBB%224<<DXLU*14\Y=BJ:UUZM9-+3LB9E/R!5W&N:
M]%1-OM;*.D8@ 1Z99=IRU,?@F.0<!7_WW&@PR$)E4F]7:-R\:S  3[*TX>[L
MYVI?T_5W\_^F&ND'G3?-4^O-:L8W4I@_:#T.?]'[9*-;1QGR1C;_?5^?<]1O
M@X88_I/6]ZU2VK I2FF)&4< J5)IMXP*P%A%S.$7E[+$.*.%2]@TKOJ18S*S
M89EU_"N_B%:?7Y-Z[N#Z^Z3^WWJ::6M ,ZESM;.O_H";WQ[Y^=OY^)?[5-W>
M!Z_KIV;^-WG;?VI[W9/F(^8Q'OWR\(KVC;%CY_FEL^O7FK*G,2W936(PQB6-
M=>%>(\_S5 *]<D96?M37T_,\F.-7V3-IX5&A]L?R1_W^?+_H9LATD[K?;>=J
M-I^;/QKNJW4_6Y8Q49"BPB MH*E8HP+0K.0@)URQ4@J>*:N2#7\5(F<M.YVT
M0]F/=MH-HN_I5?."K;T2EC?@/_SJ& =5-_?_P@%U*)F+#JQ?"9TCP($*Z6X"
M8["PSN_.XQ7:W63Y0>'=;7?RV^KH\-J\=3ZNEC]F0HI73W^N37O%N]F"+KA^
MR=SIC=>/NI5R-^0@IYSDLJJ 0D4)4(D,H:42H& Y)&7.:.56IN>N0F2?7T>:
M:K[\:YV89YVH3I.$[E3Y=[<=A0?,=KN"N."YN7:S5:NQZ[0Q[7.__-F<1_V:
M['1*]DH%'5%Q.R:!XFH/!4:-C?T!.HYO;[B3G[]J&L1,5]ERH;WAF^4#G2VF
M908E%WD*%"YR@'*>ZS 4I4 6O.1,/Y_2K83FK)3(7J=M)MT)3;XV8AUSSN<!
MLG,F-YOMYB_<+79V!8,6!5KMYV6,NJ 'S3Q>L\,?]IEULUUOE@]R]:HMUBQH
MSC@E$!1(%  )J@"5O )<%(A"I6"96:W&<S>/_>IOI26O7&:9'-EOL2F[P2K'
M;-O.(!]:UF/+7":M^%OH.2WE^J-SG&]RWH+A&25'UXPX9^2\MH>S0BY\QG?<
M+]W(NX7X7<,X_W^VJ]E:S.ICFO;+ G%)>)XJ  N2 J0X!52E#$A14L(X++@J
MW.;[#LJ+[!EJZ75.NI:?]!5P'=$[C)OED6\X-!S/<P> B%#?;FEGL!F[P])&
M'JIK9?KI%%V[R[QY'T^FCC>3ZE_3U>I)-5F)>OR0OO?WJ4"E0)!1($EI*&'3
M$E!6535QD1*5@#AS&@#B*#^R5^C$U.M!R!]ROGRL<VM^I6.NX-JYBHB0N;F.
M73K2E)\VJDR:^OA:F^1 G?I$L%8H*)^D#Q+AZ"6=I(_--ND#S1GR2:_;>!9J
MM/G1+9WOFY6G1"&>$QUS$)(9(G;M?# QU?0\):HJ2$6D4[?=62FQ-R)[F<ER
M)]2QC.$L.G8^XV:;';<I/7/OKYOK?DP_9$ZHT_2S,L8]]!XR\^1L>O##@:*#
M/:W*<KT^< %3!+G)$RA \T("E"H$&"LS0#'BD"&,2NS4].(@._+BK9LL=B76
M<RW]QC!@ $7/$" ,-@%>_SWJ)*W)80@0\<5_W?Y8+_T!R<_[PK\.R=67O<4M
M_/S*$=';AZW9R=RK9H#+_7:SWN@ 7,M]1=<S/H4E%B@K,E"A4N\T8"4 SE %
M,HE2B03FF)<NGL5)>F3?LJ,OI2UU9#,1>]?V9:8*;NOUM-!>Z'&U-%SUOQ@?
M].N>O32AFX8;W!3+&H:R93>0J/[S]^5</QJ].)DQJ"9 ;:0XLIZZ/34[3Q;M
M6;CYLA,&ST814^3>3L'JZ3)):FW"N3,O$ (Y-#?9H[HT+UB.G9K?33R.36PF
M_WV2?$[7ZYF:\3H\NU?=-*M=&>#'Y:IN^^NMZ"_++_+A<;G2"[HY[)E*KB@O
M2PX4_/^;N[+=MG$N?#]/H0<( 2VD2-X,D"XS*% @03OX;^;"X*;6:.(47C+-
MV_^D%EN.;9F'HI3>%$4@\9SS43SFV4F%,*88,:)31)BJ2F/5)15>7IBY&9_<
M?7/,I3N^]ENS.[]=.LWX<]U=61JU^5\WS&WWTS[\Z?X.$$N9<[L](E"_Z2;"
MM'!/"#=?[R!&W6_39<"UDM3SBHZW^JY*.FGZZ>*M0$E?(K?V7J:VZ_-ONO.
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M*!B3/U[\]M_.?_W/.[__AUS]-O?>_[CZZ>6O+L;W_2)]+/_Q?_[R_B1]P=,
MX^EB&::I+K 8_^MB]<WWLQ26*ZD_2=</#_Y&_1M<_!K4;P$7(/G?_USDO_W'
MO_SPPUH<\]D$/V+YH?[WMX_O+I><CQ>_C\L8\]_3[/3'^M,?7\T(#43GZM\M
MOW_%?__;8GSZ=8(7W_LRQ_+O?YLO?L^TGI!<K%?[;^M_^./5HE_GN""DK)A\
M3]\X__=UE2T)P#^7.,VXYNCBXR>S=..7)E6>L\M_.0D1)ZOOCC*.1ZM//8J+
MY3RDY4@GKTP2 @SW!A2+$5P*"EC*TBCM>41[D]]*[X((7HE_@>GOGV???J0/
M_K'*H/YA)8R5(.XLMQ;*;G1?[+=WT[JG5K+\%.($1S%RDY7*P'PIH$+Q0/^3
M8*.D'5&*93SOQ<)#*]_DYKJ2C^;IA]D\XYP,R<7289YN*/PNA,]_X\>O84X?
M!.G+>'))>)G/3EOH<#EK+-&UZHCTO_U $B@XGV-^O];<@XRNN%R2J<75;^Z#
MBC?3Y7CY_2AGDOX"%^=_^$3_\NC/\6)DDRHVN CHF0=5E #G@X!0!5."ER;M
M!^_'UQ\.(6UT.SN(H >&S#727\].PW@Z,D'3"9LR>*XB*&,0'*H"5AL9@LL!
MI=P+)7>6' X8+?4X:R74@1'QT]EB/"7J7\U("6GY"YY&G(],3L1SX*"P)#*K
M@4$@@0"*B-(B8R27O5!Q[[+#(6-/%<Y:RG- 0)PMX',(7T<G)'6L)O35)"P6
MQ^5D.4N_K_8(=Z4([LDQMYP8\4J"M]) =MD)YEV)UCP"C!(6<47U^4IK=.!D
MN;CXSA5,GB1F([B([D^8MD+O #W7Z3_?32D)N=I((BH%*D4#SH8,UNIH9%0H
MHVL,F[M4#&->&JMWUE36/:!E=GHZFZ[X.#JWEES+C(ZB6!E*!J4*@^@3F4QM
M7:93FBE>6J/E#A7#HF5?O=Z&R7Y"[@LF/YUS0"QSAN2E!1Z0C"TGXHW/$#,2
M:T$9D9L;E3M4#',('1XFNPAY8%?VGE/Y/?EB[\CL+D@LBI,+EH 7HEZQZ,B?
M"W0R^XB8>"33RUIG2BY7WP@DLGM/I:F0.P%+=?E'WOFL Y*?;YTA82#1+8,&
M87@H/!N/K$T:K:[656)D1]W= XBM!=D) #[BYW%-)E9I7/IH(TL^63*<G#!-
M@E")Y.)U]"!*=LPR);-Y[&S9'!'W+M]59-,.(ON+NA/,'$VG9V'R$;_.YLL1
M.BF9C DB3X$<*5:@T@TE>U.2%YEA&^-Q?=6N3I1V"-E9L)T XP/.Q[/\9II?
M$[I'W@N# B48PS6HK#BQ8BQH3V(@026.J@DR;BR[$334BX/&[J(=&!NOSN95
M<&_'BQ0F_PO#_(*'; C30H2:%)0D$8T0!?GL0B &+8LW:K\DZT,K;X00_6(0
MTD3 G1B03_,P78RK7,Z-(+E/G'N%('*B<(X5"N>$%!"M0)NK8%1HXYK>6GDC
MD)@7 Y(F NX$)"=?<#*A6/UKF'X_YX+B<&&RC12F2PK3-;?@,B^0M+)>*JFL
M;0.3NVMO!!3[XH"RIY"[J UX.Y[@KV?K/(Z7T7/!@&55;Z"(;,\<>=DI9,YR
MMMGM=\][>\6-8.%>#"SV$F@78+B(OJ;+7\,I>5 Z%YDY!UN+9E2*"IPF%QMS
MCIIYH[7:SSF];]6-0.%?&"CV$&P7P'@W3;,Y&;BKN/S5[&RZG']_-<LX,G0*
M)AD$T2])-CXCA(0& @J9I7&H]PQB-B!BLY09>V&X:2?WH2.<=:T#16B+V72*
MD]4V4$(%9PV'Q"0YWS$@>&LT:),\"<?&8O?+H-VWZF9 >3G)U;TEVX6!.:^N
M.?]/E0H?80PN*+*2I7!RNXLA)KSR8+-.OB9^LG^LD&3+ZL3K2V^&D9>376TC
MXTZ!(D;*Z:)#*:!=M*""]A Y0Y"BA.R,CMSM9T<>7'HSH+R<)&L;&?<$E%?T
MQ^/YI]D?4\)ZRL(4"]$D#<IB .=,!B'(7 H*W+Q-[6!RM?!F('DYZ=86\NT)
M(BN_ZGC^83[[-IXF'%FIM*CU#!$SV<1(*'<L6PA.Q>B"5U(^5ENT)4YNK;X9
M6%Y.YK69I'M"S(?98ADF_WO\=>6&Y^A53J& Y9H1%R*"EUF \$)H^A91LE_=
MR,-K;X:6EY.";23EGK!R'K"-BM+>2V/!,V5 R1 @.J^ :QML8CQRT]";/5]U
M,WR\G,SKWI+M+ Q^<QK&DW-V1H5Y$Z/T4$0A:^B2 L=)*$PFR9A(VEF_%T(>
M6WTSI+R<9&PS20^,F!-,9W/"/!?QTW@YP1$+*DE$ ;9@?0:-Y(B3)$ 9U,%H
MK@R/>Z'D]HJ;(>/E9&3WDNC :/@T#_7%_<GWTSB;C+3*7#&/8(6EF,QE#<$J
M#L0]!FV\X'Z_"YL;RVU6<?9R,JR[R[(3D_#FS_0E3#_C.N.7C<TI(S"+MCX?
MHS",BPPL<K3!Q.II-S$+UU?=#!(O)Y>ZMV2[<#S7)?JK@O^3+R3(Q?'9LK:5
MJ&@?"4:"R-I 4<&#$C%#+#*#M!I#*5J3+]7 #7V,ALU0\]*RJ\VDW@6&_HF3
MR?^8SOZ8GF @!PKSN\7B#.<C2Y8P>^X@2A= 6<G %V^A.&(J87 QMXAU'UA^
M,^2\M'1K"UEW 9K_G$TH(@OS50W$?#$2/CB??("T2N_(G,%C"N"ML\BLU1GW
M<U7O778SD+RT=.L^LNT"'.<EF.LZJ>IWD4[.%B//>;8V2_!>:/*[B@87*8S'
M+'F*&I7'%D5']Z^^&51>6K*U@:2[0,R[*7T:Q?#C;_@Z+,,Y6Z.HE=;<<A#*
M1E"8##A3$E@I8\82<Q0MTO/WK[X98EY:PK6!I+M S,HVO@I+_#R;?Q\)QZVO
MQ9?%"0Y*1TTFDK[(Q(UWTB0Z01O5,UXNNAD^7EK"=7>Y=@&+-Z<X_TR&\.?Y
M[(_EE_."77*OLBI9(FB7R;W2I1 ;Q0$SMBA>R%^7V  >]RZ^&4Q>3K:UE9S[
M@,N?5R\ UD^*1ME()P0*"*+V?0JKU^TB $9IBW R*M&BPO'NRIL!Y>4D7YM(
M>&"4O$ME?G26Q_0;1\LE+M;Z>#L)GT>.Y:",8<"U-.1CL0 A* 58<DK<.8U[
MOK%X>.W-GGN^G/1L(REW\A[G[7AZLCQ=OIG/9_-7,R(B77%3@G')*Y",65!D
M$"%R+B!Z'@PK0?$]W_@]3<-FV'DY>=S&4N\+0Q]7>P'7K^53;77Z_6@:)M\7
MX\6*LR!TL)XK8J70[HCT)X_)0_"U89W+PI;],KS;T;,9MEY.MO> VN@$9T<I
MU<J*=>9@FL,\C[PRRD@ZG1,/)"R'F2)!;X K5U3.7BML\W;P[MJ;X>?EY'P;
M2;D+3_GZ \B11,-=U I2<>J\24=0EKZX7+BUEH46>9GK:VZ&C9>6ZMU9JD-W
M#B9YY)5IK(;/!*L,8Q$*,@%*<D=.6DE0F,@BJ8!&[7=3=&.YS9#P<C*YN\NR
M"\/PBBB?A\F[:<8__P=^'VGGI-/D:)G""Z@L/7A=Z% L#E5&H81K81MN+;L9
M*%Y:LG8?V7;B85SUX7A+WUF,F-#UN9$ 9U,$Q:.!Z'@&$X0QV@3I]DS%/;#P
M9@!Y.=G:%O+M"B+KY-":"<^DE$PQ" 57[0@M.%$0HI3))NZCB;HA2*XMO1E,
M7DZVMHV,FP'EWWZ\(U?B\?>=IM*L,D;7A'63V,T&U-SYC/UGU3Q.UIYC:RH'
MH]LK7(X_49S;S#B')&J_15]JEWHCP:NDE-,R*NZ?DLBC*^SE,JX3?&_'\]-W
M><1R3F5EG*PG-P==J7D]#@:YXH%,5Q3['0,WEANFR68[9=UP%W>6X] QPYKP
M5:&E2"5Y8SAHQU1U9#($E9"\7(GU;2$YNOM-H[FVV##M,P^J_*UEV(?JWY^/
M-Z.S1[,89(1D)0=5"+5.T2E4<E3"HJ8?-5'_Q8+#],<\* 1VDF67Y_BKXU]/
MCM^_>WWTZ<WKGX[>'_WZZLW)/]Z\^72RRX'^\(<UF$*W&:%['O%W)D0<E[?C
M:9BF,?EOL_5%ZA6('+=)L "L( -EO85 46"MXI&88\S"/W:AM-< ED?H:C9Q
M9MV=G!MNG @<9.9TR!6?P-L00.B<8XF"W-C'G(6]N!QPOMW!D/#@K)GMQ=W!
M+(B'1ZE(,G^,DTR$"8F<(TTA#K):!IF$#4;*H!Z['GO^\42'A] .&MYX,-$V
MXNX -_=,RPBB,!Z=!E[#8248;2)I:[.VF'R,*8E'FW?_M0<3;:7>IP<3;2/K
M'M!R=V:.J2.&H\F0B.1:[9;!<<[ %6Z]UJ'$1[-4?]'!1%OI]>G!1-L(N2^8
M7,S,<9HKQ:0 U,6!4KD.LZ:(+41FG796%=;Z%'H!@XD:P607(7< DTLK>Y7A
MS4%%H<EW,U)YB@<I%'3%1/"\WNVDX)1]K(1]+V?EDHIA87((+V4W 7< D:/%
M I>+2__>H<DR,P[%&U;3]87\>T'N?L0D523AB-:NR4T*.G%+=M3GK)EPNX'&
M^=.=2R:\RRQ+'B"89.K-GR+_#!-84\UI= +Y8U48NR/D%B'# F4?S=X+DGW$
MW %67H7%EZ-IKO]Y\W_.QM_"A)A9'"U?A?G\^WCZ^3_#Y Q'(4<>D?:23)J8
M$@G!1U8@^^1<1LN4:1[X;$)8#UC:"P"W/9?FVN@ 8K4N=CY.2USQ=?&B4"0M
M2B)G+*<ZR,O75\O,&Y V".*/,Y%;SX:^EY!A79KV$-I?VAU YC5^K0G,Q0WQ
MC()A2JBB 4TTM5=^ 9>%@!BSY8$+Z4OK;/:]A QS770XR.PO[0X@<UY$O?B(
M"<EP4H#P*RXO>&'!92G1@*CUL\JD!%%G.O4#2IF3]>K1N4@[^3Z/T#/,T+7#
M :B9[#O T8<Y?@WC_.;/KSA=(!W&Q\LO.+^Y-616,<2Z*R2NAG90:*%= 1N#
M]86CH[\UAM,&9 TSJ.UPJ&JMB0[ =?)E-E]^POGIN^DW.J=KP+H825:?0Q<)
M4M16@]YXBE%3!.>D-+:P7-)C+XIWRNS<0\<P(]P.!Y^]9=T!7FZ"G1MG5;(<
MK".(*T[N7.3>@Z (0%G.F$ZMS<[V!J9YB?0!CZV=I;L[-&;+,&ET3LV^XGSY
M_<,DU$FXN<:+7RO(Z>@=U1HA@\%!8G5>>_$*0C8"BK6KSARU*53S ^IA>GJ(
ML9JD?)H)O0/;<DR<A/KH\#V&!7X<?_ZR/"Z_T4%;Q37*/%KF60(6/ 6, CV$
M).FOCNO G-"EN<?\*$$]Q%Q-(-1.[!U@Z%7X.B:#-OXOS+7+=A7.J]FB[H9?
M9]-T;EB3LM(*32:ZCN=6KG:\=#Y M*I$H0QM%-X82IO0U4,0U@11S970 ;"N
MN?K7F/ LZY3)9V/H!"B&]?%28>"##IR1E476^@[T7D)ZB+3:&*.]Q=P!5M;T
MC^CL=<Z2"%*6)(=4'S\2K %%K79T& 1K76ZS7KF'P*GAA=96@NS $7X_#G$\
M&2_'N""/;%5#\F4V(:$OJG>V_'XI&LS!8*:S-1I39_ 6 4YB'76'T3@F2&"M
MG>)-:>NDKN)]D\OS@RBD SMSC:_;4:A P<DN,@BKD7B8'7CK-5BM/1JCN9:M
M4S@/4S/LI>AAM/\PQ/9110>@NDB=?PC?:][\(AEAM??,AU3+&E<O^0-XR21H
M).-,DA'6/?8":I\+BYN4= .FO?3\P'W%'D+O #IO3K].9M\1/^*$['>^*ZM1
MDD$R[Q$2V>S:-MZ#0_IK"(*3]-#KV+KDYTFBACWJ#@2HMJKH %L_GX4ZHA[Q
M.$[&GU?JN6#E9BT*K[,97;9@34900A!+F#)DH;/6B8+-1]NY[ *Q36D;-F5T
M(*0=1#$# F[U"'8U!711^S'.YJ^^A/EGC"']?I69UY9+1O%HD:D6^CJ$F+R#
MH(IFT:GL\F9]"QY?9]B$4&.\M)9K!S;I9N;T0EX7,PY&!J,FI]& +B*3A2T2
M?)VSHZ02R:-$_FC3N?TSUK<I&C9+="#[TU )0UL=\@+G9S<.ZXL:@WO.;QE+
M85EX,J*%@5(N0JS/#B17Q7N9C2EI(QNTS:K#9I8.89$.)O,.[-,]' @6?"30
M RU'D:VW$9P09&%E+B*%PK-I_3)]1Q0=[-K^0'9H3V%WD+=\P))>R\-'R8,,
M10-/Z$D^+$-@*8)G&9GD7AGWV$"DAB?:EE<?S?N?#7.H[:B*#DS1;8MZ_7)'
MBB2T"V"=JA5S)D/D3M,7:4R,O*32'%0/4M--,N!PJ<I&JN@ 5->8&"5.N\RA
M 5ZT)HF(!-YX"5G)'%1@AOO6^<EKRW<3V3]+AGLK87=PL-7GU^-UO65]RS1;
M=3;'::JL>%FKP9T$%U=O=C.22(2 + HJGEAPNC5N'B&GFXC_<#AJI8P.[,]M
MJ3#E"O=U3) -=4Q0J)6?Y/-EI9DSR)QH_1IHATO;YXCO#X>>/43> 6"NS6%>
MYT1CCAJY1+!!.1)%+A"]4!"TR.B<\HFUO@^Y3<.P]VG[Z//>)AL["K<#<'R:
MDZ]_-O]^C0-?D"?%+/BDZEC42))0ELPC6J5()HDDU!@>=ZD8UB5N") ]!;P]
M1/P:(E/\7._@/K6[HL]YU4LO3#Z$<7XW/:^WO+8!5G)R"05$1DX\G9T('KT'
MKQQ+O(K*M"Y,?)JJ8;WDADAJK( .C,]12F>G9ZN[XE5\6$>\S/$+3A?C;_AN
MFF:G^'ZV6/R*R^/R*?PYR@&]0)NAR$(GMW:.(H"HP3*>M?."(3:O;=R.Q&%=
MZ99@.Z!J.D#>1UR&\13SFS"?4B2PN,;N:RSC-%Z.;)'":<9!1%OSJ*: ]\CI
M7.?&2H'%V]9@>YJJ89WMAOAJK( .('4W]AA%)X/EDH.D" .4T ZB3A&$SY9,
M<; DJ,80NDO%L+=G#2&SIX [2 D]%:R.?%!%9K*B4<6:"E5(_!@.*>J2Z0"/
M[1\L/D53-Y>OSY)DW%\MS6#V+,WC/ZRT\ 67XQ0F-UG8LY/\S4\^8%OY1UAX
MSA[S:*T7PD0HW%!0IX,"SVP"Y,QG+7@F1ZBYK7_V'O.8K0@LZ?H<O-2[&@71
M.@L:R1([RR1OWGOHQ?68WP8)3_28WT;<7;A #W7%=EZBMH+B@9)8-<_$2+V@
MM@9+"CX&95NW.7L9/>:WTO#&/>:W$7<'N+FO\7$LG#DKP)C:J2U+"1&9!1<T
M4R*BX=C\ANS%])C?2KT;])C?0M8]H.5N^W.;,AJ!#)+-EG91#3 B8\"%5K9$
MRVSS>_B7T&-^&[T^W6-^&R'W!9.+]N?<ZJ@TA09D8>MC )04)% <&LC."C+$
MSC>_*WT)/>;;P&07(7< DWM>_1;&M#*6 8N5@R 2$9_I"Z*0)?/(2^L&4YWW
MF&_BI>PFX X@<NV&A8+-X_F*H[RZR_N \Y,O)-$1"B:=U F$J0_;I#$0I+:0
M&.,.M4,RD8>[4W^(K$X<F!TU__!5>Q,U](6L%?V+H[/EE]F\]K 9*9.=SU)
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M,GV_/N7&U[C^[Z7LHLU,FQ* :UVOU14'9[" Y3'4%C9"Q=9]._:GNI/*X&>
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M X$,CUFUK)3.<I$PQ=8NQ/-R.*P;W'A_= R.#@Z)_>R$D,QF6[L9,<_JB2C
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M$#[P<.V>BB-WTF4G %XUVKS)S?(5G4G?R6:L=NH(4PJ>86VNZ7)M[R3 H4I
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MN:[ZT56O9\WUC;Z9NYNT+3Y]?SNW*RNM:K7^/_;>M+>M)$D7_BL7]WO,Y+X
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M'=.;BYQ;Z>O8//!9DE.02H% 7BD8XPKS&')IORMG5^(ZA=VAL+CKS0^BHP[
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M6+0 9B3=]\J8*K$$S EN# ODB3=?\KD/@<^S7+0Y(AMKL@.87BU/VC!8+_A
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M#C_4W-D,\^NPF$UGGY<O4KHXOSBKPY%>89FFZ6IBHDPZ<@-<UOIG+VK]LV'
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M*M\ZZ8(7P>O;@\+:P!", L<H6!0E>XZYU-ZZQO#^@8"= #G8),KQ 'FX%CJ
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M"3EQ3M;>*[+VCD)M7[SGWJ9[2VX[R[S\> -\J 4*[\J?2WQ!]J:.UT^FM@X
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ME!I2U$6;$)/4W5PA#67N1&UK7'"W,L%1D78ZJUIV%L_?Z"-6MXL/LPU:Y93
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M^88E)G.4B0OPQI" D%(VCW6SK<% ;IJ1R6TU_'_8J_F7R#KNU>!XD&JMD0Y
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M97(N:'1M4$L! A0#%     @ BX9F6*U.'P')!   %!L  !X
M ( !\ P  &%G.3 V97@Q,S(M,C!X9C(P,C-X.3 V8V5R+FAT;5!+ 0(4 Q0
M   ( (N&9EB7'S%], @  /U+   >              "  ?41  !E9S,P,F5X
M,3(Q+3(P>&8R,#(S>#,P,F-E<BYH=&U02P$"% ,4    " "+AF98>*<V_\0$
M  #/&@  '@              @ %A&@  96<Y,#9E>#$S,2TR,'AF,C R,W@Y
M,#9C97(N:'1M4$L! A0#%     @ BX9F6!KO><:%)P  \=4  !X
M     ( !81\  &5X,C)D97-C<FEP=&EO;F]F<V5C=7)I=&EE+FAT;5!+ 0(4
M Q0    ( (N&9EA@\S"/Y@,  # 9   >              "  2)'  !E>&AI
M8FET.#$M,C!X9C(P,C-X;&ES=&]F<RYH=&U02P$"% ,4    " "+AF9806C
MD/\9  !CLP  '@              @ %$2P  97AH:6)I=#DW,2UP;VQI8WEF
M;W)R96-O=F4N:'1M4$L! A0#%     @ BX9F6!!FQU.L*@0 \$TI !$
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M904 <G-K9"TR,#(S,3(S,5]G,2YJ<&=02P$"% ,4    " "+AF98;NVI)VG
M 0 J%0( %               @ $5,P8 <G-K9"TR,#(S,3(S,5]G,BYJ<&=0
M2P$"% ,4    " "+AF98M#@;+"EY  #YCP  %               @ &P\P<
M<G-K9"TR,#(S,3(S,5]G,RYJ<&=02P$"% ,4    " "+AF9879-MAFE9  #0
M<P  %               @ $+;0@ <G-K9"TR,#(S,3(S,5]G-"YJ<&=02P$"
M% ,4    " "+AF98(KVK5L@D 0#!3 L %0              @ &FQ@@ <G-K
M9"TR,#(S,3(S,5]L86(N>&UL4$L! A0#%     @ BX9F6%9R7/#CS@  N%\)
M !4              ( !H>L) ')S:V0M,C R,S$R,S%?<')E+GAM;%!+!08
1    $@ 2 /($  "WN@H    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>rskd-20231231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2023"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:rskd="http://riskified.com/20231231"
  xmlns:srt="http://fasb.org/srt/2023"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="rskd-20231231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesEConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesE1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:ConvertiblePreferredShareTrancheRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-01</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RevisionOfPriorPeriodErrorCorrectionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-28</instant>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
        </entity>
        <period>
            <startDate>2021-07-28</startDate>
            <endDate>2021-07-28</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">rskd:SeriesE1ConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-07-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-08-31</instant>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">rskd:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:SoftwareAndSoftwareDevelopmentCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">rskd:CloudComputingArrangementImplementationCostsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:EMEAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AmericasMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:FraudServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">rskd:IndemnificationServiceRevenueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:ProductConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:USGovernmentDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OtherNonoperatingIncomeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">rskd:FurnitureAndOfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IL</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelAndNonUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelAndNonUSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">rskd:WarrantIssuedToCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">rskd:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConversionOfStockByUniqueDescriptionAxis">rskd:WarrantsToPurchaseOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2013EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2013EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">rskd:ShareBasedPaymentArrangementOptionAndRestrictedStockUnitsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">rskd:A2021EquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-31</instant>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:EmployeeStockOwnershipPlanESOPDisclosuresByPlanAxis">rskd:A2021EmployeeSharePurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-07-27</instant>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefExecutiveOfficerMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">rskd:NonIsraelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">rskd:TaxYear2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">rskd:TaxYear2042Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="rskd:ExpirationPeriodAxis">us-gaap:LatestTaxYearMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertiblePreferredStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-01</startDate>
            <endDate>2024-02-29</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-02-29</instant>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-317">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-318">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">us-gaap:WarrantyReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="c-320">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001851112</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ValuationAllowancesAndReservesTypeAxis">rskd:ProvisionForChargebacksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="ilsPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:ILS</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="vote">
        <measure>rskd:vote</measure>
    </unit>
    <unit id="segment">
        <measure>rskd:segment</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-51">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-52">0001851112</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-53">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-54">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityAddressCountry contextRef="c-1" id="f-55">US</dei:EntityAddressCountry>
    <dei:EntityAddressCountry contextRef="c-2" id="f-56">US</dei:EntityAddressCountry>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-104" id="f-639">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="c-82"
      decimals="INF"
      id="f-648"
      unitRef="number">0.5</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration contextRef="c-6" id="f-733">http://fasb.org/us-gaap/2023#PrepaidExpenseAndOtherAssetsCurrent</us-gaap:DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-6" id="f-742">http://riskified.com/20231231#AccruedLiabilitiesAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration contextRef="c-6" id="f-751">http://riskified.com/20231231#AccruedLiabilitiesAndOtherLiabilitiesCurrent</us-gaap:DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration>
    <dei:DocumentType contextRef="c-1" id="f-1">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="c-1" id="f-2">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-3">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-5">2023-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-6">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="c-1" id="f-7">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-8">001-40692</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-9">Riskified Ltd.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-10">L3</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-11">220 5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-12">220 5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-13">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-14">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-15">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-16">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-2" id="f-17">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-18">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-19">10001</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-20">10001</dei:EntityAddressPostalZipCode>
    <dei:ContactPersonnelName contextRef="c-2" id="f-21">Eido Gal</dei:ContactPersonnelName>
    <dei:EntityAddressAddressLine1 contextRef="c-2" id="f-22">220 5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-23">220 5th Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-24">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressAddressLine2 contextRef="c-2" id="f-25">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-26">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCityOrTown contextRef="c-2" id="f-27">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-2" id="f-28">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-29">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-30">10001</dei:EntityAddressPostalZipCode>
    <dei:EntityAddressPostalZipCode contextRef="c-2" id="f-31">10001</dei:EntityAddressPostalZipCode>
    <dei:ContactPersonnelEmailAddress contextRef="c-2" id="f-32">ir@riskified.com</dei:ContactPersonnelEmailAddress>
    <dei:Security12bTitle contextRef="c-1" id="f-33">Class A ordinary shares, no par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-34">RSKD</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-35">NYSE</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-36" unitRef="shares">128738857</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-4" decimals="0" id="f-37" unitRef="shares">49814864</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-38">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-39">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-40">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-41">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-42">Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-43">false</dei:EntityExTransitionPeriod>
    <dei:EntityExTransitionPeriod contextRef="c-1" id="f-44">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-45">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-46">true</dei:EntityEmergingGrowthCompany>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-47">true</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:DocumentFinStmtRestatementRecoveryAnalysisFlag contextRef="c-1" id="f-48">false</dei:DocumentFinStmtRestatementRecoveryAnalysisFlag>
    <dei:DocumentAccountingStandard contextRef="c-1" id="f-49">U.S. GAAP</dei:DocumentAccountingStandard>
    <dei:EntityShellCompany contextRef="c-1" id="f-50">false</dei:EntityShellCompany>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-5" decimals="0" id="f-57" unitRef="shares">8766560</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <rskd:SeverancePayRate contextRef="c-6" decimals="4" id="f-58" unitRef="number">83.30</rskd:SeverancePayRate>
    <dei:AuditorFirmId contextRef="c-1" id="f-59">1281</dei:AuditorFirmId>
    <dei:AuditorName contextRef="c-1" id="f-60">KOST FORER GABBAY &amp; KASIERER</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-61">Tel-Aviv, Israel</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-62" unitRef="usd">440838000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-3" id="f-63" unitRef="usd">188670000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashCurrent contextRef="c-6" decimals="-3" id="f-64" unitRef="usd">0</us-gaap:RestrictedCashCurrent>
    <us-gaap:RestrictedCashCurrent contextRef="c-7" decimals="-3" id="f-65" unitRef="usd">2347000</us-gaap:RestrictedCashCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="c-6" decimals="-3" id="f-66" unitRef="usd">5000000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:DepositsAssetsCurrent contextRef="c-7" decimals="-3" id="f-67" unitRef="usd">287000000</us-gaap:DepositsAssetsCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-3" id="f-68" unitRef="usd">46886000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-7" decimals="-3" id="f-69" unitRef="usd">37547000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-6" decimals="-3" id="f-70" unitRef="usd">10607000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-7" decimals="-3" id="f-71" unitRef="usd">14371000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:ShortTermInvestments contextRef="c-6" decimals="-3" id="f-72" unitRef="usd">28968000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-7" decimals="-3" id="f-73" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-3" id="f-74" unitRef="usd">532299000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-7" decimals="-3" id="f-75" unitRef="usd">529935000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-76" unitRef="usd">15639000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-3" id="f-77" unitRef="usd">18586000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-3" id="f-78" unitRef="usd">29742000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-3" id="f-79" unitRef="usd">35158000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-6" decimals="-3" id="f-80" unitRef="usd">15562000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-7" decimals="-3" id="f-81" unitRef="usd">14383000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-3" id="f-82" unitRef="usd">8690000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-7" decimals="-3" id="f-83" unitRef="usd">8922000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-6" decimals="-3" id="f-84" unitRef="usd">601932000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-7" decimals="-3" id="f-85" unitRef="usd">606984000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent contextRef="c-6" decimals="-3" id="f-86" unitRef="usd">2573000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent contextRef="c-7" decimals="-3" id="f-87" unitRef="usd">2110000</us-gaap:AccountsPayableCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-88" unitRef="usd">24016000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-89" unitRef="usd">24134000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-6" decimals="-3" id="f-90" unitRef="usd">12719000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-7" decimals="-3" id="f-91" unitRef="usd">12361000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <rskd:ProvisionForChargebacksCurrent contextRef="c-6" decimals="-3" id="f-92" unitRef="usd">12092000</rskd:ProvisionForChargebacksCurrent>
    <rskd:ProvisionForChargebacksCurrent contextRef="c-7" decimals="-3" id="f-93" unitRef="usd">11980000</rskd:ProvisionForChargebacksCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-3" id="f-94" unitRef="usd">5615000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-7" decimals="-3" id="f-95" unitRef="usd">6214000</us-gaap:OperatingLeaseLiabilityCurrent>
    <rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-96" unitRef="usd">12796000</rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-97" unitRef="usd">15813000</rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-98" unitRef="usd">69811000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-99" unitRef="usd">72612000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-3" id="f-100" unitRef="usd">25694000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-7" decimals="-3" id="f-101" unitRef="usd">31202000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-3" id="f-102" unitRef="usd">14706000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-7" decimals="-3" id="f-103" unitRef="usd">8734000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-6" decimals="-3" id="f-104" unitRef="usd">110211000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-7" decimals="-3" id="f-105" unitRef="usd">112548000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-106" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-7" id="f-107" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-3"
      decimals="INF"
      id="f-108"
      unitRef="ilsPerShare">0</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-8" decimals="0" id="f-109" unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-3" decimals="0" id="f-110" unitRef="shares">128738857</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-3" decimals="0" id="f-111" unitRef="shares">128738857</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-8" decimals="0" id="f-112" unitRef="shares">102084746</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-8" decimals="0" id="f-113" unitRef="shares">102084746</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-3" decimals="-3" id="f-114" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-8" decimals="-3" id="f-115" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-9" decimals="0" id="f-116" unitRef="shares">232500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-4" decimals="0" id="f-117" unitRef="shares">49814864</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-4" decimals="0" id="f-118" unitRef="shares">49814864</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued contextRef="c-9" decimals="0" id="f-119" unitRef="shares">68945014</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="0" id="f-120" unitRef="shares">68945014</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue contextRef="c-4" decimals="-3" id="f-121" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue contextRef="c-9" decimals="-3" id="f-122" unitRef="usd">0</us-gaap:CommonStockValue>
    <us-gaap:TreasuryStockCommonShares contextRef="c-6" decimals="0" id="f-123" unitRef="shares">3038865</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-7" decimals="0" id="f-124" unitRef="shares">0</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockValue contextRef="c-6" decimals="-3" id="f-125" unitRef="usd">13155000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue contextRef="c-7" decimals="-3" id="f-126" unitRef="usd">0</us-gaap:TreasuryStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-6" decimals="-3" id="f-127" unitRef="usd">916371000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-7" decimals="-3" id="f-128" unitRef="usd">848609000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-3" id="f-129" unitRef="usd">74000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-7" decimals="-3" id="f-130" unitRef="usd">-1639000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-3" id="f-131" unitRef="usd">-411569000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-3" id="f-132" unitRef="usd">-352534000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-133" unitRef="usd">491721000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-134" unitRef="usd">494436000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-3" id="f-135" unitRef="usd">601932000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-7" decimals="-3" id="f-136" unitRef="usd">606984000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-137" unitRef="usd">297610000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-10" decimals="-3" id="f-138" unitRef="usd">261247000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-11" decimals="-3" id="f-139" unitRef="usd">229141000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue contextRef="c-1" decimals="-3" id="f-140" unitRef="usd">145091000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-10" decimals="-3" id="f-141" unitRef="usd">126150000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue contextRef="c-11" decimals="-3" id="f-142" unitRef="usd">106170000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-3" id="f-143" unitRef="usd">152519000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-10" decimals="-3" id="f-144" unitRef="usd">135097000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-11" decimals="-3" id="f-145" unitRef="usd">122971000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-3" id="f-146" unitRef="usd">71577000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-10" decimals="-3" id="f-147" unitRef="usd">72014000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-11" decimals="-3" id="f-148" unitRef="usd">55301000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-1" decimals="-3" id="f-149" unitRef="usd">88441000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-10" decimals="-3" id="f-150" unitRef="usd">88438000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-11" decimals="-3" id="f-151" unitRef="usd">70710000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-1" decimals="-3" id="f-152" unitRef="usd">69350000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-10" decimals="-3" id="f-153" unitRef="usd">83993000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense contextRef="c-11" decimals="-3" id="f-154" unitRef="usd">52903000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-3" id="f-155" unitRef="usd">229368000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-10" decimals="-3" id="f-156" unitRef="usd">244445000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-11" decimals="-3" id="f-157" unitRef="usd">178914000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-3" id="f-158" unitRef="usd">-76849000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-10" decimals="-3" id="f-159" unitRef="usd">-109348000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-11" decimals="-3" id="f-160" unitRef="usd">-55943000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-1" decimals="-3" id="f-161" unitRef="usd">22775000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-10" decimals="-3" id="f-162" unitRef="usd">10180000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:InterestIncomeExpenseNonoperatingNet contextRef="c-11" decimals="-3" id="f-163" unitRef="usd">591000</us-gaap:InterestIncomeExpenseNonoperatingNet>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-3" id="f-164" unitRef="usd">837000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-10" decimals="-3" id="f-165" unitRef="usd">505000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-11" decimals="-3" id="f-166" unitRef="usd">-122520000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-167" unitRef="usd">-53237000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-168" unitRef="usd">-98663000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-169" unitRef="usd">-177872000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-170" unitRef="usd">5798000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-171" unitRef="usd">6042000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-172" unitRef="usd">1558000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-173" unitRef="usd">-59035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-174" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-175" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-12"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-13"
      decimals="2"
      id="f-179"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-180"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-15"
      decimals="2"
      id="f-181"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-14"
      decimals="2"
      id="f-182"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-183"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-184"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-185"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-186"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-187"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="0" id="f-188" unitRef="shares">176773398</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="0" id="f-189" unitRef="shares">176773398</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-10" decimals="0" id="f-190" unitRef="shares">167667374</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-10" decimals="0" id="f-191" unitRef="shares">167667374</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-11" decimals="0" id="f-192" unitRef="shares">76459625</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-11" decimals="0" id="f-193" unitRef="shares">76459625</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-194" unitRef="usd">-59035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-195" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-196" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-1" decimals="-3" id="f-197" unitRef="usd">1634000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-10" decimals="-3" id="f-198" unitRef="usd">-1883000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-11" decimals="-3" id="f-199" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-1" decimals="-3" id="f-200" unitRef="usd">86000</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-10" decimals="-3" id="f-201" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax contextRef="c-11" decimals="-3" id="f-202" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-3" id="f-203" unitRef="usd">-7000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-10" decimals="-3" id="f-204" unitRef="usd">68000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-11" decimals="-3" id="f-205" unitRef="usd">0</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-206" unitRef="usd">1713000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-10" decimals="-3" id="f-207" unitRef="usd">-1815000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-11" decimals="-3" id="f-208" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-3" id="f-209" unitRef="usd">-57322000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-10" decimals="-3" id="f-210" unitRef="usd">-106520000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-11" decimals="-3" id="f-211" unitRef="usd">-179254000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-18" decimals="0" id="f-212" unitRef="shares">29878116</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-18" decimals="-3" id="f-213" unitRef="usd">159564000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-19" decimals="0" id="f-214" unitRef="shares">14310552</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-19" decimals="-3" id="f-215" unitRef="usd">4000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="0" id="f-216" unitRef="shares">0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-3" id="f-217" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-3" id="f-218" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-3" id="f-219" unitRef="usd">24366000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-3" id="f-220" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-3" id="f-221" unitRef="usd">-68399000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-18" decimals="-3" id="f-222" unitRef="usd">-44029000</us-gaap:StockholdersEquity>
    <rskd:PaymentsOfTemporaryEquityIssuanceCosts contextRef="c-25" decimals="-3" id="f-223" unitRef="usd">819000</rskd:PaymentsOfTemporaryEquityIssuanceCosts>
    <rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues contextRef="c-26" decimals="0" id="f-224" unitRef="shares">1450414</rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues contextRef="c-26" decimals="-3" id="f-225" unitRef="usd">50519000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues contextRef="c-27" decimals="0" id="f-226" unitRef="shares">962940</rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues contextRef="c-27" decimals="-3" id="f-227" unitRef="usd">6489000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <rskd:TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants contextRef="c-11" decimals="-3" id="f-228" unitRef="usd">74724000</rskd:TemporaryEquityAdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants>
    <rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants contextRef="c-28" decimals="-3" id="f-229" unitRef="usd">35778000</rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants>
    <rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants contextRef="c-11" decimals="-3" id="f-230" unitRef="usd">35778000</rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrants>
    <rskd:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-11" decimals="0" id="f-231" unitRef="shares">32291470</rskd:TemporaryEquityStockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <rskd:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-11" decimals="-3" id="f-232" unitRef="usd">291296000</rskd:TemporaryEquityStockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-29" decimals="0" id="f-233" unitRef="shares">32291470</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-28" decimals="-3" id="f-234" unitRef="usd">291296000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-11" decimals="-3" id="f-235" unitRef="usd">291296000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-29" decimals="0" id="f-236" unitRef="shares">19925000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-28" decimals="-3" id="f-237" unitRef="usd">386591000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues contextRef="c-11" decimals="-3" id="f-238" unitRef="usd">386591000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization contextRef="c-29" decimals="-3" id="f-239" unitRef="usd">-4000</rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization>
    <rskd:StockIssuedDuringPeriodSharesRecapitalization contextRef="c-30" decimals="0" id="f-240" unitRef="shares">94431636</rskd:StockIssuedDuringPeriodSharesRecapitalization>
    <rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization contextRef="c-28" decimals="-3" id="f-241" unitRef="usd">4000</rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-29" decimals="0" id="f-242" unitRef="shares">2381269</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-30" decimals="0" id="f-243" unitRef="shares">625124</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-28" decimals="-3" id="f-244" unitRef="usd">2948000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-11" decimals="-3" id="f-245" unitRef="usd">2948000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-29" decimals="0" id="f-246" unitRef="shares">7001240</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-30" decimals="0" id="f-247" unitRef="shares">-7001240</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-28" decimals="-3" id="f-248" unitRef="usd">33489000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-11" decimals="-3" id="f-249" unitRef="usd">33489000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-28" decimals="-3" id="f-250" unitRef="usd">777000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-11" decimals="-3" id="f-251" unitRef="usd">777000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-31" decimals="-3" id="f-252" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-11" decimals="-3" id="f-253" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-32" decimals="-3" id="f-254" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-255" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-33" decimals="0" id="f-256" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-33" decimals="-3" id="f-257" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-34" decimals="0" id="f-258" unitRef="shares">75909531</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-3" id="f-259" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-35" decimals="0" id="f-260" unitRef="shares">88055520</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-3" id="f-261" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-36" decimals="-3" id="f-262" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-37" decimals="-3" id="f-263" unitRef="usd">775249000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-38" decimals="-3" id="f-264" unitRef="usd">176000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-39" decimals="-3" id="f-265" unitRef="usd">-247829000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-3" id="f-266" unitRef="usd">527596000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-40" decimals="0" id="f-267" unitRef="shares">3919606</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-41" decimals="-3" id="f-268" unitRef="usd">4059000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-10" decimals="-3" id="f-269" unitRef="usd">4059000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="c-40" decimals="0" id="f-270" unitRef="shares">3145103</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-40" decimals="0" id="f-271" unitRef="shares">19110506</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-42" decimals="0" id="f-272" unitRef="shares">-19110506</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-10" decimals="0" id="f-273" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-41" decimals="-3" id="f-274" unitRef="usd">67766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-10" decimals="-3" id="f-275" unitRef="usd">67766000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-41" decimals="-3" id="f-276" unitRef="usd">1535000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-10" decimals="-3" id="f-277" unitRef="usd">1535000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-43" decimals="-3" id="f-278" unitRef="usd">-1815000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-10" decimals="-3" id="f-279" unitRef="usd">-1815000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-44" decimals="-3" id="f-280" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-281" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-7" decimals="0" id="f-282" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-7" decimals="-3" id="f-283" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-45" decimals="0" id="f-284" unitRef="shares">102084746</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-3" id="f-285" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-46" decimals="0" id="f-286" unitRef="shares">68945014</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-46" decimals="-3" id="f-287" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-47" decimals="-3" id="f-288" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-48" decimals="-3" id="f-289" unitRef="usd">848609000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-49" decimals="-3" id="f-290" unitRef="usd">-1639000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-50" decimals="-3" id="f-291" unitRef="usd">-352534000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-7" decimals="-3" id="f-292" unitRef="usd">494436000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-51" decimals="0" id="f-293" unitRef="shares">3010478</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-52" decimals="-3" id="f-294" unitRef="usd">3816000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised contextRef="c-1" decimals="-3" id="f-295" unitRef="usd">3816000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross contextRef="c-51" decimals="0" id="f-296" unitRef="shares">6365261</us-gaap:StockIssuedDuringPeriodSharesRestrictedStockAwardGross>
    <rskd:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="c-51" decimals="0" id="f-297" unitRef="shares">1187087</rskd:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="0" id="f-298" unitRef="shares">3038865</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-51" decimals="0" id="f-299" unitRef="shares">3038865</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-53" decimals="-3" id="f-300" unitRef="usd">13155000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-3" id="f-301" unitRef="usd">13155000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-51" decimals="0" id="f-302" unitRef="shares">19130150</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-54" decimals="0" id="f-303" unitRef="shares">-19130150</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits contextRef="c-1" decimals="0" id="f-304" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfUnits>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-52" decimals="-3" id="f-305" unitRef="usd">62410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-3" id="f-306" unitRef="usd">62410000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-52" decimals="-3" id="f-307" unitRef="usd">1536000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued contextRef="c-1" decimals="-3" id="f-308" unitRef="usd">1536000</us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-55" decimals="-3" id="f-309" unitRef="usd">1713000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax contextRef="c-1" decimals="-3" id="f-310" unitRef="usd">1713000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:NetIncomeLoss contextRef="c-56" decimals="-3" id="f-311" unitRef="usd">-59035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-312" unitRef="usd">-59035000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding contextRef="c-6" decimals="0" id="f-313" unitRef="shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent contextRef="c-6" decimals="-3" id="f-314" unitRef="usd">0</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-57" decimals="0" id="f-315" unitRef="shares">128738857</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-57" decimals="-3" id="f-316" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-58" decimals="0" id="f-317" unitRef="shares">49814864</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-58" decimals="-3" id="f-318" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-59" decimals="-3" id="f-319" unitRef="usd">-13155000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-60" decimals="-3" id="f-320" unitRef="usd">916371000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-61" decimals="-3" id="f-321" unitRef="usd">74000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-62" decimals="-3" id="f-322" unitRef="usd">-411569000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-3" id="f-323" unitRef="usd">491721000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-3" id="f-324" unitRef="usd">-59035000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-325" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-326" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-1" decimals="-3" id="f-327" unitRef="usd">850000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-10" decimals="-3" id="f-328" unitRef="usd">2875000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized contextRef="c-11" decimals="-3" id="f-329" unitRef="usd">-382000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-330" unitRef="usd">198000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-10" decimals="-3" id="f-331" unitRef="usd">3000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-11" decimals="-3" id="f-332" unitRef="usd">268000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-3" id="f-333" unitRef="usd">3568000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-10" decimals="-3" id="f-334" unitRef="usd">3607000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-11" decimals="-3" id="f-335" unitRef="usd">1990000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="c-1" decimals="-3" id="f-336" unitRef="usd">1532000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="c-10" decimals="-3" id="f-337" unitRef="usd">667000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedComputerSoftwareAmortization1 contextRef="c-11" decimals="-3" id="f-338" unitRef="usd">446000</us-gaap:CapitalizedComputerSoftwareAmortization1>
    <us-gaap:CapitalizedContractCostAmortization contextRef="c-1" decimals="-3" id="f-339" unitRef="usd">9567000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization contextRef="c-10" decimals="-3" id="f-340" unitRef="usd">7135000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:CapitalizedContractCostAmortization contextRef="c-11" decimals="-3" id="f-341" unitRef="usd">4667000</us-gaap:CapitalizedContractCostAmortization>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-1" decimals="-3" id="f-342" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-10" decimals="-3" id="f-343" unitRef="usd">0</us-gaap:FairValueAdjustmentOfWarrants>
    <us-gaap:FairValueAdjustmentOfWarrants contextRef="c-11" decimals="-3" id="f-344" unitRef="usd">101413000</us-gaap:FairValueAdjustmentOfWarrants>
    <rskd:FairValueAdjustmentOfRights contextRef="c-1" decimals="-3" id="f-345" unitRef="usd">0</rskd:FairValueAdjustmentOfRights>
    <rskd:FairValueAdjustmentOfRights contextRef="c-10" decimals="-3" id="f-346" unitRef="usd">0</rskd:FairValueAdjustmentOfRights>
    <rskd:FairValueAdjustmentOfRights contextRef="c-11" decimals="-3" id="f-347" unitRef="usd">21260000</rskd:FairValueAdjustmentOfRights>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-3" id="f-348" unitRef="usd">62410000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-10" decimals="-3" id="f-349" unitRef="usd">67467000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-11" decimals="-3" id="f-350" unitRef="usd">33358000</us-gaap:ShareBasedCompensation>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-1" decimals="-3" id="f-351" unitRef="usd">4605000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-10" decimals="-3" id="f-352" unitRef="usd">4211000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense contextRef="c-11" decimals="-3" id="f-353" unitRef="usd">0</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease contextRef="c-1" decimals="-3" id="f-354" unitRef="usd">-2593000</us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease>
    <us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease contextRef="c-10" decimals="-3" id="f-355" unitRef="usd">4613000</us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease>
    <us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease contextRef="c-11" decimals="-3" id="f-356" unitRef="usd">0</us-gaap:InterestIncomeDepositWithFinancialInstitutionIncreaseDecrease>
    <rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities contextRef="c-1" decimals="-3" id="f-357" unitRef="usd">1536000</rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities>
    <rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities contextRef="c-10" decimals="-3" id="f-358" unitRef="usd">1535000</rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities>
    <rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities contextRef="c-11" decimals="-3" id="f-359" unitRef="usd">777000</rskd:ProceedsFromIssuanceOfWarrantsOperatingActivities>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-3" id="f-360" unitRef="usd">-161000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-10" decimals="-3" id="f-361" unitRef="usd">-180000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-11" decimals="-3" id="f-362" unitRef="usd">121000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-3" id="f-363" unitRef="usd">9685000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-10" decimals="-3" id="f-364" unitRef="usd">1715000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-11" decimals="-3" id="f-365" unitRef="usd">-1440000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <rskd:IncreaseDecreaseInCapitalizedContractCost contextRef="c-1" decimals="-3" id="f-366" unitRef="usd">8893000</rskd:IncreaseDecreaseInCapitalizedContractCost>
    <rskd:IncreaseDecreaseInCapitalizedContractCost contextRef="c-10" decimals="-3" id="f-367" unitRef="usd">9707000</rskd:IncreaseDecreaseInCapitalizedContractCost>
    <rskd:IncreaseDecreaseInCapitalizedContractCost contextRef="c-11" decimals="-3" id="f-368" unitRef="usd">7744000</rskd:IncreaseDecreaseInCapitalizedContractCost>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-3" id="f-369" unitRef="usd">1618000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-10" decimals="-3" id="f-370" unitRef="usd">-4026000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-11" decimals="-3" id="f-371" unitRef="usd">15079000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-1" decimals="-3" id="f-372" unitRef="usd">373000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-10" decimals="-3" id="f-373" unitRef="usd">1931000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable contextRef="c-11" decimals="-3" id="f-374" unitRef="usd">-832000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-3" id="f-375" unitRef="usd">-199000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-10" decimals="-3" id="f-376" unitRef="usd">291000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-11" decimals="-3" id="f-377" unitRef="usd">8398000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <rskd:IncreaseDecreaseInGuarantorObligations contextRef="c-1" decimals="-3" id="f-378" unitRef="usd">358000</rskd:IncreaseDecreaseInGuarantorObligations>
    <rskd:IncreaseDecreaseInGuarantorObligations contextRef="c-10" decimals="-3" id="f-379" unitRef="usd">249000</rskd:IncreaseDecreaseInGuarantorObligations>
    <rskd:IncreaseDecreaseInGuarantorObligations contextRef="c-11" decimals="-3" id="f-380" unitRef="usd">-333000</rskd:IncreaseDecreaseInGuarantorObligations>
    <rskd:IncreaseDecreaseInProvisionForChargebacks contextRef="c-1" decimals="-3" id="f-381" unitRef="usd">112000</rskd:IncreaseDecreaseInProvisionForChargebacks>
    <rskd:IncreaseDecreaseInProvisionForChargebacks contextRef="c-10" decimals="-3" id="f-382" unitRef="usd">-40000</rskd:IncreaseDecreaseInProvisionForChargebacks>
    <rskd:IncreaseDecreaseInProvisionForChargebacks contextRef="c-11" decimals="-3" id="f-383" unitRef="usd">1438000</rskd:IncreaseDecreaseInProvisionForChargebacks>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-384" unitRef="usd">-4580000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-10" decimals="-3" id="f-385" unitRef="usd">-2609000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability contextRef="c-11" decimals="-3" id="f-386" unitRef="usd">0</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-1" decimals="-3" id="f-387" unitRef="usd">5126000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-10" decimals="-3" id="f-388" unitRef="usd">8710000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities contextRef="c-11" decimals="-3" id="f-389" unitRef="usd">7424000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-3" id="f-390" unitRef="usd">7279000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-10" decimals="-3" id="f-391" unitRef="usd">-26252000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-11" decimals="-3" id="f-392" unitRef="usd">-20278000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-1" decimals="-3" id="f-393" unitRef="usd">55000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-10" decimals="-3" id="f-394" unitRef="usd">463750000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:PaymentsToAcquireShortTermInvestments contextRef="c-11" decimals="-3" id="f-395" unitRef="usd">110000000</us-gaap:PaymentsToAcquireShortTermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-1" decimals="-3" id="f-396" unitRef="usd">337000000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-10" decimals="-3" id="f-397" unitRef="usd">261750000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments contextRef="c-11" decimals="-3" id="f-398" unitRef="usd">39063000</us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-1" decimals="-3" id="f-399" unitRef="usd">29086000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-10" decimals="-3" id="f-400" unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquireInvestments contextRef="c-11" decimals="-3" id="f-401" unitRef="usd">0</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-3" id="f-402" unitRef="usd">1355000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-10" decimals="-3" id="f-403" unitRef="usd">6126000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-11" decimals="-3" id="f-404" unitRef="usd">12254000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToDevelopSoftware contextRef="c-1" decimals="-3" id="f-405" unitRef="usd">0</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware contextRef="c-10" decimals="-3" id="f-406" unitRef="usd">1886000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:PaymentsToDevelopSoftware contextRef="c-11" decimals="-3" id="f-407" unitRef="usd">1250000</us-gaap:PaymentsToDevelopSoftware>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-3" id="f-408" unitRef="usd">251559000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-10" decimals="-3" id="f-409" unitRef="usd">-210012000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-11" decimals="-3" id="f-410" unitRef="usd">-84441000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c-1" decimals="-3" id="f-411" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c-10" decimals="-3" id="f-412" unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock contextRef="c-11" decimals="-3" id="f-413" unitRef="usd">26781000</us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-1" decimals="-3" id="f-414" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-10" decimals="-3" id="f-415" unitRef="usd">0</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromWarrantExercises contextRef="c-11" decimals="-3" id="f-416" unitRef="usd">6489000</us-gaap:ProceedsFromWarrantExercises>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-1" decimals="-3" id="f-417" unitRef="usd">3841000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-10" decimals="-3" id="f-418" unitRef="usd">4059000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised contextRef="c-11" decimals="-3" id="f-419" unitRef="usd">2948000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-1" decimals="-3" id="f-420" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-10" decimals="-3" id="f-421" unitRef="usd">0</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering contextRef="c-11" decimals="-3" id="f-422" unitRef="usd">392273000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-1" decimals="-3" id="f-423" unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-10" decimals="-3" id="f-424" unitRef="usd">204000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-11" decimals="-3" id="f-425" unitRef="usd">5302000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-3" id="f-426" unitRef="usd">13155000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-10" decimals="-3" id="f-427" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-11" decimals="-3" id="f-428" unitRef="usd">0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-3" id="f-429" unitRef="usd">-9314000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-10" decimals="-3" id="f-430" unitRef="usd">3855000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-11" decimals="-3" id="f-431" unitRef="usd">423189000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-3" id="f-432" unitRef="usd">297000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-10" decimals="-3" id="f-433" unitRef="usd">-1701000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-11" decimals="-3" id="f-434" unitRef="usd">0</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-3" id="f-435" unitRef="usd">249821000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-10" decimals="-3" id="f-436" unitRef="usd">-234110000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-11" decimals="-3" id="f-437" unitRef="usd">318470000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-438" unitRef="usd">191017000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-3" id="f-439" unitRef="usd">425127000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-18" decimals="-3" id="f-440" unitRef="usd">106657000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-441" unitRef="usd">440838000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-442" unitRef="usd">191017000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-3" id="f-443" unitRef="usd">425127000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-3" id="f-444" unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-10" decimals="-3" id="f-445" unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-11" decimals="-3" id="f-446" unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-3" id="f-447" unitRef="usd">17000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-10" decimals="-3" id="f-448" unitRef="usd">18000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-11" decimals="-3" id="f-449" unitRef="usd">647000</us-gaap:IncomeTaxesPaid>
    <us-gaap:PaymentsForRent contextRef="c-1" decimals="-3" id="f-450" unitRef="usd">6080000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c-10" decimals="-3" id="f-451" unitRef="usd">4357000</us-gaap:PaymentsForRent>
    <us-gaap:PaymentsForRent contextRef="c-11" decimals="-3" id="f-452" unitRef="usd">0</us-gaap:PaymentsForRent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-3" id="f-453" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-10" decimals="-3" id="f-454" unitRef="usd">792000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-11" decimals="-3" id="f-455" unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment contextRef="c-1" decimals="-3" id="f-456" unitRef="usd">811000</rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment>
    <rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment contextRef="c-10" decimals="-3" id="f-457" unitRef="usd">0</rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment>
    <rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment contextRef="c-11" decimals="-3" id="f-458" unitRef="usd">0</rskd:OperatingLeaseRightOfUseAssetLeaseModificationAdjustment>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-459" unitRef="usd">97000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-10" decimals="-3" id="f-460" unitRef="usd">926000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid contextRef="c-11" decimals="-3" id="f-461" unitRef="usd">2042000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-1" decimals="-3" id="f-462" unitRef="usd">0</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-10" decimals="-3" id="f-463" unitRef="usd">299000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount contextRef="c-11" decimals="-3" id="f-464" unitRef="usd">131000</us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount>
    <rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-465" unitRef="usd">0</rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid>
    <rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid contextRef="c-10" decimals="-3" id="f-466" unitRef="usd">0</rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid>
    <rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid contextRef="c-11" decimals="-3" id="f-467" unitRef="usd">485000</rskd:SoftwareDevelopmentExpendituresIncurredButNotYetPaid>
    <rskd:DeferredOfferingCostsIncurredButNotYetPaid contextRef="c-1" decimals="-3" id="f-468" unitRef="usd">0</rskd:DeferredOfferingCostsIncurredButNotYetPaid>
    <rskd:DeferredOfferingCostsIncurredButNotYetPaid contextRef="c-10" decimals="-3" id="f-469" unitRef="usd">0</rskd:DeferredOfferingCostsIncurredButNotYetPaid>
    <rskd:DeferredOfferingCostsIncurredButNotYetPaid contextRef="c-11" decimals="-3" id="f-470" unitRef="usd">204000</rskd:DeferredOfferingCostsIncurredButNotYetPaid>
    <rskd:WarrantsAndRightsSettled contextRef="c-63" decimals="-3" id="f-471" unitRef="usd">0</rskd:WarrantsAndRightsSettled>
    <rskd:WarrantsAndRightsSettled contextRef="c-64" decimals="-3" id="f-472" unitRef="usd">0</rskd:WarrantsAndRightsSettled>
    <rskd:WarrantsAndRightsSettled contextRef="c-65" decimals="-3" id="f-473" unitRef="usd">23738000</rskd:WarrantsAndRightsSettled>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c-1" decimals="-3" id="f-474" unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c-10" decimals="-3" id="f-475" unitRef="usd">0</us-gaap:ConversionOfStockAmountConverted1>
    <us-gaap:ConversionOfStockAmountConverted1 contextRef="c-11" decimals="-3" id="f-476" unitRef="usd">291296000</us-gaap:ConversionOfStockAmountConverted1>
    <rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity contextRef="c-1" decimals="-3" id="f-477" unitRef="usd">0</rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity>
    <rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity contextRef="c-10" decimals="-3" id="f-478" unitRef="usd">0</rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity>
    <rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity contextRef="c-11" decimals="-3" id="f-479" unitRef="usd">110502000</rskd:AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsIncludingPortionAttributableToTemporaryEquity>
    <rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization contextRef="c-1" decimals="-3" id="f-480" unitRef="usd">0</rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization>
    <rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization contextRef="c-10" decimals="-3" id="f-481" unitRef="usd">0</rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization>
    <rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization contextRef="c-11" decimals="-3" id="f-482" unitRef="usd">4000</rskd:AdjustmentsToAdditionalPaidInCapitalEliminationOfParValueUponRecapitalization>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-3" id="f-483" unitRef="usd">440838000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-7" decimals="-3" id="f-484" unitRef="usd">188670000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-33" decimals="-3" id="f-485" unitRef="usd">418143000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-6" decimals="-3" id="f-486" unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-7" decimals="-3" id="f-487" unitRef="usd">2347000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-33" decimals="-3" id="f-488" unitRef="usd">6984000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-3" id="f-489" unitRef="usd">440838000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-3" id="f-490" unitRef="usd">191017000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-33" decimals="-3" id="f-491" unitRef="usd">425127000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock contextRef="c-1" id="f-492">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;1.       Organization and Description of Business&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Riskified Ltd., together with its subsidiaries, &#x201c;Riskified&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, &#x201c;our&#x201d; or the &#x201c;Company,&#x201d; was incorporated under the laws of the State of Israel in 2012 and commenced operations in January 2013. We have built a next-generation eCommerce risk intelligence platform that allows our customers&#x2014;online merchants&#x2014;to create trusted relationships with their consumers. Our core product, the Chargeback Guarantee, is designed to ensure the legitimacy of our merchants&#x2019; online orders by approving or denying these orders with guaranteed performance levels that vary by merchant. We guarantee the outcome of our decisions by assuming the cost of fraud associated with each approval. We drive higher sales by raising approval rates and reducing fraud and other operating costs for our merchants and strive to provide superior consumer experiences, as compared to our merchants&#x2019; performance prior to onboarding us.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="c-1" id="f-493">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;2.       Summary of Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and include the accounts of Riskified Ltd. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Immaterial Prior Period Error Correction&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. We assessed the materiality of the error on the financial statements for prior years individually and in the aggregate, and concluded that it was not material to any previously issued consolidated financial statements. We corrected the error by revising the consolidated financial statements appearing herein. The impact of the errors on the Company&#x2019;s consolidated balance sheet as of January 1, 2021 was an overstatement of deferred contract acquisition costs of $0.7 million and an understatement of accumulated deficit of $0.7 million. There was no impact of the error on the consolidated statements of cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of the corrections on the Company&#x2019;s consolidated financial statements for the years ended December 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Revised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Revised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Initial Public Offering &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August&#160;2, 2021, we completed our initial public offering (&#x201c;IPO&#x201d;), in which we issued and sold 19,925,000 shares of our Class A ordinary shares at an offering price of $21.00 per share, including 2,625,000 shares of our Class A ordinary shares pursuant to the exercise in full of the underwriters&#x2019; option to purchase additional shares. We received net proceeds of $386.6 million after deducting underwriting discounts and commissions of $26.2 million, and other issuance costs of $5.7 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately prior to the closing of the IPO, 962,940 shares of Series E-1 convertible preferred shares were issued upon the exercise of the Series E-1 convertible preferred share warrants. In addition, all convertible preferred shares then outstanding automatically converted into 32,291,470 shares of our Class A ordinary shares. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the IPO, deferred offering costs, which consist primarily of accounting, legal and other fees related to our IPO, were capitalized within other assets, noncurrent in the consolidated balance sheets. Upon the consummation of the IPO, $5.7 million of deferred offering costs were reclassified into shareholders&#x2019; equity as an offset against IPO proceeds. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recapitalization&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 28, 2021, we adopted new Articles of Association (&#x201c;AoA&#x201d;), in which, among other things, we implemented, upon the closing of the IPO:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(i) a dual class ordinary share structure pursuant to which we have two classes of ordinary shares: Class A ordinary shares and Class B ordinary shares. The rights of the holders of our Class A ordinary shares and Class B ordinary shares are identical, except with respect to voting, conversion and transfer rights. Class A ordinary shareholders are entitled to one vote per share and Class B ordinary shareholders are entitled to ten votes per share. The dual class ordinary share structure concentrates voting power with our pre-IPO shareholders. Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all matters (including the election of directors) submitted to a vote of our shareholders, unless otherwise required by law or our amended and restated articles of association; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ii) the elimination of the par value per ordinary share; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(iii) a two-for-one reverse share split of our Class A ordinary shares (the &#x201c;Reverse Share Split&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Immediately after the effectiveness of the Reverse Share Split, we issued and distributed Class B ordinary shares to holders of the Class A ordinary shares on a two-for-one ratio, such that each holder of Class A ordinary shares received two Class B ordinary shares for each Class A ordinary share (the &#x201c;Additional Class B Issuance&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The historical financial statements have not been retroactively adjusted for the (i) dual class structure, (ii) elimination of par value, and (iii) Additional Class B Issuance. As a result, all information associated with these items related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, restricted share units (&#x201c;RSUs&#x201d;), and warrants to purchase convertible preferred shares are being presented prospectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All information related to our ordinary shares and their associated par value, convertible preferred shares and their associated par value, share options, RSUs, and warrants to purchase convertible preferred shares have been retroactively adjusted to give effect to the Reverse Share Split for all periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares (the &#x201c;Repurchase Program&#x201d;). Costs associated with the acquisition of Class A ordinary shares are presented as Treasury Shares on the consolidated balance sheet as a reduction of shareholders' equity. Refer to Note 10 for more information on the Repurchase Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives and investments, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#x201c;IBR&#x201d;) used for operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. We base our estimates on assumptions, both historical and forward-looking, trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the subsidiaries where the U.S. dollar is the functional currency, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars at exchange rates in effect at the end of each period. Foreign currency transaction gains and losses from these remeasurements are recognized in other income (expense), net, within the consolidated statements of operations. Foreign currency transactions resulted in net gains of $1.4&#160;million, $2.5&#160;million, and $0.2&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For subsidiaries where the functional currency is not the U.S. dollar, we use the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders&#x2019; equity, into U.S. dollars. We record translation gains and losses in accumulated other comprehensive profit (loss) as a component of shareholders&#x2019; equity in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments that are exposed to concentrations of credit risk primarily consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivable and derivative financial instruments. We maintain our cash, cash equivalents, restricted cash, short-term deposits, and short-term investments with high-quality financial institutions mainly in the United States and Israel, the composition of which are regularly monitored by us. We have not experienced any material losses in such accounts. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our customers are online merchants. For accounts receivable, we are exposed to credit risk in the event of nonpayment by online merchants to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit to online merchants and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our merchants by performing periodic evaluations of credit worthiness and consumer indebtedness and applying other credit risk monitoring procedures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt"&gt;Represents less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. We consider all highly liquid investments, with an original maturity of three months or less at the date of purchase, to be cash equivalents. Our restricted cash primarily consisted of cash deposits to back letters of credit related to certain operating leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Deposits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term deposits are reported at cost.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. We determine the appropriate classification of our investments in marketable debt securities at the time of purchase and reevaluate such designation at each balance sheet date. After consideration of our risk versus reward objectives, as well as our liquidity requirements, we may sell these debt securities prior to their effective maturities. As a result, we classify our investments, including those with maturities beyond 12 months, as current assets in the Consolidated Balance Sheets. We carry these securities at fair value, and report the unrealized gains and losses, net of taxes, as a component of shareholders&#x2019; equity, except for changes in allowance for expected credit losses, which is recorded in other income (expense), net, within the consolidated statements of operations. We periodically evaluate our available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, we consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these criteria are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;met, we write down the security to its fair value and record the impairment charge in other income (expense), net within the consolidated statements of operations. If neither of these criteria are met, we determine whether credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We measure financial assets and liabilities at fair value for each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument&#x2019;s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 &#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2 &#x2013; Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3 &#x2013; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivables, derivative financial instruments, accounts payables, accrued liabilities, indemnification guarantees. Cash and cash equivalents, short-term deposits, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Short-term investments and derivative financial instruments are stated at fair value on a recurring basis as disclosed in Note 4 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record indemnification guarantees that we issue upon approving a transaction at fair value when issued using the income approach. To measure this guarantee, we consider the premium that would have been received for the same guarantee if it were issued in a stand-alone transaction. The fair value of these indemnification guarantees is determined based on historical chargeback claims, a risk premium fee that would be required for a third party to assume this liability, and an appropriate discount rate due to the time period between issuance of the guarantee and settlement or expiration. Historical chargeback guarantee claims are not readily observable in the marketplace and are generally classified as Level 3 inputs. Indemnification guarantees are recorded at fair value when issued and not remeasured to fair value each period. Refer to Note 8 below for more information regarding indemnification guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments, in particular our indemnification guarantees, may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements. Refer to Item 5. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Financial Review and Prospects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The allowance for credit losses is based on our assessment of the collectability of accounts. We regularly review the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current merchant&#x2019;s credit worthiness, the age of the balance, the nature and size of the merchant, the financial condition of the merchant, and the amount of any receivables in dispute. Accounts &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;receivable deemed uncollectible are charged against the allowance for credit losses when identified. The allowance for doubtful accounts was $0.5 million and $0.5 million as of December&#160;31, 2023 and 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncollectible accounts charged against the allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries of amounts previously deemed uncollectible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments to manage risks relating to our ongoing business operations. We enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks attributable to our exposure to changes in the exchange rates of (a) the New Israeli Shekel (&#x201c;NIS&#x201d;) against the U.S. dollar and (b) the Euro against the U.S. dollar. Our primary objective in entering into these contracts is to reduce the volatility of forecasted earnings and cash flows associated with changes in foreign currency exchange rates. We do not use derivative instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our derivative instruments as either assets or liabilities and carry them at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. Derivative instruments are recorded as either prepaid expenses and other current assets or accrued expenses and other current liabilities in the consolidated balance sheets. We record changes in the fair value of derivative instruments that are designated as hedging instruments in accumulated other comprehensive profit (loss) in the consolidated balance sheets, until the forecasted transaction occurs upon which we reclassify the related gain or loss on the derivative to the same financial statement line item in the consolidated statements of operations to which the derivative relates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge monetary assets or liabilities denominated in currencies other than the functional currency of a subsidiary. Changes in the fair value on these contracts, as well as the related costs, are recognized in Other income (expense), net, along with the foreign currency gains and losses on the related monetary assets and liabilities. Refer to Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of our property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.125%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Software Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs related to software acquired, developed, or modified solely to meet our internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs incurred during the preliminary project stage and during the post implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized. Capitalized software development costs are recorded as part of other assets, noncurrent in the consolidated balance sheets. Maintenance costs are expensed as incurred. Capitalized software development costs are amortized on a straight-line basis over the software&#x2019;s estimated useful life, which is four years and are recorded in cost of revenue&#160;in the consolidated statements of operations. As of December&#160;31, 2023 and 2022, we have capitalized $3.5 million, net and $5.0 million, net, respectively, of qualifying software development costs. Amortization expenses related to capitalized software costs were $1.5 million, $0.7 million, and $0.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cloud Computing Arrangement Implementation Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain implementation costs incurred in a cloud computing arrangement during the application development stage pursuant to Accounting Standards Codification, or ASC, 350-40,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Internal Use Software. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These costs are amortized over the term of the hosting arrangement on a straight-line basis, and are included within operating expenses in the consolidated statements of operations. Costs incurred in the preliminary stages of development are analogous to research and development activities and are expensed as incurred. These capitalized costs are included in other assets, noncurrent in the consolidated balance sheets. We have capitalized $0.7 million and $0.2 million of qualifying cloud computing arrangement implementation costs as of December&#160;31, 2023 and 2022, respectively. Amortization expenses related to capitalized cloud computing arrangement implementation costs were $0.2 million, $0.2 million, and $0.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease accounting policy under ASC Topic 840, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; until January 1, 2022, prior to the adoption of the new lease guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases are reviewed and classified as either capital or operating leases at their inception. In certain lease agreements, we may receive renewal or expansion options, rent holidays, and other incentives. For operating leases, we recognize lease costs on a straight-line basis once we take control of the space, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted the new lease guidance for our operating lease agreements. Refer to Note 7 below for additional information. Our lease accounting policy under ASC Topic 842, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; from January 1, 2022, following the adoption of the new lease guidance is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement meets the definition of a lease at the inception of the lease, and leases are classified at commencement as either operating or finance leases. We do not have any finance leases. Operating lease ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease agreement. Operating lease ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives received prior to lease commencement. Operating lease liabilities are measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using our IBR based on the information available at the commencement date of the lease as our leases generally do not provide an implicit rate. Our IBR was estimated to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term may include options to extend or terminate the lease when it is reasonably certain that we would exercise that option. We made an accounting policy election for lease agreements with a term of 12 months or less and do not recognize operating lease ROU assets and operating lease liabilities in respect of those agreements. Payments under our lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and operating lease liabilities. Variable lease payments are mainly comprised of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected the practical expedient to not separate lease and non-lease components for our leases.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sublease certain office spaces to third parties. Operating sublease income is recognized on a straight-line basis over the term of the agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate the recoverability of long-lived assets, including property and equipment, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Recoverability of these assets is measured by comparing the carrying amounts with the future undiscounted cash flows that the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. We determined that there were no material events or changes in circumstances that indicated that our long-lived assets were impaired during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#x2019;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#x201c;guarantee obligation&#x201d;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and will be released to revenue in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being released from risk under the guarantee obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, or ASC 450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inputs and assumptions used by management to calculate this provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. These liabilities are recorded within Provision for chargebacks, net on the consolidated balance sheets and will be reduced by credits issued or cash paid to merchants. Refer to Note 8 below or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Item 5. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Financial Review and Prospects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Ordinary Share Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to IPO, warrants to purchase our Series B/C and E-1 convertible preferred shares were recorded as a liability at fair value on our consolidated balance sheets as the underlying convertible preferred shares were contingently redeemable, upon a deemed liquidation event that is outside of our control, and therefore could have obligated us to transfer assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B/C convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or upon the completion of a qualified IPO. Upon IPO, the Series B/C convertible preferred share warrants were converted to warrants to purchase ordinary shares, and the then outstanding liability was reclassified to additional paid-in capital in the consolidated balance sheets. The warrants to purchase ordinary shares may be exercised any time prior to, and shall expire upon, the earlier of (a) April 29, 2025 or (b) immediately prior to the consummation of certain deemed liquidation events. In November 2023, the outstanding warrants to purchase ordinary shares were exercised. Refer to Note 9.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series E-1 convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or the completion of a deemed liquidation event, including a qualified IPO. Upon IPO, the Series E-1 convertible preferred share warrants were automatically exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with a SaaS Agreement entered into in 2021, we issued a warrant to a customer to purchase ordinary shares. The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years. As of December 31, 2023, the warrant is outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees as noted above within &#x201c;Indemnification Guarantees&#x201d;. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#x2019; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted above within &#x201c;Indemnification Guarantees&#x201d;, our contracts with our merchants obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a six-month period from the date of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We present revenue net of cancellations and adjustments for minimum service level agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 606, revenue is recognized when a customer obtains control of promised products. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these products. To achieve the core principle of this standard, we applied the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Identification of the contract, or contracts, with the merchant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine that we have a contract with a merchant when the contract is approved, each party&#x2019;s rights and obligations regarding the products to be transferred can be identified, the payment terms for the products can be identified, we have determined the merchant has the ability and intent to pay, and the contract has commercial substance. At contract inception, we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Contracts with our merchants are typically for a period of one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the products that will be transferred to the merchant that are both capable of being distinct, whereby the merchant can benefit from the products either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the products is separately identifiable from other promises in the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For SaaS arrangements, we provide access to our cloud-hosted software platform and reviewing and approving eCommerce transaction for legitimacy, without providing the merchant the right to take possession of our software, which we consider to be a single performance obligation. Revenue generated from the issuance of indemnification guarantees is accounted for under ASC 460. Refer to &#x201c;Indemnification Guarantees&#x201d; above and Note 8 below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As our contracts include an unknown quantity of approved transactions at a fixed contractual rate per approved transaction value executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of products during that month. Certain of our contracts include additional forms of variable consideration such as service level commitments relating to uptime availability and minimum approval rates as well as provisions that provide for reimbursements should our merchant&#x2019;s consumer cancel an approved order. If we fail to meet these commitments, merchants are generally permitted to receive a refund in the form of a credit on their invoice. Under certain arrangements, when the merchant&#x2019;s consumer cancels an order that we have approved, we provide a refund of some or all of the fees owed by our merchant to us generally in the form of a credit on our merchant&#x2019;s invoice. The transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms and conditions vary by contract type, although terms generally include a requirement to pay within 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined that our contracts do not include a significant financing component. The primary purpose of our invoicing terms is to provide our merchants with simplified and predictable ways of purchasing our products; not to receive financing from our merchants or to provide merchants with financing. We applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from merchants (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. We generally do not offer a right of refund in our contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation&#x2019;s relative standalone selling price. Access to our cloud-hosted software is considered one performance obligation in the context of the contract and accordingly the transaction price is allocated to this single performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Recognition of the revenue when, or as, a performance obligation is satisfied&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the time the related performance obligation is satisfied by transferring control of the promised service to the customer. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products. For SaaS arrangements, we have determined that these arrangements meet the variable consideration allocation exception and revenue is recognized over the contract period in the month that the transactions are approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets consist of unbilled accounts receivable. The terms of our agreements are monthly, annual, or multi-year, and we typically invoice our merchants based on monthly usage. In some arrangements, a right to consideration for our performance under the merchant contract may occur before invoicing to the merchant, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost to Obtain a Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. These costs are recorded as Deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of four years. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions expenses are included in sales and marketing expense in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost to Fulfill a Contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize payroll related costs of certain integration services required in order to be able to fulfill the obligation to provide our products to our merchants. Integration services are promises that are not capable of being distinct. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and generate or enhance resources that will be used in delivering our SaaS products. These costs are recorded as deferred contract fulfillment costs in other assets, noncurrent on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs to fulfill a contract are amortized on a straight-line basis over the expected period of benefit of four years and are included in cost of revenue in the consolidated statements of operations. We &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;determine the period of benefit by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of period of benefit involve inherent uncertainties and the application of significant judgment. We periodically review these deferred contract fulfillment costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us. Amounts for chargebacks won were $25.0&#160;million, $20.3&#160;million, and $14.3&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development costs also consist of third-party software hosting fees used by our research and development teams, depreciation expense, and allocated overhead. Research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sales and Marketing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales and marketing costs primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead. Sales and marketing costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital marketing programs include advertising, promotional events, and brand-building activities. Advertising costs are expensed as incurred and were $4.9 million, $6.0 million, and $5.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and Administrative&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead. General and administrative costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to share-based awards is recognized based on the fair value of the awards granted. The fair value of each share option award is estimated on the grant date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected term of the share option, the expected volatility of the price of our ordinary shares, risk-free interest rates, and the expected dividend yield of ordinary shares. The assumptions used to determine the fair value of the option awards represent management&#x2019;s best estimates. These estimates involve inherent uncertainties and the application of management&#x2019;s judgment. The related share-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted to employees, RSUs, that vest either upon the (a) satisfaction of service-based vesting conditions only and (b) satisfaction of both service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying ordinary shares as of the grant date. We have also granted to our Chief Executive Officer (&#x201c;CEO&#x201d;), RSUs, that vest upon the satisfaction of service-based, performance-based, and market-based vesting conditions. A Monte-Carlo simulation model was used to determine the grant date fair value by simulating a range of scenarios with each outcome resulting in a determined value. The grant date fair value of this award is the average of the values determined by each simulation. The simulation was also used to derive the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For RSU awards with both service-based and performance-based vesting conditions, the service-based vesting condition has varying terms, but is generally satisfied over &lt;span style="-sec-ix-hidden:f-639"&gt;four&lt;/span&gt; to five years. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) the six month anniversary of or, if earlier, March 15 of the year following, the occurrence of an IPO or (ii) consummation of a merger and acquisition, or M&amp;amp;A, transaction of the Company. The performance-based vesting condition underlying these awards was satisfied upon our IPO. The market-based condition underlying the CEO RSU is satisfied upon the trading price of our ordinary shares meeting certain thresholds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSU awards with service-based vesting conditions only are recognized using the straight-line method. RSU awards with more than just a service-based vesting condition are recognized using the accelerated attribution method once the performance-based vesting condition is probable of occurring which results in higher expenses attributed to the earlier periods of the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Profit (Loss) Per Share Attributable to Ordinary Shareholders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compute net profit (loss) per share using the two-class method required for participating securities. The two-class method requires income available to ordinary shareholders for the period to be &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Under the two-class method, we allocate earnings proportionately to Class A and B ordinary shares outstanding for the period. Prior to IPO, we considered our convertible preferred shares to be participating securities as the holders of the convertible preferred shares would be entitled to dividends in preference to ordinary shareholders. These participating securities do not contractually require the holders of such shares to participate in our losses. As such, net loss for the periods presented was not allocated to our participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic net profit (loss) per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net profit (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net profit (loss) per share is the same as basic net profit (loss) per share in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate our business in one operating segment and therefore have one reportable segment. Operating segments are defined as components of an entity that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker, who is our CEO, in deciding how to allocate resources and assess performance. Our chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by geographical region can be found in the revenue recognition disclosures in Note 3 below. Property and equipment, net of depreciation and amortization, by geographic region can be found in Note 6 below. Operating lease ROU assets by geographic region can be found in Note 7 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an emerging growth company, or EGC, the Jumpstart Our Business Startups Act, or the JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards. We have elected to use extended transition periods permissible under the JOBS Act while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;including subsequent amendments thereafter, which established ASC 326. ASC 326 replaces the existing incurred loss impairment model with a current expected credit loss model that requires more timely recognition of estimated expected credit losses over the life of certain financial instruments. Our accounts receivable and available-for-sale debt securities are in the scope of ASC 326. We adopted ASC 326 as of January 1, 2023. The adoption of ASC 326 did not have a material impact on our financial condition and results of operations within our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reportable Segments (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses, including public entities with a single operating or reportable segment. The updated standard will be effective for annual periods beginning in fiscal 2024 and interim periods beginning in the first quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact of this standard on our financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expands disclosures in an entity&#x2019;s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The updated standard will be effective for annual periods beginning in fiscal 2026. We are currently evaluating the impact of this standard on our financial statement disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-494">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;/div&gt;The accompanying consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States, or U.S. GAAP, and include the accounts of Riskified Ltd. and its wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription contextRef="c-1" id="f-495">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Immaterial Prior Period Error Correction&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2023, we identified an immaterial error relating to the period over which certain sales commissions were amortized. We assessed the materiality of the error on the financial statements for prior years individually and in the aggregate, and concluded that it was not material to any previously issued consolidated financial statements. We corrected the error by revising the consolidated financial statements appearing herein. The impact of the errors on the Company&#x2019;s consolidated balance sheet as of January 1, 2021 was an overstatement of deferred contract acquisition costs of $0.7 million and an understatement of accumulated deficit of $0.7 million. There was no impact of the error on the consolidated statements of cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-66" decimals="-5" id="f-496" unitRef="usd">-700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-66" decimals="-5" id="f-497" unitRef="usd">-700000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-66" decimals="-5" id="f-498" unitRef="usd">-700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-66" decimals="-5" id="f-499" unitRef="usd">-700000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock contextRef="c-1" id="f-500">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the effects of the corrections on the Company&#x2019;s consolidated financial statements for the years ended December 31, 2022 and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Revised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(350,553)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,981)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(352,534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;87,722&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88,438&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(108,632)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109,348)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(97,947)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(103,989)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(104,705)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:44.066%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.736%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Previously Reported&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Adjustment&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As Revised&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accumulated deficit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(246,564)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(247,829)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;545&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,398)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,943)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Profit (loss) before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,327)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(178,885)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(545)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(179,430)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to Class A and B ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.34)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.01)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-67" decimals="-3" id="f-501" unitRef="usd">16364000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-68" decimals="-3" id="f-502" unitRef="usd">-1981000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-7" decimals="-3" id="f-503" unitRef="usd">14383000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-67" decimals="-3" id="f-504" unitRef="usd">-350553000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-68" decimals="-3" id="f-505" unitRef="usd">-1981000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-7" decimals="-3" id="f-506" unitRef="usd">-352534000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SellingAndMarketingExpense contextRef="c-69" decimals="-3" id="f-507" unitRef="usd">87722000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-70" decimals="-3" id="f-508" unitRef="usd">716000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-10" decimals="-3" id="f-509" unitRef="usd">88438000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-69" decimals="-3" id="f-510" unitRef="usd">-108632000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-70" decimals="-3" id="f-511" unitRef="usd">-716000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-10" decimals="-3" id="f-512" unitRef="usd">-109348000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-69" decimals="-3" id="f-513" unitRef="usd">-97947000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-70" decimals="-3" id="f-514" unitRef="usd">-716000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-515" unitRef="usd">-98663000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-69" decimals="-3" id="f-516" unitRef="usd">-103989000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-70" decimals="-3" id="f-517" unitRef="usd">-716000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-10" decimals="-3" id="f-518" unitRef="usd">-104705000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-69"
      decimals="2"
      id="f-519"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-69"
      decimals="2"
      id="f-520"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-70"
      decimals="2"
      id="f-521"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-70"
      decimals="2"
      id="f-522"
      unitRef="usdPerShare">0</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-10"
      decimals="2"
      id="f-523"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-10"
      decimals="2"
      id="f-524"
      unitRef="usdPerShare">0.62</us-gaap:EarningsPerShareBasic>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-71" decimals="-3" id="f-525" unitRef="usd">11630000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-72" decimals="-3" id="f-526" unitRef="usd">-1265000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-33" decimals="-3" id="f-527" unitRef="usd">10365000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-71" decimals="-3" id="f-528" unitRef="usd">-246564000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-72" decimals="-3" id="f-529" unitRef="usd">-1265000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-33" decimals="-3" id="f-530" unitRef="usd">-247829000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:SellingAndMarketingExpense contextRef="c-73" decimals="-3" id="f-531" unitRef="usd">70165000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-74" decimals="-3" id="f-532" unitRef="usd">545000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense contextRef="c-11" decimals="-3" id="f-533" unitRef="usd">70710000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:OperatingIncomeLoss contextRef="c-73" decimals="-3" id="f-534" unitRef="usd">-55398000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-74" decimals="-3" id="f-535" unitRef="usd">-545000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-11" decimals="-3" id="f-536" unitRef="usd">-55943000</us-gaap:OperatingIncomeLoss>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-73" decimals="-3" id="f-537" unitRef="usd">-177327000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-74" decimals="-3" id="f-538" unitRef="usd">-545000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-539" unitRef="usd">-177872000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:NetIncomeLoss contextRef="c-73" decimals="-3" id="f-540" unitRef="usd">-178885000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-74" decimals="-3" id="f-541" unitRef="usd">-545000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-11" decimals="-3" id="f-542" unitRef="usd">-179430000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-75"
      decimals="2"
      id="f-543"
      unitRef="usdPerShare">-2.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-75"
      decimals="2"
      id="f-544"
      unitRef="usdPerShare">-2.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-76"
      decimals="2"
      id="f-545"
      unitRef="usdPerShare">-2.34</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-76"
      decimals="2"
      id="f-546"
      unitRef="usdPerShare">-2.34</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-77"
      decimals="2"
      id="f-547"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-78"
      decimals="2"
      id="f-548"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-77"
      decimals="2"
      id="f-549"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-78"
      decimals="2"
      id="f-550"
      unitRef="usdPerShare">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-551"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-552"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-553"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-554"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-79" decimals="0" id="f-555" unitRef="shares">19925000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="c-80"
      decimals="2"
      id="f-556"
      unitRef="usdPerShare">21.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction contextRef="c-81" decimals="0" id="f-557" unitRef="shares">2625000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction contextRef="c-82" decimals="-5" id="f-558" unitRef="usd">386600000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:PaymentsOfStockIssuanceCosts contextRef="c-79" decimals="-5" id="f-559" unitRef="usd">26200000</us-gaap:PaymentsOfStockIssuanceCosts>
    <rskd:PaymentsOfOtherStockIssuanceCosts contextRef="c-82" decimals="-5" id="f-560" unitRef="usd">5700000</rskd:PaymentsOfOtherStockIssuanceCosts>
    <rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues contextRef="c-83" decimals="0" id="f-561" unitRef="shares">962940</rskd:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-79" decimals="0" id="f-562" unitRef="shares">32291470</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <rskd:PaymentsOfOtherStockIssuanceCosts contextRef="c-82" decimals="-5" id="f-563" unitRef="usd">5700000</rskd:PaymentsOfOtherStockIssuanceCosts>
    <rskd:CommonStockVotesForEachShare contextRef="c-3" decimals="INF" id="f-564" unitRef="vote">1</rskd:CommonStockVotesForEachShare>
    <rskd:CommonStockVotesForEachShare contextRef="c-4" decimals="INF" id="f-565" unitRef="vote">10</rskd:CommonStockVotesForEachShare>
    <us-gaap:StockholdersEquityPolicyTextBlock contextRef="c-1" id="f-566">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Shares&lt;/span&gt;&lt;/div&gt;In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares (the &#x201c;Repurchase Program&#x201d;). Costs associated with the acquisition of Class A ordinary shares are presented as Treasury Shares on the consolidated balance sheet as a reduction of shareholders' equity.</us-gaap:StockholdersEquityPolicyTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-84" decimals="-5" id="f-567" unitRef="usd">75000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-568">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from these estimates. On an ongoing basis, we evaluate our estimates, including those related to the estimated period of benefit on deferred contract costs, the capitalization of certain costs to fulfill a contract, the allowance for credit losses, the fair value of financial assets and liabilities including the fair value of derivatives and investments, the useful lives of property and equipment, capitalization and estimated useful life of internal-use software, share-based compensation including the determination of the fair value of our ordinary shares (prior to IPO), the fair value of indemnification guarantees and the associated systematic and rational amortization method, provisions for chargebacks, the fair value of convertible preferred share warrant liabilities and convertible preferred share tranche rights (prior to IPO), incremental borrowing rate (&#x201c;IBR&#x201d;) used for operating lease right-of-use (&#x201c;ROU&#x201d;) assets and operating lease liabilities, and the valuation of deferred tax assets and uncertain tax positions. We base our estimates on assumptions, both historical and forward-looking, trends, and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock contextRef="c-1" id="f-569">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The U.S. dollar is our functional currency and the functional currency of a majority of our subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the subsidiaries where the U.S. dollar is the functional currency, monetary assets and liabilities denominated in currencies other than the U.S. dollar are remeasured into U.S. dollars at exchange rates in effect at the end of each period. Foreign currency transaction gains and losses from these remeasurements are recognized in other income (expense), net, within the consolidated statements of operations. Foreign currency transactions resulted in net gains of $1.4&#160;million, $2.5&#160;million, and $0.2&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For subsidiaries where the functional currency is not the U.S. dollar, we use the period-end exchange rates to translate assets and liabilities, the average monthly exchange rates to translate revenue and expenses, and historical exchange rates to translate shareholders&#x2019; equity, into U.S. dollars. We record translation gains and losses in accumulated other comprehensive profit (loss) as a component of shareholders&#x2019; equity in the consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized contextRef="c-1" decimals="-5" id="f-570" unitRef="usd">1400000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized contextRef="c-10" decimals="-5" id="f-571" unitRef="usd">2500000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ForeignCurrencyTransactionGainLossRealized contextRef="c-11" decimals="-5" id="f-572" unitRef="usd">200000</us-gaap:ForeignCurrencyTransactionGainLossRealized>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-573">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Risks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our financial instruments that are exposed to concentrations of credit risk primarily consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivable and derivative financial instruments. We maintain our cash, cash equivalents, restricted cash, short-term deposits, and short-term investments with high-quality financial institutions mainly in the United States and Israel, the composition of which are regularly monitored by us. We have not experienced any material losses in such accounts. Our derivatives expose us to credit risk to the extent that the counterparties may be unable to meet the terms of the agreement. We seek to mitigate such risk by limiting our counterparties to major financial institutions and by spreading the risk across a number of major financial institutions. In addition, the potential risk of loss with any one counterparty resulting from this type of credit risk is monitored on an ongoing basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our customers are online merchants. For accounts receivable, we are exposed to credit risk in the event of nonpayment by online merchants to the extent the amounts are recorded in the consolidated balance sheets. We extend different levels of credit to online merchants and maintain reserves for potential credit losses based upon the expected collectability of accounts receivable. We manage credit risk related to our merchants by performing periodic evaluations of credit worthiness and consumer indebtedness and applying other credit risk monitoring procedures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt"&gt;Represents less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="c-1" id="f-574">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarize our merchants that represented 10% or more of Accounts receivable and Revenue:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:26.624%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;________________&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt"&gt;Represents less than 10%&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-85" decimals="2" id="f-575" unitRef="number">0.17</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-86" decimals="2" id="f-576" unitRef="number">0.22</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-87" decimals="2" id="f-577" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-88" decimals="2" id="f-578" unitRef="number">0.13</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-89" decimals="2" id="f-579" unitRef="number">0.16</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-90" decimals="2" id="f-580" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy contextRef="c-1" id="f-581">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash, Cash Equivalents, and Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash and cash equivalents consist of cash in banks, bank deposits, and money market funds. We consider all highly liquid investments, with an original maturity of three months or less at the date of purchase, to be cash equivalents. Our restricted cash primarily consisted of cash deposits to back letters of credit related to certain operating leases.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <rskd:ShortTermDepositsPolicyPolicyTextBlock contextRef="c-1" id="f-582">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Deposits&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term deposits consist of bank deposits with original maturities between 4 and 12 months and that mature within 12 months of the balance sheet date. Short-term deposits are reported at cost.&lt;/span&gt;&lt;/div&gt;</rskd:ShortTermDepositsPolicyPolicyTextBlock>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-583">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Investments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consist of marketable debt securities that we have classified and accounted for as available-for-sale. We determine the appropriate classification of our investments in marketable debt securities at the time of purchase and reevaluate such designation at each balance sheet date. After consideration of our risk versus reward objectives, as well as our liquidity requirements, we may sell these debt securities prior to their effective maturities. As a result, we classify our investments, including those with maturities beyond 12 months, as current assets in the Consolidated Balance Sheets. We carry these securities at fair value, and report the unrealized gains and losses, net of taxes, as a component of shareholders&#x2019; equity, except for changes in allowance for expected credit losses, which is recorded in other income (expense), net, within the consolidated statements of operations. We periodically evaluate our available-for-sale debt securities for impairment. If the amortized cost of an individual security exceeds its fair value, we consider our intent to sell the security or whether it is more likely than not that we will be required to sell the security before recovery of its amortized basis. If either of these criteria are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;met, we write down the security to its fair value and record the impairment charge in other income (expense), net within the consolidated statements of operations. If neither of these criteria are met, we determine whether credit loss exists. Credit loss is estimated by considering changes to the rating of the security by a rating agency, any adverse conditions specifically related to the security, as well as other factors.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-584">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We measure financial assets and liabilities at fair value for each reporting period using a fair value hierarchy which requires us to maximize the use of observable inputs and minimize the use of unobservable inputs. A financial instrument&#x2019;s classification within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. Three levels of inputs may be used to measure fair value:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1 &#x2013; Quoted prices (unadjusted) in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2 &#x2013; Inputs other than Level&#160;1 that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3 &#x2013; Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments consist of cash and cash equivalents, restricted cash, short-term deposits, short-term investments, accounts receivables, derivative financial instruments, accounts payables, accrued liabilities, indemnification guarantees. Cash and cash equivalents, short-term deposits, restricted cash, accounts receivable, accounts payable, and accrued liabilities are stated at their carrying value, which approximates fair value due to the short time to the expected receipt or payment date. Short-term investments and derivative financial instruments are stated at fair value on a recurring basis as disclosed in Note 4 below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record indemnification guarantees that we issue upon approving a transaction at fair value when issued using the income approach. To measure this guarantee, we consider the premium that would have been received for the same guarantee if it were issued in a stand-alone transaction. The fair value of these indemnification guarantees is determined based on historical chargeback claims, a risk premium fee that would be required for a third party to assume this liability, and an appropriate discount rate due to the time period between issuance of the guarantee and settlement or expiration. Historical chargeback guarantee claims are not readily observable in the marketplace and are generally classified as Level 3 inputs. Indemnification guarantees are recorded at fair value when issued and not remeasured to fair value each period. Refer to Note 8 below for more information regarding indemnification guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because of the inherent uncertainty of valuation, the estimated fair value of our financial instruments, in particular our indemnification guarantees, may differ significantly from the values that would have been used had a ready market for the financial instruments existed, and the differences could be material to our consolidated financial statements. Refer to Item 5. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Financial Review and Prospects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:TradeAndOtherAccountsReceivablePolicy contextRef="c-1" id="f-585">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are recorded at the invoiced amount, net of an allowance for credit losses. The allowance for credit losses is based on our assessment of the collectability of accounts. We regularly review the adequacy of the allowance for credit losses based on a combination of factors, including an assessment of the current merchant&#x2019;s credit worthiness, the age of the balance, the nature and size of the merchant, the financial condition of the merchant, and the amount of any receivables in dispute. Accounts &lt;/span&gt;&lt;/div&gt;receivable deemed uncollectible are charged against the allowance for credit losses when identified.</us-gaap:TradeAndOtherAccountsReceivablePolicy>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-6" decimals="-5" id="f-586" unitRef="usd">500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-7" decimals="-5" id="f-587" unitRef="usd">500000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock contextRef="c-1" id="f-588">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of the allowance for credit losses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;487&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current period provision&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;198&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncollectible accounts charged against the allowance&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Recoveries of amounts previously deemed uncollectible&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;515&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsReceivableAllowanceForCreditLossTableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-7" decimals="-3" id="f-589" unitRef="usd">487000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:ProvisionForDoubtfulAccounts contextRef="c-1" decimals="-3" id="f-590" unitRef="usd">198000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs contextRef="c-1" decimals="-3" id="f-591" unitRef="usd">170000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries contextRef="c-1" decimals="-3" id="f-592" unitRef="usd">0</us-gaap:AllowanceForDoubtfulAccountsReceivableRecoveries>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-6" decimals="-3" id="f-593" unitRef="usd">515000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:DerivativesPolicyTextBlock contextRef="c-1" id="f-594">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We enter into derivative instruments to manage risks relating to our ongoing business operations. We enter into foreign currency forward and option contracts with financial institutions to protect against foreign exchange risks attributable to our exposure to changes in the exchange rates of (a) the New Israeli Shekel (&#x201c;NIS&#x201d;) against the U.S. dollar and (b) the Euro against the U.S. dollar. Our primary objective in entering into these contracts is to reduce the volatility of forecasted earnings and cash flows associated with changes in foreign currency exchange rates. We do not use derivative instruments for trading or speculative purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for our derivative instruments as either assets or liabilities and carry them at fair value. The accounting for changes in the fair value of a derivative depends on the intended use of the derivative and the resulting designation. Derivative instruments are recorded as either prepaid expenses and other current assets or accrued expenses and other current liabilities in the consolidated balance sheets. We record changes in the fair value of derivative instruments that are designated as hedging instruments in accumulated other comprehensive profit (loss) in the consolidated balance sheets, until the forecasted transaction occurs upon which we reclassify the related gain or loss on the derivative to the same financial statement line item in the consolidated statements of operations to which the derivative relates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other derivatives not designated as hedging instruments consist primarily of foreign currency forward contracts that we use to hedge monetary assets or liabilities denominated in currencies other than the functional currency of a subsidiary. Changes in the fair value on these contracts, as well as the related costs, are recognized in Other income (expense), net, along with the foreign currency gains and losses on the related monetary assets and liabilities. Refer to Note 5 for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-595">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets. Expenditures for maintenance and repairs are expensed as incurred. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of our property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.125%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-596">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated useful lives of our property and equipment are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:58.675%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:39.125%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shorter of remaining lease term or estimated useful life&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-91" id="f-597">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-92" id="f-598">P7Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:InternalUseSoftwarePolicy contextRef="c-1" id="f-599">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Capitalized Software Costs&lt;/span&gt;&lt;/div&gt;Costs related to software acquired, developed, or modified solely to meet our internal requirements, with no substantive plans to market such software at the time of development are capitalized. Costs incurred during the preliminary project stage and during the post implementation operational stage are expensed as incurred. Eligible costs incurred during the application development stage of the project are capitalized. Capitalized software development costs are recorded as part of other assets, noncurrent in the consolidated balance sheets. Maintenance costs are expensed as incurred. Capitalized software development costs are amortized on a straight-line basis over the software&#x2019;s estimated useful life, which is four years and are recorded in cost of revenue&#160;in the consolidated statements of operations.&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cloud Computing Arrangement Implementation Costs&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize certain implementation costs incurred in a cloud computing arrangement during the application development stage pursuant to Accounting Standards Codification, or ASC, 350-40,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Internal Use Software. &lt;/span&gt;These costs are amortized over the term of the hosting arrangement on a straight-line basis, and are included within operating expenses in the consolidated statements of operations. Costs incurred in the preliminary stages of development are analogous to research and development activities and are expensed as incurred. These capitalized costs are included in other assets, noncurrent in the consolidated balance sheets.</us-gaap:InternalUseSoftwarePolicy>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-93" id="f-600">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-94" decimals="-5" id="f-601" unitRef="usd">3500000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-95" decimals="-5" id="f-602" unitRef="usd">5000000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-96" decimals="-5" id="f-603" unitRef="usd">1500000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-97" decimals="-5" id="f-604" unitRef="usd">700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-98" decimals="-5" id="f-605" unitRef="usd">400000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-99" decimals="-5" id="f-606" unitRef="usd">700000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:CapitalizedComputerSoftwareGross contextRef="c-100" decimals="-5" id="f-607" unitRef="usd">200000</us-gaap:CapitalizedComputerSoftwareGross>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-101" decimals="-5" id="f-608" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-102" decimals="-5" id="f-609" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-103" decimals="-5" id="f-610" unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-611">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease accounting policy under ASC Topic 840, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; until January 1, 2022, prior to the adoption of the new lease guidance was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leases are reviewed and classified as either capital or operating leases at their inception. In certain lease agreements, we may receive renewal or expansion options, rent holidays, and other incentives. For operating leases, we recognize lease costs on a straight-line basis once we take control of the space, without regard to deferred payment terms such as rent holidays that defer the commencement date of required payments. Additionally, incentives received are treated as a reduction of costs over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2022, we adopted the new lease guidance for our operating lease agreements. Refer to Note 7 below for additional information. Our lease accounting policy under ASC Topic 842, &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 842&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; from January 1, 2022, following the adoption of the new lease guidance is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement meets the definition of a lease at the inception of the lease, and leases are classified at commencement as either operating or finance leases. We do not have any finance leases. Operating lease ROU assets represent the right to use an underlying asset for the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease agreement. Operating lease ROU assets are measured based on the discounted present value of the remaining lease payments, initial direct costs incurred and prepaid lease payments, excluding lease incentives received prior to lease commencement. Operating lease liabilities are measured based on the discounted present value of the remaining lease payments. The discounted present value of remaining lease payments is computed using our IBR based on the information available at the commencement date of the lease as our leases generally do not provide an implicit rate. Our IBR was estimated to &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;approximate the interest rate for collateralized borrowing with similar terms and payments and in economic environments where the leased asset was located.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term may include options to extend or terminate the lease when it is reasonably certain that we would exercise that option. We made an accounting policy election for lease agreements with a term of 12 months or less and do not recognize operating lease ROU assets and operating lease liabilities in respect of those agreements. Payments under our lease agreements are primarily fixed; however, certain lease agreements contain variable payments, which are expensed as incurred and not included in the operating lease ROU assets and operating lease liabilities. Variable lease payments are mainly comprised of common area maintenance, utilities, real estate taxes, and payments affected by changes in indexes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We elected the practical expedient to not separate lease and non-lease components for our leases.&lt;/span&gt;&lt;/div&gt;We sublease certain office spaces to third parties. Operating sublease income is recognized on a straight-line basis over the term of the agreement.</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock contextRef="c-1" id="f-612">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We evaluate the recoverability of long-lived assets, including property and equipment, for possible impairment whenever events or circumstances indicate that the carrying amount of such assets may not be fully recoverable. Such events and changes may include significant changes in performance relative to expected operating results, significant changes in asset use, significant negative industry or economic trends, and changes in our business strategy. Recoverability of these assets is measured by comparing the carrying amounts with the future undiscounted cash flows that the assets are expected to generate. If such review indicates that the carrying amount of long-lived assets is not recoverable, the carrying amount of such assets is reduced to fair value. We determined that there were no material events or changes in circumstances that indicated that our long-lived assets were impaired during the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies contextRef="c-1" id="f-613">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Indemnification Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#x2019;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud (i.e., the &#x201c;guarantee obligation&#x201d;). Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Guarantees&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, or ASC 460, and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and will be released to revenue in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being released from risk under the guarantee obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue in accordance with ASC 450, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, or ASC 450&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inputs and assumptions used by management to calculate this provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. These liabilities are recorded within Provision for chargebacks, net on the consolidated balance sheets and will be reduced by credits issued or cash paid to merchants. Refer to Note 8 below or &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Item 5. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Financial Review and Prospects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&#x201d; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;for additional information.&lt;/span&gt;&lt;/div&gt;</us-gaap:GuaranteesIndemnificationsAndWarrantiesPolicies>
    <us-gaap:GuaranteeObligationsTerm contextRef="c-1" id="f-614">six</us-gaap:GuaranteeObligationsTerm>
    <us-gaap:GuaranteeObligationsTerm contextRef="c-1" id="f-615">six</us-gaap:GuaranteeObligationsTerm>
    <rskd:WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock contextRef="c-1" id="f-616">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Ordinary Share Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to IPO, warrants to purchase our Series B/C and E-1 convertible preferred shares were recorded as a liability at fair value on our consolidated balance sheets as the underlying convertible preferred shares were contingently redeemable, upon a deemed liquidation event that is outside of our control, and therefore could have obligated us to transfer assets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series B/C convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or upon the completion of a qualified IPO. Upon IPO, the Series B/C convertible preferred share warrants were converted to warrants to purchase ordinary shares, and the then outstanding liability was reclassified to additional paid-in capital in the consolidated balance sheets. The warrants to purchase ordinary shares may be exercised any time prior to, and shall expire upon, the earlier of (a) April 29, 2025 or (b) immediately prior to the consummation of certain deemed liquidation events. In November 2023, the outstanding warrants to purchase ordinary shares were exercised. Refer to Note 9.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Series E-1 convertible preferred share warrants were remeasured to fair value at the end of each reporting period with changes in fair value recognized as a gain or loss within other income (expense), net in the consolidated statements of operations until the earlier of the exercise of the warrants, the expiration of the warrants, or the completion of a deemed liquidation event, including a qualified IPO. Upon IPO, the Series E-1 convertible preferred share warrants were automatically exercised.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In conjunction with a SaaS Agreement entered into in 2021, we issued a warrant to a customer to purchase ordinary shares. The warrant vests annually, in equal amounts, over a five-year period commencing on the effective date of the SaaS Agreement. The warrant is accounted for as consideration payable to a customer under ASC 606 and will reduce revenue as we recognize revenue under the SaaS Agreement over a period of five years. As of December 31, 2023, the warrant is outstanding.&lt;/span&gt;&lt;/div&gt;</rskd:WarrantsAndRightsRightsWarrantsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-617">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily generate revenue by granting merchants access to our eCommerce risk intelligence platform and reviewing and approving eCommerce transactions for legitimacy. Revenue is also generated from the issuance of indemnification guarantees as noted above within &#x201c;Indemnification Guarantees&#x201d;. For the majority of our revenue, merchants pay us a percentage of every dollar of the gross merchandise volume, or GMV, that we approve and guarantee on their behalf. Our fee, as determined by our risk-based pricing model, in these situations is a percentage of the GMV of our merchants&#x2019; orders that we approve, prior to taxes or other charges. These arrangements do not provide merchants with the right to take possession of our software platform. Rather, merchants are granted continuous access to our software platform under a hosting arrangement over the contractual period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As noted above within &#x201c;Indemnification Guarantees&#x201d;, our contracts with our merchants obligate us to review eCommerce transactions for legitimacy as well as to stand ready to indemnify merchants for costs incurred associated with an approved transaction in the event of a chargeback due to fraud. Our fee is allocated between the consideration owed to us for our fraud review service performance obligation accounted for under ASC 606 and the consideration owed to us for issuing indemnification guarantees that are accounted for under ASC 460 and are recorded at fair value. Consideration allocated to fraud review is recognized as revenue over the contract period in the month that the transactions are approved while consideration allocated to the indemnification guarantee is recognized as we are released from risk under the guarantee, generally over a six-month period from the date of the transaction.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We present revenue net of cancellations and adjustments for minimum service level agreements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 606, revenue is recognized when a customer obtains control of promised products. The amount of revenue recognized reflects the consideration that we expect to receive in exchange for these products. To achieve the core principle of this standard, we applied the following five steps:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;1.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Identification of the contract, or contracts, with the merchant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine that we have a contract with a merchant when the contract is approved, each party&#x2019;s rights and obligations regarding the products to be transferred can be identified, the payment terms for the products can be identified, we have determined the merchant has the ability and intent to pay, and the contract has commercial substance. At contract inception, we evaluate whether two or more contracts should be combined and accounted for as a single contract and whether the combined or single contract includes more than one performance obligation. Contracts with our merchants are typically for a period of one year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Identification of the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Performance obligations promised in a contract are identified based on the products that will be transferred to the merchant that are both capable of being distinct, whereby the merchant can benefit from the products either on their own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the products is separately identifiable from other promises in the contract. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For SaaS arrangements, we provide access to our cloud-hosted software platform and reviewing and approving eCommerce transaction for legitimacy, without providing the merchant the right to take possession of our software, which we consider to be a single performance obligation. Revenue generated from the issuance of indemnification guarantees is accounted for under ASC 460. Refer to &#x201c;Indemnification Guarantees&#x201d; above and Note 8 below for additional information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;3.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Determination of the transaction price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As our contracts include an unknown quantity of approved transactions at a fixed contractual rate per approved transaction value executed on a monthly basis, the contract price is deemed variable. We allocate the variable consideration to the month in which we have the contractual right to bill under the contract as this represents the amount of consideration to which we expect to be entitled for the transfer of products during that month. Certain of our contracts include additional forms of variable consideration such as service level commitments relating to uptime availability and minimum approval rates as well as provisions that provide for reimbursements should our merchant&#x2019;s consumer cancel an approved order. If we fail to meet these commitments, merchants are generally permitted to receive a refund in the form of a credit on their invoice. Under certain arrangements, when the merchant&#x2019;s consumer cancels an order that we have approved, we provide a refund of some or all of the fees owed by our merchant to us generally in the form of a credit on our merchant&#x2019;s invoice. The transaction price is reduced to reflect our estimate of the amount of consideration to which we are entitled based on the terms of the contract.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payment terms and conditions vary by contract type, although terms generally include a requirement to pay within 30 days. In instances where the timing of revenue recognition differs from the timing of invoicing, we have determined that our contracts do not include a significant financing component. The primary purpose of our invoicing terms is to provide our merchants with simplified and predictable ways of purchasing our products; not to receive financing from our merchants or to provide merchants with financing. We applied the practical expedient in ASC 606 and did not evaluate payment terms of one year or less for the existence of a significant financing component. Revenue is recognized net of any taxes collected from merchants (e.g., sales tax and other indirect taxes), which are subsequently remitted to governmental entities. We generally do not offer a right of refund in our contracts.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;4.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Allocation of the transaction price to the performance obligations in the contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on each performance obligation&#x2019;s relative standalone selling price. Access to our cloud-hosted software is considered one performance obligation in the context of the contract and accordingly the transaction price is allocated to this single performance obligation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:45pt;text-indent:-27pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;5.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:18.66pt"&gt;Recognition of the revenue when, or as, a performance obligation is satisfied&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue is recognized at the time the related performance obligation is satisfied by transferring control of the promised service to the customer. Revenue is recognized in an amount that reflects the consideration that we expect to receive in exchange for those products. For SaaS arrangements, we have determined that these arrangements meet the variable consideration allocation exception and revenue is recognized over the contract period in the month that the transactions are approved.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Balances &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets consist of unbilled accounts receivable. The terms of our agreements are monthly, annual, or multi-year, and we typically invoice our merchants based on monthly usage. In some arrangements, a right to consideration for our performance under the merchant contract may occur before invoicing to the merchant, resulting in an unbilled accounts receivable. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was immaterial for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost to Obtain a Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize sales commissions and associated payroll taxes paid that are incremental to the acquisition of merchant contracts. These costs are recorded as Deferred contract acquisition costs on the consolidated balance sheets. We determine whether costs should be deferred based on our sales compensation plans and if the commissions are incremental and would not have occurred absent the merchant contract. Determining whether such costs are incremental to obtaining the online merchant contract requires a certain degree of judgment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions for initial contracts are amortized on a straight-line basis over an estimated period of benefit of four years. We determine the period of benefit for sales commissions by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of the period of benefit include inherent uncertainties and the application of significant judgment. Sales commissions for renewal contracts are not commensurate with sales commissions for initial contracts and are deferred and then amortized on a straight-line basis over the contractual term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales commissions expenses are included in sales and marketing expense in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Cost to Fulfill a Contract &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We capitalize payroll related costs of certain integration services required in order to be able to fulfill the obligation to provide our products to our merchants. Integration services are promises that are not capable of being distinct. These costs are capitalized to the extent they are directly related to a contract, are recoverable, and generate or enhance resources that will be used in delivering our SaaS products. These costs are recorded as deferred contract fulfillment costs in other assets, noncurrent on the consolidated balance sheets. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized costs to fulfill a contract are amortized on a straight-line basis over the expected period of benefit of four years and are included in cost of revenue in the consolidated statements of operations. We &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;determine the period of benefit by taking into consideration the estimated customer life, technological life of our software, and other factors. These factors involved in the determination of period of benefit involve inherent uncertainties and the application of significant judgment. We periodically review these deferred contract fulfillment costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. There were no impairment losses recorded during the periods presented.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:GuaranteeObligationsTerm contextRef="c-1" id="f-618">six</us-gaap:GuaranteeObligationsTerm>
    <rskd:RevenueTermOfMerchantContract contextRef="c-1" id="f-619">P1Y</rskd:RevenueTermOfMerchantContract>
    <us-gaap:CapitalizedContractCostAmortizationPeriod contextRef="c-6" id="f-620">P4Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-1" decimals="INF" id="f-621" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-11" decimals="INF" id="f-622" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-10" decimals="INF" id="f-623" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostAmortizationPeriod contextRef="c-6" id="f-624">P4Y</us-gaap:CapitalizedContractCostAmortizationPeriod>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-1" decimals="INF" id="f-625" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-11" decimals="INF" id="f-626" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CapitalizedContractCostImpairmentLoss contextRef="c-10" decimals="INF" id="f-627" unitRef="usd">0</us-gaap:CapitalizedContractCostImpairmentLoss>
    <us-gaap:CostOfSalesPolicyTextBlock contextRef="c-1" id="f-628">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of revenue primarily consist of chargeback expenses, net of chargebacks won, and other expenses related to providing our products to our merchants. These other expenses include compensation and benefits related costs, including share-based compensation expense associated with teams integral in providing our service, hosting fees and software costs, payment processing fees, amortization of capitalized software development costs and deferred contract fulfillment costs, depreciation expense, and allocated overhead.&lt;/span&gt;&lt;/div&gt;Chargeback claims can be disputed and if the decision of the dispute concludes that the order was legitimate and not fraudulent, the chargeback is classified as chargeback won. We present chargeback expenses net of chargebacks won, since such amounts are refunded to us.</us-gaap:CostOfSalesPolicyTextBlock>
    <rskd:ChargebackExpense contextRef="c-1" decimals="-5" id="f-629" unitRef="usd">25000000</rskd:ChargebackExpense>
    <rskd:ChargebackExpense contextRef="c-10" decimals="-5" id="f-630" unitRef="usd">20300000</rskd:ChargebackExpense>
    <rskd:ChargebackExpense contextRef="c-11" decimals="-5" id="f-631" unitRef="usd">14300000</rskd:ChargebackExpense>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-632">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with research and development teams that are responsible for the design, development, and testing of our ecommerce risk intelligence platform infrastructure including expenses associated with adding new features, increasing the functionality, and enhancing the usability of our platform. Research and development costs also consist of third-party software hosting fees used by our research and development teams, depreciation expense, and allocated overhead. Research and development costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <rskd:SalesAndMarketingExpensePolicyPolicyTextBlock contextRef="c-1" id="f-633">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Sales and Marketing&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Sales and marketing costs primarily consist of compensation and benefits related costs, including share-based compensation expense directly associated with our sales and marketing teams. Sales and marketing costs also consists of costs associated with conferences, events, digital marketing and advertising programs, deferred contract acquisition costs, depreciation expense, and allocated overhead. Sales and marketing costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Digital marketing programs include advertising, promotional events, and brand-building activities. Advertising costs are expensed as incurred and were $4.9 million, $6.0 million, and $5.2 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</rskd:SalesAndMarketingExpensePolicyPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-5" id="f-634" unitRef="usd">4900000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-10" decimals="-5" id="f-635" unitRef="usd">6000000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-11" decimals="-5" id="f-636" unitRef="usd">5200000</us-gaap:AdvertisingExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock contextRef="c-1" id="f-637">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;General and Administrative&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;General and administrative costs primarily consist of compensation and benefits related costs, including share-based compensation expense associated with our finance, legal, human resources, information technology and administrative functions. General and administrative costs also consist of third-party professional service fees for external legal, accounting and other consulting services, depreciation expense, and allocated overhead. General and administrative costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-638">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to share-based awards is recognized based on the fair value of the awards granted. The fair value of each share option award is estimated on the grant date &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;using the Black-Scholes option-pricing model. The Black-Scholes option-pricing model requires the input of highly subjective assumptions, including the fair value of the underlying ordinary shares, the expected term of the share option, the expected volatility of the price of our ordinary shares, risk-free interest rates, and the expected dividend yield of ordinary shares. The assumptions used to determine the fair value of the option awards represent management&#x2019;s best estimates. These estimates involve inherent uncertainties and the application of management&#x2019;s judgment. The related share-based compensation expense is recognized on a straight-line basis over the requisite service period of the awards, including awards with graded vesting and no additional conditions for vesting other than service conditions. Forfeitures are accounted for as they occur.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have granted to employees, RSUs, that vest either upon the (a) satisfaction of service-based vesting conditions only and (b) satisfaction of both service-based and performance-based vesting conditions. The fair value of each RSU award is based on the fair value of the underlying ordinary shares as of the grant date. We have also granted to our Chief Executive Officer (&#x201c;CEO&#x201d;), RSUs, that vest upon the satisfaction of service-based, performance-based, and market-based vesting conditions. A Monte-Carlo simulation model was used to determine the grant date fair value by simulating a range of scenarios with each outcome resulting in a determined value. The grant date fair value of this award is the average of the values determined by each simulation. The simulation was also used to derive the requisite service period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For RSU awards with both service-based and performance-based vesting conditions, the service-based vesting condition has varying terms, but is generally satisfied over &lt;span style="-sec-ix-hidden:f-639"&gt;four&lt;/span&gt; to five years. The performance-based vesting condition is satisfied upon the occurrence of a qualifying liquidation event which is defined as the earlier to occur of (i) the six month anniversary of or, if earlier, March 15 of the year following, the occurrence of an IPO or (ii) consummation of a merger and acquisition, or M&amp;amp;A, transaction of the Company. The performance-based vesting condition underlying these awards was satisfied upon our IPO. The market-based condition underlying the CEO RSU is satisfied upon the trading price of our ordinary shares meeting certain thresholds.&lt;/span&gt;&lt;/div&gt;RSU awards with service-based vesting conditions only are recognized using the straight-line method. RSU awards with more than just a service-based vesting condition are recognized using the accelerated attribution method once the performance-based vesting condition is probable of</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-105" id="f-640">P5Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-106" id="f-641">P6M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-642">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to income taxes in Israel, the United States, and other jurisdictions. These other jurisdictions may have different statutory rates than in Israel. Income taxes are accounted for in accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the consolidated financial statements carrying amounts of existing assets and liabilities and their respective tax basis as well as operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Valuation allowances are provided when necessary to reduce deferred tax assets to an amount that is more likely than not to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such uncertain tax positions are then measured based on the largest benefit that is more likely than not to be realized upon the ultimate settlement.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-643">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Profit (Loss) Per Share Attributable to Ordinary Shareholders &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We compute net profit (loss) per share using the two-class method required for participating securities. The two-class method requires income available to ordinary shareholders for the period to be &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;allocated between ordinary shares and participating securities based upon their respective rights to receive dividends as if all income for the period had been distributed. Under the two-class method, we allocate earnings proportionately to Class A and B ordinary shares outstanding for the period. Prior to IPO, we considered our convertible preferred shares to be participating securities as the holders of the convertible preferred shares would be entitled to dividends in preference to ordinary shareholders. These participating securities do not contractually require the holders of such shares to participate in our losses. As such, net loss for the periods presented was not allocated to our participating securities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our basic net profit (loss) per share is calculated by dividing net profit (loss) attributable to ordinary shareholders by the weighted-average number of ordinary shares outstanding for the period, without consideration of potentially dilutive securities. The diluted net profit (loss) per share is calculated by giving effect to all potentially dilutive securities outstanding for the period using the treasury stock method or the if-converted method based on the nature of such securities. Diluted net profit (loss) per share is the same as basic net profit (loss) per share in periods when the effects of potentially dilutive shares of ordinary shares are anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock contextRef="c-1" id="f-644">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segment Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We operate our business in one operating segment and therefore have one reportable segment. Operating segments are defined as components of an entity that engage in business activities for which discrete financial information is available and regularly reviewed by the chief operating decision maker, who is our CEO, in deciding how to allocate resources and assess performance. Our chief operating decision maker allocates resources and assesses performance based upon discrete financial information at the consolidated level. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue by geographical region can be found in the revenue recognition disclosures in Note 3 below. Property and equipment, net of depreciation and amortization, by geographic region can be found in Note 6 below. Operating lease ROU assets by geographic region can be found in Note 7 below.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="c-1"
      decimals="INF"
      id="f-645"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-646"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-647">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As an emerging growth company, or EGC, the Jumpstart Our Business Startups Act, or the JOBS Act, allows us to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are made applicable to private companies. The JOBS Act does not preclude an EGC from early adopting new or revised accounting standards. We have elected to use extended transition periods permissible under the JOBS Act while also early adopting certain accounting pronouncements. The adoption dates discussed below reflect these elections.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments &#x2013; Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;including subsequent amendments thereafter, which established ASC 326. ASC 326 replaces the existing incurred loss impairment model with a current expected credit loss model that requires more timely recognition of estimated expected credit losses over the life of certain financial instruments. Our accounts receivable and available-for-sale debt securities are in the scope of ASC 326. We adopted ASC 326 as of January 1, 2023. The adoption of ASC 326 did not have a material impact on our financial condition and results of operations within our consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board (FASB) issued ASU No. 2023-07, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Reportable Segments (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expands annual and interim disclosure requirements for reportable segments, primarily through enhanced disclosures about significant segment expenses, including public entities with a single operating or reportable segment. The updated standard will be effective for annual periods beginning in fiscal 2024 and interim periods beginning in the first quarter of fiscal 2025. Early adoption is permitted. We are currently evaluating the impact of this standard on our financial statement disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, which expands disclosures in an entity&#x2019;s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The updated standard will be effective for annual periods beginning in fiscal 2026. We are currently evaluating the impact of this standard on our financial statement disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock contextRef="c-1" id="f-649">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;3.       Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenue by region in which our merchants&#x2019; headquarters are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except where indicated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa (&#x201c;EMEA&#x201d;)*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific (&#x201c;APAC&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt"&gt;Revenue recognized from merchants whose headquarters are in Israel, which is our country of domicile, was $1.3 million, $3.3 million, and $2.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenue based on the nature and type of service provided to our merchants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except where indicated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fraud review service revenue (ASC 606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification guarantee service revenue (ASC 460)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We primarily generate revenue from our Chargeback Guarantee offering. Revenue generated from other offerings are not material. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The allocation of consideration between fraud review service revenue and indemnification guarantee service revenue is a function of the fair value of our chargeback guarantee which represents what we would need to pay a third party to relieve ourselves from our obligations under issued guarantees. The fair value of the chargeback guarantee is primarily determined by utilizing the historical percentage of guarantees issued that resulted in a chargeback plus a risk premium fee that we would have incurred from a third-party in order to relieve ourselves from our legal obligation under the guarantee. Refer to Item 5. &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Operating and Financial Review and Prospects&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2014; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Critical Accounting Policies and Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the percentage of revenue that are recorded as fraud review service revenue and indemnification guarantee service revenue are a function of changes in the aforementioned fair value of the chargeback guarantee and changes in the speed in which we resolve chargeback claims which impacts the systematic and rational approach that we utilize to record revenue associated with our guarantee obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost to Obtain a Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of deferred contract acquisition costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.722%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cost to Fulfill a Contract&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of deferred contract fulfillment costs that are included within in other assets, noncurrent on the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.722%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-650">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenue by region in which our merchants&#x2019; headquarters are located:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.611%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.724%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except where indicated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;182,806&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,920&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;163,681&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe, the Middle East and Africa (&#x201c;EMEA&#x201d;)*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71,443&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44,850&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific (&#x201c;APAC&#x201d;)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,416&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Americas&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,879&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:14.89pt"&gt;Revenue recognized from merchants whose headquarters are in Israel, which is our country of domicile, was $1.3 million, $3.3 million, and $2.4 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <us-gaap:Revenues contextRef="c-107" decimals="-3" id="f-651" unitRef="usd">182806000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-108" decimals="2" id="f-652" unitRef="number">0.61</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-109" decimals="-3" id="f-653" unitRef="usd">163920000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-110" decimals="2" id="f-654" unitRef="number">0.63</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-111" decimals="-3" id="f-655" unitRef="usd">163681000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-112" decimals="2" id="f-656" unitRef="number">0.71</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-113" decimals="-3" id="f-657" unitRef="usd">80547000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-114" decimals="2" id="f-658" unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-115" decimals="-3" id="f-659" unitRef="usd">71443000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-116" decimals="2" id="f-660" unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-117" decimals="-3" id="f-661" unitRef="usd">44850000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-118" decimals="2" id="f-662" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-119" decimals="-3" id="f-663" unitRef="usd">16699000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-120" decimals="2" id="f-664" unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-121" decimals="-3" id="f-665" unitRef="usd">12005000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-122" decimals="2" id="f-666" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-123" decimals="-3" id="f-667" unitRef="usd">7416000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-124" decimals="2" id="f-668" unitRef="number">0.03</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-125" decimals="-3" id="f-669" unitRef="usd">17558000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-126" decimals="2" id="f-670" unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-127" decimals="-3" id="f-671" unitRef="usd">13879000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-128" decimals="2" id="f-672" unitRef="number">0.05</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-129" decimals="-3" id="f-673" unitRef="usd">13194000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-130" decimals="2" id="f-674" unitRef="number">0.06</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-675" unitRef="usd">297610000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-131" decimals="2" id="f-676" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-10" decimals="-3" id="f-677" unitRef="usd">261247000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-132" decimals="2" id="f-678" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-11" decimals="-3" id="f-679" unitRef="usd">229141000</us-gaap:Revenues>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-133" decimals="2" id="f-680" unitRef="number">1</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-134" decimals="-3" id="f-681" unitRef="usd">1300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-135" decimals="-3" id="f-682" unitRef="usd">3300000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-136" decimals="-3" id="f-683" unitRef="usd">2400000</us-gaap:Revenues>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-684">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes revenue based on the nature and type of service provided to our merchants:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.496%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.239%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.244%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Percentage of Revenue&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except where indicated)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fraud review service revenue (ASC 606)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;156,040&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;58&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Indemnification guarantee service revenue (ASC 460)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105,207&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96,880&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;297,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;261,247&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-137" decimals="-3" id="f-685" unitRef="usd">167278000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-138" decimals="2" id="f-686" unitRef="number">0.56</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-139" decimals="-3" id="f-687" unitRef="usd">156040000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-140" decimals="2" id="f-688" unitRef="number">0.60</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-141" decimals="-3" id="f-689" unitRef="usd">132261000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-142" decimals="2" id="f-690" unitRef="number">0.58</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-143" decimals="-3" id="f-691" unitRef="usd">130332000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-144" decimals="2" id="f-692" unitRef="number">0.44</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-145" decimals="-3" id="f-693" unitRef="usd">105207000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-146" decimals="2" id="f-694" unitRef="number">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueNotFromContractWithCustomer contextRef="c-147" decimals="-3" id="f-695" unitRef="usd">96880000</us-gaap:RevenueNotFromContractWithCustomer>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-148" decimals="2" id="f-696" unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:Revenues contextRef="c-1" decimals="-3" id="f-697" unitRef="usd">297610000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-10" decimals="-3" id="f-698" unitRef="usd">261247000</us-gaap:Revenues>
    <us-gaap:Revenues contextRef="c-11" decimals="-3" id="f-699" unitRef="usd">229141000</us-gaap:Revenues>
    <us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock contextRef="c-1" id="f-700">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of deferred contract acquisition costs:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.722%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,894&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,707&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,715)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,689)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,642)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,562&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DeferredPolicyAcquisitionCostsTableTextBlock>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-7" decimals="-3" id="f-701" unitRef="usd">14383000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-33" decimals="-3" id="f-702" unitRef="usd">10365000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-18" decimals="-3" id="f-703" unitRef="usd">6263000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts contextRef="c-1" decimals="-3" id="f-704" unitRef="usd">8894000</rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts>
    <rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts contextRef="c-10" decimals="-3" id="f-705" unitRef="usd">9707000</rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts>
    <rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts contextRef="c-11" decimals="-3" id="f-706" unitRef="usd">7744000</rskd:IncreaseDecreaseToDeferredContractAcquisitionCosts>
    <rskd:CapitalizedDeferredContractAcquisitionCostAmortization contextRef="c-1" decimals="-3" id="f-707" unitRef="usd">7715000</rskd:CapitalizedDeferredContractAcquisitionCostAmortization>
    <rskd:CapitalizedDeferredContractAcquisitionCostAmortization contextRef="c-10" decimals="-3" id="f-708" unitRef="usd">5689000</rskd:CapitalizedDeferredContractAcquisitionCostAmortization>
    <rskd:CapitalizedDeferredContractAcquisitionCostAmortization contextRef="c-11" decimals="-3" id="f-709" unitRef="usd">3642000</rskd:CapitalizedDeferredContractAcquisitionCostAmortization>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-6" decimals="-3" id="f-710" unitRef="usd">15562000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-7" decimals="-3" id="f-711" unitRef="usd">14383000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <us-gaap:CapitalizedContractCostNetNoncurrent contextRef="c-33" decimals="-3" id="f-712" unitRef="usd">10365000</us-gaap:CapitalizedContractCostNetNoncurrent>
    <rskd:DeferredContractFulfillmentCostsTableTextBlock contextRef="c-1" id="f-713">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents a roll-forward of deferred contract fulfillment costs that are included within in other assets, noncurrent on the consolidated balance sheets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.912%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.722%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions to deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,635&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,189&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,789&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization of deferred contract fulfillment costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,852)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,446)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,025)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,673&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,930&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rskd:DeferredContractFulfillmentCostsTableTextBlock>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-7" decimals="-3" id="f-714" unitRef="usd">3673000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-33" decimals="-3" id="f-715" unitRef="usd">2930000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-18" decimals="-3" id="f-716" unitRef="usd">2166000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts contextRef="c-1" decimals="-3" id="f-717" unitRef="usd">2635000</rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts>
    <rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts contextRef="c-10" decimals="-3" id="f-718" unitRef="usd">2189000</rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts>
    <rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts contextRef="c-11" decimals="-3" id="f-719" unitRef="usd">1789000</rskd:IncreaseDecreaseToDeferredContractFulfillmentCosts>
    <rskd:DeferredContractFulfillmentCostsAmortizationExpense contextRef="c-1" decimals="-3" id="f-720" unitRef="usd">1852000</rskd:DeferredContractFulfillmentCostsAmortizationExpense>
    <rskd:DeferredContractFulfillmentCostsAmortizationExpense contextRef="c-10" decimals="-3" id="f-721" unitRef="usd">1446000</rskd:DeferredContractFulfillmentCostsAmortizationExpense>
    <rskd:DeferredContractFulfillmentCostsAmortizationExpense contextRef="c-11" decimals="-3" id="f-722" unitRef="usd">1025000</rskd:DeferredContractFulfillmentCostsAmortizationExpense>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-6" decimals="-3" id="f-723" unitRef="usd">4456000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-7" decimals="-3" id="f-724" unitRef="usd">3673000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <rskd:DeferredContractFulfillmentCostsNoncurrent contextRef="c-33" decimals="-3" id="f-725" unitRef="usd">2930000</rskd:DeferredContractFulfillmentCostsNoncurrent>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="c-1" id="f-726">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;4.       Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about our financial instruments that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds included within short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-733"&gt;Derivative financial instruments included in prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-742"&gt;Derivative financial instruments included in accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-751"&gt;Derivative financial instruments included in accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, we did not have any Level 3 financial instruments that are measured at fair value on a recurring basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We classify our derivative financial instruments and government bonds within Level 2 of the fair value hierarchy because they are valued using inputs other than quoted prices which are directly or indirectly observable in the market, including readily-available pricing sources for the identical underlying security which may not be actively traded. Refer to Note 5 for more information regarding our derivative financial instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Refer to Note 8 below for more information regarding the fair value of our indemnification guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Securities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.237%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no short-term investments as of December 31, 2022. The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;As of December 31, 2023, the unrealized losses related to short-term investments were not due to credit related losses. Therefore, we did not recognize an allowance for credit losses for our short-term investments. As of December 31, 2023, we did not have any available-for-sale debt securities that have been in a continuous loss position</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock contextRef="c-1" id="f-727">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables present information about our financial instruments that are measured at fair value on a recurring basis:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds included within short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-733"&gt;Derivative financial instruments included in prepaid expenses and other current assets&lt;/span&gt;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,276&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-742"&gt;Derivative financial instruments included in accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.694%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.720%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.723%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 2&#160;&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level 3&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Financial Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&lt;span style="-sec-ix-hidden:f-751"&gt;Derivative financial instruments included in accrued expenses and other current liabilities&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total financial liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:ShortTermInvestments contextRef="c-149" decimals="-3" id="f-728" unitRef="usd">28968000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-6" decimals="-3" id="f-729" unitRef="usd">28968000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:ShortTermInvestments contextRef="c-150" decimals="-3" id="f-730" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-151" decimals="-3" id="f-731" unitRef="usd">28968000</us-gaap:ShortTermInvestments>
    <us-gaap:ShortTermInvestments contextRef="c-152" decimals="-3" id="f-732" unitRef="usd">0</us-gaap:ShortTermInvestments>
    <us-gaap:DerivativeAssets contextRef="c-149" decimals="-3" id="f-734" unitRef="usd">308000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-150" decimals="-3" id="f-735" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-151" decimals="-3" id="f-736" unitRef="usd">308000</us-gaap:DerivativeAssets>
    <us-gaap:DerivativeAssets contextRef="c-152" decimals="-3" id="f-737" unitRef="usd">0</us-gaap:DerivativeAssets>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-149" decimals="-3" id="f-738" unitRef="usd">29276000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-150" decimals="-3" id="f-739" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-151" decimals="-3" id="f-740" unitRef="usd">29276000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-152" decimals="-3" id="f-741" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-149" decimals="-3" id="f-743" unitRef="usd">462000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-150" decimals="-3" id="f-744" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-151" decimals="-3" id="f-745" unitRef="usd">462000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-152" decimals="-3" id="f-746" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-149" decimals="-3" id="f-747" unitRef="usd">462000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-150" decimals="-3" id="f-748" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-151" decimals="-3" id="f-749" unitRef="usd">462000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-152" decimals="-3" id="f-750" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DerivativeLiabilities contextRef="c-153" decimals="-3" id="f-752" unitRef="usd">2397000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-154" decimals="-3" id="f-753" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-155" decimals="-3" id="f-754" unitRef="usd">2397000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities contextRef="c-156" decimals="-3" id="f-755" unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-153" decimals="-3" id="f-756" unitRef="usd">2397000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-154" decimals="-3" id="f-757" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-155" decimals="-3" id="f-758" unitRef="usd">2397000</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:LiabilitiesFairValueDisclosure contextRef="c-156" decimals="-3" id="f-759" unitRef="usd">0</us-gaap:LiabilitiesFairValueDisclosure>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-760">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term investments consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:43.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.233%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.466%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.237%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amortized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Cost&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gains&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrealized&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Losses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Government bonds&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total short-term investments&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,882&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(143)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss contextRef="c-157" decimals="-3" id="f-761" unitRef="usd">28882000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-157" decimals="-3" id="f-762" unitRef="usd">229000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-157" decimals="-3" id="f-763" unitRef="usd">143000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-157" decimals="-3" id="f-764" unitRef="usd">28968000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss contextRef="c-6" decimals="-3" id="f-765" unitRef="usd">28882000</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-6" decimals="-3" id="f-766" unitRef="usd">229000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-6" decimals="-3" id="f-767" unitRef="usd">143000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-6" decimals="-3" id="f-768" unitRef="usd">28968000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-7" decimals="-3" id="f-769" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss contextRef="c-7" decimals="-3" id="f-770" unitRef="usd">0</us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss>
    <us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock contextRef="c-1" id="f-771">The following table summarizes the estimated fair value of investments in available-for-sale marketable debt securities by effective contractual maturity dates:&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:77.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.400%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Due in 1 year or less&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,968&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock>
    <us-gaap:ShortTermInvestments contextRef="c-149" decimals="-3" id="f-772" unitRef="usd">28968000</us-gaap:ShortTermInvestments>
    <us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue contextRef="c-6" decimals="-3" id="f-773" unitRef="usd">28968000</us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-6" decimals="-3" id="f-774" unitRef="usd">28968000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock contextRef="c-1" id="f-775">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;5.       Derivative Financial Instruments and Hedging&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Notional Amount of Foreign Currency Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency contracts are denominated in NIS and Euro. The gross notional amounts of outstanding foreign currency contracts in U.S. dollar were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total derivative instruments  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effect of Foreign Currency Contracts on the Consolidated Statements of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of foreign currency contracts on the Consolidated Statements of Operations during the periods presented were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Statement of Operations Location:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gain (loss) recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Effect of Foreign Currency Contracts on Accumulated Other Comprehensive Profit (Loss)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, that were recorded in accumulated other comprehensive profit (loss) during the periods presented, and their effect on other comprehensive profit (loss) for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.073%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2021, net deferred gains totaled $0.2 million and were recognized during the year ended December 31, 2022 in the same financial statement line item as the hedged items. As of December 31, 2022, $1.7&#160;million of net deferred losses were recorded in accumulated other comprehensive profit (loss) and were recognized during the year ended December 31, 2023 in the same financial statement line item as the hedged items. As of December 31, 2023, $0.1 million of net deferred losses were recorded in accumulated other comprehensive profit (loss) of which all are expected to be recognized in the same financial statement line item in the Consolidated Statements of Operations to which the derivative relates over the next twelve months.&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfDerivativeInstrumentsTextBlock contextRef="c-1" id="f-776">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our foreign currency contracts are denominated in NIS and Euro. The gross notional amounts of outstanding foreign currency contracts in U.S. dollar were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.214%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,716&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63,998&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,314&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&#160;&#160;&#160;Total derivative instruments  &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;74,030&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77,812&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-158" decimals="-3" id="f-777" unitRef="usd">63716000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-159" decimals="-3" id="f-778" unitRef="usd">63998000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-160" decimals="-3" id="f-779" unitRef="usd">10314000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-161" decimals="-3" id="f-780" unitRef="usd">13814000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-6" decimals="-3" id="f-781" unitRef="usd">74030000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset contextRef="c-7" decimals="-3" id="f-782" unitRef="usd">77812000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock contextRef="c-1" id="f-783">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effect of foreign currency contracts on the Consolidated Statements of Operations during the periods presented were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:30.310%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.797%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Derivatives Not Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Statement of Operations Location:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;168&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(146)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(175)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,718)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,051)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(732)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,263)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(706)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 16pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total gain (loss) recognized in earnings&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(534)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,659)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-162" decimals="-3" id="f-784" unitRef="usd">168000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-163" decimals="-3" id="f-785" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-164" decimals="-3" id="f-786" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-165" decimals="-3" id="f-787" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-166" decimals="-3" id="f-788" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-167" decimals="-3" id="f-789" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-168" decimals="-3" id="f-790" unitRef="usd">-146000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-169" decimals="-3" id="f-791" unitRef="usd">-175000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-170" decimals="-3" id="f-792" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-171" decimals="-3" id="f-793" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-172" decimals="-3" id="f-794" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-173" decimals="-3" id="f-795" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-174" decimals="-3" id="f-796" unitRef="usd">-2659000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-175" decimals="-3" id="f-797" unitRef="usd">-1718000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-176" decimals="-3" id="f-798" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-177" decimals="-3" id="f-799" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-178" decimals="-3" id="f-800" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-179" decimals="-3" id="f-801" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-180" decimals="-3" id="f-802" unitRef="usd">-1051000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-181" decimals="-3" id="f-803" unitRef="usd">-732000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-182" decimals="-3" id="f-804" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-183" decimals="-3" id="f-805" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-184" decimals="-3" id="f-806" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-185" decimals="-3" id="f-807" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-186" decimals="-3" id="f-808" unitRef="usd">-1263000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-187" decimals="-3" id="f-809" unitRef="usd">-706000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-188" decimals="-3" id="f-810" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-189" decimals="-3" id="f-811" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-190" decimals="-3" id="f-812" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-191" decimals="-3" id="f-813" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-192" decimals="-3" id="f-814" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-193" decimals="-3" id="f-815" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-194" decimals="-3" id="f-816" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-195" decimals="-3" id="f-817" unitRef="usd">-534000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-196" decimals="-3" id="f-818" unitRef="usd">-1659000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-197" decimals="-3" id="f-819" unitRef="usd">59000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-198" decimals="-3" id="f-820" unitRef="usd">-4951000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-199" decimals="-3" id="f-821" unitRef="usd">-3331000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-200" decimals="-3" id="f-822" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-201" decimals="-3" id="f-823" unitRef="usd">-534000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-202" decimals="-3" id="f-824" unitRef="usd">-1659000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-203" decimals="-3" id="f-825" unitRef="usd">59000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock contextRef="c-1" id="f-826">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents the net unrealized gains (losses) of foreign currency contracts designated as hedging instruments, net of tax, that were recorded in accumulated other comprehensive profit (loss) during the periods presented, and their effect on other comprehensive profit (loss) for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.073%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.727%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Unrealized Gains (Losses) on Derivatives Designated as Hedging Instruments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;176&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,448&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,331)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,883)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,707)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) recorded in accumulated other comprehensive profit (loss)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,585&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amount of net gains (losses) reclassified from accumulated other comprehensive profit (loss) to earnings&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive profit (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,634&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(73)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity contextRef="c-204" decimals="-3" id="f-827" unitRef="usd">0</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-205" decimals="-3" id="f-828" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-200" decimals="-3" id="f-829" unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-205" decimals="-3" id="f-830" unitRef="usd">176000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:StockholdersEquity contextRef="c-206" decimals="-3" id="f-831" unitRef="usd">176000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-207" decimals="-3" id="f-832" unitRef="usd">1448000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-199" decimals="-3" id="f-833" unitRef="usd">-3331000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-207" decimals="-3" id="f-834" unitRef="usd">-1883000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:StockholdersEquity contextRef="c-208" decimals="-3" id="f-835" unitRef="usd">-1707000</us-gaap:StockholdersEquity>
    <us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax contextRef="c-209" decimals="-3" id="f-836" unitRef="usd">6585000</us-gaap:OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax>
    <us-gaap:DerivativeGainLossOnDerivativeNet contextRef="c-198" decimals="-3" id="f-837" unitRef="usd">-4951000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent contextRef="c-209" decimals="-3" id="f-838" unitRef="usd">1634000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent>
    <us-gaap:StockholdersEquity contextRef="c-210" decimals="-3" id="f-839" unitRef="usd">-73000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-206" decimals="-5" id="f-840" unitRef="usd">200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-208" decimals="-5" id="f-841" unitRef="usd">-1700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-210" decimals="-5" id="f-842" unitRef="usd">-100000</us-gaap:StockholdersEquity>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock contextRef="c-1" id="f-843">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;6.       Consolidated Balance Sheet Components&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Computer equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and office equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,593&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,531&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,702&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,576&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, gross&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,887&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,019&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,248)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,433)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization expenses were $3.6 million, $3.4 million, and $1.8 million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our property and equipment, net of depreciation and amortization, by geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,209&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,671&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,403&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of world&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,586&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Liabilities, Noncurrent&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, noncurrent consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-91" decimals="-3" id="f-844" unitRef="usd">6592000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-211" decimals="-3" id="f-845" unitRef="usd">6912000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-212" decimals="-3" id="f-846" unitRef="usd">2593000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-213" decimals="-3" id="f-847" unitRef="usd">2531000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-214" decimals="-3" id="f-848" unitRef="usd">16702000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-215" decimals="-3" id="f-849" unitRef="usd">16576000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-6" decimals="-3" id="f-850" unitRef="usd">25887000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-7" decimals="-3" id="f-851" unitRef="usd">26019000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-852" unitRef="usd">10248000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-853" unitRef="usd">7433000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-854" unitRef="usd">15639000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-3" id="f-855" unitRef="usd">18586000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-856" unitRef="usd">3600000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-10" decimals="-5" id="f-857" unitRef="usd">3400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-11" decimals="-5" id="f-858" unitRef="usd">1800000</us-gaap:Depreciation>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-216" decimals="-3" id="f-859" unitRef="usd">14209000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-217" decimals="-3" id="f-860" unitRef="usd">16671000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-218" decimals="-3" id="f-861" unitRef="usd">1403000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-219" decimals="-3" id="f-862" unitRef="usd">1796000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-220" decimals="-3" id="f-863" unitRef="usd">27000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-221" decimals="-3" id="f-864" unitRef="usd">119000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-6" decimals="-3" id="f-865" unitRef="usd">15639000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet contextRef="c-7" decimals="-3" id="f-866" unitRef="usd">18586000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-867">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,548&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,175&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,724&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative financial instruments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;462&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,397&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,062&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,853&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,796&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,813&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-868" unitRef="usd">4548000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-869" unitRef="usd">6175000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent contextRef="c-6" decimals="-3" id="f-870" unitRef="usd">6724000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:ContractWithCustomerRefundLiabilityCurrent contextRef="c-7" decimals="-3" id="f-871" unitRef="usd">5388000</us-gaap:ContractWithCustomerRefundLiabilityCurrent>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities contextRef="c-6" decimals="-3" id="f-872" unitRef="usd">462000</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:DerivativeInstrumentsAndHedgesLiabilities contextRef="c-7" decimals="-3" id="f-873" unitRef="usd">2397000</us-gaap:DerivativeInstrumentsAndHedgesLiabilities>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-874" unitRef="usd">1062000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-875" unitRef="usd">1853000</us-gaap:OtherLiabilitiesCurrent>
    <rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-6" decimals="-3" id="f-876" unitRef="usd">12796000</rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent contextRef="c-7" decimals="-3" id="f-877" unitRef="usd">15813000</rskd:AccruedLiabilitiesAndOtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock contextRef="c-1" id="f-878">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, noncurrent consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.053%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.002%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.004%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other liabilities, noncurrent&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,706&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,734&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent contextRef="c-6" decimals="-3" id="f-879" unitRef="usd">14706000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent contextRef="c-7" decimals="-3" id="f-880" unitRef="usd">8734000</us-gaap:DeferredTaxAndOtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-3" id="f-881" unitRef="usd">14706000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-7" decimals="-3" id="f-882" unitRef="usd">8734000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-883">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;7.       Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have non-cancelable operating leases for our corporate offices in Tel Aviv, Israel and in New York, New York in the United States. The leases for these facilities in Tel Aviv and New York expire in 2031 and 2029, respectively and we have options to renew these leases through 2036 and 2034, respectively. These renewal options are excluded from the calculation of operating lease ROU assets and operating lease liabilities. We sublease a portion of our office space in Tel Aviv and New York.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease cost for the years ended December&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.734%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease costs prior to the adoption of ASC 842 were $5.9 million for the year ended December 31, 2021. Sublease income was $0.1 million for the year ended December 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, the weighted average remaining lease term and the weighted average discount rate for our operating leases were 6.5 years and 4.6%, respectively. As of December&#160;31, 2022, the weighted average remaining lease term and the weighted average discount rate for our operating leases were 7.4 years and 4.6%, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The future minimum lease payments included in the measurement of our operating lease liabilities as of December&#160;31, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our operating lease ROU assets by geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Excluded from the tables above is an unsecured and undated promissory note issued in December 2020 in connection with the execution of a lease agreement for an amount of $2.9 million and $3.0 million as of December&#160;31, 2023 and 2022, respectively. The promissory note may only be withdrawn in the event of a material and fundamental breach of the lease agreement. The promissory note expires three months after the lease termination date. As of December&#160;31, 2023 and 2022, we were in full compliance of the terms and conditions of the promissory note, and the promissory note has not been withdrawn.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-884">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of operating lease cost for the years ended December&#160;31, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.592%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.733%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:19.734%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,140&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,257&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sublease income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,347)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(786)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,075&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,915&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-3" id="f-885" unitRef="usd">6242000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-10" decimals="-3" id="f-886" unitRef="usd">6140000</us-gaap:OperatingLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-3" id="f-887" unitRef="usd">1010000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-10" decimals="-3" id="f-888" unitRef="usd">1257000</us-gaap:VariableLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-3" id="f-889" unitRef="usd">170000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-10" decimals="-3" id="f-890" unitRef="usd">304000</us-gaap:ShortTermLeaseCost>
    <us-gaap:SubleaseIncome contextRef="c-1" decimals="-3" id="f-891" unitRef="usd">1347000</us-gaap:SubleaseIncome>
    <us-gaap:SubleaseIncome contextRef="c-10" decimals="-3" id="f-892" unitRef="usd">786000</us-gaap:SubleaseIncome>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-3" id="f-893" unitRef="usd">6075000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-10" decimals="-3" id="f-894" unitRef="usd">6915000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasesRentExpenseNet contextRef="c-11" decimals="-5" id="f-895" unitRef="usd">5900000</us-gaap:OperatingLeasesRentExpenseNet>
    <us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue contextRef="c-11" decimals="-5" id="f-896" unitRef="usd">100000</us-gaap:OperatingLeasesIncomeStatementSubleaseRevenue>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-897">P6Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-898" unitRef="number">0.046</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-7" id="f-899">P7Y4M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-7" decimals="3" id="f-900" unitRef="number">0.046</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-901">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The future minimum lease payments included in the measurement of our operating lease liabilities as of December&#160;31, 2023, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,744&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,759&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,804&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,851&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,183&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total undiscounted lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36,055&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,309&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our operating lease ROU assets by geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,782&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,598&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-6" decimals="-3" id="f-902" unitRef="usd">5744000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-6" decimals="-3" id="f-903" unitRef="usd">5714000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-6" decimals="-3" id="f-904" unitRef="usd">5759000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-6" decimals="-3" id="f-905" unitRef="usd">5804000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-6" decimals="-3" id="f-906" unitRef="usd">5851000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-6" decimals="-3" id="f-907" unitRef="usd">7183000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-6" decimals="-3" id="f-908" unitRef="usd">36055000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-6" decimals="-3" id="f-909" unitRef="usd">4746000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-6" decimals="-3" id="f-910" unitRef="usd">31309000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-216" decimals="-3" id="f-911" unitRef="usd">18782000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-217" decimals="-3" id="f-912" unitRef="usd">22560000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-218" decimals="-3" id="f-913" unitRef="usd">10960000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-219" decimals="-3" id="f-914" unitRef="usd">12598000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-3" id="f-915" unitRef="usd">29742000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-7" decimals="-3" id="f-916" unitRef="usd">35158000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:ContractualObligation contextRef="c-6" decimals="-3" id="f-917" unitRef="usd">2900000</us-gaap:ContractualObligation>
    <us-gaap:ContractualObligation contextRef="c-7" decimals="-3" id="f-918" unitRef="usd">3000000</us-gaap:ContractualObligation>
    <rskd:ContractualObligationTerm contextRef="c-1" id="f-919">P3M</rskd:ContractualObligationTerm>
    <us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock contextRef="c-1" id="f-920">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;8.       Guarantees, Commitments, and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt; Indemnification Guarantees&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide contractual assurances around the accuracy of our approvals so that our merchants can confidently automate a transaction&#x2019;s execution. Our contracts obligate us to stand ready to indemnify our merchants for any costs incurred from a chargeback due to fraud. Accordingly, we account for the guarantee obligation as an indemnification under the general provisions of ASC 460 and recognize a liability at fair value upon approving a transaction at an amount that represents what we would need to pay a third party to relieve ourselves from this obligation. This liability is presented as Guarantee obligations on the consolidated balance sheets and was $12.7 million and $12.4 million as of December&#160;31, 2023 and 2022, respectively, and will be released to revenue in the consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are relieved from our guarantee obligation at the earlier of (a) paying a chargeback or (b) expiration of the guarantee which is generally six months from the date of the transaction. We recognize the guarantee obligation as revenue through a systematic and rational amortization method over a six-month period that is representative of our historical pattern of being relieved from our guarantee obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our provision for chargebacks includes amounts associated with chargebacks that have been submitted and accepted but not yet paid by us as of the balance sheet date as well as estimates of chargebacks that have not yet been submitted and accepted relating to approved transactions that are &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;accounted for under &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ASC 450, Contingencies&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. While no individual transaction is probable of a chargeback occurring, when we analyze a portfolio of transactions, if we believe a future chargeback is probable and reasonably estimated, we accrue a liability and an associated expense through cost of revenue.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inputs and assumptions used by management to calculate the provision are based on the transactions approved and the features of those transactions as well as historical information about chargebacks. It is possible that the estimate may change in the near term, and the effect of the change could be material. Provision for chargebacks, net on the consolidated balance sheets were $12.1 million and $12.0 million as of December&#160;31, 2023 and 2022, respectively, and will be reduced by credits issued or cash paid to merchants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, our portfolio of potential chargeback liabilities was diversified across numerous industries, hundreds of merchants, and millions of individual transactions. The maximum potential payment to our merchants for these guarantees at a point in time, if every order we approved was fraudulent, is generally the aggregate approved transaction amount excluding cancelled orders, orders that have expired guarantees, and orders for which guarantees have already been paid. As of December&#160;31, 2023, there was $57.2 billion in outstanding indemnification guarantees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, we have had to pay approximately 0.1% of guarantees that we have issued and net chargeback expenses for the years ended December&#160;31, 2023, 2022, and 2021, were $121.8 million, $103.2 million, and $85.5 million, respectively, which was in line with our budgets for the associated periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Non-Cancelable Purchase Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, we enter into non-cancelable purchase commitments with various parties primarily for hosting and software services. As of December&#160;31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Indemnifications and Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the ordinary course of business, we agree to indemnify certain parties. In our merchant agreements, we have agreed to indemnify, defend, and hold harmless the indemnified party for third-party claims and related losses suffered or incurred by the indemnified party from actual or threatened third-party intellectual property infringement claims. For certain large or strategic merchants, we have agreed to indemnify, defend and hold harmless the indemnified party for non-compliance with certain additional representations and warranties made by us. In addition, we have entered into indemnification agreements with our directors and certain officers. As we have a limited history of prior indemnification claims and the payments we have made under such agreements have not had a material adverse effect on our results of operations, cash flows, or financial position, we are unable to reasonably estimate the maximum potential amount of future payments related to these indemnification agreements. However, to the extent that valid indemnification claims arise in the future, future payments by us could be significant and could have a material adverse effect on our results of operations or cash flows in a particular period. As of December&#160;31, 2023 and 2022, we did not have any material indemnification claims that were probable or reasonably possible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Legal Proceedings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Occasionally we may be subject to various proceedings, lawsuits, disputes, or claims. We investigate these claims as they arise and accrue liabilities when losses are probable and reasonably estimated. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2022, a putative securities class action complaint was filed in federal court in the United States by certain of our shareholders against us, certain of our current and former officers and directors, and our underwriters alleging violations of the Securities Act in connection with our IPO-related disclosures, and seeking unspecified damages. The lawsuit was captioned&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; In re Riskified Ltd. Securities Litigation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, 22 Civ. 3545 (DLC) (S.D.N.Y.). Plaintiffs filed an amended complaint on September 15, 2022. We moved to dismiss the amended complaint on October 28, 2022. On June 2, 2023, the Court granted our motion to dismiss the complaint in its entirety, with prejudice. The deadline to appeal has passed and the judgment is now final.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Although claims are inherently unpredictable, we are currently not aware of any matters that, if determined adversely to us, would individually or taken together, have a material adverse effect on our business, financial position, results of operations, or cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsContingenciesAndGuaranteesTextBlock>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-6" decimals="-5" id="f-921" unitRef="usd">12700000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsCurrentCarryingValue contextRef="c-7" decimals="-5" id="f-922" unitRef="usd">12400000</us-gaap:GuaranteeObligationsCurrentCarryingValue>
    <us-gaap:GuaranteeObligationsTerm contextRef="c-1" id="f-923">six</us-gaap:GuaranteeObligationsTerm>
    <us-gaap:GuaranteeObligationsTerm contextRef="c-1" id="f-924">six</us-gaap:GuaranteeObligationsTerm>
    <rskd:ProvisionForChargebacksCurrent contextRef="c-6" decimals="-5" id="f-925" unitRef="usd">12100000</rskd:ProvisionForChargebacksCurrent>
    <rskd:ProvisionForChargebacksCurrent contextRef="c-7" decimals="-5" id="f-926" unitRef="usd">12000000</rskd:ProvisionForChargebacksCurrent>
    <us-gaap:GuaranteeObligationsMaximumExposure contextRef="c-6" decimals="-8" id="f-927" unitRef="usd">57200000000</us-gaap:GuaranteeObligationsMaximumExposure>
    <rskd:GuarantorObligationsPercentageOfGuaranteesPaid contextRef="c-1" decimals="3" id="f-928" unitRef="number">0.001</rskd:GuarantorObligationsPercentageOfGuaranteesPaid>
    <rskd:GuarantorObligationsChargebackExpense contextRef="c-1" decimals="-5" id="f-929" unitRef="usd">121800000</rskd:GuarantorObligationsChargebackExpense>
    <rskd:GuarantorObligationsChargebackExpense contextRef="c-10" decimals="-5" id="f-930" unitRef="usd">103200000</rskd:GuarantorObligationsChargebackExpense>
    <rskd:GuarantorObligationsChargebackExpense contextRef="c-11" decimals="-5" id="f-931" unitRef="usd">85500000</rskd:GuarantorObligationsChargebackExpense>
    <us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock contextRef="c-1" id="f-932">As of December&#160;31, 2023, we had outstanding non-cancelable purchase obligations with a term of 12 months or longer as follows:&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.117%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year Ending December&#160;31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;96&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,714&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RecordedUnconditionalPurchaseObligationsTextBlock>
    <us-gaap:PurchaseObligationDueInNextTwelveMonths contextRef="c-6" decimals="-3" id="f-933" unitRef="usd">1106000</us-gaap:PurchaseObligationDueInNextTwelveMonths>
    <us-gaap:PurchaseObligationDueInSecondYear contextRef="c-6" decimals="-3" id="f-934" unitRef="usd">512000</us-gaap:PurchaseObligationDueInSecondYear>
    <us-gaap:PurchaseObligationDueInThirdYear contextRef="c-6" decimals="-3" id="f-935" unitRef="usd">96000</us-gaap:PurchaseObligationDueInThirdYear>
    <us-gaap:PurchaseObligation contextRef="c-6" decimals="-3" id="f-936" unitRef="usd">1714000</us-gaap:PurchaseObligation>
    <rskd:TemporaryEquityDisclosureTextBlock contextRef="c-1" id="f-937">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;9.       Ordinary Share Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, 1,187,087 Class A shares were issued upon the cashless exercise of the outstanding warrants to purchase ordinary shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the following warrants were issued and outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.419%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issued and Outstanding Share Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants issued to customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</rskd:TemporaryEquityDisclosureTextBlock>
    <rskd:StockIssuedDuringPeriodSharesWarrantsExercised contextRef="c-51" decimals="0" id="f-938" unitRef="shares">1187087</rskd:StockIssuedDuringPeriodSharesWarrantsExercised>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock contextRef="c-1" id="f-939">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the following warrants were issued and outstanding:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:23.419%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.643%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.845%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issued and Outstanding Share Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B Ordinary Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants issued to customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;June 2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-222" decimals="0" id="f-940" unitRef="shares">499500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-223" decimals="0" id="f-941" unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-222"
      decimals="2"
      id="f-942"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-223"
      decimals="2"
      id="f-943"
      unitRef="usdPerShare">0</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-3" decimals="0" id="f-944" unitRef="shares">499500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-4" decimals="0" id="f-945" unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-224" decimals="0" id="f-946" unitRef="shares">425325</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-225" decimals="0" id="f-947" unitRef="shares">850650</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-226"
      decimals="2"
      id="f-948"
      unitRef="usdPerShare">0.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-227"
      decimals="2"
      id="f-949"
      unitRef="usdPerShare">0.28</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-228" decimals="0" id="f-950" unitRef="shares">499500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-229" decimals="0" id="f-951" unitRef="shares">0</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-228"
      decimals="2"
      id="f-952"
      unitRef="usdPerShare">0.01</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-229"
      decimals="2"
      id="f-953"
      unitRef="usdPerShare">0</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-8" decimals="0" id="f-954" unitRef="shares">924825</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding contextRef="c-9" decimals="0" id="f-955" unitRef="shares">850650</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock contextRef="c-1" id="f-956">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;10.       Ordinary Shares and Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Ordinary Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Upon the completion of the IPO, our amended and restated AoA became effective, which authorized the issuance of up to 900,000,000 Class A ordinary shares with no par value and 232,500,000 Class B ordinary shares with no par value, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have the following ordinary shares reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase ordinary shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share options and RSUs issued and outstanding under the 2013 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,981,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,062,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share options and RSUs issued and outstanding under the 2021 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,299,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,134,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available for future issuance under the 2021 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ordinary shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,546,857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,647,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;Includes the warrants to purchase ordinary shares and warrants issued to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2023, the board of directors authorized the Company to repurchase up to $75.0&#160;million of its Class A ordinary shares. We received approval for the implementation of our Repurchase Program from the Tel Aviv District Court Economic Department (&#x201c;Israeli Court&#x201d;) on November 20, 2023. The Israeli Court approval is valid through May 19, 2024. We may file extension requests with the Israeli Court on an ongoing basis as required. During the year ended December 31, 2023, we repurchased 3,038,865 outstanding Class A ordinary shares for $13.2&#160;million, including transaction costs of approximately $0.1&#160;million, through our Repurchase Program. These shares are classified as Treasury Shares on our consolidated balance sheet. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Repurchase Program authorizes us to repurchase Class A ordinary shares, from time to time in the open market, in privately negotiated transactions or by other means in accordance with U.S. federal securities laws. The timing, as well as the number and value of any shares repurchased under the program, will be determined at our discretion under the Board authorized program and will depend on a variety of factors, including management's assessment of the intrinsic value of our ordinary shares, the market price of our ordinary shares, general market and economic conditions, available liquidity, alternative investment opportunities, and applicable legal requirements. The Repurchase Program does not obligate us to repurchase any specific number of shares and may be suspended, modified or discontinued at any time without prior notice. The share repurchases will be funded from existing cash and cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2013 Equity Incentive Plan, or the 2013 Plan, was adopted by our board of directors on July 3, 2013 and amended and restated on February 23, 2021. The 2013 Plan provided for the grant of equity-based incentive awards to our employees, directors, office holders and consultants. The U.S. Sub-Plan to the 2013 Plan, which is to be read as a continuation of the 2013 Plan, was adopted by our board of directors on May 10, 2015 and amended and restated on February 23, 2021. The U.S. Sub-Plan governed equity-based incentive awards granted to our United States employees, directors, office holders and consultants, including those who are deemed to be residents of the United States for tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We no longer grant any awards under our 2013 Plan as it was superseded by the 2021 Share Incentive Plan, or the 2021 Plan. Awards granted prior to the adoption of the 2021 Plan remain outstanding and are governed by the 2013 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Plan was adopted in connection with our IPO on July 15, 2021. The 2021 Plan provides for the grant of equity-based incentive awards to our employees, directors, office holders, service providers and consultants. The maximum number of Class A ordinary shares available for issuance under the 2021 Plan is equal to the sum of (i) 13,951,037 Class A ordinary shares, (ii) any shares subject to awards under the 2013 Plan which have expired, or were cancelled, terminated, forfeited or settled in cash in lieu of issuance of shares or became unexercisable without having been fully exercised and (iii) an annual increase on the first day of each year beginning in 2022 and on January 1st of each calendar year thereafter during the term of the 2021 Plan, equal to the lesser of (A) 5% of the outstanding Class A ordinary shares of the Company on the last day of the immediately preceding calendar year (calculated on a fully diluted, as converted basis); and (B) such amount as determined by our board of directors if so determined prior to January 1 of a calendar year, provided that no more than 13,951,037 Class A ordinary shares may be issued upon the exercise of incentive share options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Options and Shares Available for Grant&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share options generally vest over four years and expire ten years after the date of grant. We issue Class A ordinary shares upon exercise of share options. A summary of share options under our equity incentive plan and related information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Share Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Share Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share, life and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,785,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,010,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no share options granted during the years ended December&#160;31, 2023 or December&#160;31, 2022. The weighted-average grant date fair value of share options granted during the year ended December 31, 2021 was $16.63. The aggregate grant date fair value of share options vested during the years ended December&#160;31, 2023, 2022, and 2021 were $6.9 million, $12.0 million, and $3.2 million, respectively. The total intrinsic value of share options exercised during the years ended December&#160;31, 2023, 2022, and 2021 were $11.3 million, $17.4&#160;million, and $68.6 million, respectively. As of December&#160;31, 2023, unrecognized share-based compensation cost related to unvested share options was $6.4 million, which is expected to be recognized over a weighted-average period of 1.3 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes assumptions used to value the employee share options at the grant dates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.44 - 6.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.26% - 68.52%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99% - 1.12%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These assumptions and estimates were determined as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Fair Value of Ordinary Shares - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to IPO, the fair value was determined by our board of directors, with input from management and valuation reports prepared by third-party valuation specialists. Post IPO, the fair value of each ordinary share was based on the closing price of our publicly traded ordinary shares as reported on the date of the grant. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Term - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The expected term represents the period that the share options are expected to be outstanding. For share option grants that are considered to be &#x201c;plain vanilla,&#x201d; we determine the expected term using the simplified method. The simplified method deems the term to be the average of the time-to-vesting and the contractual life of the share options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Volatility - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As we have a short trading history for our ordinary shares, the expected volatility is derived from the average historical share volatilities of several unrelated public &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;companies within our industry that we consider to be comparable to our own business over a period equivalent to the option&#x2019;s expected term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Risk-Free&#160;Interest Rate - &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The risk-free rate for the expected term of the share options are based on the yields of U.S. Treasury securities with maturities appropriate for the expected term of employee share option awards. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Expected Dividend Yield.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - We have never declared or paid any cash dividends and do not presently plan to pay cash dividends in the foreseeable future. As a result, an expected dividend yield of zero percent was used.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Share Units&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs vest either upon the satisfaction of service-based vesting conditions, the satisfaction of both service-based and performance-based vesting conditions, or the satisfaction of service-based, performance-based, and market-based vesting conditions. Refer to Note 2 for more information regarding the vesting conditions of our RSUs. RSUs granted under the 2013 Plan can only vest prior to the expiration date of the award which is seven years from the date of grant. Any RSUs that have not vested will automatically terminate on their expiration date. RSUs granted under the 2021 Plan do not have an expiration date. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.925%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date Fair Value&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,412,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,904,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,365,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,040,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,911,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023, total unrecognized share-based compensation expense related to unvested RSUs was approximately $115.0 million, which is expected to be recognized over a weighted-average period of 3.3 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;2021 Employee Share Purchase Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We adopted the 2021 Employee Share Purchase Plan, or ESPP, in connection with our IPO on July 15, 2021, to enable eligible employees of the company and certain of its designated subsidiaries to use payroll deductions to purchase the company&#x2019;s Class A ordinary shares and thereby acquire ownership interests in the Company. A total of 3,742,961 Class A ordinary shares are available for sale under the ESPP, subject to adjustment as provided for in the ESPP. In addition, on the first day of each fiscal year beginning on January 1, 2022 and ending on and including January 1, 2031, such pool of Class A ordinary shares shall be increased by that number of our Class A ordinary shares equal to the lesser of: (i) 1% of the outstanding Class A ordinary shares as of the last day of the immediately preceding fiscal year (calculated on a fully diluted as-converted basis); or (ii) such smaller amount as our board of directors may determine. In accordance with the above, our board of directors determined not to increase the number of Class A ordinary shares available for sale under the ESPP as of January 1, 2022, January 1, 2023, or January 1, 2024. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Generally, all of our employees are eligible to participate if they are employed by us. However, an employee may not be granted rights to purchase our ordinary shares under the ESPP if such employee (i) &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;immediately after the grant would own capital shares or hold outstanding share options to purchase such shares possessing 5% or more of the total combined voting power or value of all classes of our shares or any of our subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2023, we have not effected any offering under the ESPP. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;CEO Multi-Year Equity Award&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2021, our board of directors and shareholders granted to our chief executive officer, Mr. Gal, a multi-year equity award, comprising 3,993,440 RSUs (the &#x201c;Multi-Year Award&#x201d;). The grant date fair value of the Multi-Year Award, which is the amount of share-based compensation expense that we recognize, is primarily determined based on the share price on the date the award was granted and is not based on our current share price. This amount is expensed utilizing the accelerated attribution method over the requisite service period of ten years. This method attributes higher expenses to the earlier periods of the requisite service period.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Multi-Year Award is structured so that meaningful value may only be realized upon the achievement of sustained and significant high performance levels. The award is divided into ten tranches that are eligible to vest based on the achievement of stock price goals, which range from $26.67 to $106.67, measured based on the average of our stock price over a trailing 60 trading day period during predefined performance periods, subject to Mr. Gal&#x2019;s continued employment as our chief executive officer through each such period. In order to earn all of the tranches, the stock price will have to be more than 5 times higher than the price at IPO. No tranches of the Multi-Year Award were earned or vested in 2023. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the service-based vesting condition, and market-based vesting condition, each described above, the Multi-Year Award is also subject to a performance-based vesting condition. The performance-based vesting condition underlying the Multi-Year Award was satisfied upon the occurrence of our IPO in 2021. We recognized $8.6&#160;million, $13.0&#160;million, and $6.0&#160;million in share-based compensation expense related to the Multi-Year Award during the years ended December 31, 2023, 2022, and 2021, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ShareholdersEquityAndShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-230" decimals="0" id="f-957" unitRef="shares">900000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-231" decimals="0" id="f-958" unitRef="shares">232500000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:ScheduleOfStockByClassTextBlock contextRef="c-1" id="f-959">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have the following ordinary shares reserved for future issuance:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.374%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase ordinary shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;499,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,775,475&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share options and RSUs issued and outstanding under the 2013 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,981,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,062,824&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share options and RSUs issued and outstanding under the 2021 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,299,528&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,134,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available for future issuance under the 2021 Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,766,560&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,674,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total ordinary shares reserved&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,546,857&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43,647,083&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;Includes the warrants to purchase ordinary shares and warrants issued to customers.</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-232" decimals="0" id="f-960" unitRef="shares">499500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-233" decimals="0" id="f-961" unitRef="shares">1775475</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-234" decimals="0" id="f-962" unitRef="shares">15981269</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-235" decimals="0" id="f-963" unitRef="shares">20062824</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-236" decimals="0" id="f-964" unitRef="shares">16299528</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-237" decimals="0" id="f-965" unitRef="shares">13134652</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-5" decimals="0" id="f-966" unitRef="shares">8766560</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-238" decimals="0" id="f-967" unitRef="shares">8674132</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-6" decimals="0" id="f-968" unitRef="shares">41546857</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-7" decimals="0" id="f-969" unitRef="shares">43647083</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-84" decimals="-5" id="f-970" unitRef="usd">75000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-1" decimals="0" id="f-971" unitRef="shares">3038865</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-51" decimals="0" id="f-972" unitRef="shares">3038865</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-53" decimals="-5" id="f-973" unitRef="usd">13200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <rskd:StockRepurchaseProgramTransactionCosts contextRef="c-1" decimals="-5" id="f-974" unitRef="usd">100000</rskd:StockRepurchaseProgramTransactionCosts>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-239" decimals="0" id="f-975" unitRef="shares">13951037</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent contextRef="c-239" decimals="2" id="f-976" unitRef="number">0.05</rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance contextRef="c-239" decimals="0" id="f-977" unitRef="shares">13951037</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-240" id="f-978">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod contextRef="c-240" id="f-979">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock contextRef="c-1" id="f-980">A summary of share options under our equity incentive plan and related information is as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.778%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.079%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.082%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Share Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Outstanding Share Options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise &lt;br/&gt;Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic &lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share, life and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,785,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34,326&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,010,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.22&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(405,202)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,369,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.39&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,303&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,849,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.13&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,904&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;There were no share options granted during the years ended December&#160;31, 2023 or December&#160;31, 2022.</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-7" decimals="0" id="f-981" unitRef="shares">13785214</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-7"
      decimals="2"
      id="f-982"
      unitRef="usdPerShare">2.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-10" id="f-983">P6Y1M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-7" decimals="-3" id="f-984" unitRef="usd">34326000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised contextRef="c-1" decimals="0" id="f-985" unitRef="shares">3010478</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-986"
      unitRef="usdPerShare">1.22</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod contextRef="c-1" decimals="0" id="f-987" unitRef="shares">405202</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="c-1"
      decimals="2"
      id="f-988"
      unitRef="usdPerShare">3.72</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber contextRef="c-6" decimals="0" id="f-989" unitRef="shares">10369534</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="c-6"
      decimals="2"
      id="f-990"
      unitRef="usdPerShare">2.39</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2 contextRef="c-1" id="f-991">P5Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue contextRef="c-6" decimals="-3" id="f-992" unitRef="usd">24303000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber contextRef="c-6" decimals="0" id="f-993" unitRef="shares">8849876</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="c-6"
      decimals="2"
      id="f-994"
      unitRef="usdPerShare">2.13</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1 contextRef="c-1" id="f-995">P5Y2M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 contextRef="c-6" decimals="-3" id="f-996" unitRef="usd">22904000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-241"
      decimals="2"
      id="f-997"
      unitRef="usdPerShare">16.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-240" decimals="-5" id="f-998" unitRef="usd">6900000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-241" decimals="-5" id="f-999" unitRef="usd">12000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 contextRef="c-242" decimals="-5" id="f-1000" unitRef="usd">3200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-1" decimals="-5" id="f-1001" unitRef="usd">11300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-10" decimals="-5" id="f-1002" unitRef="usd">17400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue contextRef="c-11" decimals="-5" id="f-1003" unitRef="usd">68600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized contextRef="c-243" decimals="-5" id="f-1004" unitRef="usd">6400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-240" id="f-1005">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="c-1" id="f-1006">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Black-Scholes assumptions used to value the employee share options at the grant dates are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:81.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:16.689%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.44 - 6.60&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67.26% - 68.52%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.99% - 1.12%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.00%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-244" id="f-1007">P5Y5M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-245" id="f-1008">P6Y7M6D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-242"
      decimals="4"
      id="f-1009"
      unitRef="number">0.6726</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-245"
      decimals="4"
      id="f-1010"
      unitRef="number">0.6852</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-244"
      decimals="4"
      id="f-1011"
      unitRef="number">0.0099</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-245"
      decimals="4"
      id="f-1012"
      unitRef="number">0.0112</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-242"
      decimals="4"
      id="f-1013"
      unitRef="number">0.0000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-240"
      decimals="INF"
      id="f-1014"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-246" id="f-1015">P7Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock contextRef="c-1" id="f-1016">&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU activity, including activity under our equity incentive plan, and related information is as follows:&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:66.207%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.925%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.927%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average&lt;br/&gt;Grant-Date Fair Value&lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19,412,262&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.06&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10,904,664&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6,365,261)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,040,402)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unvested as of December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21,911,263&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.02&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnvestedRestrictedStockUnitsRollForwardTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-7" decimals="0" id="f-1017" unitRef="shares">19412262</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-7"
      decimals="2"
      id="f-1018"
      unitRef="usdPerShare">9.06</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod contextRef="c-1" decimals="0" id="f-1019" unitRef="shares">10904664</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-1020"
      unitRef="usdPerShare">5.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod contextRef="c-1" decimals="0" id="f-1021" unitRef="shares">6365261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-1022"
      unitRef="usdPerShare">7.28</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod contextRef="c-1" decimals="0" id="f-1023" unitRef="shares">2040402</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-1"
      decimals="2"
      id="f-1024"
      unitRef="usdPerShare">6.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber contextRef="c-6" decimals="0" id="f-1025" unitRef="shares">21911263</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-6"
      decimals="2"
      id="f-1026"
      unitRef="usdPerShare">8.02</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-247" decimals="-5" id="f-1027" unitRef="usd">115000000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-248" id="f-1028">P3Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="c-249"
      decimals="0"
      id="f-1029"
      unitRef="shares">3742961</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent
      contextRef="c-249"
      decimals="2"
      id="f-1030"
      unitRef="number">0.01</rskd:CommonStockCapitalSharesReservedForFutureIssuanceAnnualIncreasePercent>
    <rskd:CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage
      contextRef="c-249"
      decimals="2"
      id="f-1031"
      unitRef="number">0.05</rskd:CommonStockCapitalSharesReservedForFutureIssuanceMaximumOwnershipPercentage>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-250" decimals="-5" id="f-1032" unitRef="usd">8600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-251" decimals="-5" id="f-1033" unitRef="usd">13000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-252" decimals="-5" id="f-1034" unitRef="usd">6000000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock contextRef="c-1" id="f-1035">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense by line item in the consolidated statements of operations is summarized as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.432%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.521%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;770&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;621&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;216&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,152&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,005&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,246&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19,420&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,253&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,710&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,068&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,588&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62,410&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;67,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,358&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-253" decimals="-3" id="f-1036" unitRef="usd">770000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-254" decimals="-3" id="f-1037" unitRef="usd">621000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-255" decimals="-3" id="f-1038" unitRef="usd">216000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-256" decimals="-3" id="f-1039" unitRef="usd">13152000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-257" decimals="-3" id="f-1040" unitRef="usd">10005000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-258" decimals="-3" id="f-1041" unitRef="usd">4246000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-259" decimals="-3" id="f-1042" unitRef="usd">19420000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-260" decimals="-3" id="f-1043" unitRef="usd">18253000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-261" decimals="-3" id="f-1044" unitRef="usd">10710000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-262" decimals="-3" id="f-1045" unitRef="usd">29068000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-263" decimals="-3" id="f-1046" unitRef="usd">38588000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-264" decimals="-3" id="f-1047" unitRef="usd">18186000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-3" id="f-1048" unitRef="usd">62410000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-10" decimals="-3" id="f-1049" unitRef="usd">67467000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-11" decimals="-3" id="f-1050" unitRef="usd">33358000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1051">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;11.       Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ordinary taxable income in Israel is subject to a corporate tax rate of 23%. However, the effective tax rate payable by a company that derives income from a Preferred Technological Enterprise (as discussed below) may be considerably less. Capital gains (which are not &#x2018;Inflationary Surplus&#x2019;, as described below) derived by an Israeli company are generally subject to the prevailing corporate tax rate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Law for the Encouragement of Capital Investments, 1959&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Law for the Encouragement of Capital Investments, 1959, generally referred to as the Investment Law, provides certain incentives for capital investments in production facilities (or other eligible assets).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Investment Law was significantly amended effective on April 1, 2005, January 1, 2011, and on January 1, 2017, or the 2017 Amendment. The 2017 Amendment introduces new benefits for Technological Enterprises, alongside the existing tax benefits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 Amendment was enacted as part of the Economic Efficiency Law that was published on December 29, 2016, and is effective as of January 1, 2017. The 2017 Amendment included new tax benefits for &#x201c;Technological Enterprises,&#x201d; as described below, and is in addition to the other existing tax beneficial programs under the Investment Law.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2017 Amendment provides that a technology company satisfying certain conditions should qualify as a &#x201c;Preferred Technology Enterprises,&#x201d; or PTE, granting a 12% tax rate in central Israel on income deriving from Benefited Intangible Assets, subject to a number of conditions being fulfilled, including a minimal amount or ratio of annual R&amp;amp;D expenditure and R&amp;amp;D employees, as well as having at least 25% of annual income derived from exports to large markets. PTE is defined as an enterprise which meets the aforementioned conditions and for which total consolidated revenues of its parent company and all subsidiaries are less than NIS 10 billion.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not adopted the PTE status currently, but believe we are eligible for the PTE status in future tax years and have tax-effected our Israel deferred tax assets and liabilities at the appropriate PTE rates. Our subsidiaries are separately taxed under the domestic tax laws of the jurisdiction of incorporation of each entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Profit (loss) before the provision for income taxes consisted of the following for the years ended December&#160;31, 2023, 2022, and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of our statutory income tax expense to our effective income tax provision is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel tax benefit at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred enterprise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tranche right revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax income/(expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our effective tax rate was (10.89)% for the year ended December&#160;31, 2023, compared to an effective tax rate of (6.12)% for the year ended December 31, 2022 and (0.88)% for the year ended December 31, 2021. The effective tax rates for the periods presented are primarily comprised of Israel statutory taxes, warrant revaluation, share-based compensation expense, uncertain tax positions, and changes in valuation allowance position. The difference in the effective tax rate of (10.89)% for the year ended December&#160;31, 2023 as compared to the effective tax rate of (6.12)% for the year ended December 31, 2022 and (0.88)% for the year ended December 31, 2021 was related to non-deductible share-based compensation, prior period adjustments, uncertain tax positions, and change in valuation allowance position in Israel and in our U.S. subsidiary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was $5.8 million, $6.0 million and $1.6&#160;million for the years ended December&#160;31, 2023, 2022, and 2021, respectively. The provision for income taxes for the year ended December&#160;31, 2023 consisted primarily of income taxes related to the United States and other foreign jurisdictions in which we conduct business.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the significant components of our deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vacation and convalescence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets/(liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, we had Israel net operating loss, or NOL, carryforwards of approximately $75.7&#160;million and $68.9&#160;million, respectively, which do not expire. As of December&#160;31, 2023 and 2022, we had U.S. Federal NOL carryforwards of approximately $11.7&#160;million and $11.2&#160;million respectively, which do not expire.  As of December&#160;31, 2023, we had U.S. State NOL carryforwards of approximately $24.8&#160;million, of which $23.3&#160;million expire between 2028 and 2043, and the remaining $1.5&#160;million do not expire. As of December&#160;31, 2022, we had U.S. State NOL carryforwards of approximately $16.6&#160;million, of which $15.4&#160;million expire between 2027 and 2042, and the remaining $1.2&#160;million do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the years ended December&#160;31, 2023, 2022, and 2021 the net change in the valuation allowance against deferred tax assets amounted to an increase of $3.0&#160;million, an increase of $12.1&#160;million, and an increase of $4.4&#160;million, respectively. The increase in the valuation allowance during the years ended December&#160;31, 2023, December 31, 2022 and December 31, 2021 was largely attributable to the generation of Israel NOLs, and certain US state NOLs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In establishing deferred income tax assets and liabilities, management makes judgments based on the enacted tax laws and published tax guidance applicable to us as well as the amount and jurisdiction of future taxable income. Deferred tax assets and liabilities are recorded and the need for valuation allowances is evaluated to reduce the deferred tax assets to amounts expected to be realized. As of December&#160;31, 2023 and 2022, we maintained a full valuation allowance on Israel and U.S. net deferred tax assets as we believe, after weighing both the positive and negative evidence, that it is more likely than not that these deferred tax assets will not be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Internal Revenue Code of 1986, as amended, imposes restrictions on the utilization of NOLs in the event of an &#x201c;ownership change&#x201d; of a corporation. Accordingly, a company&#x2019;s ability to use NOLs may be limited as prescribed under Internal Revenue Code Section 382, or IRC Section 382. Events which may cause limitations in the amount of the NOLs that we may use in any one year include, but are not limited to, a cumulative ownership change of more than 50% over a three-year period. Utilization of the U.S. federal and state NOLs may be subject to substantial annual limitation due to the ownership change limitations provided by the IRC Section 382 and similar state provisions. We have completed our evaluation of NOL utilization limitations under Internal Revenue Code, as amended, or the Code, Section 382, change of ownership rules, and have found that the NOLs would not be limited as to the amount that could be used in the current tax year.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have identified unrecognized tax benefits or uncertain tax positions. There has been a liability on uncertain tax positions recorded on our audited consolidated financial statements as of December&#160;31, 2023 and 2022. We do not expect that our assessment regarding unrecognized tax benefits and uncertain tax positions will materially change over the following 12 months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of total unrecognized tax position is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2023 and 2022, the total amount of gross unrecognized tax benefits was $16.5 million and $11.3&#160;million, respectively, which, if recognized, would affect our effective tax rate. We have elected to include interest and penalties as a component of tax expense. As of December&#160;31, 2023 and 2022, we have accumulated $1.0&#160;million and $320&#160;thousand, respectively, in both interest and penalties associated with uncertain tax positions. We do not expect unrecognized tax benefits to change significantly within the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are not currently under audit for income taxes. As of December&#160;31, 2023, tax years beginning with the year ended December 31, 2019 remain subject to examination by the Israel tax authorities and tax years beginning with the year ended December 31, 2020 remain subject to examination by the Internal Revenue Service and certain U.S. state jurisdictions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1052">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Profit (loss) before the provision for income taxes consisted of the following for the years ended December&#160;31, 2023, 2022, and 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.951%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,269)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(55,414)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(154,549)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;International &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29,968)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43,249)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,323)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(53,237)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(98,663)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(177,872)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-134" decimals="-3" id="f-1053" unitRef="usd">-23269000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-135" decimals="-3" id="f-1054" unitRef="usd">-55414000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-136" decimals="-3" id="f-1055" unitRef="usd">-154549000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-265" decimals="-3" id="f-1056" unitRef="usd">-29968000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-266" decimals="-3" id="f-1057" unitRef="usd">-43249000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-267" decimals="-3" id="f-1058" unitRef="usd">-23323000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-3" id="f-1059" unitRef="usd">-53237000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-10" decimals="-3" id="f-1060" unitRef="usd">-98663000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-11" decimals="-3" id="f-1061" unitRef="usd">-177872000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1062">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The provision for income taxes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(225)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,039&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,715&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,814&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Israel&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2,677)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,433&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total provision for income taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-134" decimals="-3" id="f-1063" unitRef="usd">-225000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-135" decimals="-3" id="f-1064" unitRef="usd">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-136" decimals="-3" id="f-1065" unitRef="usd">4000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-265" decimals="-3" id="f-1066" unitRef="usd">6039000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-266" decimals="-3" id="f-1067" unitRef="usd">8715000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-267" decimals="-3" id="f-1068" unitRef="usd">121000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1069" unitRef="usd">5814000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-1070" unitRef="usd">8719000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-1071" unitRef="usd">125000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-134" decimals="-3" id="f-1072" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-135" decimals="-3" id="f-1073" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-136" decimals="-3" id="f-1074" unitRef="usd">0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-265" decimals="-3" id="f-1075" unitRef="usd">-16000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-266" decimals="-3" id="f-1076" unitRef="usd">-2677000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-267" decimals="-3" id="f-1077" unitRef="usd">1433000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1078" unitRef="usd">-16000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-1079" unitRef="usd">-2677000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-1080" unitRef="usd">1433000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1081" unitRef="usd">5798000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-1082" unitRef="usd">6042000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-1083" unitRef="usd">1558000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1084">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of our statutory income tax expense to our effective income tax provision is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:56.111%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.682%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.683%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Israel tax benefit at statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12,245)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,528)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(40,784)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Preferred enterprise&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,652&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,573&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,052&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(785)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,050)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;912&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,717&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,753&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrant revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,325&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tranche right revaluation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prior year tax income/(expense)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,675)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,351)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Uncertain tax position&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,772&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,233&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,784&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,961&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,444&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,798&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,042&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-3" id="f-1085" unitRef="usd">-12245000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-10" decimals="-3" id="f-1086" unitRef="usd">-22528000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-11" decimals="-3" id="f-1087" unitRef="usd">-40784000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount contextRef="c-1" decimals="-3" id="f-1088" unitRef="usd">1652000</rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount contextRef="c-10" decimals="-3" id="f-1089" unitRef="usd">10573000</rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount contextRef="c-11" decimals="-3" id="f-1090" unitRef="usd">3052000</rskd:EffectiveIncomeTaxRateReconciliationPreferredEnterpriseAmount>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-3" id="f-1091" unitRef="usd">-785000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-10" decimals="-3" id="f-1092" unitRef="usd">-1050000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-11" decimals="-3" id="f-1093" unitRef="usd">912000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-3" id="f-1094" unitRef="usd">8158000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-10" decimals="-3" id="f-1095" unitRef="usd">9717000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-11" decimals="-3" id="f-1096" unitRef="usd">1753000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-268" decimals="-3" id="f-1097" unitRef="usd">0</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-269" decimals="-3" id="f-1098" unitRef="usd">0</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-270" decimals="-3" id="f-1099" unitRef="usd">23325000</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-63" decimals="-3" id="f-1100" unitRef="usd">0</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-64" decimals="-3" id="f-1101" unitRef="usd">0</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount contextRef="c-65" decimals="-3" id="f-1102" unitRef="usd">4890000</rskd:EffectiveIncomeTaxRateReconciliationWarrantRevaluationAmount>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-1" decimals="-3" id="f-1103" unitRef="usd">-302000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-10" decimals="-3" id="f-1104" unitRef="usd">-6675000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes contextRef="c-11" decimals="-3" id="f-1105" unitRef="usd">84000</us-gaap:IncomeTaxReconciliationPriorYearIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-1" decimals="-3" id="f-1106" unitRef="usd">587000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-10" decimals="-3" id="f-1107" unitRef="usd">-3351000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther contextRef="c-11" decimals="-3" id="f-1108" unitRef="usd">98000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-1" decimals="-3" id="f-1109" unitRef="usd">5772000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-10" decimals="-3" id="f-1110" unitRef="usd">7233000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationTaxContingencies contextRef="c-11" decimals="-3" id="f-1111" unitRef="usd">3784000</us-gaap:IncomeTaxReconciliationTaxContingencies>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-3" id="f-1112" unitRef="usd">2961000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-10" decimals="-3" id="f-1113" unitRef="usd">12123000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-11" decimals="-3" id="f-1114" unitRef="usd">4444000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-3" id="f-1115" unitRef="usd">5798000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-3" id="f-1116" unitRef="usd">6042000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-3" id="f-1117" unitRef="usd">1558000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-1"
      decimals="INF"
      id="f-1118"
      unitRef="number">0.1089</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-10"
      decimals="INF"
      id="f-1119"
      unitRef="number">0.0612</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-11"
      decimals="INF"
      id="f-1120"
      unitRef="number">0.0088</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-1"
      decimals="INF"
      id="f-1121"
      unitRef="number">0.1089</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-10"
      decimals="INF"
      id="f-1122"
      unitRef="number">0.0612</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="c-11"
      decimals="INF"
      id="f-1123"
      unitRef="number">0.0088</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1124" unitRef="usd">5800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-10" decimals="-5" id="f-1125" unitRef="usd">6000000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-11" decimals="-5" id="f-1126" unitRef="usd">1600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1127">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the significant components of our deferred tax assets and liabilities:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.791%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,550&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,374&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,436&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,333&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,059&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,212&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred Compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vacation and convalescence&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;746&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;799&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bad debts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;93&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,946&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;466&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;32,986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31,077&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(23,783)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,822)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,699)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,255&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;316&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,577)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,387)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred contract acquisition costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,009)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,324)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(109)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(279)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(283)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized Software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(541)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(591)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(397)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,198)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,266)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,004)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax assets/(liabilities)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,688)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-6" decimals="-3" id="f-1128" unitRef="usd">7550000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-7" decimals="-3" id="f-1129" unitRef="usd">7374000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch contextRef="c-33" decimals="-3" id="f-1130" unitRef="usd">1436000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-6" decimals="-3" id="f-1131" unitRef="usd">10333000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-7" decimals="-3" id="f-1132" unitRef="usd">9059000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-33" decimals="-3" id="f-1133" unitRef="usd">5212000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-6" decimals="-3" id="f-1134" unitRef="usd">6762000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-7" decimals="-3" id="f-1135" unitRef="usd">5214000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation contextRef="c-33" decimals="-3" id="f-1136" unitRef="usd">1009000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation>
    <rskd:DeferredTaxAssetsLeasingArrangements contextRef="c-6" decimals="-3" id="f-1137" unitRef="usd">5565000</rskd:DeferredTaxAssetsLeasingArrangements>
    <rskd:DeferredTaxAssetsLeasingArrangements contextRef="c-7" decimals="-3" id="f-1138" unitRef="usd">6456000</rskd:DeferredTaxAssetsLeasingArrangements>
    <rskd:DeferredTaxAssetsLeasingArrangements contextRef="c-33" decimals="-3" id="f-1139" unitRef="usd">0</rskd:DeferredTaxAssetsLeasingArrangements>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences contextRef="c-6" decimals="-3" id="f-1140" unitRef="usd">746000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences contextRef="c-7" decimals="-3" id="f-1141" unitRef="usd">730000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences contextRef="c-33" decimals="-3" id="f-1142" unitRef="usd">799000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsCompensatedAbsences>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-6" decimals="-3" id="f-1143" unitRef="usd">84000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-7" decimals="-3" id="f-1144" unitRef="usd">78000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts contextRef="c-33" decimals="-3" id="f-1145" unitRef="usd">93000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-6" decimals="-3" id="f-1146" unitRef="usd">1946000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-7" decimals="-3" id="f-1147" unitRef="usd">2166000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsOther contextRef="c-33" decimals="-3" id="f-1148" unitRef="usd">466000</us-gaap:DeferredTaxAssetsOther>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-3" id="f-1149" unitRef="usd">32986000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-7" decimals="-3" id="f-1150" unitRef="usd">31077000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-33" decimals="-3" id="f-1151" unitRef="usd">9015000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-3" id="f-1152" unitRef="usd">23783000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-3" id="f-1153" unitRef="usd">20822000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-33" decimals="-3" id="f-1154" unitRef="usd">8699000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-6" decimals="-3" id="f-1155" unitRef="usd">9203000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-7" decimals="-3" id="f-1156" unitRef="usd">10255000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-33" decimals="-3" id="f-1157" unitRef="usd">316000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-6" decimals="-3" id="f-1158" unitRef="usd">5577000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-7" decimals="-3" id="f-1159" unitRef="usd">6387000</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesLeasingArrangements contextRef="c-33" decimals="-3" id="f-1160" unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesLeasingArrangements>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts contextRef="c-6" decimals="-3" id="f-1161" unitRef="usd">2971000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts contextRef="c-7" decimals="-3" id="f-1162" unitRef="usd">3009000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts contextRef="c-33" decimals="-3" id="f-1163" unitRef="usd">2324000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-6" decimals="-3" id="f-1164" unitRef="usd">109000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-7" decimals="-3" id="f-1165" unitRef="usd">279000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment contextRef="c-33" decimals="-3" id="f-1166" unitRef="usd">283000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware contextRef="c-6" decimals="-3" id="f-1167" unitRef="usd">541000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware contextRef="c-7" decimals="-3" id="f-1168" unitRef="usd">591000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware contextRef="c-33" decimals="-3" id="f-1169" unitRef="usd">397000</us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedSoftware>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-6" decimals="-3" id="f-1170" unitRef="usd">9198000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-7" decimals="-3" id="f-1171" unitRef="usd">10266000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-33" decimals="-3" id="f-1172" unitRef="usd">3004000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-6" decimals="-3" id="f-1173" unitRef="usd">5000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxLiabilities contextRef="c-7" decimals="-3" id="f-1174" unitRef="usd">11000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities contextRef="c-33" decimals="-3" id="f-1175" unitRef="usd">2688000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:OperatingLossCarryforwards contextRef="c-271" decimals="-5" id="f-1176" unitRef="usd">75700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-272" decimals="-5" id="f-1177" unitRef="usd">68900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-273" decimals="-5" id="f-1178" unitRef="usd">11700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-274" decimals="-5" id="f-1179" unitRef="usd">11200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-275" decimals="-3" id="f-1180" unitRef="usd">24800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-276" decimals="-3" id="f-1181" unitRef="usd">23300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-277" decimals="-3" id="f-1182" unitRef="usd">1500000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-278" decimals="-3" id="f-1183" unitRef="usd">16600000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-279" decimals="-3" id="f-1184" unitRef="usd">15400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-280" decimals="-3" id="f-1185" unitRef="usd">1200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1186" unitRef="usd">3000000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-10" decimals="-5" id="f-1187" unitRef="usd">12100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-11" decimals="-5" id="f-1188" unitRef="usd">4400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1189">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the beginning and ending balance of total unrecognized tax position is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.957%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.843%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Unrecognized Tax Benefits&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;234&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,885&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,187&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(54)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,252&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Additions based on tax positions related to current year&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,273&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Reductions for tax positions of prior years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance &#x2013; December 31, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-18" decimals="-3" id="f-1190" unitRef="usd">234000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-11" decimals="-3" id="f-1191" unitRef="usd">3885000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-11" decimals="-3" id="f-1192" unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-33" decimals="-3" id="f-1193" unitRef="usd">4119000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-10" decimals="-3" id="f-1194" unitRef="usd">7187000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-10" decimals="-3" id="f-1195" unitRef="usd">54000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-3" id="f-1196" unitRef="usd">11252000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1197" unitRef="usd">5273000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-3" id="f-1198" unitRef="usd">13000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-3" id="f-1199" unitRef="usd">16512000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-5" id="f-1200" unitRef="usd">16500000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-7" decimals="-5" id="f-1201" unitRef="usd">11300000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-1" decimals="-5" id="f-1202" unitRef="usd">1000000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense contextRef="c-10" decimals="-3" id="f-1203" unitRef="usd">320000</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:EarningsPerShareTextBlock contextRef="c-1" id="f-1204">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;12.       Net Profit (Loss) Per Share Attributable to Ordinary Shareholders&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.265%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.460%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in computing net profit (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:21pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,005,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,768,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,450,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,216,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,757,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,702,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic and diluted net profit (loss) per share attributable to ordinary shareholders are the same for each class of ordinary shares as they are entitled to the same liquidation and dividend rights. The weighted-average potential ordinary shares that were excluded from the computation of diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive, or whose issuance is contingent upon the satisfaction of certain market conditions, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.100%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,817,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,634,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase ordinary shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,654,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,067,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,239,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,375,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,176,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,754,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,117,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,981,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,954,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;Includes the warrants to purchase ordinary shares and warrants issued to customers.</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-1205">&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.519%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:21.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.265%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.460%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.977%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.444%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.980%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 22pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(38,407)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,628)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(57,734)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46,971)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(90,953)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(88,477)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average shares used in computing net profit (loss) per share&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:21pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115,005,250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,768,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;92,450,867&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75,216,507&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38,757,558&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,702,067&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 10pt;text-align:left;text-indent:-9pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net profit (loss) per share attributable to ordinary shareholders, basic and diluted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.33)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.62)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.35)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-12" decimals="-3" id="f-1206" unitRef="usd">-38407000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-13" decimals="-3" id="f-1207" unitRef="usd">-20628000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-15" decimals="-3" id="f-1208" unitRef="usd">-57734000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-14" decimals="-3" id="f-1209" unitRef="usd">-46971000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-17" decimals="-3" id="f-1210" unitRef="usd">-90953000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-17" decimals="-3" id="f-1211" unitRef="usd">-90953000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic contextRef="c-16" decimals="-3" id="f-1212" unitRef="usd">-88477000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted contextRef="c-16" decimals="-3" id="f-1213" unitRef="usd">-88477000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-12" decimals="0" id="f-1214" unitRef="shares">115005250</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-13" decimals="0" id="f-1215" unitRef="shares">61768148</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-15" decimals="0" id="f-1216" unitRef="shares">92450867</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-14" decimals="0" id="f-1217" unitRef="shares">75216507</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-17" decimals="0" id="f-1218" unitRef="shares">38757558</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-17" decimals="0" id="f-1219" unitRef="shares">38757558</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-16" decimals="0" id="f-1220" unitRef="shares">37702067</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-12"
      decimals="2"
      id="f-1221"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-13"
      decimals="2"
      id="f-1222"
      unitRef="usdPerShare">-0.33</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-15"
      decimals="2"
      id="f-1223"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-14"
      decimals="2"
      id="f-1224"
      unitRef="usdPerShare">-0.62</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-17"
      decimals="2"
      id="f-1225"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-17"
      decimals="2"
      id="f-1226"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-16"
      decimals="2"
      id="f-1227"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-16"
      decimals="2"
      id="f-1228"
      unitRef="usdPerShare">-2.35</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock contextRef="c-1" id="f-1229">The weighted-average potential ordinary shares that were excluded from the computation of diluted net profit (loss) per share attributable to ordinary shareholders for the periods presented because including them would have been anti-dilutive, or whose issuance is contingent upon the satisfaction of certain market conditions, are as follows:&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.495%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.099%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.442%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.100%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Class B&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Convertible preferred shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,817,201&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,634,404&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:9pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase ordinary shares&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;725,334&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;873,370&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;850,650&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,488,819&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;354,243&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding share options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,654,082&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,067,720&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,239,441&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Unvested RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,375,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,176,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,131,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,562,388&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,965,604&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,754,530&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;753,565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,117,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,981,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33,107,849&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37,954,251&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;_________________&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;Includes the warrants to purchase ordinary shares and warrants issued to customers.</us-gaap:ScheduleOfWeightedAverageNumberOfSharesTableTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-281"
      decimals="0"
      id="f-1230"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-282"
      decimals="0"
      id="f-1231"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-283"
      decimals="0"
      id="f-1232"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-284"
      decimals="0"
      id="f-1233"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-285"
      decimals="0"
      id="f-1234"
      unitRef="shares">17817201</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-286"
      decimals="0"
      id="f-1235"
      unitRef="shares">35634404</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-287"
      decimals="0"
      id="f-1236"
      unitRef="shares">725334</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-288"
      decimals="0"
      id="f-1237"
      unitRef="shares">753565</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-289"
      decimals="0"
      id="f-1238"
      unitRef="shares">873370</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-290"
      decimals="0"
      id="f-1239"
      unitRef="shares">850650</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-291"
      decimals="0"
      id="f-1240"
      unitRef="shares">1488819</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-292"
      decimals="0"
      id="f-1241"
      unitRef="shares">354243</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-293"
      decimals="0"
      id="f-1242"
      unitRef="shares">11654082</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-294"
      decimals="0"
      id="f-1243"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-295"
      decimals="0"
      id="f-1244"
      unitRef="shares">16067720</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-296"
      decimals="0"
      id="f-1245"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-297"
      decimals="0"
      id="f-1246"
      unitRef="shares">12239441</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-298"
      decimals="0"
      id="f-1247"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-299"
      decimals="0"
      id="f-1248"
      unitRef="shares">23375114</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-300"
      decimals="0"
      id="f-1249"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-301"
      decimals="0"
      id="f-1250"
      unitRef="shares">16176275</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-302"
      decimals="0"
      id="f-1251"
      unitRef="shares">2131015</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-303"
      decimals="0"
      id="f-1252"
      unitRef="shares">1562388</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="c-304"
      decimals="0"
      id="f-1253"
      unitRef="shares">1965604</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-12" decimals="0" id="f-1254" unitRef="shares">35754530</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-13" decimals="0" id="f-1255" unitRef="shares">753565</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-15" decimals="0" id="f-1256" unitRef="shares">33117365</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-14" decimals="0" id="f-1257" unitRef="shares">2981665</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-17" decimals="0" id="f-1258" unitRef="shares">33107849</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-16" decimals="0" id="f-1259" unitRef="shares">37954251</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DefinedContributionPlanTextBlock contextRef="c-1" id="f-1260">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;13.       Employee Benefit Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have a defined-contribution plan in the United States intended to qualify under Section&#160;401 of the Internal Revenue Code, or the 401(k) Plan. The 401(k) Plan covers substantially all employees who meet minimum age and service requirements and allows participants to defer a portion of their annual compensation on a&#160;pre-tax&#160;basis. We offer a safe harbor matching contribution in an amount equal to 100% of participating employee contributions to the plan up to 4% of the employee&#x2019;s eligible compensation. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $1.5 million, $1.1 million, and $0.8 million, respectively, of expenses related to the 401(k) plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Israeli Severance Pay &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to Israel&#x2019;s Severance Pay Law, Israeli employees are entitled to severance pay equal to one month&#x2019;s salary for each year of employment, or a portion thereof. We have elected to include our employees in Israel under Section 14 of the Severance Pay Law, under which these employees are entitled only to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments release us from any future obligation under the Israeli Severance Pay Law to make severance payments in respect of those employees; therefore, any liability for severance pay due to these employees, and the deposits under Section 14 are not recorded as an asset in the consolidated balance sheets. During the years ended December&#160;31, 2023, 2022, and 2021, we recorded $4.2 million, $4.5 million, and $3.8 million, respectively, in severance expenses related to these employees.&lt;/span&gt;&lt;/div&gt;</us-gaap:DefinedContributionPlanTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-1"
      decimals="INF"
      id="f-1261"
      unitRef="number">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-1"
      decimals="INF"
      id="f-1262"
      unitRef="number">0.04</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-1" decimals="-5" id="f-1263" unitRef="usd">1500000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-10" decimals="-5" id="f-1264" unitRef="usd">1100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-11" decimals="-5" id="f-1265" unitRef="usd">800000</us-gaap:DefinedContributionPlanCostRecognized>
    <rskd:SeverancePayRate contextRef="c-6" decimals="4" id="f-1266" unitRef="number">83.30</rskd:SeverancePayRate>
    <us-gaap:SeveranceCosts1 contextRef="c-1" decimals="-5" id="f-1267" unitRef="usd">4200000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-10" decimals="-5" id="f-1268" unitRef="usd">4500000</us-gaap:SeveranceCosts1>
    <us-gaap:SeveranceCosts1 contextRef="c-11" decimals="-5" id="f-1269" unitRef="usd">3800000</us-gaap:SeveranceCosts1>
    <us-gaap:SubsequentEventsTextBlock contextRef="c-1" id="f-1270">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;14.       Subsequent Events&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-indent:18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In February 2024, the Company announced that it has undertaken certain actions to reduce operating expenses by initiating a reduction in force that impacted approximately 6% of the Company&#x2019;s workforce. The majority of the associated costs, which are primarily related to severance and employee benefits, will be incurred in the first quarter of 2024 and are expected to be approximately $2.0&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent
      contextRef="c-305"
      decimals="2"
      id="f-1271"
      unitRef="number">0.06</us-gaap:RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1 contextRef="c-306" decimals="-3" id="f-1272" unitRef="usd">2000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c-1" id="f-1273">&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Valuation and Qualifying Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:40.566%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.842%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.844%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Increase &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;div style="margin-bottom:9pt;text-align:center"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Decrease &lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;135,942&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(135,584)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,719&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for chargebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;121,762&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(121,650)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;106,587&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(106,338)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,361&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for chargebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;103,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(103,236)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,980&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Year Ended December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Guarantee obligations&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,445&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;96,383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(96,716)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;Provision for chargebacks, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;10,582&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;85,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(84,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;Increases in Guarantee Obligations represent the portion of amounts billed in the period that is allocated to the indemnification guarantee. Increases in Provision for chargebacks, net represent the net chargeback expense recognized in the consolidated statements of operations during the period. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:18pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Helvetica',sans-serif;font-size:8pt;font-weight:400;line-height:120%;padding-left:8.24pt"&gt;Decreases in Guarantee Obligations represent the amount released to revenue in the consolidated statements of operations during the period. Decreases in the Provision for chargebacks, net represent the amount of chargeback expenses paid during the period.&lt;/span&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-307" decimals="-3" id="f-1274" unitRef="usd">12361000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-308" decimals="-3" id="f-1275" unitRef="usd">135942000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-308" decimals="-3" id="f-1276" unitRef="usd">135584000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-309" decimals="-3" id="f-1277" unitRef="usd">12719000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-310" decimals="-3" id="f-1278" unitRef="usd">11980000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-311" decimals="-3" id="f-1279" unitRef="usd">121762000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-311" decimals="-3" id="f-1280" unitRef="usd">121650000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-312" decimals="-3" id="f-1281" unitRef="usd">12092000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-313" decimals="-3" id="f-1282" unitRef="usd">12112000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-314" decimals="-3" id="f-1283" unitRef="usd">106587000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-314" decimals="-3" id="f-1284" unitRef="usd">106338000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-307" decimals="-3" id="f-1285" unitRef="usd">12361000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-315" decimals="-3" id="f-1286" unitRef="usd">12020000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-316" decimals="-3" id="f-1287" unitRef="usd">103196000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-316" decimals="-3" id="f-1288" unitRef="usd">103236000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-310" decimals="-3" id="f-1289" unitRef="usd">11980000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-317" decimals="-3" id="f-1290" unitRef="usd">12445000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-318" decimals="-3" id="f-1291" unitRef="usd">96383000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-318" decimals="-3" id="f-1292" unitRef="usd">96716000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-313" decimals="-3" id="f-1293" unitRef="usd">12112000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-319" decimals="-3" id="f-1294" unitRef="usd">10582000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-320" decimals="-3" id="f-1295" unitRef="usd">85451000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesDeductions contextRef="c-320" decimals="-3" id="f-1296" unitRef="usd">84013000</us-gaap:ValuationAllowancesAndReservesDeductions>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-315" decimals="-3" id="f-1297" unitRef="usd">12020000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
